PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Fricke, ST; Vink, R; Chiodo, C; Cernak, I; Ileva, L; Faden, AI				Fricke, ST; Vink, R; Chiodo, C; Cernak, I; Ileva, L; Faden, AI			Consistent and reproducible slice selection in rodent brain using a novel stereotaxic device for MRI	JOURNAL OF NEUROSCIENCE METHODS			English	Article						stereotaxic; rat; mouse; magnetic resonance spectroscopy; CT; neurotrauma; stroke; PET	RAT-BRAIN; HIPPOCAMPUS; INJURY	Typically small animal radiological images are obtained after placing the animal in the center of the imaging device using beds or platforms, and then adjusting the position after obtaining a scout image. Such a process does not permit the reproducible visualization of the same anatomical plane with repeated examinations. We have developed a device that allows stereotaxic placement of an animal in precisely the same position for repeated examinations. The instrument incorporates a full range of physiological monitoring and life support systems including temperature control, anesthesia delivery and respiratory monitoring. Using magnetic resonance imaging (MRI), the accuracy and reliability of this device is demonstrated in a rat traumatic brain injury (TBI) model. (C) 2004 Elsevier B.V. All rights reserved.	Georgetown Univ, Dept Neurosci, Washington, DC 20057 USA; Univ Adelaide, Dept Pathol, Adelaide, SA, Australia; ASI Instruments Inc, Warren, MI USA		Fricke, ST (corresponding author), Georgetown Univ, Dept Neurosci, Res Bldg,Room WB-01,POB 571464, Washington, DC 20057 USA.	stf2@georgetown.edu	Vink, Robert/J-7351-2012; Vink, Robert/S-5616-2019; Cernak, Ibolja/A-6399-2008	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Ibolja, Cernak/0000-0003-3214-698X			Faden AI, 2003, J CEREBR BLOOD F MET, V23, P342, DOI 10.1097/01.WCB.0000046143.31247.FD; KAMIRYO T, 1995, ACTA NEUROCHIR, V133, P87, DOI 10.1007/BF01404955; KARGER CP, 1995, INT J RADIAT ONCOL, V33, P485, DOI 10.1016/0360-3016(95)00066-8; Khubchandani M, 2003, MAGNET RESON MED, V49, P962, DOI 10.1002/mrm.10441; Lahti KM, 1998, J NEUROSCI METH, V82, P75, DOI 10.1016/S0165-0270(98)00037-5; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Ohl F, 1999, J NEUROSCI METH, V88, P189, DOI 10.1016/S0165-0270(99)00028-X; Wolf OT, 2002, BRAIN RES PROTOC, V10, P41	8	24	24	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270			J NEUROSCI METH	J. Neurosci. Methods	JUN 15	2004	136	1					99	102		10.1016/j.jneumeth.2004.01.003			4	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	822VF	WOS:000221567800010	15126050				2022-02-06	
J	Wirz, SA; Morale, MC; Marchetti, B; Barr, AM; Sotgiu, S; Rosati, G; Pugliatti, M; Sanna, MV; Giliberto, O; Bartfai, T; Conti, B				Wirz, SA; Morale, MC; Marchetti, B; Barr, AM; Sotgiu, S; Rosati, G; Pugliatti, M; Sanna, MV; Giliberto, O; Bartfai, T; Conti, B			High frequency of TNF alleles -238A and -376A in individuals from northern Sardinia	CYTOKINE			English	Article						association; malaria; polymorphism; Sardinia; TNF	ALPHA PROMOTER POLYMORPHISM; SEVERE MALARIAL ANEMIA; MULTIPLE-SCLEROSIS; DIABETES-MELLITUS; GENE POLYMORPHISMS; CEREBRAL MALARIA; REGION; SUSCEPTIBILITY; ASSOCIATION; INFECTION	The G to A single nucleotide polymorphisms (SNPs), at position -376, -308 and -238 in the promoter of the tumor necrosis factor alpha (TNF) gene, have been independently correlated with numerous diseases. Alleles TNF-376A and TNF-238A are normally found throughout the world with very low frequencies. We investigated the frequency of these SNPs in Sicilian subjects hospitalized after traumatic brain injury and in three groups of subjects from northern Sardinia: healthy subjects and individuals with multiple sclerosis or ischemic stroke. While no significant difference was found between healthy and disease subjects, the frequency of TNF-376A and TNF-238A was elevated up to 10 times in Sardinia compared to Sicily and other populations throughout the world. These elevated frequencies may be the result of genetic drift or of selective pressure on TNF itself or on neighboring genes, including the HLA. Malaria, endemic to Sardinia until the end of the 1940s, and the bubonic plague, are among the possible causes of selection. These findings indicate that Sardinia is an ideal location to further elucidate the correlation between TNF or HLA polymorphisms and diseases, including multiple sclerosis and type-l diabetes, present with an unusually high frequency and co-morbidity in Sardinia. (C) 2004 Elsevier Ltd. All rights reserved.	Scripps Res Inst, Dept Neuropharmacol, Harold L Dorris Neurol Res Ctr, La Jolla, CA 92037 USA; OASI, Dipartimento Neurofarmacol, IRCCS, I-94018 Troina, EN, Italy; Univ Sassari, Ist Clin Neurol, I-07100 Sassari, Italy; Univ Cagliari, Dipartimento Stor Geog & Artist, I-09124 Cagliari, Italy; Osped Catania, Div Neurochirurg, I-95100 Catania, Italy		Conti, B (corresponding author), Scripps Res Inst, Dept Neuropharmacol, Harold L Dorris Neurol Res Ctr, 10550 N Torrey Pines Rd,SR307, La Jolla, CA 92037 USA.	bconti@scripps.edu	Morale, Maria Concetta/D-5847-2017; Marchetti, Bianca Maria/K-4623-2016; sotgiu, stefano/M-1011-2017	Morale, Maria Concetta/0000-0003-0624-7234; Marchetti, Bianca Maria/0000-0002-9287-8448; Conti, Bruno/0000-0002-9185-5201; Barr, Alasdair/0000-0002-3407-1574			Ackerman H, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r24; Bayley JP, 2001, CYTOKINE, V14, P316, DOI 10.1006/cyto.2001.0902; Braun N, 1996, NEUROSCI LETT, V215, P75, DOI 10.1016/0304-3940(96)12920-7; Brinkman B M, 1995, J Inflamm, V46, P32; Brinkman BMN, 1997, BRIT J RHEUMATOL, V36, P516; Contu L, 1998, TISSUE ANTIGENS, V52, P452, DOI 10.1111/j.1399-0039.1998.tb03072.x; DALFONSO S, 1994, IMMUNOGENETICS, V39, P150; DAlfonso S, 1996, TISSUE ANTIGENS, V47, P551, DOI 10.1111/j.1399-0039.1996.tb02598.x; Fernandes JAM, 2002, AUTOIMMUNITY, V35, P377, DOI 10.1080/0891693021000021549; Fernandez-Arquero M, 1999, NEUROLOGY, V53, P1361, DOI 10.1212/WNL.53.6.1361; Gourley IS, 2002, J INFECT DIS, V186, P1007, DOI 10.1086/342947; GREEN A, 1992, LANCET, V339, P905, DOI 10.1016/0140-6736(92)90938-Y; HAMANN A, 1995, BIOCHEM BIOPH RES CO, V211, P833, DOI 10.1006/bbrc.1995.1887; Hohler T, 1998, CLIN EXP IMMUNOL, V111, P579; Hohler T, 1998, J MED VIROL, V54, P173, DOI 10.1002/(SICI)1096-9071(199803)54:3<173::AID-JMV5>3.0.CO;2-2; Hohlfeld R, 1997, BRAIN, V120, P865, DOI 10.1093/brain/120.5.865; Kaluza W, 2000, J INVEST DERMATOL, V114, P1180, DOI 10.1046/j.1523-1747.2000.00001.x; Knight JC, 2003, NAT GENET, V33, P469, DOI 10.1038/ng1124; Knight JC, 1999, NAT GENET, V22, P145, DOI 10.1038/9649; Kroeger KR, 1996, BIOCHEM MOL BIOL INT, V40, P43; Marrosu MG, 2002, LANCET, V359, P1461, DOI 10.1016/S0140-6736(02)08431-3; McDermott MF, 2001, CELL MOL BIOL, V47, P619; McGuire W, 1999, J INFECT DIS, V179, P287, DOI 10.1086/314533; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; Morse HR, 1999, CYTOKINE, V11, P789, DOI 10.1006/cyto.1999.0491; Pugliatti M, 2002, NEUROLOGY, V58, P277, DOI 10.1212/WNL.58.2.277; Repo H, 2002, SCAND J RHEUMATOL, V31, P355, DOI 10.1080/030097402320817086; SANNA MV, IN PRESS IGIENE MODE; Sashio H, 2002, IMMUNOGENETICS, V53, P1020, DOI 10.1007/s00251-001-0423-7; SINISCALCO M, 1961, NATURE, V190, P1179, DOI 10.1038/1901179a0; Stephens LA, 1999, ENDOCRINOLOGY, V140, P3219, DOI 10.1210/en.140.7.3219; Wahlgren M, 1999, NAT GENET, V22, P120, DOI 10.1038/9621; Wilson A. G., 1992, Human Molecular Genetics, V1, P353, DOI 10.1093/hmg/1.5.353; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195	34	24	28	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-4666	1096-0023		CYTOKINE	Cytokine	MAY 21	2004	26	4					149	154		10.1016/j.cyto.2004.02.006			6	Biochemistry & Molecular Biology; Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Immunology	827KM	WOS:000221898400002	15149631				2022-02-06	
J	Jiang, JY; Liang, YM; Luo, QZ; Zhu, C				Jiang, JY; Liang, YM; Luo, QZ; Zhu, C			Effect of mild hypothermia on brain dialysate lactate after fluid percussion brain injury in rodents	NEUROSURGERY			English	Article						lactate; microdialysate; mild hypothermia; traumatic brain injury	EXCITATORY AMINO-ACIDS; SEVERE HEAD-INJURY; MODERATE HYPOTHERMIA; GLUCOSE-UTILIZATION; ENERGY-METABOLISM; RAT; MICRODIALYSIS; ACCUMULATION; HYPOXIA; RELEASE	OBJECTIVE: To investigate the effects of mild hypothermia on brain microdialysate lactate after fluid percussion traumatic brain injury (TBI) in rats. METHODS: Brain dialysate lactate before and after fluid percussion brain injury (2.1 +/- 0.2 atm) was measured in rats with preinjury mild hypothermia (32degreesC), postinjury mild hypothermia (32degreesC), injury normothermia (37degrees), and the sham control group. Mild hypothermia (32degreesC) was induced by partial immersion in a water bath (0degreesC) under general anesthesia and maintained for 2 hours. RESULTS: In the normothermia TBI group, brain extracellular fluid lactate increased from 0.311 +/- 0.03 to 1.275 +/- 0.08 mmol/L within 30 minutes after TBI (P < 0.01) and remained at a high level (0.546 +/- 0.05 mmol/L) (P < 0.01) at 2 hours after injury. In the postinjury mild hypothermic group, brain extracellular fluid lactate increased from 0.303 +/- 0.03 to 0.875 +/- 0.05 mmol/L at 15 minutes after TBI (P < 0.01) and then gradually decreased to 0.316 +/- 0.04 mmol/L at 2 hours after TBI (P > 0.05). In the preinjury mild hypothermic group, brain extracellular fluid lactate remained at normal levels after injury (P > 0.05). CONCLUSION: The cerebral extracellular fluid lactate level increases significantly after fluid percussion brain injury. Preinjury mild hypothermia completely inhibits the cerebral lactate accumulation, and early postinjury mild hypothermia significantly blunts the increase of cerebral lactate level after fluid percussion injury.	Shanghai Med Univ 2, Dept Neurosurg, Renji Hosp, Shanghai 200001, Peoples R China		Jiang, JY (corresponding author), Shanghai Med Univ 2, Dept Neurosurg, Renji Hosp, Shanghai 200001, Peoples R China.	jiangiyb@online.sh.cn					ANDERSEN BJ, 1992, BRAIN RES, V585, P190, DOI 10.1016/0006-8993(92)91206-T; ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; Chen T, 2000, J NEUROTRAUM, V17, P135, DOI 10.1089/neu.2000.17.135; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Di X, 1996, J NEUROTRAUM, V13, P497, DOI 10.1089/neu.1996.13.497; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; GARDINER M, 1982, J CEREBR BLOOD F MET, V2, P429, DOI 10.1038/jcbfm.1982.49; Goodman JC, 1996, J NEUROTRAUM, V13, P549, DOI 10.1089/neu.1996.13.549; HAGERDAL M, 1979, ACTA ANAESTH SCAND, V23, P89; HAMBERGER A, 1995, NEUROL RES, V17, P97, DOI 10.1080/01616412.1995.11740295; Hayashi N, 1997, NEUROCHEMISTRY, P97; Hayashi N, 2000, BRAIN HYPOTHERMIA: PATHOLOGY, PHARMACOLOGY, AND TREATMENT OF SEVERE BRAIN INJURY, P121; HOVDA DA, 1992, J NEUROTRAUMA S1, V9, P47; INAO S, 1988, J NEUROSURG, V69, P736, DOI 10.3171/jns.1988.69.5.0736; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; Kaibara T, 1999, J NEUROSURG, V90, P339, DOI 10.3171/jns.1999.90.2.0339; KALIMO H, 1981, ACTA NEUROPATHOL, V7, P135; KATAYAMA Y, 1992, BRAIN RES, V584, P329, DOI 10.1016/0006-8993(92)90916-W; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Marion DW, 1996, J NEUROTRAUM, V13, P139, DOI 10.1089/neu.1996.13.139; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; MITANI A, 1991, BRAIN RES, V562, P159, DOI 10.1016/0006-8993(91)91201-B; MITANI A, 1991, NEUROSCIENCE, V42, P661, DOI 10.1016/0306-4522(91)90035-M; Myers R E, 1979, Adv Neurol, V26, P195; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; REHNCRONA S, 1981, J CEREBR BLOOD F MET, V1, P297, DOI 10.1038/jcbfm.1981.34; ROBERTSON CS, J NEUROTRAUMA, V7, P1; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; SIEGEL JH, 1990, ARCH SURG-CHICAGO, V125, P498; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; UNTERBERG AW, 1988, J NEUROSURG, V68, P594, DOI 10.3171/jns.1988.68.4.0594; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487; YANG MS, 1985, J NEUROSURG, V63, P617, DOI 10.3171/jns.1985.63.4.0617	44	24	33	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	MAR	2004	54	3					713	717		10.1227/01.NEU.0000109535.58429.49			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	802FN	WOS:000220149500053	15028148				2022-02-06	
J	Lai, YC; Kochanek, PM; Adelson, PD; Janesko, K; Ruppel, RA; Clark, RSB				Lai, YC; Kochanek, PM; Adelson, PD; Janesko, K; Ruppel, RA; Clark, RSB			Induction of the stress response after inflicted and non-inflicted traumatic brain injury in infants and children	JOURNAL OF NEUROTRAUMA			English	Article						cerebrospinal fluid; child abuse; head injury; heat shock protein; shaken baby syndrome	HEAT-SHOCK-PROTEIN; NITRIC-OXIDE SYNTHASE; IMMATURE RAT MODEL; CEREBROSPINAL-FLUID; MESSENGER-RNA; C-FOS; EXPRESSION; HSP70; GENE; APOPTOSIS	Rapid induction of 72-kD heat shock protein (Hsp70) is a key component of the stress response and is seen after a variety of insults to the brain including experimental hyperthermia, ischemia, seizures, and traumatic brain injury (TBI). Little is known about the endogenous stress response in pediatric patients after brain injury. Accordingly, the concentration of Hsp70 was determined in 61 cerebrospinal fluid (CSF) samples from 20 infants and children after TBI. Peak Hsp70 level were increased in TBI patients vs. controls.(4.60 [1.49-78.99] vs. 2.18 [1.38-4.25] ng/mL, respectively, median (range), p = 0.01) and occurred most often on day 1 after injury. Strikingly, CSF levels of Hsp70 were positively and independently associated with inflicted vs. non-inflicted TBI (7.03 [2.30-27.22] vs. 2.06 [1.06-78.99] ng/mL, respectively, p = 0.05). Endogenous Hsp70 expression was confirmed by Western blot and immunocytochemistry using brain tissue samples removed from patients who underwent decompressive craniotomy for refractory intracranial hypertension or at autopsy. These data suggest that the endogenous stress response, as measured and quantified by the Hsp70 concentration in CSF, occurs in infants and children after TBI. The endogenous stress response is more robust in victims of child abuse, compared with patients with accidental TBI, supporting age-dependence or a difference in either injury frequency, duration, severity, or mechanism in this subgroup of TBI patients. Further studies are needed to determine the role of Hsp70 in both non-inflicted and inflicted TBI in infants and children.	Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; St Vincents Hosp, Dept Pediat, Indianapolis, IN USA		Clark, RSB (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Crit Care Med, Main Tower 6840 3705 5th Ave, Pittsburgh, PA 15213 USA.	clarkrs@ccm.upmc.edu	Adelson, David/W-2083-2019; Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X; Lai, Yi-Chen/0000-0002-9450-5506			ALEXANDER R, 1990, AM J DIS CHILD, V144, P58, DOI 10.1001/archpedi.1990.02150250068033; Amick Jonathan E., 2001, Pediatr Crit Care Med, V2, P260, DOI 10.1097/00130478-200107000-00013; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Avishai-Eliner S, 2001, J NEUROENDOCRINOL, V13, P799, DOI 10.1046/j.1365-2826.2001.00698.x; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Bell MJ, 1999, CRIT CARE MED, V27, P493, DOI 10.1097/00003246-199903000-00023; Berger RP, 2002, J NEUROTRAUM, V19, P1405, DOI 10.1089/089771502320914633; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Bertrand N, 2000, J CEREBR BLOOD F MET, V20, P1056, DOI 10.1097/00004647-200007000-00005; BLAKE MJ, 1991, AM J PHYSIOL, V260, P663; BURDON RH, 1993, MOL ASPECTS MED, V14, P83, DOI 10.1016/0098-2997(93)90020-E; Chen MZ, 1998, J NEUROTRAUM, V15, P171, DOI 10.1089/neu.1998.15.171; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Clark RSB, 2000, J PEDIATR-US, V137, P197, DOI 10.1067/mpd.2000.106903; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; DunnMeynell AA, 1997, BRAIN RES, V761, P25, DOI 10.1016/S0006-8993(97)00210-2; Dutcher SA, 1998, J NEUROTRAUM, V15, P411, DOI 10.1089/neu.1998.15.411; Dutcher SA, 1998, J NEUROTRAUM, V15, P421, DOI 10.1089/neu.1998.15.421; Gilles EE, 1996, PEDIATR NEUROL, V15, P114, DOI 10.1016/0887-8994(96)00153-1; Gilliland MGF, 1998, J FORENSIC SCI, V43, P723; GIULIAN D, 1989, J NEUROSCI, V9, P4416; Guzhova I, 2001, BRAIN RES, V914, P66, DOI 10.1016/S0006-8993(01)02774-3; Hoehn B, 2001, J CEREBR BLOOD F MET, V21, P1303, DOI 10.1097/00004647-200111000-00006; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Lindsberg PJ, 1996, J CEREBR BLOOD F MET, V16, P82, DOI 10.1097/00004647-199601000-00010; Massa SM, 1996, CEREBROVAS BRAIN MET, V8, P95; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Morris ST, 2000, ANIM SCI, V70, P363, DOI 10.1017/S1357729800054825; Panjwani NN, 2002, J IMMUNOL, V168, P2997, DOI 10.4049/jimmunol.168.6.2997; Planas AM, 1997, PROG NEUROBIOL, V51, P607, DOI 10.1016/S0301-0082(97)00004-X; RAGHUPATHI R, 1995, J CEREBR BLOOD F MET, V15, P467, DOI 10.1038/jcbfm.1995.58; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; ROGUE PJ, 1993, FEBS LETT, V334, P351, DOI 10.1016/0014-5793(93)80710-C; Ruppel RA, 2002, NEUROSURG CLIN N AM, V13, P169, DOI 10.1016/S1042-3680(01)00005-5; Ruppel RA, 2001, J PEDIATR-US, V138, P18, DOI 10.1067/mpd.2001.110979; Schwartz M, 2001, TRENDS MOL MED, V7, P252, DOI 10.1016/S1471-4914(01)01993-1; Seidberg NA, 2003, J NEUROCHEM, V84, P514, DOI 10.1046/j.1471-4159.2003.01547.x; SIMON RP, 1991, J NEUROSCI, V11, P881; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Srivastava P, 2002, ANNU REV IMMUNOL, V20, P395, DOI 10.1146/annurev.immunol.20.100301.064801; Truettner J, 1999, J NEUROTRAUM, V16, P471, DOI 10.1089/neu.1999.16.471; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003	49	24	24	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2004	21	3					229	237		10.1089/089771504322972022			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	806CI	WOS:000220411600001	15115598				2022-02-06	
J	Lowther, JL; Mayfield, J				Lowther, JL; Mayfield, J			Memory functioning in children with traumatic brain injuries: a TOMAL validity study	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						memory; pediatric; traumatic brain injury	PEDIATRIC HEAD-INJURY; NEUROPSYCHOLOGICAL SEQUELAE; TEST-PERFORMANCE; ADOLESCENTS; DEFICITS	Traumatic brain injury (TBI) leads the causes of death and disability among children and adolescents. Despite the prevalence of TBI among children, few studies have examined memory in children. The purpose of this study was to compare memory functioning, as measured by the Test of Memory and Learning (TOMAL), of children with and without TBI and with moderate and severe TBI to determine if differences existed. Of the 140 participants, 70 had sustained a head trauma and 70 served as controls. The results indicated that, when the TBI and control group were compared, significant differences were found on all of the TOMAL indexes. With the exception of the verbal delayed recall items, significant differences were demonstrated on all the TOMAL subtests. No differences were identified when moderate and severe groups were compared. These findings further the understanding of memory following pediatric TBI, as well as have implications for interventions with this population. (C) 2002 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	Texas Womans Univ, Denton, TX 76204 USA; Our Childrens House, Dallas, TX USA		Lowther, JL (corresponding author), 1919 Creek Wood Dr, Arlington, TX 76006 USA.						BASSETT SS, 1990, J PEDIATR PSYCHOL, V15, P225, DOI 10.1093/jpepsy/15.2.225; BIJUR PE, 1990, PEDIATRICS, V86, P337; Boyd T. A., 1988, ASSESSMENT ISSUES CH, P177; CLANG A, 1997, STUDENTS ACQUIRED BR; DONDERS J, 1993, BRAIN INJURY, V7, P431, DOI 10.3109/02699059309029686; Farmer JE, 1999, DEV NEUROPSYCHOL, V15, P269, DOI 10.1080/87565649909540749; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; GAIDOLFI E, 1980, ITAL J NEUROL SCI, V1, P65; Golden C. J., 1987, LURIA NEBRASKA NEURO; Golden CJ, 1985, LURIA NEBRASKA NEURO; GROSS R, 1999, ASPECTS PSYCHOL; GULBRANDSEN GB, 1984, J CLIN NEUROPSYCHOL, V6, P257, DOI 10.1080/01688638408401217; Halstead WC, 1947, BRAIN INTELLIGENCE Q; HOLIFIELD JE, 1999, DISS ABSTR INT B, V60, P2343; KAUFMAN AS, 1983, KABC KAUFMAN ASSESSM; Kelly M P, 1996, Appl Neuropsychol, V3, P147, DOI 10.1207/s15324826an0303&4_7; Keppel G., 1991, DESIGN ANAL RES HDB; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; KRAEMER BR, 1997, STUDENTS ACQUIRED BR, P3; Kraus JF, 1987, HEAD INJURY, V2, P1; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1994, J CHILD NEUROL, V9, P81, DOI 10.1177/088307389400900121; LUCAS JA, 1999, CLIN NEUROPSYCHOLOGY, P243; Mayfield JW, 1997, ARCH CLIN NEUROPSYCH, V12, P111, DOI 10.1016/S0887-6177(96)00016-9; MAYFIELD JW, 1998, ANN M NAT AC NEUR WA; *NAT CTR INJ PREV, 2000, EP TRAUM BRAIN INJ U; PERROTT SB, 1991, DEV NEUROPSYCHOL, V7, P69, DOI 10.1080/87565649109540477; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Reitan R, 1985, HALSTEAD REITAN NEUR; Reitan R. M., 1992, NEUROPSYCHOLOGICAL E; Reynolds C. R., 1997, HDB CLIN CHILD NEURO, P296; Reynolds C.R., 1994, TEST MEMORY LEARNING; Reynolds CR, 1996, ARCH CLIN NEUROPSYCH, V11, P29, DOI 10.1016/0887-6177(95)00027-5; RUSSELL EW, 1994, CLIN GUIDE NEUROPSYC, P211; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Sheslow D., 1990, WIDE RANGE ASSESSMEN; Stevens JP., 1996, APPL MULTIVARIATE ST; TEASDALE G, 1974, LANCET, V2, P81; THORNDIKE RL, 1988, STANFORD BINET INTEL; Turkstra LS, 1998, J SPEECH LANG HEAR R, V41, P137, DOI 10.1044/jslhr.4101.137; WASSERMAN JD, 1992, UNPUB CLIN GUIDELINE; Wechsler D., 1949, WECHSLER INTELLIGENC; Wechsler D., 1974, WECHSLER INTELLIGENC; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Willcutt EG, 2001, J ABNORM PSYCHOL, V110, P157, DOI 10.1037//0021-843X.1001.1.157; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78	50	24	26	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JAN	2004	19	1					105	118		10.1016/S0887-6177(02)00222-6			14	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	759MB	WOS:000187740500009	14670383	Bronze			2022-02-06	
J	Strauss, KI; Narayan, RK; Raghupathi, R				Strauss, KI; Narayan, RK; Raghupathi, R			Common patterns of bcl-2 family gene expression in two traumatic brain injury models	NEUROTOXICITY RESEARCH			English	Article						apoptosis; mRNA measurement; cerebral cortex; hippocampus; traumatic brain injury; animal models; gene expression patterns	CONTROLLED CORTICAL IMPACT; APOPTOTIC CELL-DEATH; HUMAN HEAD-INJURY; ALZHEIMERS-DISEASE; GLOBAL-ISCHEMIA; TRANSGENIC MICE; RAT-BRAIN; NEURONAL APOPTOSIS; COGNITIVE DEFICITS; APOLIPOPROTEIN-E	Cell death/survival following traumatic brain injury (TBI) may be a result of alterations in the intracellular ratio of death and survival factors. Bcl-2 family genes mediate both cell survival and the initiation of cell death. Using lysate RNase protection assays, mRNA expression of the anti-cell death genes Bcl-2 and Bcl-X-L, and the pro-cell death gene Bax, was evaluated following experimental brain injuries in adult male Sprague-Dawley rats. Both the lateral fluid-percussion (LFP) and the lateral controlled cortical impact (LCI) models of TBI showed similar patterns of gene expression. Anti-cell death bcl-2 and bcL-X-L mRNAs were attenuated early and tended to remain depressed for at least 3 days after injury in the cortex and hippocampus ipsilateral to injury. Pro-cell death bax mRNA was elevated in these areas, usually following the decrease in anti-cell death genes. These common patterns of gene expression suggest an important role for Bcl-2 genes in cell death and survival in the injured brain. Understanding the regulation of these genes may facilitate the development of new therapeutic strategies for a condition that currently has no proven pharmacologic treatments.	Univ Cincinnati, Coll Med, Dept Neurosurg, Cincinnati, OH 45267 USA; Drexel Univ, MCP Hahnemann Med Coll, Philadelphia, PA 19104 USA		Strauss, KI (corresponding author), Univ Cincinnati, Coll Med, Dept Neurosurg, Cincinnati, OH 45267 USA.	kstrauss@uc.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038654] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS038654, R01 NS038654-03] Funding Source: Medline		ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Beschorner R, 2000, ACTA NEUROPATHOL, V100, P377, DOI 10.1007/s004010000202; Bredesen DE, 1995, ANN NEUROL, V38, P839, DOI 10.1002/ana.410380604; CHEN J, 1995, NEUROREPORT, V6, P394, DOI 10.1097/00001756-199501000-00040; Chen J, 1996, J NEUROCHEM, V67, P64; Chen J, 1997, J CEREBR BLOOD F MET, V17, P2, DOI 10.1097/00004647-199701000-00002; Clark RSB, 1997, J NEUROSCI, V17, P9172; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Conti AC, 1998, J NEUROSCI, V18, P5663; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; DeBilbao F, 1996, NEUROSCIENCE, V71, P1111, DOI 10.1016/0306-4522(95)00505-6; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Gillardon F, 1996, BRAIN RES, V739, P244, DOI 10.1016/S0006-8993(96)00829-3; GILLARDON F, 1995, NEUROSCI LETT, V192, P85, DOI 10.1016/0304-3940(95)11619-8; Gillardon F, 1996, MOL BRAIN RES, V40, P254, DOI 10.1016/0169-328X(96)00059-9; Graham DI, 1999, ACT NEUR S, V73, P89; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hassouna I, 1996, NEUROSCI LETT, V204, P85, DOI 10.1016/0304-3940(96)12323-5; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Honkaniemi J, 1996, MOL BRAIN RES, V42, P79, DOI 10.1016/S0169-328X(96)00121-0; Irving EA, 1996, NEUROSCI LETT, V213, P189; Jellinger KA, 2001, EUR J NEUROL, V8, P707, DOI 10.1046/j.1468-1331.2001.00322.x; Kay AD, 2003, J NEUROTRAUM, V20, P943, DOI 10.1089/089771503770195795; Kaya SS, 1999, BRAIN RES, V818, P23, DOI 10.1016/S0006-8993(98)01204-9; KORSMEYER SJ, 1995, TRENDS GENET, V11, P101, DOI 10.1016/S0168-9525(00)89010-1; KOTAPKA MJ, 1992, ACTA NEUROPATHOL, V83, P530, DOI 10.1007/BF00310031; KRAJEWSKI S, 1995, J NEUROSCI, V15, P6364; Liu B, 2003, ENVIRON HEALTH PERSP, V111, P1065, DOI 10.1289/ehp.6361; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Nakamura M, 1999, J COMP NEUROL, V412, P681, DOI 10.1002/(SICI)1096-9861(19991004)412:4<681::AID-CNE9>3.0.CO;2-F; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; PALKOVITS M, 1973, BRAIN RES, V59, P449, DOI 10.1016/0006-8993(73)90290-4; Paxinos G, 1986, RAT BRAIN STEREOTAXI; PENTLAND B, 1986, AGE AGEING, V15, P193, DOI 10.1093/ageing/15.4.193; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; RAGHUPATHI R, 1995, BRAIN PATHOL, V5, P437, DOI 10.1111/j.1750-3639.1995.tb00622.x; Raghupathi R, 2003, J NEUROTRAUM, V20, P421, DOI 10.1089/089771503765355504; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; RINK A, 1995, AM J PATHOL, V147, P1575; ROSS DT, 1993, J NEUROTRAUM, V10, P151, DOI 10.1089/neu.1993.10.151; Shiozaki T, 2001, J NEUROTRAUM, V18, P665, DOI 10.1089/089771501750357618; Shiraiwa N, 1996, J BIOL CHEM, V271, P13258, DOI 10.1074/jbc.271.22.13258; STRAUSS KI, 1993, MOL BRAIN RES, V20, P229, DOI 10.1016/0169-328X(93)90045-Q; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Wennersten A, 2003, ACTA NEUROPATHOL, V105, P281, DOI 10.1007/s00401-002-0649-y; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; YAKOVLEV AG, 1995, J NEUROTRAUM, V12, P767, DOI 10.1089/neu.1995.12.767; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yin CY, 1997, NATURE, V385, P637, DOI 10.1038/385637a0	58	24	27	0	2	F P GRAHAM PUBLISHING CO	MOUNTAIN HOME	PO BOX 370, MOUNTAIN HOME, TN 37684 USA	1029-8428			NEUROTOX RES	Neurotox. Res.		2004	6	4					333	342		10.1007/BF03033444			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	880OH	WOS:000225798600012	15545017	Green Accepted			2022-02-06	
J	Rooker, S; Jorens, PG; Van Reempts, J; Borgers, M; Verlooy, J				Rooker, S; Jorens, PG; Van Reempts, J; Borgers, M; Verlooy, J			Continuous measurement of intracranial pressure in awake rats after experimental closed head injury	JOURNAL OF NEUROSCIENCE METHODS			English	Article						traumatic brain injury; closed head injury; rats; long-term measurement; intracranial pressure	TRAUMATIC BRAIN INJURY; EXPERIMENTAL-MODEL; AUTOREGULATION	The present study validates a method for continuous measurement of intracranial pressure (ICP) in freely moving rats after experimental induction of impact-acceleration injury. Rats subjected to either mild or moderate trauma were individually placed in a Bas-Ratturn(R) system, equipped with a sensor that synchronously turns the cage in response to the locomotor activity of the animal. In this way correct probe positioning is permanently assured and damage due to coiling is avoided. The evolution of ICP and mean arterial blood pressure (MABP) in injured rats was compared with that of a non-traumatized sham group. Since the animals regained consciousness after surgery, interference of anaesthesia on these sensitive parameters should be minimised. The results showed that immediately after induction of neurotrauma, ICP was significantly higher in traumatized rats (sham: 7.7 +/- 0.5 mmHg; mild trauma: 10.4 +/- 10.7 mmHg; moderate trauma: 14.9 +/- 2.4 mmHg; P < 0.05). Regression analysis showed a stable ICP up to 3 h post-insult for all three conditions. From 4h onwards till the end of the experiment at 10h post-insult, a significant increase in ICP was seen for sham-operated and mildly traumatized rats (16.1 +/- 3.4 and 30.5 +/- 6.9 mmHg, respectively; P < 0.05), but not for moderately traumatized rats (47.3 +/- 11.9 mmHg). The method allows observation of ICP for a critical period up to 3 h. As such the method can be regarded as clinically relevant to study early pathological aspects of intracranial hypertension and to define a therapeutic window for pharmacological intervention after traumatic brain injury (TBI). (C) 2003 Elsevier B.V. All rights reserved.	Univ Antwerp Hosp, UZA, Dept Neurosurg, B-2650 Edegem, Belgium; Univ Antwerp Hosp, Dept Intens Care Med, Edegem, Belgium; Janssen Res Fdn, Dept Life Sci, B-2340 Beerse, Belgium		Rooker, S (corresponding author), Univ Antwerp Hosp, UZA, Dept Neurosurg, Wilrijkstr 10, B-2650 Edegem, Belgium.	servanrooker@belgacom.net	Rooker, Servan/AAD-4316-2020				Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Bullock RM, 2000, J NEUROTRAUM, V17, P449; De Mulder G, 2000, ACT NEUR S, V76, P409; Engelborghs K, 2000, J NEUROTRAUM, V17, P667, DOI 10.1089/089771500415418; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; GUILLAUME J, 1951, MANOMETRIC INTRACRAN, V59, P953; LEE JG, 1994, ANESTH ANALG, V79, P58; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Rooker S, 2002, J NEUROSCI METH, V119, P83, DOI 10.1016/S0165-0270(02)00183-8; Van Reempts J, 2000, NEUROSCI RES COMMUN, V26, P161, DOI 10.1002/1520-6769(200005/06)26:3<161::AID-NRC4>3.0.CO;2-N; VANREEMPTS J, 1994, HISTOL HISTOPATHOL, V9, P185; VANREEMPTS J, 1990, CEREBRAL ISCHEMIA RE, P235	17	24	25	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	DEC 30	2003	131	1-2					75	81		10.1016/S0165-0270(03)00233-4			7	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	759EM	WOS:000187725400009	14659826				2022-02-06	
J	Arciniegas, DB; Harris, SN; Brousseau, KM				Arciniegas, DB; Harris, SN; Brousseau, KM			Psychosis following traumatic brain injury	INTERNATIONAL REVIEW OF PSYCHIATRY			English	Article							HEAD-INJURY; TARDIVE-DYSKINESIA; BIPOLAR DISORDER; SCHIZOPHRENIA; REHABILITATION; HALOPERIDOL; PSYCHOPATHOLOGY; PHENOMENOLOGY; RISPERIDONE; OLANZAPINE	Psychosis is a relatively infrequent but potentially serious and debilitating consequence of traumatic brain injury (TBI), and one about which there is considerable scientific uncertainty and disagreement. There are several substantial clinical, epidemiological, and neurobiological differences between the post-traumatic psychoses and the primary psychotic disorders. The recognition of these differences may facilitate identification and treatment of patients whose psychosis is most appropriately regarded as post-traumatic. In the service of assisting psychiatrists and other mental health clinicians in the diagnosis and treatment of persons with post-traumatic psychoses, this article will review post-traumatic psychosis, including definitions relevant to describing the clinical syndrome, as well as epidemiologic, neurobiological, and neurogenetic factors attendant to it. An approach to evaluation and treatment will then be offered, emphasizing identification of the syndrome of post-traumatic psychosis, consideration of the differential diagnosis of this condition, and careful selection and administration of treatment interventions.	Univ Colorado, Hlth Sci Ctr, Neuropsychiat Serv, Dept Psychiat, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Neurol, Behav Neurol Sect, Denver, CO 80262 USA; Spalding Rehabil Hosp, Brain Injury Rehabil Unit, Aurora, CO USA		Arciniegas, DB (corresponding author), Univ Colorado, Hlth Sci Ctr, Neuropsychiat Serv, Dept Psychiat, Campus Box C268-68,4200 E 9th Ave, Denver, CO 80262 USA.	David.Arciniegas@UCHSC.edu	Arciniegas, David/A-3792-2009				AbdelMalik P, 2003, ARCH GEN PSYCHIAT, V60, P231, DOI 10.1001/archpsyc.60.3.231; ACHTE K, 1991, PSYCHOPATHOLOGY, V24, P309, DOI 10.1159/000284731; ACHTE KA, 1969, ACTA PSYCHIAT SCAND, V45, P1, DOI 10.1111/j.1600-0447.1969.tb06197.x; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Arciniegas David B., 2001, Curr Treat Options Neurol, V3, P347, DOI 10.1007/s11940-001-0039-0; Arciniegas DB, 2001, BRAIN INJURY, V15, P649, DOI 10.1080/02699050010019800; ARCINIEGAS DB, 2000, CURRENT TREATMENT OP, V2, P167; BRACKEN P, 1987, BRIT J PSYCHIAT, V150, P690, DOI 10.1192/bjp.150.5.690; BUCKLEY P, 1993, AM J PSYCHIAT, V150, P146; Burke JG, 1999, J PSYCHIATR NEUROSCI, V24, P456; Callaghan JT, 1997, J CLIN PHARMACOL, V37, P971, DOI 10.1002/j.1552-4604.1997.tb04272.x; Cicerone KD, 1996, BRAIN INJURY, V10, P277, DOI 10.1080/026990596124458; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; CICERONE KD, 1992, NEUROREHABILITATION, V2, P12, DOI DOI 10.3233/NRE-1992-2304; CLARK AF, 1987, BRIT J PSYCHIAT, V150, P841, DOI 10.1192/bjp.150.6.841; CUMMINGS JL, 1985, BRIT J PSYCHIAT, V146, P184, DOI 10.1192/bjp.146.2.184; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; CUMMINGS JL, 1992, NEUROPSY NEUROPSY BE, V5, P144; CUTTING J, 1987, BRIT J PSYCHIAT, V151, P324, DOI 10.1192/bjp.151.3.324; Davison K, 1969, CURRENT PROBLEMS NEU, P113; De Mol J, 1982, Encephale, V8, P17; Edwards-Lee T, 2000, BEHAVIOR AND MOOD DISORDERS IN FOCAL BRAIN LESIONS, P419; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Feinstein A, 1998, J NEUROPSYCH CLIN N, V10, P448, DOI 10.1176/jnp.10.4.448; Flaum M, 2000, DIAGNOSTIC STAT MANU, P297; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; Fujii DE, 2001, J NEUROPSYCH CLIN N, V13, P61, DOI 10.1176/appi.neuropsych.13.1.61; Fujii DEM, 1996, NEUROPSY NEUROPSY BE, V9, P133; GOETHE KE, 1984, PSYCHIAT ANN, V14, P540, DOI 10.3928/0048-5713-19840701-11; GOLDSTEIN LB, 1993, J NEURAL TRANSP PLAS, V4, P175, DOI 10.1155/NP.1993.175; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hillbom E., 1960, ACTA PSYCHIATRICA S, VS142, P1; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LIEBERMAN JA, 1989, J CLIN PSYCHIAT, V50, P329; Lyketsos CG, 1996, PSYCHOSOMATICS, V37, P407, DOI 10.1016/S0033-3182(96)71527-X; Malaspina D, 2001, AM J PSYCHIAT, V158, P440, DOI 10.1176/appi.ajp.158.3.440; McAllister, 1998, Semin Clin Neuropsychiatry, V3, P211; McAllister TW, 2002, NEUROREHABILITATION, V17, P357; MCKENNA PJ, 1985, AM J PSYCHIAT, V142, P895; MICHALS ML, 1993, J CLIN PSYCHOPHARM, V13, P198; NIZAMIE SH, 1988, ACTA PSYCHIAT SCAND, V77, P637, DOI 10.1111/j.1600-0447.1988.tb05181.x; NORQUIST GS, 2000, COMPREHENSIVE TXB PS, V1, P1010; POPE HG, 1988, COMPR PSYCHIAT, V29, P34, DOI 10.1016/0010-440X(88)90035-1; Purdon SE, 2000, ARCH GEN PSYCHIAT, V57, P249, DOI 10.1001/archpsyc.57.3.249; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; RIESS H, 1987, J CLIN PSYCHIAT, V48, P29; ROSEBUSH P, 1989, AM J PSYCHIAT, V146, P717; Ruff RM, 1999, BRAIN INJURY, V13, P943; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Sachdev P, 2001, J NEUROL NEUROSUR PS, V70, P708; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; SANDEL ME, 1993, BRAIN INJURY, V7, P77, DOI 10.3109/02699059309008159; Schreiber S, 1998, INT CLIN PSYCHOPHARM, V13, P273, DOI 10.1097/00004850-199811000-00006; SHAPIRO LB, 1939, ILLINOIS MED J, V76, P250; Silver Jonathan M., 1994, P631; Smeltzer Donald J., 1994, P251; Stanislav SW, 1997, BRAIN INJURY, V11, P335, DOI 10.1080/026990597123494; TEASDALE G, 1974, LANCET, V2, P81; Thompson PM, 2001, P NATL ACAD SCI USA, V98, P11650, DOI 10.1073/pnas.201243998; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Trimble M R, 1991, Adv Neurol, V55, P143; Trzepacz Paula T., 1994, P189; VINCENT FM, 1986, NEUROSURGERY, V18, P190, DOI 10.1227/00006123-198602000-00013; VIOLON A, 1987, ACTA NEUROCHIR, V85, P96, DOI 10.1007/BF01456104; WILCOX JA, 1987, PSYCHIAT RES, V21, P303, DOI 10.1016/0165-1781(87)90013-8; Wilkinson R, 1999, BRAIN INJURY, V13, P1025; WOLF B, 1989, COMPR PSYCHIAT, V30, P534, DOI 10.1016/0010-440X(89)90084-9; YASSA R, 1984, PSYCHOSOMATICS, V25, P852, DOI 10.1016/S0033-3182(84)72946-X; YASSA R, 1984, PSYCHOSOMATICS, V25, P135, DOI 10.1016/S0033-3182(84)73083-0	71	24	26	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0954-0261	1369-1627		INT REV PSYCHIATR	Int. Rev. Psych.	NOV	2003	15	4					328	340		10.1080/09540260310001606719			13	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	739UD	WOS:000186364100005	15276954				2022-02-06	
J	Fukui, S; Fazzina, G; Amorini, AM; Dunbar, JG; Marmarou, A				Fukui, S; Fazzina, G; Amorini, AM; Dunbar, JG; Marmarou, A			Differential effects of atrial natriuretic peptide on the brain water and sodium after experimental cortical contusion in the rat	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						atrial natriuretic peptide; cyclic GMP; intraperitoneal administration; controlled cortical impact; brain edema; brain sodium concentration	ARGININE-VASOPRESSIN; EDEMA FORMATION; BARRIER; INJURY; PERMEABILITY; TRANSPORT; HEART; MECHANISMS; DIFFUSION; ISCHEMIA	Atrial natriuretic peptide (ANP) plays an important role in the regulation of water and sodium in the body via cyclic GMP (cGMP) pathway. Although ANP has been shown to be protective in cerebral ischemia or intracerebral hemorrhage, its role in traumatic brain injury (TBI) has yet to be elucidated. We herein assessed ANP effects on brain water and sodium in TBI. Controlled cortical impact (3 nun depth, 6 m/sec) was used to induce an experimental cortical contusion in rats. Continuous administration of ANP 0.2 (n = 6) or 0.7 mug/kg/24 h (n = 6), cGMP analogue (8-Bromo-cGMP) 0.1 (n = 5) or 0.3 mg/kg/24 h (n = 5), or vehicle (n = 6) was begun 15 minutes after injury, using a mini-osmotic pump implanted into the peritoneal cavity. At 24 hours after injury, ANP significantly exacerbated brain edema in the injured hemisphere in a dose-dependent manner while it reduced brain sodium concentrations in both hemispheres. These ANP effects could be mimicked by a cGMP analogue. In the second series (n = 20), BBB integrity was assessed by evaluating the extravasation of Evans blue dye. ANP or cGMP analogue significantly worsened BBB disruption in the injured hemisphere at 24 hours after injury. These findings suggest that ANP administration exacerbates brain edema after the experimental cortical contusion in rats, possibly because of an increase in the BBB permeability via cGMP pathway, whereas it reduces brain sodium levels.	Virginia Commonwealth Univ, Med Coll Virginia, Div Neurosurg, Richmond, VA 23298 USA		Marmarou, A (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Div Neurosurg, POB 950508, Richmond, VA 23298 USA.			AMORINI, Angela Maria/0000-0003-3525-9955	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS012587, R01NS019235, R56NS019235, P50NS012587] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 19235, NS 12587] Funding Source: Medline		Atkinson JLD, 2000, MAYO CLIN PROC, V75, P37, DOI 10.4065/75.1.37; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Bhasin RR, 2002, ACTA NEUROCHIR SUPPL, V81, P249; Chi OZ, 1999, MICROVASC RES, V58, P35, DOI 10.1006/mvre.1999.2152; Dijkhuizen RM, 1999, J CEREBR BLOOD F MET, V19, P341, DOI 10.1097/00004647-199903000-00012; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Ennis SR, 1996, J NEUROCHEM, V66, P756; ERMISCH A, 1991, BRAIN RES, V554, P209, DOI 10.1016/0006-8993(91)90191-W; GRAMMAS P, 1991, BRAIN RES, V562, P93, DOI 10.1016/0006-8993(91)91191-3; IBARAGI M, 1989, J NEUROCHEM, V53, P1802, DOI 10.1111/j.1471-4159.1989.tb09246.x; Jin XH, 2001, HYPERTENSION, V38, P309, DOI 10.1161/01.HYP.38.3.309; Levin ER, 1998, NEW ENGL J MED, V339, P321; LIGHT DB, 1989, SCIENCE, V243, P383, DOI 10.1126/science.2463673; Loo DDF, 1996, P NATL ACAD SCI USA, V93, P13367, DOI 10.1073/pnas.93.23.13367; Loubinoux I, 1997, STROKE, V28, P419, DOI 10.1161/01.STR.28.2.419; Mitaka C, 2002, CRIT CARE MED, V30, P1570, DOI 10.1097/00003246-200207000-00029; Mizuno O, 2001, AM J CARDIOL, V88, P863, DOI 10.1016/S0002-9149(01)01893-8; NAKAO N, 1990, NEUROSURGERY, V27, P39, DOI 10.1227/00006123-199007000-00005; NARUSE S, 1991, STROKE, V22, P61, DOI 10.1161/01.STR.22.1.61; Neumann-Haefelin T, 2000, STROKE, V31, P1965, DOI 10.1161/01.STR.31.8.1965; Potter LR, 2001, J BIOL CHEM, V276, P6057, DOI 10.1074/jbc.R000033200; PRICHARD BNC, 1991, ACTA CARDIOL, V46, P309; ROSENBERG GA, 1993, NEUROSCI LETT, V160, P117, DOI 10.1016/0304-3940(93)90927-D; ROSENBERG GA, 1992, STROKE, V23, P1767, DOI 10.1161/01.STR.23.12.1767; ROSENBERG GA, 1995, STROKE, V26, P874, DOI 10.1161/01.STR.26.5.874; Sarker MH, 2002, J PHYSIOL-LONDON, V540, P209, DOI 10.1113/jphysiol.2001.012912; Singh S, 2002, CRIT CARE MED, V30, P2575, DOI 10.1097/00003246-200211000-00028; STEARDO L, 1987, SCIENCE, V235, P470, DOI 10.1126/science.2879355; Vajda Z, 2001, NEUROSURGERY, V49, P697, DOI 10.1097/00006123-200109000-00031; VIGNE P, 1992, BIOCHEM BIOPH RES CO, V183, P640, DOI 10.1016/0006-291X(92)90530-X; Walther T, 2002, J HYPERTENS, V20, P785, DOI 10.1097/00004872-200205000-00001; Wilkins MR, 1997, LANCET, V349, P1307, DOI 10.1016/S0140-6736(96)07424-7; Wright EM, 2000, ANN NY ACAD SCI, V915, P54; YANG GY, 1994, STROKE, V25, P1658, DOI 10.1161/01.STR.25.8.1658	34	24	25	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	OCT	2003	23	10					1212	1218		10.1097/01.WCB.0000088762.02615.30			7	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	729DD	WOS:000185755500011	14526231	Bronze			2022-02-06	
J	Heimann, A; Takeshima, T; Alessandri, B; Noppens, R; Kempski, O				Heimann, A; Takeshima, T; Alessandri, B; Noppens, R; Kempski, O			Effects of hypertonic/hyperoncotic treatment after rat cortical vein occlusion	CRITICAL CARE MEDICINE			English	Article						cerebral ischemia; hypertonic solution; hydroxyethyl starch; cerebral blood flow; microcirculation	CEREBRAL-BLOOD-FLOW; SMALL-VOLUME RESUSCITATION; 7.5-PERCENT SODIUM-CHLORIDE; TRAUMATIC BRAIN INJURY; HYPERTONIC SALINE; HEMORRHAGIC-SHOCK; INTRACRANIAL HYPERTENSION; ALBUMIN THERAPY; FOCAL ISCHEMIA; INFARCT VOLUME	Objective: To examine the effects of hypertonic/hyperoncotic treatment on physiologic variables and regional cerebral blood flow and to test its neuroprotective efficiency in a model of permanent venous ischemia. Design: Randomized prospective study. Setting. University research institute. Subjects. Adult male Wistar rats, weighing 359 +/- 54 g (n = 38). Interventions. Rats were subjected to photochemical occlusion of two adjacent cortical veins. A randomized infusion with vehicle (0.9% NaCl), 10% hydroxyethyl starch 200000 (HES), or 7.5% saline plus 10% hydroxyethyl starch 200000 (HHES) was started 30 mins after two-vein occlusion. Effects on physiologic variables and regional cerebral blood flow (assessed by laser Doppler flowmetry) were studied up to 120 mins after two-vein occlusion. Two days after occlusion, the brains were removed for histologic evaluation. Measurements and Main Results. After occlusion, regional cerebral blood flow decreased by 50%, significantly in all groups (from 47.3 +/- 3 to 22.2 +/- 2.2 laser Doppler units). In the vehicle and HES groups, regional cerebral blood flow further decreased to 12.9 +/- 1.9 and 17.8 +/- 2.3 laser Doppler units, respectively. HHES improved regional cerebral blood flow significantly to 27.3 +/- 3.5 laser Doppler units, particularly by reducing no-flow/low-flow areas and reducing infarct size. onclusion: We found that HHES reduced infarct size as a consequence of an improved regional cerebral blood flow and reduced no-flow/low-flow areas in the tissue at risk in the two-vein occlusion model.	Johannes Gutenberg Univ Mainz, Inst Neurosurg Pathophysiol, Mainz, Germany		Heimann, A (corresponding author), Johannes Gutenberg Univ Mainz, Inst Neurosurg Pathophysiol, Mainz, Germany.			Heimann, Axel/0000-0003-2510-3228			Belayev L, 1998, STROKE, V29, P2587, DOI 10.1161/01.STR.29.12.2587; BERGER S, 1995, NEUROSURGERY, V37, P98, DOI 10.1227/00006123-199507000-00015; Bhardwaj A, 2000, STROKE, V31, P1694, DOI 10.1161/01.STR.31.7.1694; BITTERMAN H, 1987, CIRC SHOCK, V21, P271; CHAN R, 1983, INT J MICROCIRC, V2, P297; DEFELIPPE J, 1980, LANCET, V2, P1002; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; Fischer M, 1996, RESUSCITATION, V32, P227, DOI 10.1016/0300-9572(96)00953-7; GUNNAR W, 1988, SURGERY, V103, P398; Hartl R, 1997, J TRAUMA, V42, pS41, DOI 10.1097/00005373-199705001-00008; HARTL R, 1995, SHOCK, V3, P274; Heimann A, 1999, BRAIN RES, V838, P210, DOI 10.1016/S0006-8993(99)01740-0; HEIMANN A, 1994, J CEREBR BLOOD F MET, V14, P1100, DOI 10.1038/jcbfm.1994.144; Hossmann KA, 1997, SHOCK, V8, P95, DOI 10.1097/00024382-199708000-00004; Huh PW, 1998, BRAIN RES, V804, P105, DOI 10.1016/S0006-8993(98)00674-X; Jonas J, 2000, SHOCK, V14, P24, DOI 10.1097/00024382-200014010-00005; Junger WG, 1998, J CLIN INVEST, V101, P2768, DOI 10.1172/JCI1354; KEMPSKI O, 1995, INT J MICROCIRC, V15, P37, DOI 10.1159/000178947; Kempski O, 1996, ACT NEUR S, V66, P114; KREIMEIER U, 1988, BAILLIERE CLIN ANAES, V2, P545, DOI 10.1016/S0950-3501(88)80006-0; KREIMEIER U, 1990, CIRC SHOCK, V32, P83; MANINGAS PA, 1987, CRIT CARE MED, V15, P1121, DOI 10.1097/00003246-198712000-00009; Mazzoni MC, 1995, INT J MICROCIRC, V15, P265, DOI 10.1159/000179028; MAZZONI MC, 1988, AM J PHYSIOL, V255, pH629, DOI 10.1152/ajpheart.1988.255.3.H629; MESSMAR K, 1989, RESUSCITATION, pS51; Nakase H, 1996, J CEREBR BLOOD F MET, V16, P720, DOI 10.1097/00004647-199607000-00024; Nakase H, 1997, J NEUROSURG, V87, P307, DOI 10.3171/jns.1997.87.2.0307; NAKASE H, 1995, NEUROSURGERY BALTIMO, V37, P1; NAKAYAMA S, 1984, CIRC SHOCK, V13, P149; Otsuka H, 2000, EXP NEUROL, V162, P201, DOI 10.1006/exnr.1999.7326; PROUGH DS, 1991, ANESTHESIOLOGY, V75, P319, DOI 10.1097/00000542-199108000-00021; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; RIZOLI SB, 2002, YB INTENSIVE CARE EM, P446; SCHURER L, 1992, EUR SURG RES, V24, P1, DOI 10.1159/000129183; Soehle M, 2001, J NEUROSCI METH, V110, P91, DOI 10.1016/S0165-0270(01)00422-8; Solenski NJ, 2002, STROKE, V33, P816, DOI 10.1161/hs0302.104541; STRECKER U, 1993, INT CONGR SER, V1031, P63; TODA N, 1993, AM J PHYSIOL, V265, pH929, DOI 10.1152/ajpheart.1993.265.3.H929; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; VELASCO IT, 1980, AM J PHYSIOL, V239, pH664, DOI 10.1152/ajpheart.1980.239.5.H664	40	24	25	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	OCT	2003	31	10					2495	2501		10.1097/01.CCM.0000084893.44650.CB			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	733LZ	WOS:000186003100012	14530757				2022-02-06	
J	O'Bryant, SE; Palav, A; McCaffrey, RJ				O'Bryant, SE; Palav, A; McCaffrey, RJ			A review of symptoms commonly associated with menopause: Implications for clinical neuropsychologists and other health care providers	NEUROPSYCHOLOGY REVIEW			English	Article; Proceedings Paper	Annual Convention of the New-York-State-Psychology-Association	2001	ALBANY, NY	NY State Psychol Assoc		base rates; symptoms of menopause; neuropsychology of menopause	PSYCHOLOGICAL SYMPTOMS; ESTROGEN REPLACEMENT; NATURAL MENOPAUSE; WOMENS-HEALTH; COMPLAINTS; TRANSITION; ATTITUDES; THERAPY; SMOKING; AGE	Menopause is a process, either naturally or medically induced, that occurs in nearly all women at some point in life. Some of the most commonly reported symptoms associated with menopause are hot flushes/flashes, fatigue, headaches, irritability, insomnia, and depression. These symptoms overlap with symptoms commonly reported in Traumatic Brain Injury (TBI) as well as postconcussive syndrome. This overlap between symptoms commonly associated with menopause and neuropsychological conditions makes it necessary to have the base rates of these symptoms and conditions available. The purpose of the present review was to consolidate the clinical literature Oil the most Commonly reported menopausal symptoms and to calculate the base rates associated with these symptoms.	SUNY Albany, Dept Psychol, Albany, NY 12222 USA; Brown Med Sch, Mem Hosp Rhode Isl, Pawtucket, RI USA		McCaffrey, RJ (corresponding author), SUNY Albany, Dept Psychol, Social Sci 112, Albany, NY 12222 USA.	RJMCCAFFREY@aol.com		O'Bryant, Sid/0000-0003-0582-5266			ABRAHAM S, 1994, MATURITAS, V20, P121, DOI 10.1016/0378-5122(94)90007-8; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Anarte MT, 1998, MATURITAS, V29, P203, DOI 10.1016/S0378-5122(98)00017-6; AVIS NE, 1991, MATURITAS, V13, P65, DOI 10.1016/0378-5122(91)90286-Y; Coope J, 1996, MATURITAS, V23, P159, DOI 10.1016/0378-5122(95)00971-X; DENNERSTEIN L, 1978, MATURITAS, V1, P55, DOI 10.1016/0378-5122(78)90010-5; DENNERSTEIN L, 1993, MED J AUSTRALIA, V159, P232, DOI 10.5694/j.1326-5377.1993.tb137821.x; Dennerstein L, 1996, MATURITAS, V23, P147, DOI 10.1016/0378-5122(95)00970-1; ELWOOD RW, 1993, CLIN PSYCHOL REV, V13, P409, DOI 10.1016/0272-7358(93)90012-B; FACCHINETTI F, 1987, POSTMENOPAUSAL HORMO, P67; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; GREENE JG, 1976, J PSYCHOSOM RES, V20, P425, DOI 10.1016/0022-3999(76)90005-2; HAGSTAD A, 1986, ACTA OBSTET GYN SCAN, P59; Halbreich U, 1997, NEUROLOGY, V48, pS16, DOI 10.1212/WNL.48.5_Suppl_7.16S; HARTMANN BW, 1995, GYNECOL ENDOCRINOL, V9, P247, DOI 10.3109/09513599509160453; HIGH RV, 1994, SOC BEHAV PERSONAL, V22, P347, DOI 10.2224/sbp.1994.22.4.347; HOLTE A, 1991, MATURITAS, V13, P193, DOI 10.1016/0378-5122(91)90194-U; Holte A, 1998, MATURITAS, V29, P5, DOI 10.1016/S0378-5122(98)00023-1; HUNTER M, 1986, MATURITAS, V8, P217, DOI 10.1016/0378-5122(86)90029-0; INDIRA SN, 1980, IND J CLIN PSYCHOL, V7, P125; JASZMANN L, 1969, Medical Gynaecology and Sociology, V4, P268; JICK H, 1977, LANCET, V1, P1354; Kaufert P, 1998, MENOPAUSE, V5, P197; Kuh DL, 1997, BRIT J OBSTET GYNAEC, V104, P923, DOI 10.1111/j.1471-0528.1997.tb14352.x; Langs G, 2000, J AFFECT DISORDERS, V58, P43, DOI 10.1016/S0165-0327(99)00097-X; LAURITZEN C, 1990, MATURITAS, V12, P199, DOI 10.1016/0378-5122(90)90004-P; MATTHEWS KA, 1990, J CONSULT CLIN PSYCH, V58, P345, DOI 10.1037/0022-006X.58.3.345; MCKINLAY SM, 1992, MATURITAS, V14, P103, DOI 10.1016/0378-5122(92)90003-M; MCMORDIE WR, 1988, CLIN NEUROPSYCHOL, V2, P198; MICHNOVICZ JJ, 1986, NEW ENGL J MED, V315, P1305, DOI 10.1056/NEJM198611203152101; NERI I, 1993, MATURITAS, V17, P31, DOI 10.1016/0378-5122(93)90121-W; NEUGARTEN BL, 1965, PSYCHOSOM MED, V27, P266, DOI 10.1097/00006842-196505000-00009; NEWTON MICHAEL, 1964, SOUTHERN MED J, V57, P1309; NOTMAN MT, 1984, PSYCHIAT ANN, V14, P448, DOI 10.3928/0048-5713-19840601-10; OLDENHAVE A, 1993, AM J OBSTET GYNECOL, V168, P765, DOI 10.1016/S0002-9378(12)90816-9; Perz JM, 1997, WOMEN HEALTH, V25, P53, DOI 10.1300/J013v25n01_04; Porter M, 1996, BRIT J OBSTET GYNAEC, V103, P1025, DOI 10.1111/j.1471-0528.1996.tb09555.x; PUGH MB, 2000, STEDMANS MED DICT; REKERS H, 1992, MATURITAS, V15, P101, DOI 10.1016/0378-5122(92)90244-X; Robinson G, 1996, J NERV MENT DIS, V184, P453, DOI 10.1097/00005053-199608000-00001; RORER LG, 1982, J CONSULT CLIN PSYCH, V50, P419, DOI 10.1037/0022-006X.50.3.419; Seshadri S, 2001, ARCH NEUROL-CHICAGO, V58, P435, DOI 10.1001/archneur.58.3.435; SUKWATANA P, 1991, MATURITAS, V13, P217, DOI 10.1016/0378-5122(91)90196-W; VONMUHLEN DG, 1995, MATURITAS, V22, P71, DOI 10.1016/0378-5122(95)00917-A; *WHO, 1981, RES MEN RES WHO SCI; Wijma K, 1997, J BEHAV THER EXP PSY, V28, P251, DOI 10.1016/S0005-7916(97)00030-X	46	24	24	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1040-7308	1573-6660		NEUROPSYCHOL REV	Neuropsychol. Rev.	SEP	2003	13	3					145	152		10.1023/A:1025573529407			8	Psychology, Clinical; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Conference Proceedings Citation Index - Science (CPCI-S)	Psychology; Neurosciences & Neurology	728BA	WOS:000185694300002	14584909				2022-02-06	
J	Schallert, T; Woodlee, MT				Schallert, T; Woodlee, MT			Brain-dependent movements and cerebral-spinal connections: Key targets of cellular and behavioral enrichment in CNS injury models	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article; Proceedings Paper	Conference on Translational Research in Spinal Cord Injury	APR 03, 2003	MIAMI, FL			exercise; forced-use therapy; motor enrichment; Parkinson's disease; plasticity; neurotrophic factors; spinal cord; stroke; traumatic brain injury	BILATERAL CUTANEOUS STIMULATION; FUNCTIONAL RECOVERY; STRUCTURAL EVENTS; CORTICAL DAMAGE; MESSENGER-RNA; DORSAL COLUMN; LIMB-USE; RATS; MOTOR; CORD	One of the most difficult problems in experimental and clinical neurology is how to facilitate recovery of the ability to walk voluntarily. Local spinal mechanisms, descending input from the brain, and ascending sensory feedback to the brain are required for non-treadmill, self-initiated stepping. In evaluating the integrity of axons connecting the brain and spinal cord in neural injury models, the selection of behavioral tests may be at least as important as the histological procedures, if not more so. A comprehensive and clinically meaningful test battery should include assessments of brain-dependent movement capacity. Behavioral enrichment procedures that prominently encourage self-initiation of stepping have been used to facilitate plasticity and motor function after brain or spinal cord injury. Progressive degeneration characteristic of parkinsonian models can be slowed or halted altogether by forced exercise and limb use. Behavioral interventions may work partly because the animal adopts alternative behavioral strategies to compensate for impaired performance. However, mounting evidence suggests that motor rehabilitation can also promote restoration of function or prevent slow degeneration of tissue by engaging constitutively available mechanisms that protect, repair, rewire, or reactivate cells.	Univ Texas, Inst Neurosci, Dept Psychol, Austin, TX 78712 USA; Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Human Growth & Dev, Ann Arbor, MI 48109 USA		Schallert, T (corresponding author), Univ Texas, Inst Neurosci, Dept Psychol, Seay Bldg, Austin, TX 78712 USA.	Tschall@umich.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 23979-14] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS023979] Funding Source: NIH RePORTER		Aronowski J, 1996, J CEREBR BLOOD F MET, V16, P705, DOI 10.1097/00004647-199607000-00022; BACHYRITA P, 2000, CEREBRAL REORGANIZAT, P357; Barbeau H, 2003, NEUROREHAB NEURAL RE, V17, P3, DOI 10.1177/0888439002250442; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Bittner GD, 2000, NEUROSCIENTIST, V6, P88, DOI 10.1177/107385840000600207; Bunge MB, 2002, PROG BRAIN RES, V137, P275; Cenci MA, 2002, NAT REV NEUROSCI, V3, P574, DOI 10.1038/nrn877; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Cohen AD, 2003, J NEUROCHEM, V85, P299, DOI 10.1046/j.1471-4159.2003.01657.x; Corbett D, 1998, PROG NEUROBIOL, V54, P531, DOI 10.1016/S0301-0082(97)00078-6; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; DeBow SB, 2003, STROKE, V34, P1021, DOI 10.1161/01.STR.0000063374.89732.9F; Diener PS, 1998, J NEUROSCI, V18, P763; DIETRICH WD, 1990, STROKE, V21, P147; Dobkin BH, 1999, NEUROREHAB NEURAL RE, V13, P157, DOI 10.1177/154596839901300301; EDGERTON VR, 2002, INJURY DECREASES BDN; FEENEY DM, 1991, J NEUROL REHABIL, V5, P113; FINGER S, 1982, BRAIN DAMAGE RECOVER, P257; Gladstone DJ, 2002, STROKE, V33, P2123, DOI 10.1161/01.STR.0000025518.34157.51; GOLANI I, 1979, BRAIN RES, V164, P237, DOI 10.1016/0006-8993(79)90019-2; Goldstein LB, 1998, RESTORATIVE NEUROLOGY, P241; GomezPinilla F, 1997, BRAIN RES, V764, P1, DOI 10.1016/S0006-8993(97)00375-2; HAYCOCK JW, 1977, PSYCHOPHARMACOLOGY, V54, P21, DOI 10.1007/BF00426535; HURWITZ BE, 1991, STROKE, V22, P648, DOI 10.1161/01.STR.22.5.648; JONES TA, 1994, J NEUROSCI, V14, P2140; JONES TA, 1992, BEHAV BRAIN RES, V51, P1, DOI 10.1016/S0166-4328(05)80306-7; Karhunen H, 2003, PHARMACOL BIOCHEM BE, V74, P663, DOI 10.1016/S0091-3057(02)01053-5; Keyvani K, 2002, J NEUROPATH EXP NEUR, V61, P831, DOI 10.1093/jnen/61.10.831; Kim D, 2001, NEUROREHAB NEURAL RE, V15, P141, DOI 10.1177/154596830101500207; KLEIM JA, 2003, IN PRESS NEUROCHEM R; KOLB B, 1988, BEHAV BRAIN RES, V28, P259, DOI 10.1016/0166-4328(88)90129-5; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Liu Y, 1999, J NEUROSCI, V19, P4370; MARSHALL JF, 1974, J COMP PHYSIOL PSYCH, V86, P375, DOI 10.1037/h0035941; McKenna JE, 1999, J NEUROSCI, V19, P1885; MOROZ IA, 2002, EFFECTS FORCED LIMB; Muir GD, 1999, BEHAV BRAIN RES, V103, P45, DOI 10.1016/S0166-4328(99)00018-2; Neeper SA, 1996, BRAIN RES, V726, P49, DOI 10.1016/0006-8993(96)00273-9; Nudo RJ, 2001, MUSCLE NERVE, V24, P1000, DOI 10.1002/mus.1104; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Rossignol S, 2000, CURR OPIN NEUROBIOL, V10, P708, DOI 10.1016/S0959-4388(00)00151-3; SCHALLERT T, 1988, ANN NY ACAD SCI, V515, P108, DOI 10.1111/j.1749-6632.1988.tb32972.x; SCHALLERT T, 1984, BEHAV NEUROSCI, V98, P518; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; SCHALLERT T, 1983, PHARMACOL BIOCHEM BE, V18, P753, DOI 10.1016/0091-3057(83)90019-9; SCHALLERT T, 1982, PHARMACOL BIOCHEM BE, V16, P455, DOI 10.1016/0091-3057(82)90452-X; Schallert T, 2000, CONT NEUROS, P131; SCHALLERT T, 1978, SCIENCE, V199, P1461, DOI 10.1126/science.564552; Schallert T, 2000, J CEREBR BLOOD F MET, V20, P1513, DOI 10.1097/00004647-200011000-00001; SCHALLERT T, 1985, DEV PSYCHOBIOL, V18, P501, DOI 10.1002/dev.420180607; SCHALLERT T, 2003, PHYS MED REHAB CLIN, V14, P1; SCHALLERT T, 1998, CEREBROVASC DIS, P611; SCHALLERT T, 1988, ANN NY ACAD SCI, V515, P108; Schallert T, 2002, PHARM CEREBRAL ISCHE; Schallert T., 1992, J NEUROL T PLASTICIT, V3, P332, DOI [10.1155/NP.1992.332, DOI 10.1155/NP.1992.332]; SCHRIMSHER GW, 1993, EXP NEUROL, V120, P264, DOI 10.1006/exnr.1993.1060; Selzer ME, 1999, NEUROREHAB NEURAL RE, V13, P155; SMITH JL, 1980, J NEUROPHYSIOL, V43, P612, DOI 10.1152/jn.1980.43.3.612; Soblosky JS, 2001, BEHAV BRAIN RES, V119, P1, DOI 10.1016/S0166-4328(00)00328-4; Stoltz S, 1999, BEHAV BRAIN RES, V106, P127, DOI 10.1016/S0166-4328(99)00100-X; TAKAYUKI T, 2003, J NEUROSCI, V23, P3432; Teitelbaum P., 1983, HDB BEHAVIORAL NEURO, V6, P23; Tillerson JL, 2002, J NEUROSCI, V22, P6790; Tillerson JL, 2001, J NEUROSCI, V21, P4427, DOI 10.1523/JNEUROSCI.21-12-04427.2001; TILLERSON JL, 2003, IN PRESS NEUROSCIENC; WHISHAW IQ, 1977, ELECTROEN CLIN NEURO, V42, P389, DOI 10.1016/0013-4694(77)90175-4; Witte OW, 1998, CURR OPIN NEUROL, V11, P655, DOI 10.1097/00019052-199812000-00008; Z'Graggen WJ, 1998, J NEUROSCI, V18, P4744	70	24	24	0	4	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.	JUL-AUG	2003	40	4		1			9	17		10.1682/JRRD.2003.08.0009			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation	712ZK	WOS:000184829300003	15077644	Bronze			2022-02-06	
J	Teasdale, TW; Engberg, AW				Teasdale, TW; Engberg, AW			Cognitive dysfunction in young men following head injury in childhood and adolescence: a population study	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							TRAUMATIC BRAIN INJURY; SECULAR TRENDS; CHILDREN; CONCUSSION; ABILITIES	Objectives: To examine the prevalence of cognitive dysfunction among young men who had suffered a head injury during childhood or adolescence, in particular focusing upon the effects of age and the severity of the injury. Methods: By cross linkage of Danish national registers for hospital admissions and the draft board, 3091 young men were identified who had been injured before age 18 and tested at age 18 or shortly thereafter: 970 had suffered a single concussion and were in hospital for one day only; 521 had two concussions at separate times and were in hospital for one day only on each occasion; 961 had a cranial fracture; and 639 had a cerebral lesion. For all of these, scores on the draft board's cognitive screening test were obtained, dichotomised as dysfunctional or non-dysfunctional. Prevalences of dysfunctional scores were compared with population base rates (about 20% of all Danish men appearing before the draft board had a score classified as dysfunctional). Results: For young men who had suffered a single concussion, cranial fracture, or cerebral lesion before 12 years of age, resulting in less than 12 days of hospital admission (n = 376), rates of cognitive dysfunction did not exceed those in the general population (odds ratios < 1.4, NS), but the odds ratios became significant and > 1.4 where the injury occurred after age 11. For those with a cerebral lesion resulting in over 11 days of hospital admission (n = 263), all odds ratios were significant and greater than or equal to 2.0, irrespective of age at injury. For cases of two concussions, all odds ratios were > 1.4 but were not significant for all age groupings. Conclusions: For milder forms of single head injury before age 12 there is no evidence of enduring cognitive dysfunction. The apparent effect at later ages may reflect predisposing psychosocial factors. For more serious injury, and for cases with two concussions, the effect is marked and not clearly related to age. For the former, this suggests enduring neurological effects of the injury; for the latter, where the effect is unrelated to time between injuries, predisposing factors may again play a role.	Univ Copenhagen, Dept Psychol, DK-2300 Copenhagen S, Denmark; Copenhagen Univ Hosp, Div Neurol Rehabil, Hvidovre, Denmark		Teasdale, TW (corresponding author), Univ Copenhagen, Dept Psychol, Njalsgade 88, DK-2300 Copenhagen S, Denmark.	tom.teasdale@psy.ku.dk					Andersen TF, 1999, DAN MED BULL, V46, P263; Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Bijur PE, 1996, J DEV BEHAV PEDIATR, V17, P143, DOI 10.1097/00004703-199606000-00001; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Engberg A, 1998, EUR J EPIDEMIOL, V14, P165, DOI 10.1023/A:1007492025190; Engberg A, 1995, Acta Neurol Scand Suppl, V164, P1; Finger S, 1999, J Hist Neurosci, V8, P269, DOI 10.1076/jhin.8.3.269.1824; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Green A, 1996, DAN MED BULL, V43, P464; GRONWALL D, 1975, LANCET, V2, P995; Halperin JM, 1998, J AM ACAD CHILD PSY, V37, P575, DOI 10.1097/00004583-199806000-00007; HART K, 1988, J CLIN PSYCHOL, V44, P780, DOI 10.1002/1097-4679(198809)44:5<780::AID-JCLP2270440519>3.0.CO;2-1; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; Manly T, 2001, J CHILD PSYCHOL PSYC, V42, P1065, DOI 10.1111/1469-7610.00806; Marschark M, 2000, J HEAD TRAUMA REHAB, V15, P1227, DOI 10.1097/00001199-200012000-00004; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; Middleton JA, 2001, J CHILD PSYCHOL PSYC, V42, P165, DOI 10.1111/1469-7610.00708; MORTENSEN EL, 1989, SCAND J PSYCHOL, V30, P315, DOI 10.1111/j.1467-9450.1989.tb01094.x; Nybo T, 1999, BRAIN INJURY, V13, P759; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; TEASDALE TW, 1994, SCAND J PSYCHOL, V35, P328, DOI 10.1111/j.1467-9450.1994.tb00957.x; Teasdale TW, 2000, INTELLIGENCE, V28, P115, DOI 10.1016/S0160-2896(99)00034-3; Teasdale TW, 1997, BRIT MED J, V315, P569; Teasdale TW, 1997, NEUROPSYCHOL REHABIL, V7, P23, DOI 10.1080/713755521; Webb C, 1996, BRAIN INJURY, V10, P303, DOI 10.1080/026990596124476; WRIGHTSON P, 1995, J NEUROL NEUROSUR PS, V59, P375, DOI 10.1136/jnnp.59.4.375	29	24	27	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JUL	2003	74	7					933	936		10.1136/jnnp.74.7.933			4	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Surgery	690JB	WOS:000183543800024	12810783	Bronze, Green Published			2022-02-06	
J	Toschlog, EA; MacElligot, J; Sagraves, SG; Schenarts, PJ; Bard, MR; Goettler, CE; Rotondo, MF; Swanson, MS				Toschlog, EA; MacElligot, J; Sagraves, SG; Schenarts, PJ; Bard, MR; Goettler, CE; Rotondo, MF; Swanson, MS			The relationship of Injury Severity Score and Glasgow Coma Score to rehabilitative potential in patients suffering traumatic brain injury	AMERICAN SURGEON			English	Article; Proceedings Paper	71st Annual Meeting of the Southeastern Surgical Congress	FEB 09-11, 2003	SAVANNAH, GEORGIA	SE Surg Congress			FUNCTIONAL INDEPENDENCE MEASURE; SEVERE HEAD-INJURY; PREDICTION; DISABILITY; VARIABLES; SYSTEMS; SCALE	The predictive utility of the Injury Severity Score (ISS) and Glasgow Coma Score (GCS) in relation to rehabilitative potential and functional outcome in traumatic brain injury (TBI) is untested. The purpose of this study was to define the relationship of ISS and GCS to rehabilitative potential using the functional independence measure (FIM) score. Trauma and inpatient rehabilitation (IR) registries were queried for demographic, disposition, and injury scoring data. FIM scores at admission (A) and discharge (D) were assessed including IR FIM gain (G). Analysis of variance was used to examine the relationship of ISS and GCS to FIM with predictive utility investigated through bivariate analysis. Of 5488 patients admitted to a Level I trauma center (1999-2000) 1437 suffered TBI with 285 (20%) entering IR. Compared with low-ISS patients the high-ISS patients had significantly lower FIM-A and FIM-D, but FIM-G was static. GCS results were similar, excluding FIM-G which was significantly higher for GCS less than or equal to8 compared with GCS >8. Bivariate analysis revealed no ISS correlation with FIM-G (r = 0.16) and a weak GCS correlation (FIM-G r = -0.15). As prospective predictive measures ISS and GCS correlate weakly with rehabilitative potential in TBI patients. Severely injured patients including those with severe TBI have a rehabilitative gain toward functional independence that is similar to that of when compared with those less severely injured.	E Carolina Univ, Brody Sch Med, Univ Hlth Syst Eastern N Carolina, Ctr Excellence Trauma & Surg Crit Care,Dept Surg, Greenville, NC 27858 USA		Toschlog, EA (corresponding author), E Carolina Univ, Brody Sch Med, Univ Hlth Syst Eastern N Carolina, Ctr Excellence Trauma & Surg Crit Care,Dept Surg, Greenville, NC 27858 USA.						Alvarez M, 1998, CRIT CARE MED, V26, P142, DOI 10.1097/00003246-199801000-00030; Bouillon B, 1997, J TRAUMA, V42, P652, DOI 10.1097/00005373-199704000-00012; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; DISCALA C, 1992, AM J PHYS MED REHAB, V71, P145, DOI 10.1097/00002060-199206000-00004; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P33, DOI 10.1097/00002060-199302000-00008; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; HAMILTON BB, 1986, GUIDE USE UNIFORM DA; HART AC, 2001, INT CLASSIFICATION D; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; PRICE DJE, 1972, INJURY-BR J ACCIDENT, V3, P218, DOI 10.1016/0020-1383(72)90104-0; *RES FDN STAT U NE, 1990, GUID US UN DAT SET M; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wagner AK, 2000, AM J PHYS MED REHAB, V79, P235, DOI 10.1097/00002060-200005000-00004; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; WAXMAN K, 1991, ARCH SURG-CHICAGO, V126, P1237; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P456, DOI 10.1097/00002060-199611000-00011	24	24	25	0	4	SOUTHEASTERN SURGICAL CONGRESS	ATLANTA	141 WEST WIEUCA RD, STE B100, ATLANTA, GA 30342 USA	0003-1348			AM SURGEON	Am. Surg.	JUN	2003	69	6					491	497					7	Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Surgery	693RV	WOS:000183732900012	12852506				2022-02-06	
J	Langeluddecke, PM; Lucas, SK				Langeluddecke, PM; Lucas, SK			Wechsler Adult Intelligence Scale - Third edition findings in relation to severity of brain injury in litigants	CLINICAL NEUROPSYCHOLOGIST			English	Article							WAIS-III; SHORT FORMS; PERFORMANCE; DYSFUNCTION; VALIDITY	WAIS-III findings were reported for 150 litigants, classified into three groups according to severity of traumatic brain injury (TBI), and a general population control group. There was a significant "dose response" relationship between TBI severity and all Index/IQ scores. Effect size was greatest for the Processing Speed Index (PSI). Between group differences were significant on all subtests except Information and Digit Span. Effect sizes were greatest for Digit Symbol, Symbol Search, Similarities, and Picture Arrangement. Relative to the control group, there was a significant difference for the Severe and Extremely Severe TBI groups on all IQ/Index scores and most subtests. The Moderate TBI group differed significantly on one Index (the PSI) and none of the subtests. Clinical implications of the findings are discussed in relation to the utility of the WAIS-III in assessing the cognitive sequelae of TBI, the use of current WAIS-III IQ scores to assess intelligence - memory discrepancies, WAIS-III short forms, and estimation of premorbid intelligence.	Westmead Hosp, Dept Med Psychol, Westmead, NSW 2145, Australia		Langeluddecke, PM (corresponding author), Suite 1003,37 Bligh St, Sydney, NSW, Australia.	langeluddecke@bigpond.com					American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Axelrod BN, 2001, CLIN NEUROPSYCHOL, V15, P516, DOI 10.1076/clin.15.4.516.1884; Axelrod BN, 2002, ASSESSMENT, V9, P17, DOI 10.1177/1073191102009001003; Axelrod BN, 2001, ARCH CLIN NEUROPSYCH, V16, P293, DOI 10.1016/S0887-6177(00)00048-2; Basso MR, 2002, CLIN NEUROPSYCHOL, V16, P57, DOI 10.1076/clin.16.1.57.8329; Cohen J., 2013, STAT POWER ANAL BEHA; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Donders J, 2002, PSYCHOL ASSESSMENT, V14, P360, DOI 10.1037//1040-3590.14.3.360; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; FOX DD, 1994, ARCH CLIN NEUROPSYCH, V9, P211, DOI 10.1016/0887-6177(94)90026-4; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Hawkins KA, 2002, ARCH CLIN NEUROPSYCH, V17, P49, DOI 10.1016/S0887-6177(00)00099-8; Iverson GL, 1998, BRAIN INJURY, V12, P275, DOI 10.1080/026990598122575; Larrabee GJ, 1990, NEUROPSYCHOLOGY, V4, P239, DOI 10.1037/0894-4105.4.4.239; LeesHaley PR, 1996, ARCH CLIN NEUROPSYCH, V11, P45, DOI 10.1016/0887-6177(95)00011-9; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Marosszeky NEV, 1998, PTA PROTOCOL GUIDELI; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; Mittenberg W, 2001, CLIN NEUROPSYCHOL, V15, P440; Nelson H, 1992, NATL ADULT READING T; *PSYCH CORP, 1997, WAIS 3 WMS 3 TECHN M; *PSYCH CORP, 2001, WECHSL TEST AD READ; Psychological Corporation, 1999, WECHSL ABBR SCAL INT; Rey A., 1964, EXAMEN CLIN PSYCHOL; Ringe WK, 2002, ASSESSMENT, V9, P254, DOI 10.1177/1073191102009003004; Ryan JJ, 1998, J PSYCHOEDUC ASSESS, V16, P315, DOI 10.1177/073428299801600403; Sattler J. M., 1999, ASSESSMENT CHILDRE S; Schoenberg MR, 2002, CLIN NEUROPSYCHOL, V16, P426, DOI 10.1076/clin.16.4.426.13913; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; SPSS,, 2001, STAT PACK SOC SCI; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Warrington E, 1984, RECOGNITION MEMORY T, V1; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME	37	24	25	1	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	MAY	2003	17	2					273	284		10.1076/clin.17.2.273.16499			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	734PF	WOS:000186065200017	13680435				2022-02-06	
J	Lu, J; Moochhala, S; Shirhan, M; Ng, KC; Tan, MH; Teo, AL; Ling, EA				Lu, J; Moochhala, S; Shirhan, M; Ng, KC; Tan, MH; Teo, AL; Ling, EA			Nitric oxide induces macrophage apoptosis following traumatic brain injury in rats	NEUROSCIENCE LETTERS			English	Article						lateral fluid percussive brain injury; inducible NO synthase; transferase d-UTP nick-end labeling; caspase-3; aminoguanidine; rat	CLOSED-HEAD INJURY; CNS INJURY; EXPRESSION; PATHWAYS; SYNTHASE	This study examined the apoptotic mechanisms of macrophages following a lateral fluid percussive brain injury. A marked induction of inducible NO synthase (iNOS) immunoexpression was observed in brain macrophages in the subarachnoid space and lateral ventricles ipsilateral to the injury. Numerous apoptotic macrophages occurred in the same region 7 days after the injury as shown by in situ terminal transferase d-UTP nick-end labeling (TUNEL) and caspase-3 immunohistochemistry. Double immunofluorescence staining showed that only a small number of TUNEL positive cells were iNOS positive; many TUNEL positive cells, however, were observed in the vicinity of iNOS positive cells. Administration of aminoguanidine resulted in a marked reduction of apoptotic cells in the lesioned area suggesting that overproduction of NO is linked to diminution of brain macrophages by apoptosis. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.	Def Sci & Technol Agcy, Def Med Res Inst, Singapore 117597, Singapore; Natl Univ Singapore, Fac Med, Dept Anat, Singapore 119260, Singapore		Lu, J (corresponding author), Def Sci & Technol Agcy, Def Med Res Inst, 18 Med Dr,01-06,MD2, Singapore 117597, Singapore.			MOOCHHALA, SHABBIR/0000-0003-4521-3192			Castillo J, 2000, STROKE, V31, P852, DOI 10.1161/01.STR.31.4.852; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; GIULIAN D, 1989, J NEUROSCI, V9, P4416; KAUR C, 1987, J ANAT, V154, P215; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Lu J, 2000, NEUROSCI LETT, V290, P89, DOI 10.1016/S0304-3940(00)01307-0; Lu J, 2001, J NEUROTRAUM, V18, P399, DOI 10.1089/089771501750170976; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Messmer UK, 1998, EUR J PHARMACOL, V349, P333, DOI 10.1016/S0014-2999(98)00189-7; Nicholson DW, 1996, NAT BIOTECHNOL, V14, P297, DOI 10.1038/nbt0396-297; Petrov T, 2000, ACTA NEUROPATHOL, V100, P196, DOI 10.1007/s004019900167; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; XIE QW, 1994, J LEUKOCYTE BIOL, V56, P576, DOI 10.1002/jlb.56.5.576; Yakovlev AG, 2001, MOL NEUROBIOL, V24, P131	16	24	27	0	0	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	MAR 20	2003	339	2					147	150		10.1016/S0304-3940(03)00003-X			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	652ZW	WOS:000181411600015	12614916				2022-02-06	
J	Albrecht, RM; Malik, S; Kingsley, DD; Hart, B				Albrecht, RM; Malik, S; Kingsley, DD; Hart, B			Severity of cervical spine ligamentous injury correlates with mechanism of injury, not with severity of blunt head trauma	AMERICAN SURGEON			English	Article; Proceedings Paper	45th Annual Meeting of the Midwest-Surgical-Association	AUG 11-14, 2002	MACKINAC ISL, MI	Midwest Surg Assoc			DYNAMIC FLUOROSCOPY; ASSOCIATION; RISK	Clearance of the cervical spine (CS) in obtunded trauma patients in an intensive care unit is problematic. Patients with no osseous injuries have potential unstable extradural supportive soft tissue injury. Evaluation of the supporting structures involves dynamic fluoroscopy or MRI both of which have inherent risks and convenience issues. Defining which of these patients are at highest risk for severe supportive structure injury may improve resource utilization for CS clearance. The purpose of this study was to evaluate clinical factors that may predict the probability of CS supportive soft tissue injury in patients with traumatic brain injury. Patients who sustained traumatic brain injury with intracranial. pathology, absence of CS osseous injury, and a limited cervical spine MRI within 72 hours of injury were included. Potential clinical predictors included the severity of the traumatic brain injury defined by the Abbreviated Injury Severity Score for the cerebrum and initial Glasgow Coma Scale, the Injury Severity Score (ISS), mechanism of injury, and high versus low-velocity mechanism. Severity of soft tissue/ligament injury was graded by MRI findings. One hundred twenty-five patients met the study criteria; 81 had negative MRI findings and in 44 the MRI study was positive for potentially unstable injuries. High-velocity mechanisms of injury and ISS-not the severity of the traumatic brain injury or initial Glasgow Coma Scale score-were statistically significant predictors of severe CS supportive soft tissue injuries. Obtunded blunt trauma patients who have been involved in high-velocity-mechanism incidents and have high ISS are at greatest risk for extradural supportive soft tissue CS injuries. These patients should either remain in CS immobilization until clinical evaluation can be completed or undergo further evaluation of their supportive soft tissue structures by MRI or fluoroscopic flexion/extension.	Univ Oklahoma, Dept Surg, Oklahoma City, OK 73104 USA; Univ New Mexico, Dept Surg, Albuquerque, NM 87131 USA; Univ New Mexico, Dept Radiol, Albuquerque, NM 87131 USA		Albrecht, RM (corresponding author), Univ Oklahoma, Dept Surg, 920 Stanton L Young Blvd,WP 2140, Oklahoma City, OK 73104 USA.						Albrecht RM, 2001, WORLD J SURG, V25, P1089, DOI 10.1007/s00268-001-0063-y; [Anonymous], 2002, NEUROSURGERY S, V50, pS30; BAYLESS P, 1989, AM J EMERG MED, V7, P139, DOI 10.1016/0735-6757(89)90125-3; Benzel EC, 1996, J NEUROSURG, V85, P824, DOI 10.3171/jns.1996.85.5.0824; Blackmore CC, 1999, RADIOLOGY, V211, P759, DOI 10.1148/radiology.211.3.r99jn22759; Cox M W., 2001, Curr Surg, V58, P96, DOI 10.1016/S0149-7944(00)00441-4; D'Alise MD, 1999, J NEUROSURG, V91, P54, DOI 10.3171/spi.1999.91.1.0054; DAVIS JW, 1995, J TRAUMA, V39, P435; DAVIS JW, 1993, J TRAUMA, V34, P342, DOI 10.1097/00005373-199303000-00006; Davis JW, 2001, J TRAUMA, V50, P1044, DOI 10.1097/00005373-200106000-00011; HILLS MW, 1993, J TRAUMA, V34, P549, DOI 10.1097/00005373-199304000-00011; Iida H, 1999, J TRAUMA, V46, P450, DOI 10.1097/00005373-199903000-00018; MICHAEL D B, 1989, Journal of Neurotrauma, V6, P177; MIRVIS SE, 1996, RADIOLOGY ACUTE CERV, P114; OMALLEY KF, 1988, J TRAUMA, V28, P1476, DOI 10.1097/00005373-198810000-00013; Pasquale M, 1998, J TRAUMA, V44, P941, DOI 10.1097/00005373-199806000-00001; Patton JH, 2000, AM SURGEON, V66, P326; ROTH BJ, 1994, ARCH SURG-CHICAGO, V129, P643; Sees DW, 1998, J TRAUMA, V45, P768, DOI 10.1097/00005373-199810000-00026; Velmahos GC, 1996, J TRAUMA, V40, P768, DOI 10.1097/00005373-199605000-00015; WILLIAMS J, 1992, ANN EMERG MED, V21, P719, DOI 10.1016/S0196-0644(05)82786-6	21	24	24	0	5	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	MAR	2003	69	3					261	265					5	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	659LG	WOS:000181777700028	12678485				2022-02-06	
J	Finnie, JW; Manavis, J; Summersides, GE; Blumbergs, PC				Finnie, JW; Manavis, J; Summersides, GE; Blumbergs, PC			Brain damage in pigs produced by impact with a non-penetrating captive bolt pistol	AUSTRALIAN VETERINARY JOURNAL			English	Article							AMYLOID PRECURSOR PROTEIN; AXONAL INJURY; LAMBS; MODEL; HEAD	Objective To assess the effect of impact with a nonpenetrating captive bolt pistol in pigs by studying the resulting traumatic brain injury (TBI) and to compare the pathological changes with those found previously in the brains of sheep using a similar experimental paradigm. Procedure The unrestrained heads of six, anaesthetised, 7- to 8-week-old, Large White pigs were impacted in the temporal region with a nonpenetrating captive bolt pistol. Four hours postimpact, brains were perfusion-fixed with 4% paraformaldehyde. Coronal sections from six levels along the brain were cut and stained with haematoxylin and eosin and immunohistochemically for amyloid precursor protein, a sensitive marker of axonal injury (AI) in the brain after trauma. Results TBI in pigs was characterised only by very mild AI, whereas AI in sheep after captive bolt impact to the same head region was much more severe and widely distributed and often associated with vascular damage such as contusions, subarachnoid and intraparenchymal haemorrhage. Conclusions TBI in pigs was much less severe than in sheep after non-penetrating mechanical impact of similar magnitude, confirming the importance of interspecies differences in determining an appropriate physical method of euthanasia.	Univ Adelaide, Vet Serv Div, Adelaide, SA, Australia; Univ Adelaide, Inst Med & Vet Sci, Neuropathol Lab, Adelaide, SA, Australia; Univ Adelaide, Dept Pathol, Adelaide, SA, Australia		Finnie, JW (corresponding author), Univ Adelaide, Vet Serv Div, Adelaide, SA, Australia.						BLACKMORE DK, 1995, NEW ZEAL VET J, V43, P134, DOI 10.1080/00480169.1995.35872; Blumbergs PC, 1997, HEAD INJURY PATHOPHY, P39; DOBBING J, 1981, SCI FDN PAEDIAT, P745; Finnie J, 1999, J CLIN NEUROSCI, V6, P38, DOI 10.1016/S0967-5868(99)90601-X; Finnie JW, 2000, AUST VET J, V78, P775, DOI 10.1111/j.1751-0813.2000.tb10451.x; Finnie JW, 2001, J COMP PATHOL, V124, P159, DOI 10.1053/jcpa.2000.0446; GARHAM DI, 1997, GREENFIELDS NEUROPAT, P197; Getty R., 1975, SISSON GROSSMANS ANA; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Lewis SB, 1996, J NEUROTRAUM, V13, P505, DOI 10.1089/neu.1996.13.505; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; MAY NDS, 1964, ANATOMY SHEEP, P240; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; [No title captured]	16	24	24	0	21	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0005-0423			AUST VET J	Aust. Vet. J.	MAR	2003	81	3					153	155		10.1111/j.1751-0813.2003.tb11078.x			3	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	660NU	WOS:000181839900031	15080429				2022-02-06	
J	Benjamins, JA; Nedelkoska, L; George, EB				Benjamins, JA; Nedelkoska, L; George, EB			Protection of mature oligodendrocytes by inhibitors of caspases and calpains	NEUROCHEMICAL RESEARCH			English	Article						apoptosis; calpains; caspases; kainate; oligodendroglia; staurosporine	CELL-DEATH; MOUSE OLIGODENDROCYTES; DEMYELINATING DISEASES; APOPTOTIC PATHWAYS; MEMBRANE SHEETS; WHITE-MATTER; RAT-BRAIN; ACTIVATION; EXCITOTOXICITY; CALCIUM	Mature mouse oligodendrocytes (OLs) are susceptible to death in demyelinating diseases such as multiple sclerosis and in brain injury following neurotrauma, ischemia, or stroke. To understand mechanisms leading to death of mature OLs and develop strategies for protection, we utilized cultures of mature mouse OLs to investigate the role of caspases and calpains in OL cell death mediated by different mechanisms. The agents used were (i) staurosporine, which induces apoptotic death via inhibition of protein kinases; (ii) kainate, which activates non-NMDA glutamate receptors; (iii) thapsigargin, which releases intracellular calcium stores; and (iv) SNAP, which releases active NO species and causes necrotic cell death. Inhibitors blocking primary effector caspases (including caspase 3), the FAS (death receptor)-mediated initiator caspases (including caspase 8), and stress-induced caspases (including caspase 9), were tested for their protective effects. Inhibition of caspases 3, 8, and 9 each robustly protected OLs following insult with staurosporine, thapsigargin, or kainate when added at optimal times. The time of addition of the inhibitors for maximal protection varied with the agent, from 1 h of preincubation before addition of staurosporine to 6 h after addition of kainate. Much less protection was seen for the NO generator SNAP under any condition. The role of calcium in OL death in each model was investigated by chelating extracellular Ca++ with EGTA, and by inhibiting the Ca++-activated calpain proteases. Calcium chelation did not protect against staurosporine, but decreased OL death initiated by kainate, thapsigargin, or NO. The calpain inhibitors PD150606 and calpain inhibitor I protected from cell death initiated by staurosporine, kainate, and thapsigargin, but not from cell death initiated by the NO donor SNAP.	Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA		Benjamins, JA (corresponding author), Wayne State Univ, Sch Med, Dept Neurol, 421 E Canfield Ave, Detroit, MI 48201 USA.	joyce.benjamins@wayne.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS13143] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS013143] Funding Source: NIH RePORTER		Alberdi E, 2002, NEUROBIOL DIS, V9, P234, DOI 10.1006/nbdi.2001.0457; BENJAMINS JA, 1994, NEUROCHEM RES, V19, P631, DOI 10.1007/BF00971340; Benjamins JA, 1996, NEUROCHEM RES, V21, P471, DOI 10.1007/BF02527712; Bitko V, 2001, J CELL BIOCHEM, V80, P441, DOI 10.1002/1097-4644(20010301)80:3<441::AID-JCB170>3.0.CO;2-C; BOTTENSTEIN JE, 1986, P NATL ACAD SCI USA, V83, P1955, DOI 10.1073/pnas.83.6.1955; Boullerne AI, 2001, J NEUROSCI RES, V63, P124, DOI 10.1002/1097-4547(20010115)63:2<124::AID-JNR1004>3.0.CO;2-C; Bredesen DE, 2000, J NEUROTRAUM, V17, P801, DOI 10.1089/neu.2000.17.801; DYER CA, 1990, J CELL BIOL, V111, P625, DOI 10.1083/jcb.111.2.625; Feng GP, 2002, AM J PHYSIOL-GASTR L, V282, pG825, DOI 10.1152/ajpgi.00467.2001; Fern R, 2000, J NEUROSCI, V20, P34, DOI 10.1523/JNEUROSCI.20-01-00034.2000; Follett PL, 2000, J NEUROSCI, V20, P9235; Fujita E, 2001, CELL DEATH DIFFER, V8, P335, DOI 10.1038/sj.cdd.4400824; Green DR, 1998, CELL, V94, P695, DOI 10.1016/S0092-8674(00)81728-6; Gu CH, 1999, J NEUROSCI, V19, P3043; Itoh T, 2000, GLIA, V31, P165, DOI 10.1002/1098-1136(200008)31:2<165::AID-GLIA80>3.0.CO;2-#; Jamin N, 2001, EXP NEUROL, V172, P17, DOI 10.1006/exnr.2001.7752; Kavanaugh B, 2000, J NEUROSCI RES, V60, P725; Kruman I, 1998, J NEUROSCI RES, V51, P293, DOI 10.1002/(SICI)1097-4547(19980201)51:3<293::AID-JNR3>3.0.CO;2-B; Kruman II, 1999, J NEUROCHEM, V72, P529, DOI 10.1046/j.1471-4159.1999.0720529.x; Liu W, 2001, BRAIN RES, V916, P239, DOI 10.1016/S0006-8993(01)03006-2; Lopez E, 2000, MOL BRAIN RES, V85, P61, DOI 10.1016/S0169-328X(00)00235-7; Matute C, 2001, TRENDS NEUROSCI, V24, P224, DOI 10.1016/S0166-2236(00)01746-X; Matute C, 1997, P NATL ACAD SCI USA, V94, P8830, DOI 10.1073/pnas.94.16.8830; Matute C, 1999, ADV EXP MED BIOL, V468, P97; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McColl KS, 1998, MOL CELL ENDOCRINOL, V139, P229, DOI 10.1016/S0303-7207(98)00051-3; MITROVIC B, 1995, NEUROSCIENCE, V65, P531, DOI 10.1016/0306-4522(94)00491-M; Moore JD, 2002, BRIT J PHARMACOL, V135, P1069, DOI 10.1038/sj.bjp.0704538; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; OKA A, 1993, J NEUROSCI, V13, P1441; Oppenheim RW, 2001, J NEUROSCI, V21, P4752, DOI 10.1523/JNEUROSCI.21-13-04752.2001; Paschen W, 2001, J NEUROCHEM, V79, P719, DOI 10.1046/j.1471-4159.2001.00623.x; Pike BR, 1998, J NEUROSCI RES, V52, P505, DOI 10.1002/(SICI)1097-4547(19980601)52:5<505::AID-JNR3>3.3.CO;2-Y; Rao RV, 2001, J BIOL CHEM, V276, P33869, DOI 10.1074/jbc.M102225200; Sanchez-Gomez MV, 1999, NEUROBIOL DIS, V6, P475, DOI 10.1006/nbdi.1999.0264; Single B, 2001, EXP CELL RES, V262, P8, DOI 10.1006/excr.2000.5059; Stepczynska A, 2001, ONCOGENE, V20, P1193, DOI 10.1038/sj.onc.1204221; Studzinski DM, 2001, J NEUROSCI RES, V66, P691, DOI 10.1002/jnr.10003; Tang DM, 2000, J BIOL CHEM, V275, P9303, DOI 10.1074/jbc.275.13.9303; Tekkok SB, 2001, J NEUROSCI, V21, P4237, DOI 10.1523/JNEUROSCI.21-12-04237.2001; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Viswanath V, 2001, J NEUROSCI, V21, P9519, DOI 10.1523/JNEUROSCI.21-24-09519.2001; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Werner P, 2000, ADV RES NEURODEGENER, V8, P375; Yoshioka A, 2000, J NEUROCHEM, V74, P633, DOI 10.1046/j.1471-4159.2000.740633.x; Yoshioka A, 1998, J NEUROCHEM, V70, P2416; Yoshioka A, 2000, BRAIN RES, V854, P207, DOI 10.1016/S0006-8993(99)02359-8; Yoshioka A, 1996, J NEUROSCI RES, V46, P427; Zimmermann KC, 2001, PHARMACOL THERAPEUT, V92, P57, DOI 10.1016/S0163-7258(01)00159-0	50	24	24	0	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	JAN	2003	28	1					143	152		10.1023/A:1021612615554			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	626GJ	WOS:000179863200015	12587672				2022-02-06	
J	Sarno, S; Erasmus, LP; Lipp, B; Schlaegel, W				Sarno, S; Erasmus, LP; Lipp, B; Schlaegel, W			Multisensory integration after traumatic brain injury: a reaction time study between pairings of vision, touch and audition	BRAIN INJURY			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CLOSED-HEAD-INJURY; SUPERIOR COLLICULUS; POSTERIOR PARIETAL; SPATIAL ATTENTION; CORTEX; HUMANS; RECOGNITION; MECHANISMS; INHIBITION	Traumatic brain injury (TBI) frequently results in deficits in attention and speed of information processing. In order to disentangle the influence of sensory-specific factors and the role of cross-modal integration from the supra-modal aspects of cognitive slowing, the present reaction time (RT) study was designed. Simple and choice RT to pairings of visual, auditory and tactile stimuli were measured in 35 TBI patients and 35 matched controls. Results proved a strong influence of sensory-specific and cross-modal factors in the RTs. The tactile modality was more difficult to integrate with the visual and the auditory modality, rather than the visual and the auditory modalities between them. TBI patients showed prolonged simple and choice RTs throughout all tasks, but their difficulty with integrating the tactile modality was disproportionately higher in comparison to controls.	Therapiezentrum Burgau, D-89331 Burgau, Germany		Sarno, S (corresponding author), Therapiezentrum Burgau, Dr Friedl Str 1, D-89331 Burgau, Germany.						Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Banati RB, 2000, NEUROPSYCHOLOGIA, V38, P115, DOI 10.1016/S0028-3932(99)00074-3; Bertelson P, 2000, PERCEPT PSYCHOPHYS, V62, P321, DOI 10.3758/BF03205552; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; Calvert GA, 1999, NEUROREPORT, V10, P2619, DOI 10.1097/00001756-199908200-00033; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Foxe JJ, 2000, COGNITIVE BRAIN RES, V10, P77, DOI 10.1016/S0926-6410(00)00024-0; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; Gron G, 1996, J CLIN EXP NEUROPSYC, V18, P406, DOI 10.1080/01688639608408997; Hetherington CR, 1996, BRAIN INJURY, V10, P473, DOI 10.1080/026990596124197; Jiang W, 2001, J NEUROPHYSIOL, V85, P506, DOI 10.1152/jn.2001.85.2.506; KAAS JH, 1990, HUMAN NERVOUS SYSTEM, P813; KAWASHIMA R, 1995, P NATL ACAD SCI USA, V92, P5969, DOI 10.1073/pnas.92.13.5969; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; Macaluso E, 2000, J NEUROPHYSIOL, V83, P3062, DOI 10.1152/jn.2000.83.5.3062; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Massaro DW, 1999, TRENDS COGN SCI, V3, P310, DOI 10.1016/S1364-6613(99)01360-1; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; MEREDITH MA, 1986, J NEUROPHYSIOL, V56, P640, DOI 10.1152/jn.1986.56.3.640; Miller E, 1970, Cortex, V6, P121; Muller SV, 2002, ARCH PHYS MED REHAB, V83, P115, DOI 10.1053/apmr.2002.27472; Niemann H, 1996, NEUROPSYCHOL REV, V6, P11, DOI 10.1007/BF01875418; REGAN D, 1983, OPHTHALMOLOGY, V90, P1192; Sarno S, 2000, VISION RES, V40, P3029, DOI 10.1016/S0042-6989(00)00137-1; Segalowitz S J, 1997, J Int Neuropsychol Soc, V3, P95; SHUM DHK, 1990, J CLIN EXP NEUROPSYC, V12, P247, DOI 10.1080/01688639008400971; Spence C, 2000, EXP BRAIN RES, V134, P42, DOI 10.1007/s002210000442; Stein BE, 1996, PROG BRAIN RES, V112, P289; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Tassinari G, 1996, NEUROPSYCHOLOGIA, V34, P235, DOI 10.1016/0028-3932(95)00085-2; URBANTSCHITSCH V, 1880, PFLUGERS ARCH GESAMT, V42; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wallace MT, 1996, J NEUROPHYSIOL, V76, P1246, DOI 10.1152/jn.1996.76.2.1246; Whyte J, 1998, J INT NEUROPSYCH SOC, V4, P127, DOI 10.1017/S1355617798001271; Xing J, 2000, J COGNITIVE NEUROSCI, V12, P601, DOI 10.1162/089892900562363; Zwaagstra R, 1996, J CLIN EXP NEUROPSYC, V18, P383, DOI 10.1080/01688639608408995	40	24	25	0	9	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2003	17	5					413	426		10.1080/0269905031000070161			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	660MQ	WOS:000181837300005	12745713				2022-02-06	
J	Tuzgen, S; Tanriover, N; Uzan, M; Tureci, E; Tanriverdi, T; Gumustas, K; Kuday, C				Tuzgen, S; Tanriover, N; Uzan, M; Tureci, E; Tanriverdi, T; Gumustas, K; Kuday, C			Nitric oxide levels in rat cortex, hippocampus, cerebellum, and brainstem after impact acceleration head injury	NEUROLOGICAL RESEARCH			English	Article						nitric oxide; severe head injury; impact acceleration model	SMOOTH-MUSCLE; L-ARGININE; SYNTHASE EXPRESSION; CEREBRAL-ARTERIES; ISCHEMIA; PATHWAY; PATHOPHYSIOLOGY; NITRATE; MODELS; TRAUMA	Nitric oxide (NO) is a potential mediator of secondary brain injury in the settings of cerebral ischemia and inflammation. Traumatic brain injury (TBI) alters the levels of stable end products of NO metabolism. We investigated these changes and attempted to identify brain regions that were unique with regard to NO production in the period immediately after TBI. The experiment involved assaying nitrite-nitrate concentrations in the rat cortex, cerebellum, hippocampus, and brainstem after impact-acceleration head injury, Five rats comprised the sham-operated (control) group, five sustained mild head injury (MHI), and five sustained severe head injury (SHI). There was a uniform decline in the tissue concentrations of NO metabolites in all four brain regions in both injured groups. There were no significant differences in the concentrations of NO metabolites among the various sites tested in the MHI group; however, there appeared to be a relationship between degree of decline in NO levels and amount of trauma sustained by a given region in the SHI group. In these rats, NO dropped to the lowest levels in the brain region where the direct trauma was most severe. The results suggest that nitrite-nitrate levels in these four brain regions fall below normal in the first 5min after impact trauma. This decrease may, in part, be related to reduced activity of all nitric oxide synthase isoforms, which would cause a drop in the levels of NO metabolites. We believe that this decline may be linked to, and may even cause, the global decrease in cerebral blood flow that occurs in the initial stages of TBI. [Neurol Res 2003; 25: 31-34].	Istanbul Univ, Cerrahpasa Med Fac, Dept Neurosurg, Istanbul, Turkey; Istanbul Univ, Cerrahpasa Med Fac, Dept Anesthesiol, Istanbul, Turkey; Istanbul Univ, Cerrahpasa Med Fac, Dept Biochem, Istanbul, Turkey		Uzan, M (corresponding author), POB 5, TR-34301 Istanbul, Turkey.	uzan@istanbul.edu.tr	Gumustas, Mustafa Koray/AAC-9427-2021; Tanriverdi, Taner/C-9003-2019; Uzan, Mustafa/D-6571-2019; Tuzgen, Saffet/AAD-7881-2021; Tanriover, Necmettin/AAD-3212-2020	Gumustas, Mustafa Koray/0000-0002-0745-0640; Tanriover, Necmettin/0000-0001-7628-9443; Uzan, Mustafa/0000-0001-7214-380X; Tuzgen, Saffet/0000-0002-0490-1506			Albina J E, 1995, New Horiz, V3, P46; BREDT DS, 1992, NEURON, V8, P3, DOI 10.1016/0896-6273(92)90104-L; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; Clark RSB, 1996, CRIT CARE MED, V24, P1243, DOI 10.1097/00003246-199607000-00030; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; FARACI FM, 1994, STROKE, V25, P692, DOI 10.1161/01.STR.25.3.692; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GOODMAN JC, 1995, J NEUROTRAUM, V12, P971; IADECOLA C, 1995, J CEREBR BLOOD F MET, V15, P52, DOI 10.1038/jcbfm.1995.6; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; JACOB TD, 1993, J TRAUMA, V35, P590, DOI 10.1097/00005373-199310000-00015; KAJITA Y, 1994, J NEUROSURG, V80, P476, DOI 10.3171/jns.1994.80.3.0476; Kanwar S, 1995, New Horiz, V3, P93; KIM N, 1993, J CLIN INVEST, V91, P437, DOI 10.1172/JCI116220; Love S, 1999, BRAIN PATHOL, V9, P119; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MISRA M, 1998, CNS ANN M; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; MONCADA S, 1991, PHARMACOL REV, V43, P109; MONCADA S, 1992, ACTA PHYSIOL SCAND, V145, P201, DOI 10.1111/j.1748-1716.1992.tb09359.x; OCHOA JB, 1991, ANN SURG, V214, P621, DOI 10.1097/00000658-199111000-00013; Rao AM, 1998, BRAIN RES, V793, P265, DOI 10.1016/S0006-8993(98)00183-8; RENGASAMY A, 1991, J PHARMACOL EXP THER, V259, P310; Samdani AF, 1997, STROKE, V28, P1283, DOI 10.1161/01.STR.28.6.1283; SKAMOTO KI, 1997, J NEUROTRAUM, V14, P349; SUZUKI S, 1995, J NEUROSURG, V83, P862, DOI 10.3171/jns.1995.83.5.0862; SUZUKI Y, 1993, STROKE, V24, P1049, DOI 10.1161/01.STR.24.7.1049; Tsutsui M, 1996, CIRC RES, V79, P336, DOI 10.1161/01.RES.79.2.336; VISSER JJ, 1994, ANN INTERN MED, V120, P345, DOI 10.7326/0003-4819-120-4-199402150-00023; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; WAHL M, 1993, ACTA NEUROCHIR, P3	34	24	24	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JAN	2003	25	1					31	34		10.1179/016164103101201085			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	637TU	WOS:000180530500006	12564123				2022-02-06	
J	Tator, CH				Tator, CH			Strategies for recovery and regeneration after brain and spinal cord injury	INJURY PREVENTION			English	Article; Proceedings Paper	6th World Conference on Injury Prevention and Control	MAY 12-15, 2002	MONTREAL, CANADA				NEURAL TISSUE-TRANSPLANTATION; COMA DATA-BANK; HEAD-INJURY; STEM-CELLS; NEUROLOGICAL RECOVERY; NEUROTROPHIC FACTOR; APOLIPOPROTEIN-E; METHYLPREDNISOLONE; REPAIR; TRIAL	Current knowledge of the epidemiology and pathophysiology of neurotrauma and the key clinical and experimental strategies for promoting recovery and regeneration after brain and spinal cord trauma are reviewed. Brief overviews of the epidemiology and pathophysiology of neurotrauma are presented, and the key experimental and clinical treatments for the promotion of recovery and regeneration after brain and spinal cord trauma are discussed.	Toronto Western Hosp, Toronto, ON M5T 2S8, Canada; Univ Toronto, Toronto, ON, Canada		Tator, CH (corresponding author), Toronto Western Hosp, Room 4W-433,399 Bathurst St, Toronto, ON M5T 2S8, Canada.	charles.tator@uhn.on.ca					Anthes DL, 1996, NEUROSURGERY, V39, P804, DOI 10.1097/00006123-199610000-00032; *ASS ASI, 1992, STAND NEUR FUNCT CLA; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Bracken MB, 1998, J NEUROSURG, V89, P699, DOI 10.3171/jns.1998.89.5.0699; BREGMAN BS, 1993, EXP NEUROL, V123, P3, DOI 10.1006/exnr.1993.1136; Brunelli GA, 2001, J RECONSTR MICROSURG, V17, P631, DOI 10.1055/s-2001-18873; Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8; Cheng H, 1996, SCIENCE, V273, P510, DOI 10.1126/science.273.5274.510; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clausen T, 2001, CURR PHARM DESIGN, V7, P1517, DOI 10.2174/1381612013397267; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Darlington C, 2000, Curr Opin Investig Drugs, V1, P375; David S, 2002, NEUROSCIENTIST, V8, P33, DOI 10.1177/107385840200800108; Dietz V., 2001, Neural Plasticity, V8, P83, DOI 10.1155/NP.2001.83; Fehlings MG, 1999, J NEUROSURG, V91, P1, DOI 10.3171/spi.1999.91.1.0001; Fehlings MG, 2001, SPINE, V26, pS101, DOI 10.1097/00007632-200112151-00017; GARTON H, 2001, CLIN TRIALS NEUROLOG, P77; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Graham D I, 1993, Acta Neurochir Suppl (Wien), V57, P41; Graham DI, 1999, ACT NEUR S, V73, P89; HANSEBOUT RR, 1982, EARLY MANAGEMENT ACU, P181; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; Hurlbert RJ, 2000, J NEUROSURG, V93, P1, DOI 10.3171/spi.2000.93.1.0001; JENNETT B, 1977, LANCET, V1, P878; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kmietowicz Z, 1999, BRIT MED J, V318, P1441, DOI 10.1136/bmj.318.7196.1441; KOYANAGI I, 1993, NEUROSURGERY, V33, P285, DOI 10.1227/00006123-199308000-00016; Kraus JF, 1993, HEAD INJURY, P1; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Namiki J, 2000, J NEUROTRAUM, V17, P1219, DOI 10.1089/neu.2000.17.1219; Namiki J, 1999, J NEUROPATH EXP NEUR, V58, P489, DOI 10.1097/00005072-199905000-00008; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; *NAT TRAUM REG, 2001, INJ STAT CAN 1998 99; NEEPER SA, 1995, NATURE, V373, P109, DOI 10.1038/373109a0; Penn RD, 1997, NEUROSURGERY, V40, P94, DOI 10.1097/00006123-199701000-00021; Potter PJ, 1998, J NEUROTRAUM, V15, P837, DOI 10.1089/neu.1998.15.837; Povlishock J T, 2000, Clin Neurosurg, V46, P113; Povlishock JT., 1996, NEUROTRAUMA, P1325; REIER PJ, 1992, J NEUROTRAUM, V9, pS223; RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Schwartz M, 1999, NEUROSURGERY, V44, P1041, DOI 10.1097/00006123-199905000-00057; SCHWARTZ ML, 1984, CAN J NEUROL SCI, V11, P434, DOI 10.1017/S0317167100045960; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Stover S. L., 1995, SPINAL CORD INJURY C; TATOR CH, 1995, PARAPLEGIA, V33, P254, DOI 10.1038/sc.1995.58; Tator CH, 1998, NEUROSURGERY, V42, P696, DOI 10.1097/00006123-199804000-00007; TATOR CH, 2001, BLUE BOOK PRACT NEUR, V25, P99; Tator CH., 1996, NEUROSURGERY, V2nd ed, P2847; Tator CH, 1995, CONT MANAGEMENT SPIN, P9; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Vaccaro AR, 1997, SPINE, V22, P2609, DOI 10.1097/00007632-199711150-00006; Vale FL, 1997, J NEUROSURG, V87, P239, DOI 10.3171/jns.1997.87.2.0239; Weiss S, 1996, J NEUROSCI, V16, P7599; Wirth ED, 2001, J NEUROTRAUM, V18, P911, DOI 10.1089/089771501750451839; 2002, NEUROSURGERY, V50, pS1; [No title captured]	65	24	24	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	DEC	2002	8			4			IV33	IV36		10.1136/ip.8.suppl_4.iv33			4	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Conference Proceedings Citation Index - Science (CPCI-S)	Public, Environmental & Occupational Health	656FA	WOS:000181597100010	12460955	Bronze, Green Published			2022-02-06	
J	Kroppenstedt, SN; Sakowitz, OW; Thomale, UW; Unterberg, AW; Stover, JF				Kroppenstedt, SN; Sakowitz, OW; Thomale, UW; Unterberg, AW; Stover, JF			Influence of norepinephrine and dopamine on cortical perfusion, EEG activity, extracellular glutamate, and brain edema in rats after controlled cortical impact injury	JOURNAL OF NEUROTRAUMA			English	Article						blood pressure elevation; catecholamines; cerebral blood flow; microdialysis; secondary brain damage; traumatic brain injury	CEREBRAL BLOOD-FLOW; CEREBROSPINAL-FLUID GLUTAMATE; SENSORIMOTOR CORTEX ABLATION; AMINO-ACID; RELAXING FACTOR; HEAD TRAUMA; RECEPTORS; RECOVERY; NEURONS; RELEASE	Following traumatic brain injury, catecholamines given to ameliorate cerebral perfusion may induce brain damage via cerebral arteriolar constriction and increased neuronal excitation. In the present study the acute effects of norepinephrine and dopamine on pericontusional cortical perfusion (rCBF), electroencephalographic (EEG) activity, extracellular glutamate, and brain edema were investigated in rats following controlled cortical impact injury (CCI). rCBF, cerebral perfusion pressure (CPP), EEG activity, and glutamate were determined before, during, and after infusing norepinephrine or dopamine, increasing MABP to 120 mm Hg for 90 min at 4 h after CCI. Control rats received physiological saline. At 8 h after CCI, hemispheric swelling and water content were determined gravimetrically. Following CCI, rCBF was significantly decreased. In parallel to elevating MABP and CPP, rCBF was significantly increased by norepinephrine and dopamine, being mostly pronounced with norepinephrine (+44% vs. +29%). In controls, rCBF remained diminished (-45%). EEG activity was significantly increased by norepinephrine and dopamine, while pericontusional glutamate was only elevated by norepinephrine (28 +/- 6 vs. 8 +/- 4 muM). Brain edema was not increased compared to control rats. Despite significantly increasing MABP and CPP to the same extent, norepinephrine and dopamine seem to differentially influence pericontusional cortical perfusion and glutamatergic transmission. In addition to the pressure-passive increase in CPP local cerebral effects seem to account for the sustained norepinephrine-induced increase in pericontusional cortical perfusion. The significantly elevated pericontusional glutamate concentrations in conjunction with the increased EEG activity suggest a sustained metabolically driven increase in cortical perfusion during norepinephrine infusion.	Humboldt Univ, Charite, Virchow Med Ctr, Dept Neurosurg, Berlin, Germany		Kroppenstedt, SN (corresponding author), Humboldt Univ, Charite, Virchow Med Ctr, Dept Neurosurg, Berlin, Germany.	skroppen@charite.de		Sakowitz, Oliver/0000-0003-3248-6335			ALTURA BM, 1980, BRIT J PHARMACOL, V69, P543, DOI 10.1111/j.1476-5381.1980.tb07900.x; BASAR E, 1975, BIOL CYBERN, V20, P137, DOI 10.1007/BF00342634; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Beaumont A, 2001, J NEUROTRAUM, V18, P1359, DOI 10.1089/08977150152725650; Berridge CW, 1999, NEUROSCIENCE, V93, P1263, DOI 10.1016/S0306-4522(99)00276-6; Berridge CW, 1996, J NEUROSCI, V16, P7010; BOYESON MG, 1990, PHARMACOL BIOCHEM BE, V35, P497, DOI 10.1016/0091-3057(90)90279-Q; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; Cherian L, 1996, J NEUROTRAUM, V13, P371, DOI 10.1089/neu.1996.13.371; DeWitt D S, 1995, New Horiz, V3, P376; DIRNAGL U, 1994, AM J PHYSIOL, V267, pH296, DOI 10.1152/ajpheart.1994.267.1.H296; Dunn-Meynell AA, 1998, BRAIN RES, V800, P245, DOI 10.1016/S0006-8993(98)00524-1; FEENEY DM, 1990, CAN J PSYCHOL, V44, P233, DOI 10.1037/h0084243; FLINT RS, 1985, BRAIN RES BULL, V15, P197, DOI 10.1016/0361-9230(85)90136-4; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; Giri BK, 2000, STROKE, V31, P961, DOI 10.1161/01.STR.31.4.961; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; HANSSON E, 1992, BRAIN RES BULL, V29, P297, DOI 10.1016/0361-9230(92)90060-B; Huda K, 2001, NEUROSCI LETT, V307, P175, DOI 10.1016/S0304-3940(01)01960-7; IADECOLA C, 1993, BRAIN RES, V606, P148, DOI 10.1016/0006-8993(93)91583-E; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Kikuchi K, 2000, BRAIN RES, V860, P130, DOI 10.1016/S0006-8993(00)02034-5; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Koizumi H, 1997, BRAIN RES, V747, P304, DOI 10.1016/S0006-8993(96)01240-1; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Kroppenstedt SN, 1999, J NEUROSURG, V90, P520, DOI 10.3171/jns.1999.90.3.0520; Kroppenstedt SN, 2000, CRIT CARE MED, V28, P3792, DOI 10.1097/00003246-200012000-00004; LAWTHO D, 1993, EUR J NEUROSCI, V5, P1494, DOI 10.1111/j.1460-9568.1993.tb00217.x; LIU J, 1993, ARCH BIOCHEM BIOPHYS, V302, P118, DOI 10.1006/abbi.1993.1189; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; Myburgh JA, 1998, ACT NEUR S, V71, P19; Nemoto EM, 1996, ANESTH ANALG, V83, P1262, DOI 10.1097/00000539-199612000-00023; Noh JS, 1999, EXP NEUROL, V159, P217, DOI 10.1006/exnr.1999.7144; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; PRASAD MR, 1992, J NEUROTRAUM, V9, P269, DOI 10.1089/neu.1992.9.269; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Sebban C, 1999, BRIT J PHARMACOL, V128, P1045, DOI 10.1038/sj.bjp.0702894; Soehle M, 2001, J NEUROSCI METH, V110, P91, DOI 10.1016/S0165-0270(01)00422-8; Stibick DL, 2001, J NEUROTRAUM, V18, P303, DOI 10.1089/08977150151070955; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; SUTIN J, 1992, BRAIN RES BULL, V29, P277, DOI 10.1016/0361-9230(92)90057-5; SUTTON RL, 1992, RESTOR NEUROL NEUROS, V4, P1, DOI 10.3233/RNN-1992-4101; Talmor D, 1998, ANESTH ANALG, V87, P574, DOI 10.1097/00000539-199809000-00014; Troadec JD, 2001, J NEUROCHEM, V79, P200, DOI 10.1046/j.1471-4159.2001.00556.x; Unterberg AW, 1997, ACT NEUR S, V70, P106; von Essen C, 1972, J Pharm Pharmacol, V24, P668; Yamakura T, 2001, ANNU REV PHARMACOL, V41, P23, DOI 10.1146/annurev.pharmtox.41.1.23	49	24	27	1	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2002	19	11					1421	1432		10.1089/089771502320914651			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	620JD	WOS:000179529500003	12490007				2022-02-06	
J	Hillary, FG; Steffener, J; Biswal, BB; Lange, G; DeLuca, J; Ashburner, J				Hillary, FG; Steffener, J; Biswal, BB; Lange, G; DeLuca, J; Ashburner, J			Functional magnetic resonance imaging technology and traumatic brain injury rehabilitation: Guidelines for methodological and conceptual pitfalls	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						fMRI; methodology; rehabilitation; TBI	EVENT-RELATED FMRI; CEREBRAL-BLOOD-FLOW; WORKING-MEMORY; SUSCEPTIBILITY ARTIFACTS; DETECTING ACTIVATIONS; SPATIAL NORMALIZATION; PREFRONTAL CORTEX; MRI; SIGNAL; OXYGENATION	Objectives: To illuminate the current methodological and conceptual pitfalls inherent in conducting functional magnetic resonance imaging (fMRI) research with individuals who have sustained traumatic brain injury (TBI) and to discuss appropriate remedies. The aim is describe fMRI research, its limitations, and how to best use this technology to examine TBI. Discussion: The topics discussed in this article include issues regarding signal detection, brain activation measurement, head movement, and sources of signal artifact. issues surrounding data interpretation and the importance of analyzing the brain as a connected neural network is also discussed. Finally, problems with spatial normalization when examining individuals with TBI are reviewed. Conclusions: To date, there is a scarcity of research applying fMRI technology to the study of TBI. However, because it is a noninvasive procedure with high availability in hospital settings across the country; the next decade of TBI research will likely include a proliferation of this form of investigation. At this time, much work is needed to better understand how to optimally use this technology to examine the effects of TBI on behavior. For fMRI to enhance TBI research it will be imperative to establish valid research protocols and reliable methods of data interpretation.	Kessler Med Rehabil Res & Educ Corp, Neuropsychol & Neurosci Lab, W Orange, NJ USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA; Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England		Hillary, FG (corresponding author), 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.		Hillary, Frank/AAN-8622-2021; Ashburner, John/I-3757-2013	Ashburner, John/0000-0001-7605-2518			Aguirre GK, 2002, NEUROIMAGE, V15, P488, DOI 10.1006/nimg.2001.0990; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; Barth M, 1999, MAGN RESON IMAGING, V17, P321, DOI 10.1016/S0730-725X(98)00191-X; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Biswal B, 1996, MAGNET RESON MED, V35, P107, DOI 10.1002/mrm.1910350114; Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; Buckner RL, 1998, NEUROIMAGE, V7, P163, DOI 10.1006/nimg.1998.0328; Buckner RL, 1996, P NATL ACAD SCI USA, V93, P14878, DOI 10.1073/pnas.93.25.14878; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Clare S, 1999, MAGNET RESON MED, V42, P1117; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Cordes D, 2000, MAGN RESON IMAGING, V18, P1055, DOI 10.1016/S0730-725X(00)00199-5; D'Esposito M, 1999, PSYCHOL BULL, V125, P155, DOI 10.1037/0033-2909.125.1.155; D 'Esposito M, 2000, SEMIN NEUROL, V20, P487, DOI 10.1055/s-2000-13182; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Deichmann R, 2002, NEUROIMAGE, V15, P120, DOI 10.1006/nimg.2001.0985; Derbyshire SWG, 1997, PAIN, V73, P431, DOI 10.1016/S0304-3959(97)00138-3; Diemling M, 1997, MAGN RESON IMAGING, V15, P753, DOI 10.1016/S0730-725X(97)00030-1; Drevets WC, 2000, PROG BRAIN RES, V126, P413; Dunn JF, 1999, MAGNET RESON MED, V41, P850, DOI 10.1002/(SICI)1522-2594(199904)41:4<850::AID-MRM27>3.0.CO;2-L; EVANS AC, 1994, NATO ADV SCI INST SE, V264, P263; Fox PT, 1995, HUM BRAIN MAPP, V3, P161, DOI 10.1002/hbm.460030302; FRAHM J, 1994, NMR BIOMED, V7, P45, DOI 10.1002/nbm.1940070108; Fredrikson M, 1997, J CLIN PSYCHIAT, V58, P16; Freire L, 2001, NEUROIMAGE, V14, P709, DOI 10.1006/nimg.2001.0869; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; George MS, 1997, J NEUROPSYCH CLIN N, V9, P55; Goldman-Rakic P, 2000, NEUROIMAGE, V11, P451, DOI 10.1006/nimg.2000.0575; Gorno-Tempini ML, 2002, NEUROIMAGE, V15, P136, DOI 10.1006/nimg.2001.0967; HAJNAL JV, 1994, MAGN RESON MED, V31, P289; HEDERA P, 1995, INVEST RADIOL, V30, P625, DOI 10.1097/00004424-199511000-00001; HOROWITZ AL, 1995, MRI PHYSICS RADIOLOG; Ishii K, 2001, J NUCL MED, V42, P548; Jansma JM, 2001, J COGNITIVE NEUROSCI, V13, P730, DOI 10.1162/08989290152541403; Jezzard P, 1999, HUM BRAIN MAPP, V8, P80, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<80::AID-HBM2>3.0.CO;2-C; Jezzard P, 1996, NEUROIMAGE, V4, pS63, DOI 10.1006/nimg.1996.0056; Kraus J. F., 1999, REHABILITATION ADULT, P3; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Krings T, 1999, AM J NEURORADIOL, V20, P1907; LEVIN HS, 1995, J NEUROTRAUM, V12, P913, DOI 10.1089/neu.1995.12.913; Lindauer U, 2001, NEUROIMAGE, V13, P988, DOI 10.1006/nimg.2000.0709; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Manoach DS, 2000, BIOL PSYCHIAT, V48, P99, DOI 10.1016/S0006-3223(00)00227-4; MANOACH DS, 2000, BIOL PSYCHIAT, V15, P48; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McIntosh A. R., 1994, Human Brain Mapping, V2, P2; MCINTOSH AR, 1992, NATO ADV SCI I D-BEH, V68, P219; MINOSHIMA S, 1993, J NUCL MED, V34, P322; National Institutes of Health, 1998, REH PERS TRAUM BRAIN, V16, P1; Nemeroff CB, 1999, AM J PSYCHIAT, V156, P671; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Ojemann JG, 1997, NEUROIMAGE, V6, P156, DOI 10.1006/nimg.1997.0289; PAPANICOLAOU AC, 1998, FUNDAMENTALS FUNCTIO; Parrish TB, 2000, MAGNET RESON MED, V44, P925, DOI 10.1002/1522-2594(200012)44:6<925::AID-MRM14>3.0.CO;2-M; Pollmann S, 2000, HUM BRAIN MAPP, V9, P26, DOI 10.1002/(SICI)1097-0193(2000)9:1<26::AID-HBM3>3.3.CO;2-U; Raichle M. E., 1991, J CEREB BLOOD FLO S2, V11, pS364; Ricker JH, 2001, J HEAD TRAUMA REHAB, V16, P191, DOI 10.1097/00001199-200104000-00007; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rosenthal M, 2000, HDB REHABILITATION P; Rypma B, 1999, P NATL ACAD SCI USA, V96, P6558, DOI 10.1073/pnas.96.11.6558; Seto E, 2001, NEUROIMAGE, V14, P284, DOI 10.1006/nimg.2001.0829; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; Song AW, 1999, MAGN RESON MED, V42, P631, DOI 10.1002/(SICI)1522-2594(199910)42:4<631::AID-MRM3>3.0.CO;2-#; Song AW, 2001, MAGNET RESON MED, V46, P407, DOI 10.1002/mrm.1205; Talairach J., 1988, COPLANAR STEREOTAXIC; Tulving E, 1996, CEREB CORTEX, V6, P71, DOI 10.1093/cercor/6.1.71; TURNER R, 1991, MAGNET RESON MED, V22, P159, DOI 10.1002/mrm.1910220117; WHYTE J, 1998, REHABILITATION MED P, P1191; [No title captured]	75	24	24	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	2002	17	5					411	430		10.1097/00001199-200210000-00004			20	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	610DD	WOS:000178944700004	12802252				2022-02-06	
J	Canedo, A; Grix, MC; Nicoletti, J				Canedo, A; Grix, MC; Nicoletti, J			An analysis of assessment instruments for the minimally responsive patient (MRP): clinical observations	BRAIN INJURY			English	Article							BRAIN-INJURED PATIENTS; COMA; SCALE; REHABILITATION; CONSCIOUSNESS; RECOVERY; STATES	The purpose for presenting these cases is to report on clinical observations that way have relevance for improvement in individuals responding minimally to their environment as a result of a severe traumatic brain injury. Specifically, the authors observe that there is a sub-group of minimally responsive patients who, when given sensory stimulation, show,in increase in responding that is being under-reported with current assessment instruments. Further, subtle changes in responding can occur over a wide temporal gradient and under-reporting of said changes may result in the premature cessation of a beneficial therapeutic intervention. Advantages and disadvantages of the instruments that have been developed to specifically assess responses to sensory stimulation are discussed. The authors' observations suggest that clinical findings do not correlate with assessment scores. These provisory observations indicate that there is a need to develop methodologically sound tools that will accurately monitor individuals throughout the rehabilitative process.	Jamaica Hosp, Brady Inst, Jamaica, NY USA; Pk Terrace Care Ctr, Traumat Brain Injury Programme, Rego Pk, NY USA		Grix, MC (corresponding author), 233 7th St,3rd Floor,Suite 5, Garden City, NY 11530 USA.						ANSELL BJ, 1991, J SPEECH HEAR RES, V34, P1017, DOI 10.1044/jshr.3405.1017; Ansell BJ, 1989, W NEUROSENSORY STIMU; Burke D, 2000, BRAIN INJURY, V14, P463; DAVIS JM, 1995, J MICROCOLUMN SEP, V7, P3, DOI 10.1002/mcs.1220070102; GIACINO J, 1992, JFK COMA RECOVERY SC; Gill-Thwaites H, 1999, NEUROPSYCHOL REHABIL, V9, P305, DOI 10.1080/096020199389392; Hagen C, 1979, REHABILITATION HEAD; HALL M E, 1992, Brain Injury, V6, P435, DOI 10.3109/02699059209008139; Kater K M, 1989, West J Nurs Res, V11, P20, DOI 10.1177/019394598901100103; LEWINN EB, 1978, LANCET, V2, P156; MITCHELL S, 1990, Brain Injury, V4, P273, DOI 10.3109/02699059009026177; ODell MW, 1996, NEUROREHABILITATION, V6, P45, DOI 10.3233/NRE-1996-6106; Rader M.A., 1989, SENSORY STIMULATION; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; Shiel A, 2000, WESSEX HEAD INJURY M; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; Sosnowski C, 1994, J Neurosci Nurs, V26, P336; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 2000, INTENS CARE MED, V26, P153, DOI 10.1007/s001340050037; WILSON GJ, 1993, STRENGTH COND COACH, V1, P3; Wood R L, 1992, Brain Inj, V6, P411, DOI 10.3109/02699059209008137; [No title captured]; [No title captured]	23	24	25	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAY	2002	16	5					453	461		10.1080/02699050110119853			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	553TX	WOS:000175692500007	12097227				2022-02-06	
J	Schulman, J; Sacks, J; Provenzano, G				Schulman, J; Sacks, J; Provenzano, G			State level estimates of the incidence and economic burden of head injuries stemming from non-universal use of bicycle helmets	INJURY PREVENTION			English	Article							TRAUMATIC BRAIN INJURY; SAFETY HELMETS; UNITED-STATES; RETURN; DEATHS; WORK	Objective: To develop national and state level estimates for preventable bicycle related head injuries (BRHIs) and associated direct and indirect health costs from the failure to use bicycle helmets. Methods: Information on the effectiveness and prevalence of use of bicycle helmets was combined to estimate the avoidable fraction, that is, the proportion of BRHIs that could be prevented through the use of bicycle helmets. The avoidable fraction multiplied by the expected number of BRHIs gives an estimate of the number of preventable cases. Direct and indirect health costs are estimated from a social perspective for the number of preventable BRHIs to assess potential cost savings that would be achieved if all riders wore helmets. Results: Approximately 107 000 BRHIs could have been prevented in 1997 in the United States. These preventable injuries and deaths represent an estimated $81 million in direct and $2.3 billion in indirect health costs. Estimates range from 200 preventable BRHIs and $3 million in health costs in Wyoming (population 480 000) to 13 700 preventable BRHIs and $320 million in health costs in California (population 32.3 million). Conclusions: A number of successful approaches to increasing bicycle helmet use exist, including mandatory use laws and community based programs. The limited use of these strategies may be related to the fact that too little information is available to state agencies about the public health and economic burden of these preventable injuries. In conjunction with information on program costs, our estimates,, can assist state planners in better quantifying the number of preventable BRHIs and the costs and benefits of helmet promotion programs.	Ctr Publ Hlth Res & Evaluat, Battelle Mem Inst, Atlanta, GA 30341 USA; Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Uniintent Injury Prevent, Atlanta, GA USA		Schulman, J (corresponding author), Ctr Publ Hlth Res & Evaluat, Battelle Mem Inst, 2971 Flowers Rd,Suite 233, Atlanta, GA 30341 USA.						[Anonymous], 1995, MMWR Recomm Rep, V44, P1; Bolen JR, 1998, ARCH FAM MED, V7, P72, DOI 10.1001/archfami.7.1.72; Committee on Injury Scaling, 1990, ABBR INJ SCAL 1990 R; *CONS PROD SAF COM, 1994, NAT EL INJ SURV SYST; Consumer Products Safety Commission, 1998, CONSUMER PRODUCT SAF, V3, P4; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; GINSBERG GM, 1994, AM J PUBLIC HEALTH, V84, P653, DOI 10.2105/AJPH.84.4.653; GOLD MR, 1996, COST EFFECTIVENESS G; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; *HEALTHC COST UT P, 1994, HCUP 3 NAT INP SAMPL; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P681, DOI 10.1016/0003-9993(93)90024-5; Kopjar B, 2000, PREV MED, V30, P401, DOI 10.1006/pmed.2000.0645; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; MACKENZIE EJ, 1988, JAMA-J AM MED ASSOC, V260, P3290, DOI 10.1001/jama.260.22.3290; MACKENZIE EJ, 1987, AM J PUBLIC HEALTH, V77, P329, DOI 10.2105/AJPH.77.3.329; MCDERMOTT FT, 1993, J TRAUMA, V34, P834, DOI 10.1097/00005373-199306000-00015; MILLER TR, 1995, DATABOOK NONFATAL IN; *NAT CTR HLTH STAT, 1993, VIT STAT MORT DAT MU; PROVENZANO G, 1997, LIT REV COSTS BICYCL; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RIVARA FP, 1996, JAMA-J AM MED ASSOC, V267, P1968; Sacks J J, 1996, Inj Prev, V2, P258, DOI 10.1136/ip.2.4.258; SACKS JJ, 1991, JAMA-J AM MED ASSOC, V266, P3016, DOI 10.1001/jama.266.21.3016; SCHULMAN J, 1998, PREVENTABLE INJURIES; Sosin DM, 1996, PEDIATRICS, V98, P868; THOMPSON DC, 1990, AM J PUBLIC HEALTH, V80, P1471, DOI 10.2105/AJPH.80.12.1471; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28; WINTERBOTTOM C, 1995, STATE LEVEL DATABOOK; WOLTERS C, 1997, LIT REV EFFECTIVENES; 1994, FED REG         0624, V59	32	24	24	0	4	B M J PUBLISHING INC	SAN FRANCISCO	221 MAIN ST, PO BOX 7690, SAN FRANCISCO, CA 94120-7690 USA	1353-8047			INJ PREV	Inj. Prev.	MAR	2002	8	1					47	52		10.1136/ip.8.1.47			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	654LE	WOS:000181497700011	11928974	Green Published, Bronze			2022-02-06	
J	Uzan, M; Tanriover, N; Bozkus, H; Gumustas, K; Guzel, O; Kuday, C				Uzan, M; Tanriover, N; Bozkus, H; Gumustas, K; Guzel, O; Kuday, C			Nitric oxide (NO) metabolism in the cerebrospinal fluid of patients with severe head injury - Inflammation as a possible cause of elevated NO metabolites	SURGICAL NEUROLOGY			English	Article						inflammation; interleukin; nitric oxide; severe head injury	TRAUMATIC BRAIN INJURY; CEREBRAL BLOOD-FLOW; ENDOTHELIAL-CELLS; SMOOTH-MUSCLE; L-ARGININE; SUBARACHNOID HEMORRHAGE; NITRATE CONCENTRATIONS; SYNTHASE EXPRESSION; INTERLEUKIN-8 GENE; CYTOKINES	BACKGROUND This article investigates nitric oxide (NO) metabolism following severe head injury (SHI). We wished to clarify the alterations of NO metabolism end products that is associated with SHI, and to delineate the role of inflammation in this process. METHODS In a prospective study, we simultaneously measured the concentrations of NO metabolites and interleukin-8 (IL-8) in the ventricular cerebrospinal fluid (CSF of 11 patients who had suffered SHI. The CSF concentrations of nitrite (NO2-) and nitrate (NO3-) combined, and of IL-8 were measured during the following four time periods post-trauma: 6 to 10, 20 to 28, 40 to 56, and 64 to 74 hours. Levels were measured using the corresponding kits. RESULTS Compared to the ventricular CSF control values, all of our SHI patients had significantly elevated CSF levels of NO2- plus NO3- (NO2- + NO3-) and IL-8 during all periods tested. CSF NO2- + NO3- and IL-8 concentrations reached their maximums simultaneously at 20 to 28 hours following trauma (Spearman's rank correlation = 0.609, p < 0.05), and NO2- + NO3- levels were significantly higher wthan those measured at 6 to 10, 40 to 56, and 64 to 74 hours. [Nitrite-nitrate concentrations: 6-10 hours: 19.22 +/- 6.75, 20-28 hours: 25 +/- 6.2 mumol/l, 40-56 hours: 19.82 +/- 4.47, and 64-74 hours: 19.72 +/- 4.61 mumol/l, (p < 0.05). IL-8 concentrations: 6-10 hours: 3,232 +/- 2,976.2, 20-28 hours: 3,458.45 +/- 3,048 pg/mL, 40-56 hours: 2,616.41 +/- 2,539.21, 64-74 hours: 1,388.88 +/- 1,216.7 pg/ mL, (p < 0.001).]. This simultaneous surge in NO2- + NO3- and IL-8 in the initial 24 hours post-traumatic indicated that inflammation secondary to SHI increased the rate of NO metabolism, resulting in higher levels of metabolites in the CSF CONCLUSION In patients with SHI, CSF concentrations of the dominant metabolites of NO are elevated in the first 3 days after trauma. A similar concurrent spike in the CSF level of IL-8, a marker of acute inflammatory response, can also be demonstrated, These data indicate that the predominant cause of the higher CSF NO2- + NO3- concentrations observed in SHI is most likely inflammation. (C) 2001 by Elsevier Science Inc.	Istanbul Univ, Cerrahpasa Med Fac, Dept Neurosurg, Istanbul, Turkey; Istanbul Univ, Cerrahpasa Med Fac, Dept Biochem, Istanbul, Turkey; Amer Hosp, Dept Neurosurg, Vehbi Koc Fdn, Istanbul, Turkey; Bruni Biochem Lab, Istanbul, Turkey		Uzan, M (corresponding author), POB 5,Cerrahpasa, TR-34301 Istanbul, Turkey.		Uzan, Mustafa/D-6571-2019; Gumustas, Mustafa Koray/AAC-9427-2021; Tanriover, Necmettin/AAD-3212-2020	Gumustas, Mustafa Koray/0000-0002-0745-0640; Tanriover, Necmettin/0000-0001-7628-9443; Uzan, Mustafa/0000-0001-7214-380X			Albina J E, 1995, New Horiz, V3, P46; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; Bednar MM, 1999, STROKE, V30, P887, DOI 10.1161/01.STR.30.4.887; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; BREDT DS, 1992, NEURON, V8, P3, DOI 10.1016/0896-6273(92)90104-L; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; Clark RSB, 1996, CRIT CARE MED, V24, P1243, DOI 10.1097/00003246-199607000-00030; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; FARACI FM, 1994, STROKE, V25, P692, DOI 10.1161/01.STR.25.3.692; Feuerstein GZ, 1998, NEUROIMMUNOMODULAT, V5, P143, DOI 10.1159/000026331; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GHAJAR JB, 1996, AANS ANN M POST; GOODMAN JC, 1995, J NEUROTRAUM, V12, P971; Groeneveld PHP, 1997, CYTOKINE, V9, P138, DOI 10.1006/cyto.1996.0147; Horner H. C., 1992, Society for Neuroscience Abstracts, V18, P173; IADECOLA C, 1995, J CEREBR BLOOD F MET, V15, P378, DOI 10.1038/jcbfm.1995.47; Iwata S, 1999, NEUROSURGERY, V45, P24, DOI 10.1097/00006123-199907000-00006; JACOB TD, 1993, J TRAUMA, V35, P590, DOI 10.1097/00005373-199310000-00015; KAJITA Y, 1994, J NEUROSURG, V80, P476, DOI 10.3171/jns.1994.80.3.0476; Kanwar S, 1995, New Horiz, V3, P93; KOMAKI G, 1992, AM J PHYSIOL, V262, pE246, DOI 10.1152/ajpendo.1992.262.2.E246; KOSSMANN MC, 1999, J CEREB BLOOD FLOW M, V17, P280; Love S, 1999, BRAIN PATHOL, V9, P119; MCCALL TB, 1991, EUR J IMMUNOL, V21, P2523, DOI 10.1002/eji.1830211032; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; MCCLAIN CJ, 1987, J LAB CLIN MED, V110, P48; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; MONCADA S, 1991, PHARMACOL REV, V43, P109; MONCADA S, 1992, ACTA PHYSIOL SCAND, V145, P201, DOI 10.1111/j.1748-1716.1992.tb09359.x; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; NITTA T, 1992, NEUROSURG REV, V15, P203, DOI 10.1007/BF00345934; OCHOA JB, 1991, ANN SURG, V214, P621, DOI 10.1097/00000658-199111000-00013; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; RADOMSKI MW, 1990, P NATL ACAD SCI USA, V87, P10043, DOI 10.1073/pnas.87.24.10043; RADOMSKI MW, 1987, BIOCHEM BIOPH RES CO, V148, P1482, DOI 10.1016/S0006-291X(87)80299-1; Rao AM, 1998, BRAIN RES, V793, P265, DOI 10.1016/S0006-8993(98)00183-8; Rise IRR, 1998, J NEUROSURG, V89, P448, DOI 10.3171/jns.1998.89.3.0448; Samdani AF, 1997, STROKE, V28, P1283, DOI 10.1161/01.STR.28.6.1283; SCHNEEMANN M, 1993, IMMUNOL LETT, V35, P159, DOI 10.1016/0165-2478(93)90085-G; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; SUZUKI S, 1995, J NEUROSURG, V83, P862, DOI 10.3171/jns.1995.83.5.0862; Suzuki Y, 1997, NEUROSURGERY, V41, P807, DOI 10.1097/00006123-199710000-00008; SUZUKI Y, 1993, STROKE, V24, P1049, DOI 10.1161/01.STR.24.7.1049; TADA M, 1993, J NEURO-ONCOL, V16, P25, DOI 10.1007/BF01324831; Thompson BG, 1996, J NEUROSURG, V84, P71, DOI 10.3171/jns.1996.84.1.0071; Tsutsui M, 1996, CIRC RES, V79, P336, DOI 10.1161/01.RES.79.2.336; Villarete LH, 1997, SHOCK, V7, P29, DOI 10.1097/00024382-199701000-00003; VILLARETE LH, 1995, BIOCHEM BIOPH RES CO, V211, P671, DOI 10.1006/bbrc.1995.1864; VISSER JJ, 1994, ANN INTERN MED, V120, P345, DOI 10.7326/0003-4819-120-4-199402150-00023; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; WAHL M, 1993, ACTA NEUROCHIR, P3; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; WONG HR, 1995, CRIT CARE MED, V23, P835, DOI 10.1097/00003246-199505000-00010	55	24	27	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.	DEC	2001	56	6					350	356		10.1016/S0090-3019(01)00633-4			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	510HB	WOS:000173201700001	11755960				2022-02-06	
J	Wildering, WC; Hermann, PM; Bulloch, AGM				Wildering, WC; Hermann, PM; Bulloch, AGM			Lymnaea epidermal growth factor promotes axonal regeneration in CNS organ culture	JOURNAL OF NEUROSCIENCE			English	Article						neurotrophic factor; epidermal growth factor; axonal regeneration; invertebrate; mollusk; CNS; L-EGF; peripheral nerve regeneration; neurotrauma	CENTRAL-NERVOUS-SYSTEM; SENSORY NEURONS; FACTOR-ALPHA; RECEPTOR; INJURY; CELLS; CONNECTIONS; ACTIVATION; EXPRESSION; INTEGRINS	Members of the epidermal growth factor (EGF) family are frequently implicated in the injury response of the mammalian nervous system. Although this implication is supported by extensive molecular evidence, it is not underpinned by conclusive functional data. Recently, we found that expression of an EGF homolog from the pond snail Lymnaea stagnalis (L-EGF) is upregulated after axotomy in the adult CNS, suggesting a role for this molecule in the injury response of the CNS. In the present study we asked whether L-EGF can promote axonal regeneration of three types of identified neurons in organ-cultured CNS. Treatment with purified L-EGF substantially enhanced axonal regeneration of all three types of neurons, an effect inhibited by submicromolar doses of PD153035, a specific EGF receptor (EGFR) tyrosine kinase inhibitor. In addition, PD153035 and K252a, a nonspecific kinase inhibitor, also reduced the degree of axonal regeneration that occurs without L-EGF supplementation, indicating that L-EGF or other EGFR ligands synthesized in the CNS participate in the regenerative response. An intriguing aspect of these results is that axonal regeneration of different, intrinsically L-EGF responsive and unresponsive neurons occurred in a coordinated manner. This observation suggests that indirect in addition to direct actions contribute to the beneficial effect of L-EGF. In conclusion, we provide functional evidence that an EGF homolog can promote axonal regeneration, substantiating existing molecular evidence implicating the EGF family in peripheral nerve regeneration and emphasizes the therapeutic potential of these molecules.	Univ Calgary, Fac Med, Hlth Sci Ctr, Dept Physiol & Biophys,Neurosci Res Grp, Calgary, AB T2N 4N1, Canada		Wildering, WC (corresponding author), Univ Calgary, Fac Med, Hlth Sci Ctr, Dept Physiol & Biophys,Neurosci Res Grp, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	wilderin@ucalgary.ca		Wildering, Willem/0000-0001-9120-5930			ALLISON P, 1985, PROC R SOC SER B-BIO, V226, P135, DOI 10.1098/rspb.1985.0088; Ambron RT, 1996, MOL NEUROBIOL, V13, P61, DOI 10.1007/BF02740752; CHALAZONITIS A, 1992, J NEUROSCI, V12, P583; DUBUISSON AS, 1993, J RECONSTR MICROSURG, V9, P341, DOI 10.1055/s-2007-1006741; Ebadi M, 1997, NEUROCHEM INT, V30, P347, DOI 10.1016/S0197-0186(96)00071-X; Fainzilber M, 1996, SCIENCE, V274, P1540, DOI 10.1126/science.274.5292.1540; FERRARI G, 1991, J NEUROSCI RES, V30, P493, DOI 10.1002/jnr.490300306; FREDMAN SM, 1987, J NEUROSCI METH, V20, P181, DOI 10.1016/0165-0270(87)90050-1; Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F; FRY DW, 1994, SCIENCE, V265, P1093, DOI 10.1126/science.8066447; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; Goldberg JL, 2000, ANNU REV NEUROSCI, V23, P579, DOI 10.1146/annurev.neuro.23.1.579; Hermann PM, 2000, BEHAV NEUROSCI, V114, P410, DOI 10.1037//0735-7044.114.2.410; Hermann PM, 2000, J NEUROSCI, V20, P6355, DOI 10.1523/JNEUROSCI.20-17-06355.2000; Ide C, 1996, NEUROSCI RES, V25, P101; JANSE C, 1979, MALACOLOGIA, V18, P485; JANSE C, 1986, MECH AGEING DEV, V35, P179, DOI 10.1016/0047-6374(86)90008-4; Juliano Rudy, 1996, Bioessays, V18, P911, DOI 10.1002/bies.950181110; Justicia C, 1999, J CEREBR BLOOD F MET, V19, P128, DOI 10.1097/00004647-199902000-00002; KENIGSBERG RL, 1995, J NEUROSCI RES, V41, P734, DOI 10.1002/jnr.490410604; Kimpinski K, 2001, J NEUROSCI RES, V63, P486, DOI 10.1002/jnr.1043; KITS KS, 1990, NEUROSCI LETT, V109, P253, DOI 10.1016/0304-3940(90)90003-R; Klaassen LJ, 1998, NEUROBIOL AGING, V19, P341, DOI 10.1016/S0197-4580(98)00065-7; KNUSEL B, 1992, J NEUROCHEM, V59, P1987; KRUK PJ, 1992, J NEUROSCI RES, V31, P401, DOI 10.1002/jnr.490310302; Logan Ann, 1994, Progress in Growth Factor Research, V5, P379, DOI 10.1016/0955-2235(94)00008-9; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; MOFFETT SB, 1995, PROG NEUROBIOL, V46, P289, DOI 10.1016/0301-0082(95)00007-I; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; MORRISON RS, 1988, J NEUROSCI RES, V21, P71, DOI 10.1002/jnr.490210111; Peng H, 1998, J CEREBR BLOOD F MET, V18, P349, DOI 10.1097/00004647-199804000-00002; PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349, DOI 10.1091/mbc.6.10.1349; Porter JC, 1998, TRENDS CELL BIOL, V8, P390, DOI 10.1016/S0962-8924(98)01344-0; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; RAO G, 1986, J NEUROSCI METH, V16, P251, DOI 10.1016/0165-0270(86)90050-6; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; RODGERS W, 1998, READING UNDERSTANDIN, P169; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; Shafer OT, 1998, P ROY SOC B-BIOL SCI, V265, P2171, DOI 10.1098/rspb.1998.0555; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Terenghi G, 1999, J ANAT, V194, P1, DOI 10.1046/j.1469-7580.1999.19410001.x; TOMA JG, 1992, J NEUROSCI, V12, P2504; VONBERNHARDI R, 1995, J NEUROBIOL, V27, P353, DOI 10.1002/neu.480270308; Wildering W. C., 1997, Society for Neuroscience Abstracts, V23, P57; Xian CJ, 1999, MOL NEUROBIOL, V20, P157, DOI 10.1007/BF02742440; Xian CJ, 1999, EXP NEUROL, V157, P317, DOI 10.1006/exnr.1999.7063; Yamada M, 1997, PROG NEUROBIOL, V51, P19, DOI 10.1016/S0301-0082(96)00046-9	48	24	26	0	2	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474	1529-2401		J NEUROSCI	J. Neurosci.	DEC 1	2001	21	23					9345	9354		10.1523/JNEUROSCI.21-23-09345.2001			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	494BL	WOS:000172258400031	11717368	Bronze, Green Published			2022-02-06	
J	Lambri, M; Djurovic, V; Kibble, M; Cairns, N; Al-Sarraj, S				Lambri, M; Djurovic, V; Kibble, M; Cairns, N; Al-Sarraj, S			Specificity and sensitivity of beta APP in head injury	CLINICAL NEUROPATHOLOGY			English	Article						head injury; axonal damage; beta APP; hypoxia; ischemia	AMYLOID PRECURSOR PROTEIN; DIFFUSE AXONAL INJURY; DIAGNOSIS; NEUROPATHOLOGY; BRAIN	Introduction: beta -amyloid precursor protein (beta APP) expression has been found in traumatic brain injury, hypoxia, ischemia and infection which affect axonal transport. Although beta APP is a sensitive marker for detecting axonal damage, it has become non-specific for a particular type of injury. The aim of this study was to identify a difference in the pattern, distribution and intensity of beta APP expression in head injury compared to hypoxic/ischemic insults. Materials and methods: Thirteen primary head injury and 12 primary hypoxic/ischemic cases were selected. The anterior and posterior parts of corpus callosum, internal capsule (basal ganglia), middle cerebellar peduncles (cerebellum) and pons were examined and stained immunohistochemically for beta APP antibody. A computerized system of image analysis was used to examine the intensity (strength of staining) and density (area fraction) of beta APP. Results: Significant differences were observed in the overall intensity and density of beta APP expression (p < 0.05) and in all 5 brain regions in cases of head injury compared to the hypoxic/ischemic group (p < 0.05). Positive staining for beta APP was found in all regions in all cases of head injury, however, 4 out of 12 cases of hypoxia/ischemia were positive for beta APP. One case expressed positivity in all 5 regions, 2 cases exhibited positivity in the pons alone, with only 1 case exhibiting immunoreactivity in the posterior corpus callosum and internal capsule. Differences in the pattern of beta APP expression identified a predominantly granular pattern with a dirty background seen in hypoxia/ischemia, while fusiform swellings, beaded and thick filaments with clear background were observed in head injury. Conclusion: There are differences in the pattern, distribution and intensity of beta APP in head injury compared to hypoxia/ischemia. These could be due to pathophysiological differences. The results may be helpful in differentiating head injury from hypoxia in medicolegal cases.	Kings Coll London Hosp, Inst Psychiat, Dept Neuropathol, London, England; Kings Coll London, Guys Hosp, Dept Forens Med, London WC2R 2LS, England		Al-Sarraj, S (corresponding author), Inst Psychiat, Dept Neuropathol, Denmark Hill, London SE5 8AF, England.	S.Alsarraj@iop.kcl.ac.uk					ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; FERREIRA A, 1993, J NEUROSCI, V13, P3112; Geddes JF, 1997, J CLIN PATHOL, V50, P271, DOI 10.1136/jcp.50.4.271; Geddes JF, 1997, NEUROPATH APPL NEURO, V23, P339, DOI 10.1046/j.1365-2990.1997.4498044.x; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; Kaur B, 1999, J CLIN PATHOL, V52, P203, DOI 10.1136/jcp.52.3.203; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; LEBLANC AC, 1992, J NEUROSCI RES, V31, P635, DOI 10.1002/jnr.490310407; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; Oehmichen M, 1998, FORENSIC SCI INT, V95, P67, DOI 10.1016/S0379-0738(98)00075-9; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; POVLISHOCK JT, 1992, J NEUROTRAUMA, V9, P189; Shannon P, 1998, ACTA NEUROPATHOL, V95, P625, DOI 10.1007/s004010050849; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526	19	24	25	0	2	DUSTRI-VERLAG DR KARL FEISTLE	DEISENHOFEN-MUENCHEN	BAHNHOFSTRASSE 9 POSTFACH 49, D-82032 DEISENHOFEN-MUENCHEN, GERMANY	0722-5091			CLIN NEUROPATHOL	Clin. Neuropathol.	NOV-DEC	2001	20	6					263	271					9	Clinical Neurology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	496BT	WOS:000172375500006	11758782				2022-02-06	
J	Watanabe, S; Hoffman, JR; Craik, RL; Hand, PJ; Croul, SE; Reivich, M; Greenberg, JH				Watanabe, S; Hoffman, JR; Craik, RL; Hand, PJ; Croul, SE; Reivich, M; Greenberg, JH			A new model of localized ischemia in rat somatosensory cortex produced by cortical compression	STROKE			English	Article						cerebral blood flow; cerebral ischemia; neuronal plasticity; stroke, experimental; somatosensory cortex; rats	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; IN-VITRO MODEL; ARTERY OCCLUSION; BLOOD-FLOW; MOTOR RECOVERY; INFARCT SIZE; STROKE; REPRESENTATION; PLASTICITY	Background and Purpose-Because of its precise connectivity and functional specificity, the rat whisker-barrel system offers an excellent opportunity to study experience-dependent neuroplasticity. However, data are lacking regarding the neuroplasticity of this system after cerebral ischemia. The purpose of the present study was to develop a reproducible model for the production of ischemia/reperfusion of the posteromedial barrel subfield (PMBSF) in the rat, which is the visible representation of the large whiskers on the opposite face. Methods-Focal cortical ischemia was induced in male Sprague-Dawley rats (n = 40) by slowly compressing the intact dura (maximum 0.05 mm/s) with a 4- or 5-mm-diameter brass cylinder equipped with a laser-Doppler probe, combined with ipsilateral common carotid artery occlusion. The microvascular blood flow of PMBSF during compression ischemia was maintained at 18% to 20% of baseline flow for 1 hour. The total infarction volume was measured by 2,3,5-triphenyltetrazolium chloride staining at several reperfusion times, and pathological examination was performed on hematoxylineosin-stained sections. Results-The infarct volumes were 36.5 +/- 9.2 (n = 9), 40.7 +/- 7.7 (n = 7), and 36.6 +/- 6.4 mm(3) (n = 5) at 24 hours, 72 hours, and 7 days after ischemia, respectively, with no significant differences among these values. There was no evidence of damage to white matter or to deep gray matter and no evidence of hemorrhage. The topographic distribution of the damaged tissue was in good agreement with that of PMBSF. Conclusions-This stroke model produces a highly consistent cortical infarct in PMBSF and can facilitate the study of behavioral, functional, and structural consequences after cerebral ischemia/reperfusion in the rat somatosensory Cortex.	Univ Penn, Cerebrovasc Res Ctr, Dept Neurol, Sch Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; Arcadia Univ, Dept Biol, Glenside, PA USA; Arcadia Univ, Dept Phys Therapy, Glenside, PA USA; Med Coll Penn & Hahnemann Univ, Dept Pathol, Philadelphia, PA USA		Greenberg, JH (corresponding author), Univ Penn, Cerebrovasc Res Ctr, Dept Neurol, Sch Med, 415 Stemmler Hall,3450 Hamilton Walk, Philadelphia, PA 19104 USA.	greenberg@cvrc.med.upenn.edu	Craik, Rebecca L/J-8325-2017; Hoffman, John/ABH-8001-2020	Craik, Rebecca L/0000-0003-4816-1439; Croul, Sidney/0000-0002-2224-5485	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-33785] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS033785] Funding Source: NIH RePORTER		BARONE FC, 1991, BRAIN RES BULL, V26, P285, DOI 10.1016/0361-9230(91)90240-K; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; Browning JL, 1996, J NEUROTRAUM, V13, P583, DOI 10.1089/neu.1996.13.583; Carel C, 2000, J CEREBR BLOOD F MET, V20, P478, DOI 10.1097/00004647-200003000-00006; Cargill RS, 1996, J NEUROTRAUM, V13, P395, DOI 10.1089/neu.1996.13.395; CHAPIN JK, 1984, J COMP NEUROL, V229, P199, DOI 10.1002/cne.902290206; CHEN ST, 1986, STROKE, V17, P738, DOI 10.1161/01.STR.17.4.738; CHOLLET F, 1991, ANN NEUROL, V29, P63, DOI 10.1002/ana.410290112; CLARK RK, 1993, BRAIN RES BULL, V31, P565, DOI 10.1016/0361-9230(93)90124-T; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; DERESKI MO, 1993, ACTA NEUROPATHOL, V85, P327; DIAMOND ME, 1993, P NATL ACAD SCI USA, V90, P2082, DOI 10.1073/pnas.90.5.2082; DIRNAGL U, 1989, J CEREBR BLOOD F MET, V9, P589, DOI 10.1038/jcbfm.1989.84; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; FOX K, 1994, J NEUROSCI, V14, P7665; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; GROME JJ, 1988, J CEREBR BLOOD F MET, V8, P89, DOI 10.1038/jcbfm.1988.11; HAMADA J, 1995, J CEREBR BLOOD F MET, V15, P779, DOI 10.1038/jcbfm.1995.98; HATASHITA S, 1990, STROKE, V21, P582, DOI 10.1161/01.STR.21.4.582; ISAYAMA K, 1991, STROKE, V22, P1394, DOI 10.1161/01.STR.22.11.1394; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kawaguchi K, 1997, BRAIN RES, V749, P131, DOI 10.1016/S0006-8993(96)01311-X; LaPlaca MC, 1997, J NEUROTRAUM, V14, P355, DOI 10.1089/neu.1997.14.355; Liepert J, 1998, NEUROSCI LETT, V250, P5, DOI 10.1016/S0304-3940(98)00386-3; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; Markarian GZ, 1996, NEUROSURGERY, V38, P542; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mathew P, 1996, J NEUROSURG, V85, P860, DOI 10.3171/jns.1996.85.5.0860; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Miyazaki H, 1999, LIFE SCI, V64, P869, DOI 10.1016/S0024-3205(99)00011-9; MORIKAWA E, 1992, J CEREBR BLOOD F MET, V12, P380, DOI 10.1038/jcbfm.1992.55; Nilsson P, 1996, J NEUROTRAUM, V13, P201, DOI 10.1089/neu.1996.13.201; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Paxinos G, 1997, RAT BRAIN STEREOTAXI; PERSSON L, 1989, STROKE, V20, P641, DOI 10.1161/01.STR.20.5.641; RICE FL, 1995, BARREL CORTEX RODENT, P1; RUBINO GJ, 1988, STROKE, V19, P870, DOI 10.1161/01.STR.19.7.870; Schabitz WR, 1997, J CEREBR BLOOD F MET, V17, P500, DOI 10.1097/00004647-199705000-00003; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schiene K, 1999, J NEUROL SCI, V162, P6, DOI 10.1016/S0022-510X(98)00292-5; Staiger JF, 2000, NEUROSCIENCE, V99, P7, DOI 10.1016/S0306-4522(00)00166-4; STROEMER RP, 1995, STROKE, V26, P2135, DOI 10.1161/01.STR.26.11.2135; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Takahashi K, 1999, BRAIN RES, V829, P46, DOI 10.1016/S0006-8993(99)01335-9; WATSON BD, 1985, ANN NEUROL, V17, P497, DOI 10.1002/ana.410170513; WEI L, 1995, STROKE, V26, P1459, DOI 10.1161/01.STR.26.8.1459; WEILLER C, 1992, ANN NEUROL, V31, P463, DOI 10.1002/ana.410310502; WELKER C, 1974, J COMP NEUROL, V158, P437, DOI 10.1002/cne.901580405; WELKER C, 1976, J COMP NEUROL, V166, P173, DOI 10.1002/cne.901660205; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Zhang L, 2000, J NEUROL SCI, V174, P141, DOI 10.1016/S0022-510X(00)00268-9	53	24	29	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	NOV	2001	32	11					2615	2623		10.1161/hs1101.097384			9	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	490PG	WOS:000172059800030	11692026	Bronze, Green Submitted			2022-02-06	
J	Radanov, BP; Di Stefano, G; Augustiny, KF				Radanov, BP; Di Stefano, G; Augustiny, KF			Symptomatic approach to posttraumatic headache and its possible implications for treatment	EUROPEAN SPINE JOURNAL			English	Article						head trauma; whiplash injury; chronic posttraumatic headache; migraine; tension headache	TENSION-TYPE HEADACHE; TRAUMATIC BRAIN INJURY; CERVICOGENIC HEADACHE; WHIPLASH INJURY; MIGRAINE; PATHOPHYSIOLOGY; MECHANISMS; RECOVERY; SPECT; PAIN	We investigated 112 patients (mean age 39.5+/-10.5 years, 59% women (n=66)] with chronic posttraumatic headache following cranio-cervical acceleration/deceleration trauma after an average time interval of 2.5+/-1.9 years from trauma. Headache following minor head injury or whiplash is one of the most prominent problems in neurotraumatology. Previous research is inconclusive regarding the symptomatic approach of this type of headache. Details of the phenomenology of posttraumatic headache in the previous literature are inconclusive. This may lead to inappropriate treatment strategies, because recent advances in therapy of different headache types may be neglected. Patients were investigated at the outpatient service of the Department of Psychiatry. Headache was analyzed according to its principal location, laterality, projection, quality, precipitation or aggravation and possible additional symptoms. For this analysis, headache was diagnosed according to the classification of the International Headache Society. The results showed that 42 patients (37%) had tension-type headache, 30 (27%) were identified as suffering from migraine, whereas 20 patients (18%) had cervicogenic headache. An additional 18% of patients suffered from headache that did not fulfill criteria of a particular category. In 104 patients (93%), neck pain was associated in time with headache. Each of the diagnosed headache types in this study may require specific treatment strategies based upon empirical studies of non-traumatic headache types. For these reasons a detailed analysis of headache following cranio-cervical acceleration/deceleration trauma is necessary.	Univ Bern, Inselspital, Dept Psychiat, CH-3010 Bern, Switzerland		Radanov, BP (corresponding author), Univ Bern, Inselspital, Dept Psychiat, CH-3010 Bern, Switzerland.						Adams MA, 1998, WHIPLASH INJURIES CU, P13; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Bendtsen L, 1996, J NEUROL NEUROSUR PS, V61, P285, DOI 10.1136/jnnp.61.3.285; Bicik I, 1998, NEUROLOGY, V51, P345, DOI 10.1212/WNL.51.2.345; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BLAU JN, 1994, HEADACHE, V34, P88, DOI 10.1111/j.1526-4610.1994.hed3402088.x; BOVIM G, 1992, PAIN, V51, P43, DOI 10.1016/0304-3959(92)90007-X; Brault JR, 1998, ARCH PHYS MED REHAB, V79, P72, DOI 10.1016/S0003-9993(98)90212-X; ESSELMAN PC, 1995, BRAIN INJURY, V9, P17; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Goadsby PJ, 1997, PAIN, V73, P23, DOI 10.1016/S0304-3959(97)00074-2; Haas DC, 1997, NEUROLOGY, V48, P1735, DOI 10.1212/WNL.48.6.1735; Haas DC, 1996, CEPHALALGIA, V16, P486, DOI 10.1046/j.1468-2982.1996.1607486.x; *HEAD CLASS COMM I, 1998, CEPHALALGIA S7, V8; Hobson DE, 1997, HEADACHE, V37, P253, DOI 10.1046/j.1526-4610.1997.3704253.x; ICHISE M, 1994, J NUCL MED, V35, P217; Jensen R, 1996, CEPHALALGIA, V16, P175, DOI 10.1046/j.1468-2982.1996.1603175.x; Lord SM, 1996, SPINE, V21, P1737, DOI 10.1097/00007632-199608010-00005; MEYER S, 1998, WHIPLASH INJURIES CU, P95; MOSKOWITZ MA, 1993, NEUROLOGY, V43, P16; OMMAYA K, 1975, HDB CLIN NEUROLOGY, P67; PACKARD RC, 1992, HEADACHE, V32, P496, DOI 10.1111/j.1526-4610.1992.hed3210496.x; Packard RC, 1997, HEADACHE, V37, P142, DOI 10.1046/j.1526-4610.1997.3703142.x; Penning L, 1992, Eur Spine J, V1, P13, DOI 10.1007/BF00302136; RADANOV BP, 1993, BRIT MED J, V307, P652, DOI 10.1136/bmj.307.6905.652; RADANOV BP, 1995, MEDICINE, V74, P281, DOI 10.1097/00005792-199509000-00005; SAPER JR, 1997, HEADACHE S1, V37, P1; Schellhas KP, 1996, SPINE, V21, P300, DOI 10.1097/00007632-199602010-00009; SHEA M, 1991, J BIOMECH, V24, P95, DOI 10.1016/0021-9290(91)90354-P; SILBERSTEIN SD, 1994, NEUROLOGY, V44, P6; Sternberg PE, 1997, NEUROLOGY, V48, P1735; STURZENEGGER M, 1995, J NEUROL, V242, P443, DOI 10.1007/BF00873547; TRELEAVEN J, 1994, CEPHALALGIA, V14, P273, DOI 10.1046/j.1468-2982.1994.1404273.x; Wallis BJ, 1997, PAIN, V73, P15, DOI 10.1016/S0304-3959(97)00060-2; Warner JS, 1996, NEUROLOGY, V46, P915, DOI 10.1212/WNL.46.4.915	36	24	26	0	1	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0940-6719			EUR SPINE J	Eur. Spine J.	OCT	2001	10	5					403	407		10.1007/s005860000227			5	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	487FQ	WOS:000171863300006	11718194	Green Published			2022-02-06	
J	Basso, A; Previgliano, I; Duarte, JM; Ferrari, N				Basso, A; Previgliano, I; Duarte, JM; Ferrari, N			Advances in management of neurosurgical trauma in different continents	WORLD JOURNAL OF SURGERY			English	Article							SEVERE HEAD-INJURY; CEREBRAL PERFUSION-PRESSURE; BRAIN INJURY; EPIDEMIOLOGY; GUIDELINES; TRIAL	Neurotrauma is a major public health problem. The incidence varies from 67 to 317 per 100,000 and mortality rates are in the range of near 1% for minor injury, 18% for mild injury, and 48% for severe head injury. It is the main cause of death and disability in people under 40 years old. Several problems appear when outcome measurements, rehabilitation programs and treatment options are considered: In order to solve these problems a worldwide campaign is outlined. It focuses on epidemiology, prevention, education, treatment, rehabilitation, social reinsertion, and outcome measurements. The goals of such a program are to take into account realities in both developed and developing countries, to develop worldwide acceptable programs and guidelines, and to test those guidelines and programs and diminish mortality and morbidity, improving quality of life. We describe the concept of Centers of Excellence and an educational program, Advanced Brain Life Support. Such a program is a moral obligation because mortality and morbidity tend to decrease in Centers of Excellence.	Buenos Aires Univ Hosp, Dept Neurosurg, RA-1111 Buenos Aires, DF, Argentina; Antartida Private Hosp, Dept Neurosci, RA-1424 Buenos Aires, DF, Argentina; Antartida Private Hosp, Crit Care Unit, RA-1424 Buenos Aires, DF, Argentina		Basso, A (corresponding author), Buenos Aires Univ Hosp, Dept Neurosurg, Ayacucho 1342, RA-1111 Buenos Aires, DF, Argentina.			Duarte, Juan Manuel/0000-0003-0408-0178			Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; COOPER K D, 1983, Neuroepidemiology, V2, P70, DOI 10.1159/000110512; de Sousa R M, 1996, Rev Esc Enferm USP, V30, P484; Foulkes MA, 1991, J NEUROSURG S, V75, P8, DOI 10.3171/sup.1991.75.1s.00s8; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; JENNETT B, 1977, Lancet, V2, P696; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1997, HEAD INJURY PATHOPHY, P440; JERVARATNAM DR, 1996, BRIT MED J, V312, P944; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; Kelly DF, 1999, J NEUROSURG, V90, P1042, DOI 10.3171/jns.1999.90.6.1042; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MAHONEY F I, 1965, Md State Med J, V14, P61; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Matta B, 1996, CRIT CARE MED, V24, P1743, DOI 10.1097/00003246-199610000-00023; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; Nissen JJ, 1999, J NEUROL NEUROSUR PS, V67, P796, DOI 10.1136/jnnp.67.6.796; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Study Group on Head Injury of the Italian Society for Neurosurgery, 1996, J NEUROSURG SCI, V40, P11; TEASDALE G, 1974, LANCET, V2, P81; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; TORNER IC, 1996, HEAD INJURY POSTCONC, P19; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; VAZQUEZBARQUERO A, 1992, EUR J EPIDEMIOL, V8, P832, DOI 10.1007/BF00145328; Vukic M, 1999, ACTA NEUROCHIR, V141, P1203, DOI 10.1007/s007010050419; WANG CC, 1986, ARCH NEUROL-CHICAGO, V43, P570, DOI 10.1001/archneur.1986.00520060034013; YOUNGSU J, 1997, NO SHINKEI GEKA, V25, P529	30	24	26	0	0	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0364-2313			WORLD J SURG	World J.Surg.	SEP	2001	25	9					1174	1178					5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	471NB	WOS:000170934500015	11571955				2022-02-06	
J	Loganovsky, KN; Yuryev, KL				Loganovsky, KN; Yuryev, KL			EEG patterns in persons exposed to ionizing radiation as a result of the Chernobyl accident: Part 1: Conventional EEG analysis	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article								Prospective conventional EEG study was carried out 3-5 and 10-13 years after the Chernobyl accident (1986) in patients who had acute radiation sickness and in emergency workers in 1986 ("liquidators"). Control groups comprised healthy volunteers; veterans of the Afghanistan war with posttraumatic stress disorder; veterans with mild traumatic brain injury; and patients with dyscirculatory encephalopathy. In 3-5 years after irradiation, there were irritated EEG changes with paroxysmal activity shifted to the left frontotemporal region (cortical-limbic overactivation) that were transformed 10-13 Years after irradiation toward a low-voltage EEG pattern with excess of fast (beta) and slow (delta) activity together with depression of alpha and theta activity (organic brain damage with inhibition of the cortical-limbic system). Quantitative EEG is likely to be very informative for investigation of dose-effect relationships.	Ukraine Acad Med Sci, Res Ctr Radiat Med, Int Clin Radiol, Dept Neurol,WHO Collaborating Ctr, Kiev, Ukraine		Loganovsky, KN (corresponding author), 16D Heroes Stalingrad St,Apt 173, UA-04210 Kiev, Ukraine.		Loganovsky, Konstantin/E-2136-2016	Loganovsky, Konstantin/0000-0002-0680-8882			Abrams R., 1988, ELECTROCONVULSIVE TH; BRUMBACK RA, 1981, ELECTROENCEPHALOGR C, V52, P128; CHAYANOV NV, 1992, 3 INT C BRAIN EL TOP; DANIEL W, 1995, BIOSTATISTICS FDN AN; Danilov V M, 1994, Fiziol Zh Im I M Sechenova, V80, P88; Danysz J, 1903, CR HEBD ACAD SCI, V136, P461; Danysz J, 1903, CR HEBD ACAD SCI, V137, P1296; DAVIS H, 1939, A RES NERV MENT DIS, V19, P50; DAVYDOV BI, 1987, RAD BIOL, V8; EDISON TA, 1896, SAN FRANCISCO CHRON, V19, P1; Flor-Henry P., 1983, CEREBRAL BASIS PSYCH; FlorHenry P, 1988, EEG MENTAL ACTIVITIE, P182; Futagi Y, 1998, ELECTROEN CLIN NEURO, V106, P392, DOI 10.1016/S0013-4694(98)00002-9; GANGLOFF H, 1962, EFFECTS IONIZING RAD, P123; GOROVITZ LM, 1906, BIOL SIGNIFICANCE RA; GRIGORIEV YG, 1963, RAD DAMAGES COMPENSA; HALEY TJ, 1962, EFFECTS IONIZING RAD, P171; Holahan Jr E. V., 1987, MILITARY RADIOBIOLOG, P87; Hughes JR, 1999, J NEUROPSYCH CLIN N, V11, P190, DOI 10.1176/jnp.11.2.190; HUNT WA, 1987, MILITARY RADIOBIOLOG, P321; *IAEA, 1996, NAT REP UKR 10 YEARS; *IAEA, 1992, INT CHERN PROJ TECHN; *IAEA, 1961, P INT S VIENN; IZUMI C, 1955, FOLIO PSYCHIAT NEURO, V9, P229; Kimeldorf D. J., 1965, IONIZING RAD NEURAL; KINDSELSKY LP, 1995, CHERNOBYL CATASTROPH, P447; KONUMA M, 1961, Nagasaki Igakkai Zasshi, V36, P706; KONUMA M, 1954, JAPANESE MED J, V1544, P5; KONUMA M, 1967, HIROSHIMA MED J, V20, P231; Kuzma JW, 1984, BASIC STAT HLTH SCI; LEBEDINSKY AV, 1960, IONIZING RAD INFLUEN; LIKHTAREV I, 1996, BFS SKK SEM 10 YEARS; LIKHTAREV IA, 1994, HEALTH PHYS, V66, P643, DOI 10.1097/00004032-199406000-00004; LIVANOV MN, 1962, SOME PROBLEMS IONIZI; LOGANOVSKII KN, 1999, SOTSIALNAYA KLIN PSI, V1, P5; Loganovsky KN, 2000, ZH NEVROPATOL PSIKH, V100, P15; Loganovsky KN, 1995, P INT C MENT HLTH CO, P52; LONDON ES, 1903, BERLIN CLIN WEEKLY, V23, P523; MICKLEY GA, 1987, MILITARY RADIOBIOLOG, P303; NEMENOV MI, 1950, ROENTGENTHERAPY EXPO; Niedermeyer E, 1993, ELECTROENCEPHALOGRAP; NOSHCHENKO AG, 1994, VRACHEBNOE DELO, V2, P16; NOSHCHENKO AG, 1990, BIOL RADIOECOLOGICAL, P218; Nyagu AI, 1998, NEUROPSYCHIATRIC EFF; Nyagu AI, 1997, UKRAINIAN MED J, V2, P33; NYAGU AI, 1996, EXCLUSION ZONE, V3, P175; Nyagu AI, 1996, INT C 1 DEC CHERN BO, P347; NYAGU AI, 1999, 11 WORLD PSYCH C HAM, P161; Nyagu AI, 1999, INT J RAD MED, V2, P3; Nyagu AI, 1997, INT C SEV SPAIN NOV, P261; NYAGU AI, 1992, ZH NEVROPATOL PSYKHI, V94, P72; Oddie SD, 1998, NEUROSCI BIOBEHAV R, V22, P221, DOI 10.1016/S0149-7634(97)00003-1; PEYMER SI, 1985, REPORTS ACAD SCI UNI, V284, P1481; SOSNOVSKAYA F M, 1971, Zhurnal Nevropatologii i Psikhiatrii Imeni S. S. Korsakova, V71, P205; SYNEK VM, 1983, CLIN ELECTROENCEPHAL, V14, P102, DOI 10.1177/155005948301400211; TARKHANOV IR, 1896, HOSP NEWSPAPER BOTKI, V34, P785; TARKHANOV IR, 1896, HOSP NEWSPAPER BOTKI, V33, P753; TRAUGOTT NN, 1968, ESSAYS HUMAN PSYCHOP; TROCHERIE S, 1984, NATO, V2, P633; USHAKOV IB, 1997, CHERNOBYL RAD PSYCHO; Viatleva O A, 1996, Zh Nevrol Psikhiatr Im S S Korsakova, V96, P41; WAGEMAKER G, 1996, DIAGNOSIS TREATMENT; YAAR I, 1982, J NEUROL NEUROSUR PS, V45, P166, DOI 10.1136/jnnp.45.2.166; YURYEV KL, 1999, UKRAINIAN MED J, V4, P137; ZHAVORONKOVA LA, 1994, ZH VYSSH NERV DEYAT+, V44, P159; ZHAVORONKOVA LA, 1998, P 2 INT C LONG TERM, P233; Zhavoronkova Ludmila A., 1995, Brain Topography, V8, P161, DOI 10.1007/BF01199779; Zhirmunskaya E. A., 1991, CLIN ELECTROENCEPHAL; ZHUKOVSKY MO, 1903, REV PSYCHIAT NEUROPA, V11, P801	69	24	28	0	2	AMER PSYCHIATRIC PRESS, INC	WASHINGTON	1400 K ST, N W, STE 1101, WASHINGTON, DC 20005 USA	0895-0172			J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	FAL	2001	13	4					441	458		10.1176/appi.neuropsych.13.4.441			18	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	501VX	WOS:000172707700002	11748314				2022-02-06	
J	Mataro, M; Poca, MA; Sahuquillo, J; Pedraza, S; Ariza, M; Amoros, S; Junque, C				Mataro, M; Poca, MA; Sahuquillo, J; Pedraza, S; Ariza, M; Amoros, S; Junque, C			Neuropsychological outcome in relation to the traumatic coma data bank classification of computed tomography imaging	JOURNAL OF NEUROTRAUMA			English	Article						computerized tomography; head injury; neuropsychology; outcome	SEVERE HEAD-INJURY; INTRACRANIAL HYPERTENSION; VENTRICULAR ENLARGEMENT; BRAIN-LESIONS; EARLY INDEXES; SCALE; MILD; CT; EXPERIENCE; MANAGEMENT	The Traumatic Coma Data Bank (TCDB) classification of CT (computed tomography) scan has been related to the general outcome and intracranial pressure evolution. Our aim was to analyse the relationship of this classification with neuropsychological outcome and late indices of ventricular dilatation. Fifty-seven patients with a moderate or severe head injury (mean admission Glasgow Coma Scale Score, 7.7) were studied from 122 consecutive cases. There were 49 males and 8 females (mean age, 27.7 years). Subjects were classified into TCDB categories on the basis of their most serious acute CT scan finding. From the last control CT scan image, performed at a mean of 6.12 months postinjury, several measures of ventricular dilatation were calculated. Neuropsychological assessment at 6-month included tests of verbal and visual memory, visuoconstructive functions, fine motor speed, and frontal lobe functions. Patients with diffuse injury type I showed better neuropsychological outcome than patients with more severe diffuse injuries and those with mass lesions. Within the diffuse injury groups, the degree of diffuse damage was related to measures of verbal memory and attention and cognitive flexibility. Ventricular enlargement was more evident in patients with mass lesions and it decreased in the remaining groups as the severity of diffuse injury diminished. These results show that there is a relationship between acute intracranial lesion diagnosis according to TCDB classification and neuropsychological results and ventricular dilatation indices at 6 months postinjury.	Vall Hebron Univ Hosp, Dept Neurosurg, Barcelona 08035, Spain; Vall Hebron Univ Hosp, Neurotraumatol Res Unit, Barcelona, Spain; Hosp Univ Josep Trueta, Neuroradiol Unit, Girona, Spain; Univ Barcelona, Dept Psychiat & Clin Psychophysiol, Barcelona, Spain		Poca, MA (corresponding author), Vall Hebron Univ Hosp, Dept Neurosurg, Passeig Vall Hebron 119-129, Barcelona 08035, Spain.		pedraza, salvador/AAC-1728-2019; Sahuquillo, Juan/B-3577-2008; Mataro, Maria/B-4524-2011; Junque, Carme/B-4400-2011; Poca, Maria A./B-8475-2008; Ariza, Mar/F-2754-2019	pedraza, salvador/0000-0003-2517-4413; Sahuquillo, Juan/0000-0003-0713-5875; Mataro, Maria/0000-0002-9946-2656; Junque, Carme/0000-0002-6381-3063; Poca, Maria A./0000-0002-3831-0536; Ariza, Mar/0000-0003-1020-6945			ALEXANDRE A, 1983, J NEUROSURG, V59, P751, DOI 10.3171/jns.1983.59.5.0751; Benton A., 1976, MULTILINGUAL APHASIA; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; BIGLER ED, 1996, NEUROIMAGING, V2, P261; BROOKS DN, 1980, J NEUROL NEUROSUR PS, V43, P529, DOI 10.1136/jnnp.43.6.529; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; CORDOBES F, 1986, ACTA NEUROCHIR, V81, P27, DOI 10.1007/BF01456261; CULLUM CM, 1985, INT J NEUROSCI, V28, P279, DOI 10.3109/00207458508985395; CULLUM CM, 1986, J CLIN EXP NEUROPSYC, V8, P437, DOI 10.1080/01688638608401333; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GROSWASSER Z, 1987, SURG NEUROL, V27, P331, DOI 10.1016/0090-3019(87)90007-3; JENKINS A, 1986, LANCET, V2, P445; JENNETT B, 1975, LANCET, V1, P480; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; KlOve H, 1963, MED CLIN N AM; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; LEVIN HS, 1991, NEUROSURGERY, V28, P196, DOI 10.1227/00006123-199102000-00004; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; MACPHERSON P, 1986, J NEUROL NEUROSUR PS, V49, P29, DOI 10.1136/jnnp.49.1.29; MARSHALL LF, 1991, J NEUROSURG S, V75, P28; Marshall LF, 1991, J NEUROSURG S, V75, P14; Mataro M, 2000, J NEUROL NEUROSUR PS, V68, P615, DOI 10.1136/jnnp.68.5.615; MEYERS CA, 1983, J NEUROL NEUROSUR PS, V46, P1092, DOI 10.1136/jnnp.46.12.1092; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; Poca MA, 1998, ACT NEUR S, V71, P27; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; ROSS BL, 1994, AM J PHYS MED REHAB, V73, P341, DOI 10.1097/00002060-199409000-00007; RYE A, 1959, TEST COPIE REPROD ME; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; Smith A., 1991, SYMBOL DIGIT MODALIT; SmithSeemiller L, 1997, BRAIN INJURY, V11, P191; TEASDALE G, 1982, BRIT MED J, V285, P1695, DOI 10.1136/bmj.285.6356.1695; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; UZZELL BP, 1986, J NEUROSURG, V65, P630, DOI 10.3171/jns.1986.65.5.0630; UZZELL BP, 1987, NEUROSURGERY, V20, P396, DOI 10.1227/00006123-198703000-00007; VILKKI J, 1988, J NEUROL NEUROSUR PS, V51, P1452, DOI 10.1136/jnnp.51.11.1452; Vollmer D G, 1991, Neurosurg Clin N Am, V2, P437; WILBERGER JE, 1987, NEUROSURGERY, V20, P571, DOI 10.1227/00006123-198704000-00011; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391	53	24	25	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	2001	18	9					869	879		10.1089/089771501750451794			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	471TP	WOS:000170945000003	11565599				2022-02-06	
J	Sahlas, DJ				Sahlas, DJ			Functional neuroanatomy in the pre-hippocratic era: Observations from the Iliad of Homer	NEUROSURGERY			English	Article						history of medicine; ancient; Homer; nervous system; neuroanatomy; trauma		OBJECTIVE: To describe observations of neurological significance made in the Iliad of Homer and to interpret these relative to pre-Hippocratic concepts of health and disease in Ancient Greece. METHODS: English translations of the Iliad were analyzed for references of neurological significance, and the Homeric Creek was subsequently reviewed for accuracy. Findings are discussed in the context of ancient Creek ideas regarding anatomy and physiology, early descriptions and conceptualizations of the nervous system, ancient Creek theories concerning illness and disease, and the practice of medicine in the pre-Hippocratic era. RESULTS: Descriptions of injuries sustained by soldiers fighting in the Trojan War represent some of the earliest case histories of neurotrauma. Passages in the Iliad describe immediate death after penetrating head trauma with injury to the brain or the brainstem, make reference to clinical signs of brain injury, and mention neurological signs and symptoms after damage to the spinal cord, brachial plexus, and peripheral nerves. CONCLUSION: The Iliad of Homer contains many descriptions of traumatic injury to the nervous system and provides us with 3000-year-old references to some of the basic principles of functional neuroanatomy.	McGill Univ, Montreal Neurol Hosp, Ctr Hlth, Montreal, PQ H3A 2B4, Canada		Sahlas, DJ (corresponding author), McGill Univ, Montreal Neurol Hosp, Ctr Hlth, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.						ADAMS F, 1886, GENUINE WORKS HIPPOC; BEASLEY AW, 1972, CLIN ORTHOP RELAT R, P10; BEYE CR, 1993, ANCIENT EPIC POETRY, P1; DERENNE JP, 1994, EUR RESPIR J, V7, P2234, DOI 10.1183/09031936.94.07122234; Frolich H, 1879, MILITAR MED HOMERS; FRONIMOPOULOS J, 1990, DOC OPHTHALMOL, V74, P125; Godquin B, 1990, Chirurgie, V116, P136; Knox B., 1990, ILIAD, P3; MCHENRY LC, 1969, HIST NEUROLOGY, P3; Mettler CC, 1947, HIST MED CORRELATIVE, P495; METTLER FA, 1945, RES PUBL ASSOC RES N, V24, P1; Mumford DB, 1996, J PSYCHOSOM RES, V41, P139, DOI 10.1016/0022-3999(96)00091-8; MURRAY AT, 1999, ILIAD HOMER BOOKS 13, V2; MURRAY AT, 1995, ODYSSEY HOMER BOOKS, V1; MURRAY AT, 1999, ILIAD HOMER BOOKS 1, V2; SPILLANE JD, 1981, DOCTRINE NERVES CHAP, P7; Stahl W, 1966, Zahnarztl Prax, V17, P60; STEVENS LA, 1971, EXPLORERS BRAIN, P10; WALKER AE, 1951, HIST NEUROLOGICAL SU, P364; WALKER AE, 1951, HIST NEUROLOGICAL SU, P396; Walshe T M, 1997, J Hist Neurosci, V6, P72	21	24	24	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	JUN	2001	48	6					1352	1357		10.1097/00006123-200106000-00037			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	433XG	WOS:000168785500097	11383741				2022-02-06	
J	Cardenas, DD; Haselkorn, JK; McElligott, JM; Gnatz, SM				Cardenas, DD; Haselkorn, JK; McElligott, JM; Gnatz, SM			Bibliography of cost-effectiveness practices in physical medicine and rehabilitation: AAPM&R white paper	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; cerebrovascular accident; cost effective; rehabilitation; spinal cord injuries	SPINAL-CORD-INJURY; OUTPATIENT TREATMENT; EARLY INTERVENTION; LEG ISCHEMIA; HEAD-INJURY; LOW-BACK; STROKE; HIP; BENEFITS; PROGRAM	Cost-effectiveness studies attempt to determine the ratio of costs to outcomes of a particular intervention or treatment and to compare a standard intervention with an alternative intervention to determine if the alternative is more cost effective. The goal is to establish priorities for the resources allocation and to decide among alternative interventions for the same medical condition. The global process of rehabilitation does not usually lend itself to cost-effective analysis (due to the complex set of treatments provided) but rather to specific interventions and specific aspects of outcome. The American Academy of Physical Medicine and Rehabilitation has published a cost effectiveness annotated bibliography on the Internet (http://www.aapmr.org/memphys/cebfinala.htm) that identifies 132 studies in the literature that meet specified criteria and are related to the field of rehabilitation. This White Paper attempts to interpret and synthesize the studies in that bibliography that relate to stroke, spinal cord injury (SCI), orthopedic conditions, pain syndromes, amputations, and traumatic brain injury (TBI). Most studies support the cost effectiveness of care for stroke and SCI in dedicated units or centers rather than in a general medical unit. Studies also support back programs and revascularization procedures in limb ischemia. Studies in TBI underscore the significant financial resources for the care of these patients as well as the potential benefit from rehabilitation services even in the most severely injured. Further high quality research in this area is needed.	Univ Washington, Dept Rehabil Med, Seattle, WA USA; Pitt Cty Mem Hosp, Rehabil Ctr, Grimesland, NC USA; Vet Hlth Adm, Grimesland, NC USA; Univ Med Ctr Eastern Carolina Pitt Cty, Grimesland, NC USA; Univ Missouri, Dept Phys Med & Rehabil, Columbia, MO USA		Cardenas, DD (corresponding author), Univ Washington, Dept Rehabil Med, Box 356490, Seattle, WA USA.	dianamac@u.washington.edu					Ankjaer-Jensen A, 1994, Ugeskr Laeger, V156, P647; APELQVIST J, 1995, FOOT ANKLE INT, V16, P388, DOI 10.1177/107110079501600702; BACH JR, 1994, CHEST, V105, P1538, DOI 10.1378/chest.105.5.1538; BAKKER C, 1994, J RHEUMATOL, V21, P264; Botel U, 1997, SPINAL CORD, V35, P40, DOI 10.1038/sj.sc.3100345; BROWN KC, 1992, SPINE, V17, P1224, DOI 10.1097/00007632-199210000-00016; Bryant ET, 1993, J HEAD TRAUMA REHAB, V8, P15; CAMERON ID, 1994, J CLIN EPIDEMIOL, V47, P1307, DOI 10.1016/0895-4356(94)90136-8; CARDENAS DD, 1998, CRIT REV PHYS REHABI, V10, P359; CICALA RS, 1989, CLIN J PAIN, V5, P223, DOI 10.1097/00002508-198909000-00005; COPE D N, 1991, Brain Injury, V5, P127, DOI 10.3109/02699059109008084; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; CZYRNY JJ, 1994, AM J PHYS MED REHAB, V73, P353, DOI 10.1097/00002060-199409000-00009; DACRE JE, 1989, ANN RHEUM DIS, V48, P322, DOI 10.1136/ard.48.4.322; DINKEL R, 1984, AKTUEL RHEUMATOL, V9, P149, DOI 10.1055/s-2008-1048134; Dunn K L, 1994, Rehabil Nurs, V19, P334; Durance J P, 1989, Int Disabil Stud, V11, P127; Eneroth M, 1996, ACTA ORTHOP SCAND, V67, P459, DOI 10.3109/17453679608996668; Falconer J A, 1993, QRB Qual Rev Bull, V19, P8; FALCONER JA, 1993, QRB QUAL REV B, V19, P142; FORSTER DP, 1994, BRIT MED J, P485; Friedlieb O P, 1994, Am J Med Qual, V9, P24, DOI 10.1177/0885713X9400900105; Goossens MEJB, 1998, HEALTH ECON, V7, P39, DOI 10.1002/(SICI)1099-1050(199802)7:1<39::AID-HEC323>3.0.CO;2-S; Gupta S K, 1988, Eur J Vasc Surg, V2, P151, DOI 10.1016/S0950-821X(88)80067-7; HAMMEL JM, 1992, ARCH PHYS MED REHAB, V73, P683; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; HEINEMANN AW, 1989, ARCH NEUROL-CHICAGO, V46, P1098, DOI 10.1001/archneur.1989.00520460084017; HELEWA A, 1989, ARTHRITIS RHEUM, V32, P1505, DOI 10.1002/anr.1780321203; HELEWA A, 1990, ARTHRITIS RHEUM, V33, P1751; Hertel R, 1996, J ORTHOP TRAUMA, V10, P223, DOI 10.1097/00005131-199605000-00001; HOLLINGWORTH W, 1993, BRIT MED J, V307, P903, DOI 10.1136/bmj.307.6909.903; Holloway RG, 1999, STROKE, V30, P1340, DOI 10.1161/01.STR.30.7.1340; HUI E, 1995, STROKE, V26, P1616, DOI 10.1161/01.STR.26.9.1616; Hull RD, 1997, ARCH INTERN MED, V157, P298, DOI 10.1001/archinte.157.3.298; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P681, DOI 10.1016/0003-9993(93)90024-5; JONSSON B, 1991, SCAND J RHEUMATOL, V20, P351, DOI 10.3109/03009749109096811; Jorgensen H S, 1996, Ugeskr Laeger, V158, P4894; JORGENSEN HS, 1997, UGESKRIFT LAEGER, V159, P2570; JORGENSEN HS, 1997, UGESKRIFT LAEGER, V159, P965; KALRA L, 1993, STROKE, V24, P1462, DOI 10.1161/01.STR.24.10.1462; KALRA L, 1994, STROKE, V25, P912; Kramer AM, 1997, JAMA-J AM MED ASSOC, V277, P396, DOI 10.1001/jama.277.5.396; Kristiansen I S, 1997, Tidsskr Nor Laegeforen, V117, P2619; KRISTIANSEN IS, 1997, TIDSSKR NOR LAEGEFOR, V117, P3557; LIANG MH, 1986, ARTHRITIS RHEUM, V29, P937, DOI 10.1002/art.1780290801; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Midha M, 1998, SPINAL CORD, V36, P190, DOI 10.1038/sj.sc.3100532; Moller G, 1992, Int J Technol Assess Health Care, V8, P93; Munin MC, 1998, JAMA-J AM MED ASSOC, V279, P847, DOI 10.1001/jama.279.11.847; NANCE P, 1995, CAN J NEUROL SCI, V22, P22, DOI 10.1017/S0317167100040452; NATHAN PA, 1993, J HAND SURG-AM, V18A, P1044, DOI 10.1016/0363-5023(93)90401-N; Nordstrom DCE, 1996, SCAND J RHEUMATOL, V25, P200, DOI 10.3109/03009749609069988; OAKES DD, 1990, ARCH PHYS MED REHAB, V71, P637; OSBERG JS, 1990, AM J PHYS MED REHAB, V69, P117, DOI 10.1097/00002060-199006000-00003; PETITTI DB, 1994, MONOGRAPHS EPIDEMIOL, V24; PINZUR MS, 1988, ORTHOPEDICS, V11, P1051; PRINCE JM, 1995, ARCH PHYS MED REHAB, V76, P919, DOI 10.1016/S0003-9993(95)80067-0; RAVIOLA CA, 1988, ARCH SURG-CHICAGO, V123, P495; Ryden L A, 1988, J Community Health, V13, P222, DOI 10.1007/BF01324234; SHVARTZMAN L, 1992, SPINE, V17, P176, DOI 10.1097/00007632-199202000-00010; SIKORSKI JM, 1993, MED J AUSTRALIA, V159, P23, DOI 10.5694/j.1326-5377.1993.tb137698.x; SIKORSKI JM, 1993, MED J AUSTRALIA, V159, P708, DOI 10.5694/j.1326-5377.1993.tb138095.x; Skargren EI, 1997, SPINE, V22, P2167, DOI 10.1097/00007632-199709150-00015; SMURAWSKA LT, 1994, STROKE, V25, P1628, DOI 10.1161/01.STR.25.8.1628; STODDART GL, 1980, CLIN INVEST MED, V3, P245; SVENSSON M, 1991, HEALTH POLICY, V19, P197, DOI 10.1016/0168-8510(91)90008-L; TATOR CH, 1993, PARAPLEGIA, V31, P700, DOI 10.1038/sc.1993.112; TRAHEY PJ, 1991, AM J OCCUP THER, V45, P397, DOI 10.5014/ajot.45.5.397; UDVARHELYI IS, 1992, ANN INTERN MED, V116, P238, DOI 10.7326/0003-4819-116-3-238; *US PREV HLTH SCI, 1996, GUID CLIN PREV SERV; VERVERELI PA, 1995, CLIN ORTHOP RELAT R, P208; WEST M, 1991, ARCH PHYS MED REHAB, V72, P127; WESTBROOK L, 1990, CLIN J PAIN, V6, P32, DOI 10.1097/00002508-199003000-00006; Wielink G, 1997, EUR UROL, V31, P441; YASSI A, 1995, OCCUP MED-OXFORD, V45, P209, DOI 10.1093/occmed/45.4.209	75	24	25	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2001	82	5					711	719		10.1053/apmr.2001.24814			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	429RR	WOS:000168531200029	11346857				2022-02-06	
J	Johannes, S; Wieringa, BM; Nager, W; Muller-Vahl, KR; Dengler, R; Munte, TF				Johannes, S; Wieringa, BM; Nager, W; Muller-Vahl, KR; Dengler, R; Munte, TF			Electrophysiological measures and dual-task performance in Tourette syndrome indicate deficient divided attention mechanisms	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						attention; audition; event-related potentials; Tourette syndrome; vision	EVENT-RELATED POTENTIALS; COGNITIVE BRAIN POTENTIALS; AUDITORY ODDBALL TASKS; CLOSED-HEAD-INJURY; FUNCTIONAL NEUROANATOMY; SUSTAINED ATTENTION; INTRACRANIAL ERPS; CHILDREN; DISORDER; TARGET	Tourette syndrome has been associated with impairments of attentional functions such as distractability, even in subjects without co-morbid attention deficit hyperactivity disorder. Based on the results of earlier research we hypothesized that Tourette syndrome patients might employ altered control mechanisms of attentional processes and have concurrent difficulties in allocating their attentional resources among competing tasks. Event-related brain potentials (ERPs) were recorded in a group of Tourette syndrome patients and in a matched control group during a dual task experiment. This experiment required the simultaneous detection of visual and auditory target stimuli which were manipulated to yield two different difficulty levels each of which were varied orthogonally. The behavioural parameters confirmed the intended performance differences between difficult-to-detect targets and easy-to-detect targets. This was paralleled by lower amplitudes and longer latencies of the corresponding P3b-ERP subcomponents. Although Tourette syndrome patients were unimpaired in overall performance they showed an increased interference of visual task demands with auditory target perception. In parallel they also exhibited a reduced amplitude of the P3b component to auditory targets. The findings show that Tourette syndrome patients are not generally impaired in their dual task performance. The allocation of attentional resources to competing tasks however, is altered. We speculate that this may be related to deficient inhibitory functions.	Hannover Med Sch, Dept Neurol, D-30623 Hannover, Germany; Otto Von Guericke Univ, Dept Neuropsychol, Magdeburg, Germany; Med Hsch Hannover, Dept Clin Psychiat & Psychotherapy, Hannover, Germany		Johannes, S (corresponding author), Hannover Med Sch, Dept Neurol, D-30623 Hannover, Germany.		Munte, Thomas/C-2077-2014	Muller-Vahl, Kirsten/0000-0002-7181-7419			Adcock RA, 2000, P NATL ACAD SCI USA, V97, P3567, DOI 10.1073/pnas.060588897; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Barcelo F, 2000, NEUROPSYCHOLOGIA, V38, P1342, DOI 10.1016/S0028-3932(00)00046-4; Bornstein R A, 1991, J Neuropsychiatry Clin Neurosci, V3, P157; Bourke PA, 1997, Q J EXP PSYCHOL-A, V50, P821; Chao LL, 1997, NEUROBIOL AGING, V18, P87, DOI 10.1016/S0197-4580(96)00161-3; Clark VP, 2000, J NEUROPHYSIOL, V83, P3133, DOI 10.1152/jn.2000.83.5.3133; Clarke JM, 1999, CLIN NEUROPHYSIOL, V110, P1226, DOI 10.1016/S1388-2457(99)00064-4; Clarke JM, 1999, CLIN NEUROPHYSIOL, V110, P1210, DOI 10.1016/S1388-2457(99)00063-2; DRAKE ME, 1992, CLIN ELECTROENCEPHAL, V23, P19, DOI 10.1177/155005949202300106; Ebmeier KP, 1995, ELECTROEN CLIN NEURO, V95, P434, DOI 10.1016/0013-4694(95)00173-5; Garcia-Larrea L, 1998, EVOKED POTENTIAL, V108, P260, DOI 10.1016/S0168-5597(97)00085-3; GEORGIOU N, 1995, BRAIN, V118, P1305, DOI 10.1093/brain/118.5.1305; Halgren E, 1998, ELECTROEN CLIN NEURO, V106, P156, DOI 10.1016/S0013-4694(97)00119-3; HILLYARD SA, 1983, ANNU REV PSYCHOL, V34, P33, DOI 10.1146/annurev.ps.34.020183.000341; Isreal J B, 1980, Prog Brain Res, V54, P416, DOI 10.1016/S0079-6123(08)61653-2; JENNINGS JR, 1976, PSYCHOPHYSIOLOGY, V13, P277; Johannes S, 1997, EUR J NEUROL, V4, P152, DOI 10.1111/j.1468-1331.1997.tb00321.x; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Leclercq M, 2000, J CLIN EXP NEUROPSYC, V22, P339, DOI 10.1076/1380-3395(200006)22:3;1-V;FT339; Linden DEJ, 1999, CEREB CORTEX, V9, P815, DOI 10.1093/cercor/9.8.815; Nash AJ, 1996, INT J PSYCHOPHYSIOL, V23, P171, DOI 10.1016/S0167-8760(96)00049-9; Oades RD, 1996, BIOL PSYCHOL, V43, P163, DOI 10.1016/0301-0511(96)05189-7; Oades RD, 2000, PSYCHIAT RES, V93, P165, DOI 10.1016/S0165-1781(00)00105-0; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ozonoff S, 1998, J CHILD PSYCHOL PSYC, V39, P1109, DOI 10.1017/S0021963098003230; Palumbo D, 1997, ARCH NEUROL-CHICAGO, V54, P475, DOI 10.1001/archneur.1997.00550160101023; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; RUGG MD, 1993, NEUROPSYCHOLOGIA, V31, P373, DOI 10.1016/0028-3932(93)90161-R; Sheppard DM, 1999, CLIN PSYCHOL REV, V19, P531, DOI 10.1016/S0272-7358(98)00059-2; Sherman EMS, 1998, J CLIN EXP NEUROPSYC, V20, P644, DOI 10.1076/jcen.20.5.644.1118; Shucard DW, 1997, NEUROPSYCHOLOGY, V11, P147, DOI 10.1037/0894-4105.11.1.147; Spencer T, 1998, J CHILD PSYCHOL PSYC, V39, P1037, DOI 10.1017/S0021963098002984; Stablum F, 1996, CORTEX, V32, P261, DOI 10.1016/S0010-9452(96)80050-5; STEPHENSON WA, 1951, ELECTROEN CLIN NEURO, V3, P237, DOI 10.1016/0013-4694(51)90017-X; *TOUR SYNDR CLASS, 1994, NEUROLOGY, V50, P1013; VANWOERKOM TCAM, 1994, ACTA NEUROL SCAND, V90, P116; VERLEGER R, 1988, BEHAV BRAIN SCI, V11, P343, DOI 10.1017/S0140525X00058015; Vilkki J, 1996, NEUROPSYCHOLOGIA, V34, P1051, DOI 10.1016/0028-3932(96)00028-0; WICKENS C, 1983, SCIENCE, V221, P1080, DOI 10.1126/science.6879207; Yamazaki T, 2000, BRAIN TOPOGR, V12, P159, DOI 10.1023/A:1023467806268; Yoshiura T, 1999, NEUROREPORT, V10, P1683, DOI 10.1097/00001756-199906030-00011; Ziemann U, 1997, AM J PSYCHIAT, V154, P1277	43	24	27	0	4	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	1351-5101			EUR J NEUROL	Eur. J. Neurol.	MAY	2001	8	3					253	260		10.1046/j.1468-1331.2001.00199.x			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	430EK	WOS:000168561000009	11328334				2022-02-06	
J	Stoffel, M; Rinecker, M; Plesnila, N; Eriskat, J; Baethmann, A				Stoffel, M; Rinecker, M; Plesnila, N; Eriskat, J; Baethmann, A			Role of nitric oxide in the secondary expansion of a cortical brain lesion from cold injury	JOURNAL OF NEUROTRAUMA			English	Article						aminoguanidine; cerebral contusion; lesion growth; L-arginine; N-G-nitro-L-arginine; nitric oxide synthase; traumatic brain injury	FOCAL CEREBRAL-ISCHEMIA; L-ARGININE; MESSENGER MOLECULE; IMPACT INJURY; RAT; SYNTHASE; EDEMA; AMINOGUANIDINE; INHIBITION; MODEL	We have investigated the role of nitric oxide (NO) as mediator of the secondary growth of a traumatic cortical necrosis. For this purpose, a highly standardized focal lesion of the brain was induced in 46 Sprague-Dawley rats by cold injury. Twenty-four hours later-the timepoint of maximal lesion spread-the animals were sacrificed and brains were removed for histomorphometry of the maximal necrosis area and volume. The animals were divided into five experimental groups. Group I received the NO donor L-arginine as i.v. bolus 10 min prior to trauma (300 mg/kg body weight; n = 10) and a second bolus of the same dosage intraperitoneally 1 h after trauma. Group II (n = 10)-serving as control of group I-was infused with an i.v. bolus of 1 mL/kg isotonic saline 10 min prior to and a subsequent bolus i.p. 1 h after trauma. Group III (n = 8) received 100 mg/kg b.w. of the inducible NOS (iNOS) inhibitor aminoguanidine (AG) 1 h before and 8 1 1 after trauma by intraperitoneal route. Group IV was administered with the nitric oxide synthase (NOS) inhibitor N-G-nitro-L-arginine (L-NNA; 100 mg/kg b.w., i.p.; n = 8); group V-the controls of group III and IV-was administered with isotonic saline (1 mL/kg b.w, i.p.; n = 10) 1 h before and 8 h after trauma. In the control group with i.v./i.p. sham treatment (II), the focal lesion led to a cortical necrosis with a maximum area of 3.1 +/- 0.3 mm(2) and a lesion volume of 5.7 +/- 0.5 mm(3) at 24 h after trauma. In animals with administration of L-arginine, the focal lesion had a maximum area of 3.1 +/- 0.3 mm(2) and a volume of 5.3 +/- 0.5 mm3. Hence, the NO donor did not affect the secondary growth of necrosis. Animals with i.p. sham treatment (group V) had a maximal lesion area of 3.6 +/- 0.2 mm(2) and lesion volume of 6.2 +/- 0.4 mm(3). Administration of aminoguanidine afforded significant attenuation of the lesion growth. Accordingly, the maximal area of necrosis spread only to 2.8 +/- 0.2 mm(2) with a volume of 4.5 +/- 0.5 mm(3), respectively, at 24 h after trauma (p < 0.01 vs group V). On the other hand, administration of L-NNA did not influence the maximal lesion area (3.7 +/- 0.2 mm(2)) or lesion volume (6.5 +/- 0.5 mm(3)) evolving at 24 h after trauma. Thus, neither the enhancement of the formation of NO by L-arginine nor gross inhibition of the synthesis of NO by L-NNA did affect the secondary spread of the necrosis from a focal trauma. The marked attenuation of the posttraumatic necrosis growth by the iNOS inhibitor aminoguanidine strongly indicates an important role of iNOS product in this phenomenon. These findings, thus, demonstrate that the expansion of a primary necrotic focal lesion is a secondary process which can be therapeutically inhibited. Thereby, the growth of a focal tissue necrosis from trauma is clearly identified as a manifestation of secondary brain damage. This information is deemed important for the better understanding of the pathophysiology of traumatic brain injury and for the targeted development of specific treatment modalities.	Univ Bonn, Dept Neurosurg, D-53105 Bonn, Germany; Univ Munich, Klinikum Grosshadern, Inst Surg Res, D-8000 Munich, Germany		Stoffel, M (corresponding author), Univ Bonn, Dept Neurosurg, Sigmund Freud Str 25, D-53105 Bonn, Germany.	michael.stoffel@meb.uni-bonn.de	Plesnila, Nikolaus/T-7522-2019				BAETHMANN A, 1989, J NEUROSURG, V70, P578, DOI 10.3171/jns.1989.70.4.0578; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; Clark RSB, 1996, CRIT CARE MED, V24, P1243, DOI 10.1097/00003246-199607000-00030; Cockroft KM, 1996, STROKE, V27, P1393, DOI 10.1161/01.STR.27.8.1393; DALKARA T, 1994, AM J PHYSIOL, V267, pH678, DOI 10.1152/ajpheart.1994.267.2.H678; DALKARA T, 1994, NEUROPHARMACOLOGY, V33, P1447, DOI 10.1016/0028-3908(94)90048-5; DALKARA T, 1994, BRAIN PATHOL, V4, P49; DAWSON DA, 1992, NEUROSCI LETT, V142, P151, DOI 10.1016/0304-3940(92)90361-A; DAWSON TM, 1994, J NEUROSCI, V14, P5147; DAWSON TM, 1992, ANN NEUROL, V32, P297, DOI 10.1002/ana.410320302; DAWSON TM, 1995, NEUROSCIENTIST, V1, P7; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; Dogan A, 1999, J NEUROSURG, V90, P1078, DOI 10.3171/jns.1999.90.6.1078; EGGERT HR, 1985, NEUROSURGERY, V16, P443, DOI 10.1227/00006123-198504000-00001; ERISKAT J, 1994, ACTA NEUROCHIR, P425; FARACI FM, 1994, STROKE, V25, P692, DOI 10.1161/01.STR.25.3.692; Gahm C, 2000, NEUROSURGERY, V46, P169, DOI 10.1093/neurosurgery/46.1.169; Golding EM, 1998, J NEUROTRAUM, V15, P635, DOI 10.1089/neu.1998.15.635; Huang ZH, 1996, J CEREBR BLOOD F MET, V16, P981, DOI 10.1097/00004647-199609000-00023; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; IADECOLA C, 1994, J CEREBR BLOOD F MET, V14, P175, DOI 10.1038/jcbfm.1994.25; KLATZO I, 1958, J NEUROPATH EXP NEUR, V17, P548, DOI 10.1097/00005072-195810000-00002; Knerlich F, 1999, MOL BRAIN RES, V68, P73, DOI 10.1016/S0169-328X(99)00064-9; KOENIG H, 1989, J NEUROCHEM, V52, P101, DOI 10.1111/j.1471-4159.1989.tb10903.x; LINDSBERG PJ, 1991, J CEREBR BLOOD F MET, V11, P88, DOI 10.1038/jcbfm.1991.10; LIPTON SA, 1994, NEUROPHARMACOLOGY, V33, P1229, DOI 10.1016/0028-3908(94)90021-3; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; LIPTON SA, 1997, CEREBROVASC DIS, P210; MALINSKI T, 1993, J CEREBR BLOOD F MET, V13, P355, DOI 10.1038/jcbfm.1993.48; MONCADA S, 1991, PHARMACOL REV, V43, P109; NAGAFUJI T, 1992, NEUROSCI LETT, V147, P159, DOI 10.1016/0304-3940(92)90584-T; Nilsson BO, 1999, INFLAMM RES, V48, P509, DOI 10.1007/s000110050495; NOWICKI JP, 1991, EUR J PHARMACOL, V204, P339, DOI 10.1016/0014-2999(91)90862-K; PLESNILA N, 1997, J CEREB BLOOD FLOW M, V17, pS73; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Southan GJ, 1996, BRIT J PHARMACOL, V117, P619, DOI 10.1111/j.1476-5381.1996.tb15236.x; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; Stoffel M, 1997, J NEUROTRAUM, V14, P339, DOI 10.1089/neu.1997.14.339; TRIFILETTI RR, 1992, EUR J PHARMACOL, V218, P197, DOI 10.1016/0014-2999(92)90168-4; UNTERBERG A, 1986, J NEUROSURG, V64, P269, DOI 10.3171/jns.1986.64.2.0269; UYLINGS HBM, 1986, J NEUROSCI METH, V18, P19, DOI 10.1016/0165-0270(86)90111-1; VONHOF S, 1997, THESIS L MAXIMILIANS; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; WYRWICH W, 1997, THESIS L MAXIMILIANS; YAMAMOTO S, 1992, J CEREBR BLOOD F MET, V12, P717, DOI 10.1038/jcbfm.1992.102	47	24	24	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2001	18	4					425	434		10.1089/089771501750171010			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	425TP	WOS:000168308000006	11336443				2022-02-06	
J	Grundy, PL; Patel, N; Harbuz, MS; Lightman, SL; Sharples, PM				Grundy, PL; Patel, N; Harbuz, MS; Lightman, SL; Sharples, PM			Glucocorticoids modulate the NGF mRNA response in the rat hippocampus after traumatic brain injury	BRAIN RESEARCH			English	Article						traumatic brain injury; fluid percussion; NGF; adrenalectomy; glucocorticoid; hippocampus	NERVE GROWTH-FACTOR; FLUID-PERCUSSION INJURY; MESSENGER-RNA; HEAD-INJURY; BASAL FOREBRAIN; NEUROTROPHIN EXPRESSION; EXCITOTOXIC LESIONS; CHOLINERGIC NEURONS; ADRENAL-STEROIDS; CELL LOSS	Nerve growth factor (NGF) expression in the rat hippocampus is increased after experimental traumatic brain injury (TBI) and is neuroprotective. Glucocorticoids are regulators of brain neurotrophin levels and are often prescribed following TBI. The effect of adrenalectomy (ADX) and corticosterone (CORT) replacement on the expression of NGF mRNA in the hippocampus after TBI has not been investigated to date. We used fluid percussion injury and in situ hybridisation to evaluate the expression of NGF mRNA in the hippocampus 4 h after TBI in adrenal-intact or adrenalectomised rats (with or without CORT replacement). TBI increased expression of NGF mRNA in sham-ADX rats, but not in ADX rats. Furthermore. CORT replacement in ADX rats restored the increase in NGF mRNA induced by TBI. These findings suggest that glucocorticoids have an important role in the induction of hippocampal NGF mRNA after TBI. (C) 2001 Elsevier Science B.V. All rights reserved.	Frenchay Hosp, Acad Ctr, Dept Neurosurg, Neurosurg Res Grp, Bristol BS16 1LE, Avon, England; Univ Bristol, Univ Res Ctr Neuroendocrinol, Bristol BS15 4UB, Avon, England; Univ Bristol, Div Child Hlth, Bristol BS8 1TH, Avon, England		Grundy, PL (corresponding author), Frenchay Hosp, Acad Ctr, Dept Neurosurg, Neurosurg Res Grp, Room 1, Bristol BS16 1LE, Avon, England.	p.l.grundy@bristol.ac.uk		Lightman, Stafford/0000-0002-8546-9646			Alderson P, 1997, BRIT MED J, V314, P1855, DOI 10.1136/bmj.314.7098.1855; Barde Y A, 1994, Prog Clin Biol Res, V390, P45; BENGZON J, 1993, NEUROSCIENCE, V53, P433, DOI 10.1016/0306-4522(93)90207-V; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BURKE MA, 1994, EXP NEUROL, V130, P178, DOI 10.1006/exnr.1994.1197; CHENG B, 1991, NEURON, V7, P1031, DOI 10.1016/0896-6273(91)90347-3; CONRAD CD, 1995, HIPPOCAMPUS, V5, P1, DOI 10.1002/hipo.450050103; DEKKER AJ, 1992, NEUROSCIENCE, V48, P111, DOI 10.1016/0306-4522(92)90342-Y; DEKOSKY ST, 1994, EXP NEUROL, V130, P173, DOI 10.1006/exnr.1994.1196; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FADEN AI, 1992, TRENDS PHARMACOL SCI, V13, P29, DOI 10.1016/0165-6147(92)90013-V; FOLLESA P, 1993, MOL PHARMACOL, V43, P132; FRIM DM, 1993, J NEUROSURG, V78, P267, DOI 10.3171/jns.1993.78.2.0267; Grundy PL, 2000, NEUROREPORT, V11, P3381, DOI 10.1097/00001756-200010200-00023; HARBUZ MS, 1989, J ENDOCRINOL, V122, P705, DOI 10.1677/joe.0.1220705; JACOBSON L, 1989, ENDOCRINOLOGY, V124, P2144, DOI 10.1210/endo-124-5-2144; KOTAPKA MJ, 1992, ACTA NEUROPATHOL, V83, P530, DOI 10.1007/BF00310031; LARKFORS L, 1987, J NEUROSCI RES, V18, P525, DOI 10.1002/jnr.490180404; LAUTERBORN J, 1995, NEUROSCIENCE, V68, P363, DOI 10.1016/0306-4522(95)00150-H; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; LI YW, 1995, J NEUROSCI, V15, P2888; LINDHOLM D, 1994, J NEUROBIOL, V25, P1362, DOI 10.1002/neu.480251105; LINDHOLM D, 1994, ANN NY ACAD SCI, V746, P195; Lindsay E A, 1989, Am J Health Promot, V3, P11, DOI 10.4278/0890-1171-3.3.11; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; MCEWEN BS, 1994, ANN NY ACAD SCI, V746, P134; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mocchetti I, 1996, J NEUROSCI, V16, P2141; MUFSON EJ, 1994, J COMP NEUROL, V341, P507, DOI 10.1002/cne.903410407; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; SCULLY JL, 1995, MOL BRAIN RES, V31, P158; SHARPLES PM, 1990, BRIT MED J, V300, P87, DOI 10.1136/bmj.300.6717.87; Shi BT, 2000, EXP NEUROL, V162, P257, DOI 10.1006/exnr.2000.7360; SHIGENO T, 1991, J NEUROSCI, V11, P2914; SINSON G, 1995, J NEUROCHEM, V65, P2209; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; SUN FY, 1993, NEUROPSYCHOPHARMACOL, V8, P219, DOI 10.1038/npp.1993.24; TAKEDA A, 1993, NEUROSCIENCE, V55, P23, DOI 10.1016/0306-4522(93)90451-K; WHITELEY T, 1999, THESIS U NEWCASTLE U; YAMAKI T, 1994, J NEUROTRAUM, V11, P613, DOI 10.1089/neu.1994.11.613	41	24	29	2	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	FEB 23	2001	892	2					386	390		10.1016/S0006-8993(00)03258-3			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	403BJ	WOS:000167022400020	11172788				2022-02-06	
J	Voller, B; Auff, E; Schnider, P; Aichner, F				Voller, B; Auff, E; Schnider, P; Aichner, F			To do or not to do? Magnetic resonance imaging in mild traumatic brain injury	BRAIN INJURY			English	Article							DIFFUSE AXONAL INJURY; CLOSED-HEAD INJURY; VEGETATIVE STATE; CONCUSSION; MRI; DIAGNOSIS; LESIONS; HUMANS; SPECT; CT	Clinical quantification of mild traumatic brain injury (MTBI) patients should be based on Glasgow coma scale (GCS) score, duration of loss of consciousness (LOC) and post-traumatic amnesia (PTA). In addition, a short practicable neuropsychological test might be useful in detecting minor memory and attentional deficits. MRI appears to be the most sensitive imaging method for assessing MTBI so far, but information regarding a visualized lesion is not usually utilized in the classification of MTBI. Magnetic resonance imaging (MRI) should, therefore, play a major role in any MTBI classification scheme. An appropriate MRI protocol has to be chosen using at least T-1 weighted, T-2 weighted, proton density and gradient-echo (GRE) sequence images, all in at least two planes, in order to detect and classify all lesions precisely. Owing to the fact that acute lesions may be missed, it is advisable to perform MRI in the first 2 weeks following trauma. Further research is necessary to clarify the relationship between chronic symptoms after MTBI and MRI abnormalities. It may, thus, be possible to provide optimal strategies for emergency department management, to define a group of patients with a need for acute and rehabilitative intervention after MTBI, and to predict their outcome.	OO Landes Nervenklin Wagner Jauregg, Dept Neurol, A-4021 Linz, Austria; Univ Vienna, Dept Neurorehabil, A-1010 Vienna, Austria		Aichner, F (corresponding author), OO Landes Nervenklin Wagner Jauregg, Dept Neurol, Wagner Jauregg Weg 15, A-4021 Linz, Austria.	franz.aichner@wj.lkh.ooe.gv.at		Voller, Bernhard/0000-0001-5809-874X			Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Adams JH, 1990, HDB CLIN NEUROLOGY, P43; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Ashikaga R, 1997, NEURORADIOLOGY, V39, P239, DOI 10.1007/s002340050401; ATLAS SW, 1988, RADIOLOGY, V168, P803, DOI 10.1148/radiology.168.3.3406410; Barzo P, 1997, ACT NEUR S, V70, P243; Beauchamp NJ, 1999, RADIOLOGY, V212, P307, DOI 10.1148/radiology.212.2.r99au16307; COBURN TH, 1989, MILD HEAD INJURY, P37; DOEZEMA D, 1991, ANN EMERG MED, V20, P449; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1988, AM J NEURORADIOL, V9, P91; GENTRY LR, 1994, RADIOLOGY, V191, P1; Goodman JC, 1999, TRAUMATIC BRAIN INJU, P143; JENKINS A, 1986, LANCET, V2, P445; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Schoenhuber R, 1983, J Neurosurg Sci, V27, P157; SNOW RB, 1986, NEUROSURGERY, V18, P45, DOI 10.1227/00006123-198601000-00008; Umile EM, 1998, BRAIN INJURY, V12, P577; Voller B, 1999, BRAIN INJURY, V13, P821, DOI 10.1080/026990599121214; Wiesmann M, 1998, RADIOLOGE, V38, P645, DOI 10.1007/s001170050405; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391; WRIGHTSON P, 1989, MILD HEAD INJURY, P246; YOKOTA H, 1991, J TRAUMA, V31, P351, DOI 10.1097/00005373-199103000-00007	42	24	24	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2001	15	2					107	115		10.1080/026990501458344			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	398BG	WOS:000166733800003	11260761				2022-02-06	
J	Marschark, M; Richtsmeier, LM; Richardson, JTE; Crovitz, HF; Henry, J				Marschark, M; Richtsmeier, LM; Richardson, JTE; Crovitz, HF; Henry, J			Intellectual and emotional functioning in college students following mild traumatic brain injury in childhood and adolescence	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognitive impairment; college students; emotional functioning; fluency; memory impairment; study behavior; Symptom Checklist-90-Revised; traumatic brain injury	CLOSED-HEAD-INJURY; POSTTRAUMATIC AMNESIA; POSTCONCUSSION SYNDROME; BEHAVIOR PROBLEMS; WORKING-MEMORY; UNITED-STATES; CHILDREN; PERFORMANCE; CONCUSSION; SEQUELAE	Objective: To investigate whether college students with a history of mild traumatic brain injury (TBI) in childhood or adolescence show residual deficits in intellectual functioning, approaches to studying, or emotional stability. Design: Participants with a history of mild TBI and two control groups. Setting: Volunteers were recruited from students taking an introductory psychology course. Participants: 79 students with a history of mild TBI, 75 students with a history of general anesthesia, and 93 students with no history of either TBI or general anesthesia. Main Outcome Measures: Participants carried out tests of verbal memory, nonverbal memory, verbal fluency, and nonverbal fluency; in addition, they completed a short form of the Approaches to Studying Inventory and the symptom Checklist-90-Revised (SCL-90-R). Results: In comparison with the two control groups, the students with a history of mild TBI produced similar scores on the cognitive tests and similar orientations to studying. However, they showed a significantly higher level of emotional distress on the SCL-90-R. Conclusion: College students with a history of mild TBI in childhood or adolescence are intellectually unimpaired and approach their studying in a similar manner to their uninjured classmates. Nevertheless, they report more severe distress in terms of their general personal and emotional functioning.	Rochester Inst Technol, Natl Tech Inst Deaf, Ctr Res Teaching & Learning, Rochester, NY 14623 USA; Rochester Inst Technol, Med Ctr, Rochester, NY 14623 USA; Brunel Univ, Dept Human Sci, Uxbridge UB8 3PH, Middx, England; Duke Univ, Dept Psychol, Durham, NC 27706 USA; Univ N Carolina, Dept Psychol, Greensboro, NC 27412 USA		Marschark, M (corresponding author), Rochester Inst Technol, Natl Tech Inst Deaf, Ctr Res Teaching & Learning, Rochester, NY 14623 USA.			Richardson, John/0000-0002-6267-0603	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS27243] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS027243] Funding Source: NIH RePORTER		ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; AMPHOUX M, 1977, REV MED TRAVAIL, V5, P53; Azouvi P, 1996, J CLIN EXP NEUROPSYC, V18, P317, DOI 10.1080/01688639608408990; Baddeley A, 1996, PHILOS T ROY SOC B, V351, P1397, DOI 10.1098/rstb.1996.0123; BADDELEY A, 1987, NEUROBEHAVIORAL RECO; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Bijur P., 1995, TRAUMATIC HEAD INJUR; BIJUR PE, 1990, PEDIATRICS, V86, P337; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; BROWN SJ, 1994, J NEUROPSYCH CLIN N, V6, P15; Caplan P.J., 1997, GENDER DIFFERENCES H; CARLSSON GS, 1987, J NEUROSURG, V67, P197, DOI 10.3171/jns.1987.67.2.0197; Caveness W F, 1979, Adv Neurol, V22, P1; Cohen J., 2013, STAT POWER ANAL BEHA; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; CORKIN SH, 1987, NEUROBEHAVIORAL RECO; CROVITZ HF, 1983, CORTEX, V19, P407, DOI 10.1016/S0010-9452(83)80009-4; DEROGATIS LR, 1977, J CLIN PSYCHOL, V33, P981, DOI 10.1002/1097-4679(197710)33:4<981::AID-JCLP2270330412>3.0.CO;2-0; DEROGATIS LR, 1976, BRIT J PSYCHIAT, V128, P280, DOI 10.1192/bjp.128.3.280; Derogatis LR, 1975, SCL 90 R; Derogatis LR., 1977, SCL 90 R ADM SCORING, V1; Dikmen S, 1976, Trans Am Neurol Assoc, V101, P72; Entwistle N, 1983, UNDERSTANDING STUDEN; FORRESTER G, 1994, BRAIN INJURY, V8, P175, DOI 10.3109/02699059409150969; Gibbs G, 1992, IMPROVING QUALITY ST; Gordon WR, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199812000-00006; Graves EJ, 1997, VITAL HLTH STAT, V13; Greenwood R, 1997, LANCET, V349, P1041, DOI 10.1016/S0140-6736(05)62288-X; GRONWALL D, 1975, LANCET, V2, P995; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; Gronwall D, 1974, PSYCHOL EFFECTS CONC; HEISKANEN O, 1974, DEV MED CHILD NEUROL, V16, P11; HOWIESON DB, 1995, HDB MEMORY DISORDERS; Jennett B, 1981, MANAGEMENT HEAD INJU; JORESKOG KG, 1971, PSYCHOMETRIKA, V36, P409, DOI 10.1007/BF02291366; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; KLONOFF H, 1974, CLIN NEUROPSYCHOLOGY; Kolb B., 1990, FUNDAMENTALS HUMAN N; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; KRAUS JF, 1993, HEAD INJURY; Levin H.S., 1989, MILD HEAD INJURY; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; Light R, 1998, J CONSULT CLIN PSYCH, V66, P1023; MARSCHARK M, 1989, J EXP PSYCHOL LEARN, V15, P710, DOI 10.1037/0278-7393.15.4.710; MAYOU R, 1986, BRIT J PSYCHIAT, V149, P172, DOI 10.1192/bjp.149.2.172; MCMILLAN TM, 1987, J NEUROL NEUROSUR PS, V50, P393, DOI 10.1136/jnnp.50.4.393; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; MONTANELLI RG, 1976, PSYCHOMETRIKA, V41, P341, DOI 10.1007/BF02293559; NIES KJ, 1994, ARCH CLIN NEUROPSYCH, V9, P501, DOI 10.1016/0887-6177(94)90041-8; ODONNELL WE, 1984, J CLIN PSYCHOL, V40, P241, DOI 10.1002/1097-4679(198401)40:1<241::AID-JCLP2270400147>3.0.CO;2-6; PAIVIO A, 1968, J EXP PSYCHOL MONO 2, V76; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; RICHARDSON JTE, 1985, COGNITIVE NEUROPSYCH, V2, P149, DOI 10.1080/02643298508252864; RICHARDSON JTE, 1994, HIGH EDUC, V27, P449, DOI 10.1007/BF01384904; Richardson JTE, 1996, BEHAV RES METH INSTR, V28, P12, DOI 10.3758/BF03203631; RICHARDSON JTE, 1990, STUD HIGH EDUC, V15, P155, DOI 10.1080/03075079012331377481; Richardson JTE., 2000, CLIN NEUROPSYCHOLOGI; Richardson JTE., 2000, RES STUDENT LEARNING; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; RODIN G, 1991, DEPRESSION MENTALLY; ROSENTHAL R, 1988, ARTIFACT BEHAV RES; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; RUTHERFORD WH, 1989, MILD HEAD INJURY; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Satz P, 1999, J CLIN EXP NEUROPSYC, V21, P620, DOI 10.1076/jcen.21.5.620.870; SEGALOWITZ SJ, 1991, J LEARN DISABIL, V24, P551, DOI 10.1177/002221949102400907; Smed A, 1997, ACTA NEUROL SCAND, V95, P73, DOI 10.1111/j.1600-0404.1997.tb00072.x; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Stewart DP, 1996, ACAD EMERG MED, V3, P21, DOI 10.1111/j.1553-2712.1996.tb03297.x; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; STUSS DT, 1987, FRONTAL LOBES REVIS; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; TRANEL D, 1994, HDB NEUROPSYCHOLOGY, V9; VANZOMEREN AH, 1984, CLOSED HEAD INJURY P; VARNEY NR, 1995, J HEAD TRAUMA REHAB, V10, P18; Veltman JC, 1996, NEUROPSYCHOLOGY, V10, P357, DOI 10.1037/0894-4105.10.3.357; Wallis BJ, 1998, CEPHALALGIA, V18, P101, DOI 10.1046/j.1468-2982.1998.1802101.x; Wallis BJ, 1996, PAIN, V66, P223, DOI 10.1016/0304-3959(96)03044-8; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; WOESSNER R, 1995, J HEAD TRAUMA REHAB, V10, P78, DOI 10.1097/00001199-199504000-00009; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; [No title captured]	91	24	25	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	2000	15	6					1227	1245		10.1097/00001199-200012000-00004			19	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	378ZX	WOS:000165617400004	11056405				2022-02-06	
J	Mrazik, M; Ferrara, MS; Peterson, CL; Elliott, RE; Courson, RW; Clanton, MD; Hynd, GW				Mrazik, M; Ferrara, MS; Peterson, CL; Elliott, RE; Courson, RW; Clanton, MD; Hynd, GW			Injury severity and neuropsychological and balance outcomes of four college athletes	BRAIN INJURY			English	Article							MILD HEAD-INJURY; FOOTBALL PLAYERS; STANDARDIZED ASSESSMENT; SOCCER PLAYERS; CONCUSSION; SPORTS; MANAGEMENT	Recent evidence suggests significant short-term neurocognitive deficits following mild traumatic brain injury (MTBI) in sports. However, sequelae of mild head injuries is complicated by many factors including a history of multiple head injuries and injury severity. Few studies have considered the influence these variables may have on proper classification of a MTBI and their meaning for return-to-play guidelines. This study presents the short-term neuropsychological and balance outcomes of four college athletes who sustained mild head injuries of different severity (grade I, grade II, grade III and multiple head injured with a grade II based on American Academy of Neurology guidelines). The results demonstrated that self-report symptoms of concussion were slow to resolve in the grade III and multiple concussed individuals. For neuropsychological testing, Trails A & B, Symbol Digit Modalities Test and Digits Span Backwards were the most sensitive in identifying differences between the injuries. For balance assessments using the Neurocom Smart Balance System, the Sensory Organization Test and Reaction Time were also important variables in detecting differences among the various injuries. When these data are used together, it can assist physicians in determining safe return-to-play for athletes who sustain MTBI. There are contradindications in the numerous grading systems and return-to-play guidelines for MTBI. The results from this study provides new evidence which can be assimilated into a valid grading scale for MTBI sustained in sport.	Univ Georgia, Athens, GA 30602 USA		Mrazik, M (corresponding author), Univ Georgia, 300 River Rd, Athens, GA 30602 USA.	mmrazik@coe.uga.edu					Barth JT, 1989, MILD HEAD INJURY; Benton A., 1978, MULTILINGUAL APHASIA; Brandt J, 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; *CO MED SOC, 1991, REP SPORTS MED COMM; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; CREMONAMETEYARD SL, 1994, NEUROPSYCHOLOGIA, V32, P649, DOI 10.1016/0028-3932(94)90026-4; Delaney JS, 1999, CLIN J SPORT MED, V9, P121; FORDSMITH CD, 1995, ARCH PHYS MED REHAB, V76, P77, DOI 10.1016/S0003-9993(95)80047-6; Geurts ACH, 1999, ARCH PHYS MED REHAB, V80, P144, DOI 10.1016/S0003-9993(99)90111-9; GRONWALL D, 1975, LANCET, V2, P995; GUESKIEWICZ KM, 1995, THESIS U VIRGINIA; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 1996, J SPORT REHABIL, V5, P45, DOI 10.1123/jsr.5.1.45; Ingebrigtsen Tor, 1996, Tidsskrift for den Norske Laegeforening, V116, P3594; JORDAN BD, 1993, MED ASPECTS BOXING; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; Lahat E, 1996, PEDIATR NEUROL, V15, P299, DOI 10.1016/S0887-8994(96)00221-4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; Nelson W. E., 1984, PHYSICIAN SPORTSMED, V12, P103; Putukian M, 1996, PHYSICIAN SPORTSMED, V24, P25, DOI 10.3810/psm.1996.11.1283; ROOS R, 1996, PHYSICIAN SPORTSMEDI, V24; Smith A., 1982, SYMBOL DIGIT MODALIT; Spreen O, 1991, COMPENDIUM NEUROPSYC; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; Wechsler D, 1974, WECHSLER MEMORY SCAL; Wechsler D., 1997, WECHSLER MEMORY SCAL, VIII; Wojtys EM, 1999, AM J SPORT MED, V27, P676, DOI 10.1177/03635465990270052401	32	24	24	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2000	14	10					921	931		10.1080/026990500445736			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	364QG	WOS:000089902900006	11076137				2022-02-06	
J	Schmitter-Edgecombe, M; Nissley, HM				Schmitter-Edgecombe, M; Nissley, HM			Effects of divided attention on automatic and controlled components of memory after severe closed-head injury	NEUROPSYCHOLOGY			English	Article							PROCESS-DISSOCIATION PROCEDURE; TRAUMATIC BRAIN INJURY; WORD-STEM COMPLETION; IMPLICIT MEMORY; EXPLICIT MEMORY; UNCONSCIOUS INFLUENCES; HUNTINGTONS-DISEASE; TESTS; PERFORMANCE; FRAMEWORK	The relation between attention available at encoding and automatic and consciously controlled aspects of memory was investigated using the process-dissociation procedure. Twenty-four severely closed-head injured (CHI) participants (> 1 year postinjury) and 24 matched controls studied word lists in full- and divided-attention conditions. Recall cued with word stems was tested. In contrast to consciously controlled memory, the CHI group did not perform more poorly than the controls in estimates of automatic memory. Furthermore, for both groups, the divided-attention manipulation reduced the controlled estimates of memory, whereas automatic influences remained invariant. These results suggest that automatic memory processes may remain partially immune to the deleterious effects of severe CHI or show recovery by 1 year postinjury. They also indicate that automatic memory processes do not require additional attentional resources following severe CHI.	Washington State Univ, Dept Psychol, Pullman, WA 99164 USA		Schmitter-Edgecombe, M (corresponding author), Washington State Univ, Dept Psychol, Pullman, WA 99164 USA.	schmitter-e@wsu.edu			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03 HD35838] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD035838] Funding Source: NIH RePORTER		ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; AURENBACH SH, 1987, J HEAT TRAUMA REHABI, V1, P1; BADDELEY AD, 1969, BRIT J PSYCHOL, V60, P51, DOI 10.1111/j.2044-8295.1969.tb01175.x; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BARTZ WH, 1970, J EXP PSYCHOL, V84, P380, DOI 10.1037/h0029100; BASSILI JN, 1989, Q J EXP PSYCHOL-A, V41, P439, DOI 10.1080/14640748908402375; BENNET B, 1965, BRIT J PSYCHOL, V56, P413; BLAXTON TA, 1989, J EXP PSYCHOL LEARN, V15, P657, DOI 10.1037/0278-7393.15.4.657; BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; BROOKS DN, 1972, CORTEX, V11, P329; BUCHNER A, 1995, J EXP PSYCHOL GEN, V124, P137, DOI 10.1037/0096-3445.124.2.137; CERMAK LS, 1992, BRAIN COGNITION, V20, P367, DOI 10.1016/0278-2626(92)90027-J; Cowan N, 1996, J EXP PSYCHOL GEN, V125, P195, DOI 10.1037/0096-3445.125.2.195; CURRAN T, 1995, J EXP PSYCHOL LEARN, V21, P531, DOI 10.1037/0278-7393.21.3.531; Curran T, 1997, J EXP PSYCHOL LEARN, V23, P496, DOI 10.1037/0278-7393.23.2.496; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; Dodson CS, 1996, J EXP PSYCHOL GEN, V125, P181, DOI 10.1037/0096-3445.125.2.181; Engle R.W., 1999, MODELS WORKING MEMOR, P102, DOI DOI 10.1017/CBO9781139174909.007; FAHY JF, 1995, J INT NEUROPSYCH SOC, V1, P183; Glisky EL, 1996, J HEAD TRAUMA REHAB, V11, P31, DOI 10.1097/00001199-199604000-00004; GRAF P, 1994, EUR J COGN PSYCHOL, V6, P113, DOI 10.1080/09541449408520139; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; Hamann SB, 1996, J EXP PSYCHOL LEARN, V22, P933; Hay JF, 1996, J EXP PSYCHOL LEARN, V22, P1323, DOI 10.1037/0278-7393.22.6.1323; HEINDEL WC, 1990, BRAIN COGNITION, V13, P282, DOI 10.1016/0278-2626(90)90053-Q; Hintzman DL, 1997, J EXP PSYCHOL LEARN, V23, P511, DOI 10.1037/0278-7393.23.2.511; Jacoby LL, 1997, J EXP PSYCHOL LEARN, V23, P505, DOI 10.1037/0278-7393.23.2.505; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; JACOBY LL, 1989, J EXP PSYCHOL GEN, V118, P115, DOI 10.1037/0096-3445.118.2.115; Jacoby LL, 1998, J EXP PSYCHOL LEARN, V24, P3, DOI 10.1037/0278-7393.24.1.3; JACOBY LL, 1993, J EXP PSYCHOL GEN, V122, P139, DOI 10.1037/0096-3445.122.2.139; Jacoby LL, 1997, CARN S COGN, P13; Jacoby LL, 1997, J EXP PSYCHOL LEARN, V23, P484, DOI 10.1037/0278-7393.23.2.484; JERNIGAN TL, 1993, NEUROPSYCHOLOGY, V7, P14, DOI DOI 10.1037/0894-4105.7.1.14; JOORDENS S, 1996, J EXPT PSYCHOL GEN, V122, P462; Kuera H., 1967, COMPUTATIONAL ANAL P; LEVIN HS, 1988, SCAND J REHABIL MED, P33; Levin HS., 1982, NEUROBEHAVIORAL CONS; McKone E, 1997, MEM COGNITION, V25, P352, DOI 10.3758/BF03211291; Mulligan NW, 1997, J EXP PSYCHOL LEARN, V23, P280, DOI 10.1037/0278-7393.23.2.280; Mulligan NW, 1998, J EXP PSYCHOL LEARN, V24, P27, DOI 10.1037/0278-7393.24.1.27; Mulligan NW, 1996, MEM COGNITION, V24, P453, DOI 10.3758/BF03200934; Mulligan NW, 1997, MEM COGNITION, V25, P11, DOI 10.3758/BF03197281; NISSEN M, 1986, J HEAD TRAUMA REHAB, V1, P13; PERRUCHET P, 1989, MEM COGNITION, V17, P77, DOI 10.3758/BF03199559; RANDOLPH C, 1991, J CLIN EXP NEUROPSYC, V13, P479, DOI 10.1080/01688639108401065; REEDER KP, 1994, ARCH CLIN NEUROPSYCH, V9, P491, DOI 10.1016/0887-6177(94)90040-X; ROEDIGER HL, 1992, J EXP PSYCHOL LEARN, V18, P1251, DOI 10.1037/0278-7393.18.6.1251; ROEDIGER HL, 1990, AM PSYCHOL, V45, P1043, DOI 10.1037/0003-066X.45.9.1043; ROEDIGER HL, 1994, NEUROPSYCHOLOGY, V8, P284, DOI DOI 10.1037/0894-4105.8.2.284; Sattler J. M., 1988, ASSESSMENT CHILDREN; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; Schmitter-Edgecombe M, 1999, MEM COGNITION, V27, P512, DOI 10.3758/BF03211545; Schmitter-Edgecombe M, 1996, J Int Neuropsychol Soc, V2, P111; SchmitterEdgecombe M, 1996, NEUROPSYCHOLOGY, V10, P155; Shum D, 1996, J HEAD TRAUMA REHAB, V11, P43, DOI 10.1097/00001199-199604000-00005; SMITH ER, 1988, J EXP SOC PSYCHOL, V24, P490, DOI 10.1016/0022-1031(88)90048-0; Spreen O., 1969, NEUROSENSORY CTR COM; SQUIRE LR, 1992, J EXP PSYCHOL LEARN, V18, P106, DOI 10.1037/0278-7393.18.1.106; SRINIVAS K, 1990, J MEM LANG, V29, P389, DOI 10.1016/0749-596X(90)90063-6; SteMarie DM, 1996, CLIN NEUROPSYCHOL, V10, P25, DOI 10.1080/13854049608406660; TEASDALE G, 1974, LANCET, V2, P81; TOTH JP, 1994, J EXP PSYCHOL LEARN, V20, P290, DOI 10.1037/0278-7393.20.2.290; VAKIL E, 1994, J CLIN EXP NEUROPSYC, V16, P539, DOI 10.1080/01688639408402665; Vakil E, 1997, J Int Neuropsychol Soc, V3, P327; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; Wagner AD, 1997, J EXP PSYCHOL LEARN, V23, P305, DOI 10.1037/0278-7393.23.2.305; Watt S, 1999, NEUROPSYCHOLOGY, V13, P338, DOI 10.1037/0894-4105.13.3.338; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D, 1981, WECHSLER ADULT INTEL; Yonelinas AP, 1996, J EXP PSYCHOL GEN, V125, P422, DOI 10.1037/0096-3445.125.4.422; [No title captured], DOI DOI 10.1016/S0079-7421(08)60452-1	74	24	24	0	1	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	OCT	2000	14	4					559	569					11	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	363HZ	WOS:000089831000008	11055258				2022-02-06	
J	Burnett, DM; Silver, TM; Kolakowsky-Hayner, SA; Cifu, DX				Burnett, DM; Silver, TM; Kolakowsky-Hayner, SA; Cifu, DX			Functional outcome for African Americans and Hispanics treated at a traumatic brain injury model systems centre	BRAIN INJURY			English	Article							RACE; REHABILITATION; COMMUNITY; IMPACT; STROKE	Objective: To describe the demographics, incidence and functional outcome for African Americans and Hispanics treated at a traumatic brain injury (TBI) model systems centre. Design: Retrospective data analysis of patients admitted to an acute inpatient rehabilitation national TBI model systems centre. Setting: A tertiary care university medical centre participating in the NIDRR Traumatic Brain Injury Model Systems project. Subjects: Eighty-seven patients with TBI admitted to a Model Systems acute intensive interdisciplinary rehabilitation setting between 1989-1999. Information was extracted from the National TBI Model Systems data base for demographics such as age, race, education, gender, marital and employment status, sponsorship, injury aetiology and severity. Outcome measures: Functional outcome was determined using the Functional Independence Measure (FIM), and the Disability Rating Scale (DRS) at the time of admission and discharge. Results: Descriptive statistics were completed using SPSS. African American (94.3%) and Hispanic (5.7%) patients were injured most often as a result of motor vehicle accidents (48.8%). Males comprised 86.2% of this population, which had an average age of 34.5 years (SD = 13.1). On admission, average GCS score was 7.8 (SD = 3.6), average DRS was 13.5 (SD = 5.8), and average FIM total score was 49.8 (SD = 26.5). Average length of unconsciousness was 5.2 days (SD = 27.9), while average length of post-traumatic amnesia was 41.9 days (SD = 59.3). At the time of injury, 78.2% of the patients were not married. The majority of patients (97.7%) had private residences and 88.5% returned to their original home. Most patients had at least a high school education or passed a high school equivalent exam (49.4%) and were employed (70.1%) at the time of injury. Only 7% of the patients had a history of prior TBI. With regard to substance use, only 34.2% of patients reported pre-morbid illicit drug use. However, 50.5% met criteria for heavy or moderate alcohol use rates. Only 35.6% of patients reported a pre-morbid history of arrests, with the average number of arrests equal to 4.5 (SD = 10.2). Within this population, the number of drug or alcohol related arrests was 4.8 (SD = 13.5). Conclusions: Unmarried African American males, with an average age of 35 years, predominated at this institution. The primary mechanism of injury was motor vehicle accidents. The majority of patients had, at least, a high school education or passed an equivalency exam, were employed at the time of their injury and were discharged to their prior private residence. While half of the patients met criteria for moderate-to-heavy alcohol consumption, only one-third of the patients reported a history of premorbid illicit drug use. This descriptive analysis supports the need for further investigation of minority populations that sustain TBI and will enhance the accuracy of implications that minority status may have on functional outcome.	Virginia Commonwealth Univ, Med Coll Virginia, Dept Phys Med & Rehabil, Richmond, VA 23298 USA		Kolakowsky-Hayner, SA (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Phys Med & Rehabil, POB 980542, Richmond, VA 23298 USA.		Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909; Cifu, David/0000-0003-1600-9387			COOPER KD, 1983, NEUROEPIDEMIOLOGY, V9, P70; Ditunnio John F. Jr., 1995, P170; FRANKOWSKI RF, 1985, CENTRAL NERVOUS SYST; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC10; HOWARD G, 1994, STROKE, V25, P120; KLATSKY AL, 1991, AM J PUBLIC HEALTH, V811, P423; LILLIEBLANTON M, 1995, NATIONS INTEREST EQU; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; SAAB PG, 1991, J HYPERTENS, V9, P249, DOI 10.1097/00004872-199103000-00009; SACCO RL, 1991, STROKE, V22, P305, DOI 10.1161/01.STR.22.3.305; Twigg AR, 1998, NEUROREHABILITATION, V11, P249, DOI 10.3233/NRE-1998-11308; ZWEIFLER RM, 1995, STROKE, V26, P245, DOI 10.1161/01.STR.26.2.245	13	24	24	0	3	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	AUG	2000	14	8					713	718					6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	342XT	WOS:000088672000004	10969889				2022-02-06	
J	Karlsson, J; Emgard, M; Gido, G; Wieloch, T; Brundin, P				Karlsson, J; Emgard, M; Gido, G; Wieloch, T; Brundin, P			Increased survival of embryonic nigral neurons when grafted to hypothermic rats	NEUROREPORT			English	Article						dopamine, hypothermia; mesencephalic; neural transplantation; Parkinson's disease	FETAL MESENCEPHALIC GRAFTS; DOPAMINE NEURONS; VENTRAL MESENCEPHALON; PARKINSONS-DISEASE; INHIBITION; TRANSPLANTS; STRIATUM; ISCHEMIA; IMPROVES; ENHANCE	Hypothermia can reduce neuronal death caused by ischemia and traumatic brain injury. We therefore investigated whether mild hypothermia in rats receiving a transplant of embryonic mesencephalic rat tissue increases survival of the implanted dopaminergic neurons. Mild hypothermia (32-33 degrees C) during graft implantation and for the following 90 min significantly increased the survival of transplanted dopaminergic neurons to 171% of control values in normothermic (37 degrees C) rats. This demonstrates that treatment of the graft recipient for a relatively short period during and after surgery has a favorable effect on the survival of grafted dopaminergic neurons. These findings may be of importance for clinical neural transplantation trials which are in need of procedures that improve transplant survival. NeuroReport 11:1665-1668 (C) 2000 Lippincott Williams & Wilkins.	Univ Lund, Dept Physiol Sci, Wallenberg Neurosci Ctr, Sect Neuronal Survival, S-22362 Lund, Sweden; Univ Lund Hosp, Wallenberg Neurosci Ctr, Expt Brain Res Lab, S-22185 Lund, Sweden		Karlsson, J (corresponding author), Univ Lund, Dept Physiol Sci, Wallenberg Neurosci Ctr, Sect Neuronal Survival, Solvegatan 17, S-22362 Lund, Sweden.			Wieloch, Tadeusz/0000-0002-7669-2520			Barker RA, 1996, EXP NEUROL, V141, P79, DOI 10.1006/exnr.1996.0141; Boris-Moller F, 1998, EXP BRAIN RES, V121, P277, DOI 10.1007/s002210050461; Brundin P, 2000, CELL TRANSPLANT, V9, P179, DOI 10.1177/096368970000900205; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; CARDELL M, 1991, J NEUROCHEM, V57, P1814, DOI 10.1111/j.1471-4159.1991.tb06387.x; CASTILHO RF, 2000, IN PRESS EXP NEUROL; CHURN SB, 1990, STROKE, V21, P1715, DOI 10.1161/01.STR.21.12.1715; DOUCET G, 1990, EUR J NEUROSCI, V2, P279, DOI 10.1111/j.1460-9568.1990.tb00419.x; Emgard M, 1999, EXP NEUROL, V160, P279, DOI 10.1006/exnr.1999.7198; FAWCETT JW, 1995, EXP BRAIN RES, V106, P275; Karlsson J, 1998, BRAIN RES, V805, P155, DOI 10.1016/S0006-8993(98)00702-1; Kataoka K, 1998, NEUROSCI RES, V32, P103, DOI 10.1016/S0168-0102(98)00076-5; Kil HY, 1996, J CEREBR BLOOD F MET, V16, P100, DOI 10.1097/00004647-199601000-00012; Kordower JH, 1998, MOVEMENT DISORD, V13, P383, DOI 10.1002/mds.870130303; NAKAO N, 1994, P NATL ACAD SCI USA, V91, P12408, DOI 10.1073/pnas.91.26.12408; SAUER H, 1992, EXP BRAIN RES, V90, P54, DOI 10.1007/BF00229256; Schierle GS, 1998, NEUROREPORT, V9, P1313, DOI 10.1097/00001756-199805110-00011; Schierle GS, 1999, NAT MED, V5, P97, DOI 10.1038/4785; Schierle GSK, 1999, NEUROSCIENCE, V94, P17, DOI 10.1016/S0306-4522(99)00324-3; Sinclair SR, 1999, NEUROREPORT, V10, P1263, DOI 10.1097/00001756-199904260-00020; Todaka K, 1999, EXP NEUROL, V160, P394, DOI 10.1006/exnr.1999.7217; Van Muiswinkel FL, 1998, BRAIN RES, V792, P48, DOI 10.1016/S0006-8993(98)00120-6; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Zawada WM, 1998, BRAIN RES, V786, P96, DOI 10.1016/S0006-8993(97)01408-X	24	24	24	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0959-4965			NEUROREPORT	Neuroreport	JUN 5	2000	11	8					1665	1668		10.1097/00001756-200006050-00014			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	319YY	WOS:000087375100014	10852221				2022-02-06	
J	Blau, S; Kohen, R; Bass, P; Rubinstein, A				Blau, S; Kohen, R; Bass, P; Rubinstein, A			Relation between colonic inflammation severity and total low-molecular-weight antioxidant profiles in experimental colitis	DIGESTIVE DISEASES AND SCIENCES			English	Article						experimental colitis; dinitrobenzene sulfonic-acid; low-molecular-weight antioxidants; glutathione; oxidative stress; cyclic voltammetry	TRINITROBENZENE SULFONIC-ACID; REACTIVE OXYGEN METABOLITES; INDUCED OXIDATIVE STRESS; HAPTEN-INDUCED MODEL; EPITHELIAL L2 CELLS; CLOSED-HEAD INJURY; BOWEL-DISEASE; CYCLIC VOLTAMMETRY; GLUTATHIONE SYNTHESIS; FREE-RADICALS	Tissue antioxidant status is altered as a response to oxidative stress. This oxidative stress, caused by reactive oxygen species, is associated with inflammatory bowel disease (IBD). Our aim was to examine the relationship between total tissue low-molecular-weight antioxidant (LMWA) profile and inflammation severity in dinitrobenzene sulfonic acid (DNBS) experimental colitis in the rat. Rats were treated with three doses of DNBS: 1. 10, and 20 mg. Inflammation severity was assessed by tissue colonic wet weight, macroscopic evaluation, and tissue myeloperoxidase (MPO) activity. The capacity of water-soluble LMWA was assessed by measuring the reducing power of the tissues with cyclic voltammetry (CV) and by measuring ti;sue levels of reduced glutathione. While typical markers of inflammation (MPO, macroscopic examination, and colonic wet weight) indicated DNBS dose dependency, such dependency could not be demonstrated for the tissue LMWA as measured by reduced glutathione levels and by the tissues' reducing power. Mild colonic inflammation (induced by ethanol or by 1 mg of DNBS) caused an increase in the overall capacity of water-soluble LMWA. However, severe inflammation (induced by 20 mg of DNBS) caused a reduction in the tissue LMWA capacity. An intermediate dose of DNBS (10 mg) caused moderate inflammation, but did not cause a significant change in the tissue LMWA compared with a saline control treatment. In conclusion, LMWA changed in a biphasic pattern reflective of the severity of mucosal colonic inflammation. It is suggested that: low dose of DNBS (1 mg) and topical alcohol (25% v/v) caused an adaptation effect to the mild oxidative stress associated with mild inflammation. This resulted in an increase in the LMWA. A higher dose of DNBS (20 mg) caused more severe inflammation with an overall reduction in LMWA, The increased efflux of reactive oxygen species, associated with severe inflammation, led to an overall consumption of the tissue LMWA, which masked the increase in LMWA caused by the mild oxidative stress.	Hebrew Univ Jerusalem, Sch Pharm, Fac Med, IL-91120 Jerusalem, Israel; Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA		Rubinstein, A (corresponding author), Hebrew Univ Jerusalem, Sch Pharm, Fac Med, POB 12065, IL-91120 Jerusalem, Israel.		Kohen, Ron/ABC-2281-2021	Kohen, Ron/0000-0001-7268-9845; Rubinstein, Abraham/0000-0001-6212-3725			ARNAIZ SL, 1995, FREE RADICAL BIO MED, V19, P303, DOI 10.1016/0891-5849(95)00023-Q; BANNAI S, 1991, BIOCHIM BIOPHYS ACTA, V1092, P175, DOI 10.1016/0167-4889(91)90153-O; Blau S, 1999, MOL CELL BIOCHEM, V194, P185, DOI 10.1023/A:1006994800272; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRODY LL, 1996, DIGEST DIS SCI, V41, P2078; BUFFINTON GD, 1995, FREE RADICAL BIO MED, V19, P911, DOI 10.1016/0891-5849(95)94362-H; BUFFINTON GD, 1995, FREE RADICAL RES, V22, P131, DOI 10.3109/10715769509147535; Chamulitrat W, 1997, BBA-GEN SUBJECTS, V1336, P73, DOI 10.1016/S0304-4165(97)00012-3; Chevion S, 1997, FREE RADICAL BIO MED, V22, P411, DOI 10.1016/S0891-5849(96)00337-1; Choi J, 1997, BIOCHEM PHARMACOL, V53, P987, DOI 10.1016/S0006-2952(96)00867-2; DeMedina FS, 1996, J PHARMACOL EXP THER, V278, P771; GRISHAM MB, 1994, LANCET, V344, P859, DOI 10.1016/S0140-6736(94)92831-2; GRISHAM MB, 1991, GASTROENTEROLOGY, V101, P540, DOI 10.1016/0016-5085(91)90036-K; GRISHAM MB, 1986, AM J PHYSIOL, V251, pG567, DOI 10.1152/ajpgi.1986.251.4.G567; GRISHAM MB, 1990, METHOD ENZYMOL, V186, P729; Halliwell B., 1989, FREE RADICALS BIOL M, VSecond; HARRIS ML, 1992, PHARMACOL THERAPEUT, V53, P375, DOI 10.1016/0163-7258(92)90057-7; Hawkins JV, 1997, DIGEST DIS SCI, V42, P1969, DOI 10.1023/A:1018887832465; IRIARTE WLZ, 1996, SCAND J GASTROENTERO, V31, P985; KESHAVARZIAN A, 1992, J LAB CLIN MED, V120, P778; KESHAVARZIAN A, 1992, GASTROENTEROLOGY, V103, P177, DOI 10.1016/0016-5085(92)91111-G; KOHEN R, 1992, EXP GERONTOL, V27, P161, DOI 10.1016/0531-5565(92)90040-7; KOHEN R, 1993, J PHARMACOL TOXICOL, V29, P185, DOI 10.1016/1056-8719(93)90024-9; Kohen R, 1999, METHOD ENZYMOL, V300, P285; Kohen R, 1997, ARCH GERONTOL GERIAT, V24, P103, DOI 10.1016/S0167-4943(96)00744-3; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; LIU RY, 1992, J QINGHAI NORMAL U, V1, P1; Loguercio C, 1996, DIGEST DIS SCI, V41, P1204, DOI 10.1007/BF02088238; Lomnitski L, 1997, PHARMACOL BIOCHEM BE, V56, P669, DOI 10.1016/S0091-3057(96)00412-1; LUCK MS, 1993, J PHARMACOL EXP THER, V264, P984; Moghadasian MH, 1996, DIGEST DIS SCI, V41, P791, DOI 10.1007/BF02213136; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; MULDER TPJ, 1991, GUT, V32, P1146, DOI 10.1136/gut.32.10.1146; OBRIEN PJ, 1990, XENOBIOTICA, V20, P945, DOI 10.3109/00498259009046910; OGINO T, 1989, BIOCHIM BIOPHYS ACTA, V1006, P131, DOI 10.1016/0005-2760(89)90334-2; OSBORNE DL, 1994, J CLIN INVEST, V94, P1910, DOI 10.1172/JCI117541; Romero IA, 1996, TOXICOL APPL PHARM, V139, P94, DOI 10.1006/taap.1996.0146; SARKAR S, 1995, J TRACE ELEM MED BIO, V9, P144, DOI 10.1016/S0946-672X(11)80038-6; SHI MM, 1994, J BIOL CHEM, V269, P26512; SHI MM, 1994, AM J PHYSIOL-LUNG C, V267, pL414, DOI 10.1152/ajplung.1994.267.4.L414; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; SIMMONDS NJ, 1992, GASTROENTEROLOGY, V103, P186, DOI 10.1016/0016-5085(92)91112-H; TANNAHILL CL, 1995, GASTROENTEROLOGY, V109, P800, DOI 10.1016/0016-5085(95)90387-9; VANDERVLIET A, 1992, FREE RADICAL BIO MED, V12, P499, DOI 10.1016/0891-5849(92)90103-N; VERSPAGET HW, 1991, SCAND J GASTROENTERO, V26, P44, DOI 10.3109/00365529109111229; WALLACE JL, 1995, J PHARMACOL TOXICOL, V33, P237, DOI 10.1016/1056-8719(95)00001-X; WOODS JS, 1995, BIOCHEM PHARMACOL, V50, P1719, DOI 10.1016/0006-2952(95)02075-6; YANNAI EB, 1997, J CEREB BLOOD FLOW M, V17, P273	48	24	24	0	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	JUN	2000	45	6					1180	1187		10.1023/A:1005510321278			8	Gastroenterology & Hepatology	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology	330QF	WOS:000087972200022	10877235				2022-02-06	
J	Kurowski, K; Chandran, S				Kurowski, K; Chandran, S			The preparticipation athletic evaluation	AMERICAN FAMILY PHYSICIAN			English	Article							HYPERTROPHIC CARDIOMYOPATHY; INJURY	A comprehensive medical history that includes questions about a personal and family history of cardiovascular disease is the most important initial component of the preparticipation athletic evaluation. Additional questions should focus on any history of neurologic or musculoskeletal problems. A limited physical examination should emphasize cardiac auscultation with provocative maneuvers to screen for hypertrophic cardiomyopathy. This condition is the most common cause of sudden death in young male athletes. Other components of the physical examination include an evaluation of the spine and extremities. Screening tests such as electrocardiography. treadmill stress testing and urinalysis are not indicated in the absence of symptoms or a significant history of risk factors. Specific conditions that would exclude or limit athletic participation include hypertrophic cardiomyopathy. long QT interval syndrome, concussion. significant knee injury, sickle cell disease and uncontrolled seizures. Overall. about 1 percent of athletes who are screened are completely disqualified from sports participation.	Finch Univ Hlth Sci Chicago Med Sch, Dept Family Med, N Chicago, IL 60064 USA		Kurowski, K (corresponding author), Finch Univ Hlth Sci Chicago Med Sch, Dept Family Med, N Chicago, IL 60064 USA.						ABBOTT H G, 1969, Archives of Physical Medicine and Rehabilitation, V50, P326; [Anonymous], 1988, PEDIATRICS, V81, P737; [Anonymous], 1996, Med Sci Sports Exerc, V28, P1445; [Anonymous], 1995, SPORTSMEDICINE DIGES, V17, P3; ARENDT E, 1995, AM J SPORT MED, V23, P694, DOI 10.1177/036354659502300611; BARROW GW, 1988, AM J SPORT MED, V16, P209, DOI 10.1177/036354658801600302; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 1998, CLIN SPORT MED, V17, P137, DOI 10.1016/S0278-5919(05)70068-5; Corrado D, 1998, NEW ENGL J MED, V339, P364, DOI 10.1056/NEJM199808063390602; GOTT VL, 1986, NEW ENGL J MED, V314, P1070, DOI 10.1056/NEJM198604243141702; Grafe MW, 1997, CLIN SPORT MED, V16, P569, DOI 10.1016/S0278-5919(05)70043-0; Krowchuk DP, 1997, PEDIATR ANN, V26, P37, DOI 10.3928/0090-4481-19970101-09; Lerakis S, 1997, AM J MED SCI, V314, P324; MARON BJ, 1994, MED SCI SPORT EXER, V26, pS261; Maron BJ, 1997, LANCET, V350, P1330; Maron BJ, 1999, JAMA-J AM MED ASSOC, V281, P650, DOI 10.1001/jama.281.7.650; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; MARON BJ, 1999, JAMA-J AM MED ASSOC, V281, P2288; *NAT HIGH BLOOD PR, 1997, NIH PUBL; SMITH DM, 1997, PREPARTICIPATION PHY; Smith J, 1998, MAYO CLIN PROC, V73, P419; STOCK JG, 1991, AM FAM PHYSICIAN, V44, P515; THOMPSON PD, 1994, MED SCI SPORT EXER, V26, pS271; *US PREV SERV TASK, 1996, GUID CLIN PREV SERV, P8; VANCAMP SP, 1995, MED SCI SPORT EXER, V27, P641; WELDER AA, 1993, J PHARMACOL TOXICOL, V29, P61, DOI 10.1016/1056-8719(93)90052-G; Wiggins DL, 1997, CLIN SPORT MED, V16, P593, DOI 10.1016/S0278-5919(05)70044-2	27	24	24	0	3	AMER ACAD FAMILY PHYSICIANS	KANSAS CITY	8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797 USA	0002-838X	1532-0650		AM FAM PHYSICIAN	Am. Fam. Physician	MAY 1	2000	61	9					2683	2690					8	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	314TF	WOS:000087073100014	10821150				2022-02-06	
J	Watanabe, Y; Shiel, A; Asami, T; Taki, K; Tabuchi, K				Watanabe, Y; Shiel, A; Asami, T; Taki, K; Tabuchi, K			An evaluation of neurobehavioural problems as perceived by family members and levels of family stress 1-3 years following traumatic brain injury in Japan	CLINICAL REHABILITATION			English	Article							HEAD-INJURY; RELATIVES; SCALE	Objective: To ascertain the proportion of patients with traumatic brain injury (TBI) admitted to a Japanese district hospital and to evaluate the levels of stress and anxiety In families living with those TBI patients Design: A retrospective study of patients admitted to hospital from April 1995 to March 1997 and a questionnaire study of family members of survivors. Setting and subjects: All patients referred or transferred to the Emergency Department a? the Saga Medical School Hospital, Japan with a primary diagnosis of TBI were studied. Family members living with TBI patients were sent questionnaires. Main outcome measures: The Barthel index, the Patient Competency Rating Scale, the modified Caregiver Strain Index and the Hospital Anxiety and Depression Scale. Results. There were 34 patients who required hospitalization for care relating to TBI. Of these, nine family members took part in the questionnaire study. Three carers reported fairly high levels of stress and another three carers were considered to be at risk of anxiety and depression. There was a tendency for family members who reported that patients had difficulties in performing behavioural tasks to have higher levels of stress themselves. Conclusion: These preliminary results showed that family members experienced certain levels of stress and were also at risk of anxiety and depression. The Impact of TBI on families as well as patients should receive more attention.	Saga Med Sch, Dept Orthopaed Surg, Saga 8498501, Japan; Univ Southampton, Rehabil Res Unit, Southampton, Hants, England; Saga Med Sch, Dept Emergency Med, Saga 8498501, Japan; Saga Med Sch, Dept Neurosurg, Saga 8498501, Japan		Watanabe, Y (corresponding author), Saga Med Sch, Dept Orthopaed Surg, 5-1-1 Nabeshima, Saga 8498501, Japan.						BARNES M, 1998, REHABILITATION TRAUM; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; COLE JR, 1985, ARCH PHYS MED REHAB, V66, P38; Engli M, 1993, J Neurosci Nurs, V25, P78; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Kunishio Katsuzo, 1993, Neurologia Medico-Chirurgica, V33, P824, DOI 10.2176/nmc.33.824; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; MIZUOCHI K, 1994, RINSHO RIHEBIRITESHO, P153; *NAT HEAD INJ FDN, 1997, BRAIN INJURY, V11, P821; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; OHASHI M, 1992, RINSHO RIHABIRITESHO, V1, P511; Ohta T, 1974, No Shinkei Geka, V2, P623; PRIGATANO GP, 1997, NEUROPSYCHIATR NEURO, V6, P43; PRIGATANO GP, 1986, NEUROPSYCOLOGICAL RE; ROBINSON BC, 1983, J GERONTOL, V38, P344, DOI 10.1093/geronj/38.3.344; TEASDALE G, 1974, LANCET, V2, P81; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Wade D T, 1988, Int Disabil Stud, V10, P64; WATANABE Y, 1999, JAPANESE J REHABILIT, V36, P180; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	24	24	24	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	APR	2000	14	2					172	177		10.1191/026921500666833742			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	297QX	WOS:000086095100009	10763794				2022-02-06	
J	Levin, HS; Song, J; Scheibel, RS; Fletcher, JM; Harward, HN; Chapman, SB				Levin, HS; Song, J; Scheibel, RS; Fletcher, JM; Harward, HN; Chapman, SB			Dissociation of frequency and recency processing from list recall after severe closed head injury in children and adolescents	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							FRONTAL-LOBE LESIONS; TEMPORAL-ORDER; MEMORY; INFORMATION; JUDGMENTS; MODEL	To investigate judgment of the frequency and recency of events relative to word list recall in children following closed head injury (CHI), 124 children and adolescents, including 79 severe CHI patients (mean age at test = 13.2 years), 27 mild CHI cases (mean age at test = 12.1 years), and 18 uninjured comparison subjects (mean age = 12.8 years) were studied. The mean postinjury interval was 63.6 months for the severe and 46.7 months for the mild CHI groups. The experimental tasks included estimation of the frequency of presentation of words and designs and recency judgment to select the most recently presented of two stimuli on verbal (words) and nonverbal (faces) tasks. To compare frequency and recency judgments to performance on a task which has been shown to be sensitive to CHI severity and age at test, verbal recall was tested using the California Verbal Learning Test-Children's Version. Severity of CHI (group) affected verbal recall across trials and after delays, but had no effect on estimating frequency and isolated effects on judgment of recency. Age was also primarily related to verbal recall. A subgroup of severe CHI patients with frontal lesions was impaired on delayed recall. The results are discussed in relation to previous research on the effects of CHI on processing the frequency and recency of events.	Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Dept Pediat, Houston, TX 77225 USA; Univ Texas, Callier Ctr Commun Disorders, Dallas, TX 75235 USA		Levin, HS (corresponding author), PM&R Res Off, 1333 Moursund Ave,Room A205, Houston, TX 77030 USA.		fletcher, jack/Q-5975-2019; Fletcher, Jack/AAX-2931-2020		NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR002558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01-RR02558] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS21889] Funding Source: Medline		AGRESTI A, 1994, CATEGORICAL DATA ANA; BIJUR PE, 1990, PEDIATRICS, V86, P337; BUSCHKE H, 1974, J EXP CHILD PSYCHOL, V18, P488, DOI 10.1016/0022-0965(74)90126-X; COLTHEART M, 1981, Q J EXP PSYCHOL-A, V33, P497, DOI 10.1080/14640748108400805; DAMASIO HC, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P92; DELIS D, 1994, CALIFORNIA VERBAL LE; Diggle PJ, 1994, ANAL LONGITUDINAL DA; Fuster JM, 1989, PREFRONTAL CORTEX, V2nd; GOLDMANRAKIC PS, 1987, COGNITIVE NEUROCHEMI, P90; GOLDSTEIN D, 1983, AM J PSYCHOL, V96, P229, DOI 10.2307/1422814; HASHER L, 1984, AM PSYCHOL, V39, P1372, DOI 10.1037/0003-066X.39.12.1372; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; HUNKIN NM, 1993, CORTEX, V29, P485, DOI 10.1016/S0010-9452(13)80255-9; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; KIMURA D, 1963, ARCH NEUROL-CHICAGO, V8, P264, DOI 10.1001/archneur.1963.00460030048004; Kuera H., 1967, COMPUTATIONAL ANAL P; Levin HS, 1996, CORTEX, V32, P461, DOI 10.1016/S0010-9452(96)80004-9; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; LEVIN HS, 1988, BRAIN COGNITION, V7, P283, DOI 10.1016/0278-2626(88)90003-6; McCullagh P., 1989, GEN LINEAR MODELS 2, V2; MILNER B, 1991, NEUROPSYCHOLOGIA, V29, P601, DOI 10.1016/0028-3932(91)90013-X; MILNER B, 1982, PHILOS T R SOC B, V298, P211, DOI 10.1098/rstb.1982.0083; MOSCOVITCH M, 1992, J COGNITIVE NEUROSCI, V4, P257, DOI 10.1162/jocn.1992.4.3.257; PAIVIO A, 1968, J EXP PSYCHOL, V76, P1, DOI 10.1037/h0025327; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; SHIMAMURA AP, 1990, NEUROPSYCHOLOGIA, V28, P803, DOI 10.1016/0028-3932(90)90004-8; SMITH ML, 1988, NEUROPSYCHOLOGIA, V26, P297, DOI 10.1016/0028-3932(88)90082-6; TEASDALE G, 1974, LANCET, V2, P81; VAKIL E, 1991, J CLIN EXP NEUROPSYC, V13, P291, DOI 10.1080/01688639108401044; Wechsler D., 1974, MANUAL WECHSLER INTE; Wheeler M A, 1995, J Int Neuropsychol Soc, V1, P525; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78	34	24	24	0	6	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	FEB	2000	22	1					1	15		10.1076/1380-3395(200002)22:1;1-8;FT001			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	287BE	WOS:000085484000001	10649541				2022-02-06	
J	DelBello, MP; Soutullo, CA; Zimmerman, ME; Sax, KW; Williams, JR; McElroy, SL; Strakowski, SM				DelBello, MP; Soutullo, CA; Zimmerman, ME; Sax, KW; Williams, JR; McElroy, SL; Strakowski, SM			Traumatic brain injury in individuals convicted of sexual offenses with and without bipolar disorder	PSYCHIATRY RESEARCH			English	Article; Proceedings Paper	10th Annual Meeting of the American-Neuropsychiatric-Association	JAN 31-FEB 02, 1999	NEW ORLEANS, LOUISIANA	Amer Neuropsychiat Assoc		head injury; affective disorders; paraphilias	MANIA	The authors examined the occurrence of traumatic brain injury (TBI) in individuals convicted of sexual offenses with and without bipolar disorder and a comparison group of patients with bipolar disorder without a history of sexual offending behaviors. Individuals convicted of sexual offenses and diagnosed with bipolar disorder had greater rates of brain injury resulting from head trauma than individuals convicted of sexual offenses without bipolar disorder and comparison patients with bipolar disorder. TBI predated the first sexual offense and/or the onset of bipolar disorder in most subjects. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.	Univ Cincinnati, Coll Med, Dept Psychiat, Bipolar & Psychot Disorders Res Program, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Dept Psychiat, Biol Psychiat Program, Cincinnati, OH 45267 USA		DelBello, MP (corresponding author), Univ Cincinnati, Coll Med, Dept Psychiat, Bipolar & Psychot Disorders Res Program, 231 Bethesda Ave,POB 670559, Cincinnati, OH 45267 USA.		Esperon, Cesar Soutullo/I-1758-2017; Soutullo, Cesar/AAG-4068-2021	Esperon, Cesar Soutullo/0000-0003-4348-0772; Soutullo, Cesar/0000-0003-4348-0772			BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; First M.B., 1996, STRUCTURED CLIN INTE; GRABER B, 1982, J FORENSIC SCI, V27, P125; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; McElroy SL, 1999, J CLIN PSYCHIAT, V60, P414, DOI 10.4088/JCP.v60n0613; Mild Traumatic Brain Injury Committee, 1993, J HEAD TRAUMA REHAB, V8, P86; MILLER BL, 1986, J NEUROL NEUROSUR PS, V49, P867, DOI 10.1136/jnnp.49.8.867; Mills S., 1994, J OFFENDER REHABILIT, P145; SAX KW, IN PRESS COMORBIDITY; SHUKLA S, 1987, AM J PSYCHIAT, V144, P93; STARKSTEIN SE, 1990, ANN NEUROL, V27, P652, DOI 10.1002/ana.410270612; ZENICUS A, 1990, BRAIN INJURY, V4, P175	15	24	25	0	2	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	DEC 27	1999	89	3					281	286		10.1016/S0165-1781(99)00112-2			6	Psychiatry	Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	282KE	WOS:000085216600014	10708275				2022-02-06	
J	Byard, RW; Koszyca, B; James, R				Byard, RW; Koszyca, B; James, R			Crossbow suicide: Mechanisms of injury and neuropathologic findings	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						crossbow; suicide; axonal injury; amyloid precursor protein	AMYLOID PRECURSOR PROTEIN; CLOSED-HEAD INJURY; AXONAL INJURY; GUNSHOT WOUNDS; ARROW WOUNDS; MARKER	Crossbow injuries are rarely reported events in modern times. Two cases of death due to self-inflicted crossbow injuries to the head are reported in 2 men aged 18 and 27 years, respectively. Despite relatively low velocity and concussive force, the sharpness and propulsion force of crossbow bolts may be sufficient to enable penetration of the skull at short range. Due to the relatively low concussive force of the crossbow bolt, however, death may not be instantaneous but may occur from intraparenchymal cerebral damage sometime thereafter. Detailed neuropathologic evaluation of such cases may therefore demonstrate "red cell" hypoxic injury, as well as axonal injury, not limited to the region of the missile tract, but widely distributed, even to the point of extensive brain stem involvement. These changes may result from primary mechanical deformation at the time of injury, from secondary hypoxic damage, or from a combination of both factors. Immunohistochemical staining of brains for amyloid precursor protein to delineate more clearly the pattern of axonal damage may assist in determining the extent of injury in such cases.	Univ Adelaide, Forens Sci Ctr, Adelaide, SA, Australia		Byard, RW (corresponding author), State Forens Sci Ctr, 21 Divett Pl, Adelaide, SA 5000, Australia.			Byard, Roger/0000-0002-0524-5942			Alessi F J, 1976, J La State Med Soc, V128, P231; Besler K, 1998, INT J LEGAL MED, V111, P88, DOI 10.1007/s004140050121; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; CLAYDON SM, 1993, MED SCI LAW, V33, P349, DOI 10.1177/002580249303300414; DOWNS JCU, 1994, J FORENSIC SCI, V39, P428; Foley V., 1985, SCI AM, V252, P80; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Karger B, 1998, J TRAUMA, V45, P495, DOI 10.1097/00005373-199809000-00011; Koszyca B, 1998, J NEUROTRAUM, V15, P675, DOI 10.1089/neu.1998.15.675; OPESKIN K, 1994, AM J FOREN MED PATH, V15, P14, DOI 10.1097/00000433-199403000-00004; Payne-Gallwey R., 1995, BOOK CROSSBOW; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; RANDALL B, 1989, J FORENSIC SCI, V34, P579; ROGERS C, 1990, J FORENSIC SCI, V35, P886; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Taupin JM, 1998, J FORENSIC SCI, V43, P205; 1797, ENCY BRITANNICA, V3, P488; 1797, ENCY BRITANNICA, V2, P211	19	24	24	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0195-7910			AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	DEC	1999	20	4					347	353		10.1097/00000433-199912000-00007			7	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	267AC	WOS:000084331600007	10624928				2022-02-06	
J	Fujii, T; Yamadori, A; Endo, K; Suzuki, K; Fukatsu, R				Fujii, T; Yamadori, A; Endo, K; Suzuki, K; Fukatsu, R			Disproportionate retrograde amnesia in a patient with herpes simplex encephalitis	CORTEX			English	Article						amnesia; retrograde amnesia; anterograde amnesia; hippocampus; medial temporal lobe	ENDURING MEMORY IMPAIRMENT; ABNORMAL FORGETTING RATE; CLOSED-HEAD INJURY; EPISODIC MEMORY; DEFICIT; CONSOLIDATION; ANTEROGRADE; RETRIEVAL; RECOVERY; SYSTEMS	We describe a patient who developed a severe but temporally limited retrograde amnesia coupled with a relatively mild anterograde amnesia following herpes simplex encephalitis. The patient showed a profound retrograde amnesia for autobiographical events extending for about 10 years prior to the disease onset. Her knowledge about public events and famous persons was also impaired for this period. An MRI and SPECT demonstrated bilateral medial temporal pathology. This case represents a further instance of a relatively focal retrograde amnesia following brain damage. We review other reported cases with focal retrograde amnesia and consider theoretical and neuroanatomical accounts for the present case. Two factors may account for her amnesic patterns: a partial disruption of the store for premorbid binding codes (i.e., information that multimodal feature representations occurred synchronously); along with a relative preservation of the encoding process required to develop new synchronous codes.	Tohoku Univ, Grad Sch Med, Div Disabil Sci, Sect Neuropsychol,Aoba Ku, Sendai, Miyagi 9808575, Japan; Rotman Res Inst, Baycrest Ctr Geriatr Care, Toronto, ON, Canada		Fujii, T (corresponding author), Tohoku Univ, Grad Sch Med, Div Disabil Sci, Sect Neuropsychol,Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.						ANDREWS E, 1982, CORTEX, V18, P441, DOI 10.1016/S0010-9452(82)80041-5; Baddeley A. D., 1990, AUTOBIOGRAPHICAL MEM; Calabrese P, 1996, J NEUROL NEUROSUR PS, V61, P304, DOI 10.1136/jnnp.61.3.304; Carlesimo GA, 1998, CORTEX, V34, P449, DOI 10.1016/S0010-9452(08)70767-6; DallaBarba G, 1997, CORTEX, V33, P143, DOI 10.1016/S0010-9452(97)80010-X; DALLASALA S, 1996, METHOD MADNESS CASE, P209; DAMASIO AR, 1989, COGNITION, V33, P25, DOI 10.1016/0010-0277(89)90005-X; DeRenzi E, 1997, NEUROPSYCHOLOGIA, V35, P781, DOI 10.1016/S0028-3932(97)00018-3; DERENZI E, 1993, CORTEX, V29, P449, DOI 10.1016/S0010-9452(13)80253-5; DERENZI E, 1995, CORTEX, V31, P531, DOI 10.1016/S0010-9452(13)80064-0; DERENZI E, 1978, CORTEX, V14, P41, DOI 10.1016/S0010-9452(78)80006-9; DOBBS AR, 1989, PSYCHOL AGING, V4, P500, DOI 10.1037/0882-7974.4.4.500; Evans JJ, 1996, NEUROCASE, V2, P1; Fukatsu R, 1998, NEUROLOGY, V50, P539, DOI 10.1212/WNL.50.2.539; Fukatsu R, 1994, Rinsho Shinkeigaku, V34, P777; GOLDBERG E, 1981, SCIENCE, V213, P1392, DOI 10.1126/science.7268442; HOKKANEN L, 1995, PSYCHOL MED, V25, P203, DOI 10.1017/S0033291700028245; Hunkin N, 1997, CASE STUDIES NEUROPS, P63; HUNKIN NM, 1995, NEUROPSYCHOLOGIA, V33, P509, DOI 10.1016/0028-3932(94)00136-D; Ishihara K, 1997, Rinsho Shinkeigaku, V37, P509; Kapur N, 1997, MEMORY, V5, P115, DOI 10.1080/741941152; KAPUR N, 1989, CORTEX, V25, P387, DOI 10.1016/S0010-9452(89)80053-X; KAPUR N, 1993, CORTEX, V29, P217, DOI 10.1016/S0010-9452(13)80177-3; Kapur N, 1996, J COGNITIVE NEUROSCI, V8, P416, DOI 10.1162/jocn.1996.8.5.416; KAPUR N, 1992, BRAIN, V115, P73, DOI 10.1093/brain/115.1.73; Kroll NEA, 1997, BRAIN, V120, P1377, DOI 10.1093/brain/120.8.1377; Levine B, 1998, BRAIN, V121, P1951, DOI 10.1093/brain/121.10.1951; LUCCHELLI F, 1995, BRAIN, V118, P167, DOI 10.1093/brain/118.1.167; Maravita A, 1995, CORTEX, V31, P653, DOI 10.1016/S0010-9452(13)80018-4; MARKOWITSCH HJ, 1993, J NEUROL NEUROSUR PS, V56, P988, DOI 10.1136/jnnp.56.9.988; Markowitsch HJ, 1995, BRAIN RES REV, V21, P117, DOI 10.1016/0165-0173(95)00007-0; Mattioli F, 1996, CORTEX, V32, P121, DOI 10.1016/S0010-9452(96)80021-9; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; OCONNOR M, 1992, J CLIN EXP NEUROPSYC, V14, P159, DOI 10.1080/01688639208402821; OGDEN JA, 1993, NEUROPSYCHOLOGIA, V31, P571, DOI 10.1016/0028-3932(93)90053-3; Reed JM, 1998, J NEUROSCI, V18, P3943; RempelClower NL, 1996, J NEUROSCI, V16, P5233; ROMANCAMPOS G, 1980, CORTEX, V16, P509, DOI 10.1016/S0010-9452(80)80053-0; ROUSSEAUX M, 1984, CORTEX, V20, P575, DOI 10.1016/S0010-9452(84)80060-X; Rubin DC, 1998, P NATL ACAD SCI USA, V95, P5413, DOI 10.1073/pnas.95.9.5413; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; Starkstein SE, 1997, NEUROCASE, V3, P105, DOI 10.1093/neucas/3.2.105; STRACCIARI A, 1994, CORTEX, V30, P459, DOI 10.1016/S0010-9452(13)80341-3; STUSS DT, 1988, BRAIN COGNITION, V8, P21, DOI 10.1016/0278-2626(88)90036-X; TEYLER TJ, 1986, BEHAV NEUROSCI, V100, P147, DOI 10.1037/0735-7044.100.2.147; YONEDA Y, 1994, EUR NEUROL, V34, P243, DOI 10.1159/000117051; YONEDA Y, 1992, EUR NEUROL, V32, P340, DOI 10.1159/000116857; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	50	24	24	1	6	MASSON DIVISIONE PERIODICI	MILAN	VIA FRATELLI BRESSAN 2, 20126 MILAN, ITALY	0010-9452			CORTEX	Cortex	DEC	1999	35	5					599	614		10.1016/S0010-9452(08)70822-0			16	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	275TL	WOS:000084836200001	10656630				2022-02-06	
J	Heath, DL; Vink, R				Heath, DL; Vink, R			Brain free magnesium concentration is predictive of motor outcome following traumatic axonal brain injury in rats	MAGNESIUM RESEARCH			English	Article						magnesium; neurotrauma; magnetic resonance; brain trauma	INTRACELLULAR FREE MAGNESIUM; CLOSED-HEAD INJURY; METABOLISM; NEURONS; SPECTROSCOPY; RECEPTORS; BLOCKADE; DECREASE; MODEL	A number of studies have supported a role for brain free magnesium as an important secondary injury factor in the development of neurologic deficits following traumatic brain injury. Despite this, few studies have characterised free magnesium changes in diffuse models of brain injury relevant to clinical trauma, and none have critically examined the association between brain free magnesium concentration and degree of neurologic deficit following graded trauma. In the present study, a combination of nuclear magnetic resonance spectroscopy and rotarod motor function tests were used to characterise the relationship between brain free magnesium concentration and neurologic motor function following graded traumatic axonal brain injury in rats. Induction of moderate or severe impact-acceleration induced traumatic brain injury resulted in a profound decline (p < 0.01) in brain free magnesium concentration that persisted for a minimum of 4 days postrauma in both injury groups. Posttraumatic rotarod deficits assessed on a daily basis after injury were linearly correlated with brain free magnesium concentration measured in the same animals immediately after the motor tests were performed (r = 0.87; p < 0.001). These results suggest that brain free magnesium declines following graded diffuse axonal brain injury and that the concentration of the ion after trauma may be a prognostic indicator of motor outcome following.	James Cook Univ N Queensland, Dept Physiol & Pharmacol, Townsville, Qld 4811, Australia		Vink, R (corresponding author), James Cook Univ N Queensland, Dept Physiol & Pharmacol, Townsville, Qld 4811, Australia.		Vink, Robert/J-7351-2012; Vink, Robert/S-5616-2019	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ANDERSON D, 1994, NEUROBIOLOGY CENTRAL; Bara M., 1984, MAGNESIUM, V3, P212; Birch N.J., 1993, MAGNESIUM CELL; BOCK JL, 1987, BIOCHIM BIOPHYS ACTA, V928, P8, DOI 10.1016/0167-4889(87)90079-6; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; EBEL H, 1980, J CLIN CHEM CLIN BIO, V18, P257; FADEN AI, 1993, CRIT REV NEUROBIOL, V7, P175; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEARNSIDE MR, 1997, HEAD INJURY PATHOPHY, P3; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; GRUBBS RD, 1987, MAGNESIUM, V6, P113; GUPTA RK, 1983, PHYSIOL CHEM PHYS, V15, P265; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; HEADRICK JP, 1994, J CEREBR BLOOD F MET, V14, P853, DOI 10.1038/jcbfm.1994.107; Heath DL, 1996, BRAIN RES, V738, P150, DOI 10.1016/0006-8993(96)00957-2; Heath DL, 1998, J NEUROTRAUM, V15, P183, DOI 10.1089/neu.1998.15.183; Heath DL, 1995, J NEUROTRAUM, V12, P1027, DOI 10.1089/neu.1995.12.1027; ISHIGE M, 1987, J NEUROSURG, V6, P848; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; MULLINS PGM, 1995, NEUROREPORT, V6, P1633, DOI 10.1097/00001756-199508000-00011; Povlishock J.T., 1994, NEUROBIOLOGY CENTRAL, P109; Povlishock JT, 1996, ACT NEUR S, V66, P81; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; ROTHMAN SM, 1983, SCIENCE, V220, P536, DOI 10.1126/science.6836300; RUBIN H, 1976, J CELL PHYSIOL, V89, P613, DOI 10.1002/jcp.1040890418; SHAPIRA Y, 1993, J CEREBR BLOOD F MET, V13, P962, DOI 10.1038/jcbfm.1993.120; SMITH BF, 1993, INT HIST REV, V15, P211; Suzuki M, 1997, GEN PHARMACOL, V28, P119, DOI 10.1016/S0306-3623(96)00148-6; TERASAKI M, 1985, P NATL ACAD SCI USA, V82, P7324, DOI 10.1073/pnas.82.21.7324; VINK R, 1987, J CEREBR BLOOD F MET, V7, P563, DOI 10.1038/jcbfm.1987.106; VINK R, 1994, J NEUROTRAUM, V11, P265, DOI 10.1089/neu.1994.11.265; VINK R, 1993, MOL CHEM NEUROPATHOL, V18, P279, DOI 10.1007/BF03160120; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; Vink R, 1996, J NEUROCHEM, V66, P2477; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	42	24	26	0	0	JOHN LIBBEY & CO LTD	LONDON	13 SMITHS YARD, SUMMERLEY ST, LONDON SW18 4HR, ENGLAND	0953-1424			MAGNESIUM RES	Magnes. Res.	DEC	1999	12	4					269	277					9	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	264ZB	WOS:000084212800004	10612084				2022-02-06	
J	Shimonkevitz, R; Bar-Or, D; Harris, L; Dole, K; McLaughlin, L; Yukl, R				Shimonkevitz, R; Bar-Or, D; Harris, L; Dole, K; McLaughlin, L; Yukl, R			Transient monocyte release of interleukin-10 in response to traumatic brain injury	SHOCK			English	Article						cytokines; trauma; traumatic brain injury; monocyte; IL-10; IFN gamma; TGF beta	HEAD-INJURY; CYTOKINE PRODUCTION; CELLS; ACTIVATION; EXPRESSION; PATTERNS; SEVERITY; HUMANS; TISSUE; SEPSIS	A significant component of the immune response to trauma results in the systemic presence of cytokines which have the potential to suppress the patient's immune response to infection and contribute to post-injury complications. We assayed peripheral blood leukocytes obtained from 10 patients with head trauma to determine their production of interleukin (IL). Serum was assayed for the presence of IL-10, TGF beta(1), and IFN gamma by ELISA. Peripheral blood leukocytes were screened for intracellular IL-10 and lFN gamma by fluorescence-activated flow cytometry, and cytokine-specific mRNA was detected by the polymerase chain reaction. We detected an immediate, but transient, presence of IL-10 in the sera of all 10 patients who suffered head trauma. IL-10-specific intracytoplasmic immunofluorescence was also detected immediately after injury in peripheral blood monocytes, but not in lymphocytes or granulocytes. IL-10-specific mRNA was detected in peripheral blood leukocytes in only 50% of patients immediately after injury, when the highest serum levels of IL-10 were observed. Our data indicates that release of pre-formed IL-10 by monocytes contributes to the presence of IL-10 found in patient peripheral blood immediately after head injury.	Swedish Med Ctr, HealthOne, Trauma Res Dept, Englewood, CO 80110 USA; Swedish Med Ctr, HealthOne, Trauma Serv, Englewood, CO 80110 USA		Shimonkevitz, R (corresponding author), Swedish Med Ctr, HealthOne, Trauma Res Dept, Room 4-454,501 E Hampden Ave, Englewood, CO 80110 USA.		Bar-Or, David/AAE-9328-2020				Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; CHERNOFF AE, 1995, J IMMUNOL, V154, P5492; CIOFFI WG, 1993, ARCH SURG-CHICAGO, V128, P1260; CRARY B, 1983, J IMMUNOL, V131, P1178; De AK, 1997, CLIN IMMUNOL IMMUNOP, V82, P73, DOI 10.1006/clin.1996.4289; DONNELLY SC, 1994, RESUSCITATION, V28, P87, DOI 10.1016/0300-9572(94)90077-9; Dutcher SA, 1998, J NEUROTRAUM, V15, P411, DOI 10.1089/neu.1998.15.411; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; Groux H, 1996, J EXP MED, V184, P19, DOI 10.1084/jem.184.1.19; Hauser CJ, 1997, J TRAUMA, V42, P895, DOI 10.1097/00005373-199705000-00021; HAUSER CJ, 1995, SHOCK, V4, P247, DOI 10.1097/00024382-199510000-00003; HERSHMAN MJ, 1990, BRIT J SURG, V77, P204, DOI 10.1002/bjs.1800770225; HOYT DB, 1990, J TRAUMA, V30, P759, DOI 10.1097/00005373-199007000-00001; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Lindner H, 1997, TRANSPLANTATION, V64, P1370, DOI 10.1097/00007890-199711150-00023; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Neidhardt R, 1997, J TRAUMA, V42, P863, DOI 10.1097/00005373-199705000-00017; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; PAL J, 1989, J TRAUMA, V29, P746, DOI 10.1097/00005373-198906000-00008; Puyana JC, 1998, J TRAUMA, V44, P1037, DOI 10.1097/00005373-199806000-00017; Selzman CH, 1998, SHOCK, V10, P309, DOI 10.1097/00024382-199811000-00001; Sherry RM, 1996, J TRAUMA, V40, P613, DOI 10.1097/00005373-199604000-00016; Thornton FJ, 1997, SHOCK, V8, P391, DOI 10.1097/00024382-199712000-00001; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808	25	24	24	0	0	BIOMEDICAL PRESS	AUGUSTA	1021 15TH ST, BIOTECH PARK STE 9,, AUGUSTA, GA 30901 USA	1073-2322			SHOCK	Shock	JUL	1999	12	1					10	16		10.1097/00024382-199907000-00002			7	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	216BQ	WOS:000081421000002	10468046				2022-02-06	
J	Stover, JF; Pleines, UE; Morganti-Kossmann, MC; Stocker, R; Kossmann, T				Stover, JF; Pleines, UE; Morganti-Kossmann, MC; Stocker, R; Kossmann, T			Thiopental attenuates energetic impairment but fails to normalize cerebrospinal fluid glutamate in brain-injured patients	CRITICAL CARE MEDICINE			English	Article						barbiturate coma; cerebrospinal fluid; electroencephalogram; glutamate; hypoxanthine; intracranial pressure; lactate; thiopental; traumatic brain injury	EXCITATORY AMINO-ACIDS; SEVERE HEAD-INJURY; CORTICAL ACTIVITY; RAT; ISCHEMIA; RELEASE; ANESTHETICS; ACCUMULATION; MECHANISMS; INHIBITOR	Objectives: Brain-injured patients are susceptible to secondary brain damage related to decreased cerebral perfusion pressure associated with edema formation and increased intracranial pressure (ICP). Whenever conventional therapy fails to reduce elevated ICP, barbiturate coma represents an additional intervention that may control ICP. In patients suffering from severe traumatic brain injury, cerebrospinal fluid levels of glutamate, hypoxanthine, and lactate were measured during barbiturate coma and correlated to electroencephalographic recordings and ICP. Design: Prospective, descriptive study. Setting: Ten-bed surgical intensive care unit in a university hospital. Patients: Twenty-one patients with severe traumatic brain injury (Glasgow Coma Scale score less than or equal to 9); 11 required barbiturate coma because of refractory intracranial hypertension, and 10 were manageable with continuous administration of fentanyl and midazolam. Interventions: Thiopental was administered continuously for increased ICP within the first 24 hrs after trauma and adjusted to the burst-suppression pattern (four to six bursts per minute) on continuous electroencephalographic monitoring. Measurements and Main Results: Glutamate and hypoxanthine were analyzed using high-performance liquid chromatography, whereas lactate was measured enzymatically. Patients requiring thiopental presented with significantly higher ICP, glutamate, and hypoxanthine levels than patients receiving fentanyl and midazolam (p < .05). Within the first 24 hrs, thiopental significantly reduced cerebrospinal fluid glutamate and hypoxanthine levels in all patients, i.e., the burst-suppression pattern was successfully induced (p < .001). Interestingly, in five patients cerebrospinal fluid glutamate increased to initial values again despite unchanged neuronal activity. In these patients, ICP, hypoxanthine, and lactate remained significantly elevated compared with the six patients with steadily decreasing cerebrospinal fluid glutamate, hypoxanthine, lactate, and ICP values (p < .02). Conclusions: Barbiturate coma does not unequivocally preserve energetic stability despite successful suppression of neuronal activity. Despite the use of barbiturate coma in patients with refractory intracranial hypertension, persistent release or impaired uptake of glutamate may be associated with continuous anaerobic metabolism, as shown by increases in cerebrospinal fluid hypoxanthine and lactate levels.	Univ Zurich Hosp, Div Trauma Surg, Dept Surg, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Dept Surg, Div Surg Res, CH-8091 Zurich, Switzerland		Stover, JF (corresponding author), Charite Virchow Med Ctr, Dept Neurosurg, Augustenburger Pl 1, D-13353 Berlin, Germany.			Morganti-Kossmann, Cristina/0000-0002-0807-2063			Amakawa K, 1996, ANESTHESIOLOGY, V85, P1422, DOI 10.1097/00000542-199612000-00024; BAETHMANN A, 1989, J NEUROSURG, V70, P578, DOI 10.3171/jns.1989.70.4.0578; BALCAR VJ, 1978, BIOCHEM PHARMACOL, V27, P2955, DOI 10.1016/0006-2952(78)90214-9; BARKER JL, 1977, J PHYSL, V280, P355; BICKLER PE, 1995, ANESTHESIOLOGY, V83, P1233, DOI 10.1097/00000542-199512000-00014; BIEBUYCK JF, 1993, ANESTHESIOLOGY, V78, P615; CARLA V, 1992, NEUROSCI LETT, V146, P21, DOI 10.1016/0304-3940(92)90162-Z; DAGANI F, 1987, J NEUROCHEM, V49, P1229, DOI 10.1111/j.1471-4159.1987.tb10015.x; DANBOLT NC, 1994, PROG NEUROBIOL, V44, P377, DOI 10.1016/0301-0082(94)90033-7; DESALLES AAF, 1986, J NEUROSURG, V65, P615, DOI 10.3171/jns.1986.65.5.0615; DeWitt D S, 1995, New Horiz, V3, P376; EBLING WF, 1991, J PHARMACOKINET BIOP, V19, P123, DOI 10.1007/BF01073865; HAGBERG H, 1986, NEUROSCI LETT, V68, P311, DOI 10.1016/0304-3940(86)90508-2; HANSSON E, 1994, NEUROSCIENCE, V63, P1057, DOI 10.1016/0306-4522(94)90572-X; Ito T, 1996, LIFE SCI, V59, P169, DOI 10.1016/0024-3205(96)00199-3; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; KIMELBERG HK, 1989, MOL CHEM NEUROPATHOL, V11, P1, DOI 10.1007/BF03160036; LEVIN SD, 1984, J NEUROL NEUROSUR PS, V47, P730, DOI 10.1136/jnnp.47.7.730; Lukatch HS, 1996, ANESTHESIOLOGY, V84, P1425, DOI 10.1097/00000542-199606000-00019; MADL JE, 1993, J NEUROSCI, V13, P4429; McIntosh TK, 1996, LAB INVEST, V74, P315; MICHENFELDER JD, 1970, ANESTHESIOLOGY, V33, P315, DOI 10.1097/00000542-197009000-00008; MONTGOMERY DL, 1994, VET PATHOL, V31, P145, DOI 10.1177/030098589403100201; MUELLER RA, 1988, CELL MOL NEUROBIOL, V8, P235, DOI 10.1007/BF00711249; NEHLS DG, 1987, ANESTHESIOLOGY, V66, P453, DOI 10.1097/00000542-198704000-00002; NELSON SR, 1968, J NEUROCHEM, V15, P1271, DOI 10.1111/j.1471-4159.1968.tb05904.x; NICOLL RA, 1975, P NATL ACAD SCI USA, V72, P1460, DOI 10.1073/pnas.72.4.1460; NICOLL RA, 1975, NATURE, V258, P625, DOI 10.1038/258625a0; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; NORDBY HK, 1984, ACTA NEUROCHIR, V72, P157, DOI 10.1007/BF01406868; Obrenovitch TP, 1997, PROG NEUROBIOL, V51, P39, DOI 10.1016/S0301-0082(96)00049-4; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; OLNEY JW, 1991, SCIENCE, V254, P1515, DOI 10.1126/science.1835799; OLNEY JW, 1986, NEUROSCI LETT, V68, P29, DOI 10.1016/0304-3940(86)90224-7; Phillis JW, 1997, BRAIN RES, V758, P9, DOI 10.1016/S0006-8993(97)00155-8; STOCKER R, 1995, INTEGRATED APPROACH, P196; Stover JF, 1997, NEUROSCI LETT, V238, P25, DOI 10.1016/S0304-3940(97)00840-9; Stover JF, 1997, EUR J CLIN INVEST, V27, P1038, DOI 10.1046/j.1365-2362.1997.2250774.x; Stover JF, 1998, EUR NEUROL, V39, P223, DOI 10.1159/000007938; TORP R, 1991, NEUROSCIENCE, V41, P433, DOI 10.1016/0306-4522(91)90339-P; Wilberger J E, 1995, New Horiz, V3, P469; WONG EHF, 1991, ANNU REV PHARMACOL, V31, P401; YOSHIDA S, 1983, J NEUROCHEM, V40, P1278, DOI 10.1111/j.1471-4159.1983.tb13567.x; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	45	24	24	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JUL	1999	27	7					1351	1357		10.1097/00003246-199907000-00028			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224NZ	WOS:000081906300019	10446831				2022-02-06	
J	Mattioli, F; Miozzo, A; Vignolo, LA				Mattioli, F; Miozzo, A; Vignolo, LA			Confabulation and delusional misidentification a four year follow-up study	CORTEX			English	Article						confabulation; misidentification; autobiographical memory; closed head injury; frontal lobe; temporal lobe	FRONTAL-LOBE DYSFUNCTION; RETRIEVAL; INJURY	We describe a patient, AZ, who showed, in addition to an amnesic syndrome which eventually improved, longstanding confabulation and delusional misidentification following bilateral frontal and right temporal post-traumatic lesions. Confabulation appeared in personal recollections and on long-term verbal memory testing. Misidentification concerned mainly his wife and house. During the four year follow-up AZ's confabulation progressively shrinked so as to become restricted to verbal memory tasks. By contrast, misidentification persisted. General semantic memory was unimpaired throughout, while performance on frontal tests was initially poor and partly improved in time. We argue that confabulation and misidentification, though often intermingled and occurring after similar lesion pattern, should be considered as different neuropsychological entities.	Univ Brescia, Neurol Clin, Neuropsychol Lab, I-25125 Brescia, Italy		Mattioli, F (corresponding author), Univ Brescia, Neurol Clin, Neuropsychol Lab, Spedali Civili, I-25125 Brescia, Italy.						Alexander I., 1979, COMPUTERS DIGITAL TE, V2, P29; BADDELEY AD, 1986, AUTOBIOGRAPHICAL MEM; BENSON DF, 1976, NEUROLOGY, V26, P147, DOI 10.1212/WNL.26.2.147; Capgras J., 1923, B SOC CLIN MED MENTA, V11, P6; Conway MA, 1996, NEUROCASE, V2, P325; Dalla Barba G, 1997, NEUROCASE, V3, P425, DOI 10.1093/neucas/3.6.425; DallaBarba G, 1997, CORTEX, V33, P563, DOI 10.1016/S0010-9452(08)70237-5; DALLABARBA G, 1993, CORTEX, V29, P567, DOI 10.1016/S0010-9452(13)80281-X; DALLABARBA G, 1993, COGN NEUROPSYCHOL, V10, P1; Elliott ML, 1996, BRAIN INJURY, V10, P703, DOI 10.1080/026990596123972; Feinberg TE, 1997, BEHAV NEUROLOGY NEUR; FISHER RS, 1995, J CLIN EXPT NEUROPSY, V17, P209; HAYMAN MA, 1977, BRIT J PSYCHIAT, V130, P68, DOI 10.1192/bjp.130.1.68; JOHNSON M, 1997, TRENDS COGNITIVE NEU, V2, P137; JOHNSON MK, 1991, AWARENESS DEFICIT BR; KAPUR N, 1980, J NEUROL NEUROSUR PS, V43, P461, DOI 10.1136/jnnp.43.5.461; KAPUR N, 1988, J NEUROL NEUROSUR PS, V51, P579, DOI 10.1136/jnnp.51.4.579; Kopelman MD, 1995, NEUROCASE, V1, P71, DOI 10.1080/13554799508402348; Kroll NEA, 1997, BRAIN, V120, P1377, DOI 10.1093/brain/120.8.1377; MARIANI C, 1991, J NEUROL, V238, P395, DOI 10.1007/BF00319859; Moscovitch M, 1997, NEUROPSYCHOLOGIA, V35, P1017, DOI 10.1016/S0028-3932(97)00028-6; MOSCOVITCH M, 1989, VARIETIES MEMORY CON; Pick A, 1903, BRAIN, V26, P242, DOI 10.1093/brain/26.2.242; Sandel ME, 1996, BRAIN INJURY, V10, P719, DOI 10.1080/026990596123981; SPINNLER H, 1987, ITALIAN J NEUROLOGIC, V89, P1837; WEINSTEIN EA, 1969, HDB CLIN NEUROLOGY; [No title captured]	27	24	25	0	1	MASSON DIVISIONE PERIODICI	MILAN	VIA FRATELLI BRESSAN 2, 20126 MILAN, ITALY	0010-9452			CORTEX	Cortex	JUN	1999	35	3					413	422		10.1016/S0010-9452(08)70809-8			10	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychology	219WG	WOS:000081630400008	10440078				2022-02-06	
J	Rothoerl, RD; Woertgen, C; Holzschuh, M; Metz, C; Brawanski, A				Rothoerl, RD; Woertgen, C; Holzschuh, M; Metz, C; Brawanski, A			Rapid evaluation of S-100 serum levels. Case report and comparison to previous results	BRAIN INJURY			English	Article							NEURON-SPECIFIC ENOLASE; ISCHEMIC BRAIN-DAMAGE; CREATINE-KINASE BB; CEREBROSPINAL-FLUID; HEAD-INJURY; PROTEIN; INCREASES; STROKE; NSE; CSF	The aim of this case report is to describe the time course of S-100 serum levels of a patient, after severe head injury, whose blood sample could be drawn very soon after injury. The results were compared to a group of patients in which a correlation between S-100 serum levels and outcome after traumatic brain injury could be demonstrated. Blood samples were taken on admission (mean 2.3 hours), 6, 12 and 24 hours after trauma and then every 24 hours up until and including the fifth day. The outcome was estimated on discharge using the Glasgow Outcome Scale. The S-100 serum level of the patient described in the case report with a favourable outcome had initially risen to 10.0 mu g/l and showed a rapid decline. In the previous group, patients with unfavourable outcome had a S-100 serum level of 7 mu g/l mean concerning the fuse probe (after 2.3 hours mean) compared to 1.5 mu g/l mean (after 2.23 hours mean) in patients with favourable outcome (p < 0.05). In comparison to the literature, there seems to be differences regarding the enzyme liberation in stroke and head injury. Therefore, S-100 serum levels need to be interpreted with regard to collection time and underlying pathology.	Univ Regensburg, Dept Neurosurg, D-8400 Regensburg, Germany; Univ Regensburg, Dept Anesthesiol, D-8400 Regensburg, Germany		Rothoerl, RD (corresponding author), Univ Regensburg Klinikum, Dept Neurosurg, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany.						BARONE FC, 1993, BRAIN RES, V623, P77, DOI 10.1016/0006-8993(93)90012-C; CUNNINGHAM RT, 1991, EUR J CLIN INVEST, V21, P497, DOI 10.1111/j.1365-2362.1991.tb01401.x; HARDEMARK HG, 1989, J NEUROSURG, V71, P727, DOI 10.3171/jns.1989.71.5.0727; HAY E, 1984, J NEUROL NEUROSUR PS, V47, P724, DOI 10.1136/jnnp.47.7.724; HORN M, 1995, STROKE, V26, P290, DOI 10.1161/01.STR.26.2.290; Ingebrigtsen T, 1996, J NEUROSURG, V85, P945, DOI 10.3171/jns.1996.85.5.0945; JENNETT B, 1975, LANCET, V1, P480; KRUSE A, 1991, ACTA NEUROCHIR, V110, P106, DOI 10.1007/BF01400675; MARANGOS PJ, 1979, J NEUROCHEM, V33, P319, DOI 10.1111/j.1471-4159.1979.tb11735.x; MARSHALL LF, 1991, J NEUROSURG, V75, pS15; MISSLER U, 1995, EUR J CLIN CHEM CLIN, V33, P743; NARA T, 1988, AM J DIS CHILD, V142, P173, DOI 10.1001/archpedi.1988.02150020075032; PERSSON L, 1987, STROKE, V18, P911, DOI 10.1161/01.STR.18.5.911; PRANGE HW, 1994, Z KARDIOL, V83, P127; SKOGSEID IM, 1992, ACTA NEUROCHIR, V115, P106, DOI 10.1007/BF01406367; TEASDALE G, 1974, LANCET, V2, P81; VAAGENES P, 1986, ARCH NEUROL-CHICAGO, V43, P357, DOI 10.1001/archneur.1986.00520040043017; WOERTGEN C, 1997, ZENTRALBLATT NEUROCH, V17; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6	19	24	26	0	0	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAY	1999	13	5					387	391					5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	200LE	WOS:000080541100008	10367150				2022-02-06	
J	Jeong, BY				Jeong, BY			Comparisons of variables between fatal and nonfatal accidents in manufacturing industry	INTERNATIONAL JOURNAL OF INDUSTRIAL ERGONOMICS			English	Article						accident analysis; manufacturing industry; occupational deaths and injuries	INFORMATION; SYSTEM	This study concerns with the comparisons of variables between fatal and nonfatal accidents in Korean manufacturing industries. The national industrial accident statistics for the years 1991-1994 were extracted from the annual publications of Ministry of Labor. These data were used to compare the distributions of fatal and nonfatal injuries in terms of company size, injured person's age, work experience, accident time, activity at time of accident, accident type, injury type, injured body part, and accident agency. Results show that the distributions of the fatal injuries are statistically different from those of the nonfatal injuries: (1) nonfatal injuries occur more frequently in the younger workers, while deaths occur more frequently in the older workers; (2) the proportion of death occurring in night shift is greater than that of nonfatal injuries; (3) 'caught in and between objects' is the most common type of accident, but the second common type of accident is 'awkward or sudden movement' in the nonfatal injuries, instead of 'falls from a height' in deaths; and (4) 'fracture' is the leading caused injury and death, but the second leading type of injury is 'contusion or bruise' in the nonfatal injuries and 'cerebral concussion' in deaths.	Hansung Univ, Dept Ind Engn, Sungbuk Gu, Seoul 136792, South Korea		Jeong, BY (corresponding author), Hansung Univ, Dept Ind Engn, Sungbuk Gu, 389 Samsun Dong, Seoul 136792, South Korea.		Jeong, Byung Yong/Q-6377-2018	Jeong, Byung Yong/0000-0001-6837-1324			ANDERSSON R, 1983, ERGONOMICS, V26, P33, DOI 10.1080/00140138308963310; BIERINGSORENSEN F, 1985, ERGONOMICS, V28, P5; BUCK PC, 1985, ERGONOMICS, V28, P949, DOI 10.1080/00140138508963217; HETTINGER T, 1985, ERGONOMICS, V28, P17, DOI 10.1080/00140138508963106; Jeong BY, 1997, INT J IND ERGONOM, V20, P301; METZLER F, 1985, ERGONOMICS, V28, P21, DOI 10.1080/00140138508963107; *MIN LAB, 1972, ANN AN IND ACC; NICHOLSON AS, 1985, ERGONOMICS, V28, P31, DOI 10.1080/00140138508963109; Surry J, 1968, IND ACCIDENT RES HUM; Tanis E. A., 1997, PROBABILITY STAT INF, Vfifth; ZUIDEMA H, 1985, ERGONOMICS, V28, P45, DOI 10.1080/00140138508963110	11	24	24	1	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-8141			INT J IND ERGONOM	Int. J. Ind. Ergon.	MAR 20	1999	23	5-6					565	572					8	Engineering, Industrial; Ergonomics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering	162XP	WOS:000078372700019					2022-02-06	
J	Blackard, DO; Jensen, RL; Ebben, WP				Blackard, DO; Jensen, RL; Ebben, WP			Use of EMG analysis in challenging kinetic chain terminology	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article							LOWER-EXTREMITY; BIOMECHANICAL ANALYSIS; REHABILITATION; EXERCISE; KNEE; PERFORMANCE; EXTENSION; INJURY	Purpose: The purpose of this study was to compare mean integrated electromyographic values (EMG(int)) during biomechanically comparable closed kinetic chain/fixed external load, open kinetic chain/moveable no load, and moveable external load exercises. Methods: EMG(int) were obtained for the pectoralis major (PM) and the long head of the triceps (T) during absorption and force phases of three biomechanically comparable exercises: the push-up (PU); the bench press-load (BP-L); and the bench press-no load (BP-NL) equated to the closed kinetic chain/fixed external load; moveable external load; and open kinetic chain/moveable no load conditions respectively. A force plate was used to equate load for the PU and BP-L exercises. Ten males (24 +/- 4.4 yr) participated in the three randomly ordered exercises. A pronated, closed grip was used for all exercises. The mean integrated EMG values from three isometric maximal voluntary contractions were used to determine a reference EMG (EMG(MVC)) for each muscle. Normalized EMG values (NEMG) were determined by EMG(int)/EMG(MVC) and analyzed by one-factor repeated measures ANOVA for each muscle (PM and T) during each phase (absorption and force). Results: There was no significant difference (P > 0.05) between the equivalently loaded, different boundary exercises (PU and BP). Statistical significance (P < 0.05) was determined between the differently loaded, equivalent boundary exercises (BP and BP-NL) as well as the differently loaded, different boundary exercises (PU and BP-NL). Conclusions: Results from this study support the theory that activities of similar biomechanical motions and mass of loading, regardless of the boundary condition, have comparable EMG values of primary muscle groups. In addition, this study suggests external load is more important than boundary condition in describing human activity.	No Michigan Univ, US Olymp Educ Ctr Sports Med, Marquette, MI 49855 USA; No Michigan Univ, Dept Hlth Phys Educ & Recreat, Marquette, MI 49855 USA; Marquette Univ, Dept Strength & Conditioning, Milwaukee, WI 53233 USA		Blackard, DO (corresponding author), No Michigan Univ, US Olymp Educ Ctr Sports Med, Meyland Hall, Marquette, MI 49855 USA.	dblackar@nmu.edu					Davies GJ, 1995, J SPORT REHABIL, V4, P1; DeCarlo M., 1992, IES, V2, P24, DOI [10.3233/IES-1992-2104, DOI 10.3233/IES-1992-2104]; DILLMAN CJ, 1994, J SPORT REHABIL, V3, P228, DOI DOI 10.1123/JSR.3.3.228; GOULD JA, 1990, ORTHOPAEDIC SPORTS P, P77; Graham Victoria L., 1993, Journal of Athletic Training, V28; GRAY GW, 1992, FITNESS MANAGE, V8, P31; GRAY GW, 1989, CHAIN REACTION SUCCE, P1; Howell S M, 1993, Am J Sports Med, V21, P632, DOI 10.1177/036354659302100427; KELSEY DD, 1994, J ORTHOP SPORT PHYS, V19, P218, DOI 10.2519/jospt.1994.19.4.218; LAFREE J, 1995, J SPORT REHABIL, V4, P99; LEE HWM, 1994, J MANUAL MANIPULATIV, V2, P133; LUTZ GE, 1993, J BONE JOINT SURG AM, V75A, P732, DOI 10.2106/00004623-199305000-00014; PALMITIER RA, 1991, SPORTS MED, V11, P402, DOI 10.2165/00007256-199111060-00005; PANARIELLO RA, 1991, NATL STRENGTH COND A, V13, P29; PICCIANO AM, 1993, J ORTHOP SPORT PHYS, V18, P553, DOI 10.2519/jospt.1993.18.4.553; PODESTA L, 1990, CLIN ORTHOP RELAT R, P262; Rivera JE, 2010, J SPORT REHABIL, V3, DOI 10.1123/jsr.3.2.154; ROSENTHAL MD, 1994, J SPORT REHABIL, V3, P218; RUBINSTEIN RA, 1994, AM J SPORT MED, V22, P324, DOI 10.1177/036354659402200305; SAWYERR AM, 1991, ALIMENT PHARM THERAP, V5, P1; SETO JL, 1994, CLIN SPORT MED, V13, P695; SHELBOURNE KD, 1990, AM J SPORT MED, V18, P292, DOI 10.1177/036354659001800313; SHELBOURNE KD, 1994, SPORTS MED, V17, P132, DOI 10.2165/00007256-199417020-00005; SMIDT GL, 1973, J BIOMECH, V6, P79, DOI 10.1016/0021-9290(73)90040-7; STEINDLER A, 1973, KINESIOLOGY HUMAN BO, V63, P436; Stone Jennifer A., 1993, Journal of Athletic Training, V28, P34; White D M, 1993, Am J Sports Med, V21, P633, DOI 10.1177/036354659302100429; WORRELL TW, 1993, J ORTHOP SPORT PHYS, V18, P646, DOI 10.2519/jospt.1993.18.6.646; YACK HJ, 1993, AM J SPORTS MED, V21, P632	29	24	27	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0195-9131			MED SCI SPORT EXER	Med. Sci. Sports Exerc.	MAR	1999	31	3					443	448		10.1097/00005768-199903000-00014			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	176ME	WOS:000079154500014	10188750				2022-02-06	
J	Mazzini, L; Pisano, F; Zaccala, M; Miscio, G; Gareri, F; Galante, M				Mazzini, L; Pisano, F; Zaccala, M; Miscio, G; Gareri, F; Galante, M			Somatosensory and motor evoked potentials at different stages of recovery from severe traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							SEVERE HEAD-INJURY; CENTRAL CONDUCTION TIME; PROGNOSTIC VALUE; COMATOSE PATIENTS; PARIETAL COMPONENTS; RATING-SCALE; SENSORIMOTOR; DISABILITY; RESPONSES; SEP	Objective: To detect changes of somatosensory evoked potentials (SEPs) and motor evoked potentials (MEPs) at different stages of recovery from severe brain injury and to determine whether they can be used to predict late functional outcome. Design: Correlational study on a prospective cohort. Setting: Brain injury rehabilitation center. Patients: Twenty-seven consecutively sampled patients with severe traumatic brain injury referred to the inpatient intensive rehabilitation unit of primary care in a university-based system. Main Outcome Measures: (1) Glasgow Outcome Scale, Disability Rating Scale, and Functional Independence Measure: (2) SEPs and MEPs from upper limbs (ULs) and lower limbs (LLs). Outcome was assessed at 6 and 12 months after trauma. Correlations were computed with the nonparametric test of Spearman-Rank. Results: Both SEPs and MEPs showed dynamic changes (p < .02 for N20, p < .05 for N30, P40, and N45), with a trend toward a progressive normalization. N30 was more frequently abnormal than N20. SEPs from LLs were more frequently and more persistently abnormal than those from ULs. Clinical and functional outcome was strongly correlated with the degree of abnormality of SEPs from LLs (p < .002), whereas only mild relationships were found with SEPs from ULs. Both SEPs and MEPs showed a high negative predictive value (83% for N30 and 83% for P40), but only SEPs from LLs also had a high positive predictive value (72% for P40). Sensitivity was 88% both for N30 and P40. Specificity was 50% for N30 and 70% for P40). Conclusion: SEPs from LLs can be very useful in monitoring the postacute phase of traumatic brain injury and in identifying patients who require further intensive rehabilitation. MEPs may be of questionable value. (C) 1999 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.	Fdn Salvatore Maugeri, IRCCS, Ctr Med Veruno, Med Ctr Rehabil,Dept Phys Therapy, I-28010 Veruno, No, Italy; Fdn Salvatore Maugeri, IRCCS, Dept Neurol, Med Ctr Rehabil,Dept Phys Therapy, I-28010 Veruno, No, Italy		Mazzini, L (corresponding author), Fdn Salvatore Maugeri, IRCCS, Ctr Med Veruno, Med Ctr Rehabil,Dept Phys Therapy, I-28010 Veruno, No, Italy.		Mazzini, Letizia/AAA-2262-2021	Mazzini, Letizia/0000-0003-2479-9120			ANDERSON DC, 1984, ARCH NEUROL-CHICAGO, V41, P369, DOI 10.1001/archneur.1984.04050160031011; BRUNKO E, 1987, ELECTROEN CLIN NEURO, V66, P15, DOI 10.1016/0013-4694(87)90133-7; CANT BR, 1986, ELECTROEN CLIN NEURO, V65, P188, DOI 10.1016/0168-5597(86)90053-5; Chatrian GE, 1996, ELECTROEN CLIN NEURO, V99, P103, DOI 10.1016/0013-4694(96)96059-9; DESMEDT JE, 1987, ELECTROEN CLIN NEURO, V68, P1, DOI 10.1016/0168-5597(87)90065-7; FACCO E, 1991, ELECTROEN CLIN NEURO, V80, P469, DOI 10.1016/0168-5597(91)90128-K; FACCO E, 1989, ELECTROEN CLIN NEURO, V73, P552, DOI 10.1016/0013-4694(89)90265-4; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; GREENBERG RP, 1981, J NEUROSURG, V55, P227, DOI 10.3171/jns.1981.55.2.0227; GREENBERG RP, 1982, J NEUROSURG, V56, P1, DOI 10.3171/jns.1982.56.1.0001; GUTLING E, 1994, ELECTROEN CLIN NEURO, V92, P568, DOI 10.1016/0168-5597(94)90141-4; GUTLING E, 1993, ELECTROEN CLIN NEURO, V88, P369, DOI 10.1016/0168-5597(93)90013-F; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; HOULDEN DA, 1992, J TRAUMA, V33, P244, DOI 10.1097/00005373-199208000-00014; JENNETT B, 1975, LANCET, V1, P480; KEREN O, 1994, BRAIN INJURY, V8, P239, DOI 10.3109/02699059409150976; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LINDSAY KW, 1981, J NEUROL NEUROSUR PS, V44, P796, DOI 10.1136/jnnp.44.9.796; MAUGUIERE F, 1983, BRAIN, V106, P271, DOI 10.1093/brain/106.2.271; NAU HE, 1988, NEUROCHIRURGIA, V31, P170; PohlmannEden B, 1997, INTENS CARE MED, V23, P301, DOI 10.1007/s001340050332; por Chapman y Hall/CRC, 1990, PRACTICAL STAT MED R; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; ROSENBERG JH, 1995, NEUROLOGY, V45, P1015; ROTHSTEIN TL, 1991, ELECTROEN CLIN NEURO, V79, P101, DOI 10.1016/0013-4694(91)90046-7; TEASDALE G, 1974, LANCET, V2, P81; VECCHIO TJ, 1966, NEW ENGL J MED, V274, P1171, DOI 10.1056/NEJM196605262742104; YING Z, 1992, J NEUROL NEUROSUR PS, V55, P470, DOI 10.1136/jnnp.55.6.470; ZENTNER J, 1988, EEG-EMG-Z ELEK ELEKT, V19, P267; ZENTNER J, 1994, NEUROL RES, V16, P89; ZENTNER J, 1992, NEUROSURGERY, V31, P429, DOI 10.1227/00006123-199209000-00007	31	24	24	0	4	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	1999	80	1					33	39		10.1016/S0003-9993(99)90304-0			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	155XZ	WOS:000077973000005	9915369				2022-02-06	
J	Ricci, R; Vaishnavi, S; Chatterjee, A				Ricci, R; Vaishnavi, S; Chatterjee, A			A deficit of intermediate vision: Experimental observations and theoretical implications	NEUROCASE			English	Article						attention; object recognition; visual agnosia; simultanagnosia; pre-attentive vision	MONKEY VISUAL-CORTEX; OBJECT RECOGNITION; CONTOUR PERCEPTION; NEGLECT; SPOTLIGHT; ATTENTION; DISCRIMINATION; SPECIALIZATION; MECHANISMS; DESIGN	The nervous system constructs visual representations hierarchically. Elementary features are extracted from the visual scene and grouped to form candidate objects, which may then be selected for attentional scrutiny. We wished to learn if intermediate vision (pre-attentive and effortless grouping processes) can be damaged selectively and, if so, what the consequences of such damage might be. We present a patient with significant visual disabilities following a traumatic brain injury. Her early vision was preserved. However, she had a deficit of intermediate vision as evidenced by an inability to: (i) link visual attributes into perceptual wholes effortlessly, (ii) search for visual targets pre-attentively and (iii) accurately perceive illusory contours. By contrast, she could deploy attention both panoramically and selectively. She also recognized real objects and described pictures. We conclude that intermediate vision can be damaged selectively. Attention can be deployed on a visual scene which has not been pre-attentively parsed. Grouping processes are not needed to recognize objects, Our findings suggest that the hierarchical organization of visual processing is more interactive than implied by serial feed-forward models.	Univ Alabama, Dept Neurol, Birmingham, AL 35294 USA; Univ Turin, Dept Psychol, Turin, Italy			a_chatterjee@email.neuro.uab.edu	Ricci, Raffaella/AAK-5906-2021	Ricci, Raffaella/0000-0003-3422-2552			ALBERT ML, 1973, NEUROLOGY, V23, P658, DOI 10.1212/WNL.23.6.658; BARLOW HB, 1981, PROC R SOC SER B-BIO, V212, P1, DOI 10.1098/rspb.1981.0022; BERGEN JR, 1983, NATURE, V303, P696, DOI 10.1038/303696a0; CHATTERJEE A, 1994, NEUROPSY NEUROPSY BE, V7, P267; Coslett HB, 1995, NEUROCASE, V1, P305; COSLETT HB, 1991, BRAIN, V114, P1523, DOI 10.1093/brain/114.4.1523; DELIS DC, 1986, NEUROPSYCHOLOGIA, V24, P205, DOI 10.1016/0028-3932(86)90053-9; DRIVER J, 1992, NATURE, V360, P73, DOI 10.1038/360073a0; FARAH MJ, 1990, VISUAL AGNOSIA; Goodglass H., 1972, ASSESSMENT APHASIA R; GRABOWECKY M, 1993, J COGNITIVE NEUROSCI, V5, P288, DOI 10.1162/jocn.1993.5.3.288; GROSOF DH, 1993, NATURE, V365, P550, DOI 10.1038/365550a0; Grossberg S, 1997, TRENDS NEUROSCI, V20, P106, DOI 10.1016/S0166-2236(96)01002-8; HALLIGAN PW, 1994, COGNITIVE NEUROPSYCH, V11, P167, DOI 10.1080/02643299408251973; Heilman KM, 1993, CLIN NEUROPSYCHOLOGY, P279; HYVARINEN L, 1993, PV16 COLOR TEST QUAN; James W., 1890, PRINCIPLES PSYCHOL; KANIZSA G, 1976, SCI AM, V234, P48, DOI 10.1038/scientificamerican0476-48; KARTSOUNIS LD, 1991, NEUROPSYCHOLOGIA, V29, P969, DOI 10.1016/0028-3932(91)90061-C; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; Marr D., 1982, VISION COMPUTATIONAL, P428; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Nawrot M, 1996, VISION RES, V36, P1141, DOI 10.1016/0042-6989(95)00173-5; PELLI DG, 1988, CLIN VISION SCI, V2, P187; PETERHANS E, 1989, J NEUROSCI, V9, P1749; Stark ME, 1997, NEUROPSYCHOLOGIA, V35, P1233, DOI 10.1016/S0028-3932(97)00049-3; THAISS L, 1992, CORTEX, V28, P601; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; VANESSEN DC, 1992, SCIENCE, V255, P419, DOI 10.1126/science.1734518; VANESSEN DC, 1990, COLD SH Q B, V55, P679; Vecera SP, 1997, NEUROPSYCHOLOGY, V11, P30, DOI 10.1037/0894-4105.11.1.30; VONDERHEYDT R, 1989, J NEUROSCI, V9, P1731; Warrington E. K., 1991, VISUAL OBJECT SPATIA; WEISKRANTZ L, 1974, BRAIN, V97, P709, DOI 10.1093/brain/97.1.709; Wilson B., 1999, BEHAVIOURAL INATTENT BEHAV INATTENTION TE; ZEKI SM, 1978, NATURE, V274, P423, DOI 10.1038/274423a0	36	24	24	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1355-4794			NEUROCASE	Neurocase		1999	5	1					1	12					12	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	169VT	WOS:000078770300001					2022-02-06	
J	Fuhrer, MJ; Keith, RA				Fuhrer, MJ; Keith, RA			Facilitating patient learning during medical rehabilitation - A research agenda	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						learning; patient education; medical rehabilitation		Although patient learning is widely acknowledged to be an integral part of many medical rehabilitation practices, it has been the subject of little systematic research. A workshop conducted August 18 to 19, 1997, was organized by the National Center for Medical Rehabilitation Research (National Institute of Child Health and Human Development, National Institutes of Health) and several co-sponsoring organizations to formulate recommendations concerning learning-oriented rehabilitation practices. The recommendations and their supporting rationale are summarized in the topic areas of motor learning and control, cognitive learning, recovery of functioning, generalization and transfer of training, and applications for patients with strokes, traumatic brain injury, amputations, and infants and children.	NICHHD, Natl Ctr Med Rehabil Res, NIH, Rockville, MD 20852 USA; Casa Colina Hosp, Pomona, CA USA		Fuhrer, MJ (corresponding author), NICHHD, Natl Ctr Med Rehabil Res, NIH, Bldg 6100,Room 2A03,6100 Execut Blvd, Rockville, MD 20852 USA.						HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; *NAT I CHILD HLTH, 1993, RES PLAN NAT CTR MED; Wade DT, 1996, J NEUROL NEUROSUR PS, V61, P242, DOI 10.1136/jnnp.61.3.242	3	24	24	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	NOV-DEC	1998	77	6					557	561		10.1097/00002060-199811000-00022			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	147RZ	WOS:000077487100017	9862546				2022-02-06	
J	Choi, SC; Marmarou, A; Bullock, R; Nichols, JS; Wei, X; Pitts, LH				Choi, SC; Marmarou, A; Bullock, R; Nichols, JS; Wei, X; Pitts, LH		Amer Brain Injury Consortium Study Grp	Primary end points in phase III clinical trials of severe head trauma: DRS versus GOS	JOURNAL OF NEUROTRAUMA			English	Article						Disability Rating Scale; Glasgow Outcome Scale; outcome; traumatic brain injury	DISABILITY RATING-SCALE; GLASGOW OUTCOME SCALE; BRAIN INJURY; RECOVERY	The most commonly used primary end point in phase III clinical trials of severe head trauma is the Glasgow Outcome Scale (GOS), usually dichotomized to favorable (good) and unfavorable (poor) outcomes. The alternative endpoints include the Disability Rating Scale (DRS) with a 31-point scale, The purpose of this study was to compare DRS and GOS using the data collected from two completed clinical trials organized by the American Brain Injury Consortium and two pharmaceutical companies, The two outcome scales were examined and compared in terms of the correlation between the two scales, sensitivity, and p values between the differences between two arms of the trials. There was no indication that the DRS was more sensitive or advantageous relative to the dichotomized or four-category GOS, In addition, the highly significant correlation between the two outcome scales (r = 0.95; p < 0.0001) could not justify the DRS as an end point. The other problems with the DRS include the difficulty of determining the clinically meaningful difference in designing trials, The study suggested that the GOS is a better primary end point than DRS.	Virginia Commonwealth Univ, Med Coll Virginia, Dept Biostat, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Div Neurosurg, Richmond, VA 23298 USA; St Anthony Hosp, Dept Neurosurg, Denver, CO USA; Univ Calif San Francisco, San Francisco, CA 94143 USA		Choi, SC (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Biostat, Box 980032, Richmond, VA 23298 USA.						CLIFTON GL, 1993, NEUROSURGERY, V33, P34; DOPPENBERG EMR, 1997, ANN NY ACAD SCI, V825, P305; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; TEASDALE GM, 1997, 4 INT NEUR S SEOUL K; [No title captured]; [No title captured]	8	24	25	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	OCT	1998	15	10					771	776		10.1089/neu.1998.15.771			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	132LW	WOS:000076632400002	9814633				2022-02-06	
J	Roncone, R; Rossi, L; Muiere, E; Impallomeni, M; Matteucci, M; Giacomelli, R; Tonietti, G; Casacchia, M				Roncone, R; Rossi, L; Muiere, E; Impallomeni, M; Matteucci, M; Giacomelli, R; Tonietti, G; Casacchia, M			The Italian version of the family assessment device	SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY			English	Article							TRAUMATIC BRAIN INJURY; SUICIDAL-BEHAVIOR; MAJOR DEPRESSION; MAINTENANCE CHEMOTHERAPY; COMMUNITY MANAGEMENT; AFTERCARE TREATMENT; EXPRESSED EMOTION; CONTROLLED TRIAL; POOR ADJUSTMENT; CHRONIC ILLNESS	The aim of the study was to evaluate in a heterogeneous Italian sample (n = 340) the psyche metric properties of the Italian version of the Family Assessment Device (FAD), a 60-item questionnaire assessing family functioning. The questionnaire was administered to psychiatric (n = 116), medical (n = 114) and non-clinical samples (n = 110). In a sample of 30 non-clinical subjects the temporal stability of the FAD was investigated. The results showed a good temporal stability for Problem Solving, General Functioning, Communication, and Affective Responsiveness scales, and a good internal reliability of the scale. Factor analysis of the Italian version provided discrepancies with the hypothesized structure of the instrument, leading to the identification of seven slightly different dimensions. The proposed seven-factor model of the instrument did not provide a good fit to our data. The results of our study suggest the need for a major improvement in the adaptation of the FAD in the Italian setting.	Univ Aquila, Dept Psychiat, I-67100 Laquila, Italy; Univ Aquila, Dept Internal Med, I-67100 Laquila, Italy		Roncone, R (corresponding author), Univ Aquila, Dept Psychiat, Blocco 11,Via Vetoio, I-67100 Laquila, Italy.	rroncone@webacl.it	Roncone, Rita/H-3095-2012	Giacomelli, Roberto/0000-0003-0670-9638; RONCONE, Rita/0000-0002-1206-0970			ARPIN K, 1990, J CLIN EPIDEMIOL, V43, P373, DOI 10.1016/0895-4356(90)90123-7; BERNBAUM M, 1993, J CLIN PSYCHOL, V49, P670, DOI 10.1002/1097-4679(199309)49:5<670::AID-JCLP2270490509>3.0.CO;2-F; BERTRANDO P, 1992, BRIT J PSYCHIAT, V161, P223, DOI 10.1192/bjp.161.2.223; BROWN GW, 1972, BRIT J PSYCHIAT, V121, P241, DOI 10.1192/bjp.121.3.241; BROWNE GB, 1990, MED CARE, V28, P43, DOI 10.1097/00005650-199001000-00006; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; FALLOON IRH, 1982, NEW ENGL J MED, V306, P1437, DOI 10.1056/NEJM198206173062401; FALLOON IRH, 1985, ARCH GEN PSYCHIAT, V42, P887; FOWLER PC, 1981, J CLIN PSYCHOL, V37, P160, DOI 10.1002/1097-4679(198101)37:1<160::AID-JCLP2270370132>3.0.CO;2-Q; FRANCESCONI A, 1993, RIABILITAZIONE PSICH, P189; GOWERS SG, 1995, J CHILD PSYCHOL PSYC, V36, P993, DOI 10.1111/j.1469-7610.1995.tb01345.x; Halvorsen J G, 1991, Fam Pract Res J, V11, P21; HOGARTY GE, 1991, ARCH GEN PSYCHIAT, V48, P340; HOGARTY GE, 1986, ARCH GEN PSYCHIAT, V43, P633; JOFFE RT, 1988, AM J PSYCHIAT, V145, P1420; Joreskog K.G., 1988, LISREL 7 GUIDE PROGR, V2nd; Kabacoff R.I., 1990, J FAM PSYCHOL, V3, P431, DOI [10.1037/h0080547, DOI 10.1037/H0080547]; KEITNER G I, 1986, International Journal of Family Psychiatry, V7, P11; KEITNER GI, 1987, PSYCHIATRY, V50, P242, DOI 10.1080/00332747.1987.11024356; KEITNER GI, 1987, COMPR PSYCHIAT, V28, P54; KEITNER GI, 1995, AM J PSYCHIAT, V152, P1002; KING CA, 1993, J AM ACAD CHILD PSY, V32, P1198, DOI 10.1097/00004583-199311000-00013; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; LEFF J, 1985, BRIT J PSYCHIAT, V146, P594, DOI 10.1192/bjp.146.6.594; LIEPMAN MR, 1989, FAM PROCESS, V28, P239, DOI 10.1111/j.1545-5300.1989.00239.x; MARTIN G, 1995, ACTA PSYCHIAT SCAND, V92, P336, DOI 10.1111/j.1600-0447.1995.tb09594.x; MCKAY JR, 1993, J SUBST ABUSE TREAT, V10, P17, DOI 10.1016/0740-5472(93)90094-I; MILLER IW, 1994, FAM PROCESS, V33, P53, DOI 10.1111/j.1545-5300.1994.00053.x; MILLER IW, 1986, COMPR PSYCHIAT, V27, P302, DOI 10.1016/0010-440X(86)90006-4; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; NORTH C, 1995, BRIT J PSYCHIAT, V167, P673, DOI 10.1192/bjp.167.5.673; NORUSIS MJ, 1995, SPSS WINDOWS VERSION; OATES RK, 1994, J AM ACAD CHILD PSY, V33, P945, DOI 10.1097/00004583-199409000-00003; Reeber B J, 1992, Rehabil Nurs, V17, P332; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; SAWYER MG, 1988, J MARITAL FAM THER, V14, P287, DOI 10.1111/j.1752-0606.1988.tb00748.x; STEVENSONHINDE J, 1995, FAM PROCESS, V34, P337, DOI 10.1111/j.1545-5300.1995.00337.x; TARRIER N, 1988, BRIT J PSYCHIAT, V153, P532, DOI 10.1192/bjp.153.4.532; TARRIER N, 1989, BRIT J PSYCHIAT, V154, P625, DOI 10.1192/bjp.154.5.625; WALLER G, 1990, BRIT J PSYCHIAT, V156, P546, DOI 10.1192/bjp.156.4.546	41	24	26	0	6	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0933-7954	1433-9285		SOC PSYCH PSYCH EPID	Soc. Psychiatry Psychiatr. Epidemiol.	SEP	1998	33	9					451	461		10.1007/s001270050079			11	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	118JK	WOS:000075834600007	9766172				2022-02-06	
J	Dunn-Meynell, AA; Hassanain, M; Levin, BE				Dunn-Meynell, AA; Hassanain, M; Levin, BE			Norepinephrine and traumatic brain injury: a possible role in post-traumatic edema	BRAIN RESEARCH			English	Article						head trauma; catecholamine; contusion; cerebral edema; somatosensory cortex	SENSORIMOTOR CORTEX INJURY; CEREBRAL BLOOD-FLOW; RAT-BRAIN; NEURONAL DAMAGE; BEAM-WALKING; NORADRENALINE; RECOVERY; ISCHEMIA; IDAZOXAN; PERMEABILITY	Unilateral cerebral contusion is associated with an early (30 min) increase in norepinephrine (NE) turnover followed by a later (6-24 h) depression of turnover which is bilateral and widespread throughout the brain. Blockade of NE function during the first few hours after traumatic brain injury (TBI) impedes subsequent recovery of function without enlarging the size of the lesion. The current studies were carried out to characterize further the timing of the switch from increased to decreased NE turnover and to investigate the pathogenesis of the delayed recovery of function associated with blocking NE function. Adult male rats had unilateral somatosensory cortex contusions made with a 5 mm diameter impact piston. They were killed after 2 h and their brains analyzed for NE turnover by HPLC with electrochemical detection. In general, NE turnover (the ratio of 3-methoxy-4-hyroxyphenylglycol to NE levels) had returned to sham-lesion control levels in most brain regions by 2 h after either left or right sided contusions. The only exceptions were a persistent 87% increase at the lesion site after right-sided contusions and 22% and 32% increases in the contralateral cerebellum after right- and left-sided contusions, respectively. Blockade of alpha(1)-adrenoceptors by treatment with prazosin (3 mg/ kg, i.p.) 30 min prior to TBI produced edema in the striatum and hippocampus at 24 h which was not seen saline-treated rats nor in rats where NE reuptake was blocked with desmethylimipramine (DMI; 10 mg/kg, i.p.). DMI increased edema at the lesion site at 24 h, however. These data suggest that the early increase in NE release following unilateral cerebral contusion is protective and that this may act to stabilize the blood-brain barrier in areas adjacent to the injury site. Drugs that interfere with this enhanced noradrenergic function might enhance the damage caused by TBI. (C) 1998 Elsevier Science B.V. All rights reserved.	Va Med Ctr, Neurol Serv 127C, E Orange, NJ 07018 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurosci, Newark, NJ 07103 USA		Levin, BE (corresponding author), Va Med Ctr, Neurol Serv 127C, E Orange, NJ 07018 USA.						BOYESON MG, 1990, PHARMACOL BIOCHEM BE, V35, P497, DOI 10.1016/0091-3057(90)90279-Q; BOYESON MG, 1993, RESTOR NEUROL NEUROS, V5, P283, DOI 10.3233/RNN-1993-5404; BOYESON MG, 1992, BEHAV NEUROSCI, V106, P964, DOI 10.1037/0735-7044.106.6.964; DUNNMEYNELL A, 1994, BRAIN RES, V660, P88, DOI 10.1016/0006-8993(94)90842-7; DUNNMEYNELL AA, 1995, BRAIN RES, V675, P143, DOI 10.1016/0006-8993(95)00050-Z; DunnMeynell AA, 1997, BRAIN RES, V761, P25, DOI 10.1016/S0006-8993(97)00210-2; DunnMeynell AA, 1997, J NEUROTRAUM, V14, P43, DOI 10.1089/neu.1997.14.43; FEENEY DM, 1991, J NEUROL REHABIL, V5, P113; GINSBERG MD, 1985, BRAIN RES, V337, P59, DOI 10.1016/0006-8993(85)91609-9; Goldstein LB, 1997, PHARMACOL BIOCHEM BE, V58, P1151, DOI 10.1016/S0091-3057(97)00324-9; Goldstein LB, 1997, RESTOR NEUROL NEUROS, V11, P55, DOI 10.3233/RNN-1997-111206; GOLDSTEIN LB, 1990, BRAIN RES, V508, P305, DOI 10.1016/0006-8993(90)90413-6; GUSTAFSON I, 1991, EXP BRAIN RES, V86, P555; GUSTAFSON I, 1989, J CEREBR BLOOD F MET, V9, P171, DOI 10.1038/jcbfm.1989.25; GUSTAFSON I, 1990, J CEREBR BLOOD F MET, V10, P885, DOI 10.1038/jcbfm.1990.145; HARIK SI, 1984, ANN NEUROL, V15, P568, DOI 10.1002/ana.410150609; HEILIG M, 1990, J NEURAL TRANSM-GEN, V79, P193, DOI 10.1007/BF01245130; HIAKALA H, 1987, J NEUROCHEM, V49, P1033; IDA Y, 1982, NEUROBIOL AGING, V3, P233, DOI 10.1016/0197-4580(82)90044-6; KAMISAKI Y, 1992, EUR J PHARMACOL, V217, P57, DOI 10.1016/0014-2999(92)90511-2; LAWTHO D, 1993, EUR J NEUROSCI, V5, P1494, DOI 10.1111/j.1460-9568.1993.tb00217.x; LEVIN BE, 1983, BRAIN RES, V289, P205, DOI 10.1016/0006-8993(83)90021-5; LEVIN BE, 1995, BRAIN RES, V674, P307, DOI 10.1016/0006-8993(95)00032-L; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P221, DOI 10.1113/jphysiol.1986.sp016006; MOURADIAN RD, 1991, BRAIN RES, V546, P83, DOI 10.1016/0006-8993(91)91162-T; NISHINO K, 1991, NEUROSCIENCE, V43, P361, DOI 10.1016/0306-4522(91)90300-D; RAICHLE ME, 1975, P NATL ACAD SCI USA, V72, P3726, DOI 10.1073/pnas.72.9.3726; ROBINSON RG, 1980, BRAIN RES, V188, P63, DOI 10.1016/0006-8993(80)90557-0; SCHANBERG SM, 1968, BIOCHEM PHARMACOL, V17, P247, DOI 10.1016/0006-2952(68)90330-4; SUTTON RL, 1992, RESTOR NEUROL NEUROS, V4, P1, DOI 10.3233/RNN-1992-4101; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; WESTERINK BHC, 1984, J NEUROCHEM, V42, P934, DOI 10.1111/j.1471-4159.1984.tb12694.x	33	24	25	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	AUG 3	1998	800	2					245	252		10.1016/S0006-8993(98)00524-1			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	107YP	WOS:000075238800008	9685666				2022-02-06	
J	Ghirnikar, RS; Lee, YL; Li, JD; Eng, LF				Ghirnikar, RS; Lee, YL; Li, JD; Eng, LF			Chemokine inhibition in rat stab wound brain injury using antisense oligodeoxynucleotides	NEUROSCIENCE LETTERS			English	Article						blood-brain barrier; chemokines; inflammation; macrophage; trauma	MONOCYTE CHEMOATTRACTANT PROTEIN-1; CENTRAL-NERVOUS-SYSTEM; GRANULOMA-FORMATION; EXPRESSION; LOCALIZATION; MACROPHAGES; PEPTIDE-1	Traumatic injury to the central nervous system (CNS) results in the breakdown of the blood-brain barrier and recruitment of hematogenous cells at the site of injury. The role of chemokines in this process has been well recognized and they have been regarded as promising targets for development of anti-inflammatory therapies. The expression of monocyte chemoattractant protein (MCP-1), in particular, has been closely linked to macrophage infiltration following trauma in rat brain. In this study we determined whether inhibition of MCP-1 following stab wound injury would reduce macrophage infiltration. Stab wound injured Sprague-Dawley rats were infused with MCP-1 sense or antisense oligonucleotides using an Alzet miniosmotic pump (1 mu l/h for 3 days). Three days following injury, widespread gliosis was observed in both groups of rats as judged by glial fibrillary acidic protein (GFAP) immunoreactivity. Immunohistochemistry showed significantly less staining for MCP-1 in antisense treated animals. In addition, the number of macrophages were reduced by 30% in the antisense compared to the sense treated animals (P < 0.05). These results demonstrate that modulation of MCP-1 expression in stab wound injury directly affects monocytic infiltration and provide a basis for MCP-1 inhibition as a therapeutic strategy for controlling inflammatory events of traumatic brain injury. (C) 1998 Elsevier Science Ireland Ltd.	VAPA Hlth Care Syst, Dept Pathol, Palo Alto, CA 94304 USA; Stanford Univ, Med Ctr, Sch Med, Stanford, CA 94305 USA		Eng, LF (corresponding author), VAPA Hlth Care Syst, Dept Pathol, 3801 Miranda Ave, Palo Alto, CA 94304 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS011632] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-11632] Funding Source: Medline		Berman JW, 1996, J IMMUNOL, V156, P3017; BRYSCH W, 1994, CELL MOL NEUROBIOL, V14, P557, DOI 10.1007/BF02088837; CHENSUE SW, 1995, AM J PATHOL, V146, P130; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; FLORY CM, 1993, LAB INVEST, V69, P396; FUENTES ME, 1995, J IMMUNOL, V155, P5769; GHIRNIKAR RS, 1996, NEUROSCI RES, V46, P727; GHIRNIKAR RS, 1997, NEUROCHEM RES, V23, P333; Glabinski AR, 1996, J IMMUNOL, V156, P4363; GLABINSKI AR, 1995, INT J DEV NEUROSCI, V13, P153, DOI 10.1016/0736-5748(95)00017-B; JONES ML, 1992, J IMMUNOL, V149, P2147; Ransohoff Richard M., 1996, Cytokine and Growth Factor Reviews, V7, P35, DOI 10.1016/1359-6101(96)00003-2; SCHMOUDER RL, 1993, KIDNEY INT, V44, P43, DOI 10.1038/ki.1993.211; Sozzani S, 1996, Prog Drug Res, V47, P53; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410, DOI 10.1002/jlb.55.3.410; TANI M, 1994, BRAIN PATHOL, V4, P135, DOI 10.1111/j.1750-3639.1994.tb00824.x; Wada T, 1996, FASEB J, V10, P1418, DOI 10.1096/fasebj.10.12.8903512	17	24	27	0	1	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	MAY 8	1998	247	1					21	24		10.1016/S0304-3940(98)00268-7			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZP138	WOS:000073720200006	9637400				2022-02-06	
J	Lipton, JM; Catania, A; Delgado, R				Lipton, JM; Catania, A; Delgado, R			Peptide modulation of inflammatory processes within the brain	NEUROIMMUNOMODULATION			English	Article						alpha-MSH; melanocortins; brain; inflammation; melanocortin receptors; TNF-alpha; nitric oxide; microglia; astrocyte	TUMOR-NECROSIS-FACTOR; MELANOCYTE-STIMULATING HORMONE; FACTOR-ALPHA; MOLECULAR-CLONING; ANTIINFLAMMATORY DRUGS; MELANOCORTIN RECEPTOR; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; EXPRESSION; INJURY	It is clear that inflammatory processes contribute to neurodegenerative disease, stroke, closed head injury, encephalitis, and other CNS disorders. These inflammatory processes are marked by local increases in cytokines, in particular tumor necrosis factor-alpha (TNF-alpha). It is important to control such CNS inflammation in order to preserve neural function. The neuroimmunomodulatory peptide alpha-melanocyte-stimulating hormone (alpha-MSH) has been shown to modulate peripheral inflammation by acting on melanocortin receptors in host cells (macrophages, neutrophils) to inhibit production of such proinflammatory agents. Our results indicate that alpha-MSH likewise acts directly within the brain to modulate local inflammation. To determine if microglia are involved in anti-inflammatory responses to alpha-MSH within the brain, murine cells were tested; they produced TNF-alpha and nitric oxide in response to challenge, and production of both was reduced by alpha-MSH. In tests on human astrocytes, both alpha-MSH (1-13) and alpha-MSH (11-13) reduced TNF-alpha. Ischemia/reperfusion in the posterior circulation in dogs causes inflammatory reactions and disturbance of function, estimated from decreases in auditory-evoked potentials. These deficits were reduced by administering alpha-MSH systemically during reperfusion, moreso when the peptide was given during both ischemia and reperfusion. The results indicate that, much as for inflammation in the periphery, alpha-MSH modulates brain inflammatory responses mediated by proinflammatory agents.	Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75235 USA; Osped Maggiore, IRCCS, Div Internal Med 3, Milan, Italy		Lipton, JM (corresponding author), Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75235 USA.	james.lipton@email.swmed.edu	Hernandez, Rene Delgado/AAS-5111-2021	Hernandez, Rene Delgado/0000-0001-7051-7871; Catania, Anna/0000-0002-8261-7973	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS10046] Funding Source: Medline		AIRAGHI L, 1995, AM HEART J, V130, P204, DOI 10.1016/0002-8703(95)90430-1; Aisen PS, 1996, MOL CHEM NEUROPATHOL, V28, P83, DOI 10.1007/BF02815208; ASSPGLOU K, 1997, J IMMUNOL, V158, P438; Benveniste EN, 1997, J MOL MED-JMM, V75, P165, DOI 10.1007/s001090050101; Breitner JCS, 1996, ANNU REV MED, V47, P401; CATANIA A, 1993, ENDOCR REV, V14, P564, DOI 10.1210/er.14.5.564; Catania A, 1996, PEPTIDES, V17, P675, DOI 10.1016/0196-9781(96)00037-X; CHHAJLANI V, 1992, FEBS LETT, V309, P417, DOI 10.1016/0014-5793(92)80820-7; Chiao H, 1996, J CLIN INVEST, V97, P2038, DOI 10.1172/JCI118639; Chiao H, 1997, J CLIN INVEST, V99, P1165, DOI 10.1172/JCI119272; DULDERIAN SJ, 1995, J PEDIATR, V125, P872; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; GANTZ I, 1993, J BIOL CHEM, V268, P15174; GANTZ I, 1994, BIOCHEM BIOPH RES CO, V200, P1214, DOI 10.1006/bbrc.1994.1580; GLIMAKER M, 1993, J INFECT DIS, V167, P882, DOI 10.1093/infdis/167.4.882; Hudome S, 1997, PEDIATR RES, V41, P607, DOI 10.1203/00006450-199705000-00002; HUH SK, 1997, J NEUROSURG, V40, P132; KIMBERLIN DW, 1995, IMMUNOL INVEST, V24, P775, DOI 10.3109/08820139509060705; KOKA P, 1995, J NEUROIMMUNOL, V57, P179, DOI 10.1016/0165-5728(94)00184-P; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LABBE O, 1994, BIOCHEMISTRY-US, V33, P4543, DOI 10.1021/bi00181a015; Lassmann H, 1997, J NEURAL TRANSM-SUPP, P183; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; Lipton JM, 1997, IMMUNOL TODAY, V18, P140, DOI 10.1016/S0167-5699(97)01009-8; LIPTON JM, IN PRESS ANN NY ACAD; MASON MJ, 1989, J IMMUNOL, V142, P1646; MATSUO Y, 1995, J CEREBR BLOOD F MET, V15, P941, DOI 10.1038/jcbfm.1995.119; McGeer PL, 1996, ANN NY ACAD SCI, V777, P213, DOI 10.1111/j.1749-6632.1996.tb34421.x; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; MERRILL JE, 1992, J VIROL, V66, P2217, DOI 10.1128/JVI.66.4.2217-2225.1992; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; PERRY VH, 1988, TRENDS NEUROSCI, V11, P273, DOI 10.1016/0166-2236(88)90110-5; PERRY VH, 1985, NEUROSCIENCE, V15, P313, DOI 10.1016/0306-4522(85)90215-5; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Rajora N, 1997, J NEUROSCI, V17, P2181; Rajora N, 1996, J LEUKOCYTE BIOL, V59, P248, DOI 10.1002/jlb.59.2.248; ROSELLIREHFUSS L, 1993, P NATL ACAD SCI USA, V90, P8856, DOI 10.1073/pnas.90.19.8856; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; SELMAJ KW, 1995, NEUROLOGY, V45, pS44, DOI 10.1212/WNL.45.6_Suppl_6.S44; SKAPER SD, 1995, J NEUROCHEM, V64, P266; STAR RA, 1995, P NATL ACAD SCI USA, V92, P8016, DOI 10.1073/pnas.92.17.8016; TARLOW MJ, 1993, NEUROPATH APPL NEURO, V19, P324, DOI 10.1111/j.1365-2990.1993.tb00447.x; Tatro JB, 1996, NEUROIMMUNOMODULAT, V3, P259, DOI 10.1159/000097281; TYOR WR, 1995, J ACQ IMMUN DEF SYND, V9, P379; WILSON JF, 1988, PSYCHOPHARMACOLOGY, V96, P262; Wong KY, 1997, NEUROIMMUNOMODULAT, V4, P37; WOODROOFE MN, 1993, CYTOKINE, V5, P583, DOI 10.1016/S1043-4666(05)80008-0; XIA Y, 1995, NEUROREPORT, V6, P2193, DOI 10.1097/00001756-199511000-00022; YEUNG MC, 1995, AIDS, V9, P137, DOI 10.1097/00002030-199509020-00004; [No title captured]	50	24	26	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7401			NEUROIMMUNOMODULAT	Neuroimmunomodulation	MAY-AUG	1998	5	3-4					178	183		10.1159/000026335			6	Endocrinology & Metabolism; Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Immunology; Neurosciences & Neurology	118EV	WOS:000075826200008	9730684				2022-02-06	
J	Schwartz, ML; Carruth, F; Binns, MA; Brandys, C; Moulton, R; Snow, WG; Stuss, DT				Schwartz, ML; Carruth, F; Binns, MA; Brandys, C; Moulton, R; Snow, WG; Stuss, DT			The course of post-traumatic amnesia: Three little words	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article; Proceedings Paper	3rd International Neurotrauma Symposium	1995	TORONTO, CANADA				HEAD-INJURY; PRACTICAL SCALE	Objective: To provide a simple means of "real time" recognition of emergence from post-traumatic amnesia (PTA). Methods: Ninety-one patients with traumatic brain injury (PBI); 53 minor (GCS 13-15), 19 moderate (GCS 9-12), 18 seven (GCS 3-8), Twenty-seven control subjects treated at two regional trauma units for their acute phase and followed in a hospital-based research institute were studied prospectively. Subjects were examined repeatedly following injury with the Galveston Orientation and Amnesia Test (GOAT) and tests of their ability to learn and retain new information. Word triplets balanced for concreteness and frequency were presented. Immediate and 24-hour recall were tested. If 24-hour recall was imperfect, recognition was tested by presenting the 3 target words and 6 distracters, The target words were then re-presented and recall was tested the next day. The time intervals to first perfect recognition and first free perfect recall were compared with the patients' first GOAT score of 75 or greater on 2 successive days. Simple line drawings of common objects were also presented to the subjects using an identical paradigm, The outcome measures were GOAT, 3-word recognition and recall, 3 picture recognition and recall. Results: For all categories of head injury severity, the median interval to perfect free recall of words followed the achievement GOAT criterion by a significant interval. The mean GOAT scores for perfect 3-word recall and recognition corresponding to minor, moderate and severe injuries were 97, 90 and 88, and 97, 76 and 68 respectively, The recognition and recall of pictures preceded the recognition and recall of words by approximately 1 day. Conclusions: The orientation measures of the GOAT that contain material that the patient knew prior to injury obscure the determination of recovery of continuous memory and should be tested separately. Three-word recall which is simpler to administer than the GOAT is a more reliable measure of emergence from PTA. For patients who are dysphasic or who do not share a common language with the examiner, 3-picture recognition and recall may substitute for word recognition and recall.	Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada; St Michaels Hosp, Toronto, ON M5B 1W8, Canada; Univ Toronto, Dept Surg Neurosurg, Toronto, ON, Canada; Univ Toronto, Dept Psychol & Med Neurol, Toronto, ON, Canada		Schwartz, ML (corresponding author), 2075 Bayview Ave,Suite A129, Toronto, ON M4N 3M5, Canada.		Binns, Malcolm/AAQ-9195-2020	Binns, Malcolm/0000-0001-9998-6612			American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; DAVIDOFF G, 1988, ARCH PHYS MED REHAB, V69, P432; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KONDZIOLKA D, 1989, J TRAUMA, V29, P730, DOI 10.1097/00005373-198906000-00005; Lawless JF., 1982, STAT MODELS METHODS; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P14, DOI 10.1136/jnnp.51.1.14; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MILLER H, 1966, P ROY SOC MED, V59, P257, DOI 10.1177/003591576605900327; PAIVIO A, 1968, J EXP PSYCH MONO 2 S, V76; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Symonds CP, 1943, LANCET, V1, P7; TEASDALE G, 1974, LANCET, V2, P81	19	24	25	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	MAY	1998	25	2					108	116		10.1017/S0317167100033709			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	ZM688	WOS:000073565900003	9604131	Bronze			2022-02-06	
J	McIntosh, A; Dowdell, B; Svensson, N				McIntosh, A; Dowdell, B; Svensson, N			Pedal cycle helmet effectiveness: A field study of pedal cycle accidents	ACCIDENT ANALYSIS AND PREVENTION			English	Article						pedal cyclist; helmets; head injury; accidents	BICYCLE	The paper describes a study of pedal cycle accidents focussing on helmet effectiveness. Only accidents in which a helmet was worn and received an impact were studied. Cases were collected from hospital accident and emergency units, through the police and via direct contact. Forty-two cases, all helmeted were examined. There were four fatal accidents; all four involved a collision with a motor vehicle. Nine cases experienced a head injury of AIS severity greater than or equal to 2, although there were no skull fractures. Helmet impacts tended to be close to the rim anterio-laterally. The majority of non-fatal (ATS greater than or equal to 2) head injury cases received a helmet impact to the anterio-lateral rim, which corresponds to the temporal/parietal region of the head. This site received directly only 25% of the impacts, and of these impacts, 75% produced head injuries of at least AIS=2. Soft-shell helmets tended to disintegrate on impact, and although only a single impact occurred, a helmet should remain intact to provide protection during second impacts. There was. general increase in the percentage of subjects injured or killed in accidents that involved a second vehicle compared to single vehicle accidents, 54% to 44%, respectively. This trend was stronger with cars travelling at greater than 30 km/h. (C) 1998 Elsevier Science Ltd. All rights reserved.	Univ New S Wales, Dept Safety Sci, Dept Safety & Sci, Sydney, NSW 2052, Australia; Rd & Traff Author, Sydney, NSW, Australia		McIntosh, A (corresponding author), Univ New S Wales, Dept Safety Sci, Dept Safety & Sci, Sydney, NSW 2052, Australia.						*AUSTR BUR STAT, 1989, 45051 BIC US SAF NSW; CAMERON MH, 1994, ACCIDENT ANAL PREV, V26, P325, DOI 10.1016/0001-4575(94)90006-X; Gale A., 1985, PLASTIC RUBBER PROCE, V5, P101; *I TRANSP STUD, 1993, SURV LAW COMPL HELM; MCDERMOTT FT, 1993, J TRAUMA, V34, P834, DOI 10.1097/00005373-199306000-00015; McIntosh A S, 2010, P 37 STAPP CAR CRASH; SACKS JJ, 1991, JAMA-J AM MED ASSOC, V266, P3016, DOI 10.1001/jama.266.21.3016; THIBAULT L, 1989, 807480 HS US DEP TRA; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; WILLIAMS M, 1989, PROTECTIVE PERFORMAN	10	24	24	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575			ACCIDENT ANAL PREV	Accid. Anal. Prev.	MAR	1998	30	2					161	168		10.1016/S0001-4575(97)00089-4			8	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	YQ463	WOS:000071390200003	9450120				2022-02-06	
J	Whyte, J; Fleming, M; Polansky, M; Cavallucci, C; Coslett, HB				Whyte, J; Fleming, M; Polansky, M; Cavallucci, C; Coslett, HB			The effects of visual distraction following traumatic brain injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						attention; arousal; brain injury; reaction time	CLOSED-HEAD INJURY; ATTENTION; SEQUELAE; SCALE; COMA	Clinical assessments of individuals with traumatic brain injury (TBI) typically report attentional difficulties, with distractibility prominent among these complaints. However, laboratory-based measures have often failed to find disproportionate distraction among patients with TBI, as compared to control participants. In this experiment, we tested 21 patients hospitalized for rehabilitation following recent TBI and 21 demographically comparable control subjects on a visual reaction time go-no-go task in which the target was preceded or followed by a brightly colored moving visual stimulus, appearing above the target location. Early distracters actually served as warning stimuli, improving accuracy and speed for both participant groups. Distracters occurring at or shortly after the time of target presentation had no significant impact on accuracy or response bias in either group, but did produce slowing of RT that was significantly greater for patients than for controls. The distracter that produced maximal slowing occurred 100 ms after the presentation of the target or foil. Repeated testing sessions led to reduction in the impact of the distracter and loss of the group difference in RT impact. The degree of RT slowing induced by distraction was modestly related to injury severity, as measured by the current score on the Disability Rating Scale, and the time until the patient first followed verbal commands. There was also a trend of greater RT slowing among individuals with focal orbitofrontal lesions, as assessed on neuroimaging studies. These results document a greater susceptibility to extraneous visual distraction among patients with TBI in comparison to controls. The fact that this difference appears only in the RT domain, and is greatest when the distracter follows the target, suggests that the primary impact of visual distracters is on response preparation and execution rather than target detection.	Moss Rehabil Res Inst, Philadelphia, PA 19141 USA; Temple Univ, Sch Med, Dept Phys Med & Rehabil, Philadelphia, PA 19122 USA; Allegheny Univ Hlth Sci, Dept Clin & Hlth Psychol, Philadelphia, PA 19102 USA; Allegheny Univ Hlth Sci, Sch Publ Hlth, Philadelphia, PA 19102 USA; Temple Univ, Hlth Sci Ctr, Sch Med, Dept Neurol, Philadelphia, PA 19140 USA		Whyte, J (corresponding author), Moss Rehabil Res Inst, 1200 W Tabor Rd, Philadelphia, PA 19141 USA.			Whyte, John/0000-0002-4381-1474	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R29 NS27715] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R29NS027715] Funding Source: NIH RePORTER		CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; DENCKER SJ, 1958, ACTA PSYCHIAT N S122, V33, P5; Gronwall D, 1974, PSYCHOL EFFECTS CONC; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Kewman D G, 1988, Brain Inj, V2, P131, DOI 10.3109/02699058809150937; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; MILLER E, 1981, BRIT J CLIN PSYCHOL, V20, P69, DOI 10.1111/j.2044-8260.1981.tb00498.x; Miller E, 1970, Cortex, V6, P121; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; SCHMITTEREDGECOMBE ME, 1992, J CLIN EXP NEUROPSYC, V14, P717, DOI 10.1080/01688639208402858; STABLUM F, 1994, CORTEX, V30, P603, DOI 10.1016/S0010-9452(13)80238-9; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; TEASDALE G, 1974, LANCET, V2, P81; VAKIL E, 1995, J CLIN EXP NEUROPSYC, V17, P335, DOI 10.1080/01688639508405127; Van Zomeren A. H., 1981, REACTION TIME ATTENT; van Zomeren AH, 1987, NEUROBEHAVIORAL RECO, P398; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274; Whyte J, 1997, NEUROPSYCHOLOGIA, V35, P313, DOI 10.1016/S0028-3932(96)00092-9; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3	21	24	24	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH STREET, NEW YORK, NY 10011-4211 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAR	1998	4	2					127	136		10.1017/S1355617798001271			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	103EY	WOS:000075146200004	9529822				2022-02-06	
J	Fearnside, M; McDougall, P				Fearnside, M; McDougall, P			Moderate head injury: A system of neurotrauma care	AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY			English	Article; Proceedings Paper	Annual Scientific Meeting of the Royal-Australasian-College-of-Surgeons	MAY 07-15, 1997	BRISBANE, AUSTRALIA	Royal Australasian Coll Surgeons		computed tomography; delayed intracranial haematoma; head injury; intracranial pressure; moderate head injury; outcome	ACUTE BRAIN INJURY; SEVERITY SCORE; MEMORY; SCALE; MANAGEMENT; PRESSURE; TRAUMA; COMA	Background: The aim of the present study was to determine those factors which contribute to a poor outcome and to propose a management plan that is complementary to trauma systems in common use. Methods: A prospective study of 110 consecutive patients with moderate head il?jury (post-resuscitation Glasgow Coma Scale (GCS) 9-13) was carried out. Results: A total of 75% of the patients sustained multisystem trauma. generally of minor or moderate grade according to the Abbreviated Injury Scale (AIS). However, the death rate increased with the severity of the injury as measured by the Injury Severity Score (ISS). The initial cranial computed tomography (CT) scan was abnormal in 61% and no patient with a normal scan developed a delayed intracranial haematoma or neurological worsening. Those patients who developed a delayed intracerebral haematoma had a worse outcome. Sixteen patients underwent craniotomy fur haematoma. The intracranial pressure (ICP) was measured selectively in 20 patients and exceeded 20 mmHg in half, requiring treatment, Nine patients died, four as a result of head injury and all those had an intracranial haematoma. As a group, those who died were older and had a higher ISS. Conclusions: A plan for care of patients with moderate head Injury is proposed, complementary to the Early Management of Severe Trauma (EMST) protocol and the Neurosurgical Society of Australasia guidelines for neurotrauma management in rural and remote locations.	Univ Sydney, Dept Surg, Sydney, NSW 2006, Australia; Westmead Hosp, Dept Neurosurg, Westmead, NSW 2145, Australia		Fearnside, M (corresponding author), POB 34, Westmead, NSW 2145, Australia.	Michael_Fearnside@compuserve.com					Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOWERS SA, 1980, NEUROSURGERY, V6, P237; Bullock Ross, 1993, Journal of Emergency Medicine, V11, P23; COLOHAN ART, 1992, J NEUROTRAUM, V9, pS259; DIKMEN S, 1987, J NEUROL NEUROSUR PS, V50, P1613, DOI 10.1136/jnnp.50.12.1613; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; Hall Edward D., 1993, Journal of Emergency Medicine, V11, P31; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1975, LANCET, V1, P480; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; LABATO R, 1991, J NEUROSURG, V75, P256; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MILLER JD, 1986, NEUROSURG REV, V9, P135, DOI 10.1007/BF01743065; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; *NEUR SOC AUSTR, 1992, MAN AC NEUR RUR REM; OSLER T, 1993, AM J SURG, V165, pS43, DOI 10.1016/S0002-9610(05)81206-1; REILLY PL, 1975, LANCET, V2, P375; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RING IT, 1986, AUST NZ J SURG, V56, P557, DOI 10.1111/j.1445-2197.1986.tb07099.x; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; *ROYAL AUSTR COLL, 1992, EARL MAN SEV TRAUM M; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; STEIN SC, 1992, J NEUROSURG, V77, P562, DOI 10.3171/jns.1992.77.4.0562; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; TEASDALE G, 1974, LANCET, V2, P81; Vollmer D G, 1991, Neurosurg Clin N Am, V2, P437; WINKLER J V, 1984, Journal of Emergency Medicine, V2, P1, DOI 10.1016/0736-4679(84)90038-6	38	24	26	0	1	BLACKWELL SCIENCE	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON, VICTORIA 3053, AUSTRALIA	0004-8682			AUST NZ J SURG	Aust. N. Z. J. Surg.	JAN	1998	68	1					58	64		10.1111/j.1445-2197.1998.tb04638.x			7	Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Surgery	YQ084	WOS:000071346700014	9440458				2022-02-06	
J	Hills, EC; Geldmacher, DS				Hills, EC; Geldmacher, DS			The effect of character and array type on visual spatial search quality following traumatic brain injury	BRAIN INJURY			English	Article							ATTENTION; NEGLECT; PERFORMANCE; DOMINANCE	Disorder; of visuomotor function are common following traumatic brain injury (TBI), but spatially directed visual attention has received little study in this population. 'Cancellation' testing is a common, bedside method for assessing directed attention, which can provide information on how task properties influence visual scanning and search following severe TBI. Groups of 20 individuals after severe TBI and 21 healthy control subjects were matched for age and education. Participants performed finger tapping tests to assess motor speed as well as four cancellation tests employing letter and geometric figure stimuli in random and structured arrays. Control and TBI groups differed significantly on measures of accuracy, task completion time, and search quality. There was no significant effect of stimulus or array type on accuracy or time. Figure targets in a higher search quality, suggesting a right hemispheric dominance effect on these tasks. The findings support a deficit in visuomotor scanning performance in TBI beyond a purely motor effect. Interactions between stimulus and array types suggest that hemispheric cooperation is required for the optimal performance of these tasks, and that interhemispheric communication may be preferentially compromised by TBI.	John F Kennedy Med Ctr, JFK Johnson Rehabil Inst, Dept Rehabil Med, Edison, NJ USA; John F Kennedy Med Ctr, JFK Johnson Rehabil Inst, Ctr Head Injuries, Edison, NJ USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurol, New Brunswick, NJ 08903 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Rehabil Med, New Brunswick, NJ 08903 USA		Geldmacher, DS (corresponding author), Alzheimer Ctr, 12200 Fairhill Rd, Cleveland, OH 44120 USA.						ALBERT ML, 1973, NEUROLOGY, V23, P658, DOI 10.1212/WNL.23.6.658; DIMOND SJ, 1979, CORTEX, V15, P43, DOI 10.1016/S0010-9452(79)80005-2; FOLDI NS, 1992, J GERONTOL, V47, pP146, DOI 10.1093/geronj/47.3.P146; GELDMACHER D, 1997, J INT NEUROPSYCH SOC, V3, P16; Geldmacher DS, 1996, BRAIN COGNITION, V32, P405, DOI 10.1006/brcg.1996.0073; Geldmacher DS, 1997, BRAIN INJURY, V11, P59, DOI 10.1080/026990597123818; GELDMACHER DS, 1994, NEUROPSY NEUROPSY BE, V7, P275; GELDMACHER DS, 1995, J INT NEUROPSYCH SOC, V1, P129; Hagen C., 1972, LEVELS COGNITIVE FUN; HEILMAN KM, 1980, NEUROLOGY, V30, P327, DOI 10.1212/WNL.30.3.327; Heilman KM, 1993, CLIN NEUROPSYCHOLOGY, P279; LEVIN HS, 1988, SCAND J REHABIL MED, P33; MARK VW, 1997, J INT NEUROPSYCH SOC, V3, P72; MCNENY R, 1990, NEUROREHABILITATION, V1, P72; MESUSLAM MM, 1985, PRINCIPLES BEHAV NEU; PONSFORD JL, 1988, J CLIN EXP NEUROPSYC, V10, P693, DOI 10.1080/01688638808402808; POSNER MI, 1984, J NEUROSCI, V4, P1863; POSNER MI, 1987, NEUROBEHAVIORAL RECO, P390; Shum DHK, 1990, CLIN NEUROPSYCHOL, V4, P151, DOI DOI 10.1080/13854049008401508; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; van Zomeren AH, 1987, NEUROBEHAVIORAL RECO, P398; VILLARDITA C, 1983, ARCH NEUROL-CHICAGO, V40, P737, DOI 10.1001/archneur.1983.04050110055008; WEINTRAUB S, 1987, ARCH NEUROL-CHICAGO, V44, P621, DOI 10.1001/archneur.1987.00520180043014; WHITEHEAD R, 1991, J COGNITIVE NEUROSCI, V3, P329, DOI 10.1162/jocn.1991.3.4.329	24	24	24	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	1998	12	1					69	76		10.1080/026990598122872			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	YT347	WOS:000071592500007	9483339				2022-02-06	
J	Frosch, S; Gruber, A; Jones, C; Myers, S; Noel, E; Westerlund, A; Zavisin, T				Frosch, S; Gruber, A; Jones, C; Myers, S; Noel, E; Westerlund, A; Zavisin, T			The long term effects of traumatic brain injury on the roles of caregivers	BRAIN INJURY			English	Article							FOLLOW-UP	This study was conducted to identify the long term effects of traumatic brain injury (TBI) on the roles of caregivers. The subjects consisted of 155 caregivers of survivors with TBI who were randomly selected from 15 midwestern stale brain injury association databases. A questionnaire was developed by the researchers to determine factors affecting role changes of caregivers. The Role Checklist, by Barris, Oakley and Kielhofner, was also included with the questionnaire. Both were mailed to each selected caregiver and used for data gathering. The data obtained were analysed to determine existing trends in the data. Graphs were utilized to depict the trends that was identified. The following trends and conclusions established by this research include: (a) behavioural effects of the survivor with a TBI are associated with the number of role changes experienced by caregivers; (b) participation in support systems is associated with the number of role changes experienced by caregivers; and (c) caregivers who care for a person with a TBI in the home will show a larger number of role changes than those who do not provide direct care for a person with a TBI.	UNIV INDIANAPOLIS, OCCUPAT THERAPY DEPT, INDIANAPOLIS, IN 46227 USA								American Heritage Dictionary, 1985, AM HERITAGE DICT; BAILEY D, 1991, RES HLTH PROFESSIONA; BARRIS R, 1987, MENTAL HLTH ASSESSME, P73; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Campbell C H, 1988, Rehabil Nurs, V13, P320; FAHY TJ, 1967, LANCET, V2, P475; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; HALLETT JD, 1984, AM J OCCUPATIONAL TH, V48, P241; Krause Joan H., 1991, J HEAD TRAUMA REHAB, V6, P1; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; WILLIAMS SJ, 1993, INTRO HLTH SERVICES, P361	14	24	28	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	1997	11	12					891	906					16	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	YG767	WOS:A1997YG76700005	9413623				2022-02-06	
J	Zasler, ND				Zasler, ND			Prognostic indicators in medical rehabilitation of traumatic brain injury: A commentary and review	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							SEVERE HEAD-INJURY; EARLY INTERVENTION; PREDICTION; RECOVERY; CONSCIOUSNESS; ABNORMALITIES; EQUATIONS; SYSTEM; LENGTH; SCALE	The National Information System (NIS) project is developing consensus opinion regarding a proposed structural framework for the prognostic data to be collected as part of this proposed multicenter research effort on severe traumatic brain injury (TBI). This article provide a brief history of the process, examines challenges facing rehabilitation research in this particular area, discusses reasons for identifying prognostic data within the research context of the NIS project, and describes methodologies for use of mathematical models in predicting outcome from TBI. The literature regarding prognostic parameters in severe TBI is briefly reviewed, utilizing three broad parameter categorizations: preinjury, injury, and postinjury. The implications of this research and directions for further study within the NIS project are discussed. (C) 1997 by the American Congress of Rehabilitation Medicine.	NATL NEUROREHABIL CONSORTIUM INC,RICHMOND,VA; CONCUSS CARE CTR VIRGINIA LTD,RICHMOND,VA; TREE LIFE LLC,RICHMOND,VA								ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; BANJA J, 1994, ARCH PHYS MED REHAB, V75, pS19; BOND MR, 1976, ACTA NEUROCHIR, V34, P57, DOI 10.1007/BF01405863; BONTKE CF, 1996, NEUROTRAUMA, P841; BORN JD, 1988, ACTA NEUROCHIR, V9, P1; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHOI SC, 1983, J NEUROSURG, V59, P294, DOI 10.3171/jns.1983.59.2.0294; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; CHOI SC, 1996, NEUROTRAUMA, P779; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; ENAS GG, 1982, THESIS VIRGINIA COMM; Englander JS, 1996, J HEAD TRAUMA REHAB, V11, P15, DOI 10.1097/00001199-199610000-00003; EVANS BM, 1995, J NEUROL NEUROSUR PS, V59, P17, DOI 10.1136/jnnp.59.1.17; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; FELDMAN Z, 1996, NEUROTRAUMA, P805; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; GIACINO JT, 1995, J HEAD TRAUMA REHAB, V10, P40; GOLDSTEIN FC, 1986, J CLIN EXP NEUROPSYC, V8, P405, DOI 10.1080/01688638608401330; GROSWASSER Z, 1990, J NEUROSURG, V72, P81, DOI 10.3171/jns.1990.72.1.0081; HEISKANEN O, 1973, ACTA CHIR SCAND, V139, P605; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; JENNETT B, 1979, NEUROSURGERY, V4, P282; JENNETT B, 1992, PROGNOSIS NEUROLOGIC, P85; JOHNSTON MV, 1994, ARCH PHYS MED REHAB, V75, pS1; Katz D, 1992, J HEAD TRAUMA REHAB, V72, P1, DOI [10.1097/00001199-200501000-00008, DOI 10.1097/00001199-200501000-00008]; KATZ DI, 1995, ARCH PHYS MED REHAB, V76, P592; KATZ DI, 1989, NEUROLOGY, V39, P798; KATZ DI, 1993, ARCH PHYS MED REHAB, V74, P661; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; LEVIN HS, 1995, J NEUROTRAUM, V12, P913, DOI 10.1089/neu.1995.12.913; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MACK A, 1989, TBI STAR PM R, P13; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Mayes S D, 1989, Brain Inj, V3, P301, DOI 10.3109/02699058909029643; MYSIW WJ, 1996, MED REHABILITATION T, P53; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; RAO N, 1992, ARCH PHYS MED REHAB, V73, P911; Rappaport M, 1996, MED REHABILITATION T, P271; ROSS BL, 1994, AM J PHYS MED REHAB, V73, P341, DOI 10.1097/00002060-199409000-00007; SALCIDO R, 1992, Brain Injury, V6, P293, DOI 10.3109/02699059209029671; SIEGEL JH, 1991, CRIT CARE MED, V19, P1252, DOI 10.1097/00003246-199110000-00007; TEASDALE G, 1974, LANCET, V2, P81; Thatcher R W, 1991, Ann N Y Acad Sci, V620, P82, DOI 10.1111/j.1749-6632.1991.tb51576.x; Torner James C., 1996, P19; VOLLMER DG, 1991, NEUROSURGERY, V75, pS37; WHYTE J, 1994, AM J PHYS MED REHAB, V73, P428, DOI 10.1097/00002060-199411000-00008; WOOLF PD, 1990, ALCOHOL CLIN EXP RES, V14, P917, DOI 10.1111/j.1530-0277.1990.tb01838.x; WOOLF PD, 1988, AM J MED, V84, P201, DOI 10.1016/0002-9343(88)90414-7	55	24	25	0	5	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	1997	78	8		4			S12	S16		10.1016/S0003-9993(97)90150-7			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	XR538	WOS:A1997XR53800003	9270483				2022-02-06	
J	Kendall, E; Shum, D; Halson, D; Bunning, S; Teh, M				Kendall, E; Shum, D; Halson, D; Bunning, S; Teh, M			The assessment of social problem-solving ability following traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							SEVERE HEAD-INJURY; SUBSEQUENT LEVEL; COLLEGE-STUDENTS; COMPETENCE; SKILLS; ADULTS	Objective: To investigate the nature of social problem-solving deficits following TBI using the D'Zurilla and Goldfried(14) model of social problem solving, which consists of four social problem-solving skills that traditionally have been assessed by self-report inventory. To overcome the problems associated with self-report following TBI, the current study developed a video task for the assessment of social problem solving. Design: Cohort study. Participants: The study involved 15 community-dwelling individuals with TBI caused by motor vehicle accidents who volunteered to be involved in the study. A matched control sample without psychiatric or neurologic conditions consisted of 15 members of a community group who also volunteered to assist. Main Outcome Measures: Two measures were used, the Social Problem-Solving Inventory(17) and a problem-solving video vignette task designed specifically for the study. Both instruments assessed the components of the model-namely, problem definition and goal formulation, solution generation, decision making, and solution implementation and verification. Results: Individuals with TBI were impaired relative to the control sample in their ability to recognize and define social problems and to generate a range of solutions. However, these differences emerged only when using the video task. Correlations between the video task and the self-report scales were nonsignificant for both groups. Conclusions: Current social problem-solving training may lack validity due to an inappropriate focus on the later stages rather than the early stages of problem solving, when the major deficits following TBI tend to occur. In addition, the difficulties associated with self-report assessment following TBI can be overcome by using the video task.	GRIFFITH UNIV,SCH APPL PSYCHOL,NEUROPSYCHOL UNIT,NATHAN,QLD 4111,AUSTRALIA		Kendall, E (corresponding author), GRIFFITH UNIV,CTR STRATEG HUMAN SERV REHABIL,SCH APPL PSYCHOL,NATHAN,QLD 4111,AUSTRALIA.		kendall, elizabeth/F-5065-2013; Shum, David/A-3914-2008	Shum, David/0000-0002-4810-9262; Kendall, Elizabeth/0000-0003-2399-1460			ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; BELLACK AS, 1994, J ABNORM PSYCHOL, V103, P371, DOI 10.1037/0021-843X.103.2.371; CASTLES EE, 1986, AM J MENT RETARD, V91, P35; D'Zurilla T.J., 1990, PSYCHOL ASSESSMENT, V2, P156, DOI DOI 10.1037/1040-3590.2.2.156; DZURILLA TJ, 1992, COGNITIVE THER RES, V16, P589, DOI 10.1007/BF01175144; DZURILLA TJ, 1971, J ABNORM PSYCHOL, V78, P107, DOI 10.1037/h0031360; DZURILLA TJ, 1991, J PERS SOC PSYCHOL, V61, P841, DOI 10.1037/0022-3514.61.5.841; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; FOXX RM, 1989, BEHAV THER, V20, P61, DOI 10.1016/S0005-7894(89)80118-2; GILES GM, 1993, BRAIN INJURY REHABIL; HEPPNER PP, 1990, HDB SOCIAL CLIN PSYC; LEVINE MJ, 1993, BRAIN INJURY, V7, P153, DOI 10.3109/02699059309008169; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; Marsh NV, 1990, NEUROPSYCHOLOGY, V4, P13, DOI 10.1037/0894-4105.4.1.13; MARSH NV, 1991, J CLIN EXP NEUROPSYC, V13, P729, DOI 10.1080/01688639108401086; Moore A D, 1989, Brain Inj, V3, P171, DOI 10.3109/02699058909004549; ROSENBAUM A, 1989, AM J PSYCHIAT, V146, P1048; SPIERS MV, 1994, BRAIN INJURY, V8, P463, DOI 10.3109/02699059409150998; Varney NR., 1993, J HEAD TRAUMA REHAB, V8, P32, DOI [10.1097/00001199-199303000-00005, DOI 10.1097/00001199-199303000-00005]; VONCRAMON DY, 1990, COGNITIVE REHABILITA; VONCRAMON DY, 1992, NEUROPSYCHOL REHABIL, V2, P207; VONCRAMON DY, 1992, NEUROPSYCHOLOGICAL R; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019	24	24	24	0	3	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUN	1997	12	3					68	78		10.1097/00001199-199706000-00007			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XC699	WOS:A1997XC69900007					2022-02-06	
J	Ekman, R; Schelp, L; Welander, G; Svanstrom, L				Ekman, R; Schelp, L; Welander, G; Svanstrom, L			Can a combination of local, regional and national information substantially increase bicycle-helmet wearing and reduce injuries? Experiences from Sweden	ACCIDENT ANALYSIS AND PREVENTION			English	Article						program evaluation; bicycle helmets; bicycle-related injuries; injury prevention	SWEDISH MUNICIPALITY; CHILDREN; CAMPAIGN; HEAD	Is it possible to substantially reduce the incidence of injuries related to cycling through the provision of information on helmet wearing? This issue has been investigated in Skaraborg County, Sweden, where 90 percent of all pre-school children now use bicycle helmets. For children under 15, there was an average annual decrease in all bicycle-related injuries of 3.1 percent, equivalent to a decrease of 48 percent over the study period, 1978-93 (for head injuries, 59%). Sweden as a whole showed a reduction of 32 percent in bicycle-related injuries (head injuries, 43%). In Skaraborg, children have been the target of helmet-wearing programs at local and regional levels since 1982, and at national level since 1987. The elderly have not been targeted in helmet-wearing programs; currently, they scarcely wear helmets at all, and showed a significant increase in their injury rate over the period (4.7% annually). The number of concussions sustained by helmet-wearers is estimated to be one-third fewer than that of non-wearers. Comparisons with Australia and some parts of the U.S.A. indicate that, despite the significant decrease in Skaraborg, greater effects might be achievable if information is supplemented by compulsory-helmet-wearing legislation. (C) 1997 Elsevier Science Ltd.	SKARABORG INST,DIV PUBL HLTH,SKOVDE,SWEDEN; NATL INST PUBL HLTH,STOCKHOLM,SWEDEN		Ekman, R (corresponding author), KAROLINSKA INST,DEPT PUBL HLTH SCI,DIV SOCIAL MED,S-17283 SUNDBYBERG,SWEDEN.						BJORNSTIG U, 1992, J TRAUMA, V33, P887; CAMERON MH, 1994, ACCIDENT ANAL PREV, V26, P325, DOI 10.1016/0001-4575(94)90006-X; CASS DT, 1989, AUST NZ J SURG, V59, P719, DOI 10.1111/j.1445-2197.1989.tb01664.x; COTE TR, 1992, PEDIATRICS, V89, P1216; DIGUISEPPI CG, 1989, JAMA-J AM MED ASSOC, V262, P2256, DOI 10.1001/jama.262.16.2256; EKMAN R, 1991, SWEDISH BICYCLE HELM; *FORS, 1992, ROAD FAT STAT AUSTR; LEICESTER P, 1991, GR91 ROAD SAF DIV; LEKANDER T, 1994, COMMUNICATION; LIND MG, 1986, ACTA CHIR SCAND S, V531; *NAT SWED BOARD CO, 1992, 19923 KOVFS; *NAT SWED BOARD CO, 1992, 19922 KOVFS; NOLEN S, 1995, BICYCLE HELMET USAGE; RIVARA FP, 1994, PEDIATRICS, V93, P567; SCHEIDT PC, 1992, PEDIATRICS, V89, P1248; SCHELP L, 1990, PUBLIC HEALTH, V104, P55, DOI 10.1016/S0033-3506(05)80346-4; SCHELP L, 1988, SOC SCI MED, V26, P1087, DOI 10.1016/0277-9536(88)90183-9; SIMPSON AHRW, 1988, BRIT MED J, V296, P1161, DOI 10.1136/bmj.296.6630.1161-a; *STAT SWED, 1995, OFF STAT SWED CAUS D; Svanstrom L, 1995, Inj Prev, V1, P169, DOI 10.1136/ip.1.3.169; Svanstrom L., 1996, INT J CONSUMER SAFET, V3, P1; *SWED NAT BOARD HL, 1989, KLASS REG OL; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; THULIN H, 1991, 72 TFB VTI; THULIN H, 1995, COMMUNICATION; *UN, 1993, STAT ROAD TRAFF ACC; WAHLBERG T, 1995, LAKARTIDNINGEN, V92, P7; WELANDER G, 1994, C ROAD SAF EUR STRAT; *WHO, 1992, WHO HELM IN, V1; *WHO, 1995, WHO HELM IN, V4; [No title captured]	31	24	24	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0001-4575			ACCIDENT ANAL PREV	Accid. Anal. Prev.	MAY	1997	29	3					321	328		10.1016/S0001-4575(96)00086-3			8	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	XD126	WOS:A1997XD12600007	9183470				2022-02-06	
J	Hoane, MR; Raad, C; Barth, TM				Hoane, MR; Raad, C; Barth, TM			Non-competitive NMDA antagonists and anti-oxidant drugs reduce striatal atrophy and facilitate recovery of function following lesions of the rat cortex	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						secondary brain damage; sensorimotor behavior; neuroprotection; glutamate; recovery of function; magnesium chloride; MK-801; PEN	METHYL-D-ASPARTATE; CEREBRAL-ARTERY OCCLUSION; TRAUMATIC BRAIN INJURY; CENTRAL NERVOUS-SYSTEM; MOUSE CENTRAL NEURONS; TERT-BUTYL-NITRONE; GLUTAMATE NEUROTOXICITY; RETROSPLENIAL CORTEX; SENSORIMOTOR CORTEX; POSTERIOR CINGULATE	Following brain injury there is an excessive release of glutamate, a reduction in levels of cellular Mg++, and the generation of oxygen free radicals. These processes may contribute to the severity of the behavioral impairments seen following brain injury by leading to secondary neuronal degeneration. The present experiment investigates the relative effects of three drugs (MK-801, an NMDA antagonist; magnesium chloride, an NMDA antagonist; and N-tert-butyl-alpha-phenylnitrone (PBN), an anti-oxidant and free radical scavenger) which disrupt different aspects of the pathophysiological process, in reducing these impairments. Direct comparisons of these drugs may determine if one treatment is more effective than another, or if one is detrimental. In addition, the effects of combination treatments including PBN and MK-801 or MgCl2, were examined. These combination treatment were aimed at the possibility of potentiating the beneficial effects observed after administration of these agents alone. Rats received unilateral electrolytic lesions of the somatic sensorimotor cortex followed by a regimen of MK-801 (1 mg/kg), MgCl2 (1 mmol/kg), PBN (100 mg/kg), MK-801 + PEN (1 mg/kg, 100 mg/kg), MgCl2, + PBN (1 mmol/kg, 100 mg/kg), or saline (1 ml/kg) beginning 15 min following injury. Rats were tested on several sensorimotor tasks (i.e. forelimb placing and foot-fault) for 43 days following the cortical lesions. Rats receiving any of the single or combination drug treatments showed a significant facilitation of recovery on the sensorimotor tasks compared to saline control rats. On one behavioral test (i.e. foot-fault) there was a significant further enhancement of the recovery by combination treatments compared to the single treatment groups. These data are consistent with the idea that excessive release of glutamate, reduction in Mg++ levels, and free radical generation contribute to the severity of the behavioral impairments following cortical injury, and that arresting these processes results in a facilitation of behavioral recovery. Anatomical analysis showed that all drug treatments decreased the amount of atrophy seen in the ipsilateral striatum. (C) 1997 Elsevier Science Ireland Ltd.	TEXAS CHRISTIAN UNIV, DEPT PSYCHOL, FT WORTH, TX 76129 USA; TEXAS CHRISTIAN UNIV, PROGRAM NEUROSCI, FT WORTH, TX 76129 USA					Hoane, Michael/0000-0001-7779-2657			Aikawa J.W., 1981, MAGNESIUM ITS BIOL S, P21; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; ALTURA BT, 1982, MAGNESIUM EXP CLIN R, V1, P277; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; AUER RN, 1994, ACTA NEUROPATHOL, V87, P1; Bara M., 1984, MAGNESIUM, V3, P212; BARTH TM, 1990, STROKE, V21, P153; BARTH TM, 1994, BEHAV NEUROSCI, V108, P818, DOI 10.1037/0735-7044.108.4.818; BARTH TM, 1990, BEHAV BRAIN RES, V39, P73, DOI 10.1016/0166-4328(90)90122-U; BIELENBERG GW, 1991, BRAIN RES, V552, P338, DOI 10.1016/0006-8993(91)90101-Z; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1987, J NEUROSCI, V7, P369; CHOI DW, 1987, J NEUROSCI, V7, P357; CLOUGHHELFMAN C, 1991, FREE RADICAL RES COM, V15, P177, DOI 10.3109/10715769109049138; COX JA, 1989, BRAIN RES, V499, P267, DOI 10.1016/0006-8993(89)90774-9; DAIL WG, 1981, BRAIN RES, V211, P79, DOI 10.1016/0006-8993(81)90068-8; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; EBEL H, 1980, J CLIN CHEM CLIN BIO, V18, P257; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; FEENEY DM, 1988, PHARM APPROACHES TRE; FIX AS, 1993, EXP NEUROL, V123, P204, DOI 10.1006/exnr.1993.1153; FIX AS, 1995, BRAIN RES, V696, P194, DOI 10.1016/0006-8993(95)00842-E; FOSTER AC, 1987, NEUROSCI LETT, V76, P307, DOI 10.1016/0304-3940(87)90420-4; GARFINKEL L, 1985, Magnesium, V4, P60; GILL R, 1987, J NEUROSCI, V7, P3343; Goldstein L B, 1990, Restor Neurol Neurosci, V1, P311, DOI 10.3233/RNN-1990-1501; GRAHAM DI, 1989, CEREBROVASC DIS, P65; GUNTHER T, 1984, MAGNESIUM-B, V6, P77; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; HALL ED, 1992, J NEUROTRAUM, V9, pS425; HALL ED, 1986, J NEUROSURG, V64, P951, DOI 10.3171/jns.1986.64.6.0951; Hall Edward D., 1993, Journal of Emergency Medicine, V11, P31; HALL RD, 1974, BRAIN RES, V66, P23, DOI 10.1016/0006-8993(74)90076-6; HARA H, 1993, BRAIN RES, V618, P251, DOI 10.1016/0006-8993(93)91273-U; Hoane M. R., 1995, Society for Neuroscience Abstracts, V21, P172; Hoane M. R., 1994, Society for Neuroscience Abstracts, V20, P1430; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; HOSOKAWA S, 1985, BRAIN RES, V343, P8, DOI 10.1016/0006-8993(85)91152-7; IZUMI Y, 1991, J CEREBR BLOOD F MET, V11, P1025, DOI 10.1038/jcbfm.1991.170; JONES TA, 1992, BEHAV BRAIN RES, V51, P1, DOI 10.1016/S0166-4328(05)80306-7; MARTINEZARIZALA A, 1990, EXP NEUROL, V108, P232, DOI 10.1016/0014-4886(90)90128-F; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; McCulloch J, 1993, Acta Neurochir Suppl (Wien), V57, P73; MCDONALD JW, 1990, NEUROSCIENCE, V36, P589, DOI 10.1016/0306-4522(90)90002-L; MCDONALD JW, 1989, BRAIN RES, V490, P33, DOI 10.1016/0006-8993(89)90427-7; MCDONALD JW, 1990, SYNAPSE, V6, P179, DOI 10.1002/syn.890060210; MCDONALD JW, 1988, BRAIN RES, V459, P200, DOI 10.1016/0006-8993(88)90306-X; MCDONALD JW, 1989, EXP NEUROL, V106, P289, DOI 10.1016/0014-4886(89)90162-3; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MELDRUM B, 1989, CEREBROVASC DIS, P47; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; OLNEY JW, 1989, SCIENCE, V244, P1360, DOI 10.1126/science.2660263; OLNEY JW, 1991, SCIENCE, V254, P1515, DOI 10.1126/science.1835799; PERUCHE B, 1993, PROG NEURO-PSYCHOPH, V17, P21, DOI 10.1016/0278-5846(93)90032-N; PHILLIS JW, 1990, NEUROSCI LETT, V116, P315, DOI 10.1016/0304-3940(90)90093-O; ROTHMAN S, 1984, J NEUROSCI, V4, P1884; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; ROTHMAN SM, 1985, J NEUROSCI, V5, P1483; SAPONJIC RM, 1995, RESTOR NEUROL NEUROS, V8, P205, DOI 10.3233/RNN-1995-8406; SCHALLERT T, 1990, STROKE, V21, P143; SCHALLERT T, 1990, CAN J PSYCHOL, V44, P276, DOI 10.1037/h0084244; SCHALLERT T, 1984, BEHAV NEUROSCI, V98, P518; SCHALLERT T, 1982, PHARMACOL BIOCHEM BE, V16, P455, DOI 10.1016/0091-3057(82)90452-X; Schmanke TD, 1996, J NEUROTRAUM, V13, P293, DOI 10.1089/neu.1996.13.293; SEN S, 1994, FREE RADICAL BIO MED, V16, P685, DOI 10.1016/0891-5849(94)90183-X; Sen S., 1993, Society for Neuroscience Abstracts, V19, P636; SHARP FR, 1991, ANN NEUROL, V30, P801, DOI 10.1002/ana.410300609; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; TAMURA A, 1990, BRAIN RES, V510, P154, DOI 10.1016/0006-8993(90)90744-V; TSUDA T, 1991, NEUROSCIENCE, V44, P335, DOI 10.1016/0306-4522(91)90058-V; VACANTI FX, 1984, STROKE, V15, P695, DOI 10.1161/01.STR.15.4.695; VILLABLANCA JR, 1976, EXP NEUROL, V53, P289, DOI 10.1016/0014-4886(76)90072-8; Vink R, 1990, Magnes Res, V3, P163; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; VINK R, 1988, J BIOL CHEM, V263, P757; von Monakow C, 1969, MOOD STATES MIND; WATKINS JC, 1989, NMDA RECEPTOR, P1; YUE TL, 1992, BRAIN RES, V574, P193, DOI 10.1016/0006-8993(92)90816-R	81	24	24	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.	APR	1997	11	1-2					71	82					12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XB752	WOS:A1997XB75200008	21551530				2022-02-06	
J	McPherson, KM; Pentland, B				McPherson, KM; Pentland, B			Disability in patients following traumatic brain injury - Which measure?	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						disability; measurement; head injury	FUNCTIONAL ASSESSMENT SCALES; REHABILITATION	Head injury results in a wide range of functional sequelae. Thus, measuring solely physical aspects of functioning may fail to highlight the actual level of disability. This study compares a commonly used measure of physical disability, the Barthel Index, with three recently devised measures - the OPCS Scales of Disability, the Functional Independence Measure (FIM) and Functional Assessment Measure (FIM + FAM). Fifty-four head-injured subjects were assessed following discharge-from an in-patient rehabilitation unit utilizing each measure. The majority of subjects had no detectable disability according to the Barthel Index. In contrast, only four subjects (7%) attained maximal scores for independence with the OPCS scale; two (4%) with the FIM and only one subject (2%) with the FIM + FAM. This reflected the nature of the disabilities in activities such as intellectual functioning, communication, behaviour and wider aspects of mobility measured by the OPCS, FIM and FIM + FAM but not in the Barthel Index. The relationship between all measures was significant (Spearman ranked correlations P < 0.001) but correlations were greater between OPCS, FIM and FIM + FAM than with the Barthel. The results of this study would support considering the use of scales other than the Barthel Index when describing disability following traumatic head injury.	UNIV EDINBURGH,REHABIL STUDIES UNIT,EDINBURGH,MIDLOTHIAN,SCOTLAND					McPherson, Kath/0000-0003-0487-8497; McPherson, Kathryn/0000-0003-1240-8882			APPLEGATE WB, 1990, NEW ENGL J MED, V322, P1207; Chau N, 1994, Disabil Rehabil, V16, P63; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Frattali C M, 1993, Disabil Rehabil, V15, P1; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; GRANGER CV, 1995, INT J TECHNOL ASSESS, V11, P262, DOI 10.1017/S0266462300006875; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; GRANGER CV, 1995, AM J PHYS MED REHAB, V74, P107; Gray J.M, 1994, CLIN REHABIL, V8, P188, DOI [10.1177/026921559400800302, DOI 10.1177/026921559400800302, DOI 10.1080/09602010902949207]; Hall K, 1992, NEUROREHABILITATION, V2, P98, DOI DOI 10.3233/NRE-1992-2410; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; HAMILTON B B, 1991, Archives of Physical Medicine and Rehabilitation, V72, P790; Hamilton BB, 1987, REHABILITATION OUTCO, P137; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KIDD D, 1995, DISABIL REHABIL, V17, P10, DOI 10.3109/09638289509166622; MAHONEY F I, 1965, Md State Med J, V14, P61; Martin J., 1988, PREVALENCE DISABILIT; McPherson KM, 1996, DISABIL REHABIL, V18, P341, DOI 10.3109/09638289609165892; OTTENBACHER KJ, 1994, ARCH PHYS MED REHAB, V75, P1297; PENTLAND B, 1994, HLTH B, V52, P438; ROY CW, 1988, INT J REHABIL RES, V11, P67, DOI 10.1097/00004356-198803000-00010; Wade D, 1992, MEASUREMENT NEUROLOG; WELLWOOD I, 1995, AGE AGEING, V24, P54, DOI 10.1093/ageing/24.1.54; World Health Organization, 1980, INT CLASS IMP DIS HA; [No title captured]	26	24	24	0	2	CHAPMAN HALL LTD	LONDON	2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN	0342-5282			INT J REHABIL RES	Int. J. Rehabil. Res.	MAR	1997	20	1					1	10		10.1097/00004356-199703000-00001			10	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	WN631	WOS:A1997WN63100001	9089011				2022-02-06	
J	Leonard, JR; Grady, MS; Lee, ME; Paz, JC; Westrum, LE				Leonard, JR; Grady, MS; Lee, ME; Paz, JC; Westrum, LE			Fluid percussion injury causes disruption of the septohippocampal pathway in the rat	EXPERIMENTAL NEUROLOGY			English	Article							TRAUMATIC BRAIN INJURY; NERVE GROWTH-FACTOR; MEDIAL SEPTUM; DIAGONAL BAND; CHOLINE-ACETYLTRANSFERASE; ALZHEIMERS-DISEASE; HIPPOCAMPAL-FORMATION; HEAD-INJURY; LONG-TERM; NEURONS	Fluid percussion injury (FPI) causes memory deficits, loss of hippocampal neurons, and basal forebrain cholinergic immunoreactivity in rats. Basal forebrain septohippocampal projections terminate in specific hippocampal regions. The purpose of this study was to examine the effects of FPI on the septohippocampal pathway (SHP). Halothane-anesthetized rats received either a sham injury or a parasagittal FPI. To characterize the anatomical effects of FPI on the SHP, silver stains were performed on brains of animals at 1, 5, and 10 days following FPI and were compared to sham-injured preparations. To characterize the effects of FPI on retrograde transport in the SHP, a separate group of FPI and sham-injured animals with survival times of 2, 5, and 10 days received bilateral WGA-HRP injections into the hippocampal formation 24 h prior to sacrifice. Argyrophilic CA3 neurons were present 1 day following FPI. Five days following FPI, terminal degeneration was present in the inner third of the molecular layer of the dentate gyrus bilaterally that was not present 1 day after injury. Fiber and terminal degeneration was not observed in the basal forebrain until 10 days after FPI. WGA-HRP-labeled septal neurons decreased significantly (P < 0.05) ipsilateral to injury in animals sacrificed 5 and 10 days following FPI but not 2 days after injury. This investigation demonstrated that FPI produces focal injury in the hippocampal formation. In addition, the appearance of terminal degeneration in the dentate molecular layer correlated with the significant reduction in axonal transport 5 days following injury. This correlation illustrates the secondary processes that structurally damage the SHP up to 10 days after injury. (C) 1997 Academic Press.	UNIV WASHINGTON, DEPT NEUROL SURG, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT BIOL STRUCT, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT RESTORAT DENT, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT PSYCHOL, SEATTLE, WA 98195 USA						NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030305] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30305] Funding Source: Medline		AMARAL DG, 1985, J COMP NEUROL, V240, P37, DOI 10.1002/cne.902400104; ARENDT T, 1985, NEUROSCIENCE, V14, P1, DOI 10.1016/0306-4522(85)90160-5; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BOTHWELL M, 1991, CURR TOP MICROBIOL, V165, P55; BRIONI JD, 1990, BRAIN RES, V522, P227, DOI 10.1016/0006-8993(90)91465-S; CLARKE DJ, 1985, BRAIN RES, V360, P349, DOI 10.1016/0006-8993(85)91253-3; DAVIES P, 1976, LANCET, V2, P1403; Delahunty TM, 1995, J NEUROTRAUM, V12, P1045, DOI 10.1089/neu.1995.12.1045; DISTEFANO PS, 1992, NEURON, V8, P983, DOI 10.1016/0896-6273(92)90213-W; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; FREUND TF, 1988, NATURE, V336, P170, DOI 10.1038/336170a0; GAGE FH, 1988, J COMP NEUROL, V269, P147, DOI 10.1002/cne.902690112; GAGE FH, 1986, NEUROSCIENCE, V19, P241, DOI 10.1016/0306-4522(86)90018-7; GAYKEMA RPA, 1991, NEUROSCIENCE, V43, P349, DOI 10.1016/0306-4522(91)90299-4; GIVENS BS, 1990, BEHAV NEUROSCI, V104, P849, DOI 10.1037/0735-7044.104.6.849; GNAHN H, 1983, DEV BRAIN RES, V9, P45, DOI 10.1016/0165-3806(83)90107-4; GONATAS NK, 1979, J HISTOCHEM CYTOCHEM, V27, P728, DOI 10.1177/27.3.90065; GONATAS NK, 1973, J CELL BIOL, V59, P436, DOI 10.1083/jcb.59.2.436; GORMAN LK, 1993, BRAIN RES, V614, P29, DOI 10.1016/0006-8993(93)91014-J; GRAY JA, 1983, NEUROSCI BIOBEHAV R, V7, P119, DOI 10.1016/0149-7634(83)90014-3; HALPERIN JJ, 1975, BRAIN RES, V100, P253, DOI 10.1016/0006-8993(75)90482-5; HARRELL LE, 1987, BEHAV NEUROSCI, V101, P644, DOI 10.1037/0735-7044.101.5.644; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; HICKS RR, 1994, BRAIN RES, V655, P91, DOI 10.1016/0006-8993(94)91601-2; HJORTHSIMONSEN A, 1972, J COMP NEUROL, V144, P215, DOI 10.1002/cne.901440206; HJORTHSIMONSEN A, 1977, J COMP NEUROL, V174, P591, DOI 10.1002/cne.901740404; KISS J, 1990, NEUROSCIENCE, V36, P61, DOI 10.1016/0306-4522(90)90351-4; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; Levin H., 1987, HEAD INJURY, P442; LEWIS PR, 1967, BRAIN, V90, P521, DOI 10.1093/brain/90.3.521; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MESULAM MM, 1978, J HISTOCHEM CYTOCHEM, V26, P106, DOI 10.1177/26.2.24068; MESULAM MM, 1983, NEUROSCIENCE, V10, P1185, DOI 10.1016/0306-4522(83)90108-2; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; MOREHEAD M, 1994, J NEUROTRAUM, V11, P657, DOI 10.1089/neu.1994.11.657; Povlishock J T, 1985, Cent Nerv Syst Trauma, V2, P285; RAISMAN G, 1965, BRAIN, V88, P963, DOI 10.1093/brain/88.5.963; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; SENUT MC, 1989, NEUROSCIENCE, V30, P385, DOI 10.1016/0306-4522(89)90260-1; Sinson G, 1996, J NEUROSURG, V84, P655, DOI 10.3171/jns.1996.84.4.0655; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; SWANSON LW, 1980, BRAIN RES, V197, P207, DOI 10.1016/0006-8993(80)90446-1; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; SWANSON LW, 1977, J COMP NEUROL, V172, P49, DOI 10.1002/cne.901720104; VONEIDA TJ, 1981, ANAT REC, V201, P91, DOI 10.1002/ar.1092010112; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; WITTER MP, 1993, HIPPOCAMPUS, V3, P33; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006; [No title captured]	54	24	25	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	FEB	1997	143	2					177	187		10.1006/exnr.1996.6366			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WM449	WOS:A1997WM44900001	9056381				2022-02-06	
J	Ikeda, Y; Teramoto, A; Nakagawa, Y; Ishibashi, Y; Yoshii, T				Ikeda, Y; Teramoto, A; Nakagawa, Y; Ishibashi, Y; Yoshii, T			Attenuation of cryogenic induced brain oedema by arginine vasopressin release inhibitor RU51599	ACTA NEUROCHIRURGICA			English	Article						brain oedema; arginine vasopressin; cryogenic injury; kappa opioid	OPIOID RECEPTOR AGONIST; EXPERIMENTAL SUBARACHNOID HEMORRHAGE; FOCAL CEREBRAL-ISCHEMIA; EDEMA; INJURY; RATS; PROTECTION; U-50488H; CATS	Centrally released arginine vasopressin (AVP) has been implicated in the regulation of the brain water content and is elevated in the cerebrospinal fluid of patients with ischaemic and traumatic brain injuries. The protective effect of RU51599, which is a selective kappa opioid agonist as an AVP release inhibitor, on brain oedema was examined. Male Wistar rats, weighing 300 to 400 g each, were used. The cortical cryogenic injury was produced by application of a previously prepared metal probe cooled with dry ice to the dura of the right patietal region. Animals were separated into three groups. Group 1: sham operated rats without lesion production. Group 2: saline-treated rats with lesion production. Group 3: RU51599-treated rats with lesion production. In Group 3, rats were treated with RU51599 (0.1-3 mg/kg) at 30 minutes before lesion production, 1 hour, 2 hours, and 4 hours after lesion production. After 6 hours, animals were decapitated and brain water contents were measured using the dry-wet weight method. The extent of blood brain barrier (BBB) disruption was determined by assessment of Evans blue uptake based on extraction from tissue using dimethylformamide. The primary injured infarcted area was determined by 2,3,5-triphenyltetrazolium chloride (TTC) staining. Sodium and potassium contents in serum and brain tissue were measured using atomic absorption spectrophotometry. The antagonism of naloxone against protective effects of RU51599 on cryogenic induced brain oedema and on antinociceptive effects in acetic-acid treated animals was examined. Statistical analysis was performed using Dunnett-test and U-test following Kruskal-Wallis test. RU 51599 significantly reduced the brain water contents on the injured side and the contralateral non-injured side (p < 0.01) after 4 administration of 1 and 3 mg/kg. RU51599 neither significantly inhibited BBB disruption nor reduced the primary injured infarcted area. RU51559 significantly increased brain sodium and potassium contents in the injured brain and also increased serum sodium levels (p < 0.01). Naloxone antagonized the anti-oedema effects and antinociceptive effects of RU51599. These findings indicate that the AVP release inhibitor, RU51599 posssibly mediated by opioid receptors, has a potential protective effect on cryogenic-induced brain oedema and that centrally released AVP plays an important role in the progression of vasogenic brain oedema.	Nippon Med Sch, Dept Neurosurg, Bunkyo Ku, Tokyo 113, Japan; Expt Biomed Res Inc, Ibaraki, Osaka, Japan		Ikeda, Y (corresponding author), Nippon Med Sch, Dept Neurosurg, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 113, Japan.						BASKIN DS, 1994, STROKE, V25, P2047, DOI 10.1161/01.STR.25.10.2047; CHAN PH, 1991, ANN NEUROL, V29, P482, DOI 10.1002/ana.410290506; DICKINSON LD, 1992, J CEREBR BLOOD F MET, V12, P681, DOI 10.1038/jcbfm.1992.93; DOCZI T, 1984, NEUROSURGERY, V14, P436, DOI 10.1227/00006123-198404000-00008; DOCZI TP, 1995, ACTA NEUROCHIR, V132, P87, DOI 10.1007/BF01404853; FADEN AI, 1986, ARCH NEUROL-CHICAGO, V43, P501, DOI 10.1001/archneur.1986.00520050073026; FARACI FM, 1988, CIRC RES, V63, P373, DOI 10.1161/01.RES.63.2.373; Furui Tomoo, 1993, Neurologia Medico-Chirurgica, V33, P133, DOI 10.2176/nmc.33.133; GUENIAU C, 1995, J CEREB FLOW METAB S, V15, pS383; HALL ED, 1987, BRAIN RES, V435, P174, DOI 10.1016/0006-8993(87)91599-X; HAMON G, 1994, J AM SOC NEPHROL, V5, P272; IKEDA Y, 1994, ACTA NEUROCHIR, P119; ISOTANI E, 1994, STROKE, V25, P2198, DOI 10.1161/01.STR.25.11.2198; KUSUMOTO K, 1992, BRAIN RES, V576, P147, DOI 10.1016/0006-8993(92)90621-F; LASZLO FA, 1995, ACTA NEUROCHIR, V133, P122, DOI 10.1007/BF01420062; MCINTOSH TK, 1992, J NEUROTRAUM, V9, pS201; MCINTOSH TK, 1994, AM J PHYSIOL, V267, pR665, DOI 10.1152/ajpregu.1994.267.3.R665; NAGAO S, 1994, ACTA NEUROCHIR, P502; OISO Y, 1988, NEUROENDOCRINOLOGY, V48, P658, DOI 10.1159/000125078; RAICHLE ME, 1978, BRAIN RES, V143, P191, DOI 10.1016/0006-8993(78)90766-7; REEDER RF, 1986, J NEUROSURG, V64, P941, DOI 10.3171/jns.1986.64.6.0941; ROSENBERG GA, 1992, STROKE, V23, P1767, DOI 10.1161/01.STR.23.12.1767; SILVIA RC, 1987, BRAIN RES, V403, P52, DOI 10.1016/0006-8993(87)90121-1; SORENSEN PS, 1985, J NEUROL NEUROSUR PS, V48, P50, DOI 10.1136/jnnp.48.1.50; TANG AH, 1985, LIFE SCI, V37, P1475, DOI 10.1016/0024-3205(85)90178-X	25	24	25	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.		1997	139	12					1173	1179		10.1007/BF01410978			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	YM860	WOS:000071108900032	9479425				2022-02-06	
J	Lazar, L; Erez, I; Gutermacher, M; Katz, S				Lazar, L; Erez, I; Gutermacher, M; Katz, S			Brain concussion produces transient hypokalemia in children	JOURNAL OF PEDIATRIC SURGERY			English	Article; Proceedings Paper	29th Annual Meeting of the Pacific-Association-of-Pediatric-Surgeons	MAY 12-15, 1996	SINGAPORE, SINGAPORE	Pacific Assoc Pediat Surgeons		brain concussion; hypokalemia	HEAD-INJURY; CATECHOLAMINES; POTASSIUM	Hyperglycemia and hypokalemia caused by catecholamine discharge have been reported to occur in patients after severe head trauma. The aim of this prospective study was to evaluate whether a similar neuroendocrine and metabolic response is found in children after minor head trauma such as brain concussion (Glasgow Coma Scale (GCS) greater than or equal to 13). One hundred fifty patients aged 2 to 14 years (average, 6 years) were divided into three groups (n = 50 in each group), Group 1 included patients admitted to the emergency department for brain concussion (Glasgow Coma Scale (GCS) greater than or equal to 13); group 2 included patients admitted for fractures of long bones without head injury; and group 3 were control patients electively admitted for hernia repair. All patients had complete physical and neurological examinations. Complete blood count and blood chemistry were obtained on admission. All blood tests were repeated at 6, 12, and 24 hours in patients belonging to group 1. An electrocardiogram was obtained in selected patients and catecholamine levels were measured in some patients. Statistical analysis was performed using analysis of variance (ANOVA). Serum potassium and sodium levels in patients with brain concussion (group 1) were 3.6 +/- 0.6 and 136 +/- 3 mEq/L, respectively and were significantly lower (P < 0.01) than those in patients belonging to group 2, 4 +/- 0.4 and 138 +/- 3, respectively, and the controls (group 3), 4.2 +/- 0.5 and 140 +/- 2, respectively Serum glucose revel was 124 +/- 34 and 118 +/- 32 mg% in groups 1 and 2 and was significantly higher than that of the controls (group 3), 90 +/- 23 mg%. There was no correlation between serum electrolytes and GCS. No electrocardiogram changes or elevation of serum catecholamines were found. Hypokalemia resolved spontaneously within 24 hours. All patients recovered without neurological sequalae. Transient hypokalemia frequently occurs in children even with minor head trauma. This hypokalemia resolves spontaneously, without treatment and within 24 hours. Copyright (C) 1997 by W.B. Saunders Company	MEIR HOSP,DEPT PEDIAT SURG,SAPIR MED CTR,IL-44281 KEFAR SAVA,ISRAEL								BROWN MJ, 1983, NEW ENGL J MED, V309, P1414, DOI 10.1056/NEJM198312083092303; CLAUSEN T, 1983, ACTA MED SCAND S, V672, P111; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; CRUICKSHANK JM, 1974, BRIT HEART J, V36, P697; EPSTEIN FH, 1983, NEW ENGL J MED, V309, P1450, DOI 10.1056/NEJM198312083092308; PENTELENYI T, 1979, INJURY, V10, P201, DOI 10.1016/0020-1383(79)90009-3; POLLACK MM, 1988, CRIT CARE MED, V16, P1110, DOI 10.1097/00003246-198811000-00006; POMERANZ S, 1989, ACTA NEUROCHIR, V97, P62, DOI 10.1007/BF01577741	9	24	25	1	1	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0022-3468			J PEDIATR SURG	J. Pediatr. Surg.	JAN	1997	32	1					88	90		10.1016/S0022-3468(97)90102-0			3	Pediatrics; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	WE275	WOS:A1997WE27500025	9021578				2022-02-06	
J	Simpson, DM				Simpson, DM			Clinical trials of botulinum toxin in the treatment of spasticity	MUSCLE & NERVE			English	Article							UPPER EXTREMITY SPASTICITY; DOUBLE-BLIND	Botulinum toxin has been tested as a treatment for spasticity resulting from cerebral palsy multiple sclerosis, traumatic brain injury, spinal cord injury, and stroke. The results of 18 studies are reviewed in this article. In both open label and double-blind, placebo-controlled trials, botulinum toxin has proven to be an effective measure for reduction of focal spasticity Improvements have been documented in tone reduction, range of motion, hygiene, autonomic dysreflexia, gait pattern, positioning, and other criteria, though not all criteria tested showed improvement in all studies. In none of the studies were there significant adverse effects. Future trials may be improved by refinement of several design parameters, including patient selection, treatment timing, and selection of dose and injection site. (C) 1997 John Wiley & Sons, Inc.	Mt Sinai Med Ctr, Dept Neurol, New York, NY 10019 USA; Mt Sinai Med Ctr, Dept Clin Neurophysiol, New York, NY 10019 USA		Simpson, DM (corresponding author), Mt Sinai Med Ctr, Dept Neurol, 1 Gustave L Levy Pl, New York, NY 10019 USA.						[Anonymous], 1990, Neurology, V40, P1332; ASHWORTH B, 1964, PRACTITIONER, V192, P540; Benecke R, 1994, THERAPY BOTULINUM TO, P557; BOHLEGA S, 1995, MOVEMENT DISORD, V10, P399; BORGSTEIN J, 1993, AM J PHYS MED REHAB, V72, P364; Chutorian A, 1994, INT PEDIAT S1, V9, P35; CHUTORIAN A, 1995, MOVEMENT DISORD, V10, P364; Corry IS, 1997, DEV MED CHILD NEUROL, V39, P185; COSGROVE AP, 1992, BR J SURG B, V74, P135; DAS TK, 1989, BRIT J CLIN PRACT, V43, P401; DAS TK, 1989, POSTGRAD MED J, V65, P208, DOI 10.1136/pgmj.65.762.208; DENGLER R, 1992, J NEUROL, V239, P375; DYKSTRA DD, 1990, ARCH PHYS MED REHAB, V71, P24; GRAZKO MA, 1995, NEUROLOGY, V45, P712, DOI 10.1212/WNL.45.4.712; JABBARI B, 1995, MOVEMENT DISORD, V10, P379; Koman LA, 1994, THERAPY BOTULINUM TO, P511; LANDAU WM, 1974, ARCH NEUROL-CHICAGO, V31, P217; MEMIN B, 1992, REV NEUROL, V148, P212; PIERSON SH, 1997, MUSCLE NERVE S6, V20, pS36; Simpson DM, 1996, NEUROLOGY, V46, P1306, DOI 10.1212/WNL.46.5.1306; SNOW BJ, 1990, ANN NEUROL, V28, P512, DOI 10.1002/ana.410280407; Takenaga S, 1995, Rinsho Shinkeigaku, V35, P251; Yablon SA, 1996, NEUROLOGY, V47, P939, DOI 10.1212/WNL.47.4.939; YOUNG RR, 1989, NEW ENGL J MED, V320, P1553, DOI 10.1056/NEJM198906083202310; YOUNG RR, 1994, NEUROLOGY, V44, P512	25	24	27	0	0	JOHN WILEY & SONS INC	NEW YORK	605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0148-639X			MUSCLE NERVE	Muscle Nerve		1997				6			S169	S175					7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YQ157	WOS:000071354200011	9826988				2022-02-06	
J	SmithKnapp, K; Corrigan, JD; Arnett, JA				SmithKnapp, K; Corrigan, JD; Arnett, JA			Predicting functional independence from neuropsychological tests following traumatic brain injury	BRAIN INJURY			English	Article							ASSESSMENT SCALES	The relationship between impairment, measured by the Halstead-Reitan Neuropsychological Test Battery (HRNTB), and disability, measured by the Functional Independence Measure (FIM), was investigated in 164 subjects completing acute, inpatient rehabilitaton following traumatic brain injury. Exploratory factor analysis of the FIM supported a two-factor model of disability, with 13 items loading on a motor disability factor and five items loading on a cognitive disability factor. HRNTB findings and injury-related variables were predictive of motor disability, as five variables accounted for 39-44% of the variance in FIM Motor scores. Contrary to expectations, the relationship with cognitive disability was comparable to, but did not exceed, that for motor disability, as only 29-40% of the variance in FIM Cognitive scores was accounted for. The WAIS-R Comprehension subtest was the single best predictor of cognitive disability, accounting for 20% of variance, and suggesting that the FIM Cognitive subscale is measuring social-cognitive ability, as intended by its authors. Results are discussed in terms of the relationships among impairment and disability, including the need to further scrutinize the operationalization of these constructs as they relate to cognitive functions.	MED COLL OHIO,DEPT PHYS MED & REHABIL,TOLEDO,OH 43699; OHIO STATE UNIV,DEPT PHYS MED & REHABIL,COLUMBUS,OH 43210				Corrigan, John D./E-2921-2011				BENYISHA.Y, 1970, J CONSULT CLIN PSYCH, V34, P436, DOI 10.1037/h0029366; Committee on Trauma Research CoLS National Research Council and the IOM, 1985, INJ AM CONT PUBL HLT; *CTR FUNCT ASS RES, 1990, GUID US UN DAT SET M; DAHLBERG C, 1990, P AM SPINAL INJURY A, P23; DAVIDOFF GN, 1990, ARCH PHYS MED REHAB, V71, P326; DISLER PB, 1993, ARCH PHYS MED REHAB, V74, P139; FRANZEN MD, 1989, REALIABILITY VALIDIT; FUHRER MJ, 1987, REHABILITATION OUTCO, P1; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; GRANGER CV, 1993, ARCH PHYS MED REHAB, V74, P133; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; GRANGER CV, 1992, AM J PHYS MED REHAB, V71, P108, DOI 10.1097/00002060-199204000-00009; GRANGER CV, 1995, AM J PHYS MED REHAB, V74, P107; HAMILTON B B, 1991, Archives of Physical Medicine and Rehabilitation, V72, P790; Hamilton BB, 1987, REHABILITATION OUTCO, P137; HEATON RK, 1981, J CONSULT CLIN PSYCH, V49, P807, DOI 10.1037/0022-006X.49.6.807; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; HEINEMANN AW, 1991, PREDICTION REHABILIT; HEVERN VW, 1980, CLIN NEUROPSYCHOLOGY, V2, P49; JARVIS PE, 1984, HALSTEAD REITAN TEST; Klove H., 1974, CLIN NEUROPSYCHOLOGY, P211; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; MCCUE M, 1990, REHABIL PSYCHOL, V35, P91; PULLICINO P, 1992, STROKE, V222, P919; Reitan R, 1985, HALSTEAD REITAN NEUR; REITAN RM, 1973, ANN CONV AM PSYCH AS; Robbins D. E., 1989, RELIABILITY VALIDITY, P91; Russell E. W., 1970, ASSESSMENT BRAIN DAM; SATTLER JM, 1988, ASSESSMENT CHILDRENS; WAGNER KA, 1987, REHABILITATION OUTCO, P19; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Wilkinson, 1984, WIDE RANGE ACHIEVEME; World Health Organization, 1980, INT CLASS IMP DIS HA	34	24	24	0	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	SEP	1996	10	9					651	661		10.1080/026990596124070			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	VB635	WOS:A1996VB63500003	8853868				2022-02-06	
J	Padula, WV; Argyris, S				Padula, WV; Argyris, S			Post trauma vision syndrome and visual midline shift syndrome	NEUROREHABILITATION			English	Article						post trauma vision syndrome; visual midline shift syndrome; vision; traumatic brain injury; cerebrovascular accident		Following a neurological event such as a traumatic brain injury (TBI), cerebrovascular accident (CVA), multiple sclerosis (MS), etc. Vision imbalances can occur between affecting the focal and ambient visual process that can affect balance, posture, ambulation, reading, attention, concentration and cognitive function in general. Post Trauma Vision Syndrome (PTVS) and Visual Midline Shift Syndrome (VMSS) can be the cause of these difficulties. This paper discusses the symptoms and characteristics of these syndromes as well as methods of treatment.			Padula, WV (corresponding author), GUILDFORD MED CTR,POB 1408,652 BOSTON POST RD,GUILFORD,CT 06347, USA.						LIEBOWITZ HW, IN PRESS ORG REPRESE; Padula W. V., 1988, BEHAV VISION APPROAC; PADULA WV, 1994, BRAIN INJURY, V8, P125, DOI 10.3109/02699059409150964; THOMAS J, 1992, LECT NEUR REH ASS S; TREVARTHEN C, 1973, BRAIN, V96, P547, DOI 10.1093/brain/96.3.547	5	24	24	2	8	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1053-8135			NEUROREHABILITATION	Neurorehabilitation	JUN	1996	6	3					165	171		10.1016/1053-8135(96)00162-X			7	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UK480	WOS:A1996UK48000002	24525768				2022-02-06	
J	Franzen, MD; Paul, D; Iverson, GL				Franzen, MD; Paul, D; Iverson, GL			Reliability of alternate forms of the trail making test	CLINICAL NEUROPSYCHOLOGIST			English	Article								Initial research in a limited sample of 15 closed-head-injury patients indicated reasonable reliability for alternate forms of the Trail Making Test, Parts A and B, called Form C and D, respectively. The present study examined the reliability of these alternate forms in a larger and more heterogeneous sample of 192 subjects with neurologic, psychiatric, or substance abuse diagnoses. The two forms correlated significantly, and there were no significant differences in mean scores for the two forms. The results indicate adequate reliability, although separate cut-off values for Form C may be necessary due to a nonsignificant tendency for scores on Form C to be lower than for the Trail Making Test, Part A.	MED COLL PENN & HAHNEMANN UNIV,DEPT PSYCHIAT & ANI,PHILADELPHIA,PA; W VIRGINIA UNIV,MORGANTOWN,WV 26506					Iverson, Grant/0000-0001-7348-9570			Berg R., 1987, SCREENING BRAIN IMPA; CHARTER RA, 1987, INT J CLIN NEUROPSYC, V9, P28; DESROSIERS G, 1987, INT J CLIN NEUROPSYC, V9, P162; DYE OA, 1979, PRECEPTUAL MOTOR SKI, V48, P206; Heaton RK, 1991, COMPREHENSIVE NORMS; KELLAND DZ, 1994, CLIN NEUROPSYCHOL, V8, P295, DOI 10.1080/13854049408404136; Lewis R, 1979, MANUAL REPEATABLE CO; LEZAK MD, 1982, 5 EUR C INT NEUR SOC; MATARAZZO JD, 1974, J NERV MENT DIS, V158, P37, DOI 10.1097/00005053-197401000-00006; MCCRACKEN LM, 1992, PSYCHOL ASSESSMENT, V4, P235, DOI DOI 10.1037//1040-3590.4.2.235; Reitan M., 1985, HALSTEAD REITAN NEUR; Russell E. W., 1970, ASSESSMENT BRAIN DAM	12	24	24	0	7	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0920-1637			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	MAY	1996	10	2					125	129		10.1080/13854049608406672			5	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	UM880	WOS:A1996UM88000001					2022-02-06	
J	Patrick, CW; Kukreti, S; McIntire, LV				Patrick, CW; Kukreti, S; McIntire, LV			Quantitative effects of peripheral monocytes and nerve growth factor on CNS neural morphometric outgrowth parameters in vitro	EXPERIMENTAL NEUROLOGY			English	Article							3-DIMENSIONAL CELL-CULTURES; BLOOD MONONUCLEAR-CELLS; NEURITE OUTGROWTH; TRAUMATIC INJURY; MAMMALIAN BRAIN; NTERA-2 CELLS; NEURONS; LINE; INHIBITION; PHAGOCYTES	Wound healing of the central nervous system (CNS) is a complex process involving interactions between cells from both the vascular and the neural environments, extracellular matrix proteins, and a cocktail of agonistic and antagonistic bioactive molecules. Vascular cells, particularly peripheral monocytes and macrophages, are believed to play an important role in organizing and mediating CNS tissue reactions subsequent to penetrating injuries that compromise the blood-brain barrier. Although many investigators have studied the effect of macrophages and microglia (resident brain macrophages) on neural outgrowth, little is known regarding monocyte effects. We have combined tissue culture, video microscopy, and digital image processing and analysis to quantify morphometric parameters of neurons exposed to monocyte secretory products in vitro. The experimental system developed is simple in design but provides a quantitative understanding of cellular function and molecular mechanisms and has the ability to both study processes of graded complexity and relate cellular function to overall systems behavior. We evaluate the efficacy of the experimental model developed by measuring morphometric parameters of human neural cells (hNT cell line) in the presence of nerve growth factor (NGF). Results suggest that monocyte-conditioned media (MCM) increases neuron outgrowth parameters, such as neuritic output, mean arbor output, neurite branching, and effective cell diameter. Moreover, we show that the bioactive factor present in MCN is not IL-1 and the activity of the factor with respect to neural outgrowth is between that of 10 and 100 ng/ml NGF. (C) 1996 Academic Press, Inc.			Patrick, CW (corresponding author), RICE UNIV, COX LAB BIOMED ENGN, INST BIOSCI & BIOENGN, HOUSTON, TX 77251 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R37HL018672] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R37-HL-18672] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [O01-NS-22237] Funding Source: Medline		AEBISCHER P, 1989, J NEUROSCI, V9, P3590; ANDREESEN R, 1990, J LEUKOCYTE BIOL, V47, P490, DOI 10.1002/jlb.47.6.490; ARAUJO DM, 1993, BRAIN RES, V600, P49, DOI 10.1016/0006-8993(93)90400-H; BEATY CE, 1993, J CONTROL RELEASE, V24, P15, DOI 10.1016/0168-3659(93)90165-2; BENNETT S, 1992, J IMMUNOL METHODS, V153, P201, DOI 10.1016/0022-1759(92)90323-L; BRODKEY JA, 1993, EXP NEUROL, V123, P251, DOI 10.1006/exnr.1993.1158; BROSNAN CF, 1993, ADV NEUROL, V59, P349; BUETTNER HM, 1991, DEV BIOL, V145, P266, DOI 10.1016/0012-1606(91)90125-M; CHAMAK B, 1994, J NEUROSCI RES, V38, P221, DOI 10.1002/jnr.490380213; CHULUYAN HE, 1993, J CLIN INVEST, V92, P2768, DOI 10.1172/JCI116895; CUNHA A, 1993, BRAIN RES, V631, P39; DINARELLO CA, 1994, FASEB J, V8, P1314, DOI 10.1096/fasebj.8.15.8001745; FISHER M, 1993, J NEUROL SCI, V119, P189, DOI 10.1016/0022-510X(93)90133-J; GIULIAN D, 1989, J NEUROSCI, V9, P4416; GIULIAN D, 1993, J NEUROSCI RES, V36, P681, DOI 10.1002/jnr.490360609; GIULIAN D, 1990, ANN NEUROL, V27, P33, DOI 10.1002/ana.410270107; GIULIAN D, 1988, J NEUROSCI, V8, P2485; GIULIAN D, 1993, STROKE S1, V24, P84; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; Greene L., 1982, ADV CELL NEUROBIOL, V3, P373, DOI DOI 10.1016/B978-0-12-008303-9.50016-5; GURWITZ D, 1988, P NATL ACAD SCI USA, V85, P3440, DOI 10.1073/pnas.85.10.3440; HAMA T, 1989, NEUROSCI LETT, V104, P340, DOI 10.1016/0304-3940(89)90600-9; HARDY M, 1994, J NEUROCHEM, V63, P482; HIRKA G, 1991, J VIROL, V65, P2732, DOI 10.1128/JVI.65.5.2732-2735.1991; KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005; KREWSON CE, 1994, BIOTECHNOL BIOENG, V43, P555, DOI 10.1002/bit.260430704; LINDHOLM D, 1992, J CELL BIOL, V117, P395, DOI 10.1083/jcb.117.2.395; LYNCH EA, 1994, J IMMUNOL, V153, P300; MORGAN B, 1989, J NEUROSCI RES, V23, P41, DOI 10.1002/jnr.490230106; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; NISHINO A, 1993, J NEUROTRAUM, V10, P167, DOI 10.1089/neu.1993.10.167; PATRICK CW, 1995, BLOOD, V85, P168, DOI 10.1182/blood.V85.1.168.bloodjournal851168; PITTMAN RN, 1989, J NEUROSCI, V9, P4269; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; PLEASURE SJ, 1993, J NEUROSCI RES, V35, P585, DOI 10.1002/jnr.490350603; POUTSIAKA DD, 1991, BLOOD, V78, P1275; RECALDE HR, 1984, J IMMUNOL METHODS, V69, P71, DOI 10.1016/0022-1759(84)90278-3; RIVADEPATY I, 1994, EXP NEUROL, V128, P77, DOI 10.1006/exnr.1994.1114; ROTHWELL NJ, 1993, NEUROSCI BIOBEHAV R, V17, P217, DOI 10.1016/S0149-7634(05)80152-6; RUDGE JS, 1989, EXP NEUROL, V103, P1, DOI 10.1016/0014-4886(89)90180-5; SALTZMAN WM, 1992, ANN NY ACAD SCI, V665, P259, DOI 10.1111/j.1749-6632.1992.tb42590.x; STRIJBOS PJLM, 1995, J NEUROSCI, V15, P3468; THORPE LW, 1987, J NEUROSCI RES, V17, P128, DOI 10.1002/jnr.490170206; TROJANOWSKI JQ, 1993, EXP NEUROL, V122, P283, DOI 10.1006/exnr.1993.1128; WALICKE PA, 1989, ANNU REV NEUROSCI, V12, P103, DOI 10.1146/annurev.neuro.12.1.103; WERTKIN AM, 1993, P NATL ACAD SCI USA, V90, P9513, DOI 10.1073/pnas.90.20.9513; WOODROOFE MN, 1993, CYTOKINE, V5, P583, DOI 10.1016/S1043-4666(05)80008-0; YOUNKIN DP, 1993, P NATL ACAD SCI USA, V90, P2174, DOI 10.1073/pnas.90.6.2174	48	24	24	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	APR	1996	138	2					277	285		10.1006/exnr.1996.0066			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UF078	WOS:A1996UF07800011	8620926				2022-02-06	
J	Anderson, CV; Wood, DMG; Bigler, ED; Blatter, DD				Anderson, CV; Wood, DMG; Bigler, ED; Blatter, DD			Lesion volume, injury severity, and thalamic integrity following head injury	JOURNAL OF NEUROTRAUMA			English	Article						traumatic brain injury; magnetic resonance; lesion volume	AXONAL INJURY	Magnetic resonance scans of 63 TBI patients were analyzed to examine the relationship between injury severity, lesion volume (nonthalamic cortical/subcortical lesions), ventricle-to-brain ratio (VER), and thalamic volume. For comparison, 33 normal control subjects were used. Patients with visible nonthalamic structural lesions showed significantly smaller thalamic volumes than patients without visible lesions or control subjects. Results also indicated that patients with visible lesions had significantly more severe injuries than patients without lesions. Patients with moderate-severe injuries had significantly smaller thalamic volumes and greater VBRs than patients with mild-moderate injuries. Although several variables related to thalamic volume, the presence of nonthalamic lesions was sufficient to result in smaller thalamic volume. Decreased thalamic volume following head injury suggests that subcortical brain structures may be susceptible to transneuronal degeneration following cortical lesions, and that this can be detected by in vivo MR-based volumetric analysis.	BRIGHAM YOUNG UNIV,DEPT PSYCHOL,PROVO,UT 84602; LATTER DAY ST HOSP,DEPT RADIOL,SALT LAKE CITY,UT 84143								ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; BIGLER ED, 1994, FUNCTIONAL NEUROIMAG, P121; Bigler Erin D., 1993, Brain Injury, V7, P125, DOI 10.3109/02699059309008166; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; CLARKE LP, 1995, MAGN RESON IMAGING, V13, P343, DOI 10.1016/0730-725X(94)00124-L; GALE SD, 1994, NEUROPSY NEUROPSY BE, V7, P160; Gean AD, 1994, IMAGING HEAD TRAUMA; JESSELL TM, 1991, PRINCIPLES NEURAL SC, P258; Johnson SC, 1994, NEUROPSYCHOLOGY, V8, P307, DOI DOI 10.1037/0894-4105.8.3.301; KUCHARCZYK J, 1994, MAGNETIC RESONANCE I; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; MATTHEWS MA, 1973, J NEUROCYTOL, V2, P265, DOI 10.1007/BF01104030; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; PRAYER LM, 1994, MAGNETIC RESONANCE N, P441; ROBB RA, 1995, 3 DIMENSIONAL BIOMED; ROSENTHAL M, 1993, TRAUMATIC BRAIN INJU; ROSS DT, 1993, J NEUROTRAUM, V10, P151, DOI 10.1089/neu.1993.10.151; ROSS DT, 1990, NEUROSCIENCE, V35, P525, DOI 10.1016/0306-4522(90)90327-Z; Steward O, 1989, PRINCIPLES CELLULAR; WHITE RJ, 1992, NEW ENGL J MED, V327, P1507; WILSON JTL, 1992, J HEAD TRAUMA REHAB, V7, P29	25	24	24	0	2	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	JAN	1996	13	1					35	40		10.1089/neu.1996.13.35			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TW167	WOS:A1996TW16700005	8714861				2022-02-06	
J	Wilde, MC; Boake, C; Sherer, M				Wilde, MC; Boake, C; Sherer, M			Do recognition-free recall discrepancies detect retrieval deficits in closed-head injury? An exploratory analysis with the California verbal learning test	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article; Proceedings Paper	22nd Annual Meeting of the International-Neuropsychological-Society	FEB 02-05, 1994	CINCINNATI, OH	Int Neuropsychol Soc			HUNTINGTONS-DISEASE; MEMORY; ALZHEIMERS	The present study examined the validity of the Recognition Discriminability-Long Delay Free Recall discrepancy from the California Verbal Learning Test (CVLT) as a sign of retrieval deficits in closed-head injury (CHI). Discrepancy and nondiscrepancy groups who differed in their Recognition Discriminability performance but were equated on Long-Delay Free Recall were compared on indices hypothesized to reveal performance patterns consistent with retrieval deficits. Results showed that the discrepancy group produced fewer intrusions. The two groups did not differ in their consistency of recall or relative degree of benefit from semantic cuing. Additional analysis using a discrepancy group with normal Recognition Discriminability scores but abnormal Long-Delay Free Recall performance did not alter these results. The hypotheses were not supported when patients with language deficits were excluded. The findings did not support the use of this discrepancy from the CVLT as a marker for retrieval deficits in CHI.	BAYLOR COLL MED,DEPT PHYS MED & REHABIL,HOUSTON,TX 77030; UNIV TEXAS,HLTH SCI CTR,INST REHABIL & RES,HOUSTON,TX; UNIV TEXAS,HLTH SCI CTR,DEPT PHYS MED & REHABIL,HOUSTON,TX								Benton A, 1988, MULTILINGUAL APHASIA; BRANDT J, 1992, J CLIN EXP NEUROPSYC, V14, P773, DOI 10.1080/01688639208402862; BUTTERS N, 1986, CORTEX, V22, P11, DOI 10.1016/S0010-9452(86)80030-2; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; CROSSON B, 1993, CLIN NEUROPSYCHOL, V7, P250, DOI 10.1080/13854049308401897; CROSSON B, 1989, CLIN NEUROPSYCHOL, V3, P29, DOI DOI 10.1080/13854048908404074; CROSSON B, 1993, NEUROPSYCHOLOGY, V7, P193, DOI DOI 10.1037/0894-4105.7.2.193; DELIS D, 1987, CALIFORNIA VERBAL LE; Fridlund A, 1987, CVLT RES EDITION ADM; GRANHOLM E, 1988, BRAIN COGNITION, V7, P335, DOI 10.1016/0278-2626(88)90007-3; Haut M., 1992, NEUROPSYCHOLOGY, V6, P51; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; MASSMAN PJ, 1990, J CLIN EXP NEUROPSYC, V12, P729, DOI 10.1080/01688639008401015; MASSMAN PJ, 1992, J CLIN EXP NEUROPSYC, V14, P687, DOI 10.1080/01688639208402856; TULVING E, 1987, NEUROBEHAVIORAL RECO, P341; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; [No title captured], DOI DOI 10.1037/1040-3590.3.1.19	20	24	24	0	0	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	DEC	1995	17	6					849	855		10.1080/01688639508402434			7	Psychology, Clinical; Clinical Neurology; Psychology	Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	TM776	WOS:A1995TM77600005	8847391				2022-02-06	
J	LOKEN, WJ; THORNTON, AE; OTTO, RL; LONG, CJ				LOKEN, WJ; THORNTON, AE; OTTO, RL; LONG, CJ			SUSTAINED ATTENTION AFTER SEVERE CLOSED-HEAD INJURY	NEUROPSYCHOLOGY			English	Article							DYSFUNCTION	Sustained attention was assessed in 20 patients with severe closed head injury (CHI) and 20 normal matched controls. Participants were presented with a visual continuous performance task (CPT) with 3 levels of complexity. Performance was assessed by examining response latencies and error rates. Across all levels of complexity, the CHI patients demonstrated a vigilance decrement, whereas the performance of the matched controls was stable across time. The vigilance decrement was not differentially affected by the manipulation of task complexity in the CHI patients. However, findings suggest that the overall vigilance performance of CHI patients was differentially affected by increasing the complexity of the task.	UNIV MEMPHIS, MEMPHIS, TN USA; BRAINTREE REHABIL HOSP, BRAINTREE, MA USA					Thornton, Allen/0000-0002-9942-0122			BOND MR, 1983, REHABILITATION HEAD, P219; BROUWER WH, 1985, CORTEX, V21, P111, DOI 10.1016/S0010-9452(85)80019-8; BUCHSBAUM MS, 1987, PSYCHOPHARMACOLOGY 3, P783; BUCHTEL HA, 1987, NEUROBEHAVIORAL RECO, P372; BUCK L, 1966, PSYCHOL BULL, V65, P291, DOI 10.1037/h0023207; COHEN RM, 1987, LIFE SCI, V40, P2031, DOI 10.1016/0024-3205(87)90295-5; Conkey RC, 1938, ARCH PSYCHOL, P5; Curry S H, 1980, Prog Brain Res, V54, P507, DOI 10.1016/S0079-6123(08)61668-4; Davies DR., 1982, PSYCHOL VIGILANCE; EWING R, 1980, Journal of Clinical Neuropsychology, V2, P147, DOI 10.1080/01688638008403789; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GRONWALL D, 1974, LANCET, V2, P605; LEVIN HS, 1988, SCAND J REHABIL MED, P33; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LOKEN WJ, 1992, ARCH CLIN NEUROPSYCH, V8, P245; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; PARASURAMAN R, 1991, J CLIN EXP NEUROPSYC, V13, P789, DOI 10.1080/01688639108401090; Parasuraman R, 1984, VARIETIES ATTENTION, P243; Parasuraman R, 1977, VIGILANCE THEORY OPE, P559; Posner M.I., 1987, NEUROPSYCHOLOGICAL R, P182; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; RUGG MD, 1989, BRAIN, V112, P489, DOI 10.1093/brain/112.2.489; Seashore SH, 1941, J EXP PSYCHOL, V29, P342, DOI 10.1037/h0061571; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; van Zomeren AH, 1987, NEUROBEHAVIORAL RECO, P398; Wickens C. D., 1984, ENG PSYCHOL HUMAN PE; WILKINS AJ, 1987, NEUROPSYCHOLOGIA, V25, P359, DOI 10.1016/0028-3932(87)90024-8; WOOD RL, 1988, J LEARN DISABIL, V21, P327, DOI 10.1177/002221948802100603; [No title captured]	33	24	24	0	1	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	OCT	1995	9	4					592	598		10.1037/0894-4105.9.4.592			7	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	TA644	WOS:A1995TA64400017					2022-02-06	
J	BANDAK, FA				BANDAK, FA			ON THE MECHANICS OF IMPACT NEUROTRAUMA - A REVIEW AND CRITICAL SYNTHESIS	JOURNAL OF NEUROTRAUMA			English	Article; Proceedings Paper	Head Injury 1994 - International Symposium on Head Injury Research	OCT 12-14, 1994	WASHINGTON, DC	Natl Highway Traff Safety Adm, Head Injury Res Program, George Washington Univ		IMPACT; TBI; COMPUTATIONAL; DAI; HEMATOMA; CONTUSIONS; VASCULAR		A computational modeling technique for the simulation of head impact mechanics is proposed as a tool for the study of traumatic brain injury (TBI), The capabilities, limitations, and consequently the utilities of this technique are discussed in light of the current computing and imaging technologies and their prospective advancement, A significant portion of the mechanics, relevant to head impact simulation, has been incorporated into this computational technique resulting in automated devices that ease the technical burden of biomechanical analysis of TBI mechanisms, A brief exposition of the concepts utilized in these devices is given and their basis in experiment is discussed.	GEORGE WASHINGTON UNIV,SCH ENGN & APPL SCI,WASHINGTON,DC 20052		BANDAK, FA (corresponding author), US DEPT TRANSPORTAT,NATL HIGHWAY TRAFF SAFE ADM,WASHINGTON,DC 20590, USA.						BANDAK FA, 1995, J NEUROTRAUM, V12, P679, DOI 10.1089/neu.1995.12.679; BANDAK FA, 1995, UNPUB EXPT COMPUTATI; CHAN PC, 1995, UNPUB INFLUENCE SUBA; CHAN RKC, 1986, WIN ANN M AN; DIMASI F, 1991, AUTO TRAFFIC SAFETY, V1; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENNARELLI TA, 1987, 31ST P STAPP CAR CRA, P564; HALLQUIST J, 1994, 1018 LIV SOFTW TECHN; Holbourn AHS, 1943, LANCET, V2, P438; LILLES DR, 1978, J COMP PHYS, V26, P390; LOWENHIELM P, 1974, Z RECHTSMED, V74, P55, DOI 10.1007/BF01869185; McElhaney JH, 1973, PERSPECTIVES BIOMEDI, P215, DOI DOI 10.1007/978-1-349-01604-4_34; MEANEY DF, 1990, 1990 P IRCOBI C LYON, V11, P215; Melvin J.W., 1993, ACCIDENTAL INJURY BI, P268; OMMAYA AK, 1968, J AMER MED ASSOC, V204, P285, DOI 10.1001/jama.204.4.285; OMMAYA AK, 1994, INT J IMPACT ENG, V15, P535, DOI 10.1016/0734-743X(94)80033-6; OMMAYA AK, 1966, SCIENCE, V153, P211, DOI 10.1126/science.153.3732.211; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Ommaya AK, 1968, J BIOMECH; OMMAYA AK, 1969, ACCIDENT PATHOLOGY; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; STRICH SJ, 1961, LANCET, V2, P443; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P63; THIBAULT LE, 1982, ADV BIOENGINEERING	25	24	24	0	3	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	AUG	1995	12	4					635	649		10.1089/neu.1995.12.635			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RY920	WOS:A1995RY92000015	8683615				2022-02-06	
J	GOLDING, EM; VINK, R				GOLDING, EM; VINK, R			EFFICACY OF COMPETITIVE VS NONCOMPETITIVE BLOCKADE OF THE NMDA CHANNEL FOLLOWING TRAUMATIC BRAIN INJURY	MOLECULAR AND CHEMICAL NEUROPATHOLOGY			English	Article						NMDA ANTAGONIST; MAGNESIUM; MAGNETIC RESONANCE; PHOSPHORUS MRS; DEXTROMETHORPHAN; CGS-19755	VOLTAGE-DEPENDENT BLOCK; D-ASPARTATE RECEPTORS; MAGNETIC-RESONANCE; FREE MAGNESIUM; ACTIVATED CHANNELS; CALCIUM; NEURONS; GLUTAMATE; DAMAGE; MG-2+	N-methyl-D-aspartate (NMDA) receptor antagonists have been demonstrated widely to be neuroprotective in cerebral ischemia, hypoxia, and traumatic brain injury. However, although noncompetitive NMDA antagonists have typically proven efficacious under all of these conditions, competitive antagonists have not been shown to be beneficial following moderate traumatic brain injury. The present study has used phosphorus magnetic resonance spectroscopy ([P-31]MRS) to examine the effects of the competitive antagonist cis-4-(phosphonomethyl) piperidine-2-carboxylic acid (CGS-19755) and the noncompetitive antagonist dextromethorphan on biochemical outcome following fluid percussion-induced traumatic brain injury in rats. Five minutes prior to induction of moderate (2.8 +/- 0.2 atm) fluid percussion brain injury, animals received either CGS-19755 (10 mg/kg iv), dextromethorphan (10 mg/kg iv), or equal volume saline vehicle. [P-31]MRS spectra were then acquired for 4 h post-trauma and intracellular pH, free magnesium concentration, cytosolic phosphorylation potential, and oxidative capacity determined. Both CGS-19755-treated animals and saline treated controls demonstrated significant and sustained declines in intracellular free magnesium concentration and bioenergetic status following trauma. In contrast, administration of dextromethorphan significantly attenuated free magnesium decline and improved bioenergetic state during the post-traumatic monitoring period. These results suggest that the neuroprotective actions of NMDA antagonists following traumatic brain injury are associated with attenuation of free magnesium decline and that such actions seem to be preferentially medicated by noncompetitive blockers.	JAMES COOK UNIV N QUEENSLAND,DIV BIOCHEM & HUMAN PHYSIOL,TOWNSVILLE,QLD 4811,AUSTRALIA				Vink, Robert/J-7351-2012; Vink, Robert/S-5616-2019	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667			ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; BOCK JL, 1987, BIOCHIM BIOPHYS ACTA, V928, P8, DOI 10.1016/0167-4889(87)90079-6; BOLGER GT, 1986, PHARMACOL BIOCHEM BE, V24, P417, DOI 10.1016/0091-3057(86)90534-4; BRAAKMAN R, 1993, J NEUROTRAUMA S, V10, pS85; CARPENTER CL, 1988, BRAIN RES, V439, P372, DOI 10.1016/0006-8993(88)91497-7; CHANCE B, 1955, J BIOL CHEM, V217, P383; CHANCE B, 1986, FED PROC, V45, P2915; CHANCE B, 1986, P NATL ACAD SCI USA, V83, P9458, DOI 10.1073/pnas.83.24.9458; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; COX JA, 1989, BRAIN RES, V499, P267, DOI 10.1016/0006-8993(89)90774-9; EBEL H, 1980, J CLIN CHEM CLIN BIO, V18, P257; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FADEN AI, 1989, INTENSIVE CARE EMERG, V9, P14; GARFINKEL L, 1984, BIOCHEMISTRY-US, V23, P3547, DOI 10.1021/bi00310a025; GUPTA RK, 1978, J BIOL CHEM, V253, P6172; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; ISERI LT, 1984, AM HEART J, V108, P188, DOI 10.1016/0002-8703(84)90572-6; JOHNSON JW, 1990, BIOPHYS J, V57, P1085, DOI 10.1016/S0006-3495(90)82626-6; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; LAWSON JWR, 1979, J BIOL CHEM, V254, P6528; MALLOY CR, 1986, BIOCHIM BIOPHYS ACTA, V885, P1, DOI 10.1016/0167-4889(86)90032-7; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MCINTOSH TK, 1992, EXCITATORY AMINO ACI, P247; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; NIOKA S, 1990, J APPL PHYSIOL, V68, P2527, DOI 10.1152/jappl.1990.68.6.2527; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; PEARSON HA, 1993, NEUROPHARMACOLOGY, V32, P1171, DOI 10.1016/0028-3908(93)90011-Q; PETROFF OAC, 1985, NEUROLOGY, V35, P781, DOI 10.1212/WNL.35.6.781; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; ROTHMAN SM, 1987, TRENDS NEUROSCI, V10, P299, DOI 10.1016/0166-2236(87)90177-9; SHAPIRA Y, 1993, J CEREBR BLOOD F MET, V13, P962, DOI 10.1038/jcbfm.1993.120; Siesj? BK., 1978, BRAIN ENERGY METABOL; SIESJO BK, 1988, NEUROCHEM PATHOL, V9, P31; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; SWAN JH, 1990, J CEREBR BLOOD F MET, V10, P343, DOI 10.1038/jcbfm.1990.63; TAKIZAWA S, 1991, J CEREBR BLOOD F MET, V11, P786, DOI 10.1038/jcbfm.1991.136; VEECH RL, 1979, J BIOL CHEM, V254, P6538; VINK R, 1991, AM J PHYSIOL, V261, pR1527, DOI 10.1152/ajpregu.1991.261.6.R1527; VINK R, 1993, MOL CHEM NEUROPATHOL, V18, P279, DOI 10.1007/BF03160120; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; VINK R, 1988, J BIOL CHEM, V263, P757; VINK R, 1988, J NEUROTRAUMA, V5, P365; VINK R, 1991, MAGNESIUM EXCITABLE, P695; YOUNG W, 1992, CENTRAL NERVOUS SYST, P9; ZEEVALK GD, 1991, J PHARMACOL EXP THER, V257, P870	51	24	24	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07012	1044-7393			MOL CHEM NEUROPATHOL	Mol. Chem. Neuropathol.	FEB-APR	1995	24	2-3					137	150		10.1007/BF02962139			14	Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	QX448	WOS:A1995QX44800004	7632318				2022-02-06	
J	JOHNSTONE, B; FRANK, RG				JOHNSTONE, B; FRANK, RG			NEUROPSYCHOLOGICAL ASSESSMENT IN REHABILITATION - CURRENT LIMITATIONS AND APPLICATIONS	NEUROREHABILITATION			English	Article						NEUROPSYCHOLOGICAL EVALUATION; REHABILITATION PSYCHOLOGY; CONSTRUCT VALIDITY; ECOLOGICAL VALIDITY	CLOSED-HEAD-INJURY; VISUAL ORGANIZATION TEST; CARD SORTING TEST; TEST-PERFORMANCE; BRAIN INJURY; BATTERY; LURIA; VALIDITY; HOOPER; DYSFUNCTION	Neuropsychological assessment is a standard procedure for rehabilitation patients with cognitive dysfunction. However, the use of neuropsychological evaluations in rehabilitation settings is limited as the most commonly used measures were originally developed for diagnostic purposes with an emphasis on localization/lateralization of lesions and description of brain-behavior relationships. As a result, the functional (versus diagnostic) utility of neuropsychological evaluations is questionable at best. Furthermore, neuropsychological evaluation in rehabilitation settings will continue to be of limited utility as long as INS-APA Division 40 guidelines continue to emphasize training in neurologic and neuroanatomic factors, with minimal attention to rehabilitation issues and resources. Several factors necessitate the use of neuropsychological evaluations for functional rather than diagnostic purposes, including advances in neuroradiological evaluation, the growth of rehabilitation facilities given increased survival rates for brain injured patients, and an associated greater need for psychological services for these patients. Suggestions are offered for improving the functional utility of neuropsychological evaluations, as well as more effective ways to train neuropsychologists in rehabilitation issues and interventions.			JOHNSTONE, B (corresponding author), UNIV MISSOURI,SCH MED,DEPT PHYS MED & REHABIL,501 RRC,COLUMBIA,MO 65212, USA.			Johnstone, Brick/0000-0001-8845-9649			ADAMS KM, 1980, J CONSULT CLIN PSYCH, V48, P511, DOI 10.1037/0022-006X.48.4.511; ALBERTS MJ, 1992, STROKE, V23, P663, DOI 10.1161/01.STR.23.5.663; ANDERSON SW, 1991, J CLIN EXP NEUROPSYC, V13, P909, DOI 10.1080/01688639108405107; Barkley RA, 1994, ADHD REPORT, V2, P1; BENNETT TL, 1988, COGNITIVE REHABILITA, V6, P18; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Bigler E D, 1991, Arch Clin Neuropsychol, V6, P113, DOI 10.1016/0887-6177(91)90028-8; BLIEBERG J, 1992, PHYSICAL MED REHABIL; BOLL TJ, 1981, HDB CLIN NEUROPSYCHO; BORNSTEIN RA, 1988, ARCH CLIN NEUROPSYCH, V2, P15; BOYD JL, 1981, J CONSULT CLIN PSYCH, V49, P15, DOI 10.1037/0022-006X.49.1.15; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Chelune G. J, 1986, NEUROPSYCHOLOGY HDB, P489; COSTA L, 1988, CLIN NEUROPSYCHOL, V2, P3; DELIS DC, 1983, J CONSULT CLIN PSYCH, V51, P396; DODRILL CB, 1984, J CONSULT CLIN PSYCH, V52, P520, DOI 10.1037/0022-006X.52.4.520; Dunn E J, 1990, Arch Clin Neuropsychol, V5, P103, DOI 10.1016/0887-6177(90)90032-K; ERICKSON RC, 1986, J CLIN EXP NEUROPSYC, V8, P257, DOI 10.1080/01688638608401317; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; FITZ AG, 1992, ARCH CLIN NEUROPSYCH, V7, P243, DOI 10.1016/0887-6177(92)90166-K; FRANK RG, 1990, AM PSYCHOL, V45, P757, DOI 10.1037/0003-066X.45.6.757; FRASER R, 1988, REHABIL COUNS BULL, V31, P276; Golden C. J., 1981, HDB CLIN NEUROPSYCHO; Guilmette T J, 1990, Arch Clin Neuropsychol, V5, P373, DOI 10.1016/0887-6177(90)90016-I; Hartman D E, 1991, Arch Clin Neuropsychol, V6, P147, DOI 10.1016/0887-6177(91)90030-D; HARTMAN DE, 1988, ARCH CLIN NEUROPSYCH, V3, P299; HAUT M, 1992, STATE ART REV PHYSIC; Heaton R.K., 1981, WISCONSIN CARD SORTI; HEATON RK, 1981, J CONSULT CLIN PSYCH, V49, P807, DOI 10.1037/0022-006X.49.6.807; Heilbronner R. L., 1989, CLIN NEUROPSYCHOL, V3, P250; HEINRICHS RW, 1990, PROF PSYCHOL-RES PR, V21, P171, DOI 10.1037/0735-7028.21.3.171; Hooper H., 1958, HOOPER VISUAL ORG TE; Hooper HE., 1983, HOOPER VISUAL ORG TE; Johnston MarkV., 1992, NEUROREHABILITATION, V2, P72; KANE RL, 1989, J CLIN EXPT NEUROPSY, V4, P589; Kaplan E., 1988, CLIN NEUROPSYCHOLOGY, P125; KAZMARK P, 1992, BRAIN INJURY, V6, P213; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; KREUTZER JS, 1990, COMMUNITY INTEGRATIO, P49; LEUNG P, 1990, REHABIL PSYCHOL, V35, P157; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEWIS GP, 1979, J CONSULT CLIN PSYCH, V47, P1003, DOI 10.1037/0022-006X.47.6.1003; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; Loring D W, 1991, Arch Clin Neuropsychol, V6, P167; LORING DW, 1989, CLIN NEUROPSYCHOL, V3, P59, DOI DOI 10.1080/13854048908404077; Lynch W. J., 1990, REHABILITATION ADULT, P310; MAPOU RL, 1988, J CLIN EXP NEUROPSYC, V10, P271, DOI 10.1080/01688638808408241; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; MCSWEENY AJ, 1985, J CLIN EXP NEUROPSYC, V7, P281, DOI 10.1080/01688638508401260; MILBERG WP, 1986, NEUROPSYCHOLOGICAL A, P65; MOUNTAIN MA, 1993, CLIN NEUROPSYCHOL, V7, P108, DOI 10.1080/13854049308401893; PAOLO AM, 1994, CLIN NEUROPSYCHOL, V8, P112; PARKER HJ, 1990, REHABIL PSYCHOL, V35, P239, DOI 10.1037/0090-5550.35.4.239; Parsons O A, 1991, Arch Clin Neuropsychol, V6, P105, DOI 10.1016/0887-6177(91)90027-7; PRIGATANO G, 1986, NEUROPSYCHOLOGOCAL R; PUENTE AE, 1992, ARCH CLIN NEUROPSYCH, V7, P297, DOI 10.1016/0887-6177(92)90024-H; Putnam S.H., 1990, CLIN NEUROPSYCHOL, V4, P199, DOI [https://doi.org/10.1080/13854049008401906, DOI 10.1080/13854049008401906]; Reitan R M, 1989, Arch Clin Neuropsychol, V4, P385, DOI 10.1016/0887-6177(89)90029-2; REITAN RM, 1988, CLIN NEUROPSYCHOL, V2, P33; ROBBINS DE, 1989, RELIABILITY VALIDITY; ROSENTHAL M, 1992, NEUROREHABILITATION, V2, P1; ROTH DL, 1990, J CLIN EXP NEUROPSYC, V12, P834; Rourke B P, 1991, Arch Clin Neuropsychol, V6, P1, DOI 10.1016/0887-6177(91)90017-4; ROUSSEAUX M, 1992, STROKE, V23, P511, DOI 10.1161/01.STR.23.4.511; SEIDEL WT, 1994, CLIN NEUROPSYCHOL, V8, P59, DOI 10.1080/13854049408401543; SHERER M, 1991, J CLIN EXP NEUROPSYC, V13, P741, DOI 10.1080/01688639108401087; SHESLOW R, 1990, WIDE RANGE ASSESSMEN; Shum DHK, 1990, CLIN NEUROPSYCHOL, V4, P151, DOI DOI 10.1080/13854049008401508; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; SPIERS PA, 1981, J CONSULT CLIN PSYCH, V49, P331, DOI 10.1037/0022-006X.49.3.331; STAMBROOK M, 1983, J CLIN NEUROPSYCHOL, V5, P247, DOI 10.1080/01688638308401173; STERNE DM, 1973, J CLIN PSYCHOL, V29, P212, DOI 10.1002/1097-4679(197304)29:2<212::AID-JCLP2270290217>3.0.CO;2-S; TAMKIN AS, 1984, J CLIN PSYCHOL, V40, P1459, DOI 10.1002/1097-4679(198411)40:6<1459::AID-JCLP2270400633>3.0.CO;2-3; TAMKIN AS, 1985, J CLIN PSYCHOL, V41, P660, DOI 10.1002/1097-4679(198509)41:5<660::AID-JCLP2270410512>3.0.CO;2-B; TELLIER A, 1991, J CLIN EXP NEUROPSYC, V13, P105; TERAYAMA Y, 1991, SURG NEUROL, V36, P335, DOI 10.1016/0090-3019(91)90021-Z; VILKKI J, 1992, J CLIN EXP NEUROPSYC, V14, P518, DOI 10.1080/01688639208402841; WANG PL, 1977, PERCEPT MOTOR SKILL, V45, P723, DOI 10.2466/pms.1977.45.3.723; WEHMAN P, 1988, REHABIL COUNS BULL, V31, P298; WEHMAN P, 1989, BRAIN INJURY, V4, P397; *WI U, 1985, 12TH I REH ISS REH T; WILSON BA, 1987, REHAB MEMORY; [No title captured], DOI DOI 10.1080/13854048808520093; [No title captured]; 1987, CLIN NEUROPSYCHOL, V1, P29; 1992, DIV 22 NEWSLETT, V19, P7; [No title captured]	88	24	24	0	5	ELSEVIER SCI PUBL IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1053-8135			NEUROREHABILITATION	Neurorehabilitation	FEB	1995	5	1					75	86		10.1016/1053-8135(94)00106-5			12	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RJ879	WOS:A1995RJ87900007	24525461				2022-02-06	
J	Buxbaum, LJ; Schwartz, MF; Coslett, HB; Carew, TG				Buxbaum, LJ; Schwartz, MF; Coslett, HB; Carew, TG			Naturalistic action and praxis in callosal apraxia	NEUROCASE			English	Article						callosal disconnection; ideational apraxia; apraxic agraphia; naturalistic action	DISCONNECTION SYNDROME; IDEATIONAL APRAXIA; MECHANISMS; PATIENT	We report a subject who, subsequent to closed head injury, demonstrated a severe left hand ideational apraxia and apraxic agraphia, consistent with callosal disconnection syndrome. In contrast to the left hand, performance of the right hand was unimpaired on traditional tests of gesture to command, sight of object, and with actual object use, but proved deficient on tests of spatial and constructional ability. We examined the consequences of these hand-specific deficits for the performance of naturalistic action tasks. The patient made errors with each hand; however, the right hand performed more poorly than the left hand. In addition, the types of errors made by each hand differed in a manner consistent with the results of neuropsychological testing and indicative of disconnection phenomena. We suggest that unlike gesture, naturalistic action requires the contribution of the specialized abilities of each hemisphere, integrated across callosal structures. Traditional testing of gesture may underestimate the right hemisphere's capacity for action programming.	TEMPLE UNIV, SCH MED, PHILADELPHIA, PA 19140 USA; MOSS REHABIL RES INST, PHILADELPHIA, PA 19141 USA								ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BENTON AL, 1985, CLIN NEUROPSYCHOLOGY, V2, P151; BOLDRINI P, 1992, CORTEX, V28, P135, DOI 10.1016/S0010-9452(13)80172-4; De Renzi E., 1982, DISORDERS SPACE EXPL; DERENZI E, 1988, BRAIN, V111, P1173, DOI 10.1093/brain/111.5.1173; DERENZI E, 1982, BRAIN, V105, P301, DOI 10.1093/brain/105.2.301; DERENZI E, 1968, NEUROPSYCHOLOGIA, V6, P41, DOI 10.1016/0028-3932(68)90037-7; Foundas A L, 1995, J Int Neuropsychol Soc, V1, P62; GESCHWIN.N, 1965, BRAIN, V88, P237, DOI 10.1093/brain/88.2.237; GESCHWIND N, 1962, NEUROLOGY, V12, P675, DOI 10.1212/WNL.12.10.675; Goldstein K., 1948, LANGUAGE LANGUAGE DI; GRAFFRADFORD NR, 1987, NEUROLOGY, V37, P100, DOI 10.1212/WNL.37.1.100; Heilman K.M., 1993, CLIN NEUROPSYCHOLOGY, P141; HEILMAN KM, 1984, BRAIN, V107, P519, DOI 10.1093/brain/107.2.519; LEIGUARDA R, 1989, BRAIN, V112, P1019, DOI 10.1093/brain/112.4.1019; Liepmann H, 1900, MON PSYCHIATR NEUROL, V8, P15; Liepmann H, 1908, J PSYCHOL NEUROL, V10, P214; LORING DW, 1989, NEUROPSYCHOLOGIA, V27, P811, DOI 10.1016/0028-3932(89)90005-5; MAYER NH, 1990, NEUROPSYCHOLOGY EVER; Morlaas J., 1928, CONTRIBUTION ETUDE A; OCHIPA C, 1992, BRAIN, V115, P1061, DOI 10.1093/brain/115.4.1061; POECK K, 1980, CORTEX, V16, P273, DOI 10.1016/S0010-9452(80)80062-1; POECK K, 1983, J NEUROL, V230, P1, DOI 10.1007/BF00313591; RAPCSAK SZ, 1993, BRAIN COGNITION, V23, P181, DOI 10.1006/brcg.1993.1054; Reitan R.M., 1974, CLIN NEUROPSYCHOLOGY; ROTHI LJG, 1984, BRAIN COGNITION, V18, P35; SCHWARTZ MF, 1991, COGN NEUROPSYCHOL, V8, P381, DOI 10.1080/02643299108253379; VOLPE BT, 1982, NEUROLOGY, V32, P645, DOI 10.1212/WNL.32.6.645; WATSON RT, 1983, BRAIN, V106, P391, DOI 10.1093/brain/106.2.391; Wechsler, 1997, WECHSLER ADULT INTEL; ZAIDEL D, 1977, NEUROPSYCHOLOGIA, V15, P193, DOI 10.1016/0028-3932(77)90028-8	31	24	24	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase		1995	1	1					3	17		10.1093/neucas/1.1.3			15	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	TY680	WOS:A1995TY68000002					2022-02-06	
J	WINKLER, T; SHARMA, HS; STALBERG, E; OLSSON, Y; NYBERG, F				WINKLER, T; SHARMA, HS; STALBERG, E; OLSSON, Y; NYBERG, F			OPIOID RECEPTORS INFLUENCE SPINAL-CORD ELECTRICAL-ACTIVITY AND EDEMA FORMATION FOLLOWING SPINAL-CORD INJURY - EXPERIMENTAL-OBSERVATIONS USING NALOXONE IN THE RAT	NEUROSCIENCE RESEARCH			English	Article						NALOXONE; SPINAL CORD EVOKED POTENTIALS; EDEMA; SPINAL CORD TRAUMA; OPIOID PEPTIDES; EPIDURAL SPACE	DORSAL HORN NEURONS; IMPROVES NEUROLOGIC RECOVERY; RADIOIMMUNOASSAY TECHNIQUE; PARA-CHLOROPHENYLALANINE; EVOKED-POTENTIALS; TRAUMATIC INJURY; BRAIN INJURY; INHIBITION; MECHANISMS; DYNORPHIN	The possibility that opioid peptides participate in alteration of spinal cord conduction following trauma to the cord was investigated in a rat model using a pharmacological approach. Spinal cord injury was produced in urethane anesthetized animals by a longitudinal incision into the right dorsal horn of T10-11 segments (2 mm deep and 5 mm long). Spinal cord evoked potentials (SCEP) were recorded epidurally from the T9 (rostral) and T12 (caudal) segments after stimulation of the ipsilateral tibial and sural nerves at the ankle. SCEP from both rostral and caudal segments consisted of a small positive peak followed by a high negative peak. Infliction of trauma in untreated rats resulted in an immediate depression of the rostral maximal negative peak (MNP) amplitude. This depression was long-lasting. Later, a significant increase in the latency of the rostral MNP amplitude occurred. Naloxone was administered in a high dosage (10 mg/kg, i.p.) to block mu-, delta- and kappa-opioid receptors 30 min before injury. This drug treatment inhibited the immediate post-injury decrease of the rostral MNP amplitude without any significant effect on latency changes. Measurement of water content in the traumatized spinal cord segment showed a significant reduction in the drug treated animals 5 h after trauma (71.46 +/- 0.54) as compared with untreated controls (74.65 +/- 0.76). However, 1 mg or 5 mg/kg dosages of the drug were not effective in reducing the SCEP changes or edema after injury. These results strongly suggest that blockade of kappa-opioid receptors with high doses of naloxone is important in reduction of trauma induced alteration of SCEP and edema formation in spinal cord injury.	UNIV UPPSALA HOSP, NEUROPATHOL LAB, S-75185 UPPSALA, SWEDEN; UNIV UPPSALA HOSP, DEPT CLIN NEUROPHYSIOL, S-75185 UPPSALA, SWEDEN; BIOMED CTR, DEPT PHARMACEUT BIOSCI, S-75124 UPPSALA, SWEDEN								BAKSHI R, 1992, BRAIN RES, V580, P255, DOI 10.1016/0006-8993(92)90952-6; BALENTINE JD, 1988, J NEUROPATH EXP NEUR, V47, P77, DOI 10.1097/00005072-198803000-00001; BASKIN DS, 1993, J SPINAL DISORD, V6, P38; BENZEL EC, 1992, J SPINAL DISORD, V5, P75, DOI 10.1097/00002517-199203000-00009; BENZEL EC, 1990, NEUROSURGERY, V27, P597, DOI 10.1227/00006123-199010000-00016; BJORKLUND A, 1990, HDB CHEM NEUROANAT 2, V9; BJORKLUND A, 1990, HDB CHEM NEUROANAT 1, V9; Black P, 1991, J NEUROTRAUM, V8, P157, DOI 10.1089/neu.1991.8.157; BRACKEN MB, 1993, J NEUROSURG, V79, P500, DOI 10.3171/jns.1993.79.4.0500; DANGELO CM, 1973, J NEUROSURG, V38, P332, DOI 10.3171/jns.1973.38.3.0332; DELABAUME S, 1981, NEUROSCIENCE, V6, P315, DOI 10.1016/0306-4522(81)90125-1; DUGGAN AW, 1984, PHARMACOL REV, V35, P220; DUGGAN AW, 1993, HDB EXP PHARM, V104, P731; Faden A I, 1987, Cent Nerv Syst Trauma, V4, P227; FADEN AI, 1992, TRENDS PHARMACOL SCI, V13, P29, DOI 10.1016/0165-6147(92)90013-V; FADEN AI, 1984, EUR J PHARMACOL, V103, P115, DOI 10.1016/0014-2999(84)90196-1; FADEN AI, 1981, SCIENCE, V211, P493, DOI 10.1126/science.7455690; FADEN AI, 1981, ANN NEUROL, V10, P326, DOI 10.1002/ana.410100403; FADEN AI, 1982, NEUROLOGY, V32, P677, DOI 10.1212/WNL.32.6.677; FADEN AI, 1985, NEUROLOGY, V35, P1311, DOI 10.1212/WNL.35.9.1311; FADEN AI, 1993, HDB EXP PHARM, V104, P325; FEHLINGS MG, 1989, ELECTROEN CLIN NEURO, V74, P241, DOI 10.1016/0168-5597(89)90055-5; FITZGERALD M, 1980, PAIN, V9, P293, DOI 10.1016/0304-3959(80)90044-5; Gibson S. J., 1986, IMMUNOCYTOCHEMISTRY, P360; HERRERO JF, 1993, BRIT J PHARMACOL, V110, P303, DOI 10.1111/j.1476-5381.1993.tb13809.x; HOKFELT T, 1978, PSYCHOPHARMACOLOGY G, P39; HOMMA S, 1984, FUNDAMENTALS CLIN AP; HYLDEN JLK, 1991, PAIN, V44, P187, DOI 10.1016/0304-3959(91)90136-L; JONES SL, 1990, BRAIN RES, V532, P160, DOI 10.1016/0006-8993(90)91756-7; KIM JP, 1987, EUR J PHARMACOL, V138, P133, DOI 10.1016/0014-2999(87)90349-9; KRUMINS SA, 1986, ANN NEUROL, V19, P498, DOI 10.1002/ana.410190514; LIPTON SA, 1993, CURR OPIN NEUROL NEU, V6, P588; MACDONALD RL, 1978, SCIENCE, V199, P1449, DOI 10.1126/science.204015; MARTIN WR, 1983, PHARMACOL REV, V35, P283; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565, DOI 10.1152/ajpendo.1987.253.5.E565; MEANS ED, 1987, HDB SPINAL CORD, V5, P19; MISRA AL, 1978, FACTORS AFFECTING AC, P297; MOORE SD, 1994, J NEUROSCI, V14, P809; OLSSON Y, 1992, PROG BRAIN RES, V91, P197; OLSSON Y, 1994, IN PRESS PROGR BRAIN, V104; PARSONS CG, 1989, BRIT J PHARMACOL, V98, P533, DOI 10.1111/j.1476-5381.1989.tb12627.x; SALZMAN SK, 1990, NEURAL MONITORING PR; SHARMA HS, 1993, NEUROPHARMACOLOGY, V32, P711, DOI 10.1016/0028-3908(93)90085-H; SHARMA HS, 1991, J NEUROL SCI, V102, P150, DOI 10.1016/0022-510X(91)90063-D; SHARMA HS, 1992, NEUROSCI RES, V14, P195; SHARMA HS, 1990, ACTA NEUROPATHOL, V79, P604, DOI 10.1007/BF00294237; SHARMA HS, 1994, REG PEPT S, V1, pS91; SHARMA HS, 1995, IN PRESS PROG BRAIN, V104; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; VINK R, 1991, AM J PHYSIOL, V261, pR1527, DOI 10.1152/ajpregu.1991.261.6.R1527; WILLIS WD, 1984, FUNDAMENTALS CLIN AP, P3; Yaksh T L, 1993, HDB EXPT PHARM, V104, P53; Young Wise, 1993, Journal of Emergency Medicine, V11, P13	53	24	25	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	NOV	1994	21	1					91	101		10.1016/0168-0102(94)90072-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QB913	WOS:A1994QB91300010	7708296				2022-02-06	
J	KURTH, SM; BIGLER, ED; BLATTER, DD				KURTH, SM; BIGLER, ED; BLATTER, DD			NEUROPSYCHOLOGICAL OUTCOME AND QUANTITATIVE IMAGE-ANALYSIS OF ACUTE HEMORRHAGE IN TRAUMATIC BRAIN INJURY - PRELIMINARY FINDINGS	BRAIN INJURY			English	Article							SEVERE HEAD-INJURY; DEGENERATIVE CHANGES; COMPUTED-TOMOGRAPHY; INTELLIGENCE; LESIONS; SCAN	The effect on neuropsychological outcome of the number of acute haemorrhages, lesion volume, and lesion location in traumatic brain injury (TBI) was evaluated. Haemorrhagic lesion volume was associated with severity of injury. However, the number of petechial haemorrhages was not reliably associated with any of the clinical outcome measures. Likewise, despite the use of detailed morphometric methods to quantify volume, the acute lesion size did not significantly relate to neuropsychological sequelae. Furthermore, brain quadrant localization methods did not enhance outcome prediction. These results are discussed in the context of acute lesion analysis contrasted with chronic TBI-induced neuropathological changes associated with neuropsychological outcome.	LDS HOSP,SALT LAKE CITY,UT								ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BERROL S, 1986, J HEAD INJURY REHABI, V1; Bigler E, 1990, TRAUMATIC BRAIN INJU, P13; Bigler E D, 1991, Arch Clin Neuropsychol, V6, P113, DOI 10.1016/0887-6177(91)90028-8; BIGLER ED, 1992, BRAIN RES BULL, V28, P651, DOI 10.1016/0361-9230(92)90119-I; BIGLER ED, 1992, ARCH CLIN NEUROPSYCH, V7, P449, DOI 10.1016/0887-6177(92)90158-J; BIGLER ED, 1994, BRAIN INJURY, V8, P231, DOI 10.3109/02699059409150975; Bigler Erin D., 1993, Brain Injury, V7, P125, DOI 10.3109/02699059309008166; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; GUILBURD LL, 1990, NEUROSURGERY, V27, P428; Heaton RK, 1991, COMPREHENSIVE NORMS; HOLLIDAY PO, 1982, NEUROSURGERY, V10, P25, DOI 10.1227/00006123-198201000-00005; JERNIGAN TL, 1990, ARCH NEUROL-CHICAGO, V47, P27, DOI 10.1001/archneur.1990.00530010035015; KIMURA D, 1983, CAN J PSYCHOL, V37, P19, DOI 10.1037/h0080696; Kolb B., FUNDAMENTALS HUMAN N; KURTZKE JF, 1982, NEUROLOGY, V32, P1207, DOI 10.1212/WNL.32.11.1207; LEIFER D, 1990, NEUROLOGY, V40, P911, DOI 10.1212/WNL.40.6.911; Levin Harvey S, 1987, NEUROBEHAVIORAL RECO; LEZAK M, NEUROPSYCHOLOGICAL A; LIPPER MH, 1985, AM J ROENTGENOL, V144, P483, DOI 10.2214/ajr.144.3.483; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; MACNAMARA SE, 1992, ARCH CLIN NEUROPSYCH, V7, P275, DOI 10.1016/0887-6177(92)90169-N; MCGLONE J, 1980, BEHAV BRAIN SCI, V3, P215, DOI 10.1017/S0140525X00004398; OPPENHEIM JS, 1992, POSTGRAD MED, V91, P261; RAVEN RM, 1960, GUIDE PROGRESSIVE MA; Reitan R, 1985, HALSTEAD REITAN NEUR; Russell E. W., 1970, ASSESSMENT BRAIN DAM; SALAZAR AM, 1992, CHALLENGES NEUROLOGY, P55; SWEET RC, 1978, NEUROSURGERY, V3, P16, DOI 10.1227/00006123-197807000-00003; TURKHEIMER E, 1990, NEUROPSYCHOLOGIA, V28, P1011, DOI 10.1016/0028-3932(90)90136-C; TURKHEIMER E, 1990, J CLIN EXP NEUROPSYC, V12, P549, DOI 10.1080/01688639008401001; VILKKI J, 1992, J CLIN EXP NEUROPSYC, V14, P518, DOI 10.1080/01688639208402841; Wechsler, 1997, WECHSLER ADULT INTEL; WECHSLER D, 1975, AM PSYCHOL, V30, P135, DOI 10.1037/h0076868; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; WILBERGER JE, 1987, NEUROSURGERY, V20, P571, DOI 10.1227/00006123-198704000-00011; YEO R, 1983, CLIN NEUROPSYCHOL, V45, P1983; 1990, JAVA JANDEL VIDEO AN	41	24	24	0	0	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	AUG-SEP	1994	8	6					489	500		10.3109/02699059409151001			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	PE682	WOS:A1994PE68200001	7527266				2022-02-06	
J	LUZ, JGC; DIMASE, F				LUZ, JGC; DIMASE, F			INCIDENCE OF DENTOALVEOLAR INJURIES IN-HOSPITAL EMERGENCY ROOM PATIENTS	ENDODONTICS & DENTAL TRAUMATOLOGY			English	Article						DENTAL TRAUMA; EPIDEMIOLOGY, ORAL; TRAUMATIC INJURIES		A retrospective survey over one year of a hospital emergency room population, seen at an oral and maxillofacial surgery clinic, found 271 patients (4.6% of the total population) with dentoalveolar injuries. A very large number of injuries occurred to children between the ages of 0 and 5 years (42.1%), and there was a significant number of injured patients in the adult population (19.1%). The ratio of male to female was 1.9:1. The leading cause of injury was falls (59.8%). The largest number of injuries was seen during summer. The diagnoses were lateral luxation (27.3%), concussion (17.3%), exarticulation (14.3%), tooth fracture (12.5%), intrusive luxation (11.1%), fracture of alveolar process (7.4%), extrusive luxation (3.7%), and cases with more than one diagnosis (6.3%). Most of the involved teeth were maxillary central incisors, in both dentitions.			LUZ, JGC (corresponding author), UNIV SAO PAULO,DEPT ORAL & MAXILLOFACIAL SURG,R DUARTE DE AZEVEDO 284,S 22,BR-02036021 SAO PAULO,BRAZIL.		Luz, Joao/K-2265-2017					0	24	26	0	6	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0109-2502			ENDOD DENT TRAUMATOL	Endod. Dent. Traumatol.	AUG	1994	10	4					188	190					3	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	PE008	WOS:A1994PE00800006	7995251				2022-02-06	
J	YOUNG, WF; ROSENWASSER, RH; VASTHARE, US; TUMA, RF				YOUNG, WF; ROSENWASSER, RH; VASTHARE, US; TUMA, RF			PRESERVATION OF POSTCOMPRESSION SPINAL-CORD FUNCTION BY INFUSION OF HYPERTONIC SALINE	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						SPINAL CORD; TRAUMA; BLOOD FLOW; HYPERTONIC SALINE	HEMORRHAGIC-SHOCK; BLOOD-FLOW; INJURY; ISCHEMIA; TRAUMA; RAT; RESUSCITATION; NECROSIS; BRAIN	We tested the hypothesis that the administration of hypertonic saline, following traumatic injury to the spinal cord, could enhance blood flow to the cord and preserve function. Rats were used as the experimental model. Direct compression of the spinal cord for a period of 10 min was done to produce the injury. Somatosensory evoked potentials (SSEPs) and spinal cord blood flow were measured using a laser Doppler flow meter throughout the experiment. Comparisons of the blood flow values and SSEPs were made among four different groups of animals. The control group received no fluid resuscitation after injury. A second group received a bolus injection of isotonic saline (0.5 ml/100 g) as an i.v. infusion over a period of 1 min. A third group received a bolus infusion of 7.5% NaCl (0.5 ml/100 g) over a period of 1 min. The final group received 4 ml/100 g of 0.9% NaCl over a period of 10 min. The administration of hypertonic saline significantly reduced spinal cord vascular resistance during the first 10 min after infusion. During the first 30 min after the removal of compression, spinal cord blood flow was greater in the hypertonic saline group than in the other three groups. The hypertonic saline group had a reactive hyperemia whereas the flow in the other groups remained at or below control values. Beginning 10 min after injury and for the remainder of the 1-h observation period, the latency of the cortical peak of the SSEP in the group receiving hypertonic saline was significantly shorter than in any of the other three groups. These results indicate that the administration of hypertonic saline enhances blood flow and preserves spinal cord conduction following traumatic injury to the spinal cord.	TEMPLE UNIV, HLTH SCI CTR, SCH MED, DEPT PHYSIOL, PHILADELPHIA, PA 19140 USA; TEMPLE UNIV, HLTH SCI CTR,SCH MED,DEPT NEUROSURG, CEREBROVASC LAB, PHILADELPHIA, PA 19140 USA				ROSENWASSER, ROBERT H/L-2482-2014				Allen AR, 1914, J NERV MENT DIS, V41, P141, DOI 10.1097/00005053-191403000-00002; Allen AR., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; AMES A, 1968, AM J PATHOL, V52, P437; BAUE AE, 1967, J TRAUM, V7, P743, DOI 10.1097/00005373-196709000-00012; COLLINS WF, 1983, PARAPLEGIA, V21, P204, DOI 10.1038/sc.1983.34; DELABAUME S, 1981, NEUROSCIENCE, V6, P315, DOI 10.1016/0306-4522(81)90125-1; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; DOHRMANN GJ, 1971, J NEUROSURG, V35, P263, DOI 10.3171/jns.1971.35.3.0263; DOPPMAN JL, 1979, J NEUROSURG, V51, P201, DOI 10.3171/jns.1979.51.2.0201; FISCHER EG, 1977, STROKE, V8, P36, DOI 10.1161/01.STR.8.1.36; HALL E D, 1989, Journal of Neurotrauma, V6, P169, DOI 10.1089/neu.1989.6.169; KRAMER GC, 1989, ROLE HEMODILUTION OP, P89; MAZZONI MC, 1990, CIRC SHOCK, V31, P407; MAZZONI MC, 1988, AM J PHYSIOL, V255, pH629, DOI 10.1152/ajpheart.1988.255.3.H629; NAKAYAMA S, 1984, CIRC SHOCK, V13, P149; Nemecek S, 1978, Adv Neurol, V20, P395; NERLICH M, 1983, CIRC SHOCK, V10, P179; NYSTROM B, 1988, ACTA NEUROL SCAND, V78, P460, DOI 10.1111/j.1600-0404.1988.tb03688.x; OSTERHOLM JL, 1972, J NEUROSURG, V36, P386, DOI 10.3171/jns.1972.36.4.0386; OSTERHOLM JL, 1972, J NEUROSURG, V36, P395, DOI 10.3171/jns.1972.36.4.0395; PROUGH DS, 1991, ANESTH ANALG, V73, P736; SANDLER AN, 1976, J NEUROSURG, V45, P638, DOI 10.3171/jns.1976.45.6.0638; SANDLER AN, 1976, J NEUROSURG, V45, P660, DOI 10.3171/jns.1976.45.6.0660; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; TOCHAESILVA M, 1986, CIRC SHOCK, V19, P165; TUMA RF, 1989, ROLE HEMODILUTION OP; VASTHARE US, 1990, SURG NEUROL, V33, P261, DOI 10.1016/0090-3019(90)90046-R; VELASCO IT, 1980, AM J PHYSIOL, V239, pH664, DOI 10.1152/ajpheart.1980.239.5.H664; WALLACE MC, 1986, NEUROSURGERY, V18, P433	29	24	24	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	APR	1994	6	2					122	127					6	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	NC363	WOS:A1994NC36300008	8012171				2022-02-06	
J	LIU, SL; LYETH, BG; HAMM, RJ				LIU, SL; LYETH, BG; HAMM, RJ			PROTECTIVE EFFECT OF GALANIN ON BEHAVIORAL DEFICITS IN EXPERIMENTAL TRAUMATIC BRAIN INJURY	JOURNAL OF NEUROTRAUMA			English	Article							RAT VENTRAL HIPPOCAMPUS; CENTRAL NERVOUS-SYSTEM; PHOSPHOINOSITIDE TURNOVER; ACETYLCHOLINE-RELEASE; NEURONS; STIMULATION	The magnitude of behavioral deficits in traumatic brain injury (TBI) has been shown to be partly related to alterations in the balance between excitatory and inhibitory neurotransmitter release. Previous studies have demonstrated that extracellular excitatory neurotransmitter concentrations dramatically increase following experimental TBI. We examined the effects of a neuromodulatory peptide, galanin (GAL), on behavioral morbidity, as measured by sensory motor and memory performance tasks, associated with experimental TBI in the rat. A single intraventricular injection of GAL (1.0 mug, n = 8 or 10.0 mug, n = 10) or cerebrospinal fluid (CSF) vehicle (n = 10) was administered 5 minutes prior to central fluid percussion TBI in rats. Performance on sensory motor tasks was assessed prior to injury and for 5 days after TBI with beam-balance, beam-walking, and rotarod tasks. Memory performance was assessed on days 11-15 after TBI with the Morris water maze. TBI produced significant motor and memory deficits in the CSF-treated group. GAL-treated rats had significantly less magnitude of deficits compared to CSF-treated rats on beam-balance, beam-walking, and rotarod performance. The 1.0 mug GAL dose produced slightly greater protection than the 10.0 mug GAL dose. Neither GAL dose affected body weight loss or Morris water maze performance. These results suggest that the physiologic effects of GAL may reduce certain components of TBI morbidity, possibly by modulating neuronal excitability.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PSYCHOL,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT SURG,DIV NEUROSURG,BOX 693 MCV STN,RICHMOND,VA 23298					Lyeth, Bruce/0000-0003-4811-1474	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 29995, NS 12587] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS029995, P50NS012587, P01NS012587] Funding Source: NIH RePORTER		BENARI Y, 1989, EUR J PHARMACOL, V165, P331, DOI 10.1016/0014-2999(89)90732-2; DELAHUNTY TM, 1992, BRAIN RES, V594, P307, DOI 10.1016/0006-8993(92)91140-A; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DUTAR P, 1989, EUR J PHARMACOL, V164, P355, DOI 10.1016/0014-2999(89)90477-9; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FISONE G, 1987, P NATL ACAD SCI USA, V84, P7339, DOI 10.1073/pnas.84.20.7339; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; Jenkins LW, 1988, J NEUROTRAUM, V5, P275, DOI 10.1089/neu.1988.5.275; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; LYETH BG, 1992, J NEUROTRAUM, V9, pS463; LYETH BG, 1992, BRAIN RES, V569, P281, DOI 10.1016/0006-8993(92)90640-U; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYETH BG, 1993, MOL CHEM NEUROPATHOL, V18, P247, DOI 10.1007/BF03160117; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MELANDER T, 1986, J COMP NEUROL, V248, P475, DOI 10.1002/cne.902480404; MERCHENTHALER I, 1993, PROG NEUROBIOL, V40, P711, DOI 10.1016/0301-0082(93)90012-H; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Morris RGM., 1983, NEUROBIOLOGY HIPPOCA, P405; NORDSTROM O, 1987, NEUROSCI LETT, V73, P21, DOI 10.1016/0304-3940(87)90024-3; PALAZZI E, 1991, J NEUROCHEM, V56, P739, DOI 10.1111/j.1471-4159.1991.tb01986.x; PALAZZI E, 1988, EUR J PHARMACOL, V148, P479, DOI 10.1016/0014-2999(88)90133-1; PANTER SS, 1992, NEUROSCI LETT, V136, P165, DOI 10.1016/0304-3940(92)90040-E; PARSONS RL, 1991, NEUROSCIENCE, V43, P647, DOI 10.1016/0306-4522(91)90323-G; PRAMANIK A, 1992, BRAIN RES, V574, P317, DOI 10.1016/0006-8993(92)90832-T; ROBINSON SE, 1990, BRAIN RES, V511, P141, DOI 10.1016/0006-8993(90)90233-2; ROBINSON SE, 1990, BRAIN RES, V509, P41, DOI 10.1016/0006-8993(90)90306-V; SKOFITSCH G, 1985, PEPTIDES, V6, P509, DOI 10.1016/0196-9781(85)90118-4; SUNDSTROM E, 1988, NEUROSCI LETT, V88, P331, DOI 10.1016/0304-3940(88)90233-9; TSUDA K, 1989, HYPERTENSION, V14, P81, DOI 10.1161/01.HYP.14.1.81	31	24	24	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	FEB	1994	11	1					73	82		10.1089/neu.1994.11.73			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	NC365	WOS:A1994NC36500004	7515444				2022-02-06	
J	RIVARA, FP				RIVARA, FP			EPIDEMIOLOGY AND PREVENTION OF PEDIATRIC TRAUMATIC BRAIN INJURY	PEDIATRIC ANNALS			English	Article											RIVARA, FP (corresponding author), HARBORVIEW INJURY PREVENT & RES CTR,MAILSTOP ZX-10,325 9TH AVE,SEATTLE,WA 98104, USA.							0	24	24	0	0	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086	0090-4481			PEDIATR ANN	Pediatr. Annu.	JAN	1994	23	1					12	17		10.3928/0090-4481-19940101-06			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	MU563	WOS:A1994MU56300003	8152860				2022-02-06	
J	LEEDHAM, CS; BLOOD, CG; NEWLAND, C				LEEDHAM, CS; BLOOD, CG; NEWLAND, C			A DESCRIPTIVE ANALYSIS OF WOUNDS AMONG UNITED-STATES MARINES TREATED AT 2ND-ECHELON FACILITIES IN THE KUWAITI THEATER OF OPERATIONS	MILITARY MEDICINE			English	Article								Medical data from 120 U.S. Marine Corps trauma admissions to second-echelon facilities during Operation Desert Shield/Storm were examined. Sixty-five percent of the admissions occurred between February 22 and February 28, the time frame corresponding to the ground war and the preliminary mobilization period. Penetrating wounds were the most prevalent types of injury, followed by lacerations, open fractures, and closed fractures. The most frequent anatomical regions sustaining injuries were the leg, head, hand, and arm. Fragments were the causative agent of 63% of the admissions that had this variable recorded, while gunfire was the cause in 20% of the cases. The median injury-to-admission interval increased from 0.67 hours in the non-ground war period to 4.41 during the ground war.	USN,HLTH RES CTR,MED INFORMAT SYST & OPERAT RES DEPT,POB 85122,SAN DIEGO,CA 92186									0	24	25	0	0	ASSN MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814	0026-4075			MIL MED	Milit. Med.	AUG	1993	158	8					508	512		10.1093/milmed/158.8.508			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LT492	WOS:A1993LT49200012	8414070				2022-02-06	
J	FADEN, AI; LABROO, VM; COHEN, LA				FADEN, AI; LABROO, VM; COHEN, LA			IMIDAZOLE-SUBSTITUTED ANALOGS OF TRH LIMIT BEHAVIORAL DEFICITS AFTER EXPERIMENTAL BRAIN TRAUMA	JOURNAL OF NEUROTRAUMA			English	Article							THYROTROPIN-RELEASING-HORMONE; SPINAL-CORD INJURY; INTRACELLULAR FREE MG-2+; CARDIOVASCULAR-SYSTEM; NEUROLOGIC RECOVERY; PROLACTIN-RELEASE; DOSE-RESPONSE; RATS; HYPOTENSION; PEPTIDES	Treatment with thyrotropin releasing hormone (TRH) or TRH analogues improves outcome after experimental brain or spinal cord trauma. TRH analogues with modifications at the N-terminal position of the tripeptide are effective, whereas analogues with modifications of the C-terminal residue are not. Imidazole-substituted TRH analogues, which modify the middle amino acid (histidine) of the tripeptide, have more recently been developed but have not been evaluated in models of central nervous system (CNS) trauma. In the present studies two imidazole-substituted analogues-4(5)-NO2(Im)TRH and 2,4 diiodo(Im)TRH-are shown to improve behavioral recovery following fluid percussion-induced traumatic brain injury (TBI) in rats. Because 4(5)-NO2(Im)TRH has little endocrine activity and 2,4 diiodo(Im)TRH has minimal cardiovascular effects, these experiments support the hypothesis that the neuroprotective actions of TRH analogues are independent of their endocrine or autonomic actions.	NIDDK,BIOORGAN CHEM LAB,BETHESDA,MD; ZYMOGENET INC,SEATTLE,WA		FADEN, AI (corresponding author), GEORGETOWN UNIV,MED CTR,MED DENT BLDG,NW 101,3900 RESERVOIR RD NW,WASHINGTON,DC 20007, USA.				PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR306634-02] Funding Source: Medline		ARIAS MJ, 1987, SURG NEUROL, V28, P335, DOI 10.1016/0090-3019(87)90054-1; BASSIRI RM, 1973, J CLIN INVEST, V52, P1616, DOI 10.1172/JCI107339; FADEN AI, 1985, NEUROLOGY, V35, P1331, DOI 10.1212/WNL.35.9.1331; FADEN AI, 1981, NEW ENGL J MED, V305, P1063, DOI 10.1056/NEJM198110293051806; FADEN AI, 1992, TRENDS PHARMACOL SCI, V13, P29, DOI 10.1016/0165-6147(92)90013-V; FADEN AI, 1988, BRAIN RES, V448, P287, DOI 10.1016/0006-8993(88)91265-6; FADEN AI, 1984, NEUROLOGY, V34, P1280, DOI 10.1212/WNL.34.10.1280; FADEN AI, 1989, BRAIN RES, V486, P228, DOI 10.1016/0006-8993(89)90509-X; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FADEN AI, 1988, PHYSL BASIS FUNCTION, P531; FEUERSTEIN G, 1984, NEUROPEPTIDES, V4, P303, DOI 10.1016/0143-4179(84)90004-0; FEUERSTEIN G, 1984, CIRC SHOCK, V13, P255; FUKUDA N, 1979, FOLIA PHARM JAPAN, V75, P3221; HASHIMOTO T, 1989, Japanese Journal of Pharmacology, V49, p312P; HOLADAY JW, 1978, LIFE SCI, V22, P1537, DOI 10.1016/0024-3205(78)90009-7; KOSKINEN LOD, 1989, ANN NY ACAD SCI, P353; LABROO VM, 1987, NEUROPEPTIDES, V10, P29, DOI 10.1016/0143-4179(87)90086-2; LABROO VM, 1983, BIOCHEM BIOPH RES CO, V113, P581, DOI 10.1016/0006-291X(83)91765-5; LABROO VM, 1990, TETRAHEDRON LETT, V31, P5705, DOI 10.1016/S0040-4039(00)97937-1; LABROO VM, 1989, PEPTIDES CHEM STRUCT, P127; LABROO VM, 1985, PEPTIDES STRUCTURE F, P703; LUX WE, 1983, NATURE, V302, P822, DOI 10.1038/302822a0; MANAKA S, 1978, NEUROSCI LETT, V8, P255, DOI 10.1016/0304-3940(78)90131-3; MCINTOSH TK, 1988, AM J PHYSIOL, V254, pR785, DOI 10.1152/ajpregu.1988.254.5.R785; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; METCALF G, 1982, BRAIN RES REV, V4, P389, DOI 10.1016/0165-0173(82)90012-1; PAAKKARI I, 1990, PEPTIDES, V11, P939, DOI 10.1016/0196-9781(90)90013-U; Salzman S K, 1987, Cent Nerv Syst Trauma, V4, P181; SIREN AL, 1986, NEUROPEPTIDES, V8, P63, DOI 10.1016/0143-4179(86)90066-1; VINK R, 1987, J CEREBR BLOOD F MET, V7, P563, DOI 10.1038/jcbfm.1987.106; VINK R, 1989, BIOCHEM BIOPH RES CO, V165, P913, DOI 10.1016/S0006-291X(89)80053-1; VINK R, 1988, BRAIN RES, V460, P184, DOI 10.1016/0006-8993(88)91221-8; VINK R, 1990, J NEUROSCI, V10, P3524; VINK R, 1988, J BIOL CHEM, V263, P757; VINK R, 1988, MAGNET RESON MED, V6, P37, DOI 10.1002/mrm.1910060105; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16	36	24	24	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	SUM	1993	10	2					101	108		10.1089/neu.1993.10.101			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LM056	WOS:A1993LM05600002	8411214				2022-02-06	
J	XU, BN; YABUKI, A; MISHINA, H; MIYAZAKI, M; MAEDA, M; ISHII, S				XU, BN; YABUKI, A; MISHINA, H; MIYAZAKI, M; MAEDA, M; ISHII, S			PATHOPHYSIOLOGY OF BRAIN-SWELLING AFTER ACUTE EXPERIMENTAL BRAIN COMPRESSION AND DECOMPRESSION	NEUROSURGERY			English	Article						BRAIN EDEMA; BRAIN SWELLING; CEREBRAL ISCHEMIA; DECOMPRESSION; TRAUMA	CEREBRAL BLOOD-FLOW; SEVERE HEAD-INJURY; ACUTE SUBDURAL-HEMATOMA; COMATOSE PATIENTS; COMPUTERIZED-TOMOGRAPHY; EDEMA; METABOLISM; BIOMECHANICS; CHILDREN; MANAGEMENT	GLOBAL ISCHEMIA WAS created by controlled expansion of an epidural balloon for 25 minutes in Group A (six cats) and for minutes in Group B (six cats). The alterations of intracranial pressure, arteriovenous oxygen content difference, cerebral metabolic rate of oxygen, cerebral blood flow, and electroencephalogram were observed until brain death or 24 hours' survival with normal intracranial pressure. The animals were then killed for brain histological examination. In four other cats, a 2% solution of Evans blue dye (4 mg/kg) was injected intravenously-immediately after deflation-resulting in 25 minutes of global ischemia. Two other cats received 5 minutes of global ischemia. The cats were killed 1 hour later. Abrupt swelling occurred in Group A, and no swelling was found in Group B. A transient absolute hyperemia was found immediately after deflation in both groups. The cerebral blood flow and cerebral metabolic rate of oxygen decreased markedly with low arteriovenous oxygen content difference and flat electroencephalogram in Group A, compared with gradual recovery of cerebral blood flow and cerebral metabolic rate of oxygen with high arteriovenous oxygen content difference and reappearance of electroencephalogram activity in Group B. The extravasation of Evans blue was observed on the compressed cerebral hemisphere, thalamus, hypothalamus, and brain stem in swelling animals and only on the compressed hemisphere in nonswelling animals. Histologically, the damage and congestive dilation of capillary, degeneration, and necrosis of neuronal and glial cell were found prominently on the hypothalamus and brain stem in the swelling group. There was no obvious alteration observed in the nonswelling group. This study showed that there was a close relationship between duration of compressive global ischemia and occurrence of brain swelling. it was postulated that damage of the hypothalamus and brain stem, probably caused by distortion and ischemia during brain compression, might be responsible for the vasomotor paralysis to increase cerebral blood volume. Our study suggests that, in postdecompressive acute swelling, severe cerebral ischemia is the basic feature, and damage of the control center for the vasomotor area, such as the hypothalamus and brain stem, is pathophysiological.	CHINESE PEOPLES LIBERAT ARMY GEN HOSP, DEPT NEUROSURG, 28 FU XING RD, BEIJING 100853, PEOPLES R CHINA; JUNTENDO UNIV, DEPT NEUROSURG, TOKYO 113, JAPAN; JUNTENDO UNIV, CTR CASUALTY, TOKYO 113, JAPAN								BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; BRUCE DA, 1973, J NEUROSURG, V38, P131, DOI 10.3171/jns.1973.38.2.0131; BULLOCK R, 1985, J NEUROSURG, V63, P64, DOI 10.3171/jns.1985.63.1.0064; CHIANG J, 1968, AM J PATHOL, V52, P455; FISHMAN RA, 1975, NEW ENGL J MED, V293, P706, DOI 10.1056/NEJM197510022931407; FUJIMOTO T, 1976, DYNAMICS BRAIN EDEMA, P171; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; HATASHITA S, 1988, STROKE, V19, P91, DOI 10.1161/01.STR.19.1.91; Hossman K, 1976, DYNAMICS BRAIN EDEMA, P219; ISHII S, 1965, HEAD INJURY, P276; JENNETT B, 1981, BRAIN EDEMA, P61; JENNETT B, 1981, MANAGEMENT HEAD INJU, P153; KLATZO I, 1976, BRAIN EDEMA, P554; KOBRINE AI, 1977, J NEUROSURG, V46, P256, DOI 10.3171/jns.1977.46.2.0256; KUROIWA T, 1989, J NEUROSURG, V70, P73, DOI 10.3171/jns.1989.70.1.0073; LANGFITT TW, 1966, J NEUROSURG, V24, P47, DOI 10.3171/jns.1966.24.1.0047; LANGFITT TW, 1982, CLIN NEUR, V29, P353; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; LONG DM, 1982, CLIN NEUR, V29, P174; MAEDA M, 1986, INTRACRANIAL PRESSUR, V6, P151; Marmarou A, 1980, Adv Neurol, V28, P345; MARSHALL WJ, 1969, ARCH NEUROL-CHICAGO, V21, P545, DOI 10.1001/archneur.1969.00480170117012; MILLER JD, 1973, J NEUROSURG, V39, P186, DOI 10.3171/jns.1973.39.2.0186; MILLER JD, 1982, CLIN NEUR, V29, P162; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; NUMOTO M, 1970, J NEUROSURG, V33, P381, DOI 10.3171/jns.1970.33.4.0381; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Pasztor E, 1973, STROKE, V4, P556, DOI 10.1161/01.STR.4.4.556; PLUM F, 1963, ARCH NEUROL-CHICAGO, V9, P563, DOI 10.1001/archneur.1963.00460120013001; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; SCHETTINI A, 1989, J NEUROSURG, V71, P578, DOI 10.3171/jns.1989.71.4.0578; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; TORNHEIM PA, 1981, J NEUROSURG, V55, P407, DOI 10.3171/jns.1981.55.3.0407; WAGA S, 1979, SURG NEUROL, V11, P191; YOSHINO E, 1985, J NEUROSURG, V63, P830, DOI 10.3171/jns.1985.63.6.0830; [No title captured]	43	24	29	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	FEB	1993	32	2					289	296		10.1227/00006123-199302000-00019			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KL520	WOS:A1993KL52000019	8437667				2022-02-06	
J	CUCCINIELLO, B; MARTELLOTTA, N; NIGRO, D; CITRO, E				CUCCINIELLO, B; MARTELLOTTA, N; NIGRO, D; CITRO, E			CONSERVATIVE MANAGEMENT OF EXTRADURAL HEMATOMAS	ACTA NEUROCHIRURGICA			English	Article						HEAD INJURY; EXTRADURAL HEMATOMA; COMPUTERIZED TOMOGRAPHY; SPONTANEOUS RESOLUTION	EPIDURAL HEMATOMAS; SPONTANEOUS RESOLUTION; HEAD-INJURY; TOMOGRAPHY	The personal experiences with a series of 57 conservatively treated extradural haematomas (EDH) are presented and the criteria for conservative management outlined. Main preconditions are absence of neurological deficit, close clinical supervision and repeated CT check-ups.			CUCCINIELLO, B (corresponding author), SAN CARLO BASILICATA GEN HOSP,DEPT NEUROSURG,I-85100 POTENZA,ITALY.						AOKI N, 1988, J NEUROSURG, V68, P149, DOI 10.3171/jns.1988.68.1.0149; BENMOUSSA H, 1992, NEUROCHIRURGIE, V38, P42; BRICOLO AP, 1984, NEUROSURGERY, V14, P8, DOI 10.1227/00006123-198401000-00003; BULLOCK R, 1985, NEUROSURGERY, V16, P602, DOI 10.1227/00006123-198505000-00003; CORDOBES F, 1980, ACTA NEUROCHIR, V53, P275, DOI 10.1007/BF02074800; CORDOBES F, 1981, J NEUROSURG, V54, P179, DOI 10.3171/jns.1981.54.2.0179; DEVRIES J, 1981, NEURORADIOLOGY, V22, P167, DOI 10.1007/BF00346762; ERICSON K, 1981, ACTA RADIOL DIAGN, V22, P513, DOI 10.1177/028418518102200501; ILLINGWORTH R, 1983, J NEUROL NEUROSUR PS, V46, P558, DOI 10.1136/jnnp.46.6.558; JACKSON JJ, 1950, J NEUROSURG, V7, P444; JENNETT B, 1981, MANAGEMENT HEAD INJU, P153; KNUCKEY NW, 1989, J NEUROSURG, V70, P392, DOI 10.3171/jns.1989.70.3.0392; LECLERCQ TA, 1979, R I MED J, V62, P97; Lindenberg R., 1977, RADIOLOGY SKULL BRAI, V3, P3049; MCLAURIN RL, 1964, J NEUROSURG, V21, P364, DOI 10.3171/jns.1964.21.5.0364; MENDELOW AD, 1983, BRIT MED J, V287, P1173, DOI 10.1136/bmj.287.6400.1173; MENDELOW AD, 1979, BRIT MED J, V1, P1240, DOI 10.1136/bmj.1.6173.1240; MILLER JD, 1986, NEUROSURG REV, V9, P135, DOI 10.1007/BF01743065; MORLEY JB, 1970, J NEUROL NEUROSUR PS, V33, P679, DOI 10.1136/jnnp.33.5.679; PAGNI CA, 1968, EMATOMA EXTRADURALE, P1; PANG D, 1983, J NEUROSURG, V59, P958, DOI 10.3171/jns.1983.59.6.0958; POZZATI E, 1986, NEUROSURGERY, V18, P696, DOI 10.1227/00006123-198606000-00003; POZZATI E, 1984, NEUROSURGERY, V14, P724, DOI 10.1227/00006123-198406000-00012; SERVADEI F, 1988, J NEUROL NEUROSUR PS, V51, P526, DOI 10.1136/jnnp.51.4.526; SERVADEI F, 1989, ACTA NEUROCHIR, V96, P39, DOI 10.1007/BF01403493; TAPIERO B, 1984, HEMATOMES EXTRA DURA, P213; TEASDALE G, 1982, BRIT MED J, V285, P1695, DOI 10.1136/bmj.285.6356.1695; TEASDALE G, 1979, BRIT MED J, V1, P1793, DOI 10.1136/bmj.1.6180.1793-a; TOCHIO H, 1984, NEUROSURGERY, V15, P96, DOI 10.1227/00006123-198407000-00018; TROWBRIDGE WV, 1954, AMA ARCH SURG, V69, P824, DOI 10.1001/archsurg.1954.01270060066009; WEAVER D, 1981, J NEUROSURG, V54, P248, DOI 10.3171/jns.1981.54.2.0248; ZANDER E, 1974, ADV TECHNICAL STANDA, V1, P121; ZIMMERMAN RA, 1982, RADIOLOGY, V144, P809, DOI 10.1148/radiology.144.4.7111729; [No title captured]	34	24	25	0	0	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1993	120	1-2					47	52		10.1007/BF02001469			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KJ107	WOS:A1993KJ10700009	8434517				2022-02-06	
J	DOUCET, JP; BAZAN, NG				DOUCET, JP; BAZAN, NG			EXCITABLE-MEMBRANES, LIPID MESSENGERS, AND IMMEDIATE-EARLY GENES - ALTERATION OF SIGNAL TRANSDUCTION IN NEUROMODULATION AND NEUROTRAUMA	MOLECULAR NEUROBIOLOGY			English	Article; Proceedings Paper	SATELLITE SYMP ON MOLECULAR EVENTS IN NEUROTRANSMISSION, AT THE 13TH BIENNIAL MEETING OF THE INTERNATIONAL SOC FOR NEUROCHEMISTRY	JUL 20-22, 1991	SYDNEY, AUSTRALIA	INT SOC NEUROCHEM			PLATELET-ACTIVATING-FACTOR; LONG-TERM POTENTIATION; FREE FATTY-ACIDS; RAT CEREBRAL-CORTEX; ARACHIDONIC-ACID; C-FOS; FACTOR PAF; ELECTROCONVULSIVE SHOCK; SUBCELLULAR-LOCALIZATION; ENDOTHELIAL-CELLS		LOUISIANA STATE UNIV,MED CTR,SCH MED,LSU EYE CTR,2020 GRAVIER ST,SUITE B,NEW ORLEANS,LA 70112; LOUISIANA STATE UNIV,MED CTR,SCH MED,LSU NEUROSCI CTR,NEW ORLEANS,LA 70112				Bazan, Nicolas/AAN-4121-2020	Bazan, Nicolas/0000-0002-9243-5444			ABATE C, 1991, ONCOGENE, V6, P2179; ABRAHAM W, 1992, MOL NEUROBIOL, V5, P1; ARAI A, 1992, EUR J NEUROSCI, V4, P411, DOI 10.1111/j.1460-9568.1992.tb00890.x; AVELDANO MI, 1975, J NEUROCHEM, V25, P919, DOI 10.1111/j.1471-4159.1975.tb04432.x; AVELDANO MI, 1974, FEBS LETT, V40, P53, DOI 10.1016/0014-5793(74)80892-6; AVELDANO MI, 1975, BRAIN RES, V100, P99, DOI 10.1016/0006-8993(75)90244-9; BARBOUR B, 1989, NATURE, V342, P918, DOI 10.1038/342918a0; BARTEL DP, 1989, GENE DEV, V3, P304, DOI 10.1101/gad.3.3.304; BAUDRY M, 1991, DEV BRAIN RES, V61, P265, DOI 10.1016/0165-3806(91)90140-E; Bazan N G, 1980, Adv Neurol, V28, P197; Bazan N G, 1976, Adv Exp Med Biol, V72, P317; BAZAN NG, 1991, LIPIDS, V26, P1236, DOI 10.1007/BF02536539; BAZAN NG, 1970, BIOCHIM BIOPHYS ACTA, V218, P1, DOI 10.1016/0005-2760(70)90086-X; BAZAN NG, 1970, LIFE SCI, V9, P501, DOI 10.1016/0024-3205(70)90205-5; BAZAN NG, 1971, ACTA PHYSIOL LAT AM, V21, P101; BAZAN NG, 1984, BIOCHEM BIOPH RES CO, V125, P741, DOI 10.1016/0006-291X(84)90601-6; BAZAN NG, 1971, LIPIDS, V6, P211, DOI 10.1007/BF02533041; BAZAN NG, 1987, MOL MECHANISMS NEURO, P45; BAZAN NG, 1971, LIPIDS, V6, P212; BAZAN NG, 1986, BASIC MECH EPILEPSIE, V47, P209; BIRKLE DL, 1984, BIOCHIM BIOPHYS ACTA, V795, P564, DOI 10.1016/0005-2760(84)90187-5; BIRKLE DL, 1988, J NEUROCHEM, V51, P1900, DOI 10.1111/j.1471-4159.1988.tb01175.x; BIRKLE DL, 1987, J NEUROCHEM, V48, P1768, DOI 10.1111/j.1471-4159.1987.tb05735.x; BLANK ML, 1981, J BIOL CHEM, V256, P175; BLASQUEZ C, 1990, EUR J PHARMACOL, V177, P145, DOI 10.1016/0014-2999(90)90264-7; BOSISIO E, 1976, PROSTAGLANDINS, V11, P773, DOI 10.1016/0090-6980(76)90186-6; BRAQUET P, 1989, J LIPID MEDIATOR, V1, P75; BRAQUET P, 1987, PHARMACOL REV, V39, P97; BRAQUET P, 1990, ADV PROSTAGLANDIN TH, V21, P929; BRATTON DL, 1991, BIOCHIM BIOPHYS ACTA, V1062, P24, DOI 10.1016/0005-2736(91)90330-B; BRAUGHLER JM, 1992, J NEUROTRAUM, V9, pS1; BRAUGHLER JM, 1985, J NEUROCHEM, V45, P1288, DOI 10.1111/j.1471-4159.1985.tb05555.x; BUSSOLINO F, 1986, J BIOL CHEM, V261, P6502; BUSSOLINO F, 1989, J LIPID MEDIATOR, V1, P283; BUSSOLINO F, 1988, J NEUROCHEM, V51, P1755, DOI 10.1111/j.1471-4159.1988.tb01155.x; CENEDELLA RJ, 1975, LIPIDS, V10, P290, DOI 10.1007/BF02532702; CHILTON FH, 1984, J BIOL CHEM, V259, P2014; CHRISTY B, 1989, P NATL ACAD SCI USA, V86, P8737, DOI 10.1073/pnas.86.22.8737; CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; CLARK G, 1992, IN PRESS NEURON; CLEMENTS MP, 1991, NEUROSCIENCE, V45, P379, DOI 10.1016/0306-4522(91)90235-G; COLE AJ, 1990, J NEUROCHEM, V55, P1920, DOI 10.1111/j.1471-4159.1990.tb05777.x; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; DAVIS H, 1984, PSYCHOL BULL, V95, P518; DECALDIRONI MIA, 1979, NEUROCHEM RES, V4, P213; DELCERRO S, 1990, BEHAV NEURAL BIOL, V54, P213, DOI 10.1016/0163-1047(90)90595-W; DIENEL GA, 1984, J NEUROCHEM, V43, P913, DOI 10.1111/j.1471-4159.1984.tb12825.x; DOEBBER TW, 1987, P NATL ACAD SCI USA, V84, P7557, DOI 10.1073/pnas.84.21.7557; DOMINGO MT, 1988, BIOCHEM BIOPH RES CO, V151, P730, DOI 10.1016/S0006-291X(88)80341-3; DOUCET JP, 1990, MOL NEUROBIOL, V4, P27, DOI 10.1007/BF02935584; DUMUIS A, 1988, NATURE, V336, P68, DOI 10.1038/336068a0; EDGAR AD, 1982, J NEUROCHEM, V39, P1111, DOI 10.1111/j.1471-4159.1982.tb11503.x; FRANCEL PC, 1992, J NEUROTRAUM, V9, pS27; FRANCESCANGELI E, 1989, BIOCHEM BIOPH RES CO, V161, P107, DOI 10.1016/0006-291X(89)91567-2; FRERICHS KU, 1990, J NEUROSURG, V73, P223, DOI 10.3171/jns.1990.73.2.0223; GILBOE DD, 1991, J NEUROCHEM, V56, P311, DOI 10.1111/j.1471-4159.1991.tb02597.x; GIUSTO NM, 1983, NEUROCHEM PATHOL, V1, P17; GLASER KB, 1990, J BIOL CHEM, V265, P8658; HARRIS RA, 1985, FED PROC, V44, P858; HENSON PM, 1987, PLATELET ACTIVATING, P255; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; HERSCHMAN HR, 1989, TRENDS BIOCHEM SCI, V14, P455, DOI 10.1016/0968-0004(89)90105-9; HILLERRED L, 1990, NEW TRENDS LIPID MED, V4, P190; HO YS, 1987, J EXP MED, V165, P1524, DOI 10.1084/jem.165.6.1524; HYMAN BT, 1982, J NEUROCHEM, V38, P650, DOI 10.1111/j.1471-4159.1982.tb08680.x; IKEDA M, 1986, J NEUROCHEM, V47, P123; JORGENSEN MB, 1989, BRAIN RES, V484, P393, DOI 10.1016/0006-8993(89)90388-0; JUNIER MP, 1988, ENDOCRINOLOGY, V123, P72, DOI 10.1210/endo-123-1-72; KACZMAREK L, 1992, BEHAV NEURAL BIOL, V57, P263, DOI 10.1016/0163-1047(92)90276-A; KATO K, 1991, BRAIN RES, V563, P94, DOI 10.1016/0006-8993(91)91519-7; KAWASAKI T, 1987, BIOCHIM BIOPHYS ACTA, V920, P85, DOI 10.1016/0005-2760(87)90314-6; KENTROTI S, 1991, J NEUROSCI RES, V28, P497, DOI 10.1002/jnr.490280406; KINDY M, 1991, J MOL NEUROSCI, V27, P217; KOCHANEK PM, 1988, J CEREBR BLOOD F MET, V8, P546, DOI 10.1038/jcbfm.1988.95; KORNECKI E, 1988, SCIENCE, V240, P1792, DOI 10.1126/science.3381103; KORNECKI E, 1984, SCIENCE, V226, P1454, DOI 10.1126/science.6150550; KUMAR R, 1988, BIOCHIM BIOPHYS ACTA, V963, P375, DOI 10.1016/0005-2760(88)90304-9; LAPETINA E, 1989, ARACHIDONIC ACID MET, V59, P153; LAZAREWICZ JW, 1983, NEUROCHEM INT, V5, P471, DOI 10.1016/0197-0186(83)90077-3; LEE TC, 1988, J BIOL CHEM, V263, P1755; LEE TC, 1986, J BIOL CHEM, V261, P5373; LINDEN DJ, 1987, J NEUROSCI, V7, P3783; LINDSBERG PJ, 1990, STROKE, V21, P1452, DOI 10.1161/01.STR.21.10.1452; LUSTIG HS, 1992, NEUROSCI LETT, V139, P15, DOI 10.1016/0304-3940(92)90847-Z; MAIER JAM, 1990, J BIOL CHEM, V265, P10805; MARCHESELLI V L, 1991, Society for Neuroscience Abstracts, V17, P349; MARCHESELLI VL, 1990, J BIOL CHEM, V265, P9140; MARCHESELLI VL, 1992, T AM SOC NEUROCHHEM, V23, P329; MARCHESELLI VL, 1991, T AM SOC NEUROCHEM, V22, P187; MARION J, 1978, PROSTAGLANDINS, V16, P99, DOI 10.1016/0090-6980(78)90206-X; MASSICOTTE G, 1990, BRAIN RES, V537, P49, DOI 10.1016/0006-8993(90)90338-C; MASSICOTTE G, 1990, NEUROSCI LETT, V118, P245, DOI 10.1016/0304-3940(90)90638-P; MAZER B, 1991, J IMMUNOL, V146, P1914; MILLER B, 1992, NATURE, V355, P722, DOI 10.1038/355722a0; MILLER LG, 1991, RES COMMUN CHEM PATH, V74, P253; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; NIETO ML, 1991, J BIOL CHEM, V266, P18699; OBENAUS A, 1989, NEUROSCI LETT, V98, P172, DOI 10.1016/0304-3940(89)90505-3; OBERPICHLER H, 1990, J CEREBR BLOOD F MET, V10, P133, DOI 10.1038/jcbfm.1990.17; OKADA D, 1989, NEUROSCI LETT, V100, P141, DOI 10.1016/0304-3940(89)90674-5; ONODERA H, 1989, NEUROSCI LETT, V98, P101, DOI 10.1016/0304-3940(89)90381-9; PANETTA T, 1987, BIOCHEM BIOPH RES CO, V149, P580, DOI 10.1016/0006-291X(87)90407-4; PELLERIN L, 1991, NEUROCHEM RES, V16, P983, DOI 10.1007/BF00965841; POLITI LE, 1985, NEUROCHEM PATHOL, V3, P249; RAMESHA CS, 1986, J BIOL CHEM, V261, P7592; RANSONE LJ, 1990, ANNU REV CELL BIOL, V6, P539, DOI 10.1146/annurev.cellbio.6.1.539; RECORD M, 1989, J CELL BIOCHEM, V40, P353, DOI 10.1002/jcb.240400311; REDDY TS, 1987, J NEUROSCI RES, V18, P449, DOI 10.1002/jnr.490180311; ROUGEOT C, 1990, NEUROENDOCRINOLOGY, V51, P315; RUSTENBECK I, 1991, BIOCHIM BIOPHYS ACTA, V1069, P99, DOI 10.1016/0005-2736(91)90109-L; SAFFEN DW, 1988, P NATL ACAD SCI USA, V85, P7795, DOI 10.1073/pnas.85.20.7795; SAMIEI M, 1991, J BIOL CHEM, V266, P14889; SAWYER DB, 1989, BIOCHIM BIOPHYS ACTA, V987, P129, DOI 10.1016/0005-2736(89)90464-1; SCHULAM PG, 1991, J IMMUNOL, V146, P1642; SHENG M, 1988, MOL CELL BIOL, V8, P2787, DOI 10.1128/MCB.8.7.2787; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SHUKLA SD, 1992, FASEB J, V6, P2296, DOI 10.1096/fasebj.6.6.1312046; SIESJO BK, 1990, EUR NEUROL, V30, P3, DOI 10.1159/000117184; SIESJO BK, 1982, J NEUROCHEM, V39, P796, DOI 10.1111/j.1471-4159.1982.tb07962.x; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; SNYDER F, 1990, AM J PHYSIOL, V259, pC697, DOI 10.1152/ajpcell.1990.259.5.C697; SOGOS V, 1990, J NEUROSCI RES, V27, P706, DOI 10.1002/jnr.490270431; SPINNEWYN B, 1987, PROSTAGLANDINS, V34, P337, DOI 10.1016/0090-6980(87)90079-7; SQUINTO SP, 1990, J MOL NEUROSCI, V2, P79, DOI 10.1007/BF02876914; SQUINTO SP, 1989, J NEUROSCI RES, V24, P558, DOI 10.1002/jnr.490240414; STEWART AG, 1989, BRIT J PHARMACOL, V98, P141, DOI 10.1111/j.1476-5381.1989.tb16874.x; STEWART AG, 1989, BRIT J PHARMACOL, V96, P503, DOI 10.1111/j.1476-5381.1989.tb11845.x; STEWART AG, 1990, P NATL ACAD SCI USA, V87, P3215, DOI 10.1073/pnas.87.8.3215; STOLL LL, 1989, CELL REGUL, V1, P13, DOI 10.1091/mbc.1.1.13; SUGA K, 1990, J BIOL CHEM, V265, P12363; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; TESSNER TG, 1989, J BIOL CHEM, V264, P4794; TRIPATHI YB, 1991, LIFE SCI, V49, P1761, DOI 10.1016/0024-3205(91)90319-7; VALLARI DS, 1990, ARCH BIOCHEM BIOPHYS, V276, P538, DOI 10.1016/0003-9861(90)90756-O; WARDLOW ML, 1986, J IMMUNOL, V136, P3441; WEBER C, 1991, BIOCHIM BIOPHYS ACTA, V1133, P38, DOI 10.1016/0167-4889(91)90239-T; WILLIAMS JH, 1989, NEUROSCI LETT, V107, P301, DOI 10.1016/0304-3940(89)90835-5; WIRTHMUELLER U, 1990, BIOCHEM BIOPH RES CO, V170, P556, DOI 10.1016/0006-291X(90)92127-L; WOODARD DS, 1987, J BIOL CHEM, V262, P2520; YOREK MA, 1984, J NEUROCHEM, V42, P254, DOI 10.1111/j.1471-4159.1984.tb09726.x; YOSHIDA S, 1980, J NEUROSURG, V53, P323, DOI 10.3171/jns.1980.53.3.0323; YOUNG W, 1992, J NEUROTRAUM, V9, pS9; YUE TL, 1991, J PHARMACOL EXP THER, V257, P374; YUE TL, 1990, J NEUROCHEM, V54, P1809, DOI 10.1111/j.1471-4159.1990.tb01239.x; YUE TL, 1991, NEUROSCIENCE, V41, P177, DOI 10.1016/0306-4522(91)90208-6; ZLATANOVA J, 1990, TRENDS BIOCHEM SCI, V15, P273, DOI 10.1016/0968-0004(90)90053-E	148	24	24	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512	0893-7648			MOL NEUROBIOL	Mol. Neurobiol.	WIN	1992	6	4					407	424		10.1007/BF02757944			18	Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KJ813	WOS:A1992KJ81300008	1337456				2022-02-06	
J	GRAHAM, CJ; KITTREDGE, D; STUEMKY, JH				GRAHAM, CJ; KITTREDGE, D; STUEMKY, JH			INJURIES ASSOCIATED WITH CHILD SAFETY SEAT MISUSE	PEDIATRIC EMERGENCY CARE			English	Article						CHILD SAFETY SEAT; TRAUMA; MOTOR VEHICLE ACCIDENTS		The charts of 370 children under the age of two years who presented to a pediatric emergency department between September 1988 and August 1989 were reviewed. Twenty-seven patients (7% of the total) had injuries associated with child safety seat (CSS) misuse. Thirteen were infants and toddlers injured as motor vehicle occupants when improperly restrained-CSS harness not properly connected (8), use of an improper device (3), and CSS not anchored to the car seat (2). Fourteen were infants under one year of age who were injured falling in their CSS. Injuries included minor head trauma (17), linear skull fracture (5), concussion (1), femoral fracture (1), depressed skull fracture with epidural hematoma (1), cervical vertebral fracture (1), and intraventricular hemorrhage (1). Nine patients were hospitalized. Injuries associated with CSS misuse may be more common than previously recognized and can result in significant injury. Educational efforts should focus on correct usage.			GRAHAM, CJ (corresponding author), ARKANSAS CHILDRENS HOSP,PEDIAT EMERGENCY MED SECT,800 MARSHALL ST,LITTLE ROCK,AR 72202, USA.							0	24	24	0	3	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0749-5161			PEDIATR EMERG CARE	Pediatr. Emerg. Care	DEC	1992	8	6					351	353		10.1097/00006565-199212000-00012			3	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	KC060	WOS:A1992KC06000012	1454645				2022-02-06	
J	SWEENEY, JE				SWEENEY, JE			NONIMPACT BRAIN INJURY - GROUNDS FOR CLINICAL-STUDY OF THE NEUROPSYCHOLOGICAL EFFECTS OF ACCELERATION FORCES	CLINICAL NEUROPSYCHOLOGIST			English	Article							MINOR HEAD-INJURY; CEREBRAL CONCUSSION; REACTION-TIME; SEQUELAE; SYMPTOMS; WHIPLASH; RECOVERY	Individuals subjected to acceleration forces in motor vehicle accidents often exhibit the postconcussive syndrome and, upon examination, neuropsychological impairment. Brain injury and particular variables relating to nonimpact intracranial brain movement are reviewed. Brain injury in man can occur through exposure to acceleration forces without direct impact to the head or loss of consciousness. Hence, there are clear grounds for the neuropsychological study of victims of acceleration forces. Moreover, as with mild head injury, adequate regard for the variables of age, previous head injury, premorbid adaptive ability, socioeconomic status, motivation, and test sensitivity may assist in clarifying the specific problems in adaptation encountered by this clinical population. Clinical experience suggests that acceleration forces adversely affect attention (especially at older age levels), learning, and conceptual flexibility.									ALVES WM, 1985, CENTRAL NERVOUS SYST, P255; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BINDER LM, 1989, ASSESSMENT BEHAV CON, P37; CAFFEY J, 1974, PEDIATRICS, V54, P396; Cook J B, 1972, Scand J Rehabil Med, V4, P27; CRONHOLM B, 1958, ACTA CHIR SCAND, V113, P263; Denker P., 1944, NY STATE J MED, V44, P379; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; FISHER CM, 1966, NEUROLOGY, V16, P826, DOI 10.1212/WNL.16.8.826; FISHER CM, 1982, NEUROLOGY, V32, P667, DOI 10.1212/WNL.32.6.667; FRANKEL CJ, 1959, JAMA-J AM MED ASSOC, V169, P216, DOI 10.1001/jama.1959.03000200014004; GAY JR, 1953, JAMA-J AM MED ASSOC, V152, P1698, DOI 10.1001/jama.1953.03690180020006; GENNARELLI TA, 1990, NEUROLOGICAL SURGERY, P1953; Goggio AF, 1941, J NEUROL PSYCHIATRY, V4, P11, DOI 10.1136/jnnp.4.1.11; GRONWALL D, 1975, LANCET, V2, P995; GRONWALL D, 1974, LANCET, V2, P605; GULBRANDSEN GB, 1984, J CLIN NEUROPSYCHOL, V6, P257, DOI 10.1080/01688638408401217; GURDJIAN ES, 1943, SURG GYNECOL OBSTET, V76, P623; Hathaway S.R., 1989, MINNESOTA MULTIPHASI; Hathaway SR, 1967, MINNESOTA MULTIPHASI; Heaton RK, 1991, COMPREHENSIVE NORMS; Hirsch A. E., 1970, IMPACT INJURY CRASH, P352; Holbourn AHS, 1944, J NEUROSURG, V1, P190, DOI 10.3171/jns.1944.1.3.0190; Holbourn AHS, 1943, LANCET, V2, P438; JACOBSON SA, 1969, LATE EFFECTS HEAD IN, P35; KARZMARK P, 1985, J CLIN EXP NEUROPSYC, V7, P412, DOI 10.1080/01688638508401273; KOZOL HL, 1946, ARCH NEUROLOGY PSYCH, V53, P358; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; MARSHALL LF, 1989, MILD HEAD INJURY, P226; MCKINLAY WW, 1983, J NEUROL NEUROSUR PS, V46, P1084, DOI 10.1136/jnnp.46.12.1084; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; MERSKEY H, 1972, BRAIN, V95, P521, DOI 10.1093/brain/95.3.521; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; MILLER H, 1961, BRIT MED J, V1, P992, DOI 10.1136/bmj.1.5231.992; MILLER H, 1969, LATE EFFECTS HEAD IN, P429; Munro D., 1938, CRANIO CEREBRAL INJU; OMMAYA AK, 1964, J NEUROSURG, V21, P249, DOI 10.3171/jns.1964.21.4.0249; OMMAYA AK, 1968, J AMER MED ASSOC, V204, P285, DOI 10.1001/jama.204.4.285; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; OMMAYA AK, 1969, LANCET, V2, P237; OMMAYA AK, 1969, J NEUROSURG, V30, P25, DOI 10.3171/jns.1969.30.1.0025; OMMAYA AK, 1966, SCIENCE, V153, P211, DOI 10.1126/science.153.3732.211; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OMMAYA AK, 1966, HEAD INJURY, P260; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; REITAN R M, 1955, AMA Arch Neurol Psychiatry, V73, P28; Reitan RM, 1985, HALSTEADREITAN NEURO; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; STEADMAN JH, 1970, P ROY SOC MED, V63, P23, DOI 10.1177/003591577006300109; Strauss I, 1934, ARCH NEURO PSYCHIATR, V31, P893, DOI 10.1001/archneurpsyc.1934.02250050011001; TORRES F, 1961, ARCH NEUROL-CHICAGO, V5, P40; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; VOGT AT, 1977, PERCEPT MOTOR SKILL, V45, P607, DOI 10.2466/pms.1977.45.2.607; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; WILSON RS, 1978, J CONSULT CLIN PSYCH, V46, P1554, DOI 10.1037/0022-006X.46.6.1554; Wolfson, 1988, TRAUMATIC BRAIN INJU, VII; WOOTEN AJ, 1983, J CLIN PSYCHOL, V39, P392, DOI 10.1002/1097-4679(198305)39:3<392::AID-JCLP2270390313>3.0.CO;2-H; YARNELL PR, 1973, NEUROLOGY, V23, P196, DOI 10.1212/WNL.23.2.196; 1865, GAZETTE MED, V20, P500; 1865, GAZETTE MED, V20, P463; [No title captured]; 1865, GAZETTE MED, V20, P314; 1865, GAZETTE MED, V20, P226; 1865, GAZETTE MED, V20, P254; 1865, GAZETTE MED, V20, P382; 1865, GAZETTE MED, V20, P396	68	24	24	0	1	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0920-1637			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	NOV	1992	6	4					443	457		10.1080/13854049208401870			15	Psychology, Clinical; Clinical Neurology; Psychology	Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	KC737	WOS:A1992KC73700007					2022-02-06	
J	WANI, MA; TANDON, PN; BANERJI, AK; BHATIA, R				WANI, MA; TANDON, PN; BANERJI, AK; BHATIA, R			COLLET-SICARD SYNDROME RESULTING FROM CLOSED HEAD-INJURY - CASE-REPORT	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article								A 67-year-old man developed paralysis of the right ninth, tenth, eleventh, and twelfth cranial nerves (Collet-Sicard syndrome) after sustaining a closed head injury. Plain x-ray films of the skull revealed two linear fractures of the occipital bone (one of them probably traversing through the right occipital condyle) and a prominent soft-tissue shadow in the region of the nasopharynx, suggestive of a skull base fracture. The patient was managed conservatively. This is the only case of unilateral multiple caudal cranial nerve palsies (IX through XII), seen by us over a 20-year period, from among more than 5,000 moderate to significant head injuries.	STEGLITZ MED CTR,DEPT SURG NEUROL,W-1000 BERLIN 45,GERMANY; ALL INDIA INST MED SCI,NEW DELHI 110016,INDIA								BOLENDER N, 1978, AM J ROENTGENOL, V131, P729, DOI 10.2214/ajr.131.4.729; Collet F., 1915, LYON MED, V124, P121; DANIELS DL, 1983, AM J NEURORADIOL, V4, P1227; DICHIRO GD, 1964, J NEUROSURG, V21, P447, DOI 10.3171/jns.1964.21.6.0447; FISHBONE H, 1976, HDB CLIN NEURODLOGY, V24, P179; FROWEIN RA, 1978, NEUROSURG REV, V1, P147; GARDNERTHORPE C, 1970, BR MEKD J, V1, P405; GRUNDY DJ, 1984, SPINE, V9, P339, DOI 10.1097/00007632-198405000-00002; HARDIDNGESMITH J, 1980, J BONE JOINT SURG AM, V63, P1170; HASHIMOTO T, 1988, NEUROSURGERY, V3, P367; MOHANTY KH, 1973, J NEUROSURG, V8, P86; PALATUCCI DM, 1974, JAMA-J AM MED ASSOC, V229, P24, DOI 10.1001/jama.1974.03230390016009; Pollock LJ, 1920, ARCH NEURO PSYCHIATR, V4, P517, DOI 10.1001/archneurpsyc.1920.02180230040004; SBUMM P, 1974, ARCH KLIN EXP OHR, V205, P348; Sicard J., 1917, MARSEILLE MED, V53, P385; SPENCER JA, 1984, NEUROSURGERY, V15, P101, DOI 10.1227/00006123-198407000-00019	16	24	24	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	OCT	1991	31	10					1437	1439		10.1097/00005373-199110000-00025			3	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	GM785	WOS:A1991GM78500025	1942161				2022-02-06	
J	STAMBROOK, M; MOORE, AD; PETERS, LC; ZUBEK, E; MCBEATH, S; FRIESEN, IC				STAMBROOK, M; MOORE, AD; PETERS, LC; ZUBEK, E; MCBEATH, S; FRIESEN, IC			HEAD-INJURY AND SPINAL-CORD INJURY - DIFFERENTIAL-EFFECTS ON PSYCHOSOCIAL FUNCTIONING	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							SCALE; LIFE	Closed-head injury (CHI) and spinal cord injury (SCI) cause significant permanent alterations in life style, social-role functioning, and psychological status. While the cognitive effects of CHI are well known, there have been questions concerning the psychosocial sequelae from CHI, and whether they are unique to this disability group rather than representing general effects of a life-threatening medical emergency with permanent life-altering consequences. This issue was examined with samples of ambulatory moderate (n = 31) and severe (n = 17) CHI patients and wheelchair-dependent SCI (n = 24) patients. Results indicate that there were no significant differences between the groups on pre- and post injury demographic factors. However, while the moderate CHI and SCI groups were equivalent on many indicators of psychosocial outcome, the severe CHI group was more depressed, angry and hostile, and confused and bewildered. As well, wives of the severe CHI patients rated their husbands as more belligerent, negative, helpless, suspicious, withdrawn and retarded, and with more general psychopathology than did wives of moderate CHI or wives of SCI patients. Implications of these findings for preventative psychosocial rehabilitation are discussed.	UNIV MANITOBA,DEPT PSYCHIAT,WINNIPEG R3T 2N2,MANITOBA,CANADA; UNIV MANITOBA,DEPT MED,WINNIPEG R3T 2N2,MANITOBA,CANADA; UNIV MANITOBA,DEPT PSYCHOL,WINNIPEG R3T 2N2,MANITOBA,CANADA; UNIV MANITOBA,FAC MED,WINNIPEG R3T 2N2,MANITOBA,CANADA; UNIV VICTORIA,DEPT PSYCHOL,VICTORIA V8W 2Y2,BC,CANADA; SOC MANITOBANS DISABIL INC,WINNIPEG,MANITOBA,CANADA		STAMBROOK, M (corresponding author), HLTH SCI CLIN RES CTR,NEUROPSYCHOL RES UNIT,MS 779,820 SHERBROOK ST,WINNIPEG R3A 1M9,MANITOBA,CANADA.						BERGNER M, 1976, COPING ADAPTATION, P127; BLISHEN BR, 1967, CAN REV SOCIOL ANTHR, V4, P41; BOND MR, 1984, CLOSED HEAD INJURY P, P148; BROOKS N, 1984, CLOSED HEAD INJURY P; DIKMEN S, 1987, NEUROBEHAVIORAL RECO, P73; EISENBERG HM, 1987, NEUROBEHAVIORAL RECO, P13; HOGARTY GE, 1971, ARCH GEN PSYCHIAT, V25, P470; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; KLONOFF PS, 1986, NEUROSURGERY, V9, P735; Levin H.S., 1989, MILD HEAD INJURY; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; McNair DM, 1971, EITS MANUAL PROFILE; Moore A D, 1989, Brain Inj, V3, P171, DOI 10.3109/02699058909004549; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; STAMBROOK M, 1990, COGNITIVE REHABILITA, V8, P26; TEASDALE G, 1974, LANCET, V2, P81	19	24	24	0	0	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JUL	1991	13	4					521	530		10.1080/01688639108401068			10	Psychology, Clinical; Clinical Neurology; Psychology	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Psychology; Neurosciences & Neurology	GL617	WOS:A1991GL61700006	1918283				2022-02-06	
J	LEE, JP; WANG, ADJ				LEE, JP; WANG, ADJ			POSTTRAUMATIC BASAL GANGLIA HEMORRHAGE - ANALYSIS OF 52 PATIENTS WITH EMPHASIS ON THE FINAL OUTCOME	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							SEVERE HEAD-INJURY; COMPUTED TOMOGRAPHY; PROGNOSIS; HEMATOMA; LESIONS; COMA; CT	A series of 52 patients suffering post-traumatic basal ganglia hemorrhage (BGH) after closed head injury is reviewed. Post-traumatic BGH was associated with other intracranial lesions in most cases. The outcome in this series is rather good, with 53.8% of patients having a functional survival. Radiologically, the post-traumatic intraventricular hemorrhage (IVH) and brainstem hemorrhage usually coexisted with a poor outcome. Old age (> 60), abnormal pupil reaction, impaired oculocephalic response, and abnormal motor response to pain stimuli are reliable clinical hallmarks for poor prognosis.	CHANG GUNG MED COLL, DEPT SURG, DIV NEUROSURG, TAIPEI, TAIWAN		LEE, JP (corresponding author), CHANG GUNG MEM HOSP, DEPT SURG, DIV NEUROSURG, 199 TUNG HWA N RD, TAIPEI 10591, TAIWAN.						ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; Borovich B, 1975, Surg Neurol, V3, P25; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; CARLSSON CA, 1968, J NEUROSURG, V29, P242, DOI 10.3171/jns.1968.29.3.0242; COOPER PR, 1979, NEUROSURGERY, V5, P566, DOI 10.1227/00006123-197911000-00004; Courville CB, 1940, ARCH SURG-CHICAGO, V41, P1; CROMPTON MR, 1971, LANCET, V1, P669; DEMERINO VJ, 1976, AM J ROENTGENOL, V126, P765; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DUBLIN AB, 1977, RADIOLOGY, V122, P365, DOI 10.1148/122.2.365; FRENCH BN, 1977, SURG NEUROL, V7, P171; Gennarelli T. A., 1987, HEAD INJURY, P108; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GEORGE B, 1981, ACTA NEUROCHIR, V59, P35, DOI 10.1007/BF01411189; GUTTERMAN P, 1970, J NEUROSURG, V32, P330, DOI 10.3171/jns.1970.32.3.0330; JAMIESON KG, 1972, J NEUROSURG, V37, P528, DOI 10.3171/jns.1972.37.5.0528; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JENNETT B, 1975, LANCET, V1, P480; LANGFITT TW, 1968, AM J PHYSIOL, V215, P90, DOI 10.1152/ajplegacy.1968.215.1.90; MACPHERSON P, 1986, J NEUROL NEUROSUR PS, V49, P29, DOI 10.1136/jnnp.49.1.29; MEYER JS, 1971, NEUROLOGY, V21, P247, DOI 10.1212/WNL.21.3.247; MOSBERG WH, 1959, J NEUROSURG, V16, P209, DOI 10.3171/jns.1959.16.2.0209; Stewart W A, 1973, Surg Neurol, V1, P303; TEASDALE G, 1974, LANCET, V2, P81; TSAI FY, 1980, AM J NEURORADIOL, V1, P23; VAPALAHTI M, 1971, BMJ-BRIT MED J, V3, P404, DOI 10.1136/bmj.3.5771.404; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393; [No title captured]	28	24	26	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	1991	31	3					376	380		10.1097/00005373-199103000-00011			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	FD246	WOS:A1991FD24600010	2002524				2022-02-06	
J	PANIAK, CE; SHORE, DL; ROURKE, BP				PANIAK, CE; SHORE, DL; ROURKE, BP			RECOVERY OF MEMORY AFTER SEVERE CLOSED HEAD-INJURY - DISSOCIATIONS IN RECOVERY OF MEMORY PARAMETERS AND PREDICTORS OF OUTCOME	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article									UNIV WINDSOR,DEPT PSYCHOL,WINDSOR N9B 3P4,ONTARIO,CANADA								Bond M R, 1975, Ciba Found Symp, P141; BROOKS DN, 1984, J CLIN NEUROPSYCHOL, V6, P71, DOI 10.1080/01688638408401198; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; BUSCHKE H, 1974, T NEW YORK ACAD SCI, V36, P721, DOI 10.1111/j.2164-0947.1974.tb01606.x; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; Buschke H., 1984, NEUROPSYCHOLOGY MEMO, P33; EGAN JP, 1975, SIGNAL DETECTION THE; Flavell J H, 1970, Adv Child Dev Behav, V5, P181, DOI 10.1016/S0065-2407(08)60467-X; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; HASHER IM, 1979, J EXPT PSYCHOL GENER, V80, P356; HULICKA IM, 1967, J GERONTOL, V22, P46; HULTSCH DF, 1971, DEV PSYCHOL, V4, P338, DOI 10.1037/h0030990; Jennett B, 1981, MANAGEMENT HEAD INJU; KOHL D, 1985, MEMORY DYSFUNCTIONS, V444, P460; KRAEMER HC, 1983, PSYCHOL BULL, V94, P367, DOI 10.1037/0033-2909.94.2.367; LEVIN HS, 1985, SEMIN NEUROL, V5, P221, DOI 10.1055/s-2008-1041519; LEVIN HS, 1985, ARCH NEUROL-CHICAGO, V42, P963, DOI 10.1001/archneur.1985.04060090045012; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEVIN HS, 1979, CHILDS BRAIN, V5, P282; LEVIN HS, 1976, J PEDIATR PSYCHOL, V1, P38; LORING DW, 1987, J CLIN EXP NEUROPSYC, V9, P340, DOI 10.1080/01688638708405055; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; PAIVIO A, 1968, J EXP PSYCHOL, V76, P1, DOI 10.1037/h0025327; Russell E. W., 1970, ASSESSMENT BRAIN DAM; SHORE D, 1981, FEB M INT NEUR SOC P; SMITH AD, 1977, DEV PSYCHOL, V13, P326, DOI 10.1037/0012-1649.13.4.326; TABADDOR K, 1984, NEUROSURGERY, V14, P701, DOI 10.1227/00006123-198406000-00010; Thorndike E. L., 1944, TEACHERS WORD BOOK 3; Van Zomeren A. H., 1981, REACTION TIME ATTENT	29	24	24	1	1	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	OCT	1989	11	5					631	644		10.1080/01688638908400921			14	Psychology, Clinical; Clinical Neurology; Psychology	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Psychology; Neurosciences & Neurology	AX358	WOS:A1989AX35800004	2808654				2022-02-06	
J	COLQUHOUN, IR; BURROWS, EH				COLQUHOUN, IR; BURROWS, EH			THE PROGNOSTIC-SIGNIFICANCE OF THE 3RD VENTRICLE AND BASAL CISTERNS IN SEVERE CLOSED HEAD-INJURY	CLINICAL RADIOLOGY			English	Article									SOUTHAMPTON GEN HOSP,WESSEX NEUROL CTR,DEPT NEURORADIOL,SOUTHAMPTON SO9 4XY,HANTS,ENGLAND								BRUCE DA, 1979, CHILD BRAIN, V5, P174; GENNARELLI TA, 1985, TRAUMA CENTRAL NERVO, P169; JENNETT B, 1975, LANCET, V1, P480; KISHORE PRS, 1981, AM J ROENTGENOL, V137, P829, DOI 10.2214/ajr.137.4.829; MENDELOW AD, 1983, BRIT J SURG, V70, P641, DOI 10.1002/bjs.1800701102; MURPHY A, 1983, INTRACRANIAL PRESSUR, V5, P562; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; TABADDOR K, 1982, SURG NEUROL, V18, P212, DOI 10.1016/0090-3019(82)90395-0; TEASDALE E, 1984, J NEUROL NEUROSUR PS, V47, P600, DOI 10.1136/jnnp.47.6.600; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691	10	24	24	0	0	BLACKWELL SCIENCE LTD	OXFORD	OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL	0009-9260			CLIN RADIOL	Clin. Radiol.	JAN	1989	40	1					13	16		10.1016/S0009-9260(89)80006-6			4	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	R9919	WOS:A1989R991900005	2784083				2022-02-06	
J	CROSSON, B; BUENNING, W				CROSSON, B; BUENNING, W			AN INDIVIDUALIZED MEMORY RETRAINING PROGRAM AFTER CLOSED-HEAD INJURY - A SINGLE-CASE STUDY	JOURNAL OF CLINICAL NEUROPSYCHOLOGY			English	Article									BERT NASH MENTAL HLTH CTR,LAWRENCE,CA		CROSSON, B (corresponding author), VET ADM MED CTR,PSYCHOL SERV 183,OKLAHOMA CITY,OK 73104, USA.		Crosson, Bruce A/L-3128-2013				BADDELEY AD, 1973, NEUROPSYCHOLOGIA, V11, P159, DOI 10.1016/0028-3932(73)90003-1; Benton A. L., 1975, TEST FACIAL RECOGNIT; Benton AL, 1975, JUDGMENT LINE ORIENT; BINDER L M, 1980, Journal of Clinical Neuropsychology, V2, P71, DOI 10.1080/01688638008403782; CARTER L, 1980, CLIN NEUROPSYCHOLOGY, V2, P109; CERMAK L S, 1975, Cortex, V11, P163; CERMAK LS, 1976, NEUROPSYCHOLOGIA, V14, P311, DOI 10.1016/0028-3932(76)90025-7; CROVITZ HF, 1979, CORTEX, V15, P225, DOI 10.1016/S0010-9452(79)80027-1; CROVITZ HF, 1979, CORTEX, V15, P131, DOI 10.1016/S0010-9452(79)80013-1; DRUDGE OW, 1981, AUG M AM PSYCH ASS L; GASPARRINI B, 1979, Journal of Clinical Neuropsychology, V1, P137, DOI 10.1080/01688637908414447; GIANUTSOS R, 1981, Journal of Clinical Neuropsychology, V3, P143, DOI 10.1080/01688638108403119; GIANUTSOS R, 1980, J REHABIL, V46, P36; GIANUTSOS R, 1979, Journal of Clinical Neuropsychology, V1, P117, DOI 10.1080/01688637908414446; GIANUTSOS R, INT REHABILITATION M; Jennett B, 1981, MANAGEMENT HEAD INJU; JONES MK, 1974, NEUROPSYCHOLOGIA, V12, P21, DOI 10.1016/0028-3932(74)90023-2; JONESGOTMAN M, 1978, NEUROPSYCHOLOGIA, V16, P61, DOI 10.1016/0028-3932(78)90043-X; KALSBEEK WD, 1980, J NEUROSURGERY S, V53, P19; KNIGHT RG, 1980, PSYCHOL BULL, V88, P753; LEWINSOHN PM, 1977, J CONSULT CLIN PSYCH, V45, P717, DOI 10.1037/0022-006X.45.5.717; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; PATTEN BM, 1972, ARCH NEUROL-CHICAGO, V26, P25, DOI 10.1001/archneur.1972.00490070043006; Russell E. W., 1981, HDB CLIN NEUROPSYCHO, P287; Russell E. W., 1970, ASSESSMENT BRAIN DAM; RUSSELL EW, 1975, J CONSULT CLIN PSYCH, V43, P800, DOI 10.1037/0022-006X.43.6.800; RYAN C, 1980, J STUD ALCOHOL, V41, P437, DOI 10.15288/jsa.1980.41.437; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; VICTOR M, 1971, WERNICKEKORSAKOFF SY; WARRINGTON EK, 1971, NEUROPSYCHOLOGIA, V9, P67, DOI 10.1016/0028-3932(71)90063-7; [No title captured]	31	24	24	0	2	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0165-0475			J CLIN NEUROPSYCHOL			1984	6	3					287	301		10.1080/01688638408401219			15	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	TD295	WOS:A1984TD29500004	6470166				2022-02-06	
J	DILLON, H; LEOPOLD, RL				DILLON, H; LEOPOLD, RL			CHILDREN AND POST-CONCUSSION SYNDROME	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article																	BOCHNER AK, 1957, H LMP; DENCKER SJ, 1960, ARCH GEN PSYCHIAT, V2, P569; FABIAN AA, 1956, J NERV MENT DIS, V123, P428, DOI 10.1097/00005053-195605000-00002; HARRIS P, 1956, ARCH DIS CHILD, V32, P488; PETERSON BH, 1956, MED J AUST, V1, P689; ROWBOTHAM GF, 1954, BRIT MED J, V1, P726, DOI 10.1136/bmj.1.4864.726; SELLEY I, 1958, ACTA PSYCHIAT SCAND, V33, P209; WECHSLER IS, 1958, TEXTBOOK CLINICAL NE; [No title captured]	9	24	24	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.		1961	175	2					86	&		10.1001/jama.1961.03040020012003			0	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	3293B	WOS:A19613293B00007	13722906				2022-02-06	
J	DOMBRAIN, A				DOMBRAIN, A			TRAUMATIC OR CONCUSSION CHRONIC GLAUCOMA	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Article																	DOMBRAIN A, 1945, T OPHTHALMOL SOC AUS, V5, P116; DOMBRAIN A, 1946, T OPHTHAL SOC AUST, V6, P129; DOMBRAIN AW, 1944, MED J AUSTR, V2, P112; DUKEELDER WS, 1940, TXB OPHTHALMOLOGY, V3, P3300; POSNER A, 1948, AM J OPHTHALMOL, V31, P915, DOI 10.1016/0002-9394(48)92521-5; REESE AB, 1944, AM J OPHTHALMOL, V27, P1193	6	24	24	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161			BRIT J OPHTHALMOL	Br. J. Ophthalmol.		1949	33	8					495	500		10.1136/bjo.33.8.495			6	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	XW290	WOS:A1949XW29000005	18135478	Green Published, Bronze			2022-02-06	
J	Barrow, DW; Rhoads, HT				Barrow, DW; Rhoads, HT			Blast concussion injury	JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article																	Fulton J. F., 1942, NEW ENGL J MED, V226, P1; Gates R., 1943, U S NAVAL MED BULL, V41, P12; Hadfield G, 1941, BRIT MED J, V1941, P77, DOI 10.1136/bmj.1.4176.77; Krohn PL, 1942, LANCET, V1, P252; Logan DD, 1939, BRIT MED J, V2, P864, DOI 10.1136/bmj.2.4112.864; MCMULLIN JJA, 1943, US NAV M B, V41, P1; OREILLY JN, 1941, BRIT MED J, V2, P423; PALMA J, 1943, BRIT MED J, V41, P3; Stewart OW, 1941, LANCET, V1, P172; Sutherland GA, 1940, LANCET, V2, P641; Wilson J V, 1943, Br Med J, V1, P470; Wilson JV, 1943, LANCET, V1, P257; 1941, P ROY SOC MED, V34, P171	13	24	24	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0002-9955			J AMER MED ASSOC	J. Am. Med. Assoc.	MAY-AUG	1944	125						900	902		10.1001/jama.1944.02850310020006			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V24NU	WOS:000201658200164					2022-02-06	
J	Dennis, EL; Disner, SG; Fani, N; Salminen, LE; Logue, M; Clarke, EK; Haswell, CC; Averill, CL; Baugh, LA; Bomyea, J; Bruce, SE; Cha, J; Choi, K; Davenport, ND; Densmore, M; du Plessis, S; Forster, GL; Frijling, JL; Gonenc, A; Gruber, S; Grupe, DW; Guenette, JP; Hayes, J; Hofmann, D; Ipser, J; Jovanovic, T; Kelly, S; Kennis, M; Kinzel, P; Koch, SBJ; Koerte, I; Koopowitz, S; Korgaonkar, M; Krystal, J; Lebois, LAM; Li, G; Magnotta, VA; Manthey, A; May, GJ; Menefee, DS; Nawijn, L; Nelson, SM; Neufeld, RWJ; Nitschke, JB; O'Doherty, D; Peverill, M; Ressler, KJ; Roos, A; Sheridan, MA; Sierk, A; Simmons, A; Simons, RM; Simons, JS; Stevens, J; Suarez-Jimenez, B; Sullivan, DR; Theberge, J; Tran, JK; van den Heuvel, L; van der Werff, SJA; van Rooij, SJH; van Zuiden, M; Velez, C; Verfaellie, M; Vermeiren, RRJM; Wade, BSC; Wager, T; Walter, H; Winternitz, S; Wolff, J; York, G; Zhu, Y; Zhu, X; Abdallah, CG; Bryant, R; Daniels, JK; Davidson, RJ; Fercho, KA; Franz, C; Geuze, E; Gordon, EM; Kaufman, ML; Kremen, WS; Lagopoulos, J; Lanius, RA; Lyons, MJ; McCauley, SR; McGlinchey, R; McLaughlin, KA; Milberg, W; Neria, Y; Olff, M; Seedat, S; Shenton, M; Sponheim, SR; Stein, DJ; Stein, MB; Straube, T; Tate, DF; van der Wee, NJA; Veltman, DJ; Wang, L; Wilde, EA; Thompson, PM; Kochunov, P; Jahanshad, N; Morey, RA				Dennis, Emily L.; Disner, Seth G.; Fani, Negar; Salminen, Lauren E.; Logue, Mark; Clarke, Emily K.; Haswell, Courtney C.; Averill, Christopher L.; Baugh, Lee A.; Bomyea, Jessica; Bruce, Steven E.; Cha, Jiook; Choi, Kyle; Davenport, Nicholas D.; Densmore, Maria; du Plessis, Stefan; Forster, Gina L.; Frijling, Jessie L.; Gonenc, Atilla; Gruber, Staci; Grupe, Daniel W.; Guenette, Jeffrey P.; Hayes, Jasmeet; Hofmann, David; Ipser, Jonathan; Jovanovic, Tanja; Kelly, Sinead; Kennis, Mitzy; Kinzel, Philipp; Koch, Saskia B. J.; Koerte, Inga; Koopowitz, Sheri; Korgaonkar, Mayuresh; Krystal, John; Lebois, Lauren A. M.; Li, Gen; Magnotta, Vincent A.; Manthey, Antje; May, Geoff J.; Menefee, Deleene S.; Nawijn, Laura; Nelson, Steven M.; Neufeld, Richard W. J.; Nitschke, Jack B.; O'Doherty, Daniel; Peverill, Matthew; Ressler, Kerry J.; Roos, Annerine; Sheridan, Margaret A.; Sierk, Anika; Simmons, Alan; Simons, Raluca M.; Simons, Jeffrey S.; Stevens, Jennifer; Suarez-Jimenez, Benjamin; Sullivan, Danielle R.; Theberge, Jean; Tran, Jana K.; van den Heuvel, Leigh; van der Werff, Steven J. A.; van Rooij, Sanne J. H.; van Zuiden, Mirjam; Velez, Carmen; Verfaellie, Mieke; Vermeiren, Robert R. J. M.; Wade, Benjamin S. C.; Wager, Tor; Walter, Henrik; Winternitz, Sherry; Wolff, Jonathan; York, Gerald; Zhu, Ye; Zhu, Xi; Abdallah, Chadi G.; Bryant, Richard; Daniels, Judith K.; Davidson, Richard J.; Fercho, Kelene A.; Franz, Carol; Geuze, Elbert; Gordon, Evan M.; Kaufman, Milissa L.; Kremen, William S.; Lagopoulos, Jim; Lanius, Ruth A.; Lyons, Michael J.; McCauley, Stephen R.; McGlinchey, Regina; McLaughlin, Katie A.; Milberg, William; Neria, Yuval; Olff, Miranda; Seedat, Soraya; Shenton, Martha; Sponheim, Scott R.; Stein, Dan J.; Stein, Murray B.; Straube, Thomas; Tate, David F.; van der Wee, Nic J. A.; Veltman, Dick J.; Wang, Li; Wilde, Elisabeth A.; Thompson, Paul M.; Kochunov, Peter; Jahanshad, Neda; Morey, Rajendra A.			Altered white matter microstructural organization in posttraumatic stress disorder across 3047 adults: results from the PGC-ENIGMA PTSD consortium	MOLECULAR PSYCHIATRY			English	Article							SMALLER HIPPOCAMPAL VOLUME; FRACTIONAL ANISOTROPY; STRUCTURAL INTEGRITY; NEUROTROPHIC FACTOR; TRACT INTEGRITY; ABNORMALITIES; CONNECTIVITY; COMORBIDITY; PREVALENCE; MULTISITE	A growing number of studies have examined alterations in white matter organization in people with posttraumatic stress disorder (PTSD) using diffusion MRI (dMRI), but the results have been mixed which may be partially due to relatively small sample sizes among studies. Altered structural connectivity may be both a neurobiological vulnerability for, and a result of, PTSD. In an effort to find reliable effects, we present a multi-cohort analysis of dMRI metrics across 3047 individuals from 28 cohorts currently participating in the PGC-ENIGMA PTSD working group (a joint partnership between the Psychiatric Genomics Consortium and the Enhancing NeuroImaging Genetics through Meta-Analysis consortium). Comparing regional white matter metrics across the full brain in 1426 individuals with PTSD and 1621 controls (2174 males/873 females) between ages 18-83, 92% of whom were trauma-exposed, we report associations between PTSD and disrupted white matter organization measured by lower fractional anisotropy (FA) in the tapetum region of the corpus callosum (Cohen's d = -0.11, p = 0.0055). The tapetum connects the left and right hippocampus, for which structure and function have been consistently implicated in PTSD. Results were consistent even after accounting for the effects of multiple potentially confounding variables: childhood trauma exposure, comorbid depression, history of traumatic brain injury, current alcohol abuse or dependence, and current use of psychotropic medications. Our results show that PTSD may be associated with alterations in the broader hippocampal network.	[Dennis, Emily L.; Kelly, Sinead; Kinzel, Philipp; Koerte, Inga; Shenton, Martha] Brigham & Womens Hosp, Psychiat Neuroimaging Lab, Dept Psychiat, 75 Francis St, Boston, MA 02115 USA; [Dennis, Emily L.; Salminen, Lauren E.; Thompson, Paul M.; Jahanshad, Neda] USC, Imaging Genet Ctr, Stevens Neuroimaging & Informat Inst, Keck Sch Med, Marina Del Rey, CA 90292 USA; [Dennis, Emily L.; Velez, Carmen; Wade, Benjamin S. C.; Tate, David F.; Wilde, Elisabeth A.] Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA; [Dennis, Emily L.] Stanford Neurodev Affect & Psychopathol Lab, Stanford, CA 94305 USA; [Disner, Seth G.; Davenport, Nicholas D.; Sponheim, Scott R.] Minneapolis VA Hlth Care Syst, Minneapolis, MN USA; [Disner, Seth G.; Davenport, Nicholas D.; Sponheim, Scott R.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [Fani, Negar; Jovanovic, Tanja; Ressler, Kerry J.; Stevens, Jennifer; van Rooij, Sanne J. H.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA; [Logue, Mark; Sullivan, Danielle R.] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA USA; [Logue, Mark; Sullivan, Danielle R.; Verfaellie, Mieke] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Logue, Mark] Boston Univ, Sch Med, Biomed Genet, Boston, MA 02118 USA; [Logue, Mark] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Clarke, Emily K.; Haswell, Courtney C.; Morey, Rajendra A.] Duke Univ, Brain Imaging & Anal Ctr, Durham, NC USA; [Clarke, Emily K.; Haswell, Courtney C.; Morey, Rajendra A.] Durham VA, VISN 6 MIRECC, Durham, NC USA; [Averill, Christopher L.; Krystal, John; Abdallah, Chadi G.] Yale Univ, Sch Med, Natl Ctr PTSD, Clin Neurosci Div, New Haven, CT USA; [Averill, Christopher L.; Krystal, John; Abdallah, Chadi G.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Baugh, Lee A.; Forster, Gina L.; Fercho, Kelene A.] Univ South Dakota, Sanford Sch Med, Div Basic Biomed Sci, Vermillion, SD USA; [Baugh, Lee A.; Forster, Gina L.; Simons, Raluca M.; Fercho, Kelene A.] Univ South Dakota, Ctr Brain & Behav Res, Vermillion, SD USA; [Baugh, Lee A.; Simons, Jeffrey S.; Fercho, Kelene A.] Sioux Falls VA Hlth Care Syst, Sioux Falls, SD USA; [Bomyea, Jessica; Simmons, Alan; Kremen, William S.] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, La Jolla, CA USA; [Bomyea, Jessica; Simmons, Alan; Franz, Carol; Kremen, William S.; Stein, Murray B.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Bruce, Steven E.] Univ Missouri, Dept Psychol Sci, Ctr Trauma Recovery, St Louis, MO 63121 USA; [Cha, Jiook; Suarez-Jimenez, Benjamin; Zhu, Xi; Neria, Yuval] Columbia Univ, Dept Psychiat, Med Ctr, New York, NY USA; [Cha, Jiook; Suarez-Jimenez, Benjamin; Zhu, Xi; Neria, Yuval] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Choi, Kyle] Univ Calif San Diego, Hlth Serv Res Ctr, San Diego, CA 92103 USA; [Densmore, Maria; Neufeld, Richard W. J.; Theberge, Jean; Lanius, Ruth A.] Western Univ, Dept Psychiat, London, ON, Canada; [Densmore, Maria; Theberge, Jean; Lanius, Ruth A.] Lawson Hlth Res Inst, Imaging Div, London, ON, Canada; [du Plessis, Stefan; van den Heuvel, Leigh] Stellenbosch Univ, Dept Psychiat, Stellenbosch, South Africa; [Forster, Gina L.] Univ Otago, Brain Hlth Res Ctr, Dept Anat, Dunedin 9054, New Zealand; [Frijling, Jessie L.; Koch, Saskia B. J.; Nawijn, Laura; van Zuiden, Mirjam; Olff, Miranda] Univ Amsterdam, Amsterdam Univ Med Ctr, Locat Acad Med Ctr, Dept Psychiat,Amsterdam Neurosci, Amsterdam, Netherlands; [Gonenc, Atilla; Gruber, Staci] McLean Hosp, Cognit & Clin Neuroimaging Core, 115 Mill St, Belmont, MA 02178 USA; [Gonenc, Atilla; Gruber, Staci; Lebois, Lauren A. M.; Ressler, Kerry J.; Winternitz, Sherry; Kaufman, Milissa L.; McGlinchey, Regina; Milberg, William] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Grupe, Daniel W.; Davidson, Richard J.] Univ Wisconsin, Ctr Hlth Minds, Madison, WI USA; [Guenette, Jeffrey P.] Brigham & Womens Hosp, Div Neuroradiol, 75 Francis St, Boston, MA 02115 USA; [Hayes, Jasmeet] Ohio State Univ, Dept Psychol, Columbus, OH USA; [Hofmann, David; Straube, Thomas] Univ Munster, Inst Med Psychol & Syst Neurosci, Munster, Germany; [Ipser, Jonathan; Koopowitz, Sheri; Stein, Dan J.] Univ Cape Town, Dept Psychiat, SA Med Res Council Unit Risk & Resilience Mental, Cape Town, South Africa; [Ipser, Jonathan; Koopowitz, Sheri; Stein, Dan J.] Univ Cape Town, Neurosci Inst, Cape Town, South Africa; [Jovanovic, Tanja] Wayne State Univ, Sch Med, Dept Psychiat & Behav Neurosci, Detroit, MI USA; [Kelly, Sinead] Harvard Med Sch, Dept Psychiat, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Kennis, Mitzy; Geuze, Elbert] UMCU, Dept Psychiat, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Kennis, Mitzy; Geuze, Elbert] Minist Def, Brain Res & Innovat Ctr, Utrecht, Netherlands; [Kinzel, Philipp; Koerte, Inga] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Child & Adolescent Psychiat, Psychosomat & Psychotherapy, Munich, Germany; [Koch, Saskia B. J.; Ressler, Kerry J.] Radboud Univ Nijmegen, Ctr Cognit Neuroimaging, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Korgaonkar, Mayuresh] Univ Sydney, Brain Dynam Ctr, Westmead Inst Med Res, Westmead, NSW, Australia; [Lebois, Lauren A. M.; Wolff, Jonathan] McLean Hosp, Div Depress & Anxiety Disorders, 115 Mill St, Belmont, MA 02178 USA; [Li, Gen; Zhu, Ye; Wang, Li] Chinese Acad Sci, Inst Psychol, Lab Traumat Stress Studies, CAS Key Lab Mental Hlth, Beijing, Peoples R China; [Li, Gen; Zhu, Ye; Wang, Li] Univ Chinese Acad Sci, Dept Psychol, Beijing, Peoples R China; [Magnotta, Vincent A.] Univ Iowa, Dept Radiol, Iowa City, IA USA; [Magnotta, Vincent A.] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [Magnotta, Vincent A.] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA; [Manthey, Antje; Sierk, Anika; Walter, Henrik] Univ Med Ctr Charite, Berlin, Germany; [May, Geoff J.; Nelson, Steven M.; Gordon, Evan M.] VISN 17 Ctr Excellence Res Returning War Vet, Waco, TX USA; [May, Geoff J.; Nelson, Steven M.; Gordon, Evan M.] Baylor Univ, Dept Psychol & Neurosci, Waco, TX 76798 USA; [May, Geoff J.] Texas A&M Hlth Sci Ctr, Dept Psychiat & Behav Sci, Bryan, TX USA; [May, Geoff J.; Nelson, Steven M.; Gordon, Evan M.] Univ Texas Dallas, Ctr Vital Longev, Sch Behav & Brain Sci, Dallas, TX USA; [Menefee, Deleene S.] Baylor Coll Med, Menninger Dept Psychiat, Houston, TX 77030 USA; [Menefee, Deleene S.] South Cent MIRECC, Houston, TX USA; [Nawijn, Laura; Veltman, Dick J.] Vrije Univ Amsterdam, Amsterdam Univ Med Ctr, Locat VU Univ Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Neufeld, Richard W. J.] Western Univ, Dept Psychol, London, ON, Canada; [Neufeld, Richard W. J.; Lanius, Ruth A.] Western Univ, Dept Neurosci, London, ON, Canada; [Neufeld, Richard W. J.] Univ British Columbia, Dept Psychol, Okanagan, BC, Canada; [Nitschke, Jack B.; Davidson, Richard J.] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [O'Doherty, Daniel; Lagopoulos, Jim] Univ Sunshine Coast, Birtinya, Qld, Australia; [Peverill, Matthew] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Roos, Annerine; Seedat, Soraya] Stellenbosch Univ, South African Med Res Council, Dept Psychiat, Genom Brain Disorders Res Unit, Cape Town, South Africa; [Sheridan, Margaret A.] Univ N Carolina, Dept Psychol & Brain Sci, Chapel Hill, NC 27515 USA; [Simons, Raluca M.; Simons, Jeffrey S.] Univ South Dakota, Dept Psychol, Vermillion, SD USA; [Theberge, Jean] Western Univ, Dept Med Biophys, London, ON, Canada; [Tran, Jana K.] Houston Fire Dept, Houston, TX USA; [van der Werff, Steven J. A.; Vermeiren, Robert R. J. M.; van der Wee, Nic J. A.] LUMC, Dept Psychiat, Leiden, Netherlands; [van der Werff, Steven J. A.; van der Wee, Nic J. A.] Leiden Inst Brain & Cognit, Leiden, Netherlands; [Velez, Carmen; Wade, Benjamin S. C.; Tate, David F.] Missouri Inst Mental Hlth, St Louis, MO USA; [Velez, Carmen; Wade, Benjamin S. C.; Tate, David F.] VA Boston Healthcare Syst, Boston, MA USA; [Verfaellie, Mieke] VA Boston Healthcare Syst, Memory Disorders Res Ctr, Boston, MA USA; [Wade, Benjamin S. C.] Univ Calif Los Angeles, Dept Neurol, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90024 USA; [Wager, Tor] Dartmouth Coll, Hanover, NH 03755 USA; [Winternitz, Sherry; Kaufman, Milissa L.] McLean Hosp, Div Womens Mental Hlth, 115 Mill St, Belmont, MA 02178 USA; [York, Gerald] Joint Trauma Syst, 3698 Chambers Pass, Ft Sam Houston, TX USA; [York, Gerald] Alaska Radiol Associates, Anchorage, AK USA; [Bryant, Richard] Univ New South Wales, Sch Psychol, Sydney, NSW, Australia; [Daniels, Judith K.] Univ Groningen, Dept Clin Psychol, Groningen, Netherlands; [Davidson, Richard J.] Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA; [Fercho, Kelene A.] US Fed Aviat Adm, Civil Aerosp Med Inst, Oklahoma City, OK USA; [Franz, Carol; Kremen, William S.] Univ Calif San Diego, Ctr Behav Genet Aging, La Jolla, CA 92093 USA; [Lyons, Michael J.] Boston Univ, Dept Psychol & Brain Sci, Boston, MA 02215 USA; [McCauley, Stephen R.] Boston Univ, Dept Neurol, Boston, MA 02215 USA; [McCauley, Stephen R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [McCauley, Stephen R.; Wilde, Elisabeth A.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [McGlinchey, Regina] VA Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr, Boston, MA USA; [McGlinchey, Regina] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders, Boston, MA USA; [McLaughlin, Katie A.] Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA; [Milberg, William; Olff, Miranda] ARQ Natl Psychotrauma Ctr, Diemen, Netherlands; [Shenton, Martha] VA Boston Healthcare Syst, Brockton Div, Brockton, MA USA; [Stein, Murray B.] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Wilde, Elisabeth A.] George E Whalen Vet Affairs Med Ctr, Salt Lake City, UT USA; [Kochunov, Peter] Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Baltimore, MD 21201 USA		Dennis, EL (corresponding author), Brigham & Womens Hosp, Psychiat Neuroimaging Lab, Dept Psychiat, 75 Francis St, Boston, MA 02115 USA.; Dennis, EL (corresponding author), USC, Imaging Genet Ctr, Stevens Neuroimaging & Informat Inst, Keck Sch Med, Marina Del Rey, CA 90292 USA.; Dennis, EL (corresponding author), Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA.; Dennis, EL (corresponding author), Stanford Neurodev Affect & Psychopathol Lab, Stanford, CA 94305 USA.	emily.dennis@hsc.utah.edu	Stein, Dan J/A-1752-2008; Stevens, Jennifer/T-4290-2018; Averill, Christopher L./R-4036-2019; Gordon, Evan/J-5672-2019; Theberge, Jean/A-3087-2008; Simmons, Alan/A-9815-2008; Fani, Negar/O-8274-2017	Stein, Dan J/0000-0001-7218-7810; Stevens, Jennifer/0000-0003-4674-0314; Averill, Christopher L./0000-0001-7575-6142; Gordon, Evan/0000-0002-2276-5237; Theberge, Jean/0000-0001-7578-4469; Wade, Benjamin/0000-0003-2461-6101; Walter, Henrik/0000-0002-9403-6121; Dennis, Emily/0000-0001-7112-4009; Davidson, Richard/0000-0002-8506-4964; Gruber, Staci/0000-0002-6921-677X; Magnotta, Vincent/0000-0001-8639-5354; Baugh, Lee/0000-0001-6227-497X; van Zuiden, Mirjam/0000-0002-1225-2702; Clarke-Rubright, Emily/0000-0003-3553-2990; Simmons, Alan/0000-0003-3963-2112; Daniels, Judith/0000-0001-6304-2310; Fani, Negar/0000-0002-7720-252X	CIHRCanadian Institutes of Health Research (CIHR); CIMVHR; Dana Foundation; University of Wisconsin Institute for Clinical and Translational Research; National Science Foundation Graduate Research FellowshipNational Science Foundation (NSF) [R01MH043454, T32MH018931]; National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD003352]; Defense and Veterans Brain Injury Centers; U.S. Army Medical Research and Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-13-2-0025]; Chronic Effects of Neurotrauma Consortium (CENC) [PT108802-SC104835]; Department of DefenseUnited States Department of Defense [W81XWH-12-2-0012]; NIH from the Big Data to Knowledge (BD2K) programUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U54EB020403, R56AG058854, R01MH116147, R01MH111671, P41EB015922]; Department of Veterans AffairsUS Department of Veterans Affairs; NIAAAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); NCATSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS); DoDUnited States Department of Defense [W81XWH-101-0925]; Center for Brain and Behavior Research Pilot Grant; South Dakota Governor's Research Center Grant [F32MH109274]; Bill & Melinda Gates FoundationBill & Melinda Gates FoundationCGIAR; SAMRC Unit on Risk & Resilience in Mental Disorders; German Research Foundation grant [1222/4-1, 1539/8-2]; German Research Society (Deutsche Forschungsgemeinschaft, DFG)German Research Foundation (DFG) [SFB/TRR 58]; Clinical Science Research and Development Service, VA Office of Research and Development [MH098212, MH071537, M01RR00039, UL1TR000454, HD071982, HD085850, MH101380]; NARSADNARSAD [27040, K01MH109836]; Young Investigator Grant, Korean Scientists and Engineers Association; NHMRC ProgramNational Health and Medical Research Council of Australia [R01MH111671, 1073041, R01AG050595, R01AG022381, R01AG058822, R01EB015611, R01MH105355, R01DA035484, R01MH117601, R01AG059874, MJFF 14848, VISN6 MIRECC, R21MH112956]; Anonymous Women's Health Fund; Kasparian Fund; Trauma Scholars Fund; Barlow Family Fund; South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MRC-RFA-IFSP01-2013/SHARED ROOTS]; South African National Treasury under its Economic Competitiveness and Support Package; South African Medical Research Council through its Division of Research Capacity Development under the SAMRC CLINICIAN RESEARCHER (M.D PHD) SCHOLARSHIP PROGRAMME from the South African National Treasury; South African Research Chairs Initiative in Posttraumatic Stress Disorder through the Department of Science and Technology; National Research Foundation; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31271099, 31471004]; Research Program of the Chinese Academy of Sciences [ZDRW-XH-2019-4]; ZonMwNetherlands Organization for Health Research and Development; Netherlands organization for Health Research and DevelopmentNetherlands Organization for Health Research and Development [4000812-98-10041]; Academic Medical Center Research Council [110614]; Translational Research Center for TBI and Stress Disorders (TRACTS); VA Rehabilitation Research and Development (RR&D) Traumatic Brain Injury Center of Excellence at VA Boston Healthcare System [B9254-C]; VA CSRD [1IK2CX001680]; VISN17 Center of Excellence Pilot funding; VA RRD [1IK2RX000709, 1K1RX002325, 1K2RX002922, I01RX000622]; CDMRP from the US Department of Defense [W81XWH-08-2-0038, W81XWH08-2-0159];  [K99NS096116];  [I01-CX000715];  [I01-CX001542];  [K01MH118428];  [K23MH090366];  [K2CX001772]	K99NS096116 to ELD; CIHR, CIMVHR; Dana Foundation (to JBN); the University of Wisconsin Institute for Clinical and Translational Research (to Dr Emma Seppala); a National Science Foundation Graduate Research Fellowship (to DWG); R01MH043454 and T32MH018931 (to RJD); and a core grant to the Waisman Center from the National Institute of Child Health and Human Development (P30HD003352); Defense and Veterans Brain Injury Centers, the U.S. Army Medical Research and Materiel Command (USAMRMC; W81XWH-13-2-0025) and the Chronic Effects of Neurotrauma Consortium (CENC; PT108802-SC104835); Department of Defense award number W81XWH-12-2-0012; ENIGMA was also supported in part by NIH U54EB020403 from the Big Data to Knowledge (BD2K) program, R56AG058854, R01MH116147, R01MH111671, and P41EB015922; Department of Veterans Affairs via support for the National Center for PTSD, NIAAA via its support for (P50) Center for the Translational Neuroscience if Alcohol, and NCATS via its support of (CTSA) Yale Center for Clinical Investigation; DoD W81XWH-101-0925; Center for Brain and Behavior Research Pilot Grant; South Dakota Governor's Research Center Grant; F32MH109274; Funding from the Bill & Melinda Gates Foundation; Funding from the SAMRC Unit on Risk & Resilience in Mental Disorders; German Research Foundation grant to JKD (numbers DA 1222/4-1 and WA 1539/8-2).; German Research Society (Deutsche Forschungsgemeinschaft, DFG; SFB/TRR 58: C06, C07); I01-CX000715 & I01-CX001542; K01MH118428; K23MH090366; K2CX001772, Clinical Science Research and Development Service, VA Office of Research and Development; MH098212; MH071537; M01RR00039; UL1TR000454; HD071982; HD085850; MH101380; NARSAD 27040; NARSAD Young Investigator, K01MH109836, Young Investigator Grant, Korean Scientists and Engineers Association; NHMRC Program Grant #1073041; R01AG050595, R01AG022381; R01AG058822; R01EB015611; R01MH105355; R01MH105355, R01DA035484; R01MH111671, R01MH117601, R01AG059874, MJFF 14848; R01MH111671; VISN6 MIRECC; R21MH112956, Anonymous Women's Health Fund, Kasparian Fund, Trauma Scholars Fund, Barlow Family Fund; South African Medical Research Council for the "Shared Roots" Flagship Project, Grant no. MRC-RFA-IFSP01-2013/SHARED ROOTS" through funding received from the South African National Treasury under its Economic Competitiveness and Support Package. The work by LLvdH reported herein was made possible through funding by the South African Medical Research Council through its Division of Research Capacity Development under the SAMRC CLINICIAN RESEARCHER (M.D PHD) SCHOLARSHIP PROGRAMME from funding received from the South African National Treasury.; South African Research Chairs Initiative in Posttraumatic Stress Disorder through the Department of Science and Technology and the National Research Foundation.; the National Natural Science Foundation of China (No. 31271099, 31471004), the Key Research Program of the Chinese Academy of Sciences (No. ZDRW-XH-2019-4); The study was supported by ZonMw, the Netherlands organization for Health Research and Development (4000812-98-10041), and by a grant from the Academic Medical Center Research Council (110614) both awarded to MO.; Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development (RR&D) Traumatic Brain Injury Center of Excellence (B9254-C) at VA Boston Healthcare System.; ; VA CSR&D 1IK2CX001680; VISN17 Center of Excellence Pilot funding; VA CSR&D 822-MR-18176 and Senior Career Scientist Award; VA National Center for PTSD; VA RR&D 1IK2RX000709; VA RR&D 1K1RX002325; 1K2RX002922; VA RR&D I01RX000622; CDMRP W81XWH-08-2-0038; W81XWH08-2-0159 (PI: MBS) from the US Department of Defense. The views reflected here are strictly those of the authors and do not constitute endorsement by any of the funding sources listed here.	Abe O, 2006, PSYCHIAT RES-NEUROIM, V146, P231, DOI 10.1016/j.pscychresns.2006.01.004; Admon R, 2013, HUM BRAIN MAPP, V34, P2808, DOI 10.1002/hbm.22100; Antonow-Schlorke I, 2009, OBSTET GYNECOL, V113, P142, DOI 10.1097/AOG.0b013e3181924d3b; Aschbacher K, 2018, BRAIN IMAGING BEHAV, V12, P989, DOI 10.1007/s11682-017-9759-y; Asmundson GJG, 2000, BEHAV RES THER, V38, P203, DOI 10.1016/S0005-7967(99)00061-3; Atwoli L, 2015, CURR OPIN PSYCHIATR, V28, P307, DOI 10.1097/YCO.0000000000000167; Averill Christopher L, 2018, Mol Neuropsychiatry, V4, P75, DOI 10.1159/000490464; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bathina S, 2015, ARCH MED SCI, V11, P1164, DOI 10.5114/aoms.2015.56342; Bierer LM, 2015, PSYCHONEUROENDOCRINO, V51, P567, DOI 10.1016/j.psyneuen.2014.11.007; Boedhoe PSW, 2017, AM J PSYCHIAT, V174, P60, DOI 10.1176/appi.ajp.2016.16020201; Bolzenius JD, 2018, J HEAD TRAUMA REHAB, V33, P393, DOI 10.1097/HTR.0000000000000378; Brown PJ, 1999, PSYCHOL ADDICT BEHAV, V13, P115, DOI 10.1037/0893-164X.13.2.115; Brown PJ, 1996, PSYCHOL ADDICT BEHAV, V10, P124, DOI 10.1037/0893-164X.10.2.124; Campbell DG, 2007, J GEN INTERN MED, V22, P711, DOI 10.1007/s11606-006-0101-4; Cardenas VA, 2013, NEUROIMAGE-CLIN, V2, P804, DOI 10.1016/j.nicl.2013.06.002; Chen LZ, 2016, NEUROSCI BIOBEHAV R, V68, P838, DOI 10.1016/j.neubiorev.2016.07.022; Cloitre M, 2009, J TRAUMA STRESS, V22, P399, DOI 10.1002/jts.20444; Davenport ND, 2015, HUM BRAIN MAPP, V36, P1053, DOI 10.1002/hbm.22685; De Bellis MD, 2005, NEUROPSYCHOLOGY PTSD, P153; Dennis EL, 2018, I S BIOMED IMAGING, P1386, DOI 10.1109/ISBI.2018.8363830; Dretsch Michael N, 2017, Open Neuroimag J, V11, P46, DOI 10.2174/1874440001711010046; Durkee CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080952; Fani N, 2016, DEPRESS ANXIETY, V33, P300, DOI 10.1002/da.22483; Fani N, 2014, NEUROPSYCHOPHARMACOL, V39, P1206, DOI 10.1038/npp.2013.322; Fani N, 2012, NEUROPSYCHOPHARMACOL, V37, P2740, DOI 10.1038/npp.2012.146; Favre P, 2019, NEUROPSYCHOPHARMACOL, V44, P2285, DOI 10.1038/s41386-019-0485-6; Ferry F, 2014, SOC PSYCH PSYCH EPID, V49, P435, DOI 10.1007/s00127-013-0757-0; Frodl T, 2007, ARCH GEN PSYCHIAT, V64, P410, DOI 10.1001/archpsyc.64.4.410; Frodl T, 2012, J PSYCHIATR NEUROSCI, V37, P37, DOI 10.1503/jpn.110028; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Galinowski A, 2015, PSYCHOL MED, V45, P2285, DOI 10.1017/S0033291715000239; Geibprasert S, 2010, EUR RADIOL, V20, P1492, DOI 10.1007/s00330-009-1668-z; Ghosh SS, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00004; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Grant BF, 2004, DRUG ALCOHOL DEPEN, V74, P223, DOI 10.1016/j.drugalcdep.2004.02.004; Hart H, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00052; Hendricks AE, 2014, EUR J HUM GENET, V22, P414, DOI 10.1038/ejhg.2013.144; Hu H, 2016, J AFFECT DISORDERS, V190, P714, DOI 10.1016/j.jad.2015.09.044; Hunsberger Joshua, 2009, Dialogues Clin Neurosci, V11, P333; Jahanshad N, 2013, NEUROIMAGE, V81, P455, DOI 10.1016/j.neuroimage.2013.04.061; Jin C, 2014, PSYCHOL MED, V44, P1927, DOI 10.1017/S003329171300250X; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jovanovic T, 2009, PSYCHIAT RES, V167, P151, DOI 10.1016/j.psychres.2007.12.014; Kelly S, 2018, Mol Psychiatry, V23, P1261, DOI 10.1038/mp.2017.170; Kelly S, 2017, BIOL PSYCHIAT, V81, pS381, DOI 10.1016/j.biopsych.2017.02.667; Kennis M, 2016, NEUROIMAGE-CLIN, V10, P302, DOI 10.1016/j.nicl.2015.12.008; Kim MJ, 2005, NEUROREPORT, V16, P1049, DOI 10.1097/00001756-200507130-00004; Kim SJ, 2006, NEUROPSYCHOBIOLOGY, V54, P120, DOI 10.1159/000098262; Koch SBJ, 2017, J PSYCHIATR NEUROSCI, V42, P331, DOI 10.1503/jpn.160129; Kochunov P, 2012, NEUROBIOL AGING, V33, P9, DOI 10.1016/j.neurobiolaging.2010.01.014; Kochunov P, 2014, NEUROIMAGE, V95, P136, DOI 10.1016/j.neuroimage.2014.03.033; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lepage C, 2018, BRAIN IMAGING BEHAV, V12, P870, DOI 10.1007/s11682-017-9744-5; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Li L, 2016, EBIOMEDICINE, V4, P176, DOI 10.1016/j.ebiom.2016.01.012; Logue MW, 2018, BIOL PSYCHIAT, V83, P244, DOI 10.1016/j.biopsych.2017.09.006; Lyon M, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2019.101668; Maksimovskiy Arkadiy L, 2014, J Alcohol Drug Depend, V2, P144; Malivoire BL, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1716-9; Maller JJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37905-9; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Miller DR, 2017, BIOL PSYCHIAT-COGN N, V2, P363, DOI 10.1016/j.bpsc.2016.12.006; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; O'Doherty DCM, 2018, HUM BRAIN MAPP, V39, P1327, DOI 10.1002/hbm.23920; Olson EA, 2017, DEPRESS ANXIETY, V34, P437, DOI 10.1002/da.22615; Pechtel P, 2011, PSYCHOPHARMACOLOGY, V214, P55, DOI 10.1007/s00213-010-2009-2; Piras F, 2019, BIORXIV, DOI [DOI 10.1101/855916V1.FULL-TEXT, 10.1101/855916v1.full-text]; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Sanjuan PM, 2013, PSYCHIAT RES-NEUROIM, V214, P260, DOI 10.1016/j.pscychresns.2013.09.002; Santhanam P, 2019, J NEUROTRAUM, V36, P1093, DOI 10.1089/neu.2017.5541; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; Sexton CE, 2009, BIOL PSYCHIAT, V66, P814, DOI 10.1016/j.biopsych.2009.05.024; Shen XY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05507-6; Simmonds DJ, 2014, NEUROIMAGE, V92, P356, DOI 10.1016/j.neuroimage.2013.12.044; Sun YW, 2015, J AFFECT DISORDERS, V188, P80, DOI 10.1016/j.jad.2015.08.021; Sun YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083473; Taliaz D, 2011, J NEUROSCI, V31, P4475, DOI 10.1523/JNEUROSCI.5725-10.2011; Tapert SF, 2003, AGE, V16; Thompson PM, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-0705-1; UNO H, 1994, HORM BEHAV, V28, P336, DOI 10.1006/hbeh.1994.1030; van Velzen LS, 2020, MOL PSYCHIATR, V25, P1511, DOI 10.1038/s41380-019-0477-2; Villalon-Reina JE, 2018, PROC SPIE, V10975, DOI 10.1117/12.2513788; Vlasova RM, 2018, AM J GERIAT PSYCHIAT, V26, P874, DOI 10.1016/j.jagp.2018.04.004; Wang HH, 2010, J PSYCHIATR RES, V44, P385, DOI 10.1016/j.jpsychires.2009.10.001; Weis Carissa N, 2018, Chronic Stress (Thousand Oaks), V2, DOI 10.1177/2470547018807134; Zhang L, 2011, J AFFECT DISORDERS, V133, P294, DOI 10.1016/j.jad.2011.03.040	89	23	23	1	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	1359-4184	1476-5578		MOL PSYCHIATR	Mol. Psychiatr.	AUG	2021	26	8					4315	4330		10.1038/s41380-019-0631-x			16	Biochemistry & Molecular Biology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Neurosciences & Neurology; Psychiatry	XQ7GM	WOS:000731712800056	31857689	Green Submitted, Green Accepted			2022-02-06	
J	Lo, J; Chan, L; Flynn, S				Lo, Jessica; Chan, Leighton; Flynn, Spencer			A Systematic Review of the Incidence, Prevalence, Costs, and Activity and Work Limitations of Amputation, Osteoarthritis, Rheumatoid Arthritis, Back Pain, Multiple Sclerosis, Spinal Cord Injury, Stroke, and Traumatic Brain Injury in the United States: A 2019 Update	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Amputation; Arthritis; rheumatoid; Back pain; Brain injuries; traumatic; Cost of illness; Incidence; Multiple sclerosis; Osteoarthritis; Prevalence; Rehabilitation; Spinal cord injuries; Stroke	SYMPTOMATIC KNEE OSTEOARTHRITIS; LOWER-EXTREMITY AMPUTATION; CARE RESOURCE UTILIZATION; EMPLOYMENT OUTCOMES; ECONOMIC BURDEN; HEART-DISEASE; NATIONAL-HEALTH; RISK-FACTORS; LIMB LOSS; DISABILITY	Objectives: To present recent evidence on the prevalence, incidence, costs, activity limitations, and work limitations of common conditions requiring rehabilitation. Data Sources: Medline (PubMed), SCOPUS, Web of Science, and the gray literature were searched for relevant articles about amputation, osteoarthritis, rheumatoid arthritis, back pain, multiple sclerosis, spinal cord injury, stroke, and traumatic brain injury. Study Selection: Relevant articles (N=106) were included. Data Extraction: Two investigators independently reviewed articles and selected relevant articles for inclusion. Quality grading was performed using the Methodological Evaluation of Observational Research Checklist and Newcastle-Ottawa Quality Assessment Form. Data Synthesis: The prevalence of back pain in the past 3 months was 33.9% among community-dwelling adults, and patients with back pain contribute $365 billion in all-cause medical costs. Osteoarthritis is the next most prevalent condition (approximately 10.4%), and patients with this condition contribute $460 billion in all-cause medical costs. These 2 conditions are the most prevalent and costly (medically) of the illnesses explored in this study. Stroke follows these conditions in both prevalence (2.5%-3.7%) and medical costs ($28 billion). Other conditions may have a lower prevalence but are associated with relatively higher per capita effects. Conclusions: Consistent with previous findings, back pain and osteoarthritis are the most prevalent conditions with high aggregate medical costs. By contrast, other conditions have a lower prevalence or cost but relatively higher per capita costs and effects on activity and work. The data are extremely heterogeneous, which makes anything beyond broad comparisons challenging. Additional information is needed to determine the relative impact of each condition. Archives of Physical Medicine and Rehabilitation 2021;102:115-31 Published by Elsevier Inc. on behalf of the American Congress of Rehabilitation Medicine	[Lo, Jessica; Chan, Leighton; Flynn, Spencer] NIH, Rehabil Med Dept, Bethesda, MD 20892 USA		Chan, L (corresponding author), NIH, Clin Ctr, Rehabil Med Dept, Bldg 10,Rm 1-1469,10 Ctr Dr,MSC 1604, Bethesda, MD 20892 USA.	chanle@cc.nih.gov		Lo, Jessica/0000-0003-3429-5006; Flynn, Spencer/0000-0001-5854-3751	National Institutes of Health Intramural Research ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	Supported by the National Institutes of Health Intramural Research Program.	Agency for Healthcare Research and Quality, 2015, TOT EXP MILL COND US; [Anonymous], 2012, INT J STROKE, V11, P874; Armour BS, 2016, AM J PUBLIC HEALTH, V106, P1855, DOI 10.2105/AJPH.2016.303270; Arya R, 2012, INDIAN J PEDIATR, V79, P1482, DOI 10.1007/s12098-012-0763-3; Asemota AO, 2018, WORLD NEUROSURG, V120, pE114, DOI 10.1016/j.wneu.2018.07.228; Barbour KE, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6704a1; Barbour KE, 2017, MMWR-MORBID MORTAL W, V66, P246, DOI 10.15585/mmwr.mm6609e1; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Berkowitz M., 1998, SPINAL CORD INJURY A; Bernhard M, 2005, RESUSCITATION, V66, P127, DOI 10.1016/j.resuscitation.2005.03.005; Bishop M, 2015, REHABIL RES POL EDUC, V29, P135, DOI 10.1891/2168-6653.29.2.135; Blackwell DL., 2018, TABLES SUMMARY HLTH; Brenner AB, 2018, J AGING HEALTH, V30, P75, DOI 10.1177/0898264316666125; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Cancelliere C, 2017, J HEAD TRAUMA REHAB, V32, pE37, DOI 10.1097/HTR.0000000000000260; Carroll CA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-286; Centers for Disease Control and Prevention, 2017, STROK FACTS; Centers for Disease Control and Prevention, 2019, OST OA; Centers for Disease Control and Prevention, 2019, TBI GET FACTS; Centers for Disease Control and Prevention, DIS IMP ALL US; Centers for Disease Control and Prevention, 2014, SURV REP TRAUM BRAIN; Centers for Disease Control and Prevention National Center for Health Statistics, 2017, NATL HLTH NUTR EXAMI; Chan L, 1997, NEW ENGL J MED, V337, P978, DOI 10.1056/NEJM199710023371406; Chen AY, 2017, J CLIN NEUROSCI, V45, P180, DOI 10.1016/j.jocn.2017.06.005; Chen CI, 2018, RHEUMATOL ADV PRACT, V2, DOI 10.1093/rap/rky005; Chinthammit C, 2017, J STROKE CEREBROVASC, V26, P393, DOI 10.1016/j.jstrokecerebrovasdis.2016.09.040; Chopra A, 2018, J VASC SURG, V67, P1521, DOI 10.1016/j.jvs.2017.10.051; Cisternas MG, 2016, ARTHRIT CARE RES, V68, P574, DOI 10.1002/acr.22721; Corrigan JD, 2018, INJURY PREV, V24, P396, DOI 10.1136/injuryprev-2017-042371; Crane MM, 2015, ARTHRIT CARE RES, V67, P1646, DOI 10.1002/acr.22646; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Deeks J J, 2003, Health Technol Assess, V7, piii; Deshpande BR, 2016, ARTHRIT CARE RES, V68, P1743, DOI 10.1002/acr.22897; DeVivo MJ., 2011, TOP SPINAL CORD INJ, V16, P1, DOI DOI 10.1310/SCI1604-1; Dillahunt-Aspillaga C, 2017, J HEAD TRAUMA REHAB, V32, P271, DOI 10.1097/HTR.0000000000000275; Dilokthornsakul P, 2016, NEUROLOGY, V86, P1014, DOI 10.1212/WNL.0000000000002469; DiPiro ND, 2018, SPINAL CORD, V56, P218, DOI 10.1038/s41393-017-0031-5; DiSanto D, 2019, ARCH PHYS MED REHAB, V100, P412, DOI 10.1016/j.apmr.2018.06.022; Fang MC, 2014, AM J MED, V127, P608, DOI 10.1016/j.amjmed.2014.03.017; Finkelstein E., 2006, INCIDENCE EC BURDEN; Geiss LS, 2019, DIABETES CARE, V42, P50, DOI 10.2337/dc18-1380; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Goodney PP, 2014, JAMA SURG, V149, P34, DOI 10.1001/jamasurg.2013.4277; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Gunnarsson C, 2015, J OCCUP ENVIRON MED, V57, P635, DOI 10.1097/JOM.0000000000000461; Hall Margaret Jean, 2012, NCHS Data Brief, P1; Hall OT, 2019, ARCH PHYS MED REHAB, V100, P95, DOI 10.1016/j.apmr.2018.08.179; Hartung DM, 2017, NEUROTHERAPEUTICS, V14, P1018, DOI 10.1007/s13311-017-0566-3; Hermanowski T, 2015, POLISH ANN MED, V22, P143, DOI DOI 10.1016/J.POAMED.2015.07.003; Hresko A, 2018, ARTHRIT CARE RES, V70, P1431, DOI 10.1002/acr.23512; Hunter TM, 2017, RHEUMATOL INT, V37, P1551, DOI 10.1007/s00296-017-3726-1; Institute for Health Metrics and Evaluation, GBD RES TOOL; Ivanova JI, 2011, SPINE J, V11, P622, DOI 10.1016/j.spinee.2011.03.017; Jain NB, 2015, JAMA-J AM MED ASSOC, V313, P2236, DOI 10.1001/jama.2015.6250; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Johnson BH, 2016, CLINICOECONOMIC OUTC, V8, P53, DOI 10.2147/CEOR.S95662; Jones E, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1532-1; Joo H, 2014, NEUROLOGY, V83, P1831, DOI 10.1212/WNL.0000000000000986; Katan M, 2018, SEMIN NEUROL, V38, P208, DOI 10.1055/s-0038-1649503; Kerr Zachary Y, 2014, N C Med J, V75, P8; Kim C, 2014, ARTHRITIS RHEUMATOL, V66, P3013, DOI 10.1002/art.38795; Koton S, 2014, JAMA-J AM MED ASSOC, V312, P259, DOI 10.1001/jama.2014.7692; Krause JS, 2019, ARCH PHYS MED REHAB, V100, P931, DOI 10.1016/j.apmr.2018.11.005; Krause JS, 2018, J VOCAT REHABIL, V48, P177, DOI 10.3233/JVR-180931; Lekoubou A, 2018, J STROKE CEREBROVASC, V27, P1760, DOI 10.1016/j.jstrokecerebrovasdis.2018.02.003; Li N, 2019, J MED ECON, V22, P372, DOI 10.1080/13696998.2019.1572015; Losina E, 2015, ARTHRIT CARE RES, V67, P203, DOI 10.1002/acr.22412; Losina E, 2013, ARTHRIT CARE RES, V65, P703, DOI 10.1002/acr.21898; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; MacKenzie EJ, 2007, J BONE JOINT SURG AM, V89A, P1685, DOI 10.2106/JBJS.F.01350; MacKenzie EJ, 2006, J TRAUMA, V61, P688, DOI 10.1097/01.ta.0000195985.56153.68; Madsen TE, 2017, NEUROLOGY, V89, P990, DOI 10.1212/WNL.0000000000004325; Mahabaleshwarkar R, 2014, SPINAL CORD, V52, P139, DOI 10.1038/sc.2013.144; Makris UE, 2018, J AGING HEALTH, V30, P1482, DOI 10.1177/0898264317721555; Margolis DJ, 2014, DIABETES CARE, V37, P2296, DOI 10.2337/dc14-0788; Margolis JM, 2014, ARCH PHYS MED REHAB, V95, P2279, DOI 10.1016/j.apmr.2014.07.416; Marin JR, 2017, BRAIN INJURY, V31, P24, DOI 10.1080/02699052.2016.1217351; Marshall LM, 2017, J GERONTOL A-BIOL, V72, P1264, DOI 10.1093/gerona/glw227; Marshall LM, 2016, J GERONTOL A-BIOL, V71, P1177, DOI 10.1093/gerona/glv225; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000217, 10.1016/j.ijsu.2010.02.007]; Moore BJ., 2016, NATL INPATIENT HOSP; Moss AS, 2016, OSTEOARTHR CARTILAGE, V24, P1518, DOI 10.1016/j.joca.2016.04.012; Mu F, 2017, CURR MED RES OPIN, V33, P371, DOI 10.1080/03007995.2016.1257979; Murphy LB, 2018, ARTHRIT CARE RES, V70, P869, DOI 10.1002/acr.23425; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Myasoedova E, 2018, ANN RHEUM DIS, V77, P54, DOI 10.1136/annrheumdis-2018-eular.3788; Narres M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182081; National Spinal Cord Injury Center, 2019, SPINAL CORD INJURY F; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Newhall K, 2016, ANN VASC SURG, V30, P292, DOI 10.1016/j.avsg.2015.07.040; Ong KL, 2019, CLINICOECONOMIC OUTC, V11, P245, DOI 10.2147/CEOR.S170119; Ottomanelli L, 2009, J SPINAL CORD MED, V32, P503, DOI 10.1080/10790268.2009.11754553; Ovbiagele B, 2013, STROKE, V44, P2361, DOI 10.1161/STR.0b013e31829734f2; Parise H, 2013, J NEUROL SCI, V330, P71, DOI 10.1016/j.jns.2013.04.007; Pourhoseingholi Mohamad Amin, 2013, Gastroenterol Hepatol Bed Bench, V6, P14; Pretz CR, 2016, ARCH PHYS MED REHAB, V97, P1706, DOI 10.1016/j.apmr.2016.04.022; RTI International, 2017, CARD DIS ACOSTL BURD; Selvarajah S, 2014, J NEUROTRAUM, V31, P228, DOI 10.1089/neu.2013.3098; Shamliyan TA, 2011, DEV QUALITY CRITERIA; Shamliyan T, 2010, J CLIN EPIDEMIOL, V63, P1061, DOI 10.1016/j.jclinepi.2010.04.014; Shmagel A, 2016, ARTHRIT CARE RES, V68, P1688, DOI 10.1002/acr.22890; Shraim M, 2017, AM J IND MED, V60, P472, DOI 10.1002/ajim.22712; Skolarus LE, 2014, STROKE, V45, P224, DOI 10.1161/STROKEAHA.113.002874; Social Security Administration, 2019, SUMM ACT STAT SOC SE; Social Security Administration, 2019, ANN STAT REP SOC SEC; Stepanova M, 2013, J STROKE CEREBROVASC, V22, P491, DOI 10.1016/j.jstrokecerebrovasdis.2013.03.005; Strand V, 2018, J MANAG CARE SPEC PH, V24, P344, DOI 10.18553/jmcp.2018.24.4.344; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tennent DJ, 2018, INJURY, V49, P1193, DOI 10.1016/j.injury.2018.03.029; Tong X, 2003, TRENDS HOSP COST ASS; Trenaman L, 2015, J SPINAL CORD MED, V38, P422, DOI 10.1179/2045772315Y.0000000031; United States Bone and Joint Initiative, BURDEN MUSCULOSKELET; United States Department of Labor: Bureau of Labor Statistics, CONS PRIC IND; Wallin MT, 2019, NEUROLOGY, V92, pE1029, DOI 10.1212/WNL.0000000000007035; Wang GJ, 2014, J STROKE CEREBROVASC, V23, P861, DOI 10.1016/j.jstrokecerebrovasdis.2013.07.017; Wang SX, 2017, J MED ECON, V20, P1299, DOI 10.1080/13696998.2017.1377717; Wells G., NEWCASTLE OTTAWA SCA; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Wing JJ, 2017, ARCH GERONTOL GERIAT, V72, P1, DOI 10.1016/j.archger.2017.04.007; Yacoub Hussam A, 2015, J Vasc Interv Neurol, V8, P19; Yang HO, 2018, SPINE, V43, P28, DOI 10.1097/BRS.0000000000001665; Yang HO, 2016, J MANIP PHYSIOL THER, V39, P459, DOI 10.1016/j.jmpt.2016.07.004; Yin Hongjun, 2013, J Med Econ, V16, P820, DOI 10.3111/13696998.2013.801349; Ziegler-Graham K, 2008, ARCH PHYS MED REHAB, V89, P422, DOI 10.1016/j.apmr.2007.11.005	125	23	23	18	34	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2021	102	1					115	131		10.1016/j.apmr.2020.04.001			17	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	QA5ST	WOS:000613505800014	32339483	Green Accepted	Y	N	2022-02-06	
J	Neufeld, KJ; Leoutsakos, JMS; Yan, HJ; Lin, SH; Zabinski, JS; Dinglas, VD; Hosey, MM; Parker, AM; Hopkins, RO; Needham, DM				Neufeld, Karin J.; Leoutsakos, Jeannie-Marie S.; Yan, Haijuan; Lin, Shihong; Zabinski, Jeffrey S.; Dinglas, Victor D.; Hosey, Megan M.; Parker, Ann M.; Hopkins, Ramona O.; Needham, Dale M.			Fatigue Symptoms During the First Year Following ARDS	CHEST			English	Article						acute lung injury; cognitive function; depression; disability; rehabilitation	RESPIRATORY-DISTRESS-SYNDROME; CANCER-RELATED FATIGUE; POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; FUNCTIONAL PERFORMANCE INVENTORY; MINI-MENTAL-STATE; ACUTE LUNG INJURY; CRITICAL ILLNESS; HOSPITAL ANXIETY; SURVIVORS	BACKGROUND: Fatigue is commonly reported by ARDS survivors, but empirical data are scarce. RESEARCH QUESTION: This study evaluated fatigue prevalence and associated variables in a prospective study of ARDS survivors. STUDY DESIGN AND METHODS: This analysis is part of the ARDSNet Long-Term Outcomes Study (ALTOS) conducted at 38 US hospitals. Using ageand sex-adjusted, time-averaged random effects regression models, we evaluated associations between the validated Functional Assessment of Chronic Illness Therapy-Fatigue Scale with patient and critical illness variables, and with physical, cognitive, and mental health status at 6 and 12 months following ARDS. RESULTS: Among ARDS survivors, 501 of 711 (70%) and 436 of 659 (66%) reported clinically significant symptoms of fatigue at 6 and 12 months, respectively, with 41% and 28% reporting clinically important improvement and worsening (n 1/4 638). At 6 months, the prevalence of fatigue (70%) was greater than that of impaired physical functioning (50%), anxiety (42%), and depression (36%); 46% reported both impaired physical function and fatigue, and 27% reported co-existing anxiety, depression, and fatigue. Fatigue was less severe in men and in those employed prior to ARDS. Critical illness variables (eg, illness severity, length of stay) had little association with fatigue symptoms. Worse physical, cognitive, and mental health symptoms were associated with greater fatigue at both the 6and 12-month follow-up. INTERPRETATION: During the first year following ARDS, more than two-thirds of survivors reported clinically significant fatigue symptoms. Due to frequent co-occurrence, clinicians should evaluate and manage survivors' physical, cognitive, and mental health status when fatigue is endorsed.	[Neufeld, Karin J.; Leoutsakos, Jeannie-Marie S.; Yan, Haijuan; Lin, Shihong; Zabinski, Jeffrey S.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Dinglas, Victor D.; Parker, Ann M.; Needham, Dale M.] Johns Hopkins Univ, Sch Med, Div Pulm & Pulm & Crit Care Med, Baltimore, MD USA; [Hosey, Megan M.; Needham, Dale M.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Neufeld, Karin J.; Leoutsakos, Jeannie-Marie S.; Hosey, Megan M.; Parker, Ann M.; Needham, Dale M.] Johns Hopkins Univ, Sch Med, Outcomes Crit Illness & Surg OACIS Grp, Baltimore, MD USA; [Hopkins, Ramona O.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA; [Hopkins, Ramona O.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Hopkins, Ramona O.] Intermt Healthcare, Pulm & Crit Care Med, Murray, KY USA; [Hopkins, Ramona O.] Intermt Med Ctr, Ctr Humanizing Crit Care, Murray, KY USA		Neufeld, KJ (corresponding author), Johns Hopkins Bayview Med Ctr, A4Ctr,Ste 457,4940 Eastern Ave, Baltimore, MD 21224 USA.	kneufel2@jh.edu	Zabinski, Jeffrey/AAC-6415-2021; Hosey, Megan M./ABF-7208-2021		National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R24 HL111895, R01HL091760, R01HL091760-02S1]; Johns Hopkins Institute for Clinical and Translational Research [UL1 TR 000424-06]; Albuterol for Treatment of Acute Lung Injury Trial (ALTA); Omega Nutrition Supplement Trial (OMEGA); Statins for Acutely Injured Lungs from Sepsis Trial (SAILS) [National Heart, Lung, and Blood Institute] [HHSN268200536165C, HHSN268200536166C, HHSN268200536167C, HHSN268200536168C, HHSN268200536169C, HHSN268200536170C, HHSN268200536171C, HHSN268200536172C, HHSN268200536173C, HHSN268200536174C, HHSN268200536175C, HHSN268200536176C, HHSN268200536179C]; Early Versus Delayed Enteral Nutrition Trial (EDEN)	This research was supported by the National Heart, Lung, and Blood Institute [Grants R24 HL111895, R01HL091760, and R01HL091760-02S1], the Johns Hopkins Institute for Clinical and Translational Research [Grant UL1 TR 000424-06], and the Albuterol for Treatment of Acute Lung Injury Trial (ALTA), Early Versus Delayed Enteral Nutrition Trial (EDEN), Omega Nutrition Supplement Trial (OMEGA), and Statins for Acutely Injured Lungs from Sepsis Trial (SAILS) [National Heart, Lung, and Blood Institute contracts HHSN268200536165C to HHSN268200536176C and HHSN268200536179C].	Acaster S, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0257-x; Azoulay E, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1887-7; Barroso J, 2020, J PAIN SYMPTOM MANAG, V59, P242, DOI 10.1016/j.jpainsymman.2019.09.009; Berger AM, 2015, CA-CANCER J CLIN, V65, P190, DOI 10.3322/caac.21268; Bienvenu OJ, 2013, CHEST, V144, P24, DOI 10.1378/chest.12-0908; Cella D, 2005, J RHEUMATOL, V32, P811; Cella D, 2002, J PAIN SYMPTOM MANAG, V24, P547, DOI 10.1016/S0885-3924(02)00529-8; Cella D, 2002, CANCER-AM CANCER SOC, V94, P528, DOI 10.1002/cncr.10245; Chaboyer Wendy, 2003, Nurs Crit Care, V8, P149, DOI 10.1046/j.1478-5153.2003.00020.x; Chan KS, 2016, GEN HOSP PSYCHIAT, V42, P32, DOI 10.1016/j.genhosppsych.2016.07.004; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Davydow DS, 2008, PSYCHOSOM MED, V70, P512, DOI 10.1097/PSY.0b013e31816aa0dd; Desai SV, 2011, CRIT CARE MED, V39, P371, DOI 10.1097/CCM.0b013e3181fd66e5; Dinglas VD, 2016, THORAX, V71, P401, DOI 10.1136/thoraxjnl-2015-208017; Ebede CC, 2017, MED CLIN N AM, V101, P1085, DOI 10.1016/j.mcna.2017.06.007; Escalante CP, 2009, J GEN INTERN MED, V24, P412, DOI 10.1007/s11606-009-1056-z; Finlayson M, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1367-6; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goertz YMJ, 2019, THER ADV RESPIR DIS, V13, DOI 10.1177/1753466619878128; Hamilton L.C, 2017, STAT STATA 15; Herridge MS, 2016, INTENS CARE MED, V42, P725, DOI 10.1007/s00134-016-4321-8; Hopkins RO, 1999, AM J RESP CRIT CARE, V160, P50, DOI 10.1164/ajrccm.160.1.9708059; Jackson JC, 2014, LANCET RESP MED, V2, P369, DOI 10.1016/S2213-2600(14)70051-7; Khan F, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00177; Latronico N, 2017, INTENS CARE MED, V43, P1270, DOI 10.1007/s00134-017-4757-5; Leidy NK, 2012, INT J CHRONIC OBSTR, V7, P543, DOI 10.2147/COPD.S32032; Leidy NK, 1999, NURS RES, V48, P20, DOI 10.1097/00006199-199901000-00004; Lequerica AH, 2017, NEUROPSYCHOL REHABIL, V27, P1019, DOI 10.1080/09602011.2016.1231120; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Matthay MA, 2011, AM J RESP CRIT CARE, V184, P561, DOI 10.1164/rccm.201012-2090OC; Mohandas H, 2017, J CANCER RES THER, V13, P916, DOI 10.4103/jcrt.JCRT_50_17; Needham DM, 2016, LANCET RESP MED, V4, P203, DOI 10.1016/S2213-2600(16)00005-9; Needham Dale M, 2013, BMJ, V346, pf1532, DOI 10.1136/bmj.f1532; Nguyen S, 2017, ARCH PHYS MED REHAB, V98, P1508, DOI 10.1016/j.apmr.2017.02.031; Nikayin S, 2016, GEN HOSP PSYCHIAT, V43, P23, DOI 10.1016/j.genhosppsych.2016.08.005; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Parker AM, 2015, CRIT CARE MED, V43, P1121, DOI 10.1097/CCM.0000000000000882; Pearson EJM, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2415-9; Perazzo JD, 2017, J HOSP PALLIAT NURS, V19, P124, DOI 10.1097/NJH.0000000000000329; Rabiee A, 2016, CRIT CARE MED, V44, P1744, DOI 10.1097/CCM.0000000000001811; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rice TW, 2012, JAMA-J AM MED ASSOC, V307, P795, DOI 10.1001/jama.2012.137; Rice TW, 2011, JAMA-J AM MED ASSOC, V306, P1574; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; Spadaro S, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0554-z; Steenbergen S, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0121-x; Truwit JD, 2014, NEW ENGL J MED, V370, P2191, DOI 10.1056/NEJMoa1401520; Tur C, 2016, CURR TREAT OPTION NE, V18, DOI 10.1007/s11940-016-0411-8; Ware J., 2000, SCORE VERSION 2 SF 3; Wintermann GB, 2018, J INTENSIVE CARE, V6, DOI 10.1186/s40560-018-0295-7; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	51	23	23	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0012-3692	1931-3543		CHEST	Chest	SEP	2020	158	3					999	1007		10.1016/j.chest.2020.03.059			9	Critical Care Medicine; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Respiratory System	NQ3ZD	WOS:000570802000011	32304774	Green Published			2022-02-06	
J	Li, XW; Yang, Y; Zhao, HZ; Zhu, T; Yang, ZH; Xu, HY; Fu, YQ; Lin, F; Pan, XS; Li, L; Cui, C; Hong, M; Yang, L; Wang, KK; Tan, WH				Li, Xiaowei; Yang, Yu; Zhao, Hengzhi; Zhu, Tian; Yang, Zhihui; Xu, Haiyan; Fu, Yueqiang; Lin, Fan; Pan, Xiaoshu; Li, Long; Cui, Cheng; Hong, Min; Yang, Lu; Wang, Kevin K.; Tan, Weihong			Enhanced in Vivo Blood-Brain Barrier Penetration by Circular Tau-Transferrin Receptor Bifunctional Aptamer for Tauopathy Therapy	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							PROTEIN; AGGREGATION; ANTIBODIES; VITRO; MODEL	The lack of blood-brain barrier (BBB) penetrating ability has hindered the delivery of many therapeutic agents for tauopathy treatment. In this study, we report the synthesis of a circular bifunctional aptamer to enhance the in vivo BBB penetration for better tauopathy therapy. The circular aptamer consists of one reported transferrin receptor (TfR) aptamer to facilitate TfR-aptamer recognition-induced transcytosis across BBB endothelial cells, and one Tau protein aptamer that we recently selected to inhibit Tau phosphorylation and other tauopathy-related pathological events in the brain. This novel circular Tau-TfR bifunctional aptamer displays significantly improved plasma stability and brain exposure, as well as the ability to disrupt tauopathy and improve traumatic brain injury (TBI)-induced cognitive/memory deficits in vivo, providing important proof-of-principle evidence that circular Tau-TfR aptamer can be further developed into diagnostic and therapeutic candidates for tauopathies.	[Zhu, Tian; Yang, Zhihui; Xu, Haiyan; Fu, Yueqiang; Lin, Fan; Wang, Kevin K.] Univ Florida, McKnight Brain Inst, Dept Psychiat, Dept Emergency Med,Dept Neurosci, Gainesville, FL 32611 USA; [Wang, Kevin K.] Malcom Randall Vet Affairs Med Ctr, BRRC, Gainesville, FL 32608 USA; [Li, Xiaowei; Yang, Yu; Zhao, Hengzhi; Pan, Xiaoshu; Li, Long; Cui, Cheng; Yang, Lu; Tan, Weihong] Univ Florida, UF Genet Inst, Hlth Canc Ctr, Ctr Res Bio Nano Interface,Dept Chem, Gainesville, FL 32611 USA; [Li, Xiaowei; Yang, Yu; Zhao, Hengzhi; Pan, Xiaoshu; Li, Long; Cui, Cheng; Yang, Lu; Tan, Weihong] Univ Florida, UF Genet Inst, Hlth Canc Ctr, Ctr Res Bio Nano Interface,Dept Physiol & Funct G, Gainesville, FL 32611 USA; [Li, Xiaowei; Yang, Yu; Zhao, Hengzhi; Pan, Xiaoshu; Li, Long; Cui, Cheng; Yang, Lu; Tan, Weihong] Univ Florida, McKnight Brain Inst, Gainesville, FL 32611 USA; [Tan, Weihong] Hunan Univ, Aaptamer Engn Ctr Hunan Prov, Coll Biol,Coll Chem & Chem Engn, State Key Lab Chemo Biosensing & Chemometr,Mol Sc, Changsha 410082, Hunan, Peoples R China; [Tan, Weihong] Chinese Acad Sci, Inst Canc & Basic Med IBMC, Hangzhou 310022, Zhejiang, Peoples R China; [Tan, Weihong] Univ Chinese Acad Sci, Canc Hosp, Hangzhou 310022, Zhejiang, Peoples R China; [Hong, Min] Liaocheng Univ, Sch Chem & Chem Engn, Liaocheng 252059, Shandong, Peoples R China		Wang, KK (corresponding author), Univ Florida, McKnight Brain Inst, Dept Psychiat, Dept Emergency Med,Dept Neurosci, Gainesville, FL 32611 USA.; Tan, WH (corresponding author), Univ Florida, UF Genet Inst, Hlth Canc Ctr, Ctr Res Bio Nano Interface,Dept Chem, Gainesville, FL 32611 USA.; Tan, WH (corresponding author), Univ Florida, UF Genet Inst, Hlth Canc Ctr, Ctr Res Bio Nano Interface,Dept Physiol & Funct G, Gainesville, FL 32611 USA.; Tan, WH (corresponding author), Univ Florida, McKnight Brain Inst, Gainesville, FL 32611 USA.; Tan, WH (corresponding author), Hunan Univ, Aaptamer Engn Ctr Hunan Prov, Coll Biol,Coll Chem & Chem Engn, State Key Lab Chemo Biosensing & Chemometr,Mol Sc, Changsha 410082, Hunan, Peoples R China.; Tan, WH (corresponding author), Chinese Acad Sci, Inst Canc & Basic Med IBMC, Hangzhou 310022, Zhejiang, Peoples R China.; Tan, WH (corresponding author), Univ Chinese Acad Sci, Canc Hosp, Hangzhou 310022, Zhejiang, Peoples R China.	kwang@ufl.edu; tan@hnu.edu.cn		Yang, Yu/0000-0002-4518-3299	DODUnited States Department of Defense [AZ180105, 21827811]	We appreciate insightful scientific discussions with Drs. William E. Haskins and Henry Lowman of Gryphon Bio, Inc. This work is supported in part by DOD AZ180105 (William Haskins, K.K.W.), and 21827811 (W.H.T.).	Biffi A, 2011, J CLIN NEUROL, V7, P1, DOI 10.3988/jcn.2011.7.1.1; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Chakravarthy M, 2018, CHEM COMMUN, V54, P4593, DOI 10.1039/c8cc02256a; Chang HY, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0457-x; Chen CHB, 2008, P NATL ACAD SCI USA, V105, P15908, DOI 10.1073/pnas.0808360105; Cisek K, 2014, CURR ALZHEIMER RES, V11, P918, DOI 10.2174/1567205011666141107150331; Gotz J, 2012, BRIT J PHARMACOL, V165, P1246, DOI 10.1111/j.1476-5381.2011.01713.x; Guo T, 2017, ACTA NEUROPATHOL, V133, P665, DOI 10.1007/s00401-017-1707-9; Hu W, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00311; Iqbal K, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.225; Jiang Y, 2018, J AM CHEM SOC, V140, P6780, DOI 10.1021/jacs.8b03442; Kuai HL, 2017, J AM CHEM SOC, V139, P9128, DOI 10.1021/jacs.7b04547; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Li GL, 2010, ANN BIOMED ENG, V38, P2499, DOI 10.1007/s10439-010-0023-5; Liu D, 2014, ACS APPL MATER INTER, V6, P2131, DOI 10.1021/am405219u; Macdonald J, 2017, ACS CHEM NEUROSCI, V8, P777, DOI 10.1021/acschemneuro.6b00369; Macdonald J, 2016, NUCLEIC ACID THER, V26, P348, DOI 10.1089/nat.2015.0585; Mazanetz MP, 2007, NAT REV DRUG DISCOV, V6, P464, DOI 10.1038/nrd2111; Mietelska-Porowska A, 2014, INT J MOL SCI, V15, P4671, DOI 10.3390/ijms15034671; Omidi Y, 2003, BRAIN RES, V990, P95, DOI 10.1016/S0006-8993(03)03443-7; Pang XH, 2018, CANCERS, V10, DOI 10.3390/cancers10020047; Patel MM, 2017, CNS DRUGS, V31, P109, DOI 10.1007/s40263-016-0405-9; Paterson Judy, 2016, Drug Discov Today Technol, V20, P49, DOI 10.1016/j.ddtec.2016.07.009; Pulgar VM, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.01019; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rubenstein R, 2019, FRONT NEUROL, V10, P10; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Shamili FH, 2019, J CONTROL RELEASE, V299, P149, DOI 10.1016/j.jconrel.2019.02.032; Teng IT, 2018, J AM CHEM SOC, V140, P14314, DOI 10.1021/jacs.8b08645; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Tian T, 2018, ACS APPL MATER INTER, V10, P3414, DOI 10.1021/acsami.7b17927; van Dyck CH, 2018, BIOL PSYCHIAT, V83, P311, DOI 10.1016/j.biopsych.2017.08.010; Wang LL, 2018, J AM CHEM SOC, V140, P18066, DOI 10.1021/jacs.8b10783; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Wong KH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020381; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187017; Yu YJ, 2013, NEUROTHERAPEUTICS, V10, P459, DOI 10.1007/s13311-013-0187-4; Zheng Y, 2018, MOL THER-NUCL ACIDS, V11, P228, DOI 10.1016/j.omtn.2018.02.011; Zhou JH, 2017, NAT REV DRUG DISCOV, V16, P181, DOI 10.1038/nrd.2016.199	40	23	23	31	112	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863	1520-5126		J AM CHEM SOC	J. Am. Chem. Soc.	FEB 26	2020	142	8					3862	3872		10.1021/jacs.9b11490			11	Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	KR1DV	WOS:000517360400024	31991082				2022-02-06	
J	Bao, ZY; Fan, L; Zhao, L; Xu, XP; Liu, YL; Chao, HL; Liu, N; You, YP; Liu, Y; Wang, XM; Ji, J				Bao, Zhongyuan; Fan, Liang; Zhao, Lin; Xu, Xiupeng; Liu, Yinlong; Chao, Honglu; Liu, Ning; You, Yongping; Liu, Yan; Wang, Xiaoming; Ji, Jing			Silencing of A20 Aggravates Neuronal Death and Inflammation After Traumatic Brain Injury: A Potential Trigger of Necroptosis	FRONTIERS IN MOLECULAR NEUROSCIENCE			English	Article						necroptosis; inflammation; traumatic brain injury; A20; neuronal death	CASPASE-INDEPENDENT NECROPTOSIS; NF-KAPPA-B; MELATONIN; APOPTOSIS; CELLS; INHIBITION; ACTIVATION; UBIQUITINATION; UBIQUITYLATION; DEGENERATION	Programmed cell death is an important biological process that plays an indispensable role in traumatic brain injury (TBI). Inhibition of necroptosis, a type of programmed cell death, is pivotal in neuroprotection and in preventing associated inflammatory responses. Our results showed that necroptosis occurred in human brain tissues after TBI. Necroptosis was also induced by controlled cortical impact (CCI) injury in a rat model of TBI and was accompanied by high translocation of high-mobility group box-1 (HMGB1) to the cytoplasm. HMGB1 was then passed through the impaired cell membrane to upregulate the receptor for advanced glycation end-products (RAGE), nuclear factor(NF)-kappa B, and inflammatory factors such as interleukin-6 (IL-6), interleukin-1 (IL-1 beta), as well as NACHT, LRR and PYD domains-containing protein 3 (NLRP3). Necroptosis was alleviated by necrostatin-1 and melatonin but not Z-VAD (a caspase inhibitor), which is consistent with the characteristic of caspase-independent signaling. This study also demonstrated that tumor necrosis factor, alpha-induced protein 3 (TNFAIP3, also known as A20) was indispensable for regulating and controlling necroptosis and inflammation after CCI. We found that a lack of A20 in a CCI model led to aggressive necroptosis and attenuated the anti-necroptotic effects of necrostatin-1 and melatonin.	[Bao, Zhongyuan; Fan, Liang; Zhao, Lin; Xu, Xiupeng; Chao, Honglu; Liu, Ning; You, Yongping; Ji, Jing] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Fan, Liang] Nanchang Univ, Affiliated Hosp 1, Dept Neurosurg, Nanchang, Jiangxi, Peoples R China; [Liu, Yinlong] Nanjing Med Univ, Suzhou Municipal Hosp, Affiliated Suzhou Hosp, Dept Neurosurg, Suzhou, Peoples R China; [Liu, Yan] Nanjing Med Univ, Sch Pharm, Inst Stem Cell & Neural Regenerat, Nanjing, Jiangsu, Peoples R China; [Wang, Xiaoming] Nanjing Med Univ, Dept Immunol, Nanjing, Jiangsu, Peoples R China		Ji, J (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China.	jijing@njmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471269, 81472362, 81372709]; Jiangsu Province's Natural Science FoundationNatural Science Foundation of Jiangsu Province [BK20160047]; Jiangsu Province's Key Discipline of Medicine [XK201117]; Jiangsu Province Medical Key Talent [ZDRCB2016002]; Jiangsu Province Specially Engaged Expert [KF17]; Jiangsu Province Innovative Team; Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD)	This study was funded by grants from National Natural Science Foundation of China (Grant Nos. 81471269, 81472362 and 81372709), Jiangsu Province's Natural Science Foundation (Grant No. BK20160047), Jiangsu Province's Key Discipline of Medicine (Grant No. XK201117), Jiangsu Province Medical Key Talent (ZDRCB2016002), Jiangsu Province Specially Engaged Expert (Grant No. KF17), Jiangsu Province Innovative Team (Grant No. NR17) and the Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD).	Bi YH, 2017, CELL PHYSIOL BIOCHEM, V43, P481, DOI 10.1159/000480474; Booth LA, 2014, CELL SIGNAL, V26, P549, DOI 10.1016/j.cellsig.2013.11.028; Braun JS, 1999, NAT MED, V5, P298, DOI 10.1038/6514; Cabon L, 2012, CELL DEATH DIFFER, V19, P245, DOI 10.1038/cdd.2011.91; Calvo JR, 2013, J PINEAL RES, V55, P103, DOI 10.1111/jpi.12075; Chetsawang J, 2017, J EXP NEUROSCI, V11, DOI 10.1177/1179069517719237; Choi HS, 2015, TRANSL RES, V166, P292, DOI 10.1016/j.trsl.2015.04.002; Cui CM, 2017, CELL PHYSIOL BIOCHEM, V42, P1888, DOI 10.1159/000479571; Delavallee L, 2011, IUBMB LIFE, V63, P221, DOI 10.1002/iub.432; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Dondelinger Y, 2016, CELL MOL LIFE SCI, V73, P2165, DOI 10.1007/s00018-016-2191-4; Dusick Joshua R, 2012, Pituitary, V15, P2, DOI 10.1007/s11102-008-0130-6; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Esenaliev RO, 2018, J NEUROTRAUM, V35, P1510, DOI 10.1089/neu.2017.5249; Guedes RP, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-122; Gullo F, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00500; Hammer GE, 2011, NAT IMMUNOL, V12, P1184, DOI 10.1038/ni.2135; Han D, 2016, BRAIN BEHAV IMMUN, V51, P56, DOI 10.1016/j.bbi.2015.07.025; Heckmann BL, 2019, CELL DEATH DIFFER, V26, P41, DOI 10.1038/s41418-018-0195-3; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Hirose T, 2013, NATURE, V500, P354, DOI 10.1038/nature12329; Hu LY, 2018, BRAIN BEHAV IMMUN, V68, P132, DOI 10.1016/j.bbi.2017.10.011; Huang ZJ, 2018, CELL DEATH DIFFER, V25, P180, DOI 10.1038/cdd.2017.141; Kinsella S, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1143-3; Koshinuma S, 2014, J ANESTH, V28, P235, DOI 10.1007/s00540-013-1716-3; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Li JG, 2014, EXP THER MED, V7, P383, DOI 10.3892/etm.2013.1419; Li MF, 2013, CELL PHYSIOL BIOCHEM, V32, P1776, DOI 10.1159/000356611; Liao Y, 2017, ONCOTARGET, V8, P43201, DOI 10.18632/oncotarget.17970; Lin C, 2017, EXP NEUROL, V290, P115, DOI 10.1016/j.expneurol.2017.01.005; Lin C, 2016, J PINEAL RES, V61, P177, DOI 10.1111/jpi.12337; Liu T, 2016, SCI REP-UK, V6, DOI 10.1038/srep24547; Liu XW, 2019, INT IMMUNOPHARMACOL, V73, P108, DOI 10.1016/j.intimp.2019.05.005; Liu ZM, 2018, BIOCHEM BIOPH RES CO, V499, P112, DOI 10.1016/j.bbrc.2018.02.150; Lu JN, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01360; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; Manolidis G, 2004, Rom J Physiol, V41, P83; Martens S, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.298; Matmati M, 2011, NAT GENET, V43, P908, DOI 10.1038/ng.874; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; Meng ZY, 2017, J IMMUNOL, V198, P820, DOI 10.4049/jimmunol.1600334; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Ni HB, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00674; Onizawa M, 2015, NAT IMMUNOL, V16, P618, DOI 10.1038/ni.3172; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Polykratis A, 2019, NAT CELL BIOL, V21, P731, DOI 10.1038/s41556-019-0324-3; Remijsen Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.531; Ruhl D, 2019, J NEUROSCI, V39, P2951, DOI 10.1523/JNEUROSCI.1384-18.2019; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shen HT, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.58; Stengel A, 2011, NEUROGASTROENT MOTIL, V23, pE294, DOI 10.1111/j.1365-2982.2011.01721.x; Su Z, 2016, CELL DEATH DIFFER, V23, P748, DOI 10.1038/cdd.2016.8; Sun W, 2016, FREE RADICAL BIO MED, V92, P61, DOI 10.1016/j.freeradbiomed.2016.01.014; Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176; Tian Y, 2014, J PINEAL RES, V56, P1, DOI 10.1111/jpi.12081; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vucic D, 2011, NAT REV MOL CELL BIO, V12, P439, DOI 10.1038/nrm3143; Wang G, 2016, APOPTOSIS, V21, P121, DOI 10.1007/s10495-015-1192-3; Wang Y, 2014, NEUROSCIENCE, V266, P91, DOI 10.1016/j.neuroscience.2014.02.007; Wen SH, 2017, J CELL MOL MED, V21, P432, DOI 10.1111/jcmm.12987; Witt A, 2017, CELL DEATH DIFFER, V24, P1160, DOI 10.1038/cdd.2017.33; Wong CS, 2014, NEUROSCIENCE, V267, P147, DOI 10.1016/j.neuroscience.2014.02.032; Wu HJ, 2016, J PINEAL RES, V61, P241, DOI 10.1111/jpi.12344; Xu X, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0934-2; Yang FJ, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/2301903; Yang JS, 2010, J NEUROTRAUM, V27, P1037, DOI 10.1089/neu.2009.1229; Zhan J, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0731-3; Zhang XH, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1490-8; Zheng Cui-Fang, 2016, World J Gastrointest Pharmacol Ther, V7, P540; Zhu FM, 2017, AM J TRANSL RES, V9, P1694; Zille M, 2017, STROKE, V48, P1033, DOI 10.1161/STROKEAHA.116.015609	71	23	26	3	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5099			FRONT MOL NEUROSCI	Front. Molec. Neurosci.	SEP 19	2019	12								222	10.3389/fnmol.2019.00222			21	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IZ7TZ	WOS:000487303000002	31607859	Green Published, gold			2022-02-06	
J	Fino, PC; Becker, LN; Fino, NF; Griesemer, B; Goforth, M; Brolinson, PG				Fino, Peter C.; Becker, Lauren N.; Fino, Nora F.; Griesemer, Brett; Goforth, Michael; Brolinson, Per Gunnar			Effects of Recent Concussion and Injury History on Instantaneous Relative Risk of Lower Extremity Injury in Division I Collegiate Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; lower extremity injury; musculoskeletal injury; brain injury	TRAUMATIC BRAIN-INJURY; GAIT STABILITY; INTERNATIONAL-CONFERENCE; MUSCULOSKELETAL INJURY; CONSENSUS STATEMENT; LOCOMOTOR DEFICITS; DYNAMIC STABILITY; BALANCE CONTROL; SPORT HELD; ATTENTION	Background: Growing evidence suggests that concussion increases the risk of lower extremity (LE) musculoskeletal injury. However, it is unclear to how the effect of concussion on LE injury risk may be influenced by previous injuries. This study sought to examine the association between concussion, previous LE injuries, and the risk LE injury to the same previously injured limb (ipsilateral) or the opposite limb (contralateral). Methods: This retrospective study examined medical records from 110 concussed athletes and 110 matched controls for LE injuries in the 365 days before and after the concussion event. The effect of concussion on time to injury was assessed with a Cox proportional hazard model after adjusting for injury history. Fine and Gray subdistribution models assessed the cumulative risk of ipsilateral and contralateral injury by group. Results: Concussion was associated with an increased instantaneous relative risk of LE injury when adjusting for LE injury history [hazard ratio (HR) = 1.67, 95% confidence interval (CI) = 1.11-2.53], agreeing with previous results. Among individuals who had a history of LE injuries before the concussion event, a nonsignificant yet moderate effect of concussion on the instantaneous relative risk of ipsilateral injuries was found after adjusting for the competing risk of contralateral injuries and censored values (HR = 1.85, 95% CI = 0.76-4.46). Conclusions: This study provides independent confirmation of previous studies, reporting an association between concussion and LE injury risk. Furthermore, this study suggests that future large-scale studies should consider the competing risk of ipsilateral, contralateral, and new injuries in populations with an injury history.	[Fino, Peter C.] Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd,OP-32, Portland, OR 97239 USA; [Fino, Peter C.] Virginia Polytech Inst & State Univ, Dept Mech Engn, Blacksburg, VA 24061 USA; [Becker, Lauren N.; Brolinson, Per Gunnar] Edward Via Coll Osteopath Med, Blacksburg, VA USA; [Fino, Nora F.] Oregon Hlth & Sci Univ, Biostat & Design Program, Portland, OR 97201 USA; [Griesemer, Brett; Goforth, Michael; Brolinson, Per Gunnar] Virginia Polytech Inst & State Univ, Dept Sports Med, Blacksburg, VA 24061 USA		Fino, PC (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd,OP-32, Portland, OR 97239 USA.	fino@ohsu.edu		Fino, Peter/0000-0002-8621-3706	National Science Foundation Graduate Research FellowshipNational Science Foundation (NSF) [DGE 0822220]	This material is based on work supported by the National Science Foundation Graduate Research Fellowship under Grant No. DGE 0822220.	Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P417, DOI 10.1016/j.jshs.2015.03.010; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Catena RD, 2009, EXP BRAIN RES, V194, P67, DOI 10.1007/s00221-008-1669-1; Chiu SL, 2013, GAIT POSTURE, V38, P717, DOI 10.1016/j.gaitpost.2013.03.010; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Cossette I, 2016, BRAIN INJURY, V30, P1648, DOI 10.1080/02699052.2016.1200143; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Fino PC, 2016, GAIT POSTURE, V50, P69, DOI 10.1016/j.gaitpost.2016.08.026; Fino PC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0177-y; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; Fulton J, 2014, INT J SPORTS PHYS TH, V9, P583; Gilbert FC, 2016, SPORTS HEALTH, V8, P661, DOI 10.1177/1941738116666509; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McFadyen BJ, 2009, ARCH PHYS MED REHAB, V90, P1596, DOI 10.1016/j.apmr.2009.03.010; Murphy DF, 2003, BRIT J SPORT MED, V37, P13, DOI 10.1136/bjsm.37.1.13; Niechwiej-Szwedo E, 2007, GAIT POSTURE, V25, P70, DOI 10.1016/j.gaitpost.2006.01.002; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Powers KC, 2014, GAIT POSTURE, V39, P728, DOI 10.1016/j.gaitpost.2013.10.005; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Reed N., 2013, NEUROL NEUROPHYSIOL, V4, P171, DOI DOI 10.4172/2155-9562.1000171; Seifert TD, 2013, HEADACHE, V53, P726, DOI 10.1111/head.12087; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Swanik CB, 2007, AM J SPORT MED, V35, P943, DOI 10.1177/0363546507299532; TENENBAUM G, 1993, HDB RES SPORT PSYCHO, P171; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524	37	23	23	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2019	29	3					218	223		10.1097/JSM.0000000000000502			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	IQ4QT	WOS:000480736100008	31033615				2022-02-06	
J	Mohamed, AZ; Cumming, P; Gotz, J; Nasrallah, F				Mohamed, Abdalla Z.; Cumming, Paul; Gotz, Jurgen; Nasrallah, Fatima		Dept Def Alzheimers Dis	Tauopathy in veterans with long-term posttraumatic stress disorder and traumatic brain injury	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Article						Traumatic brain injury; Posttraumatic stress disorder; Alzheimer's disease; Tau; Positron emission tomography; US Department of Defense Alzheimer's Disease Neuroimaging Initiative	AMYLOID-BETA PLAQUES; ALZHEIMERS-DISEASE; HIPPOCAMPAL VOLUME; TAU PATHOLOGY; ACCUMULATION; ONSET; RISK; PTSD; PET; MICROTUBULES	Purpose Traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD) have emerged as independent risk factors for an earlier onset of Alzheimer's disease (AD), although the pathophysiology underlying this risk is unclear. Postmortem studies have revealed extensive cerebral accumulation of tau following multiple and single TBI incidents. We hypothesized that a history of TBI and/or PTSD may induce an AD-like pattern of tau accumulation in the brain of nondemented war veterans. Methods Vietnam War veterans (mean age 71.4 years) with a history of war-related TBI and/or PTSD underwent [F-18]AV145 PET as part of the US Department of Defense Alzheimer's Disease Neuroimaging Initiative. Subjects were classified into the following four groups: healthy controls (n = 21), TBI (n = 10), PTSD (n = 32), and TBI+PTSD (n = 17). [F-18]AV1451 reference tissue-normalized standardized uptake value (SUVr) maps, scaled to the cerebellar grey matter, were tested for differences in tau accumulation between groups using voxel-wise and region of interest approaches, and the SUVr results were correlated with neuropsychological test scores. Results Compared to healthy controls, all groups showed widespread tau accumulation in neocortical regions overlapping with typical and atypical patterns of AD-like tau distribution. The TBI group showed higher tau accumulation than the other clinical groups. The extent of tauopathy was positively correlated with the neuropsychological deficit scores in the TBI+PTSD and PTSD groups. Conclusion A history of TBI and/or PTSD may manifest in neurocognitive deficits in association with increased tau deposition in the brain of nondemented war veterans decades after their trauma. Further investigation is required to establish the burden of increased risk of dementia imparted by earlier TBI and/or PTSD.	[Mohamed, Abdalla Z.; Gotz, Jurgen; Nasrallah, Fatima] Univ Queensland, Queensland Brain Inst, Bldg 79,Upland Rd, Brisbane, Qld 4072, Australia; [Cumming, Paul] Queensland Univ Technol, Sch Psychol & Counselling, Brisbane, Qld 4059, Australia; [Cumming, Paul] Queensland Univ Technol, IHBI, Brisbane, Qld 4059, Australia; [Cumming, Paul] QIMR Berghofer Inst, Brisbane, Qld 4006, Australia; [Gotz, Jurgen] Univ Queensland, Queensland Brain Inst, CJCADR, Brisbane, Qld 4072, Australia		Nasrallah, F (corresponding author), Univ Queensland, Queensland Brain Inst, Bldg 79,Upland Rd, Brisbane, Qld 4072, Australia.	a.mohamed@uq.edu.au; f.nasrallah@uq.edu.au	Mohaned, Abdalla/ABF-9320-2021; Mohamed, Abdalla/ABG-8718-2021; Mohaned, Abdalla/AAL-8721-2020; Gotz, Jurgen/C-2448-2014; Nasrallah, Fatima/N-3398-2016	Mohaned, Abdalla/0000-0003-4499-672X; Mohaned, Abdalla/0000-0003-4499-672X; Gotz, Jurgen/0000-0001-8501-7896; Cumming, Paul/0000-0002-0257-9621; Nasrallah, Fatima/0000-0002-7385-9559	Motor Accident Insurance Commission (MAIC); Queensland Government, Australia [2014000857]; Wesley Hospital Medical Research Foundation, Brisbane, Australia; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 AG024904]; ADNI-DOD (Department of Defense) [W81XWH-12-2-0012]	This research was sponsored by the Motor Accident Insurance Commission (MAIC), the Queensland Government, Australia (grant 2014000857) and the Wesley Hospital Medical Research Foundation, Brisbane, Australia (grant 2016-19). Collection and sharing of data for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health grant U01 AG024904) and ADNI-DOD (Department of Defense award number W81XWH-12-2-0012).	Ahmadzadeh H, 2015, BIOPHYS J, V109, P2328, DOI 10.1016/j.bpj.2015.09.010; Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Alway Y, 2016, DEPRESS ANXIETY, V33, P19, DOI 10.1002/da.22396; Amen DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129659; Andersson JLR, 2007, TR07JA2 FMRIB, P21; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Cho H, 2017, NEUROBIOL AGING, V53, P103, DOI 10.1016/j.neurobiolaging.2017.01.024; Clark CM, 2012, LANCET NEUROL, V11, P669, DOI 10.1016/S1474-4422(12)70142-4; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Cummins T, 2016, J NUCL MED, V57; Daviglus ML, 2011, ARCH NEUROL-CHICAGO, V68, P1185, DOI 10.1001/archneurol.2011.100; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Dickstein DL, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.175; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Giannopoulos PF, 2013, AGING CELL, V12, P1082, DOI 10.1111/acel.12136; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Ikonomovic MD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0399-z; Isoniemi H, 2006, NEUROLOGY, V67, P756, DOI 10.1212/01.wnl.0000234140.64954.12; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Jack CR, 2014, ACTA NEUROPATHOL, V128, P773, DOI 10.1007/s00401-014-1362-3; Johnson KA, 2016, ANN NEUROL, V79, P110, DOI 10.1002/ana.24546; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Joshi S, 2017, MIL MED, V182, P124, DOI 10.7205/MILMED-D-16-00282; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kerbler GM, 2015, NEUROIMAGE-CLIN, V7, P105, DOI 10.1016/j.nicl.2014.11.015; Klein E, 2003, CAN J PSYCHIAT, V48, P28, DOI 10.1177/070674370304800106; Lemoine L, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0325-z; Li CZ, 2017, EMBO J, V36, P3120, DOI 10.15252/embj.201797724; Li W, 2016, J NEUROL, V263, P1280, DOI 10.1007/s00415-016-8093-4; Lindauer RJL, 2005, PSYCHOL MED, V35, P1421, DOI 10.1017/S0033291705005246; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Marquie M, 2017, ACTA NEUROPATHOL, V134, P619, DOI 10.1007/s00401-017-1740-8; Marquie M, 2015, ANN NEUROL, V78, P787, DOI 10.1002/ana.24517; Miller MW, 2015, PSYCHONEUROENDOCRINO, V62, P359, DOI 10.1016/j.psyneuen.2015.09.003; Mohamed AZ, 2018, NEUROIMAGE-CLIN, V19, P716, DOI 10.1016/j.nicl.2018.05.016; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Palmqvist S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01150-x; Phillips JS, 2018, HUM BRAIN MAPP, V39, P691, DOI 10.1002/hbm.23874; Polanco JC, 2018, NAT REV NEUROL, V14, P22, DOI 10.1038/nrneurol.2017.162; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Regehr C, 2017, J AM ACAD PSYCHIATRY, V45, P184; Schwarz AJ, 2016, BRAIN, V139, P1539, DOI 10.1093/brain/aww023; van Rooij SJH, 2015, PSYCHOL MED, V45, P2737, DOI 10.1017/S0033291715000707; Weiner MW, 2017, NEUROLOGY, V89, P1923, DOI 10.1212/WNL.0000000000004608; Weiner Michael W, 2015, Alzheimers Dement, V11, pe1, DOI 10.1016/j.jalz.2014.11.001; Weiner MW, 2012, ALZHEIMERS DEMENT, V9, pe111; Xia CF, 2013, ALZHEIMERS DEMENT, V9, P666, DOI 10.1016/j.jalz.2012.11.008; Xue C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120270; Yaffe K, 2010, ARCH GEN PSYCHIAT, V67, P608, DOI 10.1001/archgenpsychiatry.2010.61; Yao YM, 2005, ANN NEUROL, V58, P623, DOI 10.1002/ana.20558	56	23	27	3	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	MAY	2019	46	5					1139	1151		10.1007/s00259-018-4241-7			13	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Radiology, Nuclear Medicine & Medical Imaging	HS2DW	WOS:000463672300014	30617964	Green Published, hybrid			2022-02-06	
J	Donvito, G; Piscitelli, F; Muldoon, P; Jackson, A; Vitale, RM; D'Aniello, E; Giordano, C; Ignatowska-Jankowska, BM; Mustafa, MA; Guida, F; Petrie, GN; Parker, L; Smoum, R; Sim-Selley, L; Maione, S; Lichtman, AH; Damaj, MI; Di Marzo, V; Mechoulam, R				Donvito, Giulia; Piscitelli, Fabiana; Muldoon, Pretal; Jackson, Asti; Vitale, Rosa Maria; D'Aniello, Enrico; Giordano, Catia; Ignatowska-Jankowska, Bogna M.; Mustafa, Mohammed A.; Guida, Francesca; Petrie, Gavin N.; Parker, Linda; Smoum, Reem; Sim-Selley, Laura; Maione, Sabatino; Lichtman, Aron H.; Damaj, M. Imad; Di Marzo, Vincenzo; Mechoulam, Raphael			N-Oleoyl-glycine reduces nicotine reward and withdrawal in mice	NEUROPHARMACOLOGY			English	Article						N-oleoyl glycine; Nicotine withdrawal; Cannabinoid receptor-1 (CB1); Conditioned place preference (CPP); Insular cortex; Peroxisome proliferator-activated receptor alpha (PPAR-alpha)	INSULAR CORTEX; ACETYLCHOLINE-RECEPTOR; CANNABINOID RECEPTORS; MOLECULAR-DYNAMICS; DOPAMINE; ACID; ADDICTION; SMOKING; SEEKING; SYSTEM	Cigarette smokers with brain damage involving the insular cortex display cessation of tobacco smoking, suggesting that this region may contribute to nicotine addiction. In the present study, we speculated that molecules in the insular cortex that are sensitive to experimental traumatic brain injury (TBI) in mice might provide leads to ameliorate nicotine addiction. Using targeted lipidomics, we found that TBI elicited substantial increases of a largely uncharacterized lipid, N-acyl-glycine, N-oleoyl-glycine (OlGly), in the insular cortex of mice. We then evaluated whether intraperitoneal administration of OlGly would alter withdrawal responses in nicotine-dependent mice as well as the rewarding effects of nicotine, as assessed in the conditioned place preference paradigm (CPP). Systemic administration of OlGly reduced mecamylamine-precipitated withdrawal responses in nicotine-dependent mice and prevented nicotine CPP. However, OlGly did not affect morphine CPP, demonstrating a degree of selectivity. Our respective in vitro and in vivo observations that OlGly activated peroxisome proliferator-activated receptor alpha (PPAR-alpha) and the PPAR-alpha antagonist GW6471 prevented the OlGly-induced reduction of nicotine CPP in mice suggests that this lipid acts as a functional PPAR-alpha agonist to attenuate nicotine reward. These findings raise the possibility that the long chain fatty acid amide OlGly may possess efficacy in treating nicotine addiction. (C) 2018 Published by Elsevier Ltd.	[Donvito, Giulia; Muldoon, Pretal; Jackson, Asti; Ignatowska-Jankowska, Bogna M.; Mustafa, Mohammed A.; Sim-Selley, Laura; Lichtman, Aron H.; Damaj, M. Imad] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Med Coll Virginia Campus, Richmond, VA USA; [Piscitelli, Fabiana; Vitale, Rosa Maria; D'Aniello, Enrico; Di Marzo, Vincenzo] CNR, Inst Biomol Chem, Endocannabinoid Res Grp, Via Campi Flegrei 34, I-80078 Naples, Italy; [Giordano, Catia; Guida, Francesca; Maione, Sabatino] Univ Naples 2, Pharmacol Sect, Dept Expt Med, Endocannabinoid Res Grp, Naples, Italy; [Petrie, Gavin N.; Parker, Linda] Univ Guelph, Dept Psychol, Guelph, ON, Canada; [Petrie, Gavin N.; Parker, Linda] Univ Guelph, Collaborat Neurosci Grad Program, Guelph, ON, Canada; [Smoum, Reem; Mechoulam, Raphael] Hebrew Univ Jerusalem, Fac Med, Inst Drug Res, Jerusalem, Israel; [D'Aniello, Enrico] Stn Zool Anton Dohrn, Dept Biol & Evolut Marine Organisms, Naples, Italy; [Lichtman, Aron H.] Virginia Commonwealth Univ, Dept Med Chem, Med Coll Virginia Campus, Richmond, VA USA		Di Marzo, V (corresponding author), CNR, Inst Biomol Chem, Endocannabinoid Res Grp, Via Campi Flegrei 34, I-80078 Naples, Italy.; Lichtman, AH; Damaj, MI (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, POB 980613,Kontos Med Sci Bldg, Richmond, VA 23298 USA.	alichtma@vcu.edu; m.damaj@vcuhealth.org; vdimarzo@icb.cnr.it	Di Marzo, Vincenzo/AAD-7742-2019; Vitale, Rosa Maria/AAY-1522-2020; Piscitelli, Fabiana/A-7100-2014; Ignatowska-Jankowska, Bogna/T-2021-2019	Di Marzo, Vincenzo/0000-0002-1490-3070; Vitale, Rosa Maria/0000-0001-9243-1307; Ignatowska-Jankowska, Bogna/0000-0002-8427-1128; Maione, Sabatino/0000-0003-3850-6704	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P01DA009789, R01DA039942, P30DA033934, R01 DA032246, P50DA039841, T32DA007027]; VCU School of Pharmacy; NSERCNatural Sciences and Engineering Research Council of Canada (NSERC) [92056]; CIHRCanadian Institutes of Health Research (CIHR) [137122]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA032246, R01DA039942, P30DA033934, T32DA007027, P50DA039841] Funding Source: NIH RePORTER	This work was supported by NIH grants P01DA009789, R01DA039942, P30DA033934 (AHL); R01 DA032246 and P50DA039841 (MID), T32DA007027 (AJ), and startup funds from the VCU School of Pharmacy. NSERC (92056) and CIHR (137122) grants to LAP.	Abdolahi A, 2010, EUR J NEUROSCI, V31, P733, DOI 10.1111/j.1460-9568.2010.07114.x; Alajaji M, 2016, NEUROPHARMACOLOGY, V105, P308, DOI 10.1016/j.neuropharm.2016.01.032; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Bisogno T, 2009, EUR J LIPID SCI TECH, V111, P53, DOI 10.1002/ejlt.200800233; Boger DL, 1998, P NATL ACAD SCI USA, V95, P4810, DOI 10.1073/pnas.95.9.4810; Bradshaw HB, 2009, VITAM HORM, V81, P191, DOI 10.1016/S0083-6729(09)81008-X; Burstein SH, 2011, J CELL BIOCHEM, V112, P3227, DOI 10.1002/jcb.23245; Case D.A., 2014, AMBER 14; Castane A, 2005, PHARMACOL BIOCHEM BE, V81, P381, DOI 10.1016/j.pbb.2005.01.025; Castane A, 2002, NEUROPHARMACOLOGY, V43, P857, DOI 10.1016/S0028-3908(02)00118-1; Chaturvedi S, 2006, PROSTAG OTH LIPID M, V81, P136, DOI 10.1016/j.prostaglandins.2006.09.001; Chatzakos V, 2012, LIPIDS, V47, P355, DOI 10.1007/s11745-011-3639-9; Cohen A, 2015, ADDICT BIOL, V20, P56, DOI 10.1111/adb.12077; Cohen-Yeshurun A, 2011, J CEREBR BLOOD F MET, V31, P1768, DOI 10.1038/jcbfm.2011.53; De Biasi M, 2011, ANNU REV NEUROSCI, V34, P105, DOI 10.1146/annurev-neuro-061010-113734; DEVANE WA, 1988, MOL PHARMACOL, V34, P605; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Fedorova I, 2001, J PHARMACOL EXP THER, V299, P332; Forget B, 2010, BIOL PSYCHIAT, V68, P265, DOI 10.1016/j.biopsych.2010.01.029; Forget B, 2009, PSYCHOPHARMACOLOGY, V205, P613, DOI 10.1007/s00213-009-1569-5; Gamaleddin I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029900; Gamaleddin IH, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00041; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Hassinen T, 2001, J COMPUT CHEM, V22, P1229, DOI 10.1002/jcc.1080; Heishman SJ, 2010, PSYCHOPHARMACOLOGY, V210, P453, DOI 10.1007/s00213-010-1848-1; Huitron-Resendiz S, 2004, SLEEP, V27, P857, DOI 10.1093/sleep/27.5.857; Ignatowska-Jankowska BM, 2015, NEUROPSYCHOPHARMACOL, V40, P2948, DOI 10.1038/npp.2015.148; Ignatowska-Jankowska BM, 2013, PSYCHOPHARMACOLOGY, V229, P591, DOI 10.1007/s00213-013-3117-6; Jackson A, 2017, NEUROPHARMACOLOGY, V118, P38, DOI 10.1016/j.neuropharm.2017.03.005; Jackson KJ, 2008, J PHARMACOL EXP THER, V325, P302, DOI 10.1124/jpet.107.132977; Jackson KJ, 2009, NEUROPHARMACOLOGY, V56, P970, DOI 10.1016/j.neuropharm.2009.01.023; Justinova Z, 2015, NEUROPSYCHOPHARMACOL, V40, P2185, DOI 10.1038/npp.2015.62; Kota D, 2007, J PHARMACOL EXP THER, V322, P399, DOI 10.1124/jpet.107.121616; Kutlu MG, 2013, BEHAV BRAIN RES, V256, P273, DOI 10.1016/j.bbr.2013.08.005; Le Foll B, 2004, NEUROREPORT, V15, P2139, DOI 10.1097/00001756-200409150-00028; LITTLE PJ, 1988, J PHARMACOL EXP THER, V247, P1046; MARTIN BR, 1991, PHARMACOL BIOCHEM BE, V40, P471, DOI 10.1016/0091-3057(91)90349-7; Mascia P, 2011, BIOL PSYCHIAT, V69, P633, DOI 10.1016/j.biopsych.2010.07.009; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Melis M, 2014, PHARMACOL RES, V86, P42, DOI 10.1016/j.phrs.2014.03.009; Melis M, 2013, J NEUROSCI, V33, P6203, DOI 10.1523/JNEUROSCI.4647-12.2013; Merritt LL, 2008, J PHARMACOL EXP THER, V326, P483, DOI 10.1124/jpet.108.138321; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Naqvi NH, 2007, SCIENCE, V315, P531, DOI 10.1126/science.1135926; Naqvi NH, 2014, ANN NY ACAD SCI, V1316, P53, DOI 10.1111/nyas.12415; Naqvi NH, 2010, BRAIN STRUCT FUNCT, V214, P435, DOI 10.1007/s00429-010-0268-7; Navarrete F, 2013, NEUROPSYCHOPHARMACOL, V38, P2515, DOI 10.1038/npp.2013.157; Ortar G, 2007, J MED CHEM, V50, P6554, DOI 10.1021/jm070678q; Panlilio LV, 2012, NEUROPSYCHOPHARMACOL, V37, P1838, DOI 10.1038/npp.2012.31; Perkins KA, 2016, NICOTINE TOB RES, V18, P74, DOI 10.1093/ntr/ntv085; Piscitelli F, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-51; Pushparaj A, 2015, BEHAV BRAIN RES, V290, P77, DOI 10.1016/j.bbr.2015.04.039; Pushparaj A, 2013, NEUROPSYCHOPHARMACOL, V38, P690, DOI 10.1038/npp.2012.235; Robinson JD, 2018, ADDICT BIOL, V23, P291, DOI 10.1111/adb.12508; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Scheggi S, 2016, NEUROPHARMACOLOGY, V110, P251, DOI 10.1016/j.neuropharm.2016.07.024; Simonnet A, 2013, ADDICT BIOL, V18, P930, DOI 10.1111/j.1369-1600.2012.00476.x; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Valjent E, 2002, BRIT J PHARMACOL, V135, P564, DOI 10.1038/sj.bjp.0704479; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang SB, 2015, BIOCHEM BIOPH RES CO, V466, P438, DOI 10.1016/j.bbrc.2015.09.046; Watkins S S, 2000, Nicotine Tob Res, V2, P19; Wiley JL, 2003, EUR J PHARMACOL, V471, P185, DOI 10.1016/S0014-2999(03)01856-9	64	23	23	2	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	APR	2019	148						320	331		10.1016/j.neuropharm.2018.03.020			12	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	HR4OE	WOS:000463125000031	29567093	Green Accepted			2022-02-06	
J	Rubin, LH; Tierney, R; Kawata, K; Wesley, L; Lee, JH; Blennow, K; Zetterberg, H; Langford, D				Rubin, Leah H.; Tierney, Ryan; Kawata, Keisuke; Wesley, Leroy; Lee, Jong Hyun; Blennow, Kaj; Zetterberg, Henrik; Langford, Dianne			NFL blood levels are moderated by subconcussive impacts in a cohort of college football players	BRAIN INJURY			English	Article						Subconcussive; traumatic brain injury; neurofilament light chain; biomarker; head impact kinematics	SERUM NEUROFILAMENT LIGHT; TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; NERVOUS-SYSTEM; BIOMARKERS; PROTEIN; DISEASE; CHAIN	Introduction: Repetitive subconcussive head impacts in contact/collision sports such as in US football are believed to contribute to long-term brain changes and chronic symptoms. However, the lack of tools to measure the effects of repeated subconcussion limits our understanding of potential contributions to neuropathological alterations including cellular damage. Methods: We examined subconcussive head impacts using an accelerometer-embedded mouthguard on changes in blood levels of neurofilament light (NFL) chain in 18 Division I college football players. Plasma levels of NFL and clinical symptoms were assessed at pre-post practices. The frequency and linear and rotational head accelerations recorded via the mouthguard were examined in relation to NFL plasma changes. Results: The frequency and magnitude of head impacts associated with increased NFL levels. The greater numbers of hits and head accelerations associated with greater pre- to post-practice NFL level increases (p < 0.05). Greater pre- to post-practice increases in NFL also associated with greater pre- to post-practice increases in S100 beta (p < 0.001), but not with total tau. Years of football experience and concussion history did not associate with changes in NFL. Conclusion: Acute changes in NFL may be a clinically useful peripheral marker in tracking acute brain damage in collegiate football players, and other contact sports.	[Rubin, Leah H.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Tierney, Ryan] Temple Univ, Sch Publ Hlth, Dept Kinesiol, Philadelphia, PA 19122 USA; [Kawata, Keisuke] Indiana Univ, Dept Kinesiol, Sch Publ Hlth, Bloomington, IN 47405 USA; [Wesley, Leroy; Lee, Jong Hyun; Langford, Dianne] Temple Univ, Dept Neurosci, Lewis Katz Sch Med, MERB 750,3500 North Broad St, Philadelphia, PA 19140 USA; [Blennow, Kaj; Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden; [Blennow, Kaj; Zetterberg, Henrik] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UCL, Inst Neurol, Dept Mol Neurosci, Queen Sq, London, England; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England		Langford, D (corresponding author), Temple Univ, Dept Neurosci, Lewis Katz Sch Med, MERB 750,3500 North Broad St, Philadelphia, PA 19140 USA.	tdl@temple.edu			Pennsylvania Athletic Trainers' Society; Temple University Office of the Vice Provost for Research	This work was supported by the Pennsylvania Athletic Trainers' Society; Temple University Office of the Vice Provost for Research [NA]; Athole Jacobi, MD [n/a].	Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Byrne LM, 2017, LANCET NEUROL, V16, P601, DOI 10.1016/S1474-4422(17)30124-2; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Di Battista AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164912; Di Battista AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159929; Disanto G, 2017, ANN NEUROL, V81, P857, DOI 10.1002/ana.24954; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gisslen M, 2016, EBIOMEDICINE, V3, P135, DOI 10.1016/j.ebiom.2015.11.036; Hansson O, 2017, NEUROLOGY, V88, P930, DOI 10.1212/WNL.0000000000003680; Jonsson M, 2010, EUR J NEUROL, V17, P377, DOI 10.1111/j.1468-1331.2009.02808.x; Kawata K, 2016, INT J SPORTS MED, V37, P405, DOI 10.1055/s-0035-1569290; Kawata K, 2017, J NEUROTRAUM, V34, P2254, DOI 10.1089/neu.2016.4786; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; Lepinoux-Chambaud C, 2013, HISTOCHEM CELL BIOL, V140, P13, DOI 10.1007/s00418-013-1101-1; Lu CH, 2015, NEUROLOGY, V84, P2247, DOI 10.1212/WNL.0000000000001642; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Rohrer JD, 2016, NEUROLOGY, V87, P1329, DOI 10.1212/WNL.0000000000003154; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; TROJANOWSKI JQ, 1986, J NEUROSCI, V6, P650; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	25	23	23	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR 21	2019	33	4					456	462		10.1080/02699052.2019.1565895			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HL7QM	WOS:000458936100008	30776989	Green Submitted			2022-02-06	
J	Maegele, M; Lefering, R; Sakowitz, O; Kopp, MA; Schwab, JM; Steudel, WI; Unterberg, A; Hoffmann, R; Uhl, E; Marzi, I				Maegele, Marc; Lefering, Rolf; Sakowitz, Oliver; Kopp, Marcel A.; Schwab, Jan M.; Steudel, Wolf-Ingo; Unterberg, Andreas; Hoffmann, Reinhard; Uhl, Eberhard; Marzi, Ingo			The Incidence and Management of Moderate to Severe Head Injury A Retrospective Analysis of Data From the Trauma Register of the German Trauma Society	DEUTSCHES ARZTEBLATT INTERNATIONAL			English	Article							BRAIN-INJURY; UNITED-STATES; EPIDEMIOLOGY; PREVENTION; EUROPE	Background: The comprehensive expansion of the Trauma Register of the German Trauma Society (Deutsche Gesellschaft fur Unfallchirurgie; TR-DGU) now enables, for the first time, studies on traumatic brain injury (TBI) with special attention to care processes, clinical course, and outcomes of treatment on discharge or transfer from the acute-care hospital. Methods: Retrospective analysis of patients documented in the TR-DGU in the period 2013-2017 who had moderate to severe head injury as defined by the Abbreviated Injury Scale (AIS). Results: In the period 2013-2017, 41 101 patients with moderate to severe TBI were treated in TR-DGU-associated hospitals in Germany (n = 605 hospitals), corresponding to 8220 cases per year and thus to a population-wide incidence of 10.1 cases per 100 000 persons per year. TBI was present as an isolated injury in 39.1% of cases. The mean age of the patients was 60 years (median; range 0-104 years), and the male-to-female ratio was 2: 1. 97.5% of the patients had blunt trauma. Falls from a low height were the most common cause of TBI (38.7%). 43.6% of the patients were intubated before arriving at the hospital, and more than 95% underwent cranial tomographic imaging within 22 minutes of arrival (standard deviation [SD] = 17 minutes). 18.4% underwent an emergency neurosurgical procedure. The in-hospital mortality was 23.5%, corresponding to a population-wide mortality from TBI of 2.4 per 100 000 persons per year. More than half of the patients recovered well or with only mild disability; 14.9% had persistent severe disability or remained in a vegetative state. Conclusion: Putting these figures in the appropriate international context requires the acquisition of comparable data in multiple countries and is the main task of international TBI consortia.	[Maegele, Marc] Witten Herdecke Univ, Cologne Merheim Med Ctr, Dept Orthopaed Surg Trauma Surg & Sports Med, Cologne, Germany; [Maegele, Marc; Lefering, Rolf] Witten Herdecke Univ, Inst Res Operat Med IFOM, Cologne, Germany; [Sakowitz, Oliver] Heidelberg Univ, Acad Teaching Hosp, RKH Klinikum Ludwigsburg, Neurosurg Ctr Ludwigsburg Heilbronn, Ludwigsburg, Germany; [Kopp, Marcel A.; Schwab, Jan M.] Charite Univ Med Berlin, Dept Neurol Expt Neurol, Berlin, Germany; [Kopp, Marcel A.; Schwab, Jan M.] Berlin Inst Hlth QUEST, BIH Ctr Transforming Biomed Res, Berlin, Germany; [Schwab, Jan M.] Ohio State Univ, Spinal Cord Injury Div, Dept Neurol & Neurosci, Columbus, OH 43210 USA; [Steudel, Wolf-Ingo] Saarland Univ, Med Ctr, Homburg, Germany; [Unterberg, Andreas] Heidelberg Univ Hosp, Dept Neurosurg, Heidelberg, Germany; [Hoffmann, Reinhard] BG Trauma Ctr Frankfurt Main, Frankfurt, Germany; [Uhl, Eberhard] Univ Giessen Marburg Giessen, Dept Neurosurg Giessen, Giessen, Germany; [Marzi, Ingo] JW Goethe Univ Hosp, Dept Trauma Hand & Reconstruct Surg, Frankfurt, Germany		Maegele, M (corresponding author), Univ Witten Herdecke Campus Koln Merheim, IFOM, Klin Unfallchirurg Orthopadie & Sporttraumatol, Kliniken Stadt Koln Merheim, Ostmerheimer Str 200, D-51109 Cologne, Germany.	Marc.Maegele@t-online.de	Kopp, Marcel/AAX-3960-2020	Kopp, Marcel/0000-0001-6832-9599; Schwab, Jan/0000-0001-6784-4919; Sakowitz, Oliver/0000-0003-3248-6335	Kuratorium ZNS-Hannelore Kohl-Stiftung; German Social Accident Insurance (Deutsche Gesetzliche Unfallversicherung, DGUV)	The creation of a nationwide TBI cohort in synchrony with the TR-DGU and international TBI consortia received important initial financial support from the Kuratorium ZNS-Hannelore Kohl-Stiftung and from the German Social Accident Insurance (Deutsche Gesetzliche Unfallversicherung, DGUV).	Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Cole TB, 2004, JAMA-J AM MED ASSOC, V291, P2531, DOI 10.1001/jama.291.21.2531; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Firsching R, 2017, J NEUROL SURG PART A, V78, P478, DOI 10.1055/s-0037-1599239; Firsching R, 2001, WORLD J SURG, V25, P1221; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Fu TS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145469; Gennarelli A, 2008, ABBREVIATED INJURY S; Gesundheitberichterstattung des Bundes, GES BUND DIAGN KRANK; Hillier SL, 1997, BRAIN INJURY, V11, P649; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; LI M, 2016, GEN MED LOS ANGELES, V4, DOI DOI 10.1186/S13073-016-0341-9; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Maegele M, 2007, EUR SURG RES, V39, P372, DOI 10.1159/000107097; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Wutzler S, 2009, J AM COLL SURGEONS, V209, P75, DOI 10.1016/j.jamcollsurg.2009.03.015; 2014, INJURY S3, V45, P6, DOI DOI 10.1016/j.injury.2014.08.011	27	23	24	0	1	DEUTSCHER AERZTE-VERLAG GMBH	COLOGNE	DIESELSTRABE 2, POSTFACH 400265, D-50859 COLOGNE, GERMANY	1866-0452			DTSCH ARZTEBL INT	Dtsch. Arztebl. Int.	MAR 8	2019	116	10					167	173		10.3238/arztebl.2019.0167			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0OI	WOS:000464969800002	30995953	Green Published			2022-02-06	
J	van Essen, TA; den Boogert, HF; Cnossen, MC; de Ruiter, GCW; Haitsma, I; Polinder, S; Steyerberg, EW; Menon, D; Maas, AIR; Lingsma, HF; Peul, WC; Cecilia, A; Hadie, A; Vanni, A; Judith, A; Krisztina, A; Norberto, A; Nada, A; Lasse, A; Azasevac, A; Audny, A; Anna, A; Hilko, A; Gerard, A; Kaspars, A; Philippe, A; Luisa, AM; Camelia, B; Rafael, B; Ronald, B; Pal, B; Ursula, B; Romuald, B; Ronny, B; Javier, BF; Bo-Michael, B; Antonio, B; Remy, B; Habib, B; Thierry, B; Maurizio, B; Luigi, B; Christopher, B; Federico, B; Harald, B; Erta, B; Morten, B; Hugo, D; Pierre, B; Peter, B; Alexandra, B; Vibeke, B; Joanne, B; Camilla, B; Andras, B; Monika, B; Emiliana, C; Rosa, CM; Peter, C; Guillermo, CL; Marco, C; Elsa, C; Carpenter, K; Ana, CL; Francesco, C; Giorgio, C; Arturo, C; Giuseppe, C; Maryse, C; Mark, C; Jonathan, C; Lizzie, CK; Johnny, C; Jamie, DC; Marta, C; Amra, C; Nicola, C; Endre, C; Marek, C; Claire, DF; Francois, D; Pierre, D; Helen, D; Veronique, D; Francesco, DC; Bart, D; Godard, CWD; Dula, D; Ding, SH; Diederik, D; Abhishek, D; Emma, D; Jens, D; Guy-Loup, D; George, E; Heiko, E; Ari, E; Patrick, E; Erzsebet, E; Martin, F; Valery, LF; Feng, JF; Kelly, F; Francesca, F; Gilles, F; Ulderico, F; Shirin, F; Alex, F; Pablo, G; Damien, G; Dashiell, G; Gao, GY; Karin, G; Pradeep, G; Alexandre, G; Lelde, G; Benoit, G; Ben, G; Jagos, G; Pedro, AG; Francesca, G; Russell, LG; Deepak, G; Juanita, AH; Iain, H; Jed, AH; Raimund, H; Eirik, H; Daniel, H; Astrid, H; Stefan, H; Lindsay, H; Jilske, H; Peter, JH; Kristine, HA; Bram, J; Stefan, J; Mike, J; Bojan, J; Jiang, JY; Kelly, J; Konstantinos, K; Mladen, K; Ari, K; Maija, K; Thomas, K; Riku, K; Angelos, GK; Balint, K; Erwin, K; Ksenija, K; Daniel, K; Lars-Owe, K; Noemi, K; Alfonso, L; Linda, L; Steven, L; Fiona, L; Christian, L; Rolf, L; Valerie, L; Jin, L; Leon, L; Roger, L; Hester, L; Dirk, L; Angels, L; Andrew, IRM; Stephen, M; Marc, M; Marek, M; Sebastian, M; Alex, M; Geoffrey, M; Didier, M; Francisco, ML; Costanza, M; Armando, M; Hugues, M; Alessandro, M; Julia, M; Charles, M; Catherine, M; Bela, M; David, M; Tomas, M; Cristina, MK; Davide, M; Visakh, M; Lynnette, M; Holger, M; Nandesh, N; Ancuta, N; David, N; Virginia, N; Daan, N; Quentin, N; Jozsef, N; Mauro, O; Annemarie, O; Matej, O; Fabrizio, O; Aarno, P; Paul, MP; Adriana, P; Jean-Francois, P; Natascha, P; Vincent, P; Paolo, P; PeulWilco; Anna, PK; Sebastien, PF; Matti, P; Horia, P; Antonia, PM; Suzanne, P; Inigo, P; Jussi, P; Louis, P; Andreea, R; Arminas, R; Rahul, R; Malinka, R; Ruben, R; Veronika, R; Jonathan, R; Samuli, R; Saulius, R; Cecilie, R; Olav, R; Gerwin, R; Jonathan, R; Jeffrey, R; Christina, R; Guy, R; Rolf, R; Sandra, R; Daniel, R; Martin, R; Marco, S; Barbara, S; Juan, S; Oliver, S; Francesca, S; Renan, SP; Janos, S; Edgar, S; Luminita, S; Davide, S; Nadine, S; Inger, S; Barbara, S; Silke, S; Herbert, S; Guus, S; Frederik, SR; Elisabeth, S; Michael, S; Ozcan, S; Toril, S; Lidwien, S; Dirk, S; Peter, S; Abayomi, S; Emmanuel, S; Simon, S; Nicole, S; Ana, S; Robert, S; William, S; Ewout, WS; Nino, S; Nina, S; Anneliese, S; Silvio, TF; Riikka, T; Viktoria, T; Paivi, T; Steven, TM; Braden, TA; Olli, T; Ralph, T; Guido, T; Alice, T; Matt, T; Dick, T; Christos, T; Luaba, TJF; Tony, T; Maria, TC; Peter, V; Shirley, V; Egils, V; Gregory, V; Mathieu, V; Joukje, V; Jeroen, TJMV; Thomas, AV; Wim, V; Caroline, V; Dominique, V; Thijs, VV; Julia, V; Audrey, V; Alessia, V; Emmanuel, V; Kimberley, V; Jan, V; Paul, MV; Anne, V; Rimantas, V; Giacinta, V; Carmen, VL; Victor, V; Daphne, V; Peter, V; Zoltan, V; Derick, W; Kevin, KWW; Lei, W; Lars, W; Eno, W; Guy, W; Lindsay, W; Maren, KLW; Stefan, W; Peter, Y; Alexander, Y; Menashe, Z; Yang, ZH; Agate, Z; Fabrizio, Z				van Essen, Thomas A.; den Boogert, Hugo F.; Cnossen, Maryse C.; de Ruiter, Godard C. W.; Haitsma, Iain; Polinder, Suzanne; Steyerberg, Ewout W.; Menon, David; Maas, Andrew I. R.; Lingsma, Hester F.; Peul, Wilco C.; Cecilia, Ackerlund; Hadie, Adams; Vanni, Agnoletti; Judith, Allanson; Krisztina, Amrein; Norberto, Andaluz; Nada, Andelic; Lasse, Andreassen; Azasevac, Antun; Audny, Anke; Anna, Antoni; Hilko, Ardon; Gerard, Audibert; Kaspars, Auslands; Philippe, Azouvi; Luisa, Azzolini Maria; Camelia, Baciu; Rafael, Badenes; Ronald, Bartels; Pal, Barzo; Ursula, Bauerfeind; Romuald, Beauvais; Ronny, Beer; Francisco Javier, Belda; Bo-Michael, Bellander; Antonio, Belli; Remy, Bellier; Habib, Benali; Thierry, Benard; Maurizio, Berardino; Luigi, Beretta; Christopher, Beynon; Federico, Bilotta; Harald, Binder; Erta, Biqiri; Morten, Blaabjerg; Hugo, den Boogert; Pierre, Bouzat; Peter, Bragge; Alexandra, Brazinova; Vibeke, Brinck; Joanne, Brooker; Camilla, Brorsson; Andras, Buki; Monika, Bullinger; Emiliana, Calappi; Rosa, Calvi Maria; Peter, Cameron; Lozano Guillermo, Carbayo; Marco, Carbonara; Elsa, Carise; Carpenter, K.; Ana M, Castano-Leon; Francesco, Causin; Giorgio, Chevallard; Arturo, Chieregato; Giuseppe, Citerio; Maryse, Cnossen; Mark, Coburn; Jonathan, Coles; Lizzie, Coles-Kemp; Johnny, Collett; Jamie, Cooper D.; Marta, Correia; Amra, Covic; Nicola, Curry; Endre, Czeiter; Marek, Czosnyka; Claire, Dahyot-Fizelier; Francois, Damas; Pierre, Damas; Helen, Dawes; Veronique, De Keyser; Francesco, Della Corte; Bart, Depreitere; Godard, de Ruiter C. W.; Dula, Dilvesi; Ding Shenghao; Diederik, Dippel; Abhishek, Dixit; Emma, Donoghue; Jens, Dreier; Guy-Loup, Duliere; George, Eapen; Heiko, Engemann; Ari, Ercole; Patrick, Esser; Erzsebet, Ezer; Martin, Fabricius; Valery, Feigin L.; Feng Junfeng; Kelly, Foks; Francesca, Fossi; Gilles, Francony; Ulderico, Freo; Shirin, Frisvold; Alex, Furmanov; Pablo, Gagliardo; Damien, Galanaud; Dashiell, Gantner; Gao Guoyi; Karin, Geleijns; Pradeep, George; Alexandre, Ghuysen; Lelde, Giga; Benoit, Giraud; Ben, Glocker; Jagos, Golubovic; Pedro, Gomez A.; Francesca, Grossi; Russell, Gruen L.; Deepak, Gupta; Juanita, Haagsma A.; Iain, Haitsma; Jed, Hartings A.; Raimund, Helbok; Eirik, Helseth; Daniel, Hertle; Astrid, Hoedemaekers; Stefan, Hoefer; Lindsay, Horton; Jilske, Huijben; Peter, Hutchinson J.; Kristine, Haberg Asta; Bram, Jacobs; Stefan, Jankowski; Mike, Jarrett; Bojan, Jelaca; Jiang Ji-yao; Kelly, Jones; Konstantinos, Kamnitsas; Mladen, Karan; Ari, Katila; Maija, Kaukonen; Thomas, Kerforne; Riku, Kivisaari; Angelos, Kolias G.; Balint, Kolumban; Erwin, Kompanje; Ksenija, Kolundzija; Daniel, Kondziella; Lars-Owe, Koskinen; Noemi, Kovacs; Alfonso, Lagares; Linda, Lanyon; Steven, Laureys; Fiona, Lecky; Christian, Ledig; Rolf, Lefering; Valerie, Legrand; Jin, Lei; Leon, Levi; Roger, Lightfoot; Hester, Lingsma; Dirk, Loeckx; Angels, Lozano; Andrew, Maas I. R.; Stephen, MacDonald; Marc, Maegele; Marek, Majdan; Sebastian, Major; Alex, Manara; Geoffrey, Manley; Didier, Martin; Francisco, Martin Leon; Costanza, Martino; Armando, Maruenda; Hugues, Marechal; Alessandro, Masala; Julia, Mattern; Charles, McFadyen; Catherine, McMahon; Bela, Melegh; David, Menon; Tomas, Menovsky; Cristina, Morganti-Kossmann; Davide, Mulazzi; Visakh, Muraleedharan; Lynnette, Murray; Holger, Muehlan; Nandesh, Nair; Ancuta, Negru; David, Nelson; Virginia, Newcombe; Daan, Nieboer; Quentin, Noirhomme; Jozsef, Nyiradi; Mauro, Oddo; Annemarie, Oldenbeuving; Matej, Oresic; Fabrizio, Ortolano; Aarno, Palotie; Paul, Parizel M.; Adriana, Patruno; Jean-Francois, Payen; Natascha, Perera; Vincent, Perlbarg; Paolo, Persona; PeulWilco; Anna, Piippo-Karjalainen; Sebastien, Pili Floury; Matti, Pirinen; Horia, Ples; Maria Antonia, Poca; Suzanne, Polinder; Inigo, Pomposo; Jussi, Posti; Louis, Puybasset; Andreea, Radoi; Arminas, Ragauskas; Rahul, Raj; Malinka, Rambadagalla; Ruben, Real; Veronika, Rehorcikova; Jonathan, Rhodes; Samuli, Ripatti; Saulius, Rocka; Cecilie, Roe; Olav, Roise; Gerwin, Roks; Jonathan, Rosand; Jeffrey, Rosenfeld; Christina, Rosenlund; Guy, Rosenthal; Rolf, Rossaint; Sandra, Rossi; Daniel, Rueckert; Martin, Rusnak; Marco, Sacchi; Barbara, Sahakian; Juan, Sahuquillo; Oliver, Sakowitz; Francesca, Sala; Renan, Sanchez-Porras; Janos, Sandor; Edgar, Santos; Luminita, Sasu; Davide, Savo; Nadine, Schaeffer; Inger, Schipper; Barbara, Schloesser; Silke, Schmidt; Herbert, Schoechl; Guus, Schoonman; Frederik, Schou Rico; Elisabeth, Schwendenwein; Michael, Schoell; Ozcan, Sir; Toril, Skandsen; Lidwien, Smakman; Dirk, Smeets; Peter, Smielewski; Abayomi, Sorinola; Emmanuel, Stamatakis; Simon, Stanworth; Nicole, Steinbuechel; Ana, Stevanovic; Robert, Stevens; William, Stewart; Ewout, Steyerberg W.; Nino, Stocchetti; Nina, Sundstrom; Anneliese, Synnot; Fabio Silvio, Taccone; Riikka, Takala; Viktoria, Tamas; Paivi, Tanskanen; Steven, Taylor Mark; Braden, Te Ao; Olli, Tenovuo; Ralph, Telgmann; Guido, Teodorani; Alice, Theadom; Matt, Thomas; Dick, Tibboel; Christos, Tolias; Luaba, Tshibanda Jean-Flory; Tony, Trapani; Maria, Tudora Cristina; Peter, Vajkoczy; Shirley, Vallance; Egils, Valeinis; Gregory, Van der Steen; Mathieu, Van der Jagt; Joukje, Van der Naalt; Jeroen, van Dijck T. J. M.; Thomas, Van Essen A.; Wim, Van Hecke; Caroline, van Heugten; Dominique, Van Praag; Thijs, Vande Vyvere; Julia, Van Waesberghe; Audrey, Vanhaudenhuyse; Alessia, Vargiolu; Emmanuel, Vega; Kimberley, Velt; Jan, Verheyden; Paul, Vespa M.; Anne, Vik; Rimantas, Vilcinis; Giacinta, Vizzino; Carmen, Vleggeert-Lankamp; Victor, Volovici; Daphne, Voormolen; Peter, Vulekovic; Zoltan, Vamos; Derick, Wade; Kevin, Wang K. W.; Lei, Wang; Lars, Wessels; Eno, Wildschut; Guy, Williams; Lindsay, Wilson; Maren, Winkler K. L.; Stefan, Wolf; Peter, Ylen; Alexander, Younsi; Menashe, Zaaroor; Yang, Zhihui; Agate, Ziverte; Fabrizio, Zumbo		CENTER-TBI Investigators Partici	Variation in neurosurgical management of traumatic brain injury: a survey in 68 centers participating in the CENTER-TBI study	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Neurosurgery; Practice variation; Acute subdural hematoma	RANDOMIZED CONTROLLED-TRIALS; ACUTE SUBDURAL HEMATOMAS; SURGICAL-MANAGEMENT; GUIDELINES; MODERATE; OUTCOMES; SURGERY	BackgroundNeurosurgical management of traumatic brain injury (TBI) is challenging, with only low-quality evidence. We aimed to explore differences in neurosurgical strategies for TBI across Europe.MethodsA survey was sent to 68 centers participating in the Collaborative European Neurotrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study. The questionnaire contained 21 questions, including the decision when to operate (or not) on traumatic acute subdural hematoma (ASDH) and intracerebral hematoma (ICH), and when to perform a decompressive craniectomy (DC) in raised intracranial pressure (ICP).ResultsThe survey was completed by 68 centers (100%). On average, 10 neurosurgeons work in each trauma center. In all centers, a neurosurgeon was available within 30min. Forty percent of responders reported a thickness or volume threshold for evacuation of an ASDH. Most responders (78%) decide on a primary DC in evacuating an ASDH during the operation, when swelling is present. For ICH, 3% would perform an evacuation directly to prevent secondary deterioration and 66% only in case of clinical deterioration. Most respondents (91%) reported to consider a DC for refractory high ICP. The reported cut-off ICP for DC in refractory high ICP, however, differed: 60% uses 25mmHg, 18% 30mmHg, and 17% 20mmHg. Treatment strategies varied substantially between regions, specifically for the threshold for ASDH surgery and DC for refractory raised ICP. Also within center variation was present: 31% reported variation within the hospital for inserting an ICP monitor and 43% for evacuating mass lesions.ConclusionDespite a homogeneous organization, considerable practice variation exists of neurosurgical strategies for TBI in Europe. These results provide an incentive for comparative effectiveness research to determine elements of effective neurosurgical care.	[van Essen, Thomas A.; Peul, Wilco C.] Leiden Univ, UNCH, Dept Neurosurg, Med Ctr, Leiden, Netherlands; [van Essen, Thomas A.; de Ruiter, Godard C. W.; Peul, Wilco C.] UNCH, Haaglanden Med Ctr, Dept Neurosurg, The Hague, Netherlands; [den Boogert, Hugo F.] Radboud Univ Nijmegen, Med Ctr, Dept Neurosurg, Nijmegen, Netherlands; [Cnossen, Maryse C.; Polinder, Suzanne; Steyerberg, Ewout W.; Lingsma, Hester F.] Erasmus MC, Dept Publ Hlth, Ctr Med Decis Sci, Rotterdam, Netherlands; [Haitsma, Iain] Erasmus MC, Dept Neurosurg, Rotterdam, Netherlands; [Steyerberg, Ewout W.] Leiden Univ, Med Ctr, Dept Biomed Data Sci, Leiden, Netherlands; [Menon, David] Univ Cambridge, Div Anaesthesia, Addenbrookes Hosp, Cambridge, England; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium; [Cecilia, Ackerlund; Pradeep, George; Linda, Lanyon; Visakh, Muraleedharan; David, Nelson] Karolinska Inst, INCF Int Neuroinformat Coordinating Facil, Stockholm, Sweden; [Hadie, Adams; Angelos, Kolias G.] Addenbrookes Hosp, Div Neurosurg, Dept Clin Neurosci, Cambridge, England; [Hadie, Adams; Judith, Allanson; Angelos, Kolias G.] Univ Cambridge, Cambridge, England; [Vanni, Agnoletti; Costanza, Martino; Alessandro, Masala; Fabrizio, Zumbo] Osped Gen Provinciale M Bufalini, Dept Anesthesia & Intens Care, Cesena, Italy; [Judith, Allanson] Addenbrookes Hosp, Dept Clin Neurosci, Cambridge, England; [Krisztina, Amrein; Jozsef, Nyiradi] Univ Pecs, Janos Szentagothai Res Ctr, Pecs, Hungary; [Norberto, Andaluz; Mladen, Karan] Univ Cincinnati, Cincinnati, OH USA; [Nada, Andelic] Oslo Univ Hosp, Div Surg & Clin Neurosci, Dept Phys Med & Rehabil, Oslo, Norway; [Nada, Andelic] Univ Oslo, Oslo, Norway; [Lasse, Andreassen] Univ Hosp Northern Norway, Dept Neurosurg, Tromso, Norway; [Azasevac, Antun; Dula, Dilvesi; Jagos, Golubovic; Bojan, Jelaca; Peter, Vulekovic] Univ Novi Sad, Fac Med, Dept Neurosurg, Clin Ctr Vojvodina, Novi Sad, Serbia; [Audny, Anke] Univ Hosp Northern Norway, Dept Phys Med & Rehabil, Tromso, Norway; [Anna, Antoni; Harald, Binder; Elisabeth, Schwendenwein] Med Univ Vienna, Trauma Surg, Vienna, Austria; [Hilko, Ardon] Elisabeth Tweesteden Ziekenhuis, Dept Neurosurg, Tilburg, Netherlands; [Gerard, Audibert] Univ Hosp Nancy, Dept Anesthesiol & Intens Care, Nancy, France; [Kaspars, Auslands] Riga Eastern Clin Univ Hosp, Riga, Latvia; [Philippe, Azouvi] Hop Raymond Poincare, AP HP, Paris, France; [Luisa, Azzolini Maria; Luigi, Beretta; Rosa, Calvi Maria] S Raffaele Univ Hosp, Dept Anesthesiol & Intens Care, Milan, Italy; [Camelia, Baciu; Erta, Biqiri; Giorgio, Chevallard; Arturo, Chieregato; Francesca, Fossi; Marco, Sacchi; Giacinta, Vizzino] Osped Niguarda Ca Granda, NeuroIntens Care, Milan, Italy; [Rafael, Badenes; Francisco Javier, Belda; Federico, Bilotta; Angels, Lozano; Armando, Maruenda; Fabio Silvio, Taccone] Hosp Clin Univ Valencia, Dept Anesthesiol & Surg Trauma Intens Care, Valencia, Spain; [Ronald, Bartels; Hugo, den Boogert] Radboud Univ Nijmegen, Dept Neurosurg, Med Ctr, Nijmegen, Netherlands; [Pal, Barzo] Univ Szeged, Dept Neurosurg, Szeged, Hungary; [Ursula, Bauerfeind; Barbara, Schloesser] Witten Herdecke Univ, Inst Transfus Med ITM, Cologne, Germany; [Romuald, Beauvais; Natascha, Perera] ARTTIC, Int Projects Management, Munich, Germany; [Ronny, Beer; Raimund, Helbok] Med Univ Innsbruck, Dept Neurol, Neurol Intens Care Unit, Innsbruck, Austria; [Bo-Michael, Bellander] Karolinska Univ Hosp, Dept Neurosurg & Anesthesia & Intens Care Med, Stockholm, Sweden; [Antonio, Belli] NIHR Surg Reconstruct & Microbiol Res Ctr, Birmingham, W Midlands, England; [Remy, Bellier; Thierry, Benard; Elsa, Carise; Claire, Dahyot-Fizelier; Benoit, Giraud; Thomas, Kerforne] CHU Poitiers, Intens Care Unit, Poitiers, France; [Habib, Benali; Damien, Galanaud; Vincent, Perlbarg; Audrey, Vanhaudenhuyse] AP HP, Anesthesie Reanimat, Paris, France; [Maurizio, Berardino] AOU Citta Salute & Sci Torino, Dept Anesthesia & ICU, Orthoped & Trauma Ctr, Turin, Italy; [Christopher, Beynon; Julia, Mattern; Edgar, Santos; Michael, Schoell; Alexander, Younsi] Univ Hosp Heidelberg, Dept Neurosurg, Heidelberg, Germany; [Morten, Blaabjerg; Daniel, Hertle] Odense Univ Hosp, Dept Neurol, Odense, Denmark; [Pierre, Bouzat; Gilles, Francony; Jean-Francois, Payen] Univ Hosp Grenoble, Dept Anesthesiol & Intens Care, Grenoble, France; [Peter, Bragge] Monash Univ, Monash Sustainabil Inst, BehaviourWorks Australia, Clayton, Vic, Australia; [Alexandra, Brazinova; Marek, Majdan; Veronika, Rehorcikova; Steven, Taylor Mark] Trnava Univ, Fac Hlth Sci & Social Work, Dept Publ Hlth, Trnava, Slovakia; [Vibeke, Brinck; Mike, Jarrett; Anneliese, Synnot] Quesgen Syst Inc, Burlingame, CA USA; [Joanne, Brooker] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Dept Epidemiol & Prevent Med, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Camilla, Brorsson; Lars-Owe, Koskinen; Nina, Sundstrom] Umea Univ Hosp, Dept Neurosurg, Umea, Sweden; [Andras, Buki] Univ Pecs, Dept Neurosurg, Pecs, Hungary; [Andras, Buki] Univ Pecs, MTA PTE Clin Neurosci MR Res Grp, Hungarian Brain Res Program, Pecs, Hungary; [Andras, Buki] Univ Pecs, Janos Szentagothai Res Ctr, Hungarian Brain Res Program, Pecs, Hungary; [Monika, Bullinger] Univ Klinikum Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany; [Emiliana, Calappi; Marco, Carbonara; Davide, Mulazzi; Fabrizio, Ortolano] IRCCS Ca Granda Osped Maggiore Policlin, Neuro ICU, Milan, Italy; [Peter, Cameron; Emma, Donoghue; Dashiell, Gantner; Lynnette, Murray; Tony, Trapani] Monash Univ, Dept Epidemiol & Prevent Med, ANZIC Res Ctr, Melbourne, Australia; [Lozano Guillermo, Carbayo; Inigo, Pomposo] Hosp Cruces, Dept Neurosurg, Bilbao, Spain; [Carpenter, K.; Karin, Geleijns; Dick, Tibboel; Eno, Wildschut] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Intens Care, Rotterdam, Netherlands; [Carpenter, K.; Karin, Geleijns; Dick, Tibboel; Eno, Wildschut] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Pediat Surg, Rotterdam, Netherlands; [Ana M, Castano-Leon; Pedro, Gomez A.; Alfonso, Lagares; Shirley, Vallance] Hosp Univ 12 Octubre, Dept Neurosurg, Madrid, Spain; [Francesco, Causin] Azienda Osped Univ Padova, Dept Neurosci, Padua, Italy; [Giuseppe, Citerio] ASST Monza, NeuroIntens Care, Monza, Italy; [Giuseppe, Citerio] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy; [Maryse, Cnossen; Juanita, Haagsma A.; Hester, Lingsma; Daan, Nieboer; Suzanne, Polinder; Ewout, Steyerberg W.; Kimberley, Velt; Daphne, Voormolen] Univ Med Ctr, Dept Publ Hlth, Erasmus Med Ctr, Rotterdam, Netherlands; [Mark, Coburn; Rolf, Rossaint; Ana, Stevanovic; Julia, Van Waesberghe] Univ Hosp Aachen, Dept Anaesthesiol, Aachen, Germany; [Jonathan, Coles] Cambridge Univ Hosp NHS Fdn Trust, Dept Anesthesia & Neurointens Care, Cambridge, England; [Lizzie, Coles-Kemp; Johnny, Collett] Oxford Brookes Univ, Oxford Inst Nursing Midwifery & Allied Hlth Res, Movement Sci Grp, Oxford, England; [Jamie, Cooper D.] Monash Univ, Sch Publ Hlth & PM, Melbourne, Vic, Australia; [Jamie, Cooper D.] Alfred Hosp, Melbourne, Vic, Australia; [Marta, Correia] MRC, Cognit & Brain Sci Unit, Radiol MRI Dept, Cambridge, England; [Amra, Covic; Heiko, Engemann; Stefan, Hoefer; Jilske, Huijben; Ruben, Real; Ralph, Telgmann] Univ Med Gottingen, Inst Med Psychol & Med Sociol, Gottingen, Germany; [Nicola, Curry; Simon, Stanworth] Oxford Univ Hosp NHS Trust, Oxford, England; [Endre, Czeiter] Univ Pecs, Dept Neurosurg, Pecs, Hungary; [Endre, Czeiter] Univ Pecs, MTA PTE Clin Neurosci MR Res Grp, Hungarian Brain Res Program Grant KTIA 13 NAP A I, Pecs, Hungary; [Endre, Czeiter] Univ Pecs, Janos Szentagothai Res Ctr, Hungarian Brain Res Program Grant KTIA 13 NAP A I, Pecs, Hungary; [Marek, Czosnyka; Peter, Smielewski] Univ Cambridge, Dept Clin Neurosci, Brain Phys Lab, Div Neurosurg,Addenbrookes Hosp, Cambridge, England; [Francois, Damas; Guy-Loup, Duliere; Hugues, Marechal] CHR Citadelle, Intens Care Unit, Liege, Belgium; [Pierre, Damas] CHU, Intens Care Unit, Liege, Belgium; [Helen, Dawes; Patrick, Esser; Caroline, van Heugten; Derick, Wade] Oxford Brookes Univ, Movement Sci Grp, Fac Hlth & Life Sci, Oxford, England; [Veronique, De Keyser; Andrew, Maas I. R.; Tomas, Menovsky; Nandesh, Nair; Gregory, Van der Steen; Dominique, Van Praag] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Veronique, De Keyser; Andrew, Maas I. R.; Tomas, Menovsky; Nandesh, Nair; Gregory, Van der Steen; Dominique, Van Praag] Univ Antwerp, Edegem, Belgium; [Francesco, Della Corte; Francesca, Grossi; Luminita, Sasu] Maggiore Carita Hosp, Dept Anesthesia & Intens Care, Novara, Italy; [Bart, Depreitere] Univ Hosp Leuven, Dept Neurosurg, Leuven, Belgium; [Godard, de Ruiter C. W.; PeulWilco; Lidwien, Smakman; Jeroen, van Dijck T. J. M.; Thomas, Van Essen A.; Carmen, Vleggeert-Lankamp] Leiden Univ, Med Ctr, Dept Neurosurg, Leiden, Netherlands; [Godard, de Ruiter C. W.; PeulWilco; Lidwien, Smakman; Jeroen, van Dijck T. J. M.; Thomas, Van Essen A.; Carmen, Vleggeert-Lankamp] Med Ctr Haaglanden, Dept Neurosurg, The Hague, Netherlands; [Ding Shenghao; Feng Junfeng; Jin, Lei; Lei, Wang] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Diederik, Dippel; Kelly, Foks] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Abhishek, Dixit; Ari, Ercole; Charles, McFadyen; David, Menon; Virginia, Newcombe; Barbara, Sahakian; Emmanuel, Stamatakis; Guy, Williams] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Jens, Dreier; Peter, Vajkoczy] Charite Univ Med Berlin, Neurol Neurochirurg & Psychiat, Berlin, Germany; [George, Eapen; Stefan, Jankowski] Sheffield Teaching Hosp NHS Fdn Trust, Neurointens Care, Sheffield, S Yorkshire, England; [Erzsebet, Ezer; Zoltan, Vamos] Univ Pecs, Dept Anaesthesiol & Intens Therapy, Pecs, Hungary; [Martin, Fabricius; Daniel, Kondziella] Rigshosp, Dept Neurol, Reg Hovedstaden, Copenhagen, Denmark; [Martin, Fabricius; Daniel, Kondziella] Rigshosp, Dept Clin Neurophysiol, Reg Hovedstaden, Copenhagen, Denmark; [Martin, Fabricius; Daniel, Kondziella] Rigshosp, Dept Neuroanesthesiol, Reg Hovedstaden, Copenhagen, Denmark; [Valery, Feigin L.; Braden, Te Ao; Alice, Theadom] Auckland Univ Technol, Fac Hlth & Environm Studies, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Ulderico, Freo] Azienda Osped Univ Padova, Dept Med, Padua, Italy; [Shirin, Frisvold] Univ Hosp Northern Norway, Dept Anesthesiol & Intens care, Tromso, Norway; [Alex, Furmanov; Guy, Rosenthal] Hadassah Hebrew Univ Med Ctr, Dept Neurosurg, Jerusalem, Israel; [Pablo, Gagliardo] Fdn Inst Valenciano Neurorrehabil FIVAN, Valencia, Spain; [Gao Guoyi; Jiang Ji-yao] Shanghai Jiao Tong Univ, Sch Med, Shanghai Renji Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Alexandre, Ghuysen] CHU, Emergency Dept, Liege, Belgium; [Lelde, Giga; Egils, Valeinis; Agate, Ziverte] Pauls Stradins Clin Univ Hosp, Riga, Latvia; [Ben, Glocker; Konstantinos, Kamnitsas; Christian, Ledig; Daniel, Rueckert] Imperial Coll London, Dept Comp, London, England; [Russell, Gruen L.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Russell, Gruen L.] Monash Univ, Clayton, Vic, Australia; [Deepak, Gupta] All India Inst Med Sci, Dept Neurosurg, Neurosci Ctr, New Delhi 110029, India; [Deepak, Gupta] All India Inst Med Sci, JPN Apex Trauma Ctr, New Delhi 110029, India; [Iain, Haitsma; Victor, Volovici] Erasmus MC, Dept Neurosurg, Rotterdam, Netherlands; [Jed, Hartings A.] Univ Cincinnati, Dept Neurosurg, Cincinnati, OH USA; [Eirik, Helseth] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway; [Astrid, Hoedemaekers] Radboud Univ Nijmegen, Med Ctr, Dept Intens Care Med, Nijmegen, Netherlands; [Lindsay, Horton; Peter, Hutchinson J.; Lindsay, Wilson] Univ Stirling, Div Psychol, Stirling, Scotland; [Kristine, Haberg Asta] Norwegian Univ Sci & Technol, St Olavs Hosp, Dept Med Imaging, Trondheim, Norway; [Kristine, Haberg Asta] Norwegian Univ Sci & Technol, Dept Neurosci, Trondheim, Norway; [Bram, Jacobs; Joukje, Van der Naalt] Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Kelly, Jones] AUT Univ, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Ari, Katila; Jussi, Posti; Riikka, Takala; Olli, Tenovuo] Turku Univ, Cent Hosp, Rehabil & Brain Trauma, Turku, Finland; [Ari, Katila; Jussi, Posti; Riikka, Takala; Olli, Tenovuo] Univ Turku, Turku, Finland; [Maija, Kaukonen; Riku, Kivisaari; Anna, Piippo-Karjalainen; Rahul, Raj; Paivi, Tanskanen] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Balint, Kolumban; Noemi, Kovacs] Univ Pecs, Hungarian Brain Res Program Grant KTIA 13 NAP A I, Pecs, Hungary; [Erwin, Kompanje] Erasmus MC, Dept Intens Care, Rotterdam, Netherlands; [Erwin, Kompanje] Erasmus MC, Dept Eth & Philosophy Med, Rotterdam, Netherlands; [Ksenija, Kolundzija] Univ Novi Sad, Dept Psichiat, Clin Ctr Vojvodina, Fac Med, Novi Sad, Serbia; [Steven, Laureys; Quentin, Noirhomme; Audrey, Vanhaudenhuyse] Univ Liege, Cyclotron Res Ctr, Liege, Belgium; [Fiona, Lecky] Univ Sheffield, Sch Hlth & Related Res ScHARR, Emergency Med Res Sheffield, Hlth Serv Res Sect, Sheffield, S Yorkshire, England; [Rolf, Lefering] Witten Herdecke Univ, Inst Res Operat Med IFOM, Cologne, Germany; [Valerie, Legrand] ICON, VP Global Project Management CNS, Paris, France; [Leon, Levi; Menashe, Zaaroor] Rambam Med Ctr, Dept Neurosurg, Haifa, Israel; [Roger, Lightfoot] Univ Hosp Southhampton NHS Trust, Dept Anesthesiol & Intens Care, Southampton, Hants, England; [Dirk, Loeckx; Francisco, Martin Leon; Dirk, Smeets; Wim, Van Hecke; Thijs, Vande Vyvere; Jan, Verheyden] IcoMetrix NV, Leuven, Belgium; [Stephen, MacDonald] Cambridge Univ Hosp, Cambridge, England; [Marc, Maegele; Nadine, Schaeffer] Witten Herdecke Univ, Dept Traumatol Orthoped Surg & Sportmed, CMMC, Cologne, Germany; [Sebastian, Major; Maren, Winkler K. L.] Charite Univ Med Berlin, Ctr Schlaganfallforsch, Berlin, Germany; [Alex, Manara; Matt, Thomas] Southmead Hosp, Intens Care Unit, Bristol, Avon, England; [Geoffrey, Manley] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Didier, Martin] CHU, Dept Neurosurg, Liege, Belgium; [Catherine, McMahon] Walton Ctr NHS Fdn Trust, Dept Neurosurg, Liverpool, Merseyside, England; [Bela, Melegh] Univ Pecs, Dept Med Genet, Pecs, Hungary; [Cristina, Morganti-Kossmann; Jeffrey, Rosenfeld] Monash Univ, Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic, Australia; [Holger, Muehlan; Silke, Schmidt] Ernst Moritz Arndt Univ Greifswald, Dept Hlth & Prevent, Greifswald, Germany; [Ancuta, Negru; Horia, Ples; Maria, Tudora Cristina] Emergency Cty Hosp Timisoara, Dept Neurosurg, Timisoara, Romania; [Mauro, Oddo] CHU Vaudois, Lausanne, Switzerland; [Annemarie, Oldenbeuving] Elisabeth Tweesteden Ziekenhuis, Dept Intens Care, Tilburg, Netherlands; [Matej, Oresic] Steno Diabet Ctr, Dept Syst Med, Gentofte, Denmark; [Aarno, Palotie; Matti, Pirinen; Samuli, Ripatti] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland; [Aarno, Palotie] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Dept Med, Boston, MA 02114 USA; [Aarno, Palotie] Massachusetts Gen Hosp, Dept Psychiat, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Aarno, Palotie] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Aarno, Palotie] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Aarno, Palotie] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Paul, Parizel M.] Antwerp Univ Hosp, Dept Radiol, Edegem, Belgium; [Paul, Parizel M.] Univ Antwerp, Edegem, Belgium; [Adriana, Patruno; Francesca, Sala; Davide, Savo; Alessia, Vargiolu] ASST Monza, Dept Anesthesia & Intens Care, NeuroIntenisve Care Unit, Monza, Italy; [Paolo, Persona; Sandra, Rossi] Azienda Osped Univ Padova, Dept Anesthesia & Intens Care, Padua, Italy; [Sebastien, Pili Floury] CHRU Besancon, Intens Care Unit, Besancon, France; [Maria Antonia, Poca; Andreea, Radoi; Juan, Sahuquillo] Vall dHebron Univ Hosp, Dept Neurosurg, Barcelona, Spain; [Louis, Puybasset] Pitie Salpetriere Teaching Hosp, AP HP, Dept Anesthesiol & Crit Care, Paris, France; [Louis, Puybasset] Univ Paris 06, Paris, France; [Arminas, Ragauskas; Saulius, Rocka] Kaunas Univ Technol, Dept Neurosurg, Kaunas, Lithuania; [Arminas, Ragauskas; Saulius, Rocka] Vilnius Univ, Kaunas, Lithuania; [Malinka, Rambadagalla] Rezekne Hosp, Rezekne, Latvia; [Jonathan, Rhodes] NHS Lothian, Dept Anesthesia Crit Care & Pain Med, Edinburgh, Midlothian, Scotland; [Jonathan, Rhodes] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Cecilie, Roe] Univ Oslo, Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Olav, Roise] Oslo Univ Hosp, Div Surg & Clin Neurosci, Oslo, Norway; [Gerwin, Roks; Guus, Schoonman] Elisabeth TweeSteden Ziekenhuis, Dept Neurol, Tilburg, Netherlands; [Jonathan, Rosand] Broad Inst, Cambridge, MA USA; [Jonathan, Rosand] Harvard Med Sch, Boston, MA 02115 USA; [Jonathan, Rosand] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Christina, Rosenlund] Odense Univ Hosp, Dept Neurosurg, Odense, Denmark; [Martin, Rusnak] Int Neurotrauma Res Org, Vienna, Austria; [Oliver, Sakowitz; Renan, Sanchez-Porras] Klinikum Ludwigsburg, Klin Neurochirurg, Ludwigsburg, Germany; [Oliver, Sakowitz] Univ Hosp Heidelberg, Heidelberg, Germany; [Janos, Sandor] Univ Debrecen, Div Biostat & Epidemiol, Dept Prevent Med, Debrecen, Hungary; [Inger, Schipper] Leiden Univ, Med Ctr, Dept Traumasurg, Leiden, Netherlands; [Herbert, Schoechl] AUVA Trauma Hosp, Dept Anaesthesiol & Intens Care, Salzburg, Austria; [Frederik, Schou Rico] Odense Univ Hosp, Dept Neuroanesthesia & Neurointens Care, Odense, Denmark; [Ozcan, Sir] Radboud Univ Nijmegen, Med Ctr, Dept Emergency Care Med, Nijmegen, Netherlands; [Toril, Skandsen] St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Toril, Skandsen] Norwegian Univ Sci & Technol, Dept Neurosci, Trondheim, Norway; [Abayomi, Sorinola; Viktoria, Tamas] Univ Pecs, Dept Neurosurg, Pecs, Hungary; [Nicole, Steinbuechel] Univ Med Gottingen, Gottingen, Germany; [Robert, Stevens] Johns Hopkins Univ, Sch Med, Div Neurosci Crit Care, Baltimore, MD USA; [William, Stewart] Queen Elizabeth Univ Hosp, Dept Neuropathol, Glasgow, Lanark, Scotland; [William, Stewart] Univ Glasgow, Glasgow, Lanark, Scotland; [Ewout, Steyerberg W.] Leiden Univ, Med Ctr, Dept Dept Biomed Data Sci, Leiden, Netherlands; [Nino, Stocchetti] Milan Univ, Dept Pathophysiol & Transplantat, Milan, Italy; [Nino, Stocchetti] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neurosci ICU, Milan, Italy; [Anneliese, Synnot] La Trobe Univ, Cochrane Consumers & Commun Review Grp, Ctr Hlth Commun & Participat, Sch Psychol & Publ Hlth, Melbourne, Vic, Australia; [Guido, Teodorani] Osped Gen Provinciale M Bufalini, Dept Reahabilitat, Cesena, Italy; [Christos, Tolias] Kings Coll London, Dept Neurosurg, London, England; [Luaba, Tshibanda Jean-Flory] CHU, Radiol MRI Dept, Liege, Belgium; [Mathieu, Van der Jagt] Erasmus MC, Dept Intens Care, Rotterdam, Netherlands; [Emmanuel, Vega] Lille Univ Hosp, Dept Anesthesiol Intens Care, Lille, France; [Paul, Vespa M.] Univ Calif Los Angeles, Neurocrit Care, Los Angeles, CA USA; [Anne, Vik] St Olavs Hosp, Dept Neurosurg, Trondheim, Norway; [Anne, Vik] Norwegian Univ Sci & Technol, Dept Neurosci, Trondheim, Norway; [Rimantas, Vilcinis] Kaunas Univ Hlth Sci, Dept Neurosurg, Kaunas, Lithuania; [Kevin, Wang K. W.] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; [Lars, Wessels; Stefan, Wolf] Charite Univ Med Berlin, Interdisciplinary Neuro Intens Care Unit, Berlin, Germany; [Peter, Ylen] VTT Tech Res Ctr, Tampere, Finland; [Yang, Zhihui] Univ Florida, Gainesville, FL USA		van Essen, TA (corresponding author), Leiden Univ, UNCH, Dept Neurosurg, Med Ctr, Leiden, Netherlands.; van Essen, TA (corresponding author), UNCH, Haaglanden Med Ctr, Dept Neurosurg, The Hague, Netherlands.	essen@lumc.nl	Sacchi, Marco/F-7517-2013; de Ruiter, Godard/ABC-4074-2020; Lagares, Alfonso/B-2969-2011; Posti, Jussi P./Y-2908-2019; Radoi, Andreea/N-5613-2019; Raj, Rahul/K-7693-2012; Golubovic, Jagos/AAD-1270-2019; Maas, Andrew IR/C-5584-2013; Vande Vyvere, Thijs/AAB-5180-2022; Thijs, Vincent/M-9048-2019; Sahuquillo, Juan/B-3577-2008; Gomez, Pedro/E-2411-2014	Sacchi, Marco/0000-0003-2386-1156; Lagares, Alfonso/0000-0003-3996-0554; Posti, Jussi P./0000-0002-5925-5193; Radoi, Andreea/0000-0002-0677-3544; Raj, Rahul/0000-0003-4243-9591; Golubovic, Jagos/0000-0001-5524-246X; Maas, Andrew IR/0000-0003-1612-1264; Vande Vyvere, Thijs/0000-0003-4032-5443; Santos, Edgar/0000-0002-8976-5549; Stewart, William/0000-0003-2199-2582; Parizel, Paul M./0000-0002-0221-2854; Lanyon, Linda/0000-0002-0885-1825; Newcombe, Virginia/0000-0001-6044-9035; Feigin, Valery L./0000-0002-6372-1740; Van Essen, Thomas/0000-0003-4657-5283; Thijs, Vincent/0000-0002-6614-8417; Sahuquillo, Juan/0000-0003-0713-5875; Te Ao, Braden/0000-0002-1050-200X; Dippel, Diederik/0000-0002-9234-3515; Blaabjerg, Morten/0000-0001-6007-1861; Castano-Leon, Ana M/0000-0002-7918-5049; Badenes, Rafael/0000-0001-7017-0150; Rossi, Sandra/0000-0002-9963-8121; Coles, Jonathan/0000-0003-4013-679X; Dawes, Helen/0000-0002-2933-5213; Pirinen, Matti/0000-0002-1664-1350; Sanchez-Porras, Renan/0000-0002-9084-8114; , Johnny/0000-0003-4138-2589; Palotie, Aarno/0000-0002-2527-5874; Esser, Patrick/0000-0002-3227-0115; Gomez, Pedro/0000-0002-4185-5238	European UnionEuropean Commission [602150]; Hersenstichting Nederland (Dutch Brain Foundation) [PS2014-06]	This study was funded by the European Union Seventh Framework Program (grant 602150) for Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) and the Hersenstichting Nederland (Dutch Brain Foundation, grant PS2014-06) for The Dutch Neurotraumatology Quality Registry (Net-QuRe). There is no industry affiliation.	Albuquerque FC, 2013, WORLD NEUROSURG, V79, P598, DOI 10.1016/j.wneu.2013.03.045; Bosco JLF, 2010, J CLIN EPIDEMIOL, V63, P64, DOI 10.1016/j.jclinepi.2009.03.001; Bragge P, 2016, J NEUROTRAUM, V33, P1461, DOI 10.1089/neu.2015.4233; Brattheim BJ, 2012, EUR J VASC ENDOVASC, V44, P267, DOI 10.1016/j.ejvs.2012.04.029; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Carney N, 2016, NEUROSURGERY, V1; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cnossen MC, 2018, CLIN EPIDEMIOL, V10, P841, DOI 10.2147/CLEP.S154500; Cnossen MC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1816-9; Cnossen MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161367; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Cooper DJ, 2016, NEW ENGL J MED, V375, P2402; De Bonis P, 2013, NEW ENGL J MED, V368, P1749, DOI 10.1056/NEJMc1301076; Ergina PL, 2009, LANCET, V374, P1097, DOI 10.1016/S0140-6736(09)61086-2; Foks KA, 2017, J NEUROTRAUM, V34, P2529, DOI 10.1089/neu.2016.4919; Gregson BA, 2003, STROKE, V34, P2593, DOI 10.1161/01.STR.0000097491.82104.F3; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Huijben JA, 2017, J NEUROTRAUMA NEU, V2017, P5194; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Kolias AG, 2013, BRIT J NEUROSURG, V27, P330, DOI 10.3109/02688697.2013.779365; Li LM, 2012, ACTA NEUROCHIR, V154, P1555, DOI 10.1007/s00701-012-1428-8; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Macefield RC, 2014, LANGENBECK ARCH SURG, V399, P263, DOI 10.1007/s00423-013-1136-8; Mattei TA, 2013, WORLD NEUROSURG, V79, P602, DOI 10.1016/j.wneu.2013.03.048; Mendelow AD, 2015, J NEUROTRAUM, V32, P1312, DOI 10.1089/neu.2014.3644; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Rayan N, 2012, J TRAUMA ACUTE CARE, V72, P585, DOI 10.1097/TA.0b013e318243da4d; Servadei F, 2007, CURR OPIN CRIT CARE, V13, P163, DOI 10.1097/MCC.0b013e32807f2a94; Timmons SD, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.6.FOCUS1296; van Essen TA, 2019, J NEUROTRAUM, V36, P1184, DOI 10.1089/neu.2018.5869; van Essen TA, 2017, J NEUROTRAUM, V34, P881, DOI 10.1089/neu.2016.4495	34	23	23	2	21	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	MAR	2019	161	3					435	449		10.1007/s00701-018-3761-z			15	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HO0PZ	WOS:000460607500002	30569224	Green Published, Green Submitted, hybrid			2022-02-06	
J	Yaffe, K; Lwi, SJ; Hoang, TND; Xia, F; Barnes, DE; Maguen, S; Peltz, CB				Yaffe, Kristine; Lwi, Sandy J.; Hoang, Tina D.; Xia, Feng; Barnes, Deborah E.; Maguen, Shira; Peltz, Carrie B.			Military-related risk factors in female veterans and risk of dementia	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; ALZHEIMERS-DISEASE; COGNITIVE DECLINE; HEALTH; PREVALENCE; DEPRESSION; GENDER; WOMEN; ASSOCIATION	ObjectiveTo determine whether diagnoses of traumatic brain injury (TBI), posttraumatic stress disorder (PTSD), and depression, alone or in combination, increase dementia risk among older female veterans.MethodsThis cohort study included data from 109,140 female veterans 55 years of age receiving care from Veterans Health Administration medical centers in the United States between October 2004 and September 2015 with at least 1 follow-up visit. TBI, PTSD, depression, and medical conditions at study baseline and incident dementia were determined according to ICD-9-CM codes. Fine-Gray proportional hazards models were used to determine the association between military-related risk factors and dementia diagnosis, accounting for the competing risk of death.ResultsDuring follow-up (mean 4.0 years, SD 2.3), 4% of female veterans (n = 4,125) developed dementia. After adjustment for demographics and medical conditions, women with TBI, PTSD, and depression had a significant increase in risk of developing dementia compared to women without these diagnoses (TBI-adjusted subdistribution hazard ratio [adjusted sHR] 1.49, 95% confidence interval [CI] 1.01-2.20; PTSD adjusted sHR 1.78, 95% CI 1.34-2.36; and depression-adjusted sHR 1.67, 95% CI 1.55-1.80), while women with >1 diagnosis had the highest risk for dementia (adjusted sHR 2.15, 95% CI 1.84-2.51).ConclusionsWe found that women with military-related risk factors had an approximate to 50% to 80% increase in developing dementia relative to women without these diagnoses, while female veterans with multiple risk factors had a >2-fold risk of developing dementia. These findings highlight the need for increased screening of TBI, PTSD, and depression in older women, especially female veterans.	[Yaffe, Kristine; Lwi, Sandy J.; Hoang, Tina D.; Xia, Feng; Barnes, Deborah E.; Maguen, Shira; Peltz, Carrie B.] San Francisco Vet Affairs Hlth Care Syst, San Francisco, CA 94121 USA; [Yaffe, Kristine; Barnes, Deborah E.; Maguen, Shira] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA		Yaffe, K (corresponding author), San Francisco Vet Affairs Hlth Care Syst, San Francisco, CA 94121 USA.; Yaffe, K (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.; Yaffe, K (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.; Yaffe, K (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.	Kristine.yaffe@ucsf.edu			Department of DefenseUnited States Department of Defense [W81XWH-16-1-0507]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K24 AG031155]	This research was supported by Department of Defense grant W81XWH-16-1-0507 (principal investigator: Yaffe) and National Institute on Aging grant K24 AG031155 (principal investigator: Yaffe).	Al Hazzouri AZ, 2014, J GERONTOL A-BIOL, V69, P595, DOI 10.1093/gerona/glt139; Amoroso T, 2017, J NERV MENT DIS, V205, P318, DOI 10.1097/NMD.0000000000000621; Armed Forces Health Surveillance Branch, STAND SURV CAS DEF; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bhalerao U, 2013, BRAIN INJURY, V27, P767, DOI 10.3109/02699052.2013.793396; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; Butters Meryl A, 2008, Dialogues Clin Neurosci, V10, P345; Byers AL, 2014, ALZHEIMERS DEMENT, V10, pS166, DOI 10.1016/j.jalz.2014.04.007; Byers AL, 2012, AM J GERIAT PSYCHIAT, V20, P664, DOI 10.1097/JGP.0b013e31822001c1; Cancelliere C, 2016, ARCH PHYS MED REHAB, V97, pS5, DOI 10.1016/j.apmr.2014.11.028; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Curry JF, 2014, J AFFECT DISORDERS, V152, P434, DOI 10.1016/j.jad.2013.10.012; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; Ehlenbach WJ, 2010, JAMA-J AM MED ASSOC, V303, P763, DOI 10.1001/jama.2010.167; Eibner Christine, 2016, Rand Health Q, V5, P13; Engler-Chiurazzi EB, 2017, PROG NEUROBIOL, V157, P188, DOI 10.1016/j.pneurobio.2015.12.008; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gardner RC, 2014, ANN NEUROL, V75, P339, DOI 10.1002/ana.24121; Goveas JS, 2011, J AM GERIATR SOC, V59, P57, DOI 10.1111/j.1532-5415.2010.03233.x; Greenberg MS, 2014, ALZHEIMERS DEMENT, V10, pS155, DOI 10.1016/j.jalz.2014.04.008; Harris DP, 2009, J AM GERIATR SOC, V57, P2209, DOI 10.1111/j.1532-5415.2009.02572.x; Haskell SG, 2010, J WOMENS HEALTH, V19, P267, DOI 10.1089/jwh.2008.1262; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; JORDAN BK, 1991, ARCH GEN PSYCHIAT, V48, P207, DOI 10.1001/archpsyc.1991.01810270019002; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lehavot K, 2018, AM J PREV MED, V54, pE1, DOI 10.1016/j.amepre.2017.09.008; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Miller MW, 2018, HARVARD REV PSYCHIAT, V26, P57, DOI 10.1097/HRP.0000000000000167; Mollayeva Tatyana, 2018, Concussion, V3, pCNC51, DOI 10.2217/cnc-2017-0015; Nebel RA, 2018, ALZHEIMERS DEMENT, V14, P1171, DOI 10.1016/j.jalz.2018.04.008; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Phelan EA, 2012, JAMA-J AM MED ASSOC, V307, P165, DOI 10.1001/jama.2011.1964; Qureshi SU, 2010, J AM GERIATR SOC, V58, P1627, DOI 10.1111/j.1532-5415.2010.02977.x; Ramchand R, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0575-z; Ramsey C, 2017, AM J PUBLIC HEALTH, V107, P329, DOI 10.2105/AJPH.2016.303574; RAND Corporation, 2008, INVISIBLE WOUNDS WAR; Richardson LK, 2010, AUST NZ J PSYCHIAT, V44, P4, DOI 10.3109/00048670903393597; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; US Department of Veterans Affairs (VA) National Center for Veterans Analysis and Statistics, 2017, WOM VET REP PRES FUT; US Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Dementia Steering Committee (DSC), 2016, VHA DEM STEER COMM R; Veitch DP, 2013, CURR ALZHEIMER RES, V10, P907, DOI 10.2174/15672050113109990142; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Yaffe K, 2010, ARCH GEN PSYCHIAT, V67, P608, DOI 10.1001/archgenpsychiatry.2010.61; Yan Y, 2018, NEUROBIOL STRESS, V8, P120, DOI 10.1016/j.ynstr.2018.03.002	50	23	24	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	JAN 15	2019	92	3					E205	E211		10.1212/WNL.0000000000006778			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HQ6ZI	WOS:000462568300013	30541865	Green Published			2022-02-06	
J	Dolan, E; Gualano, B; Rawson, ES				Dolan, Eimear; Gualano, Bruno; Rawson, Eric S.			Beyond muscle: the effects of creatine supplementation on brain creatine, cognitive processing, and traumatic brain injury	EUROPEAN JOURNAL OF SPORT SCIENCE			English	Article						Phosphorylcreatine; cerebral energy metabolism; dietary supplement; cognition; concussion	MAGNETIC-RESONANCE-SPECTROSCOPY; OVO-VEGETARIAN DIET; MONOHYDRATE SUPPLEMENTATION; ORAL SUPPLEMENTATION; SLEEP-DEPRIVATION; OLDER-ADULTS; DOUBLE-BLIND; PERFORMANCE; EXERCISE; ADOLESCENTS	The ergogenic and therapeutic effects of increasing muscle creatine by supplementation are well-recognized. It appears that similar benefits to brain function and cognitive processing may also be achieved with creatine supplementation, however research in this area is more limited, and important knowledge gaps remain. The purpose of this review is to provide a comprehensive overview of the current state of knowledge about the influence of creatine supplementation on brain function in healthy individuals. It appears that brain creatine is responsive to supplementation, however higher, or more prolonged dosing strategies than those typically used to increase muscle creatine, may be required to elicit an increase in brain creatine. The optimal dosing strategy to induce this response, is currently unknown, and there is an urgent need for studies investigating this. When considering the influence of supplementation strategies on cognitive processes, it appears that creatine is most likely to exert an influence in situations whereby cognitive processes are stressed, e.g. during sleep deprivation, experimental hypoxia, or during the performance of more complex, and thus more cognitively demanding tasks. Evidence exists indicating that increased brain creatine may be effective at reducing the severity of, or enhancing recovery from mild traumatic brain injury, however, only limited data in humans are available to verify this hypothesis, thus representing an exciting area for further research.	[Dolan, Eimear; Gualano, Bruno] Univ Sao Paulo, Fac Med FMUSP, Hosp Clin HCFMUSP, Appl Physiol & Nutr Res Grp, Sao Paulo, SP, Brazil; [Rawson, Eric S.] Messiah Coll, Dept Hlth Nutr & Exercise Sci, One Coll Ave,Suite 3033, Mechanicsburg, PA 17055 USA		Rawson, ES (corresponding author), Messiah Coll, Dept Hlth Nutr & Exercise Sci, One Coll Ave,Suite 3033, Mechanicsburg, PA 17055 USA.	erawson@messiah.edu	Gualano, Bruno/C-7190-2012; Gualano, Bruno/ABA-9571-2020; Dolan, Eimear/AAX-8134-2020	Gualano, Bruno/0000-0001-7100-8681; Gualano, Bruno/0000-0001-7100-8681; Dolan, Eimear/0000-0002-1018-7601	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/11328-2, 2013/14746-4]	Eimear Dolan (2015/11328-2) and Bruno Gualano (2013/14746-4) are financially supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP).	Merege CAA, 2017, APPL PHYSIOL NUTR ME, V42, P128, DOI 10.1139/apnm-2016-0406; Ainsley Dean Philip John, 2017, Concussion, V2, pCNC34, DOI 10.2217/cnc-2016-0016; Allen PJ, 2012, NEUROSCI BIOBEHAV R, V36, P1442, DOI 10.1016/j.neubiorev.2012.03.005; Andres RH, 2008, BRAIN RES BULL, V76, P329, DOI 10.1016/j.brainresbull.2008.02.035; Barrett EC, 2014, ADV NUTR, V5, P268, DOI 10.3945/an.113.005280; Beard E, 2010, J NEUROCHEM, V115, P297, DOI 10.1111/j.1471-4159.2010.06935.x; Bender A, 2016, AMINO ACIDS, V48, P1929, DOI 10.1007/s00726-015-2165-0; Benton D, 2011, BRIT J NUTR, V105, P1100, DOI 10.1017/S0007114510004733; Braissant Olivier, 2007, V46, P67; Branch JD, 2003, INT J SPORT NUTR EXE, V13, P198, DOI 10.1123/ijsnem.13.2.198; Candow DG, 2014, ENDOCRINE, V45, P354, DOI 10.1007/s12020-013-0070-4; Chilibeck PD, 2017, OPEN ACCESS J SPORTS, V8, P213, DOI 10.2147/OAJSM.S123529; Cook CJ, 2011, J INT SOC SPORT NUTR, V8, DOI 10.1186/1550-2783-8-2; Cox C, 2002, INT J SPORT NUTR EXE, V12, P33, DOI 10.1123/ijsnem.12.1.33; Dechent P, 1999, AM J PHYSIOL-REG I, V277, pR698, DOI 10.1152/ajpregu.1999.277.3.R698; Devries MC, 2014, MED SCI SPORT EXER, V46, P1194, DOI 10.1249/MSS.0000000000000220; Pereira RTD, 2015, J PHYSIOL-LONDON, V593, P3959, DOI 10.1113/JP270861; Greenhaff PL, 2001, J PHYSIOL-LONDON, V537, P657; GREENHAFF PL, 1993, CLIN SCI, V84, P565, DOI 10.1042/cs0840565; Gualano B, 2016, AMINO ACIDS, V48, P1793, DOI 10.1007/s00726-016-2239-7; Gualano B, 2012, AMINO ACIDS, V43, P519, DOI 10.1007/s00726-011-1132-7; Gualano B, 2011, EUR J APPL PHYSIOL, V111, P749, DOI 10.1007/s00421-010-1676-3; Gualano B, 2010, AMINO ACIDS, V38, P31, DOI 10.1007/s00726-009-0263-6; Hammett ST, 2010, NEUROSCI LETT, V479, P201, DOI 10.1016/j.neulet.2010.05.054; HARRIS RC, 1992, CLIN SCI, V83, P367, DOI 10.1042/cs0830367; Hayashi AP, 2014, LUPUS, V23, P1500, DOI 10.1177/0961203314546017; Heaton LE, 2017, SPORTS MED, V47, P2201, DOI 10.1007/s40279-017-0759-2; Hellem TL, 2015, J DUAL DIAGN, V11, P189, DOI 10.1080/15504263.2015.1100471; Hultman E, 1996, J APPL PHYSIOL, V81, P232; Ipsiroglu OS, 2001, LIFE SCI, V69, P1805, DOI 10.1016/S0024-3205(01)01268-1; Kaldis P, 1996, DEV NEUROSCI-BASEL, V18, P542, DOI 10.1159/000111452; Kondo DG, 2016, AMINO ACIDS, V48, P1941, DOI 10.1007/s00726-016-2194-3; Kondo DG, 2011, J AFFECT DISORDERS, V135, P354, DOI 10.1016/j.jad.2011.07.010; Kreider RB, 2003, AM J PHYSIOL-REG I, V285, pR725, DOI 10.1152/ajpregu.00375.2003; Kreider RB, 2017, J INT SOC SPORT NUTR, V14, DOI 10.1186/s12970-017-0173-z; Laakso MP, 2003, J NEURAL TRANSM, V110, P267, DOI 10.1007/s00702-002-0783-7; Ling J, 2009, BEHAV PHARMACOL, V20, P673, DOI 10.1097/FBP.0b013e3283323c2a; Lugaresi R, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-26; Lukaszuk JM, 2005, J STRENGTH COND RES, V19, P735; Lukaszuk JM, 2002, INT J SPORT NUTR EXE, V12, P336, DOI 10.1123/ijsnem.12.3.336; Lyoo IK, 2003, PSYCHIAT RES-NEUROIM, V123, P87, DOI 10.1016/S0925-4927(03)00046-5; McMorris T, 2007, PHYSIOL BEHAV, V90, P21, DOI 10.1016/j.physbeh.2006.08.024; McMorris T, 2006, PSYCHOPHARMACOLOGY, V185, P93, DOI 10.1007/s00213-005-0269-z; McMorris T, 2007, AGING NEUROPSYCHOL C, V14, P517, DOI 10.1080/13825580600788100; Mohebbi H., 2012, Middle East Journal of Scientific Research, V12, P397; Nicastro H, 2012, AMINO ACIDS, V42, P1695, DOI 10.1007/s00726-011-0871-9; Ostojic SM, 2016, APPL PHYSIOL NUTR ME, V41, P1005, DOI 10.1139/apnm-2016-0178; Pan JW, 2007, AM J PHYSIOL-REG I, V292, pR1745, DOI 10.1152/ajpregu.00717.2006; Persky Adam M., 2007, V46, P275; Rae C, 2003, P ROY SOC B-BIOL SCI, V270, P2147, DOI 10.1098/rspb.2003.2492; Rae CD, 2015, NEUROCHEM INT, V89, P249, DOI 10.1016/j.neuint.2015.08.010; Rawson ES, 2008, PHYSIOL BEHAV, V95, P130, DOI 10.1016/j.physbeh.2008.05.009; Rawson ES, 2018, INT J SPORT NUTR EXE, V28, P188, DOI 10.1123/ijsnem.2017-0340; Rawson ES, 2017, SPORTS MED, V47, pS33, DOI 10.1007/s40279-017-0689-z; Rawson ES, 2011, AMINO ACIDS, V40, P1349, DOI 10.1007/s00726-011-0855-9; Rawson ES, 2003, J STRENGTH COND RES, V17, P822; Alves CRR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076301; Sahlin K, 2011, AMINO ACIDS, V40, P1363, DOI 10.1007/s00726-011-0856-8; Sakellaris G, 2006, J TRAUMA, V61, P322, DOI 10.1097/01.ta.0000230269.46108.d5; Sakellaris G, 2008, ACTA PAEDIATR, V97, P31, DOI 10.1111/j.1651-2227.2007.00529.x; Salomons GS, 2003, J INHERIT METAB DIS, V26, P309, DOI 10.1023/A:1024405821638; Solis MY, 2017, J APPL PHYSIOL, V123, P407, DOI 10.1152/japplphysiol.00248.2017; Solis MY, 2014, BRIT J NUTR, V111, P1272, DOI 10.1017/S0007114513003802; Souza MA, 2012, AMINO ACIDS, V43, P2491, DOI 10.1007/s00726-012-1329-4; STOCKLER S, 1994, PEDIATR RES, V36, P409; Sullivan PG, 2000, ANN NEUROL, V48, P723, DOI 10.1002/1531-8249(200011)48:5&lt;723::AID-ANA5&gt;3.0.CO;2-W; Swinton PA, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00041; Tarnopolsky MA, 2003, AM J PHYSIOL-REG I, V285, pR762, DOI 10.1152/ajpregu.00270.2003; TOMPOROWSKI PD, 1986, PSYCHOL BULL, V99, P338, DOI 10.1037/0033-2909.99.3.338; Turner CE, 2015, MAGN RESON IMAGING, V33, P1163, DOI 10.1016/j.mri.2015.06.018; Turner CE, 2015, J NEUROSCI, V35, P1773, DOI 10.1523/JNEUROSCI.3113-14.2015; Vagnozzi R, 2013, J HEAD TRAUMA REHAB, V28, P284, DOI 10.1097/HTR.0b013e3182795045; Walker J B, 1979, Adv Enzymol Relat Areas Mol Biol, V50, P177; Watanabe A, 2002, NEUROSCI RES, V42, P279, DOI 10.1016/S0168-0102(02)00007-X; Wilkinson ID, 2006, CLIN J SPORT MED, V16, P63, DOI 10.1097/01.jsm.0000176372.67398.c8	75	23	23	1	24	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1746-1391	1536-7290		EUR J SPORT SCI	Eur. J. Sport Sci.	JAN 2	2019	19	1			SI		1	14		10.1080/17461391.2018.1500644			14	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	HI2SV	WOS:000456296600001	30086660				2022-02-06	
J	Zhao, W; Ji, SB				Zhao, Wei; Ji, Songbai			White Matter Anisotropy for Impact Simulation and Response Sampling in Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						concussion; tractography; traumatic brain injury; white matter anisotropy; Worcester Head Injury Model	FINITE-ELEMENT MODELS; HEAD IMPACT; CONSTITUTIVE FRAMEWORK; COMPUTATIONAL MODELS; AXONAL DAMAGE; STRAIN; MECHANICS; SPORTS; IMPLEMENTATION; DEFORMATION	Advanced neuroimaging provides new opportunities to enhance head injury models, including the incorporation of white matter (WM) structural anisotropy. Information from high-resolution neuroimaging, however, usually has to be down-sampled to match a typically coarse brain mesh. To understand how this mesh-image resolution mismatch affects impact simulation and subsequent response sampling, we compared three competing anisotropy implementations (using either voxels, tractography, or a multiscale submodeling) and two response sampling strategies (element-wise or tractography-based, using brain mesh or neuroimaging for region segmentation, respectively). Using the combination of high resolution options as a baseline, we studied how the choice in each individual category affected the resulting injury metrics. By simulating a recorded loss of consciousness head impact, we found that injury metrics including peak strain and injury susceptibility in the deep WM regions based on fiber strain, but not on maximum principal strain, were sensitive to the anisotropy implementation, response sampling, and region segmentation. Overall, it was recommended to use tractography for anisotropy implementation and response sampling, and to employ neuroimaging for region segmentation, because they led to more accurate injury metrics. Further refining mesh locally via submodeling was unnecessary. Brain strain responses were also parametrically found to be closer to that from minimum fiber reinforcement, consistent with the fact that the majority of WM had a rather high degree of fiber dispersion. Finally, the upgraded Worcester Head Injury Model incorporating WM anisotropy was successfully re-validated against cadaveric impacts and an in vivo head rotation (good to excellent validation with an average Correlation Analysis score of 0.437 and 0.509, respectively). These investigations may facilitate further continual development of head injury models to better study traumatic brain injury.	[Zhao, Wei; Ji, Songbai] Worcester Polytech Inst, Dept Biomed Engn, 60 Prescott St, Worcester, MA 01605 USA; [Ji, Songbai] Worcester Polytech Inst, Dept Mech Engn, Worcester, MA 01609 USA		Ji, SB (corresponding author), Worcester Polytech Inst, Dept Biomed Engn, 60 Prescott St, Worcester, MA 01605 USA.	sji@wpi.edu	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS092853, R21 NS088781]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS092853, R21NS088781] Funding Source: NIH RePORTER	Funding is provided by the NIH Grants R01 NS092853 and R21 NS088781.	Abaqus, 2016, AB ONL DOC; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Bigler ED, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00055; Carlsen RW, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00028; Chatelin Simon, 2013, Journal of Biorheology, V27, P26, DOI 10.1007/s12573-012-0055-6; Chatelin S, 2011, J MECH BEHAV BIOMED, V4, P1905, DOI 10.1016/j.jmbbm.2011.06.007; Chen Y, 2010, ACTA MECH, V213, P155, DOI 10.1007/s00707-009-0274-0; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Colgan NC, 2010, PROG BIOPHYS MOL BIO, V103, P304, DOI 10.1016/j.pbiomolbio.2010.09.008; Donnelly BR, 1983, STAPP CAR CRASH J, P299; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Elkins JM, 2011, CLIN ORTHOP RELAT R, V469, P454, DOI 10.1007/s11999-010-1632-x; Feng Y, 2017, J BIOMECH, V57, P146, DOI 10.1016/j.jbiomech.2017.03.025; Finan JD, 2017, ACTA BIOMATER, V55, P333, DOI 10.1016/j.actbio.2017.03.037; Ganpule S, 2017, J NEUROTRAUM, V34, P2154, DOI 10.1089/neu.2016.4744; Garcia-Gonzalez D, 2018, J MECH PHYS SOLIDS, V112, P209, DOI 10.1016/j.jmps.2017.12.001; Garimella HT, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2823; Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073; Gehre C., 2009, 21 ESV C STUTT; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Giordano Chiara, 2016, Stapp Car Crash J, V60, P363; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Giordano C, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0914; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hernandez F, 2016, ANN BIOMED ENG, V44, P828, DOI 10.1007/s10439-015-1487-0; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Javid S, 2014, J MECH BEHAV BIOMED, V30, P290, DOI 10.1016/j.jmbbm.2013.11.010; Ji SB, 2015, ANN BIOMED ENG, V43, P1877, DOI 10.1007/s10439-014-1193-3; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Ji SB, 2014, BIOMECH MODEL MECHAN, V13, P1121, DOI 10.1007/s10237-014-0562-z; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Ji SB, 2011, FINITE ELEM ANAL DES, V47, P1178, DOI 10.1016/j.finel.2011.05.007; Kimpara Hideyuki, 2006, Stapp Car Crash J, V50, P509; King A. I., 2003, IRCOBI C LISB; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Leemans A., 2009, 17 AN M INT SOC MAGN; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mao HJ, 2013, COMPUT METHOD BIOMEC, V16, P271, DOI 10.1080/10255842.2011.617005; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; Meaney DF, 2003, BIOMECH MODEL MECHAN, V1, P279, DOI 10.1007/s10237-002-0020-1; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Miller LE, 2017, COMPUT METHOD BIOMEC, V20, P1273, DOI 10.1080/10255842.2017.1340462; Miller LE, 2016, BIOMECH MODEL MECHAN, V15, P1201, DOI 10.1007/s10237-015-0754-1; Mohammadipour A, 2017, J BIOMECH, V65, P61, DOI 10.1016/j.jbiomech.2017.09.029; Morfey, 2001, P 17 INT TECHN C ENH; National Research Council I, 2014, SPORTS RELATED CONCU; Newman J A, 2000, Stapp Car Crash J, V44, P215; Nicolle Stephane, 2004, Stapp Car Crash J, V48, P239; Ning XG, 2006, J BIOMECH ENG-T ASME, V128, P925, DOI 10.1115/1.2354208; Peden M., 2004, WORLD REPORT ROAD TR; Puso MA, 1998, J BIOMECH ENG-T ASME, V120, P62, DOI 10.1115/1.2834308; Rasanen LP, 2016, COMPUT METHOD BIOMEC, V19, P1225, DOI 10.1080/10255842.2015.1124269; Rohlmann A, 2010, EUR SPINE J, V19, P1585, DOI 10.1007/s00586-010-1386-x; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Sahoo D, 2014, J MECH BEHAV BIOMED, V33, P24, DOI 10.1016/j.jmbbm.2013.08.022; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Takhounts EG, 2008, STAPP CAR C, V52, P1; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Yang King H, 2006, Stapp Car Crash J, V50, P429; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhao W, 2015, IRCOBI C LYON FRANC, P208; Zhao W, 2018, J MECH BEHAV BIOMED, V80, P222, DOI 10.1016/j.jmbbm.2018.02.005; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P1709, DOI 10.1007/s10237-017-0915-5; Zhao W, 2016, J NEUROTRAUM, V33, P1834, DOI 10.1089/neu.2015.4239; Zhao W, 2016, INTERFACE FOCUS, V6, DOI 10.1098/rsfs.2015.0091; Zhao W, 2015, BIOMECH MODEL MECHAN, V14, P753, DOI 10.1007/s10237-014-0634-0; Zhu F, 2016, J NEUROTRAUM, V33, P859, DOI 10.1089/neu.2015.4007; Zonfrillo M., 2015, ACAD EMERG MED, V22, P872	85	23	23	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2019	36	2					250	263		10.1089/neu.2018.5634			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HM4LJ	WOS:000459444800008	29681212	Green Published			2022-02-06	
J	Vuokila, N; Lukasiuk, K; Bot, AM; van Vliet, EA; Aronica, E; Pitkanen, A; Puhakka, N				Vuokila, Niina; Lukasiuk, Katarzyna; Bot, Anna Maria; van Vliet, Erwin A.; Aronica, Eleonora; Pitkanen, Asla; Puhakka, Noora			miR-124-3p is a chronic regulator of gene expression after brain injury	CELLULAR AND MOLECULAR LIFE SCIENCES			English	Article						Big data; Bioinformatics; microRNA; miR-124-3p; Traumatic brain injury	TRACT-BINDING-PROTEIN; GIANT-CELL ASTROCYTOMA; TRAUMATIC BRAIN; MICRORNA EXPRESSION; NEURONAL DIFFERENTIATION; MAMMALIAN TARGET; MTOR INHIBITOR; LEUKEMIA-CELLS; STEM-CELLS; C-JUN	Traumatic brain injury (TBI) initiates molecular and cellular pathologies that underlie post-injury morbidities, including hippocampus-related memory decline and epileptogenesis. Non-coding small RNAs are master regulators of gene expression with the potential to affect multiple molecular pathways. To evaluate whether hippocampal gene expression networks are chronically regulated by microRNAs after TBI, we sampled the dentate gyrus of rats with severe TBI induced by lateral fluid-percussion injury 3months earlier. Ingenuity pathway analysis revealed 30 upregulated miR-124-3p targets, suggesting that miR-124-3p is downregulated post-TBI (z-score=-5.146, p<0.05). Droplet digital polymerase chain reaction (ddPCR) and in situ hybridization confirmed the chronic downregulation of miR-124-3p (p<0.05). Quantitative PCR analysis of two targets, Plp2 and Stat3, indicated that their upregulation correlated with the miR-124-3p downregulation (r=-0.647, p<0.05; r=-0.629, p<0.05, respectively). Immunohistochemical staining of STAT3 confirmed the increased protein expression. STRING analysis showed that 9 of the 30 miR-124-3p targets belonged to a STAT3 network. Reactome analysis and data mining connected the targets especially to inflammation and signal transduction. L1000CDS2 software revealed drugs (e.g., importazole, trichostatin A, and IKK-16) that could reverse the observed molecular changes. The translational value of our data was emphasized by in situ hybridization showing chronic post-traumatic downregulation of miR-124-3p in the dentate gyrus of TBI patients. Analysis of another brain injury model, status epilepticus, highlighted the fact that chronic downregulation of miR-124 is a common phenomenon after brain injury. Together, our findings indicate that miR-124-3p is a chronic modulator of molecular networks relevant to post-injury hippocampal pathologies in experimental models and in humans.	[Vuokila, Niina; Pitkanen, Asla; Puhakka, Noora] Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, Kuopio 70211, Finland; [Lukasiuk, Katarzyna; Bot, Anna Maria] Polish Acad Sci, Nencki Inst Expt Biol, 3 Pasteur Str, PL-02093 Warsaw, Poland; [van Vliet, Erwin A.; Aronica, Eleonora] Univ Amsterdam, Acad Med Ctr, Dept Neuro Pathol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Aronica, Eleonora] SEIN, Amsterdam, Netherlands		Pitkanen, A; Puhakka, N (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, Kuopio 70211, Finland.	asla.pitkanen@uef.fi; noora.puhakka@uef.fi	van Vliet, Erwin/AAS-4753-2020	van Vliet, Erwin/0000-0001-5747-3202; Aronica, Eleonora/0000-0002-3542-3770; Lukasiuk, Katarzyna/0000-0002-1582-0920	Academy of FinlandAcademy of FinlandEuropean Commission [272249, 273909]; Polish National Science Centre [2015/16/T/NZ4/00175, 2014/15/N/NZ4/04561]; European Union's Seventh Framework Programme (FP7/2007-2013) [602102]	The research leading to these results received funding from the Academy of Finland (AP) Grant nos. (272249, 273909), Polish National Science Centre Grants (2015/16/T/NZ4/00175 and 2014/15/N/NZ4/04561), as well as from the European Union's Seventh Framework Programme (FP7/2007-2013) under Grant agreement no 602102 (EPITARGET). We acknowledge the technical support generously provided by Mr. Jarmo Hartikainen, Mrs. Merja Lukkari, and Mr. Jasper Anink.	Aoki H, 2012, DEVELOPMENT, V139, P667, DOI 10.1242/dev.072272; Attilio PJ, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8398072; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Bao TH, 2014, J MOL NEUROSCI, V54, P622, DOI 10.1007/s12031-014-0344-1; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beukelaers P, 2011, STEM CELLS, V29, P713, DOI 10.1002/stem.616; Bot AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076051; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Brenes JC, 2016, J COMP NEUROL, V524, P1586, DOI 10.1002/cne.23842; Brennan GP, 2016, CELL REP, V14, P2402, DOI 10.1016/j.celrep.2016.02.042; Buss H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051847; Butler CR, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00163; Cai BZ, 2012, STEM CELLS, V30, P1746, DOI 10.1002/stem.1154; Campbell IL, 2005, BRAIN RES REV, V48, P166, DOI 10.1016/j.brainresrev.2004.12.006; Cardamone M, 2014, J PEDIATR-US, V164, P1195, DOI 10.1016/j.jpeds.2013.12.053; Carmel I, 1999, BIOCHEM PHARMACOL, V58, P273, DOI 10.1016/S0006-2952(99)00093-3; Chio CC, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0867-9; Chu HX, 2014, J CEREBR BLOOD F MET, V34, P1425, DOI 10.1038/jcbfm.2014.120; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Folkersma H, 2009, J NUCL MED, V50, P1975, DOI 10.2967/jnumed.109.067512; Forbes DJ, 2015, CURR OPIN CELL BIOL, V35, P78, DOI 10.1016/j.ceb.2015.04.012; Franz DN, 2014, LANCET ONCOL, V15, P1513, DOI 10.1016/S1470-2045(14)70489-9; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Ge XT, 2015, BRAIN RES, V1603, P150, DOI 10.1016/j.brainres.2015.01.009; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; Gorter JA, 2014, NEUROBIOL DIS, V62, P508, DOI 10.1016/j.nbd.2013.10.026; Grabenstatter HL, 2014, NEUROBIOL DIS, V62, P73, DOI 10.1016/j.nbd.2013.09.003; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Gu X, 2016, MOL NEUROBIOL, V53, P6388, DOI 10.1007/s12035-015-9540-4; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Gyoneva S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0443-0; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Handschick K, 2014, MOL CELL, V53, P193, DOI 10.1016/j.molcel.2013.12.002; He LZ, 2001, J CLIN INVEST, V108, P1321, DOI 10.1172/JCI200111537; He M, 2012, NEURON, V73, P35, DOI 10.1016/j.neuron.2011.11.010; Hu K, 2011, NEUROSCI LETT, V488, P252, DOI 10.1016/j.neulet.2010.11.040; Hu T, 2015, J MOL NEUROSCI, V57, P114, DOI 10.1007/s12031-015-0584-8; Hu ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039357; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Jadhav SP, 2014, J NEUROCHEM, V130, P388, DOI 10.1111/jnc.12731; Jiang HB, 2010, BIOCHEM BIOPH RES CO, V395, P471, DOI 10.1016/j.bbrc.2010.04.030; Johansson S, 2005, BRAIN, V128, P2961, DOI 10.1093/brain/awh644; Jost PJ, 2007, BLOOD, V109, P2700, DOI 10.1182/blood-2006-07-025809; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kletsas D, 2004, BIOCHEM PHARMACOL, V67, P1927, DOI 10.1016/j.bcp.2004.01.021; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Kok FO, 2012, DEVELOPMENT, V139, P3838, DOI 10.1242/dev.080994; Kollmann K, 2013, CANCER CELL, V24, P167, DOI 10.1016/j.ccr.2013.07.012; Kotulska K, 2013, EUR J PAEDIATR NEURO, V17, P479, DOI 10.1016/j.ejpn.2013.03.002; Kronenberg G, 2010, J NEUROSCI, V30, P3419, DOI 10.1523/JNEUROSCI.4231-09.2010; Kumar S, 2015, ANTI-CANCER AGENT ME, V15, P1297, DOI 10.2174/1871520615666150402093558; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; LEWIS DA, 1986, J COMP NEUROL, V248, P1, DOI 10.1002/cne.902480102; Licatalosi DD, 2012, GENE DEV, V26, P1626, DOI 10.1101/gad.191338.112; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103948; Liu QS, 2010, J MED CHEM, V53, P7146, DOI 10.1021/jm101144f; Lunavat TR, 2015, RNA BIOL, V12, P810, DOI 10.1080/15476286.2015.1056975; Lund IV, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1162396; Mackowiak B, 2017, MOL PHARMACOL, V92, P75, DOI 10.1124/mol.117.108621; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Mandel G, 2011, P NATL ACAD SCI USA, V108, P16789, DOI 10.1073/pnas.1113486108; Markovtsov V, 2000, MOL CELL BIOL, V20, P7463, DOI 10.1128/MCB.20.20.7463-7479.2000; McClelland S, 2014, ELIFE, V3, DOI 10.7554/eLife.01267; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meissner L, 2016, J NEUROTRAUM, V33, P713, DOI 10.1089/neu.2015.4077; Miao W, 2015, BRAZ J MED BIOL RES, V48, P433, DOI [10.1590/1414-431X20144012, 10.1590/1414-431x20144012]; Miotto E, 2014, CANCER EPIDEM BIOMAR, V23, P2638, DOI 10.1158/1055-9965.EPI-14-0503; Mitsiades CS, 2004, P NATL ACAD SCI USA, V101, P540, DOI 10.1073/pnas.2536759100; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muller S, 2009, STEM CELLS, V27, P431, DOI 10.1634/stemcells.2008-0234; Nelson PT, 2006, RNA, V12, P187, DOI 10.1261/rna.2258506; Nesti E, 2014, P NATL ACAD SCI USA, V111, pE3929, DOI 10.1073/pnas.1414770111; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Nissinen J, 2000, EPILEPSY RES, V38, P177, DOI 10.1016/S0920-1211(99)00088-1; Oliva AA, 2012, J NEUROCHEM, V120, P710, DOI 10.1111/j.1471-4159.2011.07610.x; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Owen DR, 2017, J CEREBR BLOOD F MET, V37, P2679, DOI 10.1177/0271678X17710182; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Peiffer L, 2014, J CANCER RES CLIN, V140, P1283, DOI 10.1007/s00432-014-1689-0; Pitkanen A, 2007, EPILEPSIA, V48, P13, DOI 10.1111/j.1528-1167.2007.01063.x; Polydorides AD, 2000, P NATL ACAD SCI USA, V97, P6350, DOI 10.1073/pnas.110128397; Puhakka N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172521; Racke FK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051059; Raible DJ, 2015, EXP NEUROL, V271, P445, DOI 10.1016/j.expneurol.2015.07.001; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Rodenas-Ruano A, 2012, NAT NEUROSCI, V15, P1382, DOI 10.1038/nn.3214; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rummel C, 2004, J PHYSIOL-LONDON, V557, P671, DOI 10.1113/jphysiol.2003.058834; Sabirzhanov B, 2016, CELL DEATH DIFFER, V23, P654, DOI 10.1038/cdd.2015.132; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Sandhir R, 2014, NEUROCHEM INT, V78, P117, DOI 10.1016/j.neuint.2014.09.009; Sawicka K, 2008, BIOCHEM SOC T, V36, P641, DOI 10.1042/BST0360641; Schober K, 2015, INT J LEGAL MED, V129, P701, DOI 10.1007/s00414-014-1129-3; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112019; Sharma S, 2005, MOL CELL, V19, P485, DOI 10.1016/j.molcel.2005.07.014; Siegel D, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-31; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Soderholm JF, 2011, ACS CHEM BIOL, V6, P700, DOI 10.1021/cb2000296; Soldati C, 2015, J NEUROSCI RES, V93, P1203, DOI 10.1002/jnr.23572; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Stamatovic SM, 2006, J IMMUNOL, V177, P2651, DOI 10.4049/jimmunol.177.4.2651; Su XH, 2004, MOL CELL BIOL, V24, P8018, DOI 10.1128/MCB.24.18.8018-8025.2004; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun D, 2016, EXP NEUROL, V275, P405, DOI 10.1016/j.expneurol.2015.04.017; Sun HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055693; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Taheri S, 2016, J NEUROTRAUM, V33, P1818, DOI 10.1089/neu.2015.4281; Truettner JS, 2013, BRAIN RES, V1533, P122, DOI 10.1016/j.brainres.2013.08.011; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; Valiyaveettil M, 2013, CHEM-BIOL INTERACT, V203, P371, DOI 10.1016/j.cbi.2012.10.022; Vrana JA, 1999, ONCOGENE, V18, P7016, DOI 10.1038/sj.onc.1203176; Wang GP, 2006, J MED CHEM, V49, P6139, DOI 10.1021/jm060460o; Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018; Wang Y, 2012, EXP BIOL MED, V237, P1424, DOI 10.1258/ebm.2012.012123; Watanabe Y, 2004, GENE DEV, V18, P889, DOI 10.1101/gad.1179004; Weng HC, 2011, BIOMED RES-TOKYO, V32, P135, DOI 10.2220/biomedres.32.135; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; Wong VS, 2016, NEUROSCI LETT, V625, P26, DOI 10.1016/j.neulet.2016.04.009; You WD, 2016, CHIN J TRAUMATOL, V19, P11, DOI 10.1016/j.cjtee.2016.01.004; Yu HY, 2017, MOL CANCER THER, V16, P2711, DOI 10.1158/1535-7163.MCT-17-0498; Yu HL, 2015, J NEUROCHEM, V135, P261, DOI 10.1111/jnc.13238; Yu HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036988; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002; Yuan L, 2011, BLOOD, V118, P1145, DOI 10.1182/blood-2010-10-315275; Zhang LL, 2015, HUM MOL GENET, V24, P7221, DOI 10.1093/hmg/ddv422; Zhang SZ, 2015, J CELL PHYSIOL, V230, P2476, DOI 10.1002/jcp.24982; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zhu XJ, 2007, NAT CELL BIOL, V9, P184, DOI 10.1038/ncb1535	139	23	25	0	14	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1420-682X	1420-9071		CELL MOL LIFE SCI	Cell. Mol. Life Sci.	DEC	2018	75	24					4557	4581		10.1007/s00018-018-2911-z			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GY9IH	WOS:000448955600006	30155647				2022-02-06	
J	Erdodi, LA; Abeare, CA; Medoff, B; Seke, KR; Sagar, S; Kirsch, NL				Erdodi, Laszlo A.; Abeare, Christopher A.; Medoff, Brent; Seke, Kristian R.; Sagar, Sanya; Kirsch, Ned L.			A Single Error Is One Too Many: The Forced Choice Recognition Trial of the CVLT-II as a Measure of Performance Validity in Adults with TBI	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						CVLT-II; Forced choice recognition; Traumatic brain injury; Performance validity assessment; Alternative cutoffs	TRAUMATIC BRAIN-INJURY; VERBAL-LEARNING TEST; CARD SORTING TEST; SYMPTOM VALIDITY; MEMORY TEST; RESPONSE BIAS; NEUROPSYCHOLOGICAL ASSESSMENT; DEPRESSIVE SYMPTOMS; INVALID PERFORMANCE; AMERICAN ACADEMY	Objective: The Forced Choice Recognition (FCR) trial of the California Verbal Learning Test-Second Edition (CVLT-II) was designed to serve as a performance validity test (PVT). The present study was designed to compare the classification accuracy of a more liberal alternative (<= 15) to the de facto FCR cutoff (<= 14). Method: The classification accuracy of the two cutoffs was computed in reference to psychometrically defined invalid performance, across various criterion measures, in a sample of 104 adults with TBI clinically referred for neuropsychological assessment. Results: The FCR was highly predictive (AUC: .71-.83) of Pass/Fail status on reference PVTs, but unrelated to performance on measures known to be sensitive to TBI. On average, FCR <= 15 correctly identified an additional 6% of invalid response sets compared to FCR <= 14, while maintaining .92 specificity. Patients who failed the FCR reported higher levels of emotional distress. Conclusions: Results suggest that even a single error on the FCR is a reliable indicator of invalid responding. Further research is needed to investigate the clinical significance of the relationship between failing the FCR and level of self-reported psychiatric symptoms.	[Erdodi, Laszlo A.] Univ Windsor, Dept Psychol, 168 Chrysler Hall South, Windsor, ON N9B 3P4, Canada; [Abeare, Christopher A.] Univ Windsor, Dept Psychol, 170 Chrysler Hall South, Windsor, ON N9B 3P4, Canada; [Medoff, Brent] Commonwealth Med Coll, 525 Pine St, Scranton, PA 18509 USA; [Seke, Kristian R.] Univ Windsor, Brain Cognit Neurosci Program, G105 Chrysler Hall North, Windsor, ON N9B 3P4, Canada; [Sagar, Sanya] Univ Windsor, Dept Psychol, 109 Chrysler Hall North, Windsor, ON N9B 3P4, Canada; [Kirsch, Ned L.] Univ Michigan, Dept Phys Med & Rehabil, Briarwood Circle 4, Ann Arbor, MI 48108 USA		Erdodi, LA (corresponding author), Univ Windsor, Dept Psychol, 168 Chrysler Hall South, Windsor, ON N9B 3P4, Canada.	lerdodi@gmail.com		Sagar, Sanya/0000-0001-7381-0803; Abeare, Christopher/0000-0002-7163-7434			American Psychiatric Association, 1996, DIAGN STAT MAN MENT; An KY, 2017, CLIN NEUROPSYCHOL, V31, P193, DOI 10.1080/13854046.2016.1217046; An KY, 2012, ARCH CLIN NEUROPSYCH, V27, P849, DOI 10.1093/arclin/acs085; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Ashendorf L, 2004, ARCH CLIN NEUROPSYCH, V19, P125, DOI 10.1016/S0887-6177(02)00218-4; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Baker KA, 1998, REHABIL PSYCHOL, V43, P30, DOI 10.1037/0090-5550.43.1.30; Baldo JV, 2002, J INT NEUROPSYCH SOC, V8, P539, DOI 10.1017/S135561770281428X; Bauer L, 2005, APPL NEUROPSYCHOL, V12, P202, DOI 10.1207/s15324826an1204_3; Bearden CE, 2006, PSYCHIAT RES, V142, P139, DOI 10.1016/j.psychres.2005.08.010; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Bigler ED, 2015, BRAIN IMAGING BEHAV, V9, P421, DOI 10.1007/s11682-015-9409-1; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bortnik KE, 2010, CLIN NEUROPSYCHOL, V24, P344, DOI 10.1080/13854040903307268; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; Clark LR, 2012, CLIN NEUROPSYCHOL, V26, P1201, DOI 10.1080/13854046.2012.728626; Coleman RD, 1998, J CLIN EXP NEUROPSYC, V20, P201, DOI 10.1076/jcen.20.2.201.1164; Connor D. J., 1997, AM AC NEUR BOST; Considine CM, 2011, ARCH CLIN NEUROPSYCH, V26, P445, DOI 10.1093/arclin/acr041; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; Derogatis L. R., 1994, SCL 90 R ADM SCORING, VThird; Donders J, 2011, CLIN NEUROPSYCHOL, V25, P173, DOI 10.1080/13854046.2010.536781; Egeland J, 2005, ACTA PSYCHIAT SCAND, V112, P434, DOI 10.1111/j.1600-0447.2005.00599.x; Erdodi L.A., 2017, PSYCHOL NEUROSCIENCE, V10, P325, DOI [10.1037/pne0000103, DOI 10.1037/PNE0000103, https://doi.org//10.1037/pne0000103, DOI https://doi.org/10.1037/pne0000103]; Erdodi LA, 2019, APPL NEUROPSYCH-ADUL, V26, P155, DOI 10.1080/23279095.2017.1384925; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P327, DOI 10.1080/23279095.2017.1298600; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P755, DOI 10.1037/pas0000525; Erdodi LA, 2017, BRAIN INJURY, V31, P1362, DOI 10.1080/02699052.2017.1332386; Erdodi LA, 2017, J CLIN EXP NEUROPSYC, V39, P369, DOI 10.1080/13803395.2016.1230181; Erdodi LA, 2016, PSYCHOL INJ LAW, V9, P112, DOI 10.1007/s12207-016-9254-6; Erdodi LA, 2014, PSYCHOL INJ LAW, V7, P255, DOI 10.1007/s12207-014-9197-8; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Frederick R. I., 2003, VIP VALIDITY INDICAT; GRANT I, 1996, NEUROPSYCHOLOGICAL A; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 2003, GREENS WORD MEMORY T; Green P., 2007, ASSESSMENT FEIGNED C, P50; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; Heaton R. K., 2004, REVISED COMPREHENSIV; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hoofien D, 2005, APPL NEUROPSYCHOL, V12, P30, DOI 10.1207/s15324826an1201_6; ILSLEY JE, 1995, J AFFECT DISORDERS, V35, P1, DOI 10.1016/0165-0327(95)00032-I; Iverson GL, 2003, HANDBOOK OF FORENSIC NEUROPSYCHOLOGY, P137; Keiski MA, 2007, CLIN NEUROPSYCHOL, V21, P744, DOI 10.1080/13854040600775346; Kessels RPC, 2007, CLIN NEUROL NEUROSUR, V109, P323, DOI 10.1016/j.clineuro.2006.12.009; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Langenecker SA, 2005, J CLIN EXP NEUROPSYC, V27, P320, DOI 10.1080/13803390490490515720; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2012, FORENSIC NEUROPSYCHO, P2; Leighton A, 2014, J INT NEUROPSYCH SOC, V20, P873, DOI 10.1017/S135561771400085X; Lichtenstein JD, 2017, CHILD NEUROPSYCHOL, V23, P284, DOI 10.1080/09297049.2015.1135422; Marschark M, 2000, J HEAD TRAUMA REHAB, V15, P1227, DOI 10.1097/00001199-200012000-00004; Marshall P, 2007, CLIN NEUROPSYCHOL, V21, P826, DOI 10.1080/13854040600801001; Millis SR., 2001, J FORENSIC NEUROPSYC, V2, P1, DOI [10.1300/J151v02n01_01, DOI 10.1300/J151V02N01_]; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Palav A, 2001, J HEAD TRAUMA REHAB, V16, P275, DOI 10.1097/00001199-200106000-00006; Pearson, 2009, ADV CLIN SOL WAIS 4; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Raskin SA, 1998, CLIN NEUROPSYCHOL, V12, P21, DOI 10.1076/clin.12.1.21.1724; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; Reese CS, 2012, ARCH CLIN NEUROPSYCH, V27, P176, DOI 10.1093/arclin/acr117; Reznek L, 2005, BRAIN INJURY, V19, P539, DOI 10.1080/02699050400005242; Rohling ML, 2002, ARCH CLIN NEUROPSYCH, V17, P205, DOI 10.1016/S0887-6177(01)00109-3; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Ross TP, 2016, ARCH CLIN NEUROPSYCH, V31, P97, DOI 10.1093/arclin/acv062; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Santos OA, 2014, ARCH CLIN NEUROPSYCH, V29, P609, DOI 10.1093/arclin/acu039; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Sprinkle SD, 2002, J COUNS PSYCHOL, V49, P381, DOI 10.1037//0022-0167.49.3.381; Storch EA, 2004, DEPRESS ANXIETY, V19, P187, DOI 10.1002/da.20002; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Sweet JJ, 2013, BEHAV SCI LAW, V31, P756, DOI 10.1002/bsl.2088; Tombaugh T.N., 1996, TEST MEMORY MALINGER; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Westcott MC, 2005, BRAIN INJURY, V19, P1261, DOI 10.1080/02699050500150104; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791	90	23	23	1	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	NOV	2018	33	7					845	860		10.1093/acn/acx110			16	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	HG9KC	WOS:000455325500005	29293900	Bronze			2022-02-06	
J	Ewing-Cobbs, L; Cox, CS; Clark, AE; Holubkov, R; Keenan, HT				Ewing-Cobbs, Linda; Cox, Charles S.; Clark, Amy E.; Holubkov, Richard; Keenan, Heather T.			Persistent Postconcussion Symptoms After Injury	PEDIATRICS			English	Article							TRAUMATIC-BRAIN-INJURY; POST-CONCUSSIVE SYMPTOMS; GOOD OLD DAYS; PEDIATRIC CONCUSSION; STRESS SYMPTOMS; RISK-FACTORS; HEAD-INJURY; CHILDREN; ADOLESCENTS; PREDICTORS	PCSs failed to resolve in a striking number of children with mTBI; 40%, especially girls, continued to act differently 1 year after injury. OBJECTIVES:We examined whether preinjury, demographic, and family factors influenced vulnerability to postconcussion symptoms (PCSs) persisting the year after mild traumatic brain injury (mTBI).METHODS:Children with mTBI (n = 119), complicated mild traumatic brain injury (cmTBI) (n = 110), or orthopedic injury (OI) (n = 118), recruited from emergency departments, were enrolled in a prospective, longitudinal cohort study. Caregivers completed retrospective surveys to characterize preinjury demographic, child, and family characteristics. PCSs were assessed using a validated rating scale. With multivariable general linear models adjusted for preinjury symptoms, we examined predictors of PCSs 3, 6, and 12 months after injury in children ages 4 to 8, 9 to 12, and 13 to 15 years at injury. With logistic regression, we examined predictors of chronic PCSs 1 year after traumatic brain injury.RESULTS:Postinjury somatic, emotional, cognitive, and fatigue PCSs were similar in the mTBI and cmTBI groups and significantly elevated compared with the OI group. PCS trajectories varied with age and sex. Adolescents had elevated PCSs that improved; young children had lower initial symptoms and less change. Despite similar preinjury PCSs, girls had elevated symptoms across all time points compared with boys. PCS vulnerability factors included female sex, adolescence, preinjury mood problems, lower income, and family discord. Social capital was a protective factor. PCSs persisted in 25% to 31% of the traumatic brain injury group and 18% of the OI group at 1 year postinjury. The odds of chronic PCSs were almost twice as high in girls as in boys and were >4 times higher in young children with cmTBI than in those with mTBI.CONCLUSIONS:A significant minority of children with mTBI and OI have PCSs that persisted 1 year after injury.	[Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, John P & Katherine G McGovern Med Sch, Childrens Learning Inst, Houston, TX 77030 USA; [Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, John P & Katherine G McGovern Med Sch, Dept Pediat, Houston, TX 77030 USA; [Cox, Charles S.] Univ Texas Hlth Sci Ctr Houston, John P & Katherine G McGovern Med Sch, Dept Pediat Surg, Houston, TX 77030 USA; [Clark, Amy E.; Holubkov, Richard; Keenan, Heather T.] Univ Utah, Dept Pediat, Salt Lake City, UT USA		Ewing-Cobbs, L (corresponding author), Univ Texas Hlth Sci Ctr Houston, Childrens Learning Inst, Dept Pediat, 7000 Fannin St,Suite 2401, Houston, TX 77030 USA.	linda.ewing-cobbs@uth.tmc.edu			Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01/CE002188]; National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K24HD072984]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01CE002188] Funding Source: NIH RePORTER	Supported by the Centers for Disease Control and Prevention (Cooperative Agreement U01/CE002188). Contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention. Dr Keenan was also supported by the National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development (K24HD072984). Neither the Eunice Kennedy Shriver National Institute of Child Health and Human Development nor the Centers for Disease Control and Prevention played a role in the design or conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the article; or decision to submit the article for publication. Funded by the National Institutes of Health (NIH).	Achenbach TM, 1991, MANUAL CHILD BEHAV C; Albanese BJ, 2017, PSYCHIAT RES, V252, P242, DOI 10.1016/j.psychres.2017.01.099; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Covassin T, 2018, INT J PSYCHOPHYSIOL, V132, P9, DOI 10.1016/j.ijpsycho.2017.09.010; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Ewing-Cobbs L, 2017, PSYCHONEUROENDOCRINO, V84, P66, DOI 10.1016/j.psyneuen.2017.06.003; Gallo LC, 2009, J PERS, V77, P1707, DOI 10.1111/j.1467-6494.2009.00598.x; Gennarelli TA, 2005, ABBREVIATED INJURY S; Graham R, 2013, SPORTS RELATED CONCU; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Jimenez N, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2462; Jimenez N, 2013, PEDIATRICS, V131, pE1850, DOI 10.1542/peds.2012-3354; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Max JE, 2015, J NEUROPSYCH CLIN N, V27, P112, DOI 10.1176/appi.neuropsych.13080190; McCarthy MT, 2015, ANN NY ACAD SCI, V1345, P89, DOI 10.1111/nyas.12736; McCarty CA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0459; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Moore M, 2018, J HEAD TRAUMA REHAB, V33, P177, DOI 10.1097/HTR.0000000000000348; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Runyan DK, 1998, PEDIATRICS, V101, P12, DOI 10.1542/peds.101.1.12; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Snook ML, 2017, JAMA PEDIATR, V171, P879, DOI 10.1001/jamapediatrics.2017.1140; TEASDALE G, 1974, LANCET, V2, P81; Truss K, 2017, J NEUROTRAUM, V34, P2272, DOI 10.1089/neu.2016.4842; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yuan WH, 2017, J HEAD TRAUMA REHAB, V32, P378, DOI 10.1097/HTR.0000000000000318; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216; Zogg CK, 2018, EPIDEMIOLOGY, V29, P269, DOI 10.1097/EDE.0000000000000791; Zonfrillo MR, 2014, J NEUROTRAUM, V31, P722, DOI 10.1089/neu.2013.3088	52	23	24	0	4	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	NOV	2018	142	5							e20180939	10.1542/peds.2018-0939			13	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	GY7DF	WOS:000448763700023	30323108	Green Published, Bronze			2022-02-06	
J	Rubin, TG; Catenaccio, E; Fleysher, R; Hunter, LE; Lubin, N; Stewart, WE; Kim, M; Lipton, RB; Lipton, ML				Rubin, Todd G.; Catenaccio, Eva; Fleysher, Roman; Hunter, Liane E.; Lubin, Naomi; Stewart, Walter E.; Kim, Mimi; Lipton, Richard B.; Lipton, Michael L.			MRI-defined White Matter Microstructural Alteration Associated with Soccer Heading Is More Extensive in Women than Men	RADIOLOGY			English	Article							TRAUMATIC-BRAIN-INJURY; SPORTS-RELATED CONCUSSION; SEX-DIFFERENCES; NEUROPSYCHOLOGICAL FUNCTION; GENDER-DIFFERENCES; SYMPTOMS; PLAYERS; IMPACT; ABNORMALITIES; REGISTRATION	Purpose: To examine the role of sex in abnormal white matter microstructure after soccer heading as identified by using the diffusion-tensor imaging (DTI) metric fractional anisotropy (FA). Materials and Methods: In this prospective cross-sectional study, 98 individuals who were enrolled in a larger prospective study of amateur soccer players (from 2013 to 2016) were matched 1: 1 for age and history of soccer heading in the prior 12 months. Among the subjects, 49 men (mean age, 25.7 years; range, 18-50 years) and 49 women (mean age, 25.8 years; range, 18-50 years) with median total soccer headings per year of 487 and 469, respectively, underwent 3.0-T DTI. Images were registered to the Johns Hopkins University template. A voxelwise linear regression was fitted for FA with terms for the number of headings during the previous 12 months and its interaction with sex after controlling for the following potential confounders: age, years of education, number of lifetime concussions, and handedness. In the resulting statistical maps, P < .01 indicated a statistically significant difference, with a threshold cluster size larger than 100 mm(3). Results: Among men, three regions were identified in which greater heading exposure was associated with lower FA; eight such regions were identified among women (>100 contiguous voxels, P < .01). In seven of the eight regions identified in women, the association between heading and FA was stronger in women than in men. There was no significant difference of heading with FA between the sexes for any region in which heading was associated with FA among men (P > .01, <100 contiguous voxels). Conclusion: With similar exposure to heading, women exhibit more widespread evidence of microstructural white matter alteration than do men, suggesting preliminary support for a biologic divergence of brain response to repetitive trauma. (c) RSNA, 2018	[Rubin, Todd G.; Fleysher, Roman; Hunter, Liane E.; Lubin, Naomi; Lipton, Michael L.] Albert Einstein Coll Med, Gruss Magnet Resonance Res Ctr, Dept Radiol, 1300 Morris Pk Ave, Bronx, NY 10461 USA; [Kim, Mimi; Lipton, Richard B.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, 1300 Morris Pk Ave, Bronx, NY 10461 USA; [Lipton, Richard B.] Albert Einstein Coll Med, Dept Neurol, 1300 Morris Pk Ave, Bronx, NY 10461 USA; [Lipton, Michael L.] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, 1300 Morris Pk Ave, Bronx, NY 10461 USA; [Rubin, Todd G.; Lipton, Michael L.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, 1300 Morris Pk Ave, Bronx, NY 10461 USA; [Lipton, Michael L.] Montefiore Med Ctr, Dept Radiol, 111 E 210th St, Bronx, NY 10467 USA; [Lipton, Richard B.] Montefiore Med Ctr, Dept Neurol, 111 E 210th St, Bronx, NY 10467 USA; [Catenaccio, Eva] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA; [Stewart, Walter E.] Sutter Hlth, Walnut Creek, CA USA		Lipton, ML (corresponding author), Albert Einstein Coll Med, Gruss Magnet Resonance Res Ctr, Dept Radiol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.; Lipton, ML (corresponding author), Albert Einstein Coll Med, Dept Psychiat & Behav Sci, 1300 Morris Pk Ave, Bronx, NY 10461 USA.; Lipton, ML (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, 1300 Morris Pk Ave, Bronx, NY 10461 USA.; Lipton, ML (corresponding author), Montefiore Med Ctr, Dept Radiol, 111 E 210th St, Bronx, NY 10467 USA.	michael.lipton@einstein.yu.edu	Lipton, Richard Bruce/AAY-2818-2021; Lipton, Richard B/B-5060-2011; Catenaccio, Eva/M-7250-2019	Catenaccio, Eva/0000-0003-0550-207X; Rubin, Todd/0000-0002-2821-5877	National Institutes of Health, National Institute of Neurologic Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS082432]; Dana Foundation David Mahoney Neuroimaging Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS082432] Funding Source: NIH RePORTER	Supported by the National Institutes of Health, National Institute of Neurologic Disorders and Stroke (R01 NS082432), and a grant from the Dana Foundation David Mahoney Neuroimaging Program.	Ardekani BA, 2005, J NEUROSCI METH, V142, P67, DOI 10.1016/j.jneumeth.2004.07.014; ARDEKANI BA, 1995, J COMPUT ASSIST TOMO, V19, P615, DOI 10.1097/00004728-199507000-00022; Babbs C F, 2001, ScientificWorldJournal, V1, P281; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Caccese JB, 2017, SPORTS BIOMECH, V3141, P1; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Catenaccio E, 2017, PM&R, V9, P884, DOI 10.1016/j.pmrj.2017.01.005; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Dorminy M, 2015, BRAIN INJURY, V29, P1158, DOI 10.3109/02699052.2015.1035324; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; FLEET GH, 1975, BIOCHIM BIOPHYS ACTA, V410, P318, DOI 10.1016/0005-2744(75)90234-X; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Hoptman MJ, 2008, SCHIZOPHR RES, V106, P115, DOI 10.1016/j.schres.2008.07.023; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Kanaan RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038272; Kennedy CL, 2010, GEND ISSUES, V27, P78, DOI 10.1007/s12147-010-9091-y; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Levitch CF, 2018, J INT NEUROPSYCH SOC, V24, P147, DOI 10.1017/S1355617717000790; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; Ng TSC, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt239; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Reynolds BB, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117701708; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Senne JA, SPORT J; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Stewart WF, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00240; Stewart WF, 2017, NEUROLOGY, V88, P901, DOI 10.1212/WNL.0000000000003657; Strauss SB, 2016, AM J NEURORADIOL, V37, P1983, DOI 10.3174/ajnr.A4851; Suri AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142288; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578	46	23	23	0	4	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	NOV	2018	289	2					478	486		10.1148/radiol.2018180217			9	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	GX3UJ	WOS:000447652300030	30063172	Green Published, Bronze			2022-02-06	
J	Sterpka, A; Chen, XM				Sterpka, Ashley; Chen, Xuanmao			Neuronal and astrocytic primary cilia in the mature brain	PHARMACOLOGICAL RESEARCH			English	Article						Primary cilia; Astrocytes; Type 3 adenylyl cyclase (AC3); ARL13B; Sonic Hedgehog	GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; JOUBERT SYNDROME; ADENYLYL-CYCLASE; ARL13B VARIANT; CELL-CYCLE; CILIOGENESIS; DISRUPTION; OBESITY; SYSTEM	Primary cilia are tiny microtubule-based signaling devices that regulate a variety of physiological functions, including metabolism and cell division. Defects in primary cilia lead to a myriad of diseases in humans such as obesity and cancers. In the mature brain, both neurons and astrocytes contain a single primary cilium. Although neuronal primary cilia are not directly involved in synaptic communication, their pathophysiological impacts on obesity and mental disorders are well recognized. In contrast, research on astrocytic primary cilia lags far behind. Currently, little is known about their functions and molecular pathways in the mature brain. Unlike neurons, postnatal astrocytes retain the capacity of cell division and can become reactive and proliferate in response to various brain insults such as epilepsy, ischemia, traumatic brain injury, and neurodegenerative beta-amyloid plaques. Since primary cilia derive from the mother centrioles, astrocyte proliferation must occur in coordination with the dismantling and ciliogenesis of astrocyte cilia. In this regard, the functions, signal pathways, and structural dynamics of neuronal and astrocytic primary cilia are fundamentally different. Here we discuss and compare the current understanding of neuronal and astrocytic primary cilia.	[Sterpka, Ashley; Chen, Xuanmao] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA		Chen, XM (corresponding author), Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Coll Life Sci & Agr, 46 Coll Rd,Rudman Hall, Durham, NH 03824 USA.	Xuanmao.Chen@unh.edu		Chen, Xuanmao/0000-0002-0057-8510	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [MH105746, AG054729, GM113131]; Cole Neuroscience and Behavior Faculty Research Award; UNH Summer TA Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM113131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21MH105746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K01AG054729] Funding Source: NIH RePORTER	We thank the members of the Chen Laboratory for critical review of the manuscript. This work is supported by National Institutes of Health GrantsMH105746, AG054729 and GM113131 to X.C.; a Cole Neuroscience and Behavior Faculty Research Award to X.C.; and UNH Summer TA Research Fellowship (STAF) to A.S.	Alavi MS, 2018, BIOMED PHARMACOTHER, V98, P222, DOI 10.1016/j.biopha.2017.12.056; Amador-Arjona A, 2011, J NEUROSCI, V31, P9933, DOI 10.1523/JNEUROSCI.1062-11.2011; Avasthi P, 2012, DIFFERENTIATION, V83, pS30, DOI 10.1016/j.diff.2011.11.015; Bangs FK, 2015, NAT CELL BIOL, V17, P113, DOI 10.1038/ncb3091; Bay SN, 2018, P NATL ACAD SCI USA, V115, P1570, DOI 10.1073/pnas.1706977115; Bennett MVL, 2003, TRENDS NEUROSCI, V26, P610, DOI 10.1016/j.tins.2003.09.008; Berbari NF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106576; Berbari NF, 2013, P NATL ACAD SCI USA, V110, P7796, DOI 10.1073/pnas.1210192110; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Braun D.A., 2017, COLD SPRING HARB PER, V9; Breunig JJ, 2008, P NATL ACAD SCI USA, V105, P13127, DOI 10.1073/pnas.0804558105; Brodsky M, 2017, BRAIN RES, V1660, P10, DOI 10.1016/j.brainres.2017.01.010; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Cao Hong, 2016, Integr Obes Diabetes, V2, P225; Carballo GB, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0220-7; Challis RC, 2015, CURR BIOL, V25, P2503, DOI 10.1016/j.cub.2015.07.065; Chen XM, 2016, BIOL PSYCHIAT, V80, P836, DOI 10.1016/j.biopsych.2015.12.012; Chen XM, 2012, J NEUROSCI, V32, P15769, DOI 10.1523/JNEUROSCI.2180-12.2012; Cousminer DL, 2013, HUM MOL GENET, V22, P2735, DOI 10.1093/hmg/ddt104; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Delling M, 2016, NATURE, V531, P656, DOI 10.1038/nature17426; Di Pietro C, 2017, CELL MOL NEUROBIOL, V37, P145, DOI 10.1007/s10571-016-0354-3; Doherty D, 2009, SEMIN PEDIATR NEUROL, V16, P143, DOI 10.1016/j.spen.2009.06.002; Endicott SJ, 2018, CURR BIOL, V28, P1643, DOI 10.1016/j.cub.2018.04.014; Falcon-Urrutia P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133567; Felix JF, 2016, HUM MOL GENET, V25, P389, DOI 10.1093/hmg/ddv472; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Frost GR, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170228; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Green JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046304; Green JA, 2010, CELL MOL LIFE SCI, V67, P3287, DOI 10.1007/s00018-010-0425-4; Guemez-Gamboa A, 2014, NEURON, V82, P511, DOI 10.1016/j.neuron.2014.04.024; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Han YG, 2010, CURR OPIN NEUROBIOL, V20, P58, DOI 10.1016/j.conb.2009.12.002; Higginbotham H, 2013, NAT NEUROSCI, V16, P1000, DOI 10.1038/nn.3451; Higginbotham H, 2012, DEV CELL, V23, P925, DOI 10.1016/j.devcel.2012.09.019; Humbert MC, 2012, P NATL ACAD SCI USA, V109, P19691, DOI 10.1073/pnas.1210916109; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Jackson PK, 2012, CELL, V151, P697, DOI 10.1016/j.cell.2012.10.027; Kasahara K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03117-y; Kasaharaa K, 2014, ACTA MED OKAYAMA, V68, P317; Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043; Klok MD, 2007, OBES REV, V8, P21, DOI 10.1111/j.1467-789X.2006.00270.x; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kumamoto N, 2012, NAT NEUROSCI, V15, P399, DOI 10.1038/nn.3042; Larkins CE, 2011, MOL BIOL CELL, V22, P4694, DOI 10.1091/mbc.E10-12-0994; Lee JH, 2010, NEUROBIOL DIS, V38, P167, DOI 10.1016/j.nbd.2009.12.022; Lee JE, 2011, CURR OPIN NEUROL, V24, P98, DOI 10.1097/WCO.0b013e3283444d05; Lepanto P., 2016, NEUROGENESIS, V3; Liddelow S, 2015, CELL, V162, P1170, DOI 10.1016/j.cell.2015.08.029; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Loktev A. V., 2013, CELL REP; Loskutov YV, 2018, ONCOGENE, V37, P1457, DOI 10.1038/s41388-017-0049-3; Louvi A, 2011, NEURON, V69, P1046, DOI 10.1016/j.neuron.2011.03.002; Luo JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138974; Mariani L. E., 2016, MOL BIOL CELL; Marley A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046647; Miertzschke M, 2014, BIOCHEM J, V457, P301, DOI 10.1042/BJ20131097; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mok CA, 2010, CLIN GENET, V77, P18, DOI 10.1111/j.1399-0004.2009.01305.x; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Moser JJ, 2014, BMC CLIN PATHOL, V14, DOI 10.1186/1472-6890-14-40; Moser JJ, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-37; Moser JJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-448; Mukhopadhyay Saikat, 2013, Cilia, V2, P1, DOI 10.1186/2046-2530-2-1; Myster DL, 2000, CURR BIOL, V10, pR302, DOI 10.1016/S0960-9822(00)00435-8; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; Nordman S, 2008, INT J OBESITY, V32, P407, DOI 10.1038/sj.ijo.0803742; O'Connor Amber K, 2013, Cilia, V2, P8, DOI 10.1186/2046-2530-2-8; Oswal A, 2010, OBESITY, V18, P221, DOI 10.1038/oby.2009.228; Ou Y, 2009, EXP CELL RES, V315, P2802, DOI 10.1016/j.yexcr.2009.06.028; Pan JM, 2007, CELL, V129, P1255, DOI 10.1016/j.cell.2007.06.018; Parisi MA, 2009, AM J MED GENET C, V151C, P326, DOI 10.1002/ajmg.c.30229; Park J, 2018, CELL SIGNAL, V44, P138, DOI 10.1016/j.cellsig.2018.01.007; Pekny M, 2016, BBA-MOL BASIS DIS, V1862, P483, DOI 10.1016/j.bbadis.2015.11.014; Phua SC, 2017, CELL, V168, P264, DOI 10.1016/j.cell.2016.12.032; Pillai V, 2011, BIOL PSYCHIAT, V70, P912, DOI 10.1016/j.biopsych.2011.07.016; Pitman JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110226; Pluznick JL, 2009, P NATL ACAD SCI USA, V106, P2059, DOI 10.1073/pnas.0812859106; Porter JT, 1997, PROG NEUROBIOL, V51, P439, DOI 10.1016/S0301-0082(96)00068-8; Qiu Liyan, 2016, Int J Physiol Pathophysiol Pharmacol, V8, P95; Rafiullah R, 2017, EUR J HUM GENET, V25, P1324, DOI 10.1038/s41431-017-0031-0; Rimkus TK, 2016, CANCERS, V8, DOI 10.3390/cancers8020022; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Saeed S, 2018, NAT GENET, V50, P175, DOI 10.1038/s41588-017-0023-6; Sapolsky RM, 2001, P NATL ACAD SCI USA, V98, P12320, DOI 10.1073/pnas.231475998; Sarkisian MR, 2015, NEUROSCIENTIST, V21, P136, DOI 10.1177/1073858414531074; Schou KB, 2015, EMBO REP, V16, P1099, DOI 10.15252/embr.201540530; Seixas C, 2016, MOL BIOL CELL, V27, P308, DOI 10.1091/mbc.E15-02-0061; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shao J, 2017, CANCER RES, V77, P4000, DOI 10.1158/0008-5472.CAN-16-2461; Shimada IS, 2018, CELL REP, V22, P1169, DOI 10.1016/j.celrep.2018.01.018; Siljee JE, 2018, NAT GENET, V50, P180, DOI 10.1038/s41588-017-0020-9; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Sipos E., 2018, J MOL NEUROSCI; Skafidas E, 2014, MOL PSYCHIATR, V19, P504, DOI 10.1038/mp.2012.126; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Song DK, 2018, DIABETES METAB J, V42, P117, DOI 10.4093/dmj.2018.42.2.117; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Stergiakouli E, 2014, OBESITY, V22, P2252, DOI 10.1002/oby.20840; Sun Xun, 2012, Cilia, V1, P21, DOI 10.1186/2046-2530-1-21; Thomas S, 2015, EUR J HUM GENET, V23, P621, DOI 10.1038/ejhg.2014.156; Tong CK, 2014, P NATL ACAD SCI USA, V111, P12438, DOI 10.1073/pnas.1321425111; Valente EM, 2014, NAT REV NEUROL, V10, P27, DOI 10.1038/nrneurol.2013.247; Verkhratsky A, 2018, PHYSIOL REV, V98, P239, DOI 10.1152/physrev.00042.2016; Volkov P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157776; Wang ZS, 2011, J NEUROSCI, V31, P5557, DOI 10.1523/JNEUROSCI.6561-10.2011; Wang ZS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006979; Warrington NM, 2015, INT J EPIDEMIOL, V44, P700, DOI 10.1093/ije/dyv077; Weiner Leslie P., 2008, V438, P3, DOI 10.1007/978-1-59745-133-8_1; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; Wray NR, 2012, MOL PSYCHIATR, V17, P36, DOI 10.1038/mp.2010.109; Wu L, 2016, OBES REV, V17, P907, DOI 10.1111/obr.12430; Yoshimura K, 2011, GLIA, V59, P333, DOI 10.1002/glia.21105; Youn YH, 2018, AM J PATHOL, V188, P11, DOI 10.1016/j.ajpath.2017.08.031; Yuen RKC, 2017, NAT NEUROSCI, V20, P602, DOI 10.1038/nn.4524; Zhang Z., 2017, MOL CELL BIOL, V37; Zuchero JB, 2015, DEVELOPMENT, V142, P3805, DOI 10.1242/dev.129304	122	23	24	4	22	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-6618			PHARMACOL RES	Pharmacol. Res.	NOV	2018	137						114	121		10.1016/j.phrs.2018.10.002			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	HB8QS	WOS:000451356100011	30291873	Green Accepted			2022-02-06	
J	Schulte, F; Brinkman, TM; Li, CH; Fay-McClymont, T; Srivastava, DK; Ness, KK; Howell, RM; Mueller, S; Wells, E; Strother, D; Lafay-Cousin, L; Leisenring, W; Robison, LL; Armstrong, GT; Krull, KR				Schulte, Fiona; Brinkman, Tara M.; Li, Chenghong; Fay-McClymont, Taryn; Srivastava, Deo Kumar; Ness, Kirsten K.; Howell, Rebecca M.; Mueller, Sabine; Wells, Elizabeth; Strother, Douglas; Lafay-Cousin, Lucie; Leisenring, Wendy; Robison, Leslie L.; Armstrong, Gregory T.; Krull, Kevin R.			Social adjustment in adolescent survivors of pediatric central nervous system tumors: A report from the Childhood Cancer Survivor Study	CANCER			English	Article						adolescent; brain neoplasms; cognition; social adjustment; survivors	FACIAL EXPRESSION RECOGNITION; TRAUMATIC BRAIN-INJURY; LONG-TERM SURVIVORS; DEVELOPMENTAL-PSYCHOLOGY; NEUROCOGNITIVE SEQUELAE; PEER RELATIONSHIPS; ADULT SURVIVORS; OUTCOMES; CHILDREN; SKILLS	BACKGROUND: The purpose of this study was to examine the prevalence and predictors of social difficulties in adolescent survivors of central nervous system (CNS) tumors. METHODS: Six hundred sixty-five survivors of CNS tumors (53.8% male and 51.7% treated with cranial radiation therapy [CRT]), who had a current median age of 15.0 years (range, 2.0-17.0 years) and were a median of 12.1 years (range, 8.0-17.7 years) from their diagnosis, were compared with 1376 survivors of solid tumors (50.4% male), who had a median age of 15.0 years (range, 12.0-17.0 years) and were a median of 13.2 years (range, 8.3-17.9 years) from their diagnosis, and 726 siblings (52.2% male), who had a median age of 15.0 years (range, 12.0-17.0 years). Social adjustment was measured with parent-proxy responses to the Behavior Problems Index. Latent profile analysis defined social classes. Multinomial logistic regression, adjusted for age, sex, and age at diagnosis, identified predictors of class membership. Path analyses tested mediating effects of physical limitations, sensory loss, and cognitive impairment on social outcomes. RESULTS: Caregivers reported that survivors of CNS tumors were more likely to have 0 friends (15.3%) and to interact with friends less than once per week (41.0%) in comparison with survivors of solid tumors (2.9% and 13.6%, respectively) and siblings (2.3% and 8.7%, respectively). Latent profile analysis identified 3 social classes for survivors of CNS tumors: well-adjusted (53.4%), social deficits (16.2%), and poor peer relationships (30.4%). However, 2 classes were identified for survivors of solid tumors and siblings: well-adjusted (86.2% and 91.1%, respectively) and social deficits (13.8% and 8.9%, respectively). CRT predicted class membership for CNS survivors (odds ratio [OR] for poor peer relationships, 1.16/10 Gy; 95% confidence interval [CI], 1.08-1.25; OR for social deficits 1.14/10 Gy; 95% CI, 1.04-1.25; reference, well-adjusted). Cognitive impairment mediated the association between all social outcomes and CRT (P values < .001). CONCLUSION: Almost 50% of survivors of CNS tumors experience social difficulties; the pattern is unique in comparison with solid tumor and sibling groups. Cognitive impairment is associated with increased risk, and this highlights the need for multitargeted interventions. (c) 2018 American Cancer Society.	[Schulte, Fiona; Fay-McClymont, Taryn; Strother, Douglas; Lafay-Cousin, Lucie] Univ Calgary, Calgary, AB, Canada; [Schulte, Fiona; Fay-McClymont, Taryn; Strother, Douglas; Lafay-Cousin, Lucie] Alberta Childrens Prov Gen Hosp, Calgary, AB, Canada; [Brinkman, Tara M.; Li, Chenghong; Srivastava, Deo Kumar; Ness, Kirsten K.; Robison, Leslie L.; Armstrong, Gregory T.; Krull, Kevin R.] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA; [Howell, Rebecca M.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Mueller, Sabine] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Wells, Elizabeth] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Leisenring, Wendy] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA		Schulte, F (corresponding author), Univ Calgary, Div Psychosocial Oncol, Dept Oncol, Cumming Sch Med, 2202 2nd St Southwest, Calgary, AB T2S 3C3, Canada.	fiona.schulte@ahs.ca	Schulte, Fiona/AAK-7619-2020; Armstrong, Gregory/N-8096-2018; Srivastava, Deo Kumar/P-2435-2017; Krull, Kevin R/N-3882-2018; Ness, Kirsten K/N-2550-2018	Schulte, Fiona/0000-0002-3076-9676; Srivastava, Deo Kumar/0000-0001-6693-8120; Krull, Kevin R/0000-0002-0476-7001; Ness, Kirsten K/0000-0002-2084-1507; Leisenring, Wendy/0000-0001-7405-0906; Fay-McClymont, Taryn/0000-0002-2706-6179	National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA55727]; St. Jude Children's Research Hospital through a Cancer Center Support (CORE) Grant [CA21765]; American Lebanese Syrian Associated CharitiesAmerican Lebanese Syrian Associated Charities (ALSAC); National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 CA016672]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U24CA055727, P30CA021765] Funding Source: NIH RePORTER	This work was supported by the National Cancer Institute (CA55727; principal investigator Gregory T. Armstrong). Support was also provided to St. Jude Children's Research Hospital through a Cancer Center Support (CORE) Grant (CA21765; principal investigator Charles W. M. Roberts) and by the American Lebanese Syrian Associated Charities. The University of TexasMD Anderson Cancer Center is supported by the National Institutes of Health (grant P30 CA016672).	Achenbach TM, 1991, MANUAL CHILD BEHAV C; Alderfer MA, 2010, PSYCHO-ONCOLOGY, V19, P789, DOI 10.1002/pon.1638; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; Armstrong GT, 2007, J CLIN ONCOL, V25, P4477, DOI 10.1200/JCO.2007.11.2003; Askins MA, 2009, J PEDIATR PSYCHOL, V34, P551, DOI 10.1093/jpepsy/jsn124; Barakat LP, 2003, J PEDIATR PSYCHOL, V28, P299, DOI 10.1093/jpepsy/jsg019; Barrera M, 2009, J PEDIATR PSYCHOL, V34, P1108, DOI 10.1093/jpepsy/jsp018; Barrera M, 2018, PSYCHO-ONCOLOGY, V27, P91, DOI 10.1002/pon.4385; Bonner MJ, 2008, J PEDIATR PSYCHOL, V33, P1142, DOI 10.1093/jpepsy/jsn035; Brinkman TM, 2013, J NEURO-ONCOL, V111, P195, DOI 10.1007/s11060-012-1001-6; Brinkman TM, 2012, J CLIN ONCOL, V30, P4134, DOI 10.1200/JCO.2011.40.6702; Butler RW, 2008, DEV DISABIL RES REV, V14, P251, DOI 10.1002/ddrr.33; Campbell LK, 2007, PEDIATR BLOOD CANCER, V49, P65, DOI 10.1002/pbc.20860; Conklin HM, 2015, J CLIN ONCOL, V33, P3894, DOI 10.1200/JCO.2015.61.6672; Conklin HM, 2010, J CLIN ONCOL, V28, P4465, DOI 10.1200/JCO.2010.28.4026; Devine KA, 2016, J DEV BEHAV PEDIATR, V37, P475, DOI 10.1097/DBP.0000000000000315; DieTrill M, 1996, J PSYCHOSOC ONCOL, V14, P23, DOI 10.1300/J077v14n02_02; Gurney JG, 2009, J CLIN ONCOL, V27, P2390, DOI 10.1200/JCO.2008.21.1458; Hocking MC, 2015, PEDIATR BLOOD CANCER, V62, P375, DOI 10.1002/pbc.25300; Iyer NS, 2015, BLOOD, V126, P346, DOI 10.1182/blood-2015-02-627414; Mabbott DJ, 2005, J CLIN ONCOL, V23, P2256, DOI 10.1200/JCO.2005.01.158; MASTEN AS, 1985, DEV PSYCHOL, V21, P523, DOI 10.1037/0012-1649.21.3.523; Moyer KH, 2012, PEDIATR BLOOD CANCER, V59, P1290, DOI 10.1002/pbc.24256; Mulhern RK, 2004, LANCET ONCOL, V5, P399, DOI 10.1016/S1470-2045(04)01507-4; Ness KK, 2010, CANCER-AM CANCER SOC, V116, P3034, DOI 10.1002/cncr.25051; NOLL RB, 1990, J PEDIATR PSYCHOL, V15, P43, DOI 10.1093/jpepsy/15.1.43; Noll RB, 2007, CHILD NEUROPSYCHOL, V13, P173, DOI 10.1080/09297040500473706; Piscione PJ, 2014, NEURO-ONCOLOGY, V16, P147, DOI 10.1093/neuonc/not138; Poggi G, 2005, PSYCHO-ONCOLOGY, V14, P386, DOI 10.1002/pon.855; Reddick WE, 2003, CANCER-AM CANCER SOC, V97, P2512, DOI 10.1002/cncr.11355; Robison LL, 2009, J CLIN ONCOL, V27, P2308, DOI 10.1200/JCO.2009.22.3339; Robison LL, 2002, MED PEDIATR ONCOL, V38, P229, DOI 10.1002/mpo.1316; Roelofs RL, 2017, BRAIN IMPAIR, V18, P138, DOI 10.1017/BrImp.2016.31; Schulte F, 2015, CURR OPIN ONCOL, V27, P306, DOI 10.1097/CCO.0000000000000193; Schulte F, 2010, SUPPORT CARE CANCER, V18, P1499, DOI 10.1007/s00520-010-0963-1; Schultz KAP, 2007, J CLIN ONCOL, V25, P3649, DOI 10.1200/JCO.2006.09.2486; Stovall M, 2006, RADIAT RES, V166, P141, DOI 10.1667/RR3525.1; Vannatta K, 1998, J PEDIATR PSYCHOL, V23, P279, DOI 10.1093/jpepsy/23.5.279; Vannatta K, 2007, PEDIATR BLOOD CANCER, V49, P716, DOI 10.1002/pbc.21062; Ward E, 2014, CA-CANCER J CLIN, V64, P83, DOI 10.3322/caac.21219; Ware J, 2003, VERSION 2 SF 36 HLTH; Willard VW, 2017, CHILD HEALTH CARE, V46, P181, DOI 10.1080/02739615.2015.1124769; Willard VW, 2009, PSYCHO-ONCOLOGY, V18, P893, DOI 10.1002/pon.1502; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Zebrack BJ, 2004, J CLIN ONCOL, V22, P999, DOI 10.1200/JCO.2004.06.148; Zebrack BJ, 2007, PEDIATR BLOOD CANCER, V49, P47, DOI 10.1002/pbc.20914; Zill N., 1986, BEHAV PROBLEMS INDEX	48	23	24	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0008-543X	1097-0142		CANCER-AM CANCER SOC	Cancer	SEP 1	2018	124	17					3596	3608		10.1002/cncr.31593			13	Oncology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Oncology	GX0CI	WOS:000447376600016	30067866	Green Accepted, Bronze			2022-02-06	
J	Hill, RL; Kulbe, JR; Singh, IN; Wang, JA; Hall, ED				Hill, Rachel L.; Kulbe, Jacqueline R.; Singh, Indrapal N.; Wang, Juan A.; Hall, Edward D.			Synaptic Mitochondria are More Susceptible to Traumatic Brain Injury-induced Oxidative Damage and Respiratory Dysfunction than Non-synaptic Mitochondria	NEUROSCIENCE			English	Article						lipid peroxidation; oxidative damage; synaptic mitochondria; non-synaptic mitochondria; traumatic brain injury	NEURONAL CYTOSKELETAL DEGRADATION; LIPID-PEROXIDATION; NITRIC-OXIDE; MOUSE MODEL; PROTEOMIC IDENTIFICATION; PERMEABILITY TRANSITION; CELL-DEATH; ANTIOXIDANT THERAPIES; AXONAL-TRANSPORT; RAT-BRAIN	Traumatic brain injury (TBI) results in mitochondrial dysfunction and induction of lipid peroxidation (LP). Lipid peroxidation-derived neurotoxic aldehydes such as 4-HNE and acrolein bind to mitochondrial proteins, inducing additional oxidative damage and further exacerbating mitochondrial dysfunction and LP. Mitochondria are heterogeneous, consisting of both synaptic and non-synaptic populations. Synaptic mitochondria are reported to be more vulnerable to injury; however, this is the first study to characterize the temporal profile of synaptic and non-synaptic mitochondria following TBI, including investigation of respiratory dysfunction and oxidative damage to mitochondria! proteins between 3 and 120 h following injury. These results indicate that synaptic mitochondria are indeed the more vulnerable population, showing both more rapid and severe impairments than non-synaptic mitochondria. By 24 h, synaptic respiration is significantly impaired compared to synaptic sham, whereas non-synaptic respiration does not decline significantly until 48 h. Decreases in respiration are associated with increases in oxidative damage to synaptic and non-synaptic mitochondria! proteins at 48 h and 72 h, respectively. These results indicate that the therapeutic window for mitochondria-targeted pharmacological neuroprotectants to prevent respiratory dysfunction is shorter for the more vulnerable synaptic mitochondria than for the non-synaptic population. (C) 2018 IBRO. Published by Elsevier Ltd. All rights reserved.	[Hill, Rachel L.; Kulbe, Jacqueline R.; Singh, Indrapal N.; Wang, Juan A.; Hall, Edward D.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr SCoBIRC, 741 S Limestone St, Lexington, KY 40536 USA; [Kulbe, Jacqueline R.; Singh, Indrapal N.; Hall, Edward D.] Univ Kentucky, Dept Neurosci, Coll Med, 741 S Limestone St, Lexington, KY 40536 USA		Hall, ED (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Med Ctr, Chair Neurotrauma Res, 741 S Limestone St, Lexington, KY 40536 USA.; Hall, ED (corresponding author), Univ Kentucky, Neurosci Neurosurg & Neurol & Phys Med & Rehab, Med Ctr, 741 S Limestone St, Lexington, KY 40536 USA.	edhall@uky.edu	Hall, Edward D/F-8930-2013	Kulbe, Jacqueline/0000-0002-7070-9264	Kentucky Spinal Cord & Head Injury Research Trust (KSCHIRT) [5R01 NS083405, 5R01 NS084857, 5P30 NS0512220, F30 NS096876]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS084857, R01NS100093, T32NS077889, R01NS083405] Funding Source: NIH RePORTER	This work was supported by 5R01 NS083405, 5R01 NS084857, 5P30 NS0512220, F30 NS096876, and funding from the Kentucky Spinal Cord & Head Injury Research Trust (KSCHIRT). Rachel Hill was responsible for optimizing the isolation protocol for the non-synaptic and synaptic mitochondria from cortical tissue, performed all the experiments, and carried out most of the data analysis and overall organization and presentation of the data as well as statistical analysis, wrote most of the manuscript, designed graphs/figures and performed statistical analyses. Jacqueline Kulbe contributed to writing of the manuscript and some analysis of respiration and western blot data. Indrapal Singh assisted in mitochondrial respiratory assays and Juan Wang (Amy) assisted with animal work. Edward Hall supervised the experiments in his lab and contributed to the writing and organization of the manuscript.	Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Almeida A, 2001, P NATL ACAD SCI USA, V98, P15294, DOI 10.1073/pnas.261560998; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Balog J, 2016, J CEREBR BLOOD F MET, V36, P2022, DOI 10.1177/0271678X16671528; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; BOLANOS JP, 1994, J NEUROCHEM, V63, P910; Bolanos JP, 2016, J NEUROCHEM, V139, P115, DOI 10.1111/jnc.13486; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; Bringold U, 2000, FREE RADICAL BIO MED, V29, P343, DOI 10.1016/S0891-5849(00)00318-X; Brown MR, 2004, J NEUROSCI METH, V137, P299, DOI 10.1016/j.jneumeth.2004.02.028; Brown MR, 2006, J BIOL CHEM, V281, P11658, DOI 10.1074/jbc.M510303200; Calkins MJ, 2011, HUM MOL GENET, V20, P4515, DOI 10.1093/hmg/ddr381; Carre E, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00146; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Carroll RT, 2000, CHEM RES TOXICOL, V13, P294, DOI 10.1021/tx990159t; Cavallucci V, 2013, CURR PHARM DESIGN, V19, P6440, DOI 10.2174/1381612811319360005; Cebak JE, 2017, J NEUROTRAUM, V34, P1302, DOI 10.1089/neu.2016.4624; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; Chang DTW, 2006, NEUROBIOL DIS, V22, P388, DOI 10.1016/j.nbd.2005.12.007; Cheng AW, 2010, ASN NEURO, V2, P243, DOI 10.1042/AN20100019; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Clarkson AN, 2004, FASEB J, V18, P1114, DOI 10.1096/fj.03-1203fje; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; Davey GP, 1997, J NEUROCHEM, V69, P2564; Davis CHO, 2014, P NATL ACAD SCI USA, V111, P9633, DOI 10.1073/pnas.1404651111; De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Deng-Bryant Y, 2008, J CEREBR BLOOD F MET, V28, P1114, DOI 10.1038/jcbfm.2008.10; Di Pietro V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09587-2; Dickey AS, 2011, J NEUROSCI, V31, P15716, DOI 10.1523/JNEUROSCI.3159-11.2011; Du H, 2012, ANTIOXID REDOX SIGN, V16, P1467, DOI 10.1089/ars.2011.4277; Duan YT, 2007, J PHYSIOL-LONDON, V585, P741, DOI 10.1113/jphysiol.2007.145409; Dunkley PR, 2008, NAT PROTOC, V3, P1718, DOI 10.1038/nprot.2008.171; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Flippo KH, 2017, J CELL SCI, V130, P671, DOI 10.1242/jcs.171017; Frederick RL, 2007, TRAFFIC, V8, P1668, DOI 10.1111/j.1600-0854.2007.00644.x; Gillardon F, 2007, PROTEOMICS, V7, P605, DOI 10.1002/pmic.200600728; Gilmer LK, 2010, J NEUROTRAUM, V27, P939, DOI 10.1089/neu.2009.1181; Gilmer LK, 2010, MECH AGEING DEV, V131, P133, DOI 10.1016/j.mad.2009.12.011; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; HALL ED, 1991, J PHARMACOL EXP THER, V258, P688; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hall ED, 2016, J BIOENERG BIOMEMBR, V48, P169, DOI 10.1007/s10863-015-9600-5; Hall ED, 2012, EXP NEUROL, V238, P176, DOI 10.1016/j.expneurol.2012.08.024; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hansson MJ, 2008, FREE RADICAL BIO MED, V45, P284, DOI 10.1016/j.freeradbiomed.2008.04.021; Harris NG, 2010, J NEUROPATH EXP NEUR, V69, P139, DOI 10.1097/NEN.0b013e3181cb5bee; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; HEALES SJR, 1994, BRAIN RES, V668, P243, DOI 10.1016/0006-8993(94)90530-4; Hill RL, 2017, NEUROCHEM INT, V111, P45, DOI 10.1016/j.neuint.2017.03.015; Ikegami K, 2003, NEUROSCIENCE, V122, P617, DOI 10.1016/j.neuroscience.2003.08.057; Jackson JG, 2014, J NEUROSCI, V34, P1613, DOI 10.1523/JNEUROSCI.3510-13.2014; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Jonas EA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00355; Ju WK, 2007, INVEST OPHTH VIS SCI, V48, P2145, DOI 10.1167/iovs.06-0573; Khanna P, 2007, CELL MOL NEUROBIOL, V27, P959, DOI 10.1007/s10571-007-9233-2; KIEDROWSKI L, 1995, MOL PHARMACOL, V47, P140; Kinnunen PKJ, 2012, BBA-BIOMEMBRANES, V1818, P2446, DOI 10.1016/j.bbamem.2012.04.008; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Knott AB, 2008, ANN NY ACAD SCI, V1147, P283, DOI 10.1196/annals.1427.030; Kristian T, 2006, J NEUROSCI METH, V152, P136, DOI 10.1016/j.jneumeth.2005.08.018; Kulbe JR, 2017, J NEUROTRAUM, V34, P1291, DOI 10.1089/neu.2016.4628; Kwon Seok-Kyu, 2016, Front Synaptic Neurosci, V8, P29; LAI JCK, 1977, J NEUROCHEM, V28, P625, DOI 10.1111/j.1471-4159.1977.tb10434.x; LAI JCK, 1976, BIOCHEM J, V154, P423, DOI 10.1042/bj1540423; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Llorente-Folch I, 2015, J PHYSIOL-LONDON, V593, P3447, DOI 10.1113/JP270254; LoPachin RM, 2008, NEUROTOXICOLOGY, V29, P871, DOI 10.1016/j.neuro.2008.04.016; Lopez-Fabuel I, 2016, P NATL ACAD SCI USA, V113, P13063, DOI 10.1073/pnas.1613701113; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; LOVAAS E, 1991, FREE RADICAL BIO MED, V11, P455, DOI 10.1016/0891-5849(91)90061-7; Ly CV, 2006, NEUROSCIENTIST, V12, P291, DOI 10.1177/1073858406287661; MacAskill AF, 2010, EUR J NEUROSCI, V32, P231, DOI 10.1111/j.1460-9568.2010.07345.x; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; Maciel EN, 2001, J NEUROCHEM, V79, P1237, DOI 10.1046/j.1471-4159.2001.00670.x; MAKAR TK, 1994, J NEUROCHEM, V62, P45; Manczak M, 2018, HUM MOL GENET, V27, P1332, DOI 10.1093/hmg/ddy042; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Mattson MP, 1998, EXP NEUROL, V153, P35, DOI 10.1006/exnr.1998.6863; Mbye LH, 2009, J CEREBR BLOOD F MET, V29, P87, DOI 10.1038/jcbfm.2008.93; Miller DM, 2015, EXP NEUROL, V264, P103, DOI 10.1016/j.expneurol.2014.11.008; Miller DM, 2014, J NEUROTRAUM, V31, P1194, DOI 10.1089/neu.2013.3218; Miller DM, 2013, FREE RADICAL BIO MED, V57, P1, DOI 10.1016/j.freeradbiomed.2012.12.011; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Mungarro-Menchaca X, 2002, J NEUROSCI RES, V68, P89, DOI 10.1002/jnr.10193; Mustafa AG, 2011, J NEUROCHEM, V117, P579, DOI 10.1111/j.1471-4159.2011.07228.x; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Naga KK, 2007, J NEUROSCI, V27, P7469, DOI 10.1523/JNEUROSCI.0646-07.2007; NICHOLLS D, 1982, BIOCHIM BIOPHYS ACTA, V683, P57, DOI 10.1016/0304-4173(82)90013-1; Nicholls DG, 2007, J NEUROSCI RES, V85, P3206, DOI 10.1002/jnr.21290; Nicholls DG, 2009, BBA-BIOENERGETICS, V1787, P1416, DOI 10.1016/j.bbabio.2009.03.010; Nicholls DG, 2005, CELL CALCIUM, V38, P311, DOI 10.1016/j.ceca.2005.06.011; NICHOLLS DG, 1985, PROG BRAIN RES, V63, P97; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Pandya JD, 2015, NEUROBIOL AGING, V36, P1903, DOI 10.1016/j.neurobiolaging.2015.01.018; Pandya Jignesh D, 2013, Front Neuroenergetics, V5, P10, DOI 10.3389/fnene.2013.00010; Panov A, 2007, AM J PHYSIOL-CELL PH, V292, pC708, DOI 10.1152/ajpcell.00202.2006; Patel SP, 2009, J NEUROSCI RES, V87, P130, DOI 10.1002/jnr.21814; Pivovarova NB, 2010, FEBS J, V277, P3622, DOI 10.1111/j.1742-4658.2010.07754.x; Radi R, 2002, FREE RADICAL BIO MED, V33, P1451, DOI 10.1016/S0891-5849(02)01111-5; RAPS SP, 1989, BRAIN RES, V493, P398, DOI 10.1016/0006-8993(89)91178-5; Reddy PH, 2011, CURR ALZHEIMER RES, V8, P393; Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002; Reddy PH, 2012, BBA-MOL BASIS DIS, V1822, P639, DOI 10.1016/j.bbadis.2011.10.011; Reed T, 2008, NEUROBIOL DIS, V30, P107, DOI 10.1016/j.nbd.2007.12.007; Reed TT, 2009, BRAIN RES, V1274, P66, DOI 10.1016/j.brainres.2009.04.009; Rintoul G. L., 2009, BIOCHIM BIOPHYS ACTA, V1802, P143; Rintoul GL, 2006, J NEUROCHEM, V97, P800, DOI 10.1111/j.1471-4159.2006.03788.x; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Rueda CB, 1837, BIOCHIM BIOPHYS ACTA, V2014, P1617; SAGARA J, 1993, J NEUROCHEM, V61, P1672, DOI 10.1111/j.1471-4159.1993.tb09802.x; Sava IG, 2006, FREE RADICAL BIO MED, V41, P1272, DOI 10.1016/j.freeradbiomed.2006.07.008; Schwarz TL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011304; Sengpiel B, 1998, EUR J NEUROSCI, V10, P1903, DOI 10.1046/j.1460-9568.1998.00202.x; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Singh IN, 2007, J NEUROSCI RES, V85, P2216, DOI 10.1002/jnr.21360; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Singh IN, 2013, J CEREBR BLOOD F MET, V33, P593, DOI 10.1038/jcbfm.2012.211; Song Y, 2015, NEUROSCI J, V1-10; Starkov AA, 2004, CELL CALCIUM, V36, P257, DOI 10.1016/j.ceca.2004.02.012; Starkov AA, 2010, FEBS J, V277, P3652, DOI 10.1111/j.1742-4658.2010.07756.x; Stauch KL, 2014, J PROTEOME RES, V13, P2620, DOI 10.1021/pr500295n; Sullivan PG, 2007, J NEUROTRAUM, V24, P991, DOI 10.1089/neu.2006.0242; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Tan H, 2012, INT J NEUROPSYCHOPH, V15, P1275, DOI 10.1017/S1461145711001416; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Toescu EC, 2004, J CELL MOL MED, V8, P181, DOI 10.1111/j.1582-4934.2004.tb00273.x; Trushina E, 2016, NEURAL REGEN RES, V11, P900, DOI 10.4103/1673-5374.184477; Wang LZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154354; Wu Q, 2018, INT J BIOCHEM CELL B, V94, P44, DOI 10.1016/j.biocel.2017.11.007; Wu Q, 2016, BRAIN RES, V1630, P134, DOI 10.1016/j.brainres.2015.11.016; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Xiong YQ, 2009, FREE RADICAL RES, V43, P604, DOI 10.1080/10715760902977432; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yarana C, 2012, LIFE SCI, V90, P808, DOI 10.1016/j.lfs.2012.04.004	147	23	23	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	AUG 21	2018	386						265	283		10.1016/j.neuroscience.2018.06.028			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GO8GQ	WOS:000440325500022	29960045				2022-02-06	
J	McKee, K; Glass, S; Adams, C; Stephen, CD; King, F; Parlrnan, K; Perez, DL; Kontos, N				McKee, Kathleen; Glass, Sean; Adams, Caitlin; Stephen, Christopher D.; King, Franklin; Parlrnan, Kristin; Perez, David L.; Kontos, Nicholas			The Inpatient Assessment and Management of Motor Functional Neurological Disorders: An Interdisciplinary Perspective	PSYCHOSOMATICS			English	Article						Conversion disorder; Psychogenic nonepileptic seizures; Functional movement disorders; Somatization; Neuropsychiatry	PSYCHOGENIC NONEPILEPTIC SEIZURES; TRAUMATIC BRAIN-INJURY; CONVERSION DISORDER; DIAGNOSTIC-VALUE; CLINICAL SIGNS; SYMPTOMS; EPILEPSY; PSYCHIATRISTS; WEAKNESS; CHILDREN	Background: Motor functional neurologic disorders (FND) previously termed "hysteria" and later "con- version disorder" are exceedingly common and frequently encountered in the acute hospital setting. Despite their high prevalence, patients with motor FND can be challenging to diagnose accurately and manage effectively. To date, there is limited guidance on the inpatient approach to the neuropsychiatric evaluation of patients with functional (psychogenic) neurologic symptoms. Objective: The authors outline an inpatient multidisciplinary approach, involving neurology, psychiatry, and physical therapy, for the assessment and acute inpatient management of motor FND. Methods: A vignette of a patient with motor FND is presented followed by a discussion of general assessment principles. Thereafter, a detailed description of the neurologic and psychiatric assessments is outlined Delivery of a "rule-in" diagnosis is emphasized and specific guidance for what can be accomplished postdiagnosis in the hospital is suggested. Discussion: We encourage an interdisciplinary approach beginning at the early stages of the diagnostic assessment once an individual is suspected of having motor FND. Conclusions: Practical suggestions for the inpatient assessment of motor FND are presented. It is also important to individualize the diagnostic assessment. Future research should be conducted to test best practices for motor FND management in the acute inpatient hospital setting.	[McKee, Kathleen; Stephen, Christopher D.] Massachusetts Gen Hosp, Dept Neurol, Movement Disorders Unit, Boston, MA 02114 USA; [Glass, Sean; Perez, David L.] Massachusetts Gen Hosp, Dept Psychiat, Neuropsychiat Unit, Boston, MA 02114 USA; [Glass, Sean; Adams, Caitlin; Perez, David L.] Massachusetts Gen Hosp, Dept Neurol, Cognit Behav Neurol Unit, Funct Neurol Res Grp, Boston, MA 02114 USA; [Glass, Sean; Adams, Caitlin; King, Franklin; Kontos, Nicholas] Massachusetts Gen Hosp, Dept Psychiat, Consultat Liaison Psychiat Serv, Boston, MA 02114 USA; [Adams, Caitlin] Massachusetts Gen Hosp, Dept Psychiat, Inpatient Psychiat Serv, Boston, MA 02114 USA; [Parlrnan, Kristin] Massachusetts Gen Hosp, Dept Phys Therapy, Boston, MA 02114 USA		Perez, DL; Kontos, N (corresponding author), Massachusetts Gen Hosp, 55 Fruit St, Boston, MA 02114 USA.	dlperez@nmr.mgh.harvard.edu; nkontos@mgh.harvard.edu	Stephen, Christopher/AAF-4956-2021; Perez, David/AAB-6453-2020; McKee, Kathleen/AAR-8819-2021	Perez, David/0000-0003-2721-583X; 	Sidney R. Baer Jr. Foundation; Massachusetts General Hospital Physician-Scientist Award	D.L.P. was funded by the Sidney R. Baer Jr. Foundation and the Massachusetts General Hospital Physician-Scientist Award.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th; Asadi-Pooya AA, 2015, EPILEPSY BEHAV, V46, P60, DOI 10.1016/j.yebeh.2015.03.015; Avbersek A, 2010, J NEUROL NEUROSUR PS, V81, P719, DOI 10.1136/jnnp.2009.197996; Barbey A, 2017, CURR OPIN NEUROL, V30, P427, DOI 10.1097/WCO.0000000000000464; Baslet G, 2015, CLIN EEG NEUROSCI, V46, P54, DOI 10.1177/1550059414557025; Baslet G, 2011, SEIZURE-EUR J EPILEP, V20, P1, DOI 10.1016/j.seizure.2010.10.032; Beghi M, 2017, SEIZURE-EUR J EPILEP, V52, P182, DOI 10.1016/j.seizure.2017.10.014; Behrouz R, 2014, J STROKE CEREBROVASC, V23, pE243, DOI 10.1016/j.jstrokecerebrovasdis.2013.11.010; Benbadis SR, 2005, EPILEPSY BEHAV, V6, P264, DOI 10.1016/j.yebeh.2004.12.007; Brigo F, 2013, SEIZURE-EUR J EPILEP, V22, P85, DOI 10.1016/j.seizure.2012.10.011; Brown RJ, 2016, CLIN PSYCHOL REV, V47, P55, DOI 10.1016/j.cpr.2016.06.003; Brown RJ, 2013, EPILEPSY BEHAV, V29, P178, DOI 10.1016/j.yebeh.2013.07.019; Carson Alan, 2016, Pract Neurol, V16, P56, DOI 10.1136/practneurol-2015-001242; COYLE PK, 1986, AM J PSYCHIAT, V143, P648; Czarnecki K, 2012, PARKINSONISM RELAT D, V18, P247, DOI 10.1016/j.parkreldis.2011.10.011; Daum C, 2014, J NEUROL NEUROSUR PS, V85, P180, DOI 10.1136/jnnp-2012-304607; Dixit R, 2013, EPILEPSY BEHAV, V28, P137, DOI 10.1016/j.yebeh.2013.05.004; Edwards MJ, 2014, MOVEMENT DISORD, V29, P849, DOI 10.1002/mds.25562; Friedman JH, 2010, ARCH NEUROL-CHICAGO, V67, P753, DOI 10.1001/archneurol.2010.91; Gardiner P., 2017, CNS SPECTRUMS, V23, P1; Gedzelman ER, 2014, NEUROPSYCH DIS TREAT, V10, P1979, DOI 10.2147/NDT.S49531; Gelauff J, 2014, J NEUROL NEUROSUR PS, V85, P220, DOI 10.1136/jnnp-2013-305321; Goldstein LH, 2006, J NEUROL NEUROSUR PS, V77, P616, DOI 10.1136/jnnp.2005.066878; Hall-Patch L, 2010, EPILEPSIA, V51, P70, DOI 10.1111/j.1528-1167.2009.02099.x; Hendrickson R, 2014, EPILEPSY BEHAV, V37, P210, DOI 10.1016/j.yebeh.2014.06.026; Jimenez XF, 2016, PSYCHOSOMATICS, V57, P440, DOI 10.1016/j.psym.2016.02.014; Jimenez XF, 2016, EPILEPSY BEHAV, V56, P149, DOI 10.1016/j.yebeh.2015.12.035; Jimenez XF, 2015, EPILEPSY BEHAV, V45, P164, DOI 10.1016/j.yebeh.2015.02.001; Kanaan R, 2009, BRAIN, V132, P2889, DOI 10.1093/brain/awp060; Kanaan RA, 2016, NEUROPSYCH DIS TREAT, V12, P1181, DOI 10.2147/NDT.S96330; Kanner AM, 2003, EPILEPSY BEHAV, V4, P597, DOI 10.1016/j.yebeh.2003.09.013; Kanner AM, 2011, NEUROL CLIN, V29, P163, DOI 10.1016/j.ncl.2010.11.002; Kenney C, 2007, J NEUROL SCI, V263, P94, DOI 10.1016/j.jns.2007.06.008; Kozlowska K, 2018, CLIN CHILD PSYCHOL P, V23, P140, DOI 10.1177/1359104517732118; Kozlowska K, 2018, CLIN CHILD PSYCHOL P, V23, P160, DOI 10.1177/1359104517730116; LaFrance WC, 2013, EPILEPSIA, V54, P2005, DOI 10.1111/epi.12356; LaFrance WC, 2013, EPILEPSIA, V54, P718, DOI 10.1111/epi.12053; LaFrance WC, 2013, EPILEPSIA, V54, P53, DOI 10.1111/epi.12106; LaFrance WC, 2002, EPILEPSY BEHAV, V3, pS19, DOI 10.1016/S1525-5069(02)00505-4; Lang AE, 2011, MOVEMENT DISORD, V26, P1175, DOI 10.1002/mds.23571; Lawley A, 2015, EPILEPSY BEHAV, V53, P26, DOI 10.1016/j.yebeh.2015.09.032; Matin N, 2017, J NEUROPSYCHIATRY CL; Maurer CW, 2016, PARKINSONISM RELAT D, V30, P18, DOI 10.1016/j.parkreldis.2016.06.009; McKenzie PS, 2011, J NEUROL NEUROSUR PS, V82, P967, DOI 10.1136/jnnp.2010.231886; McWhirter L, 2011, J PSYCHOSOM RES, V71, P384, DOI 10.1016/j.jpsychores.2011.09.003; Nielsen G, 2017, J NEUROL NEUROSUR PS, V88, P484, DOI 10.1136/jnnp-2016-314408; Nielsen G, 2015, J NEUROL NEUROSUR PS, V86, P1113, DOI 10.1136/jnnp-2014-309255; Parees I, 2014, J NEUROL SCI, V338, P174, DOI 10.1016/j.jns.2013.12.046; Perez DL, 2016, COGN BEHAV NEUROL, V29, P197, DOI 10.1097/WNN.0000000000000106; Perez DL, 2016, CNS SPECTRUMS, V21, P239, DOI 10.1017/S109285291600002X; Rao SR, 2017, EPILEPSY BEHAV, V77, P50, DOI 10.1016/j.yebeh.2017.09.005; Rawlings GH, 2017, SEIZURE-EUR J EPILEP, V48, P22, DOI 10.1016/j.seizure.2017.03.015; Reuber M, 2007, PSYCHOSOMATICS, V48, P230, DOI 10.1176/appi.psy.48.3.230; Reuber M, 2009, NEUROL CLIN, V27, P909, DOI 10.1016/j.ncl.2009.06.004; Robbins NM, 2016, EPILEPSY BEHAV, V55, P174, DOI 10.1016/j.yebeh.2015.12.022; Roper Louise S, 2013, Pract Neurol, V13, P396, DOI 10.1136/practneurol-2013-000549; Salinsky M, 2015, J HEAD TRAUMA REHAB, V30, pE65, DOI 10.1097/HTR.0000000000000057; Schrag A, 2004, BRAIN, V127, P2360, DOI 10.1093/brain/awh262; Stone J, 2016, HAND CLINIC, V139, P213, DOI 10.1016/B978-0-12-801772-2.00018-7; Stone J, 2016, HAND CLINIC, V139, P543, DOI 10.1016/B978-0-12-801772-2.00044-8; Stone J, 2010, CLIN NEUROL NEUROSUR, V112, P747, DOI 10.1016/j.clineuro.2010.05.011; Stone Jon, 2016, Pract Neurol, V16, P7, DOI 10.1136/practneurol-2015-001241; Stone Jon, 2015, Continuum (Minneap Minn), V21, P818, DOI 10.1212/01.CON.0000466669.02477.45; Stone J, 2012, NEUROLOGY, V79, P282, DOI 10.1212/WNL.0b013e31825fdf63; Stone J, 2011, J PSYCHOSOM RES, V71, P369, DOI 10.1016/j.jpsychores.2011.07.005; Stone J, 2010, BRAIN, V133, P1537, DOI 10.1093/brain/awq068; Stone J, 2009, BRAIN, V132, P2878, DOI 10.1093/brain/awp220; Stone Jon, 2009, Pract Neurol, V9, P179, DOI 10.1136/jnnp.2009.177204; Thenganatt MA, 2014, TREMOR OTHER HYPERK, V4, DOI 10.7916/D8FJ2F0Q; Torous J, 2015, ASIAN J PSYCHIATR, V17, P116, DOI 10.1016/j.ajp.2015.05.007; Westbrook LE, 1998, EPILEPSIA, V39, P978, DOI 10.1111/j.1528-1157.1998.tb01447.x; Williams DT, 2016, HAND CLINIC, V139, P631, DOI 10.1016/B978-0-12-801772-2.00051-5	72	23	23	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0033-3182			PSYCHOSOMATICS	Psychosomatics	JUL-AUG	2018	59	4					358	368		10.1016/j.psym.2017.12.006			11	Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry; Psychology	GK8MT	WOS:000436479700006	29628294				2022-02-06	
J	Worts, PR; Schatz, P; Burkhart, SO				Worts, Phillip R.; Schatz, Philip; Burkhart, Scott O.			Test Performance and Test-Retest Reliability of the Vestibular/Ocular Motor Screening and King-Devick Test in Adolescent Athletes During a Competitive Sport Season	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						high school; concussion; ocular; vestibular; sports; sideline; acute	ERROR SCORING SYSTEM; STANDARDIZED ASSESSMENT; POSTURAL CONTROL; BASE-LINE; CONCUSSION; EXERCISE; DEFICITS; TOOL	Background: The Vestibular/Ocular Motor Screening (VOMS) and King-Devick (K-D) test are tools designed to assess ocular or vestibular function after a sport-related concussion. Purpose: To determine the test-retestre iability and rate of false-positive results of the VOMS and K-D test in a healthy athlete sample. Study Design: Cohort study (diagnosis); Level of evidence, 2. Methods: Forty-five healthy high school student-athletes (mean age, 16.11 +/- 1.43 years) completed self-reported demographics and medical history and were administered the VOMS and K-D test during rest on day 1 (baseline). The VOMS and K-D test were administered again once during rest (prepractice) and once within 5 minutes of removal from sport practice on day 2 (removal). The Borg rating of perceived exertion scale was administered at removal. Intraclass correlation coefficients were used to determine test-retest reliability on the K-D test and the average near point of convergence (NPC) distance on the VOMS. Level of agreement was used to examine VOMS symptom provocation over the 3 administration times. Multivariate base rates were used to determine the rate of false-positive results when simultaneously considering multiple clinical cutoffs. Results: Test-retest reliability of total time on the K-D test (0.91 [95% CI, 0.86-0.95]) and NPC distance (0.91 [95% CI, 0.85-0.95]) was high across the 3 administration times. Level of agreement ranged from 48.9% to 88.9% across all 3 times for the VOMS items. Using established clinical cutoffs, false-positive results occurred in 2% of the sample using the VOMS at removal and 36% using the K-D test. Conclusion: The VOMS displayed a false-positive rate of 2% in this high school student-athlete cohort. The K-D test's false-positive rate was 36% while maintaining a high level of test-retest reliability (0.91). Results from this study support future investigation of VOMS administration in an acutely injured high school athletic sample. Going forward, the VOMS may be more stable than other neurological and symptom report screening measures and less vulnerable to false-positive results than the K-D test.	[Worts, Phillip R.; Schatz, Philip; Burkhart, Scott O.] Florida State Univ, Tallahassee, FL 32306 USA; [Burkhart, Scott O.] Childrens Hlth Andrews Inst Orthopaed & Sports Me, 7211 Preston Rd,Suite 1400, Plano, TX 75024 USA; [Worts, Phillip R.] Florida State Univ, Coll Human Sci, Dept Nutr Food & Exercise Sci, Tallahassee, FL 32306 USA; [Worts, Phillip R.] Tallahassee Orthoped Clin, Tallahassee, FL USA; [Schatz, Philip] St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA		Burkhart, SO (corresponding author), Childrens Hlth Andrews Inst Orthopaed & Sports Me, 7211 Preston Rd,Suite 1400, Plano, TX 75024 USA.	scott.burkhart@childrens.com	Worts, Phillip Robert/J-9063-2019	Worts, Phillip Robert/0000-0002-5571-5404			BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Covassin T, 2007, BRIT J SPORT MED, V41, P370, DOI 10.1136/bjsm.2006.032334; Docherty CL, 2006, CLIN J SPORT MED, V16, P203, DOI 10.1097/00042752-200605000-00003; Erkmen N, 2009, ISOKINET EXERC SCI, V17, P121, DOI 10.3233/IES-2009-0343; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; Koscs M, 2009, ATHL TRAIN SPORTS HL, V1, P24; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Oberlander TJ, 2017, J ATHL TRAINING, V52, P439, DOI 10.4085/1062-6050-52.2.12; Rahn C, 2015, CLIN J SPORT MED, V25, P248, DOI 10.1097/JSM.0000000000000141; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; SELL KE, 1994, J ORTHOP SPORT PHYS, V19, P162, DOI 10.2519/jospt.1994.19.3.162; Spradley B, 2014, SPORT J, V201419, P1; Sufrinko AM, 2017, AM J SPORT MED, V45, P1187, DOI 10.1177/0363546516685061; Sullivan SJ, 2011, BRIT J SPORT MED, V45, P46, DOI 10.1136/bjsm.2009.071225; Susco TM, 2004, J ATHL TRAINING, V39, P241; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Weber AF, 2013, J ATHL TRAINING, V48, P153, DOI 10.4085/1062-6050-48.1.07; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411	31	23	23	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	JUL	2018	46	8					2004	2010		10.1177/0363546518768750			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	GN0AK	WOS:000438619500031	29741916				2022-02-06	
J	Izrael, M; Slutsky, SG; Admoni, T; Cohen, L; Granit, A; Hasson, A; Itskovitz-Eldor, J; Paker, LK; Kuperstein, G; Lavon, N; Ionescu, SY; Solmesky, LJ; Zaguri, R; Zhuravlev, A; Volman, E; Chebath, J; Revel, M				Izrael, Michal; Slutsky, Shalom Guy; Admoni, Tamar; Cohen, Louisa; Granit, Avital; Hasson, Arik; Itskovitz-Eldor, Joseph; Paker, Lena Krush; Kuperstein, Graciela; Lavon, Neta; Ionescu, Shiran Yehezkel; Solmesky, Leonardo Javier; Zaguri, Rachel; Zhuravlev, Alina; Volman, Ella; Chebath, Judith; Revel, Michel			Safety and efficacy of human embryonic stem cell-derived astrocytes following intrathecal transplantation in SOD1(G93A) and NSG animal models	STEM CELL RESEARCH & THERAPY			English	Article						Amyotrophic lateral sclerosis; Astrocytes; Human embryonic stem cells; Superoxide dismutase 1	AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DEGENERATION; PHASE-I TRIAL; GLUTAMATE TRANSPORTER GLT-1; MESENCHYMAL STROMAL CELLS; HYPOXIA-RESPONSE ELEMENT; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; DISEASE PROGRESSION; CEREBROSPINAL-FLUID	Background: Amyotrophic lateral sclerosis (ALS) is a motor neuron (MN) disease characterized by the loss of MNs in the central nervous system. As MNs die, patients progressively lose their ability to control voluntary movements, become paralyzed and eventually die from respiratory/deglutition failure. Despite the selective MN death in ALS, there is growing evidence that malfunctional astrocytes play a crucial role in disease progression. Thus, transplantation of healthy astrocytes may compensate for the diseased astrocytes. Methods: We developed a good manufacturing practice-grade protocol for generation of astrocytes from human embryonic stem cells (hESCs). The first stage of our protocol is derivation of astrocyte progenitor cells (APCs) from hESCs. These APCs can be expanded in large quantities and stored frozen as cell banks. Further differentiation of the APCs yields an enriched population of astrocytes with more than 90% GFAP expression (hES-AS). hES-AS were injected intrathecally into hSOD1(G93A) transgenic mice and rats to evaluate their therapeutic potential. The safety and biodistribution of hES-AS were evaluated in a 9-month study conducted in immunodeficient NSG mice under good laboratory practice conditions. Results: In vitro, hES-AS possess the activities of functional healthy astrocytes, including glutamate uptake, promotion of axon outgrowth and protection of MNs from oxidative stress. A secretome analysis shows that these hES-AS also secrete several inhibitors of metalloproteases as well as a variety of neuroprotective factors (e.g. TIMP-1, TIMP-2, OPN, MIF and Midkine). Intrathecal injections of the hES-AS into transgenic hSOD1(G93A) mice and rats significantly delayed disease onset and improved motor performance compared to sham-injected animals. A safety study in immunodeficient mice showed that intrathecal transplantation of hES-AS is safe. Transplanted hES-AS attached to the meninges along the neuroaxis and survived for the entire duration of the study without formation of tumors or teratomas. Cell-injected mice gained similar body weight to the sham-injected group and did not exhibit clinical signs that could be related to the treatment. No differences from the vehicle control were observed in hematological parameters or blood chemistry. Conclusion: Our findings demonstrate the safety and potential therapeutic benefits of intrathecal injection of hES-AS for the treatment of ALS.	[Izrael, Michal; Slutsky, Shalom Guy; Admoni, Tamar; Cohen, Louisa; Granit, Avital; Hasson, Arik; Itskovitz-Eldor, Joseph; Paker, Lena Krush; Kuperstein, Graciela; Lavon, Neta; Ionescu, Shiran Yehezkel; Solmesky, Leonardo Javier; Zaguri, Rachel; Zhuravlev, Alina; Volman, Ella; Chebath, Judith; Revel, Michel] Kadimastem Ltd, Neurodegenerat Dis Dept, Pinchas Sapir 7,Weizmann Sci Pk, Ness Ziona, Israel; [Chebath, Judith; Revel, Michel] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel		Izrael, M (corresponding author), Kadimastem Ltd, Neurodegenerat Dis Dept, Pinchas Sapir 7,Weizmann Sci Pk, Ness Ziona, Israel.	m.izrael@kadimastem.com			Israel Innovation Authority National Natural [59652]	This work was supported by the Israel Innovation Authority National Natural (grant No. 59652).	Abe K, 2017, LANCET NEUROL, V16, P505, DOI 10.1016/S1474-4422(17)30115-1; Alfei L, 1999, EUR J HISTOCHEM, V43, P29; Andrews PW, 2005, BIOCHEM SOC T, V33, P1526, DOI 10.1042/BST0331526; Baba H, 1997, DEV NEUROSCI-BASEL, V19, P49, DOI 10.1159/000111185; Barbeito LH, 2004, BRAIN RES REV, V47, P263, DOI 10.1016/j.brainresrev.2004.05.003; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; Bogaert E, 2010, NEUROBIOL AGING, V31, P2185, DOI 10.1016/j.neurobiolaging.2008.12.007; Brambilla L, 2016, HUM MOL GENET, V25, P3080, DOI 10.1093/hmg/ddw161; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Collins MA, 2015, J PROTEOME RES, V14, P4486, DOI 10.1021/acs.jproteome.5b00804; Cordero-Llana O, 2011, CELL DEATH DIFFER, V18, P907, DOI 10.1038/cdd.2010.169; Das MM, 2015, NEUROBIOL AGING, V36, P1130, DOI 10.1016/j.neurobiolaging.2014.09.020; Deepa P, 2011, J NEURAL TRANSM, V118, P531, DOI 10.1007/s00702-010-0520-6; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Do-Ha D, 2018, MOL NEUROBIOL, V55, P1410, DOI 10.1007/s12035-017-0392-y; Endo F, 2015, CELL REP, V11, P592, DOI 10.1016/j.celrep.2015.03.053; Foran E, 2009, ANTIOXID REDOX SIGN, V11, P1587, DOI 10.1089/ars.2009.2444; Gao LN, 2014, J NEUROL SCI, V346, P216, DOI 10.1016/j.jns.2014.08.031; Gardner J, 2003, J NEUROSCI RES, V74, P801, DOI 10.1002/jnr.10835; Glass JD, 2012, STEM CELLS, V30, P1144, DOI 10.1002/stem.1079; Gropp M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045532; Gros-Louis F, 2003, MUSCLE NERVE, V28, P774, DOI 10.1002/mus.10498; Gupta K, 2013, BRIT J CLIN PHARMACO, V75, P907, DOI 10.1111/bcp.12022; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hafner A, 2013, AGING CELL, V12, P604, DOI 10.1111/acel.12093; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; HIRANO A, 1984, J NEUROPATH EXP NEUR, V43, P471, DOI 10.1097/00005072-198409000-00002; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Hubbard JA, 2015, ASN NEURO, V7, DOI 10.1177/1759091415605486; Israelson A, 2015, NEURON, V86, P218, DOI 10.1016/j.neuron.2015.02.034; Izrael M, 2018, ASTROCYTES PATHOGENE; Izrael M, 2007, MOL CELL NEUROSCI, V34, P310, DOI 10.1016/j.mcn.2006.11.008; Kaplan A, 2014, NEURON, V81, P333, DOI 10.1016/j.neuron.2013.12.009; Kawahara K, 2002, GLIA, V40, P337, DOI 10.1002/glia.10133; Kondo T, 2014, STEM CELL REP, V3, P242, DOI 10.1016/j.stemcr.2014.05.017; Krakora D, 2013, MOL THER, V21, P1602, DOI 10.1038/mt.2013.108; Lacomblez L, 1996, LANCET, V347, P1425, DOI 10.1016/S0140-6736(96)91680-3; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Lee AS, 2009, CELL CYCLE, V8, P2608, DOI 10.4161/cc.8.16.9353; Lee J, 2016, EXP NEUROBIOL, V25, P233, DOI 10.5607/en.2016.25.5.233; Li G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005424; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Llado J, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00181; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Mazzini L, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-014-0371-2; Meller R, 2005, J CEREBR BLOOD F MET, V25, P217, DOI 10.1038/sj.jcbfm.9600022; Meyer K, 2014, P NATL ACAD SCI USA, V111, P829, DOI 10.1073/pnas.1314085111; Miller RG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub3; Mishra PS, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0698-0; Morisaki Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep27354; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nicaise C, 2015, WORLD J STEM CELLS, V7, P380, DOI 10.4252/wjsc.v7.i2.380; Nizzardo M, 2016, HUM MOL GENET, V25, P3152, DOI 10.1093/hmg/ddw163; Oh KW, 2015, STEM CELL TRANSL MED, V4, P590, DOI 10.5966/sctm.2014-0212; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Papadeas ST, 2011, P NATL ACAD SCI USA, V108, P17803, DOI 10.1073/pnas.1103141108; Petrou P, 2016, JAMA NEUROL, V73, P337, DOI 10.1001/jamaneurol.2015.4321; Petrov D, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00068; Phatnani HP, 2013, P NATL ACAD SCI USA, V110, pE756, DOI 10.1073/pnas.1222361110; Philips T, 2015, CURRENT PROTOCOLS PH, V69; Piao C, 2015, EXP NEUROL, V273, P288, DOI 10.1016/j.expneurol.2015.09.009; Prathalingam N, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt103; Priest CA, 2015, REGEN MED, V10, P939, DOI 10.2217/rme.15.57; Prokhorova TA, 2009, STEM CELLS DEV, V18, P47, DOI 10.1089/scd.2007.0266; Przyborski SA, 2005, STEM CELLS, V23, P1242, DOI 10.1634/stemcells.2005-0014; Ramamohan PY, 2007, AMYOTROPH LATERAL SC, V8, P79, DOI 10.1080/08037060601145489; Ramot Y, 2017, NEUROTOXICOLOGY, V59, P27, DOI 10.1016/j.neuro.2017.01.003; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; Re DB, 2014, NEURON, V81, P1001, DOI 10.1016/j.neuron.2014.01.011; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Rosito M, 2012, J NEUROSCI, V32, P3154, DOI 10.1523/JNEUROSCI.4046-11.2012; Rossi S, 2016, BRAIN PATHOL, V26, P276, DOI 10.1111/bpa.12355; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Roybon L, 2013, CELL REP, V4, P1035, DOI 10.1016/j.celrep.2013.06.021; Sasaki S, 2007, ACTA NEUROPATHOL, V114, P633, DOI 10.1007/s00401-007-0299-1; Scholze AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110668; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Shruthi S, 2017, NEURODEGENER DIS, V17, P44, DOI 10.1159/000447559; Staff NP, 2016, NEUROLOGY, V87, P2230, DOI 10.1212/WNL.0000000000003359; Storkebaum E, 2004, BIOESSAYS, V26, P943, DOI 10.1002/bies.20092; Straten G, 2009, J ALZHEIMERS DIS, V18, P331, DOI 10.3233/JAD-2009-1146; Tan WZ, 2013, J NEUROSCI, V33, P11588, DOI 10.1523/JNEUROSCI.5385-12.2013; Tannenbaum SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035325; Tarasiuk J, 2012, J NEURAL TRANSM, V119, P747, DOI 10.1007/s00702-012-0806-y; Tian CL, 2013, EXP CLIN TRANSPLANT, V11, P176, DOI 10.6002/ect.2012.0053; Tong JB, 2013, EMBO J, V32, P1917, DOI 10.1038/emboj.2013.122; Tripathi P, 2017, STEM CELL REP, V9, P667, DOI 10.1016/j.stemcr.2017.06.008; Tyzack GE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5294; Van Den Bosch L, 2004, NEUROBIOL DIS, V17, P21, DOI 10.1016/j.nbd.2004.06.004; Varghese AM, 2013, CLIN PROTEOM, V10, DOI 10.1186/1559-0275-10-19; Wang S, 2013, BRAIN RES, V1532, P76, DOI 10.1016/j.brainres.2013.08.001; Wiedemann FR, 2002, J NEUROCHEM, V80, P616, DOI 10.1046/j.0022-3042.2001.00731.x; Winkler C, 2014, BRIT J PHARMACOL, V171, P905, DOI 10.1111/bph.12462; Wright MC, 2014, J NEUROSCI, V34, P1689, DOI 10.1523/JNEUROSCI.3822-13.2014; Yamanaka K, 2008, P NATL ACAD SCI USA, V105, P7594, DOI 10.1073/pnas.0802556105	99	23	23	0	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-6512			STEM CELL RES THER	Stem Cell Res. Ther.	JUN 6	2018	9								152	10.1186/s13287-018-0890-5			17	Cell & Tissue Engineering; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	GJ0BZ	WOS:000434911700001	29871694	Green Published, gold			2022-02-06	
J	Forstner, P; Rehman, R; Anastasiadou, S; Haffner-Luntzer, M; Sinske, D; Ignatius, A; Roselli, F; Knoll, B				Foerstner, Philip; Rehman, Rida; Anastasiadou, Sofia; Haffner-Luntzer, Melanie; Sinske, Daniela; Ignatius, Anita; Roselli, Francesco; Knoell, Bernd			Neuroinflammation after Traumatic Brain Injury Is Enhanced in Activating Transcription Factor 3 Mutant Mice	JOURNAL OF NEUROTRAUMA			English	Article						ATF3; chemokine; hematoma; RAG; traumatic brain injury	ADAPTIVE-RESPONSE GENE; CLOSED-HEAD INJURY; NEGATIVE REGULATOR; ATF3 EXPRESSION; ANIMAL-MODELS; INFLAMMATION; REGENERATION; NEURONS; CARDIOMYOCYTES; LIPOCALIN-2	Traumatic brain injury (TBI) induces a neuroinflammatory response resulting in astrocyte and microglia activation at the lesion site. This involves upregulation of neuroinflammatory genes, including chemokines and interleukins. However, so far, there is lack of knowledge on transcription factors (TFs) modulating this TBI-associated gene expression response. Herein, we analyzed activating transcription factor 3 (ATF3), a TF encoding a regeneration-associated gene (RAG) predominantly studied in peripheral nervous system (PNS) injury. ATF3 contributes to PNS axon regeneration and was shown before to regulate inflammatory processes in other injury models. In contrast to PNS injury, data on ATF3 in central nervous system (CNS) injury are sparse. We used Atf3 mouse mutants and a closed-head weight-drop-based TBI model in adult mice to target the rostrolateral cortex resulting in moderate injury severity. Post-TBI, ATF3 was upregulated already at early time points (i.e,. 1-4h) post-injury in the brain. Mortality and weight loss upon TBI were slightly elevated in Atf3 mutants. ATF3 deficiency enhanced TBI-induced paresis and hematoma formation, suggesting that ATF3 limits these injury outcomes in wild-type mice. Next, we analyzed TBI-associated RAG and inflammatory gene expression in the cortical impact area. In contrast to the PNS, only some RAGs (Atf3, Timp1, and Sprr1a) were induced by TBI, and, surprisingly, some RAG encoding neuropeptides were downregulated. Notably, we identified ATF3 as TF-regulating proneuroinflammatory gene expression, including CCL and CXCL chemokines (Ccl2, Ccl3, Ccl4, and Cxcl1) and lipocalin. In Atf3 mutant mice, mRNA abundance was further enhanced upon TBI compared to wild-type mice, suggesting immune gene repression by wild-type ATF3. In accord, more immune cells were present in the lesion area of ATF3-deficient mice. Overall, we identified ATF3 as a new TF-mediating TBI-associated CNS inflammatory responses.	[Foerstner, Philip; Anastasiadou, Sofia; Sinske, Daniela; Knoell, Bernd] Ulm Univ, Inst Physiol Chem, Albert Einstein Allee 11, D-89081 Ulm, Germany; [Rehman, Rida; Roselli, Francesco] Ulm Univ, Dept Neurol, Ulm, Germany; [Rehman, Rida] NUST, SMME, Dept Biomed Engn & Sci BMES, H-12, Islamabad, Pakistan; [Haffner-Luntzer, Melanie; Ignatius, Anita] Univ Ulm, Inst Orthopaed Res & Biomech, Ctr Trauma Res Ulm, Ulm, Germany		Knoll, B (corresponding author), Ulm Univ, Inst Physiol Chem, Albert Einstein Allee 11, D-89081 Ulm, Germany.	bernd.knoell@uni-ulm.de	Rehman, Rida/AAR-4811-2020; Ignatius, Anita/M-6012-2013; roselli, francesco/O-8847-2019; Haffner-Luntzer, Melanie/L-3562-2019	Rehman, Rida/0000-0003-0518-5051; Ignatius, Anita/0000-0002-4782-1979; roselli, francesco/0000-0001-9935-6899; Haffner-Luntzer, Melanie/0000-0002-3333-2613; Meyer zu Reckendorf, Sofia/0000-0001-6978-1915	Deutsche Forschungsgemeinschaft (DFG), Collaborative Research CenterGerman Research Foundation (DFG) [1149]; ERANET-NEURON initiative "External Insults to the Nervous System'', MICRONET consortium; Baustein Program of Ulm University; Ulm University-Bundeswehr Krankenhaus Ulm research initiative; Paul und Marlene Hepp-Stiftung	The work by A.I., B.K., and F.R. has been supported by the Deutsche Forschungsgemeinschaft (DFG) as part of the Collaborative Research Center 1149 "Danger Response, Disturbance Factors and Regenerative Potential after Acute Trauma.'' F.R. is also supported by the ERANET-NEURON initiative "External Insults to the Nervous System'' as part of the MICRONET consortium and by the Baustein Program of Ulm University. B.K. is supported by an Ulm University-Bundeswehr Krankenhaus Ulm research initiative and Paul und Marlene Hepp-Stiftung.	Akram A, 2010, AM J RESP CRIT CARE, V182, P489, DOI 10.1164/rccm.200906-0925OC; Aung HH, 2016, J LIPID RES, V57, P955, DOI 10.1194/jlr.M061853; Boespflug ND, 2014, BLOOD, V123, P2084, DOI 10.1182/blood-2013-06-510909; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bulsara KR, 2002, SPINE, V27, P1946, DOI 10.1097/00007632-200209010-00030; Cartagena CM, 2013, NEUROMOL MED, V15, P504, DOI 10.1007/s12017-013-8236-z; Chandran V, 2016, NEURON, V89, P956, DOI 10.1016/j.neuron.2016.01.034; Chandrasekar A, 2018, EXP NEUROL, V302, P34, DOI 10.1016/j.expneurol.2017.12.017; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Crack P, 2009, J NEURAL TRANSM, V116, P1, DOI 10.1007/s00702-008-0145-1; Fagoe ND, 2015, HUM MOL GENET, V24, P6788, DOI 10.1093/hmg/ddv383; Fagoe ND, 2014, NEUROMOL MED, V16, P799, DOI 10.1007/s12017-014-8329-3; Fahlenkamp AV, 2011, INFLAMM RES, V60, P379, DOI 10.1007/s00011-010-0281-6; Fazio EN, 2017, MOL BIOL CELL, V28, P2347, DOI 10.1091/mbc.E17-04-0254; Fernandez-Verdejo R, 2017, FASEB J, V31, P840, DOI 10.1096/fj.201600987R; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fukasawa K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30918; Gey M, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160091; Gilchrist M, 2008, J EXP MED, V205, P2349, DOI 10.1084/jem.20072254; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hai T, 2010, GENE EXPRESSION, V15, P1, DOI 10.3727/105221610X12819686555015; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hu CJ, 2017, J LEUKOCYTE BIOL, V101, P633, DOI 10.1189/jlb.2HI1115-491R; Hunt D, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00007; Isidro RA, 2016, AM J PHYSIOL-GASTR L, V311, pG59, DOI 10.1152/ajpgi.00123.2016; Jang E, 2013, FASEB J, V27, P1176, DOI 10.1096/fj.12-222257; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Ka MB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00500; Kalfon R, 2017, CARDIOVASC RES, V113, P134, DOI 10.1093/cvr/cvw228; Kawa L, 2016, EXP NEUROL, V279, P159, DOI 10.1016/j.expneurol.2016.02.019; Kelso ML, 2014, CURR PHARM DESIGN, V20, P4284; Khuu CH, 2007, MOL IMMUNOL, V44, P1598, DOI 10.1016/j.molimm.2006.08.006; Koren L, 2015, INT J CARDIOL, V198, P232, DOI 10.1016/j.ijcard.2015.06.099; Kruse F, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00026; Kwon MJ, 2016, NEURAL REGEN RES, V11, P1368, DOI 10.4103/1673-5374.191194; Labzin LI, 2015, J IMMUNOL, V195, P4446, DOI 10.4049/jimmunol.1500204; Lee LL, 2017, AM J PHYSIOL-CELL PH, V312, pC500, DOI 10.1152/ajpcell.00120.2016; Lim R, 2016, PLACENTA, V47, P63, DOI 10.1016/j.placenta.2016.09.006; Ma TC, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00043; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Patodia S, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00008; Plunet W, 2002, J NEUROSCI RES, V68, P1, DOI 10.1002/jnr.10176; Qian LL, 2017, J CELL PHYSIOL, V232, P3727, DOI 10.1002/jcp.25849; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Rao J, 2015, AM J TRANSPLANT, V15, P76, DOI 10.1111/ajt.12954; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Rynes J, 2012, MOL CELL BIOL, V32, P3949, DOI 10.1128/MCB.00429-12; Samal BB, 2015, J MOL NEUROSCI, V57, P282, DOI 10.1007/s12031-015-0626-2; Schreiber RC, 2001, NEUROREPORT, V12, P601, DOI 10.1097/00001756-200103050-00034; Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007; Seijffers R, 2006, MOL CELL NEUROSCI, V32, P143, DOI 10.1016/j.mcn.2006.03.005; Seijffers R, 2014, P NATL ACAD SCI USA, V111, P1622, DOI 10.1073/pnas.1314826111; Skoglosa Y, 1999, NEUROSCIENCE, V90, P235, DOI 10.1016/S0306-4522(98)00414-X; Stern S, 2012, J NEUROINFLAMM, V9, DOI [10.1186/1742-2094-9-79, 10.1186/1742-2094-9-78]; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Suk K, 2016, PROG NEUROBIOL, V144, P158, DOI 10.1016/j.pneurobio.2016.08.001; Tedeschi A, 2012, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmo1.2011.00060; van den Heuvel MGL, 2007, SCIENCE, V317, P333, DOI 10.1126/science.1139570; van Kesteren RE, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00046; van Landeghem FKH, 2007, ACTA NEUROPATHOL, V113, P683, DOI 10.1007/s00401-007-0208-7; Verellen Rebecca M, 2010, Therapy, V7, P527, DOI 10.2217/thy.10.57; Vos BC, 2018, CLIN J SPORT MED, V28, P91, DOI 10.1097/JSM.0000000000000432; Wang L, 2012, NEUROSCIENCE, V220, P100, DOI 10.1016/j.neuroscience.2012.06.010; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604; Zhang YP, 2014, TRANSL STROKE RES, V5, P454, DOI 10.1007/s12975-014-0327-0; Zhao YF, 2017, MOL IMMUNOL, V90, P27, DOI 10.1016/j.molimm.2017.06.037; Zmuda EJ, 2010, DIABETOLOGIA, V53, P1438, DOI 10.1007/s00125-010-1696-x; Zmuda EJ, 2010, MOL ENDOCRINOL, V24, P1423, DOI 10.1210/me.2009-0463	74	23	23	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2018	35	19					2317	2329		10.1089/neu.2017.5593		JUN 2018	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GV3OA	WOS:000434224900001	29463176				2022-02-06	
J	Brown, CS; Emmett, SD; Robler, SK; Tucci, DL				Brown, Clifford Scott; Emmett, Susan D.; Robler, Samantha Kleindienst; Tucci, Debara L.			Global Hearing Loss Prevention	OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA			English	Article						Hearing loss; Prevention; Vaccination; Cost effectiveness	TRAUMATIC BRAIN-INJURY; COCHLEAR IMPLANTATION; COST-EFFECTIVENESS; CYTOMEGALOVIRUS-INFECTION; COMMUNICATION DISORDERS; IMMUNIZATION VISION; DEAF EDUCATION; VITAMIN-A; IMPAIRMENT; CHILDREN	Hearing loss is the fourth leading contributor to years lived with a disability worldwide. Most recent estimates indicate that one-half of a billion people suffer from disabling hearing loss worldwide. The social and economic burden is significant. When attributing monetary value to years lived with disability owing to hearing loss, there is greater than $750 billion lost each year globally. There are numerous contributors to hearing loss, including congenital, infectious, noise exposure, age-related, traumatic, and immune-mediated causes. Understanding the pathophysiology of these factors allows for the development of preventative and treatment strategies specific to the underlying cause.	[Brown, Clifford Scott] Duke Univ, Med Ctr, Dept Surg, Div Head & Neck Surg & Commun Sci, 40 Duke Med Circle,M150 Green Zone,DUMC 2824, Durham, NC 27710 USA; [Emmett, Susan D.] Duke Univ, Med Ctr, Dept Surg, Div Head & Neck Surg & Commun Sci,Duke Global Hlt, Box 3805, Durham, NC 27710 USA; [Robler, Samantha Kleindienst] Norton Sound Hlth Corp, Norton Sound Hlth, POB 966, Norton, AK 99762 USA; [Tucci, Debara L.] Duke Univ, Div Head & Neck Surg Commun Sci, Dept Surg, Med Ctr, Box 3805, Durham, NC 27710 USA		Tucci, DL (corresponding author), Duke Univ, Div Head & Neck Surg Commun Sci, Dept Surg, Med Ctr, Box 3805, Durham, NC 27710 USA.	debara.tucci@duke.edu					Abrams H, 2002, J REHABIL RES DEV, V39, P549; Alexander TH, 2013, OTOL NEUROTOL, V34, P1586, DOI 10.1097/MAO.0000000000000222; Alexander TH, 2010, OTOLARYNG CLIN N AM, V43, P965, DOI 10.1016/j.otc.2010.05.001; [Anonymous], 2012, GLOB EST PREV HEAR L; [Anonymous], 1995, WHA489 WHO; Arslan E, 1999, ANN NY ACAD SCI, V884, P1; Baltussen R, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-64; Basner M, 2014, LANCET, V383, P1325, DOI 10.1016/S0140-6736(13)61613-X; Bilous J, 2006, LANCET, V367, P1464, DOI 10.1016/S0140-6736(06)68625-X; BITNUN S, 1986, J LARYNGOL OTOL, V100, P943, DOI 10.1017/S0022215100100362; Bongaarts J, 2009, PHILOS T R SOC B, V364, P2985, DOI 10.1098/rstb.2009.0137; Boothroyd Arthur, 2007, Trends Amplif, V11, P63, DOI 10.1177/1084713807301073; Bortoli R, 2007, CLIN RHEUMATOL, V26, P1809, DOI 10.1007/s10067-007-0662-6; Bovo R, 2009, EUR ARCH OTO-RHINO-L, V266, P37, DOI 10.1007/s00405-008-0801-y; Brouwer MC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004405.pub4; Brown ED, 2009, INT J PEDIATR OTORHI, V73, P707, DOI 10.1016/j.ijporl.2009.01.012; Buszman Ewa, 2003, Wiad Lek, V56, P254; Carroll Mark, 2011, Perspect Health Inf Manag, V8, p1d; Castellanos MJ, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121223; Chadambuka A, 2013, Afr Health Sci, V13, P899, DOI 10.4314/ahs.v13i4.6; Chen Y, 2007, HEARING RES, V226, P178, DOI 10.1016/j.heares.2006.05.008; Choudhury V, 2015, AM J CLIN NUTR, V102, P1030, DOI 10.3945/ajcn.115.113084; Cohen BE, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514541361; Crowson MG, 2017, OTOLARYNG HEAD NECK, V156, P137, DOI 10.1177/0194599816668325; Crowson MG, 2016, AUDIOL NEURO-OTOL, V21, P69, DOI 10.1159/000443629; Curhan SG, 2015, AM J CLIN NUTR, V102, P1167, DOI 10.3945/ajcn.115.109314; De La Sante O., REPORT INFORM CONSUL; Elemraid MA, 2009, ANN TROP PAEDIATR, V29, P85, DOI 10.1179/146532809X440707; Elliott G, 2010, TELEMED J E-HEALTH, V16, P250, DOI 10.1089/tmj.2010.0045; Emmett SD, 2015, OTOL NEUROTOL, V36, P1756, DOI 10.1097/MAO.0000000000000929; Emmett SD, 2018, AM J CLIN NUTR; Emmett SD, 2015, OTOL NEUROTOL, V36, P1357, DOI 10.1097/MAO.0000000000000823; Emmett SD, 2015, OTOL NEUROTOL, V36, P545, DOI 10.1097/MAO.0000000000000562; Emmett SD, 2014, LARYNGOSCOPE, V124, P2176, DOI 10.1002/lary.24746; Emmett SD, 2014, MED HYPOTHESES, V82, P6, DOI 10.1016/j.mehy.2013.09.028; Fechter LD, 2004, J TOXICOL ENV HEAL A, V67, P727, DOI 10.1080/15287390490428206; Galazka AM, 1999, B WORLD HEALTH ORGAN, V77, P3; Gaylor JM, 2013, JAMA OTOLARYNGOL, V139, P265, DOI 10.1001/jamaoto.2013.1744; Goderis J, 2016, J PEDIATR-US, V172, P110, DOI 10.1016/j.jpeds.2016.01.024; Groce NE, 2013, SOCIAL INJUSTICE PUB, P140; Grosse SD, 2008, J CLIN VIROL, V41, P57, DOI 10.1016/j.jcv.2007.09.004; Gurgel RK, 2014, OTOL NEUROTOL, V35, P775, DOI 10.1097/MAO.0000000000000313; HALL R, 1987, ARCH DIS CHILD, V62, P189, DOI 10.1136/adc.62.2.189; Hamamy H, 2012, J COMMUN GENET, V3, P185, DOI 10.1007/s12687-011-0072-y; Hanushek E.A., 2015, KNOWLEDGE CAPITAL NA; Harrison RV, 2008, PAED CHILD HEALT-CAN, V13, P377, DOI 10.1093/pch/13.5.377; Hassibian MR, 2016, RAZAWI INT J MED, V4; HENRY KR, 1981, ARCH OTOLARYNGOL, V107, P92; Honeth L, 2015, NOISE HEALTH, V17, P273, DOI 10.4103/1463-1741.165043; Humes LE, 2012, J AM ACAD AUDIOL, V23, P635, DOI 10.3766/jaaa.23.8.5; Jarvelin MR, 1997, BRIT J AUDIOL, V31, P165, DOI 10.3109/03005364000000019; Kemperman MH, 2002, J ROY SOC MED, V95, P171, DOI 10.1258/jrsm.95.4.171; Kennedy CR, 2006, NEW ENGL J MED, V354, P2131, DOI 10.1056/NEJMoa054915; Keppler H, 2010, ARCH OTOLARYNGOL, V136, P538, DOI 10.1001/archoto.2010.84; Kokesh J, 2008, OTOLARYNG HEAD NECK, V139, P87, DOI 10.1016/j.otohns.2008.04.008; Kokesh John, 2004, Int J Circumpolar Health, V63, P387; Kokesh J, 2011, OTOLARYNG CLIN N AM, V44, P1359, DOI 10.1016/j.otc.2011.08.010; Kokesh J, 2010, OTOLARYNG HEAD NECK, V143, P253, DOI 10.1016/j.otohns.2010.04.265; Lantos PM, 2017, J PEDIATR INFECT DIS, V6, pE55, DOI 10.1093/jpids/piw088; Lantos PM, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv143; Lee JY, 2000, CLIN MICROBIOL REV, V13, P571, DOI 10.1128/CMR.13.4.571-587.2000; Lin FR, 2013, JAMA INTERN MED, V173, P293, DOI 10.1001/jamainternmed.2013.1868; Lin FR, 2011, ARCH INTERN MED, V171, P1851, DOI 10.1001/archinternmed.2011.506; Lin FR, 2011, ARCH NEUROL-CHICAGO, V68, P214, DOI 10.1001/archneurol.2010.362; Low WK, 2005, ANN ACAD MED SINGAP, V34, P301; Mamun K Z, 2006, Mymensingh Med J, V15, P81; Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12; Martinez-Vega R, 2015, FASEB J, V29, P418, DOI 10.1096/fj.14-259283; Melse-Boonstra A, 2013, NUTR RES REV, V26, P110, DOI 10.1017/S0954422413000061; Mueller JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052464; Mulwafu W, 2016, TROP MED INT HEALTH, V21, P158, DOI 10.1111/tmi.12640; Nance WE, 2000, LANCET, V356, P500, DOI 10.1016/S0140-6736(00)02565-4; National Academies of Sciences Engineering and Medicine, 2016, HEAR HLTH CAR AD PRI; National Conference of State Legislatures, NEWB HEAR SCREEN STA; Nayak CS, 2003, ANN OTO RHINOL LARYN, V112, P817, DOI 10.1177/000348940311200913; Nelson DI, 2005, AM J IND MED, V48, P400, DOI 10.1002/ajim.20211; *NZHTA, 1998, SCREEN PROGR DET OT; Olusanya BO, 2006, JAMA-J AM MED ASSOC, V296, P441, DOI 10.1001/jama.296.4.441; Olusanya BO, 2014, B WORLD HEALTH ORGAN, V92, P367, DOI 10.2471/BLT.13.128728; Olusanya BO, 2012, ARCH DIS CHILD, V97, P654, DOI 10.1136/archdischild-2012-301786; Bolajoko BO, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-14; PAPARELLA MM, 1991, OTOLARYNGOLOGY, V2, P1571; Patricoski C, 2003, TELEMED J E-HEALTH, V9, P331, DOI 10.1089/153056203772744653; Robertson Susan E., 2003, Rev Panam Salud Publica, V14, P306, DOI 10.1590/S1020-49892003001000005; Ruben RJ, 2000, LARYNGOSCOPE, V110, P241, DOI 10.1097/00005537-200002010-00010; Saunders JE, 2015, OTOL NEUROTOL, V36, P1349, DOI 10.1097/MAO.0000000000000809; Saunders JE, 2009, OTOLARYNG HEAD NECK, V140, P103, DOI 10.1016/j.otohns.2008.09.027; Schmitz J, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d7962; Shangkuan WC, 2017, LARYNGOSCOPE, V127, P2627, DOI 10.1002/lary.26567; Simons Emily, 2012, Lancet, V379, P2173, DOI 10.1016/S0140-6736(12)60522-4; Smith A, 2003, INT C SER, V1240, P183; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; Southall K, 2010, INT J AUDIOL, V49, P804, DOI 10.3109/14992027.2010.498447; Staton CA, 2017, INT J INJ CONTROL SA, V24, P69, DOI 10.1080/17457300.2015.1061562; Stevens G, 2013, EUR J PUBLIC HEALTH, V23, P146, DOI 10.1093/eurpub/ckr176; Swanepoel D, 2017, AM J AUDIOL, V26, P426, DOI 10.1044/2017_AJA-16-0117; Tucci DL, 2010, OTOL NEUROTOL, V31, P31, DOI 10.1097/MAO.0b013e3181c0eaec; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; White KR, 2006, J AM ACAD AUDIOL, V17, P295, DOI 10.3766/jaaa.17.4.8; WHO, 2017, GLOB COSTS UN HEAR L; Wilson BS, 2008, HEARING RES, V242, P3, DOI 10.1016/j.heares.2008.06.005; Wilson BS, 2017, LANCET, V390, P2503, DOI 10.1016/S0140-6736(17)31073-5; Wolfson LJ, 2008, B WORLD HEALTH ORGAN, V86, P27, DOI 10.2471/BLT.07.045096; Wong BYK, 2000, ADV OTO-RHINO-LARYNG, V57, P377; World Health Organization, DEAFN HEAR IMP; World Health Organization, NEWB INF HEAR SCREEN; World Health Organization, 2010, TELEMEDICINE OPPORTU; World Health Organization (WHO), GRAD HEAR IMP; Zietsch BP, 2011, AM NAT, V177, P605, DOI 10.1086/659629	109	23	25	0	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0030-6665	1557-8259		OTOLARYNG CLIN N AM	Otolaryngol. Clin. N. Am.	JUN	2018	51	3					575	+		10.1016/j.otc.2018.01.006			19	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	GJ5OV	WOS:000435431700009	29525388				2022-02-06	
J	Dimitriadis, SI; Lopez, ME; Bruna, R; Cuesta, P; Marcos, A; Maestu, F; Pereda, E				Dimitriadis, Stavros I.; Lopez, Maria E.; Bruna, Ricardo; Cuesta, Pablo; Marcos, Alberto; Maestu, Fernando; Pereda, Ernesto			How to Build a Functional Connectomic Biomarker for Mild Cognitive Impairment From Source Reconstructed MEG Resting-State Activity: The Combination of ROI Representation and Connectivity Estimator Matters	FRONTIERS IN NEUROSCIENCE			English; English	Article						connectomic biomarker; magnetoencephalography; mild cognitive impairment; virtual source activity; connectome data analysis; multiplexity; cross-frequency-coupling; intrinsic coupling modes	ALZHEIMERS ASSOCIATION WORKGROUPS; POSTERIOR CINGULATE CORTEX; TRAUMATIC BRAIN-INJURY; SYNCHRONIZATION LIKELIHOOD; DIAGNOSTIC GUIDELINES; OSCILLATORY ACTIVITY; EEG SYNCHRONIZATION; NATIONAL INSTITUTE; FMRI CONNECTIVITY; DISEASE	Our work aimed to demonstrate the combination of machine learning and graph theory for the designing of a connectomic biomarker for mild cognitive impairment (MCI) subjects using eyes-closed neuromagnetic recordings. The whole analysis based on source-reconstructed neuromagnetic activity. As ROI representation, we employed the principal component analysis (PCA) and centroid approaches. As representative bi-variate connectivity estimators for the estimation of intra and cross-frequency interactions, we adopted the phase locking value (PLV), the imaginary part (iPLV) and the correlation of the envelope (CorrEnv). Both intra and cross-frequency interactions (CFC) have been estimated with the three connectivity estimators within the seven frequency bands (intra-frequency) and in pairs (CFC), correspondingly. We demonstrated how different versions of functional connectivity graphs single-layer (SL-FCG) and multi-layer (ML-FCG) can give us a different view of the functional interactions across the brain areas. Finally, we applied machine learning techniques with main scope to build a reliable connectomic biomarker by analyzing both SL-FCG and ML-FCG in two different options: as a whole unit using a tensorial extraction algorithm and as single pair-wise coupling estimations. We concluded that edge-weighed feature selection strategy outperformed the tensorial treatment of SL-FCG and ML-FCG. The highest classification performance was obtained with the centroid ROI representation and edge-weighted analysis of the SL-FCG reaching the 98% for the CorrEnv in a l :012 and 94% for the iPLV in alpha(2). Classification performance based on the multi-layer participation coefficient, a multiplexity index reached 52% for iPLV and 52% for CorrEnv. Selected functional connections that build the multivariate connectomic biomarker in the edge-weighted scenario are located in default-mode, fronto-parietal, and cingulo-opercular network. Our analysis supports the notion of analyzing FCG simultaneously in intra and cross-frequency whole brain interactions with various connectivity estimators in beamformed recordings.	[Dimitriadis, Stavros I.] Cardiff Univ, Sch Med, Div Psychol Med & Clin Neurosci, Cardiff, S Glam, Wales; [Dimitriadis, Stavros I.] Cardiff Univ, Sch Psychol, Brain Res Imaging Ctr, Cardiff, S Glam, Wales; [Dimitriadis, Stavros I.] Cardiff Univ, Sch Psychol, Cardiff, S Glam, Wales; [Dimitriadis, Stavros I.] Cardiff Univ, Sch Psychol, Brain Res Imaging Ctr, Neuroinformat Grp, Cardiff, S Glam, Wales; [Dimitriadis, Stavros I.] Cardiff Univ, Neurosci & Mental Hlth Res Inst, Cardiff, S Glam, Wales; [Lopez, Maria E.; Bruna, Ricardo; Maestu, Fernando] Univ Complutense Madrid, Dept Basic Psychol 2, Madrid, Spain; [Lopez, Maria E.; Bruna, Ricardo; Cuesta, Pablo; Maestu, Fernando; Pereda, Ernesto] Ctr Biomed Technol, Lab Cognit & Comp Neurosci, Madrid, Spain; [Lopez, Maria E.; Bruna, Ricardo; Maestu, Fernando] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Zaragoza, Spain; [Cuesta, Pablo; Pereda, Ernesto] Univ La Laguna, Dept Ind Engn, Elect Engn & Bioengn Grp, Tenerife, Spain; [Cuesta, Pablo; Pereda, Ernesto] Univ La Laguna, IUNE, Tenerife, Spain; [Marcos, Alberto] San Carlos Univ Hosp, Dept Neurol, Madrid, Spain		Dimitriadis, SI (corresponding author), Cardiff Univ, Sch Med, Div Psychol Med & Clin Neurosci, Cardiff, S Glam, Wales.; Dimitriadis, SI (corresponding author), Cardiff Univ, Sch Psychol, Brain Res Imaging Ctr, Cardiff, S Glam, Wales.; Dimitriadis, SI (corresponding author), Cardiff Univ, Sch Psychol, Cardiff, S Glam, Wales.; Dimitriadis, SI (corresponding author), Cardiff Univ, Sch Psychol, Brain Res Imaging Ctr, Neuroinformat Grp, Cardiff, S Glam, Wales.; Dimitriadis, SI (corresponding author), Cardiff Univ, Neurosci & Mental Hlth Res Inst, Cardiff, S Glam, Wales.	stidimitriadis@gmail.com	Bruna, Ricardo/F-8066-2016; Pereda, Ernesto/K-5185-2014; DIMITRIADIS, STAVROS I/AAN-8992-2020; Cuesta, Pablo/ABA-2284-2021; Lopez, Maria Eugenia/E-9311-2016; Lopez, Maria Eugenia/M-4579-2018; De Pablo, Ernesto Pereda/AAB-7440-2021; Lopez, Maria Eugenia/AAC-3233-2019; maestu, fernando/M-7480-2019	Bruna, Ricardo/0000-0003-1007-900X; Pereda, Ernesto/0000-0001-5965-164X; DIMITRIADIS, STAVROS I/0000-0002-0000-5392; Cuesta, Pablo/0000-0002-8459-3354; Lopez, Maria Eugenia/0000-0002-3928-2629; De Pablo, Ernesto Pereda/0000-0001-5965-164X; Lopez, Maria Eugenia/0000-0002-3928-2629; maestu, fernando/0000-0002-3195-0071	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/K004360/1]; MARIE-CURIE COFUND EU-UK Research Fellowship; Spanish Ministry of Economy and CompetitivenessSpanish Government [FIS2013-41057-P]; University Complutense of Madrid; Spanish MINECOSpanish Government [TEC2016-80063-C3-2-R]; Cardiff RCUK funding; MINECOSpanish Government [PSI-2015-68793-C3-1-R]; Spanish Ministry of EducationSpanish Government [FPU13/06009]	SD was supported by a MRC grant MR/K004360/1 (Behavioural and Neurophysiological Effects of Schizophrenia Risk Genes: A Multi-locus, Pathway Based Approach). SD is also supported by a MARIE-CURIE COFUND EU-UK Research Fellowship.; FM and ML were supported by the Spanish Ministry of Economy and Competitiveness under Project FIS2013-41057-P and (ML) a postdoctoral grant of the University Complutense of Madrid. Finally, EP acknowledges the financial support of Spanish MINECO under grant TEC2016-80063-C3-2-R. We would like to acknowledge Cardiff RCUK funding scheme for covering the publication fee. FM is supported by a grant PSI-2015-68793-C3-1-R from MINECO. RB is supported by a grant FPU13/06009 from the Spanish Ministry of Education. We would like to thank the reviewers for their valuable comments.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Pineda-Pardo JA, 2014, BRAIN CONNECT, V4, P312, DOI 10.1089/brain.2013.0208; Antonakakis M, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00416; Antonakakis M, 2017, NEUROSCIENCE, V356, P275, DOI 10.1016/j.neuroscience.2017.05.032; Antonakakis M, 2016, INT J PSYCHOPHYSIOL, V102, P1, DOI 10.1016/j.ijpsycho.2016.02.002; Arendt T, 2009, ACTA NEUROPATHOL, V118, P167, DOI 10.1007/s00401-009-0536-x; Aru J, 2015, CURR OPIN NEUROBIOL, V31, P51, DOI 10.1016/j.conb.2014.08.002; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Battiston F, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.032804; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brookes MJ, 2012, NEUROIMAGE, V63, P910, DOI 10.1016/j.neuroimage.2012.03.048; Brookes MJ, 2016, NEUROIMAGE, V132, P425, DOI 10.1016/j.neuroimage.2016.02.045; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Brookes MJ, 2011, NEUROIMAGE, V56, P1082, DOI 10.1016/j.neuroimage.2011.02.054; Bruna R, 2017, PHASE LOCKING VALUE; Buldu JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019584; Buzsaki Gyorgy, 2012, Dialogues Clin Neurosci, V14, P345; Cai D, 2010, P 16 ACM SIGKDD INT, P333; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Canuet L, 2015, J NEUROSCI, V35, P10325, DOI 10.1523/JNEUROSCI.0704-15.2015; Cohen MX, 2009, J COGNITIVE NEUROSCI, V21, P390, DOI 10.1162/jocn.2008.21020; Cole MW, 2014, NEUROSCIENTIST, V20, P652, DOI 10.1177/1073858414525995; Cuesta P, 2015, J ALZHEIMERS DIS, V44, P493, DOI 10.3233/JAD-141872; de Hemptinne C, 2013, P NATL ACAD SCI USA, V110, P4780, DOI 10.1073/pnas.1214546110; Delbeuck X, 2003, NEUROPSYCHOL REV, V13, P79, DOI 10.1023/A:1023832305702; Dhanjal NS, 2014, ANN NEUROL, V76, P241, DOI 10.1002/ana.24199; Dimitriadis S. I., 2013, 35 ANN INT C IEEE EM; Dimitriadis S. I., 2016, FRONT NEUR C NEUR 20, DOI [10.3389/conf.fninf.2016.20.00006, DOI 10.3389/CONF.FNINF.2016.20.00006]; Dimitriadis S. I., 2016, INT C BIOM BIOMAG 20; Dimitriadis S, 2016, IEEE T NEUR SYS REH, V24, P1017, DOI 10.1109/TNSRE.2016.2516107; Dimitriadis SI, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00694; Dimitriadis SI, 2017, BRAIN CONNECT, V7, P661, DOI 10.1089/brain.2017.0512; Dimitriadis Stavros I, 2016, Alzheimers Dement (N Y), V2, P241, DOI 10.1016/j.trci.2016.08.004; Dimitriadis SI, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00423; Dimitriadis SI, 2017, FRONT NEUROINFORM, V11, DOI 10.3389/fninf.2017.00028; Dimitriadis SI, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00454; Dimitriadis SI, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00163; Dimitriadis SI, 2015, NEUROIMAGE-CLIN, V9, P519, DOI 10.1016/j.nicl.2015.09.011; Dimitriadis SI, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00350; Dimitriadis SI, 2015, ANN BIOMED ENG, V43, P977, DOI 10.1007/s10439-014-1143-0; Dimitriadis SI, 2010, J NEUROSCI METH, V193, P145, DOI 10.1016/j.jneumeth.2010.08.027; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Durschmid S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00635; Lopez ME, 2016, J ALZHEIMERS DIS, V52, P133, DOI 10.3233/JAD-151034; Lopez ME, 2014, J NEUROSCI, V34, P14551, DOI 10.1523/JNEUROSCI.0964-14.2014; Lopez ME, 2014, AGE, V36, P1389, DOI 10.1007/s11357-014-9643-2; Farias ST, 2005, INT J GERIATR PSYCH, V20, P827, DOI 10.1002/gps.1367; FitzGerald THB, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00084; Florin E, 2015, NEUROIMAGE, V111, P26, DOI 10.1016/j.neuroimage.2015.01.054; Alonso JF, 2011, ANN BIOMED ENG, V39, P524, DOI 10.1007/s10439-010-0155-7; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Garces P, 2014, NEUROIMAGE-CLIN, V6, P214, DOI 10.1016/j.nicl.2014.09.004; Gomez C, 2009, IEEE T BIO-MED ENG, V56, P1683, DOI 10.1109/TBME.2009.2018454; Guillon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07846-w; He X, 2005, ADV NEURAL INFORM PR, V18; Hipp JF, 2012, NAT NEUROSCI, V15, P884, DOI 10.1038/nn.3101; Ito J, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00001; Jeong JS, 2004, CLIN NEUROPHYSIOL, V115, P1490, DOI 10.1016/j.clinph.2004.01.001; Jirsa V, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00078; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Koelewijn L, 2017, CLIN NEUROPHYSIOL, V128, P2347, DOI 10.1016/j.clinph.2017.04.018; Koenig T, 2005, NEUROBIOL AGING, V26, P165, DOI 10.1016/j.neurobiolaging.2004.03.008; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lizier JT, 2011, J COMPUT NEUROSCI, V30, P85, DOI 10.1007/s10827-010-0271-2; Lu HP, 2008, IEEE T NEURAL NETWOR, V19, P18, DOI 10.1109/TNN.2007.901277; Maestu F, 2006, NEUROBIOL AGING, V27, P32, DOI 10.1016/j.neurobiolaging.2005.01.005; Maestu F, 2015, NEUROIMAGE-CLIN, V9, P103, DOI 10.1016/j.nicl.2015.07.011; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Moretti DV, 2008, J ALZHEIMERS DIS, V14, P285; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Nakatani C, 2014, J COGNITIVE NEUROSCI, V26, P1168, DOI 10.1162/jocn_a_00540; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nolte G, 2003, PHYS MED BIOL, V48, P3637, DOI 10.1088/0031-9155/48/22/002; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Palva JM, 2018, NEUROIMAGE, V173, P632, DOI 10.1016/j.neuroimage.2018.02.032; Palva JM, 2011, PROG BRAIN RES, V193, P335, DOI 10.1016/B978-0-444-53839-0.00022-3; Papma JM, 2017, EUR RADIOL, V27, P3716, DOI 10.1007/s00330-017-4768-1; Parra MA, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-76; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Pijnenburg YAL, 2004, CLIN NEUROPHYSIOL, V115, P1332, DOI 10.1016/j.clinph.2003.12.029; Pollonini L, 2010, IEEE ENG MED BIO, P1730, DOI 10.1109/IEMBS.2010.5626702; Richiardi J, 2011, NEUROIMAGE, V56, P616, DOI 10.1016/j.neuroimage.2010.05.081; Roffo G., 2017, ARXIV170707538; Roffo G., 2016, ARXIV160701327; Roffo G., 2017, RANKING TO LEARN; Shah Y, 2000, GERIATRICS, V55, P62; Sheffield JM, 2015, NEUROPSYCHOLOGIA, V73, P82, DOI 10.1016/j.neuropsychologia.2015.05.006; Shen X, 2010, NEUROIMAGE, V50, P1027, DOI 10.1016/j.neuroimage.2009.12.119; Song M, 2008, NEUROIMAGE, V41, P1168, DOI 10.1016/j.neuroimage.2008.02.036; Sotero RC, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005180; Sotero RC, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00454; Spaak E, 2012, CURR BIOL, V22, P2313, DOI 10.1016/j.cub.2012.10.020; Stam CJ, 2006, NEUROIMAGE, V32, P1335, DOI 10.1016/j.neuroimage.2006.05.033; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; Szczepanski SM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001936; Takahashi RH, 2010, NEUROBIOL AGING, V31, P1145, DOI 10.1016/j.neurobiolaging.2008.07.021; Taulu S, 2004, BRAIN TOPOGR, V16, P269, DOI 10.1023/b:brat.0000032864.93890.f9; Tewarie P, 2015, NEUROIMAGE, V104, P177, DOI 10.1016/j.neuroimage.2014.10.015; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Wang JH, 2013, BIOL PSYCHIAT, V73, P472, DOI 10.1016/j.biopsych.2012.03.026; Wang SH, 2018, NEUROIMAGE, V173, P610, DOI 10.1016/j.neuroimage.2018.01.056; Yu EY, 2017, CURR ALZHEIMER RES, V14, P628, DOI 10.2174/1567205013666161201201000; Yu MC, 2017, BRAIN, V140, P1466, DOI 10.1093/brain/awx050	106	23	23	1	8	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	JUN 1	2018	12								306	10.3389/fnins.2018.00306			21	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GH8DC	WOS:000433896200001	29910704	Green Published, Green Accepted, gold			2022-02-06	
J	Ringer, FB; Soberay, KA; Rogers, ML; Hagan, CR; Chu, C; Schneider, M; Podlogar, MC; Witte, T; Holm-Denoma, J; Plant, EA; Gutierrez, PM; Joiner, TE				Ringer, Fallon B.; Soberay, Kelly A.; Rogers, Megan L.; Hagan, Christopher R.; Chu, Carol; Schneider, Matt; Podlogar, Matthew C.; Witte, Tracy; Holm-Denoma, Jill; Plant, E. Ashby; Gutierrez, Peter M.; Joiner, Thomas E.			Initial Validation of Brief Measures of Suicide Risk Factors: Common Data Elements Used by the Military Suicide Research Consortium	PSYCHOLOGICAL ASSESSMENT			English	Article						military; risk assessment; suicidal ideation; suicidal behavior; suicide	TRAUMATIC BRAIN-INJURY; INTERPERSONAL-PSYCHOLOGICAL THEORY; PSYCHOMETRIC PROPERTIES; THWARTED BELONGINGNESS; ANXIETY SENSITIVITY; PTSD CHECKLIST; SCREENING TOOL; YOUNG-ADULTS; HOPELESSNESS; IDEATION	The Military Suicide Research Consortium (MSRC) developed a 57-item questionnaire assessing suicide risk factors, referred to as the Common Data Elements (CDEs), in order to facilitate data sharing and improve collaboration across independent studies. All studies funded by MSRC are required to include the CDEs in their assessment protocol. The CDEs include shortened measures of the following: current and past suicide risk, lethality and intent of past suicide attempts, hopelessness, thwarted belongingness, anxiety sensitivity, posttraumatic stress disorder symptoms, traumatic brain injury, insomnia, and alcohol abuse. This study aimed to evaluate the psychometric properties of the CDE items drawn from empirically validated measures. Exploratory factor analysis was used to examine the overall structure of the CDE items, and confirmatory factor analyses were used to evaluate the distinct properties of each scale. Internal consistencies of the CDE scales and correlations with full measures were also examined. Merged data from 3,140 participants (81.0% military service members, 75.6% male) across 19 MSRCfunded studies were used in analyses. Results indicated that all measures exhibited adequate internal consistency, and all CDE shortened measures were significantly correlated with the corresponding full measures with moderate to strong effect sizes. Factor analyses indicated that the shortened CDE measures performed well in comparison with the full measures. Overall, our findings suggest that the CDEs are not only brief but also provide psychometrically valid scores when assessing suicide risk and related factors that may be used in future research.	[Ringer, Fallon B.; Rogers, Megan L.; Hagan, Christopher R.; Chu, Carol; Schneider, Matt; Podlogar, Matthew C.; Plant, E. Ashby; Joiner, Thomas E.] Florida State Univ, Dept Psychol, 1107 West Call St, Tallahassee, FL 32306 USA; [Soberay, Kelly A.; Gutierrez, Peter M.] Denver Vet Affairs Med Ctr, Educ & Clin Ctr, Rocky Mt Mental Illness Res, Denver, CO USA; [Witte, Tracy] Auburn Univ, Dept Psychol, Auburn, AL 36849 USA; [Holm-Denoma, Jill] Univ Denver, Dept Psychol, Denver, CO 80208 USA; [Gutierrez, Peter M.] Univ Colorado, Sch Med, Dept Psychiat, Boulder, CO 80309 USA		Ringer, FB (corresponding author), Florida State Univ, Dept Psychol, 1107 West Call St, Tallahassee, FL 32306 USA.	ringer@psy.fsu.edu	Rogers, Megan/AAC-1894-2021	Rogers, Megan/0000-0002-4969-7035; Ringer, Fallon/0000-0003-1426-6718	Military Suicide Research Consortium; Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-10-2-0181, W81XWH-10-2-0178]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32 MH093311-04]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH093311] Funding Source: NIH RePORTER	This research was supported in part by a grant from the Military Suicide Research Consortium, an effort supported by the Office of the Assistant Secretary of Defense for Health Affairs under Award W81XWH-10-2-0181 and W81XWH-10-2-0178. This research was also supported, in part, by a grant from the National Institute of Mental Health (T32 MH093311-04). Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Military Suicide Research Consortium, the Department of Defense, or the National Institute of Mental Health. We thank the following principal investigators (PIs) who provided the data presented in this article: Michael D. Anestis, PI of the study "Identifying Factors Associated with Future Suicidal Self-Directed Violence within a Sample of Mississippi National Guard Personnel"; Courtney Bagge and Ken Conner, PIs of the study "Warning Signs for Suicide Attempts"; Sean M. Barnes, PI of the study "Behaviorally Assessing Suicide Risk"; Rebecca A. Bernert, PI of the study "A Behavioral Sleep Intervention for the Prevention of Suicidal Behaviors in Military Veterans"; Nigel E. Bush, PI of the studies "Usability and Utility of a Virtual Hope Box (VHB) for Reducing Suicidal Ideation" and "Effectiveness of VHB Smartphone App in Enhancing Veteran's Coping with Suicidal Ideation"; Julie Cerel, PI of the study "Suicide Bereavement in Military and their Families"; Katherine A. Comtois, PI of the study "Military Continuity Project (MCP): A Suicide Prevention Study"; Jesse Cougle, PI of the study "Controlled Evaluation of a Computerized Anger-Reduction Treatment for Suicide Prevention"; Collin Davidson, PI of the study "Longitudinal Assessment of Physical Activity and Suicide Risk"; Peter M. Gutierrez and Thomas E. Joiner, PIs of the study "Toward a Gold Standard for Suicide Risk Assessment for Military Personnel"; Lori Johnson, PI of the study, "Suicide Risk Assessments within Suicide-Specific Group Therapy Treatment for Veterans"; Matthew K. Nock, PI of the study "New Approaches to the Measurement and Modification of Suicide-Related Cognition"; Brad Schmidt, PI of the study "Development and Evaluation of a Brief, Suicide Prevention Intervention Reducing Anxiety Sensitivity"; Gina M. Signoracci, PI of the study "Assessment of Cognitive Functioning as It Relates to Risk for Suicide in Veterans with HIV/AIDS"; and Deborah A. Yurgelun-Todd and Perry Renshaw, PIs of the study "Neuroimaging Correlates of Suicide."	Alcala-Lopez D, 2019, CORTEX, V118, P4, DOI 10.1016/j.cortex.2018.05.006; Anestis MD, 2015, J CLIN PSYCHOL, V71, P1023, DOI 10.1002/jclp.22198; Anestis MD, 2015, COMPR PSYCHIAT, V60, P78, DOI 10.1016/j.comppsych.2015.03.006; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Beck A.T., 1974, DEV SUICIDAL INTENT; Beck A.T., 1988, MANUAL BECK HOPELESS; BECK AT, 1988, J CLIN PSYCHOL, V44, P499, DOI 10.1002/1097-4679(198807)44:4<499::AID-JCLP2270440404>3.0.CO;2-6; BECK AT, 1990, AM J PSYCHIAT, V147, P190; BECK AT, 1985, AM J PSYCHIAT, V142, P559; Beck AT., 1991, MANUAL BECK SCALE SU; BECK RW, 1974, PSYCHOL REP, V34, P445, DOI 10.2466/pr0.1974.34.2.445; Brenner LA, 2013, J HEAD TRAUMA REHAB, V28, P21, DOI 10.1097/HTR.0b013e31827df0b5; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Cavanagh JTO, 2003, PSYCHOL MED, V33, P395, DOI 10.1017/S0033291702006943; Centers for Disease Control and Prevention, 2013, WEB BAS INJ STAT QUE; Chu C, 2016, J CLIN SLEEP MED, V12, P647, DOI 10.5664/jcsm.5784; Coll JE, 2011, SOC WORK HEALTH CARE, V50, P487, DOI 10.1080/00981389.2010.528727; Denneson LM, 2015, SUICIDE LIFE-THREAT, V45, P399, DOI 10.1111/sltb.12136; Gradus JL, 2010, AM J EPIDEMIOL, V171, P721, DOI 10.1093/aje/kwp456; Holma KM, 2010, AM J PSYCHIAT, V167, P801, DOI 10.1176/appi.ajp.2010.09050627; Joiner T.E., 2005, WHY PEOPLE DIE SUICI; Joiner TE, 2005, J ABNORM PSYCHOL, V114, P291, DOI 10.1037/0021-843X.114.2.291; Joiner TE, 2002, BEHAV RES THER, V40, P471, DOI 10.1016/S0005-7967(01)00017-1; Joiner TE, 2016, PSYCHOL REV, V123, P235, DOI 10.1037/rev0000020; Keen SM, 2008, J REHABIL RES DEV, V45, P465, DOI 10.1682/JRRD.2007.09.0138; LeardMann CA, 2013, JAMA-J AM MED ASSOC, V310, P496, DOI 10.1001/jama.2013.65164; LEVY P, 1967, J CLIN PSYCHOL, V23, P84, DOI 10.1002/1097-4679(196701)23:1<84::AID-JCLP2270230123>3.0.CO;2-2; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Meneses-Gaya Carolina de, 2009, Psychol. Neurosci., V2, P83, DOI 10.3922/j.psns.2009.1.12; Metalsky GI, 1997, COGNITIVE THER RES, V21, P359, DOI 10.1023/A:1021882717784; MIECZKOWSKI TA, 1993, SUICIDE LIFE-THREAT, V23, P37; Military Suicide Research Consortium, 2016, MISS AND GOALS; Morin CM, 1993, INSOMNIA PSYCHOL ASS; Mullen, 2008, ELECT J BUSINESS RES, V6, P53, DOI DOI 10.21427/D7CF7R; Muthen LK, 1998, MPLUS USERS GUIDE, V8th; Nock MK, 2013, PSYCHIATRY, V76, P97, DOI 10.1521/psyc.2013.76.2.97; Oglesby ME, 2015, PSYCHIAT RES, V226, P252, DOI 10.1016/j.psychres.2014.12.057; Osman A, 2001, ASSESSMENT, V8, P443, DOI 10.1177/107319110100800409; Pease JL, 2016, SOC WORK, V61, P83, DOI 10.1093/sw/swv050; Pigeon Wilfred R, 2012, J Clin Psychiatry, V73, pe1160, DOI 10.4088/JCP.11r07586; Ramchand R, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0575-z; Ribeiro JD, 2016, PSYCHOL MED, V46, P225, DOI 10.1017/S0033291715001804; Ribeiro JD, 2012, SUICIDE LIFE-THREAT, V42, P405, DOI 10.1111/j.1943-278X.2012.00099.x; Ribeiro JD, 2012, J AFFECT DISORDERS, V136, P743, DOI 10.1016/j.jad.2011.09.049; Schneider B, 2009, ARCH SUICIDE RES, V13, P303, DOI 10.1080/13811110903263191; Smolenski D. J., 2015, DEP DEFENSE SUICIDE; STROSAHL K, 1992, COMPR PSYCHIAT, V33, P366, DOI 10.1016/0010-440X(92)90057-W; Taylor S, 2007, PSYCHOL ASSESSMENT, V19, P176, DOI 10.1037/1040-3590.19.2.176; Van Orden KA, 2008, J CONSULT CLIN PSYCH, V76, P72, DOI 10.1037/0022-006X.76.1.72; Van Orden KA, 2012, PSYCHOL ASSESSMENT, V24, P197, DOI 10.1037/a0025358; Van Orden KA, 2010, PSYCHOL REV, V117, P575, DOI 10.1037/a0018697; Villatte Jennifer L, 2015, Mil Behav Health, V3, P316; Weathers F.W., 1993, ANN M INT SOC TRAUM; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; World Health Organization, 2015, SUICIDE	57	23	23	1	7	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	JUN	2018	30	6					767	778		10.1037/pas0000519			12	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	GH5YS	WOS:000433515100006	29130694	Bronze, Green Accepted			2022-02-06	
J	Faig, J; Haughton, M; Taylor, RC; D'Agostino, RB; Whelen, MJ; Rodriguez, KAP; Bonomi, M; Murea, M; Porosnicu, M				Faig, Jennifer; Haughton, Michael; Taylor, Richard C.; D'Agostino, Ralph B., Jr.; Whelen, Megan J.; Rodriguez, Kori A. Porosnicu; Bonomi, Marcelo; Murea, Mariana; Porosnicu, Mercedes			Retrospective Analysis of Cisplatin Nephrotoxicity in Patients With Head and Neck Cancer Receiving Outpatient Treatment With Concurrent High-dose Cisplatin and Radiotherapy	AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS			English	Article						head and neck cancer; cisplatin; radiotherapy; nephrotoxicity; acute kidney injury; chronic kidney disease	SQUAMOUS-CELL CARCINOMA; LOCALLY ADVANCED HEAD; LUNG-CANCER; RADIATION-THERAPY; CHEMOTHERAPY; MAGNESIUM; HYDRATION; PREVENTION; MANNITOL	Objectives: Cisplatin remains the pivotal chemotherapy in squamous cell carcinoma of the head and neck (SCCHN), with nephrotoxicity considered the dose-limiting toxicity. The purpose of our study was to propose an outpatient high-dose cisplatin protocol aimed at preventing nephrotoxicity and to analyze the results of its utilization in patients with SCCHN treated with concurrent radiotherapy. Materials and Methods: We retrospectively evaluated 82 SCCHN patients treated with outpatient high-dose cisplatin concurrent with radiotherapy at our institution. Acute kidney injury (AKI) and chronic kidney disease were defined by Kidney Disease Improving Global Outcomes criteria. Associated factors were identified using analysis of covariance models for categorical variables and adjusted Pearson correlations for continuous variables. Results: The incidence of AKI during treatment was 34.2%. With a median follow-up of 25.7 months, the average decrease in estimated glomerular filtration rate was 12.57 mL/min/1.73 m(2) (SD=18.58). At 1 year and at last follow-up, 5.4% and 4.4% of patients had estimated glomerular filtration rate <60 mL/min/1.73 m(2). Predictors associated with AKI and chronic kidney disease were: lower baseline weight and creatinine, higher baseline creatinine clearance, smoking, female sex, African American race, hypertension, and increased hydration and magnesium replacement requirements. Conclusions: We encountered limited early and late nephrotoxicity. Importantly, nephrotoxicity was not the main dose-limiting toxicity. Our results emphasize the importance of close monitoring and additional replacement of water and electrolytes as needed. A consistent method of measuring and reporting chemotherapy-induced nephrotoxicity would be a valuable contribution to the literature.	[Faig, Jennifer] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Rodriguez, Kori A. Porosnicu] Wake Forest Sch Med, Med Ctr Blvd, Winston Salem, NC USA; [Haughton, Michael; Bonomi, Marcelo; Porosnicu, Mercedes] Wake Forest Sch Med, Dept Internal Med, Sect Hematol & Oncol, Med Ctr Blvd, Winston Salem, NC USA; [Taylor, Richard C.] Wake Forest Sch Med, Dept Internal Med, Med Ctr Blvd, Winston Salem, NC USA; [Murea, Mariana] Wake Forest Sch Med, Dept Nephrol, Med Ctr Blvd, Winston Salem, NC USA; [D'Agostino, Ralph B., Jr.] Wake Forest Univ Hlth Sci, Div Publ Hlth Sci, Dept Biostat Sci, Med Ctr Blvd, Winston Salem, NC USA; [Whelen, Megan J.] Wake Forest Univ, Comprehens Canc Ctr, Med Ctr Blvd, Winston Salem, NC 27109 USA; [Faig, Jennifer] Icahn Sch Med Mt Sinai, One Gustave L Levy Pl, New York, NY 10029 USA; [Rodriguez, Kori A. Porosnicu] Columbia Univ, 116th St & Broadway, New York, NY 10027 USA		Porosnicu, M (corresponding author), Med Ctr Blvd, Winston Salem, NC 27157 USA.	mporosni@wakehealth.edu	porosnicu, mercedes/N-5745-2019	Porosnicu Rodriguez, Kori/0000-0003-3770-1479	Comprehensive Cancer Center of Wake Forest University NCI CCSG [P30CA012197]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA012197] Funding Source: NIH RePORTER	Biostatistical services supported by the Comprehensive Cancer Center of Wake Forest University NCI CCSG P30CA012197 grant.	Adelstein DJ, 2003, J CLIN ONCOL, V21, P92, DOI 10.1200/JCO.2003.01.008; Ali BH, 2006, FOOD CHEM TOXICOL, V44, P1173, DOI 10.1016/j.fct.2006.01.013; Bernier J, 2004, NEW ENGL J MED, V350, P1945, DOI 10.1056/NEJMoa032641; Bodnar L, 2008, EUR J CANCER, V44, P2608, DOI 10.1016/j.ejca.2008.08.005; Cooper JS, 2012, INT J RADIAT ONCOL, V84, P1198, DOI 10.1016/j.ijrobp.2012.05.008; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; Cubillo A, 2001, AM J CLIN ONCOL-CANC, V24, P192, DOI 10.1097/00000421-200104000-00018; Espeli V, 2012, ORAL ONCOL, V48, P266, DOI 10.1016/j.oraloncology.2011.10.005; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Fujieda M, 2011, HUM EXP TOXICOL, V30, P603, DOI 10.1177/0960327110376551; Furukawa N, 2012, EUR J CANCER CARE, V21, P436, DOI 10.1111/j.1365-2354.2011.01284.x; Goren MP, 2003, MED PEDIATR ONCOL, V41, P186, DOI 10.1002/mpo.10335; dos Santos NAG, 2012, ARCH TOXICOL, V86, P1233, DOI 10.1007/s00204-012-0821-7; Hanigan MH, 2005, AM J PHYSIOL-RENAL, V288, pF125, DOI 10.1152/ajprenal.00041.2003; HANSEN SW, 1988, J CLIN ONCOL, V6, P1728, DOI 10.1200/JCO.1988.6.11.1728; Hartmann JT, 1999, INT J CANCER, V83, P866, DOI 10.1002/(SICI)1097-0215(19991210)83:6<866::AID-IJC34>3.3.CO;2-0; Hotta K, 2013, JPN J CLIN ONCOL, V43, P1115, DOI 10.1093/jjco/hyt128; Lajer H, 2005, CANCER CHEMOTH PHARM, V56, P535, DOI 10.1007/s00280-005-1010-7; Launay-Vacher V, 2008, CANCER CHEMOTH PHARM, V61, P903, DOI 10.1007/s00280-008-0711-0; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Lin A, 2005, INT J RADIAT ONCOL, V63, P1413, DOI 10.1016/j.ijrobp.2005.05.012; LOEHRER PJ, 1984, ANN INTERN MED, V100, P704, DOI 10.7326/0003-4819-100-5-704; Mathe C, 2011, EUR RESPIR J, V37, P888, DOI 10.1183/09031936.00055110; Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490; Morgan KP, 2012, ANN PHARMACOTHER, V46, P276, DOI 10.1345/aph.1Q333; Okusa MD, 2014, KIDNEY INT, V85, P39, DOI 10.1038/ki.2013.378; Polycarpe E, 2004, INT J CANCER, V111, P131, DOI 10.1002/ijc.20202; Razzaque MS, 2007, NEPHROL DIAL TRANSPL, V22, P2112, DOI 10.1093/ndt/gfm378; Saleh S, 2009, CHEMOTHERAPY, V55, P399, DOI 10.1159/000262453; Santoso JT, 2003, CANCER CHEMOTH PHARM, V52, P13, DOI 10.1007/s00280-003-0620-1; SCHILSKY RL, 1982, CANCER TREAT REP, V66, P1767; Shord SS, 2006, ANTI-CANCER DRUG, V17, P207, DOI 10.1097/00001813-200602000-00013; Tiseo M, 2007, TUMORI, V93, P138	34	23	25	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0277-3732	1537-453X		AM J CLIN ONCOL-CANC	Am. J. Clin. Oncol.-Cancer Clin. Trials	MAY	2018	41	5					432	440		10.1097/COC.0000000000000301			9	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	GE3HI	WOS:000431104000002	27281266	Green Accepted			2022-02-06	
J	Gao, Y; Zhang, MY; Wang, T; Fan, YY; Yu, LS; Ye, GH; Wang, ZF; Gao, C; Wang, HC; Luo, CL; Tao, LY				Gao, Yuan; Zhang, Ming-yang; Wang, Tao; Fan, Yan-yan; Yu, Lin-sheng; Ye, Guang-hua; Wang, Zu-feng; Gao, Cheng; Wang, Hao-chen; Luo, Cheng-liang; Tao, Lu-yang			IL-33/ST2L Signaling Provides Neuroprotection Through Inhibiting Autophagy, Endoplasmic Reticulum Stress, and Apoptosis in a Mouse Model of Traumatic Brain Injury	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						autophagy; endoplasmic reticulum (ER) stress; IL-33-ST2L signaling; neurobehavioral deficits; traumatic brain injury	INDUCED CELL-DEATH; IMMUNE-RESPONSE; UP-REGULATION; RECEPTOR ST2; ER STRESS; INTERLEUKIN-33; MITOCHONDRIAL; MICE; MICROGLIA/MACROPHAGES; CONTRIBUTES	Interleukin-33 (IL-33) is a member of the interleukin-1 (IL-1) cytokine family and an extracellular ligand for the orphan IL-1 receptor ST2. Accumulated evidence shows that the IL-33/ST2 axis plays a crucial role in the pathogenesis of central nervous system (CNS) diseases and injury, including traumatic brain injury (TBI). However, the roles and molecular mechanisms of the IL-33/ST2 axis after TBI remain poorly understood. In this study, we investigated the role of IL-33/ST2 signaling in mouse TBI-induced brain edema and neurobehavioral deficits, and further exploited underlying mechanisms, using salubrinal (SAL), the endoplasmic reticulum (ER) stress inhibitor and anti-ST2L. The increase in IL-33 level and the decrease in ST2L level at injured cortex were first observed at 24 h post-TBI. By immunofluorescent double-labeled staining, IL-33 co-localized in GFAP-positive astrocytes, and Olig-2-positive oligodendrocytes, and predominantly presented in their nucleus. Additionally, TBI-induced brain water content, motor function outcome, and spatial learning and memory deficits were alleviated by IL-33 treatment. Moreover, IL-33 and SAL alone, or their combination prevented TBI-induced the increase of IL-1 beta and TNF-alpha levels, suppressed the up-regulation of ER stress, apoptosis and autophagy after TBI. However, anti-ST2L treatment could significantly invert the above effects of IL-33. Together, these data demonstrate that IL-33/ST2 signaling mitigates TBI-induced brain edema, motor function outcome, spatial learning and memory deficits, at least in part, by a mechanism involving suppressing autophagy, ER stress, apoptosis and neuroinflammation.	[Gao, Yuan; Zhang, Ming-yang; Wang, Tao; Wang, Zu-feng; Gao, Cheng; Wang, Hao-chen; Luo, Cheng-liang; Tao, Lu-yang] Soochow Univ, Med Sch, Dept Forens Sci, Suzhou, Peoples R China; [Gao, Yuan; Fan, Yan-yan; Yu, Lin-sheng; Ye, Guang-hua] Wenzhou Med Univ, Dept Forens Sci, Wenzhou, Peoples R China		Luo, CL; Tao, LY (corresponding author), Soochow Univ, Med Sch, Dept Forens Sci, Suzhou, Peoples R China.	clluo@suda.edu.cn; taoluyang@suda.edu.cn	Mingyang, Zhang/J-7412-2019	Mingyang, Zhang/0000-0001-7084-6237	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81530062, 81373251, 81400999, 81601643, 81601306, 81301039]; National High Technology Research and Development Program of China (863 Program)National High Technology Research and Development Program of China [2015AA020503]; Shanghai Key Lab of Forensic Medicine [KF1805, KF1801, KF1701]; Wenzhou Medical University Research Development Fund [89218004]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by Grant Nos. 81530062, 81373251, 81400999, 81601643, 81601306 and 81301039 from the National Natural Science Foundation of China, National High Technology Research and Development Program of China (863 Program, No. 2015AA020503), Shanghai Key Lab of Forensic Medicine (No. KF1805, KF1801 and KF1701), Wenzhou Medical University Research Development Fund (No. 89218004) and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Adhami F, 2007, AUTOPHAGY, V3, P42, DOI 10.4161/auto.3412; Allan D, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0344-1; Balduini W, 2009, AUTOPHAGY, V5, P221, DOI 10.4161/auto.5.2.7363; Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Blixt J, 2018, J NEUROTRAUM, V35, P671, DOI 10.1089/neu.2017.5015; Chandran R, 2018, J CEREBR BLOOD F MET, V38, P1818, DOI 10.1177/0271678X17738701; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Decuypere Jean-Paul, 2012, Cells, V1, P284, DOI 10.3390/cells1030284; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Erlich S, 2007, AUTOPHAGY, V3, P561, DOI 10.4161/auto.4713; Erlich S, 2006, AUTOPHAGY, V2, P49, DOI 10.4161/auto.2156; Gadani SP, 2015, NEURON, V85, P703, DOI 10.1016/j.neuron.2015.01.013; Gao Y, 2017, MOL NEUROBIOL, V54, P3879, DOI 10.1007/s12035-016-9947-6; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Gu YQ, 2016, EXP THER MED, V12, P3767, DOI 10.3892/etm.2016.3821; Harvey LD, 2015, ASN NEURO, V7, DOI 10.1177/1759091415618969; Huang LT, 2015, CELL MOL NEUROBIOL, V35, P493, DOI 10.1007/s10571-014-0143-9; Jafarzadeh Abdollah, 2016, Oman Med J, V31, P40, DOI 10.5001/omj.2016.08; Jin YC, 2015, WORLD NEUROSURG, V84, P420, DOI 10.1016/j.wneu.2015.03.039; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Lee JY, 2012, BRAIN, V135, P2375, DOI 10.1093/brain/aws171; Lee WS, 2015, CURR MOL MED, V15, P735, DOI 10.2174/1566524015666150921105453; Lin L, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.985913; Logsdon AF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00421; Longhi-Balbinot DT, 2016, CHEM-BIOL INTERACT, V256, P1, DOI 10.1016/j.cbi.2016.06.009; Lucke-Wold BP, 2015, SEIZURE-EUR J EPILEP, V33, P13, DOI 10.1016/j.seizure.2015.10.002; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luo CL, 2013, J NEUROTRAUM, V30, P597, DOI 10.1089/neu.2012.2425; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Manetti M, 2010, ANN RHEUM DIS, V69, P598, DOI 10.1136/ard.2009.119321; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; Messer JS, 2017, CELL MOL LIFE SCI, V74, P1281, DOI 10.1007/s00018-016-2403-y; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Molofsky AB, 2015, IMMUNITY, V42, P1005, DOI DOI 10.1016/j.immuni.2015.06.006; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Nakka VP, 2016, MOL NEUROBIOL, V53, P532, DOI 10.1007/s12035-014-9029-6; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Pozuelo-Rubio M, 2011, AUTOPHAGY, V7, P240, DOI 10.4161/auto.7.2.14286; Rubinszfein DC, 2005, AUTOPHAGY, V1, P11, DOI 10.4161/auto.1.1.1513; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Santopietro John, 2015, N C Med J, V76, P96; Schiavone S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09202-4; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Wang J, 2017, FREE RADICAL BIO MED, V113, P119, DOI 10.1016/j.freeradbiomed.2017.09.017; Wicher G, 2017, J NEUROTRAUM, V34, P3173, DOI 10.1089/neu.2016.4900; Xiong Z, 2014, J ALZHEIMERS DIS, V40, P297, DOI 10.3233/JAD-132081; Yasuoka S, 2011, BRAIN RES, V1385, P8, DOI 10.1016/j.brainres.2011.02.045; Zhang J, 2008, AUTOPHAGY, V4, P354, DOI 10.4161/auto.5552; Zhang MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087241	57	23	24	2	9	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	APR 25	2018	12								95	10.3389/fncel.2018.00095			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GD9IH	WOS:000430825900001	29922130	gold, Green Published			2022-02-06	
J	Dijkland, SA; Voormolen, DC; Venema, E; Roozenbeek, B; Polinder, S; Haagsma, JA; Nieboer, D; Chalos, V; Yoo, AJ; Schreuders, J; van der Lugt, A; Majoie, CBLM; Roos, YBWEM; van Zwam, WH; van Oostenbrugge, RJ; Steyerberg, EW; Dippel, DWJ; Lingsma, HF				Dijkland, Simone A.; Voormolen, Daphne C.; Venema, Esmee; Roozenbeek, Bob; Polinder, Suzanne; Haagsma, Juanita A.; Nieboer, Daan; Chalos, Vicky; Yoo, Albert J.; Schreuders, Jennifer; van der Lugt, Aad; Majoie, Charles B. L. M.; Roos, Yvo B. W. E. M.; van Zwam, Wim H.; van Oostenbrugge, Robert J.; Steyerberg, Ewout W.; Dippel, Diederik W. J.; Lingsma, Hester F.		MR CLEAN Investigators	Utility-Weighted Modified Rankin Scale as Primary Outcome in Stroke Trials A Simulation Study	STROKE			English	Article						brain ischemia; odds ratio; quality of life; self-report; stroke	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; INTRAARTERIAL TREATMENT; HEALTH STATES; DUTCH	Background and Purpose-The utility-weighted modified Rankin Scale (UW-mRS) has been proposed as a new patient-centered primary outcome in stroke trials. We aimed to describe utility weights for the mRS health states and to evaluate the statistical efficiency of the UW-mRS to detect treatment effects in stroke intervention trials. Methods-We used data of the 500 patients enrolled in the MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands). Utility values were elicited from the EuroQol Group 5-Dimension Self-Report Questionnaire assessed at 90 days after inclusion, simultaneously with the mRS. Utility weights were determined by averaging the utilities of all patients within each mRS category. We performed simulations to evaluate statistical efficiency. The simulated treatment effect was an odds ratio of 1.65 in favor of the treatment arm, similar for all mRS cutoffs. This treatment effect was analyzed using 3 approaches: linear regression with the UW-mRS as outcome, binary logistic regression with a dichotomized mRS (0-1/2-6, 0-2/3-6, and 0-4/5-6), and proportional odds logistic regression with the ordinal mRS. The statistical power of the 3 approaches was expressed as the proportion of 10 000 simulations that resulted in a statistically significant treatment effect (P <= 0.05). Results-The mean utility values (SD) for mRS categories 0 to 6 were: 0.95 (0.08), 0.93 (0.13), 0.83 (0.21), 0.62 (0.27), 0.42 (0.28), 0.11 (0.28), and 0 (0), respectively, but varied substantially between individual patients within each category. The UW-mRS approach was more efficient than the dichotomous approach (power 85% versus 71%) but less efficient than the ordinal approach (power 85% versus 87%). Conclusions-The UW-mRS as primary outcome does not capture individual variation in utility values and may reduce the statistical power of a randomized trial.	[Dijkland, Simone A.; Voormolen, Daphne C.; Venema, Esmee; Polinder, Suzanne; Haagsma, Juanita A.; Nieboer, Daan; Chalos, Vicky; Steyerberg, Ewout W.; Lingsma, Hester F.] Erasmus MC Univ, Med Ctr, Dept Publ Hlth, Room Na2424,POB 2040, NL-3000 CA Rotterdam, Netherlands; [Venema, Esmee; Roozenbeek, Bob; Chalos, Vicky; Schreuders, Jennifer; Dippel, Diederik W. J.] Erasmus MC Univ, Med Ctr, Dept Neurol, Rotterdam, Netherlands; [Roozenbeek, Bob; Chalos, Vicky; van der Lugt, Aad] Erasmus MC Univ, Med Ctr, Dept Radiol, Rotterdam, Netherlands; [Yoo, Albert J.] Texas Stroke Inst, Div Neurointervent, Dallas, TX USA; [Schreuders, Jennifer] Elisabeth TweeSteden Hosp, Dept Neurol, Tilburg, Netherlands; [Majoie, Charles B. L. M.] Acad Med Ctr, Dept Radiol, Amsterdam, Netherlands; [Roos, Yvo B. W. E. M.] Acad Med Ctr, Dept Neurol, Amsterdam, Netherlands; [van Zwam, Wim H.] Maastricht Univ, Med Ctr, Dept Radiol, Maastricht, Netherlands; [van Oostenbrugge, Robert J.] Maastricht Univ, Med Ctr, Dept Neurol, Cardiovasc Res Inst, Maastricht, Netherlands; [Steyerberg, Ewout W.] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands		Dijkland, SA (corresponding author), Erasmus MC Univ, Med Ctr, Dept Publ Hlth, Room Na2424,POB 2040, NL-3000 CA Rotterdam, Netherlands.	s.dijkland@erasmusmc.nl	Dippel, Diederik/AAJ-2192-2020; Roos, Yvo BWEM/B-9843-2013	Dippel, Diederik/0000-0002-9234-3515; Venema, Esmee/0000-0003-1631-6635; Majoie, Charles/0000-0002-7600-9568	Dutch Heart FoundationNetherlands Heart Foundation [ISRCTNI0888758]; AngioCare BV; Medtronic/Covidien/EV3; MEDAC Gmbh/LAMEPRO; Penumbra, Inc; Top Medical/Concentric	The MR CLEAN trial (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands) (International Standard Randomised Controlled Trial Number registry: ISRCTNI0888758) was partly funded by the Dutch Heart Foundation and by unrestricted grants from AngioCare BV, Medtronic/Covidien/EV3, MEDAC Gmbh/LAMEPRO, Penumbra, Inc, and Top Medical/Concentric. The funding sources had no role in the study design and conduct; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Ali M, 2013, STROKE, V44, P3161, DOI 10.1161/STROKEAHA.113.001126; Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Bath PMW, 2007, STROKE, V38, P1911, DOI 10.1161/STROKEAHA.106.474080; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Broderick JP, 2017, STROKE, V48, P2007, DOI 10.1161/STROKEAHA.117.017866; Carod-Artal FJ, 2009, CEREBROVASC DIS, V27, P204, DOI 10.1159/000200461; Chaisinanunkul N, 2015, STROKE, V46, P2238, DOI 10.1161/STROKEAHA.114.008547; Cnossen MC, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0641-9; Gershon RC, 2012, QUAL LIFE RES, V21, P475, DOI 10.1007/s11136-011-9958-8; Harrison JK, 2013, CLIN INTERV AGING, V8, P201, DOI 10.2147/CIA.S32405; HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2; Kapoor A, 2017, STROKE, V48, P1688, DOI 10.1161/STROKEAHA.117.016728; Lamers LM, 2006, HEALTH ECON, V15, P1121, DOI 10.1002/hec.1124; Lees KR, 2016, STROKE, V47, P2154, DOI 10.1161/STROKEAHA.116.012966; Lees KR, 2012, STROKE, V43, P1163, DOI 10.1161/STROKEAHA.111.641423; McHugh GS, 2010, CLIN TRIALS, V7, P44, DOI 10.1177/1740774509356580; Nogueira RG, 2018, NEW ENGL J MED, V378, P11, DOI 10.1056/NEJMoa1706442; PATRICK DL, 1994, MED DECIS MAKING, V14, P9, DOI 10.1177/0272989X9401400102; Post PN, 2001, STROKE, V32, P1425, DOI 10.1161/01.STR.32.6.1425; Prieto Luis, 2003, Health Qual Life Outcomes, V1, P80, DOI 10.1186/1477-7525-1-80; Quinn TJ, 2009, STROKE, V40, P3393, DOI [10.1161/STROKEAHA.108.522516, 10.1161/STROKEAHA.109.557256]; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Saver JL, 2011, STROKE, V42, P2356, DOI 10.1161/STROKEAHA.111.619122; Schreuders J, 2017, INT J STROKE, V12, P708, DOI 10.1177/1747493017706244; Senn S, 2009, STAT MED, V28, P3189, DOI 10.1002/sim.3603; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	27	23	23	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	APR	2018	49	4					965	+		10.1161/STROKEAHA.117.020194			11	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Cardiovascular System & Cardiology	GB6BW	WOS:000429153900037	29535271	Green Published, hybrid			2022-02-06	
J	Heimesaat, MM; Giladi, E; Kuhl, AA; Bereswill, S; Gozes, I				Heimesaat, Markus M.; Giladi, Eliezer; Kuehl, Anja A.; Bereswill, Stefan; Gozes, Illana			The octapetide NAP alleviates intestinal and extra-intestinal anti-inflammatory sequelae of acute experimental colitis	PEPTIDES			English	Article						NAP; Activity-dependent neuroprotective protein (ADNP); Acute colitis; Anti-inflammatory effects; Immunomodulatory properties; Bifidobacteria; Gut-brain axis	DEPENDENT NEUROPROTECTIVE PROTEIN; INFLAMMATORY-BOWEL-DISEASE; CAMPYLOBACTER-JEJUNI INFECTION; CLOSED-HEAD INJURY; TOXOPLASMA-GONDII; PEPTIDE; MICE; MODEL; MICROBIOTA; IMMUNOPATHOLOGY	The octapeptide NAP has been shown to exert neuroprotective properties and reduce neuro-inflammatory responses. The aim of the present study was to investigate if NAP provides anti-inflammatory effects in acute murine colitis. To address this, C57BL/6 j mice were challenged with 3.5% dextran sulfate sodium from day 0 until day 6 to induce colitis, either treated intraperitoneally with NAP or placebo (NaCl 0.9%) from day 1 until day 6 post-induction (p.i.) and subjected to in depth macroscopic, microscopic and immunological evaluations. Whereas NAP application did not alleviate macroscopic (i.e. clinical) sequelae of colitis, lower numbers of apoptotic, but higher counts of proliferating/regenerating colonic epithelial cells could be observed in NAP as compared to placebo treated mice at day 7 p.i. Furthermore, lower numbers of adaptive immune cells such as T lymphocytes and regulatory T cells were abundant in the colonic mucosa and lamina propria upon NAP versus placebo treatment that were accompanied by less colonic secretion of pro-inflammatory mediators including IFN-gamma and nitric oxide at day 7 p.i. In mesenteric lymph nodes, pro-inflammatory IFN-gamma, TNF and IL-6 concentrations were increased in placebo, but not NAP treated mice at day 7 p.i., whereas interestingly, elevated anti-inflammatory IL-10 levels could be observed in NAP treated mice only. The assessed anti-inflammatory properties of NAP were not restricted to the intestinal tract, given that in extra-intestinal compartments such as the kidneys, IFN-gamma levels increased in placebo, but not NAP treated mice upon colitis induction. NAP induced effects were accompanied by distinct changes in intestinal microbiota composition, given that colonic luminal loads of bifidobacteria, regarded as anti-inflammatory, "health-promoting" commensal species, were two orders of magnitude higher in NAP as compared to placebo treated mice and even naive controls. In conclusion, NAP alleviates intestinal and extra-intestinal pro-inflammatory sequelae of acute experimental colitis and may provide novel treatment options of intestinal inflammatory diseases in humans.	[Heimesaat, Markus M.; Bereswill, Stefan] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Dept Microbiol & Hyg, Berlin, Germany; [Heimesaat, Markus M.; Bereswill, Stefan] Berlin Inst Hlth, Berlin, Germany; [Giladi, Eliezer; Gozes, Illana] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, Tel Aviv, Israel; [Kuehl, Anja A.] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Dept Med Gastroenterol Infect Dis & Rheumatol 1,R, Berlin, Germany		Heimesaat, MM (corresponding author), Charite Univ Med Berlin, CC5, Dept Microbiol & Hyg, Campus Benjamin Franklin,FEM,Garystr 5, D-14195 Berlin, Germany.	markus.heimesaat@charite.de		Kuhl, Anja/0000-0003-2293-5387; Heimesaat, Markus/0000-0001-6399-651X	German Research Foundation (DFG)German Research Foundation (DFG) [SFB633]; German Federal Ministeries of Education and Research (BMBF) [PAC-Campy 01KI1725D]	This work was supported by grants from the German Research Foundation (DFG) to SB (SFB633, TP A7), AAK (SFB633, TP Z1), MMH (SFB633, TP B6) and from the German Federal Ministeries of Education and Research (BMBF) to SB and MMH (PAC-Campy 01KI1725D).	Alutis ME, 2015, EUR J MICROBIOL IMMU, V5, P256, DOI 10.1556/1886.2015.00033; ALUTIS ME, 2015, EUR J MICROBIOL IMMU, V5, P3; Ashur-Fabian O, 2003, PEPTIDES, V24, P1413, DOI 10.1016/j.peptides.2003.08.005; BASSAN M, 1999, PUBMED; BASSET C, 2002, PUBMED; BENIADANI L, 2001, PUBMED; BERESWILL S, 1921, PUBMED, DOI DOI 10.1186/1757-4749-6-19; BERESWILL S, 2011, PUBMED, DOI DOI 10.1371/J0URNAL.P0NE.0020953; BERESWILL S, 1942, PUBMED, DOI DOI 10.1371/J0URNAL.P0NE.0015099; BRAITCH M, 1959, PUBMED, DOI DOI 10.1159/000258695; BRYAN NS, 2007, PUBMED, DOI DOI 10.1016/J.FREERADBI0MED.2007.04.026; Chassaing B., 2014, PUBMED, V104; DIVINSKI I, 1974, PUBMED, DOI DOI 10.1074/JBC.M403197200; EKMEKCIU I, 1953, PUBMED, DOI DOI 10.1186/S13099-017-0168-Y; Ekmekciu I, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00167; Ekmekciu I, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00397; ERBEN U, 2014, PUBMED; ERRIDGE C, 1936, PUBMED, DOI DOI 10.1371/J0URNAL.P0NE.0009125; Fiebiger U, 2016, EUR J MICROBIOL IMMU, V6, P253, DOI 10.1556/1886.2016.00036; Gozes I, 2004, J ALZHEIMERS DIS, V6, pS37; Gozes Illana, 2005, Current Alzheimer Research, V2, P149, DOI 10.2174/1567205053585873; Greggio S, 2011, NEUROBIOL DIS, V44, P152, DOI 10.1016/j.nbd.2011.06.018; Haag L.M., 2012, PUBMED, V7; Haag L.M., 2012, PUBMED, V7, DOI DOI 10.1002/0471142735.IM1525S104; HAAG LM, 2012, PUBMED, DOI DOI 10.1371/J0URNAL.P0NE.0035988; HAAG LM, 1961, PUBMED, DOI DOI 10.1371/J0URNAL.P0NE.0040761; Heimesaat M.M., 2012, PUBMED, V7; Heimesaat MM, 2015, EUR J MICROBIOL IMMU, V5, P210, DOI 10.1556/1886.2015.00025; Heimesaat MM, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00077; Heimesaat MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040758; Heimesaat MM, 2010, GUT, V59, P1079, DOI 10.1136/gut.2009.197434; HEIMESAAT MM, 1985, PUBMED; HEIMESAAT MM, 1920, PUBMED, DOI DOI 10.1371/J0URNAL.P0NE.0105120; HEIMESAAT MM, 2007, PUBMED, DOI DOI 10.1371/J0URNAL.P0NE.0000662; HEIMESAAT MM, 2006, PUBMED, DOI DOI 10.1136/GUT.2006.104497; Herrlinger KR, 2001, ALIMENT PHARM THER, V15, P363, DOI 10.1046/j.1365-2036.2001.00940.x; Idan-Feldman A, 2011, NEUROBIOL DIS, V44, P327, DOI 10.1016/j.nbd.2011.06.020; IDANFELDMAN A, 2012, PUBMED, DOI DOI 10.1155/2012/493670; IVASHKOPACHIMA Y, 2016, PUBMED, DOI DOI 10.1038/MP.2016.255; Klijn A, 2005, FEMS MICROBIOL REV, V29, P491, DOI 10.1016/j.femsre.2005.04.010; KREISEL W, 1996, PUBMED; Leker RR, 2002, STROKE, V33, P1085, DOI 10.1161/01.STR.0000014207.05597.D7; MUNOZ M, 2010, PUBMED, DOI DOI 10.1111/J.1600-065X.2010.00992.X; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; Oz S, 2014, MOL PSYCHIATR, V19, P1115, DOI 10.1038/mp.2014.97; PODOLSKY D, 2002, NEW ENGL J MED, V347, P6; POKUSAEVA K, 1985, PUBMED, DOI DOI 10.1111/NM0.12904; PUBMEDPMID JPET, 1998, PUBMED; PUBMEDPMID JPET, 1971, PUBMED; PUBMEDPMID JPET, 2001, PUBMED, V28; PUBMEDPMID JPET, 1931, PUBMED; PUBMEDPMID JPET, 2009, PUBMED; QUINTANA FJ, 1969, PUBMED, DOI DOI 10.1196/ANNALS.1317.069; RANGANATHAN P, 2012, PUBMED, DOI DOI 10.1152/AJPRENAL.00702.2012; RAUSCH S, 1952, PUBMED, DOI DOI 10.1371/J0URNAL.P0NE.0074026; Rotstein M, 2006, J PHARMACOL EXP THER, V319, P332, DOI 10.1124/jpet.106.106898; SARTOR RB, 2010, PUBMED, DOI DOI 10.1053/J.GASTR0.2010.10.036; SARTOR RB, 2005, PUBMED, DOI DOI 10.1073/PNAS.0809363105; SARTOR RB, 2007, PUBMED, DOI DOI 10.1053/J.GASTR0.2007.11.059; SARTOR RB, 1995, PUBMED; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SIEGMUND B, 2001, PUBMED; SOKOLOWSKA P, 2010, PUBMED, DOI DOI 10.1016/J.NEUR0SCIENCE.2010.10.074; STROBER W, 2016, PUBMED, DOI DOI 10.1146/ANNUREV.IMMUN0L.20.100301.064816; THOENEREINEKE C, 2006, PUBMED, DOI DOI 10.1371/J0URNAL.P0NE.0113406; TOJO R, 1966, PUBMED, DOI DOI 10.3748/WJG.V20.I41.15163; Zaltzman R, 2005, PEPTIDES, V26, P1520, DOI 10.1016/j.peptides.2005.03.014; ZAMOSTIANO R, 2000, PUBMED, DOI DOI 10.1074/JBC.M007416200; ZEMLYAK I, 2000, PUBMED, V1, P39; Zucker S, 2000, ONCOGENE, V19, P6642, DOI 10.1038/sj.onc.1204097	70	23	23	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	MAR	2018	101						1	9		10.1016/j.peptides.2017.12.023			9	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	FX9ST	WOS:000426446000001	29288684	hybrid			2022-02-06	
J	Mauri, E; Sacchetti, A; Vicario, N; Peruzzotti-Jametti, L; Rossi, F; Pluchino, S				Mauri, Emanuele; Sacchetti, Alessandro; Vicario, Nunzio; Peruzzotti-Jametti, Luca; Rossi, Filippo; Pluchino, Stefano			Evaluation of RGD functionalization in hybrid hydrogels as 3D neural stem cell culture systems	BIOMATERIALS SCIENCE			English	Article							SPINAL-CORD-INJURY; TISSUE ENGINEERING APPLICATIONS; CENTRAL-NERVOUS-SYSTEM; DRUG-DELIVERY; IN-VITRO; CLICK CHEMISTRY; BIOMATERIALS; REGENERATION; THERAPIES; DIFFERENTIATION	The use of neural stem cells (NSCs) in cell therapy has become a powerful tool used for the treatment of central nervous system diseases, including traumatic brain and spinal cord injuries. However, a significant drawback is related to the limited viability after transplantation in situ. The design of three-dimensional (3D) scaffolds that are capable of resembling the architecture and physico-chemical features of an extracellular environment could be a suitable approach to improve cell survival and preserve their cellular active phase over time. In this study, we investigated NSC adhesion and proliferation in hydrogel systems. In particular, we evaluated the effect of RGD binding domains on cell fate within the polymeric scaffold. The introduction of a tripeptide via hydrogel chemical functionalization improved the percentage of proliferating cells until 8 days after seeding when compared to the unmodified scaffold. The beneficial effects of this 3D culture system was further evident when compared to a NSC monolayer (2D) culture, resulting in an approximately 40% increase in cells in the active phases at 4 and 8 days, and maintained a difference of 25% until 21 days after seeding.	[Mauri, Emanuele; Sacchetti, Alessandro; Rossi, Filippo] Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, Via Mancinelli 7, I-20131 Milan, Italy; [Vicario, Nunzio; Peruzzotti-Jametti, Luca; Pluchino, Stefano] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Dept Clin Neurosci, Div Stem Cell Neurobiol, Clifford Allbutt Bldg,Cambridge Biosci Campus, Cambridge CB2 0HA, England; [Vicario, Nunzio; Peruzzotti-Jametti, Luca; Pluchino, Stefano] Univ Cambridge, NIHR Biomed Res Ctr, Clifford Allbutt Bldg,Cambridge Biosci Campus, Cambridge CB2 0HA, England		Mauri, E (corresponding author), Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, Via Mancinelli 7, I-20131 Milan, Italy.; Pluchino, S (corresponding author), Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Dept Clin Neurosci, Div Stem Cell Neurobiol, Clifford Allbutt Bldg,Cambridge Biosci Campus, Cambridge CB2 0HA, England.; Pluchino, S (corresponding author), Univ Cambridge, NIHR Biomed Res Ctr, Clifford Allbutt Bldg,Cambridge Biosci Campus, Cambridge CB2 0HA, England.	emanuele.mauri@polimi.it; spp24@cam.ac.uk	Vicario, Nunzio/AAJ-4917-2020; Pluchino, Stefano/AAE-9037-2019; Vicario, Nunzio/AAY-3489-2021; Rossi, Filippo/D-3679-2013; Mauri, Emanuele/B-7674-2018	Vicario, Nunzio/0000-0001-5934-3962; Pluchino, Stefano/0000-0002-6267-9472; Rossi, Filippo/0000-0003-2665-120X; Peruzzotti-Jametti, Luca/0000-0002-9396-5607; sacchetti, alessandro/0000-0002-4830-0825; Mauri, Emanuele/0000-0002-6203-8405	Wellcome TrustWellcome TrustEuropean Commission [RRZA/057 RG79423]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission	The authors would like to thank Dr Simonetta Papa, Dr Pietro Veglianese and Stefano Rimondo for their fruitful discussions. This work was supported by a core support grant from the Wellcome Trust and Medical Research Council to the Wellcome Trust - MRC Cambridge Stem Cell Institute. LPJ was supported by a research training fellowship from the Wellcome Trust (RRZA/057 RG79423).	Assuncao-Silva RC, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/948040; Beria L, 2014, BIOMATER SCI-UK, V2, P67, DOI 10.1039/c3bm60171d; Bongio M, 2011, Eur Cell Mater, V22, P359; Caron I, 2016, BIOMATERIALS, V75, P135, DOI 10.1016/j.biomaterials.2015.10.024; Cha C, 2012, ACS NANO, V6, P9353, DOI 10.1021/nn304773b; Cossetti C, 2012, CELL TISSUE RES, V349, P321, DOI 10.1007/s00441-012-1341-8; Cusimano M, 2012, BRAIN, V135, P447, DOI 10.1093/brain/awr339; de Luca AC, 2016, J TISSUE ENG REGEN M, V10, P647, DOI 10.1002/term.1804; DiNunzio JC, 2008, DRUG DEV IND PHARM, V34, P1141, DOI 10.1080/03639040802020536 ; Edmondson R, 2014, ASSAY DRUG DEV TECHN, V12, P207, DOI 10.1089/adt.2014.573; Elliott Donaghue I, 2015, BIOMATER SCI-UK, V3, P65, DOI 10.1039/c4bm00311j; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Giusto E, 2014, EXP NEUROL, V260, P19, DOI 10.1016/j.expneurol.2013.03.009; Gros T, 2010, BIOMATERIALS, V31, P6719, DOI 10.1016/j.biomaterials.2010.04.035; Hadden WJ, 2017, P NATL ACAD SCI USA, V114, P5647, DOI 10.1073/pnas.1618239114; Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Kappe CO, 2004, ANGEW CHEM INT EDIT, V43, P6250, DOI 10.1002/anie.200400655; Knight E, 2015, J ANAT, V227, P746, DOI 10.1111/joa.12257; Knowlton S, 2016, BIOMATER SCI-UK, V4, P768, DOI 10.1039/c5bm00324e; Lagunas A, 2012, NANOMED-NANOTECHNOL, V8, P432, DOI 10.1016/j.nano.2011.08.001; Li HB, 2010, ANALYST, V135, P1360, DOI 10.1039/c0an00023j; Li L, 2016, REGEN BIOMATER, V3, P99, DOI 10.1093/rb/rbw007; Li XW, 2012, PROG POLYM SCI, V37, P1105, DOI 10.1016/j.progpolymsci.2012.02.004; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Ma N, 2015, DRUG DES DEV THER, V9, P1585, DOI 10.2147/DDDT.S56038; Martino G, 2011, PHYSIOL REV, V91, P1281, DOI 10.1152/physrev.00032.2010; Mauri E, 2017, RSC ADV, V7, P30345, DOI 10.1039/c7ra04584k; Mauri E, 2016, MAT SCI ENG C-MATER, V61, P851, DOI 10.1016/j.msec.2016.01.022; Mekhail M, 2015, BIOMATER SCI-UK, V3, P279, DOI 10.1039/c4bm00215f; Muskovich M, 2012, ADV HEALTHC MATER, V1, P248, DOI 10.1002/adhm.201200071; Naghdi P, 2016, J TISSUE ENG REGEN M, V10, P199, DOI 10.1002/term.1958; Pego AP, 2012, J CELL MOL MED, V16, P2564, DOI 10.1111/j.1582-4934.2012.01603.x; Perale G, 2012, J CONTROL RELEASE, V159, P271, DOI 10.1016/j.jconrel.2011.12.025; Pluchino S, 2005, BRAIN RES REV, V48, P211, DOI 10.1016/j.brainresrev.2004.12.011; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Rossi F, 2013, COLLOID SURFACE B, V108, P169, DOI 10.1016/j.colsurfb.2013.02.046; Rossi F, 2012, J APPL POLYM SCI, V123, P2211, DOI 10.1002/app.34731; Sacchetti A, 2014, TETRAHEDRON LETT, V55, P6817, DOI 10.1016/j.tetlet.2014.10.069; Sandner B, 2015, STEM CELLS BIOL REG, P155, DOI 10.1007/978-1-4939-1908-6_9; Santoro M, 2011, J PHYS CHEM B, V115, P2503, DOI 10.1021/jp1111394; Tabata Y, 2009, J R SOC INTERFACE, V6, pS311, DOI 10.1098/rsif.2008.0448.focus; Taddei M, 2014, J MED CHEM, V57, P2258, DOI 10.1021/jm401536b; Tsou YH, 2016, BIOACT MATER, V1, P39, DOI 10.1016/j.bioactmat.2016.05.001; Ullah F, 2015, MAT SCI ENG C-MATER, V57, P414, DOI 10.1016/j.msec.2015.07.053; Vanderburgh J, 2017, ANN BIOMED ENG, V45, P164, DOI 10.1007/s10439-016-1640-4; Varoni E, 2012, CONNECT TISSUE RES, V53, P548, DOI 10.3109/03008207.2012.712583; Xu M, 2016, ACS NANO, V10, P3267, DOI 10.1021/acsnano.6b00539; Yang RR, 2017, RSC ADV, V7, P41098, DOI 10.1039/c7ra06614g; Zako T, 2014, BIOMATER SCI-UK, V2, P951, DOI 10.1039/c4bm00026a; Zhang YS, 2017, SCIENCE, V356, DOI 10.1126/science.aaf3627; Zhu JM, 2009, BIOCONJUGATE CHEM, V20, P333, DOI 10.1021/bc800441v	53	23	24	4	39	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2047-4830	2047-4849		BIOMATER SCI-UK	Biomater. Sci.	MAR 1	2018	6	3					501	510		10.1039/c7bm01056g			10	Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	FX9CE	WOS:000426392200005	29368775	Green Submitted			2022-02-06	
J	Newell, EA; Todd, BP; Mahoney, J; Pieper, AA; Ferguson, PJ; Bassuk, AG				Newell, Elizabeth A.; Todd, Brittany P.; Mahoney, Jolonda; Pieper, Andrew A.; Ferguson, Polly J.; Bassuk, Alexander G.			Combined Blockade of Interleukin-1 alpha and -1 beta Signaling Protects Mice from Cognitive Dysfunction after Traumatic Brain Injury	ENEURO			English	Article						Inflammation; interleukin-1; traumatic brain injury	FLUID-PERCUSSION INJURY; RECEPTOR ANTAGONIST; CEREBROSPINAL-FLUID; NEURONAL INJURY; PHASE-II; IL-1-ALPHA; IL-1-BETA; ANAKINRA; MODEL; NEUROINFLAMMATION	Diffuse activation of interleukin-1 inflammatory cytokine signaling after traumatic brain injury (TBI) elicits progressive neurodegeneration and neuropsychiatric dysfunction, and thus represents a potential opportunity for therapeutic intervention. Although interleukin (IL)-1 alpha and IL-1 beta both activate the common type 1 IL-1 receptor (IL-1RI), they manifest distinct injury-specific roles in some models of neurodegeneration. Despite its potential relevance to treating patients with TBI, however, the individual contributions of IL-1 alpha and IL-1 beta to TBI-pathology have not been previously investigated. To address this need, we applied genetic and pharmacologic approaches in mice to dissect the individual contributions of IL-1 alpha, IL-beta, and IL-1RI signaling to the pathophysiology of fluid percussion-mediated TBI, amodel of mixed focal and diffuse TBI. IL-1RI ablation conferred a greater protective effect on brain cytokine expression and cognitive function after TBI than did individual IL-1 alpha or IL-1 beta ablation. This protective effect was recapitulated by treatment with the drug anakinra, a recombinant naturally occurring IL-1RI antagonist. Our data thus suggest that broad targeting of IL-1RI signaling is more likely to reduce neuroinflammation and preserve cognitive function after TBI than are approaches that individually target IL-1 alpha or IL-1 beta signaling.	[Newell, Elizabeth A.; Todd, Brittany P.; Mahoney, Jolonda; Ferguson, Polly J.; Bassuk, Alexander G.] Univ Iowa, Dept Pediat, Carver Coll Med, Iowa City, IA 52242 USA; [Pieper, Andrew A.] Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA; [Pieper, Andrew A.] Univ Iowa, Dept Neurol, Carver Coll Med, Iowa City, IA 52242 USA; [Pieper, Andrew A.] Univ Iowa, Comprehens Canc Ctr, Carver Coll Med,Dept Radiat Oncol, Dept Free Radical & Radiat,Biol Program, Iowa City, IA USA; [Pieper, Andrew A.] Univ Iowa, Carver Coll Med, Dept Vet Affairs, Iowa City, IA USA; [Pieper, Andrew A.] Univ Iowa, Pappajohn Biomed Inst, Iowa Neurosci Inst, Carver Coll Med, Iowa City, IA USA		Bassuk, AG (corresponding author), Univ Iowa, Dept Pediat, Hosp & Clin, 200 Hawkins Dr, Iowa City, IA 52242 USA.	alexander-bassuk@uiowa.edu		Pieper, Andrew/0000-0001-6299-6577; Bassuk, Alexander/0000-0002-4067-2157; Newell, Elizabeth/0000-0002-1476-033X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K12 HD027748, R01NS098590, 5R01AR059703]; Titan Neurology Research Fund; Brockman Medical Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD027748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR059703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS098590] Funding Source: NIH RePORTER	This work was supported by NIH grants K12 HD027748 (EAN), R01NS098590 (AGB), and 5R01AR059703 (AGB and PJF) and funds from an anonymous donor to the Mary Alice Smith Fund for Neuropsychiatry Research (AAP), the Titan Neurology Research Fund (AAP), and the Brockman Medical Research Foundation (AAP).	Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Auron PE, 1998, CYTOKINE GROWTH F R, V9, P221, DOI 10.1016/S1359-6101(98)00018-5; Bastien D, 2015, J NEUROSCI, V35, P10715, DOI 10.1523/JNEUROSCI.0498-15.2015; Basu A, 2004, J NEUROSCI RES, V78, P151, DOI 10.1002/jnr.20266; Bertheloot D, 2017, CELL MOL IMMUNOL, V14, P43, DOI 10.1038/cmi.2016.34; Boutin H, 2001, J NEUROSCI, V21, P5528, DOI 10.1523/JNEUROSCI.21-15-05528.2001; Dapul HR, 2013, J NEUROTRAUM, V30, P382, DOI 10.1089/neu.2012.2536; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Emsley HCA, 2005, J NEUROL NEUROSUR PS, V76, P1366, DOI 10.1136/jnnp.2004.054882; FAN L, 1995, MOL BRAIN RES, V30, P125; Fenn AM, 2015, J NEUROTRAUM, V32, P127, DOI 10.1089/neu.2014.3514; FISHER CJ, 1994, JAMA-J AM MED ASSOC, V271, P1836, DOI 10.1001/jama.271.23.1836; Fleischmann RM, 2006, ANN RHEUM DIS, V65, P1006, DOI 10.1136/ard.2005.048371; Fox E, 2010, J NEUROIMMUNOL, V223, P138, DOI 10.1016/j.jneuroim.2010.03.022; Gadani SP, 2015, NEURON, V87, P47, DOI 10.1016/j.neuron.2015.05.019; Galea J, 2011, J CEREBR BLOOD F MET, V31, P439, DOI 10.1038/jcbfm.2010.103; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Greenhalgh AD, 2010, BRIT J PHARMACOL, V160, P153, DOI 10.1111/j.1476-5381.2010.00684.x; GRIFFIN WST, 1994, NEUROSCI LETT, V176, P133, DOI 10.1016/0304-3940(94)90066-3; Gueorguieva I, 2008, BRIT J CLIN PHARMACO, V65, P317, DOI 10.1111/j.1365-2125.2007.03026.x; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Hoshino S, 1996, BRAIN RES, V711, P73, DOI 10.1016/0006-8993(95)01329-6; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Jin X, 2012, J SOFTWARE, V7, P6, DOI DOI 10.1371/J0URNAL.P0NE.0041892; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Kumar A, 2016, BRAIN BEHAV IMMUN, V58, P291, DOI 10.1016/j.bbi.2016.07.158; Li R, 1998, AM J FOREN MED PATH, V19, P129, DOI 10.1097/00000433-199806000-00006; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Park E, 2007, EXP NEUROL, V204, P49, DOI 10.1016/j.expneurol.2006.09.012; Qian J, 2012, P NATL ACAD SCI USA, V109, P12189, DOI 10.1073/pnas.1205207109; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; Schurman LD, 2017, NEUROSCI LETT, V653, P31, DOI 10.1016/j.neulet.2017.05.032; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Singh N, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-1; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Sinha SP, 2017, BRAIN BEHAV IMMUN, V61, P353, DOI 10.1016/j.bbi.2017.01.006; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1	47	23	24	1	1	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA		2373-2822		ENEURO	eNeuro	MAR-APR	2018	5	2							0385-17.2018	10.1523/ENEURO.0385-17.2018			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GC8BE	WOS:000430017100003	29662944	gold, Green Published			2022-02-06	
J	Schmidt, JL; Tweten, DJ; Badachhape, AA; Reiter, AJ; Okamoto, RJ; Garbow, JR; Bayly, PV				Schmidt, J. L.; Tweten, D. J.; Badachhape, A. A.; Reiter, A. J.; Okamoto, R. J.; Garbow, J. R.; Bayly, P. V.			Measurement of anisotropic mechanical properties in porcine brain white matter ex vivo using magnetic resonance elastography	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						MR elastography; Shear waves; Anisotropy; Transversely isotropic material; White matter brain tissue	FAST SHEAR-WAVES; VISCOELASTIC PROPERTIES; MR ELASTOGRAPHY; INJURY; TISSUE; PARAMETERS; STRAIN; SLOW; STEM	The mechanical properties of brain tissue, particularly those of white matter (WM), need to be characterized accurately for use in finite element (FE) models of brain biomechanics and traumatic brain injury (TBI). Magnetic resonance elastography (MRE) is a powerful tool for non-invasive estimation of the mechanical properties of soft tissues. While several studies involving direct mechanical tests of brain tissue have shown mechanical anisotropy, most MRE studies of brain tissue assume an isotropic model. In this study, an incompressible transversely isotropic (TI) material model parameterized by minimum shear modulus (22), shear anisotropy parameter (phi), and tensile anisotropy parameter (zeta) is applied to analyze MRE measurements of ex vivo porcine white matter (WM) brain tissue. To characterize shear anisotropy, "slow" (pure transverse) shear waves were propagated at 100, 200 and 300 Hz through sections of ex vivo brain tissue including both WM and gray matter (GM). Shear waves were found to propagate with elliptical fronts, consistent with TI material behavior. Shear wave fields were also analyzed within regions of interest (ROI) to find local shear wavelengths parallel and perpendicular to fiber orientation. FE simulations of a TI material with a range of plausible shear modulus (mu(2)) and shear anisotropy parameters (zeta) were run and the results were analyzed in the same fashion as the experimental case. Parameters of the FE simulations which most closely matched each experiment were taken to represent the mechanical properties of that particular sample. Using this approach, WM in the ex vivo porcine brain was found to be mildly anisotropic in shear with estimates of minimum shear modulus (actuation frequencies listed in parenthesis): mu(2) = 1.04 +/- 0.12 kPa (at 100 Hz), mu(2),= 1.94 +/- 0.29 kPa (at 200 Hz), and mu(2)= 2.88 +/- 0.34 kPa (at 300 Hz) and corresponding shear anisotropy factors of phi = 0.27 +/- 0.09 (at 100 Hz), phi= 0.29 +/- 0.14 (at 200 Hz) and phi = 0.34 +/- 0.13 (at 300 Hz). Future MRE studies will focus on tensile anisotropy, which will require both slow and fast shear waves for accurate estimation.	[Schmidt, J. L.; Tweten, D. J.; Reiter, A. J.; Okamoto, R. J.; Bayly, P. V.] Washington Univ, Mech Engn & Mat Sci, St Louis, MO 63130 USA; [Badachhape, A. A.; Bayly, P. V.] Washington Univ, Biomed Engn, St Louis, MO 63130 USA; [Garbow, J. R.] Washington Univ, Radiol, St Louis, MO 63130 USA		Schmidt, JL (corresponding author), Washington Univ, Campus Box 1185,One Brookings Dr, St Louis, MO 63130 USA.	jlschmidt@wustl.edu		Badachhape, Andrew/0000-0002-5857-9495; Okamoto, Ruth/0000-0002-3085-3878	National Science FoundationNational Science Foundation (NSF) [CMMI-1332433]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS-055951]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055951] Funding Source: NIH RePORTER	This work was supported by National Science Foundation grant CMMI-1332433 (Bayly) and National Institutes of Health grant R01 NS-055951 (Bayly).	Anderson AT, 2016, J MECH BEHAV BIOMED, V59, P538, DOI 10.1016/j.jmbbm.2016.03.005; Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; Asbach P, 2008, MAGN RESON MED, V60, P373, DOI 10.1002/mrm.21636; Atay SM, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2899575; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Clayton EH, 2011, PHYS MED BIOL, V56, P2391, DOI 10.1088/0031-9155/56/8/005; Coronado V.G., 2011, MORBIDITY MORTALITY; Feng Y, 2017, J MECH BEHAV BIOMED, V65, P490, DOI 10.1016/j.jmbbm.2016.09.020; Feng Y, 2013, J MECH BEHAV BIOMED, V23, P117, DOI 10.1016/j.jmbbm.2013.04.007; Fitzgibbon A, 1999, IEEE T PATTERN ANAL, V21, P476, DOI 10.1109/34.765658; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Green MA, 2013, NMR BIOMED, V26, P1387, DOI 10.1002/nbm.2964; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Guo J, 2015, MAGN RESON MED; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Johnson CL, 2013, MAGN RESON MED, V70, P404, DOI 10.1002/mrm.24473; Jones R., 1998, MAT SCI ENG SERIES; Klatt D, 2010, BIORHEOLOGY, V47, P133, DOI 10.3233/BIR-2010-0565; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Mariappan YK, 2009, MAGN RESON MED, V62, P1457, DOI 10.1002/mrm.22091; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Namani R, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4006848; Namani R, 2009, J BIOMECH, V42, P2047, DOI 10.1016/j.jbiomech.2009.06.007; Ning XG, 2006, J BIOMECH ENG-T ASME, V128, P925, DOI 10.1115/1.2354208; Okamoto RJ, 2011, PHYS MED BIOL, V56, P6379, DOI 10.1088/0031-9155/56/19/014; Papazoglou S, 2006, MAGN RESON MED, V56, P489, DOI 10.1002/mrm.20993; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Qin EC, 2013, J MAGN RESON IMAGING, V37, P217, DOI 10.1002/jmri.23797; Romano A, 2012, MAGN RESON MED, V68, P1410, DOI 10.1002/mrm.24141; Schmidt JL, 2016, J BIOMECH, V49, P1042, DOI 10.1016/j.jbiomech.2016.02.018; Sinkus R, 2005, MAGN RESON IMAGING, V23, P159, DOI 10.1016/j.mri.2004.11.060; Sinkus R, 2007, MAGN RESON MED, V58, P1135, DOI 10.1002/mrm.21404; Spencer A.J.M., 1984, CONTINUUM THEORY MEC; Tweten D. J., 2017, MAGN RESON MED; Tweten DJ, 2015, J BIOMECH, V48, P4002, DOI 10.1016/j.jbiomech.2015.09.009; UENO K, 1995, J NEUROTRAUM, V12, P695, DOI 10.1089/neu.1995.12.695; Van Houten EEW, 2001, MAGNET RESON MED, V45, P827, DOI 10.1002/mrm.1111; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Wuerfel J, 2010, NEUROIMAGE, V49, P2520, DOI 10.1016/j.neuroimage.2009.06.018; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	40	23	23	4	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	MAR	2018	79						30	37		10.1016/j.jmbbm.2017.11.045			8	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	FW1PQ	WOS:000425072300004	29253729	Green Accepted			2022-02-06	
J	Tierney, GJ; Denvir, K; Farrell, G; Simms, CK				Tierney, Gregory J.; Denvir, Karl; Farrell, Garreth; Simms, Ciaran K.			The Effect of Tackler Technique on Head Injury Assessment Risk in Elite Rugby Union	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						CONCUSSION; HEAD IMPACT; TACKLING; INJURY PREVENTION	INTERNATIONAL-CONFERENCE; VIDEO ANALYSIS; WORLD-CUP; CONCUSSION; SPORT; PERFORMANCE; MECHANISMS; STATEMENT; AGREEMENT; PLAYERS	Purpose This study aimed to use match video evidence of tackles in elite-level rugby union to identify tackler proficiency characteristics, for both lower body and upper body tackles, that result in head injury assessments (HIA) for the tackler. Methods A review of international rugby union matches (2013-2017) and Pro 12/European Rugby Champions Cup matches (2014-2017) from a professional rugby union club was conducted. HIA (n = 74) and non-HIA tackles (n = 233) were categorized as either front-on or side-on upper body or lower body tackles and were scored for tackling proficiency characteristics. A chi-square test (P < 0.05) and phi and Cramer's V were calculated to compare HIA and non-HIA tackling proficiency characteristics. Results In both front- and side-on upper body and lower body tackles, head up and forward/face up and head placement on correct side of ball carrier were identified as having a lower propensity to result in an HIA for the tackler. For both front-on and side-on upper body tackles, identify/track ball carrier onto shoulder and shortening steps were identified. In addition, straight back, centre of gravity forward of support base and identify/track ball carrier onto shoulder were identified for front-on and side-on lower body tackles, respectively. Conclusions This study identified tackle characteristics that had a lower propensity to result in an HIA for the tackler in both front-on and side-on upper body and lower body tackles.	[Tierney, Gregory J.; Simms, Ciaran K.] Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin 2, Ireland; [Denvir, Karl; Farrell, Garreth] Leinster Rugby, Dublin, Ireland		Tierney, GJ (corresponding author), Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin 2, Ireland.	gtierne@tcd.ie	Simms, Ciaran/K-3100-2019	Simms, Ciaran/0000-0001-5564-1620; Tierney, Gregory/0000-0002-4666-4473	Irish Research CouncilIrish Research Council for Science, Engineering and Technology	Funding for this study was provided by the Irish Research Council. The authors report no conflicts of interest.	Altman D. G., 1990, PRACTICAL STAT MED R, P229; Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Bahr R, 2005, BRIT J SPORT MED, V39, P324, DOI 10.1136/bjsm.2005.018341; Bathgate A, 2002, BRIT J SPORT MED, V36, P265, DOI 10.1136/bjsm.36.4.265; Best JP, 2005, BRIT J SPORT MED, V39, P812, DOI 10.1136/bjsm.2004.016402; Burger N, 2016, BRIT J SPORT MED, V50, P932, DOI 10.1136/bjsports-2015-095295; Cohen J, 1988, STAT POWER ANAL BEHA, P77, DOI [DOI 10.4324/9780203771587, DOI 10.1001/JAMAPSYCHIATRY.2013.504]; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Deutsch MU, 2007, J SPORT SCI, V25, P461, DOI 10.1080/02640410600631298; Fuller CW, 2007, BRIT J SPORT MED, V41, P862, DOI 10.1136/bjsm.2007.037499; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; Fuller CW, 2010, BRIT J SPORT MED, V44, P159, DOI 10.1136/bjsm.2008.050864; Fuller GW, 2017, J SCI MED SPORT, V20, P246, DOI 10.1016/j.jsams.2016.07.008; Fuller GW, 2015, BRIT J SPORT MED, V49, P529, DOI 10.1136/bjsports-2014-093498; Gabbett T, 2007, INT J SPORTS SCI COA, V2, P467, DOI [10.1260/174795407783359731, DOI 10.1260/174795407783359731]; Gabbett T, 2009, INT J SPORTS SCI COA, V4, P521, DOI 10.1260/174795409790291402; Gabbett TJ, 2008, J STRENGTH COND RES, V22, P625, DOI 10.1519/JSC.0b013e3181635a6a; Gardner AJ, 2015, BRAIN INJURY, V29, P1182, DOI 10.3109/02699052.2015.1034179; Garraway WM, 1999, BRIT J SPORT MED, V33, P37, DOI 10.1136/bjsm.33.1.37; Hendricks S, 2015, EUR J SPORT SCI, V15, P557, DOI 10.1080/17461391.2015.1046192; Hendricks S, 2014, EUR J SPORT SCI, V14, P753, DOI 10.1080/17461391.2014.905982; Hendricks S, 2014, J SPORT SCI MED, V13, P715; Hendricks S, 2010, INT J SPORTS SCI COA, V5, P117, DOI 10.1260/1747-9541.5.1.117; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; Kemp S, 2016, BRIT J SPORT MED, V50, P644, DOI 10.1136/bjsports-2015-095780; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mc Fie S., 2016, BMJ OPEN SPORT EXERC, V2, P000053, DOI [10.1136/bmjsem-2015-000053, DOI 10.1136/BMJSEM-2015-000053]; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Montgomery C, 2018, BRIT J SPORT MED, V52, P994, DOI 10.1136/bjsports-2016-096425; Quarrie KL, 2008, AM J SPORT MED, V36, P1705, DOI 10.1177/0363546508316768; Rugby Football Union, ENGL PROF RUGB INJ S; Tierney GJ, 2015, IRCOBI C P SEP 9 11, P9; Tierney GJ, 2016, ISBS C P ARCH JUL 18, P18; Tierney GJ, 2018, J SCI MED SPORT, V21, P221, DOI 10.1016/j.jsams.2017.06.023; Tierney GJ, 2018, INT J SPORTS SCI COA, V13, P415, DOI 10.1177/1747954117751345; Tierney Gregory J, 2018, Sports Biomech, V17, P33, DOI 10.1080/14763141.2016.1271905; Tierney GJ, 2016, BRAIN INJURY, V30, P1350, DOI 10.1080/02699052.2016.1193630; Viljoen W, 2009, SA RUGBY BOKSMART SA; Wilson B D, 1999, J Sci Med Sport, V2, P153, DOI 10.1016/S1440-2440(99)80195-9	40	23	23	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	MAR	2018	50	3					603	608		10.1249/MSS.0000000000001461			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FW5PC	WOS:000425368300025	29049096	Green Accepted			2022-02-06	
J	Vasterling, JJ; Jacob, SN; Rasmusson, A				Vasterling, Jennifer J.; Jacob, Shawna N.; Rasmusson, Ann			Traumatic Brain Injury and Posttraumatic Stress Disorder: Conceptual, Diagnostic, and Therapeutic Considerations in the Context of Co-Occurrence	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							PROLONGED EXPOSURE THERAPY; PLACEBO-CONTROLLED TRIAL; TREATMENT RESPONSE; OEF/OIF VETERANS; QUANTITATIVE METAANALYSIS; M-CHLOROPHENYLPIPERAZINE; PROSPECTIVE COHORT; TREATMENT PROGRAM; VERBAL MEMORY; PTSD	The events leading to traumatic brain injury (TBI) are often psychologically traumatic (e.g., motor vehicle accidents) or occur within a broader context of psychological trauma, such as military combat or recurrent interpersonal violence. In such cases, posttraumatic stress disorder (PTSD) may develop and serve to complicate TBI recovery. Likewise, brain trauma may impede emotional resolution following psychological trauma exposure. This article addresses comorbid PTSD and TBI, including the epidemiology of PTSD following TBI; the clinical presentation of the comorbidity; potential mechanisms that complicate recovery from psychological trauma and TBI when they co-occur; and considerations for the clinical management of PTSD in the context of TBI, including implications for both psychosocial and psychopharmacological PTSD treatments. Although the authors address the full spectrum of TBI severity, because PTSD more commonly co-occurs with mild TBI, compared with moderate and severe TBI, the authors focus in particular on mild TBI.	[Vasterling, Jennifer J.; Jacob, Shawna N.] VA Boston Healthcare Syst, Psychol Serv, Boston, MA 02130 USA; [Vasterling, Jennifer J.; Rasmusson, Ann] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA USA; [Vasterling, Jennifer J.; Jacob, Shawna N.; Rasmusson, Ann] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02215 USA; [Rasmusson, Ann] VA Boston Healthcare Syst, Psychiat Serv, Boston, MA USA		Vasterling, JJ (corresponding author), VA Boston Healthcare Syst, Psychol Serv, Boston, MA 02130 USA.	jennifer.vasterling@va.gov		Rasmusson, Ann/0000-0002-3488-9042			American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 2004, PRACT GUID TREATM PA; Amick MM, 2013, J INT NEUROPSYCH SOC, V19, P792, DOI 10.1017/S1355617713000544; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Batki SL, 2014, ALCOHOL CLIN EXP RES, V38, P2169, DOI 10.1111/acer.12496; Bernardy NC, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0564-2; Bonanno GA, 2012, BRIT J PSYCHIAT, V200, P317, DOI 10.1192/bjp.bp.111.096552; Brewin CR, 2010, PSYCHOL REV, V117, P210, DOI 10.1037/a0018113; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Bryant RA, 2015, BRIT J PSYCHIAT, V206, P417, DOI 10.1192/bjp.bp.114.145516; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; CHARNEY DS, 1987, PSYCHOPHARMACOLOGY, V92, P14, DOI 10.1007/BF00215473; Cnossen MC, 2017, J NEUROPSYCH CLIN N, V29, P206, DOI 10.1176/appi.neuropsych.16090165; de Abajo FJ, 2008, ARCH GEN PSYCHIAT, V65, P795, DOI 10.1001/archpsyc.65.7.795; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Felger JC, 2017, NEUROPSYCHOPHARMACOL, V42, P216, DOI 10.1038/npp.2016.143; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gregorio GW, 2014, J HEAD TRAUMA REHAB, V29, pE43, DOI 10.1097/HTR.0b013e318292fb00; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Hoskins M, 2015, BRIT J PSYCHIAT, V206, P93, DOI 10.1192/bjp.bp.114.148551; Ipser JC, 2012, INT J NEUROPSYCHOPH, V15, P825, DOI 10.1017/S1461145711001209; Isaacs K, 2017, J PSYCHIATR RES, V84, P301, DOI 10.1016/j.jpsychires.2016.10.017; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson KM, 2017, COMPR PSYCHIAT, V74, P80, DOI 10.1016/j.comppsych.2017.01.007; Judd D, 2005, BRAIN INJURY, V19, P437, DOI 10.1080/02699050400010994; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Kuhn S, 2013, BIOL PSYCHIAT, V73, P70, DOI 10.1016/j.biopsych.2012.06.029; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Mac Donald CL, 2015, BRAIN, V138, P1314, DOI 10.1093/brain/awv038; McAllister TW, 2016, NEUROPSYCHOPHARMACOL, V41, P1191, DOI 10.1038/npp.2015.282; McAllister TW, 2009, CLIN NEUROPSYCHOL, V23, P1338, DOI 10.1080/13854040903277289; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Miller SC, 2015, OCCUP ENVIRON MED, V72, P560, DOI 10.1136/oemed-2014-102646; Otis JD, 2003, J REHABIL RES DEV, V40, P397, DOI 10.1682/JRRD.2003.09.0397; Parsons RG, 2013, NAT NEUROSCI, V16, P146, DOI 10.1038/nn.3296; Patel R, 2012, NEUROSCI BIOBEHAV R, V36, P2130, DOI 10.1016/j.neubiorev.2012.06.003; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Phillips KM, 2016, J REHABIL RES DEV, V53, P413, DOI 10.1682/JRRD.2014.05.0126; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rasmusson AM, 2017, NEUROSCI LETT, V649, P156, DOI 10.1016/j.neulet.2017.01.054; Rotzinger S, 1998, DRUG METAB DISPOS, V26, P572; Rotzinger S, 1998, BIOL PSYCHIAT, V44, P1185, DOI 10.1016/S0006-3223(97)00483-6; Ruff RL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000312; Schneier FR, 2015, DEPRESS ANXIETY, V32, P570, DOI 10.1002/da.22384; Scott JC, 2017, BEHAV RES THER, V91, P24, DOI 10.1016/j.brat.2017.01.004; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Singh Balwinder, 2016, Prim Care Companion CNS Disord, V18, DOI 10.4088/PCC.16r01943; Smith K, 2000, BEHAV RES THER, V38, P709, DOI 10.1016/S0005-7967(99)00096-0; Sripada RK, 2013, J TRAUMA STRESS, V26, P369, DOI 10.1002/jts.21813; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Sullivan KA, 2016, NEUROPSYCHOL REV, V26, P173, DOI 10.1007/s11065-016-9317-1; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; VanLandingham JW, 2007, NEUROSCI LETT, V425, P94, DOI 10.1016/j.neulet.2007.08.045; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Vasterling JJ, J INT NEUROPSYCHOL S; Verfaellie M, 2016, J HEAD TRAUMA REHAB, V31, P309, DOI 10.1097/HTR.0000000000000197; Walter KH, 2014, J TRAUMA STRESS, V27, P438, DOI 10.1002/jts.21934; Walter KH, 2012, REHABIL PSYCHOL, V57, P13, DOI 10.1037/a0026254; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Watts BV, 2013, J CLIN PSYCHIAT, V74, pE541, DOI 10.4088/JCP.12r08225; Wessel I, 2008, BEHAV RES THER, V46, P496, DOI 10.1016/j.brat.2008.01.016; Wild J, 2008, BRIT J PSYCHIAT, V193, P254, DOI 10.1192/bjp.bp.107.045922; Williamson John B, 2013, Front Neuroeng, V6, P13, DOI 10.3389/fneng.2013.00013; Wolf GK, 2015, J TRAUMA STRESS, V28, P339, DOI 10.1002/jts.22029; Wolf GK, 2012, J HEAD TRAUMA REHAB, V27, P26, DOI 10.1097/HTR.0b013e31823cd01f	73	23	24	1	6	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SPR	2018	30	2					91	100		10.1176/appi.neuropsych.17090180			10	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	GM3DZ	WOS:000437980100002	29132272	Bronze			2022-02-06	
J	Zeiler, FA; Donnelly, J; Menon, DK; Smielewski, P; Hutchinson, PJA; Czosnyka, M				Zeiler, Frederick A.; Donnelly, Joseph; Menon, David K.; Smielewski, Peter; Hutchinson, Peter J. A.; Czosnyka, Marek			A Description of a New Continuous Physiological Index in Traumatic Brain Injury Using the Correlation between Pulse Amplitude of Intracranial Pressure and Cerebral Perfusion Pressure	JOURNAL OF NEUROTRAUMA			English	Article						cerebral compliance; cerebrovascular reactivity; ICP index; RAC	MULTIDISCIPLINARY CONSENSUS CONFERENCE; CEREBROVASCULAR REACTIVITY; BLOOD-FLOW; WAVE-FORM; AUTOREGULATION; STATEMENT	To describe a new continuous index of physiologic measurement in a traumatic brain injury (TBI) population, the moving correlation coefficient between intracranial pressure (ICP) pulse amplitude (AMP) and cerebral perfusion pressure (CPP), which we refer to as RAC. We use patient examples of sustained intracranial hypertension, systemic arterial hypotension, and plateau waves, as well as the retrospective analysis of 358 non-decompressive craniectomy (DC) TBI patients with high-frequency ICP and arterial blood pressure data, to explore the relationships of this new index, RAC, with AMP, ICP, CPP, RAP (correlation coefficient between AMP and ICP), pressure reactivity index (PRx), and pulse amplitude index (PAx). We compared the RAC-CPP relationship to that observed between CPP and both PRx and PAx. RAC displays temporal responsiveness to sustained increased ICP, arterial hypotension, and plateau waves, with positive values found during episodes of high ICP and low CPP. Analysis of AMP versus CPP and AMP versus ICP relationships in data from the entire non-DC cohort show lower breakpoints for AMP/CPP at CPP=40mm Hg and upper breakpoints for AMP/ICP at ICP = 50-60 mm Hg. RAC trends to positive values with increasing ICP, particularly with ICP values above the peak in AMP (ICP > 50 mm Hg), though its interpretation requires concomitant interpretation of AMP, RAP, and PRx/PAx to determine contributions of compensatory reserve and cerebrovascular responsiveness to the changes observed in RAC. There is a parabolic relationship between RAC versus CPP, with trends toward positive RAC values near (and beyond) limits for low and high CPPs, suggesting that RAC may be used in the determination of optimum CPP. RAC appears to carry information regarding both cerebrovascular responsiveness and cerebral compensatory reserve. This contributes to RAC's uniqueness and complex interpretation. Further prospective, clinical studies of RAC in CPP optimum estimation and outcome prediction in TBI are required.	[Zeiler, Frederick A.; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, GB-1 820 Sherbrook St, Winnipeg, MB R3A 1R9, Canada; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Clinician Investigator Program, Winnipeg, MB, Canada; [Zeiler, Frederick A.; Donnelly, Joseph; Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Brain Phys Lab, Cambridge, England; [Hutchinson, Peter J. A.] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Cambridge, England; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland		Zeiler, FA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England.; Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, GB-1 820 Sherbrook St, Winnipeg, MB R3A 1R9, Canada.	umzeiler@myumanitoba.ca	Donnelly, Joseph/N-6803-2019; Donnelly, Joseph/E-9235-2018	Donnelly, Joseph/0000-0002-6502-8069; Donnelly, Joseph/0000-0002-6502-8069; czosnyka, marek/0000-0003-2446-8006; Hutchinson, Peter/0000-0002-2796-1835; Zeiler, Frederick/0000-0003-1737-0510	Cambridge Commonwealth Trust Scholarship; Royal College of Surgeons of Canada-Harry S. Morton Travelling Fellowship in Surgery; University of Manitoba Clinician Investigator Program; R. Samuel McLaughlin Research and Education Award; Manitoba Medical Service Foundation; University of Manitoba Faculty of Medicine Dean's Fellowship Fund; Woolf Fisher scholarship (New Zealand); National Institute for Healthcare Research (NIHR, UK) through the Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Centre; NIHR Senior Investigator Award; NIHRNational Institute for Health Research (NIHR); European Union (CENTER-TBI) [602150]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0601025, G1002277, G0600986, G0502030] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [II-C5-0715-20005, 13/15/02, 12/35/57, NF-SI-0512-10090, NIHR-RP-R3-12-013] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0502030, G0600986, G0601025, G1002277] Funding Source: UKRI	This work was made possible through salary support through the Cambridge Commonwealth Trust Scholarship, the Royal College of Surgeons of Canada-Harry S. Morton Travelling Fellowship in Surgery, the University of Manitoba Clinician Investigator Program, R. Samuel McLaughlin Research and Education Award, the Manitoba Medical Service Foundation, and the University of Manitoba Faculty of Medicine Dean's Fellowship Fund.; J.D. is supported by the Woolf Fisher scholarship (New Zealand).; These studies were supported by National Institute for Healthcare Research (NIHR, UK) through the Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Centre, an NIHR Senior Investigator Award to D.K.M., and an NIHR Research Professorship to P.J.A.H. Authors were also supported by a European Union Framework Program 7 grant (CENTER-TBI; Grant Agreement No. 602150).	Aries MJH, 2012, NEUROCRIT CARE, V17, P67, DOI 10.1007/s12028-012-9687-z; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; CZOSNYKA M, 1994, ACTA NEUROCHIR, V126, P113, DOI 10.1007/BF01476419; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Czosnyka M, 1996, ACTA NEUROCHIR, V138, P531, DOI 10.1007/BF01411173; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2014, NEUROCRIT CARE, V21, P95, DOI 10.1007/s12028-014-0046-0; Donnelly J, 2017, J CEREBR BLOOD F MET, V37, P694, DOI 10.1177/0271678X16639060; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Le Roux P, 2014, NEUROCRIT CARE, V21, P1, DOI 10.1007/s12028-014-0041-5; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Needham E, 2017, J NEUROTRAUM, V34, P963, DOI 10.1089/neu.2016.4450; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Zweifel C, 2014, MED ENG PHYS, V36, P638, DOI 10.1016/j.medengphy.2014.03.002; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	17	23	23	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2018	35	7					963	974		10.1089/neu.2017.5241		FEB 2018	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GC0NF	WOS:000424829100001	29212405	Green Submitted			2022-02-06	
J	Xiong, XX; Pan, F; Chen, RQ; Hu, DX; Qiu, XY; Li, CY; Xie, XQ; Tian, B; Chen, XQ				Xiong, Xin Xin; Pan, Feng; Chen, Ruo Qiao; Hu, Dian Xing; Qiu, Xin Yao; Li, Chun Yang; Xie, Xiao Qiang; Tian, Bo; Chen, Xiao Qian			Neuroglobin boosts axon regeneration during ischemic reperfusion via p38 binding and activation depending on oxygen signal	CELL DEATH & DISEASE			English	Article							TRAUMATIC BRAIN-INJURY; HEPATOCELLULAR-CARCINOMA; INDUCED NEUROGENESIS; NEURONAL SURVIVAL; STROKE; RECOVERY; PROTEIN; PHOSPHORYLATION; PATHWAYS; GLOBIN	Cerebral ischemia causes severe cell death or injury including axon breakdown or retraction in the brain. Axon regeneration is crucial for the functional recovery of injured neurons or brains after ischemia/reperfusion (I/R); however, this process has been proved extremely difficult in adult brains and there is still no effective therapy for it. Here we reported that neuroglobin (Ngb), a novel oxygen-binding or sensor protein existing predominantly in neurons or brains, functions as a driving factor for axon regeneration during I/R. Ngb was upregulated and accumulated in growth cones of ischemic neurons in primary cultures, rat, and human brains, correlating positively to the elevation of axon-regeneration markers GAP43, neurofilament-200, and Tau-1. Ngb overexpression promoted while Ngb knockdown suppressed axon regeneration as well as GAP43 expression in neurons during oxygen-glucose deprivation/reoxygenation (OGD/Re). By using specific pharmacological inhibitors, we identified p38 MAPK as the major downstream player of Ngb-induced axon regeneration during OGD/Re. Mechanistically, Ngb directly bound to and activated p38 in neurons upon OGD/Re. Serial truncation and point mutation of Ngb revealed that the 7-105 aa fragment of Ngb was required and the oxygen-binding site (His(64)) of Ngb was the major regulatory site for its p38 interaction/activation. Finally, administration of exogenous TAT-Ngb peptides significantly enhanced axon regeneration in cultured neurons upon OGD/Re. Taken together, Ngb promotes axon regeneration via O-2-Ngb-p38-GAP43 signaling during I/R. This novel mechanism suggests potential therapeutic applications of Ngb for ischemic stroke and other related axonopathy.	[Xiong, Xin Xin; Chen, Ruo Qiao; Hu, Dian Xing; Qiu, Xin Yao; Li, Chun Yang; Chen, Xiao Qian] Huazhong Univ Sci & Technol, Dept Pathophysiol, Sch Basic Med, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Xiong, Xin Xin; Chen, Ruo Qiao; Hu, Dian Xing; Qiu, Xin Yao; Li, Chun Yang; Chen, Xiao Qian] Huazhong Univ Sci & Technol, Inst Brain Res, Wuhan, Hubei, Peoples R China; [Xiong, Xin Xin; Chen, Ruo Qiao; Hu, Dian Xing; Qiu, Xin Yao; Li, Chun Yang; Chen, Xiao Qian] Huazhong Univ Sci & Technol, Key Lab Neurol Dis, Minist Educ, Wuhan, Hubei, Peoples R China; [Xiong, Xin Xin; Chen, Ruo Qiao; Hu, Dian Xing; Qiu, Xin Yao; Li, Chun Yang; Chen, Xiao Qian] Huazhong Univ Sci & Technol, Hubei Prov Key Lab Neurol Dis, Wuhan, Hubei, Peoples R China; [Pan, Feng] Huazhong Univ Sci & Technol, Union Hosp, Dept Urol, Wuhan, Hubei, Peoples R China; [Xie, Xiao Qiang] Yangtze Univ, Jingzhou Cent Hosp, Dept Pathol, Clin Med Coll 2, Jingzhou, Peoples R China; [Tian, Bo] Huazhong Univ Sci & Technol, Sch Basic Med, Dept Neurobiol, Tongji Med Coll, Wuhan, Hubei, Peoples R China		Chen, XQ (corresponding author), Huazhong Univ Sci & Technol, Dept Pathophysiol, Sch Basic Med, Tongji Med Coll, Wuhan, Hubei, Peoples R China.; Chen, XQ (corresponding author), Huazhong Univ Sci & Technol, Inst Brain Res, Wuhan, Hubei, Peoples R China.; Chen, XQ (corresponding author), Huazhong Univ Sci & Technol, Key Lab Neurol Dis, Minist Educ, Wuhan, Hubei, Peoples R China.; Chen, XQ (corresponding author), Huazhong Univ Sci & Technol, Hubei Prov Key Lab Neurol Dis, Wuhan, Hubei, Peoples R China.	chenxq@mails.tjmu.edu.cn	Chen, Xiaoqian/AAH-5831-2019	xiong, xin xin/0000-0001-9329-6370	National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471386, 81672504, 31571044]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [2017KFYXJJ048]; Integrated Innovative Team for Major Human Diseases Program of Tongji Medical College, HUST; National Science Foundation of Hubei Province [2017 CFB639]; Science and Technology Planning Project of Wuhan [2017060201010202]	This work was supported by the National Nature Science Foundation of China (No. 81471386 and No. 81672504 to XQC, No. 31571044 to BT); the Fundamental Research Funds for the Central Universities (No. 2017KFYXJJ048) to XQC; the Integrated Innovative Team for Major Human Diseases Program of Tongji Medical College, HUST; National Science Foundation of Hubei Province (No. 2017 CFB639) and Science and Technology Planning Project of Wuhan (No. 2017060201010202) to FP.	Baez E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00146; Baldauf K, 2005, BRAIN RES, V1056, P158, DOI 10.1016/j.brainres.2005.07.035; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Cai J, 2012, J PATHOL, V226, P495, DOI 10.1002/path.2980; Carmichael ST, 2017, EXP NEUROL, V287, P384, DOI 10.1016/j.expneurol.2016.02.007; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; Cui Q, 2006, MOL NEUROBIOL, V33, P155, DOI 10.1385/MN:33:2:155; Dempsey RJ, 2007, NEUROSURG CLIN N AM, V18, P183, DOI 10.1016/j.nec.2006.10.011; Di Pietro V, 2014, FREE RADICAL BIO MED, V69, P258, DOI 10.1016/j.freeradbiomed.2014.01.032; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Fink KL, 2017, CELL REP, V18, P2687, DOI 10.1016/j.celrep.2017.02.058; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Hinman JD, 2014, CURR OPIN NEUROL, V27, P615, DOI 10.1097/WCO.0000000000000149; Jayaraman T, 2011, J BIOL CHEM, V286, P42679, DOI 10.1074/jbc.M111.271973; Jiang JJ, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.239; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Jung KM, 2003, MOL PHARMACOL, V63, P607, DOI 10.1124/mol.63.3.607; Kim H, 2016, J PHARMACOL EXP THER, V359, P262, DOI 10.1124/jpet.116.235127; Kudo T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124024; Lan WB, 2014, BRAIN RES, V1562, P100, DOI 10.1016/j.brainres.2014.03.020; Li L, 2014, MOL NEUROBIOL, V49, P149, DOI 10.1007/s12035-013-8506-7; Lu KT, 2011, J NEUROTRAUM, V28, P441, DOI 10.1089/neu.2010.1473; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; O'Donovan KJ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00486; Pillai VB, 2011, MOL CELL BIOL, V31, P2349, DOI 10.1128/MCB.01205-10; Qiu Xin Yao, 2014, Biomol Concepts, V5, P195, DOI 10.1515/bmc-2014-0011; Raida Zindy, 2012, Exp Transl Stroke Med, V4, P15, DOI 10.1186/2040-7378-4-15; Sharma TP, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.22; Sommer CJ, 2017, STROKE, V48, P1112, DOI 10.1161/STROKEAHA.116.013324; Stankiewicz TR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00314; Sun F, 2013, J ALZHEIMERS DIS, V36, P659, DOI 10.3233/JAD-130323; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; Tobin MK, 2014, J CEREBR BLOOD F MET, V34, P1573, DOI 10.1038/jcbfm.2014.130; Trent JT, 2001, J BIOL CHEM, V276, P30106, DOI 10.1074/jbc.C100300200; Vallone B, 2004, PROTEINS, V56, P85, DOI 10.1002/prot.20113; Wakasugi K, 2003, J BIOL CHEM, V278, P36505, DOI 10.1074/jbc.M305519200; Wang YL, 2016, ONCOTARGET, V7, P11284, DOI 10.18632/oncotarget.7022; Zhang J, 2013, MOL PHARMACOL, V83, P1109, DOI 10.1124/mol.112.083634; Zhu WS, 2011, DRUG DELIV, V18, P338, DOI 10.3109/10717544.2011.557785	39	23	28	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	FEB 7	2018	9								163	10.1038/s41419-017-0260-8			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	FZ2IN	WOS:000427401400005	29416029	gold, Green Published			2022-02-06	
J	Jacome, T; Tatum, D				Jacome, Tomas; Tatum, Danielle			Systemic Inflammatory Response Syndrome (SIRS) Score Independently Predicts Poor Outcome in Isolated Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; SIRS; Outcome; Systemic inflammatory response syndrome; Trauma	BETA-BLOCKER EXPOSURE; LENGTH-OF-STAY; HEAD-INJURY; IMPROVED SURVIVAL; COMA SCALE; CATECHOLAMINES; CLASSIFICATION; TEMPERATURE; HYPOTHERMIA; FEVER	Systemic inflammatory response syndrome (SIRS) is frequently observed after various types of acute cerebral injury and has been linked to clinical deterioration in non-traumatic brain injury (TBI). SIRS scores have also been shown to be predictive of length of stay and mortality in trauma patients. We aimed to determine the prognostic utility of SIRS present at admission in trauma patients with isolated TBI. This was a 5-year retrospective cohort study of adults (ae<yen>18 years) with isolated TBI admitted to a Level II trauma center. The prognostic value of SIRS, total SIRS scores, and each SIRS criterion was examined by I (2) and logistic regression analyses. Of the 330 patients identified, 50 (15.2%) met SIRS criteria. SIRS was significantly associated with poor outcome (P < 0.001). Relative risk of poor outcome was 2.7 times higher in patients with a SIRS score of 2 on admission (P = 0.007) and increased significantly to 6.5 times in patients with a SIRS score of 3 (P = 0.002). Logistic regression demonstrated SIRS and each criterion to be significant independent prognostic factors (SIRS, P = 0.030; body temperature, P = 0.006; tachypnea, P = 0.022, tachycardia P = 0.023). SIRS at admission is an independent predictor of poor outcome in isolated TBI patients. These data demonstrate SIRS to be an important clinical tool that may be used in facilitating prognostication, particularly in elderly trauma patients. Future prospective studies aimed at therapeutic interventions to mitigate SIRS in TBI patients are warranted. Prognostic, Level III.	[Jacome, Tomas; Tatum, Danielle] Our Lady Lake Reg Med Ctr, Trauma Specialist Program, 5000 Hennessey Blvd, Baton Rouge, LA 70808 USA		Tatum, D (corresponding author), Our Lady Lake Reg Med Ctr, Trauma Specialist Program, 5000 Hennessey Blvd, Baton Rouge, LA 70808 USA.	Danielle.Tatum@ololrmc.com					Alali AS, 2014, NEUROCRIT CARE, V20, P514, DOI 10.1007/s12028-013-9903-5; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Balvers Kirsten, 2016, J Emerg Trauma Shock, V9, P97, DOI 10.4103/0974-2700.185276; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Castillo J, 1998, STROKE, V29, P2455, DOI 10.1161/01.STR.29.12.2455; Childs C, 2006, NEUROCRIT CARE, V5, P10, DOI 10.1385/NCC:5:1:10; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Corso P, 2015, INJURY PREV, V21, P432, DOI [10.1136/injuryprev-2015-041862, 10.1136/ip.2005.010983rep]; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Enderson BL, 2007, J TRAUMA, V62, P33; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Hinson HE, 2012, CURR OPIN CRIT CARE, V18, P139, DOI 10.1097/MCC.0b013e3283513290; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Ko A, 2016, J TRAUMA ACUTE CARE, V80, P637, DOI 10.1097/TA.0000000000000959; Konstantinidis A, 2011, J TRAUMA, V71, P1627, DOI 10.1097/TA.0b013e3182159e31; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Madden LK, 2015, J NEUROSCI NURS, V47, P190, DOI 10.1097/JNN.0000000000000142; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Menger MD, 2004, LANGENBECK ARCH SURG, V389, P475, DOI 10.1007/s00423-004-0472-0; Mohseni S, 2015, WORLD J SURG, V39, P2076, DOI 10.1007/s00268-015-3039-z; Naito H, 2016, THER HYPOTHERMIA TEM, V6, P189, DOI 10.1089/ther.2016.0009; Napolitano LM, 2000, J TRAUMA, V49, P647, DOI 10.1097/00005373-200010000-00011; National Hospital Discharge Survey (NHDS), 2006, ALL DAT SOURC MAINT; NeSmith EG, 2009, AM J CRIT CARE, V18, P339, DOI 10.4037/ajcc2009267; Perel P, 2007, J EVAL CLIN PRACT, V13, P464, DOI 10.1111/j.1365-2753.2006.00713.x; Povlishock JT, 2009, J NEUROTRAUM, V26, P333, DOI 10.1089/neu.2008.0604; Schroder ML, 1996, J NEUROTRAUM, V13, P17, DOI 10.1089/neu.1996.13.17; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Sun Dong, 1999, Keio Journal of Medicine, V48, P28; TEASDALE G, 1974, LANCET, V2, P81; Thompson Hilaire J, 2010, J Trauma Nurs, V17, P173, DOI 10.1097/JTN.0b013e3181ff272e; Thompson HJ, 2003, J NEUROL NEUROSUR PS, V74, P614, DOI 10.1136/jnnp.74.5.614; Vila N, 2003, STROKE, V34, P671, DOI 10.1161/01.STR.0000057976.53301.69; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Yoshimoto Y, 2001, STROKE, V32, P1989, DOI 10.1161/hs0901.095646; Zangbar B, 2016, J SURG RES, V200, P586, DOI 10.1016/j.jss.2015.08.020	41	23	23	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2018	28	1					110	116		10.1007/s12028-017-0410-y			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FW9BQ	WOS:000425631100016	28547319				2022-02-06	
J	Konigs, M; Pouwels, PJW; van Heurn, LWE; Bakx, R; Vermeulen, RJ; Goslings, JC; Poll-The, BT; van der Wees, M; Catsman-Berrevoets, CE; Oosterlaan, J				Konigs, Marsh; Pouwels, Petra J. W.; van Heurn, L. W. Ernest; Bakx, Roel; Vermeulen, R. Jeroen; Goslings, J. Carel; Poll-The, Bwee Tien; van der Wees, Marleen; Catsman-Berrevoets, Coriene E.; Oosterlaan, Jaap			Relevance of neuroimaging for neurocognitive and behavioral outcome after pediatric traumatic brain injury	BRAIN IMAGING AND BEHAVIOR			English	Article						Diffusion tensor imaging; Tract-based spatial statistics; Pediatrics; Traumatic brain injury; Neurocognitive functioning; Behavior problems	IMAGING DTI FINDINGS; CORPUS-CALLOSUM; SPATIAL STATISTICS; WORKING-MEMORY; HEAD-INJURY; CHILDREN; TBI; MICROSTRUCTURE; DEFICITS; MODERATE	This study aims to (1) investigate the neuropathology of mild to severe pediatric TBI and (2) elucidate the predictive value of conventional and innovative neuroimaging for functional outcome. Children aged 8-14 years with trauma control (TC) injury (n = 27) were compared to children with mild TBI and risk factors for complicated TBI (mild(RF+), n = 20) or moderate/severe TBI (n = 17) at 2.8 years post-injury. Neuroimaging measures included: acute computed tomography (CT), volumetric analysis on post-acute conventional T1-weighted magnetic resonance imaging (MRI) and post-acute diffusion tensor imaging (DTI, analyzed using tract-based spatial statistics and voxel-wise regression). Functional outcome was measured using Common Data Elements for neurocognitive and behavioral functioning. The results show that intracranial pathology on acute CT-scans was more prevalent after moderate/severe TBI (65%) than after mild(RF+) TBI (35%; p = .035), while both groups had decreased white matter volume on conventional MRI (ps ae<currency> .029, ds ae<yen> -0.74). The moderate/severe TBI group further showed decreased fractional anisotropy (FA) in a widespread cluster affecting all white matter tracts, in which regional associations with neurocognitive functioning were observed (FSIQ, Digit Span and RAVLT Encoding) that consistently involved the corpus callosum. FA had superior predictive value for functional outcome (i.e. intelligence, attention and working memory, encoding in verbal memory and internalizing problems) relative to acute CT-scanning (i.e. internalizing problems) and conventional MRI (no predictive value). We conclude that children with mild(RF+) TBI and moderate/severe TBI are at risk of persistent white matter abnormality. Furthermore, DTI has superior predictive value for neurocognitive out-come relative to conventional neuroimaging.	[Konigs, Marsh; Oosterlaan, Jaap] FGB VU Univ Amsterdam, Clin Neuropsychol Sect, Van der Boechorststr 1, NL-1081 BT Amsterdam, Netherlands; [Konigs, Marsh; Oosterlaan, Jaap] Emma Childrens Hosp, Acad Med Ctr, Amsterdam, Netherlands; [Pouwels, Petra J. W.] Vrije Univ Amsterdam, Dept Phys & Med Technol, Med Ctr, Amsterdam, Netherlands; [Pouwels, Petra J. W.] Neurosci Campus Amsterdam, Amsterdam, Netherlands; [van Heurn, L. W. Ernest; Bakx, Roel] Emma Childrens Hosp, Acad Med Ctr, Pediat Surg Ctr Amsterdam, Amsterdam, Netherlands; [van Heurn, L. W. Ernest; Bakx, Roel] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Vermeulen, R. Jeroen] Vrije Univ Amsterdam, Dept Pediat Neurol, Med Ctr, Amsterdam, Netherlands; [Vermeulen, R. Jeroen] Maastricht Univ, Dept Pediat Neurol, Med Ctr, Maastricht, Netherlands; [Goslings, J. Carel] Acad Med Ctr, Trauma Unit, Amsterdam, Netherlands; [Poll-The, Bwee Tien] Emma Childrens Hosp, Dept Pediat Neurol, Acad Med Ctr, Amsterdam, Netherlands; [van der Wees, Marleen] Libra Rehabil Med & Audiol, Eindhoven, Netherlands; [Catsman-Berrevoets, Coriene E.] Sophia Childrens Univ Hosp, Erasmus Univ Hosp, Dept Pediat Neurol, Rotterdam, Netherlands; [Oosterlaan, Jaap] Vrije Univ Amsterdam, Dept Pediat, Med Ctr, Amsterdam, Netherlands		Konigs, M (corresponding author), FGB VU Univ Amsterdam, Clin Neuropsychol Sect, Van der Boechorststr 1, NL-1081 BT Amsterdam, Netherlands.; Konigs, M (corresponding author), Emma Childrens Hosp, Acad Med Ctr, Amsterdam, Netherlands.	m.konigs@vu.nl		Konigs, Marsh/0000-0003-0200-0445; Bakx, Roel/0000-0001-5884-2997; Poll-The, Bwee Tien/0000-0002-8118-5419	Netherlands' Organization for Scientific Research (NWO)Netherlands Organization for Scientific Research (NWO) [022.003.010]; Faculty of Behavioral and Movement Sciences of the Vrije Universiteit Amsterdam	This work was supported by the Netherlands' Organization for Scientific Research (NWO, http://www.nwo.nl) grant number 022.003.010 and the Faculty of Behavioral and Movement Sciences of the Vrije Universiteit Amsterdam.	Adamson C, 2013, BRAIN INJURY, V27, P454, DOI 10.3109/02699052.2012.750756; American College of Surgeons, 2004, ADV TRAUM LIF SUPP P; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bach M, 2014, NEUROIMAGE, V100, P358, DOI 10.1016/j.neuroimage.2014.06.021; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Blackman JA, 2003, J HEAD TRAUMA REHAB, V18, P493, DOI 10.1097/00001199-200311000-00003; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Dennis EL, 2015, NEUROIMAGE-CLIN, V7, P493, DOI 10.1016/j.nicl.2015.02.002; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Ewing-Cobbs L, 2016, HUM BRAIN MAPP, V37, P3929, DOI 10.1002/hbm.23286; Gerlach R, 2009, PEDIATR EMERG CARE, V25, P164, DOI 10.1097/PEC.0b013e31819a8966; Haberg AK, 2015, J NEUROSCI RES, V93, P1109, DOI 10.1002/jnr.23534; Hayes A, 2013, INTRO MEDIATION MODE, P3, DOI DOI 10.1111/JEDM.12050; IBM Corp, 2011, IBM SPSS STAT WINDOW; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johnson CP, 2011, J INT NEUROPSYCH SOC, V17, P663, DOI 10.1017/S1355617711000464; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Konigs M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144395; Konigs M, 2015, PEDIATRICS, V136, P534, DOI 10.1542/peds.2015-0437; Kort W, 2005, WISC IIINL WECHSLER; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Max J, 1998, CHILD ADOLESC PSYCHI, V37, P932; Max JE, 2012, J AM ACAD CHILD PSY, V51, P1208, DOI 10.1016/j.jaac.2012.08.026; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McCauley SR, 2011, J NEUROTRAUM, V28, P503, DOI 10.1089/neu.2010.1555; MENDELSOHN DB, 1992, NEURORADIOLOGY, V34, P384, DOI 10.1007/BF00596495; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Morey RA, 2010, HUM BRAIN MAPP, V31, P1751, DOI 10.1002/hbm.20973; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Poldrack RA, 2007, SOC COGN AFFECT NEUR, V2, P67, DOI 10.1093/scan/nsm006; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Roberts RM, 2014, DEV NEUROPSYCHOL, V39, P600, DOI 10.1080/87565641.2014.973958; Roberts RM, 2016, DEV NEUROPSYCHOL, V41, P176, DOI 10.1080/87565641.2016.1186167; Sattler J. M., 2001, ASSESSMENT CHILDREN, V774; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sigmund GA, 2007, PEDIATR NEUROL, V36, P217, DOI 10.1016/j.pediatrneurol.2007.01.003; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Statistics Netherlands, 2006, ED CAT STAND; Tabachnick BG., 2012, USING MULTIVARIATE S; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Van Beek L, 2015, BRAIN INJURY, V29, P1701, DOI 10.3109/02699052.2015.1075172; van den Burg W, 1999, ARCH CLIN NEUROPSYCH, V14, P545, DOI 10.1016/S0887-6177(98)00042-0; Verhulst F., 2013, HANDELING ASEBA VRAG; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Wechsler D., 1991, WISC 3 WECHSLER INTE; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilde EA, 2011, INT J PSYCHOPHYSIOL, V82, P86, DOI 10.1016/j.ijpsycho.2011.04.006; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	58	23	23	1	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	FEB	2018	12	1					29	43		10.1007/s11682-017-9673-3			15	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FW4TM	WOS:000425307500004	28092022	Green Published, hybrid			2022-02-06	
J	Wen, J; Jones, M; Tanaka, M; Selvaraj, P; Symes, AJ; Cox, B; Zhang, YM				Wen, Jie; Jones, Melissa; Tanaka, Mikiei; Selvaraj, Prabhuanand; Symes, Aviva J.; Cox, Brian; Zhang, Yumin			WWL70 protects against chronic constriction injury-induced neuropathic pain in mice by cannabinoid receptor-independent mechanisms	JOURNAL OF NEUROINFLAMMATION			English	Article						Endocannabinoids; ABHD6; Chronic constriction injury; Neuroinflammation; Cyclooxygenase-2; Prostaglandin E synthase; PGE2; Neuropathic pain	PERIPHERAL-NERVE INJURY; MONOCYTE CHEMOATTRACTANT PROTEIN-1; DORSAL-ROOT GANGLIA; MONOACYLGLYCEROL LIPASE; SPINAL-CORD; RAT MODEL; ENDOCANNABINOID SYSTEM; SELECTIVE-INHIBITION; INDUCED HYPERALGESIA; ALZHEIMERS-DISEASE	Background: Targeting the endocannabinoid system has emerged as an effective strategy for the treatment of inflammatory and neurological diseases. Unlike the inhibition of the principal 2-arachidonyl glycerol (2-AG) hydrolytic enzyme monoacylglycerol lipase (MAGL), which leads to 2-AG overload and cannabinoid receptor desensitization, selective inhibition of the minor 2-AG hydrolytic enzyme alpha, beta-hydrolase domain 6 (ABHD6) can provide therapeutic benefits without producing cannabimimetic side effects. We have shown that inhibition of ABHD6 significantly reduces neuroinflammation and exerts neuroprotection in animal models of traumatic brain injury and multiple sclerosis. However, the role of ABHD6 inhibition on neuropathic pain has not been explored. Methods: Neuropathic pain was induced by chronic constriction injury (CCI) of the mouse sciatic nerve and examined by Hargreaves and Von Frey tests. Activation of inflammatory cells and the production of cytokines and chemokines in the spinal cord dorsal horn, dorsal root ganglion (DRG), and sciatic nerve were assessed by qRT-PCR, enzyme-linked immunosorbent assay (ELISA), and immunohistochemistry. The levels of 2-AG and arachidonic acid (AA) in sciatic nerve were quantified by liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). Results: Treatment with the selective ABHD6 inhibitor WWL70 significantly alleviated CCI-induced thermal hyperalgesia and mechanical allodynia. Microglia activation, macrophage infiltration, and the production of nociceptive mediators were reduced in the ipsilateral lumbar spinal cord dorsal horn, DRG, and sciatic nerve of WWL70-treated animals. The diminished cytokine and chemokine production is likely due to the inhibitory effect of WWL70 on NF-.B phosphorylation. Surprisingly, the anti-nociceptive and anti-inflammatory effects of WWL70 were not reversed by addition of the cannabinoid receptor antagonists. Treatment with WWL70 did not alter the levels of 2-AG, AA, and the phosphorylation of cytosolic phospholipase A(2) (cPLA(2)), but significantly reduced the production of prostaglandin E-2 (PGE(2)) and the expression of cyclooxygenase-2 (COX-2) and prostaglandin E synthase-2 (PGES2) in the injured sciatic nerve. Conclusions: This study reveals a novel mechanism for the antinociceptive effect of the 2-AG catabolic enzyme ABHD6 inhibitor WWL70. Understanding the interaction between endocannabinoid and eicosanoid pathways might provide a new avenue for the treatment of inflammatory and neuropathic pain.	[Wen, Jie; Jones, Melissa; Tanaka, Mikiei; Selvaraj, Prabhuanand; Zhang, Yumin] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Symes, Aviva J.; Cox, Brian] Dept Pharmacol & Mol Therapeut, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Symes, Aviva J.; Cox, Brian; Zhang, Yumin] Uniformed Serv Univ Hlth Sci, Neurosci Program, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA		Zhang, YM (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.; Zhang, YM (corresponding author), Uniformed Serv Univ Hlth Sci, Neurosci Program, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	yumin.zhang@usuhs.edu	Symes, Aviva J/S-7471-2016	Symes, Aviva J/0000-0003-2557-9939	Defense Medical Research and Development Program [0130-10-00003-00002]	This work was supported by the grant from the Defense Medical Research and Development Program (0130-10-00003-00002).	Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; Alhouayek M, 2014, DRUG DISCOV TODAY, V19, P295, DOI 10.1016/j.drudis.2013.07.009; Alhouayek M, 2013, P NATL ACAD SCI USA, V110, P17558, DOI 10.1073/pnas.1314017110; Anand P, 2009, BRAIN RES REV, V60, P255, DOI 10.1016/j.brainresrev.2008.12.003; Bennett DLH, 2001, NEUROSCIENTIST, V7, P13, DOI 10.1177/107385840100700105; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; BERGJOHNSEN J, 1993, EXP BRAIN RES, V96, P241; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen RQ, 2012, CELL REP, V2, P1329, DOI 10.1016/j.celrep.2012.09.030; Crowe MS, 2015, BRIT J PHARMACOL, V172, P1700, DOI 10.1111/bph.13012; Dansereau MA, 2008, J NEUROCHEM, V106, P757, DOI 10.1111/j.1471-4159.2008.05429.x; Denk F, 2016, CELL REP, V15, P1771, DOI 10.1016/j.celrep.2016.04.063; Drew GM, 2009, J NEUROSCI, V29, P7220, DOI 10.1523/JNEUROSCI.4362-08.2009; Durrenberger PF, 2004, J PERIPHER NERV SYST, V9, P15, DOI 10.1111/j.1085-9489.2004.09104.x; Ellis A, 2013, BRIT J ANAESTH, V111, P26, DOI 10.1093/bja/aet128; Farooqui AA, 2006, PHARMACOL REV, V58, P591, DOI 10.1124/pr.58.3.7; Ghosh S, 2015, J PHARMACOL EXP THER, V354, P111, DOI 10.1124/jpet.115.222851; Gonsiorek W, 2000, MOL PHARMACOL, V57, P1045; Grace PM, 2014, NAT REV IMMUNOL, V14, P217, DOI 10.1038/nri3621; Gu N, 2016, CELL REP, V16, P605, DOI 10.1016/j.celrep.2016.06.018; Guasti L, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-35; HASSEL B, 1992, BRAIN RES, V576, P120, DOI 10.1016/0006-8993(92)90616-H; Ignatowska-Jankowska Bogna, 2015, J Pharmacol Exp Ther, V353, P424, DOI 10.1124/jpet.114.222315; Jergova S, 2007, J MOL HISTOL, V38, P245, DOI 10.1007/s10735-007-9094-5; Ji RR, 2016, SCIENCE, V354, P572, DOI 10.1126/science.aaf8924; Khan N, 2015, MOLECULES, V20, P10657, DOI 10.3390/molecules200610657; Khasabova IA, 2011, PHARMACOL RES, V64, P60, DOI 10.1016/j.phrs.2011.03.007; Kim CF, 2011, BRAIN RES, V1405, P95, DOI 10.1016/j.brainres.2011.06.022; Kinsey SG, 2009, J PHARMACOL EXP THER, V330, P902, DOI 10.1124/jpet.109.155465; Kinsey SG, 2013, J PHARMACOL EXP THER, V345, P492, DOI 10.1124/jpet.112.201426; Ledeboer A, 2005, PAIN, V115, P71, DOI 10.1016/j.pain.2005.02.009; Lee KM, 2004, EUR J NEUROSCI, V19, P3375, DOI 10.1111/j.0953-816X.2004.03441.x; Lindia JA, 2005, J PAIN, V6, P434, DOI 10.1016/j.jpain.2005.02.001; Ma WY, 2010, NEUROBIOL AGING, V31, P1227, DOI 10.1016/j.neurobiolaging.2008.08.002; Ma WY, 2005, J NEUROCHEM, V93, P664, DOI 10.1111/j.1471-4159.2005.03050.x; Marrs WR, 2010, NAT NEUROSCI, V13, P951, DOI 10.1038/nn.2601; MELLER ST, 1994, NEUROPHARMACOLOGY, V33, P1471, DOI 10.1016/0028-3908(94)90051-5; Menetski J, 2007, NEUROSCIENCE, V149, P706, DOI 10.1016/j.neuroscience.2007.08.014; Mitrirattanakul S, 2006, PAIN, V126, P102, DOI 10.1016/j.pain.2006.06.016; Muja N, 2004, GLIA, V46, P116, DOI 10.1002/glia.10349; Naydenov AV, 2014, NEURON, V83, P361, DOI 10.1016/j.neuron.2014.06.030; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Perkins NM, 2000, NEUROSCIENCE, V101, P745, DOI 10.1016/S0306-4522(00)00396-1; Pertwee RG, 2008, BRIT J PHARMACOL, V153, P199, DOI 10.1038/sj.bjp.0707442; Petrosino S, 2007, NEUROPHARMACOLOGY, V52, P415, DOI 10.1016/j.neuropharm.2006.08.011; Piro JR, 2012, CELL REP, V1, P617, DOI 10.1016/j.celrep.2012.05.001; Rahn EJ, 2009, NEUROTHERAPEUTICS, V6, P713, DOI 10.1016/j.nurt.2009.08.002; Russo R, 2007, J PHARMACOL EXP THER, V322, P236, DOI 10.1124/jpet.107.119941; Sagar DR, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-59; Savinainen JR, 2012, ACTA PHYSIOL, V204, P267, DOI 10.1111/j.1748-1716.2011.02280.x; Schafers M, 2004, EXP NEUROL, V185, P160, DOI 10.1016/j.expneurol.2003.09.015; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Smits H, 2006, NEUROSCIENCE, V143, P541, DOI 10.1016/j.neuroscience.2006.08.007; Sorkin LS, 1997, NEUROSCIENCE, V81, P255, DOI 10.1016/S0306-4522(97)00147-4; Souza GR, 2015, PHARMACOL BIOCHEM BE, V134, P49, DOI 10.1016/j.pbb.2015.04.005; Sun GY, 2007, J NEUROCHEM, V103, P1, DOI 10.1111/j.1471-4159.2007.04670.x; Tanaka M, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0783-4; Tanaka T, 2004, NEUROSCI RES, V48, P463, DOI 10.1016/j.neures.2004.01.004; Tchantchou F, 2013, J NEUROTRAUM, V30, P565, DOI 10.1089/neu.2012.2647; Thacker MA, 2009, EUR J PAIN, V13, P263, DOI 10.1016/j.ejpain.2008.04.017; Tikka TM, 2001, J IMMUNOL, V166, P7527, DOI 10.4049/jimmunol.166.12.7527; Verge GM, 2004, EUR J NEUROSCI, V20, P1150, DOI 10.1111/j.1460-9568.2004.03593.x; Wagner R, 1996, NEUROREPORT, V7, P2897, DOI 10.1097/00001756-199611250-00018; Watkins LR, 2003, NAT REV DRUG DISCOV, V2, P973, DOI 10.1038/nrd1251; Watkins LR, 1997, PAIN, V71, P225, DOI 10.1016/S0304-3959(97)03369-1; Wen J, 2015, NEUROPHARMACOLOGY, V99, P196, DOI 10.1016/j.neuropharm.2015.07.010; Wilkerson JL, 2016, J PHARMACOL EXP THER, V357, P145, DOI 10.1124/jpet.115.229971; Wolf G, 2006, PAIN, V120, P315, DOI 10.1016/j.pain.2005.11.011; Woodhams SG, 2017, NEUROPHARMACOLOGY, V124, P105, DOI 10.1016/j.neuropharm.2017.06.015; Zhang J, 2006, J NEUROCHEM, V97, P772, DOI 10.1111/j.1471-4159.2006.03746.x; Zhang J, 2007, J NEUROSCI, V27, P12396, DOI 10.1523/JNEUROSCI.3016-07.2007; Zuo YX, 2003, PAIN, V105, P467, DOI 10.1016/S0304-3959(03)00261-6	72	23	23	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	JAN 8	2018	15								9	10.1186/s12974-017-1045-9			16	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	FS1HS	WOS:000419527500002	29310667	Green Published, gold			2022-02-06	
J	Langan, J; Subryan, H; Nwogu, I; Cavuoto, L				Langan, Jeanne; Subryan, Heamchand; Nwogu, Ifeoma; Cavuoto, Lora			Reported use of technology in stroke rehabilitation by physical and occupational therapists	DISABILITY AND REHABILITATION-ASSISTIVE TECHNOLOGY			English	Article						Stroke; rehabilitation; technology; physical therapy; occupational therapy; home exercise program	RANDOMIZED-CONTROLLED-TRIAL; NINTENDO WII SPORTS(TM); TRAUMATIC BRAIN-INJURY; VIRTUAL-REALITY; INPATIENT REHABILITATION; OLDER-ADULTS; ARM FUNCTION; EXERCISE PROGRAMS; FEEDBACK; RECOVERY	Purpose: With the patient care experience being a healthcare priority, it is concerning that patients with stroke reported boredom and a desire for greater fostering of autonomy, when evaluating their rehabilitation experience. Technology has the potential to reduce these shortcomings by engaging patients through entertainment and objective feedback. Providing objective feedback has resulted in improved outcomes and may assist the patient in learning how to self-manage rehabilitation. Our goal was to examine the extent to which physical and occupational therapists use technology in clinical stroke rehabilitation home exercise programs. Materials and methods: Surveys were sent via mail, email and online postings to over 500 therapists, 107 responded. Results: Conventional equipment such as stopwatches are more frequently used compared to newer technology like Wii and Kinect games. Still, less than 25% of therapists' report using a stopwatch five or more times per week. Notably, feedback to patients is based upon objective data less than 50% of the time by most therapists. At the end of clinical rehabilitation, patients typically receive a written home exercise program and non-technological equipment, like theraband and/or theraputty to continue rehabilitation efforts independently. Conclusions: The use of technology is not pervasive in the continuum of stroke rehabilitation. IMPLICATIONS FOR REHABILITATION The patient care experience is a priority in healthcare, so when patients report feeling bored and desiring greater fostering of autonomy in stroke rehabilitation, it is troubling. Research examining the use of technology has shown positive results for improving motor performance and engaging patients through entertainment and use of objective feedback. Physical and occupational therapists do not widely use technology in stroke rehabilitation. Therapists should consider using technology in stroke rehabilitation to better meet the needs of the patient.	[Langan, Jeanne] SUNY Buffalo, Dept Rehabil Sci, 522 Kimball Tower,3435 Main St, Buffalo, NY 14260 USA; [Subryan, Heamchand] SUNY Buffalo, Sch Architecture, Buffalo, NY USA; [Nwogu, Ifeoma] SUNY Buffalo, Comp Sci & Engn, Buffalo, NY USA; [Cavuoto, Lora] SUNY Buffalo, Dept Ind & Syst Engn, Buffalo, NY USA; [Nwogu, Ifeoma] Rochester Inst Technol, Comp Sci, Rochester, NY 14623 USA		Langan, J (corresponding author), SUNY Buffalo, Dept Rehabil Sci, 522 Kimball Tower,3435 Main St, Buffalo, NY 14260 USA.	jlangan@buffalo.edu		Langan, Jeanne/0000-0003-1417-2180	University at Buffalo Center for Excellence in Home Health and Well-Being through Adaptive Smart Environments	Partial funding for this project was received from the University at Buffalo Center for Excellence in Home Health and Well-Being through Adaptive Smart Environments.	Adie K, 2014, INT J STROKE, V9, P9, DOI 10.1111/ijs.12374_13; Anderson Kelly R, 2015, Arch Phys Med Rehabil, V96, P973, DOI 10.1016/j.apmr.2014.09.008; Merchan-Baeza JA, 2015, JMIR RES PROTOC, V4, DOI 10.2196/resprot.4034; Barker RN, 2005, DISABIL REHABIL, V27, P1213, DOI 10.1080/09638280500075717; Birkenmeier RL, 2010, NEUROREHAB NEURAL RE, V24, P620, DOI 10.1177/1545968310361957; Bower KJ, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0057-x; Chen MH, 2015, CLIN REHABIL, V29, P674, DOI 10.1177/0269215514554115; Chiviacowsky S, 2007, RES Q EXERCISE SPORT, V78, P40, DOI 10.1080/02701367.2007.10599402; Colomer C, 2013, NEUROLOGIA, V28, P261, DOI 10.1016/j.nrl.2012.04.017; Conroy BE, 2009, TOP STROKE REHABIL, V16, P34, DOI 10.1310/tsr1601-34; Dobkin BH, 2010, NEUROREHAB NEURAL RE, V24, P235, DOI 10.1177/1545968309357558; Eskes GA, 2015, INT J STROKE, V10, P1130, DOI 10.1111/ijs.12557; Foley N, 2012, DISABIL REHABIL, V34, P2132, DOI 10.3109/09638288.2012.676145; Fulk GD, 2014, PHYS THER, V94, P222, DOI 10.2522/ptj.20120525; Gassaway J, 2005, ARCH PHYS MED REHAB, V86, pS16, DOI 10.1016/j.apmr.2005.08.114; Geraedts H, 2013, PATIENT EDUC COUNS, V91, P14, DOI 10.1016/j.pec.2012.10.018; Harris JE, 2009, STROKE, V40, P2123, DOI 10.1161/STROKEAHA.108.544585; Jette DU, 2009, PHYS THER, V89, P125, DOI 10.2522/ptj.20080234; Jurkiewicz MT, 2011, TOP STROKE REHABIL, V18, P277, DOI 10.1310/tsr1803-277; Klein M, 2014, J BIOMED INFORM, V51, P137, DOI 10.1016/j.jbi.2014.05.005; Langan J, 2013, J REHABIL MED, V45, P217, DOI 10.2340/16501977-1115; Lange BS, 2010, PHYS MED REH CLIN N, V21, P339, DOI 10.1016/j.pmr.2009.12.007; Lenze EJ, 2012, J AM MED DIR ASSOC, V13, P708, DOI 10.1016/j.jamda.2012.06.014; Levin MF, 2015, PHYS THER, V95, P415, DOI 10.2522/ptj.20130579; Lisi AJ, 2010, J REHABIL RES DEV, V47, P1, DOI 10.1682/JRRD.2009.07.0095; Liu KPY, 2014, ARCH PHYS MED REHAB, V95, P1262, DOI 10.1016/j.apmr.2014.03.018; Luker J, 2015, ARCH PHYS MED REHAB, V96, P1698, DOI 10.1016/j.apmr.2015.03.017; Mobini A, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0070-0; Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180; Novak I, 2011, CLIN REHABIL, V25, P1066, DOI 10.1177/0269215511410727; Peel NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160906; Proffitt R, 2015, PHYS THER, V95, P441, DOI 10.2522/ptj.20130571; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Russell KL, 2010, REHABIL PSYCHOL, V55, P74, DOI 10.1037/a0018416; Ryan RM., 2008, EUR HLTH PSYCHOL, V10, P2, DOI DOI 10.1080/17509840701827437; Schaefer SY, 2013, NEUROREHAB NEURAL RE, V27, P602, DOI 10.1177/1545968313481279; Sigrist R, 2013, PSYCHON B REV, V20, P21, DOI 10.3758/s13423-012-0333-8; Snyder A, 2011, J AM MED DIR ASSOC, V12, P590, DOI 10.1016/j.jamda.2010.06.007; Stanton R, 2015, PHYSIOTHER RES INT, V20, P166, DOI 10.1002/pri.1612; Stone K, 2014, REHABIL NURS, V39, P76, DOI 10.1002/rnj.123; Sveistrup H, 2003, CYBERPSYCHOL BEHAV, V6, P245, DOI 10.1089/109493103322011524; Talvitie U, 2000, Physiother Res Int, V5, P173, DOI 10.1002/pri.197; Thogersen-Ntoumani C, 2006, J SPORT SCI, V24, P393, DOI 10.1080/02640410500131670; Thornton M, 2005, BRAIN INJURY, V19, P989, DOI 10.1080/02699050500109944; van de Port IGL, 2006, STROKE, V37, P167, DOI 10.1161/01.STR.0000195180.69904.f2; Van Vliet PM, 2006, DISABIL REHABIL, V28, P831, DOI 10.1080/09638280500534937; Veerbeek JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087987; Wingham J, 2015, CLIN REHABIL, V29, P295, DOI 10.1177/0269215514542638; Wolf SL, 2010, STROKE, V41, P2309, DOI 10.1161/STROKEAHA.110.588723; Wuest S, 2014, GAMES HEALTH J, V3, P106, DOI 10.1089/g4h.2013.0093; Wutzke CJ, 2015, PHYS THER, V95, P1244, DOI 10.2522/ptj.20140482; Wutzke CJ, 2013, TOP STROKE REHABIL, V20, P233, DOI 10.1310/tsr2003-233	52	23	23	2	17	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1748-3107	1748-3115		DISABIL REHABIL-ASSI	Disabil. Rehabil.-Assist. Technol.		2018	13	7					641	647		10.1080/17483107.2017.1362043			7	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	GR6FJ	WOS:000442740900005	28812386				2022-02-06	
S	Sussman, ES; Pendharkar, AV; Ho, AL; Ghajar, J		Hainline, B; Stern, RA		Sussman, Eric S.; Pendharkar, Arjun V.; Ho, Allen L.; Ghajar, Jamshid			Mild traumatic brain injury and concussion: terminology and classification	SPORTS NEUROLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							SPORT; ENCEPHALOPATHY; EPIDEMIOLOGY; AGREEMENT	Traumatic brain injury (TBI) is a major cause of morbidity and mortality throughout the world. Mild TBI, which is typically defined by Glasgow Coma Scale score >= 13, accounts for the vast majority of all TBIs, particularly in the setting of sports-related injuries. The terms concussion and TBI are often used interchangeably, both in the medical literature and in clinical care of this patient population. However, the lack of clearly defined definitions of these terms often leads to confusion, and this confusion may lead to delayed diagnosis and inconsistent management of affected patients. Here, we review the current terminology and classification of mild TBI and concussion. We will also discuss recent efforts to stratify these injuries into clinically relevant subtypes or profiles that are both diagnostic- and treatment-targeted.	[Sussman, Eric S.; Pendharkar, Arjun V.; Ho, Allen L.; Ghajar, Jamshid] Stanford Univ, Sch Med, Dept Neurosurg, Palo Alto, CA 94304 USA		Ghajar, J (corresponding author), Stanford Neurosci Hlth Ctr, 213 Quarry Rd, Palo Alto, CA 94304 USA.	jghajar@stanford.edu					Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Dabek Filip J, 2016, AMIA Annu Symp Proc, V2016, P460; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Fitzpatrick J, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967116675272; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Management of Concussion/mTBI Working Group, 2009, J REHABILITATION RES, V46; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Saatman K. E., 2010, NEUROTRAUM, V25, P719; Sandel N, 2017, SPORT EXERC PERFORM, V6, P304, DOI 10.1037/spy0000098; TEASDALE G, 1974, LANCET, V2, P81; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Zemek R, 2014, CAN FAM PHYSICIAN, V60, P889	23	23	23	2	2	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-463955-4; 978-0-444-63954-7	HAND CLINIC			2018	158						21	24		10.1016/B978-0-444-63954-7.00003-3			4	Clinical Neurology; Sport Sciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Sport Sciences	BP1MW	WOS:000540371100005	30482349				2022-02-06	
J	Vela, MM; Saez, DG; Simon, AR				Vela, Maria Monteagudo; Saez, Diana Garcia; Simon, Andre R.			Current approaches in retrieval and heart preservation	ANNALS OF CARDIOTHORACIC SURGERY			English	Article						Heart retrieval; heart preservation; Organ Care System (OCS); circulatory determined death (DCD) donors	DONOR HEART; CIRCULATORY DEATH; TRANSPLANTATION; PERFUSION; PROCUREMENT; OUTCOMES	Fifty years after the first successful heart transplantation, despite multiple advances in the treatment of advanced acute and chronic heart failure, there is still no equivalent to heart transplantation as a long-term treatment for end-stage heart failure. Transplantation is, however, limited by the scarcity and quality of heart allografts. Donors are nowadays significantly older, particularly in European countries, and traumatic head injury as the cause of death has been replaced by intracerebral hemorrhage or hypoxic brain damage in the majority of cases. In addition, many donors have undergone extensive resuscitation efforts. Recipient characteristics have progressively changed too within the last couple of decades; recipients are older, often with comorbidities and nearly half of them are bridged to transplant with a wide variety of mechanical circulatory support devices. These developments have resulted in heart transplant surgery becoming significantly more challenging with longer more complex surgery and increased ischemia times for organs that were previously considered to be borderline or non-transplantable in many cases. To address this, several options have been explored within the last years and as a result, novel strategies have been developed and tested in order to optimize graft preservation and potentially increase the donor pool. The two notable developments are the ability to procure hearts from donors after circulatory death and the advent of ex-vivo perfusion of hearts. This technology has made the transplantation of extended criteria organs, including those from circulatory determined death (DCD) donors possible, and allow for out of body time of more than 12 hours in heart transplantation. In this review, we set out the basis of the current practices in organ procurement, and the opportunities for the future as demands for organ transplantation continue to increase.	[Vela, Maria Monteagudo; Saez, Diana Garcia; Simon, Andre R.] Royal Brompton & Harefield NHS Fdn Trust, Harefield Hosp, Dept Cardiothorac Transplantat & Mech Circulatory, London, England		Vela, MM (corresponding author), Royal Brompton & Harefield NHS Fdn Trust, Harefield Hosp, Dept Cardiothorac Transplantat & Mech Circulatory, London, England.	m.monteagudo-vela@rbht.nhs.uk					Ardehali A, 2015, LANCET, V385, P2577, DOI 10.1016/S0140-6736(15)60261-6; Banner NR, 2008, TRANSPLANTATION, V86, P542, DOI 10.1097/TP.0b013e31818149b9; BARNARD C N, 1967, South African Medical Journal, V41, P1271; Bruinsma BG, 2017, CURR OPIN ORGAN TRAN, V22, P281, DOI 10.1097/MOT.0000000000000403; Dhital K, 2015, HEART LUNG CIRC, V24, P1191, DOI 10.1016/j.hlc.2015.05.014; Dhital KK, 2017, CURR OPIN ORGAN TRAN, V22, P189, DOI 10.1097/MOT.0000000000000419; Dhital KK, 2015, LANCET, V385, P2585, DOI 10.1016/S0140-6736(15)60038-1; Fujisaki N, 2016, MED GAS RES, V6, P122, DOI 10.4103/2045-9912.191357; Hamed A, 2009, J HEART LUNG TRANSPL, V28, pS71, DOI 10.1016/j.healun.2008.11.025; Hausenloy DJ, 2015, NEW ENGL J MED, V373, P1408, DOI 10.1056/NEJMoa1413534; Heart Overall Statistics, ISHLT REG 2016; Heart Statistics, ISHLT REG 2016; Heart Statistics, ISHLT REG 2012; Hunt SA, 2006, NEW ENGL J MED, V355, P231, DOI 10.1056/NEJMp068048; Ladowski J S, 1985, J Heart Transplant, V4, P330; Latchana N, 2014, J THORAC DIS, V6, P1143, DOI 10.3978/j.issn.2072-1439.2014.05.14; Messer S, 2015, TRANSPL INT, V28, P634, DOI 10.1111/tri.12361; Messer SJ, 2016, J HEART LUNG TRANSPL, V35, P1443, DOI 10.1016/j.healun.2016.07.004; Saez DG, 2017, J HEART LUNG TRANSPL, V36, pS17; Saez DG, 2016, J HEART LUNG TRANSPL, V35, P1255, DOI 10.1016/j.healun.2016.05.025; Saez DG, 2014, ANN THORAC SURG, V98, P2099, DOI 10.1016/j.athoracsur.2014.06.098; WATSON DC, 1979, SURGERY, V86, P56; WICOMB WN, 1984, ANN THORAC SURG, V37, P243, DOI 10.1016/S0003-4975(10)60333-5; Zimmer HG, 2004, CLIN CARDIOL, V27, P584, DOI 10.1002/clc.4960271013; Zimmer HG, 1998, NEWS PHYSIOL SCI, V13, P203	25	23	24	0	2	AME PUBL CO	SHATIN	FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA	2225-319X	2304-1021		ANN CARDIOTHORAC SUR	Ann. Cardiothorac. Surg.	JAN	2018	7	1					67	74		10.21037/acs.2018.01.06			8	Cardiac & Cardiovascular Systems; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Surgery	FX2WJ	WOS:000425924700009	29492384	Green Published, gold			2022-02-06	
J	Wang, YB; Liu, Y; Lopez, D; Lee, M; Dayal, S; Hurtado, A; Bi, XN; Baudry, M				Wang, Yubin; Liu, Yan; Lopez, Dulce; Lee, Moses; Dayal, Sujay; Hurtado, Alexander; Bi, Xiaoning; Baudry, Michel			Protection against TBI-Induced Neuronal Death with Post-Treatment with a Selective Calpain-2 Inhibitor in Mice	JOURNAL OF NEUROTRAUMA			English	Article						calpain; cell death; neuroprotection; TBI	TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; PHARMACOLOGICAL ANALYSIS; SYNAPTIC PLASTICITY; DEGRADATION; PROTEIN; MEMORY; MOUSE; DEGENERATION; SPECTRIN	Traumatic Brain Injury (TBI) is a major cause of death and disability worldwide. The calcium-dependent protease, calpain, has been shown to be involved in TBI-induced neuronal death. However, whereas various calpain inhibitors have been tested in several animal models of TBI, there has not been any clinical trial testing the efficacy of calpain inhibitors in human TBI. One important reason for this could be the lack of knowledge regarding the differential functions of the two major calpain isoforms in the brain, calpain-1 and calpain-2. In this study, we used the controlled cortical impact (CCI) model in mice to test the roles of calpain-1 and calpain-2 in TBI-induced neuronal death. Immunohistochemistry (IHC) with calpain activity markers performed at different time-points after CCI in wild-type and calpain-1 knock-out (KO) mice showed that calpain-1 was activated early in cortical areas surrounding the impact, within 0-8h after CCI, whereas calpain-2 activation was delayed and was predominant during 8-72h after CCI. Calpain-1 KO enhanced cell death, whereas calpain-2 activity correlated with the extent of cell death, suggesting that calpain-1 activation suppresses and calpain-2 activation promotes cell death following TBI. Systemic injection(s) of a calpain-2 selective inhibitor, NA101, at 1h or 4h after CCI significantly reduced calpain-2 activity and cell death around the impact site, reduced the lesion volume, and promoted motor and learning function recovery after TBI. Our data indicate that calpain-1 activity is neuroprotective and calpain-2 activity is neurodegenerative after TBI, and that a selective calpain-2 inhibitor can reduce TBI-induced cell death.	[Wang, Yubin; Liu, Yan; Lopez, Dulce; Lee, Moses; Hurtado, Alexander; Baudry, Michel] Western Univ Hlth Sci, Grad Coll Biomed Sci, 309 E 2nd St, Pomona, CA 91766 USA; [Bi, Xiaoning] Western Univ Hlth Sci, Coll Osteopath Med Pacific, Pomona, CA USA; [Dayal, Sujay] Pitzer Coll, Claremont, CA 91711 USA		Baudry, M (corresponding author), Western Univ Hlth Sci, Grad Coll Biomed Sci, 309 E 2nd St, Pomona, CA 91766 USA.	mbaudry@westernu.edu		Wang, Yubin/0000-0002-8836-9632	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS045260-01, R01NS057128]; NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R15MH101703]; Daljit and Elaine Sarkaria Chair; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS090397] Funding Source: NIH RePORTER	This work was supported by grant P01NS045260-01 from NINDS (PI: Dr. C.M. Gall), grant R01NS057128 from NINDS to M.B., and grant R15MH101703 from NIMH to X.B. X.B. is also supported by funds from the Daljit and Elaine Sarkaria Chair.	Bains M, 2013, J NEUROCHEM, V125, P125, DOI 10.1111/jnc.12118; Baudry M, 2016, TRENDS NEUROSCI, V39, P235, DOI 10.1016/j.tins.2016.01.007; Bezprozvanny I, 2009, TRENDS MOL MED, V15, P89, DOI 10.1016/j.molmed.2009.01.001; Binder S, 2005, J HEAD TRAUMA REHAB, V20, P189, DOI 10.1097/00001199-200505000-00002; Briz V, 2013, J NEUROSCI, V33, P4317, DOI 10.1523/JNEUROSCI.4907-12.2013; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Coronado VG, 2011, SURVEILLANCE TRAUMAT; Donkor IO, 2011, EXPERT OPIN THER PAT, V21, P601, DOI 10.1517/13543776.2011.568480; Gan-Or Z, 2016, AM J HUM GENET, V98, P1038, DOI 10.1016/j.ajhg.2016.04.002; Grynspan F, 1997, BRAIN RES, V763, P145, DOI 10.1016/S0006-8993(97)00384-3; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Kobeissy FH, 2015, BRAIN NEUROTRAUMA MO; Kobeissy FH, 2015, MOL NEUROBIOL, V52, P696, DOI 10.1007/s12035-014-8898-z; Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]; Liu S, 2014, BRAIN INJURY, V28, P133, DOI 10.3109/02699052.2013.860479; Liu Y, 2016, NEUROPHARMACOLOGY, V105, P471, DOI 10.1016/j.neuropharm.2016.02.022; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; Neumar RW, 2003, J BIOL CHEM, V278, P14162, DOI 10.1074/jbc.M212255200; Ono Y, 2012, BBA-PROTEINS PROTEOM, V1824, P224, DOI 10.1016/j.bbapap.2011.08.005; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; Schoch KM, 2013, J NEUROCHEM, V125, P909, DOI 10.1111/jnc.12144; Seinfeld J, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0088-15.2016; SEUBERT P, 1987, SYNAPSE, V1, P20, DOI 10.1002/syn.890010105; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Sun JD, 2015, CELL REP, V12, P449, DOI 10.1016/j.celrep.2015.06.023; Thompson SN, 2010, J NEUROTRAUM, V27, P2233, DOI 10.1089/neu.2010.1474; Wang YB, 2016, NEUROBIOL DIS, V93, P121, DOI 10.1016/j.nbd.2016.05.007; Wang YB, 2016, CELL REP, V16, P79, DOI 10.1016/j.celrep.2016.05.044; Wang YB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4051; Wang YB, 2013, J NEUROSCI, V33, P18880, DOI 10.1523/JNEUROSCI.3293-13.2013; Yamada KH, 2012, J BIOL CHEM, V287, P13182, DOI 10.1074/jbc.M111.302612; Yan XX, 2012, CURR GERIATR REP, V1, P85, DOI 10.1007/s13670-012-0009-2; Yin YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep27283	38	23	23	2	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2018	35	1					105	117		10.1089/neu.2017.5024			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FS1WO	WOS:000419569700013	28594313	Green Published			2022-02-06	
J	Yang, LJ; Wang, F; Yang, L; Yuan, YC; Chen, Y; Zhang, GS; Fan, ZZ				Yang, Lijun; Wang, Feng; Yang, Liang; Yuan, Yunchao; Chen, Yan; Zhang, Gengshen; Fan, Zhenzeng			HMGB1 a-Box Reverses Brain Edema and Deterioration of Neurological Function in a Traumatic Brain Injury Mouse Model	CELLULAR PHYSIOLOGY AND BIOCHEMISTRY			English	Article						Traumatic brain injury (TBI); High mobility group box-1 (HMGB1)	MOBILITY GROUP BOX-1; CONTROLLED CORTICAL IMPACT; CEREBRAL EDEMA; RECEPTOR 4; RATS; HEMORRHAGE; MICE; MECHANISMS; EXPRESSION; PROTEIN	Background/Aims: Traumatic brain injury (TBI) is a complex neurological injury in young adults lacking effective treatment. Emerging evidences suggest that inflammation contributes to the secondary brain injury following TBI, including breakdown of the blood brain barrier (BBB), subsequent edema and neurological deterioration. High mobility group box-1 (HMGB1) has been identified as a key cytokine in the inflammation reaction following TBI. Here, we investigated the therapeutic efficacy of HMGB1 A-box fragment, an antagonist competing with full-length HMGB1 for receptor binding, against TBI. Methods: TBI was induced by controlled cortical impact (CCI) in adult male mice. HMGB1 A-box fragment was given intravenously at 2 mg/kg/day for 3 days after CCI. HMGB1 A-box-treated CCI mice were compared with saline-treated CCI mice and sham mice in terms of BBB disruption evaluated by Evan's blue extravasation, brain edema by brain water content, cell death by propidium iodide staining, inflammation by Western blot and ELISA assay for cytokine productions, as well as neurological functions by the modified Neurological Severity Score, wire grip and beam walking tests. Results: HMGB1 A-box reversed brain damages in the mice following TBI. It significantly reduced brain edema by protecting integrity of the BBB, ameliorated cell degeneration, and decreased expression of pro-inflammatory cytokines released in injured brain after TBI. These cellular and molecular effects were accompanied by improved behavioral performance in TBI mice. Notably, HMGB1 A-box blocked IL-1 beta-induced HMGB1 release, and preferentially attenuated TLR4, Myd88 and P65 in astrocyte cultures. Conclusion: Our data suggest that HMGB1 is involved in CCI-induced TBI, which can be inhibited by HMGB1 A-box fragment. Therefore, HMGB1 A-box fragment may have therapeutic potential for the secondary brain damages in TBI. (C) 2018 The Author(s) Published by S. Karger AG, Basel	[Yang, Lijun; Wang, Feng; Yang, Liang; Yuan, Yunchao; Chen, Yan; Zhang, Gengshen; Fan, Zhenzeng] Hebei Med Univ, Hosp 2, Dept Neurosurg, 215 Heping Rd, Shijiazhuang 050000, Hebei, Peoples R China; [Yang, Lijun] Hebei Med Univ, Clin Med Postdoctoral Mobile Stn, Shijiazhuang, Hebei, Peoples R China		Fan, ZZ (corresponding author), Hebei Med Univ, Hosp 2, Dept Neurosurg, 215 Heping Rd, Shijiazhuang 050000, Hebei, Peoples R China.	Fanzhenzeng@126.com			Natural Science Foundation of Hebei Province, ChinaNatural Science Foundation of Hebei Province [H2015206201]; foundation of the Second Hospital of Hebei Medical University [2H2201510]	This project is supported by Natural Science Foundation of Hebei Province, China (Grant No. H2015206201) and foundation of the Second Hospital of Hebei Medical University (Grant No. 2H2201510).	Au AK, 2012, J NEUROTRAUM, V29, P2013, DOI 10.1089/neu.2011.2171; Bierbach B, 2008, STROKE, V39, P213, DOI 10.1161/STROKEAHA.107.496620; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Gao TL, 2012, J TRAUMA ACUTE CARE, V72, P643, DOI 10.1097/TA.0b013e31823c54a6; Guilfoyle MR, 2015, J NEUROTRAUM, V32, P1553, DOI 10.1089/neu.2014.3764; Haruma J, 2016, SCI REP-UK, V6, DOI 10.1038/srep37755; Hidaka S, 2011, J SURG RES, V165, P142, DOI 10.1016/j.jss.2009.05.039; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kokkola R, 2003, ARTHRITIS RHEUM, V48, P2052, DOI 10.1002/art.11161; Kong XQ, 2013, J VASC SURG, V57, P194, DOI 10.1016/j.jvs.2012.06.083; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; LeBlanc PM, 2014, J BIOL CHEM, V289, P7777, DOI 10.1074/jbc.M113.541474; Li JH, 2003, MOL MED, V9, P37, DOI 10.1007/BF03402105; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Mahmood A, 2008, J NEUROTRAUM, V25, P1441, DOI 10.1089/neu.2007.0495; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Mbye LH, 2012, J CEREBR BLOOD F MET, V32, P515, DOI 10.1038/jcbfm.2011.158; Musumeci D, 2014, PHARMACOL THERAPEUT, V141, P347, DOI 10.1016/j.pharmthera.2013.11.001; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Ohnishi M, 2011, NEUROPHARMACOLOGY, V61, P975, DOI 10.1016/j.neuropharm.2011.06.026; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Urday S, 2015, NAT REV NEUROL, V11, P111, DOI 10.1038/nrneurol.2014.264; Wang DL, 2017, SCI REP-UK, V7, DOI 10.1038/srep46243; WEISSMAN DE, 1988, J NEURO-ONCOL, V6, P339; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Yang Xiao-feng, 2005, Chin J Traumatol, V8, P96; Zhang CL, 2008, MED HYPOTHESES, V70, P343, DOI 10.1016/j.mehy.2007.05.024; Zhou C, 2014, EUR J PAIN, V18, P649, DOI 10.1002/j.1532-2149.2013.00416.x; Zhou CY, 2016, J NEUROSCI, V36, P2543, DOI 10.1523/JNEUROSCI.3534-15.2016	38	23	25	0	7	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-8987	1421-9778		CELL PHYSIOL BIOCHEM	Cell. Physiol. Biochem.		2018	46	6					2532	2542		10.1159/000489659			11	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	GH2SJ	WOS:000433251900029	29742510	gold			2022-02-06	
J	Yang, Q; Zhang, DS; Li, Y; Li, YQ; Li, YP				Yang, Qiu; Zhang, Dongshan; Li, Ya; Li, Yongquan; Li, Yinpeng			Paclitaxel alleviated liver injury of septic mice by alleviating inflammatory response via microRNA-27a/TAB3/NF-kappa B signaling pathway	BIOMEDICINE & PHARMACOTHERAPY			English	Article						Sepsis; Paclitaxel; Inflammatory response; MicroRNA-27a; NF-kappa B signaling pathway	NF-KAPPA-B; TRAUMATIC BRAIN-INJURY; BREAST-CANCER; OXIDATIVE STRESS; DOWN-REGULATION; EXPRESSION; SEPSIS; ACTIVATION; MECHANISMS; INHIBITION	Excessive inflammatory response and apoptosis play an important role in the sepsis-induced liver injury. Paclitaxel, a diterpene alkaloid of Taxus brevifolia, is widely used as an anti-tumor drug and shows protective effects on acute lung and kidney injury. However, whether it has a protective effect against sepsis-induced liver injury has not been reported. The objective of this study was to investigate the protective effects of paclitaxel in septic liver injury in mice and associated molecular mechanisms. Our results showed that paclitaxel treatment improved LPS-induced liver injury, as evidenced by the reduced aminotransferase activity, histological scores and apoptosis in the liver tissues. This was accompanied by the alleviating of inflammation and oxidative stress, such as decreased levels of tumor necrosis factor alpha (TNF-alpha), interleukin-1 (IL-6) interleukin-1 beta (IL-1 beta) and malondialdehyde (MDA) and increased levels of superoxide dismutase (SOD) and glutathione peroxidase (GSHpx) in serum and liver tissues. Subsequent microarray and qRT-PCR analysis further showed that miR-27a was significantly decreased in mice with sepsis, which was recovered by paclitaxel pretreatment. Antagomir-miR-27a suppressed the therapeutic effects of paclitaxel in mice liver injury model via promoting inflammatory response. Of note, TAB3, which participated in the activation of the NF-kappa B signaling pathway, was identified as a direct target of miR-27 by luciferase reporter gene assays. Then, we revealed a reverse relationship between miR-27a expression levels and TAB3 mRNA levels in liver tissues from septic mice. Furthermore, paclitaxel treatment significantly decreased the expression of NF-kappa B p65, but increased inhibitor of nuclear factor-kappa B-a (I.Ba) protein levels in septic mice, suggesting the inactivation of NF-kappa B signaling pathway. Notably, the inhibitory effects of paclitaxel on NF-kappa B signaling pathway were reversed by antagomir-miR-27a. Our data indicated that paclitaxel significantly attenuated septic induced liver injury through reducing inflammatory response via miR-27a/TAB3/NF-kappa B signaling pathway.	[Yang, Qiu; Li, Yinpeng] Jinan Univ, Clin Med Coll 2, Dept Gastroenterol, Shenzhen Peoples Hosp, 1017 Dongmen North Rd, Shenzhen 518000, Peoples R China; [Zhang, Dongshan] Cent S Univ, Xiangya Hosp 2, Dept Emergency Med, Changsha, Hunan, Peoples R China; [Zhang, Dongshan] Cent S Univ, Xiangya Hosp 2, Dept Nephrol, Changsha, Hunan, Peoples R China; [Li, Ya; Li, Yongquan] Jinan Univ, Clin Med Coll 2, Dept Nephrol, Shenzhen, Peoples R China		Li, YP (corresponding author), Jinan Univ, Clin Med Coll 2, Dept Gastroenterol, Shenzhen Peoples Hosp, 1017 Dongmen North Rd, Shenzhen 518000, Peoples R China.	li_yinpeng65@163.com			Scientific Research Project of Shenzhen Health and Family Planning System [201507002]	This study was supported by the Scientific Research Project of Shenzhen Health and Family Planning System in 2015 (NO.: 201507002).	Ayyagari VN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185111; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bennett GJ, 2011, EUR J NEUROSCI, V33, P1667, DOI 10.1111/j.1460-9568.2011.07652.x; Cai Q, 2016, NEURAL REGEN RES, V11, P1285, DOI 10.4103/1673-5374.189194; Chausovsky A, 2000, NAT CELL BIOL, V2, P797, DOI 10.1038/35041037; Chen WW, 2017, EXP CELL RES, V350, P318, DOI 10.1016/j.yexcr.2016.12.008; CHENG Y, 2015, BIOMED RES INT, V2015; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; Christman JW, 2000, CHEST, V117, P1482, DOI 10.1378/chest.117.5.1482; Chu X, 2012, J AGR FOOD CHEM, V60, P3947, DOI 10.1021/jf2051587; Du C, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-869; Einzig Avi I., 1996, Am J Ther, V3, P750, DOI 10.1097/00045391-199611000-00003; El-Tanbouly DM, 2015, PHARMACOL REP, V67, P914, DOI 10.1016/j.pharep.2015.02.004; Fumoleau P, 1997, Expert Opin Investig Drugs, V6, P1853, DOI 10.1517/13543784.6.12.1853; Geng HH, 2016, BIOMED PHARMACOTHER, V81, P258, DOI 10.1016/j.biopha.2016.04.020; Gornstein E, 2014, NEUROPHARMACOLOGY, V76, P175, DOI 10.1016/j.neuropharm.2013.08.016; Hsiao Hung-Tsung, 2016, Acta Anaesthesiol Taiwan, V54, P6, DOI 10.1016/j.aat.2015.11.002; Huang HL, 2017, CELL PHYSIOL BIOCHEM, V42, P889, DOI 10.1159/000478644; Kamp DW, 2011, ONCOLOGY-NY, V25, P400; Kim KJ, 2015, INT J MOL SCI, V16, P27589, DOI 10.3390/ijms161126048; Kronski E, 2014, MOL ONCOL, V8, P581, DOI 10.1016/j.molonc.2014.01.005; Lee KS, 2006, MOL PHARMACOL, V69, P1829, DOI 10.1124/mol.106.022228; Li LN, 2017, ONCOL LETT, V13, P4837, DOI 10.3892/ol.2017.6041; Lin WC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178387; Lin Y, 2015, ORAL ONCOL, V51, P921, DOI 10.1016/j.oraloncology.2015.07.006; Liu XJ, 2017, INT IMMUNOPHARMACOL, V49, P50, DOI 10.1016/j.intimp.2017.05.022; Liu XP, 2015, ONCOTARGET, V6, P20070, DOI 10.18632/oncotarget.4039; Luo CF, 2015, MOL MED REP, V12, P1082, DOI 10.3892/mmr.2015.3527; Lv X, 2015, MOL MED REP, V12, P6013, DOI 10.3892/mmr.2015.4188; Lv YN, 2017, CELL MOL NEUROBIOL, V37, P195, DOI 10.1007/s10571-016-0361-4; Malacarne P, 2008, CRIT CARE MED, V36, P1105, DOI 10.1097/CCM.0b013e318169ed30; Mirzapolazova T, 2007, EUR RESPIR J, V30, P429, DOI 10.1183/09031936.00154206; Oliva-Gonzalez C, 2017, TOXICOL LETT, V280, P92, DOI 10.1016/j.toxlet.2017.08.013; Panagiotou Anthi, 2013, J Intensive Care Med, V28, P281, DOI 10.1177/0885066611425759; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Pfeiffer D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179850; ROWINSKY EK, 1993, SEMIN ONCOL, V20, P1; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Shin JS, 2016, J CELL BIOCHEM, V117, P2327, DOI 10.1002/jcb.25530; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Sun LQ, 2017, BIOCHEM BIOPH RES CO, V482, P1141, DOI 10.1016/j.bbrc.2016.12.001; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; ten Tije AJ, 2003, CLIN PHARMACOKINET, V42, P665, DOI 10.2165/00003088-200342070-00005; Wang P, 2017, INT IMMUNOPHARMACOL, V51, P9, DOI 10.1016/j.intimp.2017.07.020; Wang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080547; Wolf S, 2008, EUR J CANCER, V44, P1507, DOI 10.1016/j.ejca.2008.04.018; Wu YM, 2016, BIOMED PHARMACOTHER, V84, P1126, DOI 10.1016/j.biopha.2016.10.024; Xue WL, 2015, BIOCHEM BIOPH RES CO, V464, P855, DOI 10.1016/j.bbrc.2015.07.051; Zasadil LM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007965; Zhang BT, 2016, ONCOTARGET, V7, P5702, DOI 10.18632/oncotarget.6790; Zhang DS, 2013, J PHARMACOL EXP THER, V345, P69, DOI 10.1124/jpet.112.202481; Zhang DS, 2010, LAB INVEST, V90, P436, DOI 10.1038/labinvest.2009.149; Zhang Y., 2015, J NANOMATER, V2015, P1, DOI [DOI 10.1038/CR.2015.77, DOI 10.1080/10298436.2015.1019502]; Zhao Y. N., 2013, BIOCH BIOPHYS RES CO, V435; Zheng D, 2016, J INFECT DIS, V213, P1661, DOI 10.1093/infdis/jiv760; Zhong WH, 2016, BIOMED PHARMACOTHER, V83, P302, DOI 10.1016/j.biopha.2016.06.036; Zhou LF, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-146; Zhu HG, 2017, BIOMED PHARMACOTHER, V92, P879, DOI 10.1016/j.biopha.2017.05.143	60	23	24	1	14	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0753-3322	1950-6007		BIOMED PHARMACOTHER	Biomed. Pharmacother.	JAN	2018	97						1424	1433		10.1016/j.biopha.2017.11.003			10	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	FR4NC	WOS:000419041300171	29156532				2022-02-06	
J	Yang, YK; Wei, H; Zhou, XH; Zhang, F; Wang, CH				Yang, Yongkai; Wei, Hao; Zhou, Xiaohui; Zhang, Fan; Wang, Chunhua			Hyperbaric oxygen promotes neural stem cell proliferation by activating vascular endothelial growth factor/extracellular signal-regulated kinase signaling after traumatic brain injury	NEUROREPORT			English	Article						extracellular signal-regulated kinase; hyperbaric oxygen; neural stem cells; traumatic brain injury; vascular endothelial growth factor	RAT MODEL; VEGF; DIFFERENTIATION; NEUROGENESIS; EXPRESSION; PATHWAY	Hyperbaric oxygen (HBO) therapy and neural stem cell (NSC) transplantation can improve traumatic brain injury (TBI) clinically. This study aimed to investigate the mechanism of HBO promoting NSC proliferation and neurological recovery after TBI. Twenty-four Sprague-Dawley rats were divided randomly into three groups: a sham group, a TBI group (constructed using Feeney's free-fall method), and an HBO-treated TBI group. Neurological function was evaluated by Neurological Severity Scores on days 1, 3, and 7, and we found that TBI-induced poor neurological function was improved by HBO. On day 7 after TBI, we observed that TBI promoted NSC proliferation, migration to the lesion area, and the levels of vascular endothelial growth factor (VEGF), VEGFR2, Raf-1, MEK1/2, and phospho-extracellular signal-regulated kinase (ERK) 1/2 protein, which were further boosted by HBO, from immunohistochemistry, immunofluorescence, and Western blot experiments. In vitro, cell injury was applied to NSCs isolated from neonatal Sprague-Dawley rats by the Cell Injury Controller II system. Moreover, data from the BrdU Kit and Western blot showed that in-vitro HBO significantly accelerated NSC proliferation and the levels of proteins related to cell cycle and the VEGF/ERK pathway after cell injury, which was suppressed by the VEGFR2 inhibitor. Taken together, this study indicated that HBO may promote NSC proliferation by activating VEGF/ERK signaling and play a crucial role in neuroprotection after TBI.	[Yang, Yongkai; Wei, Hao; Zhou, Xiaohui; Zhang, Fan] Fujian Med Univ, Hosp Fuzhou City Affiliated 1, Dept Neurosurg, Fuzhou 350009, Fujian, Peoples R China; [Wang, Chunhua] Res Inst Fujian Prov, Dept Neurosurg, Fuzhou, Fujian, Peoples R China		Zhang, F (corresponding author), Fujian Med Univ, Hosp Fuzhou City Affiliated 1, Dept Neurosurg, Fuzhou 350009, Fujian, Peoples R China.	fanzhangfj@163.com			Cultural Project of Innovative Research Team in Fuzhou Health and Family Planning System [2013-S-wt1]; Special Project on Research and Development of Non Affiliated Hospitals of Fujian Medical University [FZS13002Z]; Project of the Natural Science Foundation of Fujian Province [2015J01498]	This work was supported partially by grants from the Cultural Project of Innovative Research Team in Fuzhou Health and Family Planning System (2013-S-wt1); the Special Project on Research and Development of Non Affiliated Hospitals of Fujian Medical University (FZS13002Z); and the Project of the Natural Science Foundation of Fujian Province (2015J01498).	Alexiades NG, 2015, STEM CELL RES, V15, P598, DOI 10.1016/j.scr.2015.10.005; Covacu R., 2015, NEUROSCIENTIST; Du YB, 2016, MOL MED REP, V14, P2473, DOI 10.3892/mmr.2016.5582; Feng ZC, 2013, NEURAL REGEN RES, V8, P1220, DOI 10.3969/j.issn.1673-5374.2013.13.007; Haigh CL, 2016, CELL BIOCHEM BIOPHYS, V74, P297, DOI 10.1007/s12013-016-0747-4; Han W, 2017, EPILEPSY BEHAV, V68, P159, DOI 10.1016/j.yebeh.2016.12.007; Huang L, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-21; Kirby ED, 2015, P NATL ACAD SCI USA, V112, P4128, DOI 10.1073/pnas.1422448112; Kleiderman S, 2016, STEM CELLS, V34, P2861, DOI 10.1002/stem.2483; Li XR, 2016, GENE, V590, P201, DOI 10.1016/j.gene.2015.11.047; Liu CX, 2015, CELL MOL BIOL, V61, P75; Liu XH, 2014, SPINE J, V14, P119, DOI 10.1016/j.spinee.2013.06.084; Meng XE, 2016, MED SCI MONITOR, V22, P284, DOI 10.12659/MSM.894148; Oh JS, 2012, NEUROREPORT, V23, P174, DOI 10.1097/WNR.0b013e32834f4f3a; Peng ZR, 2014, J NEUROL SCI, V342, P114, DOI 10.1016/j.jns.2014.04.037; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Takahashi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116119; Wang YM, 2007, J NEUROSCI RES, V85, P740, DOI 10.1002/jnr.21169; Wee HY, 2015, J SURG RES, V197, P382, DOI 10.1016/j.jss.2015.04.052; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088; Xu ZM, 2017, J NEUROTRAUM, V34, P925, DOI 10.1089/neu.2016.4491; Zhang P, 2016, SCI REP-UK, V6, DOI 10.1038/srep26295; Zhang XY, 2011, CELL MOL NEUROBIOL, V31, P101, DOI 10.1007/s10571-010-9559-z; Zhou Y, 2013, CHINESE MED J-PEKING, V126, P3897, DOI 10.3760/cma.j.issn.0366-6999.20130571	24	23	29	2	21	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	DEC 13	2017	28	18					1232	1238		10.1097/WNR.0000000000000901			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FN4EV	WOS:000415958000008	28953090				2022-02-06	
J	Davis-Hayes, C; Gossett, JD; Levine, WN; Shams, T; Harada, J; Mitnick, J; Noble, J				Davis-Hayes, Cecilia; Gossett, James D.; Levine, William N.; Shams, Tanzid; Harada, Jumpei; Mitnick, Jeremy; Noble, James			Sex-specific Outcomes and Predictors of Concussion Recovery	JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS			English	Article							SPORT-RELATED CONCUSSION; STATES HIGH-SCHOOL; INTERNATIONAL-CONFERENCE; AGREEMENT STATEMENT; CONSENSUS STATEMENT; SYMPTOM RESOLUTION; PROLONGED RECOVERY; FOOTBALL PLAYERS; COLLEGIATE; EPIDEMIOLOGY	Introduction: Sports-related concussion (SRC) is a substantial concern in collegiate athletics. Some studies of SRC that make comparisons by sex are limited by sample size, follow-up duration, or referral bias. Sex-specific predictors of occurrence and recovery are uncertain. Methods: A 15-year retrospective cohort study identified 1,200 Columbia University varsity athletes (822 male [68.5%], 378 female [31.5%]) at risk of collegiate SRC. Results: A total of 228 athletes experienced at least one collegiate concussion, including 88 female athletes (23.3% of female athletes) and 140 male athletes (17.0% of male athletes) (P = 0.01); follow-up data were available on 97.8% of these athletes. Postconcussion symptoms were similar by sex, with the exception of sleep disturbance (29.3% of male athletes versus 42.0% of female athletes; P = 0.048) and memory impairment (43.6% of male athletes versus 30.7% of female athletes; P = 0.052), although the latter difference was not statistically significant. Risk factors for collegiate concussion included female sex (odds ratio [OR], 1.5; 95% confidence interval [CI], 1.1 to 2.0) or precollegiate concussion (OR, 2.9; 95% CI, 2.2 to 3.9). Prolonged recovery was predicted by the presence of eight or more postconcussion symptoms for all athletes (OR, 3.77; 95% CI, 1.68 to 8.46) and for female athletes only (OR, 8.24; 95% CI, 1.58 to 43.0); this finding was not statistically significant for male athletes. Discussion: Female athletes were more likely than male athletes to experience concussion. Increasing numbers of prior concussions predicted recurrence. Although most postconcussion symptoms were highly intercorrelated, the total number of symptoms predicted a prolonged recovery period. Conclusion: This study confirms sex-based differences in SRCs. Longitudinal studies of collegiate cohorts should attempt to limit follow-up bias and offer opportunities to clarify determinants of SRC.	[Davis-Hayes, Cecilia] Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA; [Gossett, James D.; Harada, Jumpei] Columbia Univ, Columbia Athlet, New York, NY USA; [Levine, William N.] Columbia Univ, Dept Orthopaed, New York, NY USA; [Noble, James] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, Dept Neurol, New York, NY USA; [Noble, James] Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10027 USA; [Shams, Tanzid] East Tennessee State Univ, Quillen Coll Med, Dept Neurol, Johnson City, TN 37614 USA; [Mitnick, Jeremy] Univ Michigan, Dept Neurosci, Ann Arbor, MI 48109 USA		Davis-Hayes, C (corresponding author), Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA.		Noble, James/AAA-4218-2020	Noble, James/0000-0003-0648-6702			[Anonymous], EST PROB COMP COLL A; Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Erlanger D, 2001, J ATHL TRAINING, V36, P280; Erlanger DM, 2002, J HEAD TRAUMA REHAB, V17, P458, DOI 10.1097/00001199-200210000-00007; ERLANGER DM, 2002, HEADMINDER CONCUSSIO; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Houck Z, 2016, AM J SPORT MED, V44, P2269, DOI 10.1177/0363546516645070; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; Kelly JP, 1997, NEUROLOGY, V48, P581; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; National Collegiate Athletic Association, STUD ATHL PART 1981; National Collegiate Athletic Association, 2013, 2013 2014 SPORTS MED; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Resch JE, 2015, J ATHL TRAINING, V50, P1292, DOI 10.4085/1062-6050-50.12.03; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Shams T, 2013, AM NEUR ASS 2013 ANN; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537	42	23	23	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1067-151X	1940-5480		J AM ACAD ORTHOP SUR	J. Am. Acad. Orthop. Surg.	DEC	2017	25	12					818	828		10.5435/JAAOS-D-17-00276			11	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	FS5EM	WOS:000419816400008	29176505				2022-02-06	
J	Theus, MH; Brickler, T; Meza, AL; Coutermarsh-Ott, S; Hazy, A; Gris, D; Allen, IC				Theus, Michelle H.; Brickler, Thomas; Meza, Armand L.; Coutermarsh-Ott, Sheryl; Hazy, Amanda; Gris, Denis; Allen, Irving C.			Loss of NLRX1 Exacerbates Neural Tissue Damage and NF-kappa B Signaling following Brain Injury	JOURNAL OF IMMUNOLOGY			English	Article							NOD-LIKE RECEPTOR; NUCLEAR TRANSLOCATION; SUBVENTRICULAR ZONE; NLRP3 INFLAMMASOME; COLON INFLAMMATION; INDUCED APOPTOSIS; TUMOR-SUPPRESSOR; I INTERFERON; EXPRESSION; NEURONS	Traumatic and nontraumatic brain injury results from severe disruptions in the cellular microenvironment leading to massive loss of neuronal populations and increased neuroinflammation. The progressive cascade of secondary events, including ischemia, inflammation, excitotoxicity, and free-radical release, contribute to neural tissue damage. NLRX1 is a member of the NLR family of pattern recognition receptors and is a potent negative regulator of several pathways that significantly modulate many of these events. Thus, we hypothesized that NLRX1 limits immune system signaling in the brain following trauma. To evaluate this hypothesis, we used Nlrx1(-/-) mice in a controlled cortical impact (CCI) injury murine model of traumatic brain injury (TBI). In this article, we show that Nlrx1(-/-) mice exhibited significantly larger brain lesions and increased motor deficits following CCI injury. Mechanistically, our data indicate that the NF-kappa B signaling cascade is significantly upregulated in Nlrx1(-/-) animals. This upregulation is associated with increased microglia and macrophage populations in the cortical lesion. Using a mouse neuroblastoma cell line (N2A), we also found that NLRX1 significantly reduced apoptosis under hypoxic conditions. In human patients, we identify 15 NLRs that are significantly dysregulated, including significant downregulation of NLRX1 in brain injury following aneurysm. We further demonstrate a concurrent increase in NF-kappa B signaling that is correlated with aneurysm severity in these human subjects. Together, our data extend the function of NLRX1 beyond its currently characterized role in host-pathogen defense and identify this highly novel NLR as a significant modulator of brain injury progression.	[Theus, Michelle H.; Brickler, Thomas; Meza, Armand L.; Coutermarsh-Ott, Sheryl; Hazy, Amanda; Allen, Irving C.] Virginia Tech, Dept Biomed Sci & Pathobiol, Virginia Maryland Coll Vet Med, IDRF 140,Duckpond Dr, Blacksburg, VA 24061 USA; [Meza, Armand L.] Virginia Tech, Dept Neurosci, Blacksburg, VA 24061 USA; [Gris, Denis] Univ Sherbrooke, Fac Med & Sci Sante, Programme Immunol, Sherbrooke, PQ J1H 5N4, Canada		Theus, MH; Allen, IC (corresponding author), Virginia Tech, Dept Biomed Sci & Pathobiol, Virginia Maryland Coll Vet Med, IDRF 140,Duckpond Dr, Blacksburg, VA 24061 USA.	mtheus@vt.edu; icallen@vt.edu	Gris, Denis/ABE-5229-2021	Gris, Denis/0000-0003-1215-2434	National Institute of Neurological Disease and Stroke Awards [NS096281, NS081623]; National Institute of Allergy and Infectious Diseases Animal Model Research for Veterinarians Training Grant [T32-OD010430]; Virginia Tech Initiative for Maximizing Student Development program [GM0727-09]; Virginia Tech Post-Baccalaureate Research and Education Program [GM066534-14]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS096281, R15NS081623] Funding Source: NIH RePORTER	This work was supported by National Institute of Neurological Disease and Stroke Awards NS096281 and NS081623. Student work was supported by National Institute of Allergy and Infectious Diseases Animal Model Research for Veterinarians Training Grant T32-OD010430 (to S.C.-O.). Student support throughout this project was also provided by the Virginia Tech Initiative for Maximizing Student Development program (GM0727-09) and the Virginia Tech Post-Baccalaureate Research and Education Program (GM066534-14). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or any other funding agency.	Abdul-Sater AA, 2010, J BIOL CHEM, V285, P41637, DOI 10.1074/jbc.M110.137885; Allen IC, 2012, IMMUNITY, V36, P742, DOI 10.1016/j.immuni.2012.03.012; Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; Allen IC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00169; Arnoult D, 2009, J CELL SCI, V122, P3161, DOI 10.1242/jcs.051193; Bai X, 2014, NEUROCHEM RES, V39, P1405, DOI 10.1007/s11064-014-1326-y; Baumann G, 2013, EXP BIOL MED, V238, P830, DOI 10.1177/1535370213494558; Boissiere F, 1997, NEUROREPORT, V8, P2849, DOI 10.1097/00001756-199709080-00009; Brickler T, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6373506; Coutermarsh-Ott S, 2016, ONCOTARGET, V7, P33096, DOI 10.18632/oncotarget.8861; Coutermarsh-Ott S, 2016, J GEN VIROL, V97, P825, DOI 10.1099/jgv.0.000401; Denes A, 2015, P NATL ACAD SCI USA, V112, P4050, DOI 10.1073/pnas.1419090112; Eitas TK, 2014, J BIOL CHEM, V289, P4173, DOI 10.1074/jbc.M113.533034; Fann DYW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.326; Gao F, 2013, J SURG RES, V184, P944, DOI 10.1016/j.jss.2013.03.034; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P18754, DOI 10.1073/pnas.0704908104; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hayman EG, 2017, NEUROCRIT CARE, V26, P301, DOI 10.1007/s12028-016-0354-7; He Y., 2015, INT J POLYM SCI, V2015, P1, DOI DOI 10.1155/2015/685684; Hunot S, 1997, P NATL ACAD SCI USA, V94, P7531, DOI 10.1073/pnas.94.14.7531; Hwang CJ, 2015, MOL NEUROBIOL, V51, P648, DOI 10.1007/s12035-014-8739-0; Imbeault E, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0090-x; Jaworska J, 2014, P NATL ACAD SCI USA, V111, pE2110, DOI 10.1073/pnas.1322118111; Kaltschmidt B, 1997, P NATL ACAD SCI USA, V94, P2642, DOI 10.1073/pnas.94.6.2642; Kang MJ, 2015, J CLIN INVEST, V125, P2458, DOI 10.1172/JCI71747; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Koblansky AA, 2016, CELL REP, V14, P2562, DOI 10.1016/j.celrep.2016.02.064; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Lei Y, 2016, ONCOGENE, V35, P4698, DOI 10.1038/onc.2016.11; Lei Y, 2013, AUTOPHAGY, V9, P432, DOI 10.4161/auto.23026; Lei Y, 2012, IMMUNITY, V36, P933, DOI 10.1016/j.immuni.2012.03.025; Li HY, 2010, EUR J PHARMACOL, V649, P92, DOI 10.1016/j.ejphar.2010.09.023; Li L, 2009, EUR NEUROL, V62, P330, DOI 10.1159/000236911; Lian H, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-47; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Liu HQ, 2015, INT J BIOL SCI, V11, P525, DOI 10.7150/ijbs.10927; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lukens JR, 2011, DISCOV MED, V11, P65; Lukens JR, 2015, IMMUNITY, V42, P654, DOI 10.1016/j.immuni.2015.03.006; Lukiw WJ, 1998, J NEUROSCI RES, V53, P583, DOI 10.1002/(SICI)1097-4547(19980901)53:5<583::AID-JNR8>3.3.CO;2-B; Lupfer C, 2013, IMMUNOL REV, V255, P13, DOI 10.1111/imr.12089; Ma J, 2016, INFLAMMATION, V39, P2094, DOI 10.1007/s10753-016-0446-8; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Nakaoka H, 2014, STROKE, V45, P2239, DOI 10.1161/STROKEAHA.114.005851; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Saragoni L, 2000, NEUROCHEM RES, V25, P59, DOI 10.1023/A:1007587315630; Saresella M, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0088-1; Schneider M, 2012, NAT IMMUNOL, V13, P823, DOI 10.1038/ni.2378; Sehba FA, 2012, PROG NEUROBIOL, V97, P14, DOI 10.1016/j.pneurobio.2012.02.003; Simmons LJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0703-7; Singh K, 2015, BBA-MOL CELL RES, V1853, P1073, DOI 10.1016/j.bbamcr.2015.01.016; Soares F, 2014, J BIOL CHEM, V289, P19317, DOI 10.1074/jbc.M114.550111; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Theus MH, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.165; Theus MH, 2010, STEM CELLS, V28, P1231, DOI 10.1002/stem.449; Tremblay RG, 2010, J NEUROSCI METH, V186, P60, DOI 10.1016/j.jneumeth.2009.11.004; Uchiyama Y, 2004, AM J NEURORADIOL, V25, P1783; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022; Zhou Y, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0094-3	65	23	26	0	8	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	NOV 15	2017	199	10					3547	3558		10.4049/jimmunol.1700251			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FM0MK	WOS:000414660600015	28993512	Bronze, Green Accepted			2022-02-06	
J	Su, WS; Wu, CH; Chen, SF; Yang, FY				Su, Wei-Shen; Wu, Chun-Hu; Chen, Szu-Fu; Yang, Feng-Yi			Low-intensity pulsed ultrasound improves behavioral and histological outcomes after experimental traumatic brain injury	SCIENTIFIC REPORTS			English	Article							FOCUSED ULTRASOUND; HEAD-INJURY; RAT MODEL; EDEMA; STIMULATION; BARRIER; DAMAGE; PATHOPHYSIOLOGY; IMPACT; FLOW	The purpose of this study was to investigate the neuroprotective effects of low-intensity pulsed ultrasound (LIPUS) on behavioral and histological outcomes in a mouse model of traumatic brain injury (TBI). Mice subjected to controlled cortical impact injury were treated with LIPUS in the injured region daily for a period of 4 weeks. The effects of LIPUS on edema were observed by MR imaging in the mouse brain at 1 and 4 days following TBI. Brain water content, blood-brain barrier permeability, histology analysis, and behavioral studies were performed to assess the effects of LIPUS. Two-way analysis of variance and Student t test were used for statistical analyses, with a significant level of 0.05. Treatment with LIPUS significantly attenuated brain edema, blood-brain barrier permeability, and neuronal degeneration beginning at day 1. Compared with the TBI group, LIPUS also significantly improved functional recovery and reduced contusion volumes up to post-injury day 28. Post-injury LIPUS treatment reduced brain edema and improved behavioral and histological outcomes following TBI. The neuroprotective effects of LIPUS may be a promising new technique for treating TBI.	[Su, Wei-Shen; Yang, Feng-Yi] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan; [Wu, Chun-Hu] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chen, Szu-Fu] Natl Def Med Ctr, Dept Physiol, Taipei, Taiwan; [Chen, Szu-Fu] Natl Def Med Ctr, Dept Biophys, Taipei, Taiwan; [Chen, Szu-Fu] Cheng Hsin Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Yang, Feng-Yi] Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr, Taipei, Taiwan		Yang, FY (corresponding author), Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan.; Chen, SF (corresponding author), Natl Def Med Ctr, Dept Physiol, Taipei, Taiwan.; Chen, SF (corresponding author), Natl Def Med Ctr, Dept Biophys, Taipei, Taiwan.; Chen, SF (corresponding author), Cheng Hsin Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.; Yang, FY (corresponding author), Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr, Taipei, Taiwan.	szufuchen@yahoo.com.tw; fyyang@ym.edu.tw	WU, CHUN-HU/P-3958-2018	WU, CHUN-HU/0000-0001-6851-7936	Ministry of Science and Technology of TaiwanMinistry of Science and Technology, Taiwan [MOST 105-2221-E-010-003, MOST 104-2314-B-010-003-MY3, 101-2314-B-350-001-MY3]; Veterans General Hospitals University System of Taiwan Joint Research Program [VGHUST106-G7-6-1]; Cheng Hsin General Hospital Foundation [CY10622, CY10418, CHGH103-34]; Taiwan Ministry of Education's Aim for the Top University Plan	This study was supported by grants from the Ministry of Science and Technology of Taiwan (no. MOST 105-2221-E-010-003, MOST 104-2314-B-010-003-MY3, and 101-2314-B-350-001-MY3), the Veterans General Hospitals University System of Taiwan Joint Research Program (#VGHUST106-G7-6-1), the Cheng Hsin General Hospital Foundation (no. CY10622, CY10418 and CHGH103-34), and the Taiwan Ministry of Education's Aim for the Top University Plan.	Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Chen CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115694; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030294; Chen SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045763; Crisci AR, 2002, ULTRASOUND MED BIOL, V28, P1335, DOI 10.1016/S0301-5629(02)00576-8; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; FRY WJ, 1968, J ACOUST SOC AM, V44, P919, DOI 10.1121/1.1911230; Gavrilov LR, 1996, ULTRASOUND MED BIOL, V22, P179, DOI 10.1016/0301-5629(96)83782-3; GOLDSTEIN LB, 1990, J NEUROSCI METH, V31, P101, DOI 10.1016/0165-0270(90)90154-8; Hou CH, 2009, J CELL BIOCHEM, V106, P7, DOI 10.1002/jcb.21934; Huang SL, 2017, RADIOLOGY, V282, P113, DOI 10.1148/radiol.2016160095; Karmacharya MB, 2015, NEUROPATH APPL NEURO, V41, pe80, DOI 10.1111/nan.12182; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; Kovacs ZI, 2017, P NATL ACAD SCI USA, V114, pE75, DOI 10.1073/pnas.1614777114; Lee JF, 2006, J BIOL CHEM, V281, P29190, DOI 10.1074/jbc.M604310200; Lin WT, 2015, SCI REP-UK, V5, DOI 10.1038/srep09671; Liu SH, 2017, CEREB CORTEX, V27, P3152, DOI 10.1093/cercor/bhw169; Lu HB, 2006, AM J SPORT MED, V34, P1287, DOI 10.1177/0363546506286788; Marmarou A, 1980, Adv Neurol, V28, P345; Marmarou A, 2003, ACT NEUR S, V86, P7; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Namas R, 2009, LIBYAN J MED, V4, P97, DOI 10.4176/090325; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; REULEN HJ, 1977, J NEUROSURG, V46, P24, DOI 10.3171/jns.1977.46.1.0024; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Su WS, 2015, ONCOTARGET, V6, P42290, DOI 10.18632/oncotarget.5978; Wu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113397; Yang FY, 2015, BRAIN STIMUL, V8, P465, DOI 10.1016/j.brs.2014.11.017; Yang FY, 2012, J CONTROL RELEASE, V160, P652, DOI 10.1016/j.jconrel.2012.02.023; Yang FY, 2011, J NUCL MED, V52, P478, DOI 10.2967/jnumed.110.083071; Yang FY, 2011, J CONTROL RELEASE, V150, P111, DOI 10.1016/j.jconrel.2010.10.038; Yoon SH, 2012, PEDIATR NEUROSURG, V48, P102, DOI 10.1159/000343011; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	33	23	24	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	NOV 14	2017	7								15524	10.1038/s41598-017-15916-2			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM6MF	WOS:000415166000020	29138458	gold, Green Published			2022-02-06	
J	Thelin, EP; Hall, CE; Gupta, K; Carpenter, KLH; Chandran, S; Hutchinson, PJ; Patani, R; Helmy, A				Thelin, Eric Peter; Hall, Claire E.; Gupta, Kunal; Carpenter, Keri L. H.; Chandran, Siddharthan; Hutchinson, Peter J.; Patani, Rickie; Helmy, Adel			Elucidating Pro-inflammatory Cytokine Responses after Traumatic Brain Injury in a Human Stem Cell Model	JOURNAL OF NEUROTRAUMA			English	Article						cytokine exposure; human embryonic stem cell-derived neurons; interleukin-1 beta; interleukin-6; in vitro; tumor necrosis factor	NECROSIS-FACTOR-ALPHA; INTERLEUKIN-1 RECEPTOR ANTAGONIST; CENTRAL-NERVOUS-SYSTEM; ANTIINFLAMMATORY CYTOKINES; MESSENGER-RNA; NITRIC-OXIDE; HEAD-INJURY; TNF-ALPHA; IN-VITRO; EXPRESSION	Cytokine mediated inflammation likely plays an important role in secondary pathology after traumatic brain injury (TBI). The aim of this study was to elucidate secondary cytokine responses in an in vitro enriched (>80%) human stem cell-derived neuronal model. We exposed neuronal cultures to pre-determined and clinically relevant pathophysiological levels of tumor necrosis factor-alpha (TNF), interleukin-6 (IL-6) and interleukin-1 beta (IL-1 beta), shown to be present in the inflammatory aftermath of TBI. Data from this reductionist human model were then compared with our in vivo data. Human embryonic stem cell (hESC)-derived neurons were exposed to recombinant TNF (1-10,000pg/mL), IL-1 beta (1-10,000pg/mL), and IL-6 (0.1-1000ng/mL). After 1, 24, and 72h, culture supernatant was sampled and analyzed using a human cytokine/chemokine 42-plex Milliplex kit on the Luminex platform. The culture secretome revealed both a dose- and/or time-dependent release of cytokines. The IL-6 and TNF exposure each resulted in significantly increased levels of >10 cytokines over time, while IL-1 beta increased the level of C-X-C motif chemokine 10 (CXCL10/IP10) alone. Importantly, these patterns are consistent with our in vivo (human) TBI data, thus validating our human stem cell-derived neuronal platform as a clinically useful reductionist model. Our data cumulatively suggest that IL-6 and TNF have direct actions, while the action of IL-1 beta on human neurons likely occurs indirectly through inflammatory cells. The hESC-derived neurons provide a valuable platform to model cytokine mediated inflammation and can provide important insights into the mechanisms of neuroinflammation after TBI.	[Thelin, Eric Peter; Carpenter, Keri L. H.; Hutchinson, Peter J.; Helmy, Adel] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Box 167,Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Thelin, Eric Peter] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Hall, Claire E.; Patani, Rickie] UCL, Inst Neurol, Dept Mol Neurosci, Queen Sq, London WC1N 3BG, England; [Gupta, Kunal] Oregon Hlth & Sci Univ, Dept Neurol Surg, Portland, OR 97201 USA; [Carpenter, Keri L. H.; Hutchinson, Peter J.] Univ Cambridge, Dept Clin Neurosci, Wolfson Brain Imaging Ctr, Cambridge, England; [Chandran, Siddharthan] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Patani, Rickie] Francis Crick Inst, London, England		Helmy, A (corresponding author), Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Box 167,Cambridge Biomed Campus, Cambridge CB2 0QQ, England.; Patani, R (corresponding author), UCL, Inst Neurol, Dept Mol Neurosci, Queen Sq, London WC1N 3BG, England.	rickie.patani@ucl.ac.uk; adelhelmy@cantab.net	Patani, R/J-3107-2018; Helmy, Adel/AAS-3084-2020; Thelin, Eric Peter/K-2144-2012	Patani, R/0000-0002-3825-7675; Helmy, Adel/0000-0002-0531-0556; Thelin, Eric Peter/0000-0002-2338-4364; Carpenter, Keri/0000-0001-8236-7727; Gupta, Kunal/0000-0002-9847-0099	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986 ID79068]; National Institute for Health Research Biomedical Research Centre, CambridgeNational Institute for Health Research (NIHR); Swedish Society of Medicine [SLS-587221]; National Institute for Health Research Professorship; Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship; Medical Research Council/Royal College of Surgeons of England Clinical Research Training FellowshipUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Royal College of Surgeons of England Pump Priming Grant; Wellcome TrustWellcome TrustEuropean Commission [101149/Z/13/A]; National Institute for Health Research University College London Hospitals Biomedical Research CentreGeneral Electric; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G1002277, G0802251, G0600986, MR/R005036/1] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [ACF-2006-14-004, NIHR-RP-R3-12-013] Funding Source: researchfish; Wellcome TrustWellcome TrustEuropean Commission [101149/Z/13/Z] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/R005036/1, G1002277, G0802251, G0600986] Funding Source: UKRI	The author(s) gratefully acknowledge receipt of the following financial support. Medical Research Council (Grant No. G0600986 ID79068) and National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme). Authors' support: EPT - Swedish Society of Medicine (Grant no. SLS-587221); KLHC - National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme); PJH - National Institute for Health Research Professorship, Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship and the National Institute for Health Research Biomedical Research Centre, Cambridge; AH - Medical Research Council/Royal College of Surgeons of England Clinical Research Training Fellowship, Royal College of Surgeons of England Pump Priming Grant and the National Institute for Health Research Biomedical Research Centre, Cambridge; RP - Wellcome Trust Intermediate Clinical Fellow (101149/Z/13/A). We acknowledge support from the National Institute for Health Research University College London Hospitals Biomedical Research Centre. The funding bodies did not participate in the design of the study; collection, analysis, and interpretation of data; and writing of the article.	Acarin L, 2000, EUR J NEUROSCI, V12, P3505, DOI 10.1046/j.1460-9568.2000.00226.x; Ahn MJ, 2004, J NEUROTRAUM, V21, P1431, DOI 10.1089/neu.2004.21.1431; ALOISI F, 1992, J IMMUNOL, V149, P2358; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Babcock AA, 2006, J NEUROSCI, V26, P12826, DOI 10.1523/JNEUROSCI.4937-05.2006; BENVENISTE EN, 1992, AM J PHYSIOL, V263, pC1, DOI 10.1152/ajpcell.1992.263.1.C1; Carlson NG, 1999, J IMMUNOL, V163, P3963; Cavaillon JM, 2001, CELL MOL BIOL, V47, P695; Cebrian C, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00114; Cebrian C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4633; Chao CC, 1995, BRAIN BEHAV IMMUN, V9, P355, DOI 10.1006/brbi.1995.1033; Chatzipanteli K, 2012, THER HYPOTHERMIA TEM, V2, P167, DOI 10.1089/ther.2012.0016; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chen WQ, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0847-0; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; CHUNG IY, 1990, J IMMUNOL, V144, P2999; Deshpande M, 2005, NEUROTOX RES, V7, P183, DOI 10.1007/BF03036448; Downen M, 1999, GLIA, V28, P114, DOI 10.1002/(SICI)1098-1136(199911)28:2<114::AID-GLIA3>3.0.CO;2-O; FREIDIN M, 1992, P NATL ACAD SCI USA, V89, P10440, DOI 10.1073/pnas.89.21.10440; Gadient RA, 1997, PROG NEUROBIOL, V52, P379, DOI 10.1016/S0301-0082(97)00021-X; Gahring LC, 1996, NEUROIMMUNOMODULAT, V3, P289, DOI 10.1159/000097283; Gougeon PY, 2013, J NEUROSCI, V33, P3339, DOI 10.1523/JNEUROSCI.3564-12.2013; Gruol DL, 1997, MOL NEUROBIOL, V15, P307, DOI 10.1007/BF02740665; Hall CE, 2017, CELL REP, V19, P1739, DOI 10.1016/j.celrep.2017.05.024; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Hellewell S, 2016, BRAIN RES, V1640, P36, DOI 10.1016/j.brainres.2015.12.024; Helmy A, 2016, J CEREBR BLOOD F MET, V36, P1434, DOI 10.1177/0271678X15620204; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Helmy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039677; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Helmy A, 2009, J NEUROTRAUM, V26, P549, DOI 10.1089/neu.2008.0719; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Joannides AJ, 2007, STEM CELLS, V25, P731, DOI 10.1634/stemcells.2006-0562; Johansson S, 2008, STEM CELLS, V26, P2444, DOI 10.1634/stemcells.2008-0116; LEE SC, 1993, J IMMUNOL, V150, P2659; Li J, 2001, J BIOL CHEM, V276, P18579, DOI 10.1074/jbc.M100846200; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Medana IM, 2000, EUR J IMMUNOL, V30, P3623, DOI 10.1002/1521-4141(200012)30:12<3623::AID-IMMU3623>3.0.CO;2-F; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; MURPHY PG, 1995, J NEUROSCI, V15, P5130; NEUMANN H, 1995, SCIENCE, V269, P549, DOI 10.1126/science.7624779; Parnet P, 2002, J NEUROIMMUNOL, V125, P5, DOI 10.1016/S0165-5728(02)00022-X; PARNET P, 1994, MOL BRAIN RES, V27, P63, DOI 10.1016/0169-328X(94)90185-6; Patani R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007327; Perigolo-Vicente R, 2013, BIOCHEM BIOPH RES CO, V430, P512, DOI 10.1016/j.bbrc.2012.12.004; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Prabowo AS, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-12; Probert L, 2015, NEUROSCIENCE, V302, P2, DOI 10.1016/j.neuroscience.2015.06.038; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Ringheim GE, 1995, J NEUROIMMUNOL, V63, P113, DOI 10.1016/0165-5728(95)00134-4; Roberts DJ, 2013, J NEUROTRAUM, V30, P1727, DOI 10.1089/neu.2012.2842; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; SCHOBITZ B, 1993, EUR J NEUROSCI, V5, P1426, DOI 10.1111/j.1460-9568.1993.tb00210.x; Schwartz M, 2010, NAT REV NEUROL, V6, P405, DOI 10.1038/nrneurol.2010.71; SEBIRE G, 1993, J IMMUNOL, V150, P1517; Simon DW, 2017, NAT REV NEUROL, V13, P572, DOI 10.1038/nrneurol.2017.116; Spooren A, 2011, BRAIN RES REV, V67, P157, DOI 10.1016/j.brainresrev.2011.01.002; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; THELIN EP, 2017, FRONT NEUROL, V8; Thornton P, 2006, J NEUROCHEM, V98, P258, DOI 10.1111/j.1471-4159.2006.03872.x; Tsakiri N, 2008, MOL CELL NEUROSCI, V38, P259, DOI 10.1016/j.mcn.2008.02.015; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Yang LQ, 2004, SPINE, V29, P966, DOI 10.1097/00007632-200405010-00004; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	72	23	25	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2018	35	2					341	352		10.1089/neu.2017.5155		NOV 2017	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FT1TA	WOS:000414574900001	28978285	Green Published, Bronze, Green Submitted			2022-02-06	
J	Baslet, G; Tolchin, B; Dworetzky, BA				Baslet, Gaston; Tolchin, Benjamin; Dworetzky, Barbara A.			Altered responsiveness in psychogenic nonepileptic seizures and its implication to underlying psychopathology	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						Psychogenic nonepileptic seizures; Semiology; Awareness; Experiential avoidance; Emotion regulation; Resilience	PSYCHOMETRIC PROPERTIES; EXPERIENTIAL AVOIDANCE; EMOTION REGULATION; BECK DEPRESSION; ATTACK DISORDER; CONSCIOUSNESS; DISSOCIATION; DIAGNOSIS; SYMPTOMS; EPILEPSY	Purpose: Altered responsiveness during psychogenic nonepileptic seizures (PNES) is a distinct semiological feature that may signal a psychological vulnerability. We hypothesized that altered responsiveness is related to difficulties with emotion tolerance, experiential avoidance, difficulty coping, dissociation and trauma and prior experiences of loss of awareness. Methods: 71 patients with video-EEG confirmed PNES were divided into two groups based on their responsiveness at the time of the captured event during long-term monitoring. Demographic information, clinical history and self-rated questionnaires highlighting psychopathology were compared between the groups. Results: 47 patients (66%) had altered responsiveness during their captured event. Married or partnered subjects were more represented in the altered responsiveness group. Experiential avoidance, as measured by the Acceptance and Action Questionnaire-II, and affect intolerance, as measured by the Affective Style Questionnaire, were significantly higher in the altered responsiveness group. The Connor Davidson Resilience Scale was significantly higher among intact responsiveness subjects. Subjects with altered responsiveness were more likely to have a family history of seizures, comorbid headaches, and loss of consciousness (LOC) during traumatic brain injury. There were no differences in measures of dissociation, somatization, mood or anxiety, or presence of psychiatric comorbidities, including PTSD or history of trauma. Conclusion: Altered responsiveness during PNES is a marker of lower emotional resilience or ability to tolerate emotions among patients with PNES. Emotion management may be an important therapeutic target for these patients. Prior experiences with LOC also contribute to the presence of altered responsiveness. Trauma and dissociation did not differentiate responsiveness during PNES. (C) 2017 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.	[Baslet, Gaston] Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, 60 Fenwood Rd, Boston, MA 02115 USA; [Tolchin, Benjamin] Yale Univ, Sch Med, Dept Neurol, 15 York St, New Haven, CT 06510 USA; [Dworetzky, Barbara A.] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, 60 Fenwood Rd, Boston, MA USA		Baslet, G (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, 60 Fenwood Rd, Boston, MA 02115 USA.	gbaslet@bwh.harvard.edu	Baslet, Gaston/AAF-6272-2021	Baslet, Gaston/0000-0002-3039-582X			Ali F, 2010, EPILEPSY BEHAV, V19, P522, DOI 10.1016/j.yebeh.2010.08.014; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Arain AM, 2007, EPILEPSY BEHAV, V11, P409, DOI 10.1016/j.yebeh.2007.07.017; Beck A. T., 1996, MANUAL BECK DEPRESSI, VII; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Benbadis SR, 2004, EPILEPSIA, V45, P1150, DOI 10.1111/j.0013-9580.2004.14504.x; Bernstein E, 1986, J NERV MENT DIS, V185, P491; Bond FW, 2011, BEHAV THER, V42, P676, DOI 10.1016/j.beth.2011.03.007; Brown RJ, 2004, PSYCHOL BULL, V130, P793, DOI 10.1037/0033-2909.130.5.793; Cavanna AE, 2011, BEHAV NEUROL, V24, P107, DOI [10.3233/BEN-2011-0322, 10.1155/2011/645159]; Chen DK, 2012, EPILEPSY BEHAV, V24, P30, DOI 10.1016/j.yebeh.2012.03.009; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Goldstein LH, 2006, J NEUROL NEUROSUR PS, V77, P616, DOI 10.1136/jnnp.2005.066878; Griffith NM, 2008, EPILEPSY BEHAV, V13, P478, DOI 10.1016/j.yebeh.2008.06.005; Griffith NM, 2007, EPILEPSY BEHAV, V11, P105, DOI 10.1016/j.yebeh.2007.04.021; Hayes SC, 2004, PSYCHOL REC, V54, P553, DOI 10.1007/BF03395492; Hofmann SG, 2010, J PSYCHOPATHOL BEHAV, V32, P255, DOI 10.1007/s10862-009-9142-4; Interian A, 2006, PSYCHOSOMATICS, V47, P392, DOI 10.1176/appi.psy.47.5.392; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; LaFrance WC, 2013, EPILEPSIA, V54, P2005, DOI 10.1111/epi.12356; LaFrance WC, 2013, EPILEPSIA, V54, P53, DOI 10.1111/epi.12106; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; PUTNAM FW, 1997, THESIS; Reuber M, 2011, BEHAV NEUROL, V24, P95, DOI [10.1155/2011/327654, 10.3233/BEN-2011-0315]; Reuber M, 2003, ANN NEUROL, V53, P305, DOI 10.1002/ana.3000; Roberts NA, 2014, EPILEPSY BEHAV, V30, P43, DOI 10.1016/j.yebeh.2013.09.035; Selwa LM, 2000, EPILEPSIA, V41, P1330, DOI 10.1111/j.1528-1157.2000.tb04613.x; Uliaszek AA, 2012, EPILEPSY BEHAV, V23, P364, DOI 10.1016/j.yebeh.2012.01.009; van Ijzendoorn MH, 1996, CLIN PSYCHOL REV, V16, P365, DOI 10.1016/0272-7358(96)00006-2; Wong VSS, 2017, PSYCHOGENIC NONEPILE	31	23	23	0	5	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311	1532-2688		SEIZURE-EUR J EPILEP	Seizure	NOV	2017	52						162	168		10.1016/j.seizure.2017.10.011			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FP9JJ	WOS:000417963000024	29049948	Bronze			2022-02-06	
J	Kelley, ME; Kane, JM; Espeland, MA; Miller, LE; Powers, AK; Stitzel, JD; Urban, JE				Kelley, Mireille E.; Kane, Joeline M.; Espeland, Mark A.; Miller, Logan E.; Powers, Alexander K.; Stitzel, Joel D.; Urban, Jillian E.			Head impact exposure measured in a single youth football team during practice drills	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						pediatrics; football; head impacts; biomechanics; acceleration; concussion; trauma	HIGH-SCHOOL FOOTBALL; CHRONIC TRAUMATIC ENCEPHALOPATHY; LATER-LIFE; PLAYERS; CONCUSSION; COLLEGIATE; SPORT; INJURY; NFL; AGE	OBJECTIVE This study evaluated the frequency, magnitude, and location of head impacts in practice drills within a youth football team to determine how head impact exposure varies among different types of drills. METHODS On-field head impact data were collected from athletes participating in a youth football team for a single season. Each athlete wore a helmet instrumented with a Head Impact Telemetry (HIT) System head acceleration measurement device during all preseason, regular season, and playoff practices. Video was recorded for all practices, and video analysis was performed to verify head impacts and assign each head impact to a specific drill. Eleven drills were identified: dummy/sled tackling, install, special teams, Oklahoma, one-on-one, open-field tackling, passing, position skill work, multiplayer tackle, scrimmage, and tackling drill stations. Generalized linear models were fitted to log-transformed data, and Wald tests were used to assess differences in head accelerations and impact rates. RESULTS A total of 2125 impacts were measured during 30 contact practices in 9 athletes (mean age 11.1 +/- 0.6 years, mean mass 44.9 +/- 4.1 kg). Open-field tackling had the highest median and 95th percentile linear accelerations (24.7g and 97.8g, respectively) and resulted in significantly higher mean head accelerations than several other drills. The multiplayer tackle drill resulted in the highest head impact frequency, with an average of 0.59 impacts per minute per athlete, but the lowest 95th percentile linear accelerations of all drills. The front of the head was the most common impact location for all drills except dummy/sled tackling. CONCLUSIONS Head impact exposure varies significantly in youth football practice drills, with several drills exposing athletes to high-magnitude and/or high-frequency head impacts. These data suggest that further study of practice drills is an important step in developing evidence-based recommendations for modifying or eliminating certain high-intensity drills to reduce head impact exposure and injury risk for all levels of play.	[Kelley, Mireille E.; Miller, Logan E.; Stitzel, Joel D.; Urban, Jillian E.] Virginia Tech Wake Forest Univ, Sch Biomed Engn & Sci, Winston Salem, NC USA; [Kelley, Mireille E.; Kane, Joeline M.; Miller, Logan E.; Stitzel, Joel D.; Urban, Jillian E.] Wake Forest Sch Med, Dept Biomed Engn, 575 N Patterson Ave,Ste 120, Winston Salem, NC 27106 USA; [Espeland, Mark A.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Powers, Alexander K.] Wake Forest Sch Med, Dept Neurosurg, Winston Salem, NC USA		Urban, JE (corresponding author), Wake Forest Sch Med, Dept Biomed Engn, 575 N Patterson Ave,Ste 120, Winston Salem, NC 27106 USA.	jurban@wakehealth.edu	Stitzel, Joel/B-4045-2012	Stitzel, Joel/0000-0001-9762-3033; Hernandez, Joeline/0000-0002-3347-2616	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094410]; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR001421]; Childress Institute for Pediatric Trauma at Wake Forest Baptist Medical Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR001421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094410] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award No. R01NS094410. Dr. Jillian Urban was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant No. KL2TR001421. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Special thanks to the Childress Institute for Pediatric Trauma at Wake Forest Baptist Medical Center for providing support for this study. We thank the youth football league's coordinators, coaches, parents, athletes, and athletic trainer, whose support made this study possible. We also thank Megan Anderson and Leslie Hoyt for their valuable assistance in data collection.	Aspen Institute, 2014, ESPNW ASPEN I PROJ P; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Broglio SP, 2012, CURR OPIN PEDIATR, V24, P702, DOI 10.1097/MOP.0b013e3283595616; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Campolettano ET, 2016, J NEUROSURG-PEDIATR, V18, P536, DOI 10.3171/2016.5.PEDS1696; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Daniel RW, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027872; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Kelley ME, 2017, J NEUROTRAUM, V34, P1939, DOI 10.1089/neu.2016.4812; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115610545; Liao S, 2016, MED SCI SPORT EXER, V48, P1239, DOI 10.1249/MSS.0000000000000896; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pop Warner News Office, 2012, RUL CHANG REG PRACT; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Reynolds BB, 2016, J NEUROSURG, V124, P501, DOI 10.3171/2015.5.JNS15573; Rowson Steven, 2009, Biomed Sci Instrum, V45, P113; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; SCAT3, 2013, BRIT J SPORT MED, V47, P259; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Sporting Goods Manufacturers Association, 2015, 2012 SPORTS FITN LEI; Sports and Fitness Industry Association, 2013, 2013 SPORTS FITN LEI; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Wilkins SA, 2014, J NEUROSURG-PEDIATR, V13, P82, DOI 10.3171/2013.10.PEDS13241; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055	40	23	23	1	13	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	NOV	2017	20	5					489	497		10.3171/2017.5.PEDS16627			9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	FL5JA	WOS:000414270000015	28937917	Green Accepted, Bronze			2022-02-06	
J	Olczak, M; Niderla-Bielinska, J; Kwiatkowska, M; Samojlowicz, D; Tarka, S; Wierzba-Bobrowicz, T				Olczak, Mieszko; Niderla-Bielinska, Justyna; Kwiatkowska, Magdalena; Samojlowicz, Dorota; Tarka, Sylwia; Wierzba-Bobrowicz, Teresa			Tau protein (MAPT) as a possible biochemical marker of traumatic brain injury in postmortem examination	FORENSIC SCIENCE INTERNATIONAL			English	Article						Traumatic brain injury; Tau; Cerebrospinal fluid; Neuroglia pathology; Endothelial cells; Glymphatic system	CEREBROSPINAL-FLUID; RISK-FACTOR; BLOOD; DAMAGE; AMYLOID-BETA-1-42; EPIDEMIOLOGY; ASTROCYTES; BIOMARKERS; MICROGLIA; DEMENTIA	MAPT is a neuronal protein that plays an important role in axonal stabilization, neuronal development, and neuronal polarity. MAPT release into the CSF and blood has been interpreted as indicative of axonal injury as its elevated levels were observed in olympic boxers even after a mild head trauma suggesting minor CNS injuries. In our study we wanted to check the potential relevance of MAPT examination for forensic purposes. The study was carried out using cases of head injury group and cases of sudden death (cardiopulmonary failure, no injuries of the head - control group) provided by forensic pathologists at the Department of Forensic Medicine, Medical University of Warsaw. CSF and blood were collected within 24 h after death using suboccipital puncture and femoral vein puncture. Serum and cerebrospinal fluid Tau protein concentrations were compared using an enzyme-linked immunosorbent assay (elisa). Brain specimens (frontal cortex) were collected during forensic autopsies. Sections were stained histologically (hematoxylin-eosin) and immunohistochemically with anti human Tau antibody, anti glial fibrillary acid protein (GFAP), anti human macrosialin (CD68) or anti human endothelial cells (CD34). In our study we documented that elevated levels of serum and CSF MAPT may also be considered a marker for mild traumatic brain injury and traumatic brain injury (mTBI and TBI). An increase in CSF and serum levels of MAPT in the absence of visible macroscopic traumatic CNS changes indicates that even minor head injuries may result in changes at the neuronal level that could remain undiagnosed during regular forensic autopsy and routine histopathological examination. (C) 2017 Elsevier B.V. All rights reserved.	[Olczak, Mieszko; Kwiatkowska, Magdalena; Samojlowicz, Dorota; Tarka, Sylwia] Med Univ Warsaw, Dept Forens Med, 1 Oczki St, PL-02007 Warsaw, Poland; [Niderla-Bielinska, Justyna] Med Univ Warsaw, Histol & Embriol Dept, 5 Chalubinskiego St, PL-02004 Warsaw, Poland; [Tarka, Sylwia; Wierzba-Bobrowicz, Teresa] Inst Psychiat & Neurol, Dept Neuropathol, 9 Sobieskiego St, PL-02957 Warsaw, Poland		Olczak, M (corresponding author), Med Univ Warsaw, Dept Forens Med, 1 Oczki St, PL-02007 Warsaw, Poland.		Olczak, Mieszko/N-5974-2018; Samojlowicz, Dorota/Q-1895-2018	Olczak, Mieszko/0000-0001-7055-7451; Wierzba-Bobrowicz, Teresa/0000-0003-2518-8321; Samojlowicz, Dorota/0000-0002-4917-0292	Faculty of Medicine [1MB/PM11/14]	The study was carried out within a Research Project conducted in the years 2014-2015, financed from the statutory subsidy obtained by the 1st Faculty of Medicine (1MB/PM11/14).	Arendt T, 2016, BRAIN RES BULL, V126, P238, DOI 10.1016/j.brainresbull.2016.08.018; Blennow K, 2004, NEUROLOGY, V62, P159, DOI 10.1212/WNL.62.1.159; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Bolos M, 2016, J ALZHEIMERS DIS, V50, P77, DOI 10.3233/JAD-150704; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Dent KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121541; Engel S, 2000, ACTA NEUROPATHOL, V100, P313, DOI 10.1007/s004019900172; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Ikegaya H, 2004, FORENSIC SCI INT, V146, P121, DOI 10.1016/j.forsciint.2004.06.024; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jeganathan S, 2008, BIOCHEMISTRY-US, V47, P10526, DOI 10.1021/bi800783d; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; KEEP RF, 1990, DEV BRAIN RES, V56, P47, DOI 10.1016/0165-3806(90)90163-S; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Majerova P, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0161-z; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; Mollenhauer B, 2006, CLIN CHEM LAB MED, V44, P192, DOI 10.1515/CCLM.2006.035; Mollenhauer B, 2006, DEMENT GERIATR COGN, V22, P200, DOI 10.1159/000094871; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sakka L, 2011, EUR ANN OTORHINOLARY, V128, P309, DOI 10.1016/j.anorl.2011.03.002; Shi H, 2015, EXP NEUROL, V272, P17, DOI 10.1016/j.expneurol.2015.03.017; SHIN RW, 1991, LAB INVEST, V64, P693; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Sjogren M, 2001, CLIN CHEM, V47, P1776; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Thrane AS, 2014, TRENDS NEUROSCI, V37, P620, DOI 10.1016/j.tins.2014.08.010; TROJANOWSKI JQ, 1989, J HISTOCHEM CYTOCHEM, V37, P209, DOI 10.1177/37.2.2492045; Vajtr D, 2009, PHYSIOL RES, V58, P263, DOI 10.33549/physiolres.931253; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7	49	23	24	0	16	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	NOV	2017	280						1	7		10.1016/j.forsciint.2017.09.008			7	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	FM0NO	WOS:000414663900002	28942078				2022-02-06	
J	Won, SY; Dubinski, D; Brawanski, N; Strzelczyk, A; Seifert, V; Freiman, TM; Konczalla, J				Won, Sae-Yeon; Dubinski, Daniel; Brawanski, Nina; Strzelczyk, Adam; Seifert, Volker; Freiman, Thomas M.; Konczalla, Juergen			Significant increase in acute subdural hematoma in octo- and nonagenarians: surgical treatment, functional outcome, and predictors in this patient cohort	NEUROSURGICAL FOCUS			English	Article						acute subdural hematoma; elderly patient; octogenarian; nonagenarian; surgical treatment; functional outcome; predictor	TRAUMATIC BRAIN-INJURY; ELDERLY-PATIENTS; CLINICAL ARTICLE; ADULT PATIENTS; RISK-FACTORS; AGE; MORTALITY; SEIZURES; EVACUATION; DISCHARGE	OBJECTIVE Acute subdural hematoma (aSDH) is a common disease increasing in prevalence given the demographic growth of the aging population. Yet, the benefit of surgical treatment for aSDH and the subsequent functional outcome in elderly patients (age = 80 years) remain unclear. Therefore, the aims of this study were to evaluate the incidence of aSDH in patients 80 years or older, determine overall functional outcome, identify predictors of an unfavorable or favorable outcome, and establish specific risk factors for seizures. METHODS The authors retrospectively analyzed patients 80 years and older who presented with isolated aSDH in the past 10 years at their institution. The following parameters were assessed: baseline characteristics, clinical status on admission and 24 hours after surgery, and clinical course. Functional outcome was assessed at discharge and the 3-month follow-up (FU). RESULTS In the period from January 2007 to December 2016, 165 patients with aSDH were admitted to the authors' institution. Sixty-eight patients (41.2%) were 80 years old or older, and the mean age overall was 85 years (range 80-96 years). The incidence of aSDH in the elderly had significantly increased over past decade, with more than 50% of patients admitted to our institution for aSDH now being 80 years or older. The overall mortality rate was 28% at discharge and 48% at the FU. Independent predictors of an unfavorable outcome at discharge were a GCS score = 8 at 24 hours after operation (p < 0.001) and pneumonia (p < 0.02). At the FU, a GCS score = 8 at 24 hours after operation (p < 0.001) and cumulative comorbidities (= 5; p < 0.05) were significant independent predictors. All patients with more than 6 comorbidities had died by the FU. Surgical treatment in comatose compared to noncomatose patients had statistically significant, higher mortality rates at discharge and the FU. Still, 23% of the comatose patients and more than 50% of the noncomatose patients had a favorable outcome at the FU (p = 0.06). CONCLUSIONS The number of octo-and nonagenarians with aSDH significantly increased over the last decade. These patients can achieve a favorable outcome, especially those with a noncomatose status and fewer than 5 comorbidities. Surgical and nonsurgical treatment of octo-and nonagenarians during and after discharge should be optimized to increase clinical improvement.	[Won, Sae-Yeon; Dubinski, Daniel; Brawanski, Nina; Seifert, Volker; Freiman, Thomas M.; Konczalla, Juergen] Goethe Univ, Univ Hosp, Dept Neurosurg, Frankfurt, Germany; [Strzelczyk, Adam] Goethe Univ, Univ Hosp, Dept Neurol, Frankfurt, Germany; [Strzelczyk, Adam] Goethe Univ, Univ Hosp, Epilepsy Ctr Frankfurt Rhine Main, Frankfurt, Germany		Won, SY (corresponding author), Goethe Univ, Dept Neurosurg, 2-16 Schleusenweg, D-60528 Frankfurt, Hessen, Germany.	sae-yeon.won@kgu.de	Konczalla, Juergen/AAJ-8528-2021; Brawanski, Nina/AAL-7455-2020; Won, Sae-Yeon/AAK-3408-2020; Dubinski, Daniel/AAH-2910-2021; Freiman, Thomas/AAV-8494-2021	Brawanski, Nina/0000-0003-1502-4980; Dubinski, Daniel/0000-0001-5568-8429; Freiman, Thomas/0000-0002-2591-2829; Strzelczyk, Adam/0000-0001-6288-9915; Konczalla, Juergen/0000-0001-9771-7806			Busl KM, 2013, J NEUROSURG, V119, P1296, DOI 10.3171/2013.4.JNS122236; CAGETTI B, 1992, BRIT J NEUROSURG, V6, P227, DOI 10.3109/02688699209002930; de Rooij SE, 2005, CRIT CARE, V9, pR307, DOI 10.1186/cc3536; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Frontera JA, 2011, CRIT CARE MED, V39, P1619, DOI 10.1097/CCM.0b013e3182186ed6; Gebel JM, 1998, STROKE, V29, P1799, DOI 10.1161/01.STR.29.9.1799; Hamed M, 2016, WORLD NEUROSURG, V94, P501, DOI 10.1016/j.wneu.2016.07.061; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; JENNETT B, 1975, J NEUROL NEUROSUR PS, V38, P378, DOI 10.1136/jnnp.38.4.378; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Khajavikhan J, 2016, J CLIN DIAGN RES, V10, pPC16, DOI 10.7860/JCDR/2016/16390.7294; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; Leung GKK, 2012, INJURY, V43, P1419, DOI 10.1016/j.injury.2011.03.017; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Mulligan P, 2013, J NEUROSCI RURAL PRA, V4, P250, DOI 10.4103/0976-3147.118760; Okazaki T, 2016, WORLD NEUROSURG, V93, P336, DOI 10.1016/j.wneu.2016.06.070; Panczykowski DM, 2011, J NEUROSURG, V114, P47, DOI 10.3171/2010.7.JNS10446; PHUENPATHOM N, 1993, SURG NEUROL, V40, P22, DOI 10.1016/0090-3019(93)90164-V; Pollandt S, 2017, J CLIN NEUROPHYSIOL, V34, P55, DOI 10.1097/WNP.0000000000000311; Rabinstein AA, 2010, J NEUROSURG, V112, P455, DOI 10.3171/2009.7.JNS09392; Raj R, 2016, WORLD NEUROSURG, V88, P592, DOI 10.1016/j.wneu.2015.10.095; Ryan CG, 2012, J TRAUMA ACUTE CARE, V73, P1348, DOI 10.1097/TA.0b013e31826fcb30; Seifi A, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-332; Servadei F, 1997, ACTA NEUROCHIR, V139, P279, DOI 10.1007/BF01808822; Taussky P, 2012, WORLD NEUROSURG, V78, P306, DOI 10.1016/j.wneu.2011.10.030; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Weimer JM, 2017, NEUROCRIT CARE, V26, P70, DOI 10.1007/s12028-016-0279-1; Won SY, 2016, WORLD NEUROSURG, V88, DOI 10.1016/j.wneu.2015.12.099	29	23	24	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2017	43	5							E10	10.3171/2017.7.FOCUS17417			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FL5JE	WOS:000414270800003	29088952	gold			2022-02-06	
J	Qian, HH; Li, QH; Shi, WD				Qian, Huihui; Li, Qinghe; Shi, Woda			Hyperbaric oxygen alleviates the activation of NLRP-3-inflammasomes in traumatic brain injury	MOLECULAR MEDICINE REPORTS			English	Article						traumatic brain injury hyperbaric oxygen therapy; NLRP-3 inflammasome; microglia	NLRP3 INFLAMMASOME; THERAPY; NEUROPROTECTION; MECHANISMS; EXPRESSION; NEURONS; SYSTEM; FLUID; IL-18	Growing evidence has demonstrated that the nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3 (NLRP-3) inflammasome-mediated inflammatory pathways have been involved in the secondary injury of traumatic brain injury (TBI). In the present study, the authors investigated the effects of hyperbaric oxygen (HBO) therapy on the NLRP-3 inflammasome pathway following TBI. Following the evaluation of motor deficits and brain edema, the therapeutic effects of HBO on interleukin (IL)-1 beta and IL-18 expression were assessed, as well as NLRP-3 inflammasome activation following TBI. HBO may improve motor score and reduce brain edema, accompanied with the reduction of IL-1 beta and IL-18 during the 7-day observation period. Furthermore, HBO suppressed mRNA and protein expression of NLRP-3-inflammasome components, especially reducing NLRP-3 expression in microglia. Thus, these results suggested that HBO alleviates the inflammatory response in experimental TBI via modulating microglial NLRP-3-inflammasome signaling.	[Qian, Huihui] Southeast Univ, Med Coll, Affiliated Yancheng Hosp, Dept Geriatr, Yancheng 224001, Jiangsu, Peoples R China; [Li, Qinghe] Southeast Univ, Med Coll, Affiliated Yancheng Hosp, Dept Nursing, Yancheng 224001, Jiangsu, Peoples R China; [Shi, Woda] Southeast Univ, Med Coll, Affiliated Yancheng Hosp, Dept Cardiothorac Surg, 2 West XIndu Rd, Yancheng 224001, Jiangsu, Peoples R China		Shi, WD (corresponding author), Southeast Univ, Med Coll, Affiliated Yancheng Hosp, Dept Cardiothorac Surg, 2 West XIndu Rd, Yancheng 224001, Jiangsu, Peoples R China.	yc3hpucheetah@aliyun.com					Adamczak S, 2012, J NEUROSURG, V117, P1119, DOI 10.3171/2012.9.JNS12815; Adamczak SE, 2014, J CEREBR BLOOD F MET, V34, P621, DOI 10.1038/jcbfm.2013.236; Camporesi EM, 2014, UNDERSEA HYPERBAR M, V41, P247; Chen X, 2014, NEUROSCIENCE, V266, P235, DOI 10.1016/j.neuroscience.2013.11.036; Ciaramella A, 2014, NEUROIMMUNOMODULAT, V21, P8, DOI 10.1159/000354764; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Felderhoff-Mueser U, 2005, TRENDS NEUROSCI, V28, P487, DOI 10.1016/j.tins.2005.06.008; Figueroa XA, 2015, UNDERSEA HYPERBAR M, V42, P333; Freeman LC, 2016, J NEUROCHEM, V136, P29, DOI 10.1111/jnc.13217; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Jha S, 2010, J NEUROSCI, V30, P15811, DOI 10.1523/JNEUROSCI.4088-10.2010; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maier NK, 2014, J IMMUNOL, V192, P763, DOI 10.4049/jimmunol.1301434; Matsunami T, 2011, INT J CLIN EXP PATHO, V4, P255; Plesnila N, 2016, CURR OPIN PHARMACOL, V26, P110, DOI 10.1016/j.coph.2015.10.008; Ralay R. H., 2011, J NEUROTRAUM, V28, P1757, DOI DOI 10.1089/NEU.2011.1799; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Vaccari JPD, 2016, TRANSL RES, V167, P35, DOI 10.1016/j.trsl.2015.05.003; Vaccari JPD, 2009, J CEREBR BLOOD F MET, V29, P1251, DOI 10.1038/jcbfm.2009.46; Vafadari B, 2016, J NEUROCHEM, V139, P91, DOI 10.1111/jnc.13415; Wang GH, 2010, J NEUROTRAUM, V27, P1733, DOI 10.1089/neu.2009.1175; Wang Y, 2014, MED GAS RES, V4, DOI 10.1186/2045-9912-4-18; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002	28	23	27	2	11	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	OCT	2017	16	4					3922	3928		10.3892/mmr.2017.7079			7	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	FG9JA	WOS:000410753800028	29067455	hybrid, Green Submitted, Green Published			2022-02-06	
J	Vonder Haar, C; Martens, KM; Riparip, LK; Rosi, S; Wellington, CL; Winstanley, CA				Vonder Haar, Cole; Martens, Kris M.; Riparip, Lara-Kirstie; Rosi, Susanna; Wellington, Cheryl L.; Winstanley, Catharine A.			Frontal Traumatic Brain Injury Increases Impulsive Decision Making in Rats: A Potential Role for the Inflammatory Cytokine Interleukin-12	JOURNAL OF NEUROTRAUMA			English	Article						cognitive function; controlled cortical impact; cytokines; delay discounting; frontal cortex; inflammation	CONTROLLED CORTICAL IMPACT; ORBITOFRONTAL CORTEX; COGNITIVE DEFICITS; SELF-CONTROL; CHOICE; DOPAMINE; MODEL; NEUROINFLAMMATION; REINFORCEMENT; MODERATE	Traumatic brain injury (TBI) is associated with the development of numerous psychiatric diseases. Of particular concern for TBI patients is the impact of chronic impulsivity on daily functioning. Despite the scope of the human problem, little has been done to address impulsivity in animal models of brain injury. In the current study, we examined the effects of either a severe or a milder bilateral frontal controlled cortical impact injury on impulsivity using the Delay Discounting Task (DDT), in which preference for smaller-sooner over larger-later rewards is indicative of greater impulsive choice. Both milder and severe TBI caused a significant, chronic increase in impulsive decision making. Despite these pronounced changes in performance of the DDT, memory function, as assessed by the Morris Water Maze, was not impaired in more mildly injured rats and only transiently impacted in the severe TBI group. Whereas a significant lesion was only evident in severely injured rats, analysis of cytokine levels within the frontal cortex revealed a selective increase in interleukin (IL)-12 that was associated with the magnitude of the change in impulsive choice caused by both milder and severe TBI. These findings suggest that tissue loss alone cannot explain the increased impulsivity observed, and that inflammatory pathways mediated by IL-12 may be a contributing factor. The findings from this study highlight the sensitivity of sophisticated behavioral measures designed to assess neuropsychiatric dysfunction in the detection of TBI-induced cognitive impairments and their utility in identifying potential mechanistic pathways and therapeutic targets.	[Vonder Haar, Cole; Martens, Kris M.; Wellington, Cheryl L.; Winstanley, Catharine A.] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada; [Riparip, Lara-Kirstie; Rosi, Susanna] Univ Calif San Francisco, Brain & Spinal Injury Ctr, Dept Phys Therapy Rehabil Sci, San Francisco, CA 94143 USA; [Riparip, Lara-Kirstie; Rosi, Susanna] Univ Calif San Francisco, Dept Neurol Surg, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Vonder Haar, Cole; Martens, Kris M.] West Virginia Univ, Dept Psychol, Injury & Recovery Lab, Morgantown, WV 26506 USA		Vonder Haar, C (corresponding author), West Virginia Univ, Dept Psychol, Injury & Recovery Lab, Morgantown, WV 26506 USA.; Vonder Haar, C (corresponding author), West Virginia Univ, Dept Psychol, POB 6040,53 Campus Dr, Morgantown, WV 26505 USA.	cole.vonderhaar@mail.wvu.edu		Vonder Haar, Cole/0000-0001-7949-2068	Djavad Mowafaghian Centre for Brain Health; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Weston Brain Institute; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS087458]; CIHRCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for Health ResearchMichael Smith Foundation for Health Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS087458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R21AG042016] Funding Source: NIH RePORTER	Funding for this project was provided by an internal grant from the Djavad Mowafaghian Centre for Brain Health to C.V., K.M., C.L.W., and C.A.W., operating grants from the Canadian Institutes of Health Research (CIHR) awarded to C.A.W. and to C.L.W., from the Weston Brain Institute to C.L.W., and the National Institute of Neurological Disorders and Stroke (R21NS087458) awarded to S.R. C.V. was supported by a (CIHR) post-doctoral fellowship. In the past 3 years, C.A.W. has received salary support from the CIHR New Investigator Award program and the Michael Smith Foundation for Health Research.	Abe K, 2016, NEUROL RES, V38, P358, DOI 10.1080/01616412.2015.1110402; Alway Y, 2016, J NEUROTRAUM, V33, P825, DOI 10.1089/neu.2015.3992; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Blasio A, 2012, PSYCHOPHARMACOLOGY, V219, P377, DOI 10.1007/s00213-011-2517-8; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Clark KH, 2013, NEUROTOX RES, V23, P174, DOI 10.1007/s12640-012-9334-7; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Crean JP, 2000, EXP CLIN PSYCHOPHARM, V8, P155, DOI 10.1037/1064-1297.8.2.155; Cuthbert BN, 2014, PSYCHOPHYSIOLOGY, V51, P1205, DOI 10.1111/psyp.12342; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dixon MR, 2005, BEHAV INTERVENT, V20, P101, DOI 10.1002/bin.173; Donegan JJ, 2014, J NEUROSCI, V34, P953, DOI 10.1523/JNEUROSCI.3968-13.2014; Evenden JL, 1996, PSYCHOPHARMACOLOGY, V128, P161, DOI 10.1007/s002130050121; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gatson JW, 2013, J TRAUMA ACUTE CARE, V74, P470, DOI 10.1097/TA.0b013e31827e1f51; Grant JE, 2014, ADDICT BEHAV, V39, P1632, DOI 10.1016/j.addbeh.2014.04.022; Greve KW, 2001, BRAIN INJURY, V15, P255; Haar CV, 2016, ACS CHEM NEUROSCI, V7, P1531, DOI 10.1021/acschemneuro.6b00166; Hehar H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139842; Hodges H, 1996, COGNITIVE BRAIN RES, V3, P167, DOI 10.1016/0926-6410(96)00004-3; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Isung J, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.113; James LM, 2014, MIL MED, V179, P357, DOI 10.7205/MILMED-D-13-00241; Kayser AS, 2012, J NEUROSCI, V32, P9402, DOI 10.1523/JNEUROSCI.1180-12.2012; Kokjohn TA, 2013, J NEUROTRAUM, V30, P981, DOI 10.1089/neu.2012.2699; Konoeda F, 2010, BIOCHEM BIOPH RES CO, V402, P500, DOI 10.1016/j.bbrc.2010.10.058; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Loos M, 2010, CEREB CORTEX, V20, P1064, DOI 10.1093/cercor/bhp167; Madden GJ, 1997, EXP CLIN PSYCHOPHARM, V5, P256, DOI 10.1037/1064-1297.5.3.256; Mazur JE, 1987, ADJUSTING PROCEDURE; McHugh L, 2008, BRAIN INJURY, V22, P715, DOI 10.1080/02699050802263027; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; Najjar S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-43; Peper JS, 2013, CEREB CORTEX, V23, P1695, DOI 10.1093/cercor/bhs163; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Rossi S, 2015, NEUROPHARMACOLOGY, V96, P105, DOI 10.1016/j.neuropharm.2014.09.022; Rudebeck PH, 2006, NAT NEUROSCI, V9, P1161, DOI 10.1038/nn1756; Sellitto M, 2010, J NEUROSCI, V30, P16429, DOI 10.1523/JNEUROSCI.2516-10.2010; Stahel PF, 1998, NEUROSCI LETT, V249, P123, DOI 10.1016/S0304-3940(98)00410-8; Sundman M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00334; Tan M, 2011, CRITICAL CARE, V15, P1; Titus DJ, 2015, EXP NEUROL, V263, P254, DOI 10.1016/j.expneurol.2014.10.020; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Vanderveldt A, 2016, J EXP PSYCHOL-ANIM L, V42, P141, DOI 10.1037/xan0000097; Vezzani A, 2015, NEUROPHARMACOLOGY, V96, P70, DOI 10.1016/j.neuropharm.2014.10.027; Vonder Haar C, 2016, J NEUROTRAUM, V33, P1892, DOI 10.1089/neu.2015.4276; Vonder Haar C, 2014, J NEUROTRAUM, V31, P1711, DOI 10.1089/neu.2014.3459; Winstanley C. A., 2010, IMPULSIVITY BEHAV NE, P95, DOI [10.1037/12069-004, DOI 10.1037/12069-004]; Winstanley CA, 2005, NEUROPSYCHOPHARMACOL, V30, P669, DOI 10.1038/sj.npp.1300610; Winstanley CA, 2006, CLIN PSYCHOL REV, V26, P379, DOI 10.1016/j.cpr.2006.01.001; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yaguchi M, 2008, J NEUROSCI RES, V86, P1972, DOI 10.1002/jnr.21658; Zeeb FD, 2010, PSYCHOPHARMACOLOGY, V211, P87, DOI 10.1007/s00213-010-1871-2; Zgaljardic DJ, 2015, J NEUROTRAUM, V32, P1911, DOI 10.1089/neu.2014.3569	62	23	23	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2017	34	19					2790	2800		10.1089/neu.2016.4813			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FI1DZ	WOS:000411672700013	28376700	Green Published			2022-02-06	
J	Impellizzeri, D; Cordaro, M; Bruschetta, G; Siracusa, R; Crupi, R; Esposito, E; Cuzzocrea, S				Impellizzeri, Daniela; Cordaro, Marika; Bruschetta, Giuseppe; Siracusa, Rosalba; Crupi, Rosalia; Esposito, Emanuela; Cuzzocrea, Salvatore			N-Palmitoylethanolamine-Oxazoline as a New Therapeutic Strategy to Control Neuroinflammation: Neuroprotective Effects in Experimental Models of Spinal Cord and Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						ALIAmide; central nervous system; cytokines; inflammation; neurotrophic factors	ACID AMIDE HYDROLASE; FACTOR-KAPPA-B; PPAR-ALPHA; RAT MODEL; INHIBITOR; ASTROCYTES; INFLAMMATION; ACTIVATION; MICROGLIA; ROLES	Modulation of N-acylethanolamine-hydrolyzing acid amidase (NAAA) represents a potential alternative strategy in the treatment of neuroinflammation. Recent studies showed that pharmacological modulation of NAAA could be achieved with the oxazoline of palmitoylethanolamide (PEA; PEA-OXA). The aim of this study was to evaluate the neuroprotective effects of PEA-OXA in the secondary neuroinflammatory events induced by spinal and brain trauma in mice. Animals were subjected to spinal cord and brain injury models and PEA-OXA (10 mg/kg) was administered both intraperitoneally and orally 1 h and 6 h after trauma. PEA-OXA treatment markedly reduced the histological alterations induced by spinal cord injury (SCI) and traumatic brain injury (TBI) and ameliorated the motor function and behavioral deficits, as well. In addition, the expression of neurotrophic factors, such as glial cell line-derived neurotrophic factor, brain-derived neurotrophic factor, and neurotrophin-3 were increased by PEA-OXA treatment. Moreover, PEA-OXA also significantly decreased glial fibrillary acidic protein hyperexpression, the nuclear translocation of nuclear factor (NF)-kappa B, phosphorylation of Ser536 on the NF-kappa B subunit p65, and degradation of I kappa B-alpha, as well as diminished the expression of proinflammatory mediators such as cyclooxygenase-2 (COX-2), inducible nitric oxide synthase, tumor necrosis factor (TNF)-alpha and interleukin (IL)-1 beta. The modulation of intracellular NAAA by PEA-OXA treatment could thus represent a novel therapy to control neuroinflammatory conditions associated with SCI and TBI.	[Impellizzeri, Daniela; Cordaro, Marika; Bruschetta, Giuseppe; Siracusa, Rosalba; Crupi, Rosalia; Esposito, Emanuela; Cuzzocrea, Salvatore] Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Viale Ferdinando Stagno DAlcontres 31, I-98166 Messina, Italy; [Cuzzocrea, Salvatore] Univ Manchester, Sch Med, Manchester Biomed Res Ctr, Manchester Royal Infirm, Manchester, Lancs, England		Cuzzocrea, S (corresponding author), Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Viale Ferdinando Stagno DAlcontres 31, I-98166 Messina, Italy.	salvator@unime.it	Siracusa, Rosalba/AAC-3110-2022; Cordaro, Marika/K-7329-2016; Crupi, Rosalia/U-4364-2019	Siracusa, Rosalba/0000-0001-7868-2505; Cordaro, Marika/0000-0002-3980-0043; Crupi, Rosalia/0000-0002-7629-3132; Cuzzocrea, Salvatore/0000-0001-6131-3690; Impellizzeri, Daniela/0000-0001-9492-3161	 [PON01-02512]	This study was supported by grant PON01-02512.	Ahmad A, 2012, BRAIN BEHAV IMMUN, V26, P1310, DOI 10.1016/j.bbi.2012.07.021; Ahmad A, 2012, BRAIN RES, V1477, P45, DOI 10.1016/j.brainres.2012.08.006; Ahmed AU, 2014, J BIOL CHEM, V289, P27776, DOI 10.1074/jbc.M114.574541; Alhouayek M, 2014, DRUG DISCOV TODAY, V19, P1632, DOI 10.1016/j.drudis.2014.06.007; [Anonymous], 2013, Patent application WO, Patent No. [2013121449 A1, 2013121449]; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Benito C, 2012, BRIT J PHARMACOL, V166, P1474, DOI 10.1111/j.1476-5381.2012.01889.x; Blackwell TS, 1997, AM J RESP CELL MOL, V17, P3, DOI 10.1165/ajrcmb.17.1.f132; Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; Buckley CD, 2013, NAT REV IMMUNOL, V13, P59, DOI 10.1038/nri3362; Campolo M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0196-1; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; Esposito E, 2016, EUR J PHARMACOL, V782, P107, DOI 10.1016/j.ejphar.2016.03.033; Esposito E, 2014, PHARMACOL RES, V86, P26, DOI 10.1016/j.phrs.2014.05.009; Esposito E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041880; Fidaleo M, 2014, CURR MED CHEM, V21, P2803, DOI 10.2174/0929867321666140303143455; Genovese T, 2008, J PHARMACOL EXP THER, V326, P12, DOI 10.1124/jpet.108.136903; Hoyer FF, 2014, J MOL CELL CARDIOL, V66, P126, DOI 10.1016/j.yjmcc.2013.11.013; Impellizzeri D, 2016, PHARMACOL RES, V108, P23, DOI 10.1016/j.phrs.2016.04.007; Impellizzeri D, 2015, EUR J PHARMACOL, V761, P28, DOI 10.1016/j.ejphar.2015.04.025; Impellizzeri D, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0136-0; Li YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043023; Logan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059250; Madathil SK, 2011, BIOESSAYS, V33, P21, DOI 10.1002/bies.201000069; Massa PT, 2006, J NEUROCHEM, V97, P607, DOI 10.1111/j.1471-4159.2006.03810.x; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Nencini P, 2003, CEREBROVASC DIS, V15, P215, DOI 10.1159/000068831; Paterniti I, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-91; Paterniti I, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-20; Peferoen LAN, 2015, J NEUROPATH EXP NEUR, V74, P48, DOI 10.1097/NEN.0000000000000149; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Piomelli D, 2014, NAT NEUROSCI, V17, P164, DOI 10.1038/nn.3612; Raso GM, 2014, PHARMACOL RES, V86, P32, DOI 10.1016/j.phrs.2014.05.006; Ribeiro A, 2015, ACS CHEM BIOL, V10, P1838, DOI 10.1021/acschembio.5b00114; Rivera P, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00098; RIVLIN AS, 1978, SURG NEUROL, V10, P39; Sasso O, 2013, PAIN, V154, P350, DOI 10.1016/j.pain.2012.10.018; Saturnino C, 2010, BIOORG MED CHEM LETT, V20, P1210, DOI 10.1016/j.bmcl.2009.11.134; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Siegmund SV, 2013, BIOCHEM BIOPH RES CO, V437, P48, DOI 10.1016/j.bbrc.2013.06.033; Skaper SD, 2015, MOL NEUROBIOL, V52, P1034, DOI 10.1007/s12035-015-9253-8; Skaper SD, 2012, PHILOS T R SOC B, V367, P3312, DOI 10.1098/rstb.2011.0391; Solorzano C, 2009, P NATL ACAD SCI USA, V106, P20966, DOI 10.1073/pnas.0907417106; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Ueda N, 2010, PROG LIPID RES, V49, P299, DOI 10.1016/j.plipres.2010.02.003; Yamano Y, 2012, BIOORGAN MED CHEM, V20, P3658, DOI 10.1016/j.bmc.2012.03.065; Yang LH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13565; Yune TY, 2004, J NEUROTRAUM, V21, P1778, DOI 10.1089/neu.2004.21.1778; Zohar O., ACTA NEUROBIOL EXP W, V71, P36	51	23	23	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 15	2017	34	18					2609	2623		10.1089/neu.2016.4808			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FG5SC	WOS:000410395200003	28095731				2022-02-06	
J	Baratz-Goldstein, R; Toussia-Cohen, S; Elpaz, A; Rubovitch, V; Pick, CG				Baratz-Goldstein, Renana; Toussia-Cohen, Shlomi; Elpaz, Aviya; Rubovitch, Vardit; Pick, Chaim G.			Immediate and delayed hyperbaric oxygen therapy as a neuroprotective treatment for traumatic brain injury in mice	MOLECULAR AND CELLULAR NEUROSCIENCE			English	Article							ACUTE ISCHEMIC-STROKE; CEREBRAL-BLOOD-FLOW; COGNITIVE DEFICITS; DENTATE GYRUS; ANIMAL-MODEL; RAT MODEL; IN-VIVO; MECHANISMS; DAMAGE; NEUROINFLAMMATION	Background: Traumatic brain injury is the most common cause of death or chronic disability among people under-35-years-old. There is no effective pharmacological treatment currently existing for TBI. Hyperbaric oxygen therapy (HBOT) is defined as the inhalation of pure oxygen in a hyperbaric chamber that is pressurized higher than 1 atm. HBOT offers physiological and mechanical effects by inducing a state of increased pressure and hyperoxia. HBOT has been proposed as an effective treatment for moderate traumatic brain injury (mTBI), yet the exact therapeutic window and mechanism that underlies this effect is not completely understood. Methods: HBOT was administrated for 4 consecutive days, post a mouse closed head weight drop moderate TBI (mTBI) in 2 different time lines: immediate treatment-initiated 3 h post-injury and delayed treatment - initiated 7 days post-injury. Behavioral cognitive tests and biochemical changes were assessed. Results: The results were similar for both the immediate and the delayed treatments. mTBI mice exhibited impairment in learning abilities, whereas mTBI mice treated with HBO displayed significant improvement compared with the mTBI group, performing similar to the sham groups. mTBI mice had a decline in myelin basic protein, an increase in neuronal loss (NeuN staining), and an increase in the number of reactive astrocytes (GFAP). The HBO treated mice in both groups did not exhibit these changes and remained similar to the sham group. Conclusions: The delayed HBOT has a potential to serve as a neuroprotective treatment for mTBI with a long therapeutic window. Further research is needed for fully understanding the cellular changes. (C) 2017 Elsevier Inc. All rights reserved.	[Baratz-Goldstein, Renana; Toussia-Cohen, Shlomi; Elpaz, Aviya; Rubovitch, Vardit; Pick, Chaim G.] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Elpaz, Aviya; Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Dr Miriam & Sheldon G Adelson Chair, Ctr Biol Addict Dis, IL-69978 Tel Aviv, Israel		Baratz-Goldstein, R (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel.	renanaba@post.tau.ac.il			Ari and Regine Aprijaskis Fund, at Tel Aviv University	This research was supported in part by the Ari and Regine Aprijaskis Fund, at Tel Aviv University. This work was performed in partial fulfillment of the M.D. of Shlomi Toussia-Cohen thesis requirements of the Sackler Faculty of Medicine, Tel Aviv University.	Abraini JH, 2013, UNDERSEA HYPERBAR M, V40, P211; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Armstrong RC, 2016, NEUROPHARMACOLOGY, V110, P654, DOI 10.1016/j.neuropharm.2015.04.029; Assistant Secretary of Defense for Health Affairs, 2007, TRAUM BRAIN INJ DEF; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Boussi-Gross R., 2013, PLOS ONE, V15, P8; Camporesi EM, 2014, UNDERSEA HYPERBAR M, V41, P253; Campos-Pires R, 2015, CRIT CARE MED, V43, P149, DOI 10.1097/CCM.0000000000000624; Chazalviel L, 2016, BRAIN, V139, DOI 10.1093/brain/aww178; Chen X, 2014, NEUROSCIENCE, V266, P235, DOI 10.1016/j.neuroscience.2013.11.036; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Cifu DX, 2014, J HEAD TRAUMA REHAB, V29, P11, DOI 10.1097/HTR.0b013e3182a6aaf0; Sanchez EC, 2013, CRIT CARE NURS Q, V36, P290, DOI 10.1097/CNQ.0b013e318294e9e3; David HN, 2012, J APPL PHYSIOL, V112, P2068, DOI 10.1152/japplphysiol.00092.2012; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Demchenko IT, 2005, J CEREBR BLOOD F MET, V25, P1288, DOI 10.1038/sj.jcbfm.9600110; Ding Z, 2013, INTERV NEUROL, V2, P201, DOI 10.1159/000362677; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Faul M, 2010, TRAUMATIC BRAIN INJU; Gill AL, 2004, QJM-INT J MED, V97, P385, DOI 10.1093/qjmed/hch074; Hampson NB, HYPERBARIC OXYGEN TH; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Hu Q, 2016, MED GAS RES, V6, P102, DOI 10.4103/2045-9912.184720; Hu Q, 2015, MED GAS RES, V5, DOI 10.1186/s13618-015-0033-3; Huang L, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-21; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kraitsy K., 2016, MED SCI MONITOR, V22, P2608; Lavrnja L, 2015, MEDIAL INFLAMM, V2015; Lim SW, 2013, J SURG RES, V184, P1076, DOI 10.1016/j.jss.2013.04.070; Lin KC, 2012, J TRAUMA ACUTE CARE, V72, P650, DOI 10.1097/TA.0b013e31823c575f; Liu S, 2013, NEURAL REGEN RES, V8, P3334, DOI 10.3969/j.issn.1673-5374.2013.35.008; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; McDonagh MS, 2003, AHRQ PUBLICATION, V03-E050; Meng XE, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15016933; Meng XE, 2016, MED SCI MONITOR, V22, P284, DOI 10.12659/MSM.894148; Messier C, 1997, NEUROBIOL LEARN MEM, V67, P172, DOI 10.1006/nlme.1996.3755; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; NIGHOGHOSSIAN N, 1995, STROKE, V26, P1369, DOI 10.1161/01.STR.26.8.1369; Palzur E, 2004, J NEUROTRAUM, V21, P41, DOI 10.1089/089771504772695931; Palzur E, 2008, BRAIN RES, V1221, P126, DOI 10.1016/j.brainres.2008.04.078; Poff AM, 2017, COMPR PHYSIOL, V7, P213, DOI 10.1002/cphy.c150032; Saab BJ, 2009, NEURON, V63, P643, DOI 10.1016/j.neuron.2009.08.014; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Vlodavsky E, 2006, NEUROPATH APPL NEURO, V32, P40, DOI 10.1111/j.1365-2990.2005.00698.x; Wang GH, 2010, J NEUROTRAUM, V27, P1733, DOI 10.1089/neu.2009.1175; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wang Y, 2014, MED GAS RES, V4, DOI 10.1186/2045-9912-4-18; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549; Wright J., 2009, UNDERSEA HYPERB MED, V36; Yang LM, 2015, BRAIN RES, V1627, P21, DOI 10.1016/j.brainres.2015.08.011; Yang Y, 2014, NEUROSCI LETT, V563, P38, DOI 10.1016/j.neulet.2014.01.002; Zhai X, 2016, FREE RADICAL RES, V50, P454, DOI 10.3109/10715762.2015.1136411; Zhang YM, 2014, NEUROCHEM RES, V39, P950, DOI 10.1007/s11064-014-1292-4; Zhou ZW, 2007, J NEUROSURG, V106, P687, DOI 10.3171/jns.2007.106.4.687; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	63	23	23	2	13	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1044-7431	1095-9327		MOL CELL NEUROSCI	Mol. Cell. Neurosci.	SEP	2017	83						74	82		10.1016/j.mcn.2017.06.004			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FG4SO	WOS:000410256000009	28690173				2022-02-06	
J	Bhattacharjee, S; Jun, B; Belayev, L; Heap, J; Kautzmann, MA; Obenaus, A; Menghani, H; Marcell, SJ; Khoutorova, L; Yang, R; Petasis, NA; Bazan, NG				Bhattacharjee, Surjyadipta; Jun, Bokkyoo; Belayev, Ludmila; Heap, Jessica; Kautzmann, Marie-Audrey; Obenaus, Andre; Menghani, Hemant; Marcell, Shawn J.; Khoutorova, Larissa; Yang, Rong; Petasis, Nicos A.; Bazan, Nicolas G.			Elovanoids are a novel class of homeostatic lipid mediators that protect neural cell integrity upon injury	SCIENCE ADVANCES			English	Article							OXYGEN-GLUCOSE DEPRIVATION; CEREBRAL ISCHEMIC-INJURY; TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; STROKE; MECHANISMS; ELOVL4; NEUROPROTECTIN-D1; PERMEABILITY; TRANSLATION	We report the characterization of a novel class of lipid mediators termed elovanoids (ELVs) (ELV-N32 and ELV-N34), which are dihydroxylated derivatives of 32:6n3 and 34:6n3, respectively. The precursors of ELVs are made by elongation of a 22:6n3 fatty acid and catalyzed by ELOVL4 (elongation of very-long-chain fatty acids-4). The structure and stereochemistry of ELVs were established using synthetic compounds produced by stereocontrolled total synthesis. We report that ELV-mediated protection is induced in neuronal cultures undergoing either oxygen/glucose deprivation or N-methyl-D-aspartate receptor-mediated excitotoxicity, as well as in experimental ischemic stroke. The methyl ester or sodium salt of ELV-N32 and ELV-N34 resulted in reduced infarct volumes, promoted cell survival, and diminished neurovascular unit disruption when administered 1 hour following 2 hours of ischemia by middle cerebral artery occlusion. Together, our data reveal a novel prohomeostatic and neuroprotective lipid-signaling mechanism aiming to sustain neural cell integrity.	[Bhattacharjee, Surjyadipta; Jun, Bokkyoo; Belayev, Ludmila; Heap, Jessica; Kautzmann, Marie-Audrey; Menghani, Hemant; Marcell, Shawn J.; Khoutorova, Larissa; Bazan, Nicolas G.] Louisiana State Univ, Neurosci Ctr Excellence, Hlth Sci Ctr, New Orleans, LA 70112 USA; [Obenaus, Andre] Univ Calif Irvine, Dept Pediat, Irvine, CA 92697 USA; [Menghani, Hemant] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, Div Hematol Oncol, New Orleans, LA 70118 USA; [Menghani, Hemant] Childrens Hosp New Orleans, New Orleans, LA 70118 USA; [Yang, Rong; Petasis, Nicos A.] Univ Southern Calif, Loker Hydrocarbon Res Inst, Dept Chem, Los Angeles, CA 90033 USA; [Obenaus, Andre] Univ Calif Irvine, Dept Pediat, Irvine, CA 92697 USA		Bazan, NG (corresponding author), Louisiana State Univ, Neurosci Ctr Excellence, Hlth Sci Ctr, New Orleans, LA 70112 USA.	nbazan@lsuhsc.edu	Bhattacharjee, Surjyadipta/I-5354-2016; Bazan, Nicolas/AAN-4121-2020; Petasis, Nicos/B-3162-2009; Bhattacharjee, Surjyadipta/AAD-7586-2021; Yang, Rong/ABA-7587-2021	Bhattacharjee, Surjyadipta/0000-0003-0185-553X; Bazan, Nicolas/0000-0002-9243-5444; Petasis, Nicos/0000-0002-8864-4446; Bhattacharjee, Surjyadipta/0000-0003-0185-553X; , Andre/0000-0003-0081-6950; Yang, Rong/0000-0001-8837-0089	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS046741]; National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM103340]; Arthur C. Cope Scholar Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P30GM103340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046741] Funding Source: NIH RePORTER	This work was supported by the National Institute of Neurological Disorders and Stroke (grant NS046741 to N.G.B.) and the National Institute of General Medical Sciences (grant GM103340 to N.G.B.). This work was also funded by the Arthur C. Cope Scholar Fund administered by the American Chemical Society (to N.A.P.).	Agbaga MP, 2016, ADV EXP MED BIOL, V854, P129, DOI 10.1007/978-3-319-17121-0_18; Aldahmesh MA, 2011, AM J HUM GENET, V89, P745, DOI 10.1016/j.ajhg.2011.10.011; Posada-Duque RA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00231; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bazan NG, 2012, EXP NEUROL, V236, P122, DOI 10.1016/j.expneurol.2012.04.007; Bazan NG, 2011, ANNU REV NUTR, V31, P321, DOI 10.1146/annurev.nutr.012809.104635; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; Brouns R, 2011, EUR NEUROL, V65, P23, DOI 10.1159/000321965; Cameron DJ, 2007, INT J BIOL SCI, V3, P111; Chen HB, 2016, SCI REP-UK, V6, DOI 10.1038/srep30459; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Font MA, 2010, CURR CARDIOL REV, V6, P238, DOI 10.2174/157340310791658802; Haley MJ, 2017, J CEREBR BLOOD F MET, V37, P456, DOI 10.1177/0271678X16629976; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Ladecola C, 2001, P NATL ACAD SCI USA, V98, P1294, DOI 10.1073/pnas.98.3.1294; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Obenaus A, 2011, ANN NEUROL, V69, P282, DOI 10.1002/ana.22168; Panickar KS, 2005, GLIA, V50, P287, DOI 10.1002/glia.20181; Petasis NA, 2012, TETRAHEDRON LETT, V53, P1695, DOI 10.1016/j.tetlet.2012.01.032; Ratan RR, 2010, TRANSL STROKE RES, V1, P71, DOI 10.1007/s12975-010-0024-6; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Serhan CN, 2015, BBA-MOL CELL BIOL L, V1851, P397, DOI 10.1016/j.bbalip.2014.08.006; Serhan CN, 2006, J IMMUNOL, V176, P1848, DOI 10.4049/jimmunol.176.3.1848; Shi SH, 2016, MED GAS RES, V6, P147, DOI 10.4103/2045-9912.191360; Stark DT, 2011, J NEUROSCI, V31, P13710, DOI 10.1523/JNEUROSCI.3544-11.2011; Takeshita K, 2016, GENES ENVIRON, V38, DOI 10.1186/s41021-016-0047-7; Tasca CI, 2015, METHODS MOL BIOL, V1254, P197, DOI 10.1007/978-1-4939-2152-2_15; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; Thrift AG, 2017, INT J STROKE, V12, P13, DOI 10.1177/1747493016676285	34	23	23	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	2375-2548			SCI ADV	Sci. Adv.	SEP	2017	3	9							e1700735	10.1126/sciadv.1700735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU6GH	WOS:000423949400006	28959727	Green Published, gold			2022-02-06	
J	Karimi, SA; Hosseinmardi, N; Janahmadi, M; Sayyah, M; Hajisoltani, R				Karimi, Seyed Asaad; Hosseinmardi, Narges; Janahmadi, Mahyar; Sayyah, Mohammad; Hajisoltani, Razieh			The protective effect of hydrogen sulfide (H2S) on traumatic brain injury (TBI) induced memory deficits in rats	BRAIN RESEARCH BULLETIN			English	Article						Traumatic brain injury; Cognitive dysfunction; Learning and memory; Hydrogen sulfide	CEREBRAL ISCHEMIA/REPERFUSION INJURY; LONG-TERM POTENTIATION; CORTICAL IMPACT MODEL; OXIDATIVE STRESS; INFLAMMATORY RESPONSE; SIGNALING MOLECULE; NEURONAL CELLS; NEURODEGENERATION; SUPPRESSION; DISRUPTION	Traumatic brain injury (TBI), as an expanding public health epidemic, is a common cause of death among youth. TBI is associated with cognitive deficits and memory impairment. Hydrogen sulfide (H2S), a novel gaseous mediator, has been recognized as an important neuromodulator and neuroprotective agent in the central nervous system. In the present study the potential neuroprotective role of sodium hydrosulfide (NaHS), an H2S donor on TBI induced memory deficit in a rat model of controlled cortical impact (CCI) injury was investigated. CCI model was used to induce TBI. Male rats were randomly assigned into the following groups: control, sham, sham treated with NaHS, TBI, and TBI treated with NaHS (3 and 5 mg/kg). NaHS was injected intraperitoneally 5 min before TBI induction. Learning and memory were assessed using Morris water maze (MWM) on days 8-12 following injury. CCI resulted in MWM deficits. Injured animals showed a slower rate of acquisition with respect to the sham-operated animals [F (1, 24) = 13.97, P < 0.01, two-way ANOVA]. NaHS improved spatial memory impairment of injured rats. Treatment with NaHS (5 mg/kg) decreased the escape latency [F (1, 24) = 7.559, P < 0.05, two-way ANOVA] and traveled distance [F (1, 12) = 6.398, P < 0.05, Two way ANOVA)]. In probe test, injured animals spent less time in target zone (P < 0.05, unpaired t-test) and NaHS did not have any effect on this parameter (p > 0.05, one way ANOVA). These findings suggest that NaHS has a neuroprotective effect on TBI-induced memory impairment in rats.	[Karimi, Seyed Asaad; Hosseinmardi, Narges; Janahmadi, Mahyar; Hajisoltani, Razieh] Shahid Beheshti Univ Med Sci, Sch Med, Dept Physiol, Tehran, Iran; [Karimi, Seyed Asaad; Hosseinmardi, Narges; Janahmadi, Mahyar; Hajisoltani, Razieh] Shahid Beheshti Univ Med Sci, Sch Med, Neurophysiol Res Ctr, Tehran, Iran; [Sayyah, Mohammad] Pasteur Inst Iran, Dept Physiol & Pharmacol, Tehran, Iran		Hosseinmardi, N (corresponding author), Shahid Beheshti Univ Med Sci, Sch Med, Dept Physiol, Tehran, Iran.	nhosseinmardi@sbmu.ac.ir	Karimi, Seyed Asaad/V-9287-2018; Hosseinmardi, Narges/V-5835-2019; Sayyah, Mohammad/K-4871-2017; Janahmadi, Mahyar/AAU-6425-2021	Hosseinmardi, Narges/0000-0003-4661-1248; Sayyah, Mohammad/0000-0003-0603-2444; Karimi, Seyed Asaad/0000-0002-8663-6485; hajisoltani, razieh/0000-0003-2821-4556	Shahid Beheshti University of Medical Sciences; Pasteur Institute, Tehran, Iran	The authors wish to express their appreciation to Dr. Hamid Gholamipour-Badie, Jafar Doost Mohammadpour and elham ghanbari for their excellent technical assistance. The research was supported in part by grants of Shahid Beheshti University of Medical Sciences and Pasteur Institute, Tehran, Iran.	Abe K, 1996, J NEUROSCI, V16, P1066; Ben Borgens R, 2012, Q REV BIOL, V87, P89, DOI 10.1086/665457; Benetti LR, 2013, EUR J PHARMACOL, V698, P463, DOI 10.1016/j.ejphar.2012.11.025; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Chai W, 2012, J SURG RES, V176, P210, DOI 10.1016/j.jss.2011.07.016; Chu QJ, 2013, J SURG RES, V183, P330, DOI 10.1016/j.jss.2012.12.003; Coronado VG, 2006, JAMA-J AM MED ASSOC, V295, P1764; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cristofori Irene, 2015, Handb Clin Neurol, V128, P579, DOI 10.1016/B978-0-444-63521-1.00037-6; Dai H.-B., 2015, MOL NEUROBIOL, P1; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Dempsey Kenneth E, 2009, J Trauma Nurs, V16, P6, DOI 10.1097/01.JTN.0000348063.41099.a7; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Farbood Y, 2015, LIFE SCI, V124, P120, DOI 10.1016/j.lfs.2015.01.013; Ganster F, 2010, CRIT CARE, V14, DOI 10.1186/cc9257; Gheibi S, 2014, J MOL NEUROSCI, V54, P264, DOI 10.1007/s12031-014-0284-9; Gong QH, 2010, PHARMACOL BIOCHEM BE, V96, P52, DOI 10.1016/j.pbb.2010.04.006; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hannay HJ, 1999, J NEUROTRAUM, V16, P1103, DOI 10.1089/neu.1999.16.1103; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Hu LF, 2011, ANTIOXID REDOX SIGN, V15, P405, DOI 10.1089/ars.2010.3517; Ji XT, 2012, J SURG RES, V178, pE9, DOI 10.1016/j.jss.2011.12.038; Jiang XF, 2013, J SURG RES, V184, pE27, DOI 10.1016/j.jss.2013.03.067; Karlsson O, 2011, BEHAV BRAIN RES, V219, P310, DOI 10.1016/j.bbr.2011.01.056; Kimura H, 2012, ANTIOXID REDOX SIGN, V17, P45, DOI 10.1089/ars.2011.4345; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kimura Y, 2006, ANTIOXID REDOX SIGN, V8, P661, DOI 10.1089/ars.2006.8.661; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Li T., 2016, BRAIN PATHOL; Li XJ, 2015, NEURAL REGEN RES, V10, P932, DOI 10.4103/1673-5374.158353; Liu YY, 2013, NEUROCHEM INT, V62, P603, DOI 10.1016/j.neuint.2012.12.010; Loane DJ, 2011, J NEUROTRAUM, V28, P225, DOI 10.1089/neu.2010.1595; Longhi L, 2001, J CEREBR BLOOD F MET, V21, P1241, DOI 10.1097/00004647-200111000-00001; Lu M, 2010, NEUROSCI RES, V66, P92, DOI 10.1016/j.neures.2009.09.1713; Lu M, 2008, FREE RADICAL BIO MED, V45, P1705, DOI 10.1016/j.freeradbiomed.2008.09.014; Luo YG, 2013, NEUROCHEM INT, V63, P826, DOI 10.1016/j.neuint.2013.06.004; Marklund N, 2001, J NEUROTRAUM, V18, P1217, DOI 10.1089/089771501317095250; Marklund N, 2001, J CEREBR BLOOD F MET, V21, P1259, DOI 10.1097/00004647-200111000-00002; Mohammadpour JD, 2015, PHARMACOL BIOCHEM BE, V132, P33, DOI 10.1016/j.pbb.2015.02.012; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Mustafa AG, 2013, NEUROSCIENCES, V18, P222; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Penkowa M, 2000, GLIA, V32, P271, DOI 10.1002/1098-1136(200012)32:3<271::AID-GLIA70>3.0.CO;2-5; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Sa T., 2019, EMERGEN MED, DOI [10.4172/2165-7548.1000229, DOI 10.4172/2165-7548.1000229]; Shao JL, 2011, J MOL NEUROSCI, V43, P453, DOI 10.1007/s12031-010-9464-4; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Tan BH, 2010, NEUROCHEM INT, V56, P3, DOI 10.1016/j.neuint.2009.08.008; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Xiong Y, 2007, BRAIN RES, V1185, P301, DOI 10.1016/j.brainres.2007.09.052; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yang Guangdong, 2011, Expert Rev Clin Pharmacol, V4, P33, DOI 10.1586/ecp.10.131; Yin J, 2013, BRAIN RES, V1491, P188, DOI 10.1016/j.brainres.2012.10.046; Yonezawa D, 2007, TOXICOLOGY, V241, P11, DOI 10.1016/j.tox.2007.07.020; Zhang MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087241; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504	57	23	23	1	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	SEP	2017	134						177	182		10.1016/j.brainresbull.2017.07.014			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FI3HA	WOS:000411847400023	28739248				2022-02-06	
J	Williams, CN; Kirby, A; Piantino, J				Williams, Cydni N.; Kirby, Aileen; Piantino, Juan			If You Build It, They Will Come: Initial Experience with a Multi-Disciplinary Pediatric Neurocritical Care Follow-Up Clinic	CHILDREN-BASEL			English	Article						pediatric; critical care outcomes; brain injuries; meningitis; encephalitis; stroke	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; INTENSIVE-CARE; BACTERIAL-MENINGITIS; FUNCTIONAL OUTCOMES; CHILDREN; DISORDERS; HEALTH; SURVIVORS; CHILDHOOD	Pediatric Neurocritical Care diagnoses account for a large proportion of intensive care admissions. Critical care survivors suffer high rates of long-term morbidity, including physical disability, cognitive impairment, and psychosocial dysfunction. To address these morbidities in Pediatric Neurocritical Care survivors, collaboration between Pediatric Neurology and Pediatric Critical Care created a multidisciplinary follow-up clinic providing specialized evaluations after discharge. Clinic referrals apply to all Pediatric Neurocritical Care patients regardless of admission severity of illness. Here, we report an initial case series, which revealed a population that is heterogenous in age, ranging from 1 month to 18 years, and in diagnoses. Traumatic brain injuries of varying severity as well as neuroinfectious and inflammatory diseases accounted for the majority of referrals. Most patients (87%) seen in the clinic had morbidities identified, requiring ongoing evaluation and expansion of the clinic. Cognitive and psychological disturbance were seen in over half of patients at the initial clinic follow-up. Sleep disturbances, daytime fatigue, headache or chronic pain, and vision or hearing concerns were also common at initial follow-up. Data from this initial population of clinic patients reiterates the need for specialized follow-up care, but also highlights the difficulties related to providing this comprehensive care and evaluating interventions to improve outcomes.	[Williams, Cydni N.; Kirby, Aileen] Oregon Hlth & Sci Univ, Div Pediat Crit Care, Dept Pediat, CDRC P, 707 SW Gaines St, Portland, OR 97239 USA; [Piantino, Juan] Oregon Hlth & Sci Univ, Div Pediat Neurol, Dept Pediat, CDRC P, 707 SW Gaines St, Portland, OR 97239 USA		Williams, CN (corresponding author), Oregon Hlth & Sci Univ, Div Pediat Crit Care, Dept Pediat, CDRC P, 707 SW Gaines St, Portland, OR 97239 USA.	willicyd@ohsu.edu; kirbya@ohsu.edu; piantino@ohsu.edu	Piantino, Juan/AAI-2184-2019	Piantino, Juan/0000-0002-8861-5709; Williams, Cydni/0000-0002-2049-7662	Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K12HS022981]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1K12HL133115]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K12HS022981] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K12HL133115] Funding Source: NIH RePORTER	Williams is supported by the Agency for Healthcare Research and Quality (grant number K12HS022981). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality. Piantino is supported by the National Institutes of Health (grant number 1K12HL133115). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Als LC, 2013, CRIT CARE MED, V41, P1094, DOI 10.1097/CCM.0b013e318275d032; Araujo GC, 2017, J INT NEUROPSYCH SOC, V23, P529, DOI 10.1017/S1355617717000364; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Bennett T. D., 2017, JAMA PEDIAT, DOI [10.1001/jamapediatrics.2017.212728846763, DOI 10.1001/JAMAPEDIATRICS.2017.212728846763]; Bennett TD, 2016, PEDIATR CRIT CARE ME, V17, P1147, DOI 10.1097/PCC.0000000000000934; Briand C, 2016, MED MALADIES INFECT, V46, P177, DOI 10.1016/j.medmal.2016.02.009; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; Brown EA, 2016, J PEDIATR PSYCHOL, V41, P244, DOI 10.1093/jpepsy/jsv090; Buysse CMP, 2007, QUAL LIFE RES, V16, P1567, DOI 10.1007/s11136-007-9271-8; Cooper AN, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-3870; Cunha F, 2013, PEDIATR CRIT CARE ME, V14, pE8, DOI 10.1097/PCC.0b013e31826012b4; Ebrahim S, 2013, PEDIATR CRIT CARE ME, V14, P10, DOI 10.1097/PCC.0b013e31825b64b3; Gagner C, 2015, J NEUROTRAUM, V32, P1539, DOI 10.1089/neu.2014.3753; Hopkins RO, 2015, J PEDIATR INTENSIVE, V4, P204, DOI 10.1055/s-0035-1563547; Keenan H. T., 2016, J HEAD TRAUMA REHAB, DOI [10.1097/HTR.000000000000026528489701, DOI 10.1097/HTR.000000000000026528489701]; Moreau JF, 2013, PEDIATR CRIT CARE ME, V14, P801, DOI 10.1097/PCC.0b013e31828aa71f; Namachivayam P, 2010, PEDIATR CRIT CARE ME, V11, P549, DOI 10.1097/PCC.0b013e3181ce7427; Ong C, 2016, PEDIATR CRIT CARE ME, V17, pE247, DOI 10.1097/PCC.0000000000000706; Pollack MM, 2014, PEDIATR CRIT CARE ME, V15, P821, DOI 10.1097/PCC.0000000000000250; Simonetti BG, 2015, NEUROLOGY, V84, P1941, DOI 10.1212/WNL.0000000000001555; Singh K, 2016, PEDIATR NEUROL, V60, P30, DOI 10.1016/j.pediatrneurol.2016.02.013; Tarokh L, 2016, NEUROSCI BIOBEHAV R, V70, P182, DOI 10.1016/j.neubiorev.2016.08.008; Truss K, 2017, J NEUROTRAUM, V34, P2272, DOI 10.1089/neu.2016.4842; Turel O, 2013, BALK MED J, V30, P80, DOI 10.5152/balkanmedj.2012.092; Wainwright MS, 2016, CURR OPIN CRIT CARE, V22, P106, DOI 10.1097/MCC.0000000000000288	27	23	23	0	5	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2227-9067		CHILDREN-BASEL	Children-Basel	SEP	2017	4	9							83	10.3390/children4090083			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	FI6BS	WOS:000412075000009	28925974	Green Published, gold, Green Submitted			2022-02-06	
J	Guiza, F; Meyfroidt, G; Piper, I; Citerio, G; Chambers, I; Enblad, P; Nillson, P; Feyen, B; Jorens, P; Maas, A; Schuhmann, MU; Donald, R; Moss, L; Van den Berghe, G; Depreitere, B				Guiza, Fabian; Meyfroidt, Geert; Piper, Ian; Citerio, Giuseppe; Chambers, Iain; Enblad, Per; Nillson, Pelle; Feyen, Bart; Jorens, Philippe; Maas, Andrew; Schuhmann, Martin U.; Donald, Rob; Moss, Laura; Van den Berghe, Greet; Depreitere, Bart			Cerebral Perfusion Pressure Insults and Associations with Outcome in Adult Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						adults; cerebral perfusion pressure; cerebrovascular autoregulation; traumatic brain injury	SEVERE HEAD-INJURY; INTRA-CRANICAL PRESSURE; BLOOD-FLOW; REACTIVITY; AUTOREGULATION; HYPERTENSION; HYPOTENSION; MANAGEMENT; HUMANS; TIME	The definition of cerebral perfusion pressure (CPP) secondary insults in severe traumatic brain injury remains unclear. The purpose of the present study is to visualize the association of intensity and duration of episodes below or above CPP thresholds and outcome. The analysis was based on prospectively collected minute-by-minute intracranial pressure (ICP) and blood pressure data and outcome from 259 adult patients. The relationship of episodes of CPP below or above a certain threshold for certain duration with the 6-month Glasgow Outcome Score was visualized separately for episodes of active or deficient autoregulation (AR). In adults <= 65 years, an almost exponential transition curve separates the episodes of CPP associated with better outcomes from the episodes of low CPP associated with worse outcomes, indicating that lower CPP could only be tolerated for a brief time. Analysis of episodes of high CPP again showed a time-intensity dependent association with outcome. When combining the two plots, a safe CPP zone between 60 and 70mm Hg could be delineated-however, only for AR active insults. The AR status predominantly affected the transition curve for insults of low CPP. Episodes with ICP >25mm Hg were associated with poor outcome regardless of CPP. In the present study, the CPP pressure-time burden associated with poor outcome was visualized. A safe zone between 60 and 70mm Hg could be identified for adults <= 65 years, provided AR was active and ICP was <= 25mm Hg. Deficient AR reduces the tolerability for low CPP.	[Guiza, Fabian; Meyfroidt, Geert; Van den Berghe, Greet] Univ Hosp Leuven, Dept Intens Care Med, Leuven, Belgium; [Piper, Ian] Southern Gen Hosp, Dept Clin Phys, Glasgow, Lanark, Scotland; [Citerio, Giuseppe] San Gerardo Hosp, Dept Perioperat Med & Intens Care Med, Monza, Italy; [Chambers, Iain] James Cook Univ Hosp, Med Phys, Middlesbrough, England; [Enblad, Per; Nillson, Pelle] Dept Neurosci, Neurosurg, Uppsala, Sweden; [Feyen, Bart; Maas, Andrew] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Jorens, Philippe] Antwerp Univ Hosp, Dept Intens Care Med, Edegem, Belgium; [Schuhmann, Martin U.] Univ Klinikum Tubingen, Neurochirurg Klin, Tubingen, Germany; [Donald, Rob] Univ Glasgow, Sch Math & Stat, Glasgow, Lanark, Scotland; [Moss, Laura] NHS Greater Glasgow & Clyde, Dept Clin Phys & Bioengn, Glasgow, Lanark, Scotland; [Depreitere, Bart] Univ Hosp Leuven, Dept Neurosurg, Herestr 49, B-3000 Leuven, Belgium		Depreitere, B (corresponding author), Univ Hosp Leuven, Dept Neurosurg, Herestr 49, B-3000 Leuven, Belgium.	bart.depreitere@uzleuven.be	Van den Berghe, Greet/J-6788-2018; Depreitere, Bart/AAA-9846-2020; Citerio, Giuseppe/B-1839-2015; Maas, Andrew IR/C-5584-2013	Van den Berghe, Greet/0000-0002-5320-1362; Depreitere, Bart/0000-0002-7458-0648; Citerio, Giuseppe/0000-0002-5374-3161; Maas, Andrew IR/0000-0003-1612-1264; Donald, Rob/0000-0001-5301-0219; Moss, Laura/0000-0003-4968-0900; Guiza, Fabian/0000-0001-7026-0957	Fonds voor Wetenschappelijk Onderzoek VlaanderenFWO [G.0904.11, 1846113N]; Methusalem program - Flemish Governement [METH/08/07]; Flemish Governement Agency for Innovation by Science and Technology (IWT);  [FP5-QRLI-2000-00454];  [QLGT-2002-00160];  [FP7-IST-2007-217049]	This study is funded through Fonds voor Wetenschappelijk Onderzoek Vlaanderen (Research Project G.0904.11). Geert Meyfroidt receives funding from Fonds voor Wetenschappelijk Onderzoek Vlaanderen as senior clinical investigator (1846113N), Greet Van den Berghe receives structural research funding via the Methusalem program funded by the Flemish Governement (METH/08/07). Brain-IT was funded by the European Framework Program (FP5-QRLI-2000-00454), QLGT-2002-00160 and FP7-IST-2007-217049). The NEMO project in the Universty Hospital Antwerp was funded by the Flemish Governement Agency for Innovation by Science and Technology (IWT). The authors wish to acknowledge the non-author steering group members of Brain-IT: Barbara Gregson, Tim Howells, Karl Kiening, Arminas Ragauskas, Juan Sahuquillo, and Jan Oliver Neumann.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Depreitere B, 2014, J NEUROSURG, V120, P1451, DOI 10.3171/2014.3.JNS131500; Drummond JC, 1997, ANESTHESIOLOGY, V86, P1431, DOI 10.1097/00000542-199706000-00034; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; JENNETT B, 1975, LANCET, V1, P480; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Naredi S, 2001, ACTA ANAESTH SCAND, V45, P402, DOI 10.1034/j.1399-6576.2001.045004402.x; Numan T, 2014, MED ENG PHYS, V36, P1487, DOI 10.1016/j.medengphy.2014.08.001; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Piper I, 2003, ACTA NEUROCHIR, V145, P615, DOI 10.1007/s00701-003-0066-6; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Sviri GE, 2009, J NEUROSURG, V111, P695, DOI 10.3171/2008.10.17686; Tan CO, 2012, J APPL PHYSIOL, V113, P1194, DOI 10.1152/japplphysiol.00783.2012; Tzeng YC, 2010, HYPERTENSION, V56, P268, DOI 10.1161/HYPERTENSIONAHA.110.152066; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	29	23	25	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2017	34	16					2425	2431		10.1089/neu.2016.4807			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FC6RI	WOS:000406968400005	28385097	Bronze, Green Accepted, Green Published			2022-02-06	
J	Lawrence, TP; Pretorius, PM; Ezra, M; Cadoux-Hudson, T; Voets, NL				Lawrence, Tim P.; Pretorius, Pieter M.; Ezra, Martyn; Cadoux-Hudson, Tom; Voets, Natalie L.			Early detection of cerebral microbleeds following traumatic brain injury using MRI in the hyper-acute phase	NEUROSCIENCE LETTERS			English	Article						Traumatic brain injury; Traumatic cerebral microbleeds; Susceptibility weighted imaging; Hyper-acute	DIFFUSE AXONAL INJURY; HEAD-INJURY; HYPOTENSION; CHILDREN; LESIONS	Background: Traumatic brain injury (TBI) is a leading cause of death and disability in people under 45. Advanced imaging techniques to identify injury and classify severity in the first few hours and days following trauma could improve patient stratification and aid clinical decision making. Traumatic cerebral microbleeds (TCMBs), detectable on magnetic resonance susceptibility weighted imaging (SWI), can be used as markers of long-term clinical outcome. However, the relationship between TCMBs and injury severity in the first few hours after injury, and their natural evolution, is unknown. Methods: We obtained SWI scans in 10 healthy controls, and 13 patients scanned 3-24 h following TBI and again at 7-15 days. TCMBs were identified and total volume quantified for every lesion in each scan. Results: TCMBs were present in 6 patients, all with more severe injury classified by GCS. No lesions were identified in patients with an initial GCS of 15. Improvement in GCS in the first 15 days following injury was significantly associated with a reduction in microbleed volume over the same time-period. Conclusion: MRI is feasible in severely injured patients in the first 24 h after trauma. Detection of TCMBs using SWI provides an objective early marker of injury severity following trauma. TCMBs revealed in this time frame, offer the potential to help determine the degree of injury, improving stratification, in order to identify patients who require admission to hospital, transfer to a specialist center, or an extended period of intubation on intensive care. (C) 2017 The Authors. Published by Elsevier Ireland Ltd.	[Lawrence, Tim P.; Ezra, Martyn; Voets, Natalie L.] Univ Oxford, NDCN, Oxford Ctr Funct Magnet Resonance Imaging Brain F, Oxford, England; [Lawrence, Tim P.; Cadoux-Hudson, Tom; Voets, Natalie L.] Oxford Univ Hosp NHS Fdn Trust, Dept Neurosurg, Oxford, England; [Pretorius, Pieter M.] Oxford Univ Hosp NHS Fdn Trust, Dept Neuroradiol, Oxford, England		Lawrence, TP (corresponding author), John Radcliffe Hosp, Dept Neurosurg, Level 3 West Wing, Oxford OX3 9DU, England.	Tim.lawrence@ndcn.ox.ac.uk; Pieter.pretorius@ouh.nhs.uk; Martyn.ezra@ndcn.ox.ac.uk; Thomas.cadoux-hudson@ndm.ox.ac.uk; Natalie.voets@ndcn.ox.ac.uk			NIHR Biomedical Research Centre, based at Oxford University Hospitals Trust, Oxford; Wellcome TrustWellcome TrustEuropean Commission [203139/Z/16/Z]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0900806] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0900806] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [ACF-2012-13-005] Funding Source: researchfish	Supported by the NIHR Biomedical Research Centre, based at Oxford University Hospitals Trust, Oxford. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. This work was supported by core funding from the Wellcome Trust [203139/Z/16/Z].	Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; BRADLEY WG, 1993, RADIOLOGY, V189, P15, DOI 10.1148/radiology.189.1.8372185; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Cheng AL, 2013, STROKE, V44, P2782, DOI 10.1161/STROKEAHA.113.002267; Colbert CA, 2010, RADIOLOGY, V256, P898, DOI 10.1148/radiol.10091842; Fazlollahi A, 2015, COMPUT MED IMAG GRAP, V46, P269, DOI 10.1016/j.compmedimag.2015.10.001; Geurts BHJ, 2012, BRAIN INJURY, V26, P1439, DOI 10.3109/02699052.2012.694563; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Huang YL, 2015, NEUROLOGY, V84, P580, DOI 10.1212/WNL.0000000000001237; Liu J, 2014, NEURAL REGEN RES, V9, P1222, DOI 10.4103/1673-5374.135330; NICE, 2014, HEAD INJ ASS EARL MA; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Poels MMF, 2010, STROKE, V41, pS103, DOI 10.1161/STROKEAHA.110.595181; Sigmund GA, 2007, PEDIATR NEUROL, V36, P217, DOI 10.1016/j.pediatrneurol.2007.01.003; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Spitz G, 2013, J NEUROTRAUM, V30, P2038, DOI 10.1089/neu.2013.3021; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Toth A, 2016, NEUROSCI LETT, V617, P207, DOI 10.1016/j.neulet.2016.02.028; van den Heuvel TLA, 2016, NEUROIMAGE-CLIN, V12, P241, DOI 10.1016/j.nicl.2016.07.002; Watanabe J, 2016, ACTA NEUROCHIR, V158, P1247, DOI 10.1007/s00701-016-2805-5	23	23	23	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	AUG 10	2017	655						143	150		10.1016/j.neulet.2017.06.046			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FD6UK	WOS:000407663200022	28663054	Green Published, hybrid			2022-02-06	
J	Babl, FE; Dionisio, D; Davenport, L; Baylis, A; Hearps, SJC; Bressan, S; Thompson, EJ; Anderson, V; Oakley, E; Davis, GA				Babl, Franz E.; Dionisio, Diana; Davenport, Lucy; Baylis, Amy; Hearps, Stephen J. C.; Bressan, Silvia; Thompson, Emma J.; Anderson, Vicki; Oakley, Ed; Davis, Gavin A.			Accuracy of Components of SCAT to Identify Children With Concussion	PEDIATRICS			English	Article							SPORT-RELATED CONCUSSION; INTERNATIONAL-CONFERENCE; EMERGENCY-DEPARTMENT; CONSENSUS STATEMENT; MANAGEMENT; ZURICH; ADULTS	BACKGROUND: The Sport Concussion Assessment Tool version 3 (SCAT3) and its child version abstract (ChildSCAT3) are composite physical and neuropsychological scoring systems used to assess athletes after sport-related concussion. Based on limited validation data, we aimed to evaluate the ability of SCAT3 and ChildSCAT3 to differentiate children aged 5 to 16 years with concussion from controls. METHODS: Prospective observational study of children in the emergency department with concussion (CONC group) and 2 control groups ([1] upper-limb injury [ULI] and [2] Well children) with equal-sized subgroups in 3 age bands of 5 to 8, 9 to 12, and 13 to 16 years. ChildSCAT3 was used for participants aged 5 to 12 years, and SCAT3 was used for participants aged 13 to 16 years. Differences between study groups were analyzed by using analysis of variance models, adjusting for age and sex. RESULTS: We enrolled 264 children (90 CONC, 90 ULI, and 84 Well) in equal-sized age bands. The number and severity of child-and parent-reported symptom scores were significantly higher in the CONC group than either control group (P < .001). Mean double (ChildSCAT3 P < .001) and tandem stance errors (both P = .01) were also significantly higher, and immediate memory was significantly lower for the CONC group (P < .01). No statistically significant group differences were found for orientation and digit backward tasks. There were no significant differences between ULI and Well control groups. CONCLUSIONS: Overall, SCAT3 and ChildSCAT3 can differentiate concussed from nonconcussed patients, particularly in symptom number and severity.	[Babl, Franz E.; Baylis, Amy; Oakley, Ed] Royal Childrens Hosp Melbourne, Emergency Dept, Parkville, Vic, Australia; [Babl, Franz E.; Dionisio, Diana; Davenport, Lucy; Baylis, Amy; Hearps, Stephen J. C.; Bressan, Silvia; Thompson, Emma J.; Anderson, Vicki; Oakley, Ed; Davis, Gavin A.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Babl, Franz E.; Anderson, Vicki; Oakley, Ed] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Davis, Gavin A.] Austin Hlth & Cabrini Hosp, Dept Neurosurg, Malvern, Vic, Australia		Babl, FE (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Emergency Dept, Emergency Res, Flemington Rd, Parkville, Vic 3052, Australia.	franz.babl@rch.org.au	Hearps, Stephen/L-6853-2016	Hearps, Stephen/0000-0003-2984-1172	Murdoch Children's Research Institute in Melbourne; Victorian Government Research Infrastructure Support program; Royal Children's Hospital Foundation; Melbourne Campus Clinician Scientist Fellowship (Melbourne, Victoria, Australia); National Health and Medical Research Council Practitioner Fellowship (Canberra, Australian Capital Territory, Australia)	Funded in part by grants from the Murdoch Children's Research Institute in Melbourne and the Victorian Government Research Infrastructure Support program. Dr Babl's time was partly funded by a grant from the The Royal Children's Hospital Foundation and the Melbourne Campus Clinician Scientist Fellowship (Melbourne, Victoria, Australia) and a National Health and Medical Research Council Practitioner Fellowship (Canberra, Australian Capital Territory, Australia).	Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Bressan S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009427; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Glaviano NR, 2015, CLIN J SPORT MED, V25, P373, DOI 10.1097/JSM.0000000000000154; Gorman M, 2016, APPL NEUROPSYCH-CHIL, P1; Grubenhoff JA, 2010, PEDIATRICS, V126, P688, DOI 10.1542/peds.2009-2804; Hayden MG, 2007, CHILD NERV SYST, V23, P431, DOI 10.1007/s00381-006-0277-2; Jennings D, 2015, INT J SPORTS PHYS TH, V10, P667; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2002, BRIT J SPORT MED, V36, P316, DOI 10.1136/bjsm.36.5.316; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Nelson LD, 2017, CLIN J SPORT MED, V27, P381, DOI 10.1097/JSM.0000000000000369; Schnadower D, 2007, CURR OPIN PEDIATR, V19, P258, DOI 10.1097/MOP.0b013e3281084e85; Sturdivant RX, 2013, APPL LOGISTIC REGRES, V3rd	21	23	23	0	6	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	AUG	2017	140	2							e20163258	10.1542/peds.2016-3258			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	FC2IA	WOS:000406659900013		Green Published, Bronze			2022-02-06	
J	Chou, R; Totten, AM; Carney, N; Dandy, S; Fu, RW; Grusing, S; Pappas, M; Wasson, N; Newgard, CD				Chou, Roger; Totten, Annette M.; Carney, Nancy; Dandy, Spencer; Fu, Rongwei; Grusing, Sara; Pappas, Miranda; Wasson, Ngoc; Newgard, Craig D.			Predictive Utility of the Total Glasgow Coma Scale Versus the Motor Component of the Glasgow Coma Scale for Identification of Patients With Serious Traumatic Injuries	ANNALS OF EMERGENCY MEDICINE			English	Article							BRAIN-INJURY; SCORE; CHILDREN; OUTCOMES; RISK; CONSCIOUSNESS; METAANALYSIS; VALIDATION; CARE; TOOL	Study objective: The motor component of the Glasgow Coma Scale (mGCS) has been proposed as an easier-to-use alternative to the total GCS (tGCS) for field assessment of trauma patients by emergency medical services. We perform a systematic review and meta-analysis to compare the predictive utility of the tGCS versus the mGCS or Simplified Motor Scale in field triage of trauma for identifying patients with adverse outcomes (inhospital mortality or severe brain injury) or who underwent procedures (neurosurgical intervention or emergency intubation) indicating need for high-level trauma care. Methods: Ovid MEDLINE, Cumulative Index to Nursing and Allied Health Literature, PsycINFO, Health and Psychosocial Instruments, and the Cochrane databases were searched through June 2016 for English-language cohort studies. We included studies that compared the area under the receiver operating characteristic curve (AUROC) of the tGCS versus the mGCS or Simplified Motor Scale assessed in the field or shortly after arrival in the emergency department for predicting the outcomes described above. Meta-analyses were performed with a random-effects model, and subgroup and sensitivity analyses were conducted. Results: We included 18 head-to-head studies of predictive utility (n=1,703,388). For inhospital mortality, the tGCS was associated with slightly greater discrimination than the mGCS (pooled mean difference in [AUROC] 0.015; 95% confidence interval [CI] 0.009 to 0.022; I-2=85%; 12 studies) or the Simplified Motor Scale (pooled mean difference in AUROC 0.030; 95% CI 0.024 to 0.036; I-2=0%; 5 studies). The tGCS was also associated with greater discrimination than the mGCS or Simplified Motor Scale for nonmortality outcomes (differences in AUROC from 0.03 to 0.05). Findings were robust in subgroup and sensitivity analyses. Conclusion: The tGCS is associated with slightly greater discrimination than the mGCS or Simplified Motor Scale for identifying severe trauma. The small differences in discrimination are likely to be clinically unimportant and could be offset by factors such as convenience and ease of use.	[Chou, Roger; Totten, Annette M.; Carney, Nancy; Dandy, Spencer; Fu, Rongwei; Grusing, Sara; Pappas, Miranda; Wasson, Ngoc] Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Chou, Roger] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA; [Fu, Rongwei] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97201 USA; [Newgard, Craig D.] Oregon Hlth & Sci Univ, Dept Emergency Med, Ctr Policy & Res Emergency Med, Portland, OR 97201 USA		Chou, R (corresponding author), Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA.; Chou, R (corresponding author), Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA.	chour@ohsu.edu	Totten, Annette/P-7909-2019	Totten, Annette/0000-0002-9100-8678; Chou, Roger/0000-0001-9889-8610	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services [290-2015-00009-I]	By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). The authors have stated that no such relationships exist. This project was funded under contract 290-2015-00009-I from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services.	Acker SN, 2014, J TRAUMA ACUTE CARE, V77, P304, DOI 10.1097/TA.0000000000000300; Agency for Healthcare Research and Quality, 2014, AHRQ PUBLICATION, V10(14)-EHC063-EF; Al-Salamah MA, 2004, ACAD EMERG MED, V11, P834, DOI 10.1197/j.aem.2004.03.008; BAXT WG, 1987, J TRAUMA, V27, P365, DOI 10.1097/00005373-198704000-00004; BAZZOLI GJ, 1995, JAMA-J AM MED ASSOC, V273, P395; Beskind DL, 2014, PREHOSP EMERG CARE, V18, P68, DOI 10.3109/10903127.2013.844870; Beskind DL, 2011, ACAD EMERG MED, V18, P988, DOI 10.1111/j.1553-2712.2011.01148.x; Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; Brown JB, 2014, J TRAUMA ACUTE CARE, V77, P95, DOI 10.1097/TA.0000000000000280; Caterino JM, 2012, EMERG MED J, V29, P492, DOI 10.1136/emj.2010.110437; Chang SM, 2012, METHODS GUIDE MED TE; Chou R, 2016, AHRQ PUBLICATION, P290; Cicero MX, 2013, PEDIATR EMERG CARE, V29, P43, DOI 10.1097/PEC.0b013e31827b52bf; Cornell JE, 2014, ANN INTERN MED, V160, P267, DOI 10.7326/M13-2886; Corrigan JD, 2014, J NEUROTRAUM, V31, P1000, DOI 10.1089/neu.2013.3145; Davis DP, 2006, J TRAUMA, V60, P985, DOI 10.1097/01.ta.0000205860.96209.1c; Eken C, 2009, EUR J EMERG MED, V16, P29, DOI 10.1097/MEJ.0b013e32830346ab; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Gill M, 2006, ACAD EMERG MED, V13, P968, DOI 10.1197/j.aem.2006.05.019; Graham E, 2016, CRD42016035944; Haukoos JS, 2007, ANN EMERG MED, V50, P18, DOI 10.1016/j.annemergmed.2006.10.004; Hayden JA, 2013, ANN INTERN MED, V158, P280, DOI 10.7326/0003-4819-158-4-201302190-00009; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Holmes JF, 2005, ACAD EMERG MED, V12, P814, DOI 10.1197/j.aem.2005.04.019; Kupas DF, 2016, ANN EMERG MED, V68, P744, DOI 10.1016/j.annemergmed.2016.06.017; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Nance ML, 2013, NATL TRAUMA DATA BAN; Ross SE, 1998, J TRAUMA, V45, P42, DOI 10.1097/00005373-199807000-00008; Rotondo MF, 2014, RESOURCES OPTIMAL CA; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Singh B, 2013, BRAIN INJURY, V27, P293, DOI 10.3109/02699052.2012.743182; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Thompson DO, 2011, ANN EMERG MED, V58, P417, DOI 10.1016/j.annemergmed.2011.05.033; Van de Voorde P, 2008, RESUSCITATION, V76, P175, DOI 10.1016/j.resuscitation.2007.07.007; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; ZWEIG MH, 1993, CLIN CHEM, V39, P561	38	23	25	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644	1097-6760		ANN EMERG MED	Ann. Emerg. Med.	AUG	2017	70	2					143	157		10.1016/j.annemergmed.2016.11.032			15	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FD1OI	WOS:000407306200005	28089112				2022-02-06	
J	Ferguson, NM; Sarnaik, A; Miles, D; Shafi, N; Peters, MJ; Truemper, E; Vavilala, MS; Bell, MJ; Wisniewski, SR; Luther, JF; Hartman, AL; Kochanek, PM				Ferguson, Nikki Miller; Sarnaik, Ajit; Miles, Darryl; Shafi, Nadeem; Peters, Mark J.; Truemper, Edward; Vavilala, Monica S.; Bell, Michael J.; Wisniewski, Stephen R.; Luther, James F.; Hartman, Adam L.; Kochanek, Patrick M.		Investigators Approaches Decisions	Abusive Head Trauma and Mortality-An Analysis From an International Comparative Effectiveness Study of Children With Severe Traumatic Brain Injury	CRITICAL CARE MEDICINE			English	Article						abusive head injury; comparative effectiveness research; pediatric neurocritical care; pediatric traumatic brain injury; secondary injuries	OPERATIONAL CASE-DEFINITION; YOUNG-CHILDREN; UNITED-STATES; OUTCOMES; INFANTS; NEUROPATHOLOGY; DEMOGRAPHICS; BURDEN; DEATH; APNEA	Objectives: Small series have suggested that outcomes after abusive head trauma are less favorable than after other injury mechanisms. We sought to determine the impact of abusive head trauma on mortality and identify factors that differentiate children with abusive head trauma from those with traumatic brain injury from other mechanisms. Design: First 200 subjects from the Approaches and Decisions in Acute Pediatric Traumatic Brain Injury Trial-a comparative effectiveness study using an observational, cohort study design. Setting: PICUs in tertiary children's hospitals in United States and abroad. Patients: Consecutive children (age < 18 yr) with severe traumatic brain injury (Glasgow Coma Scale <= 8; intracranial pressure monitoring). Interventions: None. Measurements and Main Results: Demographics, injury-related scores, prehospital, and resuscitation events were analyzed. Children were dichotomized based on likelihood of abusive head trauma. A total of 190 children were included (n = 35 with abusive head trauma). Abusive head trauma subjects were younger (1.87 +/- 0.32 vs 9.23 +/- 0.39 yr; p < 0.001) and a greater proportion were female (54.3% vs 34.8%; p = 0.032). Abusive head trauma were more likely to 1) be transported from home (60.0% vs 33.5%; p < 0.001), 2) have apnea (34.3% vs 12.3%; p = 0.002), and 3) have seizures (28.6% vs 7.7%; p < 0.001) during prehospital care. Abusive head trauma had a higher prevalence of seizures during resuscitation (31.4 vs 9.7%; p = 0.002). After adjusting for covariates, there was no difference in mortality (abusive head trauma, 25.7% vs nonabusive head trauma, 18.7%; hazard ratio, 1.758; p = 0.60). A similar proportion died due to refractory intracranial hypertension in each group (abusive head trauma, 66.7% vs nonabusive head trauma, 69.0%). Conclusions: In this large, multicenter series, children with abusive head trauma had differences in prehospital and in-hospital secondary injuries which could have therapeutic implications. Unlike other traumatic brain injury populations in children, female predominance was seen in abusive head trauma in our cohort. Similar mortality rates and refractory intracranial pressure deaths suggest that children with severe abusive head trauma may benefit from therapies including invasive monitoring and adherence to evidence-based guidelines.	[Ferguson, Nikki Miller] Virginia Commonwealth Univ, Dept Pediat, Richmond, VA USA; [Sarnaik, Ajit] Wayne State Univ, Dept Pediat, Detroit, MI 48202 USA; [Miles, Darryl] Univ Texas Southwestern, Dept Pediat, Dallas, TX USA; [Shafi, Nadeem] Univ Tennessee, Dept Pediat, Memphis, TN USA; [Peters, Mark J.] Great Ormond St Hosp Sick Children, Dept Pediat, London, England; [Truemper, Edward] Univ Nebraska, Dept Pediat, Omaha, NE 68182 USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; [Bell, Michael J.; Kochanek, Patrick M.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Wisniewski, Stephen R.; Luther, James F.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Hartman, Adam L.] NINDS, Off Clin Res, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA		Bell, MJ (corresponding author), Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA.	bellmj4@upmc.edu	Peters, Mark/AAD-7518-2019; Hartman, Adam/W-9782-2019; Ferguson, Nikki Miller/AAA-4548-2020	Peters, Mark/0000-0003-3653-4808; Hartman, Adam/0000-0001-5672-3409; Figaji, Anthony/0000-0002-3357-6490; Bennett, Tellen/0000-0003-1483-4236; Edwards, Richard/0000-0001-8415-2180	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 NS081041]; National Institute of Neurological Disorders and Stroke (NINDS)/National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; University of PittsburghUniversity of Pittsburgh; Approaches and Decisions in Acute Pediatric Traumatic Brain Injury Trial; NIH via Childrens' Hospital Pittsburgh; NIH, Pittsburgh Children's Hospital; University of Nebraska College of Medicine, Gerber Foundation grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD079123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS081041] Funding Source: NIH RePORTER	Supported, in part, by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Number U01 NS081041. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Drs. Miller Ferguson's and Sarnaik's institution received funding from the National Institute of Neurological Disorders and Stroke (NINDS)/National Institutes of Health (NIH), and they received support for article research from the NIH. Dr. Miles's institution received funding from the University of Pittsburgh, and he received support for article research from the NIH. Dr. Shafi's institution received funding from Approaches and Decisions in Acute Pediatric Traumatic Brain Injury Trial (PI: Michael Bell, UPMC), and he received support for article research from the NIH. Dr. Peters' institution received funding from the NIH via Childrens' Hospital Pittsburgh (per patient payments and initial set-up costs), and he received support for article research from the NIH; he disclosed funding from providing expert witness services to criminal and family courts in the United Kingdom concerning causation and timing of head trauma (for both prosecution and defense). Dr. Truemper's institution received funding from the NIH, Pittsburgh Children's Hospital, the University of Nebraska College of Medicine, Gerber Foundation grant (coinvestigator in determination of embolic burden in infants with CHD undergoing corrective or palliative	Acker SN, 2014, J PEDIATR SURG, V49, P338, DOI 10.1016/j.jpedsurg.2013.10.008; Adamo MA, 2009, J NEUROSURG-PEDIATR, V4, P414, DOI 10.3171/2009.6.PEDS0939; Armstead WM, 2010, BRAIN RES, V1330, P142, DOI 10.1016/j.brainres.2010.03.024; Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; Bennett TD, 2012, ARCH PEDIAT ADOL MED, V166, P641, DOI 10.1001/archpediatrics.2012.322; Berger RP, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-3756; Chang DC, 2004, J TRAUMA, V57, P1189, DOI 10.1097/01.TA.0000145076.05111.E1; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Davies FC, 2015, EMERG MED J, V32, P921, DOI 10.1136/emermed-2015-205285; Deans KJ, 2013, J TRAUMA ACUTE CARE, V75, P157, DOI 10.1097/TA.0b013e3182984acb; Diaz-Olavarrieta C, 2011, CHILD ABUSE NEGLECT, V35, P915, DOI 10.1016/j.chiabu.2011.05.017; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Duval J, 2008, J CHILD NEUROL, V23, P663, DOI 10.1177/0883073808314161; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ferguson NM, 2016, PEDIATR CRIT CARE ME, V17, P444, DOI 10.1097/PCC.0000000000000709; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P1328, DOI 10.1097/00003246-199309000-00016; Greiner MV, 2015, J CHILD NEUROL, V30, P1778, DOI 10.1177/0883073815580285; Hymel KP, 2007, PEDIATRICS, V119, P922, DOI 10.1542/peds.2006-3111; Johnson DL, 1995, PEDIATR NEUROSURG, V23, P305, DOI 10.1159/000120976; Keenan HT, 2008, AM J PREV MED, V34, pS120, DOI 10.1016/j.amepre.2007.11.001; Keenan HT, 2006, PEDIATRICS, V117, P317, DOI 10.1542/peds.2005-0979; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kemp AM, 2003, ARCH DIS CHILD, V88, P472, DOI 10.1136/adc.88.6.472; Kesler H, 2008, J NEUROSURG-PEDIATR, V1, P351, DOI 10.3171/PED/2008/1/5/351; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Lind K, 2016, CHILD ABUSE NEGLECT, V51, P358, DOI 10.1016/j.chiabu.2015.08.001; Makaroff KL, 2003, DEV MED CHILD NEUROL, V45, P497, DOI 10.1017/S0012162203000926; Matschke J, 2015, INT J LEGAL MED, V129, P105, DOI 10.1007/s00414-014-1060-7; Mehta A, 2010, DEV NEUROSCI-BASEL, V32, P413, DOI 10.1159/000316804; Miller TR, 2014, PEDIATRICS, V134, pE1545, DOI 10.1542/peds.2014-1385; Nuno M, 2015, J NEUROSURG PEDIAT, P1; Parks S, 2012, INJURY PREV, V18, P392, DOI 10.1136/injuryprev-2011-040234; Parks SE, 2012, INJURY PREV, V18, P193, DOI 10.1136/injuryprev-2011-040128; Peterson C, 2015, CHILD MALTREATMENT, V20, P162, DOI 10.1177/1077559515583549; Peterson C, 2014, PEDIATRICS, V134, P91, DOI 10.1542/peds.2014-0117; Piteau SJ, 2012, PEDIATRICS, V130, P315, DOI 10.1542/peds.2011-1545; Scavarda D, 2010, CHILD NERV SYST, V26, P1555, DOI 10.1007/s00381-010-1150-x; Shein SL, 2012, J PEDIATR-US, V161, P716, DOI 10.1016/j.jpeds.2012.03.046; Siriussawakul A, 2011, PEDIATR ANESTH, V21, P141, DOI 10.1111/j.1460-9592.2010.03498.x; Xiang J, 2013, BRAIN INJURY, V27, P1555, DOI 10.3109/02699052.2013.831126	45	23	23	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	AUG	2017	45	8					1398	1407		10.1097/CCM.0000000000002378			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FA5FY	WOS:000405469600040	28430697	Green Submitted, Green Accepted			2022-02-06	
J	Jang, JY; Kwon, HY; Choi, EH; Lee, WY; Shim, H; Bae, KS				Jang, Ji Young; Kwon, Hye Youn; Choi, Eun Hee; Lee, Won-Yeon; Shim, Hongjin; Bae, Keum Seok			Efficacy and toxicity of high-dose nebulized colistin for critically ill surgical patients with ventilator-associated pneumonia caused by multidrug-resistant Acinetobacter baumannii	JOURNAL OF CRITICAL CARE			English	Article						Colistin; Nebulizer; Inhalation; Ventilator-associated pneumonia; Acinetobacter baumannii	GRAM-NEGATIVE BACTERIA; AEROSOLIZED COLISTIN; INHALED COLISTIN; INTRAVENOUS COLISTIN; ADJUNCTIVE TREATMENT; ACQUIRED PNEUMONIA; RISK-FACTORS; TRIAL; TRACHEOBRONCHITIS; DEFINITIONS	Purpose: Few studies have compared nebulized and intravenous (IV) colistin for multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa pneumonia. This study compared the nephrotoxicity and clinical outcomes for these two delivery routes. Methods: This study retrospectively compared 95 critically ill surgical patients who were diagnosed with Acinetobacter baumannii ventilator associated pneumonia and received colistin between March 2013 and January 2016. Results: The most common diagnoses were brain hemorrhage (27.4%), traumatic brain injury (20%), traumatic thoracic injury (15.8%), and secondary peritonitis (11.6%). Compared to the IV group, the nebulizer group was significantly older (60.0 vs. 67.5 years, p = 0.010), had higher APACHE II scores (16.3 vs. 19.9, p = 0.001), and more frequently had diabetes mellitus (6.8% vs. 21.6%, p = 0.043). Nephrotoxicity was more common in the IV group (60.5% vs. 15.7%, p < 0.0001). Both groups had similar microbiological and clinical outcomes (p = 0.921 and p= 0.719, respectively). Patients with nephrotoxicity exhibited prolonged IV or nebulized colistin treatment and more frequent combination with vancomycin. Nephrotoxicity was independently associated with IV delivery (odds ratio: 8.48, 95% confidence interval: 2.95-24.39, p < 0.0001). Conclusions: Nebulized colistinmay have less nephrotoxicity and provide similar clinical results, compared to IV colistin. (C) 2017 Elsevier Inc. All rights reserved.	[Jang, Ji Young; Kwon, Hye Youn; Shim, Hongjin; Bae, Keum Seok] Yonsei Univ, Wonju Coll Med, Dept Surg, Trauma Ctr, Seoul, South Korea; [Choi, Eun Hee] Yonsei Univ, Wonju Coll Med, Inst Lifestyle Med, Seoul, South Korea; [Lee, Won-Yeon] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Seoul, South Korea		Shim, H (corresponding author), Yonsei Univ, Wonju Coll Med, Wonju Severance Christian Hosp, Trauma Ctr,Dept Surg, 220-701 Ilsan Ro, Wonju, Gangwon Do, South Korea.	simong3@yonsei.ac.kr		Jang, Ji Young/0000-0001-6372-4194; Choi, Eunhee/0000-0002-3449-0672			Abdellatif S, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0127-7; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bassetti M, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0140-x; Boisson M, 2013, MINERVA ANESTESIOL, V79, P200; Chaari A, 2013, INT J INFECT DIS, V17, pE1225, DOI 10.1016/j.ijid.2013.07.014; Choi HK, 2014, YONSEI MED J, V55, P118, DOI 10.3349/ymj.2014.55.1.118; Choi HS, 2008, TUBERC RESPIR DIS, V64, P8, DOI 10.4046/trd.2008.64.1.8; Cisneros JM, 2005, CLIN MICROBIOL INFEC, V11, P874, DOI 10.1111/j.1469-0691.2005.01256.x; Clinical and Laboratory Standard Institute, 2009, 2009M100S17 CLSI; Coelho JM, 2006, J CLIN MICROBIOL, V44, P3623, DOI 10.1128/JCM.00699-06; Doshi NM, 2013, BMC ANESTHESIOL, V13, DOI 10.1186/1471-2253-13-45; Falagas ME, 2010, PEDIATR PULM, V45, P1135, DOI 10.1002/ppul.21302; Falagas ME, 2006, J MED MICROBIOL, V55, P1619, DOI 10.1099/jmm.0.46747-0; Ferrari F, 2009, INTENS CARE MED, V35, P1792, DOI 10.1007/s00134-009-1605-2; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Kalin G, 2012, J INFECT CHEMOTHER, V18, P872, DOI 10.1007/s10156-012-0430-7; Kofteridis DP, 2010, CLIN INFECT DIS, V51, P1238, DOI 10.1086/657242; Korbila IP, 2010, CLIN MICROBIOL INFEC, V16, P1230, DOI 10.1111/j.1469-0691.2009.03040.x; Lee SO, 2004, ANTIMICROB AGENTS CH, V48, P224, DOI 10.1128/AAC.48.1.224-228.2004; Lin CC, 2010, J MICROBIOL IMMUNOL, V43, P323, DOI 10.1016/S1684-1182(10)60050-3; Lu Q, 2012, ANESTHESIOLOGY, V117, P1335, DOI 10.1097/ALN.0b013e31827515de; Lu Q, 2010, INTENS CARE MED, V36, P1147, DOI 10.1007/s00134-010-1879-4; Manikal VM, 2000, CLIN INFECT DIS, V31, P101, DOI 10.1086/313902; Michalopoulos A, 2008, RESP MED, V102, P407, DOI 10.1016/j.rmed.2007.10.011; Motaouakkil S, 2006, J INFECTION, V53, P274, DOI 10.1016/j.jinf.2005.11.019; Munoz-Price LS, 2008, NEW ENGL J MED, V358, P1271, DOI 10.1056/NEJMra070741; Naesens R, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-317; Niederman MS, 2010, CLIN INFECT DIS, V51, pS12, DOI 10.1086/653035; Rattanaumpawan P, 2010, J ANTIMICROB CHEMOTH, V65, P2645, DOI 10.1093/jac/dkq360; Rello J, 2003, CRIT CARE MED, V31, P2544, DOI 10.1097/01.CCM.0000089928.84326.D2; Rouby JJ, 2012, ANESTHESIOLOGY, V117, P1364, DOI 10.1097/ALN.0b013e3182755d7a; Schurink CAM, 2004, INTENS CARE MED, V30, P217, DOI 10.1007/s00134-003-2018-2; Tumbarello M, 2013, CHEST, V144, P1768, DOI 10.1378/chest.13-1018; Valachis A, 2015, CRIT CARE MED, V43, P527, DOI 10.1097/CCM.0000000000000771	34	23	26	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	AUG	2017	40						251	256		10.1016/j.jcrc.2017.04.004			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FM6XC	WOS:000415204800042	28458172				2022-02-06	
J	Anderson, V; Beauchamp, MH; Yeates, KO; Crossley, L; Ryan, N; Hearps, SJC; Catroppa, C				Anderson, Vicki; Beauchamp, Miriam H.; Yeates, Keith Owen; Crossley, Louise; Ryan, Nicholas; Hearps, Stephen J. C.; Catroppa, Cathy			Social Competence at Two Years after Childhood Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						behavior; children; recovery; social skills; traumatic brain injury	PROBLEM-SOLVING SKILLS; CLOSED-HEAD-INJURY; PSYCHOSOCIAL OUTCOMES; SELF-REGULATION; CHILDREN; ADJUSTMENT; RECOVERY; ADOLESCENTS; FRIENDSHIP; TERM	Children with traumatic brain injury (TBI) are at risk for social impairment, but research has yet to document the trajectory of these skills post-injury and factors that may predict social problems. This study addressed these gaps in knowledge, reporting on findings from a prospective, longitudinal follow-up study that investigated social outcomes post-injury and explored factors contributing to these outcomes at two years post-injury. The sample included 113 children, 74 with TBI and 39 typically developing (TD) controls. TBI participants were recruited on presentation to the hospital. Parents rated pre-injury function at that time, and all children underwent magnetic resonance imaging (MRI). Participants were followed up at two years post-injury. Outcomes were social adjustment, social participation, social relationships, and social cognition. Predictors of social outcomes examined included brain lesion characteristics, child cognition (6 months post-TBI), and behavior and environmental factors (pre-injury and two years). Reduced social adjustment (p=0.011) and social participation (p<0.001) were evident in children with TBI compared with TD controls. Poor social adjustment was predicted by externalizing behavior problems and younger age at injury. Reduced social participation was linked to internalizing behavior problems. Greater lesion volume, lower socioeconomic status, and family burden contributed to poorer social relationships, whereas age at injury predicted social cognition. Within the TBI group, 23% of children exhibited social impairments. Younger age at injury, greater pre-injury, and current behavior problems and family dysfunction, and poorer intelligence quotient (IQ), processing speed, and empathy were linked to impairment. Further follow-up is required to track social recovery and the influences of cognition, brain, and environment over time.	[Anderson, Vicki; Crossley, Louise; Ryan, Nicholas; Hearps, Stephen J. C.; Catroppa, Cathy] Murdoch Childrens Res Inst, Clin Sci, Melbourne, Vic, Australia; [Anderson, Vicki; Catroppa, Cathy] Royal Childrens Hosp, Psychol Serv, Melbourne, Vic, Australia; [Anderson, Vicki; Ryan, Nicholas; Catroppa, Cathy] Univ Melbourne, Melbourne, Vic, Australia; [Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Beauchamp, Miriam H.] St Justine Hosp, Res Ctr, Montreal, PQ, Canada; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Cumming Sch Med, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Cumming Sch Med, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Calgary, AB, Canada		Anderson, V (corresponding author), Murdoch Childrens Res Inst, Child Neuropsychol, 4 West Flemington Rd, Parkville, Vic 3052, Australia.	vicki.anderson@rch.org.au	Ryan, Nicholas/K-5445-2019; Hearps, Stephen/L-6853-2016; Yeates, Keith/AAJ-4223-2020; Catroppa, Cathy/AAX-9458-2021	Ryan, Nicholas/0000-0002-0878-8889; Catroppa, Cathy/0000-0002-9750-0436; Hearps, Stephen/0000-0003-2984-1172; Yeates, Keith/0000-0001-7680-2892	Victorian Neurotrauma Initiative; Victorian Government Operational Infrastructure Scheme; NHMRCNational Health and Medical Research Council of Australia	This research was supported by the Victorian Neurotrauma Initiative and the Victorian Government Operational Infrastructure Scheme. Vicki Anderson was supported by an NHMRC Senior Practitioner fellowship.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Ackerman BP, 2006, ADV CHILD DEV BEHAV, V34, P91, DOI 10.1016/S0065-2407(06)80005-4; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Anderson V, 2014, SOC NEUROSCI-UK, V9, P471, DOI 10.1080/17470919.2014.932308; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bedell G, 2008, J HEAD TRAUMA REHAB, V23, P341, DOI 10.1097/01.HTR.0000336850.29574.7a; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; Bell HC, 2010, BEHAV BRAIN RES, V207, P7, DOI 10.1016/j.bbr.2009.09.029; Belsky J, 2011, J CHILD PSYCHOL PSYC, V52, P409, DOI 10.1111/j.1469-7610.2010.02281.x; Blakemore SJ, 2010, NEURON, V65, P744, DOI 10.1016/j.neuron.2010.03.004; Bohnert AM, 1997, DEV NEUROPSYCHOL, V13, P477, DOI 10.1080/87565649709540688; Bos KJ, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.016.2009; Bowlby J, 1962, DEPRIVATION MATERNAL; Bulotsky-Shearer RJ, 2008, DEV PSYCHOL, V44, P139, DOI 10.1037/0012-1649.44.1.139; Burgess ES, 1999, J HEAD TRAUMA REHAB, V14, P394, DOI 10.1097/00001199-199908000-00008; Burgess KB, 2006, CHILD DEV, V77, P371, DOI 10.1111/j.1467-8624.2006.00876.x; Burnett S., 2012, DEV SOCIAL NEUROSCIE, P45; Catroppa C, 2005, J INT NEUROPSYCH SOC, V11, P84, DOI 10.1017/S1355617705050101; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; Choudhury S, 2006, SOC COGN AFFECT NEUR, V1, P165, DOI 10.1093/scan/nsl024; COFFEY CE, 1991, PSYCHOPATHOLOGY BRAI; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; de la Vega A, 2016, J NEUROSCI, V36, P6553, DOI 10.1523/JNEUROSCI.4402-15.2016; Dennis M, 1998, BRAIN LANG, V61, P450, DOI 10.1006/brln.1997.1886; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Dennis M., 2012, J INT NEUROPSYCH SOC, V18, P1; Dooley JJ, 2008, BRAIN INJURY, V22, P836, DOI 10.1080/02699050802425444; Fidell L.S., 2000, USING MULTIVARIATE S; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Frith CD, 2012, ANNU REV PSYCHOL, V63, P287, DOI 10.1146/annurev-psych-120710-100449; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; Ganesalingam K, 2007, J NEUROPSYCHOL, V1, P149, DOI 10.1348/174866407X185300; Genc S, 2017, J NEUROTRAUM, V34, P798, DOI 10.1089/neu.2016.4584; Hanten G., 2008, NEUROIMAGE, V31, P429; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Heverly-Fitt S, 2014, J INT NEUROPSYCH SOC, V20, P684, DOI 10.1017/S1355617714000393; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Jackson C, 2007, OCCUP MED-OXFORD, V57, P79, DOI 10.1093/occmed/kql169; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Kaldoja ML, 2012, BRAIN INJURY, V26, P1005, DOI 10.3109/02699052.2012.660516; Kolb B, 2012, P NATL ACAD SCI USA, V109, P17186, DOI 10.1073/pnas.1121251109; Leventer RJ, 1999, NEUROLOGY, V53, P715, DOI 10.1212/WNL.53.4.715; Manly T., 1999, TEST EVERYDAY ATTENT; Masten AS, 1999, DEV PSYCHOPATHOL, V11, P143, DOI 10.1017/S0954579499001996; McMillan J, 2009, J SOCIOL, V45, P123, DOI 10.1177/1440783309103342; Moran LM, 2015, BRAIN INJURY, V29, P1682, DOI 10.3109/02699052.2015.1075140; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Parker J. G., 1989, FRIENDSHIP QUALITY Q; Prigatano GP, 2006, J HEAD TRAUMA REHAB, V21, P505, DOI 10.1097/00001199-200611000-00005; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; RUBIN KH, 1995, DEV PSYCHOPATHOL, V7, P751, DOI 10.1017/S0954579400006829; Ryan NP, 2016, NEUROSCI BIOBEHAV R, V64, P196, DOI 10.1016/j.neubiorev.2016.02.020; Ryan NP, 2015, NEUROPSYCHOLOGIA, V66, P32, DOI 10.1016/j.neuropsychologia.2014.10.040; Schachar RJ, 2015, J CAN ACAD CHILD ADO, V24, P100; Sullivan MC, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/657923; TEASDALE G, 1974, LANCET, V2, P81; Terrell-Deutsch B., 1999, LONELINESS CHILDHOOD, P11, DOI 10.1017/cbo9780511551888.002; Tonks J, 2007, BRAIN INJURY, V21, P731, DOI 10.1080/02699050701426899; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; Turkstra LS, 2008, NEUROREHABILITATION, V23, P501; UCLA: Academic Technology Services, 2012, STAT DAT AN EX TOB A; Wade SL, 2004, BEHAV RES METH INS C, V36, P261, DOI 10.3758/BF03195572; Walsh F., 2003, NORMAL FAMILY PROCES, P581, DOI DOI 10.4324/9780203428436_CHAPTER_21; Walz NC, 2010, J NEUROPSYCHOL, V4, P181, DOI 10.1348/174866410X488788; Warschausky S, 1997, Pediatr Rehabil, V1, P77; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 1999, ANUAL WECHSLER ABBRE; Wigg E. H., 1989, TEST LANGUAGE COMPET; Woods D, 2015, SOCIAL CARE NEURODIS, V5, P70, DOI [DOI 10.1108/SCN-01-2014-0001, 10.1108/SCN-01-2014-0001]; Woods D., 2014, SOCIAL CARE NEURODIS, V5, P51, DOI [10.1108/SCN-01-2013-0002, DOI 10.1108/SCN-01-2013-0002]; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	79	23	23	0	18	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2017	34	14					2261	2271		10.1089/neu.2016.4692			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EZ8RQ	WOS:000404995000009	28177265				2022-02-06	
J	Du, XP; West, MB; Cai, QF; Cheng, WH; Ewert, DL; Li, W; Floyd, RA; Kopke, RD				Du, Xiaoping; West, Matthew B.; Cai, Qunfeng; Cheng, Weihua; Ewert, Donald L.; Li, Wei; Floyd, Robert A.; Kopke, Richard D.			Antioxidants reduce neurodegeneration and accumulation of pathologic Tau proteins in the auditory system after blast exposure	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						Antioxidants; Blast; Oxidative stress; Auditory system; Neurodegeneration; Tau protein	SPIRAL GANGLION NEURONS; TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; HEARING-LOSS; INDUCED TINNITUS; IMMUNOCYTOCHEMICAL LOCALIZATION; MOLECULAR-MECHANISMS; NERVE DEGENERATION; NEUROFILAMENT-L; RAT MODEL	Cochlear neurodegeneration commonly accompanies hair cell loss resulting from aging, ototoxicity, or exposures to intense noise or blast overpressures. However, the precise pathophysiological mechanisms that drive this degenerative response have not been fully elucidated. Our laboratory previously demonstrated that non-transgenic rats exposed to blast overpressures exhibited marked somatic accumulation of neurotoxic variants of the microtubule-associated protein, Tau, in the hippocampus. In the present study, we extended these analyses to examine neurodegeneration and pathologic Tau accumulation in the auditory system in response to blast exposure and evaluated the potential therapeutic efficacy of antioxidants on short-circuiting this pathological process. Blast injury induced ribbon synapse loss and retrograde neurodegeneration in the cochlea in untreated animals. An accompanying perikaryal accumulation of neurofilament light chain and pathologic Tau oligomers were observed in neurons from both the peripheral and central auditory system, spanning from the spiral ganglion to the auditory cortex. Due to its coincident accumulation pattern and well-documented neurotoxicity, our results suggest that the accumulation of pathologic Tau oligomers may actively contribute to blast-induced cochlear neurodegeneration. Therapeutic intervention with a combinatorial regimen of 2,4-disulfonyl alpha-phenyl tertiary butyl nitrone (HPN-07) and N-acetylcysteine (NAC) significantly reduced both pathologic Tau accumulation and indications of ongoing neurodegeneration in the cochlea and the auditory cortex. These results demonstrate that a combination of HPN-07 and NAC administrated shortly after a blast exposure can serve as a potential therapeutic strategy for preserving auditory function among military personnel or civilians with blast-induced traumatic brain injuries.	[Du, Xiaoping; West, Matthew B.; Cai, Qunfeng; Cheng, Weihua; Ewert, Donald L.; Li, Wei; Kopke, Richard D.] Hough Ear Inst, 3400 NW 56th St, Oklahoma City, OK 73112 USA; [Floyd, Robert A.; Kopke, Richard D.] Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Kopke, Richard D.] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73014 USA; [Kopke, Richard D.] Univ Oklahoma, Hlth Sci Ctr, Dept Otolaryngol, Oklahoma City, OK 73014 USA		Kopke, RD (corresponding author), Hough Ear Inst, 3400 NW 56th St, Oklahoma City, OK 73112 USA.	rkopke@houghear.org			US Department of Navy, Office of Naval Research [N00014-09-1-0999]; Oklahoma Center for the Advancement of Science and Technology (OCAST) [AR14-020]	The authors would like to thank Dr. Rakez Kayed (University of Texas Medical Branch, Galveston, TX) for his kind gift of the oligomeric (T22) Tau antibody and the laboratory of Dr. Charles Liberman (Harvard Medical School, Boston, Massachusetts) for creating the custom NIH ImageJ software plug-in that we used for generating tonotopic maps of rat cochleae. This research was supported by grant N00014-09-1-0999 from the US Department of Navy, Office of Naval Research and The Oklahoma Center for the Advancement of Science and Technology (OCAST) grant AR14-020.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Bae WY, 2008, LARYNGOSCOPE, V118, P1659, DOI 10.1097/MLG.0b013e31817c1303; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; BERGLUND AM, 1991, J COMP NEUROL, V306, P393, DOI 10.1002/cne.903060304; BICHLER E, 1984, ARCH OTO-RHINO-LARYN, V240, P243; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Cave KM, 2007, MIL MED, V172, P726, DOI 10.7205/MILMED.172.7.726; Clavaguera F, 2013, BRAIN PATHOL, V23, P342, DOI 10.1111/bpa.12044; Coleman MP, 2002, TRENDS NEUROSCI, V25, P532, DOI 10.1016/S0166-2236(02)02255-5; Cowan CM, 2012, BIOCHEM SOC T, V40, P693, DOI 10.1042/BST20120135; DAU J, 1989, HEARING RES, V42, P253, DOI 10.1016/0378-5955(89)90149-4; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; DESPRES G, 1994, ACTA OTO-LARYNGOL, V114, P377, DOI 10.3109/00016489409126073; Dougherty AL, 2013, J REHABIL RES DEV, V50, P893, DOI 10.1682/JRRD.2012.02.0024; Du XP, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4159357; Du XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080138; Du XP, 2012, HEARING RES, V283, P1, DOI 10.1016/j.heares.2011.11.013; Du XP, 2003, ORL-J OTO-RHIN-LARYN, V65, P7, DOI 10.1159/000068654; ELVERLAND HH, 1980, ACTA OTO-LARYNGOL, V90, P360, DOI 10.3109/00016488009131737; Ewert DL, 2012, HEARING RES, V285, P29, DOI 10.1016/j.heares.2012.01.013; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Furman AC, 2013, J NEUROPHYSIOL, V110, P577, DOI 10.1152/jn.00164.2013; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1005, DOI 10.1682/JRRD.2012.03.0038; Gillingwater TH, 2003, J NEUROCYTOL, V32, P863, DOI 10.1023/B:NEUR.0000020629.51673.f5; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; HAFIDI A, 1989, DEV BRAIN RES, V48, P143, DOI 10.1016/0165-3806(89)90098-9; Haroutunian V, 2007, NEUROBIOL AGING, V28, P1, DOI 10.1016/j.neurobiolaging.2005.11.001; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Il Cho S., 2013, PLOS ONE, V8; Iqbal K, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00112; Ishihara T, 2001, J NEUROSCI, V21, P6026, DOI 10.1523/JNEUROSCI.21-16-06026.2001; Jensen JB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125160; Kidd AR, 2012, GERONTOLOGY, V58, P490, DOI 10.1159/000338588; Kim NH, 2004, BIOCHIMIE, V86, P553, DOI 10.1016/j.biochi.2004.07.006; Kim NH, 2003, J BIOCHEM MOL BIOL, V36, P488; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; KOWALL NW, 1987, ANN NEUROL, V22, P639, DOI 10.1002/ana.410220514; Kril JJ, 2002, ACTA NEUROPATHOL, V103, P370, DOI 10.1007/s00401-001-0477-5; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Lang HN, 2006, J NEUROSCI, V26, P3541, DOI 10.1523/JNEUROSCI.2488-05.2006; Lasagna-Reeves CA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00700; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Lee JE, 2004, ACTA OTO-LARYNGOL, V124, P1131, DOI 10.1080/00016480410017521; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lin H, 2006, ANN NEUROL, V60, P399, DOI 10.1002/ana.20965; Lovell MA, 2004, J ALZHEIMERS DIS, V6, P659; Luo H, 2014, J NEUROSCI RES, V92, P1466, DOI 10.1002/jnr.23424; Mao JC, 2012, J NEUROTRAUM, V29, P430, DOI 10.1089/neu.2011.1934; Martin L, 2011, NEUROCHEM INT, V58, P458, DOI 10.1016/j.neuint.2010.12.023; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Melov S., 2007, PLOS ONE, V2; Mondragon-Rodriguez S, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/940603; Morsch R, 1999, J NEUROPATH EXP NEUR, V58, P188, DOI 10.1097/00005072-199902000-00008; Nageris Ben I., 2008, Journal of Basic and Clinical Physiology and Pharmacology, V19, P185; Naini SMA, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/151979; Nguyen MD, 2001, NEURON, V30, P135, DOI 10.1016/S0896-6273(01)00268-9; Noble W, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00083; Olivieri G, 2001, J NEUROCHEM, V76, P224, DOI 10.1046/j.1471-4159.2001.00090.x; OSHIMA T, 1992, BRAIN RES, V590, P53, DOI 10.1016/0006-8993(92)91081-O; Patterson JH, 1997, TOXICOLOGY, V121, P29, DOI 10.1016/S0300-483X(97)03653-6; Perez M, 2000, FEBS LETT, V486, P270, DOI 10.1016/S0014-5793(00)02323-1; Phillips Y Y, 1989, Ann Otol Rhinol Laryngol Suppl, V140, P3; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Roberto M, 1989, Ann Otol Rhinol Laryngol Suppl, V140, P23; Sajja VSSS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15075; SCHMIDT ML, 1990, AM J PATHOL, V136, P1069; Shi LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081566; Shi L, 2015, ACTA OTO-LARYNGOL, V135, P1093, DOI 10.3109/00016489.2015.1061699; SLEPECKY NB, 1992, HEARING RES, V57, P201, DOI 10.1016/0378-5955(92)90152-D; Spires-Jones T.L., 2014, NEURON; Stankovic K, 2004, J NEUROSCI, V24, P8651, DOI 10.1523/JNEUROSCI.0733-04.2004; Stoothoff WH, 2005, BBA-MOL BASIS DIS, V1739, P280, DOI 10.1016/j.bbadis.2004.06.017; Su B, 2010, NEUROSCI LETT, V468, P267, DOI 10.1016/j.neulet.2009.11.010; Takashima A, 2013, J ALZHEIMERS DIS, V37, P565, DOI 10.3233/JAD-130653; Taniguchi T, 2001, J BIOL CHEM, V276, P10025, DOI 10.1074/jbc.M007427200; Tong MJ, 2013, JARO-J ASSOC RES OTO, V14, P321, DOI 10.1007/s10162-013-0374-3; Usenovic M, 2015, J NEUROSCI, V35, P14234, DOI 10.1523/JNEUROSCI.1523-15.2015; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; Valiyaveettil M, 2012, J REHABIL RES DEV, V49, P1153, DOI 10.1682/JRRD.2011.09.0182; VICKERS JC, 1994, NEUROSCIENCE, V62, P1, DOI 10.1016/0306-4522(94)90310-7; Violet M, 2015, NEUROBIOL DIS, V82, P540, DOI 10.1016/j.nbd.2015.09.003; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wan GQ, 2014, ELIFE, V3, DOI 10.7554/eLife.03564; Wang HL, 2015, INT J CLIN EXP PATHO, V8, P8680; Wolfe M.S., 2012, SCIENCE, V2012; Yankaskas K, 2013, HEARING RES, V295, P3, DOI 10.1016/j.heares.2012.04.016	90	23	23	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	JUL	2017	108						627	643		10.1016/j.freeradbiomed.2017.04.343			17	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	EX7XS	WOS:000403463500056	28438658				2022-02-06	
J	McKendy, KM; Lee, LF; Boulva, K; Deckelbaum, DL; Mulder, DS; Razek, TS; Grushka, JR				McKendy, Katherine M.; Lee, Lawrence F.; Boulva, Kerianne; Deckelbaum, Dan L.; Mulder, David S.; Razek, Tarek S.; Grushka, Jeremy R.			Epidural analgesia for traumatic rib fractures is associated with worse outcomes: a matched analysis	JOURNAL OF SURGICAL RESEARCH			English	Article						Trauma; Rib fractures; Epidural; Analgesia; Respiratory complications	BLUNT THORACIC TRAUMA; PAIN MANAGEMENT; MORBIDITY; FIXATION; SURGERY; BENEFIT; INJURY; DEATH	Background: The optimal method of pain control for patients with traumatic rib fractures is unknown. The aim of this study was to determine the effect of epidural analgesia on respiratory complications and in-hospital mortality in patients with rib fractures. Methods: Adult patients at a level I trauma center with >= 1 rib fracture from blunt trauma were included (2004-2013). Those with a blunt-penetrating mechanism, traumatic brain injury, or underwent a laparotomy or thoracotomy were excluded. Patients who were treated with epidural analgesia (EPI) were compared with those were not treated with epidural analgesia (NEPI) using coarsened exact matching. Primary outcomes were respiratory complications (pneumonia, deep vein thrombosis/pulmonary embolus, and respiratory failure) and 30-d in-hospital mortality. Secondary outcomes were total hospital and intensive care unit length of stay, and duration of ventilator support. Results: About 1360 patients (EPI: 329 and NEPI: 1031) met inclusion criteria (mean age: 54.2 y; standard deviation [SD]: 19.7; 68% male). The mean number of rib fractures was 4.8 (SD: 3.3; 21% bilateral) with a high total burden of injury (mean Injury Severity Score: 19.9 [SD: 8.9]). The overall incidence of respiratory complications was 13% and mortality was 4%. After matching, 204 EPI patients were compared with 204 NEPI patients, with no differences in baseline characteristics. EPI patients experienced more respiratory complications (19% versus 10%, P = 0.009), but no differences in 30-d mortality (5% versus 2%, P = 0.159), duration of mechanical ventilation (EPI: 148 h [SD: 167] versus NEPI: 117 h [SD: 187], P = 0.434), or duration of intensive care unit length of stay (6.5 d [SD: 7.6] versus 5.8 d [SD: 9.1], P = 0.626). Hospital stay was higher in the EPI group (16.6 d [SD: 19.6] vs 12.7 d [SD: 15.2], P = 0.026). Conclusions: Epidural analgesia is associated with increased respiratory complications without providing mortality benefit after traumatic rib fractures. Alternate analgesic strategies should be investigated to treat these severely injured patients. (C) 2017 Elsevier Inc. All rights reserved.	[McKendy, Katherine M.; Lee, Lawrence F.; Boulva, Kerianne; Deckelbaum, Dan L.; Razek, Tarek S.; Grushka, Jeremy R.] McGill Univ, Hlth Ctr, Dept Surg, Div Gen Surg, Montreal, PQ, Canada; [Mulder, David S.] McGill Univ, Hlth Ctr, Dept Surg, Div Thorac Surg, Montreal, PQ, Canada		Grushka, JR (corresponding author), McGill Univ, Hlth Ctr, Dept Crit Care Med, Div Gen,Acute Care & Trauma Surg, 1650 Cedar Ave,L9-411, Montreal, PQ H3G 1A4, Canada.	jeremy.grushka@mcgill.ca					Battle CE, 2012, INJURY, V43, P8, DOI 10.1016/j.injury.2011.01.004; Bergeron E, 2003, J TRAUMA, V54, P478, DOI 10.1097/01.TA.0000037095.83469.4C; Blackwell M, 2009, STATA J, V9, P524, DOI 10.1177/1536867X0900900402; Blecher GE, 2008, INJURY, V39, P586, DOI 10.1016/j.injury.2007.10.021; Bugaev N, 2016, J TRAUMA ACUTE CARE, V81, P699, DOI 10.1097/TA.0000000000001169; Bulger EM, 2004, SURGERY, V136, P426, DOI 10.1016/j.surg.2004.05.019; Bulger EM, 2000, J TRAUMA, V48, P1040, DOI 10.1097/00005373-200006000-00007; Carrier FM, 2009, CAN J ANAESTH, V56, P230, DOI 10.1007/s12630-009-9052-7; Crawford ME, 1996, ANESTH ANALG, V83, P1028, DOI 10.1097/00000539-199611000-00022; Farquhar J, 2016, CAN J SURG, V59, P299, DOI 10.1503/cjs.000515; Flagel BT, 2005, SURGERY, V138, P717, DOI 10.1016/j.surg.2005.07.022; Gage A, 2014, J TRAUMA ACUTE CARE, V76, P39, DOI 10.1097/TA.0b013e3182ab1b08; Galvagno SM, 2016, J TRAUMA ACUTE CARE, V81, P936, DOI 10.1097/TA.0000000000001209; Gordy S, 2014, AM J SURG, V207, P659, DOI 10.1016/j.amjsurg.2013.12.012; Hashemzadeh S, 2011, J CARDIOVASC THORAC, V3, P87, DOI 10.5681/jcvtr.2011.019; Holcomb JB, 2003, J AM COLL SURGEONS, V196, P549, DOI 10.1016/S1072-7515(02)01894-X; Leinicke JA, 2013, ANN SURG, V258, P914, DOI 10.1097/SLA.0b013e3182895bb0; LUCHETTE FA, 1994, J TRAUMA, V36, P865, DOI 10.1097/00005373-199406000-00018; Majak P, 2016, CURR OPIN CRIT CARE, V22, P572, DOI 10.1097/MCC.0000000000000364; Marik PE, 2016, CRIT CARE MED, V44, P1920, DOI 10.1097/CCM.0000000000001483; Ng JM, 2002, ANN ACAD MED SINGAP, V31, P509; Pratt WB, 2008, J GASTROINTEST SURG, V12, P1207, DOI 10.1007/s11605-008-0467-1; SHACKFORD SR, 1994, J TRAUMA, V36, P869; Shelley CL, 2016, J TRAUMA ACUTE CARE, V81, P463, DOI 10.1097/TA.0000000000001147; Simon BJ, 2005, J TRAUMA, V59, P1256, DOI 10.1097/01.ta.0000178063.77946.f5; Stevens GA, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-6; Sugimoto M, 2016, J HEPATO-BIL-PAN SCI, V23, P102, DOI 10.1002/jhbp.307; Uchida K, 2016, EUR J TRAUMA EMERG S; Wells AR, 2013, POPUL HEALTH MANAG, V16, P35, DOI 10.1089/pop.2011.0104; Yeh DD, 2012, INJURY, V43, P1667, DOI 10.1016/j.injury.2012.05.022; Zaw AA, 2015, AM SURGEON, V81, P950; ZIEGLER DW, 1994, J TRAUMA, V37, P975, DOI 10.1097/00005373-199412000-00018	32	23	23	1	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JUN 15	2017	214						117	123		10.1016/j.jss.2017.02.057			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FA3RX	WOS:000405363200016	28624032				2022-02-06	
J	Kennedy, E; Quinn, D; Tumilty, S; Chapple, CM				Kennedy, Ewan; Quinn, Dusty; Tumilty, Steve; Chapple, Cathy M.			Clinical characteristics and outcomes of treatment of the cervical spine in patients with persistent post-concussion symptoms: A retrospective analysis	MUSCULOSKELETAL SCIENCE AND PRACTICE			English	Article						Brain concussion; Neck; Cervicogenic; Physiotherapy	TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; NECK DISABILITY INDEX; CERVICOGENIC HEADACHE; MUSCULOSKELETAL DYSFUNCTION; FUNCTIONAL SCALE; WHIPLASH INJURY; RATING-SCALE; NUMERIC PAIN; NEW-ZEALAND	Background: Concussion is typically defined as a mild brain injury, and yet the brain is unlikely to be the only source of persistent post-concussion symptoms. Concurrent injury to the cervical spine in particular is acknowledged as a potential source of common persistent symptoms such as headache, dizziness and neck pain. Objectives: To describe the cervical spine findings and outcomes of treatment in a series of patients with persistent post-concussion symptoms, and describe the clinical characteristics of a cervicogenic component when it is present. Design: Retrospective chart review of a consecutive series of patients with concussion referred to a physiotherapist for cervical spine assessment. Method: Patient charts for all patients over a calendar year referred by a concussion service provider to a physiotherapist for cervical spine assessment were de-identified and transferred to the research team. Clinical data were independently extracted by two research assistants and analysed using descriptive statistics. Results/findings: Data were analysed from 46 patient charts. Those with a cervicogenic component (n = 32) were distinguished from those without a cervicogenic component (n = 14) by physical examination findings, particularly pain on manual segmental examination. Physiotherapy treatment of the cervicogenic component (n = 21) achieved improvements in function (mean increase of 3.8 in the patient-specific functional scale), and pain (mean decrease of 4.6 in the numeric pain-rating scale). Conclusions: The clinical characteristics described give preliminary support to the idea that the cervical spine may contribute to persistent post-concussion symptoms, and highlight the value of physiotherapy assessment and treatment of the cervical spine following a concussive injury. (C) 2017 Elsevier Ltd. All rights reserved.	[Kennedy, Ewan; Tumilty, Steve; Chapple, Cathy M.] Univ Otago, Sch Physiotherapy, 325 Great King St, Dunedin 9054, New Zealand; [Quinn, Dusty] Back Mot Ltd, 27-29 Albany St, Dunedin 9016, New Zealand		Kennedy, E (corresponding author), Univ Otago, Sch Physiotherapy, 325 Great King St, Dunedin 9054, New Zealand.	ewan.kennedy@otago.ac.nz	Kennedy, Ewan/Q-5803-2019	Kennedy, Ewan/0000-0002-7341-5309; Tumilty, Steve/0000-0003-2456-7055	Postdoctoral Fellowship in Orthopaedic Manual Therapy at the School of Physiotherapy, University of Otago	This research was supported by a Postdoctoral Fellowship in Orthopaedic Manual Therapy at the School of Physiotherapy, University of Otago and held by Ewan Kennedy. This Postdoctoral position is enabled by a bequest from the Alumni of the University of Otago in America, Inc.	Alexander Michael P, 2003, Pain Res Manag, V8, P19; Bogduk N, 2001, Curr Pain Headache Rep, V5, P382, DOI 10.1007/s11916-001-0029-7; Bogduk N, 2009, LANCET NEUROL, V8, P959, DOI 10.1016/S1474-4422(09)70209-1; Cleland JA, 2008, ARCH PHYS MED REHAB, V89, P69, DOI 10.1016/j.apmr.2007.08.126; Elkin BS, 2016, J ORTHOP SPORT PHYS, V46, P874, DOI 10.2519/jospt.2016.7049; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Hall T, 2004, MANUAL THER, V9, P197, DOI 10.1016/j.math.2004.04.004; Hynes LM, 2006, BRAIN INJURY, V20, P179, DOI 10.1080/02699050500443707; Jull G, 2007, CEPHALALGIA, V27, P793, DOI 10.1111/j.1468-2982.2007.01345.x; Jull G, 2002, SPINE, V27, P1835, DOI 10.1097/00007632-200209010-00004; Junn C, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0519-7; King D, 2014, J SCI MED SPORT, V17, P250, DOI 10.1016/j.jsams.2013.05.007; Kristjansson E, 2009, J ORTHOP SPORT PHYS, V39, P364, DOI 10.2519/jospt.2009.2834; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Leslie O, 2013, CLIN J SPORT MED, V23, P331, DOI 10.1097/JSM.0b013e318295bbb1; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Malmstrom EM, 2007, DISABIL REHABIL, V29, P1193, DOI 10.1080/09638280600948383; Marshall CM, 2015, PHYSICIAN SPORTSMED, V43, P274, DOI 10.1080/00913847.2015.1064301; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Nicholas P, 2012, J MAN MANIP THER, V20, P147, DOI 10.1179/2042618612Y.0000000006; Reid SA, 2008, MANUAL THER, V13, P357, DOI 10.1016/j.math.2007.03.006; Reid SA, 2015, MANUAL THER, V20, P148, DOI 10.1016/j.math.2014.08.003; Rubio-Ochoa J, 2016, MANUAL THER, V21, P35, DOI 10.1016/j.math.2015.09.008; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Sjaastad O, 1998, HEADACHE, V38, P442, DOI 10.1046/j.1526-4610.1998.3806442.x; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; TRELEAVEN J, 1994, CEPHALALGIA, V14, P273, DOI 10.1046/j.1468-2982.1994.1404273.x; Treleaven J, 2003, J REHABIL MED, V35, P36, DOI 10.1080/16501970306109; Treleaven J, 2011, SPINE, V36, pS211, DOI 10.1097/BRS.0b013e3182387f78; Vassar M, 2013, J EDUC EVAL HEALTH P, V10, DOI 10.3352/jeehp.2013.10.12; Young IA, 2010, AM J PHYS MED REHAB, V89, P831, DOI 10.1097/PHM.0b013e3181ec98e6; Zito G, 2006, MANUAL THER, V11, P118, DOI 10.1016/j.math.2005.04.007	38	23	23	0	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2468-7812			MUSCULOSKEL SCI PRAC	Musculoskelet. Sci. Pract.	JUN	2017	29						91	98		10.1016/j.msksp.2017.03.002			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	FO9WZ	WOS:000417250400021	28347935				2022-02-06	
J	Ogura, T; Lefor, AK; Nakamura, M; Fujizuka, K; Shiroto, K; Nakano, M				Ogura, Takayuki; Lefor, Alan Kawarai; Nakamura, Mitsunobu; Fujizuka, Kenji; Shiroto, Kousuke; Nakano, Minoru			ULTRASOUND-GUIDED RESUSCITATIVE ENDOVASCULAR BALLOON OCCLUSION OF THE AORTA IN THE RESUSCITATION AREA	JOURNAL OF EMERGENCY MEDICINE			English	Article						trauma; hemorrhage; resuscitative endovascular balloon occlusion of the aorta	ANEURYSM	Background: In trauma resuscitation with resuscitative endovascular balloon occlusion of the aorta (REBOA), urgent and accurate placement of the catheter in the resuscitation area without fluoroscopy can shorten the time from admission to REBOA, allowing rapid, temporary control of bleeding. Discussion: The experience-based protocol in our center for ultrasound-guided REBOA in the resuscitation area without fluoroscopy is as follows: the femoral artery is punctured and a guidewire inserted; sonography is used to verify that the guidewire is in the abdominal aorta; the position of the balloon is confirmed with ultrasound after estimating the distance to the clavicle, and the pressure in the radial artery and sheath is used to monitor correct positioning; connect the pressure transducer to the catheter sheath for continuous monitoring of the blood pressure in the sheath, and inflate the balloon until the blood pressure tracing at the sheath has disappeared; check the pulse in the left radial artery, and withdraw the catheter slightly if the pulse in the radial artery is not palpable or is decreased (if this pulse is not palpable or decreased, the balloon is in the aortic arch). In this retrospective review of our REBOA protocol, between April 2012 and March 2016, 34 patients were enrolled. Two patients had complications, including dissection of the femoral artery in one and difficult percutaneous vascular access in another. Median time needed to complete the procedure was 8 min. Overall, 24 of 34 patients survived more than 24 h (72%), and overall mortality was 47%. Patients who lived more than 24 h, and then died had severe traumatic brain injury or septic shock. Conclusions: Ultrasound-guided REBOA is presented. Monitoring the blood pressure in the left radial artery allows us to determine adequate positioning of the balloon, and the blood pressure in the catheter sheath located in the femoral artery should also be monitored to prevent aortic injuries caused by the overinflation of the balloon. (C) 2017 Elsevier Inc. All rights reserved.	[Ogura, Takayuki; Nakamura, Mitsunobu; Fujizuka, Kenji; Shiroto, Kousuke; Nakano, Minoru] Japan Red Cross Maebashi Hosp, Adv Med Emergency Dept, 371-0014 Asahi Cho 3-21-36, Maebashi, Gunma, Japan; [Ogura, Takayuki; Nakamura, Mitsunobu; Fujizuka, Kenji; Shiroto, Kousuke; Nakano, Minoru] Japan Red Cross Maebashi Hosp, Crit Care Ctr, 371-0014 Asahi Cho 3-21-36, Maebashi, Gunma, Japan; [Ogura, Takayuki] Jichi Med Univ, Dept Emergency Med, Shimotsuke, Tochigi, Japan; [Lefor, Alan Kawarai] Jichi Med Univ, Dept Surg, Shimotsuke, Tochigi, Japan		Ogura, T (corresponding author), Japan Red Cross Maebashi Hosp, Adv Med Emergency Dept, 371-0014 Asahi Cho 3-21-36, Maebashi, Gunma, Japan.; Ogura, T (corresponding author), Japan Red Cross Maebashi Hosp, Crit Care Ctr, 371-0014 Asahi Cho 3-21-36, Maebashi, Gunma, Japan.		Lefor, Alan/E-9979-2012	Lefor, Alan/0000-0001-6673-5630; Ogura, Takayuki/0000-0002-2525-4985			Assar AN, 2009, J CARDIOVASC SURG, V50, P381; Brenner ML, 2013, J TRAUMA ACUTE CARE, V75, P506, DOI 10.1097/TA.0b013e31829e5416; Chaikof EL, 2009, J VASC SURG, V50, p2S, DOI 10.1016/j.jvs.2009.07.002; Guliani S, 2015, J TRAUMA ACUTE CARE, V79, P549, DOI 10.1097/TA.0000000000000818; GUPTA BK, 1989, J TRAUMA, V29, P861, DOI 10.1097/00005373-198906000-00026; Harma M, 2004, AUST NZ J OBSTET GYN, V44, P170, DOI 10.1111/j.1479-828X.2004.00181.x; Karkos CD, 2001, ANN EMERG MED, V38, P328, DOI 10.1067/mem.2001.114408; LOW RB, 1986, ANN EMERG MED, V15, P1466, DOI 10.1016/S0196-0644(86)80945-3; MAHONEY BD, 1984, ANN EMERG MED, V13, P11, DOI 10.1016/S0196-0644(84)80376-5; Martinelli T, 2010, J TRAUMA, V68, P942, DOI 10.1097/TA.0b013e3181c40579; Miura F, 2006, J GASTROINTEST SURG, V10, P519, DOI 10.1016/j.gassur.2005.09.019; Moll FL, 2011, EUR J VASC ENDOVASC, V41, pS1, DOI 10.1016/j.ejvs.2010.09.011; Morrison JJ, 2016, J TRAUMA ACUTE CARE, V80, P324, DOI 10.1097/TA.0000000000000913; Scott DJ, 2013, J TRAUMA ACUTE CARE, V75, P122, DOI 10.1097/TA.0b013e3182946746; Stannard A, 2011, J TRAUMA, V71, P1869, DOI 10.1097/TA.0b013e31823fe90c; Tayal VS, 2003, ACAD EMERG MED, V10, P867, DOI 10.1197/aemj.10.8.867	16	23	27	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	MAY	2017	52	5					715	722		10.1016/j.jemermed.2017.01.014			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	EX9HC	WOS:000403567400031	28215930				2022-02-06	
J	Townsend, JM; Dennis, SC; Whitlow, J; Feng, Y; Wang, JX; Andrews, B; Nudo, RJ; Detamore, MS; Berkland, CJ				Townsend, Jakob M.; Dennis, S. Connor; Whitlow, Jonathan; Feng, Yi; Wang, Jinxi; Andrews, Brian; Nudo, Randolph J.; Detamore, Michael S.; Berkland, Cory J.			Colloidal Gels with Extracellular Matrix Particles and Growth Factors for Bone Regeneration in Critical Size Rat Calvarial Defects	AAPS JOURNAL			English	Article						colloidal gel; decellularized cartilage; extracellular matrix; hyaluronic acid; hydroxyapatite	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; DUAL DELIVERY; IN-VITRO; HYDROGELS; SCAFFOLDS; MODEL; MINERALIZATION; COMPLICATIONS; BIOMATERIALS	Colloidal gels encapsulating natural materials and exhibiting paste-like properties for placement are promising for filling complex geometries in craniofacial bone regeneration applications. Colloidal materials have demonstrated modest clinical outcomes as bone substitutes in orthopedic applications, but limited success in craniofacial applications. As such, development of a novel colloidal gel will fill a void in commercially available products for use in craniofacial reconstruction. One likely application for this technology is cranial reconstruction. Currently, traumatic brain injury (TBI) is often treated with a hemicraniectomy, a procedure in which half the cranium is removed to allow the injured brain to swell and herniate beyond the enclosed cranial vault. The use of colloidal gels would allow for the design of a pliable material capable of expansion during brain swelling and facilitate cranial bone regeneration alleviating the need for a second surgery to replace the previously removed hemi-cranium. In the current study, colloidal nanoparticles of hydroxyapatite (HAp), demineralized bone matrix (DBM), and decellularized cartilage (DCC) were combined with hyaluronic acid (HA) to form colloidal gels with desirable rheological properties (tau(y) >= 100 Pa). BMP-2 and VEGF growth factors were included to assess extracellular matrix (ECM) contribution of DBM and DCC. The HA-HAp (BMP-2) and HA-HAp-DCC group had 89 and 82% higher bone regeneration compared to the sham group, respectively (p < 0.01). Material retention issues observed may be alleviated by implementing chemical crosslinking. Overall, DCC may be a promising material for bone regeneration in general, and colloidal gels may hold significant potential in craniofacial applications.	[Townsend, Jakob M.; Detamore, Michael S.] Univ Oklahoma, Stephenson Sch Biomed Engn, Norman, OK 73019 USA; [Dennis, S. Connor; Whitlow, Jonathan; Berkland, Cory J.] Univ Kansas, Bioengn Program, Lawrence, KS 66047 USA; [Feng, Yi; Wang, Jinxi] Univ Kansas, Med Ctr, Dept Orthoped Surg, Kansas City, KS 66160 USA; [Andrews, Brian] Univ Kansas, Med Ctr, Dept Plast Surg, Kansas City, KS 66160 USA; [Nudo, Randolph J.] Univ Kansas, Med Ctr, Dept Rehabil Med, Kansas City, KS 66160 USA; [Berkland, Cory J.] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66047 USA		Berkland, CJ (corresponding author), Univ Kansas, Bioengn Program, Lawrence, KS 66047 USA.; Berkland, CJ (corresponding author), Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66047 USA.	berkland@ku.edu	Townsend, Jakob/AAH-9637-2019	Andrews, Brian/0000-0003-3994-6808	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 DE022472]; Kansas Bioscience Authority Rising Star Award; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [R01DE022472] Funding Source: NIH RePORTER	The authors would like to thank Dr. Emily Beck for her assistance with the cartilage decellularization process. We would like to recognize funding from the National Institutes of Health (R01 DE022472) and from the Kansas Bioscience Authority Rising Star Award.	Alexander C., 2015, NATL GEOGR, P1; Beck EC, 2015, ANN BIOMED ENG, V43, P2569, DOI 10.1007/s10439-015-1277-8; Bijlenga P, 2007, J NEUROL NEUROSUR PS, V78, P430, DOI 10.1136/jnnp.2006.099242; Converse GL, 2012, ACTA BIOMATER, V8, P2722, DOI 10.1016/j.actbio.2012.03.047; Cowan CM, 2007, TISSUE ENG, V13, P501, DOI 10.1089/ten.2006.0141; Dennis SC, 2015, TISSUE ENG PART B-RE, V21, P247, DOI [10.1089/ten.teb.2014.0419, 10.1089/ten.TEB.2014.0419]; Dennis SC, 2014, LANGMUIR, V30, P3528, DOI 10.1021/la4041985; Dennis SC, 2016, LANGMUIR; Dujovny M, 1999, CRIT REV NEUROSURG, V9, P271, DOI 10.1007/s003290050143; Fakhari A, 2014, J BIOMED MATER RES B, V102, P612, DOI 10.1002/jbm.b.33041; Ferreira JR, 2013, TISSUE ENG PT A, V19, P1803, DOI [10.1089/ten.tea.2012.0520, 10.1089/ten.TEA.2012.0520]; Gawlitta D, 2015, TISSUE ENG PT A, V21, P694, DOI [10.1089/ten.tea.2014.0117, 10.1089/ten.TEA.2014.0117]; Gruskin E, 2012, ADV DRUG DELIVER REV, V64, P1063, DOI 10.1016/j.addr.2012.06.008; Guvendiren M, 2012, SOFT MATTER, V8, P260, DOI 10.1039/c1sm06513k; Lu HD, 2012, BIOMATERIALS, V33, P2145, DOI 10.1016/j.biomaterials.2011.11.076; Marquez-Rivas J, 2013, J NEUROSURG, V119, P1657, DOI 10.3171/2013.5.JNS131034; Martin KD, 2014, ACTA NEUROCHIR, V156, P813, DOI 10.1007/s00701-014-2021-0; Oladunjoye AO, 2013, J NEUROSURG, V118, P776, DOI 10.3171/2013.1.JNS121475; Omary R, 2013, J MOL NEUROSCI, V49, P157, DOI 10.1007/s12031-012-9922-2; Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019; Renth AN, 2012, TISSUE ENG PART B-RE, V18, P341, DOI 10.1089/ten.teb.2012.0080; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Schiffer J, 1997, SURG NEUROL, V47, P231, DOI 10.1016/S0090-3019(96)00376-X; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Sutherland AJ, 2015, MACROMOL BIOSCI, V15, P979, DOI 10.1002/mabi.201400472; Sutherland AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121966; Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513; Visser J, 2015, BIOMATERIALS, V37, P174, DOI 10.1016/j.biomaterials.2014.10.020; Vo TN, 2016, BIOMATERIALS, V83, P1, DOI 10.1016/j.biomaterials.2015.12.026; Vo TN, 2015, J CONTROL RELEASE, V205, P25, DOI 10.1016/j.jconrel.2014.11.028; Wang Q, 2008, ADV MATER, V20, P236, DOI 10.1002/adma.200702099; Wang Q, 2013, TISSUE ENG PT A, V19, P2586, DOI [10.1089/ten.tea.2013.0075, 10.1089/ten.TEA.2013.0075]; Wang Q, 2011, J BIOMED MATER RES A, V96A, P520, DOI 10.1002/jbm.a.33000; Wang Q, 2010, BIOMATERIALS, V31, P4980, DOI 10.1016/j.biomaterials.2010.02.052; Wu ZZ, 2015, TISSUE ENG PT A, V21, P390, DOI [10.1089/ten.TEA.2013.0260, 10.1089/ten.tea.2013.0260]; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Young S, 2009, TISSUE ENG PT A, V15, P2347, DOI 10.1089/ten.tea.2008.0510	37	23	23	0	24	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1550-7416			AAPS J	AAPS J.	MAY	2017	19	3					703	711		10.1208/s12248-017-0045-0			9	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	ET8QM	WOS:000400565300011	28138909	Green Submitted, Green Accepted			2022-02-06	
J	Shahim, P; Tegner, Y; Marklund, N; Hoglund, K; Portelius, E; Brody, DL; Blennow, K; Zetterberg, H				Shahim, Pashtun; Tegner, Yelverton; Marklund, Niklas; Hoeglund, Kina; Portelius, Erik; Brody, David L.; Blennow, Kaj; Zetterberg, Henrik			Astroglial activation and altered amyloid metabolism in human repetitive concussion	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; INTERNATIONAL-CONFERENCE; BIOMARKERS; AFTERMATH; STATEMENT; ENCEPHALOPATHY; BARRIER; SPORT; CSF	Objective: To determine whether postconcussion syndrome (PCS) due to repetitive concussive traumatic brain injury (rcTBI) is associated with CSF biomarker evidence of astroglial activation, amyloid deposition, and blood-brain barrier (BBB) impairment. Methods: A total of 47 participants (28 professional athletes with PCS and 19 controls) were assessed with lumbar puncture (median 1.5 years, range 0.25-12 years after last concussion), standard MRI of the brain, and Rivermead Post-Concussion Symptoms Questionnaire (RPQ). The main outcome measures were CSF concentrations of astroglial activation markers (glial fibrillary acidic protein [GFAP] and YKL-40), markers reflecting amyloid precursor protein metabolism (A beta 38, A beta 40, A beta 42, sAPPa, and sAPPb), and BBB function (CSF: serum albumin ratio). Results: Nine of the 28 athletes returned to play within a year, while 19 had persistent PCS.1 year. Athletes with PCS.1 year had higher RPQ scores and number of concussions than athletes with PCS,1 year. Median concentrations of GFAP and YKL-40 were higher in athletes with PCS.1 year compared with controls, although with an overlap between the groups. YKL-40 correlated with RPQ score and the lifetime number of concussions. Athletes with rcTBI had lower concentrations of A beta 40 and A beta 42 than controls. The CSF: serum albumin ratio was unaltered. Conclusions: This study suggests that PCS may be associated with biomarker evidence of astroglial activation and b-amyloid (A beta) dysmetabolism in the brain. There was no clear evidence of Ab deposition as A beta 40 and A beta 42 were reduced in parallel. The CSF: serum albumin ratio was unaltered, suggesting that the BBB is largely intact in PCS.	[Shahim, Pashtun; Hoeglund, Kina; Portelius, Erik; Blennow, Kaj; Zetterberg, Henrik] Gothenburg Univ, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, S-41124 Gothenburg, Sweden; [Shahim, Pashtun; Hoeglund, Kina; Portelius, Erik; Zetterberg, Henrik] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Tegner, Yelverton] Lulea Univ Technol, Dept Hlth Sci, Div Med Sci, Lulea, Sweden; [Marklund, Niklas] Uppsala Univ, Dept Neurosci Neurosurg, Uppsala, Sweden; [Brody, David L.] Washington Univ, Sch Med, St Louis, MO 63130 USA; [Zetterberg, Henrik] UCL, Inst Neurol, Dept Mol Neurosci, Queen Sq, London, England		Shahim, P (corresponding author), Gothenburg Univ, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, S-41124 Gothenburg, Sweden.	pashtun.shahim@neuro.gu.se		Hoglund, Kina/0000-0002-1213-9953; Tegner, Yelverton/0000-0003-3628-0705; Marklund, Niklas/0000-0002-9797-5626	Swedish Research CouncilSwedish Research CouncilEuropean Commission; European Research CouncilEuropean Research Council (ERC)European Commission; Centrum for Idrottsforskning; Torsten Soderberg Foundation; Knut and Alice Wallenberg FoundationKnut & Alice Wallenberg Foundation; Frimurarestiftelsen	The study was supported by grants from the Swedish Research Council, the European Research Council, Centrum for Idrottsforskning, the Torsten Soderberg Foundation, the Knut and Alice Wallenberg Foundation, and Frimurarestiftelsen. The funding source had no role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.	Augutis K, 2013, MULT SCLER J, V19, P543, DOI 10.1177/1352458512460603; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Blennow K, 2015, TRENDS PHARMACOL SCI, V36, P297, DOI 10.1016/j.tips.2015.03.002; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Bonneh-Barkay D, 2010, J NEUROTRAUM, V27, P1215, DOI 10.1089/neu.2010.1310; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Ho KM, 2014, J NEUROSURG, V121, P674, DOI 10.3171/2014.6.JNS132838; Jeppsson A, 2013, NEUROLOGY, V80, P1385, DOI 10.1212/WNL.0b013e31828c2fda; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Palmqvist S, 2016, BRAIN, V139, P1226, DOI 10.1093/brain/aww015; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROSENGREN LE, 1994, J NEUROSCI METH, V51, P197, DOI 10.1016/0165-0270(94)90011-6; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Wiley CA, 2015, NEUROPATHOLOGY, V35, P95, DOI 10.1111/neup.12158; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; WISNIEWSKI K, 1979, ANN NEUROL, V5, P288, DOI 10.1002/ana.410050311	27	23	24	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	APR 11	2017	88	15					1400	1407		10.1212/WNL.0000000000003816			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ER3CW	WOS:000398674100008	28283595	Green Published			2022-02-06	
J	Kocher, GJ; Sharafi, S; Azenha, LF; Schmid, RA				Kocher, Gregor J.; Sharafi, Siamak; Azenha, Luis Filipe; Schmid, Ralph A.			Chest wall stabilization in ventilator-dependent traumatic flail chest patients: who benefits?	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article						Blunt chest trauma; Flail chest; Rib fracture; Rib and sternal fixation	SURGICAL STABILIZATION; PULMONARY CONTUSION; OPERATIVE STABILIZATION; MANAGEMENT; FIXATION; INJURIES; OUTCOMES	OBJECTIVES: Traumatic flail chest is a potentially life threatening injury, often associated with prolonged invasive mechanical ventilation and intensive care unit stay. This study evaluates the usefulness and cost-effectiveness of surgical rib stabilization in patients with flail chest resulting in ventilator dependent respiratory insufficiency. METHODS: A retrospective study on a consecutive series of patients with flail chest with the need for mechanical ventilation was performed. Effectiveness of rib fixation was evaluated in terms of predictors for prolonged ventilation, cost-effectiveness and outcome. RESULTS: A total of 61 patients underwent flail chest stabilization using a locked titanium plate fixation system between July 2010 and December 2015 at our institution. 62% (n = 38) of patients could be weaned from the ventilator within the first 72 h after surgery. Multiple linear regression analysis revealed that closed head injury, bilateral flail chest, number of stabilized ribs and severity of lung contusion were the main independent predictors for prolonged mechanical ventilation (Odds ratio (OR) 6.88; 3.25; 1.52 and 1.42) and tracheostomy (OR 9.17; 2.2; 1.76 and 0.84), respectively. Furthermore cost analysis showed that already a two day reduction in ICU stay could outweigh the cost of surgical rib fixation. CONCLUSIONS: Operative rib fixation has the potential to reduce ventilator days and ICU stay and subsequently hospital costs in selected patients with severe traumatic flail chest requiring mechanical ventilation. Especially associated closed head injury can adversely affect mechanical ventilation time. Furthermore the subgroups of patients sustaining a fall from a height and those with flail chest after cardiopulmonary re-animation seem to profit only marginally from surgical rib fixation.	[Kocher, Gregor J.; Sharafi, Siamak; Azenha, Luis Filipe; Schmid, Ralph A.] Univ Bern, Bern Univ Hosp, Div Gen Thorac Surg, Inselspital, Bern, Switzerland		Schmid, RA (corresponding author), Univ Hosp Bern, Div Gen Thorac Surg, CH-3010 Bern, Switzerland.	ralph.schmid@insel.ch		Schmid, Ralph Alexander/0000-0003-0699-079X; Kocher, Gregor Jan/0000-0001-6531-2919			AHMED Z, 1995, J THORAC CARDIOV SUR, V110, P1676, DOI 10.1016/S0022-5223(95)70030-7; Althausen PL, 2011, J ORTHOP TRAUMA, V25, P641, DOI 10.1097/BOT.0b013e318234d479; Balci Akin Eraslan, 2004, Asian Cardiovasc Thorac Ann, V12, P11; Bhatnagar A, 2012, J AM COLL SURGEONS, V215, P201, DOI 10.1016/j.jamcollsurg.2012.02.023; Bille A, 2013, GEN THORAC CARDIOVAS, V61, P345, DOI 10.1007/s11748-013-0218-4; Bottlang M, 2013, INJURY, V44, P232, DOI 10.1016/j.injury.2012.08.011; Cohn SM, 2010, WORLD J SURG, V34, P1959, DOI 10.1007/s00268-010-0599-9; de Lesquen H, 2015, INTERACT CARDIOV TH, V20, P399, DOI 10.1093/icvts/ivu397; Granetzny Andreas, 2005, Interact Cardiovasc Thorac Surg, V4, P583, DOI 10.1510/icvts.2005.111807; Karev D V, 1997, Wiad Lek, V50 Suppl 1 Pt 2, P205; Lafferty PM, 2011, J BONE JOINT SURG AM, V93A, P97, DOI 10.2106/JBJS.I.00696; Lardinois D, 2001, EUR J CARDIO-THORAC, V20, P496, DOI 10.1016/S1010-7940(01)00818-1; Leinicke JA, 2013, ANN SURG, V258, P914, DOI 10.1097/SLA.0b013e3182895bb0; Marasco SF, 2013, J AM COLL SURGEONS, V216, P924, DOI 10.1016/j.jamcollsurg.2012.12.024; Mayberry JC, 2009, AM SURGEON, V75, P389; Mouton W, 1997, THORAC CARDIOV SURG, V45, P242, DOI 10.1055/s-2007-1013735; Nirula R, 2006, AM SURGEON, V72, P307; Simon B, 2012, J TRAUMA ACUTE CARE, V73, pS351, DOI 10.1097/TA.0b013e31827019fd; Slobogean GP, 2013, J AM COLL SURGEONS, V216, P302, DOI 10.1016/j.jamcollsurg.2012.10.010; Tanaka H, 2002, J TRAUMA, V52, P727, DOI 10.1097/00005373-200204000-00020; Voggenreiter G, 1998, J AM COLL SURGEONS, V187, P130, DOI 10.1016/S1072-7515(98)00142-2	21	23	25	0	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	APR	2017	51	4					696	701		10.1093/ejcts/ezw365			6	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Respiratory System; Surgery	ER1NS	WOS:000398558800014	28007867	Bronze			2022-02-06	
J	Tso, MK; Lee, MM; Ball, CG; Morrish, WF; Mitha, AP; Kirkpatrick, AW; Wong, JH				Tso, Michael K.; Lee, Myunghyun M.; Ball, Chad G.; Morrish, William F.; Mitha, Alim P.; Kirkpatrick, Andrew W.; Wong, John H.			Clinical utility of a screening protocol for blunt cerebrovascular injury using computed tomography angiography	JOURNAL OF NEUROSURGERY			English	Article						blunt cerebrovascular injury; stroke; trauma; computed tomography angiography; screening	10-YEAR RETROSPECTIVE ANALYSIS; CAROTID-ARTERY INJURIES; TRAUMATIC GRADE 1; OUTCOMES; DIAGNOSIS; ASSOCIATION; CENTER.	OBJECTIVE Blunt cerebrovascular injury (BCVI) occurs in approximately 1% of the blunt trauma population and may lead to stroke and death. Early vascular imaging in asymptomatic patients at high risk of having BCVI may lead to earlier diagnosis and possible stroke prevention. The objective of this study was to determine if the implementation of a formalized asymptomatic BCVI screening protocol with CT angiography (CTA) would lead to improved BCVI detection and stroke prevention. METHODS Patients with vascular imaging studies were identified from a prospective trauma registry at a single Level 1 trauma center between 2002 and 2008. Detection of BCVI and stroke rates were compared during the 3-year periods before and after implementation of a consensus-based asymptomatic BCVI screening protocol using CTA in 2005. RESULTS A total of 5480 patients with trauma were identified. The overall BCVI detection rate remained unchanged postprotocol compared with preprotocol (0.8% [24 of 3049 patients] vs 0.9% [23 of 2431 patients]; p = 0.53). However, postprotocol there was a trend toward a decreased risk of stroke secondary to BCVI on a trauma population basis (0.23% [7 of 3049 patients] vs 0.53% [13 of 2431 patients]; p = 0.06). Overall, 75% (35 of 47) of patients with BCVI were treated with antiplatelet agents, but no patient developed new or progressive intracranial hemorrhage despite 70% of these patients having concomitant traumatic brain injury. CONCLUSIONS The results of this study suggest that a CTA screening protocol for BCVI may be of clinical benefit with possible reduction in ischemic complications. The treatment of BCVI with antiplatelet agents appears to be safe.	[Tso, Michael K.; Mitha, Alim P.; Wong, John H.] Univ Calgary, Dept Clin Neurosci, Div Neurosurg, Foothills Med Ctr, Calgary, AB, Canada; [Ball, Chad G.; Kirkpatrick, Andrew W.] Univ Calgary, Dept Surg, Foothills Med Ctr, Calgary, AB, Canada; [Morrish, William F.; Mitha, Alim P.; Wong, John H.] Univ Calgary, Dept Diagnost Imaging, Foothills Med Ctr, Div Neuroradiol, Calgary, AB, Canada; [Lee, Myunghyun M.] Univ Toronto, Div Cardiac Surg, Toronto, ON M5S 1A1, Canada		Wong, JH (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Div Neurosurg,Foothills Med Ctr, 1403 29 St NW, Calgary, AB T2N 2T9, Canada.	jwong@ucalgary.ca			Calgary Surgical Research Development Fund; Kinetic Concepts, Inc.; Synthes, Inc.; Life Cell Corporation; Acelity Corporation	This study obtained funding from the Calgary Surgical Research Development Fund. This study received the Synthes Craniofacial Award at the 2012 American Association of Neurological Surgeons Annual Scientific Meeting. Dr. Kirkpatrick is the principal investigator of a randomized controlled trial funded by Kinetic Concepts, Inc., and has received travel compensation to Cadaver Labs from Synthes, Inc., and Life Cell Corporation. Dr. Kirkpatrick received non study-related clinical or research support from Acelity Corporation and is a consultant for Innovative Trauma Care Corporation.	Biffl WL, 2011, ANN SURG, V253, P451, DOI 10.1097/SLA.0b013e31820d990a; Biffl WL, 2009, J TRAUMA, V67, P1150, DOI 10.1097/TA.0b013e3181c1c1d6; Biffl WL, 2006, J TRAUMA, V60, P745, DOI 10.1097/01.ta.0000204034.94034.c4; Biffl WL, 2002, ANN SURG, V235, P699, DOI 10.1097/00000658-200205000-00012; Biffl WL, 1999, J TRAUMA, V47, P845, DOI 10.1097/00005373-199911000-00004; Biffl WL, 1999, AM J SURG, V178, P517, DOI 10.1016/S0002-9610(99)00245-7; Bromberg WJ, 2010, J TRAUMA, V68, P471, DOI 10.1097/TA.0b013e3181cb43da; Burlew CC, 2012, J TRAUMA ACUTE CARE, V72, P330, DOI 10.1097/TA.0b013e31823de8a0; Cook A, 2011, J TRAUMA, V71, P114, DOI 10.1097/TA.0b013e31821c350f; Cothren CC, 2009, ARCH SURG-CHICAGO, V144, P685, DOI 10.1001/archsurg.2009.111; Cothren CC, 2005, ARCH SURG-CHICAGO, V140, P480, DOI 10.1001/archsurg.140.5.480; DiCocco JM, 2011, J AM COLL SURGEONS, V212, P549, DOI 10.1016/j.jamcollsurg.2010.12.035; DiCocco JM, 2011, ANN SURG, V253, P444, DOI 10.1097/SLA.0b013e31820d946b; Eastman AL, 2009, J TRAUMA, V67, P551, DOI 10.1097/TA.0b013e3181b84408; Fabian TC, 1996, ANN SURG, V223, P513, DOI 10.1097/00000658-199605000-00007; Malhotra AK, 2007, ANN SURG, V246, P632, DOI 10.1097/SLA.0b013e3181568cab; McKevitt EC, 2002, AM J SURG, V183, P566, DOI 10.1016/S0002-9610(02)00845-0; McKevitt EC, 2002, J TRAUMA, V53, P472, DOI 10.1097/00005373-200209000-00013; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; Miller PR, 2001, J TRAUMA, V51, P279, DOI 10.1097/00005373-200108000-00009; O'Kelly CJ, 2010, CAN J NEUROL SCI, V37, P549, DOI 10.1017/S0317167100010659; Roberts DJ, 2013, ANN SURG, V257, P621, DOI 10.1097/SLA.0b013e318288c514; Rogers FB, 1999, J TRAUMA, V46, P380, DOI 10.1097/00005373-199903000-00005; Schneidereit NP, 2006, J TRAUMA, V60, P209, DOI 10.1097/01.ta.0000195651.60080.2c; Scott WW, 2015, J NEUROSURG, V122, P1196, DOI 10.3171/2015.1.JNS14642; Scott WW, 2015, J NEUROSURG, V122, P1202, DOI 10.3171/2014.9.JNS1461; Scott WW, 2015, J NEUROSURG, V122, P610, DOI 10.3171/2014.10.JNS14875; Scott WW, 2014, J NEUROSURG, V121, P450, DOI 10.3171/2014.4.JNS132235	28	23	23	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	APR	2017	126	4					1033	1041		10.3171/2016.1.JNS151545			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EQ1NX	WOS:000397837900002	27104846	Bronze			2022-02-06	
J	Tu, TM; Kolls, BJ; Soderblom, EJ; Cantillana, V; Ferrell, PD; Moseley, MA; Wang, HC; Dawson, HN; Laskowitz, DT				Tu, Tian Ming; Kolls, Brad J.; Soderblom, Erik J.; Cantillana, Viviana; Ferrell, Paul Durham; Moseley, M. Arthur; Wang, Haichen; Dawson, Hana N.; Laskowitz, Daniel T.			Apolipoprotein E mimetic peptide, CN-105, improves outcomes in ischemic stroke	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY			English	Article							BLOOD-BRAIN-BARRIER; MURINE MODEL; INTRACEREBRAL HEMORRHAGE; INFLAMMATORY MECHANISMS; MICROGLIAL ACTIVATION; ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; CNS RESPONSE; COG1410; INJURY	Objective: At present, the absence of a pharmacological neuroprotectant represents an important unmet clinical need in the treatment of ischemic and traumatic brain injury. Recent evidence suggests that administration of apolipoprotein E mimetic therapies represent a viable therapeutic strategy in this setting. We investigate the neuroprotective and anti-inflammatory properties of the apolipoprotein E mimetic pentapeptide, CN-105, in a microglial cell line and murine model of ischemic stroke. Methods: Ten to 13-week-old male C57/BL6 mice underwent transient middle cerebral artery occlusion and were randomly selected to receive CN-105 (0.1 mg/kg) in 100 mu L volume or vehicle via tail vein injection at various time points. Survival, motor-sensory functional outcomes using rotarod test and 4-limb wire hanging test, infarct volume assessment using 2,3,5-Triphenyltetrazolium chloride staining method, and microglial activation in the contralateral hippocampus using F4/80 immunostaining were assessed at various time points. In vitro assessment of tumor necrosis factor-alpha secretion in a microglial cell line was performed, and phosphoproteomic analysis conducted to explore early mechanistic pathways of CN-105 in ischemic stroke. Results: Mice receiving CN-105 demonstrated improved survival, improved functional outcomes, reduced infarct volume, and reduced microglial activation. CN-105 also suppressed inflammatory cytokines secretion in microglial cells in vitro. Phosphoproteomic signals suggest that CN-105 reduces proinflammatory pathways and lower oxidative stress. Interpretation: CN-105 improves functional and histological outcomes in a murine model of ischemic stroke via modulation of neuroinflammatory pathways. Recent clinical trial of this compound has demonstrated favorable pharmacokinetic and safety profile, suggesting that CN-105 represents an attractive candidate for clinical translation.	[Tu, Tian Ming; Kolls, Brad J.; Cantillana, Viviana; Wang, Haichen; Dawson, Hana N.; Laskowitz, Daniel T.] Duke Univ, Sch Med, Dept Neurol, DUMC 2900, Durham, NC 27710 USA; [Tu, Tian Ming] Natl Neurosci Inst, Dept Neurol, Tan Tock Seng Campus, Singapore, Singapore; [Soderblom, Erik J.; Moseley, M. Arthur] Duke Univ, Duke Prote Core Facil, Ctr Genom & Computat Biol, DUMC 2900, Durham, NC 27710 USA; [Ferrell, Paul Durham] Duke Univ, Sch Med, Dept Pathol, DUMC 2900, Durham, NC 27710 USA		Tu, TM (corresponding author), Duke Univ, Med Ctr, Dept Neurol, DUMC 2900, Durham, NC 27710 USA.	tu.tian.ming@singhealth.com.sg	Kolls, Brad/R-9154-2019	Tu, Tian Ming/0000-0002-7175-0357	North Carolina Biotechnology Center [2014-CFG-8004]; Ministry of Health, Singapore through the National Medical Research Council Research Training FellowshipMinistry of Health-SingaporeNational Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [0012/2015]	This work was supported by a grant from the North Carolina Biotechnology Center (2014-CFG-8004) to D.T.L and by the Ministry of Health, Singapore through the National Medical Research Council Research Training Fellowship (NMRC/Fellowship/0012/2015) supporting T.M.T.	Aartsma-Rus A, 2014, JOVE-J VIS EXP, DOI 10.3791/51303; Ahmed N, 2010, LANCET NEUROL, V9, P866, DOI 10.1016/S1474-4422(10)70165-4; Amantea D, 2009, FEBS J, V276, P13, DOI 10.1111/j.1742-4658.2008.06766.x; Aono M, 2003, NEUROSCIENCE, V116, P437, DOI 10.1016/S0306-4522(02)00709-1; Aono M, 2002, NEUROBIOL DIS, V11, P214, DOI 10.1006/nbdi.2002.0541; Bejot Y, 2011, NEUROCHEM INT, V58, P102, DOI 10.1016/j.neuint.2010.10.019; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Braga Patricia, 2002, J Stroke Cerebrovasc Dis, V11, P15, DOI 10.1053/jscd.2002.123970; Cao F, 2016, J NEUROTRAUM, V33, P175, DOI 10.1089/neu.2015.3887; Corey SJ, 1999, BLOOD, V93, P1, DOI 10.1182/blood.V93.1.1; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Croy JE, 2004, BIOCHEMISTRY-US, V43, P7328, DOI 10.1021/bi036208p; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; Day EK, 2016, CURR OPIN BIOTECH, V40, P185, DOI 10.1016/j.copbio.2016.06.005; Duan RS, 2006, EXP NEUROL, V202, P373, DOI 10.1016/j.expneurol.2006.06.013; Fonarow GC, 2011, CIRCULATION, V123, P750, DOI 10.1161/CIRCULATIONAHA.110.974675; Fu Y, 2015, NAT REV NEUROL, V11, P524, DOI 10.1038/nrneurol.2015.144; Gao J, 2006, NEUROCRIT CARE, V4, P25, DOI 10.1385/NCC:4:1:025; Grupke S, 2015, CLIN NEUROL NEUROSUR, V129, P1, DOI 10.1016/j.clineuro.2014.11.013; Gu Zhen, 2013, J Neurol Neurophysiol, V2014, P10; Guttman M, 2010, J MOL BIOL, V398, P306, DOI 10.1016/j.jmb.2010.03.022; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Hafezi-Moghadam A, 2007, AM J PHYSIOL-CELL PH, V292, pC1256, DOI 10.1152/ajpcell.00563.2005; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hanrahan F, 2016, TRANSLATIONAL RES TR; Hoane MR, 2007, J NEUROTRAUM, V24, P1108, DOI 10.1089/neu.2006.0254; Hoane MR, 2009, J NEUROTRAUM, V26, P121, DOI 10.1089/neu.2008.0565; Hu JR, 1998, J NEUROCHEM, V71, P1626; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; James ML, 2009, J STROKE CEREBROVASC, V18, P144, DOI 10.1016/j.jstrokecerebrovasdis.2008.09.012; James ML, 2009, STROKE, V40, P632, DOI 10.1161/STROKEAHA.108.530402; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Kim AS, 2011, CIRCULATION, V124, P314, DOI 10.1161/CIRCULATIONAHA.111.018820; Krishnamurthy K, 2016, TRANSLATIONAL RES TR; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Laskowitz DT, 2006, ACTA NEUROL SCAND, V114, P15, DOI 10.1111/j.1600-0404.2006.00680.x; Laskowitz DT, 2007, J NEUROTRAUM, V24, P1093, DOI 10.1089/neu.2006.0192; Laskowitz DT, 2012, NEUROCRIT CARE, V16, P316, DOI 10.1007/s12028-011-9641-5; Laskowitz DT, 1997, J CEREBR BLOOD F MET, V17, P753; Laskowitz DT, 1997, J NEUROIMMUNOL, V76, P70, DOI 10.1016/S0165-5728(97)00021-0; Laskowitz DT, 2001, EXP NEUROL, V167, P74, DOI 10.1006/exnr.2001.7541; Laskowitz DT, 1998, J CEREBR BLOOD F MET, V18, P465, DOI 10.1097/00004647-199805000-00001; Lei BL, 2016, SCI REP-UK, V6, DOI 10.1038/srep34834; Lynch JR, 2003, J BIOL CHEM, V278, P48529, DOI 10.1074/jbc.M306923200; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; Lynch JR, 2001, J NEUROIMMUNOL, V114, P107, DOI 10.1016/S0165-5728(00)00459-8; Mace BE, 2007, NEUROL RES, V29, P243, DOI 10.1179/016164107X158974; Manocha GD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132604; Martinez-Gonzalez NA, 2006, J NEUROL NEUROSUR PS, V77, P1329, DOI 10.1136/jnnp.2006.097543; McColl BW, 2007, J CEREBR BLOOD F MET, V27, P477, DOI 10.1038/sj.jcbfm.9600361; Mesis Rachel G, 2006, Neurosurg Focus, V21, pE4; Methia N, 2001, MOL MED, V7, P810, DOI 10.1007/BF03401973; Misra UK, 2001, J LEUKOCYTE BIOL, V70, P677; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Pocivavsek A, 2009, GLIA, V57, P444, DOI 10.1002/glia.20772; Powers WJ, 2015, STROKE, V46, P3020, DOI 10.1161/STR.0000000000000074; Qureshi AI, 2003, CRIT CARE MED, V31, P272, DOI 10.1097/00003246-200301000-00043; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Sbarbati A, 2002, ANAT REC, V266, P118, DOI 10.1002/ar.10044; Schilling M, 2003, EXP NEUROL, V183, P25, DOI 10.1016/S0014-4886(03)00082-7; Sheng HX, 1999, STROKE, V30, P1118, DOI 10.1161/01.STR.30.5.1118; Shichita T, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00319; Skolarus LE, 2015, STROKE, V46, P1890, DOI 10.1161/STROKEAHA.115.009163; Sutherland BA, 2012, INT J STROKE, V7, P407, DOI 10.1111/j.1747-4949.2012.00770.x; Thrift AG, 2014, INT J STROKE, V9, P6, DOI 10.1111/ijs.12245; Tong D, 2012, STROKE, V43, P1912, DOI 10.1161/STROKEAHA.111.644963; Tukhovskaya EA, 2009, J NEUROSCI RES, V87, P677, DOI 10.1002/jnr.21874; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Waetzig V, 2004, NEUROSCI LETT, V361, P64, DOI 10.1016/j.neulet.2004.02.041; Wang H, 2007, NEUROSCIENCE, V144, P1324, DOI 10.1016/j.neuroscience.2006.11.017; Wang H, 2013, EXP NEUROL, V241, P67, DOI 10.1016/j.expneurol.2012.11.027; Wang RH, 2014, J NEUROSCI RES, V92, P884, DOI 10.1002/jnr.23371; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wu Y, 2016, NEUROSCI LETT, V627, P92, DOI 10.1016/j.neulet.2016.05.058; Xiao WB, 2005, J IMMUNOL, V175, P6885, DOI 10.4049/jimmunol.175.10.6885; Zhang F., 2012, ANIMAL MODELS ACUTE, P93, DOI DOI 10.1007/978-1-61779-782-8_9; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; Zhu CL, 2007, J EXP MED, V204, P1741, DOI 10.1084/jem.20070193; Zlokovic BV, 2013, JAMA NEUROL, V70, P440, DOI 10.1001/jamaneurol.2013.2152; [No title captured]	83	23	23	3	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2328-9503			ANN CLIN TRANSL NEUR	Ann. Clin. Transl. Neurol.	APR	2017	4	4					246	265		10.1002/acn3.399			20	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EU2JZ	WOS:000400856300003	28382306	Green Published, gold			2022-02-06	
J	Zamproni, LN; Mundim, MV; Porcionatto, MA; des Rieux, A				Zamproni, Laura N.; Mundim, Mayara V.; Porcionatto, Marimelia A.; des Rieux, Anne			Injection of SDF-1 loaded nanoparticles following traumatic brain injury stimulates neural stem cell recruitment	INTERNATIONAL JOURNAL OF PHARMACEUTICS			English	Article						Neural stem cells; SDF-1; Nanoparticles; Brain injury	FACTOR-I; DELIVERY; PLGA; BIOCOMPATIBILITY; MICROSPHERES; NEUROGENESIS; PROTEIN; REGENERATION; EXPRESSION; PARTICLES	Recruiting neural stem cell (NSC) at the lesion site is essential for central nervous system repair. This process could be triggered by the local delivery of the chemokine SDF-1. We compared two PLGA formulations for local brain SDF-1 delivery: SDF-1 loaded microspheres (MS) and SDF-1 loaded nanoparticles (NP). Both formulations were able to encapsulate more than 80% of SDF-1 but presented different release profiles, with 100% of SDF-1 released after 6 days for the MS and with 25% of SDF-1 released after 2 weeks for NP. SDF-1 bioactivity was demonstrated by a chemotactic assay. When injected in mouse brain after traumatic brain injury, only SDF-1 nanoparticles induced NSC migration to the damage area. More neuroblasts (DCX+ cells) could be visualized around the lesions treated with NP SDF-1 compared to the other conditions. Rostral migratory stream destabilization with massive migration of DCX+ cell toward the perilesional area was observed 2 weeks after NP SDF-1 injection. Local injection of SDF-1-loaded nanoparticles induces recruitment of NSC and could be promising for brain injury lesion. (C) 2017 Elsevier B.V. All rights reserved.	[Zamproni, Laura N.; Mundim, Mayara V.; Porcionatto, Marimelia A.] Univ Fed Sao Paulo, Neurobiol Lab, Res Bldg 2,Rua Pedro de Toledo 669, BR-04039032 Sao Paulo, Brazil; [des Rieux, Anne] Catholic Univ Louvain, Louvain Drug Res Inst, Adv Drug Delivery & Biomat, Ave E Mounier 73, B-1200 Brussels, Belgium; [des Rieux, Anne] Catholic Univ Louvain, Inst Mat & Condensed Matter, B-1348 Louvain La Neuve, Belgium		des Rieux, A (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Adv Drug Delivery & Biomat, Ave E Mounier 73, B-1200 Brussels, Belgium.	anne.desrieux@uclouvain.be	zamproni, laura/K-2422-2016; Mundim, Mayara V/N-9985-2015; Porcionatto, Marimelia/C-3322-2012; zamproni, laura/AAC-7271-2019	zamproni, laura/0000-0003-2219-6676; Porcionatto, Marimelia/0000-0001-6287-916X; zamproni, laura/0000-0003-2219-6676; des Rieux, Anne/0000-0001-9953-3816; Mundim, Mayara/0000-0002-9771-977X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); UCL (FSR)	Laura Nicoleti Zamproni was a recipient of the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). We are also grateful to UCL (FSR) for the financial support. Anne des Rieux is a Research Associate at the FRS-FNRS (Fonds de la Recherche Scientifique, Belgique).	Addington CP, 2015, BIOMARK INSIGHTS, V10, P43, DOI [10.4137/BMI.S20062, 10.4137/BMIMI.S20062]; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Berge T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009761; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Chereddy KK, 2015, NANOMED-NANOTECHNOL, V11, P1975, DOI 10.1016/j.nano.2015.07.006; Cross DP, 2011, PHARM RES-DORDR, V28, P2477, DOI 10.1007/s11095-011-0474-x; D'Mello SR, 2014, J MICROENCAPSUL, V31, P137, DOI 10.3109/02652048.2013.814728; Dibajnia P, 2013, ACTA PHARMACOL SIN, V34, P78, DOI 10.1038/aps.2012.107; Dunne M, 2000, BIOMATERIALS, V21, P1659, DOI 10.1016/S0142-9612(00)00040-5; Emerich DF, 1999, CELL TRANSPLANT, V8, P47, DOI 10.1177/096368979900800114; Fournier E, 2003, BIOMATERIALS, V24, P3311, DOI 10.1016/S0142-9612(03)00161-3; Fujio M, 2011, BONE, V49, P693, DOI 10.1016/j.bone.2011.06.024; Galindo LT, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/564089; Gaumet M, 2007, INT J PHARM, V342, P222, DOI 10.1016/j.ijpharm.2007.05.001; Ghassemi AH, 2012, PHARM RES-DORDR, V29, P110, DOI 10.1007/s11095-011-0517-3; Henderson PW, 2011, WOUND REPAIR REGEN, V19, P420, DOI 10.1111/j.1524-475X.2011.00687.x; Hines DJ, 2013, CRIT REV THER DRUG, V30, P257, DOI 10.1615/CritRevTherDrugCarrierSyst.2013006475; Ho CY, 2015, TISSUE ENG PT A, V21, P594, DOI [10.1089/ten.TEA.2013.0762, 10.1089/ten.tea.2013.0762]; Kim DH, 2015, BIOMATERIALS, V61, P115, DOI 10.1016/j.biomaterials.2015.05.025; Knudsen KB, 2014, NANOTOXICOLOGY, V8, P764, DOI 10.3109/17435390.2013.829589; Lee SM, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/208121; Li YN, 2015, STEM CELL TRANSL MED, V4, P1122, DOI 10.5966/sctm.2015-0074; Longmire M, 2008, NANOMEDICINE-UK, V3, P703, DOI 10.2217/17435889.3.5.703; Luker KE, 2009, BIOTECHNIQUES, V47, P625, DOI 10.2144/000113126; Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377; Mao WF, 2014, INT J NEUROSCI, V124, P281, DOI 10.3109/00207454.2013.838236; Pencea V, 2001, EXP NEUROL, V172, P1, DOI 10.1006/exnr.2001.7768; Rabbany SY, 2010, CELL TRANSPLANT, V19, P399, DOI 10.3727/096368909X481782; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718; Sirianni RW, 2014, BIOCONJUGATE CHEM, V25, P2157, DOI 10.1021/bc500315j; Sun WF, 2014, INFLAMM RES, V63, P287, DOI 10.1007/s00011-013-0699-8; Sun W, 2010, ANAT CELL BIOL, V43, P269, DOI 10.5115/acb.2010.43.4.269; Szebeni J, 2012, NANOMED-NANOTECHNOL, V8, P176, DOI 10.1016/j.nano.2011.06.003; Veziers J, 2001, J NEUROSURG, V95, P489, DOI 10.3171/jns.2001.95.3.0489; Vishwakarma SK, 2014, J ADV RES, V5, P277, DOI 10.1016/j.jare.2013.04.005; Wang LY, 2015, THER CLIN RISK MANAG, V11, P1337, DOI 10.2147/TCRM.S87590; Xue LP, 2014, CELL BIOCHEM BIOPHYS, V70, P1609, DOI 10.1007/s12013-014-0103-5; Yellowley Clare, 2013, Bonekey Rep, V2, P300, DOI 10.1038/bonekey.2013.34; Yoo J, 2012, NEUROSCIENCE, V209, P171, DOI 10.1016/j.neuroscience.2012.02.031; Zhang M, 2007, FASEB J, V21, P3197, DOI 10.1096/fj.06-6558com	41	23	24	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0378-5173	1873-3476		INT J PHARMACEUT	Int. J. Pharm.	MAR 15	2017	519	1-2					323	331		10.1016/j.ijpharm.2017.01.036			9	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	EQ3WT	WOS:000398005400032	28115261				2022-02-06	
J	Shumskaya, E; van Gerven, MAJ; Norris, DG; Vos, PE; Kessels, RPC				Shumskaya, Elena; van Gerven, Marcel A. J.; Norris, David G.; Vos, Pieter E.; Kessels, Roy P. C.			Abnormal connectivity in the sensorimotor network predicts attention deficits in traumatic brain injury	EXPERIMENTAL BRAIN RESEARCH			English	Article						Traumatic brain injury; Neuropsychology; Resting-state fMRI; Functional connectivity; Independent component analysis	FUNCTIONAL CONNECTIVITY; NORMATIVE DATA; DYSFUNCTION; MOTION; MODE; EDUCATION; ARTIFACT; ACCURATE; MEMORY; ROBUST	The aim of this study was to explore modifications of functional connectivity in multiple resting-state networks (RSNs) after moderate to severe traumatic brain injury (TBI) and evaluate the relationship between functional connectivity patterns and cognitive abnormalities. Forty-three moderate/severe TBI patients and 34 healthy controls (HC) underwent resting-state fMRI. Group ICA was applied to identify RSNs. Between-subject analysis was performed using dual regression. Multiple linear regressions were used to investigate the relationship between abnormal connectivity strength and neuropsychological outcome. Forty (93%) TBI patients showed moderate disability, while 2 (5%) and 1 (2%) upper severe disability and low good recovery, respectively. TBI patients performed worse than HC on the domains attention and language. We found increased connectivity in sensorimotor, visual, default mode (DMN), executive, and cerebellar RSNs after TBI. We demonstrated an effect of connectivity in the sensorimotor RSN on attention (p < 10(-3)) and a trend towards a significant effect of the DMN connectivity on attention (p = 0.058). A group-by-network interaction on attention was found in the sensorimotor network (p = 0.002). In TBI, attention was positively related to abnormal connectivity within the sensorimotor RSN, while in HC this relation was negative. Our results show altered patterns of functional connectivity after TBI. Attention impairments in TBI were associated with increased connectivity in the sensorimotor network. Further research is needed to test whether attention in TBI patients is directly affected by changes in functional connectivity in the sensorimotor network or whether the effect is actually driven by changes in the DMN.	[Shumskaya, Elena; van Gerven, Marcel A. J.; Norris, David G.; Kessels, Roy P. C.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Norris, David G.] Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany; [Norris, David G.] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Enschede, Netherlands; [Vos, Pieter E.] Slingeland Hosp, Dept Neurol, Doetinchem, Netherlands; [Vos, Pieter E.] Radboud Univ Nijmegen, Dept Neurol, Med Ctr, Nijmegen, Netherlands; [Kessels, Roy P. C.] Radboud Univ Nijmegen, Dept Med Psychol, Med Ctr, Nijmegen, Netherlands; [Kessels, Roy P. C.] Radboud Univ Nijmegen, Donders Ctr Cognit, Montessorilaan 3, NL-6525 HR Nijmegen, Netherlands		Kessels, RPC (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.; Kessels, RPC (corresponding author), Radboud Univ Nijmegen, Dept Med Psychol, Med Ctr, Nijmegen, Netherlands.; Kessels, RPC (corresponding author), Radboud Univ Nijmegen, Donders Ctr Cognit, Montessorilaan 3, NL-6525 HR Nijmegen, Netherlands.	elena.shumskaya@donders.ru.nl; m.vangerven@donders.ru.nl; d.norris@donders.ru.nl; p.vos@slingeland.nl; r.kessels@donders.ru.nl	Norris, David G/A-1937-2010; Kessels, Roy P.C./D-1902-2010; van Gerven, Marcel A. J./D-7800-2012	Norris, David G/0000-0002-3699-6917; Kessels, Roy P.C./0000-0001-9500-9793; van Gerven, Marcel A. J./0000-0002-2206-9098	Netherlands Brain Foundation (Hersenstichting Nederland) [2009(1)-20]	This study was funded by the Netherlands Brain Foundation (Hersenstichting Nederland) [2009(1)-20].	Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Brands AMA, 2007, J INT NEUROPSYCH SOC, V13, P288, DOI 10.1017/S1355617707070312; Bucks R. S., 2011, LOCATION LEARNING TE; Burgess PW, 1996, CORTEX, V32, P241, DOI 10.1016/S0010-9452(96)80049-9; Dahdah MN, 2014, J HEAD TRAUMA REHAB, V29, P451, DOI 10.1097/HTR.0b013e3182a61983; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Koerts JAC, 2012, HDB NEUROPSYCHOLOGIC, P543; Lee MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040370; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Merkley TL, 2013, J INT NEUROPSYCH SOC, V19, P899, DOI 10.1017/S135561771300074X; Poser BA, 2006, MAGN RESON MED, V55, P1227, DOI 10.1002/mrm.20900; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Schmand B, 2008, Tijdschr Gerontol Geriatr, V39, P64; Schmand BL., 1992, NEDERLANDSE LEESLIJS NEDERLANDSE LEESTEST; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Van der Elst W, 2006, ASSESSMENT, V13, P62, DOI 10.1177/1073191105283427; Van der Elst W, 2005, J INT NEUROPSYCH SOC, V11, P290, DOI 10.1017/S1355617705050344; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Loon-Vervoorn W. A., 2006, TIJDSCHRIFT NEUROPSY, V1, P30; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wester AJ, 2013, NEUROPSYCH DIS TREAT, V9, P875, DOI 10.2147/NDT.S44973; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Xiao H, 2015, NEURAL REGEN RES, V10, P2062, DOI 10.4103/1673-5374.172328; Zimmermann P, 2002, APPLIED NEUROPSYCHOLOGY OF ATTENTION: THEORY DIAGNOSIS AND REHABILITATION, P110	42	23	24	0	10	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	MAR	2017	235	3					799	807		10.1007/s00221-016-4841-z			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EM1HO	WOS:000395068900014	27885406	Green Published, hybrid			2022-02-06	
J	Roy, N; Veetil, DK; Khajanchi, MU; Kumar, V; Solomon, H; Kamble, J; Basak, D; Tomson, G; von Schreeb, J				Roy, Nobhojit; Veetil, Deepa Kizhakke; Khajanchi, Monty Uttam; Kumar, Vineet; Solomon, Harris; Kamble, Jyoti; Basak, Debojit; Tomson, Goran; von Schreeb, Johan			Learning from 2523 trauma deaths in India-opportunities to prevent in-hospital deaths	BMC HEALTH SERVICES RESEARCH			English	Article							MIDDLE-INCOME COUNTRIES; QUALITY-IMPROVEMENT; CARE; GUIDELINES; MORTALITY; INJURIES; BURDEN	Background: A systematic analysis of trauma deaths is a step towards trauma quality improvement in Indian hospitals. This study estimates the magnitude of preventable trauma deaths in five Indian hospitals, and uses a peer-review process to identify opportunities for improvement (OFI) in trauma care delivery. Methods: All trauma deaths that occurred within 30 days of hospitalization in five urban university hospitals in India were retrospectively abstracted for demography, mechanism of injury, transfer status, injury description by clinical, investigation and operative findings. Using mixed methods, they were quantitatively stratified by the standardized Injury Severity Score (ISS) into mild (1-8), moderate (9-15), severe (16-25), profound (26-75) ISS categories, and by time to death within 24 h, 7, or 30 days. Using peer-review and Delphi methods, we defined optimal trauma care within the Indian context and evaluated each death for preventability, using the following categories: Preventable (P), Potentially preventable (PP), Non-preventable (NP) and Non-preventable but care could have been improved (NPI). Results: During the 18 month study period, there were 11,671 trauma admissions and 2523 deaths within 30 days (21.6%). The overall proportion of preventable deaths was 58%, among 2057 eligible deaths. In patients with a mild ISS score, 71% of deaths were preventable. In the moderate category, 56% were preventable, and 60% in the severe group and 44% in the profound group were preventable. Traumatic brain injury and burns accounted for the majority of non-preventable deaths. The important areas for improvement in the preventable deaths subset, inadequacies in airway management (14.3%) and resuscitation with hemorrhage control (16.3%). System-related issues included lack of protocols, lack of adherence to protocols, pre-hospital delays and delays in imaging. Conclusion: Fifty-eight percent of all trauma deaths were classified as preventable. Two-thirds of the deaths with injury severity scores of less than 16 were preventable. This large subgroup of Indian urban trauma patients could possibly be saved by urgent attention and corrective action. Low-cost interventions such as airway management, fluid resuscitation, hemorrhage control and surgical decision-making protocols, were identified as OFI. Establishment of clinical protocols and timely processes of trauma care delivery are the next steps towards improving care.	[Roy, Nobhojit; Tomson, Goran; von Schreeb, Johan] Karolinska Inst, Dept Publ Hlth Sci, Hlth Syst & Policy, Stockholm, Sweden; [Roy, Nobhojit] Bhabha Atom Res Ctr Hosp, Dept Surg, Bombay, Maharashtra, India; [Roy, Nobhojit; Veetil, Deepa Kizhakke; Kamble, Jyoti; Basak, Debojit] Tata Inst Social Sci, Sch Habitat, Bombay, Maharashtra, India; [Khajanchi, Monty Uttam] King Edward Mem Hosp, Dept Surg, Bombay, Maharashtra, India; [Kumar, Vineet] Lokmanya Tilak Municipal Med Coll & Gen Hosp, Dept Surg, Bombay, Maharashtra, India; [Solomon, Harris] Duke Univ, Dept Cultural Anthropol & Global Hlth, Global Hlth Inst, 205 Friedl Bldg,Box 90091, Durham, NC 27708 USA; [Tomson, Goran] Karolinska Inst, Dept Learning Informat Management & Eth LIME & Pu, Stockholm, Sweden		Roy, N (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Hlth Syst & Policy, Stockholm, Sweden.; Roy, N (corresponding author), Bhabha Atom Res Ctr Hosp, Dept Surg, Bombay, Maharashtra, India.; Roy, N (corresponding author), Tata Inst Social Sci, Sch Habitat, Bombay, Maharashtra, India.	nobhojit.roy@ki.se		Roy, Nobhojit/0000-0003-2022-7416; Solomon, Harris/0000-0002-8792-469X	Swedish National Board of Health and Welfare; Laerdal Foundation for Acute Care Medicine, Norway	The TITCO dataset by the research consortium of Indian Universities [4] was funded by grants from the Swedish National Board of Health and Welfare and the Laerdal Foundation for Acute Care Medicine, Norway. The funding agencies had no influence on the conduct of the study, the contents of the manuscript, or the decision to send the manuscript for publication.	Abioye IA, 2012, INT J SURG, V10, P209, DOI 10.1016/j.ijsu.2012.03.003; Baker T, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-140; Berbiglia L, 2013, AM SURGEON, V79, P764; Chadbunchachai Witaya, 2001, Journal of the Medical Association of Thailand, V84, P782; Chandran A, 2010, EPIDEMIOL REV, V32, P110, DOI 10.1093/epirev/mxq009; Costa Carlos Dario da Silva, 2012, Rev. Col. Bras. Cir., V39, P249; Crowley-Matoka M, 2012, CULT ANTHROPOL, V27, P689, DOI 10.1111/j.1548-1360.2012.01167.x; Donabedian A, 1997, ARCH PATHOL LAB MED, V121, P1145; Gerdin M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090064; Gruen RL, 2006, T M AM SURG ASS, V124, P37, DOI [10.1097/01.sla.0000234655.83517.56, DOI 10.1097/01.SLA.0000234655.83517.56]; Haghparast-Bidgoli Hassan, 2013, J Inj Violence Res, V5, P28, DOI 10.5249/jivr.v5i1.195; Hashmi ZG, 2013, J TRAUMA ACUTE CARE, V75, P60, DOI 10.1097/TA.0b013e31829880a0; Hoogervorst EM, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-79; Hsiao M, 2012, PLOS ONE, V7, P1; Inaba K, 2013, AM SURGEON, V79, P1134; Jat Afzal Ali, 2004, Asian J Surg, V27, P58, DOI 10.1016/S1015-9584(09)60247-5; Kesinger MR, 2014, WORLD J SURG, V38, P1869, DOI 10.1007/s00268-014-2534-y; Kleber C, 2010, WORLD J SURG, V2013, P1154; Kumar GA, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-285; Laing G, 2015, WORLD J SURG, V39, P70, DOI 10.1007/s00268-014-2766-x; Lashoher A, 2017, WORLD J SURG, V41, P954, DOI 10.1007/s00268-016-3759-8; Latifi R, 2014, WORLD J SURG, V38, P1898, DOI 10.1007/s00268-014-2538-7; Martin BT, 2007, J TRAUMA, V62, P69, DOI 10.1097/TA.0b013e31802d08e5; Mock C, 2009, INJURY PREV, V15, P359, DOI 10.1136/ip.2009.024315; Mock C, 2012, WORLD J SURG, V36, P959, DOI 10.1007/s00268-012-1459-6; Mock C, 2009, B WORLD HEALTH ORGAN, V87, P382, DOI 10.2471/BLT.08.057059; Montmany S, 2015, INJURY ELSEVIER LTD, V47, P669; O'Reilly D, 2013, BRIT J SURG, V100, P749, DOI 10.1002/bjs.9096; Parra MW, 2013, TELEMED E-HEALTH, V19, P699, DOI 10.1089/tmj.2012.0254; Roy N, 2016, WORLD J SURG, V40, P1299, DOI 10.1007/s00268-016-3452-y; Saltzherr TP, 2011, INJURY, V42, P870, DOI 10.1016/j.injury.2010.04.007; Sanddal TL, 2011, J TRAUMA, V70, P970, DOI 10.1097/TA.0b013e3181fec9ba; Santana MJ, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.07.010; Shah MT, 2015, WORLD J SURG, V39, P363, DOI 10.1007/s00268-014-2805-7; Stelfox HT, 2012, J TRAUMA ACUTE CARE, V72, P962, DOI 10.1097/TA.0b013e31824a7bd8; Stelfox HT, 2012, WORLD J SURG, V36, P1978, DOI 10.1007/s00268-012-1593-1; Stewart BT, 2016, INJURY, V47, P211, DOI 10.1016/j.injury.2015.09.007; Stewart BT, 2015, WORLD J SURG, V39, P2428, DOI 10.1007/s00268-015-3132-3; Stewart RM, 2003, J TRAUMA, V54, P66, DOI 10.1097/00005373-200301000-00009; Tsang B, 2013, WORLD J EMERG SURG, V8, DOI 10.1186/1749-7922-8-39; Vioque SM, 2014, AM J SURG, V208, P187, DOI 10.1016/j.amjsurg.2014.02.006; Willett K, 2010, PUBLIC HEALTH, V124, P180, DOI 10.1016/j.puhe.2010.01.011; Yeboah D, 2014, WORLD J SURG, V38, P1707, DOI 10.1007/s00268-014-2452-z	43	23	25	0	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1472-6963			BMC HEALTH SERV RES	BMC Health Serv. Res.	FEB 16	2017	17								142	10.1186/s12913-017-2085-7			8	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	EK7MV	WOS:000394110800001	28209192	Green Published, gold			2022-02-06	
J	Stern, RA; Seichepine, D; Tschoe, C; Fritts, NG; Alosco, ML; Berkowitz, O; Burke, P; Howland, J; Olshaker, J; Cantu, RC; Baugh, CM; Holsapple, JW				Stern, Robert A.; Seichepine, Daniel; Tschoe, Christine; Fritts, Nathan G.; Alosco, Michael L.; Berkowitz, Oren; Burke, Peter; Howland, Jonathan; Olshaker, Jonathan; Cantu, Robert C.; Baugh, Christine M.; Holsapple, James W.			Concussion Care Practices and Utilization of Evidence-Based Guidelines in the Evaluation and Management of Concussion: A Survey of New England Emergency Departments	JOURNAL OF NEUROTRAUMA			English	Article						clinical practice guidelines; concussion; emergency department; New England; traumatic brain injury	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSIONS; RETURN-TO-PLAY; HEALTH-CARE; MILD; PHYSICIANS; QUALITY; KNOWLEDGE; POLICY; ADULTS	Evidence-based clinical practice guidelines can facilitate proper evaluation and management of concussions in the emergency department (ED), often the initial and primary point of contact for concussion care. There is no universally adopted set of guidelines for concussion management, and extant evidence suggests that there may be variability in concussion care practices and limited application of clinical practice guidelines in the ED. This study surveyed EDs throughout New England to examine current practices of concussion care and utilization of evidence-based clinical practice guidelines in the evaluation and management of concussions. In 2013, a 32-item online survey was e-mailed to 149/168 EDs throughout New England (Connecticut, Rhode Island, Massachusetts, Vermont, New Hampshire, Maine). Respondents included senior administrators asked to report on their EDs use of clinical practice guidelines, neuroimaging decision-making, and discharge instructions for concussion management. Of the 72/78 respondents included, 35% reported absence of clinical practice guidelines, and 57% reported inconsistency in the type of guidelines used. Practitioner preference guided neuroimaging decision-making for 57%. Although 94% provided written discharge instructions, there was inconsistency in the recommended time frame for follow-up care (13% provided no specific time frame), the referral specialist to be seen (25% did not recommend any specialist), and return to activity instructions were inconsistent. There is much variability in concussion care practices and application of evidence-based clinical practice guidelines in the evaluation and management of concussions in New England EDs. Knowledge translational efforts will be critical to improve concussion management in the ED setting.	[Stern, Robert A.; Cantu, Robert C.; Baugh, Christine M.] Boston Univ, Sch Med, Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA; [Stern, Robert A.; Tschoe, Christine; Cantu, Robert C.; Baugh, Christine M.; Holsapple, James W.] Boston Univ, Sch Med, Dept Neurol, 72 E Concord St,Suite B7800, Boston, MA 02118 USA; [Stern, Robert A.; Berkowitz, Oren; Cantu, Robert C.] Boston Univ, Sch Med, Dept Neurosurg, 72 E Concord St,Suite B7800, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Anat & Neurobiol, 72 E Concord St,Suite B7800, Boston, MA 02118 USA; [Seichepine, Daniel; Fritts, Nathan G.] Boston Univ, Alzheimers Dis & CTE Ctr, Boston, MA USA; [Alosco, Michael L.] Boston Univ, Sch Med, Dept Neurol, Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA; [Berkowitz, Oren] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Burke, Peter] Boston Univ, Sch Med, Boston Med Ctr, Dept Surg,Div Gen Surg,Sect Acute Care & Trauma S, Boston, MA 02118 USA; [Howland, Jonathan] Boston Univ, Sch Med, Boston Med Ctr, Injury Prevent Ctr, Boston, MA 02118 USA; [Howland, Jonathan; Olshaker, Jonathan] Boston Univ, Sch Med, Dept Emergency Med, Boston, MA 02118 USA; [Olshaker, Jonathan] Boston Med Ctr, Dept Emergency Med, Boston, MA USA; [Baugh, Christine M.] Harvard Univ, Interfac Initiat Hlth Policy, Cambridge, MA 02138 USA		Stern, RA (corresponding author), Boston Univ, Sch Med, Dept Neurol, 72 E Concord St,Suite B7800, Boston, MA 02118 USA.; Stern, RA (corresponding author), Boston Univ, Sch Med, Dept Neurosurg, 72 E Concord St,Suite B7800, Boston, MA 02118 USA.; Stern, RA (corresponding author), Boston Univ, Sch Med, Dept Anat & Neurobiol, 72 E Concord St,Suite B7800, Boston, MA 02118 USA.	bobstern@bu.edu	Berkowitz, Oren/L-5006-2019; , Bob/ABA-8507-2020; Baugh, Christine/AAG-2324-2020	Berkowitz, Oren/0000-0002-4919-4921; Baugh, Christine/0000-0002-9340-6338	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS 078337, R56 NS 078337, P30 AG13846]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG06697]; National Institutes of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019733]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F32NS096803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG013846, T32AG036697] Funding Source: NIH RePORTER	This study was supported by grants from the National Institutes of Health (R01 NS 078337; R56 NS 078337; P30 AG13846). Michael L. Alosco is supported by the National Institute on Aging under award number T32AG06697. Christine Baugh is currently supported by the National Institutes of Mental Health under award number T32MH019733. There were no restrictions on the design and conduct of the study, collection, management, analysis, and interpretation of the data, preparation, review, or approval of the manuscript, or decision to submit the manuscript for publication. There is no sponsor.	American Hospital Association, 1999, AHA GUID HLTH CAR FI; Bay E, 2011, ADV EMERG NURS J, V33, P181, DOI 10.1097/TME.0b013e318217c958; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Bazarian JJ, 2001, CLIN PEDIATR, V40, P207, DOI 10.1177/000992280104000405; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Blostein P, 2003, J TRAUMA, V55, P450, DOI 10.1097/01.TA.0000038545.24879.4D; Bosch M, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-281; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Cantu RC, 2011, PM&R, V3, pS440, DOI 10.1016/j.pmrj.2011.07.013; Chinn NR, 2013, COMMUNITY COLL J RES, V37, P409, DOI 10.1080/10668926.2012.710127; Colorado Medical Society Sports Medicine Committee, 1994, P MILD BRAIN INJ SPO, P106; Donaldson A., 2014, AM J LIFESTYLE MED; Easter JS, 2015, JAMA-J AM MED ASSOC, V314, P2672, DOI 10.1001/jama.2015.16316; Fung M, 2006, BRAIN INJURY, V20, P889, DOI 10.1080/02699050600831934; Giebel S, 2011, J EMERG MED, V41, P649, DOI 10.1016/j.jemermed.2011.03.021; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grimshaw JM, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-50; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Heskestad B, 2008, J TRAUMA, V65, P1309, DOI 10.1097/TA.0b013e31815e40cd; Hollis SJ, 2012, BRIT J SPORT MED, V46, P735, DOI 10.1136/bjsm.2011.085332; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; Kelly JP, 1997, NEUROLOGY, V48, P581; Kroshus E., 2015, CLIN J SPORT MED; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; Kroshus E, 2015, HEALTH EDUC RES, V30, P1004, DOI 10.1093/her/cyv047; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Poulos RG, 2012, BRIT J SPORT MED, V46, P585, DOI 10.1136/bjsports-2011-090469; Rivara FP, 2015, JAMA-J AM MED ASSOC, V314, P2629, DOI 10.1001/jama.2015.17298; Schuster MA, 2005, MILBANK Q, V83, P843, DOI 10.1111/j.1468-0009.2005.00403.x; Scorza KA, 2012, AM FAM PHYSICIAN, V85, P123; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Stoller J, 2014, CAN FAM PHYSICIAN, V60, P548; Stuart B, 2012, J EMERG NURS, V38, P435, DOI 10.1016/j.jen.2011.04.006; Tavender EJ, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-8; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x; Upchurch C, 2015, CLIN J SPORT MED, V25, P297, DOI 10.1097/JSM.0000000000000123; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; VanGeest JB, 2007, EVAL HEALTH PROF, V30, P303, DOI 10.1177/0163278707307899; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171	47	23	23	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2017	34	4					861	868		10.1089/neu.2016.4475			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EL0XD	WOS:000394344200013	27112592	Green Published			2022-02-06	
J	Sawant-Pokam, PM; Suryavanshi, P; Mendez, JM; Dudek, FE; Brennan, KC				Sawant-Pokam, P. M.; Suryavanshi, P.; Mendez, J. M.; Dudek, F. E.; Brennan, K. C.			Mechanisms of Neuronal Silencing After Cortical Spreading Depression	CEREBRAL CORTEX			English	Article						cortical spreading depression; excitation inhibition balance; somatosensory; whole-cell recording	RAT HIPPOCAMPAL SLICES; LONG-TERM POTENTIATION; INHIBITORY SYNAPTIC-TRANSMISSION; WHOLE-CELL PATCH; PYRAMIDAL CELLS; CEREBRAL-CORTEX; NEOCORTICAL NEURONS; RECEPTOR ACTIVATION; BARREL CORTEX; IN-VIVO	Cortical spreading depression (CSD) is associated with migraine, stroke, and traumatic brain injury, but its mechanisms remain poorly understood. One of the major features of CSD is an hour-long silencing of neuronal activity. Though this silencing has clear ramifications for CSD-associated disease, it has not been fully explained. We used in vivo whole-cell recordings to examine the effects of CSD on layer 2/3 pyramidal neurons in mouse somatosensory cortex and used in vitro recordings to examine their mechanism. We found that CSD caused a reduction in spontaneous synaptic activity and action potential (AP) firing that lasted over an hour. Both pre-and postsynaptic mechanisms contributed to this silencing. Reductions in frequency of postsynaptic potentials were due to a reduction in presynaptic transmitter release probability as well as reduced AP activity. Decreases in postsynaptic potential amplitudewere due to an inhibitory shift in the ratio of excitatory and inhibitory postsynaptic currents. This inhibitory shift in turn contributed to the reduced frequency of APs. Thus, distinct but complementary mechanisms generate the long neuronal silence that follows CSD. These cellular changes could contribute to wider network dysfunction in CSD-associated disease, while the pre-and postsynaptic mechanisms offer separate targets for therapy.	[Sawant-Pokam, P. M.; Suryavanshi, P.; Mendez, J. M.; Brennan, K. C.] Univ Utah, Sch Med, Dept Neurol, 383 Colorow Dr, Salt Lake City, UT 84108 USA; [Dudek, F. E.] Univ Utah, Sch Med, Dept Neurosurg, Salt Lake City, UT USA		Brennan, KC (corresponding author), Univ Utah, Sch Med, Dept Neurol, 383 Colorow Dr, Salt Lake City, UT 84108 USA.	k.c.brennan@hsc.utah.edu	Suryavanshi, Pratyush/ABE-6107-2021		National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS085413, R21 NS083010]; Department of DefenseUnited States Department of Defense [CDMRP PR 100060, PR 130373]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS085413] Funding Source: NIH RePORTER	This study was supported by the National Institutes of Health (R01 NS085413, R21 NS083010) and the Department of Defense (CDMRP PR 100060, PR 130373).	Aiba I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110849; Aiba I, 2012, J PHYSIOL-LONDON, V590, P5877, DOI 10.1113/jphysiol.2012.234476; Alle H, 2009, SCIENCE, V325, P1405, DOI 10.1126/science.1174331; Atwood BK, 2014, TRENDS NEUROSCI, V37, P663, DOI 10.1016/j.tins.2014.07.010; Balestrino M, 1999, BRAIN RES, V838, P37, DOI 10.1016/S0006-8993(99)01674-1; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; BERNANDER O, 1994, J NEUROPHYSIOL, V72, P2743, DOI 10.1152/jn.1994.72.6.2743; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; CALABRESI P, 1995, J CEREBR BLOOD F MET, V15, P1141, DOI 10.1038/jcbfm.1995.142; Cao Y, 1999, ARCH NEUROL-CHICAGO, V56, P548, DOI 10.1001/archneur.56.5.548; Castillo PE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005728; Chang JC, 2010, BRAIN, V133, P996, DOI 10.1093/brain/awp338; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; CZEH G, 1993, BRAIN RES, V632, P195, DOI 10.1016/0006-8993(93)91154-K; De PM, 2015, NEUROSCIENCE, DOI [doi:10.1016/j.neuroscience.2015.04.001., DOI 10.1016/J.NEUROSCIENCE.2015.04.001]; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; El-Hussein AE, 2000, SCIENCE, V290, P1364; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Forti L, 1997, NATURE, V388, P874, DOI 10.1038/42251; FRERKING M, 1995, NEURON, V15, P885, DOI 10.1016/0896-6273(95)90179-5; Gao BX, 1998, J NEUROPHYSIOL, V79, P2277, DOI 10.1152/jn.1998.79.5.2277; Ghadiri MK, 2012, CEPHALALGIA, V32, P116, DOI 10.1177/0333102411431308; Gniel HM, 2010, J NEUROPHYSIOL, V104, P3203, DOI 10.1152/jn.00922.2009; GRAFSTEIN B, 1956, J NEUROPHYSIOL, V19, P154, DOI 10.1152/jn.1956.19.2.154; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Halabisky B, 2010, J NEUROPHYSIOL, V104, P2214, DOI 10.1152/jn.00147.2010; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Haydon PG, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020438; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; HERRERAS O, 1993, BRAIN RES, V610, P276, DOI 10.1016/0006-8993(93)91411-K; HIGASHIDA H, 1974, BRAIN RES, V65, P411, DOI 10.1016/0006-8993(74)90232-7; Hille B, 2001, ION CHANNELS EXCITAB, V3rd; Hughes S, 2013, NAT NEUROSCI, V16, P115, DOI 10.1038/nn.3313; Jia YS, 2010, J NEUROSCI, V30, P14440, DOI 10.1523/JNEUROSCI.3310-10.2010; JING J, 1991, BRAIN RES, V557, P177, DOI 10.1016/0006-8993(91)90132-F; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Jones MV, 1997, J NEUROSCI, V17, P7626; KAKU T, 1994, BRAIN RES, V658, P39, DOI 10.1016/S0006-8993(09)90008-7; Karmazinova M, 2010, PHYSIOL RES, V59, pS1, DOI 10.33549/physiolres.932000; Kawahara N, 1997, NEUROSCI RES, V29, P37, DOI 10.1016/S0168-0102(97)00069-2; Kazemi H, 2012, IRAN J BASIC MED SCI, V15, P926; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Kovalchuk Y, 2002, SCIENCE, V295, P1729, DOI 10.1126/science.1067766; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Laviv T, 2010, NEURON, V67, P253, DOI 10.1016/j.neuron.2010.06.022; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; LEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409; Lemieux M, 2015, J NEUROPHYSIOL, V113, P768, DOI 10.1152/jn.00858.2013; Li WC, 2004, J NEUROPHYSIOL, V92, P380, DOI 10.1152/jn.01238.2003; Lindquist BE, 2012, NEUROSCIENCE, V223, P365, DOI 10.1016/j.neuroscience.2012.07.053; Lindquist BE, 2014, J CEREBR BLOOD F MET, V34, P1779, DOI 10.1038/jcbfm.2014.146; Lisman JE, 2007, NAT REV NEUROSCI, V8, P597, DOI 10.1038/nrn2191; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MARSHALL WH, 1959, PHYSIOL REV, V39, P239, DOI 10.1152/physrev.1959.39.2.239; McAllister SD, 2002, PROSTAG LEUKOTR ESS, V66, P161, DOI 10.1054/plef.2001.0344; McCormick DA, 2003, CEREB CORTEX, V13, P1219, DOI 10.1093/cercor/bhg104; MODY I, 1987, J NEUROPHYSIOL, V57, P869, DOI 10.1152/jn.1987.57.3.869; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; Muller M, 2000, J NEUROPHYSIOL, V84, P1869, DOI 10.1152/jn.2000.84.4.1869; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; OTIS TS, 1994, P NATL ACAD SCI USA, V91, P7698, DOI 10.1073/pnas.91.16.7698; PERKEL DJ, 1993, J PHYSIOL-LONDON, V471, P481, DOI 10.1113/jphysiol.1993.sp019911; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Pietrobon D, 2013, ANNU REV PHYSIOL, V75, P365, DOI 10.1146/annurev-physiol-030212-183717; Piilgaard H, 2009, J CEREBR BLOOD F MET, V29, P1517, DOI 10.1038/jcbfm.2009.73; Postlethwaite M, 2007, J PHYSIOL-LONDON, V579, P69, DOI 10.1113/jphysiol.2006.123612; PRINCE DA, 1992, P NATL ACAD SCI USA, V89, P8586, DOI 10.1073/pnas.89.18.8586; Raghavachari S, 2004, J NEUROPHYSIOL, V92, P2456, DOI 10.1152/jn.00258.2004; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; Scheckenbach KEL, 2006, EXP NEUROL, V202, P449, DOI 10.1016/j.expneurol.2006.07.007; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; SNOW RW, 1983, J NEUROPHYSIOL, V50, P561, DOI 10.1152/jn.1983.50.3.561; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; SPRUSTON N, 1992, J NEUROPHYSIOL, V67, P508, DOI 10.1152/jn.1992.67.3.508; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Steriade M, 1997, CEREB CORTEX, V7, P583, DOI 10.1093/cercor/7.6.583; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; SUGAYA E, 1975, J NEUROPHYSIOL, V38, P822, DOI 10.1152/jn.1975.38.4.822; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Theriot JJ, 2012, J NEUROSCI, V32, P15252, DOI 10.1523/JNEUROSCI.2092-12.2012; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; Timofeev I, 2000, J PHYSIOLOGY-PARIS, V94, P343, DOI 10.1016/S0928-4257(00)01097-4; Tottene A, 2009, NEURON, V61, P762, DOI 10.1016/j.neuron.2009.01.027; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005736; ULRICH D, 1993, J NEUROPHYSIOL, V69, P1769, DOI 10.1152/jn.1993.69.5.1769; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; Wei YN, 2014, J NEUROSCI, V34, P11733, DOI 10.1523/JNEUROSCI.0516-14.2014; Wilson Charles, 2008, Scholarpedia J, V3, P1410; WU LG, 1994, NEURON, V12, P1139, DOI 10.1016/0896-6273(94)90321-2; YAWO H, 1993, NATURE, V365, P256, DOI 10.1038/365256a0; YOON KW, 1991, J NEUROSCI, V11, P1375; Zhou N, 2013, J CEREBR BLOOD F MET, V33, P1582, DOI 10.1038/jcbfm.2013.113; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171	104	23	24	0	6	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	FEB	2017	27	2					1311	1325		10.1093/cercor/bhv328			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EP3BN	WOS:000397257600033	26733536	Bronze, Green Published			2022-02-06	
J	Weintraub, AH; Gerber, DJ; Kowalski, RG				Weintraub, Alan H.; Gerber, Donald J.; Kowalski, Robert G.			Posttraumatic Hydrocephalus as a Confounding Influence on Brain Injury Rehabilitation: Incidence, Clinical Characteristics, and Outcomes	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Cerebrospinal fluid; Hydrocephalus; Intracranial pressure; Rehabilitation; Ventriculoperitoneal shunt	NORMAL-PRESSURE HYDROCEPHALUS; SEVERE HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; RISK-FACTORS; SHUNT IMPLANTATION; CSF DYNAMICS; CONSCIOUSNESS; DISORDERS; COMPLICATIONS; COMORBIDITIES	Objective: To describe incidence, clinical characteristics, complications, and outcomes in posttraumatic hydrocephalus (PTH) after traumatic brain injury (TBI) for patients treated in an inpatient rehabilitation program. Design: Cohort study with retrospective comparative analysis. Setting: Inpatient rehabilitation hospital. Participants: All patients admitted for TBI from 2009 to 2013 diagnosed with PTH (N=59), defined as ventriculomegaly, delayed clinical recovery discordant with injury severity, hydrocephalus symptoms, or positive lumbar puncture results. Interventions: None. Main Outcome Measures: Primary measures were incidence of PTH and patient and injury characteristics. Secondary measures included frequency and timing of ventriculoperitoneal (VP) shunt, related complications, emergence from and duration of posttraumatic amnesia (PTA), Rancho Los Amigos Scale (RLAS) score, and FIM score at rehabilitation admission and discharge. Results: Of 701 patients with TBI admitted, 59 (8%) were diagnosed with PTH. Of these, the median age was 25 years, with 73% being men. At initial presentation, 52 (88%) did not follow commands. Fifty-two (90%) patients with PTH had a VP shunt placed. Median time from injury to shunt placement was 69 (range, 9-366) days. Seven (12%) patients with PTH experienced postsurgical seizure, 3 (6%) had shunt infection, and 7 (12%) had shunt malfunction. Thirty-six (61%) patients with PTH emerged from PTA during rehabilitation. Median total FIM score at rehabilitation admission was 20 (range, 18-76), and at discharge it was 43 (range, 18-118). Injury severity predicted outcome at rehabilitation admission, whereas shunt timing predicted outcome at rehabilitation discharge. Conclusions: Incidence of PTH was observed in 8% of patients with TBI in inpatient rehabilitation. Earlier shunting predicted improved outcome during rehabilitation. Future studies should prospectively examine clinical decision rules, type, and timing of intervention and the coeffectiveness of rehabilitation treatment on outcomes. (C) 2016 by the American Congress of Rehabilitation Medicine	[Weintraub, Alan H.] CNS Med Grp, Englewood, CO USA; [Weintraub, Alan H.; Gerber, Donald J.; Kowalski, Robert G.] Craig Hosp, Res Dept, Englewood, CO USA		Weintraub, AH (corresponding author), Craig Hosp, 3425 S Clarkson St, Englewood, CO 80113 USA.	AWeintraub@CraigHospital.org			Craig Hospital Foundation	Supported by the Craig Hospital Foundation.	[Anonymous], 2011, Continuum (Minneap Minn), V17, P646, DOI 10.1212/01.CON.0000399079.30556.03; Bauer DF, 2011, NEUROSURGERY, V68, P85, DOI 10.1227/NEU.0b013e3181fd85f4; Chen Z, 2014, J REHABIL MED, V46, P876, DOI 10.2340/16501977-1856; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P1308, DOI 10.1016/j.clineuro.2012.12.011; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P49, DOI 10.1016/j.clineuro.2012.04.012; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Denes Z, 2010, IDEGGYOGY SZEMLE, V63, P397; Ding J, 2014, ARQ NEURO-PSIQUIAT, V72, P715, DOI 10.1590/0004-282X20140106; Exposito-Tirado JA, 2003, REV NEUROLOGIA, V36, P1126, DOI 10.33588/rn.3612.2002371; Ganesh S, 2013, ARCH PHYS MED REHAB, V94, P1899, DOI 10.1016/j.apmr.2012.12.026; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Guyot LL, 2000, NEUROL RES, V22, P25; Hakim S, 1965, J Neurol Sci, V2, P307, DOI 10.1016/0022-510X(65)90016-X; Honeybul S, 2014, INJURY, V45, P1332, DOI 10.1016/j.injury.2014.03.007; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Ishikawa M, 2010, NEUROL MED-CHIR, V50, P119, DOI 10.2176/nmc.50.119; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Kammersgaard LP, 2013, NEUROREHABILITATION, V33, P473, DOI 10.3233/NRE-130980; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Ki HJ, 2015, J KOREAN NEUROSURG S, V58, P254, DOI 10.3340/jkns.2015.58.3.254; Kiefer M, 2012, DTSCH ARZTEBL INT, V109, P15, DOI 10.3238/arztebl.2012.0015; Lesniak MS, 2002, BRIT J NEUROSURG, V16, P555; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Linnemann M, 2014, NEUROREHABILITATION, V35, P755, DOI 10.3233/NRE-141160; Long D., 2013, DIAGNOSIS MANAGEMENT; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Missori P, 2006, NEUROSURG REV, V29, P224, DOI 10.1007/s10143-006-0027-7; Muramatsu H, 2002, AM J PHYS MED REHAB, V81, P571, DOI 10.1097/00002060-200208000-00003; Osuka S, 2010, J NEUROSURG, V112, P832, DOI 10.3171/2009.7.JNS09550; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Piatt JH, 1996, NEUROSURGERY, V39, P722, DOI 10.1097/00006123-199610000-00014; Poca MA, 2005, J NEUROTRAUM, V22, P1303, DOI 10.1089/neu.2005.22.1303; Rekate HL, 2009, SEMIN PEDIATR NEUROL, V16, P9, DOI 10.1016/j.spen.2009.01.002; Seel RT, 2013, ARCH PHYS MED REHAB, V94, P1908, DOI 10.1016/j.apmr.2012.11.052; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; SELIGER G M, 1992, Brain Injury, V6, P71, DOI 10.3109/02699059209008125; SHEFFLER LR, 1994, ARCH PHYS MED REHAB, V75, P338, DOI 10.1016/0003-9993(94)90039-6; Silver B V, 1997, Pediatr Rehabil, V1, P123; Takeuchi S, 2013, J CLIN NEUROSCI, V20, P377, DOI 10.1016/j.jocn.2012.03.035; Tian HL, 2008, SURG NEUROL, V69, P241, DOI 10.1016/j.surneu.2007.02.032; Torbic H, 2013, AM J HEALTH-SYST PH, V70, P759, DOI 10.2146/ajhp120203; Tribl G, 2000, BRAIN INJURY, V14, P345; VANNESTE J, 1992, ARCH NEUROL-CHICAGO, V49, P366, DOI 10.1001/archneur.1992.00530280046021; Wen L, 2009, BRAIN INJURY, V23, P61, DOI 10.1080/02699050802635265; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1851, DOI 10.1016/j.apmr.2013.07.003; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1877, DOI 10.1016/j.apmr.2012.12.027; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041	48	23	24	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2017	98	2					312	319		10.1016/j.apmr.2016.08.478			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	EK4XB	WOS:000393930100015	27670926				2022-02-06	
J	Zaccaria, L; Tharakan, SJ; Altermatt, S				Zaccaria, Laura; Tharakan, Sasha Job; Altermatt, Stefan			Hydroxyapatite ceramic implants for cranioplasty in children: a single-center experience	CHILDS NERVOUS SYSTEM			English	Article						Pediatric; Hydroxyapatite; Cranioplasty; Hounsfield unit; Osteointegration	TRAUMATIC BRAIN-INJURY; AUTOLOGOUS BONE FLAP; DECOMPRESSIVE CRANIECTOMY; CRANIAL REPAIR; COMPLICATIONS; PROSTHESES; DEFECT; OLD	Purpose The use of hydroxyapatite ceramic (HAC) implants for the treatment of skull defects in pediatric patients started 2010 at our institution. Ceramic implants facilitate osteoblast migration and therefore optimize osteointegration with the host bone. The purpose of this study is to report a single-center experience with this treatment modality. Methods A retrospective review of all patients from July 2010 through June 2014 undergoing a cranioplasty using hydroxyapatite ceramic implant and managed at a single institution was performed. Indication for cranioplasty, the hospital course, and follow-up were reviewed. Bone density was measured in Hounsfield Units (HU) and osteointegration was calculated using Mimics Software (R) (Mimics Innovation Suite v17.0 Medical, Materialize, Leuven, Belgium). Results Over the 4-year period, six patients met criteria for the study. Five patients had an osteointegration of nearly 100%. One patient had an incomplete osteointegration with a total bone-implant contact area of 69%. The mean bone density was 2800 HU (2300-3000 HU). Bone density alone is estimated to have a Hounsfield value between 400 and 2000 HU depending on the body region and bone quality. There were no major complications, and the patients were highly satisfied with the esthetical result. Conclusion Hydroxyapatite ceramic implants for cranioplasty in pediatric patients are a good choice for different indications. The implants show excellent osteointegration and esthetical results.	[Zaccaria, Laura] Univ Childrens Hosp, Dept Pediat Surg, Bern, Switzerland; [Tharakan, Sasha Job; Altermatt, Stefan] Univ Childrens Hosp Zurich, Dept Pediat Surg, Steinwiesstr 75, CH-8032 Zurich, Switzerland		Altermatt, S (corresponding author), Univ Childrens Hosp Zurich, Dept Pediat Surg, Steinwiesstr 75, CH-8032 Zurich, Switzerland.	stefan.altermatt@kispi.uzh.ch					Agner C, 2003, MINIM INVAS NEUROSUR, V46, P186; Appelboom G, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.8.FOCUS11177; Bibb R, 2015, MED MODELLING APPL A, P8; Brevi BC, 2010, J PEDIATR SURG, V45, pE17, DOI 10.1016/j.jpedsurg.2010.01.011; Chen TM, 2002, ANN PEDIAT SURG, V49; D'Urso PS, 2000, BRIT J PLAST SURG, V53, P200, DOI 10.1054/bjps.1999.3268; De Bonis P, 2012, J NEUROTRAUM, V29, P1071, DOI 10.1089/neu.2011.2116; Della Puppa A, 2010, ACTA NEUROCHIR, V152, P155, DOI 10.1007/s00701-009-0374-6; Di Rienzo A., 2012, SURG NEOROLOGY INT, V3, P161; El Ghoul W, 2014, BR J NEUROSURG EARLY, P1; Eppley BL, 2005, J CRANIOFAC SURG, V16, P140, DOI 10.1097/00001665-200501000-00028; Frassanito P, 2015, ACTA NEUROCHIR, V157, P115, DOI 10.1007/s00701-014-2254-y; Frassanito P, 2013, CLIN NEUROL NEUROSUR, V115, P1496, DOI 10.1016/j.clineuro.2012.11.032; Frassanito P, 2012, ACTA NEUROCHIR, V154, P927, DOI 10.1007/s00701-011-1253-5; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Lee SC, 2009, J CLIN NEUROSCI, V16, P56, DOI 10.1016/j.jocn.2008.04.001; Lemee JM, 2013, NEUROCHIRURGIE, V59, P60, DOI 10.1016/j.neuchi.2012.10.138; Martin KD, 2014, ACTA NEUROCHIR, V156, P813, DOI 10.1007/s00701-014-2021-0; Martini L, 2012, PLAST RECONSTR SURG, V129, p625E, DOI 10.1097/PRS.0b013e318244220d; Pechmann A, 2015, NEUROPEDIATRICS, V46, P5, DOI 10.1055/s-0034-1393707; Perlyn CA, 2005, PLAST RECONSTR SURG, V115, P1129, DOI 10.1097/01.PRS.0000156217.33683.2B; Rocque BG, 2013, J NEUROSURG-PEDIATR, V12, P120, DOI 10.3171/2013.4.PEDS12605; Shah AM, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.2.FOCUS13561; Staffa G, 2007, ACTA NEUROCHIR, V149, P161, DOI 10.1007/s00701-006-1078-9; Staffa G, 2012, J CRANIO MAXILL SURG, V40, pE65, DOI 10.1016/j.jcms.2011.04.014; Stefini Roberto, 2013, Surg Neurol Int, V4, P12, DOI 10.4103/2152-7806.106290; Wehrli LA, 2012, EUR J PEDIATR SURG, V22, P479, DOI 10.1055/s-0032-1313349; Zins JE, 2007, PLAST RECONSTR SURG, V120, P1332, DOI 10.1097/01.prs.0000279557.29134.cd	28	23	24	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	FEB	2017	33	2					343	348		10.1007/s00381-016-3327-4			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	EO7XT	WOS:000396904100022	28013335				2022-02-06	
J	MacManus, DB; Pierrat, B; Murphy, JG; Gilchrist, MD				MacManus, David B.; Pierrat, Baptiste; Murphy, Jeremiah G.; Gilchrist, Michael D.			A viscoelastic analysis of the P56 mouse brain under large-deformation dynamic indentation	ACTA BIOMATERIALIA			English	Article						Traumatic brain injury; Prony; Dynamic modulus; Damping ratio; neo-Hookean	MECHANICAL CHARACTERIZATION; IN-VIVO; TISSUE; HEAD; SHEAR; EPIDEMIOLOGY; VALIDATION; MODELS	The brain is a complex organ made up of many different functional and structural regions consisting of different types of cells such as neurons and glia, as well as complex anatomical geometries. It is hypothesized that the different regions of the brain exhibit significantly different mechanical properties which may be attributed to the diversity of cells within individual brain regions. The regional viscoelastic properties of P56 mouse brain tissue, up to 70 mu m displacement, are presented and discussed in the context of traumatic brain injury, particularly how the different regions of the brain respond to mechanical loads. Force-relaxation data obtained from micro-indentation measurements were fit to both linear and quasi-linear viscoelastic models to determine the time and frequency domain viscoelastic response of the pons, cortex, medulla oblongata, cerebellum, and thalamus. The damping ratio of each region was also determined. Each region was found to have a unique mechanical response to the applied displacement, with the pons and thalamus exhibiting the largest and smallest force-response, respectively. All brain regions appear to have an optimal frequency for the dissipation of energies which lies between 1 and 10 Hz. Statement of significance We present the first mechanical characterization of the viscoelastic response for different regions of mouse brain. Force-relaxation tests are performed under large strain dynamic micro-indentation, and viscoelastic models are used subsequently, providing time-dependent mechanical properties of brain tissue under loading conditions comparable to what is experienced in TBI. The unique mechanical properties of different brain regions are highlighted, with substantial variations in the viscoelastic properties and damping ratio of each region. Cortex and pons were the stiffest regions, while the thalamus and medulla were most compliant. The cerebellum and thalamus had highest damping ratio values and those of the medulla were lowest. The reported material parameters can be implemented into finite element computer models of the mouse to investigate the effects of trauma on individual brain regions. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[MacManus, David B.; Pierrat, Baptiste; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland; [Murphy, Jeremiah G.] Dublin City Univ, Dept Mech & Mfg Engn, Dublin, Ireland		Gilchrist, MD (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland.	david.mac-manus@ucdconnect.ie; baptiste.pierrat@emse.fr; jeremiah.murphy@dcu.ie; michael.gilchrist@ucd.ie		Pierrat, Baptiste/0000-0001-8064-8496; MacManus, David/0000-0003-2959-698X	Science Foundation IrelandScience Foundation IrelandEuropean Commission [12/IP/1732]	This work was supported by Science Foundation Ireland (Grant No. 12/IP/1732).	Antona-Makoshi J., 2012, IRCOBI C, P441; Atkin R. J., 2005, INTRO THEORY ELASTIC, P79; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Bernick K.B., 2010, 27 ARM SCI C ASC ORL; Bilston L.E., 2016, STRUCTURE BASED MECH, P1, DOI [DOI 10.1007/978-1-4899-7630-7, 10.1007/978-1-4899-7630-7]; Bilston LE, 1997, BIORHEOLOGY, V34, P377, DOI 10.1016/S0006-355X(98)00022-5; Chen FQ, 2015, ANN BIOMED ENG, V43, P2903, DOI 10.1007/s10439-015-1350-3; Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070; Cullen DK, 2006, J NEUROTRAUM, V23, P1304, DOI 10.1089/neu.2006.23.1304; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Elkin BS, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025386; Elkin BS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004494; England M. A., 1996, COLOUR ATLAS BRAIN S, P10; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferrer I, 2007, J NEUROPATH EXP NEUR, V66, P35, DOI 10.1097/nen.0b013e31802c3e7d; Finan JD, 2012, ANN BIOMED ENG, V40, P70, DOI 10.1007/s10439-011-0394-2; Fountoulakis M, 2001, EXP NEUROL, V167, P86, DOI 10.1006/exnr.2000.7529; Gilchrist MD, 2003, KEY ENG MATER, V245-2, P417, DOI 10.4028/www.scientific.net/KEM.245-246.417; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki T.B., 2014, NEUROSURGERY, V75; Howard MA, 1999, IEEE T BIO-MED ENG, V46, P891, DOI 10.1109/10.771205; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Jiang Y, 2015, BIOMECH MODEL MECHAN, V14, P1119, DOI 10.1007/s10237-015-0658-0; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; Libertiaux V, 2011, J MECH BEHAV BIOMED, V4, P1177, DOI 10.1016/j.jmbbm.2011.03.028; Lin DC, 2009, BIOMECH MODEL MECHAN, V8, P345, DOI 10.1007/s10237-008-0139-9; MacManus DB, 2015, J BIOMECH, V48, P3213, DOI 10.1016/j.jbiomech.2015.06.028; MacManus DB, 2016, SCI REP-UK, V6, DOI 10.1038/srep21569; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Menard H.P., 2008, DYNAMIC MECH ANAL PR, P151; Pervin F, 2011, NEUROIMAGE, V54, pS98, DOI 10.1016/j.neuroimage.2010.03.077; PHARR GM, 1992, J MATER RES, V7, P613, DOI 10.1557/JMR.1992.0613; Prevost TP, 2011, ACTA BIOMATER, V7, P4090, DOI 10.1016/j.actbio.2011.06.032; Puso MA, 1998, J BIOMECH ENG-T ASME, V120, P62, DOI 10.1115/1.2834308; Rashid B, 2013, J MECH BEHAV BIOMED, V28, P71, DOI 10.1016/j.jmbbm.2013.07.017; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Urbanczyk CA, 2015, ULTRASOUND MED BIOL, V41, P713, DOI 10.1016/j.ultrasmedbio.2014.10.019; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; Wang TW, 2009, ACTA BIOMATER, V5, P2371, DOI 10.1016/j.actbio.2009.03.033; Willinger R, 1999, CR ACAD SCI II B, V327, P125, DOI 10.1016/S1287-4620(99)80021-0; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang J, 2011, J BIOMECH, V44, P1909, DOI 10.1016/j.jbiomech.2011.04.034; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang MG, 2014, J APPL MECH-T ASME, V81, DOI 10.1115/1.4027973	50	23	24	0	20	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	JAN 15	2017	48						309	318		10.1016/j.actbio.2016.10.029			10	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	EJ5GY	WOS:000393247000026	27777117				2022-02-06	
J	Churchill, NW; Hutchison, MG; Graham, SJ; Schweizer, TA				Churchill, Nathan W.; Hutchison, Michael G.; Graham, Simon J.; Schweizer, Tom A.			Symptom correlates of cerebral blood flow following acute concussion	NEUROIMAGE-CLINICAL			English	Article						Sport concussion; Cerebral blood flow; ASL; Symptoms	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; PERFUSION; RECOVERY; FMRI; TIME	Concussion is associated with significant symptoms within hours to days post-injury, including disturbances in physical function, cognition, sleep and emotion. However, little is known about how subjective impairments correlate with objective measures of cerebrovascular function following brain injury. This study examined the relationship between symptoms and cerebral blood flow (CBF) in individuals following sport-related concussion. Seventy university level athletes had CBF measured using Arterial Spin Labelling (ASL), including 35 with acute concussion and 35 matched controls and their symptoms were assessed using the Sport Concussion Assessment Tool 3 (SCAT3). For concussed athletes, greater total symptom severity was associated with elevated posterior cortical CBF, although mean CBF was not significantly different from matched controls (p = 0.46). Examining symptom clusters, athletes reporting greater cognitive symptoms also had lower frontal and subcortical CBF, relative to athletes with greater somatic symptoms. The "cognitive" and "somatic" subgroups also exhibited significant differences in CBF relative to controls (p <= 0.026). This study demonstrates objective CBF correlates of symptoms in recently concussed athletes and shows that specific symptom clusters may have distinct patterns of altered CBF, significantly extending our understanding of the neurobiology of concussion and traumatic brain injury.	[Churchill, Nathan W.; Schweizer, Tom A.] St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada; [Churchill, Nathan W.; Hutchison, Michael G.; Schweizer, Tom A.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Graham, Simon J.] Univ Toronto, Sunnybrook Hosp, Dept Med Biophys, Toronto, ON, Canada; [Graham, Simon J.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Phys Sci Platform, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Fac Med Neurosurg, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Inst Biomat & Biomed Engn IBBME, Toronto, ON, Canada		Churchill, NW (corresponding author), St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada.; Churchill, NW (corresponding author), St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada.	ChurchillN@smh.ca; michael.hutchison@utoronto.ca; sgraham@sri.utoronto.ca; schweizert@smh.ca			Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [RN294001-367456]; Defence Research and Development Canada (DRDC); Canadian Institutes of Military and Veterans Health (CIMVHR) [W7714-145967]; Siemens Canada Ltd.	This work was supported by the Canadian Institutes of Health Research (CIHR) [grant number RN294001-367456]; the Defence Research and Development Canada (DRDC) and the Canadian Institutes of Military and Veterans Health (CIMVHR) [grant number W7714-145967]; and pilot funding from Siemens Canada Ltd.	Barlow K. M., 2016, J NEUROTRAUMA; Becelewski J., 2002, NEUROL NEUROCHIR POL, V37, P339; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Di Battista AP, 2016, SHOCK, V46, P96, DOI 10.1097/SHK.0000000000000642; Di Battista AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159929; Fassbender K, 2001, J NEUROL NEUROSUR PS, V70, P534, DOI 10.1136/jnnp.70.4.534; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Hanninen T, 2017, J SCI MED SPORT, V20, P424, DOI 10.1016/j.jsams.2016.09.009; Hutchison MG, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000252; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Lane RD, 1998, J COGNITIVE NEUROSCI, V10, P525, DOI 10.1162/089892998562924; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Lin CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149109; Marchal G, 1996, BRAIN, V119, P409, DOI 10.1093/brain/119.2.409; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Wang Y, 2015, J NEUROTRAUMA	33	23	25	2	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2017	16						234	239		10.1016/j.nicl.2017.07.019			6	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FK1IU	WOS:000413235100025	28794982	gold, Green Published			2022-02-06	
J	Kaneko, Y; Pappas, C; Malapira, T; Vale, FL; Tajiri, N; Borlongan, CV				Kaneko, Yuji; Pappas, Colleen; Malapira, Teresita; Vale, Fernando L.; Tajiri, Naoki; Borlongan, Cesar V.			Extracellular HMGB1 Modulates Glutamate Metabolism Associated with Kainic Acid Induced Epilepsy-Like Hyperactivity in Primary Rat Neural Cells	CELLULAR PHYSIOLOGY AND BIOCHEMISTRY			English	Article						Epilepsy; HMGB1; Kainic acid; Primary rat neural cells; Glutamate; GABA	MOBILITY GROUP BOX-1; TRAUMATIC BRAIN-INJURY; RECEPTOR 4; IN-VITRO; PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; P-GLYCOPROTEIN; PROTEIN HMGB1; UP-REGULATION; MOUSE MODEL	Background/Aims: Neuroinflammatory processes have been implicated in the pathophysiology of seizure/epilepsy. High mobility group box 1 (HMGB1), a non-histone DNA binding protein, behaves like an inflammatory cytokine in response to epileptogenic insults. Kainic acid (KA) is an excitotoxic reagent commonly used to induce epilepsy in rodents. However, the molecular mechanism by which KA-induced HMGB1 affords the initiation of epilepsy, especially the role of extracellular HMGB1 in neurotransmitter expression, remains to be elucidated. Methods: Experimental early stage of epilepsy-related hyperexcitability was induced in primary rat neural cells (PRNCs) by KA administration. We measured the localization of HMGB1, cell viability, mitochondrial activity, and expression level of glutamate metabolism-associated enzymes. Results: KA induced the translocation of HMGB1 from nucleus to cytosol, and its release from the neural cells. The translocation is associated with post-translational modifications. An increase in extracellular HMGB1 decreased PRNC cell viability and mitochondrial activity, downregulated expression of glutamate decarboxylase67 (GAD67) and glutamate dehydrogenase (GLUD1/2), and increased intracellular glutamate concentration and major histocompatibility complex II (MHC II) level. Conclusions: That a surge in extracellular HMGB1 approximated seizure initiation suggests a key pathophysiological contribution of HMGB1 to the onset of epilepsy-related hyperexcitability. (C) 2017 The Author(s)	[Kaneko, Yuji; Malapira, Teresita; Vale, Fernando L.; Tajiri, Naoki; Borlongan, Cesar V.] Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain, 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA; [Pappas, Colleen] Univ S Florida, Sch Aging Studies, Tampa, FL USA		Kaneko, Y; Borlongan, CV (corresponding author), Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain, 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.	ykaneko@health.usf.edu; cborlong@health.usf.edu		Pappas, Colleen/0000-0001-9140-3558	USF ORI [HSC-18330, COM HSC-18300]; NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RO1 1R01NS071956-01]; USF Department of Neurosurgery and Brain Repair Funds	This work was supported by USF OR&I HSC-18330 & COM HSC-18300 (YK), NIH NINDS RO1 1R01NS071956-01 (CVB), and USF Department of Neurosurgery and Brain Repair Funds (CVB). YK and CVB contributed to study design. YK, CP, NT, and CVB contributed to data acquisition. YK, CP, TM, FV, NT, and CVB wrote the manuscript.	Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Alexopoulou Z, 2016, P NATL ACAD SCI USA, V113, pE4688, DOI 10.1073/pnas.1523597113; Bauer B, 2008, MOL PHARMACOL, V73, P1444, DOI 10.1124/mol.107.041210; BAXEVANIS AD, 1995, NUCLEIC ACIDS RES, V23, P1604, DOI 10.1093/nar/23.9.1604; Bell E, 2003, DIABETES, V52, P2731, DOI 10.2337/diabetes.52.11.2731; Bialer M, 2010, NAT REV DRUG DISCOV, V9, P68, DOI 10.1038/nrd2997; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Cendes F, 2012, NAT REV NEUROL, V8, P70, DOI 10.1038/nrneurol.2011.223; Chen Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140918; Chen ZA, 2015, CELL PHYSIOL BIOCHEM, V37, P1379, DOI 10.1159/000430403; Cheng YJ, 2015, CELL PHYSIOL BIOCHEM, V36, P1577, DOI 10.1159/000430320; Choi JS, 2003, MOL BRAIN RES, V119, P10, DOI 10.1016/j.molbrainres.2003.08.010; DIMOV SI, 1990, BIOCHEM BIOPH RES CO, V166, P819, DOI 10.1016/0006-291X(90)90883-O; Evankovich J, 2010, J BIOL CHEM, V285, P39888, DOI 10.1074/jbc.M110.128348; Fang P, 2012, MOL NEUROBIOL, V45, P499, DOI 10.1007/s12035-012-8264-y; Fenalti G, 2007, NAT STRUCT MOL BIOL, V14, P280, DOI 10.1038/nsmb1228; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Grahenstatter HL, 2008, EPILEPSIA, V49, P1787; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; Hwang JS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15971; Kaneko Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep35659; Kaneko Y, 2016, MOL NEUROBIOL, V53, P1874, DOI 10.1007/s12035-015-9126-1; Kaneko Y, 2014, CNS NEUROSCI THER, V20, P275, DOI 10.1111/cns.12208; Kash SF, 1999, P NATL ACAD SCI USA, V96, P1698, DOI 10.1073/pnas.96.4.1698; Kass I, 2014, P NATL ACAD SCI USA, V111, pE2524, DOI 10.1073/pnas.1403182111; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; KIMURA K, 1985, BIOCHEM J, V227, P271, DOI 10.1042/bj2270271; Kleen JK, 2010, NAT MED, V16, P369, DOI 10.1038/nm0410-369; Kuo MF, 2002, PEDIATR NEUROL, V26, P146, DOI 10.1016/S0887-8994(01)00357-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li XF, 2016, CELL PHYSIOL BIOCHEM, V39, P1850, DOI 10.1159/000447884; Liu JB, 2016, CELL PHYSIOL BIOCHEM, V40, P847, DOI 10.1159/000453144; Liu Y, 2015, J NEUROSCI, V35, P11514, DOI 10.1523/JNEUROSCI.5288-14.2015; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Lu B, 2014, P NATL ACAD SCI USA, V111, P3068, DOI 10.1073/pnas.1316925111; Luo L, 2014, CELL MOL NEUROBIOL, V34, P987, DOI 10.1007/s10571-014-0075-4; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Mazarati A, 2011, EXP NEUROL, V232, P143, DOI 10.1016/j.expneurol.2011.08.012; Min SW, 2015, NAT MED, V21, P1154, DOI 10.1038/nm.3951; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Papageorgiou IE, 2011, GLIA, V59, P1706, DOI 10.1002/glia.21217; Sada N, 2015, SCIENCE, V347, P1362, DOI 10.1126/science.aaa1299; Sasaki T, 2016, EXP NEUROL, V275, P220, DOI 10.1016/j.expneurol.2015.11.003; Segref A, 2009, EMBO REP, V10, P44, DOI 10.1038/embor.2008.229; Tang DL, 2007, J IMMUNOL, V179, P1236, DOI 10.4049/jimmunol.179.2.1236; van Vliet EA, 2006, EPILEPSIA, V47, P672, DOI 10.1111/j.1528-1167.2006.00496.x; VanGuilder HD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-138; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang JC, 2015, CELL PHYSIOL BIOCHEM, V35, P767, DOI 10.1159/000369736; Yang WS, 2016, CELL PHYSIOL BIOCHEM, V38, P2139, DOI 10.1159/000445570; Yang WS, 2015, CELL PHYSIOL BIOCHEM, V35, P2309, DOI 10.1159/000374034; Yasuhara T, 2013, INT J MOL SCI, V14, P23390, DOI 10.3390/ijms141223390; Youn JH, 2006, J IMMUNOL, V177, P7889, DOI 10.4049/jimmunol.177.11.7889; Yu Y, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00093; Zsurka G, 2015, LANCET NEUROL, V14, P956, DOI 10.1016/S1474-4422(15)00148-9	55	23	25	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-8987	1421-9778		CELL PHYSIOL BIOCHEM	Cell. Physiol. Biochem.		2017	41	3					947	959		10.1159/000460513			13	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	EU3GB	WOS:000400915500008	28222432	gold			2022-02-06	
J	Nardone, R; Holler, Y; Langthaler, PB; Lochner, P; Golaszewski, S; Schwenker, K; Brigo, F; Trinka, E				Nardone, R.; Hoeller, Y.; Langthaler, P. B.; Lochner, P.; Golaszewski, S.; Schwenker, K.; Brigo, F.; Trinka, E.			rTMS of the prefrontal cortex has analgesic effects on neuropathic pain in subjects with spinal cord injury	SPINAL CORD			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; BRAIN ANATOMY; BACK-PAIN; DEPRESSION; MODULATION; MECHANISMS; DEPENDS; DISEASE; PLACEBO; SESSION	Study design: Repetitive transcranial magnetic stimulation study. Objectives: The analgesic effects of repetitive transcranial magnetic stimulation (rTMS) in chronic pain have been the focus of several studies. In particular, rTMS of the premotor cortex/dorsolateral prefrontal cortex (PMC/DLPFC) changes pain perception in healthy subjects and has analgesic effects in acute postoperative pain, as well as in fibromyalgia patients. However, its effect on neuropathic pain in patients with traumatic spinal cord injury (SCI) has not been assessed. Setting: Merano (Italy) and Salzburg (Austria). Methods: In this study, we performed PMC/DLPFC rTMS in subjects with SCI and neuropathic pain. Twelve subjects with chronic cervical or thoracic SCI were randomized to receive 1250 pulses at 10 Hz rTMS (n=6) or sham rTMS (n=6) treatment for 10 sessions over 2 weeks. The visual analog scale, the sensory and affective pain rating indices of the McGill Pain Questionnaire (MPQ), the Hamilton Depression Rating Scale and the Hamilton Anxiety Rating Scale were used to assed pain and mood at baseline (T0), 1 day after the first week of treatment (T1), 1 day (T2), 1 week (T3) and 1 month (T4) after the last intervention. Results: Subjects who received active rTMS had a statistically significant reduction in pain symptoms in comparison with their baseline pain, whereas sham rTMS participants had a non-significant change in daily pain from their baseline pain. Conclusion: The findings of this preliminary study in a small patient sample suggest that rTMS of the PMC/DLPFC may be effective in relieving neuropathic pain in SCI patients.	[Nardone, R.; Hoeller, Y.; Langthaler, P. B.; Golaszewski, S.; Schwenker, K.; Trinka, E.] Paracelsus Med Univ, Christian Doppler Klin, Dept Neurol, Salzburg, Austria; [Nardone, R.; Hoeller, Y.; Langthaler, P. B.; Golaszewski, S.; Schwenker, K.; Trinka, E.] Ctr Cognit Neurosci, Salzburg, Austria; [Nardone, R.; Lochner, P.; Brigo, F.] Franz Tappeiner Hosp, Dept Neurol, Merano, Italy; [Nardone, R.; Hoeller, Y.; Langthaler, P. B.; Golaszewski, S.; Schwenker, K.; Trinka, E.] Paracelsus Med Univ, Spinal Cord Injury & Tissue Regenerat Ctr, Salzburg, Austria; [Langthaler, P. B.] Paris Lodron Univ Salzburg, Dept Math, Salzburg, Austria; [Brigo, F.] Univ Verona, Dept Neurol & Movement Sci, Verona, Italy		Nardone, R (corresponding author), Franz Tappeiner Hosp, Dept Neurol, Via Rossini,5, I-39012 Merano, Italy.	raffaele.nardone@asbmeran-o.it	Lochner, Piergiorgio/AAB-6784-2020; Holler, Yvonne/I-8928-2017; Brigo, Francesco/H-6513-2013	Lochner, Piergiorgio/0000-0002-2101-6066; Holler, Yvonne/0000-0002-1727-8557; Nardone, Raffaele/0000-0001-5243-6760; Brigo, Francesco/0000-0003-0928-1577			Ahdab R, 2010, NEUROPHYSIOL CLIN, V40, P27, DOI 10.1016/j.neucli.2010.01.001; Andre-Obadia N, 2008, NEUROLOGY, V71, P833, DOI 10.1212/01.wnl.0000325481.61471.f0; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Avery DH, 2007, J NERV MENT DIS, V195, P378, DOI 10.1097/NMD.0b013e31802f58d1; de Oliveira RAA, 2014, J PAIN, V15, P1271, DOI 10.1016/j.jpain.2014.09.009; Baron R, 1999, NEUROLOGY, V53, P548, DOI 10.1212/WNL.53.3.548; Boggio PS, 2005, MOVEMENT DISORD, V20, P1178, DOI 10.1002/mds.20508; Borckardt JJ, 2011, PAIN, V152, P182, DOI 10.1016/j.pain.2010.10.018; Borckardt JJ, 2008, BRAIN STIMUL, V1, P122, DOI 10.1016/j.brs.2008.04.002; Brighina F, 2011, J HEADACHE PAIN, V12, P185, DOI 10.1007/s10194-011-0322-8; Chouinard PA, 2003, J NEUROPHYSIOL, V90, P1071, DOI 10.1152/jn.01105.2002; de Andrade DC, 2014, PAIN, V155, P598, DOI 10.1016/j.pain.2013.12.022; Defrin R, 2007, ARCH PHYS MED REHAB, V88, P1574, DOI 10.1016/j.apmr.2007.07.025; Dersh J, 2002, PSYCHOSOM MED, V64, P773, DOI 10.1097/01.PSY.0000024232.11538.54; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; Fierro B, 2010, EXP BRAIN RES, V203, P31, DOI 10.1007/s00221-010-2206-6; Fitzgerald PB, 2009, BRAIN STIMUL, V2, P234, DOI 10.1016/j.brs.2009.03.002; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; GEORGE MS, 1994, CONVULSIVE THER, V10, P251; Gustin SM, 2010, CEREB CORTEX, V20, P1409, DOI 10.1093/cercor/bhp205; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; HARDY SGP, 1985, BRAIN RES, V339, P285; HARDY SGP, 1985, BRAIN RES, V339, P281; Jette F, 2013, NEUROREHAB NEURAL RE, V27, P636, DOI 10.1177/1545968313484810; Kang BS, 2009, ARCH PHYS MED REHAB, V90, P1766, DOI 10.1016/j.apmr.2009.04.008; Klein MM, 2015, PAIN, V156, P1601, DOI 10.1097/j.pain.0000000000000210; Lefaucheur JP, 2014, CLIN NEUROPHYSIOL, V125, P2150, DOI 10.1016/j.clinph.2014.05.021; Lefaucheur JP, 2009, BRAIN STIMUL, V2, P138, DOI 10.1016/j.brs.2009.01.002; Lefaucheur JP, 2004, J NEUROL NEUROSUR PS, V75, P612, DOI 10.1136/jnnp.2003.022236; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Loubinoux I, 2012, J CELL MOL MED, V16, P1961, DOI 10.1111/j.1582-4934.2012.01555.x; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nahmias F, 2009, PAIN, V147, P224, DOI 10.1016/j.pain.2009.09.016; Noguchi K, 2012, J STAT SOFTW, V50, P1, DOI 10.18637/jss.v050.i12; Obermann M, 2013, NEUROIMAGE, V74, P352, DOI 10.1016/j.neuroimage.2013.02.029; Paus T, 2001, EUR J NEUROSCI, V14, P1405, DOI 10.1046/j.0953-816x.2001.01757.x; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Pincus T, 1999, J PSYCHOSOM RES, V47, P211, DOI 10.1016/S0022-3999(99)00045-8; PRICE DD, 1988, PAIN, V34, P245, DOI 10.1016/0304-3959(88)90119-4; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; Rumi DO, 2005, BIOL PSYCHIAT, V57, P162, DOI 10.1016/j.biopsych.2004.10.029; Schweinhardt P, 2008, NEUROIMAGE, V40, P759, DOI 10.1016/j.neuroimage.2007.12.016; Seminowicz DA, 2011, J NEUROSCI, V31, P7540, DOI 10.1523/JNEUROSCI.5280-10.2011; Short EB, 2011, PAIN, V152, P2477, DOI 10.1016/j.pain.2011.05.033; Stanwell P, 2010, NEUROIMAGE, V53, P544, DOI 10.1016/j.neuroimage.2010.06.051; Strafella AP, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-15-j0003.2001; Tazoe T, 2015, ARCH PHYS MED REHAB, V96, pS145, DOI 10.1016/j.apmr.2014.07.418; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Yilmaz B, 2014, J SPINAL CORD MED, V37, P397, DOI 10.1179/2045772313Y.0000000172; Yoon EJ, 2013, BRAIN RES, V1540, P64, DOI 10.1016/j.brainres.2013.10.007	54	23	28	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	JAN	2017	55	1					20	25		10.1038/sc.2016.87			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EK9XA	WOS:000394276000004	27241450	Bronze			2022-02-06	
J	Sawyer, RJ; Testa, SM; Dux, M				Sawyer, R. John, II; Testa, S. Marc; Dux, Moira			Embedded performance validity tests within the Hopkins Verbal Learning Test - Revised and the Brief Visuospatial Memory Test - Revised	CLINICAL NEUROPSYCHOLOGIST			English	Article						Embedded performance validity tests (PVTs); sensitivity and specificity; veterans; HVLT; BVMT	TRAUMATIC BRAIN-INJURY; RESPONSE BIAS; BASE RATES; TEST-II; NEUROPSYCHOLOGICAL EVALUATION; CLINICAL NEUROPSYCHOLOGY; INCOMPLETE EFFORT; AMERICAN ACADEMY; CROSS-VALIDATION; NORMATIVE DATA	Objective: Various research studies and neuropsychology practice organizations have reiterated the importance of developing embedded performance validity tests (PVTs) to detect potentially invalid neurocognitive test data. This study investigated whether measures within the Hopkins Verbal Learning Test - Revised (HVLT-R) and the Brief Visuospatial Memory Test - Revised (BVMT-R) could accurately classify individuals who fail two or more PVTs during routine clinical assessment. Method: The present sample of 109 United States military veterans (Mean age=52.4, SD=13.3), all consisted of clinically referred patients and received a battery of neuropsychological tests. Based on performance validity findings, veterans were assigned to valid (n=86) or invalid (n=23) groups. Of the 109 patients in the overall sample, 77 were administered the HLVT-R and 75 were administered the BVMT-R, which were examined for classification accuracy. Results: The HVLT-R Recognition Discrimination Index and the BVMT-R Retention Percentage showed good to adequate discrimination with an area under the curve of .78 and .70, respectively. The HVLT-R Recognition Discrimination Index showed sensitivity of .53 with specificity of .93. The BVMT-R Retention Percentage demonstrated sensitivity of .31 with specificity of .92. Conclusions: When used in conjunction with other PVTs, these new embedded PVTs may be effective in the detection of invalid test data, although they are not intended for use in patients with dementia.	[Sawyer, R. John, II; Dux, Moira] Baltimore Vet Affairs Med Ctr, Baltimore, MD 21201 USA; [Testa, S. Marc] Sinai Hosp, Berman Brain & Spine Inst, 2401 W Belvedere Ave, Baltimore, MD 21215 USA; [Sawyer, R. John, II] Ochnser Hlth Syst, New Orleans, LA 70121 USA		Sawyer, RJ (corresponding author), Baltimore Vet Affairs Med Ctr, Baltimore, MD 21201 USA.; Sawyer, RJ (corresponding author), Ochnser Hlth Syst, New Orleans, LA 70121 USA.	robert.sawyer@ochsner.org					Ardolf BR, 2007, CLIN NEUROPSYCHOL, V21, P899, DOI 10.1080/13825580600966391; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Arnold G., 2007, ASSESSMENT FEIGNED C, P178; Axelrod BN, 2010, CLIN NEUROPSYCHOL, V24, P873, DOI 10.1080/13854040903527295; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; BABIKIAN T, 2007, ASSESSMENT FEIGNED C, P00103; Barr W. B., 2008, NAT AC NEUR NEW YORK; Bauer L, 2005, APPL NEUROPSYCHOL, V12, P202, DOI 10.1207/s15324826an1204_3; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Boone, 2007, ASSESSMENT FEIGNED C, P152; Boone K. B., 2002, DOT COUNTING TEST MA; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bortnik KE, 2010, CLIN NEUROPSYCHOL, V24, P344, DOI 10.1080/13854040903307268; Brandt J., 1991, HOPKINS VERBAL LEARN; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Chafetz MD, 2008, CLIN NEUROPSYCHOL, V22, P529, DOI 10.1080/13854040701346104; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P1224, DOI 10.1080/13854046.2014.987167; Davis JJ, 2012, CLIN NEUROPSYCHOL, V26, P1397, DOI 10.1080/13854046.2012.728627; DeRight J, 2015, CHILD NEUROPSYCHOL, V21, P1, DOI 10.1080/09297049.2013.864383; Goldberg H.E., 2007, ASSESSMENT FEIGNED C, P281; Green P., 2003, WORD MEMORY TEST WIN; Green P, 2004, GREENS MED SYMPTOM V; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Horwitz JE, 2006, APPL NEUROPSYCHOL, V13, P175, DOI 10.1207/s15324826an1303_5; Inman TH, 2002, ARCH CLIN NEUROPSYCH, V17, P1, DOI 10.1016/S0887-6177(00)00073-1; Jones R. G., 2012, NAT AC NEURO NASHV; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Lu P. H., 2007, ASSESSMENT FEIGNED C, P128; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Novitski J, 2012, ARCH CLIN NEUROPSYCH, V27, P190, DOI 10.1093/arclin/acr119; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Reedy SD, 2013, ARCH CLIN NEUROPSYCH, V28, P30, DOI 10.1093/arclin/acs106; Schroeder RW, 2011, CLIN NEUROPSYCHOL, V25, P437, DOI 10.1080/13854046.2011.556668; Schutte C., 2013, MILD TRAUMATIC BRAIN, P159; Schutte C, 2011, CLIN NEUROPSYCHOL, V25, P454, DOI 10.1080/13854046.2010.550635; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Sweet JJ, 2015, CLIN NEUROPSYCHOL, V29, P1069, DOI 10.1080/13854046.2016.1140228; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Victor TL, 2004, PROF PSYCHOL-RES PR, V35, P373, DOI 10.1037/0735-7028.35.4.373; Webb JW, 2012, CLIN NEUROPSYCHOL, V26, P1377, DOI 10.1080/13854046.2012.728248; WETTER MW, 1995, PROF PSYCHOL-RES PR, V26, P474, DOI 10.1037/0735-7028.26.5.474; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791; Young JC, 2016, CLIN NEUROPSYCHOL, V30, P497, DOI 10.1080/13854046.2016.1159730; Young JC, 2012, CLIN NEUROPSYCHOL, V26, P147, DOI 10.1080/13854046.2011.647083; Youngjohn, 1995, ASSESSMENT, V2, DOI [https://doi.org/10.1177/1073191195002003007, DOI 10.1177/1073191195002003007]	57	23	23	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2017	31	1					207	218		10.1080/13854046.2016.1245787			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	EK2VR	WOS:000393785300013	27758163				2022-02-06	
J	Zuckerman, A; Ram, O; Ifergane, G; Matar, MA; Sagi, R; Ostfeld, I; Hoffman, JR; Kaplan, Z; Sadot, O; Cohen, H				Zuckerman, Amitai; Ram, Omri; Ifergane, Gal; Matar, Michael A.; Sagi, Ram; Ostfeld, Ishay; Hoffman, Jay R.; Kaplan, Zeev; Sadot, Oren; Cohen, Hagit			Controlled Low-Pressure Blast-Wave Exposure Causes Distinct Behavioral and Morphological Responses Modelling Mild Traumatic Brain Injury, Post-Traumatic Stress Disorder, and Comorbid Mild Traumatic Brain Injury-Post-Traumatic Stress Disorder	JOURNAL OF NEUROTRAUMA			English	Article						animal model; blast-wave; PTSD; mTBI	ANIMAL-MODEL; DENDRITIC MORPHOLOGY; SPATIAL MEMORY; CA3 NETWORK; HIPPOCAMPUS; SEQUELAE; PLACE; CELLS; PROJECTIONS; SUBREGION	The intense focus in the clinical literature on the mental and neurocognitive sequelae of explosive blast-wave exposure, especially when comorbid with post-traumatic stress-related disorders (PTSD) is justified, and warrants the design of translationally valid animal studies to provide valid complementary basic data. We employed a controlled experimental blast-wave paradigm in which unanesthetized animals were exposed to visual, auditory, olfactory, and tactile effects of an explosive blast-wave produced by exploding a thin copper wire. By combining cognitive-behavioral paradigms and ex vivo brain MRI to assess mild traumatic brain injury (mTBI) phenotype with a validated behavioral model for PTSD, complemented by morphological assessments, this study sought to examine our ability to evaluate the biobehavioral effects of low-intensity blast overpressure on rats, in a translationally valid manner. There were no significant differences between blast-and sham-exposed rats on motor coordination and strength, or sensory function. Whereas most male rats exposed to the blast-wave displayed normal behavioral and cognitive responses, 23.6% of the rats displayed a significant retardation of spatial learning acquisition, fulfilling criteria for mTBI-like responses. In addition, 5.4% of the blastexposed animals displayed an extreme response in the behavioral tasks used to define PTSD-like criteria, whereas 10.9% of the rats developed both long-lasting and progressively worsening behavioral and cognitive "symptoms,'' suggesting comorbid PTSD-mTBI-like behavioral and cognitive response patterns. Neither group displayed changes on MRI. Exposure to experimental blast-wave elicited distinct behavioral and morphological responses modelling mTBI-like, PTSD-like, and comorbid mTBI-PTSD-like responses. This experimental animal model can be a useful tool for elucidating neurobiological mechanisms underlying the effects of blast-wave-induced mTBI and PTSD and comorbid mTBI-PTSD.	[Zuckerman, Amitai; Matar, Michael A.; Kaplan, Zeev; Cohen, Hagit] Ben Gurion Univ Negev, Fac Hlth Sci, Minist Hlth, Anxiety & Stress Res Unit, Beer Sheva, Israel; [Ram, Omri; Sadot, Oren] Ben Gurion Univ Negev, Dept Mech Engn, Beer Sheva, Israel; [Ifergane, Gal] Ben Gurion Univ Negev, Headache Clin, Soroka Med Ctr, Dept Neurol, Beer Sheva, Israel; [Sagi, Ram; Ostfeld, Ishay] Israel Def Forces Med Corps, Tel Aviv, Israel; [Hoffman, Jay R.] Univ Cent Florida, Inst Exercise Physiol & Wellness Sport & Exercise, Orlando, FL 32816 USA		Cohen, H (corresponding author), Ben Gurion Univ Negev, Anxiety & Stress Res Unit, Minist Hlth, Mental Hlth Ctr,Fac Hlth Sci, POB 4600, IL-84170 Beer Sheva, Israel.	hagitc@bgu.ac.il	Hoffman, Jay/AAF-2005-2019; Ifergane, Gal/AAD-3653-2019; ostfeld, ishay/AAC-3781-2020	Hoffman, Jay/0000-0002-0073-6603; Sadot, Oren/0000-0002-2627-550X; RAM, OMRI/0000-0002-2398-9822	Israel Defense Forces (IDF) Medical Corps; Directorate of Defense and Development, Israeli Ministry of Defense (IMOD DDRD); Adelis Brain Research Awards	This study was supported by a grant from the Israel Defense Forces (IDF) Medical Corps and Directorate of Defense and Development, Israeli Ministry of Defense (IMOD DDR&D) and by the Adelis Brain Research Awards.	Bains JS, 1999, NAT NEUROSCI, V2, P720, DOI 10.1038/11184; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Centers for Disease Control and Prevention (CDC), 2015, GUID WRIT TRAUM BRAI; Cherubini E, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00019; Cohen H, 2005, BIOL PSYCHIAT, V58, P640, DOI 10.1016/j.biopsych.2005.04.002; Cohen H, 2004, NEUROPSYCHOPHARMACOL, V29, P1962, DOI 10.1038/sj.npp.1300523; Cohen H, 2003, BIOL PSYCHIAT, V53, P463, DOI 10.1016/S0006-3223(02)01909-1; Cohen H, 2004, ANN NY ACAD SCI, V1032, P167, DOI 10.1196/annals.1314.014; COHEN H, 2013, CURR PROTOC NEUROSCI, pCH9, DOI [DOI 10.1002/0471142301.NS0945S64, 10.1002/0471142301.ns0945s64]; Cohen H, 2008, BIOL PSYCHIAT, V64, P708, DOI 10.1016/j.biopsych.2008.05.025; Cohen H, 2012, NEUROPHARMACOLOGY, V62, P715, DOI 10.1016/j.neuropharm.2011.04.023; Cohen H, 2012, NEUROPSYCHOPHARMACOL, V37, P350, DOI 10.1038/npp.2011.230; DETKE MJ, 1995, PSYCHOPHARMACOLOGY, V121, P66, DOI 10.1007/BF02245592; Diehl LA, 2012, NEUROCHEM RES, V37, P700, DOI 10.1007/s11064-011-0660-6; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Eakin K, 2012, J NEUROTRAUM, V29, P1180, DOI 10.1089/neu.2011.2192; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Faul M, 2010, TRAUMATIC BRAIN INJU; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; FILE SE, 1993, PHYSIOL BEHAV, V54, P1109, DOI 10.1016/0031-9384(93)90333-B; FITCH JM, 1989, BRAIN RES, V479, P105, DOI 10.1016/0006-8993(89)91340-1; Genovese RF, 2013, NEUROSCIENCE, V254, P120, DOI 10.1016/j.neuroscience.2013.09.021; Gilbert PE, 2009, PROG NEURO-PSYCHOPH, V33, P774, DOI 10.1016/j.pnpbp.2009.03.037; Gilbert PE, 2003, BEHAV NEUROSCI, V117, P1385, DOI 10.1037/0735-7044.117.6.1385; GREEN EJ, 1985, EXP BRAIN RES, V59, P582; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hunsaker MR, 2006, BEHAV NEUROSCI, V120, P1252, DOI 10.1037/0735-7044.120.6.1252; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Jaffee MS, 2009, J REHABIL RES DEV, V46, P655, DOI 10.1682/JRRD.2008.09.0114; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; Mitra R, 2005, P NATL ACAD SCI USA, V102, P9371, DOI 10.1073/pnas.0504011102; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Ojo JO, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00213; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; Pape TLB, 2013, PM&R, V5, P856, DOI 10.1016/j.pmrj.2013.06.007; Pavlidis P, 2000, J NEUROSCI, V20, P4497, DOI 10.1523/JNEUROSCI.20-12-04497.2000; Pikkarainen M, 1999, J COMP NEUROL, V403, P229; Porsolt R D, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0810as14; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Ram O, 2012, EXP FLUIDS, V53, P1335, DOI 10.1007/s00348-012-1339-8; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Renno-Costa C, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003641; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Rolls ET, 2007, LEARN MEMORY, V14, P714, DOI 10.1101/lm.631207; Rolls ET, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00098; ROLLS ET, 1989, J NEUROSCI, V9, P1835; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; SHOLL DA, 1956, PROG NEUROBIOL, V2, P324; Slattery DA, 2012, NAT PROTOC, V7, P1009, DOI 10.1038/nprot.2012.044; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Steffenach HA, 2002, P NATL ACAD SCI USA, V99, P3194, DOI 10.1073/pnas.042700999; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Walcott BP, 2011, NEW ENGL J MED, V365, P860, DOI 10.1056/NEJMc1107891; Wang CZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113264; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wittner L, 2007, BRAIN STRUCT FUNCT, V212, P75, DOI 10.1007/s00429-007-0148-y; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Zola-Morgan S, 1991, Hippocampus, V1, P207, DOI 10.1002/hipo.450010208	70	23	23	1	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2017	34	1					145	164		10.1089/neu.2015.4310			20	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EF6DE	WOS:000390420100018	26885687				2022-02-06	
J	Di Iorgi, N; Morana, G; Allegri, AEM; Napoli, F; Gastaldi, R; Calcagno, A; Patti, G; Loche, S; Maghnie, M				Di Iorgi, Natascia; Morana, Giovanni; Allegri, Anna Elsa Maria; Napoli, Flavia; Gastaldi, Roberto; Calcagno, Annalisa; Patti, Giuseppa; Loche, Sandro; Maghnie, Mohamad			Classical and non-classical causes of GH deficiency in the paediatric age	BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM			English	Article						hypopituitarism; GHD; MRI; pituitary stalk; anterior pituitary; ectopic posterior pituitary	GROWTH-HORMONE DEFICIENCY; PITUITARY-STALK INTERRUPTION; ECTOPIC POSTERIOR PITUITARY; CENTRAL DIABETES-INSIPIDUS; TRAUMATIC BRAIN-INJURY; SEPTO-OPTIC DYSPLASIA; INTERNAL CAROTID-ARTERY; FOLLOW-UP; EMPTY SELLA; IMAGING ABNORMALITIES	Growth hormone deficiency (GHD) may result from a failure of hypothalamic GHRH production or release, from congenital disorders of pituitary development, or from central nervous system insults including tumors, surgery, trauma, radiation or infiltration from inflammatory diseases. Idiopathic, isolated GHD is the most common sporadic form of hypopituitarism. GHD may also occur in combination with other pituitary hormone deficiencies, and is often referred to as hypopituitarism, combined pituitary hormone deficiency (CPHD), multiple pituitary hormone deficiency (MPHD) or panhypopituitarism. Children without any identifiable cause of their GHD are commonly labeled as having idiopathic hypopituitarism. MRI imaging is the technique of choice in the diagnosis of children with hypopituitarism. Marked differences in MRI pituitary gland morphology suggest different etiologies of GHD and different prognoses. Pituitary stalk agenesis and ectopic posterior pituitary (EPP) are specific markers of permanent GHD, and patients with these MRI findings show a different clinical and endocrine outcome compared to those with normal pituitary anatomy or hypoplastic pituitary alone. Furthermore, the classic triad of ectopic posterior pituitary gland, pituitary stalk hypoplasia/agenesis, and anterior pituitary gland hypoplasia is generally associated with permanent GHD. T2 DRIVE images aid in the identification of pituitary stalk without the use of contrast medium administration. Future developments in imaging techniques will undoubtedly reveal additional insights. Mutations in a number of genes encoding transcription factors - such as HESX1, SOX2, SOX3, LHX3, LHX4, PROP1, POUlF1, PITX, GLI3, GLI2, OTX2, ARNT2, IGSF1, FGF8, FGFR1, PROKR2, PROK2, CHD7, WDR11, NFKB2, PAX6, TCF7L1, IFT72, GPR161 and CDON - have been associated with pituitary dysfunction and abnormal pituitary gland development; the correlation of genetic mutations to endocrine and MRI phenotypes has improved our knowledge of pituitary development and management of patients with hypopituitarism, both in terms of possible genetic counseling, and of early diagnosis of evolving anterior pituitary hormone deficiencies. (C) 2016 Elsevier Ltd. All rights reserved.	[Di Iorgi, Natascia; Allegri, Anna Elsa Maria; Napoli, Flavia; Gastaldi, Roberto; Calcagno, Annalisa; Patti, Giuseppa; Maghnie, Mohamad] Univ Genoa, Ist Giannina Gaslini, Dept Pediat, Genoa, Italy; [Morana, Giovanni] Ist Giannina Gaslini, Neuroradiol Unit, Genoa, Italy; [Loche, Sandro] Osped Pediat Microcitem A Cao, SSD Endocrinol Pediat, Cagliari, Italy; [Di Iorgi, Natascia; Allegri, Anna Elsa Maria; Napoli, Flavia; Gastaldi, Roberto; Calcagno, Annalisa; Patti, Giuseppa; Maghnie, Mohamad] Univ Genoa, Ist Giannina Gaslini, Dept Endocrine Unit, Genoa, Italy		Maghnie, M (corresponding author), IRCCS Giannina Gaslini, Dept Pediat, Largo Gerolamo Gaslini 5, I-16147 Genoa, Italy.	mohamadmaghnie@gaslini.org	CALCAGNO, ANNALISA/AAA-8142-2020; patti, giusi/AAB-4362-2021; Napoli, Flavia/AAA-7624-2020; Morana, Giovanni/J-6134-2018; Morana, Giovanni/AAZ-1673-2021; Allegri, Anna Elsa Maria/AAB-5750-2021; GASTALDI, ROBERTO/AAB-4584-2020; Di Iorgi, Natascia/AAB-8486-2021	patti, giusi/0000-0002-6217-1919; Morana, Giovanni/0000-0001-8707-5969; Morana, Giovanni/0000-0001-8707-5969; Allegri, Anna Elsa Maria/0000-0002-5927-049X; Di Iorgi, Natascia/0000-0002-4492-4585; GASTALDI, ROBERTO/0000-0002-2157-1158			ADAN L, 1994, J CLIN ENDOCR METAB, V78, P353, DOI 10.1210/jc.78.2.353; Akcay A, 2013, EUR J MED GENET, V56, P445, DOI 10.1016/j.ejmg.2013.06.006; Alatzoglou KS, 2014, ENDOCR REV, V35, P376, DOI 10.1210/er.2013-1067; Arends NJT, 2002, CLIN ENDOCRINOL, V57, P719, DOI 10.1046/j.1365-2265.2002.01605.x; Argente J, 2014, EMBO MOL MED, V6, P299, DOI 10.1002/emmm.201303573; ARGYROPOULOU M, 1992, J PEDIATR-US, V120, P886, DOI 10.1016/S0022-3476(05)81955-9; Asakura Yumi, 2015, Clin Pediatr Endocrinol, V24, P27, DOI 10.1297/cpe.24.27; Bancalari RE, 2012, ENDOCR DEV, V23, P1, DOI 10.1159/000341733; BAO XL, 1992, CHINESE MED J-PEKING, V105, P401; Barnes N, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00101; Bas F, 2006, J PEDIATR ENDOCR MET, V19, P535; Bashamboo A, 2016, J CLIN ENDOCR METAB, V101, P12, DOI 10.1210/jc.2015-2995; Bensing S, 2007, P NATL ACAD SCI USA, V104, P949, DOI 10.1073/pnas.0610070104; Bonneville F, 2006, RADIOGRAPHICS, V26, P93, DOI 10.1148/rg.261055045; CACCIARI E, 1994, J CLIN ENDOCR METAB, V78, P767, DOI 10.1210/jc.78.3.767; Casano-Sancho P, 2013, CLIN ENDOCRINOL, V79, P853, DOI 10.1111/cen.12237; Castinetti F, 2016, EUR J ENDOCRINOL, V174, pR239, DOI 10.1530/EJE-15-1095; Caturegli P, 2005, ENDOCR REV, V26, P599, DOI 10.1210/er.2004-0011; Cervantes Luisa F, 2006, Radiology, V241, P936, DOI 10.1148/radiol.2413032060; Chemaitilly W, 2015, J CLIN ONCOL, V33, P492, DOI 10.1200/JCO.2014.56.7933; Chen S, 1999, J CLIN ENDOCR METAB, V84, P2408, DOI 10.1210/jc.84.7.2408; Chernov MF, 2009, J NEURO-ONCOL, V91, P191, DOI 10.1007/s11060-008-9698-y; Child CJ, 2016, EUR J ENDOCRINOL, V15, P1203; Clayton PE, 2005, EUR J ENDOCRINOL, V152, P165, DOI 10.1530/eje.1.01829; Clement SC, 2014, PEDIATR BLOOD CANCER, V61, P2285, DOI 10.1002/pbc.25176; Correa FA, 2015, ENDOCR CONNECT, V4, P100, DOI 10.1530/EC-15-0015; Coutant R, 2001, J CLIN ENDOCR METAB, V86, P4649, DOI 10.1210/jc.86.10.4649; COX TD, 1991, RADIOLOGY, V179, P721, DOI 10.1148/radiology.179.3.2027981; Darzy Ken H., 2009, V15, P1, DOI 10.1159/000207607; De Bellis A, 2012, J CLIN ENDOCR METAB, V97, P3684, DOI 10.1210/jc.2012-2269; De Bellis A, 2006, J CLIN ENDOCR METAB, V91, P2484, DOI 10.1210/jc.2006-0040; De Bellis A, 2016, EUR J ENDOCRINOL, V174, P381, DOI 10.1530/EJE-15-0766; de Graaff LCG, 2008, CLIN ENDOCRINOL, V69, P112, DOI 10.1111/j.1365-2265.2007.03167.x; De Luca F, 1992, ACTA PAEDIATR, V85, P1167; Deal C, 2013, HORM RES PAEDIAT, V79, P283, DOI 10.1159/000350829; Degnan AJ, 2011, AM J NEURORADIOL, V32, P1986, DOI 10.3174/ajnr.A2404; Demaerel P, 2008, NEURORADIOLOGY, V50, P85, DOI 10.1007/s00234-007-0323-0; Demurger F, 2015, EUR J HUM GENET, V23, P92, DOI 10.1038/ejhg.2014.62; di Iorgi N, 2007, J CLIN ENDOCR METAB, V92, P3875, DOI 10.1210/jc.2007-1081; Di Iorgi N, 2015, CLIN ENDOCRINOL, V83, P449, DOI 10.1111/cen.12769; Di Iorgi N, 2015, BEST PRACT RES CL EN, V29, P415, DOI 10.1016/j.beem.2015.04.013; Di Iorgi N, 2014, J CLIN ENDOCR METAB, V99, P1264, DOI 10.1210/jc.2013-3724; Di Iorgi N, 2012, ENDOCR DEV, V23, P16, DOI 10.1159/000341736; Di Iorgi N, 2012, HORM RES PAEDIAT, V77, P69, DOI 10.1159/000336333; DIETRICH RB, 1995, AM J NEURORADIOL, V16, P1413; Dupuis-Girod S, 2001, J PEDIATR-US, V138, P129, DOI 10.1067/mpd.2001.109200; Eldevik OP, 1996, AM J NEURORADIOL, V17, P1427; ELSTER AD, 1990, RADIOLOGY, V174, P681, DOI 10.1148/radiology.174.3.2305049; ELSTER AD, 1993, RADIOLOGY, V187, P1; Fink AM, 2005, J CLIN ENDOCR METAB, V90, P3274, DOI 10.1210/jc.2004-1558; Franca MM, 2010, J CLIN ENDOCR METAB, V95, pE384, DOI 10.1210/jc.2010-1050; FUJITA K, 1992, EUR J PEDIATR, V151, P266, DOI 10.1007/BF02072226; Gabbay LB, 2014, ARQ NEURO-PSIQUIAT, V72, P548, DOI 10.1590/0004-282X20140063; Gan HW, 2015, J CLIN ENDOCR METAB, V100, P3787, DOI 10.1210/jc.2015-2028; Gaston-Massuet C, 2016, P NATL ACAD SCI USA, V113, pE548, DOI 10.1073/pnas.1503346113; Genovese E, 1997, PEDIATR RADIOL, V27, P48, DOI 10.1007/s002470050062; Gleeson H, 2008, EUR J ENDOCRINOL, V159, pS95, DOI 10.1530/EJE-08-0400; Gleeson HK, 2004, ENDOCR-RELAT CANCER, V11, P589, DOI 10.1677/erc.1.00779; Gregory LC, 2015, J CLIN ENDOCR METAB, V100, P2158, DOI 10.1210/jc.2014-4484; Gregory LC, 2015, CLIN ENDOCRINOL, V82, P728, DOI 10.1111/cen.12637; Gregory LC, 2013, J CLIN ENDOCR METAB, V98, pE737, DOI 10.1210/jc.2012-3467; Halasz Z, 2008, J ENDOCRINOL INVEST, V31, P74, DOI 10.1007/BF03345570; Hamilton J, 1998, AM J MED GENET, V80, P128, DOI 10.1002/(SICI)1096-8628(19981102)80:2<128::AID-AJMG7>3.0.CO;2-C; Hasi-Zogaj M, 2015, AM J MED GENET C, V169, P251, DOI 10.1002/ajmg.c.31445; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Hopper N, 2006, J PEDIATR ENDOCR MET, V19, P325; Iorgi ND, 2012, CLIN ENDOCRINOL, V76, P161, DOI 10.1111/j.1365-2265.2011.04238.x; Joustra SD, 2016, J CLIN ENDOCR METAB, V101, P1627, DOI 10.1210/jc.2015-3880; Kalra AA, 2011, J CHILD NEUROL, V26, P87, DOI 10.1177/0883073810373278; Karaca E, 2015, J CLIN ENDOCR METAB, V100, pE140, DOI 10.1210/jc.2014-1984; Kaulfers AMD, 2010, J PEDIATR-US, V157, P894, DOI 10.1016/j.jpeds.2010.07.004; KIKUCHI K, 1988, J CLIN ENDOCR METAB, V67, P817, DOI 10.1210/jcem-67-4-817; Kjellin IB, 1999, PEDIATR RADIOL, V29, P586, DOI 10.1007/s002470050654; LACEY KA, 1974, LANCET, V1, P42; LARIZZA D, 1993, EUR J PEDIATR, V152, P424, DOI 10.1007/BF01955903; LARIZZA D, 1990, J MED GENET, V27, P53, DOI 10.1136/jmg.27.1.53; Leger J, 2005, J CLIN ENDOCR METAB, V90, P650, DOI 10.1210/jc.2004-1274; Lenz Anne M, 2012, Pediatr Endocrinol Rev, V9, P710; LINDSAY R, 1994, J PEDIATR-US, V125, P29, DOI 10.1016/S0022-3476(94)70117-2; Lubinsky MS, 1997, AM J MED GENET, V69, P235, DOI 10.1002/(SICI)1096-8628(19970331)69:3<235::AID-AJMG4>3.3.CO;2-5; Lucas-Herald AK, 2015, J CLIN ENDOCR METAB, V100, P1221, DOI 10.1210/jc.2014-3852; Maghnie M, 1999, J CLIN ENDOCR METAB, V84, P1324, DOI 10.1210/jc.84.4.1324; MAGHNIE M, 1994, RADIOLOGY, V193, P493, DOI 10.1148/radiology.193.2.7972767; Maghnie M, 1998, J CLIN ENDOCR METAB, V83, P3089, DOI 10.1210/jc.83.9.3089; Maghnie M, 2000, NEW ENGL J MED, V343, P998, DOI 10.1056/NEJM200010053431403; Maghnie M, 1998, EUR J ENDOCRINOL, V139, P635, DOI 10.1530/eje.0.1390635; Maghnie M, 2005, EUR J ENDOCRINOL, V152, P589, DOI 10.1530/eje.1.01873; Maghnie M, 2004, J ENDOCRINOL INVEST, V27, P496, DOI 10.1007/BF03345298; Maghnie M, 2004, J CLIN ENDOCR METAB, V89, P1891, DOI 10.1210/jc.2003-031608; MAGHNIE M, 1993, EUR J PEDIATR, V152, P175, DOI 10.1007/BF02072501; Maghnie M, 1996, CLIN ENDOCRINOL, V45, P281, DOI 10.1046/j.1365-2265.1996.00789.x; Maghnie M, 2002, J CLIN ENDOCR METAB, V87, P2740, DOI 10.1210/jc.87.6.2740; MAGHNIE M, 1991, J CLIN ENDOCR METAB, V73, P79, DOI 10.1210/jcem-73-1-79; MAGHNIE M, 1990, PEDIATR RADIOL, V20, P229, DOI 10.1007/BF02019654; Maghnie M, 2006, J CLIN ENDOCR METAB, V91, P2900, DOI 10.1210/jc.2006-0050; Maghnie M, 2013, EUR J ENDOCRINOL, V168, P211, DOI 10.1530/EJE-12-0801; Marziali S, 2004, PEDIATR RADIOL, V34, P547, DOI 10.1007/s00247-004-1208-6; McCabe MJ, 2013, J CLIN ENDOCR METAB, V98, pE547, DOI 10.1210/jc.2012-3067; McCabe MJ, 2011, J CLIN ENDOCR METAB, V96, pE1709, DOI 10.1210/jc.2011-0454; McMahon CL, 2001, TERATOLOGY, V64, P83, DOI 10.1002/tera.1049; Mehta A, 2009, CLIN ENDOCRINOL, V71, P376, DOI 10.1111/j.1365-2265.2009.03572.x; Melo C, 2013, GENE, V529, P186, DOI 10.1016/j.gene.2013.07.031; Merchant TE, 2011, J CLIN ONCOL, V29, P4776, DOI 10.1200/JCO.2011.37.9453; Migliaretti G, 2006, J ENDOCRINOL INVEST, V29, P438, DOI 10.1007/BF03344127; Morana G, 2010, ENDOCRIN DEV, V17, P160, DOI 10.1159/000262537; Muller HL, 2014, ENDOCR REV, V35, P513, DOI 10.1210/er.2013-1115; Murray PG, 2008, CLIN ENDOCRINOL, V69, P597, DOI 10.1111/j.1365-2265.2008.03236.x; Murray PG, 2009, CLIN ENDOCRINOL, V71, P215, DOI 10.1111/j.1365-2265.2009.03554.x; Murray PG, 2005, J PEDIATR ENDOCR MET, V18, P471; Netchine I, 2000, NAT GENET, V25, P182, DOI 10.1038/76041; Oguz KK, 2003, EUR RADIOL, V13, P1056, DOI 10.1007/s00330-002-1580-2; Orrico A, 2002, EUR J NEUROL, V9, P679, DOI 10.1046/j.1468-1331.2002.00473.x; Pampanini V, 2015, HORM RES PAEDIAT, V84, P323, DOI 10.1159/000439590; Parano E, 2000, NEUROPEDIATRICS, V31, P325, DOI 10.1055/s-2000-12957; PARKIN JM, 1974, ARCH DIS CHILD, V49, P904, DOI 10.1136/adc.49.11.904; Patat O, 2013, MOL SYNDROMOL, V4, P302, DOI 10.1159/000353727; Petryk A, 2015, J CLIN ENDOCR METAB, V100, P803, DOI 10.1210/jc.2014-4357; Pfaeffle RW, 2008, J CLIN ENDOCR METAB, V93, P1062, DOI 10.1210/jc.2007-1525; Pfaeffle RW, 2007, J CLIN ENDOCR METAB, V92, P1909, DOI 10.1210/jc.2006-2177; PHILLIPS JA, 1994, J CLIN ENDOCR METAB, V78, P11, DOI 10.1210/jc.78.1.11; Pinto G, 1997, J CLIN ENDOCR METAB, V82, P3450, DOI 10.1210/jc.82.10.3450; Poretti A, 2013, PEDIATR RADIOL, V43, P28, DOI 10.1007/s00247-012-2428-9; Quentien MH, 2012, J CLIN ENDOCR METAB, V97, pE121, DOI 10.1210/jc.2011-0407; Quigley Charmian A, 2013, Int J Pediatr Endocrinol, V2013, P6, DOI 10.1186/1687-9856-2013-6; Reifschneider K, 2015, J CLIN MED, V4, P1536, DOI 10.3390/jcm4081536; Reynaud R, 2012, J CLIN ENDOCR METAB, V97, pE1068, DOI 10.1210/jc.2011-3056; Righini A, 2009, AM J NEURORADIOL, V30, P1014, DOI 10.3174/ajnr.A1481; RONA RJ, 1977, ARCH DIS CHILD, V52, P197, DOI 10.1136/adc.52.3.197; Rossi A, 2006, J PEDIATR ENDOCR MET, V19, P299; Rossi A, 2010, PEDIATR RADIOL, V40, P999, DOI 10.1007/s00247-010-1613-y; Secco A, 2011, EUR J ENDOCRINOL, V165, P411, DOI 10.1530/EJE-11-0437; Secco A, 2009, J CLIN ENDOCR METAB, V94, P4251, DOI 10.1210/jc.2009-0779; Secco A, 2009, J CLIN ENDOCR METAB, V94, P4195, DOI 10.1210/jc.2009-0602; Sergouniotis PI, 2015, J HUM GENET, V60, P199, DOI 10.1038/jhg.2014.122; SIEGEL SF, 1995, EUR J ENDOCRINOL, V133, P87, DOI 10.1530/eje.0.1330087; Sobrier ML, 2006, J CLIN ENDOCR METAB, V91, P4528, DOI 10.1210/jc.2006-0426; Stagi S, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0037-y; SURTEES R, 1987, HORM RES, V28, P5, DOI 10.1159/000180918; Takagi M, 2015, EUR J ENDOCRINOL, V172, DOI 10.1530/EJE-14-0255; Takano K, 1999, AM J NEURORADIOL, V20, P312; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Thomas M, 2004, EUR J ENDOCRINOL, V151, P67, DOI 10.1530/eje.0.1510067; Tortori-Donati P, 2005, PEDIAT NEURORADIOLOG, P855; TRIULZI F, 1994, PEDIATRICS, V93, P409; Tsunoda A, 1997, AM J NEURORADIOL, V18, P551; Turton JPG, 2005, J CLIN ENDOCR METAB, V90, P4762, DOI 10.1210/jc.2005-0570; Vega RM, 2015, CANCER-AM CANCER SOC, V121, P1694, DOI 10.1002/cncr.29209; VIMPANI GV, 1977, BMJ-BRIT MED J, V2, P427, DOI 10.1136/bmj.2.6084.427; Vincent A, 2014, J MED GENET, V51, P797, DOI 10.1136/jmedgenet-2014-102620; Voutetakis A, 2004, J CLIN ENDOCR METAB, V89, P2200, DOI 10.1210/jc.2003-031765; Wang YJ, 2010, CHILD NERV SYST, V26, P1773, DOI 10.1007/s00381-010-1247-2; Webb EA, 2013, BRAIN, V136, P3096, DOI 10.1093/brain/awt218; Werther GA, 1996, J PEDIATR-US, V128, pS47, DOI 10.1016/S0022-3476(96)70011-2; Williamson KA, 2014, EUR J MED GENET, V57, P369, DOI 10.1016/j.ejmg.2014.05.002; Wit JM, 2016, EUR J ENDOCRINOL, V174, pR145, DOI 10.1530/EJE-15-0937; Xu H, 2015, BIOMED RES INT, pExpression; Yamamoto M, 2011, J CLIN INVEST, V121, P113, DOI 10.1172/JCI44073; Zenaty D, 2003, CLIN ENDOCRINOL, V58, P647; Zygmunt-Gorska A, 2009, J PEDIATR ENDOCR MET, V22, P653	159	23	24	0	10	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1521-690X	1532-1908		BEST PRACT RES CL EN	Best Pract. Res. Clin. Endoc. Metab.	DEC	2016	30	6					705	736		10.1016/j.beem.2016.11.008			32	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	EG5LE	WOS:000391084500004	27974186				2022-02-06	
J	Raikes, AC; Schaefer, SY				Raikes, Adam C.; Schaefer, Sydney Y.			Sleep Quantity and Quality during Acute Concussion: A Pilot Study	SLEEP			English	Article						actigraph; concussion; sleep duration; sleep quality	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; COGNITIVE PERFORMANCE; DEPRESSIVE SYMPTOMS; POSTURAL STABILITY; ACUTE-PHASE; ADOLESCENTS; DISTURBANCES; VARIABILITY; INSOMNIA	Study Objectives: A number of subjective and objective studies provide compelling evidence of chronic post-concussion changes in sleep, yet very little is known about the acute effects of concussion on sleep quality and quantity. Therefore, the purpose of this prospective pilot study was to use actigraphy to examine the changes in sleep quality and quantity acutely following concussion at home rather than in a hospital or sleep laboratory. Methods: Seventeen young adults (7 with acute concussion, 10 controls) were recruited for this study. All participants completed two 5-day testing sessions separated by 30 days from intake (controls) or day of injury (concussion). Participants wore actigraphs and kept a sleep journal. Sleep parameter outcomes included nighttime total sleep time (nTST), 24-h total sleep time (TST), wake after sleep onset (WASO), and sleep efficiency (SE). The coefficient of variation (CV) for each sleep parameter was computed for each session. Results: nTST and TST CV was significantly greater in the concussion group. There is the additional indication that individuals with a concussion may require and obtain more sleep shortly after injury and subsequently have a shorter duration of sleep at 1 mo post-injury. This pattern was not seen in the measures of sleep quality (WASO, SE). Conclusions: Individuals with a concussion demonstrated increased nighttime sleep duration variability. This increase persisted at 1 mo post-injury and may be associated with previously documented self-reports of poor sleep quality lasting months and years after a concussion. Additionally, this increase may predispose individuals to numerous negative health outcomes if left untreated.	[Raikes, Adam C.] Utah State Univ, Coll Educ & Human Serv, Motor Rehabil & Learning Lab, Logan, UT 84322 USA; [Schaefer, Sydney Y.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ USA		Raikes, AC (corresponding author), Utah State Univ, 7000 Old Main Hill, Logan, UT 84322 USA.	adam.raikes@usu.edu	Raikes, Adam/M-2600-2019	Raikes, Adam/0000-0002-1609-6727	National Athletic Trainers' Association Research and Education Foundation	This was not an industry supported study. This study was partially funded by the National Athletic Trainers' Association Research and Education Foundation. The authors have indicated no financial conflicts of interest. All research was conducted at Utah State University. This was not a clinical trial.	Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Anderson B, 2009, PEDIATRICS, V123, pE701, DOI 10.1542/peds.2008-1182; Baron KG, 2016, BEHAV SLEEP MED, P1; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Billiard M, 2013, SLEEP MED, V14, P462, DOI 10.1016/j.sleep.2013.01.009; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Chiu HY, 2014, INT J NURS STUD, V51, P892, DOI 10.1016/j.ijnurstu.2013.10.020; Chiu HY, 2013, J FORMOS MED ASSOC, V112, P545, DOI 10.1016/j.jfma.2013.06.007; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; COLE RJ, 1992, SLEEP, V15, P461, DOI 10.1093/sleep/15.5.461; de Souza L, 2003, SLEEP, V26, P81, DOI 10.1093/sleep/26.1.81; Dean PJA, 2015, BRAIN INJURY, V29, P1211, DOI 10.3109/02699052.2015.1035334; DIJK DJ, 1992, J SLEEP RES, V1, P112, DOI 10.1111/j.1365-2869.1992.tb00021.x; Dillon HR, 2014, J GERONTOL B-PSYCHOL; Duncan MJ, 2015, J PUBLIC HLTH, P1; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Finch CF, 2013, BRIT J SPORT MED, V47, P12, DOI 10.1136/bjsports-2012-091796; Fuligni AJ, 2006, J RES ADOLESCENCE, V16, P353, DOI 10.1111/j.1532-7795.2006.00498.x; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; He F, 2015, SLEEP MED, V16, P1489, DOI 10.1016/j.sleep.2015.07.028; He F, 2015, SLEEP MED, V16, P856, DOI 10.1016/j.sleep.2015.03.004; Imbach LL, 2016, NEUROLOGY; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Lemola S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071292, 10.1371/journal.pone.0082059]; Littner M, 2003, SLEEP, V26, P337, DOI 10.1093/sleep/26.3.337; Matos MG, 2016, INT J PSYCHOL, V51, P323, DOI 10.1002/ijop.12167; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; Mezick EJ, 2009, PSYCHONEUROENDOCRINO, V34, P1346, DOI 10.1016/j.psyneuen.2009.04.005; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Milroy G, 2008, J PEDIATR PSYCHOL, V33, P242, DOI 10.1093/jpepsy/jsm099; Monk TH, 2003, CHRONOBIOL INT, V20, P97, DOI 10.1081/CBI-120017812; Mysliwiec V, 2013, SLEEP, V36, P167, DOI 10.5665/sleep.2364; Okun ML, 2011, PSYCHOSOM MED, V73, P142, DOI 10.1097/PSY.0b013e3182020d08; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Patel SR, 2014, INT J OBESITY, V38, P1159, DOI 10.1038/ijo.2014.13; Pilcher JJ, 1997, J AM COLL HEALTH, V46, P121, DOI 10.1080/07448489709595597; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Rao V, 2011, J NEUROPSYCH CLIN N, V23, P201, DOI 10.1176/appi.neuropsych.23.2.201; Reilly T, 2007, PHYSIOL BEHAV, V90, P274, DOI 10.1016/j.physbeh.2006.09.017; Roane BM, 2015, BEHAV SLEEP MED, V13, P491, DOI 10.1080/15402002.2014.940109; Rodriguez-Colon SM, 2015, SLEEP MED, V16, P67, DOI 10.1016/j.sleep.2014.10.007; Sadeh A, 2011, SLEEP MED REV, V15, P259, DOI 10.1016/j.smrv.2010.10.001; Sinclair KL, 2014, BEHAV SLEEP MED, V12, P13, DOI 10.1080/15402002.2012.726203; Sommerauer M, 2013, J SLEEP RES, V22, P634, DOI 10.1111/jsr.12068; Sumpter RE, 2013, J INT NEUROPSYCH SOC, V19, P829, DOI 10.1017/S1355617713000465; Telzer EH, 2015, DEV COGN NEUROS-NETH, V14, P16, DOI 10.1016/j.dcn.2015.05.007; Thomas M, 2000, J SLEEP RES, V9, P335, DOI 10.1046/j.1365-2869.2000.00225.x; Trenchard SO, 2013, BRAIN INJURY, V27, P1217, DOI 10.3109/02699052.2013.812240; Valko PO, 2015, ANN NEUROL, V77, P177, DOI 10.1002/ana.24298; Vanderlind WM, 2014, SLEEP MED, V15, P144, DOI 10.1016/j.sleep.2013.10.006; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Villemure R, 2011, BRAIN INJURY, V25, P53, DOI 10.3109/02699052.2010.531881; Wallace DM, 2011, SLEEP MED, V12, P850, DOI 10.1016/j.sleep.2011.06.004; Watson NF, 2007, J CLIN SLEEP MED, V3, P363; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Williams BR, 2008, CLIN NEUROPHYSIOL, V119, P429, DOI 10.1016/j.clinph.2007.11.003	74	23	23	0	10	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA		1550-9109		SLEEP	Sleep	DEC 1	2016	39	12					2141	2147	PII sp-00300-16	10.5665/sleep.6314			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	ED5ZK	WOS:000388932700008	27748242	Green Published, Bronze			2022-02-06	
J	Yu, YW; Hsieh, TH; Chen, KY; Wu, JCC; Hoffer, BJ; Greig, NH; Li, YZ; Lai, JH; Chang, CF; Lin, JW; Chen, YH; Yang, LY; Chiang, YH				Yu, Yu-Wen; Hsieh, Tsung-Hsun; Chen, Kai-Yun; Wu, John Chung-Che; Hoffer, Barry J.; Greig, Nigel H.; Li, Yazhou; Lai, Jing-Huei; Chang, Cheng-Fu; Lin, Jia-Wei; Chen, Yu-Hsin; Yang, Liang-Yo; Chiang, Yung-Hsiao			Glucose-Dependent Insulinotropic Polypeptide Ameliorates Mild Traumatic Brain Injury-Induced Cognitive and Sensorimotor Deficits and Neuroinflammation in Rats	JOURNAL OF NEUROTRAUMA			English	Article						amyloid-beta precursor protein; BMX; cognitive dysfunction; controlled cortical impact; GFAP; glucagon-like peptide-1; glucose-dependent insulinotropic polypeptide; mild traumatic brain injury; neuroinflammation	GLUCAGON-LIKE PEPTIDE-1; GASTRIC-INHIBITORY POLYPEPTIDE; CENTRAL-NERVOUS-SYSTEM; CLOSED HEAD-INJURY; ALZHEIMERS-DISEASE; GENE-EXPRESSION; NEURODEGENERATIVE DISEASE; SYNAPTIC PLASTICITY; DIABETES-MELLITUS; SIGNALING PATHWAY	Mild traumatic brain injury (mTBI) is a major public health issue, representing 75-90% of all cases of TBI. In clinical settings, mTBI, which is defined as a Glascow Coma Scale (GCS) score of 13-15, can lead to various physical, cognitive, emotional, and psychological-related symptoms. To date, there are no pharmaceutical-based therapies to manage the development of the pathological deficits associated with mTBI. In this study, the neurotrophic and neuroprotective properties of glucose-dependent insulinotropic polypeptide (GIP), an incretin similar to glucagon-like peptide-1 (GLP-1), was investigated after its steady-state subcutaneous administration, focusing on behavior after mTBI in an in vivo animal model. The mTBI rat model was generated by a mild controlled cortical impact (mCCI) and used to evaluate the therapeutic potential of GIP. We used the Morris water maze and novel object recognition tests, which are tasks for spatial and recognition memory, respectively, to identify the putative therapeutic effects of GIP on cognitive function. Further, beam walking and the adhesive removal tests were used to evaluate locomotor activity and somatosensory functions in rats with and without GIP administration after mCCI lesion. Lastly, we used immunohistochemical (IHC) staining and Western blot analyses to evaluate the inflammatory markers, glial fibrillary acidic protein (GFAP), amyloid-beta precursor protein (APP), and bone marrow tyrosine kinase gene in chromosome X (BMX) in animals with mTBI. GIP was well tolerated and ameliorated mTBI-induced memory impairments, poor balance, and sensorimotor deficits after initiation in the post-injury period. In addition, GIP mitigated mTBI-induced neuroinflammatory changes on GFAP, APP, and BMX protein levels. These findings suggest GIP has significant benefits in managing mTBI-related symptoms and represents a novel strategy for mTBI treatment.	[Yu, Yu-Wen; Hsieh, Tsung-Hsun; Chen, Kai-Yun; Hoffer, Barry J.; Chiang, Yung-Hsiao] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Neural Regenerat Med, Taipei, Taiwan; [Yu, Yu-Wen; Hsieh, Tsung-Hsun; Chen, Kai-Yun; Hoffer, Barry J.; Chiang, Yung-Hsiao] Natl Hlth Res Inst, Taipei, Taiwan; [Hsieh, Tsung-Hsun; Chen, Kai-Yun; Lai, Jing-Huei; Chiang, Yung-Hsiao] Taipei Med Univ, Ctr Neurotrauma & Neuroregenerat, Taipei, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Univ, Coll Med, Dept Phys Therapy, Taoyuan, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Univ, Coll Med, Grad Inst Rehabil Sci, Taoyuan, Taiwan; [Wu, John Chung-Che; Lai, Jing-Huei; Chang, Cheng-Fu; Lin, Jia-Wei; Chiang, Yung-Hsiao] Taipei Med Univ, Coll Med, Dept Surg, Taipei, Taiwan; [Hoffer, Barry J.] Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH USA; [Greig, Nigel H.; Li, Yazhou] NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA; [Chen, Yu-Hsin; Yang, Liang-Yo] Taipei Med Univ, Sch Med, Dept Physiol, Coll Med, Taipei, Taiwan; [Chen, Yu-Hsin] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Yang, Liang-Yo] Taipei Med Univ, Res Ctr Biomed Devices & Prototyping Prod, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Med Res, Translat Lab, Taipei, Taiwan; [Yang, Liang-Yo] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan		Yang, LY (corresponding author), China Med Univ, Sch Med, Coll Med, Taichung, Taiwan.; Chiang, YH (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Neural Regenerat Med, 250 Wu Hsing St, Taipei 11031, Taiwan.	ychiang@tmu.edu.tw	Hsieh, Tung-Hsun/AAZ-5010-2020	Hsieh, Tung-Hsun/0000-0002-1794-7941; YU, YU-WEN/0000-0002-7279-2532; Chen, Yu-Hsin/0000-0002-7829-4008	Ministry of Science and TechnologyMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [MOST 103-2321-B-038-003, NSC 101-2321-B-038-004, NSC 102-2321-B-038-004, NSC 101-2632-B-038-001-MY3, MOST 103-2314-B-038-038]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG000333] Funding Source: NIH RePORTER	This study was supported by the Ministry of Science and Technology, grant number MOST 103-2321-B-038-003, NSC 101-2321-B-038-004, NSC 102-2321-B-038-004 and NSC 101-2632-B-038-001-MY3, MOST 103-2314-B-038-038 and the Intramural Research Program of the National Institute on Aging.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081585; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; BARTH TM, 1990, BEHAV BRAIN RES, V39, P73, DOI 10.1016/0166-4328(90)90122-U; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Buhren BA, 2009, J NEUROSCI RES, V87, P1858, DOI 10.1002/jnr.22001; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Cerecedo-Lopez CD, 2014, MED HYPOTHESES, V82, P171, DOI 10.1016/j.mehy.2013.11.028; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Darsalia V, 2015, J CEREBR BLOOD F MET, V35, P718, DOI 10.1038/jcbfm.2015.17; Deacon CF, 2000, J CLIN ENDOCR METAB, V85, P3575, DOI 10.1210/jc.85.10.3575; Ding KH, 2006, PEPTIDES, V27, P2750, DOI 10.1016/j.peptides.2006.05.011; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Eakin K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082016; Ekmark-Lewen S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-44; Elahi D., 2015, ENDOCR RES, P1; Faivre E, 2011, J NEUROPHYSIOL, V105, P1574, DOI 10.1152/jn.00866.2010; Faul M, 2010, TRAUMATIC BRAIN INJU; Figueiredo CP, 2010, BEHAV PHARMACOL, V21, P394, DOI 10.1097/FBP.0b013e32833c8544; Finan B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007218; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Funato H, 1998, AM J PATHOL, V152, P983; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Garner Jeff, 2007, Anesthesiol Clin, V25, P147; Gault VA, 2008, BIOCHEM PHARMACOL, V75, P2325, DOI 10.1016/j.bcp.2008.03.011; Gault VA, 2008, J NEUROPHYSIOL, V99, P1590, DOI 10.1152/jn.01161.2007; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Greig NH, 2014, ALZHEIMERS DEMENT, V10, pS62, DOI 10.1016/j.jalz.2013.12.011; Hakon J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120074; Helmy A, 2009, J NEUROTRAUM, V26, P549, DOI 10.1089/neu.2008.0719; Herman GA, 2006, J CLIN ENDOCR METAB, V91, P4612, DOI 10.1210/jc.2006-1009; Holscher C, 2014, ALZHEIMERS DEMENT, V10, pS47, DOI 10.1016/j.jalz.2013.12.009; Howard PK, 2011, ADV EMERG NURS J, V33, P274, DOI 10.1097/TME.0b013e318233d43c; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Irwin N, 2005, J MED CHEM, V48, P1244, DOI 10.1021/jm049262s; Janus C, 2001, Curr Neurol Neurosci Rep, V1, P451, DOI 10.1007/s11910-001-0105-8; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kamoi K, 2012, ENDOCR J, V59, P353, DOI 10.1507/endocrj.EJ11-0245; Kim SJ, 2008, MOL CELL BIOL, V28, P1644, DOI 10.1128/MCB.00325-07; Kobori N, 2015, J NEUROTRAUM, V32, P139, DOI 10.1089/neu.2014.3487; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Lennox RR, 2015, MOL MED REP, V12, P1544, DOI 10.3892/mmr.2015.3447; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; Li YZ, 2015, J NEUROCHEM, V135, P1203, DOI 10.1111/jnc.13169; Li YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032008; Li YZ, 2010, J NEUROCHEM, V113, P1621, DOI 10.1111/j.1471-4159.2010.06731.x; Li YZ, 2010, J ALZHEIMERS DIS, V19, P1205, DOI 10.3233/JAD-2010-1314; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Lin CM, 2009, SURG NEUROL, V72, P50, DOI 10.1016/j.wneu.2009.09.004; Lindsay J.S., 2014, IMMUNOENDOCRINOL, V1, pe391; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Martin CMA, 2013, BBA-GEN SUBJECTS, V1830, P3407, DOI 10.1016/j.bbagen.2013.03.011; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Meier JJ, 2004, DIABETES, V53, P654, DOI 10.2337/diabetes.53.3.654; Meneilly GS, 2003, DIABETES CARE, V26, P2835, DOI 10.2337/diacare.26.10.2835; Monami M, 2009, EUR J ENDOCRINOL, V160, P909, DOI 10.1530/EJE-09-0101; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Nyberg J, 2005, J NEUROSCI, V25, P1816, DOI 10.1523/jneurosci.4920-04.2005; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Okawa T, 2014, J DIABETES INVEST, V5, P31, DOI 10.1111/jdi.12129; OTSUKA N, 1991, BRAIN RES, V568, P335, DOI 10.1016/0006-8993(91)91422-W; Paavonen K, 2004, MOL BIOL CELL, V15, P4226, DOI 10.1091/mbc.E04-03-0241; Palmer CD, 2008, BLOOD, V111, P1781, DOI 10.1182/blood-2007-07-102343; Paratore Sabrina, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P210; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Perry T, 2002, J PHARMACOL EXP THER, V300, P958, DOI 10.1124/jpet.300.3.958; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; PIKE CJ, 1995, EXP NEUROL, V132, P172, DOI 10.1016/0014-4886(95)90022-5; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Prusky GT, 2000, BEHAV BRAIN RES, V116, P135, DOI 10.1016/S0166-4328(00)00267-9; Rachmany L, 2013, AGE, V35, P1621, DOI 10.1007/s11357-012-9464-0; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Salcedo I, 2012, BRIT J PHARMACOL, V166, P1586, DOI 10.1111/j.1476-5381.2012.01971.x; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Schultz BA, 2011, NEUROREHABILITATION, V28, P309, DOI 10.3233/NRE-2011-0659; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Spielman L. J., 2014, IMMUNOENDOCRINOLOGY, V1, P1, DOI [10.14800/Immunoendocrinology.391, DOI 10.1016/J.JNEUR0IM.2014.06.004]; Taglialatela G, 2009, BEHAV BRAIN RES, V200, P95, DOI 10.1016/j.bbr.2008.12.034; Tan T, 2013, CURR OPIN PHARMACOL, V13, P996, DOI 10.1016/j.coph.2013.09.005; Tatarkiewicz K, 2014, DIABETES OBES METAB, V16, P75, DOI 10.1111/dom.12181; Tian JQ, 2010, SCAND J IMMUNOL, V72, P1, DOI 10.1111/j.1365-3083.2010.02400.x; Titus DJ, 2013, NEUROSCIENCE, V231, P182, DOI 10.1016/j.neuroscience.2012.12.002; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; Tweedie D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-106; Verkhratsky A, 2010, NEUROTHERAPEUTICS, V7, P399, DOI 10.1016/j.nurt.2010.05.017; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wenk Gary L, 2004, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0805as26; Wu JCC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039226; Wu TZ, 2016, HANDB EXP PHARMACOL, V233, P137, DOI 10.1007/164_2015_9; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838	107	23	23	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2016	33	22					2044	2054		10.1089/neu.2015.4229			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EC4OL	WOS:000388112300008	26972789	Green Published, hybrid, Green Submitted			2022-02-06	
J	Zhao, S; Yu, A; Wang, XT; Gao, X; Chen, JH				Zhao, Shu; Yu, Alex; Wang, Xiaoting; Gao, Xiang; Chen, Jinhui			Post-Injury Treatment of 7,8-Dihydroxyflavone Promotes Neurogenesis in the Hippocampus of the Adult Mouse	JOURNAL OF NEUROTRAUMA			English	Article						brain-derived neurotrophic factor; cell survival; dendrite development; neurogenesis; traumatic brain injury	TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; MOLECULE TRKB AGONIST; DENTATE GYRUS; NEUROTROPHIC FACTOR; NEURONAL DIFFERENTIATION; ENHANCED NEUROGENESIS; CELL-PROLIFERATION; DENDRITIC GROWTH; IMMATURE NEURONS	Traumatic brain injury (TBI) at the moderate level of impact induces massive cell death and results in extensive dendrite degeneration in the brain, leading to persistent cognitive, sensory, and motor dysfunction. Our previous reports have shown that adult-born immature granular neurons in the dentate gyrus are the most vulnerable cell type in the hippocampus after receiving a moderate TBI with a controlled cortical impact (CCI) device. There is no effective approach to prevent immature neuron death or degeneration following TBI. Our recent study found that pretreatment of 7,8-dihydroxyflavone (DHF), a small molecule imitating brain-derived neurotrophic factor, protected immature neurons in the hippocampus from death following TBI. In the present study, we systemically treated moderate CCI-TBI mice or sham surgery mice with DHF once a day for 2 weeks via intraperitoneal injection, and then assessed the immature neurons in the hippocampus the 2nd day after the last DHF injection. We found that post-injury treatment of DHF for 2 weeks not only increased the number of adult-born immature neurons in the hippocampus, but also promoted their dendrite arborization in the injured brain following TBI. Thus, DHF may be a promising compound that can promote neurogenesis and enhance immature neuron development following TBI.	[Zhao, Shu; Wang, Xiaoting; Gao, Xiang; Chen, Jinhui] Indiana Univ, Spinal Cord & Brain Injury Res Grp, Stark Neurosci Res Inst, Dept Neurosurg, Indianapolis, IN 46204 USA; [Yu, Alex] Carmel High Sch, Indianapolis, IN USA		Chen, JH (corresponding author), Indiana Univ Sch Med, 320 W 15th St, Indianapolis, IN 46202 USA.	chen204@iupui.edu			Indiana Spinal Cord and Brain Injury Research Grants; Ralph W. and Grace M. Showalter Research Award; Indiana University; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RR025761, 1R21NS072631, R21NS075733]	This work was supported by funding from Indiana Spinal Cord and Brain Injury Research Grants, the Ralph W. and Grace M. Showalter Research Award, Indiana University Biological Research Grant, and National Institutes of Health grants RR025761, 1R21NS072631, and R21NS075733 to J. Chen.	Agrawal R, 2015, BBA-MOL BASIS DIS, V1852, P862, DOI 10.1016/j.bbadis.2015.01.018; Agrawal R, 2014, BBA-MOL BASIS DIS, V1842, P535, DOI 10.1016/j.bbadis.2013.12.004; Andero R, 2012, HIPPOCAMPUS, V22, P399, DOI 10.1002/hipo.20906; Andero R, 2011, AM J PSYCHIAT, V168, P163, DOI 10.1176/appi.ajp.2010.10030326; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Babu H, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.001.2009; Bonislawski DP, 2007, NEUROBIOL DIS, V25, P163, DOI 10.1016/j.nbd.2006.09.002; Braun H, 2002, J NEUROTRAUM, V19, P975, DOI 10.1089/089771502320317122; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Carlson SW, 2014, J NEUROPATH EXP NEUR, V73, P734, DOI 10.1097/NEN.0000000000000092; Chen L, 2015, J NEUROPATH EXP NEUR, V74, P557, DOI 10.1097/NEN.0000000000000199; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Devi L, 2012, NEUROPSYCHOPHARMACOL, V37, P434, DOI 10.1038/npp.2011.191; Dijkhuizen PA, 2005, J NEUROBIOL, V62, P278, DOI 10.1002/neu.20100; Donovan MH, 2008, HIPPOCAMPUS, V18, P435, DOI 10.1002/hipo.20410; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Gao X, 2009, J NEUROTRAUM, V26, P1325, DOI [10.1089/neu.2008.0744, 10.1089/neu.2008-0744]; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Horch HW, 2004, REV NEUROSCIENCE, V15, P117; Isoniemi H, 2006, NEUROLOGY, V67, P756, DOI 10.1212/01.wnl.0000234140.64954.12; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; Johnson RA, 2012, J APPL PHYSIOL, V112, P704, DOI 10.1152/japplphysiol.01361.2011; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; KIRSCHENBAUM B, 1995, P NATL ACAD SCI USA, V92, P210, DOI 10.1073/pnas.92.1.210; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Leuner B, 2007, P NATL ACAD SCI USA, V104, P17169, DOI 10.1073/pnas.0708228104; Liu X, 2010, J MED CHEM, V53, P8274, DOI 10.1021/jm101206p; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; TIMMUSK T, 1994, NEUROSCIENCE, V60, P287, DOI 10.1016/0306-4522(94)90242-9; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Wu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113397; Yacoubian T., 2000, NAT NEUROSCI, P3; Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618; Zeng Y, 2012, J ALZHEIMERS DIS, V31, P765, DOI 10.3233/JAD-2012-120886; Zhao S., 2015, MOL NEUROBIOL; Zhou HZ, 2012, J NEUROPATH EXP NEUR, V71, P348, DOI 10.1097/NEN.0b013e31824ea078	61	23	24	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2016	33	22					2055	2064		10.1089/neu.2015.4036			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EC4OL	WOS:000388112300009	26715291	Green Published, Green Submitted			2022-02-06	
J	Lv, YN; Qian, YS; Ou-yang, AJ; Fu, LS				Lv, Yanni; Qian, Yisong; Ou-yang, Aijun; Fu, Longsheng			Hydroxysafflor Yellow A Attenuates Neuron Damage by Suppressing the Lipopolysaccharide-Induced TLR4 Pathway in Activated Microglial Cells	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Hydroxysafflor yellow A; Toll-like receptor 4; Neuroprotective effect; Microglia; Neurons; Co-culture system; Anti-inflammatory; Neurotrophic	TRAUMATIC BRAIN-INJURY; CEREBRAL ISCHEMIA/REPERFUSION INJURY; INFLAMMATORY RESPONSE; NEUROTROPHIC FACTOR; SIGNALING PATHWAYS; INNATE IMMUNITY; DOWN-REGULATION; SAFFLOR YELLOW; BV2 MICROGLIA; RECEPTOR 4	Microglia activation initiates a neurological deficit cascade that contributes to substantial neuronal damage and impairment following ischemia stroke. Toll-like receptor 4 (TLR4) has been demonstrated to play a critical role in this cascade. In the current study, we tested the hypothesis that hydroxysafflor yellow A (HSYA), an active ingredient extracted from Flos Carthami tinctorii, alleviated inflammatory damage, and mediated neurotrophic effects in neurons by inducing the TLR4 pathway in microglia. A non-contact Transwell co-culture system comprised microglia and neurons was treated with HSYA followed by a 1 mg/mL lipopolysaccharide (LPS) stimulation. The microglia were activated prior to neuronal apoptosis, which were induced by increasing TLR4 expression in the activated microglia. However, HSYA suppressed TLR4 expression in the activated microglia, resulting in less neuronal damage at the early stage of LPS stimulation. Western blot analysis and immunofluorescence indicated that dose-dependently HSYA down-regulated TLR4-induced downstream effectors myeloid differentiation factor 88 (MyD88), nuclear factor kappa b (NF-kappa B), and the mitogen-activated protein kinases (MAPK)-regulated proteins c-Jun NH2-terminal protein kinase (JNK), protein kinase (ERK) 1/2 (ERK1/2), p38 MAPK (p38), as well as the LPS-induced inflammatory cytokine release. However, HSYA up-regulated brain-derived neurotrophic factor (BDNF) expression. Our data suggest that HSYA could exert neurotrophic and anti-inflammatory functions in response to LPS stimulation by inhibiting TLR4 pathway-mediated signaling.	[Lv, Yanni; Ou-yang, Aijun; Fu, Longsheng] Nanchang Univ, Dept Pharm, Affiliated Hosp 1, Yongwai St 17, Nanchang 330006, Peoples R China; [Qian, Yisong] Nanchang Univ, Inst Translat Med, Nanchang 330001, Peoples R China		Lv, YN (corresponding author), Nanchang Univ, Dept Pharm, Affiliated Hosp 1, Yongwai St 17, Nanchang 330006, Peoples R China.	lvyanni@126.com					Balaji Prathab S, 2015, PHARM BIOCH BEHAV, V137, P60, DOI [10.1016/j.pbb.2015.08.007, DOI 10.1016/J.PBB.2015.08.007]; Barbierato M, 2015, CNS NEUROL DISORD-DR, P608; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bozic I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118372; Buchanan MM, 2010, J NEUROCHEM, V114, P13, DOI 10.1111/j.1471-4159.2010.06736.x; Chen L, 2013, NEUROCHEM RES, V38, P2268, DOI 10.1007/s11064-013-1135-8; Chen L, 2015, BRAIN RES, V1624, P433, DOI 10.1016/j.brainres.2015.08.007; de Bernardo S, 2003, J NEUROSCI RES, V73, P818, DOI 10.1002/jnr.10704; Doeppner TR, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.359; He Y, 2013, NEURAL REGEN RES, V8, P2744, DOI 10.3969/j.issn.1673-5374.2013.29.006; Hines DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060388; Ji DB, 2009, VASC PHARMACOL, V50, P137, DOI 10.1016/j.vph.2008.11.009; Jiang ZL, 2014, IMMUNOL LETT, V160, P17, DOI 10.1016/j.imlet.2014.03.006; Kawamura K, 2012, ENDOCRINOLOGY, V153, P3972, DOI 10.1210/en.2012-1167; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Klintworth H, 2009, NEUROSCI LETT, V462, P1, DOI 10.1016/j.neulet.2009.06.065; Kraft AD, 2011, INT J ENV RES PUB HE, V8, P2980, DOI 10.3390/ijerph8072980; Kurpius D, 2006, GLIA, V54, P58, DOI 10.1002/glia.20355; Laflamme N, 2001, FASEB J, V15, P155, DOI 10.1096/fj.00-0339com; Lee EJ, 2015, MOL NEURODEGENER, V10, P61; Lee KM, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0652-1; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Lehnardt S, 2008, J NEUROSCI, V28, P2320, DOI 10.1523/JNEUROSCI.4760-07.2008; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Li GZ, 2011, BRAIN RES, V1396, P96, DOI 10.1016/j.brainres.2011.04.014; Li J, 2013, NEUROSCI LETT, V535, P51, DOI 10.1016/j.neulet.2012.12.056; LINDVALL O, 1992, P NATL ACAD SCI USA, V89, P648, DOI 10.1073/pnas.89.2.648; Lv YN, 2015, EUR J PHARMACOL, V769, P324, DOI 10.1016/j.ejphar.2015.11.036; Madeddu F, 2004, NEUROREPORT, V15, P2045, DOI 10.1097/00001756-200409150-00010; Morrison HW, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-4; Nakajima Kazuyuki, 2004, Curr Drug Targets Cardiovasc Haematol Disord, V4, P65, DOI 10.2174/1568006043481284; Pardo B, 1997, BRAIN RES PROTOC, V1, P127, DOI 10.1016/S1385-299X(96)00020-7; Park J, 2015, NEUROSCI LETT, V584, P191, DOI 10.1016/j.neulet.2014.10.016; Shulga A, 2009, MOL CELL NEUROSCI, V42, P408, DOI 10.1016/j.mcn.2009.09.002; Song J, 2014, INT J MOL SCI, V15, P15512, DOI 10.3390/ijms150915512; Song M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-92; Sun CY, 2010, PHYTOTHER RES, V24, P1788, DOI 10.1002/ptr.3166; Tanaka S, 2006, J NEUROSCI RES, V83, P557, DOI 10.1002/jnr.20752; Tao XF, 2015, FREE RADICAL BIO MED, V84, P103, DOI 10.1016/j.freeradbiomed.2015.03.003; Tian JW, 2008, PHARMACOLOGY, V82, P121, DOI 10.1159/000141653; Umschweif G, 2014, J CEREBR BLOOD F MET, V34, P1381, DOI 10.1038/jcbfm.2014.93; Walker PA, 2012, SURGERY, V152, P790, DOI 10.1016/j.surg.2012.06.006; Wang W, 2014, NEUROSCI RES, V81-82, P21, DOI 10.1016/j.neures.2014.01.005; Wang XY, 2009, J IMMUNOL, V183, P7471, DOI 10.4049/jimmunol.0900762; Wu B, 2015, J NEUROINFLAMM, V12, P133; Wu Y, 2012, BIOL PHARM BULL, V35, P515, DOI 10.1248/bpb.35.515; Yao LL, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-23; Yoo KY, 2011, NEUROCHEM RES, V36, P2417, DOI 10.1007/s11064-011-0569-0; Zhang L, 2015, J NEUROCHEM, V132, P713, DOI 10.1111/jnc.13021; Zhang X, 2014, CELL PHYSIOL BIOCHEM, V34, P715, DOI 10.1159/000363036; Zhang ZH, 2014, BRAIN RES, V1563, P72, DOI 10.1016/j.brainres.2014.03.036; Zhang ZH, 2014, NEUROSCI LETT, V562, P39, DOI 10.1016/j.neulet.2014.01.005; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59	54	23	24	3	21	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	NOV	2016	36	8					1241	1256		10.1007/s10571-015-0322-3			16	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	DY5VX	WOS:000385173600003	26754542				2022-02-06	
J	Treble-Barna, A; Sohlberg, MM; Harn, BE; Wade, SL				Treble-Barna, Amery; Sohlberg, McKay Moore; Harn, Beth E.; Wade, Shari L.			Cognitive Intervention for Attention and Executive Function Impairments in Children With Traumatic Brain Injury: A Pilot Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						child; cognitive remediation; cognitive rehabilitation; executive function; pilot projects; traumatic brain injury	REMEDIATION PROGRAM; WORKING-MEMORY; REHABILITATION; CHILDHOOD; DEFICITS; ADHD; SELF; RECOMMENDATIONS; METAANALYSIS; SURVIVORS	Objective: To test the effectiveness of the Attention Improvement and Management (AIM) program, a cognitive intervention for improving impairments in attention and executive functions (EFs) after pediatric traumatic brain injury (TBI). Setting: Tertiary care children's hospital. Participants: A total of 13 children with complicated mild-to-severe TBI (average of 5 years postinjury) and 11 healthy comparison children aged 9 to 15 years completed the study. Design: Open-label pilot study with a nontreated control group. Main Measures: Subtests from the Test of Everyday Attention-for Children (TEA-Ch) and the Delis-Kaplan Executive Function System (D-KEFS), the self-and parent-report from the Behavior Rating Inventory of Executive Function (BRIEF), and the Goal Attainment Scale (GAS). Results: Relative to the healthy comparison group, children with TBI demonstrated significant improvement postintervention on a neuropsychological measure of sustained attention, as well as on parent-reported EFs. The majority of families also reported expected or more-than-expected personalized goal attainment. Conclusions: The study provides preliminary evidence for the effectiveness of AIM in improving parent-reported EFs and personalized real-world goal attainment in children with TBI.	[Treble-Barna, Amery] Cincinnati Childrens Hosp Med Ctr, Dept Phys Med & Rehabil, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Sohlberg, McKay Moore] Univ Oregon, Commun Disorders & Sci, Eugene, OR 97403 USA; [Harn, Beth E.] Univ Oregon, Dept Special Educ & Clin Sci, Eugene, OR 97403 USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, 3333 Burnet Ave, Cincinnati, OH 45229 USA		Treble-Barna, A (corresponding author), Cincinnati Childrens Hosp Med Ctr, Phys Med & Rehabil, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	amery.treble-barna@cchmc.org			Department of Education's National Institute on Disability and Rehabilitation Research (Center on Interventions for Children and Youth with Traumatic Brain Injury) [H133B090010-10]; Ohio Department of Public Safety Emergency Medical Services Program	This project was supported in part by grants from the Department of Education's National Institute on Disability and Rehabilitation Research (Center on Interventions for Children and Youth with Traumatic Brain Injury; Grant number H133B090010-10) and the Ohio Department of Public Safety Emergency Medical Services Program. This material does not necessarily represent the policy of these agencies, nor is the material necessarily endorsed by the Federal Government.	Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Beardmore S, 1999, NEUROPSYCHOL REHABIL, V9, P45, DOI 10.1080/713755588; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Bouwens SFM, 2009, CLIN REHABIL, V23, P310, DOI 10.1177/0269215508101744; Butler RW, 2008, J CONSULT CLIN PSYCH, V76, P367, DOI 10.1037/0022-006X.76.3.367; Byerley AK, 2013, REHABIL PSYCHOL, V58, P412, DOI 10.1037/a0034228; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Chapman SB, 2015, CEREB CORTEX, V25, P396, DOI 10.1093/cercor/bht234; Cicerone KD, 1999, J HEAD TRAUMA REHAB, V14, P316, DOI 10.1097/00001199-199906000-00011; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Collins A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001293; Delis DC., 2001, DELIS KAPLAN EXECUTI; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Evans JJ, 2012, CURR OPIN NEUROL, V25, P651, DOI 10.1097/WCO.0b013e3283598f75; Faul M, 2010, TRAUMATIC BRAIN INJU; Feingold A, 2013, REV GEN PSYCHOL, V17, P111, DOI 10.1037/a0030048; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA IP, 2000, BEHAV RATING INVENTO; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Krasny-Pacini A, 2015, DEV NEUROREHABIL, P1; Krasny-Pacini A, 2014, J HEAD TRAUMA REHAB, V29, pE49, DOI 10.1097/HTR.0000000000000015; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Langer N, 2013, CORTEX, V49, P2424, DOI 10.1016/j.cortex.2013.01.008; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Luton LM, 2011, BRAIN INJURY, V25, P409, DOI 10.3109/02699052.2011.558044; Malec JF, 1999, NEUROPSYCHOL REHABIL, V9, P253, DOI 10.1080/096020199389365; Manly T, 2001, J CHILD PSYCHOL PSYC, V42, P1065, DOI 10.1111/1469-7610.00806; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Morrison AB, 2012, J APPL RES MEM COGN, V1, P208, DOI 10.1016/j.jarmac.2012.07.005; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; OTTENBACHER KJ, 1990, AM J OCCUP THER, V44, P519, DOI 10.5014/ajot.44.6.519; Posner MI, 2007, ANNU REV PSYCHOL, V58, P1, DOI 10.1146/annurev.psych.58.110405.085516; Robinson KE, 2014, J PEDIATR PSYCHOL, V39, P846, DOI 10.1093/jpepsy/jsu031; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Sjo NM, 2010, ACTA PAEDIATR, V99, P230, DOI 10.1111/j.1651-2227.2009.01587.x; Slomine B, 2009, DEV DISABIL RES REV, V15, P133, DOI 10.1002/ddrr.56; Sohlberg MM, 2003, BRAIN INJURY, V17, P609, DOI 10.1080/0269905031000070189; Sohlberg MM, 2001, ANN NY ACAD SCI, V931, P359; Sohlberg MM., 2014, CLIN PRACT PEDIAT PS, V2, P263, DOI [10.1037/cpp0000072, DOI 10.1037/CPP0000072]; Takeuchi H, 2015, BRAIN STRUCT FUNCT, V220, P3101, DOI 10.1007/s00429-014-0845-2; Tamm L, 2015, ADHD-ATTEND DEFICIT, V7, P183, DOI 10.1007/s12402-014-0162-x; Tamm L, 2014, J ATTEN DISORD, V18, P551, DOI 10.1177/1087054712445782; TEASDALE G, 1974, LANCET, V2, P81; Ten Have TR, 2008, PSYCHIAT ANN, V38, P772, DOI 10.3928/00485713-20081201-10; Trombly CA, 2002, AM J OCCUP THER, V56, P489, DOI 10.5014/ajot.56.5.489; Van't Hooft I, 2005, BRAIN INJURY, V19, P511, DOI 10.1080/02699050400025224; van 't Hooft I, 2007, NEUROREHABILITATION, V22, P109; van't Hooft I, 2010, NEUROREHABILITATION, V26, P105, DOI 10.3233/NRE-2010-0541; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446; Wolraich ML, 2003, J PEDIATR PSYCHOL, V28, P559, DOI 10.1093/jpepsy/jsg046; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Zou P, 2012, ARCH CLIN NEUROPSYCH, V27, P915, DOI 10.1093/arclin/acs095	56	23	23	1	28	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2016	31	6					407	418		10.1097/HTR.0000000000000200			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EC0IW	WOS:000387784800012	26580695				2022-02-06	
J	Elkin, BS; Elliott, JM; Siegmund, GP				Elkin, Benjamin S.; Elliott, James M.; Siegmund, Gunter P.			Whiplash Injury or Concussion? A Possible Biomechanical Explanation for Concussion Symptoms in Some Individuals Following a Rear-End Collision	JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY			English	Article						brain; car crash; cervical spine; finite element model; football	CLINICAL-PREDICTION RULE; HEAD IMPACT SEVERITY; MODERATE/SEVERE DISABILITY; PROFESSIONAL FOOTBALL; PROGNOSTIC-FACTORS; FULL RECOVERY; BRAIN-DAMAGE; RISK-FACTORS; MODEL; PHYSIOTHERAPY	STUDY DESIGN: Finite element modeling of experimental data. BACKGROUND: The clinical presentations of whiplash injury and concussion have considerable overlap. Both diagnoses are generally based on presenting signs and symptoms, and a history of neck or head trauma. With incomplete knowledge of the trauma, differentiating between whiplash injury and concussion can be clinically challenging. OBJECTIVES: To estimate the brain strains that develop during rear-end car crashes, evaluate how these strains vary with different head kinematic parameters, and compare these strains to those generated during potentially concussive football helmet impacts. METHODS: Head kinematic data were analyzed from 2 prior studies, one that focused on head restraint impacts in rear-end crash tests and another that focused on football helmet impacts. These data were used as inputs to a finite element model of the human brain. Brain strains were calculated and compared to different peak kinematic parameters and between the 2 impact conditions. RESULTS: Brain strains correlated best with the head's angular velocity change for both impact conditions. The 4 crashes with head angular velocity changes greater than 30 rad/s (greater than 1719 degrees/s) generated the highest brain stains. One crash, in which the head wrapped onto the top of the head restraint, generated brain strains similar to a 9.3-m/s rear football helmet impact, a level previously associated with concussion. CONCLUSION: This work provides new insight into a potential biomechanical link between whiplash injury and concussion, and advances our understanding of how head restraint interaction during a rear-end crash may cause an injury more typically associated with sports-related head impacts.	[Elkin, Benjamin S.] MEA Forens Engineers & Scientists, Toronto, ON, Canada; [Elliott, James M.] Northwestern Univ, Feinberg Sch Med, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA; [Siegmund, Gunter P.] MEA Forens Engineers & Scientists, 11-11151 Horseshoe Way, Richmond, BC V7A 4S5, Canada; [Siegmund, Gunter P.] Univ British Columbia, Sch Kinesiol, Vancouver, BC, Canada		Siegmund, GP (corresponding author), MEA Forens Engineers & Scientists, 11-11151 Horseshoe Way, Richmond, BC V7A 4S5, Canada.	gunter.siegmund@meaforensic.com	Siegmund, Gunter P/B-7003-2013				Alexander MP, 1998, NEUROLOGY, V51, P336, DOI 10.1212/WNL.51.2.336; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Berglund A, 2001, J CLIN EPIDEMIOL, V54, P851, DOI 10.1016/S0895-4356(00)00369-3; Borchgrevink GE, 1998, SPINE, V23, P25, DOI 10.1097/00007632-199801010-00006; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Carroll LJ, 2008, SPINE, V33, pS83, DOI 10.1097/BRS.0b013e3181643eb8; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Davidsson J., 1999, BIORID II FINAL REPO; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Elliott JM, 2009, J ORTHOP SPORT PHYS, V39, P312, DOI 10.2519/jospt.2009.2826; Erichsen JE., 1867, ON RAILWAY AND OTHER; FRANKEL CJ, 1959, JAMA-J AM MED ASSOC, V169, P216, DOI 10.1001/jama.1959.03000200014004; Funk J R, 2007, Annu Proc Assoc Adv Automot Med, V51, P343; GAY JR, 1953, JAMA-J AM MED ASSOC, V152, P1698, DOI 10.1001/jama.1953.03690180020006; Gennarelli T.A., 1972, SAE TECHNICAL PAPER; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Hynes LM, 2006, BRAIN INJURY, V20, P179, DOI 10.1080/02699050500443707; Ivancic PC, 2013, ACCIDENT ANAL PREV, V50, P323, DOI 10.1016/j.aap.2012.05.008; Iverson GL, 2005, BRAIN INJURY, V19, P11, DOI 10.1080/02699050410001720068; Jakobsson L, 2000, ACCIDENT ANAL PREV, V32, P307, DOI 10.1016/S0001-4575(99)00107-4; Ji SB, 2014, BIOMECH MODEL MECHAN, V13, P1121, DOI 10.1007/s10237-014-0562-z; Jull G, 2013, PAIN, V154, P1798, DOI 10.1016/j.pain.2013.05.041; Kamper SJ, 2008, PAIN, V138, P617, DOI 10.1016/j.pain.2008.02.019; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Lamb SE, 2013, LANCET, V381, P546, DOI 10.1016/S0140-6736(12)61304-X; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Marshall CM, 2015, PHYSICIAN SPORTSMED, V43, P274, DOI 10.1080/00913847.2015.1064301; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Michaleff ZA, 2014, LANCET, V384, P133, DOI 10.1016/S0140-6736(14)60457-8; OMMAYA AK, 1968, J AMER MED ASSOC, V204, P285, DOI 10.1001/jama.204.4.285; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Ommaya AK, 1967, SAE TECHNICAL PAPER, DOI http://dx.doi.org/10.4271/670906; Ommaya AK, 1966, SAE TECHNICAL PAPER; Ommaya AK., 1985, BIOMECHANICS TRAUMA, P245; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pan J, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15607; Panzer MB, 2016, INT J AUTOMOT ENG, V7, P37, DOI 10.20485/jsaeijae.7.1_37; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; PETTERSSON K, 1994, ACTA ORTHOP SCAND, V65, P525, DOI 10.3109/17453679409000906; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Ritchie C, 2015, J ORTHOP SPORT PHYS, V45, P242, DOI 10.2519/jospt.2015.5642; Ritchie C, 2013, PAIN, V154, P2198, DOI 10.1016/j.pain.2013.07.001; Ronnen HR, 1996, RADIOLOGY, V201, P93, DOI 10.1148/radiology.201.1.8816527; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Siegmund G.P., 1997, STAPP CAR CRASH J, VP-315, P357, DOI [10.4271/973341, DOI 10.4271/973341]; Siegmund GP, 2008, SPINE, V33, P1643, DOI 10.1097/BRS.0b013e31817b5bcf; Siegmund Gunter P, 2005, Traffic Inj Prev, V6, P267, DOI 10.1080/15389580590969427; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Siegmund GP, 2014, ANN BIOMED ENG, V42, P1834, DOI 10.1007/s10439-014-1052-2; Stancin T, 2001, J TRAUMA, V51, P69, DOI 10.1097/00005373-200107000-00011; Stancin T, 1998, J TRAUMA, V45, P1031, DOI 10.1097/00005373-199812000-00010; STURZENEGGER M, 1994, NEUROLOGY, V44, P688, DOI 10.1212/WNL.44.4.688; STURZENEGGER M, 1995, J NEUROL, V242, P443, DOI 10.1007/BF00873547; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Takhounts EG, 2008, STAPP CAR C, V52, P1; Voyvodic F, 1997, NEURORADIOLOGY, V39, P35, DOI 10.1007/s002340050363; Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126; Walton DM, 2013, J ORTHOP SPORT PHYS, V43, P31, DOI 10.2519/jospt.2013.4507; Walton DM, 2009, J ORTHOP SPORT PHYS, V39, P334, DOI 10.2519/jospt.2009.2765; Yarnell P R, 1988, Brain Inj, V2, P255, DOI 10.3109/02699058809150950; Zumsteg D, 2006, CAN J NEUROL SCI, V33, P379, DOI 10.1017/S0317167100005333	63	23	23	0	14	J O S P T	ALEXANDRIA	1111 NORTH FAIRFAX ST, STE 100, ALEXANDRIA, VA 22314-1436 USA	0190-6011	1938-1344		J ORTHOP SPORT PHYS	J. Orthop. Sports Phys. Ther.	OCT	2016	46	10					874	885		10.2519/jospt.2016.7049			12	Orthopedics; Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Rehabilitation; Sport Sciences	DX5CW	WOS:000384398400009	27690834	Bronze			2022-02-06	
J	Smith, NA; Chounthirath, T; Xiang, HY				Smith, Nicholas A.; Chounthirath, Thiphalak; Xiang, Huiyun			Soccer-Related Injuries Treated in Emergency Departments: 1990-2014	PEDIATRICS			English	Article							HIGH-SCHOOL SPORTS; CRUCIATE LIGAMENT INJURIES; LOWER-EXTREMITY INJURIES; STATES HIGH-SCHOOL; RISK-FACTORS; ADOLESCENT SOCCER; HEAD-INJURIES; YOUTH SOCCER; EPIDEMIOLOGY; CONCUSSIONS	OBJECTIVE: To investigate the epidemiology of youth soccer-related injuries treated in emergency departments in the United States. METHODS: A retrospective analysis was conducted of soccer-related injuries among children 7 through 17 years of age from 1990 through 2014 with data from the National Electronic Injury Surveillance System. Injury rates were calculated from soccer participation data. RESULTS: An estimated 2 995 765 (95% confidence interval [CI], 2 309 112-3 682 418) children 7 through 17 years old were treated in US emergency departments for soccer-related injuries during the 25-year study period, averaging 119 831 (95% CI, 92 364-147 297) annually. The annual injury rate per 10 000 soccer participants increased significantly, by 111.4%, from 1990 to 2014. Patients 12 to 17 years old accounted for 72.7% of injuries, 55.5% of patients were male, and most injuries occurred in a place of sport or recreation (68.5%) or school (25.7%). Struck by (38.5%) and fell (28.7%) were the leading mechanisms of injury. Injuries most commonly were diagnosed as sprain or strain (34.6%), fracture (23.2%), and soft tissue injury (21.9%), and occurred to the upper extremity (20.7%), ankle (17.8%), and head or neck (17.7%). Concussions or other closed head injuries accounted for 7.3% of the injuries, but the annual rate of concussions/closed head injuries per 10 000 participants increased significantly, by 1595.6%, from 1990 to 2014. CONCLUSIONS: This study is the first to comprehensively investigate soccer-related injuries and calculate injury rates based on soccer participation data among children at the national level. The increasing number and rate of pediatric soccer-related injuries, especially soccer-related concussions/closed head injuries, underscore the need for increased efforts to prevent these injuries.	[Smith, Nicholas A.; Chounthirath, Thiphalak; Xiang, Huiyun] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA; [Xiang, Huiyun] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA		Xiang, HY (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	huiyun.xiang@nationwidechildrens.org					Adams AL, 2006, ACAD EMERG MED, V13, P571, DOI 10.1197/j.aem.2005.12.015; Anderson SJ, 2000, PEDIATRICS, V105, P659, DOI 10.1542/peds.105.3.640; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Bayt DR, 2016, INJURY PREV, V22, P361, DOI 10.1136/injuryprev-2015-041757; Buzas D, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114528460; Caine D, 2005, MED SPORT SCI, V48, P1, DOI [10.1159/000085330, 10.1159/000084274]; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Collins CL, 2008, INJURY PREV, V14, P34, DOI 10.1136/ip.2007.017277; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Dai BY, 2014, J SPORT HEALTH SCI, V3, P299, DOI 10.1016/j.jshs.2014.06.002; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Emery CA, 2005, AM J SPORT MED, V33, P1882, DOI 10.1177/0363546505279576; Emery CA, 2006, AM J SPORT MED, V34, P1636, DOI 10.1177/0363546506288018; Esquivel AO, 2015, SPORTS HEALTH, V7, P366, DOI 10.1177/1941738115579854; Fernandez WG, 2007, ACAD EMERG MED, V14, P641, DOI [10.1197/j.aem.2007.03.1354, 10.1111/j.1553-2712.2007.tb01851.x]; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Jacobson NA, 2013, ORTHOP J SPORTS MED, V1, DOI 10.1177/2325967113517860; Joseph AM, 2013, J ATHL TRAINING, V48, P810, DOI 10.4085/1062-6050-48.6.03; Junge A, 2002, AM J SPORT MED, V30, P652, DOI 10.1177/03635465020300050401; Kerr ZY, 2011, CLIN PEDIATR, V50, P594, DOI 10.1177/0009922810390513; Koutures CG, 2010, PEDIATRICS, V125, P410, DOI 10.1542/peds.2009-3009; Leininger RE, 2007, AM J SPORT MED, V35, P288, DOI 10.1177/0363546506294060; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Monfort SM, 2015, AM J SPORT MED, V43, P802, DOI 10.1177/0363546514564541; National Sporting Goods Association, STAT ABSTR US PART S; National Sporting Goods Association, PROQUEST STAT ABSTR; Pickett W, 2005, BRIT J SPORT MED, V39, P226, DOI 10.1136/bjsm.2004.013169; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Swenson DM, 2013, CLIN J SPORT MED, V23, P190, DOI 10.1097/JSM.0b013e31827d21fe; Swenson DM, 2013, MED SCI SPORT EXER, V45, P462, DOI 10.1249/MSS.0b013e318277acca; Tourny C, 2014, J SPORT MED PHYS FIT, V54, P526; United States Soccer Federation, 2015, US SOCC CONC GUID; *US CONS PROD SAF, NEISS SAMPL DES IMPL; US Youth Soccer, KEY STAT US YOUTH SO; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020; Yard EE, 2008, AM J SPORT MED, V36, P1930, DOI 10.1177/0363546508318047	41	23	23	0	17	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	OCT	2016	138	4							e20160346	10.1542/peds.2016-0346			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	DX3ZT	WOS:000384317700017					2022-02-06	
J	Wagner, N; Akbarpour, A; Mors, K; Voth, M; Stormann, P; Auner, B; Lehnert, M; Marzi, I; Relja, B				Wagner, Nils; Akbarpour, Annahita; Moers, Katharina; Voth, Maika; Stoermann, Philipp; Auner, Birgit; Lehnert, Mark; Marzi, Ingo; Relja, Borna			ALCOHOL INTOXICATION REDUCES SYSTEMIC INTERLEUKIN-6 LEVELS AND LEUKOCYTE COUNTS AFTER SEVERE TBI COMPARED WITH NOT INTOXICATED TBI PATIENTS	SHOCK			English	Article						Alcohol; inhospital complications; outcome; systemic inflammatory markers; traumatic brain injury	TRAUMATIC BRAIN-INJURY; CONSENSUS CONFERENCE; IMMUNE-SYSTEM; MORTALITY; SCORE; HYPOTHERMIA; CYTOKINES; MODERATE; SCALE; CARE	Background: The effect of alcohol consumption on inflammatory state and outcome in brain-injured patients remains controversial. We analyzed the influence of positive blood alcohol concentration (BAC) on inflammatory changes, inhospital complications, and mortality in traumatic brain injury (TBI) patients. Patients and Methods: Patients with an Injury Severity Score (ISS) at least 16 and Abbreviated Injury Scale of head (AIS-head) at least 3 were included upon arrival in the emergency room and grouped according to positive BAC (>0.5 parts per thousand, BAC) vs. less than 0.5 parts per thousand alcohol (no BAC). Injury severity, vital signs, complications, mortality, and systemic interleukin (IL)-6 levels were prospectively determined, and BAC was quantified. According to ISS, AIS-head, age, and sex, we performed matched-pair analysis. Results: A total of 101 TBI patients were included. Of them 74 patients were dedicated to no BAC group and 27 to BAC group. ISS was significantly higher in the no BAC group. Positive BAC group required significantly less packed red blood cells and fresh frozen plasma (P<0.05). Shorter ICU stays were found in BAC-positive patients. Inhospital complications, including single/multiple organ failure, systemic inflammatory response syndrome, sepsis, pneumonia, and acute respiratory distress syndrome, showed no significant differences. Systemic IL-6 levels and leukocyte counts (IL-6: 65.0 +/- 8.0 vs. 151.8 +/- 22.3; leukocytes: 10.2 +/- 0.9 vs. 13.2 +/- 0.8, both P<0.05) were significantly lower in BAC-positive patients. Matched-pair analysis was performed with 27 pairs. No significant differences in transfusions were monitored after matching. However, lowered systemic IL-6 levels and leukocyte counts in the BAC group were also detected after matching, indicating that this effect is ISS-independent. Conclusions: This study shows that positive BAC in TBI patients is associated with lower systemic IL-6 levels and leukocyte numbers, indicating that positive BAC may have immunosuppressive effects in this cohort of patients compared with TBI patients who were not alcohol intoxicated.	[Wagner, Nils; Akbarpour, Annahita; Moers, Katharina; Voth, Maika; Stoermann, Philipp; Auner, Birgit; Lehnert, Mark; Marzi, Ingo; Relja, Borna] Goethe Univ Frankfurt, Univ Hosp Frankfurt, Dept Trauma Hand & Reconstruct Surg, D-60590 Frankfurt, Germany		Wagner, N (corresponding author), Goethe Univ Frankfurt, Univ Hosp Frankfurt, Dept Trauma Hand & Reconstruct Surg, D-60590 Frankfurt, Germany.	nils.wagner@kgu.de	Relja, Borna/B-6642-2016	Relja, Borna/0000-0002-5625-8823			Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Aibiki M, 1999, RESUSCITATION, V41, P263, DOI 10.1016/S0300-9572(99)00052-0; Andresen M, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0121-3; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BERNARD GR, 1994, INTENS CARE MED, V20, P225, DOI 10.1007/BF01704707; Berry C, 2011, AM SURGEON, V77, P1416; Calandra T, 2005, CRIT CARE MED, V33, P1538, DOI 10.1097/01.CCM.0000168253.91200.83; Choi Y, 2009, AM J EMERG MED, V27, P956, DOI 10.1016/j.ajem.2008.07.035; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Erskine S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-99; Feuerstein GZ, 1998, NEUROIMMUNOMODULAT, V5, P143, DOI 10.1159/000026331; Goodman MD, 2013, J SURG RES, V184, P1053, DOI 10.1016/j.jss.2013.04.058; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Gunnarsdottir AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006327; Hadjibashi AA, 2012, J SURG RES, V173, P212, DOI 10.1016/j.jss.2011.05.029; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; JENNETT B, 1975, LANCET, V1, P480; Katada R, 2009, J NEUROTRAUM, V26, P2015, DOI 10.1089/neu.2008.0552; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Lin HL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/619231; Lustenberger T, 2011, J NEUROTRAUM, V28, P1699, DOI 10.1089/neu.2011.1866; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; Marzi I, PRAXISBUCH POLYTRAUM; Molina PE, 2010, ALCOHOL RES HEALTH, V33, P97; Neugebauer EAM, 2012, DTSCH ARZTEBL INT, V109, P102, DOI 10.3238/arztebl.2012.0102; Pandit V, 2014, J SURG RES, V190, P634, DOI 10.1016/j.jss.2014.04.039; Plurad D, 2010, J EMERG MED, V38, P12, DOI 10.1016/j.jemermed.2007.09.048; Raj R, 2015, J NEUROTRAUM, V32, P95, DOI 10.1089/neu.2014.3488; Relja B, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/983427; Relja B, 2012, BRIT J PHARMACOL, V165, P1188, DOI 10.1111/j.1476-5381.2011.01595.x; Roerecke M, 2013, ADDICTION, V108, P1562, DOI 10.1111/add.12231; Romeo J, 2007, BRIT J NUTR, V98, pS111, DOI 10.1017/S0007114507838049; Rundhaug NP, 2015, J NEUROSURG, V122, P211, DOI 10.3171/2014.9.JNS14322; Samraj RS, 2013, SHOCK, V40, P358, DOI 10.1097/SHK.0b013e3182a66bd6; Scheyerer MJ, 2014, EMERG MED J, V31, P813, DOI 10.1136/emermed-2013-202804; Statistisches Bundesamt, 2013, STAT BUNDESAMT TODES; TEASDALE G, 1974, LANCET, V2, P81; Teng SX, 2014, J NEUROTRAUM, V31, P378, DOI 10.1089/neu.2013.3093; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; Turk EE, 2010, FORENSIC SCI MED PAT, V6, P106, DOI 10.1007/s12024-010-9142-4; Vaaramo K, 2014, EUR J NEUROL, V21, P293, DOI 10.1111/ene.12302; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI [10.2471/BLT.07.045120, 10.1371/journal.pmed.0040296]; Wang T, 2013, J NEUROSURG, V118, P390, DOI 10.3171/2012.8.JNS12736; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Zhao Yongzhen, 2014, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V26, P153, DOI 10.3760/cma.j.issn.2095-4352.2014.03.006	50	23	24	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	SEP	2016	46	3					261	269		10.1097/SHK.0000000000000620			9	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	DU6KI	WOS:000382323100006	27058046				2022-02-06	
J	Walker, PH; Pock, A; Ling, CG; Kwon, KN; Vaughan, M				Walker, Patricia Hinton; Pock, Arnyce; Ling, Catherine G.; Kwon, Kyung Nancy; Vaughan, Megan			Battlefield acupuncture: Opening the door for acupuncture in Department of Defense/Veteran's Administration health care	NURSING OUTLOOK			English	Article						Battlefield acupuncture; Pain management; Military; Veterans; Interdisciplinary education; Advanced practice nurses	PAIN RATING-SCALE; VALIDATION; MANAGEMENT; DEFENSE; DVPRS	Battlefield acupuncture is a unique auricular acupuncture procedure which is being used in a number of military medical facilities throughout the Department of Defense (DOD). It has been used with anecdotal published positive impact with warriors experiencing polytrauma, post-traumatic stress disorder, and traumatic brain injury. It has also been effectively used to treat warriors with muscle and back pain from carrying heavy combat equipment in austere environments. This article highlights the history within the DoD related to the need for nonpharmacologic/opioid pain management across the continuum of care from combat situations, during evacuation, and throughout recovery and rehabilitation. The article describes the history of auricular acupuncture and details implementation procedures. Training is necessary and partially funded through DoD and Veteran's Administration (VA) internal Joint Incentive Funds grants between the DoD and the VA for multidisciplinary teams as part of a larger initiative related to the recommendations from the DoD Army Surgeon General's Pain Management Task Force. Finally, Uniformed Services University of the Health Sciences School of Medicine and Graduate School of Nursing faculty members present how this interdisciplinary training is currently being integrated into both schools for physicians and advanced practice nurses at the Uniformed Services University of the Health Sciences. Current and future research challenges and progress related to the use of acupuncture are also presented.	[Walker, Patricia Hinton] Uniformed Serv Univ Hlth Sci, Off President, Bethesda, MD 20814 USA; [Pock, Arnyce] Uniformed Serv Univ Hlth Sci, Sch Med, Bethesda, MD 20814 USA; [Ling, Catherine G.] Daniel K Inouye Grad Sch Nursing, DNP & NP Program, Bethesda, MD USA; [Kwon, Kyung Nancy] Henry Jackson Fdn, DVCIPM, Res Management, Rockville, MD USA; [Vaughan, Megan] Def Vet Ctr Pain Management DVCIPM, Rockville, MD USA		Walker, PH (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.	phintonwalker@comcast.net	Ling, Catherine/N-4969-2016	Ling, Catherine/0000-0002-4187-8683			Ahn AC, 2008, BIOELECTROMAGNETICS, V29, P245, DOI 10.1002/bem.20403; [Anonymous], 2010, 77 PAIN MAN TASK FOR; Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Brennan T., 2014, THE DAILY NEWS; Brennan T., 2014, STARS STRIPES; Buckenmaier CC, 2013, PAIN MED, V14, P110, DOI 10.1111/j.1526-4637.2012.01516.x; Buckenmaier CC, 2012, J AM ACAD ORTHOP SUR, V20, pS35, DOI 10.5435/JAAOS-20-08-S35; Buckenmaier CC, 2010, MIL MED, V175, P7, DOI 10.7205/MILMED-D-10-00172; Buckenmaier III C. C., 2011, MILITARY ADV REGIONA; Cahana A, 2013, PAIN MED, V14, P1, DOI 10.1111/pme.12042; ClinicalTrials.gov, 2016, SERV US NAT I HLTH; Dart RC, 2015, NEW ENGL J MED, V372, P241, DOI [10.1056/NEJMsa1406143, 10.1056/NEJMc1501822]; Ernst E, 2007, CAN MED ASSOC J, V176, P1307, DOI 10.1503/cmaj.1070008; Goertz CMH, 2006, MIL MED, V171, P1010, DOI 10.7205/MILMED.171.10.1010; Koffman RL, 2013, PSYCHIAT ANN, V43, P236, DOI 10.3928/00485713-20130503-09; Kukral L., 2012, PERFORMANCE TRIAD CH; Langevin HM, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/180805; Nassif TH, 2015, PAIN MED, V16, P2152, DOI 10.1111/pme.12866; National Center for Complementary and Integrative Health, 2016, USE COMPL ALT MED US; Niemtzow RC, 2007, MED ACUPUNCT, V19, P225, DOI 10.1089/acu.2007.0603; OLESON TD, 1980, PAIN, V8, P217, DOI 10.1016/0304-3959(88)90009-7; Ramsay DJ, 1998, JAMA-J AM MED ASSOC, V280, P1518; Sherman KJ, 2003, ALTERN THER HEALTH M, V9, P54; Soliman N, 1999, Phys Med Rehabil Clin N Am, V10, P547; Spotswood S., 2014, AURICULAR ACUPUNCTUR; Vickers AJ, 2012, ARCH INTERN MED, V172, P1444, DOI 10.1001/archinternmed.2012.3654; World Health Organization, 2002, AC REV AN REP CONTR	27	23	23	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0029-6554	1528-3968		NURS OUTLOOK	Nurs. Outlook	SEP-OCT	2016	64	5			SI		491	498		10.1016/j.outlook.2016.07.008			8	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	DW6CE	WOS:000383733200012	27601311				2022-02-06	
J	Selwyn, RG; Cooney, SJ; Khayrullina, G; Hockenbury, N; Wilson, CM; Jaiswal, S; Bermudez, S; Armstrong, RC; Byrnes, KR				Selwyn, Reed G.; Cooney, Sean J.; Khayrullina, Guzal; Hockenbury, Nicole; Wilson, Colin M.; Jaiswal, Shalini; Bermudez, Sara; Armstrong, Regina C.; Byrnes, Kimberly R.			Outcome after Repetitive Mild Traumatic Brain Injury Is Temporally Related to Glucose Uptake Profile at Time of Second Injury	JOURNAL OF NEUROTRAUMA			English	Article						FDG-PET; fluorodeoxyglucose; histopathology; locomotor function; repeated mild traumatic brain injury	CORTICAL IMPACT INJURY; CEREBRAL-BLOOD-FLOW; AXONAL INJURY; PROFESSIONAL FOOTBALL; MACAQUE MONKEYS; MOUSE MODEL; ISOFLURANE; RAT; VULNERABILITY; NEUROTRAUMA	Repeated mild traumatic brain injury (rmTBI) results in worsened outcomes, compared with a single injury, but the mechanism of this phenomenon is unclear. We have previously shown that mild TBI in a rat lateral fluid percussion model results in globally depressed glucose uptake, with a peak depression at 24 h that resolves by 16 days post-injury. The current study investigated the outcomes of a repeat injury conducted at various times during this period of depressed glucose uptake. Adult male rats were therefore subjected to rmTBI with a latency of 24 h, 5 days, or 15 days between injuries, followed by assessment of motor function, histopathology, and glucose uptake using positron emission tomography (PET). Rats that received a 24 h rmTBI showed significant deficits in motor function tasks, as well as significant increases in lesion volume and neuronal damage. The level of microglial and astrocytic activation also was associated with the timing of the second impact. Finally, rmTBI with latencies of 24 h and 5 days showed significant alterations in [F-18]fluorodeoxyglucose uptake, compared with baseline scans. Therefore, we conclude that the state of the metabolic environment, as indicated by FDG-PET at the time of the repeat injury, significantly influences neurological outcomes.	[Selwyn, Reed G.; Cooney, Sean J.; Wilson, Colin M.; Jaiswal, Shalini; Armstrong, Regina C.; Byrnes, Kimberly R.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Selwyn, Reed G.] Uniformed Serv Univ Hlth Sci, Dept Radiol, Bethesda, MD 20814 USA; [Cooney, Sean J.; Khayrullina, Guzal; Hockenbury, Nicole; Bermudez, Sara; Armstrong, Regina C.; Byrnes, Kimberly R.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd,Room B2048, Bethesda, MD 20814 USA; [Selwyn, Reed G.] Univ New Mexico, Dept Radiol, Albuquerque, NM 87131 USA		Byrnes, KR (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd,Room B2048, Bethesda, MD 20814 USA.	kimberly.byrnes@usuhs.edu					Abrous DN, 1999, BRAIN RES, V826, P181, DOI 10.1016/S0006-8993(99)01259-7; Allen GV, 2000, NEUROSCIENCE, V99, P93, DOI 10.1016/S0306-4522(00)00185-8; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; DeRoss AL, 2002, J TRAUMA, V52, P708, DOI 10.1097/00005373-200204000-00017; Donnelly DJ, 2009, J NEUROSCI METH, V181, P36, DOI 10.1016/j.jneumeth.2009.04.010; Farhad K, 2013, J NEUROTRAUM, V30, P84, DOI 10.1089/neu.2011.2283; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; GRAHAMJONES S, 1983, NEUROSCIENCE, V9, P679, DOI 10.1016/0306-4522(83)90184-7; Holschneider DP, 2013, J NEUROTRAUM, V30, P907, DOI 10.1089/neu.2012.2657; Kabadi SV, 2012, J CEREBR BLOOD F MET, V32, P137, DOI 10.1038/jcbfm.2011.117; Li CX, 2014, MAGN RESON IMAGING, V32, P956, DOI 10.1016/j.mri.2014.04.019; Li CX, 2013, NEUROSCI LETT, V541, P58, DOI 10.1016/j.neulet.2013.02.007; Li J, 2012, J NEUROTRAUM, V29, P2635, DOI 10.1089/neu.2012.2411; Liu YR, 2010, J NUCL MED, V51, P1788, DOI 10.2967/jnumed.110.078626; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Makaryus R, 2011, J CEREBR BLOOD F MET, V31, P1432, DOI 10.1038/jcbfm.2011.1; Manville J, 2007, J MOL NEUROSCI, V31, P95, DOI 10.1385/JMN/31:02:95; Miyauchi T, 2013, J NEUROTRAUM, V30, P1664, DOI 10.1089/neu.2013.2995; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Nijland PG, 2014, GLIA, V62, P1125, DOI 10.1002/glia.22667; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161	34	23	23	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2016	33	16					1479	1491		10.1089/neu.2015.4129			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DU6ED	WOS:000382305900002	26650903				2022-02-06	
J	Hefter, D; Kaiser, M; Weyer, SW; Papageorgiou, IE; Both, M; Kann, O; Muller, UC; Draguhn, A				Hefter, Dimitri; Kaiser, Martin; Weyer, Sascha W.; Papageorgiou, Ismini E.; Both, Martin; Kann, Oliver; Mueller, Ulrike C.; Draguhn, Andreas			Amyloid Precursor Protein Protects Neuronal Network Function after Hypoxia via Control of Voltage-Gated Calcium Channels	JOURNAL OF NEUROSCIENCE			English	Article						APP; hippocampus; hypoxia; L-type calcium channels; neuroprotection; nifedipine	TRAUMATIC BRAIN-INJURY; RAT HIPPOCAMPAL SLICE; WAVE-RIPPLE COMPLEXES; ALZHEIMERS-DISEASE; APPS-ALPHA; ACTIVITY PATTERNS; SECRETED FORMS; BETA; INTERNEURONS; ISCHEMIA	Acute cerebral ischemia and chronic neurovascular diseases share various common mechanisms with neurodegenerative diseases, such as disturbed cellular calcium and energy homeostasis and accumulation of toxic metabolites. A link between these conditions may be constituted by amyloid precursor protein (APP), which plays a pivotal role in the pathogenesis of Alzheimer's disease, but has also been associated with the response to acute hypoxia and regulation of calcium homeostasis. We therefore studied hypoxia-induced loss of function and recovery upon reoxygenation in hippocampal slices of mice lacking APP (APP(-/-)) or selectively expressing its soluble extracellular domain (APPs alpha-KI). Transient hypoxia disrupted electrical activity at the network and cellular level. In mice lacking APP, these impairments were significantly more severe, showing increased rise of intracellular calcium, faster loss of function, and higher incidence of spreading depression. Likewise, functional recovery upon reoxygenation was much slower and less complete than in controls. Most of these deficits were rescued by selective expression of the soluble extracellular fragment APPs alpha, or by pharmacological block of L-type calcium channels. We conclude that APP supports neuronal resistance toward acute hypoxia. This effect is mediated by the secreted APPs alpha-domain and involves L-type calcium channels.	[Hefter, Dimitri; Kaiser, Martin; Papageorgiou, Ismini E.; Both, Martin; Kann, Oliver; Draguhn, Andreas] Heidelberg Univ, Inst Physiol & Pathophysiol, Neuenheimer Feld 326, D-69210 Heidelberg, Germany; [Weyer, Sascha W.; Mueller, Ulrike C.] Heidelberg Univ, Dept Bioinformat & Funct Genom, Inst Pharm & Mol Biotechnol, D-69210 Heidelberg, Germany		Draguhn, A (corresponding author), Heidelberg Univ, Inst Physiol & Pathophysiol, Neuenheimer Feld 326, D-69210 Heidelberg, Germany.	andreas.draguhn@physiologie.uniheidelberg.de	Papageorgiou, Ismini/AAI-7329-2020; Kann, Oliver/M-4302-2019; Hefter, Dimitri/AAD-3732-2021	Papageorgiou, Ismini/0000-0001-5810-0483; Kann, Oliver/0000-0003-4365-8067; 	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [MU 1457/9-1, MU 1457/9-2, DRA 326/7-2]	This work was supported by the Deutsche Forschungsgemeinschaft Grants MU 1457/9-1, MU 1457/9-2, and DRA 326/7-2.	Aitken PG, 1998, J NEUROPHYSIOL, V80, P1514, DOI 10.1152/jn.1998.80.3.1514; Anekonda TS, 2011, BBA-MOL BASIS DIS, V1812, P1584, DOI 10.1016/j.bbadis.2011.08.013; Attems J, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0206-2; Aydin D, 2012, EXP BRAIN RES, V217, P423, DOI 10.1007/s00221-011-2861-2; Bahner F, 2011, P NATL ACAD SCI USA, V108, pE607, DOI 10.1073/pnas.1103546108; Bahmani P, 2011, J CEREBR BLOOD F MET, V31, P1311, DOI 10.1038/jcbfm.2010.233; Berridge MJ, 2010, PFLUG ARCH EUR J PHY, V459, P441, DOI 10.1007/s00424-009-0736-1; Both M, 2008, HIPPOCAMPUS, V18, P899, DOI 10.1002/hipo.20446; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cantrell AR, 2001, NAT REV NEUROSCI, V2, P397, DOI 10.1038/35077553; Clarke J, 2007, EUR J NEUROSCI, V26, P1845, DOI 10.1111/j.1460-9568.2007.05807.x; Cousins SL, 2009, J NEUROCHEM, V111, P1501, DOI 10.1111/j.1471-4159.2009.06424.x; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; De La Torre JC, 2002, ANN NY ACAD SCI, V977, P196; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Fol R, 2016, ACTA NEUROPATHOL, V131, P247, DOI 10.1007/s00401-015-1498-9; Foster KA, 2005, NEUROSCIENCE, V132, P645, DOI 10.1016/j.neuroscience.2005.01.040; Garaschuk O, 2006, NAT PROTOC, V1, P380, DOI 10.1038/nprot.2006.58; Green KN, 2008, NEURON, V59, P190, DOI 10.1016/j.neuron.2008.07.013; Hick M, 2015, ACTA NEUROPATHOL, V129, P21, DOI 10.1007/s00401-014-1368-x; Hoyer A, 2005, J NEURAL TRANSM, V112, P239, DOI 10.1007/s00702-004-0176-1; Huchzermeyer C, 2013, J CEREBR BLOOD F MET, V33, P263, DOI 10.1038/jcbfm.2012.165; Kann O, 2014, J CEREBR BLOOD F MET, V34, P1270, DOI 10.1038/jcbfm.2014.104; Kann O, 2012, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00090; KIRINO T, 1992, J CEREBR BLOOD F MET, V12, P408, DOI 10.1038/jcbfm.1992.58; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Kogel D, 2012, EXP BRAIN RES, V217, P471, DOI 10.1007/s00221-011-2932-4; Koike MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042665; Li ZW, 1996, P NATL ACAD SCI USA, V93, P6158, DOI 10.1073/pnas.93.12.6158; Liotta A, 2012, J CEREBR BLOOD F MET, V32, P2076, DOI 10.1038/jcbfm.2012.116; LOBNER D, 1993, J NEUROSCI, V13, P4861; Maier N, 2003, J PHYSIOL-LONDON, V550, P873, DOI 10.1113/jphysiol.2003.044602; MARTIN RL, 1994, TRENDS NEUROSCI, V17, P251, DOI 10.1016/0166-2236(94)90008-6; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Milosch N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.352; Misonou H, 2005, J NEUROSCI, V25, P11184, DOI 10.1523/JNEUROSCI.3370-05.2005; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nimmrich V, 2005, J PHYSIOL-LONDON, V563, P663, DOI 10.1113/jphysiol.2004.079558; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Obregon D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1781; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Pfeiffer T, 2014, NEUROIMAGE, V94, P239, DOI 10.1016/j.neuroimage.2014.03.030; Price JL, 2001, ARCH NEUROL-CHICAGO, V58, P1395, DOI 10.1001/archneur.58.9.1395; Reichinnek S, 2010, J NEUROSCI, V30, P15441, DOI 10.1523/JNEUROSCI.2535-10.2010; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Sanchez MM, 2011, J ALZHEIMERS DIS, V26, P29, DOI 10.3233/JAD-2011-0050; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; Schurr A, 1999, METHODS, V18, P117, DOI 10.1006/meth.1999.0765; Smith IF, 2005, CELL CALCIUM, V38, P427, DOI 10.1016/j.ceca.2005.06.021; SMITHSWINTOSKY VL, 1994, J NEUROCHEM, V63, P781, DOI 10.1046/j.1471-4159.1994.63020781.x; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Thibault O, 2007, AGING CELL, V6, P307, DOI 10.1111/j.1474-9726.2007.00295.x; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Webster NJ, 2006, NEUROBIOL AGING, V27, P439, DOI 10.1016/j.neurobiolaging.2005.02.002; Weyer SW, 2011, EMBO J, V30, P2266, DOI 10.1038/emboj.2011.119; Yang L, 2009, J NEUROSCI, V29, P15660, DOI 10.1523/JNEUROSCI.4104-09.2009; Yu SP, 1997, SCIENCE, V278, P114, DOI 10.1126/science.278.5335.114; Zhang CY, 2002, NEUROSCI LETT, V328, P265, DOI 10.1016/S0304-3940(02)00543-8; Zhang XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061198; Zhang X, 2010, EXP NEUROL, V223, P299, DOI 10.1016/j.expneurol.2009.07.033	65	23	23	0	9	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474	1529-2401		J NEUROSCI	J. Neurosci.	AUG 10	2016	36	32					8356	8371		10.1523/JNEUROSCI.4130-15.2016			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DU6GQ	WOS:000382312700008	27511009	Bronze, Green Published			2022-02-06	
J	Hayward, R; Britto, J; Dunaway, D; Jeelani, O				Hayward, Richard; Britto, Jonathan; Dunaway, David; Jeelani, Owase			Connecting raised intracranial pressure and cognitive delay in craniosynostosis: many assumptions, little evidence	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article							CEREBRAL-BLOOD-FLOW; SINGLE-SUTURE CRANIOSYNOSTOSIS; TRANSCRANIAL DOPPLER SONOGRAPHY; TRAUMATIC BRAIN-INJURY; SYNDROMIC CRANIOSYNOSTOSIS; PLATEAU WAVES; COMPLEX CRANIOSYNOSTOSIS; SEVOFLURANE ANESTHESIA; VENOUS HYPERTENSION; MENTAL FUNCTION		[Hayward, Richard; Jeelani, Owase] Great Ormond St Children NHS Trust, Dept Neurosurg, London, England; [Britto, Jonathan; Dunaway, David] Great Ormond St Children NHS Trust, Dept Craniofacial Surg, London, England		Hayward, R (corresponding author), Great Ormond St Children NHS Trust, Dept Neurosurg, London, England.			Dunaway, David/0000-0001-5063-9943; Jeelani, Noor/0000-0002-3240-681X			Abu-Sittah GS, 2016, J NEUROSURG-PEDIATR, V17, P469, DOI 10.3171/2015.6.PEDS15177; Aicardi J, 2009, DIS NERVOUS SYSTEM C, P531; Anderson VA, 2014, DEV MED CHILD NEUROL, V56, P329, DOI 10.1111/dmcn.12387; Arnaud E, 2002, PLAST RECONSTR SURG, V110, P6, DOI 10.1097/00006534-200207000-00002; Avery RA, 2010, NEW ENGL J MED, V363, P891, DOI 10.1056/NEJMc1004957; Barkovich AJ, 2007, DIAGNOSTIC IMAGING P, P26; Bartels MC, 2004, J CRANIOFAC SURG, V15, P1019, DOI 10.1097/00001665-200411000-00026; Bottero L, 1998, PLAST RECONSTR SURG, V102, P952, DOI 10.1097/00006534-199809040-00002; Bowler JV, 2000, NEUROSURGERY SCI BAS, P127; BRINKMANN G, 1993, AM J MED GENET, V47, P800, DOI 10.1002/ajmg.1320470540; Ciasca SM, 2001, ARQ NEURO-PSIQUIAT, V59, P342, DOI 10.1590/S0004-282X2001000300006; Cohen SR, 1998, CLEFT PALATE-CRAN J, V35, P194, DOI 10.1597/1545-1569(1998)035<0194:IPISSC>2.3.CO;2; Collmann H, 2005, CHILD NERV SYST, V21, P902, DOI 10.1007/s00381-004-1116-y; David LR, 1996, J CRANIOFAC SURG, V7, P177, DOI 10.1097/00001665-199605000-00003; David LR, 1999, J CRANIOFAC SURG, V10, P38, DOI 10.1097/00001665-199901000-00008; Di Rocco F, 2014, HUM MOL GENET, V23, P2914, DOI 10.1093/hmg/ddu004; Dwyer CM, 2013, J NEUROSURG-PEDIATR, V11, P144, DOI 10.3171/2012.10.PEDS1299; Eide PK, 2007, PEDIATR NEUROSURG, V43, P472, DOI 10.1159/000108790; Eide PK, 2003, ACTA NEUROCHIR, V145, P351, DOI 10.1007/s00701-003-0029-y; Eide PK, 2002, PEDIATR NEUROSURG, V37, P310, DOI 10.1159/000066311; Eley KA, 2012, PLAST RECONSTR SURG, V130, p690E, DOI 10.1097/PRS.0b013e318267d5ae; Feinsod M, 2003, NEUROSURGERY, V53, P723, DOI 10.1227/01.NEU.0000079627.28240.63; Florisson JMG, 2014, J CRANIOMAXILLOFAC S, V43, P312; FOK H, 1992, BRIT J PLAST SURG, V45, P394, DOI 10.1016/0007-1226(92)90013-N; Forsyth RJ, 2008, PEDIATR CRIT CARE ME, V9, P8, DOI 10.1097/01.PCC.0000298759.78616.3A; Gonsalez S, 1997, EUR RESPIR J, V10, P367, DOI 10.1183/09031936.97.10020367; GRADY MS, 1986, J NEUROSURG, V65, P199, DOI 10.3171/jns.1986.65.2.0199; HAYASHI M, 1985, J NEUROSURG, V63, P556, DOI 10.3171/jns.1985.63.4.0556; HAYREH SS, 1977, ARCH OPHTHALMOL-CHIC, V95, P1553, DOI 10.1001/archopht.1977.04450090075006; Hayward R, 2005, CHILD NERV SYST, V21, P880, DOI 10.1007/s00381-004-1114-0; Hayward R, 2005, J NEUROSURG, V102, P16, DOI 10.3171/ped.2005.102.1.0016; Hebb DO, 1949, ORG BEHAV NEUROPSYCH; Hecht Jacqueline T, 2014, Handb Clin Neurol, V119, P551, DOI 10.1016/B978-0-7020-4086-3.00036-9; Horinek D, 2008, BRIT J NEUROSURG, V22, P219, DOI 10.1080/02688690701882014; IQBAL JB, 1994, CHILD NERV SYST, V10, P259, DOI 10.1007/BF00301165; Johnson D, 2011, EUR J HUM GENET, V19, P369, DOI 10.1038/ejhg.2010.235; JOHNSTON IH, 1973, J NEUROL NEUROSUR PS, V36, P161, DOI 10.1136/jnnp.36.2.161; JOHNSTON IH, 1972, J NEUROL NEUROSUR PS, V35, P285, DOI 10.1136/jnnp.35.3.285; Julliand S, 2012, AM J MED GENET A, V158A, P1987, DOI 10.1002/ajmg.a.35441; Kabeya R, 2000, NEUROL MED-CHIR, V40, P287, DOI 10.2176/nmc.40.287; Khan SH, 2005, BRIT J OPHTHALMOL, V89, P1643, DOI 10.1136/bjo.2005.075978; Kim SG, 2012, NEUROIMAGE, V62, P672, DOI 10.1016/j.neuroimage.2012.01.015; King JAJ, 2009, J NEUROSURG-PEDIATR, V4, P297, DOI 10.3171/2009.3.PEDS08344; Krishnakumar D, 2014, DEV MED CHILD NEUROL, V56, P749, DOI 10.1111/dmcn.12475; Lee AG, 2012, CURR NEUROL NEUROSCI, V12, P334, DOI 10.1007/s11910-012-0257-8; LUNDBERG N, 1972, P ROY SOC MED, V65, P19, DOI 10.1177/003591577206500108; Martini M, 2014, CHILD NERV SYST, V30, P1367, DOI 10.1007/s00381-014-2418-3; Marucci DD, 2008, PLAST RECONSTR SURG, V122, P1162, DOI 10.1097/PRS.0b013e31818458f0; MILLER NR, 1982, WALSH HOYTS CLIN NEU, P175; Mursch K, 1999, CHILD NERV SYST, V15, P110, DOI 10.1007/s003810050344; Naumann HL, 2012, PEDIATR ANESTH, V22, P1053, DOI 10.1111/j.1460-9592.2012.03843.x; Patel A, 2014, PLAST RECONSTR SURG, V134, p608E, DOI 10.1097/PRS.0000000000000511; Randhawa PS, 2011, J CRANIOFAC SURG, V22, P125, DOI 10.1097/SCS.0b013e3181f6f82c; Renier D, 1996, J NEUROSURG, V85, P66, DOI 10.3171/jns.1996.85.1.0066; RENIER D, 1988, Annals Academy of Medicine Singapore, V17, P415; RENIER D, 1982, J NEUROSURG, V57, P370, DOI 10.3171/jns.1982.57.3.0370; Rich PM, 2003, AM J NEURORADIOL, V24, P45; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; SAINTEROSE C, 1984, J NEUROSURG, V60, P727, DOI 10.3171/jns.1984.60.4.0727; SATOH M, 1990, Kaku Igaku, V27, P1411; Schaller BJ, 2012, J CRANIO MAXILL SURG, V40, P195, DOI 10.1016/j.jcms.2011.04.003; SEN A, 1995, J NUCL MED, V36, P394; Sgouros S, 1999, J NEUROSURG, V91, P617, DOI 10.3171/jns.1999.91.4.0617; Shipster C, 2002, INT J LANG COMM DIS, V37, P325, DOI 10.1080/13682820210138816; SILBERSTEIN SD, 1992, HEADACHE, V32, P84, DOI 10.1111/j.1526-4610.1992.hed3202084.x; Soiberman U, 2011, CHILD NERV SYST, V27, P1913, DOI 10.1007/s00381-011-1470-5; Speltz ML, 2007, PLAST RECONSTR SURG, V119, P1874, DOI 10.1097/01.prs.0000259184.88265.3f; Spruijt B, 2015, PLAST RECONSTR SURG, V136, P331, DOI 10.1097/PRS.0000000000001434; Standridge SM, 2010, PEDIATR NEUROL, V43, P377, DOI 10.1016/j.pediatrneurol.2010.08.001; Starr JR, 2007, J NEUROSURG, V107, P103, DOI 10.3171/PED-07/08/103; STEINBOK P, 1989, J NEUROSURG, V71, P42, DOI 10.3171/jns.1989.71.1.0042; Swift D, 2012, J NEUROSURG-PEDIATR, V9, P73, DOI 10.3171/2011.10.PEDS1169; Taki Y, 2011, HUM BRAIN MAPP, V32, P1973, DOI 10.1002/hbm.21163; Taylor WJ, 2001, J NEUROSURG, V94, P377, DOI 10.3171/jns.2001.94.3.0377; THOMPSON DNP, 1995, CHILD NERV SYST, V11, P269, DOI 10.1007/BF00301758; Tuite GF, 1996, NEUROSURGERY, V38, P272, DOI 10.1097/00006123-199602000-00009; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; Varier S, 2011, J INT NEUROPSYCH SOC, V17, P1030, DOI 10.1017/S1355617711000993; Vavilala MS, 2003, J NEUROSURG ANESTH, V15, P307, DOI 10.1097/00008506-200310000-00003; Vavilala MS, 2003, BRIT J ANAESTH, V90, P636, DOI 10.1093/bja/aeg119; Virtanen R, 1999, PEDIATRICS, V103, P791, DOI 10.1542/peds.103.4.791; Wall SA, 2014, J NEUROSURG-PEDIATR, V14, P674, DOI 10.3171/2014.8.PEDS1425; WALSH TJ, 1969, AM J OPHTHALMOL, V67, P954, DOI 10.1016/0002-9394(69)90094-4; Wang BY, 2010, J CRANIOFAC SURG, V21, P432, DOI 10.1097/SCS.0b013e3181cfa7bf; WHITTLE IR, 1984, SURG NEUROL, V21, P367, DOI 10.1016/0090-3019(84)90116-2; Wilkie AOM, 2010, PEDIATRICS, V126, pE391, DOI 10.1542/peds.2009-3491; Youroukos S, 2000, J CHILD NEUROL, V15, P453, DOI 10.1177/088307380001500706; Yri HM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004376	88	23	23	1	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	AUG	2016	18	2					242	250		10.3171/2015.6.PEDS15144			9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	DS4LX	WOS:000380753700018	27176895	Bronze			2022-02-06	
J	Damianakis, T; Tough, A; Marziali, E; Dawson, DR				Damianakis, Thecla; Tough, Alicia; Marziali, Elsa; Dawson, Deirdre R.			Therapy Online: A Web-Based Video Support Group for Family Caregivers of Survivors With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; family caregiving; online intervention; support group; videoconferencing	SOCIAL SUPPORT; COPING STYLE; INTERVENTION; BURDEN; INDIVIDUALS; PREDICTORS; PROGRAM; ADULTS; NEEDS; TBI	Objective: This innovative descriptive study explores the benefits of a traumatic brain injury (TBI) caregiver support group intervention provided using videoconferencing within a password protected Web-based platform. Methods: Ten caregivers of family members with TBI were registered to a password-protected Web site (Caring for Others) that provided information about caring for a person with TBI and access to a videoconferencing support group intervention program. Where needed, caregivers were provided with computer equipment, Internet access, and training to negotiate the Web site links. Two groups of 5 caregivers of survivors of TBI participated (average age of survivor-20 years, average time since injury-4.6 years) and met online with a trained clinician weekly for 10 sessions. Using directed content analysis, transcripts of each session were coded with NVivo software. Results: The content analysis reported group process themes, therapeutic interventions used, caregiver outcomes, and the challenges for clinicians delivering a therapeutic intervention online. Conclusions: Traumatic brain injury caregivers shared similar concerns and problem-solving strategies for managing caregiving tasks. Overall, participants found the sessions helpful for managing the emotional impact of caring for a family member with TBI.	[Damianakis, Thecla] Univ Windsor, Sch Social Work, Windsor, ON, Canada; [Damianakis, Thecla; Dawson, Deirdre R.] Baycrest, Rotman Res Inst, Toronto, ON, Canada; [Tough, Alicia] Gestalt Inst Toronto, Ctr Rehabil & Hlth, Toronto, ON, Canada; [Marziali, Elsa] Univ Toronto, Fac Med, Toronto, ON, Canada; [Marziali, Elsa] Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada; [Dawson, Deirdre R.] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Ste 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada; [Dawson, Deirdre R.] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada		Dawson, DR (corresponding author), Univ Toronto, Dept Occupat Sci & Occupat Therapy, Ste 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	ddawson@research.baycrest.org	Dawson, Deirdre/I-8882-2014	Dawson, Deirdre/0000-0001-7517-6121	Bell Laboratories at the University of Toronto; Ontario Neurotrauma Foundation; Quebec Rehabilitation Research Network (ONF-REPAR)	Dr Marziali received a grant from Bell Laboratories at the University of Toronto. Dr Dawson received a grant from the Ontario Neurotrauma Foundation in collaboration with the Quebec Rehabilitation Research Network (ONF-REPAR). Ms Tough was a student in the Department of Occupational Science and Occupational Therapy, University of Toronto while this research was being carried out.	ACORN S, 1993, J ADV NURS, V18, P39, DOI 10.1046/j.1365-2648.1993.18010039.x; ACORN S, 1995, J ADV NURS, V21, P872, DOI 10.1046/j.1365-2648.1995.21050872.x; Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Albert SM, 2002, J HEAD TRAUMA REHAB, V17, P175, DOI 10.1097/00001199-200204000-00007; *AM GROUP PSYCH AS, PRACT GUID GROUP PSY; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; Brauer J, 2011, OCCUP THER HEALTH CA, V25, P119, DOI 10.3109/07380577.2011.570420; Brown FL, 2013, J HEAD TRAUMA REHAB, V28, P349, DOI 10.1097/HTR.0b013e318245fed5; Brown R, 1999, J HEAD TRAUMA REHAB, V14, P257, DOI 10.1097/00001199-199906000-00006; Chronister J, 2006, REHABIL PSYCHOL, V51, P190, DOI 10.1037/0090-5550.51.3.190; Dawson DR, 2010, OCCUP THER HEALTH CA, V24, P295, DOI 10.3109/07380577.2010.514383; Dawson DR, 2006, BRAIN COGNITION, V60, P214; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Gan C, 2010, NEUROREHABILITATION, V27, P5, DOI 10.3233/NRE-2010-0577; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hunt A, 2004, HDB CAREGIVERS FAMIL; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Kreutzer JS, 2002, J HEAD TRAUMA REHAB, V17, P349, DOI 10.1097/00001199-200208000-00008; Lincoln YS, 1985, NAT INQ, V289, P289, DOI DOI 10.1016/0147-1767(85)90062-8; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Marziali E, 2006, GERONTOLOGIST, V46, P398, DOI 10.1093/geront/46.3.398; Marziali E, 2005, FAM SOC, V86, P375, DOI 10.1606/1044-3894.3435; Marziali E, 2011, AM J ALZHEIMERS DIS, V26, P36, DOI 10.1177/1533317510387586; Marziali E, 2009, TELEMED J E-HEALTH, V15, P176, DOI 10.1089/tmj.2008.0082; McLaughlin KA, 2013, J HEAD TRAUMA REHAB, V28, P341, DOI 10.1097/HTR.0b013e31824e1d43; McReynolds Connie J., 2001, Work, V16, P57; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; Rotondi AJ, 2005, J HEAD TRAUMA REHAB, V20, P173, DOI 10.1097/00001199-200503000-00005; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Sander AM, 2009, J HEAD TRAUMA REHAB, V24, P248, DOI 10.1097/HTR.0b013e3181ad593a; Sosin DM, 1996, BRAIN INJURY, V10, P47; Van Baalen B, 2007, BRAIN INJURY, V21, P925, DOI 10.1080/02699050701553197; Wade SL, 2008, J HEAD TRAUMA REHAB, V23, P369, DOI 10.1097/01.HTR.0000341432.67251.48; Wade SL, 2006, J CONSULT CLIN PSYCH, V51, P178; Wongvatunyu S, 2008, J FAM NURS, V14, P314, DOI 10.1177/1074840708321473; Yalom I. D., 2005, THEORY PRACTICE GROU, V5th	43	23	22	1	19	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2016	31	4					E12	E20		10.1097/HTR.0000000000000178			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DR3FW	WOS:000379789000002	26291634				2022-02-06	
J	King, DA; Hume, PA; Gissane, C; Clark, TN				King, Doug A.; Hume, Patria A.; Gissane, Conor; Clark, Trevor N.			Similar head impact acceleration measured using instrumented ear patches in a junior rugby union team during matches in comparison with other sports	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						injury; linear; rotational; impact; rugby union; wireless head impact sensor; trauma	COLLEGIATE FOOTBALL PLAYERS; TRAUMATIC BRAIN-INJURY; KING-DEVICK TEST; HIGH-SCHOOL; SCREENING TOOL; CONCUSSION; EXPOSURE; STATISTICS; BIOMECHANICS; MAGNITUDE	OBJECTIVE Direct impact with the head and the inertial loading of the head have been postulated as major mechanisms of head-related injuries, such as concussion. METHODS This descriptive observational study was conducted to quantify the head impact acceleration characteristics in under-9-year-old junior rugby union players in New Zealand. The impact magnitude, frequency, and location were collected with a wireless head impact sensor that was worn by 14 junior rugby players who participated in 4 matches. RESULTS A total of 721 impacts > 10g were recorded. The median (interquartile range [IQR]) number of impacts per player was 46 (IQR 37-58), resulting in 10 (IQR 4-18) impacts to the head per player per match. The median impact magnitudes recorded were 15g (IQR 12g-21g) for linear acceleration and 2296 rad/sec(2) (IQR 1352-4152 rad/sec(2)) for rotational acceleration. CONCLUSIONS There were 121 impacts (16.8%) above the rotational injury risk limit and 1 (0.1%) impact above the linear injury risk limit. The acceleration magnitude and number of head impacts in junior rugby union players were higher than those previously reported in similar age-group sports participants. The median linear acceleration for the under 9-year-old rugby players were similar to 7- to 8-year-old American football players, but lower than 9- to 12-year-old youth American football players. The median rotational accelerations measured were higher than the median and 95th percentiles in youth, high school, and collegiate American football players.	[King, Doug A.; Hume, Patria A.] Auckland Univ Technol, Fac Hlth & Environm Sci, Sch Sport & Recreat, Sports Performance Res Inst New Zealand, Auckland, New Zealand; [Gissane, Conor] St Marys Univ, Sch Sport Hlth & Appl Sci, Twickenham, Middx, England; [Clark, Trevor N.] Australian Coll Phys Educ, Fac Sport Performance, Sydney Olympic Pk, NSW, Australia		King, DA (corresponding author), Hutt Valley Dist Hlth Board, Emergency Dept, Private Bag 31-907, Lower Hutt, New Zealand.	dking@aut.ac.nz	Hume, Patria/AAN-5514-2021; Hume, Patria Anne/P-1084-2017; Gissane, Conor/I-3661-2019	Hume, Patria/0000-0003-1847-8128; Hume, Patria Anne/0000-0003-1847-8128; Gissane, Conor/0000-0003-4677-3853; Clark, Dr Trevor/0000-0002-2853-0068			ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daniel RW, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027872; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Goldsmith W, 2004, AM J FOREN MED PATH, V25, P89, DOI 10.1097/01.paf.0000127407.28071.63; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Harpham JA, 2014, ANN BIOMED ENG, V42, P1, DOI 10.1007/s10439-013-0881-8; Hopkins WG, 2007, CLIN J SPORT MED, V17, P208, DOI 10.1097/JSM.0b013e3180592a68; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Krause LM, 2015, J SCI MED SPORT, V18, P358, DOI 10.1016/j.jsams.2014.05.012; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lennon A., 2015, THESIS; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Meehan WP, 2011, CLIN SPORT MED, V30, P133, DOI 10.1016/j.csm.2010.08.004; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Nevins D, 2015, PROCEDIA ENGINEER, V112, P175, DOI 10.1016/j.proeng.2015.07.195; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Tjarks BJ, 2013, J NEUROL SCI, V334, P148, DOI 10.1016/j.jns.2013.08.015; Vopat LM, 2015, IOC MANUAL OF EMERGENCY SPORTS MEDICINE, P205; Wong RH, 2014, CLIN NEUROL NEUROSUR, V118, P1, DOI 10.1016/j.clineuro.2013.11.036; Wu L.C., 2015, ANN BIOMED ENG; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	40	23	23	0	13	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JUL	2016	18	1					65	72		10.3171/2015.12.PEDS15605			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	DQ1SC	WOS:000378979700010	26942267	Bronze			2022-02-06	
J	Hopp, S; Albert-Weissenberger, C; Mencl, S; Bieber, M; Schuhmann, MK; Stetter, C; Nieswandt, B; Schmidt, PM; Monoranu, CM; Alafuzoff, I; Marklund, N; Nolte, MW; Siren, AL; Kleinschnitz, C				Hopp, Sarah; Albert-Weissenberger, Christiane; Mencl, Stine; Bieber, Michael; Schuhmann, Michael K.; Stetter, Christian; Nieswandt, Bernhard; Schmidt, Peter M.; Monoranu, Camelia-Maria; Alafuzoff, Irina; Marklund, Niklas; Nolte, Marc W.; Siren, Anna-Leena; Kleinschnitz, Christoph			Targeting Coagulation Factor XII as a Novel Therapeutic Option in Brain Trauma	ANNALS OF NEUROLOGY			English	Article							MOLECULAR-WEIGHT HEPARIN; THROMBUS FORMATION; CEREBRAL-ISCHEMIA; IN-VIVO; INTRAVASCULAR COAGULATION; HEMODYNAMIC DEPRESSION; HEAD-INJURY; RATS; MICE; MODEL	Objective: Traumatic brain injury is a major global public health problem for which specific therapeutic interventions are lacking. There is, therefore, a pressing need to identify innovative pathomechanism-based effective therapies for this condition. Thrombus formation in the cerebral microcirculation has been proposed to contribute to secondary brain damage by causing pericontusional ischemia, but previous studies have failed to harness this finding for therapeutic use. The aim of this study was to obtain preclinical evidence supporting the hypothesis that targeting factor XII prevents thrombus formation and has a beneficial effect on outcome after traumatic brain injury. Methods: We investigated the impact of genetic deficiency of factor XII and acute inhibition of activated factor XII with a single bolus injection of recombinant human albumin-fused infestin-4 (rHA-Infestin-4) on trauma-induced microvascular thrombus formation and the subsequent outcome in 2 mouse models of traumatic brain injury. Results: Our study showed that both genetic deficiency of factor XII and an inhibition of activated factor XII in mice minimize trauma-induced microvascular thrombus formation and improve outcome, as reflected by better motor function, reduced brain lesion volume, and diminished neurodegeneration. Administration of human factor XII in factor XII-deficient mice fully restored injury-induced microvascular thrombus formation and brain damage. Interpretation: The robust protective effect of rHA-Infestin-4 points to a novel treatment option that can decrease ischemic injury after traumatic brain injury without increasing bleeding tendencies.	[Hopp, Sarah; Albert-Weissenberger, Christiane; Mencl, Stine; Bieber, Michael; Schuhmann, Michael K.; Kleinschnitz, Christoph] Univ Hosp Wurzburg, Dept Neurol, Josef Schneider Str 11, D-97080 Wurzburg, Germany; [Hopp, Sarah; Albert-Weissenberger, Christiane; Stetter, Christian; Siren, Anna-Leena] Univ Hosp Wurzburg, Dept Neurosurg, D-97080 Wurzburg, Germany; [Bieber, Michael] Univ Hosp Wurzburg, Comprehens Heart Failure Ctr DZHI, D-97080 Wurzburg, Germany; [Nieswandt, Bernhard] Univ Wurzburg, Rudolf Virchow Ctr, German Res Soc, Res Ctr Expt Biomed, D-97070 Wurzburg, Germany; [Schmidt, Peter M.] CSL Ltd, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic, Australia; [Monoranu, Camelia-Maria] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, Inst Pathol, Dept Neuropathol, D-97070 Wurzburg, Germany; [Alafuzoff, Irina] Uppsala Univ, Dept Immunol, Uppsala, Sweden; [Alafuzoff, Irina] Uppsala Univ, Dept Pathol, Uppsala, Sweden; [Marklund, Niklas] Uppsala Univ, Dept Neurosci, Neurosurg, Uppsala, Sweden; [Nolte, Marc W.] CSL Behring, Marburg, Germany		Kleinschnitz, C (corresponding author), Univ Hosp Wurzburg, Dept Neurol, Josef Schneider Str 11, D-97080 Wurzburg, Germany.	christoph.kleinschnitz@uni-wuerzburg.de	Schmidt, Peter/V-3882-2019; Siren, Anna-Leena/AAE-1374-2019	Schmidt, Peter/0000-0003-1340-9086; Siren, Anna-Leena/0000-0002-2217-0081; Marklund, Niklas/0000-0002-9797-5626; Kleinschnitz, Christoph/0000-0002-1650-8875; Bieber, Michael/0000-0002-5535-6480	CSL Behring, Germany; Else Kroner-Fresenius Foundation, Germany; German Research FoundationGerman Research Foundation (DFG) [SFB 688 TP A13]; German Federal Ministry of Education and ResearchFederal Ministry of Education & Research (BMBF) [BMBF 01EW1502B]; Interdisciplinary Clinical Research Center Wurzburg [E-313]	This work was supported by CSL Behring, Germany, the Else Kroner-Fresenius Foundation, Germany, the German Research Foundation (SFB 688 TP A13), the German Federal Ministry of Education and Research under the framework of EU-ERA-NET NEURON CnsAFlame (BMBF 01EW1502B), and the Interdisciplinary Clinical Research Center Wurzburg (E-313).	Adelson PD, 2011, CHILD NERV SYST, V27, P1465, DOI 10.1007/s00381-011-1476-z; Albert-WeiSSenberger Christiane, 2012, Exp Transl Stroke Med, V4, P1, DOI 10.1186/2040-7378-4-1; Albert-Weissenberger C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00269; Albert-Weissenberger C, 2012, J CEREBR BLOOD F MET, V32, P1747, DOI 10.1038/jcbfm.2012.62; Albrecht JS, 2014, JAMA INTERN MED, V174, P1244, DOI 10.1001/jamainternmed.2014.2534; Chelladurai Yohalakshmi, 2013, F1000Res, V2, P132, DOI 10.12688/f1000research.2-132.v1; Chen JW, 2012, JACC-CARDIOVASC IMAG, V5, P1127, DOI 10.1016/j.jcmg.2012.01.025; Cheng QF, 2010, BLOOD, V116, P3981, DOI 10.1182/blood-2010-02-270918; Choudhri TF, 1997, STROKE, V28, P2296, DOI 10.1161/01.STR.28.11.2296; Dietrich WD, 1996, J CEREBR BLOOD F MET, V16, P481, DOI 10.1097/00004647-199605000-00015; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Dudley RR, 2010, J NEUROTRAUM, V27, P2165, DOI 10.1089/neu.2010.1366; Franchini M, 2006, HEMATOLOGY, V11, P307, DOI 10.1080/10245330600921964; Gailani D, 1997, BLOOD COAGUL FIBRIN, V8, P134, DOI 10.1097/00001721-199703000-00008; Hagedorn I, 2010, CIRCULATION, V121, P1510, DOI 10.1161/CIRCULATIONAHA.109.924761; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; HEKMATPANAH J, 1985, J NEUROSURG, V62, P888, DOI 10.3171/jns.1985.62.6.0888; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; HUBER A, 1993, INT J LEGAL MED, V106, P152, DOI 10.1007/BF01225238; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010; Kim Luke, 2014, J Emerg Trauma Shock, V7, P141, DOI 10.4103/0974-2700.136846; Kleinschnitz C, 2006, J EXP MED, V203, P513, DOI 10.1084/jem.20052458; Kuijpers MJE, 2014, ARTERIOSCL THROM VAS, V34, P1674, DOI 10.1161/ATVBAHA.114.303315; Lafuente JV, 1999, J NEUROTRAUM, V16, P425, DOI 10.1089/neu.1999.16.425; Lu DY, 2004, J NEUROTRAUM, V21, P1756, DOI 10.1089/neu.2004.21.1756; Maeda T, 1997, ACT NEUR S, V70, P102; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Matafonov A, 2014, BLOOD, V123, P1739, DOI 10.1182/blood-2013-04-499111; Menon DK, 2015, NAT REV NEUROL, V11, P71, DOI 10.1038/nrneurol.2014.261; Minshall CT, 2011, J TRAUMA, V71, P396, DOI 10.1097/TA.0b013e31822734c9; Pauer HU, 2004, THROMB HAEMOSTASIS, V92, P503, DOI 10.1160/TH04-04-0250; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Renne T, 2005, J EXP MED, V202, P271, DOI 10.1084/jem.20050664; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Shen X, 2015, J HEAD TRAUMA REHAB, V30, pE29, DOI 10.1097/HTR.0000000000000077; Shiina G, 1998, AM J NEURORADIOL, V19, P297; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Stutzmann JM, 2002, CNS DRUG REV, V8, P1; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; VANDERSANDE JJ, 1981, J NEUROSURG, V54, P21, DOI 10.3171/jns.1981.54.1.0021; Wright DW, 2014, ACAD EMERG MED, V21, P1414, DOI 10.1111/acem.12532	45	23	24	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	JUN	2016	79	6					970	982		10.1002/ana.24655			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DN0ST	WOS:000376775400011	27043916	Green Published, hybrid			2022-02-06	
J	Hubscher, CH; Montgomery, LR; Fell, JD; Armstrong, JE; Poudyal, P; Herrity, AN; Harkema, SJ				Hubscher, Charles H.; Montgomery, Lynnette R.; Fell, Jason D.; Armstrong, James E.; Poudyal, Pradeepa; Herrity, April N.; Harkema, Susan J.			Effects of exercise training on urinary tract function after spinal cord injury	AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY			English	Article						bladder; kidney; locomotor training; contusion	MALE SEXUAL FUNCTION; H-REFLEX; VENTROLATERAL FUNICULUS; MECHANICAL-PROPERTIES; MOTONEURON PROPERTIES; LOCOMOTOR-ACTIVITY; NEURAL CIRCUITS; RENAL-FUNCTION; FOLLOW-UP; T-CELLS	Spinal cord injury (SCI) causes dramatic changes in the quality of life, including coping with bladder dysfunction which requires repeated daily and nightly catheterizations. Our laboratory has recently demonstrated in a rat SCI model that repetitive sensory information generated through task-specific stepping and/or loading can improve nonlocomotor functions, including bladder function (Ward PJ, Herrity AN, Smith RR, Willhite A, Harrison BJ, Petruska JC, Harkema SJ, Hubscher CH. J Neurotrauma 31: 819- 833, 2014). To target potential underlying mechanisms, the current study included a forelimb-only exercise group to ascertain whether improvements may be attributed to general activity effects that impact target organ-neural interactions or to plasticity of the lumbosacral circuitry that receives convergent somatovisceral inputs. Male Wistar rats received a T9 contusion injury and were randomly assigned to three groups 2 wk postinjury: quadrupedal locomotion, forelimb exercise, or a nontrained group. Throughout the study (including preinjury), all animals were placed in metabolic cages once a week for 24 h to monitor water intake and urine output. Following the 10-wk period of daily 1-h treadmill training, awake cystometry data were collected and bladder and kidney tissue harvested for analysis. Metabolic cage frequency-volume measurements of voiding and cystometry reveal an impact of exercise training on multiple SCI-induced impairments related to various aspects of urinary tract function. Improvements in both the quadrupedal and forelimb-trained groups implicate underlying mechanisms beyond repetitive sensory information from the hindlimbs driving spinal network excitability of the lumbosacral urogenital neural circuitry. Furthermore, the impact of exercise training on the upper urinary tract (kidney) underscores the health benefit of activity-based training on the entire urinary system within the SCI population.	[Hubscher, Charles H.; Montgomery, Lynnette R.; Fell, Jason D.; Armstrong, James E.; Poudyal, Pradeepa] Univ Louisville, Dept Anat Sci & Neurobiol, 511 S Floyd St, Louisville, KY 40202 USA; [Hubscher, Charles H.; Montgomery, Lynnette R.; Herrity, April N.; Harkema, Susan J.] Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40202 USA; [Herrity, April N.; Harkema, Susan J.] Univ Louisville, Frazier Rehab Inst, Louisville, KY 40202 USA; [Harkema, Susan J.] Univ Louisville, Dept Neurol Surg, Louisville, KY 40202 USA		Hubscher, CH (corresponding author), Univ Louisville, Dept Anat Sci & Neurobiol, 511 S Floyd St, Louisville, KY 40202 USA.	chhubs01@louisville.edu			Department of Defense GrantUnited States Department of Defense [W81XWH-11-1-0668]; National Institutes of Health/National Center for Research Resources Grant [P30 8P30GM103507]	This study was supported by Department of Defense Grant W81XWH-11-1-0668. This project utilized KSCIRC Neuroscience Core facilities supported by National Institutes of Health/National Center for Research Resources Grant P30 8P30GM103507.	Abbate M, 2002, AM J PATHOL, V161, P2179, DOI 10.1016/S0002-9440(10)64495-1; Anderson KD, 2007, SPINAL CORD, V45, P328, DOI 10.1038/sj.sc.3101977; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Balsara ZR, 2013, INFECT IMMUN, V81, P3018, DOI 10.1128/IAI.00255-13; Basoni C, 2005, FASEB J, V19, P822, DOI 10.1096/fj.04-3085fje; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beaumont E, 2008, NEUROSCI RES, V62, P147, DOI 10.1016/j.neures.2008.07.003; Behmran AL, 2000, PHYS THER, V80, P688, DOI 10.1093/ptj/80.7.688; Behrman AL, 2005, PHYS THER, V85, P1356, DOI 10.1093/ptj/85.12.1356; BIYANI A, 1993, INJURY, V24, P671, DOI 10.1016/0020-1383(93)90318-Z; BORDER WA, 1990, KIDNEY INT, V37, P689, DOI 10.1038/ki.1990.35; Button DC, 2008, J PHYSIOL-LONDON, V586, P529, DOI 10.1113/jphysiol.2007.141499; CARDENAS DD, 1995, ARCH PHYS MED REHAB, V76, P272, DOI 10.1016/S0003-9993(95)80615-6; CARP JS, 1994, J NEUROPHYSIOL, V72, P431, DOI 10.1152/jn.1994.72.1.431; Cha J, 2007, J NEUROTRAUM, V24, P1000, DOI 10.1089/neu.2006.0233; Colombo G, 1998, ANN NY ACAD SCI, V860, P536, DOI 10.1111/j.1749-6632.1998.tb09097.x; COPE TC, 1986, J NEUROPHYSIOL, V55, P1202, DOI 10.1152/jn.1986.55.6.1202; de Groat W C, 1997, Adv Neurol, V72, P347; de Groat WC, 1998, BEHAV BRAIN RES, V92, P127, DOI 10.1016/S0166-4328(97)00185-X; DENNY-BROWN D., 1933, BRAIN, V56, P397, DOI 10.1093/brain/56.4.397; Dietz V, 2004, J APPL PHYSIOL, V96, P1954, DOI 10.1152/japplphysiol.00942.2003; Dietz V, 1997, TRENDS NEUROSCI, V20, P346; DIETZ V, 1987, J PHYSIOL-LONDON, V386, P149, DOI 10.1113/jphysiol.1987.sp016527; DIETZ V, 1994, LANCET, V344, P1260, DOI 10.1016/S0140-6736(94)90751-X; Dietz V, 1998, SPINAL CORD, V36, P380, DOI 10.1038/sj.sc.3100590; Ditunno PL, 2008, SPINAL CORD, V46, P500, DOI 10.1038/sj.sc.3102172; Duffield JS, 2010, SEMIN NEPHROL, V30, P234, DOI 10.1016/j.semnephrol.2010.03.003; Edgerton V R, 1991, J Am Paraplegia Soc, V14, P150; Ferrero SL, 2015, J NEUROTRAUM, V32, P200, DOI 10.1089/neu.2013.3247; Fischer MJ, 2012, AM J NEPHROL, V36, P542, DOI 10.1159/000345460; FORSSBERG H, 1980, ACTA PHYSIOL SCAND, V108, P269, DOI 10.1111/j.1748-1716.1980.tb06533.x; Fujiu K, 2011, J CLIN INVEST, V121, P3425, DOI 10.1172/JCI57582; Furlan JC, 2009, SPINE, V34, P501, DOI 10.1097/BRS.0b013e31819712f5; Gardiner PF, 2006, EXERC SPORT SCI REV, V34, P54, DOI 10.1249/00003677-200604000-00003; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Gloeckner DC, 2002, J UROLOGY, V167, P2247, DOI 10.1016/S0022-5347(05)65137-3; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Goumenos DS, 2002, NEPHROL DIAL TRANSPL, V17, P2145, DOI 10.1093/ndt/17.12.2145; Grau JW, 2004, J NEUROTRAUM, V21, P1795, DOI 10.1089/0897715042664948; Gupta DS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00028; Hall BJ, 2010, J PAIN, V11, P864, DOI 10.1016/j.jpain.2009.12.008; Harkema SJ, 1997, J NEUROPHYSIOL, V77, P797, DOI 10.1152/jn.1997.77.2.797; Harkema S, 2011, LANCET, V377, P1938, DOI 10.1016/S0140-6736(11)60547-3; Harkema SJ, 2012, ARCH PHYS MED REHAB, V93, P1588, DOI 10.1016/j.apmr.2012.04.032; Hew-Butler T, 2010, BRIT J SPORT MED, V44, P710, DOI 10.1136/bjsm.2008.051771; Horst M, 2013, J UROLOGY, V189, P747, DOI 10.1016/j.juro.2012.08.200; Hubscher C, 2015, 2015 ABSTRACT VIEWER; Hubscher CH, 2013, J NEUROPHYSIOL, V110, P1997, DOI 10.1152/jn.00297.2013; Hubscher CH, 2006, EXP NEUROL, V197, P177, DOI 10.1016/j.expneurol.2005.09.007; Hubscher CH, 1999, J NEUROPHYSIOL, V82, P1381, DOI 10.1152/jn.1999.82.3.1381; Hubscher CH, 2000, J NEUROPHYSIOL, V83, P2508, DOI 10.1152/jn.2000.83.5.2508; Jayaraman A, 2008, J SPINAL CORD MED, V31, P185, DOI 10.1080/10790268.2008.11760710; JOLESZ FA, 1982, SCIENCE, V216, P1243, DOI 10.1126/science.7200635; Kaddumi EG, 2006, J PHYSIOL-LONDON, V572, P393, DOI 10.1113/jphysiol.2005.102574; KHOKHAR AM, 1978, J ENDOCRINOL, V79, P375, DOI 10.1677/joe.0.0790375; Kilinc S, 1999, SPINAL CORD, V37, P332, DOI 10.1038/sj.sc.3100814; Kliesch WF, 1996, PARAPLEGIA, V34, P82, DOI 10.1038/sc.1996.14; Knikou M, 2009, INT J NEUROSCI, V119, P2056, DOI 10.1080/00207450903139747; Ku JH, 2005, UROL RES, V33, P435, DOI 10.1007/s00240-005-0504-4; KUHLEMEIER KV, 1984, J UROLOGY, V131, P439, DOI 10.1016/S0022-5347(17)50441-3; Leicht CA, 2013, EXERC IMMUNOL REV, V19, P144; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; MAGGI CA, 1986, J PHARMACOL METHOD, V15, P157, DOI 10.1016/0160-5402(86)90064-1; MAI J, 1976, ACTA NEUROL SCAND, V53, P395, DOI 10.1111/j.1600-0404.1976.tb04358.x; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; NIELSEN J, 1993, EXP BRAIN RES, V97, P173; Pagliacci MC, 2007, SPINAL CORD, V45, P404, DOI 10.1038/sj.sc.3101991; PEDERSEN E, 1986, J NEUROL NEUROSUR PS, V49, P273, DOI 10.1136/jnnp.49.3.273; PERUZZI WT, 1994, CRIT CARE MED, V22, P252, DOI 10.1097/00003246-199402000-00016; RABB H, 1994, AM J PHYSIOL-RENAL, V267, pF1052, DOI 10.1152/ajprenal.1994.267.6.F1052; Reed WR, 2009, BRAIN RES, V1302, P76, DOI 10.1016/j.brainres.2009.09.049; Rodriguez-Romero V, 2013, SPINAL CORD, V51, P528, DOI 10.1038/sc.2013.35; SATO A, 1977, NEUROSCIENCE, V2, P111, DOI 10.1016/0306-4522(77)90072-0; Schalow G, 2010, Electromyogr Clin Neurophysiol, V50, P155; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Shirreffs SM, 2004, BRIT J NUTR, V91, P951, DOI 10.1079/BJN20041149; Skinner RD, 1996, BRAIN RES, V729, P127, DOI 10.1016/S0006-8993(96)00556-2; Smith RR, 2009, J NEUROTRAUM, V26, P1017, DOI [10.1089/neu.2008.0829, 10.1089/neu.2008-0829]; Stover SL, 1999, ARCH PHYS MED REHAB, V80, P1365, DOI 10.1016/S0003-9993(99)90246-0; Tai CF, 2006, RESTOR NEUROL NEUROS, V24, P69; Timoszyk WK, 2005, BRAIN RES, V1050, P180, DOI 10.1016/j.brainres.2005.05.041; Toosi KK, 2008, ANN BIOMED ENG, V36, P1470, DOI 10.1007/s10439-008-9525-9; Trimble M H, 2001, J Spinal Cord Med, V24, P74; VISINTIN M, 1994, PARAPLEGIA, V32, P540, DOI 10.1038/sc.1994.86; Vizzard MA, 2006, PROG BRAIN RES, V152, P97, DOI 10.1016/S0079-6123(05)52007-7; WADE CE, 1984, MED SCI SPORT EXER, V16, P506, DOI 10.1249/00005768-198410000-00015; WADE CE, 1980, J APPL PHYSIOL, V49, P930, DOI 10.1152/jappl.1980.49.6.930; Wang J, 2012, SCAND J MED SCI SPOR, V22, P643, DOI 10.1111/j.1600-0838.2010.01288.x; Ward PJ, 2014, J NEUROTRAUM, V31, P819, DOI 10.1089/neu.2013.3082; Ward PJ, 2012, J NEUROTRAUM, V29, P2490, DOI 10.1089/neu.2012.2402; Yoshiyama M, 1999, UROLOGY, V54, P929, DOI 10.1016/S0090-4295(99)00234-4; Yoshiyama M, 2013, AM J PHYSIOL-RENAL, V304, pF390, DOI 10.1152/ajprenal.00574.2012; Yu L, 2003, KIDNEY INT, V64, P844, DOI 10.1046/j.1523-1755.2003.00162.x; Zhou TB, 2012, RENAL FAILURE, V34, P194, DOI 10.3109/0886022X.2011.643364; Zinck NDT, 2007, EXP NEUROL, V204, P777, DOI 10.1016/j.expneurol.2007.01.011	96	23	23	0	12	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	1931-857X	1522-1466		AM J PHYSIOL-RENAL	Am. J. Physiol.-Renal Physiol.	JUN 1	2016	310	11					F1258	F1268		10.1152/ajprenal.00557.2015			11	Physiology; Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology; Urology & Nephrology	DN9YM	WOS:000377436600014	26984956	Bronze, Green Published			2022-02-06	
J	Leng, TD; Si, HF; Li, J; Yang, T; Zhu, MY; Wang, BH; Simon, RP; Xiong, ZG				Leng, Tian-Dong; Si, Hong-Fang; Li, Jun; Yang, Tao; Zhu, Mengyuan; Wang, Binghe; Simon, Roger P.; Xiong, Zhi-Gang			Amiloride Analogs as ASIC1a Inhibitors	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						Acid-sensing ion channel; Amiloride; Benzamil; Neuroprotection; Stroke	SENSING ION CHANNELS; EXCHANGE INHIBITOR; HIPPOCAMPAL-NEURONS; BRAIN-INJURY; ACID; CONTRIBUTES; NA+; NEUROPROTECTION; ISCHEMIA; FEAR	Background: ASIC1a, the predominant acid-sensing ion channels (ASICs), is implicated in neurological disorders including stroke, traumatic spinal cord injury, and ALS. Potent ASIC1a inhibitors should have promising therapeutic potential for ASIC1a-related diseases. Aims: We examined the inhibitory effects of a number of amiloride analogs on ASIC1a currents, aimed at understanding the structure-activity relationship and identifying potent ASIC1a inhibitors for stroke intervention. Methods: Whole-cell patch-clamp techniques and a mouse model of middle cerebral artery occlusion (MCAO)-induced focal ischemia were used. Surflex-Dock was used to dock the analogs into the pocket with default parameters. Results: Amiloride and its analogs inhibit ASIC1a currents expressed in Chinese hamster ovary cells with a potency rank order of benzamil > phenamil > 5-(N, N-dimethyl) amiloride (DMA) > amiloride > 5-(N, N-hexamethylene) amiloride (HMA) >= 5-(N-methyl-N-isopropyl) amiloride (MIA) > 5-(N-ethyl-N-isopropyl) amiloride (EIPA). In addition, amiloride and its analogs inhibit ASIC currents in cortical neurons with the same potency rank order. In mice, benzamil and EIPA decreased MCAO-induced infarct volume. Similar to its effect on the ASIC current, benzamil showed a much higher potency than EIPA. Conclusion: Addition of a benzyl group to the terminal guanidinyl group resulted in enhanced inhibitory activity on ASIC1a. On the other hand, the bulky groups added to the 5-amino residues slightly decreased the activity. Among the tested amiloride analogs, benzamil is the most potent ASIC1a inhibitor.	[Leng, Tian-Dong; Yang, Tao; Simon, Roger P.; Xiong, Zhi-Gang] Morehouse Sch Med, Neurosci Inst, 720 Westview Dr SW, Atlanta, GA 30310 USA; [Si, Hong-Fang; Li, Jun] Anhui Med Univ, Sch Pharm, Hefei, Anhui, Peoples R China; [Zhu, Mengyuan; Wang, Binghe] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; [Zhu, Mengyuan; Wang, Binghe] Georgia State Univ, Ctr Diagnost & Therapeut, Atlanta, GA 30303 USA		Xiong, ZG (corresponding author), Morehouse Sch Med, Neurosci Inst, 720 Westview Dr SW, Atlanta, GA 30310 USA.; Wang, BH (corresponding author), Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA.; Wang, BH (corresponding author), Georgia State Univ, Ctr Diagnost & Therapeut, Atlanta, GA 30303 USA.	wang@gsu.edu; zxiong@msm.edu	Wang, Binghe/D-4257-2009	Wang, Binghe/0000-0002-2200-5270	NIMHD [S21MD000101, U54NS08932]; AHAAmerican Heart Association [084013];  [R01NS066027]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS066027, U54NS083932] Funding Source: NIH RePORTER; National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [S21MD000101] Funding Source: NIH RePORTER	This work is supported by R01NS066027, NIMHD S21MD000101, U54NS08932, and AHA 084013.	Antcliff A C, 1972, Br J Clin Pract, V26, P413; Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Chen XM, 2010, NEUROPHARMACOLOGY, V58, P1045, DOI 10.1016/j.neuropharm.2010.01.011; Coryell MW, 2007, BIOL PSYCHIAT, V62, P1140, DOI 10.1016/j.biopsych.2007.05.008; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Duan B, 2007, J NEUROSCI, V27, P11139, DOI 10.1523/JNEUROSCI.3364-07.2007; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Gregoire S, 2009, J NEUROSCI, V29, P6053, DOI 10.1523/JNEUROSCI.0752-09.2009; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Hwang IK, 2008, EXP NEUROL, V212, P314, DOI 10.1016/j.expneurol.2008.04.007; Jain AN, 2007, J COMPUT AID MOL DES, V21, P281, DOI 10.1007/s10822-007-9114-2; Jain AN, 1996, J COMPUT AID MOL DES, V10, P427, DOI 10.1007/BF00124474; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Jeon D, 2008, CELL CALCIUM, V43, P482, DOI 10.1016/j.ceca.2007.08.003; Johanson CE, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-10; Kendall GS, 2006, PEDIATR RES, V59, P227, DOI 10.1203/01.pdr.0000196805.68082.22; KLEYMAN TR, 1988, J MEMBRANE BIOL, V105, P1, DOI 10.1007/BF01871102; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Leng TD, 2015, CNS NEUROSCI THER, V21, P32, DOI 10.1111/cns.12318; Leng TD, 2013, ACTA PHARMACOL SIN, V34, P33, DOI 10.1038/aps.2012.81; Leng TD, 2014, PROG NEUROBIOL, V115, P189, DOI 10.1016/j.pneurobio.2013.12.008; Leng TD, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-27; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Matsuda T, 2001, J PHARMACOL EXP THER, V298, P249; MCKEAN W I, 1970, New Zealand Medical Journal, V72, P110; Miteva MA, 2005, J MED CHEM, V48, P6012, DOI 10.1021/jm050262h; Phillis JW, 1999, BRAIN RES, V839, P199, DOI 10.1016/S0006-8993(99)01705-9; Pignataro G, 2004, STROKE, V35, P2566, DOI 10.1161/01.STR.0000143730.29964.93; Pignataro G, 2007, BRAIN, V130, P151, DOI 10.1093/brain/awl325; Pignataro Giuseppe, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P1; Pignataro G, 2011, J CEREBR BLOOD F MET, V31, P362, DOI 10.1038/jcbfm.2010.100; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Qadri YJ, 2012, AM J PHYSIOL-CELL PH, V302, pC943, DOI 10.1152/ajpcell.00019.2012; Schroder UH, 1999, NEUROPHARMACOLOGY, V38, P319, DOI 10.1016/S0028-3908(98)00198-1; Sobolevsky AI, 1999, NEUROPHARMACOLOGY, V38, P1235, DOI 10.1016/S0028-3908(99)00040-4; Ugawa S, 2002, J CLIN INVEST, V110, P1185, DOI 10.1172/JCI200215709; Voilley N, 2001, J NEUROSCI, V21, P8026, DOI 10.1523/JNEUROSCI.21-20-08026.2001; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wang X, 2008, AM J PHYSIOL-RENAL, V295, pF272, DOI 10.1152/ajprenal.00200.2007; Wang YP, 2008, EUR J NEUROSCI, V28, P51, DOI 10.1111/j.1460-9568.2008.06304.x; Wang YZ, 2011, MOL NEUROBIOL, V44, P350, DOI 10.1007/s12035-011-8204-2; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wong HK, 2008, HUM MOL GENET, V17, P3223, DOI 10.1093/hmg/ddn218; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100	50	23	25	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	JUN	2016	22	6					468	476		10.1111/cns.12524			9	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	DS8DH	WOS:000381012800005	26890278	Green Accepted, Green Published			2022-02-06	
J	Robinson, S; Winer, JL; Berkner, J; Chan, LAS; Denson, JL; Maxwell, JR; Yang, YR; Sillerud, LO; Tasker, RC; Meehan, WP; Mannix, R; Jantzie, LL				Robinson, Shenandoah; Winer, Jesse L.; Berkner, Justin; Chan, Lindsay A. S.; Denson, Jesse L.; Maxwell, Jessie R.; Yang, Yirong; Sillerud, Laurel O.; Tasker, Robert C.; Meehan, William P., III; Mannix, Rebekah; Jantzie, Lauren L.			Imaging and serum biomarkers reflecting the functional efficacy of extended erythropoietin treatment in rats following infantile traumatic brain injury	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						controlled cortical impact; diffusion tensor imaging; diffusivity; erythropoietin; infant; serum biomarker; traumatic brain injury; trauma	CONTROLLED CORTICAL IMPACT; DOSE RECOMBINANT ERYTHROPOIETIN; OLIGODENDROCYTE PRECURSOR PROLIFERATION; CHLORIDE CO-TRANSPORTERS; DEVELOPING SPINAL-CORD; BIRTH-WEIGHT INFANTS; CLOSED-HEAD INJURY; PRETERM INFANTS; IMMATURE RAT; NEONATAL-RATS	OBJECTIVE Traumatic brain injury (TBI) is a leading cause of death and severe morbidity for otherwise healthy full term infants around the world. Currently, the primary treatment for infant TBI is supportive, as no targeted therapies exist to actively promote recovery. The developing infant brain, in particular, has a unique response to injury and the potential for repair, both of which vary with maturation. Targeted interventions and objective measures of therapeutic efficacy are needed in this special population. The authors hypothesized that MRI and serum biomarkers can be used to quantify outcomes following infantile TBI in a preclinical rat model and that the potential efficacy of the neuro-reparative agent erythropoietin (EPO) in promoting recovery can be tested using these biomarkers as surrogates for functional outcomes. METHODS With institutional approval, a controlled cortical impact (CCI) was delivered to postnatal Day (P)12 rats of both sexes (76 rats). On postinjury Day (PID)1, the 49 CCI rats designated for chronic studies were randomized to EPO (3000 U/kg/dose, CCI-EPO, 24 rats) or vehicle (CCI-veh, 25 rats) administered intraperitoneally on PID1-4, 6, and 8. Acute injury (PID3) was evaluated with an immunoassay of injured cortex and serum, and chronic injury (PID13-28) was evaluated with digitized gait analyses, MRI, and serum immunoassay. The CCI-veh and CCI-EPO rats were compared with shams (49 rats) primarily using 2-way ANOVA with Bonferroni post hoc correction. RESULTS Following CCI, there was 4.8% mortality and 55% of injured rats exhibited convulsions. Of the injured rats designated for chronic analyses, 8.1% developed leptomeningeal cyst like lesions verified with MRI and were excluded from further study. On PID3, Western blot showed that EPO receptor expression was increased in the injured cortex (p = 0.008). These Western blots also showed elevated ipsilateral cortex calpain degradation products for all-spectrin (alpha II-SDPs; p < 0.001), potassium chloride cotransporter 2 (KCC2-DPs; p = 0.037), and glial fibrillary acidic protein (GFAP-DPs; p = 0.002), as well as serum GFAP (serum GFAP-DPs; p = 0.001). In injured rats multiplex electrochemiluminescence analyses on PID3 revealed elevated serum tumor necrosis factor alpha (TNF alpha; p = 0.01) and chemokine (CXC) ligand 1 (CXCL1). Chronically, that is, in PID13-16 CCI-veh rats, as compared with sham rats, gait deficits were demonstrated (p = 0.033) but then were reversed (p = 0.022) with EPO treatment. Diffusion tensor MRI of the ipsilateral and contralateral cortex and white matter in PID16-23 CCI-veh rats showed widespread injury and significant abnormalities of functional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD); MD, AD, and RD improved after EPO treatment. Chronically, P13-P28 CCI-veh rats also had elevated serum CXCL1 levels, which normalized in CCI-EPO rats. CONCLUSIONS Efficient translation of emerging neuro-reparative interventions dictates the use of age-appropriate preclinical models with human clinical trial compatible biomarkers. In the present study, the authors showed that CCI produced chronic gait deficits in P12 rats that resolved with EPO treatment and that chronic imaging and serum biomarkers correlated with this improvement.	[Robinson, Shenandoah; Winer, Jesse L.; Berkner, Justin; Chan, Lindsay A. S.; Tasker, Robert C.; Meehan, William P., III; Mannix, Rebekah] Harvard Univ, Sch Med, Brain Injury Ctr, Boston, MA USA; [Robinson, Shenandoah; Winer, Jesse L.; Chan, Lindsay A. S.] Harvard Univ, Sch Med, Dept Neurosurg, Boston, MA USA; [Robinson, Shenandoah; Tasker, Robert C.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Berkner, Justin; Mannix, Rebekah] Harvard Univ, Sch Med, Dept Emergency Med, Boston, MA USA; [Meehan, William P., III] Harvard Univ, Sch Med, Dept Sports Med, Boston, MA USA; [Tasker, Robert C.] Harvard Univ, Sch Med, Dept Anesthesiol, Boston, MA USA; [Robinson, Shenandoah] Harvard Univ, Sch Med, FM Kirby Ctr Neurobiol, Boston Childrens Hosp, Boston, MA USA; [Denson, Jesse L.; Maxwell, Jessie R.; Jantzie, Lauren L.] Univ New Mexico, Sch Med, Dept Pediat, Albuquerque, NM 87131 USA; [Jantzie, Lauren L.] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA; [Yang, Yirong; Sillerud, Laurel O.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA		Robinson, S (corresponding author), Boston Childrens Hosp, Dept Neurosurg, 300 Longwood Ave, Boston, MA 02115 USA.	shenandoah.robinson@childrens.harvard.edu	Tasker, Robert C/R-5837-2019; Mannix, Rebekah/AAD-8702-2020; Maxwell, Jessie R./N-1890-2019	Maxwell, Jessie R./0000-0001-8990-7239; Tasker, Robert/0000-0003-3647-8113	Dedicated Health Research funds from the University of New Mexico School of Medicine; Centers for Biomedical Research Excellence Pilot Award [CoBRE P30GM103400/PI:Liu]; Boston Children's Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P30GM103400] Funding Source: NIH RePORTER	We thank Eun-Hyoung Park, PhD, for her excellent assistance with the MATLAB illustrations. This project was supported in part by the Dedicated Health Research funds from the University of New Mexico School of Medicine and the Centers for Biomedical Research Excellence Pilot Award to Lauren L. Jantzie, PhD (CoBRE P30GM103400/PI:Liu), and Boston Children's Hospital.	Adelson PD, 2013, CHILD NERV SYST, V29, P43, DOI 10.1007/s00381-012-1932-4; Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; Aloizos S, 2015, TURK NEUROSURG, V25, P552, DOI 10.5137/1019-5149.JTN.9685-14.4; Anblagan D, 2015, NEUROIMAGE-CLIN, V8, P51, DOI 10.1016/j.nicl.2015.03.021; Arango JI, 2012, CHILD NERV SYST, V28, P1925, DOI 10.1007/s00381-012-1863-0; Aung Wint Yan, 2013, Imaging Med, V5, P427; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Blaesse P, 2015, PFLUG ARCH EUR J PHY, V467, P615, DOI 10.1007/s00424-014-1547-6; Bondi CO, 2014, NEUROSCI BIOBEHAV RE; Bonislawski DP, 2007, NEUROBIOL DIS, V25, P163, DOI 10.1016/j.nbd.2006.09.002; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Boutte A.M., 2015, J NEUROTRAUMA; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Campbell SL, 2015, GLIA, V63, P23, DOI 10.1002/glia.22730; Cao DL, 2014, EXP NEUROL, V261, P328, DOI 10.1016/j.expneurol.2014.05.014; Chen CY, 2013, DEV NEUROSCI-BASEL, V35, P474, DOI 10.1159/000355874; Dennis EL, 2015, NEUROIMAGE-CLIN, V7, P493, DOI 10.1016/j.nicl.2015.02.002; Dent KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121541; Di Battista AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00110; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Donelan JM, 2004, J BIOMECH, V37, P827, DOI 10.1016/j.jbiomech.2003.06.002; Edman LC, 2008, STEM CELLS, V26, P1891, DOI 10.1634/stemcells.2007-0753; Fauchere JC, 2008, PEDIATRICS, V122, P375, DOI 10.1542/peds.2007-2591; Fauchere JC, 2015, J PEDIATR-US, V167, P52, DOI 10.1016/j.jpeds.2015.02.052; Fraser DD, 2011, PEDIATR CRIT CARE ME, V12, P319, DOI 10.1097/PCC.0b013e3181e8b32d; Gobbel GT, 2007, CHILD NERV SYST, V23, P1171, DOI 10.1007/s00381-007-0345-2; Gu XH, 2015, EXP NEUROL, V267, P135, DOI 10.1016/j.expneurol.2015.02.029; Hellewell SC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-156; Huang XJ, 2015, J NEUROTRAUM, V32, P1179, DOI 10.1089/neu.2015.3873; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Huppi PS, 2006, SEMIN FETAL NEONAT M, V11, P489, DOI 10.1016/j.siny.2006.07.006; Jantzie LL, 2014, MOL CELL NEUROSCI, V61, P152, DOI 10.1016/j.mcn.2014.06.009; Jantzie LL, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00347; Jantzie LL, 2015, CEREB CORTEX, V25, P2683, DOI 10.1093/cercor/bhu066; Jantzie LL, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-131; Jantzie LL, 2013, PEDIATR RES, V74, P658, DOI 10.1038/pr.2013.155; Jantzie LL, 2015, DEV NEUROSCI; Juul SE, 2008, PEDIATRICS, V122, P383, DOI 10.1542/peds.2007-2711; Keller M, 2006, NEUROBIOL DIS, V24, P357, DOI 10.1016/j.nbd.2006.07.007; Kellert BA, 2007, PEDIATR RES, V61, P451, DOI 10.1203/pdr.0b013e3180332cec; Knabe W, 2005, ANAT EMBRYOL, V210, P209, DOI 10.1007/s00429-005-0019-3; Knabe W, 2004, ANAT EMBRYOL, V207, P503, DOI 10.1007/s00429-003-0365-y; Kocaman C, 2012, BRAIN DEV-JPN, V34, P133, DOI 10.1016/j.braindev.2011.04.003; Leuchter RHV, 2014, JAMA-J AM MED ASSOC, V312, P817, DOI 10.1001/jama.2014.9645; Leventhal JM, 2010, PEDIATRICS, V126, pE104, DOI 10.1542/peds.2009-1076; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mannix R, 2014, J NEUROSURG, V121, P1337, DOI 10.3171/2014.8.JNS14715; Mannix RC, 2013, BRAIN INJURY, V27, P743, DOI 10.3109/02699052.2013.771797; Mannix RC, 2011, J NEUROTRAUM, V28, P1855, DOI 10.1089/neu.2011.1759; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; Mazur M, 2010, J NEUROSURG-PEDIATR, V6, P206, DOI 10.3171/2010.5.PEDS1032; McAdams RM, 2013, J PERINATOL, V33, P226, DOI 10.1038/jp.2012.78; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; Meng YL, 2011, J NEUROSURG, V115, P550, DOI 10.3171/2011.3.JNS101721; Ment LR, 2009, LANCET NEUROL, V8, P1042, DOI 10.1016/S1474-4422(09)70257-1; Miller TR, 2014, PEDIATRICS, V134, pE1545, DOI 10.1542/peds.2014-1385; Miskowiak KW, 2014, J CLIN PSYCHIAT, V75, P1347, DOI 10.4088/JCP.13m08839; Miskowiak KW, 2014, NEUROPSYCHOPHARMACOL, V39, P1399, DOI 10.1038/npp.2013.335; Murray KJ, 2009, INJURY PREV, V15, P240, DOI 10.1136/ip.2009.021550; O'Neill BR, 2015, J NEUROSURG-PEDIATR, V16, P167, DOI 10.3171/2014.12.PEDS14263; Ohls RK, 2014, PEDIATRICS, V133, P1023, DOI 10.1542/peds.2013-4307; Pallud J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008065; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Pellegrino C, 2011, J PHYSIOL-LONDON, V589, P2475, DOI 10.1113/jphysiol.2010.203703; Peng WJ, 2014, J NEUROSURG, V121, P653, DOI 10.3171/2014.6.JNS132577; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Ponce Lucido L, 2013, Pathophysiology, V20, P31, DOI 10.1016/j.pathophys.2012.02.005; Puskarjov M, 2012, J NEUROSCI, V32, P11356, DOI 10.1523/JNEUROSCI.6265-11.2012; Quayle KS, 2014, NEW ENGL J MED, V371, P1945, DOI 10.1056/NEJMc1407902; Raghupathi R, 2007, J NEUROTRAUM, V24, P1596, DOI 10.1089/neu.2007.3790; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Robinson S, 1998, J NEUROSCI, V18, P10457; Robinson S, 2001, DEV NEUROSCI-BASEL, V23, P338, DOI 10.1159/000048717; Robinson S, 2010, J NEUROPATH EXP NEUR, V69, P565, DOI 10.1097/NEN.0b013e3181dd25bc; Rutkoski JD, 2011, J SURG RES, V166, P199, DOI 10.1016/j.jss.2010.05.051; Sanford RA, 2010, J NEUROSURG-PEDIATR, V5, P213, DOI 10.3171/2009.9.PEDS09180; Sashindranath M, 2015, BEHAV BRAIN RES, V286, P33, DOI 10.1016/j.bbr.2015.02.038; Schober ME, 2015, NEUROTRAUMA; Schober ME, 2014, BRAIN RES, V1574, P105, DOI 10.1016/j.brainres.2014.05.046; Schober ME, 2014, J NEUROTRAUM, V31, P358, DOI 10.1089/neu.2013.2922; Semple BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103386; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Shang Y, 2007, APOPTOSIS, V12, P2187, DOI 10.1007/s10495-007-0141-1; Sierra A, 2015, BRAIN STRUCT FUNCT, V220, P781, DOI 10.1007/s00429-013-0683-7; Sivakumaran S, 2015, J NEUROSCI, V35, P8291, DOI 10.1523/JNEUROSCI.5205-14.2015; Soblosky JS, 1996, BEHAV BRAIN RES, V79, P79, DOI 10.1016/0166-4328(95)00264-2; Statler PA, 2007, PEDIATR RES, V61, P671, DOI 10.1203/pdr.0b013e31805341dc; Tasker RC, 2010, DEV NEUROSCI-BASEL, V32, P374, DOI 10.1159/000316806; Tsai HH, 2002, CELL, V110, P373, DOI 10.1016/S0092-8674(02)00838-3; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Webster SJ, 2015, J NEUROSCI, V35, P6554, DOI 10.1523/JNEUROSCI.0291-15.2015; Winkelmann A, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.127; Wu Q, 2000, J NEUROSCI, V20, P2609; Wu YW, 2012, PEDIATRICS, V130, P683, DOI 10.1542/peds.2012-0498; Xiong Y, 2011, J NEUROSURG, V114, P549, DOI 10.3171/2010.10.JNS10925; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Xu J, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-38; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Zhang Z, 2015, J NEUROTRAUM, V32, P1369, DOI 10.1089/neu.2014.3701; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698; Zhou HY, 2012, J BIOL CHEM, V287, P33853, DOI 10.1074/jbc.M112.395830	108	23	23	0	7	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JUN	2016	17	6					739	755		10.3171/2015.10.PEDS15554			17	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	DM6PX	WOS:000376476000018	26894518	Bronze, Green Accepted			2022-02-06	
J	Iverson, GL; Gioia, GA				Iverson, Grant L.; Gioia, Gerard A.			Returning to School Following Sport-Related Concussion	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Sports; Concussion; Mild traumatic brain injury; TBI; Youth; Pediatric		Following sport-related concussion, the priorities for student athletes are return to school and extracurricular activities. Consensus-based practice recommendations emphasize rest and gradual resumption of activities. Specific evidence-based recommendations are not available. This article provides recommendations, strategies, and a general approach to the recovery process. Most youth recover clinically and return to their normal activities within the first month following injury. It is best to avoid prolonged time off from school and restrictions on social and recreational activities because these might result in adverse consequences, such as life stress, depression, and falling behind in school.	[Iverson, Grant L.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.] MassGen Hosp Children, Sport Concuss Program, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Red Sox Fdn, Home Base Program, Boston, MA 02114 USA; [Iverson, Grant L.] Harvard Univ, Sch Med, Ctr Hlth & Rehabil, Dept Phys Med & Rehabil, 79-96 Thirteenth St, Charlestown, MA 02129 USA; [Gioia, Gerard A.] George Washington Univ, Sch Med, Dept Pediat & Psychiat & Behav Sci, Div Pediat Neuropsychol,Childrens Natl Hlth Syst, 15245 Shady Grove Rd,Suite 350, Rockville, MD 20850 USA		Gioia, GA (corresponding author), George Washington Univ, Sch Med, Dept Pediat & Psychiat & Behav Sci, Div Pediat Neuropsychol,Childrens Natl Hlth Syst, 15245 Shady Grove Rd,Suite 350, Rockville, MD 20850 USA.	ggioia@childrensnational.org		Iverson, Grant/0000-0001-7348-9570	CDCCentre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U17/CCU323352, U49CE001385]; NIH from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [M01RR020359]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30/HD040677-07]	G. Gioia notes that this article was supported in part by CDC Awards U17/CCU323352 and U49CE001385, and NIH Grants #M01RR020359 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH #P30/HD040677-07.	[Anonymous], 2011, BRAIN 101 CONCUSSION; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Centers for Disease Control and Prevention, 2015, HEADS SCH KNOW YOUR; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Collins MW, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P498; Gioia GA, 2015, J HEAD TRAUMA REHABI; Gioia GA, 2016, J CHILD NEUROL, V31, P93, DOI 10.1177/0883073814555604; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Pennsylvania Department of Education Brain Injury Association of Pennsylvania Pennsylvania Department of Health, BRAINSTEPS STRAT TEA; Rocky Mountain Hospital for Children, CONC MAN REAP 2015; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008	12	23	23	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	MAY	2016	27	2					429	+		10.1016/j.pmr.2015.12.002			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	DN4RU	WOS:000377055700006	27154854				2022-02-06	
J	Kokiko-Cochran, O; Ransohoff, L; Veenstra, M; Lee, S; Saber, M; Sikora, M; Teknipp, R; Xu, GX; Bemiller, S; Wilson, G; Crish, S; Bhaskar, K; Lee, YS; Ransohoff, RM; Lamb, BT				Kokiko-Cochran, Olga; Ransohoff, Lena; Veenstra, Mike; Lee, Sungho; Saber, Maha; Sikora, Matt; Teknipp, Ryan; Xu, Guixiang; Bemiller, Shane; Wilson, Gina; Crish, Samuel; Bhaskar, Kiran; Lee, Yu-Shang; Ransohoff, Richard M.; Lamb, Bruce T.			Altered Neuroinflammation and Behavior after Traumatic Brain Injury in a Mouse Model of Alzheimer's Disease	JOURNAL OF NEUROTRAUMA			English	Article						Alzheimer's disease; traumatic brain injury; neuroinflammation; macrophage	AMYLOID PRECURSOR PROTEIN; CENTRAL-NERVOUS-SYSTEM; CONTROLLED CORTICAL IMPACT; FLUID PERCUSSION INJURY; A-BETA DEPOSITION; HEAD-INJURY; TRANSGENIC MICE; RISK-FACTOR; FRONTOTEMPORAL DEMENTIA; MICROGLIAL ACTIVATION	Traumatic brain injury (TBI) has acute and chronic sequelae, including an increased risk for the development of Alzheimer's disease (AD). TBI-associated neuroinflammation is characterized by activation of brain-resident microglia and infiltration of monocytes; however, recent studies have implicated beta-amyloid as a major manipulator of the inflammatory response. To examine neuroinflammation after TBI and development of AD-like features, these studies examined the effects of TBI in the presence and absence of beta-amyloid. The R1.40 mouse model of cerebral amyloidosis was used, with a focus on time points well before robust AD pathologies. Unexpectedly, in R1.40 mice, the acute neuroinflammatory response to TBI was strikingly muted, with reduced numbers of CNS myeloid cells acquiring a macrophage phenotype and decreased expression of inflammatory cytokines. At chronic time points, macrophage activation substantially declined in non-Tg TBI mice; however, it was relatively unchanged in R1.40 TBI mice. The persistent inflammatory response coincided with significant tissue loss between 3 and 120 days post-injury in R1.40 TBI mice, which was not observed in non-Tg TBI mice. Surprisingly, inflammatory cytokine expression was enhanced in R1.40 mice compared with non-Tg mice, regardless of injury group. Although R1.40 TBI mice demonstrated task-specific deficits in cognition, overall functional recovery was similar to non-Tg TBI mice. These findings suggest that accumulating beta-amyloid leads to an altered post-injury macrophage response at acute and chronic time points. Together, these studies emphasize the role of post-injury neuroinflammation in regulating long-term sequelae after TBI and also support recent studies implicating beta-amyloid as an immunomodulator.	[Kokiko-Cochran, Olga; Ransohoff, Lena; Veenstra, Mike; Lee, Sungho; Saber, Maha; Sikora, Matt; Teknipp, Ryan; Xu, Guixiang; Bemiller, Shane; Lee, Yu-Shang; Lamb, Bruce T.] Cleveland Clin, Dept Neurosci, NC30,9500 Euclid Ave, Cleveland, OH 44195 USA; [Wilson, Gina; Crish, Samuel] Northeast Ohio Med Univ, Dept Pharmaceut Sci, Rootstown, OH USA; [Bhaskar, Kiran] Univ New Mexico, Dept Mol Genet Microbiol & Neurol, Albuquerque, NM 87131 USA; [Ransohoff, Richard M.] Biogen Idec Inc, Cambridge, MA USA; [Lamb, Bruce T.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Lamb, Bruce T.] Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA		Lamb, BT (corresponding author), Cleveland Clin, Dept Neurosci, NC30,9500 Euclid Ave, Cleveland, OH 44195 USA.	lambb@ccf.org	Bhaskar, Kiran/AAF-2755-2020	Lee, Sungho/0000-0003-2111-5504	NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY022358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS083704, R01NS069765] Funding Source: NIH RePORTER; NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [EY022358, R01 EY022358] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RF1 NS083704, R01 NS069765] Funding Source: Medline		Abrahamson EE, 2006, EXP NEUROL, V197, P437, DOI 10.1016/j.expneurol.2005.10.011; Abrahamson EE, 2009, ANN NEUROL, V66, P407, DOI 10.1002/ana.21731; Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Bhaskar K, 2014, NEUROBIOL DIS, V62, P273, DOI 10.1016/j.nbd.2013.10.007; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; Cady J, 2014, JAMA NEUROL, V71, P449, DOI 10.1001/jamaneurol.2013.6237; Campanella M, 2002, STROKE, V33, P586, DOI 10.1161/hs0202.103399; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Cardona AE, 2006, NAT PROTOC, V1, P1947, DOI 10.1038/nprot.2006.327; Carson MJ, 1998, GLIA, V22, P72, DOI 10.1002/(SICI)1098-1136(199801)22:1<72::AID-GLIA7>3.0.CO;2-A; Ciallella JR, 2002, J NEUROTRAUM, V19, P1555, DOI 10.1089/089771502762300229; Corrigan F, 2014, J NEUROCHEM, V128, P196, DOI 10.1111/jnc.12391; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Engel S, 2000, ACTA NEUROPATHOL, V100, P313, DOI 10.1007/s004019900172; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Grant JL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004145; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guerreiro RJ, 2013, JAMA NEUROL, V70, P78, DOI 10.1001/jamaneurol.2013.579; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Jiang Y, 2012, J NEUROTRAUM, V29, P2332, DOI 10.1089/neu.2012.2362; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kawabori M, 2015, J NEUROSCI, V35, P3384, DOI 10.1523/JNEUROSCI.2620-14.2015; Krabbe G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060921; LAMB BT, 1993, NAT GENET, V5, P22, DOI 10.1038/ng0993-22; Lamb BT, 1997, HUM MOL GENET, V6, P1535, DOI 10.1093/hmg/6.9.1535; Lee CYD, 2010, J NEURAL TRANSM, V117, P949, DOI 10.1007/s00702-010-0433-4; Lill C.M., 2015, ALZHEIMERS DEMENT; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; LUBERNAROD J, 1988, NEUROSCI LETT, V94, P17, DOI 10.1016/0304-3940(88)90263-7; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; MCGEER PL, 1988, ACTA NEUROPATHOL, V76, P550, DOI 10.1007/BF00689592; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Murai H, 1998, J COMP NEUROL, V392, P428, DOI 10.1002/(SICI)1096-9861(19980323)392:4<428::AID-CNE2>3.0.CO;2-2; Nakagawa Y, 1999, J COMP NEUROL, V411, P390; Nakagawa Y, 2000, EXP NEUROL, V163, P244, DOI 10.1006/exnr.2000.7375; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Ferreira APO, 2014, PSYCHOPHARMACOLOGY, V231, P1935, DOI 10.1007/s00213-013-3336-x; Pajoohesh-Ganji A, 2014, BRAIN RES, V1560, P73, DOI 10.1016/j.brainres.2014.02.049; Pan XD, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-45; Pierce JES, 1996, J NEUROSCI, V16, P1083; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Rayaprolu S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-19; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; ROGERS J, 1988, NEUROBIOL AGING, V9, P339, DOI 10.1016/S0197-4580(88)80079-4; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Schwetye KE, 2010, NEUROBIOL DIS, V40, P555, DOI 10.1016/j.nbd.2010.06.018; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Sieber MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052982; Smith DH, 1998, AM J PATHOL, V153, P1005, DOI 10.1016/S0002-9440(10)65643-X; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Tajiri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078851; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Thal DR, 2000, ACTA NEUROPATHOL, V100, P608, DOI 10.1007/s004010000242; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Vlad SC, 2008, NEUROLOGY, V70, P1672, DOI 10.1212/01.wnl.0000311269.57716.63; Washington PM, 2014, J NEUROTRAUM, V31, P125, DOI 10.1089/neu.2013.3017; Webster SJ, 2015, J NEUROSCI, V35, P6554, DOI 10.1523/JNEUROSCI.0291-15.2015; Whiting M. D., INJURY MODELS CENTRA	79	23	23	0	13	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2016	33	7					625	640		10.1089/neu.2015.3970			16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DI6QK	WOS:000373624700002	26414955	Green Published			2022-02-06	
J	Mittwede, PN; Clemmer, JS; Bergin, PF; Xiang, LS				Mittwede, Peter N.; Clemmer, John S.; Bergin, Patrick F.; Xiang, Lusha			OBESITY AND CRITICAL ILLNESS: INSIGHTS FROM ANIMAL MODELS	SHOCK			English	Article						Animal model; critical illness; hemorrhage; obese; sepsis; trauma	TRAUMATIC BRAIN-INJURY; DIET-INDUCED OBESITY; ACUTE KIDNEY INJURY; BODY-MASS INDEX; HIGH-FAT DIET; IMMUNE-RESPONSE; FUNCTIONAL VASODILATION; INFLAMMATORY RESPONSES; HEPATIC-DYSFUNCTION; INCREASED MORTALITY	Critical illness is a major cause of morbidity and mortality around the world. While obesity is often detrimental in the context of trauma, it is paradoxically associated with improved outcomes in some septic patients. The reasons for these disparate outcomes are not well understood. A number of animal models have been used to study the obese response to various forms of critical illness. Just as there have been many animal models that have attempted to mimic clinical conditions, there are many clinical scenarios that can occur in the highly heterogeneous critically ill patient population that occupies hospitals and intensive care units. This poses a formidable challenge for clinicians and researchers attempting to understand the mechanisms of disease and develop appropriate therapies and treatment algorithms for specific subsets of patients, including the obese. The development of new, and the modification of existing animal models, is important in order to bring effective treatments to a wide range of patients. Not only do experimental variables need to be matched as closely as possible to clinical scenarios, but animal models with pre-existing comorbid conditions need to be studied. This review briefly summarizes animal models of hemorrhage, blunt trauma, traumatic brain injury, and sepsis. It also discusses what has been learned through the use of obese models to study the pathophysiology of critical illness in light of what has been demonstrated in the clinical literature.	[Mittwede, Peter N.; Clemmer, John S.; Xiang, Lusha] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Bergin, Patrick F.] Univ Mississippi, Med Ctr, Dept Orthoped Surg, Jackson, MS 39216 USA		Xiang, LS (corresponding author), 2500 North State St, Jackson, MS 39216 USA.	Lxiang2@umc.edu		Clemmer, John/0000-0003-2250-2960	American Heart AssociationAmerican Heart Association [14PRE17810005, 14PRE20380069, 12SDG12050525]; Depuy-Synthes, Acumed, National Institutes of Health [P20GM104357]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P20GM104357]; Orthopaedic Trauma Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM104357] Funding Source: NIH RePORTER	PNM: American Heart Association (14PRE17810005); Orthopaedic Trauma Association. JSC: American Heart Association (14PRE20380069). PFB: Depuy-Synthes, Acumed, National Institutes of Health (P20GM104357). LX: National Institutes of Health (P20GM104357); American Heart Association (12SDG12050525); Orthopaedic Trauma Association.	Andruszkow H, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/345702; Bosarge Patrick L, 2013, Adv Surg, V47, P287; Brown CVR, 2006, J TRAUMA, V61, P572, DOI 10.1097/01.ta.0000200842.19740.38; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Bussey CT, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0161-4; CHOBAN PS, 1991, J TRAUMA, V31, P1253, DOI 10.1097/00005373-199109000-00009; Clemmer JS, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12215; Collier B, 2010, J TRAUMA, V68, P57, DOI 10.1097/TA.0b013e3181c40262; de Lima DC, 2008, METAB BRAIN DIS, V23, P361, DOI 10.1007/s11011-008-9101-x; Deitch EA, 1998, SHOCK, V9, P1, DOI 10.1097/00024382-199801000-00001; Ditillo M, 2014, J TRAUMA ACUTE CARE, V76, P176, DOI 10.1097/TA.0b013e3182ab0d7c; Duburcq T, 2014, SHOCK, V41, P546, DOI 10.1097/SHK.0000000000000158; Dupuy V, 2012, SHOCK, V38, P351, DOI 10.1097/SHK.0b013e318268810f; Farooqi IS, 2005, ANNU REV MED, V56, P443, DOI 10.1146/annurev.med.56.062904.144924; Frink M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/797383; Frisbee JC, 2006, J APPL PHYSIOL, V100, P465, DOI 10.1152/japplphysiol.01062.2005; Frisbee JC, 2014, AM J PHYSIOL-HEART C, V307, pH1714, DOI 10.1152/ajpheart.00605.2014; Gadek JE, 1999, CRIT CARE MED, V27, P1409, DOI 10.1097/00003246-199908000-00001; Gharib M, 2015, J TRAUMA ACUTE CARE, V78, P866, DOI 10.1097/TA.0000000000000597; Glance LG, 2014, ANN SURG, V259, P576, DOI 10.1097/SLA.0000000000000330; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Griffiths J, 2013, CRIT CARE, V28, P7; Guo RF, 2007, ANTIOXID REDOX SIGN, V9, P1991, DOI 10.1089/ars.2007.1785; Hariri N, 2010, NUTR RES REV, V23, P270, DOI 10.1017/S0954422410000168; Henry ML, 2008, BLOOD COAGUL FIBRIN, V19, P124, DOI 10.1097/MBC.0b013e3282f41e56; Hoane MR, 2011, BEHAV BRAIN RES, V223, P119, DOI 10.1016/j.bbr.2011.04.028; Hogue CW, 2009, INTENS CARE MED, V35, P1152, DOI 10.1007/s00134-009-1424-5; Huttunen R, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-13; Hwabejire JO, 2015, AM J SURG, V209, P659, DOI 10.1016/j.amjsurg.2014.12.016; Iskander KN, 2013, PHYSIOL REV, V93, P1247, DOI 10.1152/physrev.00037.2012; Jensen GL, 2012, CURR OPIN CRIT CARE, V18, P206, DOI 10.1097/MCC.0b013e328351683a; Kaplan JM, 2012, OBESITY, V20, P1995, DOI 10.1038/oby.2012.40; Kapoor JR, 2010, AM HEART J, V159, P75, DOI 10.1016/j.ahj.2009.10.026; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Khan M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/719853; Kobbe P, 2008, SHOCK, V30, P686, DOI 10.1097/SHK.0b013e31816f257e; Kobbe P, 2008, SHOCK, V30, P43, DOI [10.1097/SHK.0b013e31815d190b, 10.1097/SHK.0b013e318d190b]; Kumar MA, 2012, NEUROCRIT CARE, V16, P286, DOI 10.1007/s12028-011-9576-x; Kuperman EF, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-377; Lasocki S, 2015, CRIT CARE MED, V43, P240, DOI 10.1097/CCM.0000000000000646; Lawrence CB, 2012, DIS MODEL MECH, V5, P649, DOI 10.1242/dmm.009068; Lichte P, 2012, CURR OPIN CRIT CARE, V18, P647, DOI 10.1097/MCC.0b013e328359fd57; Lilley E, 2015, SHOCK, V43, P304, DOI 10.1097/SHK.0000000000000318; Liu T, 2013, INJURY, V44, P1145, DOI 10.1016/j.injury.2012.10.038; Lomas-Niera JL, 2005, SHOCK, V24, P33, DOI 10.1097/01.shk.0000191411.48719.ab; Lord JM, 2014, LANCET, V384, P1455, DOI 10.1016/S0140-6736(14)60687-5; Lutz T.A., 2012, CURR PROT PHARM, V61, P1; Majde JA, 2003, J TRAUMA, V54, pS100, DOI 10.1097/01.TA.0000064503.24416.F4; Mariappan MM, 2014, AM J PHYSIOL-CELL PH, V306, pC202, DOI 10.1152/ajpcell.00144.2013; Marques MB, 2013, CRIT CARE MED, V41, P317, DOI 10.1097/CCM.0b013e318265f21c; Matheson PJ, 2012, J AM COLL SURGEONS, V214, P517, DOI 10.1016/j.jamcollsurg.2011.12.016; Matheson PJ, 2009, SURGERY, V146, P739, DOI 10.1016/j.surg.2009.06.037; McCully BH, 2014, J TRAUMA ACUTE CARE, V77, P873, DOI 10.1097/TA.0000000000000461; Medby C, 2014, SHOCK, V41, P47, DOI 10.1097/SHK.0000000000000117; Menzel CL, 2011, J SURG RES, V166, pE149, DOI 10.1016/j.jss.2010.11.914; Mittwede PN, 2015, CRIT CARE MED, V43, pE321, DOI 10.1097/CCM.0000000000000996; Mittwede PN, 2015, AM J PHYSIOL-RENAL, V308, pF157, DOI 10.1152/ajprenal.00537.2014; Nelson J, 2012, CRIT CARE, V16, DOI 10.1186/cc11334; Nilsson C, 2012, ACTA PHARMACOL SIN, V33, P173, DOI 10.1038/aps.2011.203; Oberholzer A, 2001, SHOCK, V16, P83, DOI 10.1097/00024382-200116020-00001; Pickkers P, 2013, CRIT CARE MED, V41, P1878, DOI 10.1097/CCM.0b013e31828a2aa1; Pieracci F, 2008, SURG INFECT, V9, P121, DOI 10.1089/sur.2007.039; Pini M, 2013, CYTOKINE, V61, P71, DOI 10.1016/j.cyto.2012.08.027; Prescott HC, 2014, CRIT CARE MED, V42, P1766, DOI 10.1097/CCM.0000000000000336; Redl H, 2005, SHOCK, V24, P88, DOI 10.1097/01.shk.0000191339.46777.63; Robinson MK, 2015, CRIT CARE MED, V43, P87, DOI 10.1097/CCM.0000000000000602; Rogers FB, 2012, J TRAUMA ACUTE CARE, V73, P511, DOI 10.1097/TA.0b013e3182588b54; Sakai S, 2013, J SURG RES, V185, P353, DOI 10.1016/j.jss.2013.06.002; Schreihofer AM, 2005, AM J PHYSIOL-REG I, V288, pR253, DOI 10.1152/ajpregu.00498.2004; Sebai M, 2011, AM J PHYSIOL-HEART C, V301, pH1090, DOI 10.1152/ajpheart.00233.2011; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Siegl D, 2014, ANESTHESIOLOGY, V121, P98, DOI 10.1097/ALN.0000000000000192; Singer G, 2009, SHOCK, V31, P275, DOI 10.1097/SHK.0b013e3181834ab3; Singh P, 2013, CLIN EXP PHARMACOL P, V40, P138, DOI 10.1111/1440-1681.12036; Speakman J, 2007, OBES REV, V8, P55, DOI 10.1111/j.1467-789X.2007.00319.x; Strandberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007605; Straub RH, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4688; Tagliaferri F, 2009, J TRAUMA, V66, P727, DOI 10.1097/TA.0b013e31815edefd; Takao K, 2015, P NATL ACAD SCI USA, V112, P1167, DOI 10.1073/pnas.1401965111; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Tsukamoto T, 2009, SHOCK, V31, P3, DOI 10.1097/SHK.0b013e31817fdabf; Vachharajani V, 2007, MICROCIRCULATION, V14, P223, DOI 10.1080/10739680601139153; Vachharajani V, 2006, MICROCIRCULATION, V13, P477, DOI 10.1080/10739680600777599; Valparaiso AP, 2015, J SURG RES, V194, P220, DOI 10.1016/j.jss.2014.10.025; Vincent JL, 2014, LANCET RESP MED, V2, P380, DOI 10.1016/S2213-2600(14)70061-X; Wacharasint P, 2013, CRIT CARE, V17, DOI 10.1186/cc12794; Winfield RD, 2014, NUTR CLIN PRACT, V29, P747, DOI 10.1177/0884533614553234; Winfield RD, 2013, J AM COLL SURGEONS, V216, P1193, DOI 10.1016/j.jamcollsurg.2013.01.055; Winfield RD, 2012, SHOCK, V37, P253, DOI 10.1097/SHK.0b013e3182449c0e; Winfield RD, 2010, CRIT CARE MED, V38, P51, DOI 10.1097/CCM.0b013e3181b08089; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Xiang LS, 2008, AM J PHYSIOL-HEART C, V294, pH1658, DOI 10.1152/ajpheart.01206.2007; Xiang LS, 2014, AM J PHYSIOL-HEART C, V307, pH621, DOI 10.1152/ajpheart.00208.2014; Xiang LS, 2014, AM J PHYSIOL-HEART C, V306, pH684, DOI 10.1152/ajpheart.00868.2013; Xiang LS, 2013, LIFE SCI, V93, P214, DOI 10.1016/j.lfs.2013.06.006; Xiang LS, 2010, MICROCIRCULATION, V17, P650, DOI 10.1111/j.1549-8719.2010.00061.x; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yuzefovych LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054059; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	100	23	24	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	APR	2016	45	4					349	358		10.1097/SHK.0000000000000512			10	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	DK2QY	WOS:000374760700003	26513706	Green Accepted			2022-02-06	
J	O'Donnell, ML; Alkemade, N; Creamer, MC; McFarlane, AC; Silove, D; Bryant, RA; Forbes, D				O'Donnell, Meaghan L.; Alkemade, Nathan; Creamer, Mark C.; McFarlane, Alexander C.; Silove, Derrick; Bryant, Richard A.; Forbes, David			The Long-Term Psychiatric Sequelae of Severe Injury: A 6-Year Follow-Up Study	JOURNAL OF CLINICAL PSYCHIATRY			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH; DISABILITY; DEPRESSION; BURDEN; FEAR; US	Objective: The impact of mental health on disease burden associated with injury represents a major public health issue, yet almost no information is available on the associated long-term mental health outcomes. The primary aim of this study was to assess the psychiatric outcomes 6 years after a severe injury and their subsequent impact on long-term disability. The secondary aim was to investigate the relationship between a mild traumatic brain injury (mTBI) and long-term psychiatric disorder and its impact on disability. Methods: From April 2004 to February 2006, randomly selected injury patients admitted to 4 hospitals across Australia were assessed during hospitalization and at 72 months after trauma (N = 592). Injury characteristics, the presence of an mTBI (ICD-9 criteria), and previous psychiatric history were assessed during hospitalization. Structured clinical interviews for psychiatric disorders (DSM-IV and DSM-5) and a self-report measure of disability (WHODAS II) were administered at 72 months. Results: At 72 months after a severe injury, 28% of patients met criteria for at least 1 psychiatric disorder, with 45% of those presenting with comorbid diagnoses. The most prevalent psychiatric disorder was a major depressive episode (11%) followed by substance use disorder (9%), agoraphobia (9%), posttraumatic stress disorder (6%), and generalized anxiety disorder (6%). The presence of any psychiatric disorder was found to increase the risk for disability (P<.001, odds ratio = 6.04). An mTBI was found to increase the risk for having some anxiety disorders but not to increase disability by itself. Conclusions: The long-term psychiatric consequences of severe injury are substantial and represent a significant contributor to long-term disability. This study points to an important intersection between injury and psychiatric disorder as a leading contributor to disease burden and suggests this growing burden will impose new challenges on health systems. (C) Copyright 2016 Physicians Postgraduate Press, Inc.	[O'Donnell, Meaghan L.; Alkemade, Nathan; Forbes, David] Phoenix Australia, Ctr Posttraumat Mental Hlth, Level 3,Alan Gilbert Bldg,161 Barry St, Carlton, Vic 3053, Australia; [O'Donnell, Meaghan L.; Alkemade, Nathan; Creamer, Mark C.; Forbes, David] Univ Melbourne, Dept Psychiat, Parkville, Vic, Australia; [Bryant, Richard A.] Univ New South Wales, Sch Psychol, Sydney, NSW, Australia; [Silove, Derrick] Univ New South Wales, Sch Psychiat, Sydney, NSW, Australia; [McFarlane, Alexander C.] Univ Adelaide, Ctr Traumat Stress, Adelaide, SA, Australia; [Silove, Derrick] Mental Hlth Ctr, Psychiat Res & Teaching Unit, Liverpool, NSW, Australia		O'Donnell, ML (corresponding author), Phoenix Australia, Ctr Posttraumat Mental Hlth, Level 3,Alan Gilbert Bldg,161 Barry St, Carlton, Vic 3053, Australia.	mod@unimelb.edu.au	Bryant, Richard/AAA-6479-2019	Bryant, Richard/0000-0002-9607-819X; O'Donnell, Meaghan/0000-0003-4349-0022; Forbes, David/0000-0001-9145-1605	National Health and Medical Research Council Program GrantNational Health and Medical Research Council of Australia [568970]	This study was supported by a National Health and Medical Research Council Program Grant (568970).	Andrews G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008343; Andruszkow H, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-26; Aziz Mohamed A, 2004, J Psychiatr Pract, V10, P307, DOI 10.1097/00131746-200409000-00004; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bonanno GA, 2012, PSYCHOL TRAUMA-US, V4, P74, DOI 10.1037/a0017829; Bryant RA, 2008, PSYCHOL MED, V38, P555, DOI 10.1017/S0033291707002231; Bryant RA, 2015, BRIT J PSYCHIAT, V206, P417, DOI 10.1192/bjp.bp.114.145516; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; Findley PA, 2011, DISABIL REHABIL, V33, P1608, DOI 10.3109/09638288.2010.540294; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8; Kenardy J, 2015, ARCH PHYS MED REHAB, V96, P410, DOI 10.1016/j.apmr.2014.10.007; Levin HS, 1995, NEUROTRAUMA, P749; Mayou R, 1997, PSYCHOSOM MED, V59, P578, DOI 10.1097/00006842-199711000-00004; McAllister TW, 2010, PSYCHIAT ANN, V40, P533, DOI 10.3928/00485713-20101018-04; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; O'Donnell ML, 2013, J CLIN PSYCHIAT, V74, pE137, DOI 10.4088/JCP.12m08011; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schweininger S, 2015, DEPRESS ANXIETY, V32, P64, DOI 10.1002/da.22288; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Shih RA, 2010, J TRAUMA, V69, P1560, DOI 10.1097/TA.0b013e3181e59c05; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Slade T, 2009, AUST NZ J PSYCHIAT, V43, P594, DOI 10.1080/00048670902970882; TEASDALE G, 1974, LANCET, V2, P81; WHODAS Group, 2000, WHO DIS ASS SCHED 2; World Health Organization ( WHO), 2009, GLOB HLTH RISKS MORT; Zatzick D, 2008, ANN SURG, V248, P429, DOI 10.1097/SLA.0b013e318185a6b8; Zhang Y, 2007, BIOMETRICS, V63, P865, DOI 10.1111/j.1541-0420.2006.00735.x; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542; Zoellner LA, 2014, DEPRESS ANXIETY, V31, P97, DOI 10.1002/da.22133	35	23	23	0	10	PHYSICIANS POSTGRADUATE PRESS	MEMPHIS	P O BOX 752870, MEMPHIS, TN 38175-2870 USA	0160-6689	1555-2101		J CLIN PSYCHIAT	J. Clin. Psychiatry	APR	2016	77	4					E473	E479		10.4088/JCP.14m09721			7	Psychology, Clinical; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	DQ5LU	WOS:000379247700013	27137435				2022-02-06	
J	Vera-Estay, E; Seni, AG; Champagne, C; Beauchamp, MH				Vera-Estay, Evelyn; Seni, Anne G.; Champagne, Caroline; Beauchamp, Miriam H.			All for One: Contributions of Age, Socioeconomic Factors, Executive Functioning, and Social Cognition to Moral Reasoning in Childhood	FRONTIERS IN PSYCHOLOGY			English	Article						moral reasoning; executive functions; affect recognition; theory of mind; childhood	TRAUMATIC BRAIN-INJURY; FACIAL EXPRESSIONS; EFFORTFUL CONTROL; NEURAL BASIS; CHILDRENS; EMOTION; EMPATHY; MIND; RECOGNITION; BEHAVIOR	Moral reasoning (MR) is a socio-cognitive skill essential to appropriate social functioning in childhood, and evolves in quality and complexity during ontogenetic development. Past research suggests that MR is related to age, socioeconomic factors, as well as some social and cognitive skills, such as executive functioning (EF), theory of mind (ToM), empathy, and affect recognition. However, their contributions have been studied in silos rather than comprehensively, with little integration of the relative and combined contribution of these skills to MR. Furthermore, few studies have addressed the putative links between these factors in childhood, a period during which these skills are in maturation. The aim of this study was to explore what factors predict moral maturity in typically developing children (n = 76, 47.4% males, M = 9.2, SD = 1.67 years), explore the potential moderating and mediating role of executive functions and social cognition in the relationship between age and MR maturity, and identify the specific contributions of age, socioeconomic factors, EF, and social cognition, using an innovative visual MR assessment tool (So-Moral). The results indicate that MR maturity was correlated with age, EF (inhibition, verbal fluency, and attentional control), and social cognition (ToM and affect recognition). Neither EF nor social cognition moderated the effect of age on MR maturity. However, verbal fluency and third-order false beliefs had a moderating role in this link. MR maturity in children was predicted by three variables from each of the three domains: age, verbal fluency, and third-order ToM. These results contribute to a better understanding of the underpinnings of MR during childhood, suggesting that MR is not reducible to general developmental factors such as age, but that higher order skills, such EF and social cognition also contribute to moral maturity. The findings have relevance for both typically developing and clinical populations in which social skills may be reduced, as well as for the identification of potential loci for intervention in children at-risk for socially maladaptive behaviors.	[Vera-Estay, Evelyn; Seni, Anne G.; Champagne, Caroline; Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, CP 6128, Montreal, PQ H3C 3J7, Canada; [Vera-Estay, Evelyn; Beauchamp, Miriam H.] Hop St Justine, Ctr Rech, Montreal, PQ H3T 1C5, Canada		Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, CP 6128, Montreal, PQ H3C 3J7, Canada.; Beauchamp, MH (corresponding author), Hop St Justine, Ctr Rech, Montreal, PQ H3T 1C5, Canada.	miriam.beauchamp@umontreal.ca			Social Sciences and Humanities Research Council of CanadaSocial Sciences and Humanities Research Council of Canada (SSHRC); Government of Chile (CONICYT)	This study was funded by the Social Sciences and Humanities Research Council of Canada and a scholarship to EV-E from the Government of Chile (CONICYT). The funding body was not involved in the study design, collection, analysis or interpretation of data, nor in the writing of the manuscript and the decision to submit the article for publication.	Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Arsenio WF, 2006, COGNITIVE DEV, V21, P388, DOI 10.1016/j.cogdev.2006.06.005; Baird JA, 2004, NEW DIR CHILD ADOLES, V103, P37, DOI 10.1002/cd.96; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Beauchamp MH, 2013, BRAIN INJURY, V27, P896, DOI 10.3109/02699052.2013.775486; Beauchamp M. H., 2012, ADM CODING MANUAL SO; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bechi M, 2012, PSYCHIAT RES, V198, P371, DOI 10.1016/j.psychres.2012.02.004; BERKOWITZ MW, 1983, MERRILL PALMER QUART, V29, P399; Birch SAJ, 2004, TRENDS COGN SCI, V8, P255, DOI 10.1016/j.tics.2004.04.011; Blair RJR, 2001, PERS INDIV DIFFER, V31, P799, DOI 10.1016/S0191-8869(00)00181-1; Blair RJR, 2001, J ABNORM CHILD PSYCH, V29, P491, DOI 10.1023/A:1012225108281; Bowen KL, 2014, J PSYCHOPATHOL BEHAV, V36, P60, DOI 10.1007/s10862-013-9368-z; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Brune M, 2005, PSYCHIAT RES, V133, P135, DOI 10.1016/j.psychres.2004.10.007; BRYANT BK, 1982, CHILD DEV, V53, P413, DOI 10.2307/1128984; Caravita SCS, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00262; Carlson SM, 2001, CHILD DEV, V72, P1032, DOI 10.1111/1467-8624.00333; Cohen J, 1998, STAT POWER ANAL BEHA; Couper E., 2002, BRAIN IMPAIR, V3, P105, DOI [DOI 10.1375/BRIM.3.2.105, 10.1375/brim.3.2.105]; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; Cui LX, 2016, J ABNORM CHILD PSYCH, V44, P663, DOI 10.1007/s10802-015-0079-7; Cushman F, 2013, COGNITION, V127, P6, DOI 10.1016/j.cognition.2012.11.008; Dadds MR, 2008, CHILD PSYCHIAT HUM D, V39, P111, DOI 10.1007/s10578-007-0075-4; Daniel E, 2014, J ADOLESCENCE, V37, P1201, DOI 10.1016/j.adolescence.2014.08.009; Decety J, 2006, THESCIENTIFICWORLDJO, V6, P1146, DOI 10.1100/tsw.2006.221; Decety J, 2015, MORAL BRAIN: A MULTIDISCIPLINARY PERSPECTIVE, P279; Decety J, 2014, TRENDS COGN SCI, V18, P337, DOI 10.1016/j.tics.2014.04.008; Decety J, 2013, CHILD DEV PERSPECT, V7, P49, DOI 10.1111/cdep.12020; Decety J, 2012, CEREB CORTEX, V22, P209, DOI 10.1093/cercor/bhr111; Devine RT, 2014, CHILD DEV, V85, P1777, DOI 10.1111/cdev.12237; Dooley JJ, 2010, BRAIN IMPAIR, V11, P152, DOI 10.1375/brim.11.2.152; Dumontheil I, 2010, DEVELOPMENTAL SCI, V13, P331, DOI 10.1111/j.1467-7687.2009.00888.x; Dunn J, 2000, BRIT J DEV PSYCHOL, V18, P159, DOI 10.1348/026151000165625; Eisenberg N, 2004, CHILD DEV, V75, P25, DOI 10.1111/j.1467-8624.2004.00652.x; Eisenberg N, 2003, CROSS CONT, P253; Eisenberg N, 2002, J PERS SOC PSYCHOL, V82, P993, DOI 10.1037//0022-3514.82.6.993; EISENBERG N, 1990, MOTIV EMOTION, V14, P131, DOI 10.1007/BF00991640; EISENBERGBERG N, 1978, DEV PSYCHOL, V14, P185; Gibbs J.C., 2013, MORAL DEV REALITY TH; GIBBS JC, 2010, MORAL DEV REALITY TH; HAIDT J, 1993, J PERS SOC PSYCHOL, V65, P613, DOI 10.1037/0022-3514.65.4.613; Hastings ME, 2008, PERS INDIV DIFFER, V44, P1474, DOI 10.1016/j.paid.2008.01.004; Hayes, 2018, INTRO MEDIATION MODE; Hayes A.F., 2012, PROCESS VERSATILE CO; Herba CM, 2006, J CHILD PSYCHOL PSYC, V47, P1098, DOI 10.1111/j.1469-7610.2006.01652.x; Hinnant JB, 2013, COGNITION EMOTION, V27, P1460, DOI 10.1080/02699931.2013.789792; Hoffman M.L, 2000, EMPATHY MORAL DEV IM, DOI [10.1017/CBO9780511805851, DOI 10.1017/CBO9780511805851, 10.1017/cbo9780511805851, 10.1017/ CBO9780511805851]; Hooper SR, 2010, SCHOOL PSYCHOL QUART, V25, P1, DOI 10.1037/a0018329; Janus M., 2007, EARLY EDUC DEV, V18, P375, DOI [10.1080/10409280701610796a, DOI 10.1080/10409280701610796A]; Johnson M. H., 1991, BIOL COGNITIVE DEV C; Kerr A, 2004, BRAIN COGNITION, V55, P148, DOI 10.1016/s0278-2626(03)00275-6; Killen M., 2011, EMERGENCE MORALITY C, P9; Killen M, 2011, COGNITION, V119, P197, DOI 10.1016/j.cognition.2011.01.006; Kochanska G, 2000, DEV PSYCHOL, V36, P220, DOI 10.1037//0012-1649.36.2.220; Kohlberg Lawrence., 1983, MORAL STAGES CURRENT; Korkman M., 2007, NEPSY 2 CLIN TNTERPR; Korkmaz B, 2011, PEDIATR RES, V69, p101R, DOI 10.1203/PDR.0b013e318212c177; Kretschmer A, 2014, INT J DEV DISABIL, V60, P174, DOI 10.1179/2047387714Y.0000000045; Lagattuta KH, 2005, CHILD DEV, V76, P713, DOI 10.1111/j.1467-8624.2005.00873.x; Lane JD, 2010, BRIT J DEV PSYCHOL, V28, P871, DOI 10.1348/026151009X483056; Liddle B., 2006, J CULTURAL EVOLUTION, V4, P231, DOI [10.1556/jcep.4.2006.3-4.3, DOI 10.1556/JCEP.4.2006.3-4.3]; Malti T, 2013, SOC DEV, V22, P773, DOI 10.1111/sode.12031; Malti T, 2010, NEW DIR CHILD ADOLES, V129, P1, DOI 10.1002/cd.272; Martel MM, 2007, DEV PSYCHOPATHOL, V19, P541, DOI 10.1017/S0954579407070265; Mathersul D, 2009, J CLIN EXP NEUROPSYC, V31, P278, DOI 10.1080/13803390802043619; Miller M, 2010, J ABNORM CHILD PSYCH, V38, P315, DOI 10.1007/s10802-009-9369-2; Miller PA, 1996, DEV PSYCHOL, V32, P210, DOI 10.1037/0012-1649.32.2.210; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Preacher KJ, 2011, PSYCHOL METHODS, V16, P93, DOI 10.1037/a0022658; Rhodes M, 2013, PSYCHOL SCI, V24, P999, DOI 10.1177/0956797612466267; Roberts W, 1996, CHILD DEV, V67, P449, DOI 10.2307/1131826; Rosenqvist J, 2014, CHILD NEUROPSYCHOL, V20, P281, DOI 10.1080/09297049.2013.778235; Sharp C, 2008, SOCIAL COGNITION DEV; Smetana JG, 2012, DEV PSYCHOL, V48, P1144, DOI 10.1037/a0025891; Statistics Canada, 2015, MED TOT INC FAM TYP; Stevens D, 2001, J GENET PSYCHOL, V162, P201, DOI 10.1080/00221320109597961; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tappan MB, 1997, DEV REV, V17, P78, DOI 10.1006/drev.1996.0422; Thomas LA, 2007, DEVELOPMENTAL SCI, V10, P547, DOI 10.1111/j.1467-7687.2007.00614.x; Turiel E., 2002, CULTURE MORALITY SOC; Turiel Elliot, 1983, DEV SOCIAL KNOWLEDGE; Vera-Estay E, 2015, J MORAL EDUC, V44, P17, DOI 10.1080/03057240.2014.986077; Wainryb C, 2006, ADV CHILD DEV BEHAV, V34, P131, DOI 10.1016/S0065-2407(06)80006-6; Walker LJ, 2000, CHILD DEV, V71, P1033, DOI 10.1111/1467-8624.00207; WALKER LJ, 1991, CHILD DEV, V62, P264, DOI 10.2307/1131002; Wechsler D., 2005, ECHELLE INTELLIGENCE; Wechsler D., 2011, WECHSLER ABBREVIATED; Young L, 2007, P NATL ACAD SCI USA, V104, P8235, DOI 10.1073/pnas.0701408104	90	23	23	1	64	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	MAR 8	2016	7								277	10.3389/fpsyg.2016.00227			13	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	DF5MY	WOS:000371397300001	27014110	gold, Green Published			2022-02-06	
J	Smith, NM; Gachulincova, I; Ho, DW; Bailey, C; Bartlett, CA; Norret, M; Murphy, J; Buckley, A; Rigby, PJ; House, MJ; Pierre, TS; Fitzgerald, M; Iyer, KS; Dunlop, SA				Smith, Nicole M.; Gachulincova, Ivana; Ho, Diwei; Bailey, Charlotte; Bartlett, Carole A.; Norret, Marck; Murphy, John; Buckley, Alysia; Rigby, Paul J.; House, Michael J.; Pierre, Timothy St.; Fitzgerald, Melinda; Iyer, K. Swaminathan; Dunlop, Sarah A.			An Unexpected Transient Breakdown of the Blood Brain Barrier Triggers Passage of Large Intravenously Administered Nanoparticles	SCIENTIFIC REPORTS			English	Article							SECONDARY DEGENERATION; DELIVERY; INJURY; CONTRIBUTE; TRANSPORT; IMMUNE; CELLS; CNS	The highly restrictive blood-brain barrier (BBB) plays a critically important role in maintaining brain homeostasis and is pivotal for proper neuronal function. The BBB is currently considered the main limiting factor restricting the passage of large (up to 200 nm) intravenously administered nanoparticles to the brain. Breakdown of the barrier occurs as a consequence of cerebrovascular diseases and traumatic brain injury. In this article, we report that remote injuries in the CNS are also associated with BBB dysfunction. In particular, we show that a focal partial transection of the optic nerve triggers a previously unknown transient opening of the mammalian BBB that occurs in the visual centres. Importantly, we demonstrate that this transient BBB breakdown results in a dramatic change in the biodistribution of intravenously administered large polymeric nanoparticles which were previously deemed as BBB-impermeable.	[Smith, Nicole M.; Gachulincova, Ivana; Bailey, Charlotte; Bartlett, Carole A.; Fitzgerald, Melinda; Dunlop, Sarah A.] Univ Western Australia, Sch Anim Biol, Expt & Regenerat Neurosci, Perth, WA 6009, Australia; [Smith, Nicole M.; Ho, Diwei; Norret, Marck; Iyer, K. Swaminathan] Univ Western Australia, Sch Chem & Biochem, Perth, WA 6009, Australia; [Murphy, John; Buckley, Alysia; Rigby, Paul J.] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Perth, WA 6009, Australia; [House, Michael J.; Pierre, Timothy St.] Univ Western Australia, Sch Phys, Perth, WA 6009, Australia		Dunlop, SA (corresponding author), Univ Western Australia, Sch Anim Biol, Expt & Regenerat Neurosci, Perth, WA 6009, Australia.; Iyer, KS (corresponding author), Univ Western Australia, Sch Chem & Biochem, Perth, WA 6009, Australia.	swaminatha.iyer@uwa.edu.au; sarah.dunlop@uwa.edu.au	Fitzgerald, Melinda/C-4235-2011; Smith, Nicole/L-2502-2013; House, Michael J/B-6477-2008; St Pierre, Timothy G/A-5509-2008	Fitzgerald, Melinda/0000-0002-4823-8179; Smith, Nicole/0000-0002-5519-8152; House, Michael J/0000-0002-1752-6274; St Pierre, Timothy G/0000-0003-4682-4972; Dunlop, Sarah/0000-0002-1306-3962; Ho, Diwei/0000-0002-4560-1112	Australian Research Council (ARC)Australian Research Council; National Health & Medical Research Council (NHMRC)UK Research & Innovation (UKRI)Medical Research Council UK (MRC)National Health and Medical Research Council of Australia [NHMRC APP1028681, APP1087114]; Neurotrauma Research Program (NRP); Australian Microscopy & Microanalysis Research Facility at the Centre for Microscopy, Characterisation Analysis; University of Western Australia	We thank Dr. C.W. Evans for providing us with a schematic of the optic nerve. This work was funded by the Australian Research Council (ARC), the National Health & Medical Research Council (NH&MRC APP1028681 and APP1087114) and the Neurotrauma Research Program (NRP). The authors acknowledge the Australian Microscopy & Microanalysis Research Facility at the Centre for Microscopy, Characterisation & Analysis, and The University of Western Australia, funded by the University, State and Commonwealth Governments.	Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Beggs S, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-74; BUTT AM, 1990, J PHYSIOL-LONDON, V429, P47, DOI 10.1113/jphysiol.1990.sp018243; CHAN PH, 1984, NEUROLOGY, V34, P315, DOI 10.1212/WNL.34.3.315; del Valle J, 2008, J NEUROSCI METH, V174, P42, DOI 10.1016/j.jneumeth.2008.06.025; Ding D, 2013, SMALL, V9, P3093, DOI 10.1002/smll.201300171; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Fitzgerald M, 2009, INVEST OPHTH VIS SCI, V50, P5456, DOI 10.1167/iovs.09-3717; Hains BC, 2006, J NEUROSCI, V26, P4308, DOI 10.1523/JNEUROSCI.0003-06.2006; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Kerschensteiner M, 2003, ANN NEUROL, V53, P292, DOI 10.1002/ana.10446; Koffie RM, 2011, P NATL ACAD SCI USA, V108, P18837, DOI 10.1073/pnas.1111405108; Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010; Kreuter J, 2002, J DRUG TARGET, V10, P317, DOI 10.1080/10611860290031877; Kuffler DP, 2012, THER CLIN RISK MANAG, V8, P185, DOI 10.2147/TCRM.S16196; Laterra J, 1999, BASIC NEUROCHEMISTRY, V6th; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Lozic I, 2014, METALLOMICS, V6, P455, DOI 10.1039/c3mt00336a; Lu W, 2005, J CONTROL RELEASE, V107, P428, DOI 10.1016/j.jconrel.2005.03.027; Lu W, 2007, J CONTROL RELEASE, V118, P38, DOI 10.1016/j.jconrel.2006.11.015; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; MOLLGARD K, 1986, NEUROPATH APPL NEURO, V12, P337, DOI 10.1111/j.1365-2990.1986.tb00146.x; Nahirney PC, 2016, J CEREBR BLOOD F MET, V36, P413, DOI 10.1177/0271678X15608396; Nance EA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003594; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013; Pardridge WM, 2012, J CEREBR BLOOD F MET, V32, P1959, DOI 10.1038/jcbfm.2012.126; Rao KS, 2008, BIOMATERIALS, V29, P4429, DOI 10.1016/j.biomaterials.2008.08.004; Savigni DL, 2013, NEUROPHARMACOLOGY, V75, P380, DOI 10.1016/j.neuropharm.2013.07.034; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; TENNANT M, 1992, VISUAL NEUROSCI, V9, P149, DOI 10.1017/S0952523800009615; TORNHEIM PA, 1984, J NEUROSURG, V60, P473, DOI 10.3171/jns.1984.60.3.0473; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Wiley DT, 2013, P NATL ACAD SCI USA, V110, P8662, DOI 10.1073/pnas.1307152110	37	23	24	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 4	2016	6								22595	10.1038/srep22595			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF4UZ	WOS:000371348200001	26940762	Green Published, Green Submitted, gold			2022-02-06	
J	Armstead, WM; Riley, J; Vavilala, MS				Armstead, William M.; Riley, John; Vavilala, Monica S.			Preferential Protection of Cerebral Autoregulation and Reduction of Hippocampal Necrosis With Norepinephrine After Traumatic Brain Injury in Female Piglets*	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						extracellular signal-regulated kinase; mitogen-activated protein kinase; cerebral autoregulation; traumatic brain injury; interleukin-6; vasopressor	TRANSIENT HYPEREMIC RESPONSE; PERFUSION-PRESSURE; NITROUS-OXIDE; INTRACRANIAL-PRESSURE; HYPOTENSION; IMPAIRMENT; CHILDREN; NEWBORN; PHENYLEPHRINE; INTERLEUKIN-6	Objectives: Traumatic brain injury contributes to morbidity in children and boys is disproportionately represented. Cerebral autoregulation is impaired after traumatic brain injury, contributing to poor outcome. Cerebral perfusion pressure is often normalized by the use of vasopressors to increase mean arterial pressure. In prior studies, we observed that phenylephrine prevented impairment of autoregulation in female but exacerbated in male piglets after fluid percussion injury. In contrast, dopamine prevented impairment of autoregulation in both sexes after fluid percussion injury, suggesting that pressor choice impacts outcome. The extracellular signal-regulated kinase isoform of mitogen-activated protein kinase produces hemodynamic impairment after fluid percussion injury, but the role of the cytokine interleukin-6 is unknown. We investigated whether norepinephrine sex-dependently protects autoregulation and limits histopathology after fluid percussion injury and the role of extracellular signal-regulated kinase and interleukin-6 in that outcome. Design: Prospective, randomized animal study. Setting: University laboratory. Subjects: Newborn (1-5 d old) pigs. Interventions: Cerebral perfusion pressure, cerebral blood flow, and pial artery diameter were determined before and after fluid percussion injury in piglets equipped with a closed cranial window and post-treated with norepinephrine. Cerebrospinal fluid extracellular-signal-regulated kinase mitogen-activated protein kinase was determined by enzyme-linked immunosorbent assay. Measurements and Main Results: Norepinephrine does not protect autoregulation or prevent reduction in cerebral blood flow in male but fully protects autoregulation in female piglets after fluid percussion injury. Papaverine-induced dilation was unchanged by fluid percussion injury and norepinephrine. Norepinephrine increased extracellular signal-regulated kinase mitogen-activated protein kinase up-regulation in male but blocked such up-regulation in female piglets after fluid percussion injury. Norepinephrine aggravated interleukin-6 upregulation in males in an extracellular signal-regulated kinase mitogen-activated protein kinase-dependent mechanism but blocked interleukin-6 up-regulation in females after fluid percussion injury. Norepinephrine augments loss of neurons in CA1 and CA3 hippocampus of male piglets after fluid percussion injury in an extracellular signal-regulated kinase mitogen-activated protein kinase-dependent and interleukin-6-dependent manner but prevents loss of neurons in females after fluid percussion injury. Conclusion: Norepinephrine protects autoregulation and limits hippocampal neuronal cell necrosis via modulation of extracellular signal-regulated kinase mitogen-activated protein kinase and interleukin-6 after fluid percussion injury in a sex-dependent manner.	[Armstead, William M.; Riley, John] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Armstead, William M.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol Pediat & Neurol Surg, Seattle, WA 98195 USA		Armstead, WM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.; Armstead, WM (corresponding author), Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA.	armsteaw@uphs.upenn.edu		Riley, John/0000-0002-7932-8935	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS090998]; University of Pennsylvania Research Foundation; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS090998] Funding Source: NIH RePORTER	Supported, in part, by National Institutes of Health (NIH) RO1 NS090998.; Dr. Armstead received support for article research from the University of Pennsylvania Research Foundation. Dr. Riley received support for article research from the National Institutes of Health (NIH). Dr. Vavilala received support for article research from the NIH.	Armstead WM, 2007, J CEREBR BLOOD F MET, V27, P1702, DOI 10.1038/sj.jcbfm.9600473; Armstead WM, 2013, PEDIATR CRIT CARE ME, V14, pE103, DOI 10.1097/PCC.0b013e3182712b44; Armstead WM, 2012, J NEUROTRAUM, V29, P1794, DOI 10.1089/neu.2012.2328; Armstead WM, 2010, CRIT CARE MED, V38, P1868, DOI 10.1097/CCM.0b013e3181e8ac1a; Armstead WM, 2010, J NEUROTRAUM, V27, P391, DOI 10.1089/neu.2009.1094; Armstead WM, 2000, MICROCIRCULATION, V7, P225, DOI 10.1080/713773978; Bedford NM, 1999, ANESTH ANALG, V89, P170; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Biestro A, 1998, ACT NEUR S, V71, P5; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Bratton SL, 2007, J NEUROTRAUMA, V24, pS7; Carter BG, 2008, CHILD NERV SYST, V24, P245, DOI 10.1007/s00381-007-0461-z; Catala-Temprano A, 2007, J NEUROSURG, V106, P463, DOI 10.3171/ped.2007.106.6.463; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Di Gennaro JL, 2010, DEV NEUROSCI-BASEL, V32, P420, DOI 10.1159/000322083; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Girling KJ, 1999, ANESTH ANALG, V89, P175, DOI 10.1097/00000539-199907000-00031; Ishikawa S, 2009, ANESTH ANALG, V108, P1631, DOI 10.1213/ane.0b013e31819d94e3; Keenan Heather T, 2005, Pediatr Crit Care Med, V6, P537, DOI 10.1097/01.PCC.0000164638.44600.67; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS24, DOI 10.1097/PCC.0b013e31823f4450; Kroppenstedt SN, 2003, CRIT CARE MED, V31, P2211, DOI 10.1097/01.CCM.0000080482.06856.62; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Malhotra AK, 2003, J NEUROTRAUM, V20, P827, DOI 10.1089/089771503322385764; Newacheck PW, 2004, PEDIATRICS, V114, P79, DOI 10.1542/peds.114.1.79; Oto J, 2008, J ANESTH, V22, P207, DOI 10.1007/s00540-008-0639-x; Sharma D, 2010, J NEUROSURG ANESTH, V22, P132, DOI 10.1097/ANA.0b013e3181c9fbf1; Sookplung P, 2011, NEUROCRIT CARE, V15, P46, DOI 10.1007/s12028-010-9448-9; Steiner LA, 2004, CRIT CARE MED, V32, P1049, DOI 10.1097/01.CCM.0000120054.32845.A6; Tibble RK, 2001, ANESTH ANALG, V93, P171; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037	31	23	24	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	MAR	2016	17	3					e130	e137		10.1097/PCC.0000000000000603			8	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	DG0ID	WOS:000371747600005	26741414	Green Accepted			2022-02-06	
J	Holcomb, EM; Schwartz, DJ; McCarthy, M; Thomas, B; Barnett, SD; Nakase-Richardson, R				Holcomb, Erin M.; Schwartz, Daniel J.; McCarthy, Marissa; Thomas, Bryan; Barnett, Scott D.; Nakase-Richardson, Risa			Incidence, Characterization, and Predictors of Sleep Apnea in Consecutive Brain Injury Rehabilitation Admissions	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognition; rehabilitation; head injury; sleep	POSITIVE AIRWAY PRESSURE; COGNITIVE IMPAIRMENT; RISK-FACTOR; INPATIENT REHABILITATION; CARDIOVASCULAR-DISEASE; PRACTICE PARAMETERS; DISORDERS; STROKE; MORTALITY; ASSOCIATION	Objective: To prospectively examine the incidence and risk factors for sleep apnea in consecutive brain injury rehabilitation admissions. Setting: Inpatient neurorehabilitation hospital. Participants: Participants (n = 86) were consecutive neurorehabilitation admissions. Design: Retrospective analysis of prospectively collected data. Main Measures: Polysomnography. Results: Half (49%) of the sample was diagnosed with sleep apnea. For the full sample, univariate logistic regression revealed age (odds ratio: 1.08; 95% confidence interval: 1.04-1.11) and hypertension (odds ratio: 7.77; 95% confidence interval: 2.81-21.47) as significant predictors of sleep apnea diagnosis. Results of logistic regression conducted within the traumatic brain injury group revealed age (odds ratio: 1.07; 95% confidence interval: 1.02-1.13) as the only significant predictor of apnea diagnosis after adjustment for other variables. Hierarchical generalized linear regression models for the prediction of apnea severity (ie, apnea-hypopnea index found that Functional Independence Measure Cognition Score (P = .01) and age (P < .01) were significant predictors. Following adjustment for all other terms, only age (P < .01) remained significant. Conclusion: Sleep apnea is prevalent in acute neurorehabilitation admissions and traditional risk profiles for sleep apnea may not effectively screen for the disorder. Given the progressive nature of obstructive sleep apnea and morbidity associated with even mild obstructive sleep apnea, early identification and intervention may address comorbidities influencing acute and long-term outcome.	[Holcomb, Erin M.; Nakase-Richardson, Risa] James A Haley Vet Hosp, Dept MHBS, Tampa, FL 33612 USA; [Schwartz, Daniel J.] James A Haley Vet Hosp, Dept Med, Tampa, FL 33612 USA; [McCarthy, Marissa; Thomas, Bryan] James A Haley Vet Hosp, Dept Rehabil Med, Tampa, FL 33612 USA; [Schwartz, Daniel J.; Nakase-Richardson, Risa] Univ S Florida, Dept Med, Tampa, FL USA; [McCarthy, Marissa; Thomas, Bryan] Univ S Florida, Dept Neurol, Tampa, FL 33620 USA; [Barnett, Scott D.] James A Haley Vet Hosp, Dept Res, Tampa, FL 33612 USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, Ctr Innovat Disabil Rehabil & Res CINDRR, Tampa, FL 33612 USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, Def & Vet Brain Injury Ctr, Tampa, FL 33612 USA		Holcomb, EM (corresponding author), James A Haley Vet Hosp, Polytrauma Mail Code 117,13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	Risa.Richardson@va.gov			Department of Veterans AffairsUS Department of Veterans Affairs; Department of Education, National Institute on Disability, Independent Living, and Rehabilitation Research; VHA Central Office VA TBI Model System Program of Research; General Dynamics Health Solutions from the Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC), U.S. Department of Veterans Affairs [W91YTZ-13-C-0015, 1 I50 HX001233-01, W81XWH-13-2-0095]; General Dynamics Health Solutions from U.S. Department of Defense Congressionally Directed Medical Research Programs	The Polytrauma Rehabilitation Center Traumatic Brain Injury (TBI) Model System collaboration is funded through an Interagency Agreement between the Department of Veterans Affairs and the Department of Education, National Institute on Disability, Independent Living, and Rehabilitation Research. This research is sponsored by VHA Central Office VA TBI Model System Program of Research, and Subcontract from General Dynamics Health Solutions (W91YTZ-13-C-0015) from the Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC), U.S. Department of Veterans Affairs grants (1 I50 HX001233-01, W81XWH-13-2-0095), and U.S. Department of Defense Congressionally Directed Medical Research Programs. The authors acknowledge the contributions of Jeffrey Garofano, MA, William M. Anderson, MD, Courtney Lynn, MS, Carolos Diez-Sien, RPSGT, and Ryan Smith, RPSGT.	Aaronson JA, 2015, SLEEP MED, V16, P691; Alattar MA, 2009, SLEEP BREATH, V13, P201, DOI 10.1007/s11325-008-0221-7; Aloia MS, 2004, J INT NEUROPSYCH SOC, V10, P772, DOI 10.1017/S1355617704105134; American Physical Therapy Association NSTETF, 2012, REP TBI EDGE TASK FO; AncoliIsrael S, 1996, SLEEP, V19, P277, DOI 10.1093/sleep/19.4.277; ANCOLIISRAEL S, 1991, J AM GERIATR SOC, V39, P258, DOI 10.1111/j.1532-5415.1991.tb01647.x; Antic NA, 2011, SLEEP, V34, P111, DOI 10.1093/sleep/34.1.111; Balk EM, 2012, FUTURE RES NEEDS DIA; Bassetti C, 1999, SLEEP, V22, P217, DOI 10.1093/sleep/22.2.217; Beebe DW, 2002, J SLEEP RES, V11, P1, DOI 10.1046/j.1365-2869.2002.00289.x; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Blackwell T, 2015, J AM GERIATR SOC, V63, P453, DOI 10.1111/jgs.13321; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; BRADLEY PA, 1995, THORAX, V50, P1201, DOI 10.1136/thx.50.11.1201; Bravata DM, 2011, SLEEP, V34, P1271, DOI 10.5665/SLEEP.1254; BRETELER MMB, 1994, NEUROLOGY, V44, P1246, DOI 10.1212/WNL.44.7.1246; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Castriotta RJ, 2009, J CLIN SLEEP MED, V5, P137; Castriotta RJ, 2001, ARCH PHYS MED REHAB, V82, P1403, DOI 10.1053/apmr.2001.26081; Castronovo V, 2014, SLEEP, V37, P1465, DOI 10.5665/sleep.3994; Chang WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078655; Chesson AL, 2003, SLEEP, V26, P907, DOI 10.1093/sleep/26.7.907; Chung F, 2008, ANESTHESIOLOGY, V108, P812, DOI 10.1097/ALN.0b013e31816d83e4; Collop NA, 2007, J CLIN SLEEP MED, V3, P737; Cooke JR, 2009, J CLIN SLEEP MED, V5, P305; Crenn P, 2014, CLIN NUTR, V33, P348, DOI 10.1016/j.clnu.2013.06.003; Dash MB, 2009, J NEUROSCI, V29, P580, DOI 10.1523/JNEUROSCI.5486-08.2009; Dhandapani SS, 2007, INDIAN J NEUROTRAUM, V4, P35, DOI 10.1016/S0973-0508(07)80009-8; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; El-Ad B, 2005, INT REV PSYCHIATR, V17, P277, DOI 10.1080/09540260500104508; Engleman HM, 1999, AM J RESP CRIT CARE, V159, P461, DOI 10.1164/ajrccm.159.2.9803121; Engleman HM, 2000, SLEEP, V23, pS102; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Field L H, 1989, Brain Inj, V3, P19, DOI 10.3109/02699058909008069; FINDLEY LJ, 1986, CHEST, V90, P686, DOI 10.1378/chest.90.5.686; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; Gimenez S, 2007, PSYCHOPHARMACOLOGY, V190, P507, DOI 10.1007/s00213-006-0633-7; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Harrison-Felix C, 2015, J NEUROTRAUM, V32, P1893, DOI 10.1089/neu.2014.3353; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; HE J, 1988, CHEST, V94, P9, DOI 10.1378/chest.94.1.9; IBM Corp, IBM SPSS STAT WIND V; Ip MSM, 2002, AM J RESP CRIT CARE, V165, P670, DOI 10.1164/ajrccm.165.5.2103001; Javaheri S, 2010, CLIN CHEST MED, V31, P235, DOI 10.1016/j.ccm.2010.02.013; Jennum P, 2011, THORAX, V66, P560, DOI 10.1136/thx.2010.143958; Jobin V, 2007, J APPL PHYSIOL, V102, P1587, DOI 10.1152/japplphysiol.00439.2006; Johnson KG, 2010, J CLIN SLEEP MED, V6, P131; Jordan AS, 2003, SLEEP MED REV, V7, P377, DOI 10.1053/smrv.2002.0260; Kamba M, 2001, J NEUROL NEUROSUR PS, V71, P334, DOI 10.1136/jnnp.71.3.334; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kim H, 2013, SLEEP, V36, P709, DOI 10.5665/sleep.2632; Knauert MP, 2014, HEART LUNG, V43, P445, DOI 10.1016/j.hrtlng.2014.06.049; Kushida CA, 2006, SLEEP, V29, P240, DOI 10.1093/sleep/29.2.240; Lattimore JL, 2006, THORAX, V61, P491, DOI 10.1136/thx.2004.039164; Lee YC, 2013, J KOREAN MED SCI, V28, P1373, DOI 10.3346/jkms.2013.28.9.1373; Longordo F, 2009, EUR J NEUROSCI, V29, P1810, DOI 10.1111/j.1460-9568.2009.06719.x; Macey PM, 2002, AM J RESP CRIT CARE, V166, P1382, DOI 10.1164/rccm.200201-050OC; MAN GCW, 1995, CHEST, V108, P388, DOI 10.1378/chest.108.2.388; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Martinez-Garcia MA, 2006, CHEST, V129, P238, DOI 10.1378/chest.129.2.238; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McDermott CM, 2003, J NEUROSCI, V23, P9687; McEvoy R Doug, 2010, J Thorac Dis, V2, P138, DOI 10.3978/j.issn.2072-1439.2010.02.03.5; Morrell MJ, 2003, SLEEP MED, V4, P451, DOI 10.1016/S1389-9457(03)00159-X; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Mysliwiec V, 2013, SLEEP, V36, P167, DOI 10.5665/sleep.2364; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, pe43; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Ng YS, 2007, ANN ACAD MED SINGAP, V36, P3; Nieto FJ, 2012, AM J RESP CRIT CARE, V186, P190, DOI 10.1164/rccm.201201-0130OC; O'Hara R, 2009, J REHABIL RES DEV, V46, P837, DOI 10.1682/JRRD.2008.10.0140; Ostermeier AM, 1997, ANESTH ANALG, V85, P452, DOI 10.1097/00000539-199708000-00037; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Parra O, 2000, AM J RESP CRIT CARE, V161, P375, DOI 10.1164/ajrccm.161.2.9903139; Parrino L, 1996, PSYCHOPHARMACOLOGY, V126, P1, DOI 10.1007/BF02246405; Pistoia F, 2015, J NEUROTRAUM, V32, P682, DOI 10.1089/neu.2014.3659; Quan SF, 1999, SLEEP, V22, P662, DOI 10.1093/sleep/22.5.662; Redline S, 2010, AM J RESP CRIT CARE, V182, P269, DOI 10.1164/rccm.200911-1746OC; Reichmuth KJ, 2005, AM J RESP CRIT CARE, V172, P1590, DOI 10.1164/rccm.200504-637OC; Robbins J, 2005, J CLIN SLEEP MED, V1, P159; Rodenstein D, 2009, RESPIRATION, V78, P241, DOI 10.1159/000222811; ROTH T, 1987, J ALLERGY CLIN IMMUN, V80, P94, DOI 10.1016/S0091-6749(87)80197-5; Rutherford GW, 2009, J HEAD TRAUMA REHAB, V24, P421, DOI 10.1097/HTR.0b013e3181c13439; SAS, 2011, BAS SAS 9 2 PROC GUI; Sassani A, 2004, SLEEP, V27, P453, DOI 10.1093/sleep/27.3.453; SHEPARD JW, 1992, CLIN CHEST MED, V13, P437; Sivertsen B, 2008, EUR RESPIR J, V32, P1497, DOI 10.1183/09031936.00044908; Sjosten N, 2009, RESP MED, V103, P1047, DOI 10.1016/j.rmed.2009.01.014; Sjosten N, 2009, CHEST, V136, P130, DOI 10.1378/chest.08-2201; Sobanski E, 2008, SLEEP, V31, P375, DOI 10.1093/sleep/31.3.375; Somers VK, 2008, CIRCULATION, V118, P1080, DOI 10.1161/CIRCULATIONAHA.107.189375; Strobel RJ, 1996, SLEEP, V19, P104, DOI 10.1093/sleep/19.2.104; Teran-Santos J, 1999, NEW ENGL J MED, V340, P847, DOI 10.1056/NEJM199903183401104; Thornton JD, 2010, SLEEP, V33, P1255, DOI 10.1093/sleep/33.9.1255; Torelli F, 2011, NEUROIMAGE, V54, P787, DOI 10.1016/j.neuroimage.2010.09.065; Tuomilehto H, 2014, SLEEP MED, V15, P329, DOI 10.1016/j.sleep.2013.11.786; Vaughn BV, 2008, CHEST, V134, P1310, DOI 10.1378/chest.08-0812; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Walker JM, 2007, J CLIN SLEEP MED, V3, P455; Wallace A, 2013, SLEEP, V36, P203, DOI 10.5665/sleep.2374; Wallace DM, 2012, INT J STROKE, V7, P231, DOI 10.1111/j.1747-4949.2011.00760.x; Wang X, 2013, INT J CARDIOL, V169, P207, DOI 10.1016/j.ijcard.2013.08.088; Watson NF, 2007, J CLIN SLEEP MED, V3, P363; Weaver TE, 2007, SLEEP MED REV, V11, P99, DOI 10.1016/j.smrv.2006.08.001; Webster JB, 2001, ARCH PHYS MED REHAB, V82, P316, DOI 10.1053/apmr.2001.20840; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilde MC, 2007, ARCH PHYS MED REHAB, V88, P1284, DOI 10.1016/j.apmr.2007.07.012; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Yamadera H, 1998, PSYCHIAT CLIN NEUROS, V52, P439, DOI 10.1046/j.1440-1819.1998.00403.x; Young T, 1997, SLEEP, V20, P608, DOI 10.1093/sleep/20.8.608; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Young T, 2005, J APPL PHYSIOL, V99, P1592, DOI 10.1152/japplphysiol.00587.2005; Young T, 2004, JAMA-J AM MED ASSOC, V291, P2013, DOI 10.1001/jama.291.16.2013; Young T, 1997, SLEEP, V20, P705, DOI 10.1093/sleep/20.9.705; Young Terry, 2009, WMJ, V108, P246; Zimmerman ME, 2006, J CLIN SLEEP MED, V2, P461; Zunzunegui C, 2011, SLEEP, V34, P1261, DOI 10.5665/SLEEP.1252	122	23	23	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2016	31	2			SI		82	100		10.1097/HTR.0000000000000230			19	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DH7NO	WOS:000372981100002	26959663				2022-02-06	
J	Olympia, RP; Ritter, JT; Brady, J; Bramley, H				Olympia, Robert P.; Ritter, Jed T.; Brady, Jodi; Bramley, Harry			Return to Learning After a Concussion and Compliance With Recommendations for Cognitive Rest	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						school health services; cerebral concussion; nurses	SPORT-RELATED CONCUSSION; UNITED-STATES; RECOVERY	Objective: To determine the compliance of schools and school nurses in the United States with national recommendations for cognitive rest in students who sustain a concussion. Design: Cross-sectional questionnaire based. Participants: Members of the National Association of School Nurses working at the high school level. Intervention: A questionnaire, developed by the authors and based on recommendations for cognitive rest, was electronically distributed 3 times during the 2012 to 2013 academic year. Main Outcome Measures: Self-reported responses were collected regarding demographics and compliance of schools and school nurses with recommendations for the management of the postconcussion student, including the presence of specific guidelines for individualized care and the responsibility of the nurse for the prevention, detection, and management of concussions. Results: Analysis was performed on 1033 completed questionnaires (36% usable response rate). Fifty-three percent of schools have guidelines to assist students when returning to school after a concussion. These guidelines include extension of assignment deadlines (87%), rest periods during the school day (84%), postponement or staggering of tests (75%), reduced workload (73%), and accommodation for light or noise sensitivity (64%). Sixty-six percent of nurses in our sample have had special training in the recognition and management of concussions. Nurses reported involvement in the following roles: identifying suspected concussions (80%), providing emotional support for recovering students dealing with concussion-related depression (59%), and guiding the student's postconcussion graduated academic and activity re-entry process (58%). Conclusions: We detected a wide variability in compliance of schools and school nurses with national recommendations for cognitive rest. Clinical Relevance: Ensuring that schools have policies established for a student's return to learning, having specific guidelines to provide an individualized approach to return to learning based on postconcussion signs/symptoms, training school nurses in the recognition and management of concussions, and involving school nurses in the re-entry process are identified areas for improvement. Schools in the United States should be aware of these recommendations to guide a student's postconcussion graduated academic re-entry process.	[Olympia, Robert P.] Penn State Hershey Med Ctr, Dept Emergency Med, 500 Univ Dr,POB 850, Hershey, PA 17033 USA; [Ritter, Jed T.] Penn State Coll Med, Hershey, PA USA; [Brady, Jodi; Bramley, Harry] Penn State Hershey Childrens Hosp, Dept Pediat, Hershey, PA USA		Olympia, RP (corresponding author), Penn State Hershey Med Ctr, Dept Emergency Med, 500 Univ Dr,POB 850, Hershey, PA 17033 USA.	rolympia@hmc.psu.edu					CHOI BCK, 2005, PREV CHRONIC DIS; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; National Association of School Nurses, 2012, CONC ROL SCH NURS PO; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	14	23	24	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2016	26	2					115	119		10.1097/JSM.0000000000000208			5	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	DF4DM	WOS:000371297600004	25961156				2022-02-06	
J	Posti, JP; Piitulainen, JM; Hupa, L; Fagerlund, S; Frantzen, J; Aitasalo, KMJ; Vuorinen, V; Serlo, W; Syrjanen, S; Vallittu, PK				Posti, Jussi P.; Piitulainen, Jaakko M.; Hupa, Leena; Fagerlund, Susanne; Frantzen, Janek; Aitasalo, Kalle M. J.; Vuorinen, Ville; Serlo, Willy; Syrjanen, Stina; Vallittu, Pekka K.			A glass fiber-reinforced composite - bioactive glass cranioplasty implant: A case study of an early development stage implant removed due to a late infection	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Bioactive glass; Fiber-reinforced composite; Cranioplasty; Decompressive craniectomy; Calvarial reconstruction; Traumatic brain injury	BIOCOMPATIBLE GLASSES; AUTOGENOUS BONE; RECONSTRUCTION; S53P4; SPONDYLODESIS; BEHAVIOR; REPAIR	This case study describes the properties of an early development stage bioactive glass containing fiber-reinforced composite calvarial implant with histology that has been in function for two years and three months. The patient is a 33-year old woman with a history of substance abuse, who sustained a severe traumatic brain injury later unsuccessfully treated with an autologous bone flap and a custom-made porous polyethylene implant. She was thereafter treated with developmental stage glass fiber-reinforced composite - bioactive glass implant. After two years and three months, the implant was removed due to an implant site infection. The implant was analyzed histologically, mechanically, and in terms of chemistry and dissolution of bioactive glass. Mechanical integrity of the load bearing fiber-reinforced composite part of the implant was not affected by the in vivo period. Bioactive glass particles demonstrated surface layers of hydroxyapatite like mineral and dissolution, and related increase of pH was considerably less after two and three months period than that for fresh bioactive glass. There was a difference in the histology of the tissues inside the implant areas near to the margin of the implant that absorbed blood during implant installation surgery, showed fibrous tissue with blood vessels, osteoblasts, collagenous fibers with osteoid formation, and tiny clusters of more mature hard tissue. In the center of the implant, where there was less absorbed blood, only fibrous tissue was observed. This finding is in line with the combined positron emission tomography - computed tomography examination with (18F)-fluoride marker, which demonstrated activity of the mineralizing bone by osteoblasts especially at the area near to the margin of the implant 10 months after implantation. Based on these promising reactions found in the bioactive glass containing fiber reinforced composite implant that has been implanted for two years and three months, calvarial reconstruction with the presented material appears to be a feasible method. (C) 2015 Elsevier Ltd. All rights reserved.	[Posti, Jussi P.; Frantzen, Janek; Vuorinen, Ville] Turku Univ Hosp, Dept Neurosurg, Div Clin Neurosci, POB 52, Turku 20521, Finland; [Posti, Jussi P.; Frantzen, Janek] Turku Univ Hosp, Dept Rehabil & Brain Trauma, Div Clin Neurosci, POB 52, Turku 20521, Finland; [Posti, Jussi P.] Univ Turku, Dept Neurol, Turku 20014, Finland; [Posti, Jussi P.; Piitulainen, Jaakko M.; Aitasalo, Kalle M. J.] Univ Turku, Inst Dent, Dept Biomat Sci, Lemminkaisenkatu 2, FIN-20520 Turku, Finland; [Posti, Jussi P.; Piitulainen, Jaakko M.; Aitasalo, Kalle M. J.] Univ Turku, Inst Dent, TCBC, Lemminkaisenkatu 2, FIN-20520 Turku, Finland; [Piitulainen, Jaakko M.; Aitasalo, Kalle M. J.; Vallittu, Pekka K.] Turku Univ Hosp, Div Surg & Canc Dis, Dept Otorhinolaryngol Head & Neck Surg, POB 52, Turku 20521, Finland; [Hupa, Leena; Fagerlund, Susanne] Abo Akad Univ, Johan Gadolin Proc Chem Ctr, Piispankatu 9, SF-20500 Turku, Finland; [Serlo, Willy] Oulu Univ Hosp, Dept Children & Adolescents, Oys 90029, Finland; [Serlo, Willy] Oulu Univ, MRC Oulu, POB 23, Oulu, Finland; [Serlo, Willy] Oulu Univ, PEDEGO Res Ctr, POB 23, Oulu, Finland; [Syrjanen, Stina] Univ Turku, Inst Dent, Dept Oral Pathol & Radiol, Turku 20014, Finland; [Syrjanen, Stina] Turku Univ Hosp, Dept Pathol, POB 52, Turku 20521, Finland; [Vallittu, Pekka K.] City Turku Welf Div, POB 670, Turku 20101, Finland		Posti, JP (corresponding author), Turku Univ Hosp, Dept Neurosurg, Clin Neurosci, POB 52, Turku 20521, Finland.	jussi.posti@utu.fi	Posti, Jussi P./Y-2908-2019; Hupa, Leena/A-5774-2016	Posti, Jussi P./0000-0002-5925-5193; Hupa, Leena/0000-0001-7745-7779; Piitulainen, Jaakko/0000-0001-9788-8904; Syrjanen, Stina/0000-0003-0738-5698	Personal EVO Funding (Finland); Maire Taponen Foundation	This work was partially funded by the Personal EVO Funding (Finland) and grant from Maire Taponen Foundation (JPP).	Aitasalo KMJ, 2014, HEAD NECK-J SCI SPEC, V36, P722, DOI 10.1002/hed.23370; Azenha MR, 2012, ORAL MAXILLOFAC SURG, V16, P393, DOI 10.1007/s10006-011-0308-3; Bhaskar IP, 2014, WORLD NEUROSURG, V82, pE531, DOI 10.1016/j.wneu.2013.01.013; Boccaccini AR, 2012, BIOGLASSES INTRO, P121; Bouillaguet S, 2006, J BIOMED MATER RES B, V76B, P98, DOI 10.1002/jbm.b.30349; De Bonis P, 2012, J NEUROTRAUM, V29, P1071, DOI 10.1089/neu.2011.2116; Fagerlund S, 2013, ACTA BIOMATER, V9, P5400, DOI 10.1016/j.actbio.2012.08.051; Frantzen J, 2011, J SPINAL DISORD TECH, V24, P455, DOI 10.1097/BSD.0b013e31822a20c6; Honeybul S, 2013, J NEUROSURG, V119, P1566, DOI 10.3171/2013.8.JNS13857; Hupa L., 2015, J NONCRYSOL IN PRESS; Hupa L, 2010, GLASS TECHNOL-PART A, V51, P89; Klinger DR, 2014, WORLD NEUROSURG, V82, pE525, DOI 10.1016/j.wneu.2013.08.005; Lee EI, 2014, PLAST RECONSTR SURG, V133, P675, DOI 10.1097/01.prs.0000438061.46290.33; Lindfors NC, 2010, J BIOMED MATER RES B, V94B, P157, DOI 10.1002/jbm.b.31636; Mylonas AI, 2007, J CRANIO MAXILL SURG, V35, P63, DOI 10.1016/j.jcms.2006.10.004; Pernaa K, 2011, J Long Term Eff Med Implants, V21, P139; Piitulainen JM, 2015, WORLD NEUROSURG, V83, P708, DOI 10.1016/j.wneu.2015.01.014; Piitulainen JM, 2015, ACTA NEUROCHIR, V157, P681, DOI 10.1007/s00701-015-2363-2; Rantakokko J, 2012, SCAND J SURG, V101, P66, DOI 10.1177/145749691210100113; Stoor P, 2001, J BIOMED MATER RES, V58, P113, DOI 10.1002/1097-4636(2001)58:1<113::AID-JBM170>3.0.CO;2-V; Stoor P, 1998, ACTA ODONTOL SCAND, V56, P161, DOI 10.1080/000163598422901; Sundseth J, 2014, ACTA NEUROCHIR, V156, P805, DOI 10.1007/s00701-013-1992-6; Truntzer Jeremy, 2015, Eur J Orthop Surg Traumatol, V25, P211, DOI 10.1007/s00590-014-1488-y; Tunkel A.R., 2010, PRINCIPLES PRACTICE, V1, P1279; Tuusa SMR, 2008, J BIOMED MATER RES B, V84B, P510, DOI 10.1002/jbm.b.30898; Ullmark G, 2013, ACTA ORTHOP, V84, P138, DOI 10.3109/17453674.2013.786632; Vallittu PK, 2007, INT J PROSTHODONT, V20, P43; Varila L, 2012, J MATER SCI-MATER M, V23, P2425, DOI 10.1007/s10856-012-4693-4; Zhang D, 2010, J BIOMED MATER RES A, V93A, P475, DOI 10.1002/jbm.a.32564	29	23	24	0	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	MAR	2016	55						191	200		10.1016/j.jmbbm.2015.10.030			10	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	DE8LD	WOS:000370886600017	26594779				2022-02-06	
J	Hadanny, A; Meir, O; Bechor, Y; Fishlev, G; Bergan, J; Efrati, S				Hadanny, A.; Meir, O.; Bechor, Y.; Fishlev, G.; Bergan, J.; Efrati, S.			Seizures during hyperbaric oxygen therapy: retrospective analysis of 62,614 treatment sessions	UNDERSEA AND HYPERBARIC MEDICINE			English	Article						hyperbaric oxygenation; hyperbaric oxygen therapy; central nervous system oxygen toxicity; complications; adverse effects; side effects	TOXICITY SEIZURES; PRESSURE; TRIAL	Introduction: Hyperbaric oxygen (HBO2) therapy is considered to be a generally safe therapy. However, data regarding seizure incidence during HBO2 therapy as a clinical presentation of central nervous system(CNS) related oxygen toxicity are conflicting (ranging from 1:10,000 to 1:600 seizures:hyperbaric sessions). The risk for seizures is of significant importance for the growing population of patients suffering from chronic neurological disorders such as traumatic brain injury and stroke who are treated with HBO2. The aim of this study was to evaluate the incidence of seizures during HBO2 therapy in a large cohort of patients and determine whether patients with known chronic neurological disorders are at increased risk. Methods: Retrospective analysis of 2,334 patients treated at the Sagol Center of Hyperbaric Medicine and Research, Assaf Harofeh Medical Center, Israel, between June 2010 and December 2014. Patients were grouped into one of three categories according to indication for HBO2 therapy: Category A- non neurological indications; Category B- neurological indications; and Category C- acute indications. Results: A total of 62,614 hyperbaric sessions, administered to 2,334 patients, were included in the analysis. The overall incidence of seizures during hyperbaric sessions was 0.011% (1:8,945), occurring in seven (0.3%) patients. Only one patient had a clear oxygen toxicity-induced seizure, with an overall incidence of 1:62,614. Conclusions: Seizures induced by oxygen toxicity during HBO2 therapy are extremely rare. Moreover, in relation to oxygen-induced seizures, HBO2 therapy can be considered safe for patients suffering with chronic neurological disorders except for uncontrolled epilepsy.	[Hadanny, A.; Meir, O.; Bechor, Y.; Fishlev, G.; Bergan, J.; Efrati, S.] Assaf Harofeh Med Ctr, Sagol Ctr Hyperbar Med & Res, IL-70300 Zerifin, Israel; [Hadanny, A.; Efrati, S.] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Hadanny, A.; Efrati, S.] Assaf Harofeh Med Ctr, Res & Dev Unit, IL-70300 Zerifin, Israel; [Efrati, S.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel		Hadanny, A; Efrati, S (corresponding author), Assaf Harofeh Med Ctr, Sagol Ctr Hyperbar Med & Res, IL-70300 Zerifin, Israel.; Hadanny, A; Efrati, S (corresponding author), Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel.; Hadanny, A; Efrati, S (corresponding author), Assaf Harofeh Med Ctr, Res & Dev Unit, IL-70300 Zerifin, Israel.; Efrati, S (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel.	amir.had@gmail.com; efratishai@013.net					Banham NDG, 2011, DIVING HYPERB MED, V41, P202; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Chavko M, 2003, NITRIC OXIDE-BIOL CH, V9, P18, DOI 10.1016/S1089-8603(03)00045-4; CLARK JM, 1971, PHARMACOL REV, V23, P37; Clark JM, 1982, OXYGEN TOXICITY PHYS, P200; Efrati S, 2014, EXPERT REV NEUROTHER, V14, P233, DOI 10.1586/14737175.2014.884928; Efrati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053716; Hampson N, 2003, UNDERSEA HYPERBAR M, V30, P147; Hampson NB, 2006, UNDERSEA HYPERBAR M, V33, P27; Hampson NB, 2014, UNDERSEA HYPERBAR M, V41, P605; Heyboer M, 2014, UNDERSEA HYPERBAR M, V41, P379; Jain KK, 1999, OXYGEN TOXICITY TXB, P47; KELLOGG RH, 1978, RESP PHYSIOL, V34, P1, DOI 10.1016/0034-5687(78)90046-4; Peleg RK, 2013, DIVING HYPERB MED, V43, P218; Plafki C, 2000, AVIAT SPACE ENVIR MD, V71, P119; Sanders Robert W, 2012, J Emerg Med, V42, pe69, DOI 10.1016/j.jemermed.2008.12.017; Seidel R, 2013, UNDERSEA HYPERBAR M, V40, P515; Smerz RW, 2004, UNDERSEA HYPERBAR M, V31, P199; TORBATI D, 1992, FREE RADICAL BIO MED, V13, P101, DOI 10.1016/0891-5849(92)90070-W; WASSMANN W, 1980, EEG-EMG-Z ELEK ELEKT, V11, P97; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121; Yildiz S, 2004, AVIAT SPACE ENVIR MD, V75, P992	22	23	24	0	6	UNDERSEA & HYPERBARIC MEDICAL SOC INC	DURHAM	21 WEST COLONY PLACE, STE 280, DURHAM, NC 27705 USA	1066-2936			UNDERSEA HYPERBAR M	Undersea Hyperb. Med.	JAN-FEB	2016	43	1					21	28					8	Marine & Freshwater Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Marine & Freshwater Biology; Research & Experimental Medicine	DD4GK	WOS:000369880300003	27000010				2022-02-06	
J	Houston, MN; Bay, RC; McLeod, TCV				Houston, Megan N.; Bay, R. Curtis; McLeod, Tamara C. Valovich			The relationship between post-injury measures of cognition, balance, symptom reports and health-related quality-of-life in adolescent athletes with concussion	BRAIN INJURY			English	Article						Brain injury; assessment; patient-reported outcome measures; paediatric	MULTIDIMENSIONAL FATIGUE SCALE; CLINICAL-OUTCOMES ASSESSMENT; SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; GENERIC CORE SCALES; STATES HIGH-SCHOOL; INTERNATIONAL-CONFERENCE; STANDARDIZED ASSESSMENT; CONSENSUS STATEMENT; RELIABILITY	Background: Little is known about the relationship between post-concussion impairments and health-related quality-of-life (HRQoL). The primary purpose of this study was to determine the relationship between traditional concussion assessments and HRQoL in adolescent athletes post-concussion. The secondary purpose was to determine the association between HRQoL deficits and time lost. Methods: In total, 1134 athletes completed a baseline assessment battery. HRQoL measures included the Pediatric Quality of Life Inventory (PedsQL), Multidimensional Fatigue Scale (MFS) and Headache Impact Test-6. In total, 122 athletes sustained a concussion and underwent follow-up testing at 3 and 10 days post-injury. Results: The strongest relationships were between symptom severity and HRQoL. For concurrent regression analyses at Day 3, PedsQL-Physical accounted for 17.9% of the variance in time lost beyond that accounted for by traditional measures. At Day 10, PedsQL-School accounted for 15.2% and symptom severity for 7.1% of this variance. In predictive analyses, at Day 3, PedsQL-Physical accounted for 3.9% and MFS-General for 3.3% of the variance in time lost beyond that accounted for by traditional measures. At Day 10, MFS-Cognitive accounted for 12.0% of this variance. Conclusions: HRQoL appears to play a role in time lost post-concussion and should be measured in combination with traditional concussion assessments.	[Houston, Megan N.] Keller Army Hosp, West Point, NY 10996 USA; [Bay, R. Curtis; McLeod, Tamara C. Valovich] AT Still Univ, Dept Interdisciplinary Hlth Sci, Mesa, AZ USA; [McLeod, Tamara C. Valovich] AT Still Univ, Sch Osteopath Med, Mesa, AZ USA		Houston, MN (corresponding author), Keller Army Hosp, West Point, NY 10996 USA.	megan.n.houston.ctr@mail.mil	Meijer, Anna/K-5118-2016; Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722; Bay, Ralph/0000-0003-3525-9269	National Operating Committee on Standards for Athletic Equipment (NOCSAE)	The authors report no conflicts of interest. This study was funded by a grant from the National Operating Committee on Standards for Athletic Equipment (NOCSAE).	Aiken L. S., 2013, APPL MULTIPLE REGRES, DOI 10.4324/9780203774441; Bayliss M., 2002, HIT 6 USERS GUIDE; Boyce SH, 2003, SCOT MED J, V48, P88, DOI 10.1177/003693300304800308; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; D'Amico D, 2003, NEUROL SCI, V24, pS97; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Jette AM, 2006, PHYS THER, V86, P726, DOI 10.1093/ptj/86.5.726; Kelly KD, 2001, CLIN J SPORT MED, V11, P77, DOI 10.1097/00042752-200104000-00003; Kuehl MD, 2010, CLIN J SPORT MED, V20, P86, DOI 10.1097/JSM.0b013e3181cf4534; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; Mainwaring LM, 2004, J SPORT EXERCISE PSY, V26, P119, DOI 10.1123/jsep.26.1.119; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; McLeod TCV, 2011, J SPORT REHABIL, V20, P46, DOI 10.1123/jsr.20.1.46; Piebes SK, 2011, J SPORT REHABIL, V20, P129, DOI 10.1123/jsr.20.1.129; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Snyder AR, 2008, J ATHL TRAINING, V43, P428, DOI 10.4085/1062-6050-43.4.428; Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306; Valovich McLeod TC, 2010, ATHL TRAIN SPORTS HL, V2, P219; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-9; Varni James W, 2005, Expert Rev Pharmacoecon Outcomes Res, V5, P705, DOI 10.1586/14737167.5.6.705; Varni JW, 2010, INT J PEDIATR OBES, V5, P34, DOI 10.3109/17477160903111706; Varni JW, 2009, PEDIATR DIABETES, V10, P321, DOI 10.1111/j.1399-5448.2008.00482.x; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 2004, J RHEUMATOL, V31, P2494; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Williams RM, 2015, J ATHL TRAINING, V50, P262, DOI 10.4085/1062-6050-49.3.81; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59	44	23	23	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	7					891	898		10.3109/02699052.2016.1146960			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DP2MI	WOS:000378322400008	27088297				2022-02-06	
J	Mansouri, MT; Farbood, Y; Naghizadeh, B; Shabani, S; Mirshekar, MA; Sarkaki, A				Mansouri, Mohammad Taghi; Farbood, Yaghoub; Naghizadeh, Bahareh; Shabani, Sohreh; Mirshekar, Mohammad Ali; Sarkaki, Alireza			Beneficial effects of ellagic acid against animal models of scopolamine- and diazepam-induced cognitive impairments	PHARMACEUTICAL BIOLOGY			English	Article						Elevated plus maze; memory deficit; passive avoidance	OXIDATIVE STRESS; MEMORY IMPAIRMENTS; PASSIVE-AVOIDANCE; INVOLVEMENT; BRAIN; RAT; BENZODIAZEPINES; SYSTEM; CELLS; MAZE	Context In a previous study, it has been shown that ellagic acid ( EA), a polyphenolic compound found in pomegranate and different berries, prevents cognitive and hippocampal long-term potentiation (LTP) impairments induced by traumatic brain injury in rats through antioxidant and anti-inflammatory mechanisms. Objective The present study was conducted to assess the potential of EA as a memory enhancer. Materials and methods The elevated plus maze (EPM) and passive avoidance (PA) paradigm were used to evaluate learning and memory parameters. Three doses (10, 30 and 100 mg/kg, i.p.) of EA were administered to animals. Memory impairment was induced by scopolamine treatment (0.4 mg/kg, i.p.) and/or diazepam (1 mg/kg, i.p.). Acquisition trials were carried out 30 min after scopolamine treatment and retention trials were performed for 5 min 24 h after the acquisition trials. Results EA at doses 30 and 100 mg/kg significantly reversed the amnesia induced by scopolamine (0.4 mg/kg, i.p.) in the EPM and PA tests in mice. Also, EA at doses 30 and 100 mg/kg significantly antagonized the amnesia induced by diazepam (1 mg/kg, i.p.) in EPM test in rats. Moreover, chronic administration of EA at dose 30 mg/kg ameliorated the memory deficit induced by diazepam (1 mg/kg, i.p.) in rats. Discussion and conclusion This study demonstrates that ellagic acid is effective in preventing scopolamine- and diazepam-induced cognitive impairments without altering the animals' locomotion. This suggests the potential of EA application as a useful memory restorative agent in the treatment of dementia seen in elderly persons.	[Mansouri, Mohammad Taghi; Naghizadeh, Bahareh] Ahvaz Jundishapur Univ Med Sci, Sch Med, Dept Pharmacol, Ahvaz, Iran; [Mansouri, Mohammad Taghi; Farbood, Yaghoub; Shabani, Sohreh; Sarkaki, Alireza] Ahvaz Jundishapur Univ Med Sci, Physiol Res Ctr, Ahvaz, Iran; [Farbood, Yaghoub; Shabani, Sohreh; Sarkaki, Alireza] Ahvaz Jundishapur Univ Med Sci, Sch Med, Dept Physiol, Ahvaz, Iran; [Mirshekar, Mohammad Ali] Zahedan Univ Med Sci, Sch Med, Dept Physiol, Zahedan, Iran		Mansouri, MT (corresponding author), Ahvaz Jundishapur Univ Med Sci, Sch Med, Pharmacol, Ahvaz, Iran.	mansouri_smt@yahoo.com	Mansouri, Seyed Mohammad Taghi/F-3847-2014; Sarkaki, Alireza/Q-8363-2017; Shabani, Sahreh/AAG-4488-2021; Mirshekar, Mohammad Ali/S-4167-2017; Farbood, Yaghoob/M-3076-2017	Mansouri, Seyed Mohammad Taghi/0000-0002-7549-0708; Sarkaki, Alireza/0000-0001-9272-6228; Mirshekar, Mohammad Ali/0000-0002-0449-6440; Farbood, Yaghoob/0000-0002-6390-0079	Physiology Research Center - Vice Chancellor of Research, Ahvaz Jundishapur University of Medical Sciences (Iran) [PRC-121]	This research was financially supported by grants (PRC-121) from the Physiology Research Center, funded by the Vice Chancellor of Research, Ahvaz Jundishapur University of Medical Sciences (Iran).	Blokland A, 1995, BRAIN RES REV, V21, P285, DOI 10.1016/0165-0173(95)00016-X; Buniatian GH, 2003, CELL PROLIFERAT, V36, P307, DOI 10.1046/j.1365-2184.2003.00287.x; Choi YH, 2009, BIOL PHARM BULL, V32, P1118, DOI 10.1248/bpb.32.1118; Dolatshahi M, 2015, IRAN J BASIC MED SCI, V18, P38; Farbood Y, 2015, LIFE SCI, V124, P120, DOI 10.1016/j.lfs.2015.01.013; Feng Y, 2009, BIOCHEM BIOPH RES CO, V390, P1250, DOI 10.1016/j.bbrc.2009.10.130; Festa F, 2001, ANTICANCER RES, V21, P3903; Gacar N, 2011, PHARMACOL BIOCHEM BE, V99, P316, DOI 10.1016/j.pbb.2011.05.017; Ghasemzadeh-Dehkordi, 2014, J HERB DRUGS, V5, P1; Girish C, 2013, EUR J PHARMACOL, V710, P49, DOI 10.1016/j.ejphar.2013.04.003; Girish C, 2012, EUR J PHARMACOL, V682, P118, DOI 10.1016/j.ejphar.2012.02.034; Hartman RE, 2006, NEUROBIOL DIS, V24, P506, DOI 10.1016/j.nbd.2006.08.006; Hassoun EA, 2004, J BIOCHEM MOL TOXIC, V18, P196, DOI 10.1002/jbt.20030; HUNTER B, 1988, HDB PSYCHOPHARMACOLO, V19, P531; ITOH J, 1991, EUR J PHARMACOL, V194, P71, DOI 10.1016/0014-2999(91)90125-A; Iversen SD, 1997, LIFE SCI, V60, P1145, DOI 10.1016/S0024-3205(97)00059-3; Karlsson S, 2010, BRIT J NUTR, V103, P1102, DOI 10.1017/S0007114509992935; Kim DH, 2007, EUR J PHARMACOL, V574, P140, DOI 10.1016/j.ejphar.2007.07.042; LISTER RG, 1985, NEUROSCI BIOBEHAV R, V9, P87, DOI 10.1016/0149-7634(85)90034-X; Liu QS, 2011, J ETHNOPHARMACOL, V135, P786, DOI 10.1016/j.jep.2011.04.026; MAJID S, 1991, BIOCHEM PHARMACOL, V42, P1441, DOI 10.1016/0006-2952(91)90457-G; Mansouri MT, 2014, PHARMACOL BIOCHEM BE, V120, P43, DOI 10.1016/j.pbb.2014.02.009; Mansouri MT, 2013, EUR J PHARMACOL, V707, P46, DOI 10.1016/j.ejphar.2013.03.031; Mansouri MT, 2013, FOOD CHEM, V138, P1028, DOI 10.1016/j.foodchem.2012.11.022; Park SJ, 2012, EUR J PHARMACOL, V676, P64, DOI 10.1016/j.ejphar.2011.11.050; Pavlica S, 2005, FREE RADICAL RES, V39, P1377, DOI 10.1080/09670260500197660; Reddy DS, 1998, BRAIN RES, V799, P215, DOI 10.1016/S0006-8993(98)00419-3; Reeta KH, 2009, BRAIN RES, V1301, P52, DOI 10.1016/j.brainres.2009.09.027; Sellappan S, 2002, J AGR FOOD CHEM, V50, P2432, DOI 10.1021/jf011097r; Spencer JPE, 2010, BRIT J NUTR, V104, pS40, DOI 10.1017/S0007114510003934; THIEBOT MH, 1985, NEUROSCI BIOBEHAV R, V9, P95, DOI 10.1016/0149-7634(85)90035-1; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Uzar E, 2012, NEUROL SCI, V33, P567, DOI 10.1007/s10072-011-0775-1	33	23	23	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1388-0209	1744-5116		PHARM BIOL	Pharm. Biol.		2016	54	10					1947	1953		10.3109/13880209.2015.1137601			7	Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy	DZ7JP	WOS:000386041500001	26828763				2022-02-06	
J	Minert, A; Devor, M				Minert, Anne; Devor, Marshall			Brainstem node for loss of consciousness due to GABA(A) receptor-active anesthetics	EXPERIMENTAL NEUROLOGY			English	Article						Brainstem; Coma; Concussion; General anesthesia; Loss-of-consciousness; MPTA	GENERAL-ANESTHESIA; INTRACEREBRAL MICROINJECTION; MESOPONTINE TEGMENTUM; RAT; MECHANISMS; ACTIVATION; PATHWAYS; PROPOFOL; SYSTEMS; NEURONS	The molecular agents that induce loss of consciousness during anesthesia are classically believed to act by binding to cognate transmembrane receptors widely distributed in the CNS and critically suppressing local processing and network connectivity. However, previous work has shown that microinjection of anesthetics into a localized region of the brainstem mesopontine tegmentum (MPTA) rapidly and reversibly induces anesthesia in the absence of global spread. This implies that functional extinction is determined by neural pathways rather than vascular distribution of the anesthetic agent. But does clinical (systemic-induced) anesthesia employ MPTA-linked circuitry? Here we show that cell-selective lesioning of the MPTA in rats does not, in itself, induce anesthesia or coma. However, it increases the systemic dose of pentobarbital required to induce anesthesia, in a manner proportional to the extent of the lesion. Such lesions also affect emergence, extending the duration of anesthesia. Off-target and sham lesions were ineffective. Combined with the prior microinjection data, we conclude that drug delivery to the MPTA is sufficient to induce loss-of-consciousness and that neurons in this locus are necessary for anesthetic induction at clinically relevant doses. Together, the results support an architecture for anesthesia with the MPTA serving as a key node in an endogenous network of dedicated pathways that switch between wake and unconsciousness. As such, the MPTA might also play a role in syncope, concussion and sleep. (C) 2015 Elsevier Inc. All rights reserved.	[Devor, Marshall] Hebrew Univ Jerusalem, Inst Life Sci, Dept Cell & Dev Biol, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Ctr Res Pain, IL-91904 Jerusalem, Israel		Devor, M (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Cell & Dev Biol, IL-91904 Jerusalem, Israel.	marshlu@mail.huji.ac.il		Minert, Anne/0000-0002-8462-013X; Devor, Marshall/0000-0001-8206-3301	Israeli Ministry of Health; Hebrew University Center for Research on Pain	This study was supported by grants from the Israeli Ministry of Health and the Hebrew University Center for Research on Pain. We thank Adi Goldenberg, Yelena Fishman Ph.D., Roni Jortner, Natalie Padon and Vladimir Zalkind for their assistance.	Abulafia R, 2009, J NEUROSCI, V29, P7053, DOI 10.1523/JNEUROSCI.1357-08.2009; Alkire MT, 2005, PROG BRAIN RES, V150, P229, DOI 10.1016/S0079-6123(05)50017-7; ALKIRE MT, 1995, ANESTHESIOLOGY, V82, P393, DOI 10.1097/00000542-199502000-00010; Antognini JF, 1998, TOXICOL LETT, V101, P51, DOI 10.1016/S0378-4274(98)00164-7; Bleckwenn A, 2002, MOLECULAR AND BASIC MECHANISMS OF ANESTHESIA, P550; Brown EN, 2011, ANNU REV NEUROSCI, V34, P601, DOI 10.1146/annurev-neuro-060909-153200; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Devor M, 2001, PAIN, V94, P101, DOI 10.1016/S0304-3959(01)00345-1; Faingold C., 1987, EPILEPSY RETICULAR F, P39; Fields HL, 2006, WALL MELZACKS TXB PA, P125; Finney D.J., 1971, PROBIT ANAL; FORD B, 1995, J COMP NEUROL, V363, P177, DOI 10.1002/cne.903630203; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Fuller P, 2011, J COMP NEUROL, V519, P933, DOI 10.1002/cne.22559; Grasshoff C, 2005, CURR OPIN ANESTHESIO, V18, P386, DOI 10.1097/01.aco.0000174961.90135.dc; HAYES RL, 1984, SCIENCE, V223, P301, DOI 10.1126/science.6701514; JARRARD LE, 1989, J NEUROSCI METH, V29, P251, DOI 10.1016/0165-0270(89)90149-0; Joiner WJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003605; Kendig JJ, 2002, BRIT J ANAESTH, V89, P91, DOI 10.1093/bja/aef158; Leung LS, 2014, PROG NEUROBIOL, V122, P24, DOI 10.1016/j.pneurobio.2014.08.001; Lu J, 2008, J COMP NEUROL, V508, P648, DOI 10.1002/cne.21685; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90219-9; Namjoshi DR, 2009, J NEUROPHYSIOL, V102, P700, DOI 10.1152/jn.90933.2008; Nunez A, 1998, BRAIN RES, V804, P144, DOI 10.1016/S0006-8993(98)00681-7; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Raines, 2003, NEURAL MECH ANESTHES; Sandoval-Herrera V, 2011, HORM BEHAV, V60, P448, DOI 10.1016/j.yhbeh.2011.07.013; Scharf M. T., 2013, CURR ANESTHESIOL REP, V3, P1; Sukhotinsky I, 2005, J COMP NEUROL, V489, P425, DOI 10.1002/cne.20636; Sukhotinsky I, 2007, EUR J NEUROSCI, V25, P1417, DOI 10.1111/j.1460-9568.2007.05399.x; Sukhotinsky I, 2003, PROG PAIN RES MANAG, V24, P305; Tononi G, 2005, PROG BRAIN RES, V150, P109, DOI 10.1016/S0079-6123(05)50009-8; Voss LJ, 2005, ANAESTH INTENS CARE, V33, P373, DOI 10.1177/0310057X0503300313; WHELAN G, 1992, LAB ANIM-UK, V26, P153, DOI 10.1258/002367792780740602; YAMAMOTO S, 1961, ELECTROEN CLIN NEURO, V13, P248, DOI 10.1016/0013-4694(61)90141-9; Zeilhofer Hanns Ulrich, 2015, Adv Pharmacol, V73, P71, DOI 10.1016/bs.apha.2014.11.007	39	23	23	0	13	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JAN	2016	275		1				38	45		10.1016/j.expneurol.2015.10.001			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CZ9MA	WOS:000367420500005	26436687				2022-02-06	
J	Papa, L; Mittal, MK; Ramirez, J; Ramia, M; Kirby, S; Silvestri, S; Giordano, P; Weber, K; Braga, CF; Tan, CN; Ameli, NJ; Lopez, M; Zonfrillo, M				Papa, Linda; Mittal, Manoj K.; Ramirez, Jose; Ramia, Michelle; Kirby, Sara; Silvestri, Salvatore; Giordano, Philip; Weber, Kurt; Braga, Carolina F.; Tan, Ciara N.; Ameli, Neema J.; Lopez, Marco; Zonfrillo, Mark			In Children and Youth with Mild and Moderate Traumatic Brain Injury, Glial Fibrillary Acidic Protein Out-Performs S100b in Detecting Traumatic Intracranial Lesions on Computed Tomography	JOURNAL OF NEUROTRAUMA			English	Article						computed tomography (CT); glial fibrillary acidic protein (GFAP); head trauma; mild traumatic brain injury; S100B	SERUM S-100B LEVELS; HEAD-INJURY; GFAP; BIOMARKERS	In adults, glial fibrillary acidic protein (GFAP) has been shown to out-perform S100 in detecting intracranial lesions on computed tomography (CT) in mild traumatic brain injury (TBI). This study examined the ability of GFAP and S100 to detect intracranial lesions on CT in children and youth involved in trauma. This prospective cohort study enrolled a convenience sample of children and youth at two pediatric and one adult Level 1 trauma centers following trauma, including both those with and without head trauma. Serum samples were obtained within 6h of injury. The primary outcome was the presence of traumatic intracranial lesions on CT scan. There were 155 pediatric trauma patients enrolled, 114 (74%) had head trauma and 41 (26%) had no head trauma. Out of the 92 patients who had a head CT, eight (9%) had intracranial lesions. The area under the receiver operating characteristic curve (AUC) for distinguishing head trauma from no head trauma for GFAP was 0.84 (0.77-0.91) and for S100 was 0.64 (0.55-0.74; p<0.001). Similarly, the AUC for predicting intracranial lesions on CT for GFAP was 0.85 (0.72-0.98) versus 0.67 (0.50-0.85) for S100 (p=0.013). Additionally, we assessed the performance of GFAP and S100 in predicting intracranial lesions in children ages 10 years or younger and found the AUC for GFAP was 0.96 (95% confidence interval [CI] 0.86-1.00) and for S100 was 0.72 (0.36-1.00). In children younger than 5 years old, the AUC for GFAP was 1.00 (95% CI 0.99-1.00) and for S100 0.62 (0.15-1.00). In this population with mild TBI, GFAP out-performed S100 in detecting head trauma and predicting intracranial lesions on head CT. This study is among the first published to date to prospectively compare these two biomarkers in children and youth with mild TBI.	[Papa, Linda; Ramia, Michelle; Silvestri, Salvatore; Giordano, Philip; Weber, Kurt; Braga, Carolina F.; Tan, Ciara N.; Ameli, Neema J.; Lopez, Marco] Orlando Reg Med Ctr Inc, Dept Emergency Med, Orlando, FL 32806 USA; [Papa, Linda; Ramirez, Jose; Silvestri, Salvatore; Giordano, Philip; Weber, Kurt] Arnold Palmer Hosp Children, Dept Pediat Emergency Med, Orlando, FL USA; [Mittal, Manoj K.; Kirby, Sara; Zonfrillo, Mark] Childrens Hosp Philadelphia, Div Emergency Med, Philadelphia, PA 19104 USA; [Mittal, Manoj K.; Zonfrillo, Mark] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA		Papa, L (corresponding author), Orlando Reg Med Ctr Inc, Dept Emergency Med, 86 W Underwood S-200, Orlando, FL 32806 USA.	lpstat@aol.com	Zonfrillo, Mark R./H-9403-2017	Zonfrillo, Mark R./0000-0002-0610-9563	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS057676]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS057676] Funding Source: NIH RePORTER	The project described was supported in part by Award Number R01NS057676 from the National Institute of Neurological Disorders and Stroke. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders And Stroke or the National Institutes of Health.	Bechtel K, 2009, PEDIATRICS, V124, pE697, DOI 10.1542/peds.2008-1493; Berger RP, 2002, J NEUROTRAUM, V19, P1405, DOI 10.1089/089771502320914633; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Castellani C, 2009, ACTA PAEDIATR, V98, P1607, DOI 10.1111/j.1651-2227.2009.01423.x; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Herrmann M, 2001, NEUROSURGERY, V49, P1272, DOI 10.1097/00006123-200111000-00058; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Olsson B, 2011, PROG NEUROBIOL, V95, P520, DOI 10.1016/j.pneurobio.2011.04.006; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Romner B, 2001, NEUROSURGERY, V49, P1490, DOI 10.1097/00006123-200112000-00053; Rothoerl RD, 2001, NEUROSURGERY, V49, P1490, DOI 10.1097/00006123-200112000-00054; Swanson CA, 2010, J TRAUMA, V68, P1072, DOI 10.1097/TA.0b013e3181d7a6f2; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Vajtr D., 2013, SOUD LEK, V57, P7; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	26	23	24	1	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2016	33	1					58	64		10.1089/neu.2015.3869			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CZ4EW	WOS:000367057200007	25752485	Green Published			2022-02-06	
J	Ranganathan, P; Kumar, RG; Davis, K; McCullough, EH; Berga, SL; Wagner, AK				Ranganathan, Prerna; Kumar, Raj G.; Davis, Kendra; McCullough, Emily H.; Berga, Sarah L.; Wagner, Amy K.			Longitudinal sex and stress hormone profiles among reproductive age and post-menopausal women after severe TBI: A case series analysis	BRAIN INJURY			English	Article						Hypogonadism; sex hormone physiology; traumatic brain injury; cortisol; amenorrhea; luteal hormone; functional hypothalamic amenorrhea	CORTICOTROPIN-RELEASING HORMONE; TRAUMATIC BRAIN-INJURY; NEUROENDOCRINE DYSFUNCTION; HYPOTHALAMIC AMENORRHEA; CORTISOL SECRETION; HEAD TRAUMA; RESPONSES; COMA; HYPOGONADISM; DISABILITY	Primary objectives: To describe hormone profiles for pre-/post-menopausal women, to monitor time to resumption of menstruation among pre-menopausal women and to describe cortisol associated LH suppression and phasic variation in other sex hormones over time Methods and procedures: This study determined amenorrhea duration and characterized acute (days 0-7) and chronic (months 1-6) gonadotropins [luteinizing hormone and follicle stimulating hormone (LH, FSH)], sex hormones (progesterone, estradiol) and stress hormone (cortisol) profiles. Women were pre-menopausal (n = 3) or post-menopausal (n = 3). Among premenopausal women, menstrual cycle resolution and phase association (luteal/follicular) was monitored using self-report monthly reproductive history questionnaires. This study compared post-TBI hormone profiles, stratified by menopausal status, to hormone levels from seven controls and described 6- and 12-month outcomes for these women. Main outcomes and results: Consistent with functional hypothalamic amenorrhea (FHA), menstruation resumption among pre-menopausal women occurred when serum cortisol normalized to luteal phase control levels. For post-menopausal women, serum cortisol reductions corresponded with resolution of suppressed LH levels. Conclusions: The stress of TBI results in anovulation and central hypothalamic-pituitary-ovarian (HPG) axis suppression. Future work will examine acute/chronic consequences of post-TBI hypercortisolemia and associated HPG suppression, the temporal association of HPG suppression with other neuroendocrine adaptations and how HPG suppression impacts multidimensional recovery for women with TBI.	[Ranganathan, Prerna; Kumar, Raj G.; Davis, Kendra; McCullough, Emily H.; Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Berga, Sarah L.] Wake Forest Univ, Dept Obstet Gynecol, Winston Salem, NC 27109 USA; [Wagner, Amy K.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA		Wagner, AK (corresponding author), 3471 Fifth Ave,Kaufman Bldg,Suite 202, Pittsburgh, PA 15237 USA.	wagnerak@upmc.edu			University of Pittsburgh Women's Studies Faculty Research Fund [CDC: R49 CCR 323155, DOD: W81XWH-071-0701, NIDRR H133A120087]	The authors report no conflicts of interest. This work was supported by CDC: R49 CCR 323155, DOD: W81XWH-071-0701, NIDRR H133A120087, University of Pittsburgh Women's Studies Faculty Research Fund.	[Anonymous], 2013, TRAUMATIC BRAIN INJU; ARIMURA A, 1971, P SOC EXP BIOL MED, V136, P290; Ashman T, 2014, J HEAD TRAUMA REHAB, V29, P467, DOI 10.1097/HTR.0000000000000098; Barbieri RL, 2014, METHODS MOL BIOL, V1154, P145, DOI 10.1007/978-1-4939-0659-8_7; Barton DJ, 2015, J HEAD TRAUMA REHAB; BERGA SL, 1989, J CLIN ENDOCR METAB, V68, P301, DOI 10.1210/jcem-68-2-301; Berga SL, 1997, FERTIL STERIL, V67, P1024, DOI 10.1016/S0015-0282(97)81434-3; BILLER BMK, 1990, J CLIN ENDOCR METAB, V70, P311, DOI 10.1210/jcem-70-2-311; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; BOYAR RM, 1977, NEW ENGL J MED, V296, P190, DOI 10.1056/NEJM197701272960403; Bughi Stefan, 2008, Endocr Pract, V14, P437; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Caronia LM, 2011, NEW ENGL J MED, V364, P215, DOI 10.1056/NEJMoa0911064; CASPER RC, 1979, J CLIN ENDOCR METAB, V49, P406, DOI 10.1210/jcem-49-3-406; Childers MK, 1998, BRAIN INJURY, V12, P517, DOI 10.1080/026990598122476; COOKE RS, 1995, INJURY, V26, P399, DOI 10.1016/0020-1383(95)00064-G; Fernandez-Rodriguez Eva, 2011, Front Endocrinol (Lausanne), V2, P25, DOI 10.3389/fendo.2011.00025; Foy MR, 2000, CURR DIR PSYCHOL SCI, V9, P148, DOI 10.1111/1467-8721.00081; Gordon CM, 2010, NEW ENGL J MED, V363, P365, DOI 10.1056/NEJMcp0912024; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; HILLIARD J, 1971, ENDOCRINOLOGY, V88, P730, DOI 10.1210/endo-88-3-730; HOTTA M, 1986, J CLIN ENDOCR METAB, V62, P319, DOI 10.1210/jcem-62-2-319; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kassi E, 2000, ENDOTEXT; KIMURA D, 1994, CURR DIR PSYCHOL SCI, V3, P57, DOI 10.1111/1467-8721.ep10769964; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; LOUCKS AB, 1989, J CLIN ENDOCR METAB, V68, P402, DOI 10.1210/jcem-68-2-402; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; May AK, 2008, CRIT CARE MED, V36, P62, DOI 10.1097/01.CCM.0000292015.16171.6D; Meczekalski B, 2008, GYNECOL ENDOCRINOL, V24, P4, DOI 10.1080/09513590701807381; Michopoulos V, 2013, FERTIL STERIL, V99, P2084, DOI 10.1016/j.fertnstert.2013.02.036; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; REAME NE, 1985, J CLIN ENDOCR METAB, V61, P851, DOI 10.1210/jcem-61-5-851; Reynolds RM, 2010, DIABETES CARE, V33, P714, DOI 10.2337/dc09-1796; Ripley DL, 2008, ARCH PHYS MED REHAB, V89, P1090, DOI 10.1016/j.apmr.2007.10.038; ROLIH CA, 1995, MED CLIN N AM, V79, P211, DOI 10.1016/S0025-7125(16)30093-1; Santarsieri M, 2014, J NEUROTRAUM, V31, P699, DOI 10.1089/neu.2013.3177; SCHALLY AV, 1964, ENDOCRINOLOGY, V75, P608, DOI 10.1210/endo-75-4-608; SCHALLY AV, 1973, SCIENCE, V179, P341, DOI 10.1126/science.179.4071.341; SCHALLY AV, 1973, ENDOCRINOLOGY, V93, P893, DOI 10.1210/endo-93-4-893; Spratt DI, 2008, AM J PHYSIOL-ENDOC M, V295, pE63, DOI 10.1152/ajpendo.00472.2007; SPRATT DI, 1993, J CLIN ENDOCR METAB, V76, P1542, DOI 10.1210/jc.76.6.1542; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wagner AK, 2012, BRAIN INJURY, V26, P1226, DOI 10.3109/02699052.2012.667594; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; WOOLF PD, 1986, CLIN ENDOCRINOL, V25, P265, DOI 10.1111/j.1365-2265.1986.tb01691.x; WOOLF PD, 1992, CRIT CARE MED, V20, P216, DOI 10.1097/00003246-199202000-00011; WOOLLEY CS, 1993, J COMP NEUROL, V336, P293, DOI 10.1002/cne.903360210; YUAN XQ, 1991, FRONT NEUROENDOCRIN, V12, P209	52	23	24	1	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	4					452	461		10.3109/02699052.2016.1144081			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DK1BF	WOS:000374646200010	26963638				2022-02-06	
J	Wackym, PA; Balaban, CD; Mackay, HT; Wood, SJ; Lundell, CJ; Carter, DM; Siker, DA				Wackym, P. Ashley; Balaban, Carey D.; Mackay, Heather T.; Wood, Scott J.; Lundell, Christopher J.; Carter, Dale M.; Siker, David A.			Longitudinal Cognitive and Neurobehavioral Functional Outcomes Before and After Repairing Otic Capsule Dehiscence	OTOLOGY & NEUROTOLOGY			English	Article						Cognitive dysfunction; Depression; Memory; Migraine; Otic capsule dehiscence syndrome; Perilymph fistula; Superior canal dehiscence syndrome; Traumatic brain injury	SEMICIRCULAR CANAL DEHISCENCE; DUAL-TASK INTERFERENCE; VESTIBULAR STIMULATION; PARABRACHIAL NUCLEUS; SURGICAL-MANAGEMENT; MOTION SICKNESS; SPATIAL MEMORY; DEPRESSION; ANXIETY; SYSTEM	Objective:Patients with peripheral vestibular dysfunction because of gravitational receptor asymmetries display signs of cognitive dysfunction and are assumed to have neurobehavioral sequelae. This was tested with pre- and postoperatively quantitative measurements in three cohort groups with superior semicircular canal dehiscence syndrome (SSCDS) symptoms with: 1) superior canal dehiscence (SCD) repaired via a middle cranial fossa craniotomy and canal plugging only; 2) otic capsule defects not visualized with imaging (no-iOCD) repaired with round window reinforcement (RWR) only; or 3) both SCD plugging and subsequent development of no-iOCD followed by RWR.Study Design:Prospective patient series.Setting:Tertiary referral center.Patients:There were 13 adult and 4 pediatric patients with SSCDS who had completion of neuropsychology test batteries pre- and every 3 months postoperatively. Eight patients had no-iOCD and RWR exclusively, 5 had SCD and plugging exclusively, and 4 had both SCD plugging and then development of no-iOCD with RWR. These cohorts included SSCDS with 2 different dehiscence locations.Interventions:Completion of a neuropsychology test battery preoperatively and at 3, 6, 9, and 12 months postoperatively that included: Beck Depression Inventory-II (BDI); Wide Range Intelligence Test (WRIT FSIQ) including average verbal (crystallized intelligence) and visual (fluid intelligence); Wide Range Assessment of Memory and Learning (WRAML), including the four domains of verbal memory, visual memory, attention/concentration, and working memory; and Delis-Kaplan Executive Function System (D-KEFS). The Dizziness Handicap Inventory (DHI) and the Headache Impact Test (HIT-6) were also completed to assess the impact of their disease on activities pre- and postoperatively.Main Outcome Measures:Quantitative and statistical analysis of their cognitive and neurobehavioral function.Results:The pattern of differences between the SCD group and the no-iOCD group from WRAML verbal, visual, and attention test performance indicate different postoperative clinical trajectories. For the WRAML, there was a statistically significant improvement for visual memory and verbal memory for the no-iOCD only and both (SCD and subsequent no-iOCD) groups, but no mean improvement for the SCD only group. By contrast, the no-iOCD group had significantly lower scores on the WRAML attention test preoperatively, but they recovered postoperatively to match the other groups. The preoperative findings and postoperative outcomes did not differ significantly among patient groups on the WRAML working memory test, D-KEFS motor scores, D-KEFS number and letter scores, or Wide Range Intelligence Test scores. There was a significant decrease in the BDI for all groups. The IQ scores were unchanged. There was a statistically significant improvement in the DHI and HIT-6 scores postoperatively in all groups.Conclusions:There was a marked overall improvement in cognitive and neurobehavioral function postoperatively. Variability may result from duration of underlying disease before intervention. The initial decrement or delay in performance improvement measured in several patients may represent brain reorganization. Greater longitudinal data and greater subject numbers are necessary to better understand and optimize cognitive recovery.	[Wackym, P. Ashley; Mackay, Heather T.; Lundell, Christopher J.] Ear & Skull Base Ctr, Portland, OR 97232 USA; [Wackym, P. Ashley; Mackay, Heather T.; Lundell, Christopher J.] Legacy Res Inst, Portland, OR USA; [Balaban, Carey D.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [Wood, Scott J.] Azusa Pacific Univ, Dept Psychol, Azusa, CA USA; [Carter, Dale M.] NW Headache & Wellness Ctr, Portland, OR USA; [Siker, David A.] Siker Med Imaging, Portland, OR USA		Wackym, PA (corresponding author), Ear & Skull Base Ctr, 1225 NE 2nd Ave,Suite 305, Portland, OR 97232 USA.	wackym@neurotology.org	Balaban, Carey/I-3467-2017; Balaban, Carey/O-6586-2019	Balaban, Carey/0000-0002-3570-3844; Balaban, Carey/0000-0002-3570-3844; Wackym, P. Ashley/0000-0002-2904-5072	Legacy Good Samaritan Foundation; Ear and Skull Base Center	The Legacy Good Samaritan Foundation and the Ear and Skull Base Center provided funding to help support this work.	Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Andersson G, 1998, AM J OTOL, V19, P632; Baek JH, 2010, NEUROBIOL LEARN MEM, V94, P402, DOI 10.1016/j.nlm.2010.08.007; Balaban CD, 2012, BRAIN RES, V1482, P101, DOI 10.1016/j.brainres.2012.08.040; Balaban CD, 2004, BRAIN RES, V996, P126, DOI 10.1016/j.brainres.2003.10.026; Balaban CD, 2002, J NEUROPHYSIOL, V88, P3175, DOI 10.1152/jn.00499.2002; Balaban CD, 2001, J ANXIETY DISORD, V15, P53, DOI 10.1016/S0887-6185(00)00042-6; Balabann CD, 2011, EXPERT REV NEUROTHER, V11, P379, DOI [10.1586/ern.11.19, 10.1586/ERN.11.19]; Bayliss M, 2002, HIT 6TM USERS GUIDE; Bear ZW, 2015, ACTA OTO-LARYNGOL, V135, P974, DOI 10.3109/00016489.2015.1060630; Bechterew W., 1883, PFLUGERS ARCH, V30, P312; BECK AT, 1974, PSYCHOL REP, V34, P1184; BECK AT, 1984, J CLIN PSYCHOL, V40, P1365, DOI 10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bergquist F, 2008, J PHYSIOL-LONDON, V586, P4441, DOI 10.1113/jphysiol.2008.155291; Besnard S, 2012, HIPPOCAMPUS, V22, P814, DOI 10.1002/hipo.20942; Bilgrei R, PSYCHOL VESTIBULAR 1; BLACK FO, 1987, OTOLARYNG HEAD NECK, V96, P125, DOI 10.1177/019459988709600203; BLACK FO, 1992, AM J OTOL, V13, P254; Brandt T, 2005, BRAIN, V128, P2732, DOI 10.1093/brain/awh617; Calamia M, 2012, CLIN NEUROPSYCHOL, V26, P543, DOI 10.1080/13854046.2012.680913; Coalson D, 2008, WAIS 4 TECHNICAL INT; Delis D.C., 2001, EXAMINERS MANUAL; Delis DC, 2004, J INT NEUROPSYCH SOC, V10, P301, DOI 10.1017/S1355617704102191; Deroualle D, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00016; Dodson MJ, 2004, J NEUROL NEUROSUR PS, V75, P168; Elmali M, 2013, EUR J RADIOL, V82, pE606, DOI 10.1016/j.ejrad.2013.06.022; Furman JM, 2013, LANCET NEUROL, V12, P706, DOI 10.1016/S1474-4422(13)70107-8; Gizzi M, 2003, J HEAD TRAUMA REHAB, V18, P398, DOI 10.1097/00001199-200309000-00002; Glutting J, 2000, WIDE RANGE INTELLIGE; GRIMM RJ, 1989, ACTA OTO-LARYNGOL, P1, DOI 10.3109/00016488909138632; Guedry FE, 1974, HDB SENSORY PHYSL VESTIBULAR SYSTEM 2, P3; Gurvich C, 2013, BRAIN RES, V1537, P244, DOI 10.1016/j.brainres.2013.08.058; Heilbronner RL, 2010, CLIN NEUROPSYCHOL, V24, P1267, DOI 10.1080/13854046.2010.526785; Ho TW, 2010, NAT REV NEUROL, V6, P573, DOI 10.1038/nrneurol.2010.127; Hufner K, 2007, HIPPOCAMPUS, V17, P471, DOI 10.1002/hipo.20283; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Jessup AB, 2014, J DIABETES METAB, V5, P383; Kennedy RS, 1997, AVIAT SPACE ENVIR MD, V68, P13; KENNEDY RS, 1988, HUM FACTORS, V30, P153, DOI 10.1177/001872088803000203; KOHL RL, 1983, AVIAT SPACE ENVIR MD, V54, P464; Levine J, 2012, BRAIN STIMUL, V5, P267, DOI 10.1016/j.brs.2011.03.004; MARGOLIS RH, 1995, ARCH OTOLARYNGOL, V121, P44; Meiklejohn DA, 2015, OTOL NEUROTOL, V36, P1383, DOI 10.1097/MAO.0000000000000811; OMAN CM, 1990, CAN J PHYSIOL PHARM, V68, P294, DOI 10.1139/y90-044; Park JJH, 2015, AM J OTOLARYNG, V36, P347, DOI 10.1016/j.amjoto.2014.12.006; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Reason J. T., 1975, MOTION SICKNESS; REDFERN MS, 1994, J VESTIBUL RES-EQUIL, V4, P221; Schmidt M., 2003, J INT NEUROPSYCH SOC, V9, P962, DOI DOI 10.1017/S1355617703230162; Sharp LK, 2002, AM FAM PHYSICIAN, V66, P1001; SHARP PE, 1995, J NEUROSCI, V15, P173; Sheslow D, 2004, WIDE RANGE ASSESSMEN; Smith PF, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00678; Smith Paul F, 2010, Front Neurol, V1, P141, DOI 10.3389/fneur.2010.00141; Smith PF, 2010, HIPPOCAMPUS, V20, P36, DOI 10.1002/hipo.20588; Smith PF, 2005, PROG NEUROBIOL, V75, P391, DOI 10.1016/j.pneurobio.2005.04.004; SMITH PF, 1989, BRAIN RES REV, V14, P155, DOI 10.1016/0165-0173(89)90013-1; Staab JP, 2013, SEMIN NEUROL, V33, P297, DOI 10.1055/s-0033-1356462; Talkowski ME, 2005, J COGNITIVE NEUROSCI, V17, P1432, DOI 10.1162/0898929054985419; Vlastarakos PV, 2009, EUR ARCH OTO-RHINO-L, V266, P177, DOI 10.1007/s00405-008-0840-4; Wackym P Ashley, 2015, Ear Nose Throat J, V94, pE8; Wackym PA, 2012, OTOL NEUROTOL, V33, P1392, DOI 10.1097/MAO.0b013e318268d234; WACKYM PA, 1993, AM J OTOL, V14, P41; Wackym PA, 1998, OTOLARYNG HEAD NECK, V118, pS16, DOI 10.1016/S0194-5998(98)70003-8; Wackym PA, 2015, COGNITIVE DYSFUNCTIO; Wackym PA, 2015, TUNING FORK TESTING; Wackym PA, 2012, VESTIBULAR MIGRAINE; Wackym PA, 2015, TRAUMATIC OTIC CAPSU; Wackym PA, 2015, LEFT OTIC CAPSULE DE; Wackym PA, 2014, RIGHT PERILYMPH FIST; Wackym PA, 2015, OTIC CAPSULE DEHISCE; Ward BK, 2012, OTOL NEUROTOL, V33, P1386, DOI 10.1097/MAO.0b013e318268d20d; Watanabe K, 2014, NAT NEUROSCI, V17, P601, DOI 10.1038/nn.3667; WINTER DA, 2004, BIOMECHANICS MOTOR C; Winter L, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00499; Wood SJ, 2012, GAIT POSTURE, V36, P487, DOI 10.1016/j.gaitpost.2012.04.014; Yang M, 2011, CEPHALALGIA, V31, P357, DOI 10.1177/0333102410379890; Yardley L, 2001, J NEUROL NEUROSUR PS, V71, P48, DOI 10.1136/jnnp.71.1.48; Young L, 2010, OTOL NEUROTOL, V31, P697, DOI 10.1097/MAO.0b013e31819bd803; Zheng YW, 2014, HIPPOCAMPUS, V24, P541, DOI 10.1002/hipo.22247	82	23	23	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1531-7129	1537-4505		OTOL NEUROTOL	Otol. Neurotol.	JAN	2016	37	1					70	82		10.1097/MAO.0000000000000928			13	Clinical Neurology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Otorhinolaryngology	DA7XM	WOS:000368018900013	26649608	Green Published			2022-02-06	
J	McDevitt, J; Tierney, RT; Phillips, J; Gaughan, JP; Torg, JS; Krynetskiy, E				McDevitt, Jane; Tierney, Ryan Timothy; Phillips, Jacqueline; Gaughan, John P.; Torg, Joseph S.; Krynetskiy, Evgeny			Association between GRIN2A promoter polymorphism and recovery from concussion	BRAIN INJURY			English	Article							SPORT-RELATED CONCUSSION; HIGH-SCHOOL; RISK; PREDICTORS; STATEMENT; FOOTBALL; INJURY		[McDevitt, Jane; Tierney, Ryan Timothy; Phillips, Jacqueline] Temple Univ, Dept Kinesiol, Philadelphia, PA 19122 USA; [Gaughan, John P.] Biostat Consulting Ctr, Philadelphia, PA USA; [Torg, Joseph S.] Temple Univ, Sch Med, Dept Orthoped Surg, Philadelphia, PA 19122 USA; [Krynetskiy, Evgeny] Temple Univ, Sch Pharm, Philadelphia, PA 19122 USA		McDevitt, J (corresponding author), 102 Linden Pl, Douglassville, PA 19518 USA.	jane.mcdevitt@temple.edu			Eastern Athletic Training Association (EATA) [p0219092]	The authors report no conflicts of interest. Funding was received in part by the Eastern Athletic Training Association (EATA) grant (award number p0219092).	Bao W, 2010, AM J EPIDEMIOL, V172, P631, DOI 10.1093/aje/kwq162; CHOI DW, 1987, J NEUROSCI, V7, P369; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Costa KD, 2002, CELL MOTIL CYTOSKEL, V52, P266, DOI 10.1002/cm.10056; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Giza CC, 2001, J ATHL TRAINING, V36, P228; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Imle P, 2005, METH MOL B, V311, P139; Inoue H, 2010, GENES BRAIN BEHAV, V9, P269, DOI 10.1111/j.1601-183X.2009.00557.x; Itokawa M, 2003, NEUROSCI LETT, V345, P53, DOI 10.1016/S0304-3940(03)00501-9; Itokawa M, 2003, PHARMACOGENETICS, V13, P271, DOI 10.1097/00008571-200305000-00006; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iwayama-Shigeno Y, 2005, NEUROSCI LETT, V378, P102, DOI 10.1016/j.neulet.2004.12.013; Kristman VL, 2008, CLIN J SPORT MED, V18, P322, DOI 10.1097/JSM.0b013e31817e6f3e; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Mansell JL, 2010, BRAIN INJURY, V24, P1070, DOI 10.3109/02699052.2010.494589; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McDevitt JK, 2011, BRAIN INJURY, V25, P1108, DOI 10.3109/02699052.2011.607790; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Osteen CL, 2004, J NEUROTRAUM, V18, P141; Parkman HP, 2012, J CLIN GASTROENTEROL, V46, P494, DOI 10.1097/MCG.0b013e3182522624; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; ROTH S, 2007, GENETICS PRIMER EXER; Rueda B, 2007, ARTHRITIS RHEUM-US, V56, P3953, DOI 10.1002/art.23048; Schaal K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019007; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Terrell TR, 2012, CLIN J SPORT MED, V22, P172; Thurman DJ, 2001, HEAD TRAUMA THERAPEU, P45; Tierney RT, 2010, CLIN J SPORT MED, V20, P464, DOI 10.1097/JSM.0b013e3181fc0a81	43	23	23	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2015	29	13-14					1674	1681		10.3109/02699052.2015.1075252			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CY8LL	WOS:000366659800020	26502998				2022-02-06	
J	Buckley, EM; Miller, BF; Golinski, JM; Sadeghian, H; McAllister, LM; Vangel, M; Ayata, C; Meehan, WP; Franceschini, MA; Whalen, MJ				Buckley, Erin M.; Miller, Benjamin F.; Golinski, Julianne M.; Sadeghian, Homa; McAllister, Lauren M.; Vangel, Mark; Ayata, Cenk; Meehan, William P., III; Franceschini, Maria Angela; Whalen, Michael J.			Decreased microvascular cerebral blood flow assessed by diffuse correlation spectroscopy after repetitive concussions in mice	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						animal models; brain trauma; optical imaging	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; COGNITIVE IMPAIRMENT; MILD; PERFUSION; SINGLE; RECOVERY; DEFICITS; DISEASE; MODELS	Repetitive concussions are associated with long-term cognitive dysfunction that can be attenuated by increasing the time intervals between concussions; however, biomarkers of the safest rest interval between injuries remain undefined. We hypothesize that deranged cerebral blood flow (CBF) is a candidate biomarker for vulnerability to repetitive concussions. Using a mouse model of human concussion, we examined the effect of single and repetitive concussions on cognition and on an index of CBF (CBFi) measured with diffuse correlation spectroscopy. After a single mild concussion, CBFi was reduced by 35 +/- 4% at 4 hours (P < 0.01 versus baseline) and returned to preinjury levels by 24 hours. After five concussions spaced 1 day apart, CBFi was also reduced from preinjury levels 4 hours after each concussion but had returned to preinjury levels by 72 hours after the final concussion. Interestingly, in this repetitive concussion model, lower CBFi values measured both preinjury and 4 hours after the third concussion were associated with worse performance on the Morris water maze assessed 72 hours after the final concussion. We conclude that low CBFi measured either before or early on in the evolution of injury caused by repetitive concussions could be a useful predictor of cognitive outcome.	[Buckley, Erin M.; Miller, Benjamin F.; Vangel, Mark; Franceschini, Maria Angela] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Charlestown, MA 02129 USA; [Golinski, Julianne M.; McAllister, Lauren M.; Whalen, Michael J.] Massachusetts Gen Hosp, Dept Pediat, Div Crit Care Med, Charlestown, MA 02129 USA; [Sadeghian, Homa; Ayata, Cenk] Massachusetts Gen Hosp, Dept Radiol, Neurovasc Res Lab, Charlestown, MA 02129 USA; [Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Meehan, William P., III] Boston Childrens Hosp, Div Sports Med, Div Emergency Med, Boston, MA USA		Whalen, MJ (corresponding author), Massachusetts Gen Hosp, Dept Pediat Crit Care Med, Charlestown, MA 02129 USA.	mwhalen@mgh.harvard.edu	Franceschini, Maria Angela/AAV-5397-2021		National Football League Players Association [PO1NS 55104 06]; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-EB001954]; Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health) [UL1 TR001102]; Harvard University; MGH ECOR Fund for Medical Discovery; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB001954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS055104] Funding Source: NIH RePORTER	This study was supported by National Football League Players Association Grant to Harvard College and PO1NS 55104 06 (MJW); National Institute of Health award R01-EB001954 (MAF); the Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health award UL1 TR001102) and financial contributions from Harvard University and its affiliated academic healthcare centers; and MGH ECOR Fund for Medical Discovery (EMB).	Agrawal D, 2005, J NEUROSURG, V102, P167, DOI 10.3171/jns.2005.102.2.0167; Angoa-Perez M, 2014, J NEUROCHEM, V129, P916, DOI 10.1111/jnc.12690; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Boas DA, 1997, J OPT SOC AM A, V14, P192, DOI 10.1364/JOSAA.14.000192; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Buckley EM, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.1.011009; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Dimou S, 2014, J NEUROTRAUM, V31, P413, DOI 10.1089/neu.2013.3050; Diop M, 2011, BIOMED OPT EXPRESS, V2, P2068, DOI 10.1364/BOE.2.002068; Durduran T, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/7/076701; Durduran T, 2014, NEUROIMAGE, V85, P51, DOI 10.1016/j.neuroimage.2013.06.017; Garry PS, 2015, EXP NEUROL, V263, P235, DOI 10.1016/j.expneurol.2014.10.017; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Henninger N, 2007, CRIT CARE MED, V35, P2607, DOI 10.1097/01.CCM.0000286395.79654.8D; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Jain V, 2014, J CEREBR BLOOD F MET, V34, P380, DOI 10.1038/jcbfm.2013.214; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; PATTERSON MS, 1995, APPL OPTICS, V34, P22, DOI 10.1364/AO.34.000022; R Development Core Team, 2011, R LANG ENV STAT COMP; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Weber JT, 2007, PROG BRAIN RES, V161, P253, DOI 10.1016/S0079-6123(06)61018-2; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022	40	23	23	0	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	DEC	2015	35	12					1995	2000		10.1038/jcbfm.2015.161			6	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	CX7OI	WOS:000365891300011	26154866	Bronze, Green Published			2022-02-06	
J	Silva, PPB; Bhatnagar, S; Herman, SD; Zafonte, R; Klibanski, A; Miller, KK; Tritos, NA				Silva, Paula P. B.; Bhatnagar, Saurabha; Herman, Seth D.; Zafonte, Ross; Klibanski, Anne; Miller, Karen K.; Tritos, Nicholas A.			Predictors of Hypopituitarism in Patients with Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						adrenal insufficiency; diabetes insipidus; growth hormone deficiency; hypogonadism; hypopituitarism; hypothyroidism; traumatic brain injury	ANEURYSMAL SUBARACHNOID HEMORRHAGE; ANTERIOR-PITUITARY FUNCTION; INSULIN TOLERANCE-TEST; BODY-MASS INDEX; GROWTH-HORMONE; NEUROENDOCRINE DYSFUNCTION; ACUTE-PHASE; PREVALENCE; SECRETION	Hypopituitarism may often occur in association with traumatic brain injury (TBI). Identification of reliable predictors of pituitary dysfunction is of importance in order to establish a rational testing approach. We searched the records of patients with TBI, who underwent neuroendocrine evaluation in our institution between 2007 and 2013. One hundred sixty-six adults (70% men) with TBI (median age: 41.6 years; range: 18-76) were evaluated at a median interval of 40.4 months (0.2-430.4).Of these, 31% had 1 pituitary deficiency, including 29% of patients with mild TBI and 35% with moderate/severe TBI. Growth hormone deficiency was the most common deficiency (21%); when body mass index (BMI)-dependent cutpoints were used, this was reduced to 15%. Central hypoadrenalism occurred in10%, who were more likely to have suffered a motor vehicle accident (MVA, p=0.04), experienced post-traumatic seizures (p=0.04), demonstrated any intracranial hemorrhage (p=0.05), petechial brain hemorrhages (p=0.017), or focal cortical parenchymal contusions (p=0.02). Central hypothyroidism occurred in 8% and central hypogonadism in 12%; the latter subgroup had higher BMI (p=0.03), were less likely to be working after TBI (p=0.002), and had lower Global Assessment of Functioning (GAF) scores (p=0.03). Central diabetes insipidus (DI) occurred in 6%, who were more likely to have experienced MVA (p<0.001) or sustained moderate/severe TBI (p<0.001). Patients with MVA and those with post-traumatic seizures, intracranial hemorrhage, petechial brain hemorrhages, and/or focal cortical contusions are at particular risk for serious pituitary dysfunction, including adrenal insufficiency and DI, and should be referred for neuroendocrine testing. However, a substantial proportion of patients without these risk factors also developed hypopituitarism.	[Silva, Paula P. B.; Klibanski, Anne; Miller, Karen K.; Tritos, Nicholas A.] Massachusetts Gen Hosp, Neuroendocrine Unit, Boston, MA 02114 USA; [Bhatnagar, Saurabha; Herman, Seth D.; Zafonte, Ross] Massachusetts Gen Hosp, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA; [Bhatnagar, Saurabha; Herman, Seth D.; Zafonte, Ross] Harvard Univ, Sch Med, Boston, MA USA		Tritos, NA (corresponding author), Massachusetts Gen Hosp, Neuroendocrine Unit, Zero Emerson Pl 112, Boston, MA 02114 USA.	ntritos@mgh.harvard.edu	Miller, Karen/AAI-6901-2021; Tritos, Nicholas/W-1594-2019	Tritos, Nicholas/0000-0001-8867-607X	NIDILRR TBIMS grants [90DP0039-01-02, W81XWH-08-2-0159]	No conflicting financial interests exist. The work was supported in part by NIDILRR TBIMS grants nos. 90DP0039-01-02 and W81XWH-08-2-0159.	Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2007, NAT CLIN PRACT ENDOC, V3, P318, DOI 10.1038/ncpendmet0460; Baxter D, 2013, ANN NEUROL, V74, P527, DOI 10.1002/ana.23958; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Berg C, 2010, EUR J ENDOCRINOL, V162, P477, DOI 10.1530/EJE-09-0824; Bonert VS, 2004, J CLIN ENDOCR METAB, V89, P3397, DOI 10.1210/jc.2003-032213; Boughey JC, 2004, AM SURGEON, V70, P500; Bredella MA, 2009, J CLIN ENDOCR METAB, V94, P3995, DOI 10.1210/jc.2009-0438; Coronado VG, 2011, MMWR SURVEILL SUMM, V60, P1; Dichtel LE, 2014, J CLIN ENDOCR METAB, V99, P4712, DOI 10.1210/jc.2014-2830; Frieden TR, 2013, MMWR-MORBID MORTAL W, V62, P1; Glynn N, 2013, CLIN ENDOCRINOL, V78, P17, DOI 10.1111/cen.12010; HALL RCW, 1995, PSYCHOSOMATICS, V36, P267, DOI 10.1016/S0033-3182(95)71666-8; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Kokshoorn NE, 2011, EUR J ENDOCRINOL, V165, P225, DOI 10.1530/EJE-11-0365; Kopczak A, 2011, EUR J ENDOCRINOL, V164, P31, DOI 10.1530/EJE-10-0821; Kopczak A, 2014, J NEUROTRAUM, V31, P99, DOI 10.1089/neu.2013.3002; Leong KS, 2001, CLIN ENDOCRINOL, V54, P463, DOI 10.1046/j.1365-2265.2001.01169.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Qu XD, 2005, J CLIN ENDOCR METAB, V90, P1563, DOI 10.1210/jc.2004-1450; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Tanriverdi F, 2011, J ENDOCRINOL INVEST, V34, P541, DOI 10.3275/7805; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; Traumatic Brain Injury Model Systems National Database Syllabus, 2009, TRAUM BRAIN INJ MOD; Vahl N, 1997, AM J PHYSIOL-ENDOC M, V272, pE1108, DOI 10.1152/ajpendo.1997.272.6.E1108; Wilkinson C. W., 2012, FRONT NEUROL, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011; Yuen KCJ, 2009, J CLIN ENDOCR METAB, V94, P2702, DOI 10.1210/jc.2009-0299	35	23	25	0	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2015	32	22					1789	1795		10.1089/neu.2015.3998			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CV6ST	WOS:000364401500009	26413767				2022-02-06	
J	Lorente, L; Martin, MM; Argueso, M; Ramos, L; Sole-Violan, J; Riano-Ruiz, M; Jimenez, A; Borreguero-Leon, JM				Lorente, Leonardo; Martin, Maria M.; Argueso, Monica; Ramos, Luis; Sole-Violan, Jordi; Riano-Ruiz, Marta; Jimenez, Alejandro; Borreguero-Leon, Juan M.			Serum caspase-3 levels and mortality are associated in patients with severe traumatic brain injury	BMC NEUROLOGY			English	Article						Caspase-3; Patients; Mortality; Injury; Brain	CEREBROSPINAL-FLUID; CELL-DEATH; APOPTOSIS; INCREASES	Background: Different apoptosis pathways activate caspase-3. In a study involving 27 patients with traumatic brain injury (TBI), higher caspase-3 levels were found in contusion brain tissue resected from non-survivors than from survivors. The objective of this study was to determine whether there is an association in TBI patients between serum caspase-3 levels (thus using an easier, quicker, less expensive and less invasive procedure) and mortality, in a larger series of patients. Methods: We carried out a prospective, observational and multicenter study in six Spanish Hospital Intensive Care Units including 112 patients with severe TBI. All had Glasgow Coma Scale (GCS) scores lower than 9. Patients with an Injury Severity Score (ISS) in non-cranial aspects higher than 9 were excluded. Blood samples were collected on day 1 of TBI to measure serum caspas-3 levels. The endpoint was 30-day mortality. Results: We found that non-surviving patients (n = 31) showed higher (p = 0.003) serum caspase-3 levels compared to survivors (n = 81). Kaplan-Meier survival analysis showed a higher risk of death in TBI patients with serum caspase-3 levels > 0.20 ng/mL than in patients with lower concentrations (Hazard Ratio = 3.15; 95 % CI = 1.40 to 7.08; P < 0.001). Multiple logistic regression analysis showed that serum caspase-3 levels > 0.20 ng/mL were associated with mortality at 30 days in TBI patients controlling for Marshall CT classification, age and GCS (Odds ratio = 7.99; 95 % CI = 2.116 to 36.744; P = 0.001). Conclusions: The association between serum caspase-3 levels and mortality in TBI patients was the major novel finding of our study.	[Lorente, Leonardo] Hosp Univ Canarias, Intens Care Unit, San Cristobal la Laguna 38320, Santa Cruz De T, Spain; [Martin, Maria M.] Hosp Univ Nuestra Senora Candelaria, Intens Care Unit, Santa Cruz De Tenerife 38010, Spain; [Argueso, Monica] Hosp Clin Univ Valencia, Intens Care Unit, Valencia 46004, Spain; [Ramos, Luis] Hosp Gen La Palma, Intens Care Unit, Brena Alta 38713, La Palma, Spain; [Sole-Violan, Jordi] Hosp Univ Dr Negrin, Intens Care Unit, CIBERES, Las Palmas Gran Canaria 35010, Spain; [Riano-Ruiz, Marta] Complejo Hosp Univ Insular Maternoinfantil, Serv Bioquim Clin, Las Palmas Gran Canaria 35016, Spain; [Jimenez, Alejandro] Hosp Univ Canarias, Res Unit, San Cristobal la Laguna 38320, Santa Cruz De T, Spain; [Borreguero-Leon, Juan M.] Hosp Univ Canarias, Lab Dept, San Cristobal la Laguna 38320, Santa Cruz De T, Spain		Lorente, L (corresponding author), Hosp Univ Canarias, Intens Care Unit, Ofra S-N, San Cristobal la Laguna 38320, Santa Cruz De T, Spain.	lorentemartin@msn.com		Borreguero Leon, Juan Maria/0000-0001-7414-5278; Argueso, Monica/0000-0001-5917-1056			Abrahamson EE, 2006, EXP NEUROL, V197, P437, DOI 10.1016/j.expneurol.2005.10.011; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cavallucci V, 2011, CURR PHARM DESIGN, V17, P215, DOI 10.2174/138161211795049705; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; Eberspacher E, 2006, ANESTH ANALG, V103, P1527, DOI 10.1213/01.ane.0000247803.30582.2d; Harter L, 2001, J NEUROIMMUNOL, V121, P76, DOI 10.1016/S0165-5728(01)00409-X; Hentze H, 2001, BIOCHEM BIOPH RES CO, V283, P1111, DOI 10.1006/bbrc.2001.4918; Jia F, 2009, J NEUROTRAUM, V26, P243, DOI 10.1089/neu.2008.0670; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kunz A, 2010, BEST PRACT RES-CLIN, V24, P495, DOI 10.1016/j.bpa.2010.10.001; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Nathoo N, 2004, J NEUROSURG, V101, P233, DOI 10.3171/jns.2004.101.2.0233; Rovegno M, 2012, MED INTENSIVA, V36, P37, DOI 10.1016/j.medin.2011.06.008; Saykally JN, 2012, NEUROSCIENCE, V223, P305, DOI 10.1016/j.neuroscience.2012.07.070; Shah SA, 2006, EXP GERONTOL, V41, P1201, DOI 10.1016/j.exger.2006.07.006; Soustiel JF, 2005, J NEUROTRAUM, V22, P345, DOI 10.1089/neu.2005.22.345; TEASDALE G, 1974, LANCET, V2, P81; Uzan M, 2006, ACTA NEUROCHIR, V148, P1157, DOI 10.1007/s00701-006-0887-1; Wang K, 2014, CHINESE MED J-PEKING, V127, P1964, DOI 10.3760/cma.j.issn.0366-6999.20120638	24	23	23	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	NOV 6	2015	15								228	10.1186/s12883-015-0485-z			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CW9CV	WOS:000365297000001	26545730	gold, Green Published			2022-02-06	
J	Galindo, AN; Kussmann, M; Dayon, L				Galindo, Antonio Nunez; Kussmann, Martin; Dayon, Loic			Proteomics of Cerebrospinal Fluid: Throughput and Robustness Using a Scalable Automated Analysis Pipeline for Biomarker Discovery	ANALYTICAL CHEMISTRY			English	Article							PROTEIN DEPLETION METHODS; ALZHEIMERS-DISEASE; PLASMA-PROTEINS; CSF; IDENTIFICATION; QUANTITATION; DIAGNOSIS; WORKFLOW	Cerebrospinal fluid (CSF) is a body fluid of high clinical relevance and an important source of potential biomarkers for brain-associated damages, such as traumatic brain injury and stroke, and for brain diseases, such as Alzheimer's and Parkinson's. Herein, we have implemented, evaluated, and validated a scalable automated proteomic pipeline (ASAP(2)) for the sample preparation and proteomic analysis of CSF, enabling increased throughput and robustness for biomarker discovery. Human CSF samples were depleted from abundant proteins and subjected to automated reduction, alkylation, protein digestion, tandem mass tag (TMT) 6-plex labeling, pooling, and sample cleanup in a 96-well-plate format before reversed-phase liquid chromatography tandem mass spectrometry (RP-LC MS/MS). We showed the impact on the CSF proteome coverage of applying the depletion of abundant proteins, which is usually performed on blood plasma or serum samples. Using ASAP(2) to analyze 96 identical CSF samples, we determined the analytical figures of merit of our shotgun proteomic approach regarding proteome coverage consistency (i.e., 387 proteins), quantitative accuracy, and individual protein variability. We demonstrated that, as for human plasma samples, ASAP(2) is efficient in analyzing large numbers of human CSF samples and is a valuable tool for biomarker discovery. The data has been deposited to the ProteomeXchange with identifier PXD003024.	[Galindo, Antonio Nunez; Kussmann, Martin; Dayon, Loic] Nestle Inst Hlth Sci SA, Mol Biomarkers Core, Lausanne, Switzerland		Dayon, L (corresponding author), Nestle Inst Hlth Sci SA, Mol Biomarkers Core, EPFL Innovat Pk,Batiment H, Lausanne, Switzerland.	loic.dayon@rd.nestle.com	Kussmann, Martin/AAB-7453-2022; Dayon, Loic/J-2499-2019	Kussmann, Martin/0000-0002-0966-2313; Dayon, Loic/0000-0002-8499-270X			Abdi F, 2006, J ALZHEIMERS DIS, V9, P293; Borg Jacques, 2011, Clin Proteomics, V8, P6, DOI 10.1186/1559-0275-8-6; Carrasquillo MM, 2009, NAT GENET, V41, P192, DOI 10.1038/ng.305; Choe L, 2007, PROTEOMICS, V7, P3651, DOI 10.1002/pmic.200700316; Cominetti O., 2015, UNPUB; Dayon L, 2008, ANAL CHEM, V80, P2921, DOI 10.1021/ac702422x; Dayon L, 2014, J PROTEOME RES, V13, P3837, DOI 10.1021/pr500635f; De Meyer G, 2010, ARCH NEUROL-CHICAGO, V67, P949, DOI 10.1001/archneurol.2010.179; Griggs R. C., 2012, GOLDMANS CECIL MED, P2228; Guldbrandsen A, 2014, MOL CELL PROTEOMICS, V13, P3152, DOI 10.1074/mcp.M114.038554; Hirabayashi Takahiro, 2014, Adv Neurobiol, V8, P293; Holtta M, 2015, J PROTEOME RES, V14, P654, DOI 10.1021/pr501076j; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jedrychowski MP, 2015, CELL METAB, V22, P734, DOI 10.1016/j.cmet.2015.08.001; Liu GY, 2012, J NEUROCHEM, V120, P190, DOI 10.1111/j.1471-4159.2011.07547.x; Liu YS, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145728; Maurer MH, 2010, MASS SPECTROM REV, V29, P17, DOI 10.1002/mas.20213; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Ogata Y, 2005, J PROTEOME RES, V4, P837, DOI 10.1021/pr049750o; Percy AJ, 2014, J PROTEOME RES, V13, P3733, DOI 10.1021/pr500317d; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Roche S, 2008, PROTEOM CLIN APPL, V2, P428, DOI 10.1002/prca.200780040; Rosenberg G. A., 2012, BRADLEYS NEUROLOGY C; Schutzer SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010980; Shores KS, 2007, J PROTEOME RES, V6, P3739, DOI 10.1021/pr070293w; Tu CJ, 2010, J PROTEOME RES, V9, P4982, DOI 10.1021/pr100646w; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Yadav AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024442; Yuan XL, 2005, J CHROMATOGR B, V815, P179, DOI 10.1016/j.jchromb.2004.06.044	31	23	23	0	27	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0003-2700	1520-6882		ANAL CHEM	Anal. Chem.	NOV 3	2015	87	21					10755	10761		10.1021/acs.analchem.5b02748			7	Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	CV6BE	WOS:000364354900018	26452177				2022-02-06	
J	Dahm, J; Ponsford, J				Dahm, Jane; Ponsford, Jennie			LONG-TERM EMPLOYMENT OUTCOMES FOLLOWING TRAUMATIC BRAIN INJURY AND ORTHOPAEDIC TRAUMA: A TEN-YEAR PROSPECTIVE STUDY	JOURNAL OF REHABILITATION MEDICINE			English	Article						traumatic brain injury; orthopaedics; employment; prospective studies	QUALITY-OF-LIFE; HEAD-INJURY; DISABILITY; WORK; PREDICTORS; MODERATE; RETURN; SEVERITY; ADULTS	Objective: To investigate the trajectory and predictors of employment over a period of 10 years following traumatic brain injury and traumatic orthopaedic injury. Design: Prospective follow-up at 1, 2, 5 and 10 years postinjury. Participants: Seventy-nine individuals with traumatic brain injury and 79 with traumatic orthopaedic injury recruited from Epworth HealthCare in Melbourne, Australia during inpatient rehabilitation. Methods: Information was obtained from medical files and self-report questionnaires. Results: Individuals with traumatic brain injury were less likely to be competitively employed during the period up to 10 years post-injury compared with individuals with traumatic orthopaedic injury, although there was evidence of increasing employment participation during that time. More severe traumatic brain injury, older age, pre-injury psychological treatment, and studying or having a blue-collar occupation at time of injury were associated with poorer employment outcomes. Individuals with traumatic brain injury had spent less time with their current employer and were less likely to have increased responsibility since the injury than those with traumatic orthopaedic injury. At least half of each group reported difficulty at work due to fatigue. Conclusion: Given the potential for gains in employment participation over an extended time-frame, there may be benefit in ongoing access to individualized vocational rehabilitation. Particular areas of focus would include managing fatigue and psychiatric disorders, and exploring supported occupational activity for all levels of injury severity.	[Dahm, Jane; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia; [Ponsford, Jennie] Epworth HealthCare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia		Dahm, J (corresponding author), Monash Univ, Sch Psychol Sci, Bldg 17, Clayton, Vic 3800, Australia.	janedahm@bigpond.com			Transport Accident Commission (TAC) through the Institute for Safety, Compensation and Recovery Research (ISCRR)	Information for individuals with TBI was accessed from data collected for the Longitudinal Head Injury Study funded by the Transport Accident Commission (TAC; www.tac.vic.gov.au), through the Institute for Safety, Compensation and Recovery Research (ISCRR; www.iscrr.com.au).	Airey CM, 2001, DISABIL REHABIL, V23, P509; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andruszkow H, 2013, CLIN ORTHOP RELAT R, V471, P2899, DOI 10.1007/s11999-013-3031-6; Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; Australian Bureau of Statistics, 2014, LAB FORC AUSTR; Australian Bureau of Statistics; Statistics New Zealand, 2013, ANZSCO AUSTR NZ STAN; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Braithwaite IJ, 1998, INJURY, V29, P55; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Evans SA, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-8; Forslund MV, 2014, BRAIN INJURY, V28, P980, DOI 10.3109/02699052.2014.888770; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; Groswasser Z, 1999, NEUROPSYCHOL REHABIL, V9, P493, DOI 10.1080/096020199389545; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; Jennett B, 1981, MANAGEMENT HEAD INJU; Kelley E, 2014, J HEAD TRAUMA REHAB, V29, P147, DOI 10.1097/HTR.0b013e31826db6b9; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; MacKenzie EJ, 2006, J TRAUMA, V61, P688, DOI 10.1097/01.ta.0000195985.56153.68; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Ouellet MC, 2009, J HEAD TRAUMA REHAB, V24, P262, DOI 10.1097/HTR.0b013e3181a68b73; Overgaard M, 2011, J TRAUMA, V71, P435, DOI 10.1097/TA.0b013e31820e7ec3; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Ponsford J, 2008, J TRAUMA, V64, P1001, DOI 10.1097/TA.0b013e31809fec16; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P579, DOI 10.1016/j.apmr.2012.08.197; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; Redmill DA, 2006, INJURY, V37, P243, DOI 10.1016/j.injury.2005.11.014; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Satz P, 2011, J CLIN EXP NEUROPSYC, V33, P121, DOI 10.1080/13803395.2010.493151; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Soberg HL, 2011, J TRAUMA, V71, P425, DOI 10.1097/TA.0b013e3181eff54f; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; World Health Organization, 2007, INT CLASS FUNCT DIS	40	23	23	1	12	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	NOV	2015	47	10					932	940		10.2340/16501977-2016			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	CW3XE	WOS:000364924900006	26550768	Green Submitted, gold			2022-02-06	
J	Dematteo, C; Volterman, KA; Breithaupt, PG; Claridge, EA; Adamich, J; Timmons, BW				Dematteo, Carol; Volterman, Kimberly A.; Breithaupt, Peter G.; Claridge, Everett A.; Adamich, John; Timmons, Brian W.			Exertion Testing in Youth with Mild Traumatic Brain Injury/Concussion	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						RETURN TO PLAY; HEAD INJURY; BRAIN CONCUSSION; POSTCONCUSSION SYNDROME; CHILDREN; ADOLESCENTS	COLLEGIATE FOOTBALL PLAYERS; SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; POSTCONCUSSION SYNDROME; CHILDREN; RETURN; REHABILITATION; ADOLESCENTS; DEPRESSION; STATEMENT	Purpose The decision regarding return to activity (RTA) after mild traumatic brain injuries/concussion is one of the most difficult and controversial areas in concussion management, particularly for youth. This study investigated how youth with postconcussion syndrome (PCS) are affected by exertion and whether standardized exertion testing using the McMaster All-Out Progressive Continuous Cycling Test can contribute to clinical decision making for safe RTA. Methods Fifty-four youth (8.5-18.3 yr) with a previously confirmed concussion participated in the study. Each participant performed exertion testing on a cycle ergometer and completed a Postconcussion Symptom scale at the following time points: before exertion (baseline), 5 and 30 min, and 24 h after exertion. A modified Postconcussion Symptom scale was administered at 2-min intervals during exertion. Results Participants had a mean SD symptom duration of 6.3 +/- 6.9 months after the most recent concussive injury, with a median of 4.1 months (range, 0.7-35 months). Sixty-three percent of participants had symptoms during exertion testing. Symptom profile (number and severity) significantly affected perception of exertion at 50% peak mechanical power. During acute assessment of symptoms (30-min after exertion), headache (P = 0.39), nausea (P = 0.63), and dizziness (P = 0.35) did not change. However, both the number and severity of symptoms significantly improved over 24 h, with 56.8% of youth showing improvements. The time from the most recent injury had a significant effect on the symptom score at baseline, 30 min after exertion, and 24 h after exertion. Conclusions Exertion testing has an important role in the evaluation of symptoms and readiness to RTA, particularly in youth who are slow to recover. Overall, controlled exertion seemed to lesson symptoms for most youth.	[Dematteo, Carol; Claridge, Everett A.; Adamich, John; Timmons, Brian W.] McMaster Univ, CanChild Ctr Childhood Disabil Res, Hamilton, ON L8S 1C7, Canada; [Dematteo, Carol] McMaster Univ, Sch Rehabil Sci, Hamilton, ON L8S 1C7, Canada; [Volterman, Kimberly A.; Breithaupt, Peter G.; Timmons, Brian W.] McMaster Univ, Dept Pediat, Child Hlth & Exercise Med Program, Hamilton, ON L8S 1C7, Canada		Dematteo, C (corresponding author), McMaster Univ, Sch Rehabil Sci, 1400 Main St West,IAHS 433, Hamilton, ON L8S 1C7, Canada.	dematteo@mcmaster.ca	Timmons, Brian Timmons/AAX-1154-2021	Timmons, Brian Timmons/0000-0002-4063-9656	Pollock Foundation through McMaster's CanChild Centre for Childhood Disability Research; Pollock Foundation through CanChild Centre for Childhood Disability and Research	We offer our gratitude to the children and their families who participated in this study. This study was funded by the Pollock Foundation through McMaster's CanChild Centre for Childhood Disability Research.; Carol DeMatteo and Brian Timmons received a $7000 grant from the Pollock Foundation through CanChild Centre for Childhood Disability and Research.	Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; DeMatteo C, 2015, DISABIL REHABIL, V37, P1107, DOI 10.3109/09638288.2014.952452; DeMatteo C, 2015, CLIN PEDIATR, V54, P152, DOI 10.1177/0009922814558256; Doolan AW, 2012, ANN BIOMED ENG, V40, P106, DOI 10.1007/s10439-011-0413-3; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Emery CA, 2010, BRIT J SPORT MED, V44, P64, DOI 10.1136/bjsm.2009.068353; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Johnson LSM, 2012, J SCHOOL HEALTH, V82, P180, DOI 10.1111/j.1746-1561.2011.00684.x; Kelly KD, 2001, CLIN J SPORT MED, V11, P77, DOI 10.1097/00042752-200104000-00003; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Meehan WP, 2011, CLIN SPORT MED, V30, P133, DOI 10.1016/j.csm.2010.08.004; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Ploeger HE, 2011, J PEDIATR-US, V158, P814, DOI 10.1016/j.jpeds.2010.10.020; Purcell LK, 2012, PAED CHILD HEALT-CAN, V17, P36; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Swaine BR, 2007, PEDIATRICS, V119, P749, DOI 10.1542/peds.2006-1186; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	39	23	23	0	18	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	NOV	2015	47	11					2283	2290		10.1249/MSS.0000000000000682			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	CT6RU	WOS:000362940900005	25871465				2022-02-06	
J	Sawyer, K; Bell, KR; Ehde, DM; Temkin, N; Dikmen, S; Williams, RM; Dillworth, T; Hoffman, JM				Sawyer, Kathryn; Bell, Kathleen R.; Ehde, Dawn M.; Temkin, Nancy; Dikmen, Sureyya; Williams, Rhonda M.; Dillworth, Tiara; Hoffman, Jeanne M.			Longitudinal Study of Headache Trajectories in the Year After Mild Traumatic Brain Injury: Relation to Posttraumatic Stress Disorder Symptoms	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Headache; Rehabilitation; Stress disorders; post-traumatic	CHRONIC PAIN; US SOLDIERS; VETERANS; PTSD; DEPRESSION; DIAGNOSIS; SEVERITY; MODERATE; HEALTH	Objective: To examine headache trajectories among persons with mild traumatic brain injury (MTBI) in the year after injury and the relation of headache trajectory to posttraumatic stress disorder (PTSD) at 1 year postinjury. Design: Prospective, longitudinal study. Setting: Participants were recruited through a university medical center and participated in follow-up assessments by telephone. Participants: Prospectively enrolled individuals (N=212) within 1 week of MTBI who were hospitalized for observation or other system injuries. Participants were assessed at baseline and 3, 6, and 12 months postinjury. Interventions: Not applicable. Main Outcome Measures: Participants rated average headache pain intensity using the 0 to 10 numerical rating scale at each assessment period. The PTSD Checklist-Civilian Version was completed at 12 months postinjury. Results: Latent class growth analysis produced a 4-trajectory group model, with groups labeled resolved, worsening, improving, and chronic. Multivariate regression modeling revealed that younger age and premorbid headache correlated with membership in the worse trajectory groups (worsening and chronic; P<.001). Univariate regression revealed a significant association between PTSD and membership in the worse trajectory groups (P<.001). Conclusions: Headache is common in the year after MTBI, with younger people, persons who previously had headaches, and persons with PTSD more likely to report chronic or worsening headache. Further research is needed to examine whether PTSD symptoms exacerbate headaches or whether problematic headache symptoms exacerbate PTSD. (C) 2015 by the American Congress of Rehabilitation Medicine	[Sawyer, Kathryn; Ehde, Dawn M.; Temkin, Nancy; Dikmen, Sureyya; Williams, Rhonda M.; Dillworth, Tiara; Hoffman, Jeanne M.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Bell, Kathleen R.] Univ Texas SW Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Temkin, Nancy; Dikmen, Sureyya] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Temkin, Nancy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Dikmen, Sureyya] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Williams, Rhonda M.] Vet Affairs Puget Sound Healthcare Syst, Seattle, WA USA		Sawyer, K (corresponding author), Univ Washington, Sch Med, Box 359612, Seattle, WA 98195 USA.	kasawyer@uw.edu	Ehde, Dawn/K-1883-2016	Bell, Kathleen/0000-0002-0928-2046; Ehde, Dawn/0000-0002-9555-2347	Department of Education, National Institute on Disability and Rehabilitation Research [H133G090022]; Department of Defense Congressionally Directed Medical Research ProgramsUnited States Department of Defense [W81XWH-12-2-0109]	Supported by the Department of Education, National Institute on Disability and Rehabilitation Research (grant no. H133G090022) and Department of Defense Congressionally Directed Medical Research Programs (grant no. W81XWH-12-2-0109).	Afari N, 2009, HEADACHE, V49, P1267, DOI 10.1111/j.1526-4610.2009.01517.x; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Kozminski M, 2010, J AM OSTEOPATH ASSOC, V110, P514; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCrea M., 2008, MILD TRAUMATIC BRAIN, P85; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; NAGIN DS, 1993, CRIMINOLOGY, V31, P327, DOI 10.1111/j.1745-9125.1993.tb01133.x; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Otis JD, 2003, J REHABIL RES DEV, V40, P397, DOI 10.1682/JRRD.2003.09.0397; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; RESICK PA, 1992, J CONSULT CLIN PSYCH, V60, P748, DOI 10.1037/0022-006X.60.5.748; Rosenthal JF, 2013, HEADACHE, V53, P1564, DOI 10.1111/head.12200; Ruff RL, 2009, J REHABIL RES DEV, V46, P1071, DOI 10.1682/JRRD.2009.05.0062; Scioli-Salter ER, 2015, CLIN J PAIN, V31, P363, DOI 10.1097/AJP.0000000000000115; SERLIN RC, 1995, PAIN, V61, P277, DOI 10.1016/0304-3959(94)00178-H; Sharp TJ, 2001, CLIN PSYCHOL REV, V21, P857, DOI 10.1016/S0272-7358(00)00071-4; Shipherd JC, 2007, J REHABIL RES DEV, V44, P153, DOI 10.1682/JRRD.2006.06.0065; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Theeler BJ, 2012, HEADACHE, V52, P732, DOI 10.1111/j.1526-4610.2012.02112.x; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158	32	23	23	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	2015	96	11					2000	2006		10.1016/j.apmr.2015.07.006			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	DB1YX	WOS:000368306600009	26220236				2022-02-06	
J	Little, CE; Emery, C; Black, A; Scott, SH; Meeuwisse, W; Nettel-Aguirre, A; Benson, B; Dukelow, S				Little, C. Elaine; Emery, Carolyn; Black, Amanda; Scott, Stephen H.; Meeuwisse, Willem; Nettel-Aguirre, Alberto; Benson, Brian; Dukelow, Sean			Test-retest reliability of KINARM robot sensorimotor and cognitive assessment: in pediatric ice hockey players	JOURNAL OF NEUROENGINEERING AND REHABILITATION			English	Article							HIGH-SCHOOL; CONCUSSION; RECOVERY; TASK; SET; ADOLESCENTS; NUMBER; INJURY; ERROR; SENSE	Background: Better diagnostic and prognostic tools are needed to address issues related to early diagnosis and management of concussion across the continuum of aging but particularly in children and adolescents. The purpose of the current study was to evaluate the reliability of robotic technology (KINARM robot) assessments of reaching, position sense, bimanual motor function, visuospatial skills, attention and decision making in youth ice hockey players (ages 10-14). Methods: Thirty-four male children attended two testing days, one week apart. On day one, each subject completed five tasks on the robot with two examiners (alternating examiner sequence); the 2nd examiner followed the same procedure as the 1st immediately afterwards. One consistent examiner tested subjects one week later. This is a testretest reliability study. The robotic tasks characterize sensorimotor and/or cognitive performance; 63 parameters from 5 tasks are reported. Session 1 was the 1st time the subject performed the 5 tasks, session 2 the 2nd time on day 1, and session 3 one week following. Results: Intra-class correlation coefficients ranged from 0.06 to 0.91 and 0.09 to 0.90 for session 1 to 2 and 2 to 3, respectively. Bland-Altman plots showed agreement in a majority of the parameters and a learning effect in 25 % and 24 % of parameters in session 1 vs 2 and 1 vs 3, respectively but none for session 2 vs 3. Of those that showed a learning effect, only 8 % of parameters in session 1 vs 2 and 10 % in session 1 vs 3 had a clinical relevance measure >= 0.8. Conclusions: The relative homogeneity of the sample and the effect of learning seen in some of the task parameters appears to have negatively impacted the intra-class correlation coefficients from session 1 to 2, with less impact for 2 to 3. The Bland-Altman analysis supports good absolute reliability in healthy male children with no neurological impairment ranging in age from 10 to 14. The clinically relevant learning effect seen, in a small number of parameters could be addressed by creating a learning effect adjustment factor and/or implementing a practice session, which would eliminate the learning effect.	[Little, C. Elaine; Emery, Carolyn; Black, Amanda; Meeuwisse, Willem] Univ Calgary, Dept Kinesiol, Calgary, AB, Canada; [Scott, Stephen H.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Nettel-Aguirre, Alberto] Univ Calgary, Dept Pediat, Alberta Childrens Hosp, Calgary, AB T2N 1N4, Canada; [Nettel-Aguirre, Alberto] Univ Calgary, Dept Community Hlth Sci, Alberta Childrens Hosp, Calgary, AB, Canada; [Benson, Brian] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Dukelow, Sean] Univ Calgary, Dept Clin Neurosci, Hotchkiss Brain Inst, Calgary, AB, Canada		Little, CE (corresponding author), Univ Calgary, Dept Kinesiol, Calgary, AB, Canada.	littlec@ucalgary.ca	Nettel-Aguirre, Alberto/ABB-9412-2021; Black, Amanda/O-7675-2017; Meijer, Anna/K-5118-2016; Emery, Carolyn/AAI-2761-2020	Black, Amanda/0000-0001-5668-9706; Dukelow, Sean/0000-0002-0609-981X; Nettel-Aguirre, Alberto/0000-0001-6604-0652	Canadian Institutes Health Research Team Grant [201210]; Mild Traumatic Brain Injury in Children and Youth, Hotchkiss Brain Institute; Talisman Energy Fund in support of Healthy Living and Injury Prevention; Alberta Children's Hospital Research Institute for Child and Maternal Health; Alberta Innovates [201201160] Funding Source: researchfish	This work was supported by a Canadian Institutes Health Research Team Grant (201210): Mild Traumatic Brain Injury in Children and Youth, Hotchkiss Brain Institute (Co-PI's - CE, WM) and the Talisman Energy Fund in support of Healthy Living and Injury Prevention and the Alberta Children's Hospital Research Institute for Child and Maternal Health.	Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; [Anonymous], 2014, KINARM ROB US GUID; [Anonymous], 2012, INJ PREV CONTR TRAUM; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Coderre AM, 2010, NEUROREHAB NEURAL RE, V24, P528, DOI 10.1177/1545968309356091; Cohen J, 1977, STAT POWER ANAL BEHA; Dalecki MS, 2015, PROLONGED COGNITIVE; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; Debert CT, 2012, J NEUROL PHYS THER, V36, P58, DOI 10.1097/NPT.0b013e318254bd4f; Dukelow SP, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-72; Dukelow SP, 2010, NEUROREHAB NEURAL RE, V24, P178, DOI 10.1177/1545968309345267; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Field A., 2017, DISCOVERING STAT USI, V5th; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fuelscher I, 2015, J EXP CHILD PSYCHOL, V140, P74, DOI 10.1016/j.jecp.2015.06.013; Halberda J, 2012, P NATL ACAD SCI USA, V109, P11116, DOI 10.1073/pnas.1200196109; Herter TM, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-43; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; KAZIS LE, 1989, MED CARE, V27, pS178, DOI 10.1097/00005650-198903001-00015; Langenecker SA, 2007, J CLIN EXP NEUROPSYC, V29, P842, DOI 10.1080/13803390601147611; Little CE, 2014, EXP BRAIN RES, V232, P2049, DOI 10.1007/s00221-014-3894-0; Mayfield R, 2013, ATHLETIC TRAINING SP, V5, P265, DOI DOI 10.3928/19425864-20131017-01; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Ouatman-Yates C, 2014, PHYSICIAN SPORTSMED, V42, P32; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Rishiraj N, 2009, J SPORT MED PHYS FIT, V49, P159; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Soukup V M, 1998, Appl Neuropsychol, V5, P65, DOI 10.1207/s15324826an0502_2; Stewart TC, 2014, J TRAUMA ACUTE CARE, V76, P736, DOI 10.1097/TA.0b013e3182aafdf5; Stratford PW, 1997, PHYS THER, V77, P745, DOI 10.1093/ptj/77.7.745; Subbian V, 2014, IEEE ENG MED BIO, P5353, DOI 10.1109/EMBC.2014.6944835; TESTA MA, 1987, J HYPERTENS, V5, pS9; Tyryshkin K, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-47; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Waljas M, 2015, J NEUROTRAUM, V32, P1; Wyrwich KW, 2000, J EVAL CLIN PRACT, V6, P39, DOI 10.1046/j.1365-2753.2000.00238.x	50	23	23	0	25	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1743-0003			J NEUROENG REHABIL	J. NeuroEng. Rehabil.	SEP 5	2015	12								78	10.1186/s12984-015-0070-0			18	Engineering, Biomedical; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology; Rehabilitation	CQ4VT	WOS:000360603400001	26341424	gold, Green Published			2022-02-06	
J	Gardani, M; Morfiri, E; Thomson, A; O'Neill, B; McMillan, TM				Gardani, Maria; Morfiri, Eleni; Thomson, Allan; O'Neill, Brian; McMillan, Thomas M.			Evaluation of Sleep Disorders in Patients With Severe Traumatic Brain Injury During Rehabilitation	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Circadian rhythm; Rehabilitation; Sleep; Sleep disorders; Sleep initiation and maintenance disorders	SCALE; INSOMNIA; DIFFICULTIES; DISTURBANCE; ACTIGRAPHY; COMPLAINTS; FATIGUE; INDEX	Objective: To explore the presence and types of sleep disorders in chronic patients with severe traumatic brain injury (TBI) undergoing inpatient rehabilitation using formal diagnostic criteria based on the International Classification of Sleep Disorders, 2nd edition. Design: Cross-sectional study. Setting: Inpatient brain injury rehabilitation units. Participants: Chronic inpatients with severe TBI (N=30) were evaluated during rehabilitation. Interventions: Not applicable. Main Outcome Measures: Participants wore an actiwatch for 7 days and completed self-report measures on sleep, mood, fatigue, pain, and daytime sleepiness. Results: Twenty participants (67%) had a sleep-wake cycle disturbance, of which 15 (50%) met diagnostic criteria for a sleep disorder. Diagnosed sleep disorders in the sample were insomnia (26.7%), posttraumatic hypersomnia (6.7%), delayed sleep phase syndrome (10%), irregular sleep-wake pattern disorder (3.3%), and periodic limb movement disorder (3.3%). Sleep quality was estimated by senior clinical staff as interfering with rehabilitation in 36.6% of the sample. Poor sleep quality was associated with greater anxiety, fatigue, and daytime sleepiness. Conclusions: Consistent with previous studies, the present study showed high levels of sleep-wake cycle disturbances in patients with severe TBI undergoing rehabilitation, which were associated with anxiety, fatigue, and daytime sleepiness. These findings highlight the importance of assessing and treating sleep problems in patients with TBI undergoing rehabilitation. (C) 2015 by the American Congress of Rehabilitation Medicine	[Gardani, Maria; McMillan, Thomas M.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow G12 0XH, Lanark, Scotland; [Morfiri, Eleni] Natl Hlth Serv Greater Glasgow & Clyde, Glasgow, Lanark, Scotland; [Thomson, Allan] Natl Hlth Serv Fife, Kirkcaldy, Fife, Scotland; [O'Neill, Brian] Brain Injury Rehabil Trust, Glasgow, Lanark, Scotland; [O'Neill, Brian] Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland		Gardani, M (corresponding author), Univ Glasgow, Gartnavel Royal Hosp, Inst Hlth & Wellbeing, 1055 Great Western Rd, Glasgow G12 0XH, Lanark, Scotland.	maria.gardani@glasgow.ac.uk	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146; Gardani, Maria/0000-0003-0975-5971	National Health Service Education Scotland; Sackler Foundation	Supported in part by National Health Service Education Scotland and the Sackler Foundation.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, V2nd; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Bloomfield ILM, 2010, J INT NEUROPSYCH SOC, V16, P17, DOI 10.1017/S1355617709990798; Borgaro SR, 2004, BRAIN INJURY, V18, P685, DOI 10.1080/02699050310001646080; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; Ebrahim IO, 2013, ALCOHOL CLIN EXP RES, V37, DOI 10.1111/acer.12006; Fichtenberg NL, 2000, BRAIN INJURY, V14, P659; Gardani M, 2014, BRAIN INJURY, V28, P773; ISD Scotland, 2014, DRUG MIS STAT SCOTL; ISD Scotland, 2011, ALC STAT SCOTL 2011; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Johns MW, 2000, J SLEEP RES, V9, P5, DOI 10.1046/j.1365-2869.2000.00177.x; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Legros B, 2003, SLEEP MED, V4, P51, DOI 10.1016/S1389-9457(02)00217-4; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McMillan TM, 2013, J NEUROTRAUM, V30, P970, DOI 10.1089/neu.2012.2703; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; O'Neill B, 2014, BRAIN INJURY, V28, P378, DOI 10.3109/02699052.2013.865264; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Sinclair KL, 2014, BEHAV SLEEP MED, V12, P13, DOI 10.1080/15402002.2012.726203; Tyerman A, 2012, NEUROREHABILITATION, V31, P51, DOI 10.3233/NRE-2012-0774; Waters F, 2011, J INT NEUROPSYCH SOC, V17, P571, DOI 10.1017/S1355617711000610; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson SJ, 2010, J PSYCHOPHARMACOL, V24, P1577, DOI 10.1177/0269881110379307; Worthington AD, 2006, BRAIN INJURY, V20, P327, DOI 10.1080/02699050500488249; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zollman FS, 2010, BRAIN INJURY, V24, P748, DOI 10.3109/02699051003692167	40	23	23	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	SEP	2015	96	9					1691	1697		10.1016/j.apmr.2015.05.006			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	CR1JT	WOS:000361081700018	26003285				2022-02-06	
J	Sours, C; George, E; Zhuo, JC; Roys, S; Gullapalli, R				Sours, Chandler; George, Elijah O.; Zhuo, Jiachen; Roys, Steven; Gullapalli, Rao P.			Hyper-connectivity of the thalamus during early stages following mild traumatic brain injury	BRAIN IMAGING AND BEHAVIOR			English	Article						Mild traumatic brain injury; Resting state functional connectivity; Thalamus; H-1 magnetic resonance spectroscopy	DEFAULT-MODE NETWORK; MAGNETIC-RESONANCE-SPECTROSCOPY; STATE FUNCTIONAL CONNECTIVITY; PROTON MR SPECTROSCOPY; RECEPTOR SUBUNITS; CORTEX; CONCUSSION; INTEGRITY; SYMPTOMS; DYSFUNCTION	The thalamo-cortical resting state functional connectivity of seven sub-thalamic regions were examined in a prospectively recruited population of 77 acute mild TBI (mTBI) patients within the first 10 days (mean 6 +/- 3 days) of injury and 35 neurologically intact control subjects using the Oxford thalamic connectivity atlas. Neuropsychological assessments were conducted using the Automated Neuropsychological Assessment Metrics (ANAM). A subset of participants received a magentic resonance spectroscopy (MRS) exam to determine metabolite concentrations in the thalamus and the posterior cingulate cortex. Results show that patients performed worse than the control group on various subtests of ANAM and the weighted throughput score, suggesting reduced cognitive performance at this early stage of injury. Both voxel and region of interest based analysis of the resting state fMRI data demonstrated that acute mTBI patients have increased functional connectivity between the various sub-thalamic regions and cortical regions associated with sensory processing and the default mode network (DMN). In addition, a significant reduction in NAA/Cr was observed in the thalamus in the mTBI patients. Furthermore, an increase in Cho/Cr ratio specific to mTBI patients with self-reported sensory symptoms was observed compared to those without self-reported sensory symptoms. These results provide novel insights into the neural mechanisms of the brain state related to internal rumination and arousal, which have implications for new interventions for mTBI patients with persistent symptoms. Furthermore, an understanding of heightened sensitivity to sensory related inputs during early stages of injury may facilitate enhanced prediction of safe return to work.	[Sours, Chandler; George, Elijah O.; Zhuo, Jiachen; Roys, Steven; Gullapalli, Rao P.] Univ Maryland, Sch Med, Magnet Resonance Res Ctr, Baltimore, MD 21201 USA; [Sours, Chandler; George, Elijah O.; Zhuo, Jiachen; Roys, Steven; Gullapalli, Rao P.] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA; [George, Elijah O.; Gullapalli, Rao P.] Univ Maryland, Dept Bioengn, College Pk, MD 20740 USA		Gullapalli, R (corresponding author), Univ Maryland, Sch Med, Magnet Resonance Res Ctr, Baltimore, MD 21201 USA.	rgullapalli@umm.edu			Department of DefenseUnited States Department of Defense [W81XWH-08-1-0725, W81XWH-12-1-0098]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR019214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03NS088014, F31NS081984] Funding Source: NIH RePORTER	The authors would like to thank Joshua Betz, Jacqueline Janowich, Teodora Stoica and Joseph Rosenberg for their help with patient recruitment, Dr. Robert Kane for providing access to ANAM, and and George Makris for his help with acquiring and processing the data. Support for this work was in part provided by the Department of Defense (W81XWH-08-1-0725 & W81XWH-12-1-0098 to RPG).	Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Bey T, 2009, WEST J EMERG MED, V10, P6; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Callard F, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00321; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; DAVIE CA, 1993, LANCET, V341, P630, DOI 10.1016/0140-6736(93)90390-3; Di X, 2014, PEERJ, V2, DOI 10.7717/peerj.367; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; Faul M, 2010, TRAUMATIC BRAIN INJU; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Galarreta M, 2001, NAT REV NEUROSCI, V2, P425, DOI 10.1038/35077566; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; George EO, 2014, J NEUROTRAUM, V31, P1018, DOI 10.1089/neu.2013.3224; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Grossman Elan J, 2010, Top Magn Reson Imaging, V21, P379, DOI 10.1097/RMR.0b013e31823e65b8; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Hattingen E, 2009, BRAIN, V132, P3285, DOI 10.1093/brain/awp293; He J.H., 2014, ACTA NEUROL SCAND; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holshouser BA, 2006, J MAGN RESON IMAGING, V24, P33, DOI 10.1002/jmri.20607; Huusko N, 2014, NEUROSCIENCE, V267, P30, DOI 10.1016/j.neuroscience.2014.02.026; Inglese M, 2003, MAGNET RESON MED, V50, P190, DOI 10.1002/mrm.10481; Iraji A., 2014, J NEUROTRAUM; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kane RL, 2007, ARCH CLIN NEUROPSYCH, V22, pS115, DOI 10.1016/j.acn.2006.10.006; Kapogiannis D, 2013, NEUROIMAGE, V64, P112, DOI 10.1016/j.neuroimage.2012.09.029; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kirov I, 2007, BRAIN INJURY, V21, P1147, DOI 10.1080/02699050701630383; Kirov II, 2013, J NEUROL, V260, P242, DOI 10.1007/s00415-012-6626-z; Kucyi A, 2014, J NEUROSCI, V34, P3969, DOI 10.1523/JNEUROSCI.5055-13.2014; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Laouchedi M, 2014, J NEURORADIOL, V10, P1016; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mathias JL, 2014, J NEUROTRAUM, V31, P658, DOI 10.1089/neu.2013.3160; Mayer A., 2013, J NEUROTRAUMA; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; McCrea M., 2000, STANDARDIZED ASSESSM; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reich S, 2005, VALIDATION ANAM TEST; Robinson M. E., 2014, HUM BRAIN MAPP; Sarmento E, 2009, HEADACHE, V49, P1345, DOI 10.1111/j.1526-4610.2009.01494.x; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Sours C, 2014, BRAIN IMAGING BEHAV; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Squarcina L, 2012, NEUROIMAGE, V63, P779, DOI 10.1016/j.neuroimage.2012.07.016; Stokum J., 2014, BRAIN INJUR IN PRESS; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Wang X, 2014, NEUROSCIENCE, V278, P291, DOI 10.1016/j.neuroscience.2014.08.006; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358; Yeo RA, 2006, J NEUROTRAUM, V23, P1427, DOI 10.1089/neu.2006.23.1427; Yin Y, 2011, BRAIN RES, V1411, P98, DOI 10.1016/j.brainres.2011.07.016; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zhou Y., 2013, J MAGN RESON IMAGING; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	88	23	23	0	11	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	SEP	2015	9	3					550	563		10.1007/s11682-015-9424-2			14	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CR8LQ	WOS:000361604300015	26153468	Green Accepted			2022-02-06	
J	Presley, C; Abidi, A; Suryawanshi, S; Mustafa, S; Meibohm, B; Moore, BM				Presley, Chaela; Abidi, Ammaar; Suryawanshi, Satyendra; Mustafa, Suni; Meibohm, Bernd; Moore, Bob M., II			Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonist	PHARMACOLOGY RESEARCH & PERSPECTIVES			English	Article						ACTOne; cannabinoid receptor 2; inverse agonist; microglia; polarization	TRAUMATIC BRAIN-INJURY; CB2 RECEPTOR; ENDOCANNABINOID SYSTEM; MICROGLIAL ACTIVATION; NEUROMYELITIS-OPTICA; MULTIPLE-SCLEROSIS; GENE-EXPRESSION; LIPOPOLYSACCHARIDE; CELLS; ANTAGONIST	Cannabinoid receptor 2 agonists and inverse agonists are emerging as new therapeutic options for a spectrum of autoimmune-related disease. Of particular interest, is the ability of CB2 ligands to regulate microglia function in neurodegenerative diseases and traumatic brain injury. We have previously reported the receptor affinity of 30,50-dichloro-2,6-dihydroxy-biphenyl-4-yl)-phenyl-methanone ( SMM-189) and the characterization of the beneficial effects of SMM-189 in the mouse model of mild traumatic brain injury. Herein, we report the further characterization of SMM-189 as a potent and selective CB2 inverse agonist, which acts as a noncompetitive inhibitor of CP 55,940. The ability of SMM-189 to regulate microglial activation, in terms of chemokine expression and cell morphology, has been determined. Finally, we have determined that SMM-189 possesses acceptable biopharmaceutical properties indicating that the triaryl class of CB2 inverse agonists are viable compounds for continued preclinical development for the treatment of neurodegenerative disorders and traumatic brain injury.	[Presley, Chaela; Abidi, Ammaar; Suryawanshi, Satyendra; Mustafa, Suni; Meibohm, Bernd; Moore, Bob M., II] Univ Tennessee, Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, Memphis, TN USA		Moore, BM (corresponding author), 847 Monroe Ave,Ste 327, Memphis, TN 38163 USA.	bmoore@uthsc.edu		Abidi, Ammaar/0000-0003-1826-9377; Meibohm, Bernd/0000-0003-3923-3648	University of Tennessee Health Science Center (UTHSC), College of Pharmacy; UTHSC Neuroscience Institute; Endece LLC; National Institutes of Health (Meibohm)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1S10OD016226]	The University of Tennessee Health Science Center (UTHSC), College of Pharmacy, and the UTHSC Neuroscience Institute provided the stipend for Chaela Presley. Endece LLC provided funding for the ACTOne assay and the biopharmaceutical evaluation of SMM189. This work was also funded in part by National Institutes of Health grant 1S10OD016226 (Meibohm).	Ashton JC, 2007, CURR NEUROPHARMACOL, V5, P73, DOI 10.2174/157015907780866884; Askovic S, 2001, J VIROL, V75, P2665, DOI 10.1128/JVI.75.6.2665-2674.2001; Bhattacharjee H, 2009, BIOORG MED CHEM LETT, V19, P1691, DOI 10.1016/j.bmcl.2009.01.100; Blanchard C, 2006, J CLIN INVEST, V116, P536, DOI 10.1172/JCI26679; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bouaboula M, 1996, EUR J BIOCHEM, V237, P704, DOI 10.1111/j.1432-1033.1996.0704p.x; Carroll FY, 2001, MOL PHARMACOL, V59, P965, DOI 10.1124/mol.59.5.965; Chen ZH, 2012, J NEUROSCI, V32, P11706, DOI 10.1523/JNEUROSCI.0730-12.2012; Conant K, 1998, P NATL ACAD SCI USA, V95, P3117, DOI 10.1073/pnas.95.6.3117; Crowe MS, 2014, BRAIN BEHAV IMMUN, V42, P1, DOI 10.1016/j.bbi.2014.06.007; Croxford JL, 2003, CNS DRUGS, V17, P179, DOI 10.2165/00023210-200317030-00004; D'Aversa TG, 2004, J NEUROVIROL, V10, P86, DOI 10.1080/13550280490279807; DeJesus Edwin, 2007, J Int Assoc Physicians AIDS Care (Chic), V6, P95, DOI 10.1177/1545109707300157; Depboylu C, 2012, EXP NEUROL, V238, P183, DOI 10.1016/j.expneurol.2012.08.020; Duan RS, 2008, NEUROCHEM RES, V33, P1085, DOI 10.1007/s11064-007-9554-z; Ebner F, 2013, J IMMUNOL, V191, P5594, DOI 10.4049/jimmunol.1203331; Elliott MB, 2011, J NEUROTRAUM, V28, P973, DOI 10.1089/neu.2010.1672; Fitzsimons CP, 2004, J BIOL CHEM, V279, P34431, DOI 10.1074/jbc.M400738200; Fraga D, 2011, J NEUROIMMUNE PHARM, V6, P566, DOI 10.1007/s11481-011-9291-6; Friese MA, 2007, BRAIN, V130, P2755, DOI 10.1093/brain/awm246; Fujinaga M, 2010, BIOORG MED CHEM LETT, V20, P1565, DOI 10.1016/j.bmcl.2010.01.074; Garwood Claire J, 1800, Front Psychiatry, V1, P136, DOI 10.3389/fpsyt.2010.00136; Gibaldi M., 1982, PHARMACOKINETICS; Glomme A, 2005, J PHARM SCI-US, V94, P1, DOI 10.1002/jps.20212; Govaerts SJ, 2004, EUR J PHARM SCI, V23, P233, DOI 10.1016/j.ejps.2004.07.013; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; HERMAN TS, 1979, NEW ENGL J MED, V300, P1295, DOI 10.1056/NEJM197906073002302; Hilliard A., 2012, ISRN NEUROL, V2012, DOI DOI 10.5402/2012/802649; Ho L, 2012, J ALZHEIMERS DIS, V31, P301, DOI 10.3233/JAD-2012-120598; Kerns EH, 2004, J PHARM SCI-US, V93, P1440, DOI 10.1002/jps.20075; Khilnani G, 2011, INDIAN J PHARMACOL, V43, P492, DOI 10.4103/0253-7613.84947; Kozela E, 2010, J BIOL CHEM, V285, P1616, DOI 10.1074/jbc.M109.069294; Krishnamurthy M, 2008, BIOORGAN MED CHEM, V16, P6489, DOI 10.1016/j.bmc.2008.05.034; Kuhle J, 2009, EUR J NEUROL, V16, P771, DOI 10.1111/j.1468-1331.2009.02560.x; Laforte V, 2014, HUPO 13 ANN WORLD C; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Lively S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-75; Lou ZY, 2011, MOL IMMUNOL, V49, P453, DOI 10.1016/j.molimm.2011.09.016; Louvet A, 2011, HEPATOLOGY, V54, P1217, DOI 10.1002/hep.24524; Lunn CA, 2008, BRIT J PHARMACOL, V153, P226, DOI 10.1038/sj.bjp.0707480; Martin-Moreno AM, 2011, MOL PHARMACOL, V79, P964, DOI 10.1124/mol.111.071290; Merighi S, 2012, BRIT J PHARMACOL, V165, P1773, DOI 10.1111/j.1476-5381.2011.01673.x; Michael BD, 2013, CYTOKINE, V64, P90, DOI 10.1016/j.cyto.2013.07.019; Mukhopadhyay S, 2006, J NEUROIMMUNOL, V181, P82, DOI 10.1016/j.jneuroim.2006.08.002; Narikawa K, 2004, J NEUROIMMUNOL, V149, P182, DOI 10.1016/j.jneuroim.2003.12.010; Ortega-Gutierrez S, 2005, FASEB J, V19, P1338, DOI 10.1096/fj.04-2464fje; Porter RHP, 2005, J PHARMACOL EXP THER, V315, P711, DOI 10.1124/jpet.105.089839; Pulliam L, 2007, J NEUROIMMUNE PHARM, V2, P87, DOI 10.1007/s11481-006-9053-z; Reiner A, 2015, INT J MOL SCI, V16, P758, DOI 10.3390/ijms16010758; Rhee Man-Hee, 2002, J Vet Sci, V3, P179; Ribeiro R, 2013, PROSTAG OTH LIPID M, V100, P1, DOI 10.1016/j.prostaglandins.2012.11.003; Romero-Sandoval EA, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-25; Selenica MLB, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-86; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Sipe JC, 2005, J LEUKOCYTE BIOL, V78, P231, DOI 10.1189/jlb.0205111; Smit MJ, 1996, P NATL ACAD SCI USA, V93, P6802, DOI 10.1073/pnas.93.13.6802; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Tam WY, 2014, SCI REP-UK, V4, DOI 10.1038/srep07279; Tanuma N, 2006, ACTA NEUROPATHOL, V112, P195, DOI 10.1007/s00401-006-0083-7; Thomas A, 2007, BRIT J PHARMACOL, V150, P613, DOI 10.1038/sj.bjp.0707133; Vainchtein ID, 2014, GLIA, V62, P1724, DOI 10.1002/glia.22711; Walter L, 2003, J NEUROSCI, V23, P1398, DOI 10.1523/JNEUROSCI.23-04-01398.2003; Westin K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030525; White RE, 2000, ANNU REV PHARMACOL, V40, P133, DOI 10.1146/annurev.pharmtox.40.1.133; WISNIEWSKI HM, 1991, ACTA NEUROPATHOL, V81, P588, DOI 10.1007/BF00310142; Witkamp R, 2014, CURR OPIN CLIN NUTR, V17, P130, DOI 10.1097/MCO.0000000000000027; Wohnsland F, 2001, J MED CHEM, V44, P923, DOI 10.1021/jm001020e; Zarruk JG, 2012, STROKE, V43, P211, DOI 10.1161/STROKEAHA.111.631044; Zhang Y, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-79; Zoppi S, 2014, BRIT J PHARMACOL, V171, P2814, DOI 10.1111/bph.12607	71	23	23	0	0	JOHN WILEY & SONS LTD	CHICHESTER	THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND	2052-1707			PHARMACOL RES PERSPE	Pharmacol. Res. Perspect.	AUG	2015	3	4							00159	10.1002/prp2.159			17	Pharmacology & Pharmacy	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy	VA7PC	WOS:000410341100010	26196013	Green Published, gold			2022-02-06	
J	Dixon, KJ; Theus, MH; Nelersa, CM; Mier, J; Travieso, LG; Yu, TS; Kernie, SG; Liebl, DJ				Dixon, Kirsty J.; Theus, Michelle H.; Nelersa, Claudiu M.; Mier, Jose; Travieso, Lissette G.; Yu, Tzong-Shiue; Kernie, Steven G.; Liebl, Daniel J.			Endogenous Neural Stem/Progenitor Cells Stabilize the Cortical Microenvironment after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						gliosis; neural stem; progenitor cell ablation; neurogenesis; neuronal survival; traumatic brain injury	ENDOTHELIAL GROWTH-FACTOR; STEM-CELLS; INTERMEDIATE-FILAMENT; NEURONAL PRECURSORS; REACTIVE ASTROCYTES; ADULT BRAIN; NEUROGENESIS; RAT; PROLIFERATION; EXPRESSION	Although a myriad of pathological responses contribute to traumatic brain injury (TBI), cerebral dysfunction has been closely linked to cell death mechanisms. A number of therapeutic strategies have been studied in an attempt to minimize or ameliorate tissue damage; however, few studies have evaluated the inherent protective capacity of the brain. Endogenous neural stem/progenitor cells (NSPCs) reside in distinct brain regions and have been shown to respond to tissue damage by migrating to regions of injury. Until now, it remained unknown whether these cells have the capacity to promote endogenous repair. We ablated NSPCs in the subventricular zone to examine their contribution to the injury microenvironment after controlled cortical impact (CCI) injury. Studies were performed in transgenic mice expressing the herpes simplex virus thymidine kinase gene under the control of the nestin promoter exposed to CCI injury. Two weeks after CCI injury, mice deficient in NSPCs had reduced neuronal survival in the perilesional cortex and fewer Iba-1-positive and glial fibrillary acidic protein-positive glial cells but increased glial hypertrophy at the injury site. These findings suggest that the presence of NSPCs play a supportive role in the cortex to promote neuronal survival and glial cell expansion after TBI injury, which corresponds with improvements in motor function. We conclude that enhancing this endogenous response may have acute protective roles after TBI.	[Dixon, Kirsty J.; Nelersa, Claudiu M.; Mier, Jose; Travieso, Lissette G.; Liebl, Daniel J.] Univ Miami, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Dixon, Kirsty J.; Nelersa, Claudiu M.; Mier, Jose; Travieso, Lissette G.; Liebl, Daniel J.] Univ Miami, Dept Neurol Surg, Miami, FL 33136 USA; [Theus, Michelle H.] Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA; [Yu, Tzong-Shiue; Kernie, Steven G.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA		Liebl, DJ (corresponding author), Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg, 1095 NW 14th Terrace,R-48, Miami, FL 33136 USA.	dliebl@med.miami.edu	Kernie, Steven/AAT-9912-2020	Kernie, Steven/0000-0003-1371-0549; Yu, Tzong-Shiue/0000-0003-4277-6213	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS007459, NS049545, NS30291, NS064699, R01 NS048192] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F32NS064699, R01NS049545, T32NS007459, R01NS048192, P50NS030291] Funding Source: NIH RePORTER		Ahlemeyer B, 2013, J NEUROSCI METH, V212, P156, DOI 10.1016/j.jneumeth.2012.09.016; Gomez-Climent MA, 2011, CEREB CORTEX, V21, P1028, DOI 10.1093/cercor/bhq177; Arias-Carrion O, 2006, J NEUROSCI RES, V84, P1425, DOI 10.1002/jnr.21068; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Benner EJ, 2013, NATURE, V497, P369, DOI 10.1038/nature12069; Bernal GM, 2011, AGING CELL, V10, P466, DOI 10.1111/j.1474-9726.2011.00694.x; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Budinich CS, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/378307; Butti E, 2012, BRAIN, V135, P3320, DOI 10.1093/brain/aws194; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Chiu CC, 2005, CANCER DETECT PREV, V29, P286, DOI 10.1016/j.cdp.2005.02.001; Cromwell HC, 1996, J NEUROSCI, V16, P3444; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; Doyon J, 1996, EUR J NEUROSCI, V8, P637, DOI 10.1111/j.1460-9568.1996.tb01249.x; Ehninger D, 2011, CELL TISSUE RES, V345, P69, DOI 10.1007/s00441-011-1200-z; Ekmark-Lewen S, 2010, RESTOR NEUROL NEUROS, V28, P311, DOI 10.3233/RNN-2010-0529; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Faiz M, 2008, MOL CELL NEUROSCI, V38, P170, DOI 10.1016/j.mcn.2008.02.002; Galindo LT, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/564089; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Giunti D, 2012, STEM CELLS, V30, P2044, DOI 10.1002/stem.1174; Guerra-Crespo M, 2009, NEUROSCIENCE, V160, P470, DOI 10.1016/j.neuroscience.2009.02.029; Heymach Jr. J. V., 1995, NATURE, P374; HEYMACH JV, 1995, NATURE, V374, P405, DOI 10.1038/374405a0; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107; Krum JM, 1998, EXP NEUROL, V154, P57, DOI 10.1006/exnr.1998.6930; Lai B, 2008, NEUROSCI LETT, V442, P305, DOI 10.1016/j.neulet.2008.07.032; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Li B, 2010, BRAIN RES, V1327, P91, DOI 10.1016/j.brainres.2010.02.030; Liu YP, 2009, ACTA NEUROPATHOL, V117, P469, DOI 10.1007/s00401-009-0516-1; Lossinsky AS, 2004, HISTOL HISTOPATHOL, V19, P535, DOI 10.14670/HH-19.535; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Luo Chun, 2002, Chin J Traumatol, V5, P24; Ma YH, 2011, BRAIN RES BULL, V86, P441, DOI 10.1016/j.brainresbull.2011.07.007; Mizuno Y, 2006, J NEUROL SCI, V246, P131, DOI 10.1016/j.jns.2006.02.019; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Nakano K, 2000, BRAIN DEV-JPN, V22, pS5; Neves SS, 2006, BBA-BIOMEMBRANES, V1758, P1703, DOI 10.1016/j.bbamem.2006.08.021; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; O'Connor CA, 2006, ACTA NEUROCHIR SUPPL, V96, P121; Petridis AK, 2011, J CLIN NEUROSCI, V18, P265, DOI 10.1016/j.jocn.2010.06.021; Proia P, 2008, INT J MOL MED, V21, P63; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rani SB, 2006, INDIAN J MED RES, V124, P269; Ricard J, 2006, MOL CELL NEUROSCI, V31, P713, DOI 10.1016/j.mcn.2006.01.002; Salhia B, 2000, BRAIN RES, V883, P87, DOI 10.1016/S0006-8993(00)02825-0; Snapyan M, 2009, J NEUROSCI, V29, P4172, DOI 10.1523/JNEUROSCI.4956-08.2009; Sun CR, 2013, J NEUROSCI, V33, P17314, DOI 10.1523/JNEUROSCI.2129-13.2013; Sun F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046326; Suzuki R, 2006, ACTA NEUROCHIR SUPPL, V96, P398; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Taupin Philippe, 2008, Int J Med Sci, V5, P127; Teramoto T, 2003, J CLIN INVEST, V111, P1125, DOI 10.1172/JCI200317170; Theus M. H., 2012, CURR PROTOC STEM CEL; Thored P, 2007, STROKE, V38, P3032, DOI 10.1161/STROKEAHA.107.488445; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Wang XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0045036, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0040084]; Wei SJ, 1998, EXP CELL RES, V241, P66, DOI 10.1006/excr.1998.4005; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008	60	23	25	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2015	32	11					753	764		10.1089/neu.2014.3390			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CV0YU	WOS:000363980700001	25290253	Green Published			2022-02-06	
J	Theadom, A; Parmar, P; Jones, K; Barker-Collo, S; Starkey, NJ; McPherson, KM; Ameratunga, S; Feigin, VL				Theadom, Alice; Parmar, Priya; Jones, Kelly; Barker-Collo, Suzanne; Starkey, Nicola J.; McPherson, Kathryn M.; Ameratunga, Shanthi; Feigin, Valery L.		BIONIC Res Grp	Frequency and Impact of Recurrent Traumatic Brain Injury in a Population-Based Sample	JOURNAL OF NEUROTRAUMA			English	Article						repetitive injury; cognitive functioning; recurrent injury; postconcussion symptoms; traumatic brain injury	CONCUSSION SYMPTOMS QUESTIONNAIRE; MILD HEAD-INJURY; RELIABILITY; SCALE; DIAGNOSIS; VALIDITY; AMNESIA; PLAYERS; RETURN	The aim of this study was to determine the frequency, mechanism(s), and impact of recurrent traumatic brain injury (TBI) over a 1-year period. Population-based TBI incidence and 1-year outcomes study with embedded case-control analysis. All participants (adults and children) who experienced a recurrent TBI (more than one) in the 12 months after an index injury and matched controls who sustained one TBI within the same period were enrolled in a population-based TBI incidence and outcomes study. Details of all recurrent TBIs sustained within 12 months of the initial index injury were recorded. Each recurrent TBI case was matched to a case sustaining one TBI based on age (+/- 2 years), gender, and index TBI severity. Cognitive ability, disability, and postconcussion symptoms (PCS) were assessed 1 year after the index injury. Overall, 9.9% (n=72) of TBI cases experienced at least one recurrent TBI within the year after initial index injury. Males, people <35 years of age, and those who had experienced a TBI before their index injury were at highest risk of recurrent TBI. Recurrent TBI cases reported significantly increased PCS at 1 year, compared to the matched controls (n=72) sustaining one TBI. There was no difference in overall cognitive ability and disability between the two groups. People experiencing recurrent TBIs are more likely to experience increased frequency and severity of PCS. Greater public awareness of the potential effects of recurrent brain injury is needed.	[Theadom, Alice; Parmar, Priya; Jones, Kelly; Feigin, Valery L.] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Auckland 1142, New Zealand; [Barker-Collo, Suzanne] Univ Auckland, Dept Psychol, Auckland, New Zealand; [Starkey, Nicola J.] Univ Waikato, Sch Psychol, Hamilton, New Zealand; [McPherson, Kathryn M.] Auckland Univ Technol, Person Ctr Res Ctr, Hlth & Rehabil Inst, Auckland 1142, New Zealand; [Ameratunga, Shanthi] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand		Theadom, A (corresponding author), Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Fac Hlth & Environm Studies, AA254C,90 Akoranga Dr,Northcote 0627, Auckland 1142, New Zealand.	alice.theadom@aut.ac.nz	Jones, Kelly/I-5199-2019; Starkey, Nicola/AAJ-3795-2020; Feigin, Valery/AAF-2313-2019	Starkey, Nicola/0000-0002-4370-8186; Theadom, Alice/0000-0003-0351-6216; McPherson, Kath/0000-0003-0487-8497; Ameratunga, Shanthi/0000-0001-8042-2251; Parmar, Priya/0000-0001-6001-9326; Feigin, Valery L./0000-0002-6372-1740; McPherson, Kathryn/0000-0003-1240-8882	Health Research Council of New ZealandHealth Research Council of New Zealand [09/063A, 11/192]; ABI Management Rehabilitation	This work was funded by the Health Research Council of New Zealand (09/063A, 11/192). A.T. was cofunded by ABI Management Rehabilitation, and K.M. holds the Laura Fergusson Trust Chair. The authors thank the research team for their dedication and performance; the staff at the coroner's office in Hamilton; the staff of the New Zealand Accident Compensation Corporation and Health Information Service; Waikato District Health Board; Waikato University Staff; the many doctors, nurses, and rehabilitation professionals and service providers, such as ABI Management and administrative staff within and outside Hamilton; and the BIONIC participants and their families and friends. The authors also thank Helen McDonald for her administrative support for the study and CNS Vital Signs for their support with the neuropsychological assessment.	[Anonymous], 2010, NAT METHODS, V7, P331, DOI 10.1038/nmeth0510-331; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chapman RCG, 2010, BRAIN INJURY, V24, P797, DOI 10.3109/02699051003709607; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gualtieri C. T., 2004, AM NEUR ASS ANN M FE; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/316575; JAGGER J, 1984, J TRAUMA, V24, P40, DOI 10.1097/00005373-198401000-00006; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; SALCIDO R, 1992, Brain Injury, V6, P293, DOI 10.3109/02699059209029671; Saunders LL, 2009, BRAIN INJURY, V23, P866, DOI 10.1080/02699050903283213; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Silverberg ND, 2013, J NEUROTRAUM, V30, P1398, DOI 10.1089/neu.2012.2827; Statistics New Zealand, 2006, REG SUMM TABL TERR A; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; TEASDALE G, 1974, LANCET, V2, P81; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Winqvist S, 2008, BRAIN INJURY, V22, P780, DOI 10.1080/02699050802339397; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906	40	23	23	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2015	32	10					674	681		10.1089/neu.2014.3579			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	CH3ZP	WOS:000353970200002	25334048				2022-02-06	
J	Allen, RS; Olsen, TW; Sayeed, I; Cale, HA; Morrison, KC; Oumarbaeva, Y; Lucaciu, I; Boatright, JH; Pardue, MT; Stein, DG				Allen, Rachael S.; Olsen, Timothy W.; Sayeed, Iqbal; Cale, Heather A.; Morrison, Katherine C.; Oumarbaeva, Yuliya; Lucaciu, Irina; Boatright, Jeffrey H.; Pardue, Machelle T.; Stein, Donald G.			Progesterone Treatment in Two Rat Models of Ocular Ischemia	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						progesterone; retinal ischemia; electroretinogram; middle cerebral artery occlusion; anterior ischemia optic neuropathy	CEREBRAL-ARTERY OCCLUSION; TRAUMATIC BRAIN-INJURY; RETINAL GLIAL-CELLS; NF-KAPPA-B; OPTIC NEUROPATHY; GLUCOCORTICOID RECEPTOR; EXPERIMENTAL STROKE; SIGNALING PATHWAY; OXIDATIVE STRESS; GENE-EXPRESSION	PURPOSE. To determine whether the neurosteroid progesterone, shown to have protective effects in animal models of traumatic brain injury, stroke, and spinal cord injury, is also protective in ocular ischemia animal models. METHODS. Progesterone treatment was tested in two ocular ischemia models in rats: a rodent anterior ischemic optic neuropathy (rAION) model, which induces permanent monocular optic nerve stroke, and the middle cerebral artery occlusion (MCAO) model, which causes transient ischemia in both the retina and brain due to an intraluminal filament that blocks the ophthalmic and middle cerebral arteries. Visual function and retinal histology were assessed to determine whether progesterone attenuated retinal injury in these models. Additionally, behavioral testing and 2% 2,3,5 - triphenyltetrazolium chloride (TTC) staining in brains were used to compare progesterone's neuroprotective effects in both retina and brain using the MCAO model. RESULTS. Progesterone treatment showed no effect on visual evoked potential (VEP) reduction and retinal ganglion cell loss in the permanent rAION model. In the transient MCAO model, progesterone treatment reduced (1) electroretinogram (ERG) deficits, (2) MCAO - induced upregulation of glutamine synthetase (GS) and glial fibrillary acidic protein (GFAP), and (3) retinal ganglion cell loss. As expected, progesterone treatment also had significant protective effects in behavioral tests and a reduction in infarct size in the brain. CONCLUSIONS. Progesterone treatment showed protective effects in the retina following MCAO but not rAION injury, which may result from mechanistic differences with injury type and the therapeutic action of progesterone.	[Allen, Rachael S.; Sayeed, Iqbal; Cale, Heather A.; Morrison, Katherine C.; Oumarbaeva, Yuliya; Lucaciu, Irina; Stein, Donald G.] Emory Univ, Emergency Med, Atlanta, GA 30322 USA; [Allen, Rachael S.; Olsen, Timothy W.; Boatright, Jeffrey H.; Pardue, Machelle T.] Emory Univ, Dept Ophthalmol, Atlanta, GA 30322 USA; [Allen, Rachael S.; Boatright, Jeffrey H.; Pardue, Machelle T.] Atlanta VA Ctr Visual & Neurocognit Rehabil, Decatur, GA USA		Allen, RS (corresponding author), Atlanta VA Ctr Visual & Neurocognit Rehabil, Res Serv Oph 151, 1670 Clairmont Rd, Decatur, GA 30033 USA.	restewa@emory.edu	Lucaciu, Irina/AAZ-8624-2020; Stein, Donald/AAJ-5139-2020		H. Allen and Company; Atlanta VA Rehab R&D Center of Excellence; Abraham J. and Phyllis Katz Foundation; Foundation Fighting BlindnessEuropean Commission; Research to Prevent BlindnessResearch to Prevent Blindness (RPB); National Eye InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY014026, R01EY016470, R24EY017045, P30EY006360, T32EY007092-24]; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY014026, R01EY016470, T32EY007092, R24EY017045, P30EY006360] Funding Source: NIH RePORTER	Supported by H. Allen and Company; Atlanta VA Rehab R&D Center of Excellence; The Abraham J. and Phyllis Katz Foundation; Foundation Fighting Blindness; an unrestricted departmental grant from Research to Prevent Blindness; and National Eye Institute Grants R01EY014026, R01EY016470, R24EY017045, P30EY006360, and T32EY007092-24.	Allen RS, 2014, EXP NEUROL, V254, P206, DOI 10.1016/j.expneurol.2014.02.005; Ardeshiri A, 2006, EUR J NEUROSCI, V24, P2567, DOI 10.1111/j.1460-9568.2006.05142.x; Avitabile T, 2007, CURR EYE RES, V32, P999, DOI 10.1080/02713680701679006; Barnett NL, 2000, INVEST OPHTH VIS SCI, V41, P585; Benavente O, 2001, NEW ENGL J MED, V345, P1084, DOI 10.1056/NEJMoa002994; Bernstein SL, 2003, INVEST OPHTH VIS SCI, V44, P4153, DOI 10.1167/iovs.03-0274; Block F, 1997, NEUROSCI LETT, V232, P45, DOI 10.1016/S0304-3940(97)00575-2; Cai WY, 2008, NEUROPHARMACOLOGY, V55, P127, DOI 10.1016/j.neuropharm.2008.04.023; Cascio C, 2007, EXP EYE RES, V85, P166, DOI 10.1016/j.exer.2007.02.008; Chang CH, 2014, EXP EYE RES, V118, P109, DOI 10.1016/j.exer.2013.11.012; Coca-Prados M, 2003, J STEROID BIOCHEM, V86, P207, DOI 10.1016/j.jsbmb.2003.08.001; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Cutler SM, 2006, EXP NEUROL, V200, P378, DOI 10.1016/j.expneurol.2006.02.137; Cutler SM, 2005, EXP NEUROL, V195, P423, DOI 10.1016/j.expneurol.2005.06.003; Doonan F, 2011, J NEUROCHEM, V118, P915, DOI 10.1111/j.1471-4159.2011.07354.x; Dvoriantchikova G, 2009, EUR J NEUROSCI, V30, P175, DOI 10.1111/j.1460-9568.2009.06814.x; Espinosa-Garcia C, 2013, NEUROSCI LETT, V550, P98, DOI 10.1016/j.neulet.2013.06.023; Fazzone HE, 2003, BRIT J OPHTHALMOL, V87, P1193, DOI 10.1136/bjo.87.9.1193; Ghoumari AM, 2005, NEUROSCIENCE, V135, P47, DOI 10.1016/j.neuroscience.2005.05.023; Gronberg NV, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-115; GUARNERI P, 1994, J NEUROCHEM, V63, P86; Hangai M, 1996, OPHTHALMIC RES, V28, P248, DOI 10.1159/000267910; HAYREH SS, 1974, BRIT J OPHTHALMOL, V58, P955, DOI 10.1136/bjo.58.12.955; Helenius J, 2012, ANN NEUROL, V72, P286, DOI 10.1002/ana.23597; Hill JK, 1999, BRAIN RES, V820, P45, DOI 10.1016/S0006-8993(98)01140-8; HILLERED L, 1989, J CEREBR BLOOD F MET, V9, P607, DOI 10.1038/jcbfm.1989.87; Iandiev I, 2006, NEUROSCI LETT, V408, P108, DOI 10.1016/j.neulet.2006.08.084; Ishrat T, 2012, NEUROSCIENCE, V210, P442, DOI 10.1016/j.neuroscience.2012.03.008; Ishrat T, 2010, EXP NEUROL, V226, P183, DOI 10.1016/j.expneurol.2010.08.023; Ishrat T, 2009, BRAIN RES, V1257, P94, DOI 10.1016/j.brainres.2008.12.048; Kalloniatis M, 1995, J Am Optom Assoc, V66, P750; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; Knight SR, 2012, J NEUROENDOCRINOL, V24, P1135, DOI 10.1111/j.1365-2826.2012.02319.x; Koulen P, 2008, CELL PHYSIOL BIOCHEM, V21, P161, DOI 10.1159/000113758; Labombarda F, 2013, NEUROPHARMACOLOGY, V71, P46, DOI 10.1016/j.neuropharm.2013.03.010; Langmade SJ, 2006, P NATL ACAD SCI USA, V103, P13807, DOI 10.1073/pnas.0606218103; LANTHIER A, 1988, BRAIN RES, V463, P403, DOI 10.1016/0006-8993(88)90419-2; LANTHIER A, 1986, J STEROID BIOCHEM, V25, P445, DOI 10.1016/0022-4731(86)90259-1; LANTHIER A, 1987, J STEROID BIOCHEM, V28, P697, DOI 10.1016/0022-4731(87)90400-6; Li Xin-Juan, 2012, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V28, P472; Li YC, 1997, J MOL NEUROSCI, V8, P145, DOI 10.1007/BF02736779; Liu AL, 2012, ENDOCRINOLOGY, V153, P3747, DOI 10.1210/en.2012-1138; Liu Y, 2012, FREE RADICAL BIO MED, V52, P909, DOI 10.1016/j.freeradbiomed.2011.12.013; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lu Na, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P2026; Maurice T, 1998, NEUROSCIENCE, V83, P413, DOI 10.1016/S0306-4522(97)00405-3; Mead GE, 2002, STROKE, V33, P2383, DOI 10.1161/01.STR.0000029827.93497.97; MILLER NR, 1982, WALSH HOYTS CLIN NEU, P212; Moller A, 2003, VISUAL NEUROSCI, V20, P535, DOI 10.1017/S0952523803205071; MONNET FP, 1995, P NATL ACAD SCI USA, V92, P3774, DOI 10.1073/pnas.92.9.3774; Neumann F, 2010, NEUROCHEM RES, V35, P522, DOI 10.1007/s11064-009-0092-8; Nilsen J, 2002, ENDOCRINOLOGY, V143, P205, DOI 10.1210/en.143.1.205; OGATA T, 1993, NEUROSCIENCE, V55, P445, DOI 10.1016/0306-4522(93)90513-F; Ozacmak VH, 2009, PHYSIOL RES, V58, P909, DOI 10.33549/physiolres.931647; Panchami, 2013, J CLIN DIAGN RES, V7, P1322, DOI 10.7860/JCDR/2013/5325.3145; Perlman JI, 1996, CURR EYE RES, V15, P589, DOI 10.3109/02713689609008898; PRICE MJ, 1988, GRAEF ARCH CLIN EXP, V226, P542, DOI 10.1007/BF02169202; Puia Giulia, 2001, Trends in Pharmacological Sciences, V22, P266, DOI 10.1016/S0165-6147(00)01706-5; Puig N, 2000, CEREBROVASC DIS, V10, P449, DOI 10.1159/000016106; Reddy DS, 2005, NEUROPHARMACOLOGY, V48, P14, DOI 10.1016/j.neuropharm.2004.09.002; Sakamoto H, 2001, J COMP NEUROL, V439, P291, DOI 10.1002/cne.1351; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Sayeed L, 2007, RESTOR NEUROL NEUROS, V25, P151; Schmidt-Kastner R, 2000, MOL BRAIN RES, V79, P88, DOI 10.1016/S0169-328X(00)00104-2; Schneider A, 1999, NAT MED, V5, P554, DOI 10.1038/8432; Schumacher M, 2014, PROG NEUROBIOL, V113, P6, DOI 10.1016/j.pneurobio.2013.09.004; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; Sharma RK, 2002, ADLERS PHYSL EYE, P319; SLEPYAN DH, 1975, STROKE, V6, P493, DOI 10.1161/01.STR.6.5.493; Steele EC, 2008, STROKE, V39, P2099, DOI 10.1161/STROKEAHA.107.504357; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; Su TP, 2003, CURR MED CHEM, V10, P2073, DOI 10.2174/0929867033456783; SVEC F, 1989, ENDOCRINOLOGY, V125, P3103, DOI 10.1210/endo-125-6-3103; SVEC F, 1980, ENDOCRINOLOGY, V107, P566, DOI 10.1210/endo-107-2-566; Swiatek-De Lange M, 2007, GLIA, V55, P1061, DOI 10.1002/glia.20523; Wali B, 2014, BRAIN, V137, P486, DOI 10.1093/brain/awt319; Wang JP, 2010, BEHAV BRAIN RES, V209, P119, DOI 10.1016/j.bbr.2010.01.026; Wang XY, 2013, EXP THER MED, V6, P263, DOI 10.3892/etm.2013.1116; Wickham LA, 2000, ACTA OPHTHALMOL SCAN, V78, P146, DOI 10.1034/j.1600-0420.2000.078002146.x; Won S, 2014, J CEREBR BLOOD F MET, V34, P72, DOI 10.1038/jcbfm.2013.163; Yang CS, 1996, FREE RADICAL BIO MED, V20, P245, DOI 10.1016/0891-5849(95)02042-X; Yousuf S, 2013, NEUROSCIENCE, V239, P92, DOI 10.1016/j.neuroscience.2012.10.017; Yousuf S, 2014, J CEREBR BLOOD F MET, V34, P297, DOI 10.1038/jcbfm.2013.198; Yucel I, 2005, CAN J OPHTHALMOL, V40, P51, DOI 10.1016/S0008-4182(05)80117-6; Zador Zsolt, 2009, Handb Exp Pharmacol, P159, DOI 10.1007/978-3-540-79885-9_7; Zhang C, 2005, EXP EYE RES, V81, P700, DOI 10.1016/j.exer.2005.04.008; Zhang Y, 2005, INVEST OPHTH VIS SCI, V46, P2133, DOI 10.1167/iovs.04-1235; ZIAI N, 1994, ARCH OPHTHALMOL-CHIC, V112, P801, DOI 10.1001/archopht.1994.01090180099043	89	23	23	0	8	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	MAY	2015	56	5					2880	2891		10.1167/iovs.14-16070			12	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	CK7UJ	WOS:000356439200013	26024074	Green Published			2022-02-06	
J	Lee, JC; Rittenhouse, K; Bupp, K; Gross, B; Rogers, A; Rogers, FB; Horst, M; Estrella, L; Thurmond, J				Lee, John C.; Rittenhouse, Katelyn; Bupp, Katherine; Gross, Brian; Rogers, Amelia; Rogers, Frederick B.; Horst, Michael; Estrella, Lisa; Thurmond, James			An analysis of Brain Trauma Foundation traumatic brain injury guideline compliance and patient outcome	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury; Mortality; Compliance; Guidelines	CARE	Introduction: Evidence-based guidelines for the care of severe traumatic brain injury have been available from the Brain Trauma Foundation (BTF) since 1995. A total of 15 recommendations compose the current guidelines. Although each individual guideline has been validated in isolation, to date, little research has examined the guidelines in composite. We examined the relationship between compliance with the BTF severe TBI guidelines and mortality. Materials and methods: In a Pennsylvania-verified, mature Level II trauma centre, patients with an admission Glasgow Coma Scale (GCS) <= 8 and an abnormal head CT from 2007 to 2012 were queried from the trauma registry. Exclusion criteria included: patients who sustained a non-survivable injury (AIS head 6), died <= 24 h, and/or were transferred to a paediatric trauma centre. Strict adherence to the BTF guidelines was determined in a binary fashion (yes/no). We then calculated each patient's percent compliance with total number of guidelines. Bivariate analysis was used to find significant predictors of mortality (p < 0.05), including percent BTF guidelines compliance. Significant factors were added to a multivariable logistic regression model to look at mortality rates across the percent compliance spectrum. Results: 185 Patients met inclusion criteria. Percent compliance ranged from 28.6% to 94.4%, (median = 71.4%). Following adjustment for age, AIS head, and GCS motor, patients with 55-75% compliance (AOR: 0.20; 95% CI: 0.06-0.70) and >75% compliance (AOR: 0.27; 95% CI: 0.08-0.94) had reduced odds of mortality, as compared to <55% compliance to the BTF guidelines. When the unadjusted rate of mortality was compared across the compliance spectrum, the odds of mortality decreased as compliance increased until 75%, and then reversed. Conclusion: Our data indicate that full compliance with all 15 severe TBI guidelines is difficult to achieve and may not be necessary to optimally care for patients. (C) 2015 Elsevier Ltd. All rights reserved.	[Lee, John C.; Rittenhouse, Katelyn; Bupp, Katherine; Gross, Brian; Rogers, Amelia; Rogers, Frederick B.; Horst, Michael; Estrella, Lisa; Thurmond, James] Lancaster Gen Hlth, Trauma Serv, Lancaster, PA 17601 USA		Lee, JC (corresponding author), Lancaster Gen Hlth, Trauma Serv, 555 N,Duke St, Lancaster, PA 17601 USA.	jclee@lghealth.org; kr061@lghealth.org; kbupp2@lghealth.org; bg029@lghealth.org; atrogers89@gmail.com; frogers2@lghealth.org; mahorst@lghealth.org; lestrella2@lghealth.org; jthurmond2@lghealth.org					Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Biersteker HAR, 2012, CRIT CARE MED, V40, P1914, DOI 10.1097/CCM.0b013e3182474bde; Brain Injury Association of America, 2014, BRAIN INJ; Brain Trauma Foundation, 2014, HIST BTF; Bulger EM, 2002, NEUROL CRIT CARE, V52, P1202; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Centers for Disease Control and Prevention, 2014, SEV TRAUM BRAIN INJ; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; English SW, 2013, NEUROCRIT CARE, V18, P131, DOI 10.1007/s12028-012-9748-3; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Shafi S, 2014, J NEUROSURG, V120, P773, DOI 10.3171/2013.12.JNS132151; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255	16	23	24	0	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2015	46	5					854	858		10.1016/j.injury.2014.12.023			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	CG2ZJ	WOS:000353144900016	25661105				2022-02-06	
J	Shamloo, A; Manuchehrfar, F; Rafii-Tabar, H				Shamloo, Amir; Manuchehrfar, Farid; Rafii-Tabar, Hashem			A viscoelastic model for axonal microtubule rupture	JOURNAL OF BIOMECHANICS			English	Article						Axon; Microtubule; Rupture; Standard Linear Solid; Viscoelastic	HEAD-INJURY; DYNAMIC INSTABILITY; BRAIN-INJURY; BREAKING	Axon is an important part of the neuronal cells and axonal microtubules are bundles in axons. In axons, microtubules are coated with microtubule-associated protein tau, a natively unfolded filamentous protein in the central nervous system. These proteins are responsible for cross-linking axonal microtubule bundles. Through complimentary dimerization with other tau proteins, bridges are formed between nearby microtubules creating bundles. Formation of bundles of microtubules causes their transverse reinforcement and has been shown to enhance their ability to bear compressive loads. Though microtubules are conventionally regarded as bearing compressive loads, in certain circumstances during traumatic brain injuries, they are placed in tension. In our model, microtubule bundles were formed from a large number of discrete masses. We employed Standard Linear Solid model (SLS), a viscoelastic model, to computationally simulate microtubules. In this study, we investigated the dynamic responses of two dimensional axonal microtubules under suddenly applied end forces by implementing discrete masses connected to their neighboring masses with a Standard Linear Solid unit. We also investigated the effect of the applied force rate and magnitude on the deformation of bundles. Under tension, a microtubule fiber may rupture as a result of a sudden force. Using the developed model, we could predict the critical regions of the axonal microtubule bundles in the presence of varying end forces. We finally analyzed the nature of microtubular failure under varying mechanical stresses. (C) 2015 Elsevier Ltd. All rights reserved.	[Shamloo, Amir; Manuchehrfar, Farid] Sharif Univ Technol, Sch Mech Engn, CEEC, Tehran, Iran; [Shamloo, Amir; Rafii-Tabar, Hashem] Inst Res Fundamental Sci, Tehran, Iran		Shamloo, A (corresponding author), Sharif Univ Technol, Sch Mech Engn, CEEC, POB 11155-9567, Tehran, Iran.	shamloo@sharif.edu		, amir/0000-0002-0131-0567			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; Buxton GA, 2010, PROG NEUROBIOL, V92, P478, DOI 10.1016/j.pneurobio.2010.08.003; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; ERICKSON HP, 1992, ANNU REV BIOPH BIOM, V21, P145, DOI 10.1146/annurev.bb.21.060192.001045; FADIC R, 1985, J COMP NEUROL, V236, P258, DOI 10.1002/cne.902360209; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FLYVBJERG H, 1994, PHYS REV LETT, V73, P2372, DOI 10.1103/PhysRevLett.73.2372; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Kilinc D, 2009, COMPUT METH PROG BIO, V95, P62, DOI 10.1016/j.cmpb.2009.01.002; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; MEANEY DF, 1994, J NEUROTRAUM, V11, P599, DOI 10.1089/neu.1994.11.599; Peter SJ, 2012, BIOPHYS J, V102, P749, DOI 10.1016/j.bpj.2011.11.4024; Sanjith S, 2011, INDIAN J NEUROTRAUM, V8, P71, DOI 10.1016/S0973-0508(11)80003-1; Shahinnejad A, 2013, PROCEDIA ENGINEER, V59, P16, DOI 10.1016/j.proeng.2013.05.088; SHIMA K, 1991, J NEUROSURG, V74, P270, DOI 10.3171/jns.1991.74.2.0270; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Teixeira CA, 2014, NEUROBIOL DIS, V66, P92, DOI 10.1016/j.nbd.2014.02.012; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Yamamoto T, 1988, J NEUROTRAUM, V5, P69, DOI 10.1089/neu.1988.5.69; YU WQ, 1994, J NEUROSCI, V14, P2818	26	23	23	0	10	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	MAY 1	2015	48	7					1241	1247		10.1016/j.jbiomech.2015.03.007			7	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	CH0ZP	WOS:000353751200002	25835789				2022-02-06	
J	Tao, X; Chen, X; Hao, S; Hou, Z; Lu, T; Sun, M; Liu, B				Tao, X.; Chen, X.; Hao, S.; Hou, Z.; Lu, T.; Sun, M.; Liu, B.			PROTECTIVE ACTIONS OF PJ34, A POLY(ADP-RIBOSE)POLYMERASE INHIBITOR, ON THE BLOOD-BRAIN BARRIER AFTER TRAUMATIC BRAIN INJURY IN MICE	NEUROSCIENCE			English	Article						poly(ADP-ribose) polymerase; blood-brain barrier; brain edema; traumatic brain injury; NF-kappa B	FOCAL CEREBRAL-ISCHEMIA; NF-KAPPA-B; CLOSED-HEAD INJURY; CELL-DEATH; SUBARACHNOID HEMORRHAGE; POLYMERASE INHIBITION; EDEMA FORMATION; WHITE-MATTER; RAT-BRAIN; MATRIX-METALLOPROTEINASE-9	Poly(ADP-ribose) polymerase (PARP) is activated by oxidative stress and plays an important role in traumatic brain injury (TBI). The objective of this study was to investigate whether PARP activation participated in the blood-brain barrier (BBB) disruption and edema formation in a mouse model of controlled cortical impact (CCI). N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide (PJ34) (10 mg/kg), a selective PARP inhibitor, was administered intraperitoneally at 5 min and 8 h after experimental CCI. After 6 h and 24 h of CCI, the permeability of the cortical BBB was determined after Evans Blue administration. The water content of the brain was also measured. Treatment with PJ34 markedly attenuated the permeability of the BBB and decreased the brain edema at 6 h and 24 h after CCI. Our data showed the up-regulation of nuclear factor-kappa B in cytosolic fractions and nuclear fractions in the injured cortex, and these changes were reversed by PJ34. Moreover, PJ34 significantly lessened the activities of myeloperoxidase and the levels of matrix metalloproteinase-9, enhanced the levels of occludin, laminin, collagen IV and integrin beta 1, reduced neurological deficits, decreased the contusion volume, and attenuated the necrotic and apoptotic neuronal cell death. These data suggest the protective effects of PJ34 on BBB integrity and cell death during acute TBI. (C) 2015 IBRO. Published by Elsevier Ltd. All rights reserved.	[Tao, X.; Chen, X.; Hao, S.; Hou, Z.; Lu, T.; Liu, B.] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing 100050, Peoples R China; [Liu, B.] Capital Med Univ, Dept Neurotrauma, Beijing Neurosurg Inst, Beijing 100050, Peoples R China; [Sun, M.] Capital Med Univ, Dept Neuropharmacol, Beijing Neurosurg Inst, Beijing 100050, Peoples R China; [Liu, B.] Nerve Injury & Repair Ctr Beijing Inst Brain Diso, Beijing 100050, Peoples R China; [Liu, B.] Gen Hosp Armed Police Forces, Dept Neurotrauma, Beijing 100039, Peoples R China; [Liu, B.] China Natl Clin Res Ctr Neurol Dis Beijing, Beijing 100050, Peoples R China; [Liu, B.] Beijing Key Lab Cent Nervous Syst Injury, Beijing 100050, Peoples R China		Sun, M (corresponding author), Capital Med Univ, Dept Neuropharmacol, Beijing Neurosurg Inst, 6 Tiantan Xili, Beijing 100050, Peoples R China.	sunming999@yahoo.com; liubaiyun1963@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171144]	This work was supported by research grants from the National Natural Science Foundation of China (No. 81171144).	Akamatsu Y, 2011, NEUROSCI LETT, V503, P110, DOI 10.1016/j.neulet.2011.08.018; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Biber N, 2009, BRAIN INJURY, V23, P577, DOI 10.1080/02699050902926317; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Chang WJ, 2001, J BIOL CHEM, V276, P47664, DOI 10.1074/jbc.M104666200; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030294; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Chiarugi A, 2003, J NEUROCHEM, V85, P306, DOI 10.1046/j.1471-4159.2003.01684.x; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gidday JM, 2005, AM J PHYSIOL-HEART C, V289, pH558, DOI 10.1152/ajpheart.01275.2004; Glushakov AV, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-132; Ha HC, 2002, P NATL ACAD SCI USA, V99, P3270, DOI 10.1073/pnas.052712399; Haddad M, 2006, BRIT J PHARMACOL, V149, P23, DOI 10.1038/sj.bjp.0706837; Haddad M, 2008, EUR J PHARMACOL, V588, P52, DOI 10.1016/j.ejphar.2008.04.013; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hosomi N, 2005, J CEREBR BLOOD F MET, V25, P959, DOI 10.1038/sj.jcbfm.9600086; Kauppinen UM, 2005, J IMMUNOL, V174, P2288, DOI 10.4049/jimmunol.174.4.2288; Koedel U, 2002, J CEREBR BLOOD F MET, V22, P39, DOI 10.1097/00004647-200201000-00005; Koh SH, 2004, EUR J NEUROSCI, V20, P1461, DOI 10.1111/j.1460-9568.2004.03632.x; Komjati K, 2004, INT J MOL MED, V13, P373; Krizbai IA, 2005, SHOCK, V24, P428, DOI 10.1097/01.shk.0000183389.98519.d3; Lenzser G, 2007, J CEREBR BLOOD F MET, V27, P1318, DOI 10.1038/sj.jcbfm.9600437; Lescot T, 2010, J NEUROTRAUM, V27, P1069, DOI 10.1089/neu.2009.1188; Li PY, 2014, STROKE, V45, P857, DOI 10.1161/STROKEAHA.113.004100; Lian H, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-47; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; Lin Y, 2012, LAB INVEST, V92, P1623, DOI 10.1038/labinvest.2012.118; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Moroni F, 2008, CURR OPIN PHARMACOL, V8, P96, DOI 10.1016/j.coph.2007.10.005; Pacher P, 2005, ANTIOXID REDOX SIGN, V7, P1568, DOI 10.1089/ars.2005.7.1568; Park EM, 2004, STROKE, V35, P2896, DOI 10.1161/01.STR.0000147042.53659.6c; Romero IA, 2003, NEUROSCI LETT, V344, P112, DOI 10.1016/S0304-3940(03)00348-3; Rosenberg GA, 2002, NEUROSCIENTIST, V8, P586, DOI 10.1177/1073858402238517; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Satchell MA, 2003, J NEUROCHEM, V85, P697, DOI 10.1046/j.1471-4159.2003.01707.x; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Sehba FA, 2004, J NEUROSURG, V101, P633, DOI 10.3171/jns.2004.101.4.0633; Solaroglu I, 2006, NEUROSCIENCE, V143, P965, DOI 10.1016/j.neuroscience.2006.09.014; Sozen T, 2009, STROKE, V40, P2519, DOI 10.1161/STROKEAHA.109.549592; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stoica BA, 2014, J NEUROTRAUM, V31, P758, DOI 10.1089/neu.2013.3194; Sun M, 2008, CELL MOL NEUROBIOL, V28, P593, DOI 10.1007/s10571-007-9183-8; Switzer JA, 2011, STROKE, V42, P2633, DOI 10.1161/STROKEAHA.111.618215; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375	52	23	25	0	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	APR 16	2015	291						26	36		10.1016/j.neuroscience.2015.01.070			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CD7VN	WOS:000351303100003	25668593				2022-02-06	
J	Xydakis, MS; Mulligan, LP; Smith, AB; Olsen, CH; Lyon, DM; Belluscio, L				Xydakis, Michael S.; Mulligan, Lisa P.; Smith, Alice B.; Olsen, Cara H.; Lyon, Dina M.; Belluscio, Leonardo			Olfactory impairment and traumatic brain injury in blast-injured combat troops A cohort study	NEUROLOGY			English	Article							HEAD-INJURY; DYSFUNCTION; DEFICITS; MILD; TOMOGRAPHY; DEMENTIA; ANOSMIA; IMPACT; DAMAGE	Objective: To determine whether a structured and quantitative assessment of differential olfactory performance-recognized between a blast-injured traumatic brain injury (TBI) group and a demographically comparable blast-injured control group-can serve as a reliable antecedent marker for preclinical detection of intracranial neurotrauma. Methods: We prospectively and consecutively enrolled 231 polytrauma inpatients, acutely injured from explosions during combat operations in either Afghanistan or Iraq and requiring immediate stateside evacuation and sequential admission to our tertiary care medical center over a 21/2-year period. This study correlates olfactometric scores with both contemporaneous neuroimaging findings as well as the clinical diagnosis of TBI, tabulates population-specific incidence data, and investigates return of olfactory function. Results: Olfactometric score predicted abnormal neuroimaging significantly better than chance alone (area under the curve = 0.78, 95% confidence interval [CI] 0.70-0.87). Normosmia was present in all troops with mild TBI (i. e., concussion) and all control subjects. Troops with radiographic evidence of frontal lobe injuries were 3 times more likely to have olfactory impairment than troops with injuries to other brain regions (relative risk 3.0, 95% CI 0.98-9.14). Normalization of scores occurred in all anosmic troops available for follow-up testing. Conclusion: Quantitative identification olfactometry has limited sensitivity but high specificity as a marker for detecting acute structural neuropathology from trauma. When considering whether to order advanced neuroimaging, a functional disturbance with central olfactory impairment should be regarded as an important tool to inform the decision process. Classification of evidence: This study provides Class III evidence that central olfactory dysfunction identifies patients with TBI who have intracranial radiographic abnormalities with a sensitivity of 35% (95% CI 20.6%-51.7%) and specificity of 100% (95% CI 97.7%-100.0%).	[Xydakis, Michael S.] Walter Reed Natl Mil Med Ctr, Otorhinolaryngol Head & Neck Surg, Bethesda, MD 20889 USA; [Mulligan, Lisa P.] Walter Reed Natl Mil Med Ctr, Neurosurg, Bethesda, MD USA; [Smith, Alice B.] Walter Reed Natl Mil Med Ctr, Neuroradiol, Bethesda, MD USA; [Xydakis, Michael S.; Mulligan, Lisa P.; Lyon, Dina M.] Uniformed Serv Univ Hlth Sci, Traumat Brain Injury Surg Res Program, Bethesda, MD 20814 USA; [Xydakis, Michael S.] Uniformed Serv Univ Hlth Sci, Otorhinolaryngol Head & Neck Surg, Bethesda, MD 20814 USA; [Mulligan, Lisa P.] Uniformed Serv Univ Hlth Sci, Neurosurg, Bethesda, MD 20814 USA; [Smith, Alice B.] Uniformed Serv Univ Hlth Sci, Neuroradiol, Bethesda, MD 20814 USA; [Olsen, Cara H.] Uniformed Serv Univ Hlth Sci, Prevent Med & Biostat, Bethesda, MD 20814 USA; [Xydakis, Michael S.; Mulligan, Lisa P.; Smith, Alice B.; Lyon, Dina M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Belluscio, Leonardo] NIH, Neurol Disorders & Stroke, Bethesda, MD 20892 USA		Xydakis, MS (corresponding author), Walter Reed Natl Mil Med Ctr, Otorhinolaryngol Head & Neck Surg, Bethesda, MD 20889 USA.	michael.xydakis@usuhs.edu			US Department of Defense Combat Casualty Care Medical Research and Development Program [DMRDP: ID-D10-I-AR-J6-626]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS003116] Funding Source: NIH RePORTER	US Department of Defense Combat Casualty Care Medical Research and Development Program (DMRDP: ID-D10-I-AR-J6-626).	ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Berendse HW, 2001, ANN NEUROL, V50, P34, DOI 10.1002/ana.1049; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Charland-Verville V, 2012, AM J RHINOL ALLERGY, V26, P222, DOI 10.2500/ajra.2012.26.3769; de Kruijk JR, 2003, BRAIN INJURY, V17, P73, DOI 10.1080/0269905021000010221; Defense and Veterans Brain Injury Center, 2013, VA DOD CLIN PRACT GU; Department of Defense, 2012, DOD POL GUID MAN MIL; Devanand DP, 2015, NEUROLOGY, V84, P182, DOI 10.1212/WNL.0000000000001132; Doty RL, 1995, CHEM SENSES, V20, P645, DOI 10.1093/chemse/20.6.645; Coello AF, 2010, J NEUROSURG, V113, P547, DOI 10.3171/2010.6.JNS091620; Fortin A, 2010, BRAIN INJURY, V24, P27, DOI 10.3109/02699050903446815; Green P, 2003, BRAIN INJURY, V17, P479, DOI 10.1080/0269905031000070242; Gudziol V, 2014, EUR ARCH OTO-RHINO-L, V271, P1533, DOI 10.1007/s00405-013-2687-6; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Heyanka DJ, 2014, APPL NEUROPSYCH-ADUL, V21, P176, DOI 10.1080/09084282.2013.782031; JAFEK BW, 1989, ARCH NEUROL-CHICAGO, V46, P300, DOI 10.1001/archneur.1989.00520390066018; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kern RC, 2000, LARYNGOSCOPE, V110, P2106, DOI 10.1097/00005537-200012000-00025; LEVIN HS, 1985, BRAIN, V108, P579, DOI 10.1093/brain/108.3.579; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Maruta J, 2014, MIL MED, V179, P619, DOI 10.7205/MILMED-D-13-00420; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Murphy C, 2002, JAMA-J AM MED ASSOC, V288, P2307, DOI 10.1001/jama.288.18.2307; POTTER H, 1980, NEUROPSYCHOLOGIA, V18, P621, DOI 10.1016/0028-3932(80)90101-3; Riechers RG, 2005, J NEUROTRAUM, V22, P1327, DOI 10.1089/neu.2005.22.1327; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rolet A, 2013, EUR NEUROL, V69, P166, DOI 10.1159/000345482; Ruff RL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000312; Sandford AA, 2006, INT J PEDIATR OTORHI, V70, P1015, DOI 10.1016/j.ijporl.2005.10.013; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; USAISR, JOINT TRAUM SYST PRA; Vent J, 2010, BRAIN RES, V1320, P1, DOI 10.1016/j.brainres.2010.01.007; Wilson DA, 2003, TRENDS NEUROSCI, V26, P243, DOI 10.1016/S0166-2236(03)00076-6; Xydakis MS, 2007, NEW ENGL J MED, V357, P830, DOI 10.1056/NEJMc076071; Xydakis MS, 2013, ANN NEUROL, V74, P152, DOI 10.1002/ana.23895; Xydakis MS, 2012, ANN NEUROL, V72, P673, DOI 10.1002/ana.23757	40	23	24	2	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	APR 14	2015	84	15					1559	1567		10.1212/WNL.0000000000001475			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CG1OH	WOS:000353042100012	25788559	Green Published, hybrid			2022-02-06	
J	Iordens, GIT; Den Hartog, D; Van Lieshout, EMM; Tuinebreijer, WE; De Haan, J; Patka, P; Verhofstad, MHJ; Schep, NWL				Iordens, Gijs I. T.; Den Hartog, Dennis; Van Lieshout, Esther M. M.; Tuinebreijer, Wim E.; De Haan, Jeroen; Patka, Peter; Verhofstad, Michael H. J.; Schep, Niels W. L.		Dutch Elbow Collaborative	Good Functional Recovery of Complex Elbow Dislocations Treated With Hinged External Fixation: A Multicenter Prospective Study	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							ULNAR COLLATERAL LIGAMENT; FRACTURE-DISLOCATIONS; RADIAL HEAD; CORONOID FRACTURES; PRIMARY REPAIR; INSTABILITY; MANAGEMENT; INJURIES; JOINT; COMPLICATIONS	After a complex dislocation, some elbows remain unstable after closed reduction or fracture treatment. Function after treatment with a hinged external fixator theoretically allows collateral ligaments to heal without surgical reconstruction. However, there is a lack of prospective studies that assess functional outcome, pain, and ROM. We asked: (1) In complex elbow fracture-dislocations, does treatment with a hinged external fixator result in reduction of disability and pain, and in improvement in ROM, function, and quality of life? (2) Does delayed treatment (7 days or later) have a negative effect on ROM after 1 year? (3) What are the complications seen after external fixator treatment? During a 2-year period, 11 centers recruited 27 patients 18 years or older who were included and evaluated at 2 and 6 weeks and at 3, 6, and 12 months after surgery as part of this prospective case series. During the study period, the participating centers agreed on general indications for use of the hinged external fixator, which included persistent instability after closed reduction alone or closed reduction combined with surgical treatment of associated fracture(s), when indicated. Functional outcome was evaluated using the Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH; primary outcome) score, the Mayo Elbow Performance Index (MEPI), the Oxford Elbow Score, and the level of pain (VAS). ROM, adverse events, secondary interventions, and radiographs also were evaluated. A total of 26 of the 27 patients (96%) were available for followup at 1 year. All functional and pain scores improved. The median QuickDASH score decreased from 30 (25(th)-75(th) percentiles [P-25-P-75], 23-40) at 6 weeks to 7 (P-25-P-75, 2-12) at 1 year with a median difference of -25 (p < 0.001). The median MEPI score increased from 80 (P-25-P-75, 64-85) at 6 weeks to 100 (P-25-P-75, 85-100) at 1 year with a median difference of 15 (p < 0.001). The median Oxford Elbow Score increased from 60 (P-25-P-75, 44-68) at 6 weeks to 90 (P-25-P-75, 73-96) at 1 year with a median difference of 29 (p < 0.001). The median VAS decreased from 2.8 (P-25-P-75, 1.0-5.0) at 2 weeks to 0.5 (P-25-P-75, 0.0-1.9) at 1 year with a median difference of -2.1 (p = 0.001). ROM also improved. The median flexion-extension arc improved from 50A degrees (P-25-P-75, 33A degrees-80A degrees) at 2 weeks to 118A degrees (P-25-P-75, 105A degrees-138A degrees) at 1 year with a median difference of 63A degrees (p < 0.001). Similarly, the median pronation-supination arc improved from 90A degrees (P-25-P-75, 63A degrees-124A degrees) to 160A degrees (P-25-P-75, 138A degrees-170A degrees) with a median difference of 75A degrees (p < 0.001). At 1 year, the median residual deficit compared with the uninjured side was 30A degrees (P-25-P-75, 5A degrees-35A degrees) for the flexion-extension arc, and 3A degrees (P-25-P-75, 0A degrees-25A degrees) for the pronation-supination arc. Ten patients (37%) experienced a fixator-related complication, and seven patients required secondary surgery (26%). One patient reported recurrent instability. A hinged external elbow fixator provides enough stability to start early mobilization after an acute complex elbow dislocation and residual instability. This was reflected in good functional outcome scores and only slight disability despite a relatively high complication rate. Level IV, therapeutic study.	[Iordens, Gijs I. T.; Den Hartog, Dennis; Van Lieshout, Esther M. M.; Tuinebreijer, Wim E.; Patka, Peter; Verhofstad, Michael H. J.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Surg, Trauma Res Unit, NL-3000 CA Rotterdam, Netherlands; [De Haan, Jeroen] Westfriesgasthuis, Dept Surg, Hoorn, Netherlands; [Schep, Niels W. L.] Univ Amsterdam, Acad Med Ctr, Dept Surg, Trauma Unit, NL-1105 AZ Amsterdam, Netherlands		Den Hartog, D (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Surg, Trauma Res Unit, POB 2040, NL-3000 CA Rotterdam, Netherlands.	d.denhartog@erasmusmc.nl			Osteosynthesis and Trauma Care (OTC) Foundation (Zuchwil, Switzerland) [2009-NSPP]; Orthofix SRL (Bussolengo, Italy)	The institution of one or more of the authors (GITI, DDH, EMMVL, PP, MHJV) has received, during the study period, funding from the Osteosynthesis and Trauma Care (OTC) Foundation (Zuchwil, Switzerland) (No. 2009-NSPP) and from Orthofix SRL (Bussolengo, Italy).	Anakwe RE, 2011, J BONE JOINT SURG AM, V93A, P1220, DOI 10.2106/JBJS.J.00860; Beaton D E, 2001, J Hand Ther, V14, P128; Cheung EV, 2008, J SHOULDER ELB SURG, V17, P447, DOI 10.1016/j.jse.2007.10.006; Dawson J, 2008, J BONE JOINT SURG BR, V90B, P466, DOI 10.1302/0301-620X.90B4.20290; Duckworth AD, 2008, J SHOULDER ELB SURG, V17, P281, DOI 10.1016/j.jse.2007.06.007; Egol KA, 2007, BULL HOSP JT DIS, V65, P263; Floor S, 2006, Ned Tijdschr Geneeskd, V150, P1724; Forthman C, 2007, J HAND SURG-AM, V32A, P1200, DOI 10.1016/j.jhsa.2007.06.019; Foruria Antonio M, 2013, J Bone Joint Surg Am, V95, pe66, DOI 10.2106/JBJS.K.01533; Garrigues GE, 2011, J BONE JOINT SURG AM, V93A, P1873, DOI 10.2106/JBJS.I.01673; HEFTI F, 1995, ORTHOPADE, V24, P237; Hudak PL, 1996, AM J IND MED, V29, P602, DOI 10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L; Ivo R, 2009, STRATEG TRAUMA LIMB, V4, P49, DOI 10.1007/s11751-009-0064-1; JOHNSTON G W, 1962, Ulster Med J, V31, P51; JOSEFSSON PO, 1987, J BONE JOINT SURG AM, V69A, P605, DOI 10.2106/00004623-198769040-00018; Jupiter JB, 2002, J BONE JOINT SURG AM, V84A, P1630, DOI 10.2106/00004623-200209000-00017; Maripuri SN, 2007, INJURY, V38, P1254, DOI 10.1016/j.injury.2007.02.040; McKee MD, 1998, J BONE JOINT SURG BR, V80B, P1031, DOI 10.1302/0301-620X.80B6.8536; McKee Michael D, 2005, J Bone Joint Surg Am, V87 Suppl 1, P22, DOI 10.2106/JBJS.D.02933; MEHLHOFF TL, 1988, J BONE JOINT SURG AM, V70A, P244, DOI 10.2106/00004623-198870020-00013; MORREY BF, 1981, J BONE JOINT SURG AM, V63, P872, DOI 10.2106/00004623-198163060-00002; MORREY BF, 1995, J BONE JOINT SURG AM, V77A, P316, DOI 10.2106/00004623-199502000-00019; Morrey BF, ELBOW ITS DISORDERS, P2; Mughal M, 2013, J HAND SURG-EUR VOL, V38, P686, DOI 10.1177/1753193412449579; ODRISCOLL SW, 1991, J BONE JOINT SURG AM, V73A, P440, DOI 10.2106/00004623-199173030-00015; Pollock JW, 2009, J SHOULDER ELB SURG, V18, P408, DOI 10.1016/j.jse.2009.01.009; PROTZMAN RR, 1978, J BONE JOINT SURG AM, V60, P539, DOI 10.2106/00004623-197860040-00019; Pugh DMW, 2004, J BONE JOINT SURG AM, V86A, P1122, DOI 10.2106/00004623-200406000-00002; Rafai M, 1999, Chir Main, V18, P272; REGAN W, 1989, J BONE JOINT SURG AM, V71A, P1348, DOI 10.2106/00004623-198971090-00011; Ring D, 2002, J BONE JOINT SURG AM, V84A, P547, DOI 10.2106/00004623-200204000-00006; Ring D, 2004, J HAND SURG-AM, V29A, P470, DOI 10.1016/j.jhsa.2004.01.005; Ring D, 2014, CLIN ORTHOP RELAT R, V472, P2044, DOI 10.1007/s11999-014-3510-4; Ruch D S, 2001, Injury, V32 Suppl 4, pSD70; Savoie FH, 2008, AM J SPORT MED, V36, P1066, DOI 10.1177/0363546508315201; Schep NWL, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-130; Schippinger G, 1999, LANGENBECK ARCH SURG, V384, P294, DOI 10.1007/s004230050206; Sorensen AKB, 2011, J SHOULDER ELB SURG, V20, P1300, DOI 10.1016/j.jse.2011.06.002; Stavlas P, 2004, INJURY, V35, P1158, DOI 10.1016/j.injury.2003.09.002; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Yu JR, 2007, J SHOULDER ELB SURG, V16, P60, DOI 10.1016/j.jse.2006.01.008; Zeiders GJ, 2008, J BONE JOINT SURG AM, V90A, P75, DOI 10.2106/JBJS.H.00893	42	23	26	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	APR	2015	473	4					1451	1461		10.1007/s11999-014-3959-1			11	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	CD2DY	WOS:000350885600041	25352259	Green Published, Green Submitted			2022-02-06	
J	Kelly, ML; Banerjee, A; Nowak, M; Steinmetz, M; Claridge, JA				Kelly, Michael L.; Banerjee, Aman; Nowak, Michael; Steinmetz, Michael; Claridge, Jeffrey A.			Decreased mortality in traumatic brain injury following regionalization across hospital systems	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	73rd Annual Meeting of the American-Association-for-the-Surgery-of-Trauma / Clinical Congress of Acute Care Surgery	SEP 09-13, 2014	Philadelphia, PA	Amer Assoc Surg Trauma		Traumatic brain injury; regionalization; health systems; outcomes; mortality	UNITED-STATES; HEAD-INJURY; LEVEL I; CARE; OUTCOMES; ADMISSION; TRENDS; IMPACT	BACKGROUND: The Northern Ohio Trauma System (NOTS) was established to improve outcomes of trauma patients across the region. We hypothesized that mortality in patients with traumatic brain injury (TBI) would improve after regionalization. METHODS: All patients older than 14 years with a TBI were identified from NOTS, a regional trauma system consisting of two large health care systems and regional emergency medical services providers. Data from 2008 through 2012 were analyzed before and after NOTS formation in 2010. Multivariate logistic regression analysis was performed to evaluate independent predictors of survival. RESULTS: A total of 11,220 patients were identified with TBI in the NOTS database, 4,507 (40%) before NOTS and 6,713 (60%) after NOTS formation. Admissions to the regional Level 1 center post-NOTS formation increased from 36% to 46% (p < 0.0001). Injury Severity Scores (ISSs) and Abbreviated Injury Scale (AIS) scores were similar between periods. The mortality rate decreased from 6.2% to 4.9% (p = 0.005) among all TBIs and from 19% to 14% (p < 0.0001) in TBIs with a head AIS score of 3 or greater (n = 3,538). Craniotomy procedures increased from 1.8% to 2.7% (p = 0.003) overall and from 5.9% to 8.1% (p = 0.02) in TBIs with head AIS score of 3 or greater. Logistic regression analysis demonstrated an independent effect on survival for post-NOTS period in all patients (odds ratio, 0.76; 95% confidence interval, 0.62-0.94; C statistic = 0.96) and in TBIs with head AIS score of 3 or greater (odds ratio, 0.72; 95% confidence interval, 0.58-0.89; C statistic = 0.86). CONCLUSION: Regionalization of trauma care across hospital systems is associated with a reduced mortality rate for patients with TBI, particularly for patients with a head AIS score of 3 or greater. Mortality decreased by 24% for all TBIs and by 28% for severe TBIs. These findings support regionalization of trauma care with collaboration and consolidation of care across health care systems. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.	[Kelly, Michael L.] Cleveland Clin, Dept Neurosurg, Neurol Inst, Cleveland, OH 44106 USA; [Steinmetz, Michael] Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH 44109 USA; [Banerjee, Aman; Nowak, Michael; Claridge, Jeffrey A.] Case Western Reserve Univ, Sch Med, Metrohlth Med Ctr, Cleveland, OH 44109 USA; [Banerjee, Aman; Nowak, Michael; Claridge, Jeffrey A.] Case Western Reserve Univ, Sch Med, Northern Ohio Trauma Syst, Cleveland, OH 44109 USA; [Banerjee, Aman; Nowak, Michael; Claridge, Jeffrey A.] Case Western Reserve Univ, Sch Med, Dept Surg, Cleveland, OH 44109 USA		Claridge, JA (corresponding author), Case Western Reserve Univ, Sch Med, Metrohlth Med Ctr, Northern Ohio Trauma Syst,Dept Surg, Cleveland, OH 44109 USA.	jclaridge@metrohealth.org					[Anonymous], 2010, OH TRAUM REG ANN DAT; Bailey J, 2012, SURG CLIN N AM, V92, P1009, DOI 10.1016/j.suc.2012.04.008; Claridge JA, 2013, SURGERY, V154, P875, DOI 10.1016/j.surg.2013.07.013; Farhad K, 2013, J NEUROTRAUM, V30, P84, DOI 10.1089/neu.2011.2283; Gabbe BJ, 2012, ANN SURG, V255, P1009, DOI 10.1097/SLA.0b013e31824c4b91; Gabbe BJ, 2011, ANN SURG, V253, P138, DOI 10.1097/SLA.0b013e3181f6685b; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Moore L, 2010, WORLD J SURG, V34, P2069, DOI 10.1007/s00268-010-0588-z; MULLINS RJ, 1994, JAMA-J AM MED ASSOC, V271, P1919, DOI 10.1001/jama.271.24.1919; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Rivara FP, 2008, J TRAUMA, V64, P1594, DOI 10.1097/TA.0b013e3181493099; STONE JL, 1986, J TRAUMA, V26, P445, DOI 10.1097/00005373-198605000-00006; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675; Tiesman H, 2007, J NEUROTRAUM, V24, P1189, DOI 10.1089/neu.2006.0196; TRUNKEY D, 1995, JAMA-J AM MED ASSOC, V273, P421, DOI 10.1001/jama.273.5.421; Twijnstra MJ, 2010, ANN SURG, V251, P339, DOI 10.1097/SLA.0b013e3181c0e910	17	23	23	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	APR	2015	78	4					715	720		10.1097/TA.0000000000000590			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	CE8EJ	WOS:000352074000009	25807401				2022-02-06	
J	Wiley, CA; Bonneh-Barkay, D; Dixon, CE; Lesniak, A; Wang, GJ; Bissel, SJ; Kochanek, PM				Wiley, Clayton A.; Bonneh-Barkay, Dafna; Dixon, C. Edward; Lesniak, Andrew; Wang, Guoji; Bissel, Stephanie J.; Kochanek, Patrick M.			Role for mammalian chitinase 3-like protein 1 in traumatic brain injury	NEUROPATHOLOGY			English	Article						BRP-39; chitinase 3-like protein 1; controlled cortical impact; neuroinflammation; traumatic brain injury	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; REACTIVE ASTROCYTES; TRANSGENIC INHIBITION; YKL-40 EXPRESSION; INFLAMMATION; TISSUE; DEGENERATION; MICE; EVOLUTION; CHI3L1	Traumatic brain injury (TBI) is accompanied by inflammatory infiltrates and CNS tissue response. The astrocytosis associated with TBI has been proposed to have both beneficial and detrimental effects on surviving neural tissue. We recently observed prominent astrocytic expression of YKL-40/chitinase 3-like protein 1 (CHI3L1) associated with severity of brain injury. The physiological role of CHI3L1 in the CNS is unknown; however, its distribution at the perimeter of contusions and temporal course of expression suggested that in TBI it might be an important component of the astrocytic response to modulate CNS inflammation. To address this hypothesis, we used serially sectioned brains to quantitatively compare the neuropathological outcomes of TBI produced by controlled cortical impact in wild type (WT) and chi3l1 knockout (KO) mice where the murine YKL-40 homologue, breast regression protein 39 (BRP-39/CHI3l1), had been homozygously disrupted. At 21 days post-injury, chi3l1KO mice displayed greater astrocytosis (increased GFAP staining) in the hemispheres ipsilateral and contralateral to impact compared with WT mice. Similarly, Iba1 expression as a measure of microglial/macrophage response was significantly increased in chi3l1KO compared with WT in the hemisphere contralateral to impact. We conclude that astrocytic expression of CHI3L1 limits the extent of both astrocytic and microglial/macrophage facets of neuroinflammation and suggests a novel potential therapeutic target for modulating neuroinflammation.	[Wiley, Clayton A.; Bonneh-Barkay, Dafna; Lesniak, Andrew; Wang, Guoji; Bissel, Stephanie J.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA; [Dixon, C. Edward] Univ Pittsburgh, VA Pittsburgh Healthcare Syst, Dept Neurosurg Anesthesiol, Pittsburgh, PA 15213 USA; [Dixon, C. Edward] Univ Pittsburgh, VA Pittsburgh Healthcare Syst, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Dixon, C. Edward] Univ Pittsburgh, VA Pittsburgh Healthcare Syst, Dept Crit Care Med, Pittsburgh, PA 15213 USA; [Dixon, C. Edward] Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Neurosurg Anesthesiol, Pittsburgh, PA 15213 USA; [Dixon, C. Edward] Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Dixon, C. Edward; Kochanek, Patrick M.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Crit Care Med, Pittsburgh, PA 15213 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Anesthesiol & Pediat, Pittsburgh, PA 15213 USA		Wiley, CA (corresponding author), Univ Pittsburgh, Dept Pathol, S701 Scaife Hall 200 Lothrop, Pittsburgh, PA 15213 USA.	wiley1@pitt.edu	Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X	NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 070003, NS079061, NS 30318, K24 MH01717]; Pittsburgh Foundation Emmerling funds	We thank Mark Stauffer, Arlene Carbone-Wiley and Advait Salgarkar for valuable technical assistance. This work was supported, partly by funds from NIH NINDS NS 070003 to PMK; NS079061 to CED; NS 30318 to CED and PMK; K24 MH01717 to CAW, and Pittsburgh Foundation Emmerling funds to DB-B.	Bonneh-Barkay D, 2008, AM J PATHOL, V173, P130, DOI 10.2353/ajpath.2008.080045; Bonneh-Barkay D, 2012, J NEUROPATH EXP NEUR, V71, P948, DOI 10.1097/NEN.0b013e31826eaee7; Bonneh-Barkay D, 2010, J NEUROTRAUM, V27, P1215, DOI 10.1089/neu.2010.1310; Bonneh-Barkay D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-34; Brambilla R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-213; Brambilla R, 2009, J IMMUNOL, V182, P2628, DOI 10.4049/jimmunol.0802954; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Bussink AP, 2007, GENETICS, V177, P959, DOI 10.1534/genetics.107.075846; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; DEOLMOS JS, 1994, NEUROTOXICOL TERATOL, V16, P545, DOI 10.1016/0892-0362(94)90033-7; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Foley LM, 2009, J NEUROTRAUM, V26, P1509, DOI 10.1089/neu.2008.0747; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Haroon F, 2011, J IMMUNOL, V186, P6521, DOI 10.4049/jimmunol.1001135; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Hoffman GE, 2004, PEPTIDES, V25, P425, DOI 10.1016/j.peptides.2004.02.004; Isse K, 2012, AM J TRANSPLANT, V12, P27, DOI 10.1111/j.1600-6143.2011.03797.x; Johansen JS, 2006, DAN MED BULL, V53, P172; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kirkpatrick RB, 1997, EXP CELL RES, V237, P46, DOI 10.1006/excr.1997.3764; Kochanek PM, 2006, J CEREBR BLOOD F MET, V26, P565, DOI 10.1038/sj.jcbfm.9600218; Kular L, 2011, BIOCHIMIE, V93, P377, DOI 10.1016/j.biochi.2010.11.010; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Lee CG, 2009, J EXP MED, V206, P1149, DOI 10.1084/jem.20081271; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Ober C, 2009, CURR OPIN ALLERGY CL, V9, P401, DOI 10.1097/ACI.0b013e3283306533; Rehli M, 2003, J BIOL CHEM, V278, P44058, DOI 10.1074/jbc.M306792200; Rhodes J, 2011, CURR OPIN CRIT CARE, V17, P122, DOI 10.1097/MCC.0b013e3283447948; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Switzer RC, 2000, TOXICOL PATHOL, V28, P70, DOI 10.1177/019262330002800109; Tehranian R, 2006, BRAIN RES, V1101, P126, DOI 10.1016/j.brainres.2006.05.049; Voskuhl RR, 2009, J NEUROSCI, V29, P11511, DOI 10.1523/JNEUROSCI.1514-09.2009	38	23	24	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	APR	2015	35	2					95	106		10.1111/neup.12158			12	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	CF5WV	WOS:000352628900001	25377763				2022-02-06	
J	Dickert, NW; Scicluna, VM; Baren, JM; Biros, MH; Fleischman, RJ; Govindarajan, PR; Jones, EB; Pancioli, AM; Wright, DW; Pentz, RD				Dickert, Neal W.; Scicluna, Victoria M.; Baren, Jill M.; Biros, Michelle H.; Fleischman, Ross J.; Govindarajan, Prasanthi R.; Jones, Elizabeth B.; Pancioli, Arthur M.; Wright, David W.; Pentz, Rebecca D.			Patients' Perspectives of Enrollment in Research Without Consent: The Patients' Experiences in Emergency Research-Progesterone for the Treatment of Traumatic Brain Injury Study	CRITICAL CARE MEDICINE			English	Article						acute care research; bioethics; emergency research; informed consent; research ethics; traumatic brain injury	RANDOMIZED CONTROLLED-TRIAL; INFORMED-CONSENT; COMMUNITY CONSULTATION; RANDOM ALLOCATION; EXCEPTION; RESUSCITATION; PERCEPTIONS; SETTINGS; MEDICINE; CARE	Objective: Research in acute illness often requires an exception from informed consent. Few studies have assessed the views of patients enrolled in exception from informed consent trials. This study was designed to assess the views of patients and their surrogates of exception from informed consent enrollment within the context of a randomized, placebo-controlled trial of an investigational agent for traumatic brain injury. Design: Interactive interview study. Setting: Nested within the Progesterone for the Treatment of Traumatic Brain Injury trial, a Phase III randomized controlled trial in acute traumatic brain injury. Subjects: Patients and surrogates (for patients incapable of being interviewed) enrolled in Progesterone for the Treatment of Traumatic Brain Injury under exception from informed consent at 12 sites. Interventions: None. Measurements and Main Results: Interviews focused on respondents' acceptance of exception from informed consent enrollment in Progesterone for the Treatment of Traumatic Brain Injury, use of placebo and randomization, understanding of major study elements, and views regarding regulatory protections. Descriptive statistical analysis was performed; textual data were analyzed thematically. Eighty-five individuals were interviewed. Eighty-four percent had positive attitudes toward Progesterone for the Treatment of Traumatic Brain Injury inclusion. Seventy-eight percent found their inclusion under exception from informed consent acceptable, and 72% found use of exception from informed consent in Progesterone for the Treatment of Traumatic Brain Injury acceptable in general. Only two respondents clearly disagreed with both personal and general exception from informed consent enrollment. The most common concerns (26%) related to absence of consent. Eighty percent and 92% were accepting of placebo use and randomization, respectively. Although there were few black respondents (n = 11), they were less accepting of personal exception from informed consent enrollment than white respondents (55% vs 83%; p= 0.0494). Conclusions: Acceptance of exception from informed consent in this placebo-controlled trial of an investigational agent was high and exceeded acceptance among community consultation participants. Exception from informed consent enrollment appears generally consistent with patients' preferences.	[Dickert, Neal W.; Scicluna, Victoria M.] Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA 30322 USA; [Dickert, Neal W.] Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA USA; [Dickert, Neal W.] Atlanta VA Med Ctr, Atlanta, GA USA; [Baren, Jill M.] Univ Penn, Perelman Sch Med, Dept Emergency Med, Philadelphia, PA 19104 USA; [Biros, Michelle H.] Hennepin Cty Med Ctr, Dept Emergency Med, Minneapolis, MN 55415 USA; [Biros, Michelle H.] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Fleischman, Ross J.] Harbor UCLA Med Ctr, Dept Emergency Med, Torrance, CA 90509 USA; [Govindarajan, Prasanthi R.] Univ Calif San Francisco, Sch Med, Dept Emergency Med, San Francisco, CA USA; [Jones, Elizabeth B.] Univ Texas Houston, Dept Emergency Med, Med Sch Houston, Houston, TX USA; [Pancioli, Arthur M.] Univ Cincinnati, Sch Med, Dept Emergency Med, Cincinnati, OH USA; [Wright, David W.] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA USA; [Pentz, Rebecca D.] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA		Dickert, NW (corresponding author), Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA 30322 USA.	njr@emory.edu			Greenwall Foundation; National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [F32HL095358-01A1]; National Institute for Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5U01NS062778]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute for Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); National Institute for Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); NIH-NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Department of DefenseUnited States Department of Defense; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [F32HL095358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U10NS059032, U01NS062778, U10NS058930] Funding Source: NIH RePORTER	Supported, in part, by the Greenwall Foundation and the National Heart, Lung, and Blood Institute (F32HL095358-01A1). The parent trial was supported by the National Institute for Neurological Disorders and Stroke (5U01NS062778). Study sponsors played no role in the design or conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the article; or decision to submit the article for publication.; Dr. Dickert received support for article research from the National Institutes of Health (NIH) and the Greenwall Foundation. His institution received grant support from the Greenwall Foundation and the NIH. Ms. Scicluna's institution received grant support from the NIH. Dr. Baren's institution received support from the National Institute for Neurological Disorders and Stroke (NINDS), the National Heart, Lung, and Blood Institute, and the National Institute for Child Health and Human Development. Dr. Biros received royalties from Rosen's Textbook of Emergency Medicine and Up to Date. Her institution received grant support from the NINDS. Dr. Jones received support for article research and travel support from the NIH-NINDS. Her institution received grant support from the NIH-NINDS. Dr. Pancioli received support for article research from the NIH. His institution received grant support from the NIH. Dr. Wright is entitled to royalty through Emory University, derived from any BHR Pharma sales of progesterone for use in traumatic brain injury. The terms of this arrangement have been reviewed and approved by Emory University in accordance with its conflict of interest policies. Dr. Wright received support for article research from the NIH and grant support from NIH and the Department of Defense. Dr. Pentz received support for article research from the NIH. Her institution received grant support from the NIH. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Abboud PA, 2006, J MED ETHICS, V32, P468, DOI 10.1136/jme.2005.012633; Appelbaum Paul S, 2004, IRB, V26, P1, DOI 10.2307/3564231; Biros MH, 2009, RESUSCITATION, V80, P1382, DOI 10.1016/j.resuscitation.2009.08.019; Bulger EM, 2009, ANN EMERG MED, V53, P341, DOI 10.1016/j.annemergmed.2008.07.021; Cassell C, 2008, SAGE DICT QUALITATIV; Contant C, 2006, CRIT CARE MED, V34, P2049, DOI 10.1097/01.CCM.0000227649.72651.F1; Dickert NW, 2014, CRIT CARE MED, V42, P272, DOI 10.1097/CCM.0b013e3182a27759; Dickert NW, 2013, RESUSCITATION, V84, P1416, DOI 10.1016/j.resuscitation.2013.04.006; Dickert NW, 2009, SOC SCI MED, V68, P183, DOI 10.1016/j.socscimed.2008.10.001; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Falagas ME, 2009, AM J SURG, V198, P420, DOI 10.1016/j.amjsurg.2009.02.010; Fallowfield LJ, 1998, EUR J CANCER, V34, P1554, DOI 10.1016/S0959-8049(98)00193-2; Featherstone K, 1998, BRIT MED J, V317, P1177, DOI 10.1136/bmj.317.7167.1177; Govindarajan P, 2013, ACAD EMERG MED, V20, P98, DOI 10.1111/acem.12039; Holloway KFC, 2006, AM J BIOETHICS, V6, P7, DOI 10.1080/15265160600685556; Horng Sam, 2003, IRB, V25, P11, DOI 10.2307/3564408; Kamarainen A, 2012, RESUSCITATION, V83, P81, DOI 10.1016/j.resuscitation.2011.07.018; Kasner SE, 2011, ANN EMERG MED, V57, P346, DOI 10.1016/j.annemergmed.2010.07.009; Kim Scott Y H, 2013, IRB, V35, P1; Largent EA, 2010, ARCH INTERN MED, V170, P668, DOI 10.1001/archinternmed.2010.80; Lecouturier Jan, 2008, BMC Med Ethics, V9, P9, DOI 10.1186/1472-6939-9-9; Lo B, 2006, CRIT CARE MED, V34, P2236, DOI 10.1097/01.CCM.0000229632.85246.3A; Mason J., 2002, QUALITATIVE RES; Nishimura A, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-28; Potter JE, 2013, INTENS CARE MED, V39, P472, DOI 10.1007/s00134-012-2732-8; Schmidt TA, 2003, ANN EMERG MED, V41, P79, DOI 10.1067/mem.2003.17; Snowdon C, 1997, SOC SCI MED, V45, P1337, DOI 10.1016/S0277-9536(97)00063-4; US Department of Health and Human Services Food and Drug Administration Office of Good Clinical Practice Center for Drug Evaluation and Research Center for Biologics Evaluation and Research Center for Devices and Radiological Health, 2013, GUID I REV BOARDS CL	28	23	23	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	MAR	2015	43	3					603	612		10.1097/CCM.0000000000000747			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CB9PI	WOS:000349963600025	25574795	Green Accepted			2022-02-06	
J	Fernandez-Rodriguez, E; Bernabeu, I; Castro, AI; Casanueva, FF				Fernandez-Rodriguez, Eva; Bernabeu, Ignacio; Castro, Ana I.; Casanueva, Felipe F.			Hypopituitarism After Traumatic Brain Injury	ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA			English	Article						Traumatic brain injury; Hypopituitarism; Growth hormone deficiency; Hormone replacement therapy	ANTERIOR-PITUITARY FUNCTION; ANEURYSMAL SUBARACHNOID HEMORRHAGE; GROWTH-HORMONE REPLACEMENT; LONG-TERM; HYPOTHALAMOPITUITARY DYSFUNCTION; POSTTRAUMATIC HYPOPITUITARISM; COGNITIVE REHABILITATION; CONSENSUS GUIDELINES; SPONTANEOUS-RECOVERY; HIGH-RISK	The prevalence of hypopituitarism after traumatic brain (TBI) injury is widely variable in the literature; a meta-analysis determined a pooled prevalence of anterior hypopituitarism of 27.5%. Growth hormone deficiency is the most prevalent hormone insufficiency after TBI; however, the prevalence of each type of pituitary deficiency is influenced by the assays used for diagnosis, severity of head trauma, and time of evaluation. Recent studies have demonstrated improvement in cognitive function and cognitive quality of life with substitution therapy in GH-deficient patients after TBI.	[Fernandez-Rodriguez, Eva; Bernabeu, Ignacio; Castro, Ana I.; Casanueva, Felipe F.] Univ Santiago Compostela, Complejo Hosp, SERGAS, Dept Med,Endocrinol Div, Santiago De Compostela 15706, A Coruna, Spain; [Castro, Ana I.; Casanueva, Felipe F.] Inst Salud Carlos III, Res Ctr Physiopathol Obes & Nutr, Santiago De Compostela, Spain		Casanueva, FF (corresponding author), Univ Santiago Compostela, Hosp Clin, Div Endocrinol, Travesia da Choupana S-N, Santiago De Compostela 15706, A Coruna, Spain.	endocrine@usc.es	Bernabeu, Ignacio/P-2049-2014	Bernabeu, Ignacio/0000-0001-8421-7394; CASANUEVA, FELIPE F./0000-0002-9052-8161			Agha A, 2005, AM J PHYS MED REHAB, V84, P381, DOI 10.1097/01.PHM.0000156898.47097.93; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Agha Amar, 2005, Am J Med, V118, P1416; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Blair JC, 2010, BRIT J NEUROSURG, V24, P10, DOI 10.3109/02688690903536637; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Bondanelli M, 2010, J CLIN ENDOCR METAB, V95, P4660, DOI 10.1210/jc.2010-0611; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Bushnik T, 2004, J HEAD TRAUMA REHAB, V19, P296, DOI 10.1097/00001199-200407000-00004; Castro AI, 2007, J ENDOCRINOL INVEST, V30, P224, DOI 10.1007/BF03347429; DANIEL PM, 1959, LANCET, V2, P927; Dusick Joshua R, 2012, Pituitary, V15, P2, DOI 10.1007/s11102-008-0130-6; Gasco V, 2012, PITUITARY, V15, P20, DOI 10.1007/s11102-010-0235-6; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Glynn N, 2013, CLIN ENDOCRINOL, V78, P17, DOI 10.1111/cen.12010; Hamrahian AH, 2004, NEW ENGL J MED, V350, P1629, DOI 10.1056/NEJMoa020266; Heather NL, 2012, J CLIN ENDOCR METAB, V97, P599, DOI 10.1210/jc.2011-2284; Hellawell DJ, 2001, DISABIL REHABIL, V23, P300, DOI 10.1080/769979114; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Jochberger S, 2006, J CLIN ENDOCR METAB, V91, P4381, DOI 10.1210/jc.2005-2830; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Klose M, 2008, PITUITARY, V11, P255, DOI 10.1007/s11102-008-0102-x; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Klose M, 2014, J CLIN ENDOCR METAB, V99, P101, DOI 10.1210/jc.2013-2397; Kokshoorn NE, 2011, EUR J ENDOCRINOL, V165, P225, DOI 10.1530/EJE-11-0365; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; Kreitschmann-Andermahr I, 2008, GROWTH HORM IGF RES, V18, P472, DOI 10.1016/j.ghir.2008.08.007; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Lorenzo Monica, 2005, Pituitary, V8, P233, DOI 10.1007/s11102-006-6046-0; Maiya B, 2008, INTENS CARE MED, V34, P468, DOI 10.1007/s00134-007-0902-x; Moreau OK, 2013, J NEUROTRAUM, V30, P998, DOI 10.1089/neu.2012.2705; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Popovic V, 2000, LANCET, V356, P1137, DOI 10.1016/S0140-6736(00)02755-0; Reimunde P, 2011, BRAIN INJURY, V25, P65, DOI 10.3109/02699052.2010.536196; Ruggeri RM, 2010, HORM-INT J ENDOCRINO, V9, P332, DOI 10.14310/horm.2002.1285; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Salehi F, 2007, BRAIN INJURY, V21, P651, DOI 10.1080/02699050701426956; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schneider M, 2008, CLIN ENDOCRINOL, V68, P206, DOI 10.1111/j.1365-2265.2007.03020.x; Sundaram NK, 2013, ENDOCRIN METAB CLIN, V42, P565, DOI 10.1016/j.ecl.2013.05.003; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tanriverdi F, 2010, PITUITARY, V13, P111, DOI 10.1007/s11102-009-0204-0; Tanriverdi F, 2008, EUR J ENDOCRINOL, V159, P7, DOI 10.1530/EJE-08-0050; Tanriverdi F, 2008, ANN INTERN MED, V148, P827, DOI 10.7326/0003-4819-148-11-200806030-00005; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; Tanriverdi F, 2010, J NEUROTRAUM, V27, P301, DOI 10.1089/neu.2009.1102; TEASDALE G, 1974, LANCET, V2, P81; Van den Berghe G, 1998, J CLIN ENDOCR METAB, V83, P1827, DOI 10.1210/jc.83.6.1827; Wachter D, 2009, J CLIN NEUROSCI, V16, P202, DOI 10.1016/j.jocn.2008.01.009	65	23	24	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0889-8529	1558-4410		ENDOCRIN METAB CLIN	Endocrinol. Metabol. Clin. North Amer.	MAR	2015	44	1					151	+		10.1016/j.ecl.2014.10.012			11	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	CE4MN	WOS:000351804800018	25732651				2022-02-06	
J	Jackson, JC; Mitchell, N; Hopkins, RO				Jackson, James C.; Mitchell, Nathaniel; Hopkins, Ramona O.			Cognitive Functioning, Mental Health, and Quality of Life in ICU Survivors: An Overview	PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						Cognitive impairments; Critical illness; Critical care outcomes; Psychiatric disorders; Quality of life	INTENSIVE-CARE-UNIT; POSTTRAUMATIC-STRESS-DISORDER; MECHANICALLY VENTILATED PATIENTS; CONFUSION ASSESSMENT METHOD; TRAUMATIC BRAIN INJURY; CRITICAL ILLNESS; RISK-FACTORS; DELIRIUM; OUTCOMES; MEMORY	Critical illness can and often does lead to significant cognitive impairment and to the development of psychological disorders. These conditions are persistent and, although they improve with time, often fail to completely abate. Although the functional correlates of cognitive and psychological morbidity (depression, anxiety, and posttraumatic stress disorder) have been studied, they may include poor quality of life, inability to return to work or to work at previously established levels, and inability to function effectively in emotional and interpersonal domains. The potential etiologies of cognitive impairment and psychological morbidity in ICU survivors are particularly poorly understood and may vary widely across patients. Potential contributors may include the potentially toxic effects of sedatives and narcotics, delirium, hypoxia, glucose dysregulation, metabolic derangements, and inflammation. Patients with preexisting vulnerabilities, including predisposing genetic factors, and frail elderly populations may be at particular risk for emergence of acceleration of conditions such as mild cognitive impairment.	[Jackson, James C.] Vanderbilt Univ, Med Ctr, Sch Med, Ctr Hlth Serv Res, Nashville, TN 37232 USA; [Jackson, James C.] VA Tennessee Valley Hlth Syst VA TVHS, Murfreesboro, TN 37129 USA; [Mitchell, Nathaniel] Spalding Univ, Dept Psychol, Louisville, KY 40203 USA; [Hopkins, Ramona O.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Hopkins, Ramona O.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA; [Hopkins, Ramona O.] Intermt Med Ctr, Dept Med, Pulm & Crit Care Div, Murray, UT USA		Jackson, JC (corresponding author), Vanderbilt Univ, Med Ctr, Sch Med, Ctr Hlth Serv Res, 6th Floor MCE Suite 6100, Nashville, TN 37232 USA.	james.c.jackson@vanderbilt.edu					ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Angus DC, 2001, AM J RESP CRIT CARE, V163, P1389, DOI 10.1164/ajrccm.163.6.2005123; Angus DC, 2003, INTENS CARE MED, V29, P368, DOI 10.1007/s00134-002-1624-8; [Anonymous], 1988, LANCET, V2, P349; BONTKE CF, 1996, J HEAD TRAUMA REHAB, V11, P95, DOI DOI 10.1097/00001199-199602000-00011; Brewin CR, 1996, PSYCHOL REV, V103, P670, DOI 10.1037/0033-295X.103.4.670; Brewin CR, 2001, BEHAV RES THER, V39, P373, DOI 10.1016/S0005-7967(00)00087-5; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Capuzzo M, 2005, Minerva Anestesiol, V71, P167; Capuzzo M, 2004, CRIT CARE, V8, pR48, DOI 10.1186/cc2416; Cheung AM, 2006, AM J RESP CRIT CARE, V174, P538, DOI 10.1164/rccm.200505-693OC; Combes A, 2003, CRIT CARE MED, V31, P1373, DOI 10.1097/01.CCM.0000065188.87029.C3; Dowdy DW, 2008, CRIT CARE MED, V36, P2726, DOI 10.1097/CCM.0b013e31818781f5; Dowdy DW, 2009, CRIT CARE MED, V37, P1702, DOI 10.1097/CCM.0b013e31819fea55; Dowdy DW, 2005, INTENS CARE MED, V31, P611, DOI 10.1007/s00134-005-2592-6; Eikelenboom P, 1999, DEMENT GERIATR COGN, V10, P319, DOI 10.1159/000017162; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Ely EW, 2001, SEMIN RESP CRIT CARE, V22, P115, DOI 10.1055/s-2001-13826; Fong TG, 2006, J GERONTOL A-BIOL, V61, P1294, DOI 10.1093/gerona/61.12.1294; Foreman M, 2004, PRIM PSYCHIAT, V11, P46; Galanakis P, 2001, INT J GERIATR PSYCH, V16, P349, DOI 10.1002/gps.327; Girard TD, 2006, DURATION DELIRIUM PA, pA739; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Heyland DK, 2000, CRIT CARE MED, V28, P3599, DOI 10.1097/00003246-200011000-00006; Hopkins R. O., 2005, P AM THORAC SOC, V2, pA36; Hopkins RO, 2006, CURR OPIN CRIT CARE, V12, P388, DOI 10.1097/01.ccx.0000244115.24000.f5; Hopkins RO, 2006, CHEST, V130, P869, DOI 10.1378/chest.130.3.869; Hopkins RO, 2005, AM J RESP CRIT CARE, V171, P340, DOI 10.1164/rccm.200406-763OC; Hopkins RO, 2005, CURR OPIN CRIT CARE, V11, P369, DOI 10.1097/01.ccx.0000166399.88635.a5; Hopkins RO, 2004, J INT NEUROPSYCH SOC, V10, P1005, DOI 10.1017/S135561770410711X; Hopkins RO, 1999, AM J RESP CRIT CARE, V160, P50, DOI 10.1164/ajrccm.160.1.9708059; Inouye SK, 1998, J GEN INTERN MED, V13, P234, DOI 10.1046/j.1525-1497.1998.00073.x; Jackson JC, 2007, CRIT CARE, V11, DOI 10.1186/cc5707; Jackson JC, 2004, NEUROPSYCHOL REV, V14, P87, DOI 10.1023/B:NERV.0000028080.39602.17; Jackson JC, 2004, INTENS CARE MED, V30, P2009, DOI 10.1007/s00134-004-2422-2; Jackson JC, 2003, CRIT CARE MED, V31, P1226, DOI 10.1097/01.CCM.0000059996.30263.94; Jones C, 2003, CRIT CARE MED, V31, P2456, DOI 10.1097/01.CCM.0000089938.56725.33; Jones C, 2001, CRIT CARE MED, V29, P573, DOI 10.1097/00003246-200103000-00019; Jones C, 2000, MEMORY, V8, P81; Kapfhammer HP, 2004, AM J PSYCHIAT, V161, P45, DOI 10.1176/appi.ajp.161.1.45; KATON W, 1990, Journal of Clinical Psychiatry, V51, P3; Katz IR, 1996, AM J GERIAT PSYCHIAT, V4, P1, DOI 10.1097/00019442-199624410-00001; Klein E, 2003, CAN J PSYCHIAT, V48, P28, DOI 10.1177/070674370304800106; Kress JP, 2003, AM J RESP CRIT CARE, V168, P1457, DOI 10.1164/rccm.200303-455OC; LIPOWSKI ZJ, 1989, NEW ENGL J MED, V320, P578; Lyketsos CG, 2005, AM J GERIAT PSYCHIAT, V13, P656, DOI 10.1176/appi.ajgp.13.8.656; MacLullich AMJ, 2009, INT REV PSYCHIATR, V21, P30, DOI 10.1080/09540260802675031; MALT U, 1988, BRIT J PSYCHIAT, V153, P810, DOI 10.1192/bjp.153.6.810; Meagher DJ, 2001, BMJ-BRIT MED J, V322, P144, DOI 10.1136/bmj.322.7279.144; MOODY DM, 1990, AM J NEURORADIOL, V11, P431; Nelson BJ, 2000, CRIT CARE MED, V28, P3626, DOI 10.1097/00003246-200011000-00013; OKEEFE ST, 1994, BRIT J ANAESTH, V73, P673, DOI 10.1093/bja/73.5.673; Orme J, 2003, AM J RESP CRIT CARE, V167, P690, DOI 10.1164/rccm.200206-542OC; Pandharipande P, 2005, CURR OPIN CRIT CARE, V11, P360; Pandharipande P, 2008, J TRAUMA, V65, P34, DOI 10.1097/TA.0b013e31814b2c4d; Parkin AJ, 1999, CURR BIOL, V9, pR582, DOI 10.1016/S0960-9822(99)80378-9; Pollack MH, 1996, AM J PSYCHIAT, V153, P110; Pomara N, 2005, ARCH GEN PSYCHIAT, V62, P209, DOI 10.1001/archpsyc.62.2.209; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; Rothenhausler HB, 2001, GEN HOSP PSYCHIAT, V23, P88, DOI 10.1016/S0163-8343(01)00123-2; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; SCHACTER DL, 1993, ANNU REV NEUROSCI, V16, P159, DOI 10.1146/annurev.ne.16.030193.001111; Schillerstrom JE, 2005, PSYCHOSOMATICS, V46, P411, DOI 10.1176/appi.psy.46.5.411; Schillerstrom JE, 2005, PSYCHOSOMATICS, V46, P508, DOI 10.1176/appi.psy.46.6.508; Sessler CN, 2001, CHEST, V120, P1390, DOI 10.1378/chest.120.4.1390; Silverstone PH, 1996, J NERV MENT DIS, V184, P43, DOI 10.1097/00005053-199601000-00008; Silverstone PH, 1996, CAN J PSYCHIAT, V41, P67, DOI 10.1177/070674379604100202; Skodol A E, 1999, Semin Clin Neuropsychiatry, V4, P64; SQUIRE LR, 1992, J COGNITIVE NEUROSCI, V4, P232, DOI 10.1162/jocn.1992.4.3.232; Starr JM, 1996, J AM GERIATR SOC, V44, P411, DOI 10.1111/j.1532-5415.1996.tb06412.x; STARR JM, 1994, DRUG SAFETY, V11, P310, DOI 10.2165/00002018-199411050-00003; STRAUSS JS, 1981, PSYCHIAT RES, V4, P333, DOI 10.1016/0165-1781(81)90035-4; SUCHYTA MR, 2004, AM J RESP CRIT CARE, V169, pA18; Sukantarat KT, 2005, ANAESTHESIA, V60, P847, DOI 10.1111/j.1365-2044.2005.04148.x; Teunissen CE, 2003, J NEUROIMMUNOL, V134, P142, DOI 10.1016/S0165-5728(02)00398-3; Toshima MT, 1992, J CARDIOPULM REHABIL, V12, P261; Trzepacz P T, 2000, Semin Clin Neuropsychiatry, V5, P132; Uldall KK, 2000, AIDS PATIENT CARE ST, V14, P95, DOI 10.1089/108729100318037; Ursano RJ, 1999, AM J PSYCHIAT, V156, P589; Weinert CR, 1997, AM J RESP CRIT CARE, V156, P1120, DOI 10.1164/ajrccm.156.4.9611047; Yaffe K, 2003, NEUROLOGY, V61, P76, DOI 10.1212/01.WNL.0000073620.42047.D7	85	23	26	0	16	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0193-953X	1558-3147		PSYCHIAT CLIN N AM	Psychiatr. Clin. North Amer.	MAR	2015	38	1					91	104		10.1016/j.psc.2014.11.002			14	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	CE4MM	WOS:000351804700007	25725571				2022-02-06	
J	Ryan, NP; Catroppa, C; Beare, R; Coleman, L; Ditchfield, M; Crossley, L; Beauchamp, MH; Anderson, VA				Ryan, Nicholas P.; Catroppa, Cathy; Beare, Richard; Coleman, Lee; Ditchfield, Michael; Crossley, Louise; Beauchamp, Miriam H.; Anderson, Vicki A.			Predictors of longitudinal outcome and recovery of pragmatic language and its relation to externalizing behaviour after pediatric traumatic brain injury	BRAIN AND LANGUAGE			English	Article						Child; Brain injuries; Magnetic resonance imaging; Pragmatic language; Neurobiology	CLOSED-HEAD-INJURY; CORPUS-CALLOSUM; SOCIAL BRAIN; COGNITIVE-DEVELOPMENT; EXECUTIVE FUNCTION; CHILDHOOD; CHILDREN; LESIONS; TERM; DISCOURSE	The purpose of the present investigation was to evaluate the contribution of age-at-insult and brain pathology on longitudinal outcome and recovery of pragmatic language in a sample of children and adolescents with traumatic brain injury (TBI). Children and adolescents with mild to severe TBI (n = 112) were categorized according to timing of brain insult: (i) Middle Childhood (5-9 years; n = 41); (ii) Late Childhood (10-11 years; n = 39); and (iii) Adolescence (12-15 years; n = 32) and group-matched for age, gender and socio-economic status (SES) to a typically developing (TD) control group (n = 43). Participants underwent magnetic resonance imaging (MRI) including a susceptibility weighted imaging (SWI) sequence 2-8 weeks after injury and were assessed on measures of pragmatic language and behavioural functioning at 6- and 24-months after injury. Children and adolescents with TBI of all severity levels demonstrated impairments in these domains at 6-months injury before returning to age-expected levels at 2-years post-TBI. However, while adolescent TBI was associated with post-acute disruption to skills that preceded recovery to age-expected levels by 2-years post injury, the middle childhood TBI group demonstrated impairments at 6-months post-injury that we're maintained at 2-year follow up. Reduced pragmatic communication was associated with frontal, temporal and corpus callosum lesions, as well as more frequent externalizing behaviour at 24-months post injury. Findings show that persisting pragmatic language impairment after pediatric TBI is related to younger age at brain insult, as well as microhemorrhagic pathology in brain regions that contribute to the anatomically distributed social brain network. Relationships between reduced pragmatic communication and more frequent externalizing behavior underscore the need for context-sensitive rehabilitation programs that aim to increase interpersonal effectiveness and reduce risk for maladaptive behavior trajectories into the long-term post injury. (C) 2015 Elsevier Inc. All rights reserved.	[Ryan, Nicholas P.; Catroppa, Cathy; Ditchfield, Michael; Crossley, Louise; Anderson, Vicki A.] Murdoch Childrens Res Inst, Australian Ctr Child Neuropsychol Studies, Melbourne, Vic, Australia; [Catroppa, Cathy; Anderson, Vicki A.] Royal Childrens Hosp, Dept Psychol, Melbourne, Vic, Australia; [Ryan, Nicholas P.; Catroppa, Cathy; Anderson, Vicki A.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Beare, Richard] Murdoch Childrens Res Inst, Dev Imaging, Melbourne, Vic, Australia; [Coleman, Lee] Royal Childrens Hosp, Dept Radiol, Melbourne, Vic, Australia; [Catroppa, Cathy; Anderson, Vicki A.] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Beauchamp, Miriam H.] Ste Justine Res Ctr, Montreal, PQ, Canada		Ryan, NP (corresponding author), Murdoch Childrens Res Inst, Child Neuropsychol, Flemington Rd, Parkville, Vic 3052, Australia.	nicholas.ryan@mcri.edu.au; cathy.catroppa@mcri.edu.au; richard.beare@mcri.edu.au; lee.coleman@rch.org.au; michael.ditchfield@southernhealth.org.au; louise.crossley@mcri.edu.au; Miriam.beauchamp@umontreal.ca; vicki.anderson@rch.org.au	Ryan, Nicholas/K-5445-2019; Catroppa, Cathy/AAX-9458-2021	Ryan, Nicholas/0000-0002-0878-8889; Catroppa, Cathy/0000-0002-9750-0436; Beare, Richard/0000-0002-7530-5664			Achenbach TM, 2001, ASEBA SCH AGE FORMS; Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V., 2011, BRAIN; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Badre D, 2006, P NATL ACAD SCI USA, V103, P7186, DOI 10.1073/pnas.0509550103; Barnes MA, 2001, BRAIN LANG, V76, P253, DOI 10.1006/brln.2000.2385; Bates E, 1997, DEV NEUROPSYCHOL, V13, P275, DOI 10.1080/87565649709540682; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Beauchamp MH, 2011, BRAIN INJURY, V25, P950, DOI 10.3109/02699052.2011.589791; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Beauchamp MH, 2009, J NEUROTRAUM, V26, P1645, DOI [10.1089/neu.2009.0916, 10.1089/neu.2009-0916]; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Catroppa C, 2004, BRAIN LANG, V88, P68, DOI 10.1016/S0093-934X(03)00159-7; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Chapman SB, 1998, BRAIN LANG, V61, P420, DOI 10.1006/brln.1997.1885; Chapman SB, 2004, DEV NEUROPSYCHOL, V25, P37, DOI 10.1207/s15326942dn2501&2_4; Choudhury S, 2006, SOC COGN AFFECT NEUR, V1, P165, DOI 10.1093/scan/nsl024; Coffey CE, 1991, PSYCHOPATHOL BRAIN, P243; Cohen J., 2013, STAT POWER ANAL BEHA; Colbert CA, 2010, RADIOLOGY, V256, P898, DOI 10.1148/radiol.10091842; Crowe LM, 2012, J PEDIATR PSYCHOL, V37, P745, DOI 10.1093/jpepsy/jss070; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Dennis M, 1989, CLIN NEUROPSYCHOLOGY, P85; Didus E, 1999, Pediatr Rehabil, V3, P177; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Dumontheil I, 2010, DEVELOPMENTAL SCI, V13, P331, DOI 10.1111/j.1467-7687.2009.00888.x; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 2012, INT J DEV NEUROSCI, V30, P247, DOI 10.1016/j.ijdevneu.2011.07.004; Factor P. I., 2013, J ATTENTION DISORDER; Farina E., 2007, PSYCHOL LANGUAGE COM, V11, P3; Ferstl EC, 2008, HUM BRAIN MAPP, V29, P581, DOI 10.1002/hbm.20422; Geraci A, 2010, BRAIN INJURY, V24, P978, DOI 10.3109/02699052.2010.487477; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giedd JN, 1996, DEV BRAIN RES, V91, P274; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Glascher J, 2010, P NATL ACAD SCI USA, V107, P4705, DOI 10.1073/pnas.0910397107; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Hallett T L, 1997, Pediatr Rehabil, V1, P219; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Hattier MA, 2011, DEV NEUROREHABIL, V14, P221, DOI 10.3109/17518423.2011.573836; HEBB D. O., 1942, PROC AMER PHIL SOC, V85, P275; Jacobs R, 2007, CORTEX, V43, P792, DOI 10.1016/S0010-9452(08)70507-0; Johnson MH, 2005, DEV PSYCHOPATHOL, V17, P599, DOI 10.1017/S0954579405050297; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Kolb B, 2004, BRAIN COGNITION, V55, P104, DOI 10.1016/s0278-2626(03)00278-1; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Luders E, 2010, J NEUROSCI, V30, P10985, DOI 10.1523/JNEUROSCI.5122-09.2010; Manly T, 1999, TEA CH TEST EVERYDAY; Masten AS, 2010, DEV PSYCHOPATHOL, V22, P491, DOI 10.1017/S0954579410000222; McMillan J, 2009, J SOCIOL, V45, P123, DOI 10.1177/1440783309103342; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Ryan NP, 2015, NEUROPSYCHOLOGIA, V66, P32, DOI 10.1016/j.neuropsychologia.2014.10.040; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Ryan NP, 2013, INT J DEV NEUROSCI, V31, P811, DOI 10.1016/j.ijdevneu.2013.10.002; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Sehgal V, 2005, J MAGN RESON IMAGING, V22, P439, DOI 10.1002/jmri.20404; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Spitz G, 2013, J NEUROTRAUM, V30, P2038, DOI 10.1089/neu.2013.3021; Stowe LA, 1998, NEUROREPORT, V9, P2995, DOI 10.1097/00001756-199809140-00014; Sullivan JR, 2010, APPL NEUROPSYCHOL, V17, P93, DOI 10.1080/09084281003708852; Tabachnick B.G., 2001, USING MULTIVARIATE S; Tasker RC, 2006, DEV NEUROSCI-BASEL, V28, P302, DOI 10.1159/000094156; Taylor MJ, 2014, AM J MED GENET B, V165, P587, DOI 10.1002/ajmg.b.32262; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 1999, WASI WECHSLER ABBREV; Wigg E. H., 1989, TEST LANGUAGE COMPET; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	89	23	23	0	36	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0093-934X	1090-2155		BRAIN LANG	Brain Lang.	MAR	2015	142						86	95		10.1016/j.bandl.2015.01.007			10	Audiology & Speech-Language Pathology; Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Psychology	CD0QU	WOS:000350779800010	25677376				2022-02-06	
J	Ryan, NP; Hughes, N; Godfrey, C; Rosema, S; Catroppa, C; Anderson, VA				Ryan, Nicholas P.; Hughes, Nathan; Godfrey, Celia; Rosema, Stefanie; Catroppa, Cathy; Anderson, Vicki A.			Prevalence and Predictors of Externalizing Behavior in Young Adult Survivors of Pediatric Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						antisocial behavior; crime; externalizing behavior (EB); traumatic brain injury; young adulthood	ANTISOCIAL-BEHAVIOR; NEUROPSYCHOLOGICAL MEASURES; EXECUTIVE DYSFUNCTION; EMOTION PERCEPTION; SUBSTANCE USE; CHILDHOOD; OUTCOMES; CHILDREN; SKILLS; VULNERABILITY	Objectives: To investigate rates of clinically significant externalizing behavior (EB) in young adult survivors of pediatric traumatic brain injury (TBI) and evaluate the contribution of pre- and postinjury risk and resilience factors to EB outcomes 16 years after injury. Setting: Melbourne, Australia. Participants: Fifty-five young adults (mean age = 23.85 years; injury age: 1.0-12 years) admitted to an emergency department following TBI between 1993 and 1997. Design: Longitudinal prospective study with data collected at the acute, 10-year, and 16-year postinjury time points. Main Measures: Severity of TBI, adaptive functioning, family functioning, full-scale IQ, executive functioning, social communication, and symptoms of EB. Results: One of every 4 young people with a history of pediatric TBI demonstrated clinical or subthreshold levels of EB in young adulthood. More frequent EB was associated with poorer preinjury adaptive functioning, lower full-scale IQ, and more frequent pragmatic communication difficulty. Conclusion: Pediatric TBI is associated with an elevated risk for externalizing disorders in the transition to adulthood. Results underscore the need for screening and assessment of TBI among young offenders and suggest that early and long-term targeted interventions may be required to address risk factors for EB in children and young people with TBI.	[Ryan, Nicholas P.; Hughes, Nathan; Godfrey, Celia; Rosema, Stefanie; Catroppa, Cathy; Anderson, Vicki A.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Ryan, Nicholas P.; Hughes, Nathan; Godfrey, Celia; Catroppa, Cathy; Anderson, Vicki A.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Hughes, Nathan] Univ Birmingham, Birmingham B15 2TT, W Midlands, England; [Rosema, Stefanie; Catroppa, Cathy; Anderson, Vicki A.] Royal Childrens Hosp Melbourne, Melbourne, Vic 3052, Australia		Ryan, NP (corresponding author), Royal Childrens Hosp Melbourne, Murdoch Childrens Res Inst, Level 4 West,Flemington Rd, Melbourne, Vic 3052, Australia.	nicholas.ryan@mcri.edu.au	Ryan, Nicholas/K-5445-2019; Catroppa, Cathy/AAX-9458-2021; Hughes, Nathan/O-8600-2014	Ryan, Nicholas/0000-0002-0878-8889; Catroppa, Cathy/0000-0002-9750-0436; Hughes, Nathan/0000-0002-5859-808X	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia; Victorian Neurotrauma initiative; Murdoch Children's Research Institute, Clinical Sciences; Victorian Government's Operational Infrastructure Scheme	This work was funded through research grants awarded by the National Health and Medical Research Council, the Victorian Neurotrauma initiative and the Murdoch Children's Research Institute, Clinical Sciences, and supported by the Victorian Government's Operational Infrastructure Scheme.	Achenbach TM, 2009, ACHENBACH SYSTEM EMP; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Bayley N., 1969, BAYLEY SCALES INFANT; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Beitchman JH, 1999, J CLIN CHILD PSYCHOL, V28, P312, DOI 10.1207/S15374424jccp280303; Bor W, 2007, YOUNG ADULT OUTCOMES; Bottoms A, 2011, ESCAPE ROUTES: CONTEMPORARY PERSPECTIVES ON LIFE AFTER PUNISHMENT, P43; BRESLAU N, 1990, ARCH GEN PSYCHIAT, V47, P15; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; Brownlie EB, 2004, J ABNORM CHILD PSYCH, V32, P453, DOI 10.1023/B:JACP.0000030297.91759.74; Catroppa C, 1999, Pediatr Rehabil, V3, P167; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Catroppa C, 2011, BRAIN INJURY, V25, P858, DOI 10.3109/02699052.2011.589794; Catroppa C, 2009, NEUROPSYCHOL REHABIL, V19, P716, DOI 10.1080/09602010902732868; Ciccetti D., 1984, VINELAND ADAPTIVE BE; Daniel A., 1983, POWER PRIVILEGE PRES; Davies RC, 2012, J HEAD TRAUMA REHAB, V27, pE21, DOI 10.1097/HTR.0b013e31825360da; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dockrell J. E., 2007, RAISING ACHIEVEMENTS; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Farrington D. P., 1992, THE SCH YEARS, P123; FARRINGTON DP, 1995, J CHILD PSYCHOL PSYC, V36, P929, DOI 10.1111/j.1469-7610.1995.tb01342.x; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gioia GA IP, 2000, BEHAV RATING INVENTO; Green L, 2012, DEV NEUROREHABIL, V15, P105, DOI 10.3109/17518423.2011.638331; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Henry B, 1997, HDB ANTISOCIAL BEHAV, P280; Hines PJ, 2010, SCIENCE, V328, P447, DOI 10.1126/science.328.5977.447; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Kenny DT, 2007, CONT ISSUES CRIME JU, V107, P1; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Lowe K, 2007, J INTELL DISABIL RES, V51, P625, DOI 10.1111/j.1365-2788.2006.00948.x; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; Moore E, 2014, J HEAD TRAUMA REHAB, V29, P239, DOI 10.1097/HTR.0b013e31828f9876; Morgan AB, 2000, CLIN PSYCHOL REV, V20, P113, DOI 10.1016/S0272-7358(98)00096-8; Mulvey Edward P, 2004, Youth Violence Juv Justice, V2, P213, DOI 10.1177/1541204004265864; Office of the Surgeon General (US); National Center for Injury Prevention and Control (US); National Institute of Mental Health (US); Center for Mental Health Services (US), 2001, YOUTH VIOL REP SURG; Ogilvie JM, 2011, CRIMINOLOGY, V49, P1063, DOI 10.1111/j.1745-9125.2011.00252.x; Pearson, 2009, ADV CLIN SOLUTIONS W; Prior D, 2004, PREVENTING CHILDRENS; Raine A, 2005, J ABNORM PSYCHOL, V114, P38, DOI 10.1037/0021-843X.114.1.38; Rosema S, 2014, J NEUROTRAUM, V31, P899, DOI 10.1089/neu.2013.3226; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Ryan NP, 2013, INT J DEV NEUROSCI, V31, P811, DOI 10.1016/j.ijdevneu.2013.10.002; Schofield PW, 2006, BRAIN INJURY, V20, P1409, DOI 10.1080/02699050601130443; SEGALOWITZ SJ, 1991, J LEARN DISABIL, V24, P551, DOI 10.1177/002221949102400907; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Snow P, 2012, TRENDS ISSUES CR APR; Snow PC, 2011, INT J SPEECH-LANG PA, V13, P480, DOI 10.3109/17549507.2011.578661; Tasker RC, 2005, PEDIATR RES, V58, P302, DOI 10.1203/01.PDR.0000169965.08854.25; TEASDALE G, 1974, LANCET, V2, P81; Tenneij NH, 2007, J APPL RES INTELLECT, V20, P391, DOI 10.1111/j.1468-3148.2007.00383.x; Tonks J, 2011, BRAIN INJURY, V25, P870, DOI 10.3109/02699052.2011.581641; Tonks J, 2009, DEV MED CHILD NEUROL, V51, P8, DOI 10.1111/j.1469-8749.2008.03219.x; Turkstra LS, 2008, NEUROREHABILITATION, V23, P501; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wechsler D., 1989, MANUAL PRESCHOOL PRI; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; Woods DT, 2011, DEV NEUROREHABIL, V14, P274, DOI 10.3109/17518423.2011.586371; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; [No title captured]	72	23	23	1	31	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2015	30	2					75	85		10.1097/HTR.0000000000000123			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CF1MG	WOS:000352309300010	25734838	Green Published			2022-02-06	
J	Krieg, SM; Sonanini, S; Plesnila, N; Trabold, R				Krieg, Sandro M.; Sonanini, Sebastian; Plesnila, Nikolaus; Trabold, Raimund			Effect of Small Molecule Vasopressin V-1a and V-2 Receptor Antagonists on Brain Edema Formation and Secondary Brain Damage following Traumatic Brain Injury in Mice	JOURNAL OF NEUROTRAUMA			English	Article						brain edema; traumatic brain injury; CBF; arginine vasopressin	EXPERIMENTAL SUBARACHNOID HEMORRHAGE; PLASMA ARGININE-VASOPRESSIN; CONTROLLED CORTICAL IMPACT; RAT-BRAIN; STROKE PATIENTS; WATER; PERMEABILITY; ASTROCYTES; EXPRESSION; MECHANISM	The attenuation of brain edema is a major therapeutic target after traumatic brain injury (TBI). Vasopressin (AVP) is well known to play a major role in the regulation of brain water content and vasoendothelial functions and to be involved in brain edema formation. Therefore, the aim of the current study was to analyze the antiedematous efficacy of a clinically relevant, nonpeptidic AVP V-1a and V-2 receptor antagonists. C57Bl6 mice were subjected to controlled cortical impact (CCI) and V-1a or V-2 receptors were inhibited by using the highly selective antagonists SR-49059 or SR-121463A either by systemic (intraperitoneal, IP) or intracerebroventricular (ICV) application. After 24 h, brain edema, intracranial pressure (ICP), and contusion volume were assessed. Systemically applied AVP receptor antagonists could not reduce secondary lesion growth. In contrast, ICV administration of AVP V-1a receptor antagonist decreased brain edema formation by 68%, diminished post-traumatic increase of ICP by 46%, and reduced secondary contusion expansion by 43% 24 h after CCI. The ICV inhibition of V-2 receptors resulted in significant reduction of post-traumatic brain edema by 41% 24 h after CCI, but failed to show further influence on ICP and lesion growth. Hence, centrally applied vasopressin V-1a receptor antagonists may be used to reduce brain edema formation after TBI.	[Krieg, Sandro M.; Sonanini, Sebastian; Plesnila, Nikolaus; Trabold, Raimund] Univ Munich, Univ Munich Med Ctr Grosshadern, Lab Expt Neurosurg, Munich, Germany; [Plesnila, Nikolaus] Univ Munich, Univ Munich Med Ctr Grosshadern, Inst Stroke & Dementia Res, Munich, Germany; [Plesnila, Nikolaus; Trabold, Raimund] Univ Munich, Univ Munich Med Ctr Grosshadern, Dept Neurosurg, Munich, Germany		Plesnila, N (corresponding author), Inst Stroke & Dementia Res, Feodor Lynen Str 17, D-81377 Munich, Germany.	nikolaus.plesnila@med.uni-muenchen.de	Krieg, Sandro M./L-8902-2016; Plesnila, Nikolaus/T-7522-2019	Krieg, Sandro M./0000-0003-4050-1531; 	Program for Research and Medical Education (Forderprogramm fur Forschung und Lehre) of the Faculty of Medicine, Ludwig-Maximilians-University, Munich	This study was supported by grants of the Program for Research and Medical Education (Forderprogramm fur Forschung und Lehre) of the Faculty of Medicine, Ludwig-Maximilians-University, Munich. The authors thank Sanofi Aventis and Dr. Serradeil-Le Gal for providing SR-49059 and SR-121463A.	Armstead WM, 2001, BRAIN RES, V910, P19, DOI 10.1016/S0006-8993(01)02716-0; Barreca T, 2001, CEREBROVASC DIS, V11, P113, DOI 10.1159/000047622; Bemana I, 1999, NEUROSURGERY, V44, P148, DOI 10.1097/00006123-199901000-00091; Ben Borgens R, 2012, Q REV BIOL, V87, P89, DOI 10.1086/665457; BRINTON RE, 1984, P NATL ACAD SCI-BIOL, V81, P7248, DOI 10.1073/pnas.81.22.7248; Brouard R, 1998, ADV EXP MED BIOL, V449, P455; BUIJS RM, 1980, J HISTOCHEM CYTOCHEM, V28, P357, DOI 10.1177/28.4.6989899; CHEN Y, 1992, CAN J PHYSIOL PHARM, V70, pS367, DOI 10.1139/y92-285; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; DELBIGIO MR, 1990, ACT NEUR S, V51, P14; DICKINSON LD, 1992, J CEREBR BLOOD F MET, V12, P681, DOI 10.1038/jcbfm.1992.93; DOCZI T, 1984, NEUROSURGERY, V14, P436, DOI 10.1227/00006123-198404000-00008; DOCZI T, 1982, NEUROSURGERY, V11, P402; FARACI FM, 1990, AM J PHYSIOL, V258, pR94, DOI 10.1152/ajpregu.1990.258.1.R94; FARACI FM, 1988, AM J PHYSIOL, V255, pH70, DOI 10.1152/ajpheart.1988.255.1.H70; Fernandez N, 2001, BRIT J PHARMACOL, V132, P1837, DOI 10.1038/sj.bjp.0704034; Giacoppo S, 2012, NEUROCRIT CARE, V16, P470, DOI 10.1007/s12028-012-9707-z; Hertz L, 2000, AM J PHYSIOL-ENDOC M, V278, pE1175, DOI 10.1152/ajpendo.2000.278.6.E1175; Hockel K, 2012, STROKE, V43, P227, DOI 10.1161/STROKEAHA.111.626168; Huang WD, 2008, J ENDOCRINOL INVEST, V31, P996, DOI 10.1007/BF03345638; JOYNT RJ, 1981, ANN NEUROL, V9, P182, DOI 10.1002/ana.410090212; KATO Y, 1995, DIFFERENTIATION, V59, P163, DOI 10.1046/j.1432-0436.1995.5930163.x; Kermer P, 1999, CELL TISSUE RES, V298, P383, DOI 10.1007/s004410050061; LIU XF, 1991, CHINESE MED J-PEKING, V104, P480; LOLAIT SJ, 1995, P NATL ACAD SCI USA, V92, P6783, DOI 10.1073/pnas.92.15.6783; Manaenko A, 2011, NEUROCHEM INT, V58, P542, DOI 10.1016/j.neuint.2011.01.018; MATHER HM, 1981, J NEUROL NEUROSUR PS, V44, P216, DOI 10.1136/jnnp.44.3.216; NAGAO S, 1994, ACTA NEUROCHIR, P502; Niermann H, 2001, J NEUROSCI, V21, P3045, DOI 10.1523/JNEUROSCI.21-09-03045.2001; OSTROWSKI NL, 1994, ENDOCRINOLOGY, V135, P1511, DOI 10.1210/en.135.4.1511; Pascale CL, 2006, J PHYSIOL PHARMACOL, V57, P161; Pearl GS, 1998, CLIN LAB MED, V18, P39; RAICHLE ME, 1978, BRAIN RES, V143, P191, DOI 10.1016/0006-8993(78)90766-7; RIPHAGEN CL, 1986, FASEB J, V45, P2318; ROSENBERG GA, 1986, AM J PHYSIOL, V251, pF485, DOI 10.1152/ajprenal.1986.251.3.F485; ROSENBERG GA, 1992, STROKE, V23, P1767, DOI 10.1161/01.STR.23.12.1767; Serradeil-Le Gal C, 2002, J PHARMACOL EXP THER, V300, P1122; SERRADEILLEGAL C, 1993, J CLIN INVEST, V92, P224, DOI 10.1172/JCI116554; SerradeilLeGal C, 1996, J CLIN INVEST, V98, P2729, DOI 10.1172/JCI119098; Thal SC, 2007, J NEUROSCI METH, V159, P261, DOI 10.1016/j.jneumeth.2006.07.016; Trabold R, 2006, BRAIN RES, V1071, P237, DOI 10.1016/j.brainres.2005.11.095; Trabold R, 2008, J NEUROTRAUM, V25, P1459, DOI 10.1089/neu.2008.0597; Vakili A, 2005, J CEREBR BLOOD F MET, V25, P1012, DOI 10.1038/sj.jcbfm.9600097; von Baumgarten L, 2008, J CEREBR BLOOD F MET, V28, P1353, DOI 10.1038/jcbfm.2008.30; Xu Miao, 2007, Chin J Traumatol, V10, P90; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	47	23	24	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2015	32	4					221	227		10.1089/neu.2013.3274			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CB0KN	WOS:000349314900002	25111427	Green Published			2022-02-06	
J	Budohoski, KP; Czosnyka, M; Kirkpatrick, PJ; Reinhard, M; Varsos, GV; Kasprowicz, M; Zabek, M; Pickard, JD; Smielewski, P				Budohoski, Karol P.; Czosnyka, Marek; Kirkpatrick, Peter J.; Reinhard, Matthias; Varsos, Georgios V.; Kasprowicz, Magdalena; Zabek, Miroslaw; Pickard, John D.; Smielewski, Peter			Bilateral Failure of Cerebral Autoregulation is Related to Unfavorable Outcome After Subarachnoid Hemorrhage	NEUROCRITICAL CARE			English	Article						Cerebral autoregulation; Delayed cerebral ischemia; Subarachnoid hemorrhage; Transcranial Doppler	TRAUMATIC BRAIN-INJURY; PRESSURE-AUTOREGULATION; BLOOD-FLOW; CEREBROVASCULAR AUTOREGULATION; TRANSCRANIAL DOPPLER; ASYMMETRY; ISCHEMIA; REACTIVITY; IMPAIRMENT; PREDICTION	The extent of hemodynamic disturbances following subarachnoid hemorrhage (SAH) varies. We aim to determine the prognostic implications of unilateral and bilateral autoregulatory failure on delayed cerebral ischemia (DCI) and outcome. Ninety-eight patients with aneurysmal SAH were recruited. Autoregulation was assessed using systolic flow index-Sxa. Interhemispheric difference in autoregulation was calculated to assess the spatial distribution and symmetry of autoregulatory changes. Assessment of interhemispheric difference in autoregulation in combination with overall autoregulation was used to measure the extent of autoregulatory impairment. Patients were dichotomized by the presence of DCI and 3-month mRS. Higher flow velocity and worse autoregulation (p < 0.0000001, 95 % CI 10.7-21.3 and p = 0.00001, 95 % CI 0.03-0.07 for difference in FV and Sxa, respectively) were found ipsilateral to the ischemic hemisphere or location of aneurysm (if no ischemia detected). DCI group had a higher interhemispheric difference of autoregulation than non-DCI group (p = 0.035, 95 % CI 0.003-0.08). 16/18 patients with unfavorable outcome vs. 17/72 with favorable outcome had overall poor autoregulation with low interhemispheric differences (p = 0.0013, chi (2)). Unilateral autoregulatory failure was seen on a median day 3, bilateral on day 4, and vasospasm was detected on day 6. Unilateral autoregulation failure was seen in patients who developed DCI (worse ipsilateral to the ischemic hemisphere). Bilateral autoregulation failure was seen more frequently in patients with unfavorable outcome. Analysis of the temporal profile showed unilateral dysautoregulation as the primary event predisposing to DCI, which in selected cases led to bilateral failure and unfavorable outcomes.	[Budohoski, Karol P.; Czosnyka, Marek; Kirkpatrick, Peter J.; Varsos, Georgios V.; Kasprowicz, Magdalena; Pickard, John D.; Smielewski, Peter] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge CB2 0QQ, England; [Reinhard, Matthias] Univ Freiburg, Dept Neurol, Freiburg, Germany; [Kasprowicz, Magdalena] Wroclaw Univ Technol, Inst Biomed Engn & Instrumentat, PL-50370 Wroclaw, Poland; [Zabek, Miroslaw] Mazovia Brodno Hosp, Dept Neurosurg, Postgrad Med Ctr, Warsaw, Poland		Budohoski, KP (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Hills Rd, Cambridge CB2 0QQ, England.	karol.budohoski@gmail.com		Kasprowicz, Magdalena/0000-0002-2271-7737; czosnyka, marek/0000-0003-2446-8006; Zabek, Miroslaw/0000-0001-6847-2424; Smielewski, Peter/0000-0001-5096-3938	St Catherine's College, University of Cambridge; Polish Ministry of Science and Higher EducationMinistry of Science and Higher Education, Poland; National Institute of Health Research Senior Investigator Awards; National Institute of Health Research Senior Investigator Award - CSF dynamics; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986, G9439390, G0001237] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390, G0001237, G0600986] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish	KPB received a grant from St Catherine's College, University of Cambridge. MK was supported by Polish Ministry of Science and Higher Education. JDP is a recipient of National Institute of Health Research Senior Investigator Awards. MC is a recipient of National Institute of Health Research Senior Investigator Award - CSF dynamics.	Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Budohoski KP, 2012, STROKE, V43, P3230, DOI 10.1161/STROKEAHA.112.669788; Budohoski KP, 2012, NEUROCRIT CARE, V17, P211, DOI 10.1007/s12028-011-9572-1; Claassen J, 2001, STROKE, V32, P2012, DOI 10.1161/hs0901.095677; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; CZOSNYKA M, 1994, NEUROSURGERY, V35, P287, DOI 10.1227/00006123-199408000-00015; Gooskens I, 2003, ACTA NEUROCHIR, V145, P527, DOI 10.1007/s00701-003-0045-y; HARPER AM, 1972, NEURORADIOLOGY, V3, P134, DOI 10.1007/BF00341495; HEILBRUN MP, 1972, J NEUROSURG, V37, P36, DOI 10.3171/jns.1972.37.1.0036; Hop JW, 1997, STROKE, V28, P660, DOI 10.1161/01.STR.28.3.660; Hu K, 2009, J NEUROTRAUM, V26, P227, DOI 10.1089/neu.2008.0643; Jaeger M, 2007, STROKE, V38, P981, DOI 10.1161/01.STR.0000257964.65743.99; Jaeger M, 2012, STROKE, V43, P2097, DOI 10.1161/STROKEAHA.112.659888; Komotar RJ, 2009, NEUROSURGERY, V64, P397, DOI 10.1227/01.NEU.0000338946.42939.C7; Lam JMK, 2000, NEUROSURGERY, V47, P819, DOI 10.1097/00006123-200010000-00004; Lang EW, 2003, J CLIN NEUROSCI, V10, P670, DOI 10.1016/S0967-5868(03)00197-8; Lang EW, 2001, CRIT CARE MED, V29, P158, DOI 10.1097/00003246-200101000-00031; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Mayor SA, 1999, NEUROLOGY, V52, P1602, DOI 10.1212/WNL.52.8.1602; Molyneux AJ, 2009, LANCET NEUROL, V8, P427, DOI 10.1016/S1474-4422(09)70080-8; PICKARD JD, 1980, J NEUROSURG, V53, P305, DOI 10.3171/jns.1980.53.3.0305; Piechnik SK, 2001, J CEREBR BLOOD F MET, V21, P182, DOI 10.1097/00004647-200102000-00010; Ratsep T, 2001, J NEUROSURG, V95, P393, DOI 10.3171/jns.2001.95.3.0393; Reinhard M, 2003, STROKE, V34, P2138, DOI 10.1161/01.STR.0000087788.65566.AC; Rinne J, 1996, NEUROSURGERY, V38, P2, DOI 10.1097/00006123-199601000-00002; Schmidt EA, 2003, J NEUROIMAGING, V13, P248, DOI 10.1177/1051228403013003008; Schmidt EA, 2003, J NEUROSURG, V99, P991, DOI 10.3171/jns.2003.99.6.0991; Sorrentino E, 2011, NEUROCRIT CARE, V14, P188, DOI 10.1007/s12028-010-9492-5; Telman G, 2006, EUR J VASC ENDOVASC, V32, P375, DOI 10.1016/j.ejvs.2006.04.031; Tseng MY, 2005, STROKE, V36, P1627, DOI 10.1161/01.STR.0000176743.67564.5d; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Zweifel C, 2010, STROKE, V41, P1963, DOI 10.1161/STROKEAHA.109.577320	33	23	23	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2015	22	1					65	73		10.1007/s12028-014-0032-6			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CA3FH	WOS:000348791300009	25056137				2022-02-06	
J	Kelso, ML; Elliott, BR; Haverland, NA; Mosley, RL; Gendelman, HE				Kelso, Matthew L.; Elliott, Bret R.; Haverland, Nicole A.; Mosley, R. Lee; Gendelman, Howard E.			Granulocyte-Macrophage Colony Stimulating Factor Exerts Protective and Immunomodulatory Effects in Cortical Trauma	JOURNAL OF NEUROIMMUNOLOGY			English	Article						Traumatic brain injury; Immunity; Microglia; Neuroinflammation; T cell	REGULATORY T-CELLS; EXPERIMENTAL MYASTHENIA-GRAVIS; BRAIN-INJURY; GM-CSF; PARKINSONS-DISEASE; IN-VIVO; NEUROPROTECTIVE ACTIVITIES; MICROGLIAL ACTIVATION; CEREBRAL-ISCHEMIA; MICE	Neurodegeneration after traumatic brain injury is facilitated by innate and adaptive immunity and can be harnessed to affect brain repair. In mice subjected to controlled cortical impact (CCI), we show that treatment with granulocyte macrophage colony stimulating factor (GM-CSF) affects regulatory T cell numbers in the cervical lymph nodes coincident with decreased lesion volumes and increased cortical tissue sparing. This paralleled increases in neurofilament and diminished reactive microglial staining. Transcriptomic analysis showed that GM-CSF induces robust immune neuroprotective responses seven days following CCI. Together, these results support the therapeutic potential of GM-CSF for TBI. (C) 2014 Elsevier B.V. All rights reserved.	[Kelso, Matthew L.] Univ Nebraska Med Ctr, Coll Pharm, Dept Pharm Practice, Omaha, NE 68198 USA; [Elliott, Bret R.; Haverland, Nicole A.; Mosley, R. Lee; Gendelman, Howard E.] Univ Nebraska Med Ctr, Coll Med, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA		Kelso, ML (corresponding author), Univ Nebraska Med Ctr, Coll Pharm, Dept Pharm Practice, Omaha, NE 68198 USA.	hegendel@unmc.edu			Carol Swarts Neuroscience Research Laboratory; Frances and Louie Blumkin Foundation; Department of DefenseUnited States Department of Defense [W81XWH11-1-0700]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1P01DA028555, 2R01NS034239, 2R01NS36126, P01NS43985, P01MH64570]; Centers of Biomedical Research Excellence grant [P20GM103480]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM103480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P30MH062261, P01MH064570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS070190, P01NS043985, R13NS083315, R37NS036126, R01NS036126, P01NS031492, T32NS007488, R01NS034239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG043540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [P01DA028555, P01DA026146] Funding Source: NIH RePORTER	We thank Dr. Pawel Ciborowski, Department of Pharmacology and Experimental Neuroscience, for support provided for the transcriptome analyses. Acquisition of flow cytometric data was performed by the UNMC Cell Analysis Facility. This work was supported by the Carol Swarts Neuroscience Research Laboratory, the Frances and Louie Blumkin Foundation, Department of Defense Grant W81XWH11-1-0700, and National Institutes of Health grants (1P01DA028555, 2R01NS034239, 2R01NS36126, P01NS43985, and P01MH64570) to H.E.G. and a Centers of Biomedical Research Excellence grant (P20GM103480) to M.K. and H.E.G.	Boulet T, 2013, J NEUROTRAUM, V30, P1512, DOI 10.1089/neu.2012.2788; Buchsel Patricia C, 2002, Clin J Oncol Nurs, V6, P198; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Dash PK, 2011, J NEUROSCI, V31, P3148, DOI 10.1523/JNEUROSCI.5473-10.2011; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Gendelman HE, 2011, TRENDS MOL MED, V17, P687, DOI 10.1016/j.molmed.2011.08.005; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Kelso ML, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-108; Kelso ML, 2006, BRAIN RES, V1083, P204, DOI 10.1016/j.brainres.2006.01.127; Kim NK, 2009, EUR J NEUROSCI, V29, P891, DOI 10.1111/j.1460-9568.2009.06653.x; Kong T, 2009, J NEUROSURG, V111, P155, DOI 10.3171/2008.12.JNS08172; Kosloski LM, 2013, J NEUROIMMUNOL, V265, P1, DOI 10.1016/j.jneuroim.2013.10.009; Kox M, 2008, NEUROLOGY, V70, P480, DOI 10.1212/01.wnl.0000279479.69502.3e; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Li PY, 2013, ANN NEUROL, V74, P458, DOI 10.1002/ana.23815; Liesz A, 2013, J NEUROSCI, V33, P17350, DOI 10.1523/JNEUROSCI.4901-12.2013; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Liljefors M, 2008, CANCER IMMUNOL IMMUN, V57, P379, DOI 10.1007/s00262-007-0377-1; Liu YW, 2006, NAT MED, V12, P518, DOI 10.1038/nm1402; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Mangano EN, 2011, NEUROBIOL DIS, V43, P99, DOI 10.1016/j.nbd.2011.02.011; Marshall SA, 2013, NEUROBIOL DIS, V54, P239, DOI 10.1016/j.nbd.2012.12.016; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Nakagawa T, 2006, BRAIN RES, V1089, P179, DOI 10.1016/j.brainres.2006.03.059; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nishihara T, 2011, EXP NEUROL, V229, P507, DOI 10.1016/j.expneurol.2011.04.006; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reynolds AD, 2007, J LEUKOCYTE BIOL, V82, P1083, DOI 10.1189/jlb.0507296; Reynolds AD, 2010, J IMMUNOL, V184, P2261, DOI 10.4049/jimmunol.0901852; Reynolds AD, 2009, J PROTEOME RES, V8, P3497, DOI 10.1021/pr9001614; Ridwan S, 2012, J NEURAL TRANSM, V119, P1389, DOI 10.1007/s00702-012-0794-y; Schabitz WR, 2008, J CEREBR BLOOD F MET, V28, P29, DOI 10.1038/sj.jcbfm.9600496; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Segev-Amzaleg N, 2013, BRAIN BEHAV IMMUN, V30, P176, DOI 10.1016/j.bbi.2012.12.016; Sheng JR, 2008, CLIN IMMUNOL, V128, P172, DOI 10.1016/j.clim.2008.03.509; Sheng JR, 2011, J NEUROIMMUNOL, V240, P65, DOI 10.1016/j.jneuroim.2011.10.010; Shultz SR, 2014, J NEUROTRAUM, V31, P976, DOI 10.1089/neu.2013.3106; Soares HD, 1995, J NEUROSCI, V15, P8223; Trajkovic V, 2004, GLIA, V47, P168, DOI 10.1002/glia.20046; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Ziebell J. M., 2014, METAB BRAIN DIS; Zou T, 2011, TRANSFUSION, V51, p160S, DOI 10.1111/j.1537-2995.2011.03379.x	52	23	23	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	JAN 15	2015	278						162	173		10.1016/j.jneuroim.2014.11.002			12	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	CA9UC	WOS:000349269300021	25468272	Green Accepted			2022-02-06	
J	Ma, JH; Liu, N; Yi, B; Zhang, XC; Gao, BB; Zhang, YS; Xu, RX; Li, X; Dai, YW				Ma, Jianhua; Liu, Ning; Yi, Bo; Zhang, Xiaochong; Gao, Bing Bing; Zhang, Yesen; Xu, Ruxiang; Li, Xin; Dai, Yiwu			Transplanted hUCB-MSCs migrated to the damaged area by SDF-1/CXCR4 signaling to promote functional recovery after traumatic brain injury in rats	NEUROLOGICAL RESEARCH			English	Article						hUCB-MSCs; Traumatic brain injury; SDF-1/CXCR4	MESENCHYMAL STEM-CELLS; THERAPY	Transplanted human umbilical cord mesenchymal stem cells (hUC-MSCs) have exhibited considerable therapeutic potential for traumatic brain injury (TBI). However, how hUC-MSCs migrating to the injury region and the mechanism of hUC-MSCs promoting functional recovery after TBI are still unclear. In this study, we investigated whether stromal cell-derived factor-1 (SDF-1) was involved in the hUC-MSCs migration and the possible mechanisms that might be involved in the beneficial effect on functional recovery. In vitro experiments demonstrated that SDF-1 induces a concentration-dependent migration of hUC-MSCs. Furthermore, pre-treatment with the CXCR4-specific antagonist AMD3100 significantly prevented the migration of hUC-MSCs in vitro. We found that the expression of SDF-1 increased significantly around the damaged area. Transplanted hUC-MSCs were localized to regions where SDF-1 was highly expressed. Additionally, our results showed that hUC-MSCs-treated animals showed significantly improved functional recovery compared with controls. In hUC-MSCs-transplanted group, terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL)-positive cells were decreased and BrdU-positive cells were significantly increased compared with control group, more of BrdU-positive cells co-localized with GFAP. These suggest that SDF-1 plays an important role in the migration of hUC-MSCs to the damaged area and hUC-MSCs are beneficial for functional recovery after TBI.	[Ma, Jianhua; Li, Xin] Peoples Hosp Feicheng Shandong Prov, Feicheng, Peoples R China; [Liu, Ning; Zhang, Yesen; Xu, Ruxiang; Dai, Yiwu] Gen Hosp Beijing Mil Reg, Affiliated Bayi Brain Hosp, Beijing 100700, Peoples R China; [Yi, Bo; Gao, Bing Bing] Anhui Med Univ, Clin Coll Gen Hosp Beijing Mil Reg, Hefei, Peoples R China; [Zhang, Xiaochong] Hebei Med Univ, Hosp 4, Shijiazhuang 050000, Peoples R China		Dai, YW (corresponding author), Gen Hosp Beijing Mil Reg, Affiliated Bayi Brain Hosp, Nan Men Cang 5, Beijing 100700, Peoples R China.	majh1206@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271391]	This work was supported by the National Natural Science Foundation of China (81271391).	Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Itoh T, 2012, J NEURAL TRANSM, V119, P877, DOI 10.1007/s00702-011-0764-9; Keilhoff G, 2006, CELL MOL NEUROBIOL, V26, P1235, DOI 10.1007/s10571-006-9029-9; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Li QM, 2013, FITOTERAPIA, V86, P29, DOI 10.1016/j.fitote.2013.01.015; Li SH, 2012, BRAIN RES, V1444, P76, DOI 10.1016/j.brainres.2011.12.055; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Lim JY, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt79; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Mao WF, 2014, INT J NEUROSCI, V124, P281, DOI 10.3109/00207454.2013.838236; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Shi W, 2012, BIOMATERIALS, V33, P3119, DOI 10.1016/j.biomaterials.2012.01.009; Shukla D, 2010, J NEUROSCI RURAL PRA, V1, P82, DOI 10.4103/0976-3147.71723; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Tong YH, 2011, PHYTOMEDICINE, V18, P443, DOI 10.1016/j.phymed.2010.10.009; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020; Wang Y, 2008, BRAIN RES, V1195, P104, DOI 10.1016/j.brainres.2007.11.068; Yu J, 2010, J CARDIOVASC PHARM, V55, P496, DOI 10.1097/FJC.0b013e3181d7a384; Zendedel A, 2012, BRAIN RES, V1473, P214, DOI 10.1016/j.brainres.2012.07.037	20	23	24	2	21	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JAN	2015	37	1					50	56		10.1179/1743132814Y.0000000399			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AT9DQ	WOS:000345228600008	24919714				2022-02-06	
J	McCammack, KC; Sadler, C; Guo, YY; Ramaswamy, RS; Farid, N				McCammack, Kevin C.; Sadler, Charlotte; Guo, Yueyang; Ramaswamy, Raja S.; Farid, Nikdokht			Routine Repeat Head CT may not be Indicated in Patients on Anticoagulant/Antiplatelet Therapy Following Mild Traumatic Brain Injury	WESTERN JOURNAL OF EMERGENCY MEDICINE			English	Article						Anticoagulation; antiplatelet; mild traumatic brain injury; head computed tomography; intracranial hemorrhage	CRANIAL COMPUTED-TOMOGRAPHY; INTRACRANIAL HEMORRHAGE; SUBARACHNOID HEMORRHAGE; ANTICOAGULATED PATIENTS; DIAGNOSIS; WARFARIN; RISK	Introduction: Evaluation recommendations for patients on anticoagulant and antiplatelet ( ACAP) therapy that present after mild traumatic brain injury (TBI) are controversial. At our institution, an initial noncontrast head computed tomography (HCT) is performed, with a subsequent HCT performed six hours later to exclude delayed intracranial hemorrhage (ICH). This study was performed to evaluate the yield and advisability of this approach. Methods: We performed a retrospective review of subjects undergoing evaluation for ICH after mild TBI in patients on ACAP therapy between January of 2012 and April of 2013. We assessed for the frequency of ICH on both the initial noncontrast HCT and on the routine six-hour follow-up HCT. Additionally, chart review was performed to evaluate the clinical implications of ICH, when present, and to interrogate whether pertinent clinical and laboratory data may predict the presence of ICH prior to imaging. We used multivariate generalized linear models to assess whether presenting Glasgow Coma Score (GCS), loss of consciousness (LOC), neurological or physical examination findings, international normalized ratio, prothrombin time, partial thromboplastin time, platelet count, or specific ACAP regimen predicted ICH. Results: 144 patients satisfied inclusion criteria. Ten patients demonstrated initial HCT positive for ICH, with only one demonstrating delayed ICH on the six-hour follow-up HCT. This patient was discharged without any intervention required or functional impairment. Presenting GCS deviation (p<0.001), LOC (p=0.04), neurological examination findings (p<0.001), clopidogrel (p=0.003), aspirin (p=0.03) or combination regimen (p=0.004) use were more commonly seen in patients with ICH. Conclusion: Routine six-hour follow-up HCT is likely not indicated in patients on ACAP therapy, as our study suggests clinically significant delayed ICH does not occur. Additionally, presenting GCS deviation, LOC, neurological examination findings, clopidogrel, aspirin or combination regimen use may predict ICH, and, in the absence of these findings, HCT may potentially be forgone altogether.	[McCammack, Kevin C.; Guo, Yueyang; Ramaswamy, Raja S.; Farid, Nikdokht] Univ Calif San Diego, Dept Radiol, 200 W Arbor Dr,8756, San Diego, CA 92103 USA; [Sadler, Charlotte] Univ Calif San Diego, Dept Emergency Med, San Diego, CA 92103 USA; [Guo, Yueyang] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA		McCammack, KC (corresponding author), Univ Calif San Diego, Dept Radiol, 200 W Arbor Dr,8756, San Diego, CA 92103 USA.	kmccammack@ucsd.edu					Brewer ES, 2011, J TRAUMA, V70, pE1, DOI 10.1097/TA.0b013e3181e5e286; Byyny RL, 2008, ANN EMERG MED, V51, P697, DOI 10.1016/j.annemergmed.2007.10.007; Garra G, 1999, ACAD EMERG MED, V6, P121, DOI 10.1111/j.1553-2712.1999.tb01048.x; Gittleman AM, 2005, AM J NEURORADIOL, V26, P603; HART RG, 1995, STROKE, V26, P1471, DOI 10.1161/01.STR.26.8.1471; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Kaen A, 2010, J TRAUMA, V68, P895, DOI 10.1097/TA.0b013e3181b28a76; Kirley K, 2012, CIRC-CARDIOVASC QUAL, V5, P615, DOI 10.1161/CIRCOUTCOMES.112.967299; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; Mack LR, 2003, J EMERG MED, V24, P157, DOI 10.1016/S0736-4679(02)00714-X; McLaughlin GE, 2002, ANN INTERN MED, V137, P622, DOI 10.7326/0003-4819-137-7-200210010-00024; Morgenstern LB, 1998, ANN EMERG MED, V32, P297; Nayak NV, 2013, J TRAUMA ACUTE CARE, V75, P273, DOI 10.1097/TA.0b013e3182905eb4; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Peck KA, 2011, J TRAUMA, V71, P1600, DOI 10.1097/TA.0b013e31823b9ce1; Reynolds FD, 2003, J TRAUMA, V54, P492, DOI 10.1097/01.TA.0000051601.60556.FC; Sidman R, 1996, ACAD EMERG MED, V3, P827, DOI 10.1111/j.1553-2712.1996.tb03526.x; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Tauber M, 2009, J TRAUMA, V67, P521, DOI 10.1097/TA.0b013e3181a7c184; Thomas KE, 2008, J SAFETY RES, V39, P269, DOI 10.1016/j.jsr.2008.05.001; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d	21	23	23	0	3	WESTJEM	ORANGE	C/O SHAHRAM LOTFIPOUR, MD, MPH, 333 CITY BLVD W STE 640, RT 128-01, ORANGE, CA 92868 USA	1936-900X	1936-9018		WEST J EMERG MED	West. J. Emerg. Med.	JAN	2015	16	1					43	49		10.5811/westjem.2014.10.19488			7	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	DH9IH	WOS:000373109200008	25671007	gold, Green Published			2022-02-06	
J	Norup, A; Perrin, PB; Cuberos-Urbano, G; Anke, A; Andelic, N; Doyle, ST; Quijano, MC; Caracuel, A; Sosa, DMD; Jove, IGE; Arango-Lasprilla, JC				Norup, Anne; Perrin, Paul B.; Cuberos-Urbano, Gustavo; Anke, Audny; Andelic, Nada; Doyle, Sarah T.; Cristina Quijano, Maria; Caracuel, Alfonso; Diaz Sosa, Dulce Maria; Espinosa Jove, Irma Guadalupe; Carlos Arango-Lasprilla, Juan			Family needs after brain injury: A cross cultural study	NEUROREHABILITATION			English	Article						Traumatic brain injury; caregivers; family needs; cultural differences; global regions	QUALITY-OF-LIFE; CAREGIVER BURDEN; REHABILITATION; HEALTH; TBI; INDIVIDUALS; IMPACT; MODERATE; COMMUNICATION; SATISFACTION	OBJECTIVE: The objective of this study was to explore differences by country in the importance of family needs after traumatic brain injury (TBI), as well as differences in met/unmet needs. METHOD: Two hundred and seventy-one family members of an individual with TBI in Mexico, Colombia, Spain, Denmark, and Norway completed the Family Needs Questionnaire. RESULTS: Eight of the ten needs rated as most important globally were from the Health Information subscale. Importance ratings on the Health Information, Professional Support, and Involvement With Care subscales were similar across countries, but Mexican family members rated Instrumental Support needs as less important than Colombian, Spanish, and Danish family members, and also rated their Community Support needs as less important than Danish and Spanish family members. Mexican family member's rated emotional support needs as less important than Colombian, Spanish, and Danish family members. Globally, the needs rated as most often met were from the Health Information subscale, and the most unmet needs were from the Emotional Support subscale. CONCLUSION: Despite some similarities across countries several differences were identified, and these can help professionals to provide more culturally appropriate rehabilitation services for family members in order to improve informal care for TBI.	[Norup, Anne] Copenhagen Univ Hosp, Traumat Brain Injury Unit, Dept Neurorehabil, RUBRIC Res Unit Brain Injury Rehabil Copenhagen, Glostrup, Denmark; [Perrin, Paul B.; Doyle, Sarah T.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Caracuel, Alfonso] Univ Granada, Mind Brain & Behav Res Ctr, Dept Dev & Educ Psychol, Granada, Spain; [Anke, Audny] Univ Hosp North Norway, Dept Rehabil, Tromso, Norway; [Anke, Audny] Univ Tromso, Dept Clin Med, Fac Hlth Sci, N-9001 Tromso, Norway; [Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Cristina Quijano, Maria] Javeriana Univ, Cali, Colombia; [Andelic, Nada] Univ Oslo, Fac Med, Inst Hlth & Soc, CHARM Res Ctr Habilitat & Rehabil Models & Serv, Oslo, Norway; [Cuberos-Urbano, Gustavo] Univ Granada, Dept Personal Assessment & Psychol Treatment, Granada, Spain; [Diaz Sosa, Dulce Maria] Univ Nacl Autonoma Mexico, Dept Psychol, Mexico City 04510, DF, Mexico; [Espinosa Jove, Irma Guadalupe] Inst Nacl Rehabil Mexico, Mexico City, DF, Mexico; [Carlos Arango-Lasprilla, Juan] Univ Deusto, Ikerbasque, Basque Fdn Sci, Bilbao, Spain		Arango-Lasprilla, JC (corresponding author), Univ Deusto, Ikerbasque, Basque Fdn Sci, Dept Psychol, Bilbao, Spain.	jcarango@deusto.es	Caracuel, Alfonso/V-3695-2019; Perrin, Paul/L-5373-2015	Caracuel, Alfonso/0000-0002-9738-8456; Norup, Anne/0000-0002-5598-6116; Quijano Martinez, Maria Cristina/0000-0003-3548-1628; Anke, Audny/0000-0002-2491-2560; Perrin, Paul/0000-0003-2070-215X; Andelic, Nada/0000-0002-3719-4406			Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Andelic N., 2012, LANCET NEUROLOGY; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Arango-Lasprilla JC, 2011, J REHABIL MED, V43, P983, DOI 10.2340/16501977-0883; Arango-Lasprilla JC, 2010, NEUROREHABILITATION, V27, P83, DOI 10.3233/NRE-2010-0583; Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; Arango-Lasprilla JC, 2009, PM&R, V1, P41, DOI 10.1016/j.pmrj.2008.07.001; Gorn SB, 2013, REV PANAM SALUD PUBL, V33, P252, DOI 10.1590/S1020-49892013000400003; Borg J, 2011, AM J PHYS MED REHAB, V90, P65, DOI 10.1097/PHM.0b013e3181fc80e7; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Engberg Aase Worsaae, 2007, Ugeskr Laeger, V169, P204; Engberg AW, 2006, ACTA NEUROL SCAND, V113, P178, DOI 10.1111/j.1600-0404.2005.00570.x; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Forslund MV, 2013, J REHABIL MED, V45, P801, DOI 10.2340/16501977-1168; Galanti Geri-Ann, 2003, J Transcult Nurs, V14, P180, DOI 10.1177/1043659603014003004; Gamboa AM, 2006, NEUROREHABILITATION, V21, P327; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Javouhey E, 2006, ACCIDENT ANAL PREV, V38, P225, DOI 10.1016/j.aap.2005.08.001; Kolakowsky-Hayner SA, 2000, ARCH CLIN NEUROPSYCH, V15, P810; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lehan TJ, 2012, NEUROREHABILITATION, V30, P75, DOI 10.3233/NRE-2012-0729; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; Leibach GG, 2014, NEUROREHABILITATION, V34, P167, DOI 10.3233/NRE-131013; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; Moules S, 1999, BRAIN INJURY, V13, P983; Norup A., 2013, SEVERE BRAIN INJURY; Norup A, 2012, BRAIN INJURY, V26, P1192, DOI 10.3109/02699052.2012.672790; Norup A, 2010, BRAIN INJURY, V24, P81, DOI 10.3109/02699050903508200; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Wright J., 2009, PERCEPTIONS MENTAL H	52	23	23	0	11	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2015	36	2					203	214		10.3233/NRE-151208			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CK9CW	WOS:000356539100006	26410614				2022-02-06	
J	Sun, M; Zhao, YM; Gu, Y; Zhang, YZ				Sun, Ming; Zhao, Yumei; Gu, Yi; Zhang, Yazhuo			Protective Effects of Taurine against Closed Head Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						oxidative stress; closed head injury; neuroprotection; taurine	TRAUMATIC BRAIN-INJURY; DOWN-REGULATING CALPAIN; FOCAL CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; LIPID-PEROXIDATION; CELL-DAMAGE; PATHOPHYSIOLOGY; ANTIOXIDANTS; STROKE; MODEL	Taurine, an abundant amino acid in the nervous system, is reported to reduce ischemic brain injury in a dose-dependent manner. This study was designed to investigate whether taurine protected the brain against closed head injury (CHI) in rats. Taurine was administered intravenously 30 min after CHI. It was found that taurine lessened body-weight loss and improved neurological functions at 7 days after CHI. Moreover, it lowered brain edema and blood-brain barrier permeability, enhanced activity of superoxide dismutase and the level of glutathione, and reduced levels of malondialdehyde and lactic acid in traumatic tissue 24 h after CHI. In addition, it attenuated neuronal cell death in hippocampal CA1 and CA3 subfields 7 days after CHI. All of these effects were dose dependent. These data demonstrated the dose-dependent protection of taurine against experimental CHI and suggest that taurine treatment might be beneficial in reducing trauma-induced oxidative damage to the brain, thus showing the potential for clinical implications.	[Sun, Ming; Zhao, Yumei; Gu, Yi] Beijing Neurosurg Inst, Dept Neuropharmacol, Beijing 100050, Peoples R China; [Zhang, Yazhuo] Beijing Neurosurg Inst, Dept Cytobiol, Beijing 100050, Peoples R China		Zhang, YZ (corresponding author), Beijing Neurosurg Inst, Dept Cytobiol, 6 Tiantan Xili, Beijing 100050, Peoples R China.	yazhuozhang@yahoo.com					Beni SM, 2004, FASEB J, V18, P149, DOI 10.1096/fj.03-0323fje; Birdsall T C, 1998, Altern Med Rev, V3, P128; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRALET J, 1991, BRAIN RES, V539, P175, DOI 10.1016/0006-8993(91)90703-X; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; CARRUTHERSJONES DI, 1978, NEUROCHEM RES, V3, P115, DOI 10.1007/BF00964364; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chao PK, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-121; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; El Idrissi A, 2008, AMINO ACIDS, V34, P321, DOI 10.1007/s00726-006-0396-9; El Idrissi A, 2003, ADV EXP MED BIOL, V526, P515; Furukawa S., 1991, J JPN PHARM THER, V19, P275; Griesemer D, 2007, J NEUROTRAUM, V24, P1823, DOI 10.1089/neu.2006.0237; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hanna J, 2004, EXP TOXICOL PATHOL, V56, P189, DOI 10.1016/j.etp.2004.08.004; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; JACOBSON I, 1985, J NEUROSCI METH, V15, P263, DOI 10.1016/0165-0270(85)90107-4; Lallemand F, 2004, AMINO ACIDS, V26, P111, DOI 10.1007/s00726-003-0058-0; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; Louzada PR, 2004, FASEB J, V18, P511, DOI 10.1096/fj.03-0739com; Mankovskaya I N, 2000, High Alt Med Biol, V1, P105, DOI 10.1089/15270290050074242; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McCarthy MM, 2003, EXP NEUROL, V184, P40, DOI 10.1016/j.expneurol.2003.08.020; Messina SA, 2000, ADV EXP MED BIOL, V483, P355; Michalk DV, 1996, ADV EXP MED BIOL, V403, P223; Nishizawa Y., 1991, JPN PHARMACOL THER, V19, P307; PASANTESMORALES H, 1981, J NEUROSCI RES, V6, P465, DOI 10.1002/jnr.490060404; Pushpakiran G, 2004, AMINO ACIDS, V27, P91, DOI 10.1007/s00726-004-0066-8; RASCHKE P, 1995, FREE RADICAL BIO MED, V19, P461, DOI 10.1016/0891-5849(95)00044-X; Runnerstam M, 2001, J NEUROTRAUM, V18, P259, DOI 10.1089/08977150151070892; SANBERG PR, 1980, NEUROSCI LETT, V16, P297, DOI 10.1016/0304-3940(80)90014-2; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; Saransaari P, 2000, AMINO ACIDS, V19, P509, DOI 10.1007/s007260070003; Schaffer SW, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S2; Schuller-Levis GB, 2004, NEUROCHEM RES, V29, P117, DOI 10.1023/B:NERE.0000010440.37629.17; Shao A, 2008, REGUL TOXICOL PHARM, V50, P376, DOI 10.1016/j.yrtph.2008.01.004; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; SIESJO BK, 1985, J CEREBR BLOOD F MET, V5, P253, DOI 10.1038/jcbfm.1985.32; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Smith SL, 1996, J NEUROSURG, V84, P229, DOI 10.3171/jns.1996.84.2.0229; Sun M, 2008, CELL MOL NEUROBIOL, V28, P593, DOI 10.1007/s10571-007-9183-8; Sun M, 2012, AMINO ACIDS, V42, P1735, DOI 10.1007/s00726-011-0885-3; Sun M, 2011, AMINO ACIDS, V40, P1419, DOI 10.1007/s00726-010-0751-8; Sun M, 2009, NEUROCHEM INT, V54, P339, DOI 10.1016/j.neuint.2008.12.017; Tamai I, 1995, BIOCHEM PHARMACOL, V50, P1783, DOI 10.1016/0006-2952(95)02046-2; URQUHART N, 1974, J NEUROCHEM, V22, P871, DOI 10.1111/j.1471-4159.1974.tb04309.x; Ustun ME, 2001, J NEUROSURG ANESTH, V13, P227; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wojcik OP, 2010, ATHEROSCLEROSIS, V208, P19, DOI 10.1016/j.atherosclerosis.2009.06.002; Yildirim ZL, 2007, ANN NY ACAD SCI, V1100, P553, DOI 10.1196/annals.1395.061	53	23	23	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2015	32	1					66	74		10.1089/neu.2012.2432			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AX4JX	WOS:000346900100009	23327111				2022-02-06	
J	Hochstadter, E; Stewart, TC; Alharfi, IM; Ranger, A; Fraser, DD				Hochstadter, Elana; Stewart, Tanya Charyk; Alharfi, Ibrahim M.; Ranger, Adrianna; Fraser, Douglas D.			Subarachnoid Hemorrhage Prevalence and Its Association with Short-Term Outcome in Pediatric Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Children; Severe traumatic brain injury; Subarachnoid hemorrhage; Mortality	SEVERE HEAD-INJURY; COMPUTERIZED-TOMOGRAPHY; POSTTRAUMATIC VASOSPASM; PROGRESSIVE HEMORRHAGE; CEREBRAL VASOSPASM; PROGNOSTIC FACTORS; RISK-FACTORS; TIME-COURSE; CHILDREN; COAGULOPATHY	Subarachnoid hemorrhage (SAH) is an independent prognostic indicator of outcome in adult severe traumatic brain injury (sTBI). There is a paucity of investigations on SAH in pediatric sTBI. The goal of this study was to determine in pediatric sTBI patients SAH prevalence, associated factors, and its relationship to short-term outcome. We retrospectively analyzed 171 sTBI patients (pre-sedation GCS a parts per thousand currency sign8 and head MAIS a parts per thousand yen4) who underwent CT head imaging within the first 24 h of hospital admission. Data were analyzed with both univariate and multivariate techniques. SAH was found in 42 % of sTBI patients (n = 71/171), and it was more frequently associated with skull fractures, cerebral edema, diffuse axonal injury, contusion, and intraventricular hemorrhage (p < 0.05). Patients with SAH had higher Injury Severity Scores (p = 0.032) and a greater frequency of fixed pupil(s) on admission (p = 0.001). There were no significant differences in etiologies between sTBI patients with and without SAH. Worse disposition occurred in sTBI patients with SAH, including increased mortality (p = 0.009), increased episodes of central diabetes insipidus (p = 0.002), greater infection rates (p = 0.002), and fewer ventilator-free days (p = 0.001). In sTBI survivors, SAH was associated with increased lengths of stay (p < 0.001) and a higher level of care required on discharge (p = 0.004). Despite evidence that SAH is linked to poorer outcomes on univariate analyses, multivariate analysis failed to demonstrate an independent association between SAH and mortality (p = 0.969). SAH was present in almost half of pediatric sTBI patients, and it was indicative of TBI severity and a higher level of care on discharge. SAH in pediatric patients was not independently associated with increased risk of mortality.	[Hochstadter, Elana; Alharfi, Ibrahim M.; Fraser, Douglas D.] Univ Western Ontario, Dept Pediat, London, ON N6A 3K7, Canada; [Stewart, Tanya Charyk] Univ Western Ontario, Dept Surg, London, ON N6A 3K7, Canada; [Stewart, Tanya Charyk] London Hlth Sci Ctr, Trauma Program, London, ON, Canada; [Alharfi, Ibrahim M.] King Fahad Med City, Childrens Hosp, Pediat Crit Care, Riyadh, Saudi Arabia; [Ranger, Adrianna; Fraser, Douglas D.] Univ Western Ontario, London, ON, Canada; [Ranger, Adrianna; Fraser, Douglas D.] Childrens Hlth Res Inst, London, ON, Canada; [Fraser, Douglas D.] Translat Res Ctr, London, ON, Canada; [Fraser, Douglas D.] LHSC, Childrens Hosp, London, ON N6A 5W9, Canada		Fraser, DD (corresponding author), LHSC, Childrens Hosp, Room C2-C82,800 Commissioners Rd E, London, ON N6A 5W9, Canada.	douglas.fraser@lhsc.on.ca					Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Alharfi IM, 2014, J NEUROTRAUM, V31, P452, DOI [10.1089/neu.2013.2904, 10.1089/NEU.2013.2904]; Alharfi IM, 2013, J NEUROTRAUM, V30, P361, DOI 10.1089/neu.2012.2410; Alharfi IM, 2013, PEDIATR CRIT CARE ME, V14, P203, DOI 10.1097/PCC.0b013e31827127b5; American College of Surgeons, 2008, ADV TRAUM LIF SUPP D; Aminmansour B, 2009, J RES MED SCI, V14, P343; Armin SS, 2006, NEUROL RES, V28, P445, DOI 10.1179/016164106X115053; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Chiaretti A, 2001, PEDIATR NEUROSURG, V34, P131, DOI 10.1159/000056008; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Chun KA, 2010, J NEUROTRAUM, V27, P325, DOI 10.1089/neu.2009.1115; Teruel GC, 2007, J PEDIATR SURG, V42, P1903, DOI 10.1016/j.jpedsurg.2007.07.020; Compton J S, 1987, Br J Neurosurg, V1, P435, DOI 10.3109/02688698708999633; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Franschman G, 2012, J NEUROTRAUM, V29, P128, DOI 10.1089/neu.2011.2044; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; Greene KA, 1996, J TRAUMA, V41, P964, DOI 10.1097/00005373-199612000-00004; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hirsch W, 2002, PAEDIATR ANAESTH, V12, P337, DOI 10.1046/j.1460-9592.2002.00837.x; Hosmer D, 1989, APPL LOGISTIC REGRES; Hutchison J, 2006, DEV NEUROSCI-BASEL, V28, P291, DOI 10.1159/000094155; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; KALFF R, 1989, CHILD NERV SYST, V5, P156, DOI 10.1007/BF00272118; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; Morrison Gavin, 2013, Pathophysiology, V20, P49, DOI 10.1016/j.pathophys.2012.02.006; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Ngo QN, 2009, PEDIATR CRIT CARE ME, V10, P346, DOI 10.1097/PCC.0b013e3181a320cd; O'Brien NF, 2010, INTENS CARE MED, V36, P680, DOI 10.1007/s00134-009-1747-2; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pillai S, 2001, PEDIATR NEUROSURG, V34, P98, DOI 10.1159/000056002; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Servadei F, 2002, NEUROSURGERY, V50, P7; Shahlaie K, 2011, J NEUROSURG, V115, P602, DOI 10.3171/2011.5.JNS101667; Sigurta A, 2013, INTENS CARE MED, V39, P129, DOI 10.1007/s00134-012-2748-0; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Stewart TC, 2013, J TRAUMA ACUTE CARE, V75, P836, DOI 10.1097/TA.0b013e3182a685b0; Taneda M, 1996, J NEUROSURG, V84, P762, DOI 10.3171/jns.1996.84.5.0762; Tomberg T, 1996, ACTA NEUROCHIR, V138, P543, DOI 10.1007/BF01411174; Tu CJ, 2011, J INT MED RES, V39, P1757, DOI 10.1177/147323001103900518; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wong M. F. M., 1998, Annals Academy of Medicine Singapore, V27, P340	54	23	23	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2014	21	3					505	513		10.1007/s12028-014-9986-7			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AT2TY	WOS:000344790100017	24798696				2022-02-06	
J	Jonsson, CCA; Emanuelson, IM; Smedler, AC				Jonsson, Catherine C. Aaro; Emanuelson, Ingrid M.; Smedler, Ann Charlotte			Variability in quality of life 13 years after traumatic brain injury in childhood	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						children; long-term outcomes; quality of life; traumatic brain injury	PORTLAND ADAPTABILITY INVENTORY; CHILDREN; ADOLESCENTS; OUTCOMES; HEALTH; REHABILITATION; EPIDEMIOLOGY; DISABILITY; DEFICITS; RATINGS	With the aim of describing variability in the long-term outcome of quality of life after neurosurgically treated pediatric traumatic brain injury, mostly self-reports of 21 individuals with mild or moderate/severe injury were gathered using Mayo-Portland Adaptability Inventory in telephone interviews 13 years aftyer injury. A majority of the participants reported brain injury-related problems. The median outcome on Mayo-Portland Adaptability Inventory was mild to moderate limitations. The variation within the moderate/severe group varied between relatively good outcome and moderate/severe limitations. Concentration, irritability, fatigue, and transportation were reported as the most problematic areas, whereas self-care was reported as well functioning. Societal participation appeared to be the best functional domain in this Swedish study. Examples of individual reports of the life-situation at various outcome levels were provided. Variability in outcome is large within severity groups, and research may gain by addressing both outcomes of the individuals and groups. Objective questions of outcome should be accompanied by questions of actual functioning in everyday life. To ensure long-term support for quality of life for those with remaining dysfunction after pediatric traumatic brain injury, healthcare systems should implement systematic routines for referral to rehabilitation and support. (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Jonsson, Catherine C. Aaro] Ostersund Hosp, Jamtland Cty Council Child & Youth Rehabil, Res & Dev Unit, S-83183 Ostersund, Sweden; [Emanuelson, Ingrid M.] Univ Gothenburg, Dept Pediat, Inst Clin Sci, Gothenburg, Sweden; [Smedler, Ann Charlotte] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden		Jonsson, CCA (corresponding author), Ostersund Hosp, Jamtland Cty Council Child & Youth Rehabil, Res & Dev Unit, S-83183 Ostersund, Sweden.	catherine.aaro.jonsson@jll.se					Aaro Jonsson C, 2010, THESIS STOCKHOLM U S; Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Anderson V, 2012, J NEUROTRAUM, V29, P143, DOI 10.1089/neu.2011.2012; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Beardmore S, 1999, NEUROPSYCHOL REHABIL, V9, P45, DOI 10.1080/713755588; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Chapman SB, 2001, J HEAD TRAUMA REHAB, V16, P441, DOI 10.1097/00001199-200110000-00004; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Emanuelson I, 1998, Pediatr Rehabil, V2, P65; Emanuelson I, 1997, ACTA PAEDIATR, V86, P730, DOI 10.1111/j.1651-2227.1997.tb08576.x; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Green L, 2012, DEV NEUROREHABIL, V15, P105, DOI 10.3109/17518423.2011.638331; Hanten G, 2004, DEV NEUROPSYCHOL, V25, P85, DOI 10.1207/s15326942dn2501&2_6; Horneman G, 2005, INT J REHABIL RES, V28, P245, DOI 10.1097/00004356-200509000-00007; Jacobsson LJ, 2011, NEUROPSYCHOL REHABIL, V21, P383, DOI 10.1080/09602011.2011.566711; Johansson B, 2012, BRAIN INJURY, V26, P1621, DOI 10.3109/02699052.2012.700082; Jonsson CA, 2009, BRAIN INJURY, V23, P1008, DOI 10.3109/02699050903379354; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Lexell J, 2012, J REHABIL MED, V44, P65, DOI 10.2340/16501977-0897; Malec JF, 2004, BRAIN INJURY, V18, P563, DOI 10.1080/02699050310001646134; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Martin-Herz SP, 2012, CLIN CHILD FAM PSYCH, V15, P192, DOI 10.1007/s10567-012-0115-x; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Nybo T, 2004, J INT NEUROPSYCH SOC, V10, P719, DOI 10.1017/S1355617704105109; Oddson B, 2006, DEV MED CHILD NEUROL, V48, P918, DOI 10.1017/S0012162206002003; Renstrom B, 2012, BRAIN INJURY, V26, P1405, DOI 10.3109/02699052.2012.694559; Segui-Gomez M, 2003, EPIDEMIOL REV, V25, P3, DOI 10.1093/epirev/mxg007; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Walther SM, 2003, INTENS CARE MED, V29, P933, DOI 10.1007/s00134-003-1757-4	35	23	23	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0342-5282	1473-5660		INT J REHABIL RES	Int. J. Rehabil. Res.	DEC	2014	37	4					317	322		10.1097/MRR.0000000000000073			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	AT4NM	WOS:000344916100006	25153788				2022-02-06	
J	Shih, J; Liu, L; Mason, A; Higashimori, H; Donmez, G				Shih, Jennifer; Liu, Lei; Mason, Andrew; Higashimori, Haruki; Donmez, Gizem			Loss of SIRT4 decreases GLT-1-dependent glutamate uptake and increases sensitivity to kainic acid	JOURNAL OF NEUROCHEMISTRY			English	Article						excitotoxicity; GLT-1; glutamate transport; kainic acid; sirtuins	SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; TRANSPORTER GLT1; SIRTUINS; EXCITOTOXICITY; METABOLISM; ASTROCYTES; PHYSIOLOGY; SYNAPSES; NEURONS	Glutamate transport is a critical process in the brain that maintains low extracellular levels of glutamate to allow for efficient neurotransmission and prevent excitotoxicity. Loss of glutamate transport function is implicated in epilepsy, traumatic brain injury, and amyotrophic lateral sclerosis. It remains unclear whether or not glutamate transport can be modulated in these disease conditions to improve outcome. Here, we show that sirtuin (SIRT)4, a mitochondrial sirtuin, is up-regulated in response to treatment with the potent excitotoxin kainic acid. Loss of SIRT4 leads to a more severe reaction to kainic acid and decreased glutamate transporter expression and function in the brain. Together, these results indicate a critical and novel stress response role for SIRT4 in promoting proper glutamate transport capacity and protecting against excitotoxicity.	[Shih, Jennifer; Liu, Lei; Mason, Andrew; Higashimori, Haruki; Donmez, Gizem] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; [Shih, Jennifer] Tufts Univ, Sackler Sch Biomed Sci, Neurosci Program, Boston, MA 02111 USA		Donmez, G (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, 136 Harrison Ave, Boston, MA 02111 USA.	gizem.donmez@tufts.edu	Liu, Lei/P-8355-2016; Yalcin, Gizem Donmez/AAG-5056-2019	Liu, Lei/0000-0001-5992-7423; Yalcin, Gizem Donmez/0000-0002-5121-8232	Tufts University Department of Neuroscience startup fund; Tufts Center for Neuroscience Research Pilot Award; Charlton Research Award	We thank Dr Yongjie Yang for help with the glutamate uptake assay and for providing reagents and antibodies for pilot studies. We thank Dr Laura Liscum and members of the Liscum laboratory for use of radioactivity facilities. We thank Dr Rob Jackson, Dr Chris Dulla, Dr Michele Jacob, and Dr Yongjie Yang for critical reading of manuscript drafts. This study was supported by funds from the Tufts University Department of Neuroscience startup fund (to G.D.), the Tufts Center for Neuroscience Research Pilot Award (to G.D.), and the Charlton Research Award (to G.D.). The authors disclose that they have no conflicts of interest.	Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Bai Fengju, 2007, V43, P77, DOI 10.1007/978-1-4020-5943-8_6; Berdichevsky A, 2006, CELL CYCLE, V5, P2588, DOI 10.4161/cc.5.22.3513; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Conti F, 1999, TRENDS NEUROSCI, V22, P451, DOI 10.1016/S0166-2236(99)01445-9; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Donmez G, 2012, TRENDS PHARMACOL SCI, V33, P494, DOI 10.1016/j.tips.2012.05.007; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Gimenez-Cassina A, 2012, NEURON, V74, P719, DOI 10.1016/j.neuron.2012.03.032; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Higashimori H, 2013, HUM MOL GENET, V22, P2041, DOI 10.1093/hmg/ddt055; Jabaudon D, 2000, P NATL ACAD SCI USA, V97, P5610, DOI 10.1073/pnas.97.10.5610; Jeong SM, 2013, CANCER CELL, V23, P450, DOI 10.1016/j.ccr.2013.02.024; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; KENNEDY BK, 1995, CELL, V80, P485, DOI 10.1016/0092-8674(95)90499-9; Komlos D, 2013, GLIA, V61, P394, DOI 10.1002/glia.22442; Laurent G, 2013, MOL CELL, V50, P686, DOI 10.1016/j.molcel.2013.05.012; Ho L, 2013, AGING-US, V5, P835, DOI 10.18632/aging.100616; Matute C, 2002, EUR J PHARMACOL, V447, P239, DOI 10.1016/S0014-2999(02)01847-2; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; NOVELLI A, 1988, BRAIN RES, V451, P205, DOI 10.1016/0006-8993(88)90765-2; Pellerin L, 2004, NEUROSCIENTIST, V10, P53, DOI 10.1177/1073858403260159; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Robinson MB, 2002, J NEUROCHEM, V80, P1, DOI 10.1046/j.0022-3042.2001.00698.x; Rothstein J. D., 1994, ADV NEUROL, V68, P7; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Shih Jennifer, 2013, Genes Cancer, V4, P91, DOI 10.1177/1947601912474931; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Trotti D, 1999, NAT NEUROSCI, V2, P427, DOI 10.1038/8091; Voutsinos-Porche B, 2003, NEURON, V37, P275, DOI 10.1016/S0896-6273(02)01170-4; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Xu NJ, 2003, J NEUROSCI, V23, P4775	37	23	25	1	11	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	DEC	2014	131	5					573	581		10.1111/jnc.12942			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	AU0YQ	WOS:000345348500005	25196144	Bronze			2022-02-06	
J	Sun, YJ; Lin, YF; Cao, XL; Xiang, L; Qi, JH				Sun, Yujuan; Lin, Yanfei; Cao, Xueli; Xiang, Lan; Qi, Jianhua			Sterols from Mytilidae Show Anti-Aging and Neuroprotective Effects via Anti-Oxidative Activity	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						neuroprotection; anti-aging; anti-oxidative stress; Mytilidae; sterols; UTH1; SOD; Alzheimer's disease	TRAUMATIC BRAIN-INJURY; OXIDATIVE-STRESS; ALZHEIMERS-DISEASE; LIFE-SPAN; PATHWAY; YEAST; NEURODEGENERATION; CRINOSTEROL; RAPAMYCIN; SOD	For screening anti-aging samples from marine natural products, K6001 yeast strain was employed as a bioassay system. The active mussel extract was separated to give an active sterol fraction (SF). SF was further purified, and four sterol compounds were obtained. Their structures were determined to be cholesterol (CHOL), brassicasterol, crinosterol, and 24-methylenecholesterol. All compounds showed similar anti-aging activity. To understand the action mechanism involved, anti-oxidative experiments, reactive oxygen species (ROS) assays, and malondialdehyde (MDA) tests were performed on the most abundant compound, CHOL. Results indicated that treatment with CHOL increases the survival rate of yeast under oxidative stress and decreases ROS and MDA levels. In addition, mutations of uth1, skn7, sod1, and sod2, which feature a K6001 background, were employed and the lifespans of the mutations were not affected by CHOL. These results demonstrate that CHOL exerts anti-aging effects via anti-oxidative stress. Based on the connection between neuroprotection and anti-aging, neuroprotective experiments were performed in PC12 cells. Paraquat was used to induce oxidative stress and the results showed that the CHOL and SF protect the PC12 cells from the injury induced by paraquat. In addition, these substance exhibited nerve growth factor (NGF) mimic activities again confirmed their neuroprotective function.	[Sun, Yujuan; Lin, Yanfei; Cao, Xueli; Xiang, Lan; Qi, Jianhua] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310058, Zhejiang, Peoples R China		Xiang, L (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Yu Hang Tang Rd 866, Hangzhou 310058, Zhejiang, Peoples R China.	11119014@zju.edu.cn; 11219008@zju.edu.cn; 11319006@zju.edu.cn; lxiang@zju.edu.cn; qijianhua@zju.edu.cn			Key Construction Program of the National "985" Project [2012HY017B]; International Science and Technology Cooperation Program of China [2014DFG32690]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81273385]	This work was financially supported by Key Construction Program of the National "985" Project (Grant No. 2012HY017B); International Science and Technology Cooperation Program of China (Grant No. 2014DFG32690); and National Natural Science Foundation of China (Grant No. 81273385). We are grateful to Michael Breitenbach (Salzburg University, Austria) for gifts of K6001 yeast strain and also grateful to Akira Matsuura (Chiba University, Japan) for gifts of strain BY4741 and all mutations with the K6001 background.	[Anonymous], 2008, SPSS BIOST SOFTW VER; Bandara PDS, 1998, CURR GENET, V34, P259, DOI 10.1007/s002940050395; BERGMANN W, 1949, J ORG CHEM, V14, P1078, DOI 10.1021/jo01158a016; Blagosklonny MV, 2009, AGING-US, V1, P281, DOI 10.18632/aging.100034; BOLKER HI, 1967, NATURE, V213, P905, DOI 10.1038/213905a0; Chen W, 2014, NEUROCHEM INT, V68, P28, DOI 10.1016/j.neuint.2014.01.015; Hamaguchi T, 2010, CNS NEUROSCI THER, V16, P285, DOI 10.1111/j.1755-5949.2010.00147.x; Hughes KA, 2005, ANNU REV ENTOMOL, V50, P421, DOI 10.1146/annurev.ento.50.071803.130409; Jiang T, 2014, BRIT J PHARMACOL, V171, P3146, DOI 10.1111/bph.12655; Kickstein E, 2010, P NATL ACAD SCI USA, V107, P21830, DOI 10.1073/pnas.0912793107; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kiyoshi S., 1963, CHEM PHARM BULL, V11, P650; LANG RW, 1982, HELV CHIM ACTA, V65, P407, DOI 10.1002/hlca.19820650144; Lu WG, 2004, STEROIDS, V69, P803, DOI 10.1016/j.steroids.2004.09.010; Mulford KE, 2011, EUKARYOT CELL, V10, P761, DOI 10.1128/EC.00328-10; Olsher M, 2005, BIOCHEMISTRY-US, V44, P2080, DOI 10.1021/bi047710s; Orr ME, 2014, NEUROBIOL AGING, V35, P1233, DOI 10.1016/j.neurobiolaging.2013.12.006; Pan TH, 2008, NEUROBIOL DIS, V32, P16, DOI 10.1016/j.nbd.2008.06.003; Prince M., 2013, WORLD ALZHEIMER REPO; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; Roberti G, 2014, J CELL PHYSIOL, V229, P1130, DOI 10.1002/jcp.24573; SMITH LL, 1991, FREE RADICAL BIO MED, V11, P47, DOI 10.1016/0891-5849(91)90187-8; Sun KY, 2013, INT J MOL SCI, V14, P4461, DOI 10.3390/ijms14034461; Thapa A, 2013, LANGMUIR, V29, P11713, DOI 10.1021/la4020459; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Turton HE, 1997, J BACTERIOL, V179, P1096, DOI 10.1128/jb.179.4.1096-1101.1997; Walhovd KB, 2014, SCAND J PSYCHOL, V55, P244, DOI 10.1111/sjop.12120; Weng YF, 2010, BIOORGAN MED CHEM, V18, P999, DOI 10.1016/j.bmc.2009.12.070; Wu WQ, 2014, FOOD FUNCT, V5, P158, DOI 10.1039/c3fo60400d; Xiang L, 2011, BIOSCI BIOTECH BIOCH, V75, P854, DOI 10.1271/bbb.100774; [杨若林 Yang Ruolin], 2003, [中国海洋药物, Chinese Journal of Marine Drugs], V22, P31; Yang W, 2013, INT J MOL SCI, V14, P24200, DOI 10.3390/ijms141224200; Yi JH, 2008, BRAIN RES, V1244, P164, DOI 10.1016/j.brainres.2008.09.074	33	23	25	7	53	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1661-6596	1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	DEC	2014	15	12					21660	21673		10.3390/ijms151221660			14	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	AX2TM	WOS:000346797400005	25429428	Green Published, Green Submitted, gold			2022-02-06	
J	Cocchi, MN; Boone, MD; Giberson, B; Giberson, T; Farrell, E; Salciccioli, JD; Talmor, D; Williams, D; Donnino, MW				Cocchi, Michael N.; Boone, Myles D.; Giberson, Brandon; Giberson, Tyler; Farrell, Emily; Salciccioli, Justin D.; Talmor, Daniel; Williams, Donna; Donnino, Michael W.			Fever After Rewarming: Incidence of Pyrexia in Postcardiac Arrest Patients Who Have Undergone Mild Therapeutic Hypothermia	JOURNAL OF INTENSIVE CARE MEDICINE			English	Article						cardiac arrest; fever; therapeutic hypothermia	HOSPITAL CARDIAC-ARREST; BRAIN-INJURY; STROKE; HYPERTHERMIA; TEMPERATURE; RESUSCITATION; METAANALYSIS; SURVIVORS	Background: Induction of mild therapeutic hypothermia (TH; temperature 32-34 degrees C) has become standard of care in many hospitals for comatose survivors of cardiac arrest. Pyrexia, or fever, is known to be detrimental in patients with neurologic injuries such as stroke or trauma. The incidence of pyrexia in the postrewarming phase of TH is unknown. We attempted to determine the incidence of fever after TH and hypothesized that those patients who were febrile after rewarming would have worse clinical outcomes than those who maintained normothermia in the postrewarming period. Methods: Retrospective data analysis of survivors of out-of-hospital cardiac arrest (OHCA) over a period of 29 months (December 2007 to April 2010). Inclusion criteria: OHCA, age >18, return of spontaneous circulation, and treatment with TH. Exclusion criteria: traumatic arrest and pregnancy. Data collected included age, sex, neurologic outcome, mortality, and whether the patient developed fever (temperature >100.4 degrees F, 38 degrees C) within 24 hours after being fully rewarmed to a normal core body temperature after TH. We used simple descriptive statistics and Fisher exact test to report our findings. Results: A total of 149 patients were identified; of these, 82 (55%) underwent TH. The mean age of the TH cohort was 66 years, and 28 (31%) were female. In all, 54 patients survived for >24 hours after rewarming and were included in the analysis. Among the analyzed cohort, 28 (52%) of 54 developed fever within 24 hours after being rewarmed. Outcome measures included in-hospital mortality as well as neurologic outcome as defined by a dichotomized Cerebral Performance Category (CPC) score. When comparing neurologic outcomes between the groups, 16 (57%) of 28 in the postrewarming fever group had a poor outcome (CPC score 3-5), while 15 (58%) of 26 in the no-fever group had a favorable outcome (P = .62). In the fever group, 15 (52%) of 28 died, while in the no-fever group, 14 (54%) of 26 died (P = .62). Conclusion: Among a cohort of patients who underwent mild TH after OHCA, more than half of these patients developed pyrexia in the first 24 hours after rewarming. Although there were no significant differences in outcomes between febrile and nonfebrile patients identified in this study, these findings should be further evaluated in a larger cohort. Future investigations may be needed to determine whether postrewarming temperature management will improve the outcomes in this population.	[Cocchi, Michael N.; Giberson, Brandon; Giberson, Tyler; Farrell, Emily; Salciccioli, Justin D.; Donnino, Michael W.] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Cocchi, Michael N.; Boone, Myles D.; Talmor, Daniel] Beth Israel Deaconess Med Ctr, Div Crit Care, Dept Anesthesia Crit Care, Boston, MA 02215 USA; [Williams, Donna] Beth Israel Deaconess Med Ctr, Div Cardiol, Dept Med, Boston, MA 02215 USA; [Donnino, Michael W.] Beth Israel Deaconess Med Ctr, Div Pulm Crit Care, Dept Med, Boston, MA 02215 USA		Cocchi, MN (corresponding author), Beth Israel Deaconess Med Ctr, Dept Emergency Med, West CC 2,One Deaconess Rd, Boston, MA 02215 USA.	mcocchi@bidmc.harvard.edu			Harvard Clinical and Translational Science Center, from the National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1 RR025758]; American Heart AssociationAmerican Heart Association [10CRP2640126]; NHLBIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [1K02HL107447-01A1]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K02HL107447] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship and/or publication of this article: The project described was supported, in part, by Grant Number UL1 RR025758-Harvard Clinical and Translational Science Center, from the National Center for Research Resources. Dr Cocchi was funded by the American Heart Association during the time of this investigation (10CRP2640126). Dr Donnino is supported by NHLBI (1K02HL107447-01A1).	[Anonymous], 2002, N ENGL J MED, V346, P549; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; Corbett D, 2000, BRAIN PATHOL, V10, P145; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; Dietrich WD, 2007, PROG BRAIN RES, V162, P201, DOI 10.1016/S0079-6123(06)62011-6; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Hajat C, 2000, STROKE, V31, P410, DOI 10.1161/01.STR.31.2.410; Herlitz J, 2000, EUR HEART J, V21, P1251, DOI 10.1053/euhj.2000.2150; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; MALKINSON TJ, 1990, AM J PHYSIOL, V258, pR783, DOI 10.1152/ajpregu.1990.258.3.R783; Pusswald G, 2000, RESUSCITATION, V47, P241, DOI 10.1016/S0300-9572(00)00240-9; SATOH T, 1989, INT J HYPERTHER, V5, P683, DOI 10.3109/02656738909140493; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Takasu A, 2001, RESUSCITATION, V49, P273, DOI 10.1016/S0300-9572(00)00360-9; TAKINO M, 1991, INTENS CARE MED, V17, P419, DOI 10.1007/BF01720680; Thornhill J, 2001, CAN J PHYSIOL PHARM, V79, P254, DOI 10.1139/cjpp-79-3-254; Wang Y, 2000, STROKE, V31, P404, DOI 10.1161/01.STR.31.2.404; Zeiner A, 2001, ARCH INTERN MED, V161, P2007, DOI 10.1001/archinte.161.16.2007; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254	21	23	23	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0885-0666	1525-1489		J INTENSIVE CARE MED	J. Intensive Care Med.	NOV-DEC	2014	29	6					365	369		10.1177/0885066613491932			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS6LR	WOS:000344375600007	23783999	Green Accepted			2022-02-06	
J	Larrabee, GJ				Larrabee, Glenn J.			Test Validity and Performance Validity: Considerations in Providing a Framework for Development of an Ability-Focused Neuropsychological Test Battery	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Assessment; Test construction; Meta-analysis; Head injury; Traumatic brain injury; Alzheimer's disease; Cerebrovascular disease/accident and stroke	TRAUMATIC BRAIN-INJURY; VERBAL-LEARNING TEST; MILD COGNITIVE IMPAIRMENT; ADULT INTELLIGENCE SCALE; CARD SORTING TEST; ALZHEIMERS-DISEASE; SYMPTOM VALIDITY; CONSTRUCT-VALIDITY; RESPONSE BIAS; HEAD-INJURY	Literature on test validity and performance validity is reviewed to propose a framework for specification of an ability-focused battery (AFB). Factor analysis supports six domains of ability: first, verbal symbolic; secondly, visuoperceptual and visuospatial judgment and problem solving; thirdly, sensorimotor skills; fourthly, attention/working memory; fifthly, processing speed; finally, learning and memory (which can be divided into verbal and visual subdomains). The AFB should include at least three measures for each of the six domains, selected based on various criteria for validity including sensitivity to presence of disorder, sensitivity to severity of disorder, correlation with important activities of daily living, and containing embedded/derived measures of performance validity. Criterion groups should include moderate and severe traumatic brain injury, and Alzheimer's disease. Validation groups should also include patients with left and right hemisphere stroke, to determine measures sensitive to lateralized cognitive impairment and so that the moderating effects of auditory comprehension impairment and neglect can be analyzed on AFB measures.			Larrabee, GJ (corresponding author), 2650 Bahia Vista St,308, Sarasota, FL 34242 USA.	glarrabee@aol.com					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Backman L, 2005, NEUROPSYCHOLOGY, V19, P520, DOI 10.1037/0894-4105.19.4.520; Baddeley A.D., 2007, COMMUNICATION 0913; Barbey AK, 2013, NEUROPSYCHOLOGIA, V51, P1361, DOI 10.1016/j.neuropsychologia.2012.05.017; Barrash J, 2004, J CLIN EXP NEUROPSYC, V26, P125, DOI 10.1076/jcen.26.1.125.23928; Bauer RM, 2000, CLIN GUIDE NEUROPSYC, P419; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Ben-Porath Y., 2012, INTERPRETING MMPI 2; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benton A., 1994, CONTRIBUTIONS NEUROP; Benton AL, 1994, MULTILINGUAL APHASIA; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone K.B., 2007, ASSESSMENT FEIGNED C; Boone KB, 2005, ARCH CLIN NEUROPSYCH, V20, P301, DOI 10.1016/j.acn.2004.08.001; Borenstein M., 2009, INTRO META ANAL; Brandt J., 1991, CLIN NEUROPSYCHOL, V5, P124; Brown FC, 2007, CLIN NEUROPSYCHOL, V21, P811, DOI 10.1080/13854040600878777; Brown FC, 2010, EPILEPSY BEHAV, V17, P215, DOI 10.1016/j.yebeh.2009.11.026; Brown LB, 2005, ARCH CLIN NEUROPSYCH, V20, P209, DOI 10.1016/j.acn.2004.06.003; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carroll J.B., 1993, HUMAN COGNITIVE ABIL, DOI DOI 10.1017/CBO9780511571312; Chafetz MD, 2008, CLIN NEUROPSYCHOL, V22, P529, DOI 10.1080/13854040701346104; Chelune GJ, 2010, CLIN NEUROPSYCHOL, V24, P454, DOI 10.1080/13854040802360574; Christensen H, 1997, J Int Neuropsychol Soc, V3, P631; Cohen J., 2013, STAT POWER ANAL BEHA; Crook TH, 1988, NEUROPSYCHOLOGY, V2, P1, DOI 10.1037//0894-4105.2.1.1; Davis JJ, 2012, CLIN NEUROPSYCHOL, V26, P1397, DOI 10.1080/13854046.2012.728627; Delis D, 2000, CALIFORNIA VERBAL LE; Delis DC, 2003, J INT NEUROPSYCH SOC, V9, P936, DOI 10.1017/S1355617703960139; Delis DC, 1987, CALIFORNIA VERBAL LE; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Donders J, 2002, PSYCHOL ASSESSMENT, V14, P360, DOI 10.1037//1040-3590.14.3.360; Earnst KS, 2001, AGING NEUROPSYCHOL C, V8, P109, DOI 10.1076/anec.8.2.109.839; Evans JD, 2004, SCHIZOPHR RES, V70, P331, DOI 10.1016/j.schres.2004.01.011; FAWCETT T, 2003, HP INVEN, V6, P27; Frazier TW, 2004, J INT NEUROPSYCH SOC, V10, P578, DOI 10.1017/S1355617704104049; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gervais RO, 2008, CLIN NEUROPSYCHOL, V22, P1061, DOI 10.1080/13854040701756930; Golden CJ, 1978, STROOP COLOR WORD TE; GOLDEN CJ, 1985, MANUAL LURIA NEBRASK; Green P, 2003, BRAIN INJURY, V17, P479, DOI 10.1080/0269905031000070242; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Greiffenstein M F, 1996, J Int Neuropsychol Soc, V2, P477; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; Griffith HR, 2006, J INT NEUROPSYCH SOC, V12, P166, DOI 10.1017/S1355617706060267; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; HANNAY HJ, 1979, CORTEX, V15, P269, DOI 10.1016/S0010-9452(79)80031-3; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heaton R. K., 2004, REVISED COMPREHENSIV; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hill B. D., 2013, 41 ANN C INT NEUR SO; Hill BD, 2013, ARCH CLIN NEUROPSYCH, V28, P640, DOI 10.1093/arclin/act045; Holdnack JA, 2013, PRACT RESOUR MENT, P331, DOI 10.1016/B978-0-12-386934-0.00007-9; Holdnack JA, 2011, ASSESSMENT, V18, P178, DOI 10.1177/1073191110393106; Houston C. M., 2007, CLIN NEUROPSYCHOL, V20, P145; HSIAO JK, 1989, ARCH GEN PSYCHIAT, V46, P664; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Iverson G L, 2001, Appl Neuropsychol, V8, P167, DOI 10.1207/S15324826AN0803_6; Jacobs ML, 2007, ARCH CLIN NEUROPSYCH, V22, P143, DOI 10.1016/j.acn.2006.12.002; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; Jastak J., 1984, WIDE RANGE ACHIEVEME; Kaplan E, 1983, BOSTON NAMING TEST; Keifer E, 2013, J CLIN EXP NEUROPSYC, V35, P1048, DOI 10.1080/13803395.2013.854319; Killgore WDS, 2000, J CLIN EXP NEUROPSYC, V22, P761; Langeluddecke PM, 2003, ARCH CLIN NEUROPSYCH, V18, P181, DOI 10.1016/S0887-6177(01)00195-0; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee G. J., 1992, J CLIN EXPT NEUROPSY, V14, P65; Larrabee G.L., 2012, FORENSIC NEUROPSYCHO, V2nd ed, P116; LARRABEE GJ, 1985, J CLIN EXP NEUROPSYC, V7, P497, DOI 10.1080/01688638508401281; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P395, DOI 10.1076/clin.17.3.395.18087; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P54, DOI 10.1076/clin.17.1.54.15627; Larrabee GJ, 2003, J INT NEUROPSYCH SOC, V9, P947, DOI 10.1017/S1355617703960140; LARRABEE GJ, 1995, J CLIN EXP NEUROPSYC, V17, P536, DOI 10.1080/01688639508405144; LARRABEE GJ, 1985, J CLIN EXP NEUROPSYC, V7, P239, DOI 10.1080/01688638508401257; LARRABEE GJ, 1986, INT J NEUROSCI, V29, P141, DOI 10.3109/00207458608985644; Larrabee GJ, 2000, CLIN NEUROPSYCHOL, V14, P139, DOI 10.1076/1385-4046(200002)14:1;1-8;FT139; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P813, DOI 10.1080/13854040701625846; Larrabee GJ, 1988, NEUROPSYCHOLOGY, V2, P173, DOI 10.1037//0894-4105.2.3-4.173; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P167, DOI 10.1080/13854040801968443; Lemeshow S, 2000, APPL LOGISTIC REGRES; Leonberger FT, 1992, NEUROPSYCHOLOGY, V6, P239, DOI DOI 10.1037/0894-4105.6.3.239; Levin HS., 1982, NEUROBEHAVIORAL CONS; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; LOEWENSTEIN DA, 1999, HDB ASSESSMENT CLIN, P529; Loring DW, 2008, J INT NEUROPSYCH SOC, V14, P394, DOI 10.1017/S1355617708080582; Loring DW, 2006, CLIN NEUROPSYCHOL, V20, P221, DOI 10.1080/13854040590947443; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; MARSON DC, 1995, ARCH NEUROL-CHICAGO, V52, P949, DOI 10.1001/archneur.1995.00540340029010; McGrew KS, 2009, INTELLIGENCE, V37, P1, DOI 10.1016/j.intell.2008.08.004; McGurk SR, 2003, PSYCHIAT SERV, V54, P1129, DOI 10.1176/appi.ps.54.8.1129; MEYERS J, 1995, MEYERS SCORING SYSTE; Meyers J E, 1999, Appl Neuropsychol, V6, P208, DOI 10.1207/s15324826an0604_3; Meyers JE, 2004, ARCH CLIN NEUROPSYCH, V19, P637, DOI 10.1016/j.acn.2003.08.007; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Meyers JE, 2014, APPL NEUROPSYCH-ADUL, V21, P60, DOI 10.1080/09084282.2012.737881; Meyers JE, 2014, ARCH CLIN NEUROPSYCH, V29, P224, DOI 10.1093/arclin/acu001; Miller JB, 2010, CLIN NEUROPSYCHOL, V24, P678, DOI 10.1080/13854041003601493; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Morgan J. E., 2009, NEUROPSYCHOLOGY MALI; Novack TA, 2006, BRAIN INJURY, V20, P455, DOI 10.1080/02699050600664541; Osterrieth PA, 1994, ARCH PSYCHOL, V30, P286; Pearson, 2009, ADV CLIN SOLUTIONS U; Powell J B, 1991, Arch Clin Neuropsychol, V6, P241, DOI 10.1016/0887-6177(91)90001-P; Purves D., 2008, PRINCIPLES COGNITIVE; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Rice ME, 2005, LAW HUMAN BEHAV, V29, P615, DOI 10.1007/s10979-005-6832-7; Rohling M. L., 2008, 6 ANN C AM AC CLIN N; Rohling ML, 2011, PSYCHOL BULL, V137, P708, DOI 10.1037/a0023327; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rohling ML, 2004, NEUROPSYCHOL REV, V14, P155, DOI 10.1023/B:NERV.0000048182.55980.4b; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Russell E. W., 1993, HALSTEAD RUSSEL NEUR; Salmon DP, 1999, J INT NEUROPSYCH SOC, V5, P692, DOI 10.1017/S1355617799577126; Salthouse TA, 2005, NEUROPSYCHOLOGY, V19, P532, DOI 10.1037/0894-4105.19.4.532; Salthouse TA, 2010, PRACT RESOUR MENT, P217, DOI 10.1016/B978-0-12-375035-8.10008-4; Schmidt M., 1996, REY AUDITORY VERBAL; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sherod MG, 2009, J INT NEUROPSYCH SOC, V15, P258, DOI 10.1017/S1355617709090365; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Smith A, 1983, SYMBOL DIGIT MODALIT; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Sweet JJ, 2011, CLIN NEUROPSYCHOL, V25, P12, DOI 10.1080/13854046.2010.544165; SWETS JA, 1973, SCIENCE, V182, P990, DOI 10.1126/science.182.4116.990; TABACHNICK B. G., 2005, USING MULTIVARIATE S; Tellegen A., 2008, MMPI2RF; Tenhula WN, 1996, CLIN NEUROPSYCHOL, V10, P104, DOI 10.1080/13854049608406669; TRAHAN DE, 1990, J CLIN EXP NEUROPSYC, V12, P857, DOI 10.1080/01688639008401027; Trahan DE, 1988, CONTINUOUS VISUAL ME; TRAHAN DE, 1989, CLIN NEUROPSYCHOL, V3, P169, DOI DOI 10.1080/13854048908403290; Trenerry MR, 1989, STROOP NEUROPSYCHOLO; Tulsky DS, 2003, PSYCHOL ASSESSMENT, V15, P149, DOI 10.1037/1040-3590.15.2.149; Valenstein, 2012, CLIN NEUROPSYCHOLOGY, P296; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Volbrecht ME, 2000, ARCH CLIN NEUROPSYCH, V15, P251, DOI 10.1016/S0887-6177(99)00016-5; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D, 2008, WAIS 4; Wechsler D., 2009, WMS 4 TECHNICAL INTE; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 1997, WAIS 3 WMS 3 TECHNIC; WELSH KA, 1994, NEUROLOGY, V44, P609, DOI 10.1212/WNL.44.4.609; Whelihan WM, 2005, ARCH CLIN NEUROPSYCH, V20, P217, DOI 10.1016/j.acn.2004.07.002; Wilkinson G. S, 1993, WRAT 3 WIDE RANGE AC; Wilkinson G. S., 2006, WIDE RANGE ACHIEVMEN; Williams MW, 2013, CLIN NEUROPSYCHOL, V27, P356, DOI 10.1080/13854046.2013.765507; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791; Wolfson, 1993, HALSTEAD REITAN NEUR; Wygant DB, 2007, ARCH CLIN NEUROPSYCH, V22, P489, DOI 10.1016/j.acn.2007.01.027; Zakzanis K. K., 1999, STUD NEUROPSYCHOL DE; [No title captured]	177	23	23	0	21	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	NOV	2014	29	7					695	714		10.1093/arclin/acu049			20	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	AU9DA	WOS:000345890600012	25280794	Green Published			2022-02-06	
J	Morris, DC; Cui, Y; Cheung, WL; Lu, M; Zhang, L; Zhang, ZG; Chopp, M				Morris, D. C.; Cui, Y.; Cheung, W. L.; Lu, M.; Zhang, L.; Zhang, Z. G.; Chopp, M.			A dose-response study of thymosin beta 4 for the treatment of acute stroke	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Thymosin; Rat model; Embolic stroke; Neurorestorative therapy; Actin-binding protein; Oligodendrocyte	TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; MULTIPLE-SCLEROSIS; ANIMAL-MODELS; RAT MODEL; REMYELINATION; BIOLOGY; CNS	Background: Thymosin beta 4 (T beta 4) is a 5 K actin binding peptide. T beta 4 improves neurological outcome in a rat model of embolic stroke and research is now focused on optimizing its dose for clinical trials. The purpose of this study was to perform a dose-response study of T beta 4 to determine the optimal dose of neurological improvement in a rat model of embolic stroke. Methods: Male Wistar rats were subjected to embolic middle cerebral artery occlusion (MCAo). Rats were divided into 4 groups of 10 animals/group: control, 2,12 and 18 mg/kg. T beta 4 was administered intraperitoneally 24 h after MCAo and then every 3 days for 4 additional doses in a randomized controlled fashion. Neurological tests were performed after MCAo and before treatment and up to 8 weeks after treatment. The rats were sacrificed 56 days after MCAo and lesion volumes measured. Generalized estimating equation was used to compare the treatment effect on long term functional recovery at day 56. A quartic regression model was used for an optimal dose determination. Results: T beta 4 significantly improved neurological outcome at dose of 2 and 12 mg/kg at day 14 and extended to day 56 (p-values <0.05). The higher dose of 18 mg/kg did not show significant improvement. The estimated optimal dose of 3.75 mg/kg would provide optimal neurological improvement. Conclusions: This study shown that T beta 4 significantly improved the long term neurological functional recovery at day 56 after MCAo with an optimal dose of 3.75 mg/kg. These results provide preclinical data for human clinical trials. (C) 2014 Elsevier B.V. All rights reserved.	[Morris, D. C.; Cheung, W. L.] Henry Ford Hlth Syst, Dept Emergency Med, Detroit, MI 48202 USA; [Cui, Y.; Zhang, L.; Zhang, Z. G.; Chopp, M.] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA; [Lu, M.] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI 48202 USA; [Chopp, M.] Oakland Univ, Dept Phys, Rochester, MI 48309 USA		Morris, DC (corresponding author), Henry Ford Hosp, Dept Emergency Med, 2799 West Grand Blvd,CFP-2, Detroit, MI 48202 USA.	morris@neuro.hfh.edu; yisheng@neuro.hfh.edu; wcheung1@hfhs.org; mlu1@hfhs.org; lzhang@neuro.hfh.edu; zhazh@neuro.hfh.edu; michael.chopp@gmail.com		Cheung, Wing Lee/0000-0001-8281-8903	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 AG038648, R01 NS079612, R01 AG037506]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS079612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG037506, R01AG038648] Funding Source: NIH RePORTER	Grant support: NIH, R01 AG038648 (DM), R01 NS079612 (ZG) and R01 AG037506 (MC).	Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Cenci MA, 2002, NAT REV NEUROSCI, V3, P574, DOI 10.1038/nrn877; Chen J, 2006, NEUROSCIENCE, V141, P737, DOI 10.1016/j.neuroscience.2006.04.042; Crockford D, 2007, ANN NY ACAD SCI, V1112, P385, DOI 10.1196/annals.1415.051; Draper, 1987, EMPIRICAL MODEL BUIL, V37, P82; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Franklin RJM, 2008, J NEUROL, V255, P19, DOI 10.1007/s00415-008-1004-6; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Kleindorfer D, 2009, STROKE, V40, P3580, DOI 10.1161/STROKEAHA.109.554626; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; Malinda KM, 1999, J INVEST DERMATOL, V113, P364, DOI 10.1046/j.1523-1747.1999.00708.x; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Mitka M, 2010, JAMA-J AM MED ASSOC, V303, P17, DOI 10.1001/jama.2009.1862; Morris DC, 2010, NEUROSCIENCE, V169, P674, DOI 10.1016/j.neuroscience.2010.05.017; Nait-Oumesmar B, 2008, J NEUROL SCI, V265, P26, DOI 10.1016/j.jns.2007.09.032; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Ruff D, 2010, ANN NY ACAD SCI, V1194, P223, DOI 10.1111/j.1749-6632.2010.05474.x; SAS Institute I, 2010, US GUID SAS STAT 9 2; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Xiong Y, 2011, J NEUROSURG, V114, P102, DOI 10.3171/2010.4.JNS10118; Zhang J, 2009, NEUROSCIENCE, V164, P1887, DOI 10.1016/j.neuroscience.2009.09.054; Zhang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011016; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59; Zhang RL, 1997, BRAIN RES, V766, P83, DOI 10.1016/S0006-8993(97)00580-5; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	27	23	26	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	OCT 15	2014	345	1-2					61	67		10.1016/j.jns.2014.07.006			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AR6JJ	WOS:000343689600009	25060418	Green Accepted			2022-02-06	
J	Hewitt, J; Williams, M; Pearce, L; Black, A; Benson, E; Tarrant, M; Chakrabati, M; Stechman, MJ; Moug, SJ; McCarthy, K				Hewitt, Jonathan; Williams, Matthew; Pearce, Lyndsay; Black, Amy; Benson, Emily; Tarrant, Madelaine; Chakrabati, Mahua; Stechman, Michael J.; Moug, Susan J.; McCarthy, Kathryn			The prevalence of cognitive impairment in emergency general surgery	INTERNATIONAL JOURNAL OF SURGERY			English	Article						Cognitive impairment; Acute general surgery; MoCA; Older people; Elderly	TRAUMATIC BRAIN-INJURY; POSTOPERATIVE DELIRIUM; VALIDATION; MOCA; VERSION	Objectives: Rates of all surgical procedures are increasing at a faster rate than the population is ageing. However, this encouraging statistic, necessitates a robust evidence base. The epidemiological evidence base in acute general surgery in the older person is sparse. This is the first assessment of the prevalence of cognitive impairment measured using the Montreal Cognitive Assessment tool (MoCA) in acute general surgery. Methods: In three sites in Wales, England and Scotland comprising rural and urban populations, we studied consecutive patients aged over 65 years. We considered any older person admitted to the acute general surgical unit. We assessed them for baseline demographic data. They each underwent a MoCA assessment. Results: We collected data on 245 people, mean age 76.9 years (8.1, standard deviation), 136 (55.5%) were women. Of these 201 completed the MoCA test, mean score of 18.9 and median score 20 (range 0-30). There were 37 (15.1%) MoCA scores in the normal range (>= 26) and 44 (18%) people were unable to attempt (or complete) the MoCA. Increasing age (p < 0.01) but not sex (p = 0.14) predicted an abnormal MoCA. Considering only the 44 people who were unable to attempt the MoCA assessment, 11 (25%) were known to have a diagnosis of dementia, 9 (20.5%) were too unwell and the remainder unable to complete the assessment to due pre-existing disability. Conclusions: In a representative UK wide population, a high proportion of older people admitted with an acute general surgical problem had cognitive impairment when assessed using the MoCA. (C) 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.	[Hewitt, Jonathan; Williams, Matthew; Black, Amy] Cardiff Univ, Cardiff CF10 3AX, S Glam, Wales; [Pearce, Lyndsay] North West Surg Rotat, Liverpool, Merseyside, England; [Benson, Emily; Tarrant, Madelaine; McCarthy, Kathryn] North Bristol NHS Trust, Bristol, Avon, England; [Stechman, Michael J.] Univ Hosp, Cardiff, S Glam, Wales; [Moug, Susan J.] Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland		Hewitt, J (corresponding author), Univ Hosp Llandough, Cardiff CF64 2XX, S Glam, Wales.	hewittj2@cardiff.ac.uk	Moug, Susan/ABB-9234-2021; HEWITT, JONATHAN/AAC-9713-2019	HEWITT, JONATHAN/0000-0002-7924-1792	Cardiff University Research Opportunity Program (CUROP) [pound1340]	One author, Matthew Williams, a medical student, obtained a competitive grant for a living allowance over his summer holiday to help support he undertakes part of this project. Grant 1340 pound Cardiff University Research Opportunity Program (CUROP).	Boos Gustavo Luchi, 2005, Rev. Bras. Anestesiol., V55, P517, DOI 10.1590/S0034-70942005000500006; de Guise E, 2013, BRAIN INJURY, V27, P1428, DOI 10.3109/02699052.2013.835867; Evered LA, 2011, ANESTHESIOLOGY, V114, P1297, DOI 10.1097/ALN.0b013e31821b1aab; HODKINSON H M, 1972, Age and Ageing, V1, P233, DOI 10.1093/ageing/1.4.233; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Ismail Z, 2010, INT J GERIATR PSYCH, V25, P111, DOI 10.1002/gps.2306; Lee JY, 2008, J GERIATR PSYCH NEUR, V21, P104, DOI 10.1177/0891988708316855; Lifshitz M, 2012, J GERIATR PSYCH NEUR, V25, P155, DOI 10.1177/0891988712457047; Luis CA, 2009, INT J GERIATR PSYCH, V24, P197, DOI 10.1002/gps.2101; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Newman JC, 2011, NEW ENGL J MED, V365, P2447, DOI 10.1056/NEJMp1110652; Ni Chonchubhair A., 1995, BRIT J ANAESTH, V75, P481; Osborne RA, 2014, J NEUROL SCI, V336, P191, DOI 10.1016/j.jns.2013.10.038; Partridge JSL, 2013, INT J GERIATR PSYCH, V28, P804, DOI 10.1002/gps.3900; Partridge JSL, 2012, AGE AGEING, V41, P142, DOI 10.1093/ageing/afr182; Saczynski JS, 2012, NEW ENGL J MED, V367, P30, DOI 10.1056/NEJMoa1112923; Sasajima Y, 2012, EUR J VASC ENDOVASC, V44, P411, DOI 10.1016/j.ejvs.2012.06.028; Sweet L, 2011, INT PSYCHOGERIATR, V23, P1582, DOI 10.1017/S1041610211001451; Wong GKC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059946; Wong GKC, 2013, BRAIN INJURY, V27, P394, DOI 10.3109/02699052.2012.750746	20	23	23	0	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1743-9191	1743-9159		INT J SURG	Int. J. Surg.	OCT	2014	12	10					1031	1035		10.1016/j.ijsu.2014.07.020			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	AR4XG	WOS:000343588800002	25128866	Bronze			2022-02-06	
J	Picetti, E; De Angelis, A; Villani, F; Antonini, MV; Rossi, I; Servadei, F; Caspani, ML				Picetti, Edoardo; De Angelis, Antonino; Villani, Fabio; Antonini, Marta Velia; Rossi, Ilaria; Servadei, Franco; Caspani, Maria Luisa			Intravenous paracetamol for fever control in acute brain injury patients: cerebral and hemodynamic effects	ACTA NEUROCHIRURGICA			English	Article						Brain injury; Fever; Management; Paracetamol	ACUTE ISCHEMIC STROKE; INTENSIVE-CARE-UNIT; BODY-TEMPERATURE; INDUCED HYPOTENSION; CLINICAL-TRIAL; ACETAMINOPHEN; HYPERTHERMIA; IMPACT; MANAGEMENT; PROTOCOLS	Fever occurs frequently in acute brain injury patients, and its occurrence is associated with poorer outcomes. Paracetamol, an antipyretic frequently employed in patients with cerebral damage, may cause hypotension. We evaluated the cerebral and hemodynamic effects of intravenous (IV) paracetamol for the control of fever in Neuro-Intensive Care Unit (NICU) patients. This is a prospective observational study in which we enrolled 32 NICU patients: Subarachnoid Hemorrhage (SAH, n = 18), Traumatic Brain Injury (TBI, n = 10), Intracerebral Hemorrhage (ICH, n = 2) and Acute Ischemic Stroke (AIS, n = 2). The administration of paracetamol resulted in a decrease of core body temperature (Tc) (p = 0,0001), mean arterial pressure (MAP) (p = 0,0006), cerebral perfusion pressure (CPP) (p = 0,0033), and jugular venous oxygen saturation (SjVO2) (p = 0.0193), and in an increase of arteriojugular venous differences of oxygen (AVDO2) (p = 0.0012). The proportion of patients who had an infusion of norepinephrine increased from 47 % to 75 % (p = 0.0039 McNemar Test). When intracranial pressure (ICP) at the start of paracetamol infusion (t-0) was compared with the measurement of ICP after 2 h, a significant correlation was observed (r = 0.669, p = 0.0002). This marked and significant correlation can be explained by the fact that for the higher levels of ICP assessed at t-0 (greater than 15 mmHg), we observed a marked reduction of ICP concomitant with the decrease of Tc. No problems related to norepinephrine administration and/or increase in dosage were observed. Paracetamol administration is effective but exposes patients to hypotensive episodes that must be recognized and treated expeditiously to prevent further damage to the injured brain.	[Picetti, Edoardo; Antonini, Marta Velia; Rossi, Ilaria; Caspani, Maria Luisa] Azienda Osped Univ Parma, Serv Anestesia & Rianimaz 1, I-43100 Parma, Italy; [De Angelis, Antonino; Villani, Fabio] Univ Parma, Scuola Specializzaz Anestesia & Rianimaz, I-43100 Parma, Italy; [Servadei, Franco] Azienda Osped Univ Parma, I-43100 Parma, Italy		Picetti, E (corresponding author), Azienda Osped Univ Parma, Serv Anestesia & Rianimaz 1, Via Gramsci 14, I-43100 Parma, Italy.	edoardopicetti@hotmail.com	Viani, Rafael/V-1196-2018	Servadei, Franco/0000-0002-3595-3464			Boyle M, 1997, Aust Crit Care, V10, P120, DOI 10.1016/S1036-7314(97)70414-4; Brown G, 1996, HEART LUNG, V25, P137, DOI 10.1016/S0147-9563(96)80116-6; Cormio M, 2000, INTENS CARE MED, V26, P552, DOI 10.1007/s001340051203; de Maat MM, 2010, EUR J CLIN PHARMACOL, V66, P713, DOI 10.1007/s00228-010-0806-5; den Hertog HM, 2012, ACTA NEUROL SCAND, V125, P265, DOI 10.1111/j.1600-0404.2011.01529.x; den Hertog HM, 2009, LANCET NEUROL, V8, P434, DOI 10.1016/S1474-4422(09)70051-1; Dietrich WD, 2007, PROG BRAIN RES, V162, P201, DOI 10.1016/S0079-6123(06)62011-6; Dippel DWJ, 2001, STROKE, V32, P1607, DOI 10.1161/01.STR.32.7.1607; Duggan ST, 2009, DRUGS, V69, P101, DOI 10.2165/00003495-200969010-00007; Graham GG, 2013, INFLAMMOPHARMACOLOGY, V21, P201, DOI 10.1007/s10787-013-0172-x; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Hersch M, 2008, PHARMACOTHERAPY, V28, P1205, DOI 10.1592/phco.28.10.1205; Johnston NJ, 2006, RESUSCITATION, V70, P254, DOI 10.1016/j.resuscitation.2006.02.010; Kasner SE, 2002, STROKE, V33, P130, DOI 10.1161/hs0102.101477; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Koennecke HC, 2001, NEUROLOGY, V57, P2301, DOI 10.1212/WNL.57.12.2301; Mackenzie I, 2000, INTENS CARE MED, V26, P1408, DOI 10.1007/s001340000614; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Middleton S, 2011, LANCET, V378, P1699, DOI 10.1016/S0140-6736(11)61485-2; Mrozek S, 2009, ANN FR ANESTH, V28, P448, DOI 10.1016/j.annfar.2009.01.018; Peacock WF, 2011, ACAD EMERG MED, V18, P360, DOI 10.1111/j.1553-2712.2011.01043.x; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; Stocchetti N, 2005, J NEUROL NEUROSUR PS, V76, P1135, DOI 10.1136/jnnp.2004.041269; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Tu YK, 2005, EUR J ORAL SCI, V113, P279, DOI 10.1111/j.1600-0722.2005.00229.x; Tu YK, 2007, STAT MED, V26, P443, DOI 10.1002/sim.2538	28	23	23	0	10	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	OCT	2014	156	10					1953	1959		10.1007/s00701-014-2129-2			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AP6SX	WOS:000342209100020	24838770				2022-02-06	
J	Mencl, S; Hennig, N; Hopp, S; Schuhmann, MK; Albert-Weissenberger, C; Siren, AL; Kleinschnitz, C				Mencl, Stine; Hennig, Nelli; Hopp, Sarah; Schuhmann, Michael K.; Albert-Weissenberger, Christiane; Siren, Anna-Leena; Kleinschnitz, Christoph			FTY720 does not protect from traumatic brain injury in mice despite reducing posttraumatic inflammation	JOURNAL OF NEUROIMMUNOLOGY			English	Article						FTY720; Traumatic brain injury; Inflammation; Blood-brain barrier; Lymphocytes; Edema	CLOSED-HEAD INJURY; SPHINGOSINE 1-PHOSPHATE RECEPTOR; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CONTROLLED CORTICAL IMPACT; MULTIPLE-SCLEROSIS; ISCHEMIC-STROKE; WEIGHT-DROP; B1 PROTECTS; FINGOLIMOD; BARRIER	Inflammation is a pathological hallmark of traumatic brain injury (TBI). Recent evidence suggests that immune cells such as lymphocytes are of particular relevance for lesion development after TBI. FTY720, a sphingosine-1-phosphate (SIP) receptor modulator, sequesters T lymphocytes in lymphoid organs and has been shown to improve outcome in a variety of neurological disease models. We investigated the mode of FTY720 action in models of TBI. Focal cortical cryolesion was induced in C57BL/6 mice treated with FTY720 (1 mg/kg) or vehicle immediately before injury. Lesion size was assessed 24 h later. Immune cells in the blood and brain were counted by flow cytometry and immunocytochemistry. The integrity of the blood-brain barrier was analyzed using Evans Blue dye. To validate the findings in a diffuse brain trauma model, FTY720-treated mice and controls were subjected to weight drop contusion injury and neurological deficits were assessed until day 7. As expected FTY720 significantly lowered the numbers of circulating lymphocytes and attenuated the invasion of immune cells into the damaged brain parenchyma. However, FTY720 was unable to improve lesion size or functional outcome in both trauma models at either stage, i.e. acute vs chronic. Accordingly, the extent of blood-brain barrier disruption and neuronal apoptosis was similar between FTY720-treated mice and controls. We conclude that pharmacological SIP receptor modulation is an unfavorable strategy to combat TBI. Moreover, our findings put into perspective the pathophysiological relevance of inflammatory cells in traumatic neurodegeneration. (C) 2014 The Authors. Published by Elsevier B.V.	[Mencl, Stine; Hopp, Sarah; Schuhmann, Michael K.; Albert-Weissenberger, Christiane; Kleinschnitz, Christoph] Univ Hosp Wurzburg, Dept Neurol, D-97080 Wurzburg, Germany; [Hennig, Nelli; Siren, Anna-Leena] Univ Hosp Wurzburg, Dept Neurosurg, D-97080 Wurzburg, Germany		Kleinschnitz, C (corresponding author), Univ Hosp Wurzburg, Dept Neurol, Josef Schneider Str 11, D-97080 Wurzburg, Germany.	christoph.kleinschnitz@uni-wuerzburg.de	Siren, Anna-Leena/AAE-1374-2019	Siren, Anna-Leena/0000-0002-2217-0081; Kleinschnitz, Christoph/0000-0002-1650-8875	Interdisciplinary Center for Clinical Research (IZKF) Wurzburg [A226]; Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG) [SFB 688 TP13]; Novartis Pharma GmbH, Nurnberg, Germany	This work was supported by the Interdisciplinary Center for Clinical Research (IZKF) Wurzburg (Project A226 to ALS and CK), the Deutsche Forschungsgemeinschaft (DFG, SFB 688 TP13 to CK) and the Novartis Pharma GmbH, Nurnberg, Germany (unrestricted grant to ALS and CK).	Albert-WeiSSenberger Christiane, 2012, Exp Transl Stroke Med, V4, P1, DOI 10.1186/2040-7378-4-1; Albert-Weissenberger C, 2012, J CEREBR BLOOD F MET, V32, P1747, DOI 10.1038/jcbfm.2012.62; Balatoni B, 2007, BRAIN RES BULL, V74, P307, DOI 10.1016/j.brainresbull.2007.06.023; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Campos F, 2013, STROKE, V44, P505, DOI 10.1161/STROKEAHA.112.679043; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Czech B, 2009, BIOCHEM BIOPH RES CO, V389, P251, DOI 10.1016/j.bbrc.2009.08.142; Czigner A, 2007, ACTA NEUROCHIR, V149, P281, DOI 10.1007/s00701-006-1095-8; Deogracias R, 2012, P NATL ACAD SCI USA, V109, P14230, DOI 10.1073/pnas.1206093109; Dev KK, 2008, PHARMACOL THERAPEUT, V117, P77, DOI 10.1016/j.pharmthera.2007.08.005; Engel S, 1996, Acta Neurochir Suppl, V66, P89; Fee D, 2003, J NEUROIMMUNOL, V136, P54, DOI 10.1016/S0165-5728(03)00008-0; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gillingwater TH, 2012, BRIT J PHARMACOL, V165, P858, DOI 10.1111/j.1476-5381.2011.01612.x; Hartl R, 1997, ACT NEUR S, V70, P240; Hartl R, 1997, J CEREBR BLOOD F MET, V17, P1210; Hasegawa Y, 2010, STROKE, V41, P368, DOI 10.1161/STROKEAHA.109.568899; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Kataoka H, 2005, CELL MOL IMMUNOL, V2, P439; Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010; Kraft P, 2013, STROKE, V44, P3202, DOI 10.1161/STROKEAHA.113.002880; Langhauser F, 2012, BLOOD, V120, P4082, DOI 10.1182/blood-2012-06-440057; Liesz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021312; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miron VE, 2008, J NEUROL SCI, V274, P13, DOI 10.1016/j.jns.2008.06.031; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Norimatsu Y, 2012, AM J PATHOL, V180, P1625, DOI 10.1016/j.ajpath.2011.12.012; Pfeilschifter W, 2010, STROKE, V41, pE193, DOI 10.1161/STROKEAHA.110.578278; Raslan Furat, 2012, Exp Transl Stroke Med, V4, P6, DOI 10.1186/2040-7378-4-6; Raslan F, 2010, J CEREBR BLOOD F MET, V30, P1477, DOI 10.1038/jcbfm.2010.28; Rolland WB, 2013, EXP NEUROL, V241, P45, DOI 10.1016/j.expneurol.2012.12.009; Schwarzmaier SM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-32; Soares HD, 1995, J NEUROSCI, V15, P8223; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; van Doom R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-133; Weckbach S, 2012, J NEUROTRAUM, V29, P1233, DOI 10.1089/neu.2011.2169; Wei Y, 2011, ANN NEUROL, V69, P119, DOI 10.1002/ana.22186; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Whalen MJ, 1999, J NEUROTRAUM, V16, P583, DOI 10.1089/neu.1999.16.583; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008; Zhang Z, 2008, NEUROPATH APPL NEURO, V34, P330, DOI 10.1111/j.1365-2990.2007.00893.x; Zhang ZY, 2007, J CELL MOL MED, V11, P307, DOI 10.1111/j.1582-4934.2007.00019.x; Zhu DH, 2010, BLOOD, V115, P4963, DOI 10.1182/blood-2010-01-262386	48	23	23	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	SEP 15	2014	274	1-2					125	131		10.1016/j.jneuroim.2014.07.010			7	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	AQ5TN	WOS:000342871600015	25081505	hybrid			2022-02-06	
J	Meng, YL; Chopp, M; Zhang, YL; Liu, ZW; An, A; Mahmood, A; Xiong, Y				Meng, Yuling; Chopp, Michael; Zhang, Yanlu; Liu, Zhongwu; An, Aaron; Mahmood, Asim; Xiong, Ye			Subacute Intranasal Administration of Tissue Plasminogen Activator Promotes Neuroplasticity and Improves Functional Recovery following Traumatic Brain Injury in Rats	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; MARROW STROMAL CELLS; NEUROTROPHIC FACTOR; INFARCT VOLUME; DENTATE GYRUS; UP-REGULATION; SPINAL-CORD; ERYTHROPOIETIN RECEPTOR	Traumatic brain injury (TBI) is a major cause of death and long-term disability worldwide. To date, there are no effective pharmacological treatments for TBI. Recombinant human tissue plasminogen activator (tPA) is the effective drug for the treatment of acute ischemic stroke. In addition to its thrombolytic effect, tPA is also involved in neuroplasticity in the central nervous system. However, tPA has potential adverse side effects when administered intravenously including brain edema and hemorrhage. Here we report that tPA, administered by intranasal delivery during the subacute phase after TBI, provides therapeutic benefit. Animals with TBI were treated intranasally with saline or tPA initiated 7 days after TBI. Compared with saline treatment, subacute intranasal tPA treatment significantly 1) improved cognitive (Morris water maze test) and sensorimotor (footfault and modified neurological severity score) functional recovery in rats after TBI, 2) reduced the cortical stimulation threshold evoking ipsilateral forelimb movement, 3) enhanced neurogenesis in the dentate gyrus and axonal sprouting of the corticospinal tract originating from the contralesional cortex into the denervated side of the cervical gray matter, and 4) increased the level of mature brain-derived neurotrophic factor. Our data suggest that subacute intranasal tPA treatment improves functional recovery and promotes brain neurogenesis and spinal cord axonal sprouting after TBI, which may be mediated, at least in part, by tPA/plasmin-dependent maturation of brain-derived neurotrophic factor.	[Meng, Yuling; Zhang, Yanlu; An, Aaron; Mahmood, Asim; Xiong, Ye] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Chopp, Michael; Liu, Zhongwu] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA		Xiong, Y (corresponding author), Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA.	yxiong1@hfhs.org		Xiong, Ye/0000-0001-9770-6031	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RO1 NS062002]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [RO1 AG037506]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS062002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG037506] Funding Source: NIH RePORTER	The research presented herein was supported by National Institute of Neurological Disorders and Stroke RO1 NS062002 (YX), and National Institute on Aging RO1 AG037506 (MC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibhatla RM, 2008, CNS NEUROL DISORD-DR, V7, P243, DOI 10.2174/187152708784936608; Ahn MY, 1999, BRAIN RES, V837, P169, DOI 10.1016/S0006-8993(99)01645-5; Armstead WM, 2013, J NEUROTRAUM, V30, P1898, DOI 10.1089/neu.2013.2962; Armstead WM, 2012, J NEUROTRAUM, V29, P1794, DOI 10.1089/neu.2012.2328; Armstead WM, 2011, NEUROL RES, V33, P726, DOI 10.1179/016164110X12807570509853; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Barnes P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003248; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Bukhari N, 2011, J NEUROSCI, V31, P14931, DOI 10.1523/JNEUROSCI.3339-11.2011; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Cho E, 2012, NEUROBIOL DIS, V46, P215, DOI 10.1016/j.nbd.2012.01.010; Choi SH, 2006, J NEUROSCI METH, V156, P182, DOI 10.1016/j.jneumeth.2006.03.002; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Dhuria SV, 2010, J PHARM SCI-US, V99, P1654, DOI 10.1002/jps.21924; Ding Q, 2011, NEUROSCIENCE, V192, P773, DOI 10.1016/j.neuroscience.2011.06.032; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FESTOFF BW, 1994, J CELL PHYSIOL, V159, P11, DOI 10.1002/jcp.1041590103; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; FRIBERGER P, 1978, HAEMOSTASIS, V7, P138; Gao X, 2009, J NEUROTRAUM, V26, P1325, DOI [10.1089/neu.2008.0744, 10.1089/neu.2008-0744]; Garcia AN, 2011, PM&R, V3, pS18, DOI 10.1016/j.pmrj.2011.03.017; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Glover LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033646; Goto H, 2007, J NEUROTRAUM, V24, P745, DOI 10.1089/neu.2006.0183; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Han XD, 2011, J NEUROTRAUM, V28, P995, DOI 10.1089/neu.2010.1563; Je HS, 2012, P NATL ACAD SCI USA, V109, P15924, DOI 10.1073/pnas.1207767109; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; KARTJETILLOTSON G, 1985, BRAIN RES, V332, P103, DOI 10.1016/0006-8993(85)90393-2; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Koshimizu H, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-27; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; Liu ZW, 2008, STROKE, V39, P2571, DOI 10.1161/STROKEAHA.107.511659; Liu ZW, 2007, BRAIN RES, V1149, P172, DOI 10.1016/j.brainres.2007.02.047; Liu ZW, 2012, NEUROBIOL DIS, V45, P804, DOI 10.1016/j.nbd.2011.11.004; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Lu DY, 2003, J NEUROSURG, V99, P351, DOI 10.3171/jns.2003.99.2.0351; Mahmood A, 2007, NEUROSURGERY, V60, P546, DOI 10.1227/01.NEU.0000255346.25959.99; Mahmood A, 2011, J NEUROTRAUM, V28, P1199, DOI 10.1089/neu.2010.1694; Marklund N, 2009, NEUROSCIENCE, V163, P540, DOI 10.1016/j.neuroscience.2009.06.042; Mast TG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031978; Meng YL, 2011, J NEUROSURG, V115, P550, DOI 10.3171/2011.3.JNS101721; Minor K, 2009, J NEUROCHEM, V109, P706, DOI 10.1111/j.1471-4159.2009.05977.x; MISKIN R, 1981, ANAL BIOCHEM, V118, P252, DOI 10.1016/0003-2697(81)90187-1; Mori T, 2001, NEUROREPORT, V12, P4117, DOI 10.1097/00001756-200112210-00051; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; Ning RZ, 2011, BRAIN RES, V1384, P140, DOI 10.1016/j.brainres.2011.01.099; Obiang P, 2011, NEUROBIOL LEARN MEM, V96, P121, DOI 10.1016/j.nlm.2011.03.004; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Qu CS, 2010, J NEUROTRAUM, V27, P1625, DOI 10.1089/neu.2010.1359; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Rodier M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092416; Samson AL, 2006, NEURON, V50, P673, DOI 10.1016/j.neuron.2006.04.013; Sashindranath M, 2012, BRAIN, V135, P3251, DOI 10.1093/brain/aws178; Shen LH, 2011, STROKE, V42, P459, DOI 10.1161/STROKEAHA.110.593863; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; Stein SC, 2009, J NEUROTRAUM, V26, P1585, DOI [10.1089/neu.2008.0720, 10.1089/neu.2008-0720]; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035883; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Tamas A, 2006, J NEUROTRAUM, V23, P686, DOI 10.1089/neu.2006.23.686; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Thorne RG, 2004, NEUROSCIENCE, V127, P481, DOI 10.1016/j.neuroscience.2004.05.029; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; Vivar C, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00015; Vivien D, 2000, J CEREBR BLOOD F MET, V20, P755, DOI 10.1097/00004647-200005000-00001; Wang Y, 2007, BRIT J PHARMACOL, V151, P1377, DOI 10.1038/sj.bjp.0707285; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Wu YP, 2000, J CELL BIOL, V148, P1295, DOI 10.1083/jcb.148.6.1295; Xin HQ, 2011, J CEREBR BLOOD F MET, V31, P2181, DOI 10.1038/jcbfm.2011.116; Xin HQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009027; Xiong Y, 2008, BRAIN RES, V1230, P247, DOI 10.1016/j.brainres.2008.06.127; Xiong Y, 2008, J NEUROSURG, V109, P510, DOI 10.3171/JNS/2008/109/9/0510; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2012, J NEUROSURG, V116, P1081, DOI 10.3171/2012.1.JNS111729; Xiong Y, 2011, J NEUROSURG, V114, P102, DOI 10.3171/2010.4.JNS10118; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Yang JM, 2014, CELL REP, V7, P796, DOI 10.1016/j.celrep.2014.03.040; Yepes M, 2004, EXP BIOL MED, V229, P1097, DOI 10.1177/153537020422901103; Yi JH, 2012, J COMP NEUROL, V520, P3295, DOI 10.1002/cne.23156; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59; Zhang RL, 1998, J NEUROL SCI, V160, P1, DOI 10.1016/S0022-510X(98)00155-5; Zhang YL, 2010, BRAIN RES, V1353, P249, DOI 10.1016/j.brainres.2010.07.046; Zhang YL, 2009, BRAIN RES, V1294, P153, DOI 10.1016/j.brainres.2009.07.077; Zhang Y, 2006, BRAIN RES, V1111, P227, DOI 10.1016/j.brainres.2006.07.005; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	102	23	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106238	10.1371/journal.pone.0106238			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	WOS:000341257700043	25184365	Green Submitted, Green Published, gold			2022-02-06	
J	Bazley, FA; Maybhate, A; Tan, CS; Thakor, NV; Kerr, C; All, AH				Bazley, Faith A.; Maybhate, Anil; Tan, Chuen Seng; Thakor, Nitish V.; Kerr, Candace; All, Angelo H.			Enhancement of Bilateral Cortical Somatosensory Evoked Potentials to Intact Forelimb Stimulation Following Thoracic Contusion Spinal Cord Injury in Rats	IEEE TRANSACTIONS ON NEURAL SYSTEMS AND REHABILITATION ENGINEERING			English	Article						Contusion spinal cord injury; cortical plasticity; electrophysiology; somatosensory evoked potentials; unilateral spinal cord injury	INDUCED MOVEMENT THERAPY; PLASTICITY; RECOVERY; DIFFERENTIATION; REORGANIZATION; REGENERATION; MODELS; STROKE	The adult central nervous system is capable of significant reorganization and adaptation following neurotrauma. After a thoracic contusive spinal cord injury (SCI) neuropathways that innervate the cord below the epicenter of injury are damaged, with minimal prospects for functional recovery. In contrast, pathways above the site of injury remain intact and may undergo adaptive changes in response to injury. We used cortical somatosensory evoked potentials (SSEPs) to evaluate changes in intact forelimb pathways. Rats received a midline contusion SCI, unilateral contusion SCI, or laminectomy with no contusion at the T8 level and were monitored for 28 days post-injury. In the midline injury group, SSEPs recorded from the contralateral forelimb region of the primary somatosensory cortex were 59.7% (CI 34.7%, 84.8%; c(2) = 21.9; dof = 1; p = 2.9 x 10(-6)) greater than the laminectomy group; SSEPs from the ipsilateral somatosensory cortex were 47.6% (CI 18.3%, 77%; c(2) = 10.1; dof = 1; p = 0.001) greater. Activation of the ipsilateral somatosensory cortex was further supported by BOLD-fMRI, which showed increased oxygenation at the ipsilateral hemisphere at day seven post-injury. In the unilateral injury group, ipsilesional side was compared to the contralesional side. SSEPs on day 14 (148%; CI 111%, 185%) and day 21 (137%; CI 110%, 163%) for ipsilesional forelimb stimulation were significantly increased over baseline (100%). SSEPs recorded from the hindlimb sensory cortex upon ipsilesional stimulation were 33.9% (CI 14.3%, 53.4%; c(2) = 11.6; dof = 1; p = 0.007) greater than contralesional stimulation. Therefore, these results demonstrate the ability of SSEPs to detect significant enhancements in the activation of forelimb sensory pathways following both midline and unilateral contusive SCI at T8. Reorganization of forelimb pathways may occur after thoracic SCI, which SSEPs can monitor to aid the development of future therapies.	[Bazley, Faith A.; Thakor, Nitish V.; All, Angelo H.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Bazley, Faith A.; Thakor, Nitish V.; All, Angelo H.] Natl Univ Singapore, Singapore Inst Neurotechnol, Singapore 117456, Singapore; [Thakor, Nitish V.] Natl Univ Singapore, Dept Elect & Comp Engn Bioengn & Med, Singapore 117456, Singapore; [Maybhate, Anil] Johns Hopkins Univ, Whiting Sch Engn, Baltimore, MD 21218 USA; [Tan, Chuen Seng] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore; [Kerr, Candace] Univ Maryland, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [All, Angelo H.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [All, Angelo H.] Natl Univ Singapore, Dept Orthopaed Surg Bioengn & Med, Singapore 117456, Singapore		Bazley, FA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	fbazley1@jhu.edu; anil.maybhate@jhu.edu; chuen_seng_tan@nuhs.edu.sg; nitish@jhu.edu; ckerr@som.umaryland.edu; hmn@jhu.edu	Tan, Chuen Seng/I-6854-2019; Tan, Chuen Seng/K-1078-2013; Thakor, Nitish/G-9110-2015; Thakor, Nitish V/A-5878-2008	Tan, Chuen Seng/0000-0002-6513-2309; Tan, Chuen Seng/0000-0002-6513-2309; Thakor, Nitish/0000-0002-9981-9395; 	Maryland Stem Cell Research Fund [2009-MSCRFII-0091-00, 2013-MSCRFII-0109-00]; National University of SingaporeNational University of Singapore [R-175-000-121-133, R-175-000-121-733, R-175-000-122-112, R-711-201-026-133]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01HL071568]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL071568] Funding Source: NIH RePORTER	This work was supported in part by Maryland Stem Cell Research Fundunder Grant 2009-MSCRFII-0091-00 and Grant 2013-MSCRFII-0109-00 (PI A. H. All); in part by the National University of Singaporeunder Grant R-175-000-121-133, Grant R-175-000-121-733, Grant R-175-000-122-112, and Grant R-711-201-026-133 (PI A. H. All); and in part by the National Institutes of Healthunder Grant 5R01HL071568 (PI N. V. Thakor).	Agrawal G, 2010, J CLIN NEUROSCI, V17, P1159, DOI 10.1016/j.jocn.2010.02.005; Agrawal G, 2010, SPINE, V35, P1122, DOI 10.1097/BRS.0b013e3181be5fa7; Agrawal G, 2009, J CLIN NEUROSCI, V16, P1052, DOI 10.1016/j.jocn.2008.08.009; Agrawal G, 2008, IEEE ENG MED BIO, P4688, DOI 10.1109/IEMBS.2008.4650259; All AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047645; All AH, 2010, NEUROL SCI, V31, P595, DOI 10.1007/s10072-010-0329-y; All AH, 2009, J NEUROL SCI, V284, P81, DOI 10.1016/j.jns.2009.04.025; Battistuzzo CR, 2012, J NEUROTRAUM, V29, P1600, DOI 10.1089/neu.2011.2199; Bazley FA, 2013, IEEE ENG MED BIO, P6321, DOI 10.1109/EMBC.2013.6610999; Bazley FA, 2012, IEEE ENG MED BIO, P82, DOI 10.1109/EMBC.2012.6345876; Bazley FA, 2012, J NEUROSURG-SPINE, V16, P414, DOI 10.3171/2012.1.SPINE11684; Bazley FA, 2011, IEEE ENG MED BIO, P2005, DOI 10.1109/IEMBS.2011.6090564; Blesch A, 2009, TRENDS NEUROSCI, V32, P41, DOI 10.1016/j.tins.2008.09.008; Boakye M, 2012, J NEUROSURG-SPINE, V17, P141, DOI 10.3171/2012.5.AOSPINE1296; Cafferty WBJ, 2008, TRENDS NEUROSCI, V31, P215, DOI 10.1016/j.tins.2008.02.004; Chaerkady R, 2011, PROTEOMICS, V11, P4007, DOI 10.1002/pmic.201100107; Chen HC, 2012, INTEGR SER INFORM SY, V30, P203, DOI 10.1007/978-1-4614-1557-2_11; Cote MP, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00330; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Curt A, 2008, J NEUROTRAUM, V25, P677, DOI 10.1089/neu.2007.0468; DeVivo MJ, 2012, SPINAL CORD, V50, P365, DOI 10.1038/sc.2011.178; Dietz V, 2012, EXP NEUROL, V235, P110, DOI 10.1016/j.expneurol.2011.04.007; Edgerton VR, 2004, ANNU REV NEUROSCI, V27, P145, DOI 10.1146/annurev.neuro.27.070203.144308; Endo T, 2007, BRAIN, V130, P2951, DOI 10.1093/brain/awm237; Fouad K., 2010, BRAIN RES B; Fuzaro AC, 2012, REV BRAS FISIOTER, V16, P157, DOI 10.1590/S1413-35552012005000010; Ghosh A, 2010, NAT NEUROSCI, V13, P97, DOI 10.1038/nn.2448; Harkema SJ, 2008, BRAIN RES REV, V57, P255, DOI 10.1016/j.brainresrev.2007.07.012; Hodgetts S. I., 2012, CELL TRANSPLANT, V22, P383; Hofstetter CP, 2003, EUR J NEUROSCI, V18, P3061, DOI 10.1111/j.1460-9568.2003.03062.x; Huebner EA, 2009, RESULTS PROBL CELL D, V48, P339, DOI 10.1007/400_2009_19; Iyer S, 2010, J NEUROSCI METH, V193, P210, DOI 10.1016/j.jneumeth.2010.08.017; Kerr CL, 2010, INT J NEUROSCI, V120, P305, DOI 10.3109/00207450903585290; Letzen BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010480; Madhok J, 2010, CRIT CARE MED, V38, P1709, DOI 10.1097/CCM.0b013e3181e7dd29; Maier IC, 2008, J NEUROSCI, V28, P9386, DOI 10.1523/JNEUROSCI.1697-08.2008; Maybhate A, 2012, CRIT CARE MED, V40, P573, DOI 10.1097/CCM.0b013e318232d97e; Onifer S. M., 2011, NEUROTHERAPEUTICS, P1; Paxinos G, 2006, RAT BRAIN STEREOTAXI; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Ramu J, 2007, EXP NEUROL, V204, P58, DOI 10.1016/j.expneurol.2006.09.015; Ramu J, 2006, J NEUROSCI RES, V84, P1235, DOI 10.1002/jnr.21030; Rao J.-S., BIOMED RES INT, V2013; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Sydekum E, 2009, NEUROIMAGE, V44, P1345, DOI 10.1016/j.neuroimage.2008.10.015; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Yague JG, 2011, EXP NEUROL, V227, P252, DOI 10.1016/j.expneurol.2010.11.011	47	23	25	0	10	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1534-4320	1558-0210		IEEE T NEUR SYS REH	IEEE Trans. Neural Syst. Rehabil. Eng.	SEP	2014	22	5					953	964		10.1109/TNSRE.2014.2319313			12	Engineering, Biomedical; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Rehabilitation	AP4WN	WOS:000342080400006	24801738	hybrid			2022-02-06	
J	Irimia, A; Goh, SYM; Torgerson, CM; Vespa, PM; Van Horn, JD				Irimia, A.; Goh, S-Y M.; Torgerson, C. M.; Vespa, P. M.; Van Horn, J. D.			Structural and connectomic neuroimaging for the personalized study of longitudinal alterations in cortical shape, thickness and connectivity after traumatic brain injury	JOURNAL OF NEUROSURGICAL SCIENCES			English	Article						Brain injuries; Neuroimaging; Magnetic resonance imaging; Connectome	MRI TISSUE CHARACTERIZATION; WHITE-MATTER INTEGRITY; SURFACE-BASED ANALYSIS; FLAIR PULSE SEQUENCES; CLOSED HEAD-INJURY; DIFFUSION-TENSOR; QUANTITATIVE-ANALYSIS; MULTIPLE-SCLEROSIS; COORDINATE SYSTEM; SEGMENTATION	The integration of longitudinal brain structure analysis with neurointensive care strategies continues to be a substantial difficulty facing the traumatic brain injury (TBI) research community. For patient-tailored case analysis, it remains challenging to establish how lesion profile modulates longitudinal changes in cortical structure and connectivity, as well as how these changes lead to behavioral, cognitive and neural dysfunction. Additionally, despite the clinical potential of morphometric and connectomic studies, few analytic tools are available for their study in TBI. Here we review the state of the art in structural and connectomic neuroimaging for the study of TBI and illustrate a set of recently-developed, patient-tailored approaches for the study of TBI-related brain atrophy and alterations in morphometry as well as inter-regional connectivity. The ability of such techniques to quantify how injury modulates longitudinal changes in cortical shape, structure and circuitry is highlighted. Quantitative approaches such as these can be used to assess and monitor the clinical condition and evolution of TBI victims, and can have substantial translational impact, especially when used in conjunction with measures of neuropsychological function.	[Irimia, A.; Goh, S-Y M.; Torgerson, C. M.; Van Horn, J. D.] Univ So Calif, Keck Sch Med, Inst Neuroimaging & Informat, Dept Neurol, Los Angeles, CA 90032 USA; [Vespa, P. M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Brain Injury Res Ctr, Los Angeles, CA 90095 USA		Van Horn, JD (corresponding author), Univ So Calif, Keck Sch Med, Inst Neuroimaging & Informat, Los Angeles, CA 90032 USA.	jvanhorn@usc.edu	Irimia, Andrei/B-8275-2008	Irimia, Andrei/0000-0002-9254-9388; Van Horn, John/0000-0003-1537-0816	National Alliance for Medical Image Computing (NA-MIC) under NIH Roadmap Initiative [2U54EB005149]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS058489, R41NS081792]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015922, U54EB005149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R41NS081792, P01NS058489] Funding Source: NIH RePORTER	This work was supported by the National Alliance for Medical Image Computing (NA-MIC; www.na-mic.org), under NIH Roadmap Initiative grant 2U54EB005149, sub-award to J. D. V. H., by the NINDS, grant P01NS058489 to P. V., and R41NS081792, sub-award to J. D. V. H.	Achard S, 2012, P NATL ACAD SCI USA, V109, P20608, DOI 10.1073/pnas.1208933109; Ashikaga R, NEURORAIOLOGY, V7, P239; Atlas SW, ADIOLOGY, V88, P803; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Caeyenberghs K, 2011, NEUROREHAB NEURAL RE, V25, P492, DOI 10.1177/1545968310394870; CULLUM CM, 1986, J CLIN EXP NEUROPSYC, V8, P437, DOI 10.1080/01688638608401333; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DECOENE B, 1992, AM J NEURORADIOL, V13, P1555; Defense_Centers_of_ Excellence, 2013, NEUROIMAGING FOLLOWI; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; GALE SD, 1995, J NEUROTRAUM, V12, P151, DOI 10.1089/neu.1995.12.151; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1994, RADIOLOGY, V191, P1; Hagmann P, 2010, J NEUROSCI METH, V194, P34, DOI 10.1016/j.jneumeth.2010.01.014; Hajnal JV, J COMPUT ASSST TOMO, V92, P841; Hamann P, 2008, PLOS BIOL, V6, P1479; Hillary FG, 2009, IMAGING BEHAV, V3, P1122; Irimia A, NEUROIMAGE CIN, V201, P1; Irimia A, 2012, NEUROIMAGE, V60, P1340, DOI 10.1016/j.neuroimage.2012.01.107; Irimia Andrei, 2012, Front Neurol, V3, P10, DOI 10.3389/fneur.2012.00010; Irimia A, 2011, J NEUROTRAUM, V28, P2287, DOI 10.1089/neu.2011.1920; Itti L, 2001, J NEUROIMAGING, V11, P412, DOI 10.1111/j.1552-6569.2001.tb00071.x; Jacobs MA, 2001, STROKE, V32, P950, DOI 10.1161/01.STR.32.4.950; Jacobs MA, 2001, STROKE, V32, P943, DOI 10.1161/01.STR.32.4.943; Johnston B, 1996, IEEE T MED IMAGING, V15, P154, DOI 10.1109/42.491417; JONES KM, 1992, AM J ROENTGENOL, V158, P1313, DOI 10.2214/ajr.158.6.1590133; Kaas JH, 2008, EXP NEUROL, V209, P407, DOI 10.1016/j.expneurol.2007.06.014; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kirkby BS, 1934, NEUROPSYCHOOGIA, P689; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Krzywnski M, GENOME RES, V20919; Kuzma BB, 2000, SRG NEURO, V53, P400; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Liao CC, 2009, COMPUT MED IMAG GRAP, V33, P423, DOI 10.1016/j.compmedimag.2009.04.001; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Mitsias PD, 2002, STROKE, V33, P2839, DOI 10.1161/01.STR.0000043072.76353.7C; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77; Niethammer M, 2011, LECT NOTES COMPUT SC, V6892, P639, DOI 10.1007/978-3-642-23629-7_78; Park E, 2006, J NEUROPATH EXP NEUR, V65, P226, DOI 10.1097/01.jnen.0000202888.29705.93; Prataa M.W., 2012, P SOC PHOTO-OPT INS; Raff U, 2000, ACAD RADIOL, V7, P237, DOI 10.1016/S1076-6332(00)80473-0; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; Schlaug G, 2009, STROKE, V40, pE123; Seghier ML, 2008, NEUROIMAGE, V41, P1253, DOI 10.1016/j.neuroimage.2008.03.028; Sehgal V, 2005, J MAGN RESON IMAGING, V22, P439, DOI 10.1002/jmri.20404; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Spaos GK, 2007, AM J NEURORADIOL, V28, P537; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Strangman GE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00182; Thatcher RW, 1997, J NEUROTRAUM, V14, P1, DOI 10.1089/neu.1997.14.1; van Horn JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037454; Warach S, AN EUROL, V1, P231; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Wn B, IEEE INT S BIOM ENG; Xie K, 2005, EUR J RADIOL, V56, P12, DOI 10.1016/j.ejrad.2005.03.028; Zakaria N, 2007, J NEUROTRAUM, V24, P1233	71	23	24	0	9	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0390-5616	1827-1855		J NEUROSURG SCI	J. Neurosurg. Sci.	SEP	2014	58	3					129	144					16	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AR1XH	WOS:000343377400001	24844173				2022-02-06	
J	Jepsen, CH; deMoya, MA; Perner, A; Sillesen, M; Ostrowski, SR; Alam, HB; Johansson, PI				Jepsen, Cecilie Heerdegen; deMoya, Marc A.; Perner, Anders; Sillesen, Martin; Ostrowski, Sisse R.; Alam, Hasan B.; Johansson, Paer I.			Effect of valproic acid and injury on lesion size and endothelial glycocalyx shedding in a rodent model of isolated traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; endothelial dysfunction; valproic acid; S100 beta; rats	PROTEIN; DAMAGE; S100B; DEGRADATION; BIOMARKERS; EXPRESSION; MARKER; SERUM; COAGULOPATHY	BACKGROUND: In isolated traumatic brain injury (TBI), little is known about the endothelial response and the effects of endothelial glycocalyx shedding. We have previously shown that treatment with valproic acid (VPA) improves outcomes following TBI and hemorrhagic shock. In this model, we hypothesized that severe isolated TBI would cause shedding of the endothelial glycocalyx, as measured by serum syndecan-1 (sSDC-1) levels. We further hypothesized that VPA treatment would reduce this response and reduce lesion size volume. METHODS: Forty Sprague-Dawley rats were allocated to TBI + VPA (n = 8), TBI + saline vehicle control infusion (n = 8), sham + saline vehicle control infusion (n = 6), or sham + VPA (n = 8). TBI animals were subjected to severe controlled cortical impact and killed 6 hours after injury. VPA 300 mg/kg was given as an intravenous bolus 30 minutes after injury. Serum samples were analyzed for sSDC-1, and lesion size was determined on Nissl-stained cryosections. RESULTS: sSDC-1 was significantly elevated in injured compared with uninjured animals at 3 hours (p = 0.0009) and 6 hours (p = 0.0007) after injury. This effect was significantly more pronounced in the animals treated with VPA (p = 0.019) 3 hours after injury, in which sSDC-1 levels were also significantly inversely correlated with lesion size (Q = -0.55, p = 0.038). Lesion size was significantly smaller in TBI + VPA (40.45 mm(3) +/- 13.83 mm(3)) as compared with vehicle control (59.57 mm(3) +/- 16.83 mm(3)) (p = 0.023). CONCLUSION: Severe isolated TBI caused shedding of the endothelial glycocalyx. Treatment with VPA was associated with increased glycocalyx shedding and reduced lesion size volume in injured animal Copyright (C) 2014 by Lippincott Williams & Wilkins	[Jepsen, Cecilie Heerdegen; deMoya, Marc A.; Sillesen, Martin] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Surg,Div Trauma Emergency Surg & Surg Crit C, Boston, MA 02114 USA; [Jepsen, Cecilie Heerdegen; Sillesen, Martin; Ostrowski, Sisse R.; Johansson, Paer I.] Rigshosp, Copenhagen Univ Hosp, Capital Reg Blood Bank, DK-2100 Copenhagen, Denmark; [Perner, Anders] Rigshosp, Copenhagen Univ Hosp, Dept Intens Care, DK-2100 Copenhagen, Denmark; [Alam, Hasan B.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Johansson, Paer I.] Univ Texas Med Sch Houston, Dept Surg, Houston, TX USA		Jepsen, CH (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Surg,Div Trauma Emergency Surg & Surg Crit C, 165 Cambridge St,Suite 810, Boston, MA 02114 USA.	ceciliehjepsen@gmail.com	Ostrowski, Sisse R/E-7423-2011; Johansson, Par I/P-9283-2015	Ostrowski, Sisse R/0000-0001-5288-3851; Johansson, Par I/0000-0001-9778-5964; Perner, Anders/0000-0002-4668-0123; Sillesen, Martin/0000-0001-9494-5475	Polsky family	The authors declare no conflicts of interest. This study was supported by the Polsky family.	Alam HB, 2009, SURGERY, V146, P325, DOI 10.1016/j.surg.2009.04.007; Babcock L, 2012, BRAIN INJURY, V26, P1372, DOI 10.3109/02699052.2012.694565; Causey MW, 2012, J VASC SURG, V55, P1096, DOI 10.1016/j.jvs.2011.08.060; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; da Rocha AB, 2006, CLIN CHEM LAB MED, V44, P1234, DOI 10.1515/CCLM.2006.218; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; Egea-Guerrero JJ, 2012, BRAIN INJURY, V26, P76, DOI 10.3109/02699052.2011.635360; Genet GF, 2013, J NEUROTRAUM, V30, P301, DOI 10.1089/neu.2012.2612; Haywood-Watson RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023530; Henrich M, 2010, THESCIENTIFICWORLDJO, V10, P917, DOI 10.1100/tsw.2010.88; Iseki K, 2002, GLIA, V39, P1, DOI 10.1002/glia.10078; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Johansson PI, 2010, MED HYPOTHESES, V75, P564, DOI 10.1016/j.mehy.2010.07.031; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Kleindienst A, 2006, J NEUROTRAUM, V23, P1185, DOI 10.1089/neu.2006.23.1185; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Kozar RA, 2011, ANESTH ANALG, V112, P1289, DOI 10.1213/ANE.0b013e318210385c; Li YQ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/523481; Ostrowski SR, 2012, J TRAUMA ACUTE CARE, V73, P60, DOI 10.1097/TA.0b013e31825b5c10; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Properzi F, 2008, EUR J NEUROSCI, V27, P593, DOI 10.1111/j.1460-9568.2008.06042.x; Stein DM, 2012, J NEUROTRAUM, V29, P1140, DOI 10.1089/neu.2011.2149	23	23	25	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2014	77	2					292	297		10.1097/TA.0000000000000333			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	AN0EJ	WOS:000340255700018	25058256				2022-02-06	
J	Voicu, S; Deye, N; Malissin, I; Vigue, B; Brun, PY; Haik, W; Champion, S; Megarbane, B; Sideris, G; Mebazaa, A; Carli, P; Manivet, P; Baud, FJ				Voicu, Sebastian; Deye, Nicolas; Malissin, Isabelle; Vigue, Bernard; Brun, Pierre-Yves; Haik, William; Champion, Sebastien; Megarbane, Bruno; Sideris, Georgios; Mebazaa, Alexandre; Carli, Pierre; Manivet, Philippe; Baud, Frederic J.			Influence of alpha-Stat and pH-Stat Blood Gas Management Strategies on Cerebral Blood Flow and Oxygenation in Patients Treated With Therapeutic Hypothermia After Out-of-Hospital Cardiac Arrest: A Crossover Study	CRITICAL CARE MEDICINE			English	Article						blood gases; carbon dioxide; cardiac arrest; cerebral blood flow; cerebral oxygen extraction; therapeutic hypothermia	2010 INTERNATIONAL CONSENSUS; CARDIOVASCULAR CARE SCIENCE; ARTERIAL CARBON-DIOXIDE; TRAUMATIC BRAIN-INJURY; CARDIOPULMONARY BYPASS; CIRCULATORY ARREST; MILD HYPOTHERMIA; CEREBROVASCULAR REACTIVITY; TREATMENT RECOMMENDATIONS; INTRACRANIAL-PRESSURE	Objectives: In patients treated with therapeutic hypothermia after out-of-hospital cardiac arrest, two blood gas management strategies are used regarding the Paco(2) target: alpha-stat or pH-stat. We aimed to compare the effects of these strategies on cerebral blood flow and oxygenation. Design: Prospective observational single-center crossover study. Setting: ICU of University hospital. Patients: Twenty-one therapeutic hypothermia-treated patients after out-of-hospital cardiac arrest more than 18 years old without history of cerebrovascular disease were included. Interventions: Cerebral perfusion and oxygenation variables were compared in a-stat (Paco(2) measured at 37 degrees C) versus pH-stat (Paco(2) measured at 32-34 degrees C), both strategies maintaining physiological Paco(2) values: 4.8-5.6 kPa (36-42 torr). Measurements and Main Results: Bilateral transcranial middle cerebral artery flow velocities using Doppler and jugular vein oxygen saturation were measured in both strategies 18 hours (14-23 hr) after the return of spontaneous circulation. Pulsatility and resistance indexes and cerebral oxygen extraction were calculated. Data are expressed as median (interquartile range 25-75) in alpha-stat versus pH-stat. No differences were found in temperature, arterial blood pressure, and oxygenation between alpha-stat and pH-stat. Significant differences were found in minute ventilation (p = 0.006), temperature-corrected Paco(2) (4.4 kPa [4.1-4.6 kPa] vs 5.1 kPa [5.0-5.3 kPa], p = 0.0001), and temperature-uncorrected Paco(2) (p = 0.0001). No differences were found in cerebral blood velocities and pulsatility and resistance indexes in the overall population. Significant differences were found in jugular vein oxygen saturation (83.2% [79.2-87.6%] vs 86.7% [83.2-88.2%], p = 0.009) and cerebral oxygen extraction (15% [11-20%] vs 12% [10-16%], p = 0.01), respectively. In survivors, diastolic blood velocities were 25 cm/s (19-30 cm/s) versus 29 cm/s (23-35 cm/s) (p = 0.004), pulsatility index was 1.10 (0.97-1.18) versus 0.94 (0.89-1.05) (p = 0.027), jugular vein oxygen saturation was 79.2 (71.1-81.8) versus 83.3% (76.6-87.8) (p = 0.033), respectively. However, similar results were not found in nonsurvivors. Conclusions: In therapeutic hypothermia-treated patients after out-of-hospital cardiac arrest at physiological Paco(2), alpha-stat strategy increases jugular vein blood desaturation and cerebral oxygen extraction compared with pH-stat strategy and decreases cerebral blood flow velocities in survivors.	[Voicu, Sebastian; Deye, Nicolas; Malissin, Isabelle; Brun, Pierre-Yves; Haik, William; Champion, Sebastien; Megarbane, Bruno; Baud, Frederic J.] Lariboisiere Univ Hosp, APHP, Med & Toxicol Intens Care Dept, Paris, France; [Voicu, Sebastian; Deye, Nicolas; Sideris, Georgios; Mebazaa, Alexandre; Manivet, Philippe] Univ Paris Diderot, INSERM, U942, Paris, France; [Voicu, Sebastian; Sideris, Georgios] Lariboisiere Univ Hosp, APHP, Dept Cardiol, Paris, France; [Vigue, Bernard] CHU Bicetre, APHP, Dept Anesthesiol & Crit Care, Le Kremlin Bicetre, France; [Megarbane, Bruno; Baud, Frederic J.] Univ Paris Denis Diderot, INSERM, U705, Paris, France; [Mebazaa, Alexandre] Lariboisiere Univ Hosp, APHP, Dept Anaesthesia & Intens Care, Paris, France; [Carli, Pierre] Paris Descartes Univ, Necker Hosp, APHP, Med Sch,SAMU 75, Paris, France; [Carli, Pierre] Paris Descartes Univ, Necker Hosp, APHP, Dept Anesthesiol,Med Sch, Paris, France; [Manivet, Philippe] Lariboisiere Univ Hosp, APHP, Biochem Lab, Paris, France; Lariboisiere Univ Hosp, Intens Care Unit Dept, Paris, France		Deye, N (corresponding author), Lariboisiere Univ Hosp, APHP, Med & Toxicol Intens Care Dept, Paris, France.	nicolas.deye@lrb.aphp.fr	voicu, sebastian/AAM-5348-2020; Manivet, Philippe/AAA-1884-2021	Mebazaa, Alexandre/0000-0001-8715-7753; Megarbane, Bruno/0000-0002-2522-2764	Thermofischer; Ministere Francais de la Sante	Dr. Vigue lectured for Laboratoire francais du Fractionnement et de Biotechnologie (LFB) and Octapharma. Dr. Vigue and his institution consulted for LFB and received grant support from Thermofischer. Dr. Mebazaa consulted for Bayer, Cardiorentis, and Vifor and lectured for Alere, Edwards, Novartis, and Orion. Dr. Baud received support for article research from the Ministere Francais de la Sante. The remaining authors have disclosed that they do not have any potential conflicts of interest.	AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Aziz KAA, 2010, INTERACT CARDIOV TH, V10, P271, DOI 10.1510/icvts.2009.214130; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bhatia A, 2007, INTENS CARE MED, V33, P1263, DOI 10.1007/s00134-007-0678-z; Bisschops LLA, 2012, CRIT CARE MED, V40, P2362, DOI 10.1097/CCM.0b013e318255d983; Bisschops LLA, 2010, CRIT CARE MED, V38, P1542, DOI 10.1097/CCM.0b013e3181e2cc1e; Buunk G, 1997, STROKE, V28, P1569, DOI 10.1161/01.STR.28.8.1569; Chamorro C, 2010, ANESTH ANALG, V110, P1328, DOI 10.1213/ANE.0b013e3181d8cacf; Curley G, 2010, CRIT CARE, V14, DOI 10.1186/cc8926; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Deakin CD, 2010, RESUSCITATION, V81, pE93, DOI 10.1016/j.resuscitation.2010.08.027; Duebener LF, 2002, CIRCULATION, V106, pI103, DOI 10.1161/01.cir.0000032916.33237.a9; Falkenbach P, 2009, RESUSCITATION, V80, P990, DOI 10.1016/j.resuscitation.2009.04.044; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; HENRIKSEN L, 1983, J THORAC CARDIOV SUR, V86, P202; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hoover LR, 2009, ANESTH ANALG, V108, P1389, DOI 10.1213/ane.0b013e318187c39d; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; JENNETT B, 1975, LANCET, V1, P480; Joshi B, 2010, ANESTH ANALG, V110, P321, DOI 10.1213/ANE.0b013e3181c6fd12; Kiziltan HT, 2003, ANESTH ANALG, V96, P644, DOI [10.1213/01.ANE.000048826.67870.85, 10.1213/01.ANE.0000048826.67870.85]; KLINGELHOFER J, 1992, STROKE, V23, P962, DOI 10.1161/01.STR.23.7.962; Kollmar R, 2009, NEUROCRIT CARE, V10, P173, DOI 10.1007/s12028-008-9162-z; Krejza J, 1999, AM J ROENTGENOL, V172, P213, DOI 10.2214/ajr.172.1.9888770; Laffey JG, 2002, NEW ENGL J MED, V347, P43, DOI 10.1056/NEJMra012457; Laussen PC, 2002, PAEDIATR ANAESTH, V12, P199, DOI 10.1046/j.1460-9592.2002.00779.x; Lemiale V, 2008, RESUSCITATION, V76, P17, DOI 10.1016/j.resuscitation.2007.06.028; Macmillan CSA, 2001, J NEUROL NEUROSUR PS, V70, P101, DOI 10.1136/jnnp.70.1.101; Marti-Fabregas J, 2003, NEUROLOGY, V61, P1051, DOI 10.1212/01.WNL.0000090520.67254.14; Millar SA, 1999, BRIT J ANAESTH, V83, P936, DOI 10.1093/bja/83.6.936; Morrison LJ, 2010, CIRCULATION, V122, P8345, DOI 10.1161/CIRCULATIONAHA.110.971051; MURKIN JM, 1987, ANESTH ANALG, V66, P825; Nauphal M, 2007, EUR J ANAESTH, V24, P15, DOI 10.1017/S0265021506000998; Pokela M, 2003, ANN THORAC SURG, V76, P1215, DOI 10.1016/S0003-4975(03)00834-8; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Priestley MA, 2001, J THORAC CARDIOV SUR, V121, P336, DOI 10.1067/mtc.2001.112338; Pynnonen L, 2011, RESUSCITATION, V82, P1174, DOI 10.1016/j.resuscitation.2011.04.022; Roberts BW, 2013, CIRCULATION, V127, P2107, DOI 10.1161/CIRCULATIONAHA.112.000168; Schneider AG, 2013, RESUSCITATION, V84, P927, DOI 10.1016/j.resuscitation.2013.02.014; Sideris G, 2011, RESUSCITATION, V82, P1148, DOI 10.1016/j.resuscitation.2011.04.023; SORTEBERG W, 1990, J ULTRAS MED, V9, P403; Sunde K, 2007, RESUSCITATION, V73, P29, DOI 10.1016/j.resuscitation.2006.08.016; Sundgreen C, 2001, STROKE, V32, P128, DOI 10.1161/01.STR.32.1.128; van Genderen ME, 2012, CRIT CARE MED, V40, P2287, DOI 10.1097/CCM.0b013e31825333b2; Vigue B, 2000, INTENS CARE MED, V26, P722, DOI 10.1007/s001340051238; Wessels T, 2006, ULTRASOUND MED BIOL, V32, P1845, DOI 10.1016/j.ultrasmedbio.2006.06.023	46	23	23	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	AUG	2014	42	8					1849	1861		10.1097/CCM.0000000000000339			13	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7QV	WOS:000339330700034	24717455				2022-02-06	
J	Bragge, P; Pattuwage, L; Marshall, S; Pitt, V; Piccenna, L; Stergiou-Kita, M; Tate, RL; Teasell, R; Wiseman-Hakes, C; Kua, A; Ponsford, J; Velikonja, D; Bayley, M				Bragge, Peter; Pattuwage, Loyal; Marshall, Shawn; Pitt, Veronica; Piccenna, Loretta; Stergiou-Kita, Mary; Tate, Robyn L.; Teasell, Robert; Wiseman-Hakes, Catherine; Kua, Ailene; Ponsford, Jennie; Velikonja, Diana; Bayley, Mark			Quality of Guidelines for Cognitive Rehabilitation Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						clinical practice guidelines; cognitive rehabilitation; traumatic brain injury	CLINICAL-PRACTICE GUIDELINES; INCOG RECOMMENDATIONS; AGREE II; MANAGEMENT; MEDICINE; MODERATE	Introduction: Cognitive rehabilitation following traumatic brain injury can aid in optimizing function, independence, and quality of life by addressing impairments in attention, executive function, cognitive communication, and memory. This study aimed to identify and evaluate the methodological quality of clinical practice guidelines for cognitive rehabilitation following traumatic brain injury. Methods: Systematic searching of databases and Web sites was undertaken between January and March 2012 to identify freely available, English language clinical practice guidelines from 2002 onward. Eligible guidelines were evaluated using the validated Appraisal of Guidelines for Research and Evaluation II instrument. Results: The 11 guidelines that met inclusion criteria were independently rated by 4 raters. Results of quality appraisal indicated that guidelines generally employed systematic search and appraisal methods and produced unambiguous, clearly identifiable recommendations. Conversely, only 1 guideline incorporated implementation and audit information, and there was poor reporting of processes for formulating, reviewing, and ensuring currency of recommendations and incorporating patient preferences. Intraclass correlation coefficients for agreement between raters showed high agreement (intraclass correlation coefficient > 0.80) for all guidelines except for 1 (moderate agreement; intraclass correlation coefficient = 0.76). Conclusion: Future guidelines should address identified limitations by providing implementation information and audit criteria, along with better reporting of guideline development processes and stakeholder engagement.	[Bragge, Peter; Pattuwage, Loyal; Pitt, Veronica; Piccenna, Loretta] Monash Univ, Natl Trauma Res Inst, Melbourne, Vic 3004, Australia; [Bragge, Peter; Pattuwage, Loyal; Pitt, Veronica; Piccenna, Loretta] Alfred Hosp, Melbourne, Vic, Australia; [Marshall, Shawn] Univ Ottawa, Ottawa Hosp Rehabil Ctr, Ottawa, ON, Canada; [Stergiou-Kita, Mary] Univ Toronto, Toronto, ON, Canada; [Stergiou-Kita, Mary] Toronto Rehabil Inst, Toronto, ON, Canada; [Bayley, Mark] Univ Toronto, Dept Med, UHN Toronto Rehabil Inst, Toronto, ON, Canada; [Bayley, Mark] Univ Toronto, Dept Med, Div Physiatry, Toronto, ON, Canada; [Tate, Robyn L.] Univ Sydney, Sydney Med Sch Northern, Rehabil Studies Unit, Sydney, NSW 2006, Australia; [Teasell, Robert] St Josephs Hlth Ctr, Lawson Res Inst, London, ON, Canada; [Teasell, Robert] Univ Western Ontario, London, ON, Canada; [Wiseman-Hakes, Catherine] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Kua, Ailene] Toronto Rehabil Inst, Toronto, ON, Canada; [Ponsford, Jennie] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Richmond, Vic, Australia; [Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia; [Velikonja, Diana] McMaster Univ, DeGroote Sch Med, Hamilton Hlth Sci, Acquired Brain Injury Program, Hamilton, ON, Canada		Bragge, P (corresponding author), Monash Univ, Natl Trauma Res Inst, Level 4,89 Commercial Rd, Melbourne, Vic 3004, Australia.	peter.bragge@monash.edu	piccenna, Loretta/I-2533-2014; Wiseman-Hakes, Catherine/AAC-8303-2021	piccenna, Loretta/0000-0003-3895-8145; Wiseman-Hakes, Catherine/0000-0001-8441-884X; Bragge, Peter/0000-0003-0745-5131; Bayley, Mark/0000-0001-7860-9463	Monash UniversityMonash University; Ontario Neurotrauma Foundation	This project was funded through Monash University's Strategic Grants Scheme (Lead CI: Peter Bragge) and the Ontario Neurotrauma Foundation (Lead CI: Mark Bayley).	Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; ABIEBR Project, 2007, ABIKUS GUID; Access Economics, 2009, EC COST SPIN CORD IN, P115; AGREE Next Steps Consortium, APPR GUID RES EV 2 A; Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P290, DOI 10.1097/HTR.0000000000000070; Berrigan L, 2011, BRAIN INJURY, V25, P742, DOI 10.3109/02699052.2011.580317; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE472, DOI 10.1503/cmaj.091716; Brouwers MC, 2010, CAN MED ASSOC J, V182, P1045, DOI 10.1503/cmaj.091714; Cappa SF, 2005, EUR J NEUROL, V12, P665; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Alarcon JD, 2013, J TRAUMA ACUTE CARE, V75, P311, DOI 10.1097/TA.0b013e3182924bf8; Ehlhardt LA, 2008, NEUROPSYCHOL REHABIL, V18, P300, DOI 10.1080/09602010701733190; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Field MJ, 1990, CLIN PRACTICE GUIDEL; Glasziou P, 2011, BMJ QUAL SAF, V20, pI13, DOI 10.1136/bmjqs.2010.046524; Hurdowar A, 2007, J EVAL CLIN PRACT, V13, P657, DOI 10.1111/j.1365-2753.2007.00708.x; International Committee of Medical Journal Editors, 2014, AUTH RESP CONFL INT; Kalechstein AD, 2003, J CLIN EXP NEUROPSYC, V25, P1186, DOI 10.1076/jcen.25.8.1186.16723; Katrak Persis, 2004, BMC Med Res Methodol, V4, P22, DOI 10.1186/1471-2288-4-22; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Keris V, 2007, WORLD J SURG, V31, P1352, DOI 10.1007/s00268-007-9002-x; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Lawson JH, 2004, SEMIN HEMATOL, V41, P55, DOI 10.1053/j.seminhematol.2003.11.012; Murray CJL, 1996, GLOBAL HLTH STAT; New Zealand Guidelines Group, 2006, TRAUM BRAIN INJ GUID, P244; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Rees L, 2007, BRAIN INJURY, V21, P161, DOI 10.1080/02699050701201813; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Royal College of Physicians and British Society of Rehabilitation Medicine, 2003, REH FOLL ACQ BRAIN I, P81; Rusnak M, 2008, BRATISL MED J, V109, P374; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Satz P, 1998, BRAIN INJURY, V12, P555, DOI 10.1080/026990598122322; Scottish Intercollegiate Guidelines Network, 2013, SIGN PUBL, V130; Sohlberg MM, 2007, J MED SPEECH-LANG PA, V15, pXV; Sohlberg MM, 2003, J MED SPEECH-LANG PA, V11, pXIX; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Turkstra L, 2005, J MED SPEECH-LANG PA, V13, pIX; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527	45	23	23	0	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2014	29	4					277	289		10.1097/HTR.0000000000000066			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AM2AK	WOS:000339650300006	24984092				2022-02-06	
J	Niemeier, JP; Perrin, PB; Holcomb, MG; Rolston, CD; Artman, LK; Lu, J; Nersessova, KS				Niemeier, Janet P.; Perrin, Paul B.; Holcomb, Megan G.; Rolston, Cynthia D.; Artman, Laura K.; Lu, Juan; Nersessova, Karine S.			Gender Differences in Awareness and Outcomes During Acute Traumatic Brain Injury Recovery	JOURNAL OF WOMENS HEALTH			English	Article							SYSTEMS BEHAVIOR SCALE; COMPETENCE RATING-SCALE; HEAD-INJURY; PROGESTERONE; TBI; SEX; REHABILITATION; PERSPECTIVE; COGNITION; PARTICIPATION	Background: Recent literature on traumatic brain injury (TBI), though mixed when reporting outcomes, seems collectively to suggest possible gender advantage for women in postinjury recovery, especially in executive functions. Hormonal neuroprotection, through female reproductive hormones, is often proposed as an underlying factor in these results. We explored potential gender differences in an aspect of executive functions, self-awareness (SA), which is often impaired after TBI, limits patient effort in critical rehabilitation, and increases caregiver burden. Methods: Within a prospective survey, repeated-measures design, 121 patients with moderate or severe TBI undergoing acute rehabilitation in a Level 1 trauma center, a family member or caregiver informant, and a treating clinician were asked to complete the Patient Competency Rating Scale (PCRS) and the Frontal Systems Behavior Scale (FrSBe) at admission and discharge. Results: Although overall, women and men with TBI showed generally similar levels of SA, women had significantly better awareness of their injury-related deficits at acute rehabilitation discharge, even when controlling for age, education, and injury severity. Conclusions: Mixed findings in this study mirror the pattern of results that dominate the published literature on gender and TBI. Gender differences in executive dysfunction may not be as large or robust as some researchers argue. In addition, complex interplays of socialization, gender-role expectations, naturally occurring male and female ability differences, and differences in access to postinjury rehabilitation are understudied potential moderators.	[Niemeier, Janet P.] Carolinas Rehabil, Dept Phys Med & Rehabil, Charlotte, NC 28203 USA; [Perrin, Paul B.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Holcomb, Megan G.] Vet Hosp, Dept Psychol, Pensacola, FL USA; [Rolston, Cynthia D.; Artman, Laura K.; Nersessova, Karine S.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Lu, Juan] Virginia Commonwealth Univ, Dept Epidemiol, Richmond, VA USA		Niemeier, JP (corresponding author), Carolinas Rehabil, Dept Phys Med & Rehabil, 1100 Blythe Blvd, Charlotte, NC 28203 USA.	janet.niemeier@carolinashealthcare.org	; Perrin, Paul/L-5373-2015	Lu, Juan/0000-0002-5389-7603; Perrin, Paul/0000-0003-2070-215X	National Center for Medical Rehabilitation Research (NCMRR); Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1R01HD052922-01A2]; NIH CTSA AwardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1 TR00058]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD052922] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000058] Funding Source: NIH RePORTER	This research was supported by the National Center for Medical Rehabilitation Research (NCMRR), the Eunice Kennedy Shriver National Institute of Child Health and Human Development, 1R01HD052922-01A2, and, in part, by NIH CTSA Award UL1 TR00058.	Addis ME, 2003, AM PSYCHOL, V58, P5, DOI 10.1037/0003-066X.58.1.5; Alston M, 2012, AUST SOC WORK, V65, P39, DOI 10.1080/0312407X.2011.594898; BASDEVANT A, 1986, Journal de Gynecologie Obstetrique et biologie de la Reproduction, V15, P147; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Bingefors K, 2004, EUR J PAIN, V8, P435, DOI 10.1016/j.ejpain.2004.01.005; Bounds TA, 2003, NEUROREHABILITATION, V18, P189; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; de Abreu PMJE, 2014, MEMORY, V22, P323, DOI 10.1080/09658211.2013.781186; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Drapeau A, 2009, J BEHAV HEALTH SER R, V36, P372, DOI 10.1007/s11414-009-9168-0; Farace E, 2000, Neurosurg Focus, V8, pe6; Fleming J., 2010, INT ENCY REHABILITAT; Fritz MA, 2011, CLIN GYNECOLOGIC END, P193; Giacino JT, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199810000-00003; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Goranson TE, 2003, BRAIN INJURY, V17, P759, DOI 10.1080/0269905031000088513; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Heaton PDRK., 1993, WISCONSIN CARD SORTI; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; JOHNSON WS, 1971, J AM CHEM SOC, V93, P4332, DOI 10.1021/ja00746a062; Katz Noomi, 2002, Can J Occup Ther, V69, P281; Keenan HT, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1984; Kolakowsky-Hayner SA, 2012, J HEAD TRAUMA REHAB, V27, P83, DOI 10.1097/HTR.0b013e31823645db; Komesaroff P A, 2001, Climacteric, V4, P144; Kraus J F, 2000, Neurosurg Focus, V8, pe5; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Lane-Brown AT, 2009, BRAIN INJURY, V23, P999, DOI 10.3109/02699050903379347; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lezak M., 2010, J HEAD TRAUMA REHAB, V8, P24; Liossi C, 2009, J NEUROPSYCH CLIN N, V21, P43, DOI 10.1176/appi.neuropsych.21.1.43; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; Mauritz W, 2009, EUR J EMERG MED, V16, P153, DOI 10.1097/MEJ.0b013e32832a0864; Moore DW, 2010, NEUROPSYCHOL REHABIL, V20, P340, DOI 10.1080/09602010903250928; Munro CA, 2012, AGING NEUROPSYCHOL C, V19, P759, DOI 10.1080/13825585.2012.690366; Murre JMJ, 2013, ACTA PSYCHOL, V142, P96, DOI 10.1016/j.actpsy.2012.10.005; Niemeier JP, 2007, NEUROPSYCHOL REHABIL, V17, P293, DOI 10.1080/09602010600814729; Niemeier JP, 2013, NEUROPSYCHOL REHABIL, V23, P363, DOI 10.1080/09602011.2012.761944; Olga NK, 2006, BEHAV BRAIN RES, V170, P233, DOI 10.1016/j.bbr.2006.02.026; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Ponsford JL, 2008, INJURY, V39, P67, DOI 10.1016/j.injury.2007.08.028; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P359, DOI 10.1097/00001199-200507000-00007; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Razmjou H, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-66; Redpath SJ, 2010, BRAIN INJURY, V24, P802, DOI 10.3109/02699051003709623; Soules M R, 2001, Menopause, V8, P402, DOI 10.1097/00042192-200111000-00004; Soules MR, 2005, MENOPAUSE, V12, P117, DOI 10.1097/00042192-200512020-00001; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Stein DG, 2013, HORM BEHAV, V63, P291, DOI 10.1016/j.yhbeh.2012.05.004; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; Stout JC, 2003, ASSESSMENT, V10, P79, DOI 10.1177/1073191102250339; Sveen U, 2008, CLIN REHABIL, V22, P45, DOI 10.1177/0269215507080768; TAYLOR J, 1987, J PERS, V55, P139, DOI 10.1111/j.1467-6494.1987.tb00432.x; VanHeest Jaci L, 2007, Curr Sports Med Rep, V6, P190, DOI 10.1007/s11932-007-0027-6; Velligan DI, 2002, PSYCHIAT RES, V113, P227, DOI 10.1016/S0165-1781(02)00264-0; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wood W, 1997, J PERS SOC PSYCHOL, V73, P523, DOI 10.1037/0022-3514.73.3.523; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yeung JHH, 2011, ARCH SURG-CHICAGO, V146, P436, DOI 10.1001/archsurg.2011.46	68	23	23	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1540-9996	1931-843X		J WOMENS HEALTH	J. Womens Health	JUL	2014	23	7					573	580		10.1089/jwh.2013.4535			8	Public, Environmental & Occupational Health; Medicine, General & Internal; Obstetrics & Gynecology; Women's Studies	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; General & Internal Medicine; Obstetrics & Gynecology; Women's Studies	AL5KK	WOS:000339172300003	24932911	Green Published			2022-02-06	
J	Sedney, CL; Julien, T; Manon, J; Wilson, A				Sedney, Cara L.; Julien, Terrence; Manon, Jacinto; Wilson, Alison			The effect of craniectomy size on mortality, outcome, and complications after decompressive craniectomy at a rural trauma center	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						Craniectomy; neurotrauma; traumatic brain injury		Introduction: Decompressive craniectomy (DC) has increasing support with current studies suggesting an improvement in both survival rates and outcomes with this intervention. However, questions surround this procedure; specifically, no evidence has indicated the optimal craniectomy size. Larger craniectomy is thought to better decrease intracranial pressure, but with a possible increase in complication rates. Our hypothesis is that a larger craniectomy may improve mortality and outcome, but may increase complication rates. Materials and Methods: A retrospective observational therapeutic study was undertaken to determine if craniectomy size is related to complication rates, mortality, or outcome. Our institution's Trauma Registry was searched for patients undergoing DC. Craniectomy size was measured by antero-posterior (AP) diameter. Mortality, outcome (through admission and discharge Glasgow Coma Score and Glasgow Outcome Scale), and complications (such as re-bleeding, re-operation, hygroma, hydrocephalus, infection, and syndrome of the trephined) were noted. Complications, mortality, and outcome were then compared to craniectomy size, to determine if any relation existed to support our hypothesis. Results: 20 patients met criteria for inclusion in this study. Craniectomy size as measured by AP diameter was correlated with a statistically significant improvement in mortality within the group. All patients with a craniectomy size less than 10 cm died. However, outcome was not significantly related to craniectomy size in the group. Similarly, complication rates did not differ significantly compared to craniectomy size. Discussion: This study provides Level 3 evidence that craniectomy size may be significantly related to improved mortality within our group, supporting our initial hypothesis; however, no significant improvement in outcome was seen. Similarly, in contrast to our hypothesis, complication rates did not significantly correlate with craniectomy size.	[Sedney, Cara L.] West Virginia Univ, Dept Neurosurg, Morgantown, WV 26506 USA; [Julien, Terrence] Marshall Univ, Dept Neurosci, Huntington, WV 25755 USA; [Manon, Jacinto] Mem Hosp, Penrose Cent Hosp, Colorado Springs, CO 80920 USA; [Wilson, Alison] West Virginia Univ, Dept Surg, Morgantown, WV 26506 USA		Sedney, CL (corresponding author), West Virginia Univ, Dept Neurosurg, Robert C Byrd Hlth Sci Ctr, POB 9183, Morgantown, WV 26506 USA.	csedney@hsc.wvu.edu		Sedney, Cara/0000-0003-1290-7083			Aarabi B, 2009, NEUROSURGERY, V64, P927, DOI 10.1227/01.NEU.0000341907.30831.D2; Amorim RL, 2012, J NEURORADIOLOGY, V39, P346, DOI 10.1016/j.neurad.2012.02.006; Bor-Seng-Shu E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/750809; Bor-Seng-Shu E, 2013, NEUROSURG REV, V36, P361, DOI 10.1007/s10143-013-0453-2; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Csokay A, 2002, SURG NEUROL, V57, P126, DOI 10.1016/S0090-3019(01)00686-3; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Gao CP, 2008, ACTA NEUROCHIR SUPPL, V102, P279, DOI 10.1007/978-3-211-85578-2_52; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Mitchell P, 2004, ACTA NEUROCHIR, V146, P159, DOI 10.1007/s00701-003-0186-z; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; Schmidt JH, 2007, J NEUROSURG, V107, P678, DOI 10.3171/JNS-07/09/0678; Servadei F, 2011, NEW ENGL J MED, V364, P1558, DOI 10.1056/NEJMe1102998; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; Wirtz C R, 1997, Neurosurg Focus, V2, pE3	23	23	25	0	1	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	JUL-SEP	2014	5	3					212	217		10.4103/0976-3147.133555			6	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3W5V	WOS:000218652600003	25002758	gold, Green Published			2022-02-06	
J	Gu, YL; Zhang, LW; Ma, N; Ye, LL; Wang, DX; Gao, X				Gu, Ying Li; Zhang, Li Wei; Ma, Ning; Ye, Lin Lin; Wang, De Xin; Gao, Xu			Cognitive improvement of mice induced by exercise prior to traumatic brain injury is associated with cytochrome c oxidase	NEUROSCIENCE LETTERS			English	Article						Traumatic brain injury; Cognitive; Cytochrome c oxidase; Exercise	EXPRESSION; HIPPOCAMPUS; PLASTICITY; PROTEINS; INCREASE; DEFICITS; CORTEX	Though the evidence demonstrated that voluntary exercise programs could be implemented to enhance recovery of cognitive function induced by traumatic brain injury (TBI), the exact mechanisms were still not known. We proposed that the cognitive improvement induced by exercise in TBI mice is associated with cytochrome c oxidase (COX). To demonstrate this hypothesis, adult mice were housed with or without access to a running wheel (RW) for three weeks followed by TBI operation. Acquisition of spatial learning and memory retention was assessed by using the Morris Water Maze (MWM) on days 15 post TBI. The synaptic density was measured by Golji staining. Immunohistochemistry (IHC) for NeuN, GFAP and growth associated protein 43 (GAP43) were also performed. Using Western blot, the expressions of COX I, II, III, BDNF, synapsin I, synaptophysin (SYP) and GAP43 in hippocampus of TBI mice were determinated. Lastly, CcO activity and ATP amount were also detected. Results showed that voluntary exercise prior TBI: (i) counteracted the cognitive deficits and neuron and synaptic density loss associated with the injury; (ii) increased the levels of COX I, II, III, BDNF, synapsin I, SYP and GAP43; (iii) switched the mitochondrial CcO activity and ATP amounts. These studies demonstrated that the COX plays an important role in exercise's cognitive effects in TBI model and also provide evidence that RW training is a promise exercise for traumatically injured mice. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Gu, Ying Li; Zhang, Li Wei; Ye, Lin Lin] Harbin Med Univ, Affiliated Hosp 4, Dept Neurol, Harbin 150001, Peoples R China; [Ma, Ning; Gao, Xu] Harbin Med Univ, Dept Biochem & Mol Biol, Harbin 150081, Peoples R China; [Wang, De Xin] Beichen Hosp Tradit Chinese Med, Dept Neurol, Tianjin 300400, Peoples R China		Gao, X (corresponding author), Harbin Med Univ, Dept Biochem & Mol Biol, Harbin 150081, Peoples R China.	gaoxu2014@126.com	gao, xu/U-4765-2019; GU, YINGLI/ABA-6790-2020; Ye, Linlin/Y-7497-2018; GU, YINGLI/AAQ-3591-2021		Health Department of Heilongjiang Province [2013097]	We thank Dr. M.J.. Keven for his valuable comments on this manuscript. This research was supported by the Health Department of Heilongjiang Province (No. 2013097).	Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ashman TA, 2006, MT SINAI J MED, V73, P999; Balaratnasingam C, 2009, J NEUROSCI RES, V87, P2973, DOI 10.1002/jnr.22120; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Binder S, 2005, J HEAD TRAUMA REHAB, V20, P189, DOI 10.1097/00001199-200505000-00002; Dai W, 2009, BRAIN RES, V1251, P287, DOI 10.1016/j.brainres.2008.11.034; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Guarnieri S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053267; Harris LK, 2001, J NEUROTRAUM, V18, P993, DOI 10.1089/08977150152693692; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hoffman AN, 2011, EUR J NEUROSCI, V34, P1023, DOI 10.1111/j.1460-9568.2011.07820.x; Huttemann M, 2008, NEUROSCIENCE, V151, P148, DOI 10.1016/j.neuroscience.2007.09.029; JASLOVE SW, 1992, NEUROSCIENCE, V47, P495, DOI 10.1016/0306-4522(92)90161-T; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Loane David J, 2012, Wiley Interdiscip Rev Membr Transp Signal, V1, P136; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Rosi S, 2012, HIPPOCAMPUS, V22, P544, DOI 10.1002/hipo.20920; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Tisdall MM, 2008, J NEUROSURG, V109, P424, DOI 10.3171/JNS/2008/109/9/0424; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Wilde MC, 2007, ARCH PHYS MED REHAB, V88, P1284, DOI 10.1016/j.apmr.2007.07.012; XiYang YB, 2013, BMC BIOCHEM, V14, DOI 10.1186/1471-2091-14-21; Xu T, 2014, INT J MOL SCI, V15, P3299, DOI 10.3390/ijms15023299	25	23	23	0	18	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JUN 6	2014	570						86	91		10.1016/j.neulet.2014.04.004			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AI6VM	WOS:000337015100019	24746931				2022-02-06	
J	Gudziol, V; Hoenck, I; Landis, B; Podlesek, D; Bayn, M; Hummel, T				Gudziol, Volker; Hoenck, Irene; Landis, Basile; Podlesek, Dino; Bayn, Maria; Hummel, Thomas			The impact and prospect of traumatic brain injury on olfactory function: a cross-sectional and prospective study	EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY			English	Article						Trauma; Smell; Olfactory sensitivity; Odor identification; Odor threshold	UPPER RESPIRATORY-TRACT; TERM-FOLLOW-UP; ODOR IDENTIFICATION; HEAD-INJURY; DISCRIMINATION; ANOSMIA; BULB; NEUROGENESIS; RELIABILITY; DYSFUNCTION	Traumatic brain injury (TBI) can cause olfactory loss. The aim of this cross-sectional and prospective study was to determine the prevalence of olfactory loss among 110 patients with TBI within 3 months after the trauma. In 81 patients ("cross-sectional"-group), olfactory function could be measured using the validated "Sniffin' Sticks" test for odor threshold and odor identification. In addition, the prospective change of olfactory function was studied in 36 patients ("follow-up"-group) by means of a validated odor threshold, discrimination and identification test. Olfactory function was significantly better in patients with TBI IA degrees compared to individuals with TBI IIA degrees and IIIA degrees. Clinically significant improvement of olfactory function was found in 36 % of the patients, most frequently during the first 6 months after the injury, in a median follow-up interval of 21 months. TBI IA degrees has in general no major effect on olfaction. In contrast, patients with TBI IIA degrees and IIIA degrees exhibit smell loss in 57 %. Chances for olfactory recovery were highest within the first 6 months after the trauma.	[Gudziol, Volker; Hoenck, Irene; Hummel, Thomas] Univ Dresden, Sch Med, Smell & Taste Clin, Dept Otorhinolaryngol, D-01307 Dresden, Germany; [Landis, Basile] Univ Geneva, Sch Med, Univ Hosp Geneva, Dept Otorhinolaryngol,Geneva Neurosci Ctr CMU, CH-1211 Geneva 4, Switzerland; [Podlesek, Dino] Univ Dresden, Sch Med, Dept Neurosurg, D-01307 Dresden, Germany; [Bayn, Maria] Klin Bavaria, Dept Neurol, D-01731 Kreischa, Germany		Gudziol, V (corresponding author), Univ Dresden, Sch Med, Smell & Taste Clin, Dept Otorhinolaryngol, Fetscherstr 74, D-01307 Dresden, Germany.	volker.gudziol@uniklinikum-dresden.de	Podlesek, D/O-5236-2019				ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; [Anonymous], 1994, PSCHYREMBEL, V257; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Costanzo RM, 1986, CLIN MEASUREMENTS TA, P565; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Damm M, 2004, HNO, V52, P112, DOI 10.1007/s00106-003-0877-z; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; DUNCAN HJ, 1995, ARCH OTOLARYNGOL, V121, P1183; Ehrenstein W. H., 1999, MODERN TECHNIQUES NE, P1211, DOI [10.1007/978-3-642-58552-4_43, DOI 10.1007/978-3-642-58552-4_43]; ESKENAZI B, 1986, NEUROPSYCHOLOGIA, V24, P553, DOI 10.1016/0028-3932(86)90099-0; Feghali J G, 1998, Ear Nose Throat J, V77, P282; Feghali JG, 1998, ENT-EAR NOSE THROAT, V77, P282; Feghali JG, 1998, ENT-EAR NOSE THROAT, V77, P280; Coello AF, 2010, J NEUROSURG, V113, P547, DOI 10.3171/2010.6.JNS091620; GRAZIADEI PP, 1971, Z ZELLFORSCH MIK ANA, V116, P305, DOI 10.1007/BF00330630; GRAZIADEI PP, 1973, J CELL BIOL, V59, P525, DOI 10.1083/jcb.59.2.525; Green P, 2003, BRAIN INJURY, V17, P479, DOI 10.1080/0269905031000070242; Gudziol V, 2009, BRAIN, V132, P3096, DOI 10.1093/brain/awp243; Gudziol V, 2006, LARYNGOSCOPE, V116, P1858, DOI 10.1097/01.mlg.0000234915.51189.cb; Haehner A, 2009, CHEM SENSES, V34, P705, DOI 10.1093/chemse/bjp057; Ho WK, 2002, AM J OTOLARYNG, V23, P209, DOI 10.1053/ajot.2002.123436; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Hummel T, 2001, ANN OTO RHINOL LARYN, V110, P976, DOI 10.1177/000348940111001015; Hummel T, 1996, BRAIN RES, V717, P160, DOI 10.1016/0006-8993(96)00094-7; Hummel T, 2009, LARYNGOSCOPE, V119, P496, DOI 10.1002/lary.20101; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; Koster EP, 1991, HUMAN SENSE SMELL, P199, DOI DOI 10.1007/978-3-642-76223-9_; Landis BN, 2003, CHEM SENSES, V28, P691, DOI 10.1093/chemse/bjg061; Leigh AD, 1943, LANCET, V1, P38; MIFKA P, 1964, Wien Med Wochenschr, V114, P793; Mueller Christian A, 2009, J Med Case Rep, V3, P9283, DOI 10.4076/1752-1947-3-9283; Nissant A, 2009, NAT NEUROSCI, V12, P728, DOI 10.1038/nn.2298; Plant GW, 2011, EXP NEUROL, V229, P99, DOI 10.1016/j.expneurol.2010.09.010; Reden J, 2006, ARCH OTOLARYNGOL, V132, P265, DOI 10.1001/archotol.132.3.265; SUMNER D, 1964, BRAIN, V87, P107, DOI 10.1093/brain/87.1.107; Vennemann MM, 2008, J NEUROL, V255, P1121, DOI 10.1007/s00415-008-0807-9; Welge-Lussen A, 2012, RHINOLOGY, V50, P67, DOI 10.4193/Rhino11.141; ZUSHO H, 1982, ARCH OTOLARYNGOL, V108, P90	38	23	25	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-4477	1434-4726		EUR ARCH OTO-RHINO-L	Eur. Arch. Oto-Rhino-Laryn.	JUN	2014	271	6					1533	1540		10.1007/s00405-013-2687-6			8	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	AH0AS	WOS:000335782000029	24071856				2022-02-06	
J	Krewer, C; Hartl, S; Muller, F; Koenig, E				Krewer, Carmen; Hartl, Sandra; Mueller, Friedemann; Koenig, Eberhard			Effects of Repetitive Peripheral Magnetic Stimulation on Upper-Limb Spasticity and Impairment in Patients With Spastic Hemiparesis: A Randomized, Double-Blind, Sham-Controlled Study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Hemiparesis; Magnetic stimulation therapy; Movement; Rehabilitation; Spastic paraparesis; Stroke; Traumatic brain injury	NEUROMUSCULAR ELECTRICAL-STIMULATION; TARDIEU SCALE; ASHWORTH SCALE; STROKE; DEPRESSION; RECOVERY; INJURY; WRIST; TONE; RPMS	Objective: To investigate short-term and long-term effects of repetitive peripheral magnetic stimulation (rpMS) on spasticity and motor function. Design: Monocentric, randomized, double-blind, sham-controlled trial. Setting: Neurologic rehabilitation hospital. Participants: Patients (N=66) with severe hemiparesis and mild to moderate spasticity resulting from a stroke or a traumatic brain injury. The average time +/- SD since injury for the intervention groups was 26 +/- 71 weeks or 37 +/- 82 weeks. Interventions: rpMS for 20 minutes or sham stimulation with subsequent occupational therapy for 20 minutes, 2 times a day, over a 2-week period. Main Outcome Measures: Modified Tardieu Scale and Fugl-Meyer Assessment (arm score), assessed before therapy, at the end of the 2-week treatment period, and 2 weeks after study treatment. Additionally, the Tardieu Scale was assessed after the first and before the third therapy session to determine any short-term effects. Results: Spasticity (Tardieu >0) was present in 83% of wrist flexors, 62% of elbow flexors, 44% of elbow extensors, and 10% of wrist extensors. Compared with the sham stimulation group, the rpMS group showed short-term effects on spasticity for wrist flexors (P=.048), and long-term effects for elbow extensors (P<.045). Arm motor function (rpMS group: median 5 [4-27]; sham group: median 4 [4-9]) did not significantly change over the study period in either group, whereas rpMS had a positive effect on sensory function. Conclusions: Therapy with rpMS increases sensory function in patients with severe limb paresis. The magnetic stimulation, however, has limited effect on spasticity and no effect on motor function. (C) 2014 by the American Congress of Rehabilitation Medicine	[Krewer, Carmen; Hartl, Sandra; Mueller, Friedemann; Koenig, Eberhard] Schoen Klin Bad Aibling, Motor Res Dept, D-83043 Bad Aibling, Germany		Krewer, C (corresponding author), Schoen Klin Bad Aibling, Kolbermoorer Str 72, D-83043 Bad Aibling, Germany.	CKrewer@schoen-kliniken.de	Krewer, Carmen/H-2845-2019	Krewer, Carmen/0000-0002-4153-0791			Burridge JH, 2005, DISABIL REHABIL, V27, P69, DOI 10.1080/09638280400014592; Dietz V, 2007, LANCET NEUROL, V6, P725, DOI 10.1016/S1474-4422(07)70193-X; Gladstone DJ, 2002, NEUROREHAB NEURAL RE, V16, P232, DOI 10.1177/154596802401105171; Haugh AB, 2006, DISABIL REHABIL, V28, P899, DOI 10.1080/09638280500404305; Heldmann B, 2000, NEUROREPORT, V11, P3193, DOI 10.1097/00001756-200009280-00029; Krause P, 2003, SUPPL CLIN NEUROPHYS, V56, P220; MAHONEY F I, 1965, Md State Med J, V14, P61; Malhotra S, 2013, CLIN REHABIL, V27, P579, DOI 10.1177/0269215512464502; McIntyre RS, 2005, CAN MED ASSOC J, V173, P1327, DOI 10.1503/cmaj.050786; Mehrholz J, 2005, CLIN REHABIL, V19, P751, DOI 10.1191/0269215505cr889oa; Muller MM, 2008, THESIS TECHNISCHE U; Nielsen J F, 1996, Mult Scler, V2, P227; Pandyan AD, 2005, DISABIL REHABIL, V27, P2, DOI 10.1080/09638280400014576; Paolucci S, 1999, ARCH PHYS MED REHAB, V80, P985, DOI 10.1016/S0003-9993(99)90048-5; Patrick E, 2006, CLIN REHABIL, V20, P173, DOI 10.1191/0269215506cr922oa; Rosewilliam S, 2012, ARCH PHYS MED REHAB, V93, P1715, DOI 10.1016/j.apmr.2012.05.017; Shumway-Cook A, 2001, MOTOR CONTROL THEORY, V2; Struppler A, 2003, SUPPL CLIN NEUROPHYS, V56, P358; Struppler A, 2004, EXP BRAIN RES, V157, P59, DOI 10.1007/s00221-003-1817-6; Struppler A, 2003, NEUROREHABILITATION, V18, P69; Sunnerhagen KS, 2013, NEUROLOGY, V80, pS35, DOI 10.1212/WNL.0b013e3182764aa2; Thibaut A, 2013, BRAIN INJURY, V27, P1093, DOI 10.3109/02699052.2013.804202; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Wissel J, 2010, J NEUROL, V257, P1067, DOI 10.1007/s00415-010-5463-1	24	23	33	3	18	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	2014	95	6					1039	1047		10.1016/j.apmr.2014.02.003			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	AI3OY	WOS:000336773000006	24561057				2022-02-06	
J	Hue, CD; Cao, SQ; Bass, CR; Meaney, DF; Morrison, B				Hue, Christopher D.; Cao, Siqi; Bass, Cameron R Dale; Meaney, David F.; Morrison, Barclay, III			Repeated Primary Blast Injury Causes Delayed Recovery, but not Additive Disruption, in an In Vitro Blood-Brain Barrier Model	JOURNAL OF NEUROTRAUMA			English	Article						shock tube; repeated blast injury; traumatic brain injury; endothelial cells; blood-brain barrier	POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE FUNCTION; TEMPORAL WINDOW; HEAD-INJURY; RAT MODEL; EXPOSURE; PERMEABILITY; MECHANISMS; PATHOPHYSIOLOGY; VULNERABILITY	Recent studies have demonstrated increased susceptibility to breakdown of the cerebral vasculature associated with repetitive traumatic brain injury. We hypothesized that exposure to two consecutive blast injuries would result in exacerbated damage to an in vitro model of the blood-brain barrier (BBB) compared with exposure to a single blast of the same severity. Contrary to our hypothesis, however, repeated mild or moderate primary blast delivered with a 24 or 72 h interval between injuries did not significantly exacerbate reductions in transendothelial electrical resistance (TEER) across a brain endothelial monolayer compared with sister cultures receiving a single exposure of the same intensity. Permeability of the barrier to a range of different-sized solutes remained unaltered after single and repeated blast, supporting that the effects of repeated blast on BBB integrity were not additive. Single blast exposure significantly reduced immunostaining of ZO-1 and claudin-5 tight junction proteins, but subsequent exposure did not cause additional damage to tight junctions. Although repeated blast did not further reduce TEER, the second exposure delayed TEER recovery in BBB cultures. Similarly, recovery of hydraulic conductivity through the BBB was delayed by a second exposure. Extending the interinjury interval to 72 h, the effects of multiple injuries on the BBB were found to be independent given sufficient recovery time between consecutive exposures. Careful investigation of the effects of repeated blast on the BBB will help identify injury levels and a temporal window of vulnerability associated with BBB dysfunction, ultimately leading to improved strategies for protecting warfighters against repeated blast-induced disruption of the cerebral vasculature.	[Hue, Christopher D.; Cao, Siqi; Morrison, Barclay, III] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Bass, Cameron R Dale] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA		Morrison, B (corresponding author), Columbia Univ, 351 Engn Terrace,MC8904,1210 Amsterdam Ave, New York, NY 10027 USA.	bm2119@columbia.edu	Morrison, Barclay/B-7132-2008	Morrison, Barclay/0000-0001-7676-0864; , Siqi/0000-0001-9779-4174; Meaney, David/0000-0002-0954-4122	Multidisciplinary University Research Initiative from the Army Research Office [W911MF 10 1-0526]; National Science FoundationNational Science Foundation (NSF) [DGE-07-07425]	This work was supported by a Multidisciplinary University Research Initiative from the Army Research Office (W911MF 10 1-0526), and a National Science Foundation Graduate Research Fellowship (C.D.H.; DGE-07-07425). The authors would like to acknowledge Gwen B. Effgen and Edward W. Vogel III for helpful discussions and insightful suggestions pertaining to experimental design and development of the blast injury model. We also thank Dr. Scott A. Banta for providing access to a microplate reader.	Abbott NJ, 2012, EPILEPSIA, V53, P1, DOI 10.1111/j.1528-1167.2012.03696.x; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Blennow K, 2011, ACTA NEUROL SCAND, V123, P245, DOI 10.1111/j.1600-0404.2010.01408.x; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Brown RC, 2007, BRAIN RES, V1130, P17, DOI 10.1016/j.brainres.2006.10.083; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Greish K, 2007, J DRUG TARGET, V15, P457, DOI 10.1080/10611860701539584; Gumbleton M, 2001, J PHARM SCI-US, V90, P1681, DOI 10.1002/jps.1119; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hue CD, 2013, J NEUROTRAUM, V30, P1652, DOI 10.1089/neu.2012.2773; Kamnaksh A, 2012, ELECTROPHORESIS, V33, P3680, DOI 10.1002/elps.201200319; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Li GL, 2010, ANN BIOMED ENG, V38, P2499, DOI 10.1007/s10439-010-0023-5; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Madara JL, 1998, ANNU REV PHYSIOL, V60, P143, DOI 10.1146/annurev.physiol.60.1.143; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Omidi Y, 2003, BRAIN RES, V990, P95, DOI 10.1016/S0006-8993(03)03443-7; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Panzer Matthew B, 2012, Front Neurol, V3, P46, DOI 10.3389/fneur.2012.00046; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; SILL HW, 1995, AM J PHYSIOL-HEART C, V268, pH535, DOI 10.1152/ajpheart.1995.268.2.H535; Simon MJ, 2011, ANN BIOMED ENG, V39, P394, DOI 10.1007/s10439-010-0144-x; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Valiyaveettil M, 2013, NEUROSCI LETT, V539, P1, DOI 10.1016/j.neulet.2013.01.028; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7	54	23	24	1	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2014	31	10					951	960		10.1089/neu.2013.3149			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AH1ES	WOS:000335863200007	24372353				2022-02-06	
J	Jin, W; Ming, X; Hou, XS; Zhu, TS; Yuan, BY; Wang, J; Ni, HB; Jiang, J; Wang, HD; Liang, WB				Jin, Wei; Ming, Xing; Hou, Xiaoshan; Zhu, Tiansheng; Yuan, Baoyu; Wang, Jing; Ni, Hongbin; Jiang, Jian; Wang, Handong; Liang, Weibang			Protective effects of erythropoietin in traumatic spinal cord injury by inducing the Nrf2 signaling pathway activation	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Erythropoietin; nuclear factor erythroid 2-related factor 2; spinal cord injury; rats	HEME OXYGENASE-1 EXPRESSION; RESPONSE ELEMENT PATHWAY; BRAIN-INJURY; POSSIBLE INVOLVEMENT; NEURONAL APOPTOSIS; CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; RAT MODEL; DAMAGE	BACKGROUND: Erythropoietin has demonstrated neuroprotective effects against traumatic spinal cord injury (SCI), but the underlying mechanisms remain unclear. The signaling pathway of an antioxidant transcription factor, nuclear factor erythroid 2-related factor 2 (Nrf2), has been shown to play an important role in protecting SCI-induced secondary spinal cord damage. This study was undertaken to explore the effect of recombinant human erythropoietin (rhEPO) on the activation of Nrf2 signaling pathway and secondary spinal cord damage in rats after SCI. METHODS: Adultmale Sprague-Dawley rats were subjected to laminectomy at T8-T9 and compression with avascular clip. Three groups were analyzed: (1) sham group, (2) SCI group, and (3) SCI + rhEPO group (n = 16 per group). In the SCI + rhEPO group, rhEPO was administered at a dose of 5,000 IU/kg at 30 minutes after SCI. Spinal cord samples were extracted at 72 hours after the trauma. RESULTS: As a result, we found that the treatment with rhEPO markedly up-regulated the messenger RNA expressions and activities of Nrf2 signaling pathway-related agents, including Nrf2, NAD(P) H: quinone oxidoreductase 1(NQO1), and glutathione S-transferase. The administration of rhEPO also significantly ameliorated the secondary spinal cord damage, as shown by a decreased severity of locomotion deficit, spinal cord edema, and apoptosis. CONCLUSION: Post-SCI rhEPO administration induces Nrf2-mediated cytoprotective response in the injured spinal cord, and this may be a mechanism whereby rhEPO improves the outcome following SCI. (J Trauma Acute Care Surg. 2014; 76: 1228-1234. Copyright (C) 2014 by Lippincott Williams & Wilkins)	[Jin, Wei; Ming, Xing; Hou, Xiaoshan; Zhu, Tiansheng; Yuan, Baoyu; Wang, Jing; Ni, Hongbin; Jiang, Jian; Liang, Weibang] Drum Tower Hosp, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Handong] Nanjing Univ, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Handong] Nanjing Univ, Sch Med, Jingling Hosp, Nanjing 210008, Jiangsu, Peoples R China		Liang, WB (corresponding author), Drum Tower Hosp, Dept Neurosurg, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.	hdwang_jw@163.com; njneurosurgery@163.com		yuan, baoyu/0000-0002-2498-7829	Medical Science and Technology Development Foundation, Nanjing Department of Health [QYK10148]	This work was supported by a grant from Medical Science and Technology Development Foundation, Nanjing Department of Health (QYK10148).	Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Cadotte DW, 2011, CLIN ORTHOP RELAT R, V469, P732, DOI 10.1007/s11999-010-1674-0; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Chen XL, 2004, CURR PHARM DESIGN, V10, P879, DOI 10.2174/1381612043452901; Choo AM, 2008, EXP NEUROL, V212, P490, DOI 10.1016/j.expneurol.2008.04.038; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Genc K, 2010, CELL BIOCHEM FUNCT, V28, P197, DOI 10.1002/cbf.1639; Gorio A, 2005, P NATL ACAD SCI USA, V102, P16379, DOI 10.1073/pnas.0508479102; Jain AK, 2005, J BIOL CHEM, V280, P29158, DOI 10.1074/jbc.M502083200; Jia Z, 2012, SPINAL CORD, V50, P264, DOI 10.1038/sc.2011.111; Jin W, 2011, J TRAUMA, V71, P680, DOI 10.1097/TA.0b013e3181f6b984; Jin W, 2011, INJURY, V42, P714, DOI 10.1016/j.injury.2011.03.009; Jin W, 2011, ANN CLIN LAB SCI, V41, P25; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Kasper C., 2003, CYTOKINE HDB, VI, P149; Katavetin P, 2007, BIOCHEM BIOPH RES CO, V359, P928, DOI 10.1016/j.bbrc.2007.05.207; Kilic E, 2005, FASEB J, V19, P2026, DOI 10.1096/fj.05-3941fje; Liang WB, 2010, BIOMATERIALS, V31, P8634, DOI 10.1016/j.biomaterials.2010.07.084; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Mao L, 2012, J TRAUMA ACUTE CARE, V72, P189, DOI 10.1097/TA.0b013e31821bf541; Matis GK, 2009, EUR SPINE J, V18, P314, DOI 10.1007/s00586-008-0829-0; Ning B, 2011, NEUROSCI LETT, V490, P57, DOI 10.1016/j.neulet.2010.12.025; Okutan O, 2007, J CLIN NEUROSCI, V14, P364, DOI 10.1016/j.jocn.2006.01.022; Osburn WO, 2006, ARCH BIOCHEM BIOPHYS, V454, P7, DOI 10.1016/j.abb.2006.08.005; Owuor ED, 2002, BIOCHEM PHARMACOL, V64, P765, DOI 10.1016/S0006-2952(02)01137-1; Ozturk Erdogan, 2005, Prog Neuropsychopharmacol Biol Psychiatry, V29, P922, DOI 10.1016/j.pnpbp.2005.04.028; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Stammers AT, 2012, J NEUROSCI RES, V90, P782, DOI 10.1002/jnr.22820; Vitellaro-Zuccarello L, 2008, NEUROSCIENCE, V151, P452, DOI 10.1016/j.neuroscience.2007.11.004; Wang XL, 2012, J NEUROTRAUM, V29, P936, DOI 10.1089/neu.2011.1922; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yazihan N, 2008, INJURY, V39, P1408, DOI 10.1016/j.injury.2008.03.010; Zhang J, 2010, CYTOKINE, V52, P252, DOI 10.1016/j.cyto.2010.08.011; Zhu L, 2009, BRAIN RES, V1289, P96, DOI 10.1016/j.brainres.2009.07.015	35	23	26	0	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAY	2014	76	5					1228	1234		10.1097/TA.0000000000000211			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	AG6YA	WOS:000335563800016	24747453				2022-02-06	
J	Lippa, SM; Pastorek, NJ; Romesser, J; Linck, J; Sim, AH; Wisdom, NM; Miller, BI				Lippa, Sara M.; Pastorek, Nicholas J.; Romesser, Jennifer; Linck, John; Sim, Anita H.; Wisdom, Nick M.; Miller, Brian I.			Ecological Validity of Performance Validity Testing	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Performance validity test; Mild traumatic brain injury; Response bias; Veterans; Mayo-Portland Adaptability Inventory Participation Index	TRAUMATIC BRAIN-INJURY; MALINGERED NEUROCOGNITIVE DYSFUNCTION; FAKE-BAD SCALE; SYMPTOM VALIDITY; NEUROPSYCHOLOGICAL ASSESSMENT; HEAD-INJURY; MMPI-2; COMPENSATION; EXAGGERATION; INCENTIVES	Performance validity tests (PVTs) have been shown to relate to neuropsychological performance, but no studies have looked at the ecological validity of these measures. Data from 131 veterans with a history of mild traumatic brain injury from a multicenter Veterans Administration consortium were examined to determine the relation between scores on a self-report version of the Mayo-Portland Adaptability Inventory Participation Index, a measure of community participation, and the Word Memory Test, a PVT. A restricted regression model, including education, age, history of loss of consciousness, cognitive measures, and a measure of symptom validity test performance, was not significantly associated with self-reported community reintegration. Adding PVT results to the restricted model, however, did significantly improve the prediction of community reintegration as PVT failure was associated with lower self-reported community participation. The results of this study indicate that PVTs may also serve as an indicator of patients' functioning in the community.	[Lippa, Sara M.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders, Boston, MA 02130 USA; [Pastorek, Nicholas J.; Wisdom, Nick M.; Miller, Brian I.] Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA; [Pastorek, Nicholas J.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Romesser, Jennifer] George E Wahlen Dept Vet Affairs Med Ctr, Salt Lake City, UT 84148 USA; [Linck, John] Oklahoma City VA Med Ctr, Oklahoma City, OK 73104 USA; [Sim, Anita H.] Minneapolis VA Hlth Care Syst, Minneapolis, MN 55417 USA; [Wisdom, Nick M.; Miller, Brian I.] Baylor Coll Med, Menninger Dept Psychiat, Houston, TX 77030 USA		Pastorek, NJ (corresponding author), Michael E DeBakey VA Med Ctr, 2002 Holcombe Blvd RECL 117, Houston, TX 77030 USA.	nicholas.pastorek@va.gov		Pastorek, Nicholas/0000-0002-9290-380X	Department of Veterans Affairs, Veterans Health Administration, Office of Research and DevelopmentUS Department of Veterans Affairs; VA RR&D Traumatic Brain Injury Center of Excellence, Neurorehabilitation: Neurons to Networks [B6812C]; Minnesota Veterans Medical Research & Education Foundation	No pharmaceutical or corporate funding was used in the preparation of this manuscript or collection of data. This material is based upon work supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development; B6812C (PI-Levin HS) VA RR&D Traumatic Brain Injury Center of Excellence, Neurorehabilitation: Neurons to Networks, as well as the Minnesota Veterans Medical Research & Education Foundation.	Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P828, DOI 10.1093/arclin/acs086; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Boone K.B., 2007, ASSESSMENT FEIGNED C; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carone DA, 2010, CLIN NEUROPSYCHOL, V24, P759, DOI 10.1080/13854041003712951; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention, 2003, MILD TRAUM BRAIN INJ; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Cook J B, 1972, Scand J Rehabil Med, V4, P27; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; Diehr MC, 2003, J CLIN EXP NEUROPSYC, V25, P571, DOI 10.1076/jcen.25.4.571.13876; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Evered L, 2003, ASSESSMENT, V10, P420, DOI 10.1177/1073191103259539; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Gervais RO, 2001, J RHEUMATOL, V28, P1892; Green P, 2003, CHILD NEUROPSYCHOL, V9, P189, DOI 10.1076/chin.9.3.189.16460; Green P., 2005, GREENS WORD MEMORY T, Vrev. ed.; Greiffenstein M.F., 2007, ASSESSMENT FEIGNED C, P210; Greiffenstein MF, 2004, CLIN NEUROPSYCHOL, V18, P573, DOI 10.1080/13854040490888512; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P54, DOI 10.1076/clin.17.1.54.15627; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; LOFTUS EF, 1992, APPL COGNITIVE PSYCH, V6, P93, DOI 10.1002/acp.2350060202; Malec J., 2005, MAYO PORTLAND ADAPTA; MILLER H, 1961, BRIT MED J, V1, P992, DOI 10.1136/bmj.1.5231.992; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Poyner G, 2010, PSYCHOL INJ LAW, V3, P130, DOI 10.1007/s12207-010-9076-x; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reynolds S, 2003, J HEAD TRAUMA REHAB, V18, P139, DOI 10.1097/00001199-200303000-00005; Ross SR, 2004, J CLIN EXP NEUROPSYC, V26, P115, DOI 10.1076/jcen.26.1.115.23933; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Spooner DM, 2006, ARCH CLIN NEUROPSYCH, V21, P327, DOI 10.1016/j.acn.2006.04.004; Terrio HP, 2011, REHABIL PSYCHOL, V56, P26, DOI 10.1037/a0022685; Van Dyke SA, 2010, MIL MED, V175, P947, DOI 10.7205/MILMED-D-10-00337; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X	48	23	23	0	17	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2014	29	3					236	244		10.1093/arclin/acu002			9	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	AG9WC	WOS:000335769700003	24681945	hybrid			2022-02-06	
J	Alexiou, GA; Lianos, G; Fotakopoulos, G; Michos, E; Pachatouridis, D; Voulgaris, S				Alexiou, George A.; Lianos, Georgios; Fotakopoulos, George; Michos, Evaggelos; Pachatouridis, Dimitrios; Voulgaris, Spyridon			Admission glucose and coagulopathy occurrence in patients with traumatic brain injury	BRAIN INJURY			English	Article						Coagulopathy; glucose; traumatic brain injury	HYPERGLYCEMIA	Introduction: Coagulopathy after traumatic brain injury (TBI) is a frequent event and is associated with patients' prognosis. TBI is also associated with a stress response that includes hyperglycemia. This study investigated if coagulopathy occurrence is associated with admission blood glucose levels in patients with TBI. Methods: This study retrospectively evaluated patients with TBI who were admitted to a neurosurgical department over a 4-year period. Coagulopathy was defined as an aPTT >40 seconds and/or INR >1.2 and/or a platelet count <120*10(9) per litre. Results: One-hundred and forty-nine patients were included in the study. Thirty-four patients developed coagulopathy. Patients with coagulopathy had significantly lower haemoglobin levels, increased INR and increased aPTT. Patients with severe TBI had more frequent coagulopathy. Patients with severe TBI had significant higher serum glucose levels compared to patients with mild TBI. Using ROC curves it was found that a serum glucose of 151 mg dl(-1) was the threshold for the discrimination of patients that developed coagulopathy. Logistic regression analysis revealed that serum glucose greater than 151 mg dl(-1) and haemoglobin levels lower than 12.4 mg dL(-1) were significantly associated with coagulopathy occurrence. Conclusion: Coagulopathy frequently occur after TBI. Patients with lower GCS score and lower haemoglobin levels and increased blood glucose levels at admission are at greater risk.	[Alexiou, George A.; Fotakopoulos, George; Michos, Evaggelos; Pachatouridis, Dimitrios; Voulgaris, Spyridon] Univ Hosp Ioannina, Dept Neurosurg, Ioannina, Greece; [Lianos, Georgios] Univ Hosp Ioannina, Dept Surg, Ioannina, Greece		Alexiou, GA (corresponding author), POB 103, Ioannina, Greece.	alexiougrg@yahoo.gr	Alexiou, George A/B-3995-2012	Alexiou, George A/0000-0003-0257-4481; fotakopoulos, george/0000-0002-2491-2886			Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Bochicchio GV, 2005, AM SURGEON, V71, P171; Brealey David, 2009, J Diabetes Sci Technol, V3, P1250; Du XL, 1998, DIABETOLOGIA, V41, P249, DOI 10.1007/s001250050900; Duchen MR, 2004, DIABETES, V53, pS96, DOI 10.2337/diabetes.53.2007.S96; Greuters S, 2011, CRITICAL CARE, V15, P1; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Innerhofer P, 2013, INJURY, V44, P209, DOI 10.1016/j.injury.2012.08.047; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Levi M, 1999, NEW ENGL J MED, V341, P586, DOI 10.1056/NEJM199908193410807; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; Meier R, 2008, CRIT CARE, V12, DOI 10.1186/cc6974; Pahatouridis D, 2010, BRAIN INJURY, V24, P1189, DOI 10.3109/02699052.2010.490510; Salim A, 2009, AM SURGEON, V75, P25; Schreiber MA, 2005, J TRAUMA, V58, P475, DOI 10.1097/01.TA.0000153938.77777.26; Sung J, 2005, J TRAUMA, V59, P80, DOI 10.1097/01.TA.0000171452.96585.84; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Vespa PM, 2008, CRIT CARE, V12, DOI 10.1186/cc6986; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; WEISSMAN C, 1990, ANESTHESIOLOGY, V73, P308, DOI 10.1097/00000542-199008000-00020; Yendamuri S, 2003, J TRAUMA, V55, P33, DOI 10.1097/01.TA.0000074434.39928.72	25	23	24	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2014	28	4					438	441		10.3109/02699052.2014.888769			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AF5GL	WOS:000334741900006	24564221				2022-02-06	
J	Buzas, D; Jacobson, NA; Morawa, LG				Buzas, David; Jacobson, Nathan A.; Morawa, Lawrence G.			Concussions From 9 Youth Organized Sports Results From NEISS Hospitals Over an 11-Year Time Frame, 2002-2012	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						concussion; epidemiology; NEISS; pediatrics; head injuries		Background: Youth sports programs are extremely popular throughout the United States, with children starting formal sports participation as young as 4 years. This places children at greater risk for concussions and other trauma. Purpose: To describe the epidemiology of concussions sustained during participation in 9 organized sports prior to participation in high school athletics. Methods: Over an 11-year span from January 2002 to December 2012, the authors reviewed the concussions sustained by athletes aged 4 to 13 years while playing basketball, baseball, football, gymnastics, hockey, lacrosse, soccer, softball, and wrestling, as evaluated in emergency departments (EDs) in the United States and captured by the National Electronic Injury Surveillance System (NEISS) database of the US Consumer Product Safety Commission. Study Design: Descriptive epidemiology study. Results: There were 4864 (national estimate [NE] = 117,845) youth athletes evaluated in NEISS EDs as sustaining concussions from 2002 to 2012. Except for the year 2007, concussion frequencies trended upward throughout the 11-year time frame as well as with increasing age. Loss of consciousness (LOC) occurred in 499 cases (NE, 12,129; 10%). Football had the highest frequency of concussions, with 2013 (NE, 51,220; 41%), followed by basketball, with 977 (NE, 22,099; 20%), and soccer, with 801 (NE, 18,916; 17%). The majority of concussions were treated in the outpatient setting, with 4444 (91.4%) patients being treated and released; 412 (9%) patients required admission and were found to have increased frequencies of LOC (n = 17; 18.0%) compared with LOC in the total group (n = 499, 10%). The total number of player-to-player injury mechanisms mirrored the total number of concussions by year, which increased throughout the 11-year span, except for the year 2007. Subgroup analysis of athletes aged 4 to 7 years demonstrated a difference in the mechanism of injury distribution, with a ball-to-head mechanism increase of 5% from 15% to 20% and a player-to-other object mechanism of injury increase by more than double to 13% compared with the entire cohort over the 11-year time frame. Conclusion: Within the 4-to 13-year age range, there were a significant number of young athletes who presented to EDs with concussion as a result of playing organized sports. The 4-to 7-year age group had a disproportionately higher player-to-other object mechanism of injury. Clinical Relevance: Younger children are more susceptible to long-term sequelae from head injuries, and therefore, improved systems of monitoring for these athletes are required to monitor the patterns of injury, identify risk factors, and develop evidencebased prevention programs.	[Buzas, David; Jacobson, Nathan A.; Morawa, Lawrence G.] Wayne State Univ, Dept Orthopaed Surg, 10000 Telegraph Rd, Taylor, MI 48180 USA		Buzas, D (corresponding author), Wayne State Univ, Dept Orthopaed Surg, 10000 Telegraph Rd, Taylor, MI 48180 USA.	dbuzas@med.wayne.edu					[Anonymous], 2013, NAT FED STAT HIGH S; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lowrey KM, 2012, SUMMARY MATRIX STATE; Mueller FO, 2010, 28 ANNUAL REPORT U N; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Putukian Margot, 2006, Curr Sports Med Rep, V5, P15; Schroeder R, 2001, NEISS SAMPLE DESIGN; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8	21	23	23	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2325-9671			ORTHOP J SPORTS MED	Orthop. J. Sports Med.	APR	2014	2	4							2325967114528460	10.1177/2325967114528460			8	Orthopedics; Sport Sciences	Emerging Sources Citation Index (ESCI)	Orthopedics; Sport Sciences	V0R3F	WOS:000216487800001	26535315	gold, Green Published			2022-02-06	
J	Krellman, JW; Kolakowsky-Hayner, SA; Spielman, L; Dijkers, M; Hammond, FM; Bogner, J; Hart, T; Cantor, JB; Tsaousides, T				Krellman, Jason W.; Kolakowsky-Hayner, Stephanie A.; Spielman, Lisa; Dijkers, Marcel; Hammond, Flora M.; Bogner, Jennifer; Hart, Tessa; Cantor, Joshua B.; Tsaousides, Theodore			Predictors of Follow-Up Completeness in Longitudinal Research on Traumatic Brain Injury: Findings From the National Institute on Disability and Rehabilitation Research Traumatic Brain Injury Model Systems Program	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Bias (epidemiology); Follow-up studies; Lost to follow-up; Outcome assessment (health care); Rehabilitation	ATTRITION; BIAS; OUTCOMES; COHORT; IMPACT; RATES	Objective: To identify baseline participant variables in the domains of demographics, medical/psychosocial history, injury characteristics, and postinjury functional status associated with longitudinal follow-up completeness in persons with traumatic brain injury (TBI) using the TBI Model Systems (TBIMS) National Database (NDB). Design: Exhaustive chi-square automatic interaction detection was used to identify factors that classified participants according to level of follow-up completeness. Setting: Retrospective analysis of a multi-center longitudinal database. Participants: Individuals (N=8249) enrolled in the TBIMS NDB between 1989 and 2009 who were eligible for at least the first (year 1) follow-up up to the fifth (year 15) follow-up. Interventions: None. Main Outcome Measures: Follow-up completeness as defined by 6 different longitudinal response patterns (LRPs): completing all follow-ups, wave nonresponse, dropping out, completing no follow-ups without formally withdrawing, formally withdrawing before completing any follow-ups, and formally withdrawing after completing some. follow-ups. Results: Completing all follow-ups was associated with higher levels of education, living with parents or others, and having acute care payer data entered in the NDB. Subgroups more vulnerable to loss to follow-up (LTFU) included those with less education, racial/ethnic minority backgrounds, those with better motor functioning on rehabilitation discharge, and those for whom baseline data on education, employment, and acute care payer were not collected. No subgroups were found to be more likely to have the LRPs of dropping out or formal withdrawal. Conclusions: These data identify subgroups in which retention strategies beyond those most commonly used might reduce LTFU in longitudinal studies of persons with TBI, such as the TBIMS, and suggest future investigations into factors associated with missing baseline data. (C) 2014 by the American Congress of Rehabilitation Medicine	[Krellman, Jason W.; Spielman, Lisa; Dijkers, Marcel; Cantor, Joshua B.; Tsaousides, Theodore] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Kolakowsky-Hayner, Stephanie A.] Rehabil Res Ctr, Santa Clara Valley Med Ctr, San Jose, CA USA; [Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Bogner, Jennifer] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Hart, Tessa] Moss Rehabil Res Inst, Elkins Pk, PA USA		Krellman, JW (corresponding author), Icahn Sch Med Mt Sinai, 1 Gustave L Levy Pl,Box 1163, New York, NY 10029 USA.	jason.krellman@mountsinai.org	Kolakowsky-Hayner, Stephanie A./I-9858-2019; Bogner, Jennifer/E-2773-2011	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909; Dijkers, Marcel/0000-0002-8362-5596	National Institute on Disability and Rehabilitation Research, U.S. Department of EducationUS Department of Education [H133P050004, H133B980013, H133A070038, H133A120035, H133A070042, H133A070029, H133A120086, H133A070040, H133A120037]; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [1R49CE001171-01]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001171] Funding Source: NIH RePORTER	Supported by the National Institute on Disability and Rehabilitation Research, U.S. Department of Education (grants nos. H133P050004, H133B980013, and H133A070038 [Mt. Sinai]; H133A070038 [Santa Clara]; H133A120035 and H133A070042 [Indiana University]; H133A070029 and H133A120086 [Ohio State], and H133A070040 and H133A120037 [Moss]) and the Centers for Disease Control and Prevention (grant no. 1R49CE001171-01 [Mt. Sinai]).	Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Bell KR, 2008, AM J PHYS MED REHAB, V87, P330, DOI 10.1097/PHM.0b013e318168d092; Bergman P, 2010, INT J SOC PSYCHIATR, V56, P119, DOI 10.1177/0020764008098838; Bigs D., 1991, J APPL STAT, V18, P49, DOI 10.1080/02664769100000005; Brilleman SL, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-71; Brown DM, 2006, AIDS CARE, V18, P821, DOI 10.1080/09540120500466747; Bushnik T, 2012, J HEAD TRAUMA REHAB, V27, pE36, DOI 10.1097/HTR.0b013e318273375c; Claus RE, 2002, J PSYCHOACTIVE DRUGS, V34, P69, DOI 10.1080/02791072.2002.10399938; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; de Groot S, 2009, J REHABIL MED, V41, P382, DOI 10.2340/16501977-0346; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; GREENLAND S, 1977, AM J EPIDEMIOL, V106, P184, DOI 10.1093/oxfordjournals.aje.a112451; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Harrison-Felix C, 1998, PREDICTORS LOSS FOLL; Holavanahalli RK, 2006, J BURN CARE RES, V27, P703, DOI 10.1097/01.BCR.0000238085.87863.81; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; Hunt JR, 1998, EPIDEMIOL REV, V20, P57, DOI 10.1093/oxfordjournals.epirev.a017972; Kass GV., 1980, J R STAT SOC C-APPL, V29, P119, DOI DOI 10.2307/2986296; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kleschinsky JH, 2009, J STUD ALCOHOL DRUGS, V70, P751, DOI 10.15288/jsad.2009.70.751; Kristman VL, 2005, EUR J EPIDEMIOL, V20, P657, DOI 10.1007/s10654-005-7919-7; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Scott CK, 2006, J TRAUMA STRESS, V19, P757, DOI 10.1002/jts.20186; Scott CK, 2004, DRUG ALCOHOL DEPEN, V74, P21, DOI 10.1016/j.drugalcdep.2003.11.007; Touloumi G, 2001, STAT MED, V20, P3715, DOI 10.1002/sim.1114; Traumatic Brain Injury Model Systems National Data and Statistical Center, GUID STRAT MAX FOLL; Traumatic Brain Injury Model Systems National Data and Statistical Center, 2012, TBI MOD SYST PRES	30	23	24	0	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2014	95	4					633	641		10.1016/j.apmr.2013.10.016			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	AF3YJ	WOS:000334648300008	24211496				2022-02-06	
J	Poltavski, DV; Biberdorf, D				Poltavski, Dmitri V.; Biberdorf, David			Screening for lifetime concussion in athletes: Importance of oculomotor measures	BRAIN INJURY			English	Article						Concussion; hockey; ImPACT; NPFD; oculomotor measures; Visagraph	METABOLIC BRAIN VULNERABILITY; STATES HIGH-SCHOOL; TEMPORAL WINDOW; NEUROPSYCHOLOGICAL PERFORMANCE; SPORTS CONCUSSION; VISUAL FUNCTION; SYMPTOM SURVEY; HISTORY; INJURY; REHABILITATION	Hypothesis/objective: The purpose of the present study was to determine the utility of oculomotor-based evaluation protocols in screening for lifetime concussion incidence in elite hockey players. Methods: Forty-two Division I collegiate male and female hockey players were evaluated using the guidelines of an overall oculomotor-based diagnostic clinical test protocol for the mTBI population. The sensitivity of the collected measures to lifetime concussion was then compared with the corresponding sensitivity of measures of neuropsychological functioning (ImPACT) often used with athletes for acute concussion diagnosis. Results: This model showed that a hockey player with a Near Point of Fixation Disparity (NPFD) equal to or greater than 15 cm, Visagraph comprehension rate less than 85% and the total score on part A of an ADHD questionnaire equal to or greater than 11 was on average 10.72-times more likely to have previously suffered a concussion than an athlete with lower values on the NPFD and ADHD questionnaire and a higher comprehension rate on the Visagraph. None of the IMPACT baseline assessment measures were significantly predictive of the individual's concussion history. Conclusion: The study provides a relatively sensitive screening tool to assess the probability of previous concussion(s) in an athlete. This model may allow athletic personnel to address in a timely manner the risks associated with repeat concussions and to develop individualized concussion management protocols.	[Poltavski, Dmitri V.] Univ N Dakota, Dept Psychol, Grand Forks, ND 58202 USA; [Biberdorf, David] Valley Vis Clin, Grand Forks, ND USA		Poltavski, DV (corresponding author), Univ N Dakota, Dept Psychol, 319 Harvard St,Stop 8380, Grand Forks, ND 58202 USA.	dmitri.poltavski@email.und.edu					Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Borsting EJ, 2003, OPTOMETRY VISION SCI, V80, P832, DOI 10.1097/00006324-200312000-00014; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Chen AH, 2000, OPHTHAL PHYSL OPT, V20, P185; Ciuffreda K. J., 2005, BRAIN INJURY PROFESS, V2, P16; Ciuffreda K. J., 2012, VISUAL DIAGNOSIS CAR, P95; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda KJ, 2006, NEUROREHABILITATION, V21, P9; Ciuffreda KJ, 2011, OPTOMETRY, V82, P61, DOI 10.1016/j.optm.2010.11.011; Cohen M, 1989, Brain Inj, V3, P187, DOI 10.3109/02699058909004551; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Cooper J, 2012, OPTOMETRY, V83, P20; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; DuPaul G.J., 1998, ADHD RATING SCALE 4; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Esposito G, 1996, J NUCL MED, V37, P559; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Han Y, 2004, BRAIN RES PROTOC, V14, P1, DOI 10.1016/j.brainresprot.2004.06.002; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hosmer DW, 2000, WILEY PS TX, V2nd, P147; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kapoor N, 2004, ARCH PHYS MED REHAB, V85, P1667, DOI 10.1016/j.apmr.2003.12.044; Kessler RC, 2007, INT J METH PSYCH RES, V16, P52, DOI 10.1002/mpr.208; KROHEL GB, 1986, ANN OPHTHALMOL, V18, P101; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lederer PJ, 2010, 40 ANN COVD M PUERT; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Nolin P, 2012, BRAIN INJURY, V26, P1564, DOI 10.3109/02699052.2012.698359; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Shuttleworth-Edwards AB, 2008, J CLIN EXP NEUROPSYC, V30, P870, DOI 10.1080/13803390701846914; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI70, DOI 10.1136/bjsm.2005.019646; Tannen B. M., 2007, J BEHAV OPTOMETRY, V18, P143; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Terry DP, 2012, BRAIN INJURY, V26, P1684, DOI 10.3109/02699052.2012.722259; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; McLeod TCV, 2008, CLIN J SPORT MED, V18, P235, DOI 10.1097/JSM.0b013e3181705756; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	58	23	23	0	30	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2014	28	4					475	485		10.3109/02699052.2014.888771			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AF5GL	WOS:000334741900012	24702485				2022-02-06	
J	Addington, CP; Pauken, CM; Caplan, MR; Stabenfeldt, SE				Addington, Caroline P.; Pauken, Christine M.; Caplan, Michael R.; Stabenfeldt, Sarah E.			The role of SDF-1 alpha-ECM crosstalk in determining neural stem cell fate	BIOMATERIALS			English	Article						Neural stem cell; ECM; Chemotaxis; Laminin; Progenitor cell	TRAUMATIC BRAIN-INJURY; ADULT-RAT BRAIN; EXTRACELLULAR-MATRIX; SUBVENTRICULAR ZONE; PROGENITOR CELLS; IN-VITRO; NEUROSPHERE CULTURES; CEREBRAL-ISCHEMIA; SIGNALING PATHWAY; CANCER CELLS	The consequences of central nervous system injury are far-reaching and debilitating and, while an endogenous repair response to neural injury has been observed in recent years, the mechanisms behind this response remain unclear. Neural progenitor/stem cell (NPSC) migration to the site of injury from the neural stem cell niches (e.g. subventricular zone and hippocampus) has been observed to be vasophilic in nature. While the chemotactic stimuli directing NPSC homing to injury is not well established, it is thought to be due in part to an increasing gradient of chemotactic cytokines, such as stromal cell-derived factor Ice (SDF-1 alpha). Based on these recent findings, we hypothesize that critical crosstalk between SDF-1 alpha and the extracellular matrix (ECM) drives injury-induced NPSC behavior. In this study, we investigated the effect of SDF-1 alpha and ECM substrates (Matrigel, laminin, and vitronectin) on the migration, differentiation, and proliferation of NPSCs in vitro using standard assays. The results demonstrated that SDF-1 alpha and laminin-based ECM (Matrigel and laminin) significantly and synergistically enhanced NPSC migration and acute neuronal differentiation. These effects were significantly attenuated with the addition of AMD3100 (an antagonist against the SDF-1 alpha receptor, CXCR4). SDF-1 alpha alone significantly increased NPSC proliferation regardless of ECM substrate, however no synergy was observed between SDF-1 alpha and the ECM. These results serve to elucidate the relationship between adhesive and soluble signaling factors of interest and their effect on NPSC behavior following neural injury. Furthermore, these results better inform the next generation of biomaterials aimed at stimulating endogenous neural regeneration for neural injury and neurodegenerative diseases. (C) 2014 Elsevier Ltd. All rights reserved.	[Addington, Caroline P.; Pauken, Christine M.; Caplan, Michael R.; Stabenfeldt, Sarah E.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA		Stabenfeldt, SE (corresponding author), Arizona State Univ, Sch Biol & Hlth Syst Engn, POB 879709, Tempe, AZ 85287 USA.	sarah.stabenfeldt@asu.edu		Addington, Caroline/0000-0003-4534-8222	Mayo Clinic Center for Regenerative Medicine; Arizona State University Start-Up Funding; Ira A. Fulton Schools of Engineering Dean's Fellowship	This work was supported by the Mayo Clinic Center for Regenerative Medicine, Arizona State University Start-Up Funding, and the Ira A. Fulton Schools of Engineering Dean's Fellowship.	Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Azari H, 2011, JOVE-J VIS EXP, DOI 10.3791/2457; Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084952102000940; Banisadr G, 2011, NEUROBIOL DIS, V44, P19, DOI 10.1016/j.nbd.2011.05.019; Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; Barker TH, 2011, BIOMATERIALS, V32, P4211, DOI 10.1016/j.biomaterials.2011.02.027; Bez A, 2003, BRAIN RES, V993, P18, DOI 10.1016/j.brainres.2003.08.061; Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199; Carbajal KS, 2010, P NATL ACAD SCI USA, V107, P11068, DOI 10.1073/pnas.1006375107; Christie KJ, 2013, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00070; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Garzon-Muvdi T, 2010, ILAR J, V51, P3, DOI 10.1093/ilar.51.1.3; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; Grossman H, 2006, MT SINAI J MED, V73, P985; Grzesiak JJ, 2007, SURGERY, V141, P804, DOI 10.1016/j.surg.2006.12.016; Hall Margaret Jean, 2012, NCHS Data Brief, P1; Harting MT, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E17; Hartman NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015856; Hou SW, 2008, STROKE, V39, P2837, DOI 10.1161/STROKEAHA.107.510982; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Ishido M, 2010, TOXICOL IN VITRO, V24, P552, DOI 10.1016/j.tiv.2009.11.005; Jacques TS, 1998, DEVELOPMENT, V125, P3167; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; Kucia M, 2004, J MOL HISTOL, V35, P233; Leong SY, 2011, STEM CELLS, V29, P332, DOI 10.1002/stem.577; Li MZ, 2011, GLIA, V59, P108, DOI 10.1002/glia.21080; Li WW, 2000, DEV NEUROSCI-BASEL, V22, P68, DOI 10.1159/000017428; LIN CQ, 1993, FASEB J, V7, P737, DOI 10.1096/fasebj.7.9.8330681; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Magnon C, 2011, METHODS MOL BIOL, V750, P3, DOI 10.1007/978-1-61779-145-1_1; Maheshwari G, 2000, J CELL SCI, V113, P1677; Mani N, 2010, J NEUROSCI RES, V88, P248, DOI 10.1002/jnr.22197; MCGUIRE PG, 1989, J CELL BIOCHEM, V40, P215, DOI 10.1002/jcb.240400210; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Mercier F, 2002, J COMP NEUROL, V451, P170, DOI 10.1002/cne.10342; NOBLE PB, 1987, J CELL SCI, V87, P241; Nolan S, 2005, CRIT CARE NURS Q, V28, P188, DOI 10.1097/00002727-200504000-00010; Olstorn H, 2011, NEUROSURGERY, V68, P213, DOI 10.1227/NEU.0b013e3181fd2c11; Park DS, 1998, YONSEI MED J, V39, P130, DOI 10.3349/ymj.1998.39.2.130; Parmar M, 2003, MOL CELL NEUROSCI, V24, P741, DOI 10.1016/S1044-7431(03)00239-2; Peng H, 2004, J NEUROSCI RES, V76, P35, DOI 10.1002/jnr.20045; Peng H, 2007, J NEUROIMMUNE PHARM, V2, P251, DOI 10.1007/s11481-007-9081-3; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Rudiger C, 2005, BIOCHEM BIOPH RES CO, V335, P1107, DOI 10.1016/j.bbrc.2005.08.006; Shanley DK, 2006, BRAIN RES, V1067, P85, DOI 10.1016/j.brainres.2005.10.008; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Stabenfeldt SE, 2010, TISSUE ENG PT A, V16, P3747, DOI [10.1089/ten.tea.2009.0837, 10.1089/ten.TEA.2009.0837]; Streuli C, 1999, CURR OPIN CELL BIOL, V11, P634, DOI 10.1016/S0955-0674(99)00026-5; Sun YX, 2007, PROSTATE, V67, P61, DOI 10.1002/pros.20500; Tate MC, 2004, MOL CELL NEUROSCI, V27, P22, DOI 10.1016/j.mcn.2004.05.001; Thored P, 2007, STROKE, V38, P3032, DOI 10.1161/STROKEAHA.107.488445; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Tran PB, 2007, J COMP NEUROL, V500, P1007, DOI 10.1002/cne.21229; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Vishnubhotla Ramana, 2012, Int J Cell Biol, V2012, P259142, DOI 10.1155/2012/259142; VUKICEVIC S, 1992, EXP CELL RES, V202, P1, DOI 10.1016/0014-4827(92)90397-Q; Wachs FP, 2006, J NEUROPATH EXP NEUR, V65, P358, DOI 10.1097/01.jnen.0000218444.53405.f0; Wang JH, 2005, CELL SIGNAL, V17, P1578, DOI 10.1016/j.cellsig.2005.03.022; Wang LL, 2010, MOL BIOL REP, V37, P1971, DOI 10.1007/s11033-009-9645-9; Wei L, 2012, NEUROBIOL DIS, V46, P635, DOI 10.1016/j.nbd.2012.03.002; White DE, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002952; Whittemore SR, 1999, EXP CELL RES, V252, P75, DOI 10.1006/excr.1999.4621; Wojcik-Stanaszek L, 2011, ACTA NEUROBIOL EXP, V71, P103; Worthylake RA, 2003, J BIOL CHEM, V278, P13578, DOI 10.1074/jbc.M211584200; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yanagawa Y, 2001, IMMUNOLOGY, V104, P43, DOI 10.1046/j.1365-2567.2001.01292.x; Yang SH, 2003, GENE, V320, P3, DOI 10.1016/S0378-1119(03)00816-3; Yu YQ, 2007, J NEUROL SCI, V255, P81, DOI 10.1016/j.jns.2007.01.076; Zhang Q, 2011, MOLECULES, V16, P10146, DOI 10.3390/molecules161210146	77	23	23	0	19	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	MAR	2014	35	10					3263	3272		10.1016/j.biomaterials.2013.12.102			10	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	AC0MC	WOS:000332188400013	24438907				2022-02-06	
J	Rasmussen, KW; Berntsen, D				Rasmussen, Katrine W.; Berntsen, Dorthe			Autobiographical memory and episodic future thinking after moderate to severe traumatic brain injury	JOURNAL OF NEUROPSYCHOLOGY			English	Article							MENTAL TIME-TRAVEL; CLOSED-HEAD-INJURY; HIPPOCAMPAL DAMAGE; CONSTRUCTION; EVENTS; EXPERIENCE; DEFICITS; IMAGINE; MIND; CONSCIOUSNESS	Converging evidence suggests that autobiographical memory and episodic future thinking share a common neurocognitive basis. Although previous research has shown that traumatic brain injury (TBI) can impair the ability to remember the personal past, episodic future thinking has not previously been systematically examined within this population. In this study, we examined the ability to remember events in the personal past and the ability to imagine possible events in the personal future in a sample of moderate-to-severe TBI patients. We present data on nine patients and nine healthy controls, who were asked to report a series of events that had happened to them in the past and a series of events that might happen to them in the future. Transcriptions were scored according to a reliable system for categorizing internal (episodic) and external (semantic) information. For each event described, participants also completed two modified Autobiographical Memory Questionnaire items to assess self-reported phenomenal qualities associated with remembering and imagining. In addition, TBI patients underwent neuropsychological assessment. Results revealed that TBI patients recalled/imagined proportionally fewer episodic event-specific details for both past and future events compared to healthy controls ((2)(p)=0.78). In contrast, there were no group differences in ratings of phenomenal characteristics. These results are discussed in relation to theories suggesting that remembering and imagining the future are the expression of the same underlying neurocognitive system.	[Rasmussen, Katrine W.; Berntsen, Dorthe] Aarhus Univ, Dept Psychol & Behav Sci, Ctr Autobiog Memory Res, DK-8000 Aarhus C, Denmark		Rasmussen, KW (corresponding author), Aarhus Univ, Bartholins Alle 9, DK-8000 Aarhus C, Denmark.	katrine@psy.au.dk			Danish National Research FoundationDanmarks Grundforskningsfond; Danish Council for Independent Research for the Humanities	We thank the patients for giving their time; the Regional Hospital Hammel Neurocenter and in particular Eva Lind for clinical assistance and helpful suggestions. We also thank Lise Fischer-Mogensen and Nadia Nielsen for their help. This work was supported by the Danish National Research Foundation as well as the Danish Council for Independent Research for the Humanities.	Addis DR, 2008, PSYCHOL SCI, V19, P33, DOI 10.1111/j.1467-9280.2008.02043.x; Addis DR, 2007, BRAIN, V130, P2327, DOI 10.1093/brain/awm166; Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Addis DR, 2009, NEUROPSYCHOLOGIA, V47, P2660, DOI 10.1016/j.neuropsychologia.2009.05.018; Andelman F, 2010, NEUROCASE, V16, P426, DOI 10.1080/13554791003623318; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Barsalou L. W., 1988, REMEMBERING RECONSID, P193; Berntsen D, 2004, MEM COGNITION, V32, P427, DOI 10.3758/BF03195836; Berryhill ME, 2010, NEUROPSYCHOLOGIA, V48, P1385, DOI 10.1016/j.neuropsychologia.2010.01.004; Botzung A, 2008, BRAIN COGNITION, V66, P202, DOI 10.1016/j.bandc.2007.07.011; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Burgess P, 1996, BEHAV ASSESSMENT DYS; Carlesimo GA, 1998, CORTEX, V34, P1, DOI 10.1016/S0010-9452(08)70734-2; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Cooper JM, 2011, NEUROPSYCHOLOGIA, V49, P1843, DOI 10.1016/j.neuropsychologia.2011.03.008; D'Argembeau A, 2004, CONSCIOUS COGN, V13, P844, DOI 10.1016/j.concog.2004.07.007; Dalla Barba G, 1997, NEUROCASE, V3, P425, DOI 10.1093/neucas/3.6.425; Dalsgaard I., 1998, DANISH ADULT R UNPUB; de Vito S, 2012, NEUROPSYCHOLOGIA, V50, P1494, DOI 10.1016/j.neuropsychologia.2012.03.001; Gade A., 1994, S 81 UDVIDET N UNPUB, P81; Gaesser B, 2011, PSYCHOL AGING, V26, P80, DOI 10.1037/a0021054; Gamboz N, 2010, NEUROPSYCHOLOGIA, V48, P2091, DOI 10.1016/j.neuropsychologia.2010.03.030; Golden C. J., 1998, STROOP COLOR WORLD T; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Hassabis D, 2009, PHILOS T R SOC B, V364, P1263, DOI 10.1098/rstb.2008.0296; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P62, DOI 10.1016/j.neuropsychologia.2005.04.011; Hopkins RO, 2005, NEUROPSYCHOLOGY, V19, P233, DOI 10.1037/0894-4105.19.2.233; Klein SB, 2002, SOC COGNITION, V20, P353, DOI 10.1521/soco.20.5.353.21125; Knight RG, 2009, J CLIN EXP NEUROPSYC, V31, P575, DOI 10.1080/13803390802363710; Kwan D, 2010, NEUROPSYCHOLOGIA, V48, P3179, DOI 10.1016/j.neuropsychologia.2010.06.011; LEVIN HS, 1985, J NEUROL NEUROSUR PS, V48, P556, DOI 10.1136/jnnp.48.6.556; Levine B, 2002, PSYCHOL AGING, V17, P677, DOI 10.1037//0882-7974.17.4.677; Maguire EA, 2011, P NATL ACAD SCI USA, V108, pE39, DOI 10.1073/pnas.1018876108; Maguire EA, 2010, NEUROPSYCHOLOGIA, V48, P3187, DOI 10.1016/j.neuropsychologia.2010.06.037; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; Mortensen I. K., 1994, STAND MAT S 94 UNPUB; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Okuda J, 2003, NEUROIMAGE, V19, P1369, DOI 10.1016/S1053-8119(03)00179-4; Piolino P, 2007, CORTEX, V43, P176, DOI 10.1016/S0010-9452(08)70474-X; PONSFORD J, 1995, TRAUMATIC BRAIN INJU, P1; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Race E, 2011, J NEUROSCI, V31, P10262, DOI 10.1523/JNEUROSCI.1145-11.2011; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rubin DC, 2003, MEM COGNITION, V31, P887, DOI 10.3758/BF03196443; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schacter DL, 2007, PHILOS T R SOC B, V362, P773, DOI 10.1098/rstb.2007.2087; Schacter DL, 2008, ANN NY ACAD SCI, V1124, P39, DOI 10.1196/annals.1440.001; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Spreng RN, 2006, MEM COGNITION, V34, P1644, DOI 10.3758/BF03195927; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Squire LR, 2010, P NATL ACAD SCI USA, V107, P19044, DOI 10.1073/pnas.1014391107; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Suddendorf T, 2005, LEARN MOTIV, V36, P110, DOI 10.1016/j.lmot.2005.02.010; Suddendorf T, 1997, GENET SOC GEN PSYCH, V123, P133; Suddendorf T, 2007, BEHAV BRAIN SCI, V30, P299, DOI 10.1017/S0140525X07001975; Szpunar KK, 2008, CONSCIOUS COGN, V17, P330, DOI 10.1016/j.concog.2007.04.006; Szpunar KK, 2007, P NATL ACAD SCI USA, V104, P642, DOI 10.1073/pnas.0610082104; Szpunar KK, 2010, PERSPECT PSYCHOL SCI, V5, P142, DOI 10.1177/1745691610362350; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; TEASDALE G, 1974, LANCET, V2, P81; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Trope Y, 2003, PSYCHOL REV, V110, P403, DOI 10.1037/0033-295X.110.3.403; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; TULVING E, 1988, BRAIN COGNITION, V8, P3, DOI 10.1016/0278-2626(88)90035-8; Tulving E., 1985, CANADIAN PSYCHOL, V25, P1, DOI DOI 10.1037/H0080017; Wechsler D., 1997, WECHSLERS MEMORY SCA; Wheeler MA, 1997, PSYCHOL BULL, V121, P331, DOI 10.1037/0033-2909.121.3.331; Williams JMG, 1996, MEM COGNITION, V24, P116, DOI 10.3758/BF03197278	71	23	23	2	14	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-6645	1748-6653		J NEUROPSYCHOL	J. Neuropsychol.	MAR	2014	8	1					34	52		10.1111/jnp.12003			19	Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	AA9YD	WOS:000331448100003	23253283	Green Submitted			2022-02-06	
J	Wang, F; Franco, R; Skotak, M; Hu, G; Chandra, N				Wang, Fang; Franco, Rodrigo; Skotak, Maciej; Hu, Gang; Chandra, Namas			Mechanical stretch exacerbates the cell death in SH-SY5Y cells exposed to paraquat: mitochondrial dysfunction and oxidative stress	NEUROTOXICOLOGY			English	Article						Traumatic brain injury; Paraquat; Mitochondria; Reactive oxygen species; MnSOD	TRAUMATIC BRAIN-INJURY; PARKINSONS-DISEASE; PESTICIDE EXPOSURE; HEAD-INJURY; STRAIN-RATE; GLUTATHIONE; NEURONS; MODEL; RISK; VULNERABILITY	Recent studies suggest that traumatic brain injury (TBI) and pesticide exposure increase the risk of Parkinson's disease (PD), but the molecular mechanisms involved remain unclear. Using an in vitro model of TBI, we evaluated the role of mitochondrial membrane potential (Delta psi m) and mitochondrial reactive oxygen species (ROS) induced by stretch on dopaminergic cell death upon paraquat exposure. Human dopaminergic neuroblastoma SH-SY5Y cells grown on silicone membrane were stretched at mild (25%) and moderate (50%) strain prior to paraquat exposure. We observed that moderate stretch (50% strain) increased the vulnerability of cells to paraquat demonstrated by the loss of plasma membrane integrity (propidium iodide-uptake) and decreased mitochondrial activity (MTT assay). Mitochondrial depolarization occurred immediately after stretch, while mitochondrial ROS increased rapidly and remained elevated for up to 4 h after the stretch injury. Intracellular glutathione (GSH) stores were also transiently decreased immediately after moderate stretch. Cells treated with paraquat, or moderate stretch exhibited negligible mitochondrial depolarization at 48 h post treatment, whereas in cells stretched prior to paraquat exposure, a significant mitochondria] depolarization occurred compared to samples exposed to either paraquat or stretch. Moderate stretch also increased mitochondrial ROS formation, as well as exacerbated intracellular GSH loss induced by paraquat. Overexpression of manganese superoxide dismutase (MnSOD) markedly diminished the deleterious effects of stretch in paraquat neurotoxicity. Our findings demonstrate that oxidative stress induced by mitochondrial dysfunction plays a critical role in the synergistic toxic effects of stretch (TBI) and pesticide exposure. Mitigation of oxidative stress via mitochondria-targeted antioxidants appears an attractive route for treatment of neurodegeneration mediated by TBI. Published by Elsevier Inc.	[Wang, Fang; Hu, Gang] Nanjing Med Univ, Jiangsu Key Lab Neurodegenerat, Dept Pharmacol, Nanjing 210029, Jiangsu, Peoples R China; [Wang, Fang; Skotak, Maciej] Univ Nebraska, Dept Mech & Mat Engn, Lincoln, NE 68588 USA; [Franco, Rodrigo] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68583 USA; [Franco, Rodrigo] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68583 USA; [Chandra, Namas] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA		Hu, G (corresponding author), Nanjing Med Univ, Jiangsu Key Lab Neurodegenerat, Dept Pharmacol, Nanjing 210029, Jiangsu, Peoples R China.	ghu@njmu.edu.cn; namas.chandra@njit.edu	Franco, Rodrigo/D-9470-2013; Skotak, Maciej/H-4769-2019	Franco, Rodrigo/0000-0003-3241-8615; Skotak, Maciej/0000-0003-2584-7294	US Army Research Office project "Army-UNL Center of Trauma Mechanics" [W911NF08-10483]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P20RR17675]; Centers of Biomedical Research Excellence (COBRE)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR); NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR017675] Funding Source: NIH RePORTER	This work was supported by the US Army Research Office project "Army-UNL Center of Trauma Mechanics" (Contract No.W911NF08-10483) and the National Institutes of Health Grant P20RR17675, Centers of Biomedical Research Excellence (COBRE). We are grateful to Dr. Charles A. Kuszynski, and Zhi Hong Gill at the Nebraska Center for Virology for their help with flow cytometry analyses.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; Allen MT, 2013, CRIT REV TOXICOL, V43, P515, DOI 10.3109/10408444.2013.798719; Arif IA, 2010, TOXICOL IND HEALTH, V26, P121, DOI 10.1177/0748233710362382; Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Chaturvedi RK, 2013, FREE RADICAL BIO MED, V63, P1, DOI 10.1016/j.freeradbiomed.2013.03.018; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Cheung YT, 2009, NEUROTOXICOLOGY, V30, P127, DOI 10.1016/j.neuro.2008.11.001; Franco R, 2012, ANTIOXID REDOX SIGN, V17, P1694, DOI 10.1089/ars.2012.4553; Freire C, 2012, NEUROTOXICOLOGY, V33, P947, DOI 10.1016/j.neuro.2012.05.011; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Geddes DM, 2001, J BIOMECH ENG-T ASME, V123, P247, DOI 10.1115/1.1374201; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Goldman SM, 2012, ANN NEUROL, V71, P40, DOI 10.1002/ana.22499; Hussain SP, 2004, CANCER RES, V64, P2350, DOI 10.1158/0008-5472.CAN-2287-2; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Jafari B, 2004, RESPIROLOGY, V9, P43, DOI 10.1111/j.1440-1843.2003.00527.x; Kieburtz K, 2013, MOVEMENT DISORD, V28, P8, DOI 10.1002/mds.25150; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Onizuka S, 2011, J ANESTH, V25, P229, DOI 10.1007/s00540-010-1079-y; PEREZOTANO I, 1994, NEUROSCI LETT, V175, P121, DOI 10.1016/0304-3940(94)91094-4; Redell JB, 2013, J NEUROTRAUM, V30, P752, DOI 10.1089/neu.2012.2437; Rodriguez-Rocha H, 2013, FREE RADICAL BIO MED, V61, P370, DOI 10.1016/j.freeradbiomed.2013.04.021; Sabirov RZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055646; Sauerbeck A, 2012, EXP NEUROL, V234, P85, DOI 10.1016/j.expneurol.2011.12.012; Schneider L, 2011, FREE RADICAL BIO MED, V51, P2007, DOI 10.1016/j.freeradbiomed.2011.08.030; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; Skotak M, 2012, J NEUROSCI METH, V205, P159, DOI 10.1016/j.jneumeth.2012.01.001; Stack EC, 2008, BBA-MOL BASIS DIS, V1782, P151, DOI 10.1016/j.bbadis.2007.12.006; Szczygielski J, 2005, J NEURAL TRANSM, V112, P1547, DOI 10.1007/s00702-005-0326-0; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018	38	23	25	0	18	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0161-813X	1872-9711		NEUROTOXICOLOGY	Neurotoxicology	MAR	2014	41						54	63		10.1016/j.neuro.2014.01.002			10	Neurosciences; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Toxicology	AE6HW	WOS:000334092200006	24462953	Green Accepted			2022-02-06	
J	Agarwalla, PK; Stapleton, CJ; Ogilvy, CS				Agarwalla, Pankaj K.; Stapleton, Christopher J.; Ogilvy, Christopher S.			Craniectomy in Acute Ischemic Stroke	NEUROSURGERY			English	Article						Decompressive craniectomy; Edema; Ischemic stroke; Suboccipital decompression	MIDDLE CEREBRAL-ARTERY; AGGRESSIVE DECOMPRESSIVE SURGERY; OCCUPYING HEMISPHERIC INFARCTION; TRAUMATIC BRAIN-INJURY; OF-THE-LITERATURE; CEREBELLAR INFARCTION; SURGICAL DECOMPRESSION; MALIGNANT INFARCTION; INTRACRANIAL-PRESSURE; TERRITORY INFARCTION	Anterior and posterior circulation acute ischemic stroke carries significant morbidity and mortality as a result of malignant cerebral edema. Decompressive craniectomy has evolved as a viable neurosurgical intervention in the armamentarium of treatment options for this life-threatening edema. In this review, we highlight the history of craniectomy for stroke and discuss recent data relevant to its efficacy in modern neurosurgical practice.	[Ogilvy, Christopher S.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA		Ogilvy, CS (corresponding author), Massachusetts Gen Hosp, Dept Neurosurg, 55 Fruit St,ACC 745, Boston, MA 02114 USA.	cogilvy@partners.org	Stapleton, Christopher/AAZ-5389-2021; Mingmei, Zhao/N-7178-2014	Stapleton, Christopher/0000-0003-4805-0093; Mingmei, Zhao/0000-0002-0047-5220			Akins PT, 2008, NEUROCRIT CARE, V9, P269, DOI 10.1007/s12028-007-9033-z; Amar AP, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.2.FOCUS11369; Poca MA, 2010, J NEUROSURG, V112, P648, DOI 10.3171/2009.7.JNS081677; Bardutzky J, 2007, STROKE, V38, P3084, DOI 10.1161/STROKEAHA.107.490193; Carter BS, 1997, NEUROSURGERY, V40, P1168, DOI 10.1097/00006123-199706000-00010; CHEN HJ, 1992, STROKE, V23, P957, DOI 10.1161/01.STR.23.7.957; Cho DY, 2003, SURG NEUROL, V60, P227, DOI 10.1016/S0090-3019(03)00266-0; CLARK K, 1968, J NEUROSURG, V29, P367, DOI 10.3171/jns.1968.29.4.0367; Curry WT, 2005, NEUROSURGERY, V56, P681, DOI 10.1227/01.NEU.0000156604.41886.62; Cushing H, 1908, ANN SURG, V47, P641, DOI 10.1097/00000658-190805000-00001; DELASHAW JB, 1990, STROKE, V21, P874, DOI 10.1161/01.STR.21.6.874; Doerfler A, 2001, STROKE, V32, P813, DOI 10.1161/01.STR.32.3.813; FAIRBURN B, 1956, BMJ-BRIT MED J, V1, P1335, DOI 10.1136/bmj.1.4979.1335; FORSTING M, 1995, STROKE, V26, P259, DOI 10.1161/01.STR.26.2.259; Georgiadis D, 2002, STROKE, V33, P1584, DOI 10.1161/01.STR.0000016970.51004.D9; Gerriets T, 2001, STROKE, V32, P442, DOI 10.1161/01.STR.32.2.442; Geurts M, 2013, STROKE, V44, P2506, DOI 10.1161/STROKEAHA.113.002014; GREENWOOD J, 1968, JOHNS HOPKINS MED J, V122, P254; Guresir E, 2011, J NEUROSURG, V114, P954, DOI 10.3171/2009.12.JNS091065; Gupta R, 2004, STROKE, V35, P539, DOI 10.1161/01.STR.0000109772.64650.18; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; HACKE W, 1995, INTENS CARE MED, V21, P856, DOI 10.1007/BF01700973; HEROS RC, 1992, STROKE, V23, P937, DOI 10.1161/01.STR.23.7.937; Hofmeijer J, 2007, J NEUROL NEUROSUR PS, V78, P1124, DOI 10.1136/jnnp.2006.110726; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Holtkamp M, 2001, J NEUROL NEUROSUR PS, V70, P226, DOI 10.1136/jnnp.70.2.226; HORNIG CR, 1994, STROKE, V25, P372, DOI 10.1161/01.STR.25.2.372; Huttner HB, 2009, LANCET NEUROL, V8, P949, DOI 10.1016/S1474-4422(09)70224-8; IVAMOTO HS, 1974, STROKE, V5, P365, DOI 10.1161/01.STR.5.3.365; Jauss M, 1999, J NEUROL, V246, P257, DOI 10.1007/s004150050344; JOURDAN C, 1993, NEUROCHIRURGIE, V39, P304; Juttler E, 2009, STROKE, V40, P3060, DOI 10.1161/STROKEAHA.109.550913; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kahle KT, 2009, PHYSIOLOGY, V24, P257, DOI 10.1152/physiol.00015.2009; KALIA KK, 1993, ARCH NEUROL-CHICAGO, V50, P1293, DOI 10.1001/archneur.1993.00540120010005; Kasner SE, 2001, STROKE, V32, P2117, DOI 10.1161/hs0901.095719; Kidwell CS, 2003, STROKE, V34, P2729, DOI 10.1161/01.STR.0000097608.38779.CC; Kilincer C, 2005, ACTA NEUROCHIR, V147, P587, DOI 10.1007/s00701-005-0493-7; Kimberly WT, 2011, NEUROLOGY, V76, pS50, DOI 10.1212/WNL.0b013e31820c35f4; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; Klein A, 2012, NEUROCRIT CARE, V16, P456, DOI 10.1007/s12028-012-9677-1; Koh MS, 2000, SURG NEUROL, V53, P225, DOI 10.1016/S0090-3019(00)00163-4; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; KONDZIOLKA D, 1988, NEUROSURGERY, V23, P143, DOI 10.1227/00006123-198808000-00002; Krieger DW, 1999, STROKE, V30, P287, DOI 10.1161/01.STR.30.2.287; Kudo Hiroshi, 2007, J Stroke Cerebrovasc Dis, V16, P259, DOI 10.1016/j.jstrokecerebrovasdis.2007.09.001; LEHRICH JR, 1970, ARCH NEUROL-CHICAGO, V22, P490, DOI 10.1001/archneur.1970.00480240010002; Leonhardt G, 2002, J NEUROL, V249, P1433, DOI 10.1007/s00415-002-0875-1; LINDGREN SO, 1956, J NEUROSURG, V13, P575, DOI 10.3171/jns.1956.13.6.0575; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; MATHEW P, 1995, J NEUROL NEUROSUR PS, V59, P287, DOI 10.1136/jnnp.59.3.287; Mori K, 2001, ACTA NEUROCHIR, V143, P483, DOI 10.1007/s007010170078; Mori K, 2001, ACTA NEUROCHIR, V143, P491; Mostofi Keyvan, 2013, Surg Neurol Int, V4, P28, DOI 10.4103/2152-7806.107906; Mumert ML, 2012, J CLIN NEUROSCI, V19, P455, DOI 10.1016/j.jocn.2011.09.004; Neugebauer H, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-115; Oladunjoye AO, 2013, J NEUROSURG, V118, P776, DOI 10.3171/2013.1.JNS121475; Pfefferkorn T, 2009, STROKE, V40, P3045, DOI 10.1161/STROKEAHA.109.550871; Piedra MP, 2013, J NEUROSURG, V118, P109, DOI 10.3171/2012.10.JNS121037; Pullicino PM, 1997, NEUROLOGY, V49, P1090, DOI 10.1212/WNL.49.4.1090; Qureshi AI, 2003, CRIT CARE MED, V31, P272, DOI 10.1097/00003246-200301000-00043; Raco A, 2003, NEUROSURGERY, V53, P1061, DOI 10.1227/01.NEU.0000088766.34559.3E; Ramaswamy V, 2008, J CHILD NEUROL, V23, P889, DOI 10.1177/0883073808314960; RENGACHARY SS, 1981, NEUROSURGERY, V8, P321, DOI 10.1227/00006123-198103000-00004; RIEKE K, 1995, CRIT CARE MED, V23, P1576, DOI 10.1097/00003246-199509000-00019; Sakai K, 1998, NEUROL MED-CHIR, V38, P131, DOI 10.2176/nmc.38.131; SCARCELLA G, 1956, J NEUROSURG, V13, P366; Schwab S, 1996, NEUROLOGY, V47, P393, DOI 10.1212/WNL.47.2.393; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; Shah S, 2013, WORLD NEUROSURG, V80, P126, DOI 10.1016/j.wneu.2013.06.001; Sims JR, 2009, NEUROLOGY, V72, P2104, DOI 10.1212/WNL.0b013e3181aa5329; Staykov D, 2011, STROKE, V42, P513, DOI 10.1161/STROKEAHA.110.605642; Stiver SI, 2008, J NEUROSURG, V109, P245, DOI 10.3171/JNS/2008/109/8/0245; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Takeuchi S, 2013, J CLIN NEUROSCI, V20, P377, DOI 10.1016/j.jocn.2012.03.035; TANEDA M, 1982, J NEUROSURG, V57, P83, DOI 10.3171/jns.1982.57.1.0083; TOMSICK TA, 1994, AM J NEURORADIOL, V15, P16; Tsitsopoulos PP, 2011, ACTA NEUROL SCAND, V123, P345, DOI 10.1111/j.1600-0404.2010.01404.x; Tsitsopoulos PP, 2011, ACTA NEUROCHIR, V153, P2075, DOI 10.1007/s00701-011-1120-4; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; VANLOON J, 1993, ACTA NEUROCHIR, V122, P187, DOI 10.1007/BF01405527; VONKUMMER R, 1994, AM J NEURORADIOL, V15, P9; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; Walcott BP, 2013, J NEUROSURG, V118, P757, DOI 10.3171/2013.1.JNS121626; Walz B, 2002, J NEUROL, V249, P1183, DOI 10.1007/s00415-002-0798-x; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Wirtz C R, 1997, Neurosurg Focus, V2, pE3; YOUNG PH, 1982, SOUTHERN MED J, V75, P473, DOI 10.1097/00007611-198204000-00025; Zhao JW, 2012, NEUROCRIT CARE, V17, P161, DOI 10.1007/s12028-012-9703-3	90	23	24	1	8	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	FEB	2014	74			1			S151	S162		10.1227/NEU.0000000000000226			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AL3VU	WOS:000339059800018	24402484				2022-02-06	
J	Huang, APH; Tsai, JC; Kuo, LT; Lee, CW; Lai, HS; Tsai, LK; Huang, SJ; Chen, CM; Chen, YS; Chuang, HY; Wintermark, M				Huang, Abel Po-Hao; Tsai, Jui-Chang; Kuo, Lu-Ting; Lee, Chung-Wei; Lai, Hong-Shiee; Tsai, Li-Kai; Huang, Sheng-Jean; Chen, Chien-Min; Chen, Yuan-Shen; Chuang, Hao-Yu; Wintermark, Max			Clinical application of perfusion computed tomography in neurosurgery Clinical article	JOURNAL OF NEUROSURGERY			English	Article						aneurysmal subarachnoid hemorrhage; perfusion CT; blood-brain barrier	MIDDLE CEREBRAL-ARTERY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; BRAIN-BARRIER PERMEABILITY; SINKING SKIN FLAP; EXTRACRANIAL-INTRACRANIAL BYPASS; POSITRON-EMISSION-TOMOGRAPHY; ACUTE ISCHEMIC-STROKE; DYNAMIC CT PERFUSION; SEVERE HEAD TRAUMA; INTRACEREBRAL HEMORRHAGE	Object. Currently, perfusion CT (PCT) is a valuable imaging technique that has been successfully applied to the clinical management of patients with ischemic stroke and aneurysmal subarachnoid hemorrhage (SAH). However, recent literature and the authors' experience have shown that PCT has many more important clinical applications in a variety of neurosurgical conditions. Therefore, the authors share their experiences of its application in various diseases of the cerebrovascular, neurotraumatology, and neurooncology fields and review the pertinent literature regarding expanding PCT applications for neurosurgical conditions, including pitfalls and future developments. Methods. A pertinent literature search was conducted of English-language articles describing original research, case series, and case reports from 1990 to 2011 involving PCT and with relevance and applicability to neurosurgical disorders. Results. In the cerebrovascular field, PCT is already in use as a diagnostic tool for patients suspected of having an ischemic stroke. Perfusion CT can be used to identify and define the extent of the infarct core and ischemic penumbra core, and thus aid patient selection for acute reperfusion therapy. For patients with aneurysmal SAH, PCT provides assessment of early brain injury, cerebral ischemia, and infarction, in addition to vasospasm. It may also be used to aid case selection for aggressive treatment of patients with poor SAH grade. In terms of oncological applications, PCT can be used as an imaging biomarker to assess angiogenesis and response to antiangiogenetic treatments, differentiate between glioma grades, and distinguish recurrent tumor from radiation necrosis. In the setting of traumatic brain injury, PCT can detect and delineate contusions at an early stage. In patients with mild head injury, PCT results have been shown to correlate with the severity and duration of postconcussion syndrome. In patients with moderate or severe head injury, PCT results have been shown to correlate with patients' functional outcome. Conclusions. Perfusion CT provides quantitative and qualitative data that can add diagnostic and prognostic value in a number of neurosurgical disorders, and also help with clinical decision making. With emerging new technical developments in PCT, such as characterization of blood-brain barrier permeability and whole-brain PCT, this technique is expected to provide more and more insight into the pathophysiology of many neurosurgical conditions.	[Huang, Abel Po-Hao; Tsai, Jui-Chang; Kuo, Lu-Ting; Lee, Chung-Wei; Tsai, Li-Kai; Huang, Sheng-Jean; Chen, Yuan-Shen] Natl Taiwan Univ Hosp, Div Neurosurg, Taipei, Taiwan; [Huang, Abel Po-Hao; Kuo, Lu-Ting; Lai, Hong-Shiee; Chen, Yuan-Shen] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Tsai, Jui-Chang] Natl Taiwan Univ, Coll Med, Ctr Optoelect Biomed, Taipei, Taiwan; [Huang, Abel Po-Hao; Kuo, Lu-Ting; Huang, Sheng-Jean; Chen, Yuan-Shen] Natl Taiwan Univ Hosp, Dept Surg, Yun Lin Branch, Div Neurosurg, Yunlin, Taiwan; [Chen, Chien-Min] Chang Hau Christian Hosp, Dept Neurosurg, Chang Ha, Taiwan; [Chuang, Hao-Yu] China Med Univ, Dept Neurosurg, Bei Gang Hosp, Yunlin, Taiwan; [Wintermark, Max] Univ Virginia, Med Ctr, Dept Radiol, Neuroradiol Div, Charlottesville, VA 22908 USA		Wintermark, M (corresponding author), Univ Virginia, Med Ctr, Dept Radiol, Neuroradiol Div, 1215 Lee St New Hosp,POB 800170, Charlottesville, VA 22908 USA.	max.wintermark@virginia.edu	Kuo, Lu-Ting/AAU-3205-2021	HUANG, ABEL PO-HAO/0000-0002-5689-6761; Wintermark, Max/0000-0002-6726-3951; TSAI, JUI-CHANG/0000-0003-2723-6841; Lai, Hong-Shiee/0000-0002-7958-2183; LEE, CHUNG-WEI/0000-0002-3573-2506; Kuo, Lu-Ting/0000-0002-1405-8700; Tsai, Li-Kai/0000-0001-8420-6951	GE HealthcareGeneral ElectricGE Healthcare	Dr. Wintermark has received clinical or research support for this study from GE Healthcare.	Abou-Chebl A, 2010, STROKE, V41, P1996, DOI 10.1161/STROKEAHA.110.578997; Aviv RI, 2009, RADIOLOGY, V250, P867, DOI 10.1148/radiol.2503080257; BARTOLINI A, 1994, COMPUT MED IMAG GRAP, V18, P145, DOI 10.1016/0895-6111(94)90023-X; BEDERSON JB, 1995, STROKE, V26, P1086, DOI 10.1161/01.STR.26.6.1086; Bektas H, 2010, STROKE, V41, P2539, DOI 10.1161/STROKEAHA.110.591362; Bhujwalla ZM, 2003, CLIN CANCER RES, V9, P355; Broome DR, 2007, AM J ROENTGENOL, V188, P586, DOI 10.2214/AJR.06.1094; Cahill J, 2009, STROKE, V40, pS86, DOI 10.1161/STROKEAHA.108.533315; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; Chang CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019886; Cheung A, 2005, NEUROCRIT CARE, V3, P216, DOI 10.1385/NCC:3:3:216; Cianfoni A, 2006, J NEURORADIOLOGY, V33, P164, DOI 10.1016/S0150-9861(06)77254-6; Dittrich R, 2008, J NEUROL, V255, P896, DOI 10.1007/s00415-008-0802-1; Donnan GA, 2009, LANCET NEUROL, V8, P261, DOI 10.1016/S1474-4422(09)70041-9; Ellika SK, 2007, AM J NEURORADIOL, V28, P1981, DOI 10.3174/ajnr.A0688; Escudero D, 2007, Med. Intensiva, V31, P335; Escudero D, 2009, NEUROCRIT CARE, V11, P261, DOI 10.1007/s12028-009-9243-7; Etminan N, 2012, STROKE, V43, P759, DOI 10.1161/STROKEAHA.111.616730; Frolich AMJ, 2012, STROKE, V43, P97, DOI 10.1161/STROKEAHA.111.630954; Galvez M, 2004, AM J NEURORADIOL, V25, P1205; Gass A, 2007, CEREBROVASC DIS, V23, P4, DOI 10.1159/000096298; Han JS, 2011, STROKE, V42, P3047, DOI 10.1161/STROKEAHA.111.615955; Hemphill JC, 2005, AM J NEURORADIOL, V26, P1095; Herweh C, 2007, STROKE, V38, P2941, DOI 10.1161/STROKEAHA.107.486977; Herweh C, 2010, J NEUROIMAGING, V20, P350, DOI 10.1111/j.1552-6569.2009.00408.x; Hopyan JJ, 2008, AM J NEURORADIOL, V29, P1826, DOI 10.3174/ajnr.A1257; Huang APH, 2011, J TRAUMA, V71, P1593, DOI 10.1097/TA.0b013e31822c8865; Huang APH, 2011, J TRAUMA, V70, P1578, DOI 10.1097/TA.0b013e3182178c71; Huang APH, 2010, NEUROSURGERY, V67, P964, DOI 10.1227/NEU.0b013e3181ee359c; Huang APH, 2009, CEREBROVASC DIS, V28, P247, DOI 10.1159/000228254; Huang APH, 2008, J NEUROTRAUM, V25, P1347, DOI 10.1089/neu.2008.0625; Ivens S, 2010, J NEUROL, V257, P615, DOI 10.1007/s00415-009-5384-z; Jain R, 2011, AM J NEURORADIOL, V32, P1570, DOI 10.3174/ajnr.A2263; Jain R, 2011, AM J NEURORADIOL, V32, P388, DOI 10.3174/ajnr.A2280; Jongen LM, 2010, CEREBROVASC DIS, V29, P538, DOI 10.1159/000306639; Kang KH, 2008, AM J NEURORADIOL, V29, P1487, DOI 10.3174/ajnr.A1129; Kemmling A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-80; Kirkman MA, 2011, BRIT J NEUROSURG, V25, P523, DOI 10.3109/02688697.2011.578773; Komotar RJ, 2009, NEUROSURGERY, V64, P397, DOI 10.1227/01.NEU.0000338946.42939.C7; Kostov DB, 2012, WORLD NEUROSURG, V78, P480, DOI 10.1016/j.wneu.2011.12.080; Kudo K, 2003, AM J NEURORADIOL, V24, P419; Kuroda S, 2001, STROKE, V32, P2110, DOI 10.1161/hs0901.095692; Leclerc X, 2006, J NEURORADIOLOGY, V33, P90, DOI 10.1016/S0150-9861(06)77237-6; Levy EI, 2009, STROKE, V40, P3552, DOI 10.1161/STROKEAHA.109.561274; Lin K, 2007, AM J NEURORADIOL, V28, P1292, DOI 10.3174/ajnr.A0539; Mandell DM, 2011, AM J NEURORADIOL, V32, P721, DOI 10.3174/ajnr.A2365; Martin ET, 2004, J AM COLL CARDIOL, V43, P1315, DOI 10.1016/j.jacc.2003.12.016; Metting Z, 2010, J NEUROTRAUM, V27, P2183, DOI 10.1089/neu.2010.1395; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Mordasini P, 2012, AM J NEURORADIOL, V33, P154, DOI 10.3174/ajnr.A2715; Muehlschlegel S, 2007, NEUROLOGY, V68, P1437, DOI 10.1212/01.wnl.0000260621.86593.39; NARIAI T, 1995, AM J NEURORADIOL, V16, P563; Nemoto EM, 2003, STROKE, V34, P2, DOI 10.1161/01.STR.0000041048.33908.18; Oppenheim C, 2000, STROKE, V31, P2175, DOI 10.1161/01.STR.31.9.2175; Park JC, 2010, CEREBROVASC DIS, V30, P547, DOI 10.1159/000319026; Parsons MW, 2007, NEUROLOGY, V68, P730, DOI 10.1212/01.wnl.0000256366.86353.ff; Patel HC, 2010, BRIT J NEUROSURG, V24, P179, DOI 10.3109/02688690903536603; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Pellon R, 2010, NEUROPEDIATRICS, V41, P189, DOI 10.1055/s-0030-1267209; Pham M, 2007, NEUROLOGY, V69, P762, DOI 10.1212/01.wnl.0000267641.08958.1b; Provenzale JM, 2005, AM J ROENTGENOL, V185, P763, DOI 10.2214/ajr.185.3.01850763; Rim NJ, 2008, AM J NEURORADIOL, V29, P1658, DOI 10.3174/ajnr.A1229; Roberts HC, 2001, AM J NEURORADIOL, V22, P1077; Rosand J, 2002, CEREBROVASC DIS, V14, P214, DOI 10.1159/000065681; Sakamoto S, 2006, ACTA NEUROCHIR, V148, P77, DOI 10.1007/s00701-005-0634-z; Sakamoto S, 2006, CLIN NEUROL NEUROSUR, V108, P583, DOI 10.1016/j.clineuro.2005.03.012; Salomon EJ, 2009, CLIN NEURORADIOL, V19, P187, DOI 10.1007/s00062-009-9019-7; Sanelli PC, 2011, AM J NEURORADIOL, V32, P2047, DOI 10.3174/ajnr.A2693; Sarov M, 2010, STROKE, V41, P560, DOI 10.1161/STROKEAHA.109.568543; Sarrafzadeh AS, 2010, J CEREBR BLOOD F MET, V30, P36, DOI 10.1038/jcbfm.2009.199; Sato K, 2010, J CEREBR BLOOD F MET, V30, P1110, DOI 10.1038/jcbfm.2009.264; Schaefer PW, 2008, STROKE, V39, P2986, DOI 10.1161/STROKEAHA.107.513358; Schichor C, 2010, J NEUROSURG, V112, P722, DOI 10.3171/2009.9.JNS081255; Shankar JJS, 2012, NEURORADIOLOGY, V54, P197, DOI 10.1007/s00234-011-0876-9; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Smith LM, 2008, J NEURORADIOLOGY, V35, P157, DOI 10.1016/j.neurad.2007.11.002; So Y, 2005, STROKE, V36, P1485, DOI 10.1161/01.STR.0000170709.95185.b1; Soustiel JF, 2008, NEURORADIOLOGY, V50, P189, DOI 10.1007/s00234-007-0337-7; Stiver SI, 2008, J NEUROSURG, V109, P245, DOI 10.3171/JNS/2008/109/8/0245; Stiver SI, 2008, ACTA NEUROCHIR SUPPL, V102, P273, DOI 10.1007/978-3-211-85578-2_51; Vagal AS, 2009, AM J NEURORADIOL, V30, P876, DOI 10.3174/ajnr.A1538; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Vernieri F, 1999, STROKE, V30, P593, DOI 10.1161/01.STR.30.3.593; Vespa PM, 2009, STROKE, V40, P1547, DOI 10.1161/STROKEAHA.108.542803; Wintermark M, 2004, CRIT CARE MED, V32, P1579, DOI 10.1097/01.CCM.0000130171.08842.72; Wintermark M, 2004, RADIOLOGY, V232, P211, DOI 10.1148/radiol.2321030824; Wintermark M, 2002, STROKE, V33, P2025, DOI 10.1161/01.STR.0000023579.61630.AC; Wintermark M, 2001, AM J NEURORADIOL, V22, P905; Yang Y, 2011, STROKE, V42, P3323, DOI 10.1161/STROKEAHA.110.608257	89	23	32	0	10	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	FEB	2014	120	2					473	488		10.3171/2013.10.JNS13103			16	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	301UA	WOS:000330556400031	24266541				2022-02-06	
J	Coelho, F; Oliveira, AM; Paiva, WS; Freire, FR; Calado, VT; Amorim, RL; Neville, IS; de Andrade, AF; Bor-Seng-Shu, E; Anghinah, R; Teixeira, MJ				Coelho, Fernanda; Oliveira, Arthur Maynart; Paiva, Wellingson Silva; Freire, Fabio Rios; Calado, Vanessa Tome; Amorim, Robson Luis; Neville, Iuri Santana; de Andrade, Almir Ferreira; Bor-Seng-Shu, Edson; Anghinah, Renato; Teixeira, Manoel Jacobsen			Comprehensive cognitive and cerebral hemodynamic evaluation after cranioplasty	NEUROPSYCHIATRIC DISEASE AND TREATMENT			English	Article						cranioplasty; decompressive craniotomy; perfusion CT; traumatic brain injury; cognition; neuropsychological test	SINKING SKIN-FLAP; TRAUMATIC BRAIN-INJURY; BLOOD-FLOW REGULATION; DECOMPRESSIVE CRANIECTOMY; NEUROLOGICAL IMPROVEMENT; INTRACRANIAL-PRESSURE; CT; HEMICRANIECTOMY; RECOVERY; MULTICENTER	Decompressive craniectomy is an established procedure to lower intracranial pressure and can save patients' lives. However, this procedure is associated with delayed cognitive decline and cerebral hemodynamics complications. Studies show the benefits of cranioplasty beyond cosmetic aspects, including brain protection, and functional and cerebrovascular aspects, but a detailed description of the concrete changes following this procedure are lacking. In this paper, the authors report a patient with trephine syndrome who underwent cranioplasty; comprehensive cognitive and cerebral hemodynamic evaluations were performed prior to and following the cranioplasty. The discussion was based on a critical literature review.	[Coelho, Fernanda; Freire, Fabio Rios; Calado, Vanessa Tome; Anghinah, Renato] Univ Sao Paulo, Sch Med, Neurorehabil Grp, Div Neurol, BR-05403010 Sao Paulo, Brazil; [Oliveira, Arthur Maynart; Paiva, Wellingson Silva; Amorim, Robson Luis; Neville, Iuri Santana; de Andrade, Almir Ferreira; Teixeira, Manoel Jacobsen] Univ Sao Paulo, Sch Med, Div Neurosurg, BR-05403010 Sao Paulo, Brazil; [Bor-Seng-Shu, Edson] Univ Sao Paulo, Sch Med, Neurosonol & Cerebral Hemodynam Grp, BR-05403010 Sao Paulo, Brazil		Neville, IS (corresponding author), Univ Sao Paulo, Sch Med, 255 Eneas Aguiar St,Off 4080, BR-05403010 Sao Paulo, Brazil.	iurineville@yahoo.com.br	BOR-SENG-SHU, EDSON/AAC-9762-2019; Neville, Iuri/AAI-2852-2021; Amorim, Robson/AAK-1368-2021; Paiva, Wellingson S/G-5517-2013; Neville, Iuri S/P-5360-2014	BOR-SENG-SHU, EDSON/0000-0002-6713-8974; Neville, Iuri/0000-0002-8561-9069; Amorim, Robson/0000-0003-2391-7519; Paiva, Wellingson S/0000-0002-5165-7040; Neville, Iuri S/0000-0002-8561-9069			Agner C, 2002, ACTA NEUROCHIR, V144, P1033, DOI 10.1007/s00701-002-0996-4; Amorim RL, 2012, J NEURORADIOLOGY, V39, P346, DOI 10.1016/j.neurad.2012.02.006; Bijlenga P, 2007, J NEUROL NEUROSUR PS, V78, P430, DOI 10.1136/jnnp.2006.099242; Bohman LE, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0392-x; Carota A, 2011, EUR NEUROL, V66, P227, DOI 10.1159/000331939; Chibbaro S, 2013, REV NEUROL-FRANCE, V169, P240, DOI 10.1016/j.neurol.2012.06.016; Chibbaro S, 2007, SURG NEUROL, V68, P632, DOI 10.1016/j.surneu.2006.12.046; Chieregato A, 2006, INTENS CARE MED, V32, P1668, DOI 10.1007/s00134-006-0302-7; Cushing H, 1905, SURG GYNECOL OBSTET, V1, P297; de Quintana-Schmidt C, 2011, REV NEUROLOGIA, V52, P661, DOI 10.33588/rn.5211.2010732; Di Stefano C, 2012, BRIT J NEUROSURG, V26, P827, DOI 10.3109/02688697.2012.692838; Erdogan E, 2003, NEUROL INDIA, V51, P479; FARRINGTON P R, 1945, Rocky Mt Med J, V42, P842; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; FODSTAD H, 1984, ACTA NEUROCHIR, V70, P21, DOI 10.1007/BF01406039; Gottlob Irene, 2002, Strabismus, V10, P271, DOI 10.1076/stra.10.4.271.13830; Grant FC, 1939, ANN SURG, V110, P488, DOI 10.1097/00000658-193910000-00002; GRANTHAM EG, 1948, J NEUROSURG, V5, P19, DOI 10.3171/jns.1948.5.1.0019; Han PY, 2008, J KOREAN NEUROSURG S, V43, P51, DOI 10.3340/jkns.2008.43.1.51; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Honeybul S, 2013, BRIT J NEUROSURG, V27, P636, DOI 10.3109/02688697.2013.817532; Isago T, 2004, ANN PLAS SURG, V53, P288, DOI 10.1097/01.sap.0000106433.89983.72; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Joseph V, 2009, J NEUROSURG, V111, P650, DOI 10.3171/2009.3.JNS0984; Kemmling A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-80; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; KONDZIOLKA D, 1988, NEUROSURGERY, V23, P143, DOI 10.1227/00006123-198808000-00002; Kumar GSS, 2004, NEUROL INDIA, V52, P504; Kuo JR, 2004, J CLIN NEUROSCI, V11, P486, DOI 10.1016/j.jocn.2003.06.005; Langfitt T.W, 1968, CLIN NEUROSURG, V16, P436; Maeshima S, 2005, EUR NEUROL, V53, P164, DOI 10.1159/000086129; Mokri B, 2010, HEADACHE, V50, P1206, DOI 10.1111/j.1526-4610.2010.01715.x; NAKAMURA T, 1980, Neurologia Medico-Chirurgica, V20, P89, DOI 10.2176/nmc.20.89; Ng D, 1997, J CLIN NEUROSCI, V4, P346, DOI 10.1016/S0967-5868(97)90103-X; RICHAUD J, 1985, NEUROCHIRURGIE, V31, P183; ROYALL DR, 1992, J AM GERIATR SOC, V40, P1221, DOI 10.1111/j.1532-5415.1992.tb03646.x; Sakamoto S, 2006, CLIN NEUROL NEUROSUR, V108, P583, DOI 10.1016/j.clineuro.2005.03.012; Sarov M, 2010, STROKE, V41, P560, DOI 10.1161/STROKEAHA.109.568543; Schiffer J, 1997, SURG NEUROL, V47, P231, DOI 10.1016/S0090-3019(96)00376-X; SEGAL DH, 1994, NEUROSURGERY, V34, P729, DOI 10.1227/00006123-199404000-00024; Stiver SI, 2008, J NEUROSURG, V109, P245, DOI 10.3171/JNS/2008/109/8/0245; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Stiver SI, 2008, ACTA NEUROCHIR SUPPL, V102, P273, DOI 10.1007/978-3-211-85578-2_51; STULA D, 1985, NEUROCHIRURGIA, V28, P164; Sugiyama K, 2004, JPN J REHABIL MED, V41, P104; SUZUKI N, 1993, ACTA NEUROCHIR, V122, P49, DOI 10.1007/BF01446986; TABADDOR K, 1976, J NEUROSURG, V44, P506, DOI 10.3171/jns.1976.44.4.0506; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; YAMAURA A, 1977, Neurologia Medico-Chirurgica, V17, P43, DOI 10.2176/nmc.17pt1.43; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99; Yoshida K, 1996, J NEUROL NEUROSUR PS, V61, P166, DOI 10.1136/jnnp.61.2.166	51	23	29	0	4	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-2021			NEUROPSYCH DIS TREAT	Neuropsychiatr. Dis. Treat.		2014	10						695	701		10.2147/NDT.S52875			7	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	AG3KE	WOS:000335314100001	24833902	gold, Green Published, Green Submitted			2022-02-06	
J	DeFazio, MV; Rammo, RA; Robles, JR; Bramlett, HM; Dietrich, WD; Bullock, MR				DeFazio, Michael V.; Rammo, Richard A.; Robles, Jaime R.; Bramlett, Helen M.; Dietrich, W. Dalton; Bullock, M. Ross			The Potential Utility of Blood-Derived Biochemical Markers as Indicators of Early Clinical Trends Following Severe Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Biomarkers; D-dimer; MMP-9; S-100B; Trauma; Traumatic brain injury	NEUROTROPHIC PROTEIN S100B; D-DIMER; HEAD-INJURY; OUTCOME PREDICTION; ISCHEMIC-STROKE; S-100B PROTEIN; SERUM S-100B; DAMAGE; BARRIER; MATRIX-METALLOPROTEINASE-9	OBJECTIVE: Severe traumatic brain injury (TBI) is a dynamic neuropathologic process in which a substantial proportion of patients die within the first 48-hours. The assessment of injury severity and prognosis are of primary concern in the initial management of severe TBI. Supplemental testing that aids in the stratification of patients at high risk for deterioration may significantly improve posttraumatic management in the acute setting. METHODS: This retrospective study assessed the utility of both single-marker and multimarker models as predictive indicators of acute clinical status after severe TBI. Forty-four patients who sustained severe TBI (admission Glasgow Coma Scale [GCS] score <= 8) were divided into two cohorts according to a dichotomized clinical outcome at 72 hours after admission: Poor status (death or GCS score <= 8) and improved status (GCS score improved to >8). Threshold values for clinical status prediction were calculated for serum S-100B, matrix metalloproteinase-9, and plasma D-dimer, upon admission and at 24 hours after TBI by the use of receiver operating characteristic analysis. Performance characteristics of these single-marker predictors were compared with those derived from a multimarker logistic regression analysis. RESULTS: Biomarkers with the greatest predictive value for poor status at 72 hours included serum S-100B on admission, as well as plasma D-dimer and serum S-100B at 24 hours, for which, associations were strongly significant. Multimarker analysis indicated no substantial improvement in prediction accuracy over the best single predictors during this time frame. CONCLUSION: In conjunction with other clinical, physical, and radiologic evidence, blood-derived biochemical markers may serve to enhance prediction of early clinical trends after severe TBI.	[DeFazio, Michael V.; Rammo, Richard A.; Bramlett, Helen M.; Dietrich, W. Dalton; Bullock, M. Ross] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Robles, Jaime R.] Virginia Commonwealth Univ, Sch Pharm, Richmond, VA USA		Bullock, MR (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA.	rbullock@med.miami.edu			Miami Project to Cure Paralysis, State of Florida; Ryder Trauma Center, Neurosurgical Intensive Care Unit at Jackson Memorial Hospital, and Biosite, Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042133] Funding Source: NIH RePORTER	This work was supported by The Miami Project to Cure Paralysis, State of Florida, Ryder Trauma Center, Neurosurgical Intensive Care Unit at Jackson Memorial Hospital, and Biosite, Inc.	Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Barber M, 2004, STROKE, V35, P1421, DOI 10.1161/01.STR.0000126890.63512.41; Brain Trauma Foundation American Association of Neurological Surgeons Congress of Neurological Surgeons AANS/CNS Joint Section on Neurotrauma and Critical Care, 2008, J NEUROTRAUM, V25, P276; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; da Rocha AB, 2006, CLIN CHEM LAB MED, V44, P1234, DOI 10.1515/CCLM.2006.218; Delgado P, 2006, NEUROLOGY, V67, P94, DOI 10.1212/01.wnl.0000223349.97278.e0; Dimopoulou I, 2003, NEUROLOGY, V60, P947, DOI 10.1212/01.WNL.0000049931.77887.7F; Dunn KL, 2002, J AM COLL CARDIOL, V40, P1475, DOI 10.1016/S0735-1097(02)02172-1; Gibler W Brian, 2003, Rev Cardiovasc Med, V4 Suppl 4, pS47; Goncalves CA, 2008, CLIN BIOCHEM, V41, P755, DOI 10.1016/j.clinbiochem.2008.04.003; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Juvela S, 2006, STROKE, V37, P1451, DOI 10.1161/01.STR.0000221710.55467.33; Kai HK, 1998, J AM COLL CARDIOL, V32, P368, DOI 10.1016/S0735-1097(98)00250-2; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Kleindienst A, 2007, PROG BRAIN RES, V161, P317, DOI 10.1016/S0079-6123(06)61022-4; Kleindienst A, 2006, J NEUROTRAUM, V23, P1185, DOI 10.1089/neu.2006.23.1185; Kuo JR, 2007, EUR J NEUROL, V14, P1073, DOI 10.1111/j.1468-1331.2007.01908.x; Kuo JR, 2004, J CLIN NEUROSCI, V11, P710, DOI 10.1016/j.jocn.2003.10.011; Laskowitz DT, 2009, STROKE, V40, P77, DOI 10.1161/STROKEAHA.108.516377; Missler U, 2002, CLIN CHIM ACTA, V321, P29, DOI 10.1016/S0009-8981(02)00061-X; Montaner J, 2008, STROKE, V39, P2280, DOI 10.1161/STROKEAHA.107.505354; Mussack T, 2002, CRIT CARE MED, V30, P2669, DOI 10.1097/00003246-200212000-00010; Nylen K, 2008, ACTA NEUROCHIR, V150, P221, DOI 10.1007/s00701-007-1489-2; Olivecrona M, 2009, J NEUROL NEUROSUR PS, V80, P1241, DOI 10.1136/jnnp.2008.158196; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Raabe A, 1999, BRIT J NEUROSURG, V13, P56, DOI 10.1080/02688699944195; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Raabe A, 2003, RESTOR NEUROL NEUROS, V21, P159; Rainey T, 2009, RESUSCITATION, V80, P341, DOI 10.1016/j.resuscitation.2008.11.021; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Shigemori Y, 2006, ACTA NEUROCHIR SUPPL, V96, P130; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Tian HL, 2010, NEUROSURG REV, V33, P359, DOI 10.1007/s10143-010-0251-z; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; Townend WJ, 2002, J NEUROL NEUROSUR PS, V73, P542, DOI 10.1136/jnnp.73.5.542; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Williams MT, 2003, CRIT CARE CLIN, V19, P185, DOI 10.1016/S0749-0704(02)00048-9; Woertgen C, 1999, J TRAUMA, V47, P1126, DOI 10.1097/00005373-199912000-00026; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807	44	23	26	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2014	81	1					151	158		10.1016/j.wneu.2013.01.015			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AC2DV	WOS:000332309200046	23313262	Green Accepted			2022-02-06	
J	Goodrich, GL; Martinsen, GL; Flyg, HM; Kirby, J; Garvert, DW; Tyler, CW				Goodrich, Gregory L.; Martinsen, Gary L.; Flyg, Heidi M.; Kirby, Jennine; Garvert, Donn W.; Tyler, Christopher W.			Visual function, traumatic brain injury, and posttraumatic stress disorder	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						binocular vision; blast-related; medication side effects; non-blast-related; oculomotor function; posttraumatic stress disorder; traumatic brain injury; vision function; vision loss; visual symptoms	CONVERGENCE INSUFFICIENCY; MILITARY; VETERANS; BLAST; AFGHANISTAN; DYSFUNCTION; DEPRESSION; IMPAIRMENT; OUTCOMES; IRAQI	Traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD) are signature injuries of the Iraq and Afghanistan conflicts. The conditions can be comorbid and have overlapping signs and symptoms, making it difficult to diagnose and treat each. TBI is associated with numerous changes in vision function, but vision problems secondary to PTSD have not been documented. To address this shortcoming, we reviewed the medical records of 100 patients with a history of TBI, noting PTSD diagnoses, visual symptoms, vision function abnormalities, and medications with visual side effects. Forty-one patients had PTSD and 59 did not. High rates of binocular vision and oculomotor function deficits were measured in patients with a history of TBI, but no significant differences between patients with or without PTSD were evident. However, compared to patients without PTSD, patients with PTSD had more self-reported visual symptoms in all four assessments and the complaint rates were significantly higher for light sensitivity and reading problems. Together, these findings may be beneficial in understanding vision problems in patients with TBI and PTSD as comorbid conditions compared with those with TBI alone.	[Goodrich, Gregory L.; Martinsen, Gary L.; Flyg, Heidi M.; Kirby, Jennine; Garvert, Donn W.] Dept Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Tyler, Christopher W.] Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA		Goodrich, GL (corresponding author), Dept Vet Affairs Palo Alto Hlth Care Syst, 795 Willow Rd,Bldg T-365, Menlo Pk, CA 94025 USA.	Gregory.Goodrich@va.gov	Goodrich, Gregory L./AAF-7184-2019		Department of Veterans Affairs Quality Enhancement Research InitiativeUS Department of Veterans Affairs [RRP 11-008]; Department of DefenseUnited States Department of Defense [W81XWH-11-2-0066]	This material was based on work supported in part by the Department of Veterans Affairs Quality Enhancement Research Initiative (grant RRP 11-008) and by a subcontract to Dr. Goodrich of Department of Defense grant W81XWH-11-2-0066 to Dr. Tyler.	[Anonymous], DSM CRITERIA FOR PTS; Bahraini N, 2012, FRONT NEUROL, V3; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bentley S., 2005, SHORT HIST PTSD THER; Borsting E, 1999, OPTOMETRY VISION SCI, V76, P221, DOI 10.1097/00006324-199904000-00025; Bower K.M., 2003, AM SOC QUAL, V2, P35, DOI DOI 10.1080/01621459.1974.10482955; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Burgess Paula, 2010, J Emerg Trauma Shock, V3, P164, DOI 10.4103/0974-2700.62120; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Dougherty AL, 2011, BRAIN INJURY, V25, P8, DOI 10.3109/02699052.2010.536195; Drugs.com, 2014, TRAZODONE; GELLIS LA, 2010, PRIM CARE COMPANION, V12; GERSONS BPR, 1992, BRIT J PSYCHIAT, V161, P742, DOI 10.1192/bjp.161.6.742; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Han M H Esther, 2008, Optometry, V79, P252, DOI 10.1016/j.optm.2008.01.001; Hofstetter, 1944, AM J OPTOM ARCH AM A, V21, P345, DOI [10.1097/00006324-194409000-00001, DOI 10.1097/00006324-194409000-00001]; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jaffee CMS, 2009, CLIN NEUROPSYCHOL, V23, P1291, DOI 10.1080/13854040903307250; Kendall-Tackett KA, 2000, CHILD ABUSE NEGLECT, V24, P799, DOI 10.1016/S0145-2134(00)00136-8; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Litz B. T., 2009, PTSD RES Q, V20, P1; Liu DJ, 2013, J MOL NEUROSCI, V49, P360, DOI 10.1007/s12031-012-9874-6; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Maples W. C., 1992, J BEHAV OPTOM, V3, P143; O'Donnell ML, 2003, CLIN PSYCHOL REV, V23, P587, DOI 10.1016/S0272-7358(03)00036-9; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; PubMed Health, DRUGS A Z; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Scheiman M, 2005, ARCH OPHTHALMOL-CHIC, V123, P14, DOI 10.1001/archopht.123.1.14; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; SUMMERALL EL, TRAUMATIC BRAIN INJU; Tanielian T., 2008, INVISIBLE WOUNDS OF; Trachtman JN, 2010, OPTOMETRY, V81, P240, DOI 10.1016/j.optm.2009.07.017; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warden DL, 1997, J NEUROPSYCH CLIN N, V9, P18; Weichel ED, 2008, OPHTHALMOLOGY, V115, P2235, DOI 10.1016/j.ophtha.2008.08.033	46	23	23	1	19	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2014	51	4					547	558		10.1682/JRRD.2013.02.0049			12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	AN8ZR	WOS:000340895400004	25144168	Bronze, Green Accepted			2022-02-06	
J	Jalali, R; Rezaei, M				Jalali, Rostam; Rezaei, Mansour			A Comparison of the Glasgow Coma Scale Score with Full Outline of Unresponsiveness Scale to Predict Patients' Traumatic Brain Injury Outcomes in Intensive Care Units	CRITICAL CARE RESEARCH AND PRACTICE			English	Article							INTERRATER RELIABILITY; VALIDATION; CONSCIOUSNESS; VALIDITY	Background. Neurological assessment is an essential element of early warning scores used to recognize critically ill patients. We compared the performance of the Glasgow Coma Scale (GCS) with Full Outline of Unresponsiveness (FOUR) scale as an alternative method in the identification of clinically relevant outcomes in traumatic brain injury. Objective. The purpose of this study was to compare the performance of GCS with FOUR scale. Methods. For this study 104 patients with brain injury were recruited from the ICU of Taleghani Hospital, a major teaching hospital in Kermanshah in the western part of Iran. Data was collected concurrently from the ICU admissions by three well-educated nurses and then checked for accuracy by the researcher. Patients were followed up until two weeks or hospital discharge to record their survival status. As a final point expected risk of mortality was calculated using the original formulas for each scale. Results. The mean age of 104 participants was 41.38 +/- 18.22 (rang 17 to 86 years) mostly (81 patients 77.9%) males. The FOUR scale has a better prediction for death than GCS. Conclusion. It appears that FOUR scale had better predictive power for mortality and may be a suitable alternative or complementary tool for GCS.	[Jalali, Rostam; Rezaei, Mansour] Kermanshah Univ Med Sci, Kermanshah 6718974589, Iran		Jalali, R (corresponding author), Kermanshah Univ Med Sci, Kermanshah 6718974589, Iran.	ks_jalali@yahoo.com	Jalali, Rostam/V-5820-2017	Jalali, Rostam/0000-0003-1781-9939; Rezaei, Mansour/0000-0002-6446-7289	Research Committee of Kermanshah University of Medical Sciences	This study was approved and funded by the Research Committee of Kermanshah University of Medical Sciences.	Akavipat P, 2011, ACTA MED OKAYAMA, V65, P205; Akavipat P, 2009, NEUROL MED-CHIR, V49, P565, DOI 10.2176/nmc.49.565; Bruno MA, 2011, NEUROCRIT CARE, V15, P447, DOI 10.1007/s12028-011-9547-2; Cohen J, 2009, J NEUROSCI NURS, V41, P261, DOI 10.1097/JNN.0b013e3181b2c766; Eken C, 2009, EUR J EMERG MED, V16, P29, DOI 10.1097/MEJ.0b013e32830346ab; Fischer M, 2010, CRIT CARE, V14, DOI 10.1186/cc8963; Fugate JE, 2010, NEUROCRIT CARE, V13, P205, DOI 10.1007/s12028-010-9407-5; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Goodacre S, 2006, EMERG MED J, V23, P372, DOI 10.1136/emj.2005.028522; Iyer VN, 2009, MAYO CLIN PROC, V84, P694, DOI 10.1016/S0025-6196(11)60519-3; Kevric J, 2011, EMERG MED J, V28, P486, DOI 10.1136/emj.2009.085845; Kim Y, 2012, NEUROL ASIA, V17, P219; Ledoux D., 2009, CRITICAL CARE, V13; McNarry AF, 2004, ANAESTHESIA, V59, P34, DOI 10.1111/j.1365-2044.2004.03526.x; Murthy TVSP, 2009, INDIAN J NEUROTRAUM, V6, P59, DOI 10.1016/S0973-0508(09)80028-2; Sadaka F, 2012, NEUROCRIT CARE, V16, P95, DOI 10.1007/s12028-011-9617-5; Sut N, 2010, ULUS TRAVMA ACIL CER, V16, P149; Wijdicks Eelco F M, 2006, Rev Neurol Dis, V3, P109; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wolf CA, 2007, MAYO CLIN PROC, V82, P435, DOI 10.4065/82.4.435; Wolf CA, 2011, MIL MED, V176, P204, DOI 10.7205/MILMED-D-10-00214	21	23	25	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-1305	2090-1313		CRIT CARE RES PRACT	Crit. Care Res. Pract.		2014	2014								289803	10.1155/2014/289803			4	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V33WQ	WOS:000215795900008	25013727	Green Published, gold			2022-02-06	
J	Mura, E; Pistoia, F; Sara, M; Sacco, S; Carolei, A; Govoni, S				Mura, Elisa; Pistoia, Francesca; Sara, Marco; Sacco, Simona; Carolei, Antonio; Govoni, Stefano			Pharmacological Modulation of the State of Awareness in Patients with Disorders of Consciousness: An Overview	CURRENT PHARMACEUTICAL DESIGN			English	Article						Consciousness; vegetative state; coma; minimally conscious state; awakenings; drugs; pharmacology	TRAUMATIC BRAIN-INJURY; PERSISTENT VEGETATIVE STATE; HISTAMINERGIC TUBEROMAMMILLARY NEURONS; VENTROLATERAL PREOPTIC NUCLEUS; CEREBRAL GLUCOSE-METABOLISM; PLACEBO-CONTROLLED TRIAL; INTRATHECAL BACLOFEN; IMPAIRED CONSCIOUSNESS; TRANSIENT IMPROVEMENT; NEUROTROPHIC FACTOR	The neurobiological approach to consciousness moves from the assumption that all phenomenal experiences are based on neuronal activity in the brain. Consciousness has two main components: wakefulness and awareness. While it may be relatively easy to determine the neuronal correlates of wakefulness, it is not the same for awareness, of which the neural correlates are poorly understood. Knowledge of the circuitry and the neurochemistry of the sleep/wake condition is necessary but not sufficient to understand the circuitry and neurochemistry of consciousness. Disorders of consciousness (DOCs) include coma, vegetative state and minimally conscious state. The study of DOCs and of the electrophysiological changes underlying general anaesthesia-induced loss of consciousness may help in understanding the neuronal correlates of consciousness. In turn, the understanding of the neural bases of consciousness may help in designing interventions aimed at restoring consciousness in DOC patients. Sporadic cases of recovery from a DOC have been reported after the administration of various pharmacological agents (baclofen, zolpidem, amantadine etc.). This review provides an overview of such drugs, which are from various and diverging classes but can be grouped into two main categories: CNS stimulants and CNS depressants. The available data seem to suggest an awakening effect obtained with CNS depressants rather than stimulants, the latter being more effective at improving functional cognitive and behavioral recovery in patients who have spontaneously regained an appreciable level of consciousness. There is a need for more rigorous systematic trials and further investigation of the above treatments, with particular attention paid to their mechanisms of action and the neurotransmitters involved.	[Mura, Elisa; Govoni, Stefano] Univ Pavia, Pharmacol Sect, Dept Drug Sci, I-27100 Pavia, Italy; [Pistoia, Francesca; Sacco, Simona; Carolei, Antonio] Univ Aquila, Neurol Inst, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy; [Pistoia, Francesca; Sara, Marco] IRCCS San Raffaele Pisana, Cassino, Italy		Govoni, S (corresponding author), Univ Pavia, Pharmacol Sect, Dept Drug Sci, Viale Taramelli 14, I-27100 Pavia, Italy.	govonis@unipv.it	Sara, Marco/AAB-3651-2019; mura, elisa/ABD-9249-2020; Pistoia, Francesca/AAC-1027-2019; Sacco, Simona/I-5253-2012	Sacco, Simona/0000-0003-0651-1939; PISTOIA, Francesca/0000-0003-0790-4240			[Anonymous], 2003, Clin Med (Lond), V3, P249; Aquilani R, 2008, ARCH PHYS MED REHAB, V89, P1642, DOI 10.1016/j.apmr.2008.02.023; ASTONJONES G, 1981, J NEUROSCI, V1, P876; Babiloni C, 2010, CLIN NEUROPHYSIOL, V121, P1816, DOI 10.1016/j.clinph.2010.04.027; Barreca S, 2003, BRAIN INJURY, V17, P1065, DOI 10.1080/0269905031000110535; Besser M, 1999, J IMMUNOL, V162, P6303; BOGEN JE, 1995, CONSCIOUS COGN, V4, P52, DOI 10.1006/ccog.1995.1003; Boly M, 2012, J NEUROSCI, V32, P7082, DOI 10.1523/JNEUROSCI.3769-11.2012; Boly M, 2011, SCIENCE, V332, P858, DOI 10.1126/science.1202043; Boutrel B, 2004, SLEEP, V27, P1181, DOI 10.1093/sleep/27.6.1181; Calabresi P, 2003, NEUROBIOL DIS, V12, P82, DOI 10.1016/S0969-9961(02)00016-5; Canedo A, 2002, BRAIN INJURY, V16, P453, DOI 10.1080/02699050110119853; Clauss R, 2006, NEUROREHABILITATION, V21, P23; Clauss R, 2004, NEW ENGL J MED, V351, P511, DOI 10.1056/NEJM200407293510522; Clauss RP, 2010, MED HYPOTHESES, V75, P287, DOI 10.1016/j.mehy.2010.03.005; Clauss RP, 2000, S AFR MED J, V90, P68; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cohen L, 2004, NEW ENGL J MED, V350, P949, DOI 10.1056/NEJM200402263500922; Coulter DA, 1997, J CHILD NEUROL, V12, pS2, DOI 10.1177/0883073897012001031; Crosby NJ, 2003, COCHRANE DB SYST REV, pCD003467, DOI DOI 10.1002/14651858; D'Aleo G, 1994, Funct Neurol, V9, P189; Dario A, 2007, ACTA NEUROCHIR SUPPL, V97, P461; Du B, 2013, AM J MED SCI; Fellerhoff Barbara, 2012, J Med Case Rep, V6, P6, DOI 10.1186/1752-1947-6-6; Formisano R, 2001, Ann Ist Super Sanita, V37, P627; Formisano R, 2011, BRAIN INJURY, V25, P638, DOI 10.3109/02699052.2011.572948; Fridman EA, 2010, BRAIN INJURY, V24, P636, DOI 10.3109/02699051003610433; Fridman EA, 2009, BRAIN INJURY, V23, P172, DOI 10.1080/02699050802649662; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; HAIG AJ, 1990, ARCH PHYS MED REHAB, V71, P1081; Hall SD, 2010, CLIN NEUROPHYSIOL, V121, P549, DOI 10.1016/j.clinph.2009.11.084; HALLANGER AE, 1987, J COMP NEUROL, V262, P105, DOI 10.1002/cne.902620109; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; HASSELMO ME, 1993, TRENDS NEUROSCI, V16, P218, DOI 10.1016/0166-2236(93)90159-J; Hattori N, 2003, J NUCL MED, V44, P1709; HILL DR, 1981, NATURE, V290, P149, DOI 10.1038/290149a0; Hoarau X, 2012, BRAIN INJURY, V26, P1451, DOI 10.3109/02699052.2012.694564; HORIGUCHI J, 1990, CLIN NEUROPHARMACOL, V13, P84, DOI 10.1097/00002826-199002000-00009; Huang ZL, 2011, CURR TOP MED CHEM, V11, P1047, DOI 10.2174/156802611795347654; Huang ZL, 2001, P NATL ACAD SCI USA, V98, P9965, DOI 10.1073/pnas.181330998; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Huynh F, 2009, THER DRUG MONIT, V31, P153, DOI 10.1097/FTD.0b013e318196fb9f; Imas OA, 2006, NEUROSCI LETT, V402, P216, DOI 10.1016/j.neulet.2006.04.003; Isono M, 2002, BRAIN INJURY, V16, P705, DOI 10.1080/02699050210127303; JACKSON RD, 1985, ARCH PHYS MED REHAB, V66, P180; Jones EG, 2002, PROG BRAIN RES, V136, P333; Ketter TA, 2003, J CLIN PSYCHOPHARM, V23, P484, DOI 10.1097/01.jcp.0000088915.02635.e8; Kim YW, 2009, CLIN NEUROPHARMACOL, V32, P335, DOI 10.1097/WNF.0b013e3181b40678; Kraus MF, 2005, BRAIN INJURY, V19, P471, DOI 10.1080/02699050400025059; Krause T, 2004, ANAESTHESIA, V59, P364, DOI 10.1111/j.1365-2044.2004.03658.x; Krimchansky BZ, 2004, BRAIN INJURY, V18, P1099, DOI 10.1080/02699050310001646206; Kroeger D, 2007, J NEUROSCI, V27, P10597, DOI 10.1523/JNEUROSCI.3440-07.2007; Lancioni GE, 2010, RES DEV DISABIL, V31, P1121, DOI 10.1016/j.ridd.2010.06.019; Lanni C, 2009, CELL MOL LIFE SCI, V66, P2985, DOI 10.1007/s00018-009-0055-x; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; Liepert J, 2008, CURR OPIN NEUROL, V21, P639, DOI 10.1097/WCO.0b013e32831897a3; Lo YL, 2008, ANN NEUROL, V64, P477, DOI 10.1002/ana.21183; Lombardi F, 2007, FUNCT NEUROL, V22, P47; Lu J, 2000, J NEUROSCI, V20, P3830, DOI 10.1523/JNEUROSCI.20-10-03830.2000; Ma Q, 2011, PHARMACOL REV, V63, P437, DOI 10.1124/pr.110.003533; Machado C, 2007, CLIN EEG NEUROSCI, V38, P124, DOI 10.1177/155005940703800306; Machado C, 2011, CAN J NEUROL SCI, V38, P341, DOI 10.1017/S0317167100011562; Magee WL, 2005, NEUROPSYCHOL REHABIL, V15, P522, DOI 10.1080/09602010443000461; Markram K, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00224; Mathiesen C, 2011, J NEUROSCI, V31, P18327, DOI 10.1523/JNEUROSCI.4526-11.2011; Matsuda W, 2005, NEUROPSYCHOL REHABIL, V15, P414, DOI 10.1080/09602010443000588; Matsuda W, 2003, J NEUROL NEUROSUR PS, V74, P1571, DOI 10.1136/jnnp.74.11.1571; MCGINTY DJ, 1976, BRAIN RES, V101, P569, DOI 10.1016/0006-8993(76)90480-7; McMahon MA, 2009, AM J PHYS MED REHAB, V88, P525, DOI 10.1097/PHM.0b013e3181a5ade3; Meythaler JM, 2001, BRAIN INJURY, V15, P321, DOI 10.1080/026990501750111274; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Moein H, 2006, CLIN NEUROL NEUROSUR, V108, P539, DOI 10.1016/j.clineuro.2005.09.003; Monti JM, 2007, SLEEP MED REV, V11, P113, DOI 10.1016/j.smrv.2006.08.003; Monti JM, 2011, SLEEP MED REV, V15, P269, DOI 10.1016/j.smrv.2010.11.003; Murphy M, 2011, SLEEP, V34, P283, DOI 10.1093/sleep/34.3.283; MYSIW WJ, 1988, AM J PHYS MED REHAB, V67, P29, DOI 10.1097/00002060-198802000-00006; NICKELS JL, 1994, BRAIN INJURY, V8, P709, DOI 10.3109/02699059409151025; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Okun MS, 2012, NEW ENGL J MED, V367, P1529, DOI [10.1056/NEJMct1208070, 10.1056/NEJMc1214078]; Owen AM, 2008, NAT REV NEUROSCI, V9, P235, DOI 10.1038/nrn2330; Pape TLB, 2009, BRAIN STIMUL, V2, P22, DOI 10.1016/j.brs.2008.09.004; Passler MA, 2001, ARCH PHYS MED REHAB, V82, P311, DOI 10.1053/apmr.2001.20831; Patrick PD, 2003, BRAIN INJURY, V17, P497, DOI 10.1080/0269905031000070279; Petit D, 2004, J PSYCHOSOM RES, V56, P487, DOI 10.1016/j.jpsychores.2004.02.001; Peyron C, 1998, J NEUROSCI, V18, P9996; Pistoia F, 2013, ARCH PHYS MED REHABI; Pistoia F, 2012, J NEUROTRAUM, V29, P2328, DOI 10.1089/neu.2009.1257; Pistoia F, 2010, CNS DRUGS, V24, P625, DOI 10.2165/11535940-000000000-00000; Plum F., 1983, DIAGNOSIS STUPOR COM; Prajapati KD, 2011, REV NEUROSCIENCE, V22, P355, DOI 10.1515/RNS.2011.028; Reinhard DL, 1996, ARCH PHYS MED REHAB, V77, P80, DOI 10.1016/S0003-9993(96)90225-7; Rogoz Z, 2008, PHARMACOL REP, V60, P817; Sacco S, 2011, BRAIN INJURY, V25, P488, DOI 10.3109/02699052.2011.558043; Saint-Mleux B, 2004, J NEUROSCI, V24, P63, DOI 10.1523/JNEUROSCI.0232-03.2004; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; SALVA P, 1995, CLIN PHARMACOKINET, V29, P142, DOI 10.2165/00003088-199529030-00002; Sanger DJ, 2004, CNS DRUGS, V18, P9, DOI 10.2165/00023210-200418001-00004; Sanna E, 2002, EUR J PHARMACOL, V451, P103, DOI 10.1016/S0014-2999(02)02191-X; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Sara M, 2008, BRAIN INJURY, V22, P33, DOI 10.1080/02699050701810670; Sara M, 2007, BRAIN INJURY, V21, P101, DOI 10.1080/02699050601151761; Sara M, 2012, LANCET, V379, P1702, DOI 10.1016/S0140-6736(12)60716-8; Sara M, 2011, NEUROREHAB NEURAL RE, V25, P35, DOI 10.1177/1545968310378508; Sara M, 2010, NONLIN DYNAM PSYCHOL, V14, P1; Sara M, 2010, J NEUROTRAUM, V27, P771, DOI [10.1089/neu.2008.0804, 10.1089/neu.2008-0804]; Sara M, 2009, ARCH PHYS MED REHAB, V90, P1245, DOI 10.1016/j.apmr.2009.01.012; SATOH K, 1986, J COMP NEUROL, V253, P277, DOI 10.1002/cne.902530302; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schnakers C, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.124099; Schwartz JRL, 2008, CURR NEUROPHARMACOL, V6, P367, DOI 10.2174/157015908787386050; Seibert PS, 2000, BRAIN INJURY, V14, P295; Shames JL, 2008, ARCH PHYS MED REHAB, V89, P386, DOI 10.1016/j.apmr.2007.08.137; Sherin JE, 1998, J NEUROSCI, V18, P4705; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; Shirota Y, 2013, NEUROLOGY, V80, P1400, DOI 10.1212/WNL.0b013e31828c2f66; Showalter PEC, 2000, BRAIN INJURY, V14, P997; Singh R, 2008, BRAIN INJURY, V22, P103, DOI 10.1080/02699050701829704; Snyman N, 2010, NEUROPEDIATRICS, V41, P223, DOI 10.1055/s-0030-1269893; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Stover JF, 1999, CRIT CARE MED, V27, P1351, DOI 10.1097/00003246-199907000-00028; Taira T, 2007, ACTA NEUROCHIR SUPPL, V97, P227; Takahashi K, 2006, J NEUROSCI, V26, P10292, DOI 10.1523/JNEUROSCI.2341-06.2006; Thakkar MM, 2011, SLEEP MED REV, V15, P65, DOI 10.1016/j.smrv.2010.06.004; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Tononi G, 2001, NEUROPSYCHOPHARMACOL, V25, pS28, DOI 10.1016/S0893-133X(01)00322-0; Treiman DM, 2001, EPILEPSIA, V42, P8, DOI 10.1046/j.1528-1157.2001.042suppl.3008.x; Ugoya SO, 2010, CLIN NEUROPHARMACOL, V33, P279, DOI 10.1097/WNF.0b013e3182011070; Vega JA, 2003, J ANAT, V203, P1, DOI 10.1046/j.1469-7580.2003.00203.x; Verweij BH, 2007, PROG BRAIN RES, V161, P111, DOI 10.1016/S0079-6123(06)61008-X; vom Berg J, 2012, NAT MED, V18, P1812, DOI 10.1038/nm.2965; WADA H, 1991, TRENDS NEUROSCI, V14, P415, DOI 10.1016/0166-2236(91)90034-R; WALKERBATSON D, 1995, STROKE, V26, P2254, DOI 10.1161/01.STR.26.12.2254; Watson CJ, 2010, SLEEP MED CLIN, V5, DOI 10.1016/j.jsmc.2010.08.003; Wheaton P, 2009, J CLIN PSYCHOPHARM, V29, P468, DOI 10.1097/JCP.0b013e3181b66f04; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; Whyte J, 2007, AM J PHYS MED REHAB, V86, P86, DOI 10.1097/PHM.0b013e31802f0434; Whyte J, 2009, AM J PHYS MED REHAB, V88, P410, DOI 10.1097/PHM.0b013e3181a0e3a0; Wilhelm MJ, 2000, J HEART LUNG TRANSPL, V19, P414, DOI 10.1016/S1053-2498(00)00073-5; Worzniak M, 1997, J FAM PRACTICE, V44, P495; Wroblewski Bruno, 1993, Brain Injury, V7, P353, DOI 10.3109/02699059309034962; Wu HM, 2004, NEUROSURGERY, V55, P1306, DOI 10.1227/01.NEU.0000143028.08719.42; Wu HM, 2004, J NEUROTRAUM, V21, P149, DOI 10.1089/089771504322778613; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yamaguchi M, 2005, STROKE, V36, P2212, DOI 10.1161/01.STR.0000182238.08510.c5; Yamamoto T, 2012, WORLD NEUROSURG; Yoshida K, 2006, J COMP NEUROL, V494, P845, DOI 10.1002/cne.20859; Zafonte RD, 1998, BRAIN INJURY, V12, P617; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256	152	23	24	0	11	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1381-6128	1873-4286		CURR PHARM DESIGN	Curr. Pharm. Design		2014	20	26					4121	4139					19	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pharmacology & Pharmacy	AK6AA	WOS:000338508000002	24025054				2022-02-06	
J	Yokobori, S; Mazzeo, AT; Gajavelli, S; Bullock, MR				Yokobori, Shoji; Mazzeo, Anna T.; Gajavelli, Shyam; Bullock, Malcolm R.			Mitochondrial Neuroprotection in Traumatic Brain Injury: Rationale and Therapeutic Strategies	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Apoptosis; astrocyte-neuron lactate shuttle; cyclosporine A; mitochondrial dysfunction; mitochondrial permeability transition pore; secondary brain injury; traumatic brain injury	EXCITATORY AMINO-ACIDS; TRANSIENT FOREBRAIN ISCHEMIA; CYCLOSPORINE-A TREATMENT; INDUCED AXONAL DAMAGE; PERMEABILITY TRANSITION; CELL-DEATH; CEREBRAL-ISCHEMIA; CYTOCHROME-C; IMPAIRED MITOCHONDRIAL; MAGNETIC-RESONANCE	Traumatic brain injury (TBI) is still the worldwide, leading cause of mortality and morbidity in young adults. The prognosis of TBI patients is strongly affected by secondary brain damage including mitochondrial dysfunctions. In many basic and clinical studies, mitochondrial dysfunctions, including the opening of mitochondrial permeability transition (mPT) pore, and treatments including cyclosporine A (CsA) have been studied. These evidences suggest an important role for mitochondria as therapeutic targets for neuroprotection after TBI. This review summarizes the data about normal and pathological mitochondrial function after TBI, TBI pathobiology relating to mitochondrial dysfunction and therapeutic strategies including drug treatment. This review also mentioned about glucose, lactate, and pyruvate metabolisms in TBI, including the "astrocyte-neuron lactate shuttle (ANLS)" hypothesis. Mitochondrial pathophysiology in TBI is still unclear. Thus, the pharmacological treatment in TBI patient is still challenging. This review could help further understanding of this topic. Hopefully, this could help further development and innovation for drug therapies in TBI.	[Yokobori, Shoji; Gajavelli, Shyam; Bullock, Malcolm R.] Univ Miami, Miller Sch Med, Dept Neurosurg, Miami, FL 33136 USA; [Yokobori, Shoji] Nippon Med Sch, Dept Emergency & Crit Care Med, Tokyo 113, Japan; [Mazzeo, Anna T.] Univ Messina, Dept Neurosci Anesthesiol & Psychiat Sci, I-98100 Messina, Italy		Bullock, MR (corresponding author), Univ Miami, Miller Sch Med, Dept Neurosurg, Lois Pope LIFE Ctr, Room 3-20,1095 NW 14th Terrace, Miami, FL 33136 USA.	RBullock@med.miami.edu	Gajavelli, Shyam/AAI-1374-2019	Gajavelli, Shyam/0000-0002-5947-6973; Mazzeo, Anna Teresa/0000-0002-8454-7243			Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; ANDERSEN BJ, 1992, BRAIN RES, V585, P190, DOI 10.1016/0006-8993(92)91206-T; ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Aubert A, 2005, P NATL ACAD SCI USA, V102, P16448, DOI 10.1073/pnas.0505427102; Bergersen LH, 2007, NEUROSCIENCE, V145, P11, DOI 10.1016/j.neuroscience.2006.11.062; Binder S, 2005, J HEAD TRAUMA REHAB, V20, P189, DOI 10.1097/00001199-200505000-00002; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; Chen T, 2000, J NEUROTRAUM, V17, P135, DOI 10.1089/neu.2000.17.135; Clausen T, 2001, BRAIN RES, V908, P35, DOI 10.1016/S0006-8993(01)02566-5; Clausen T, 2001, CURR PHARM DESIGN, V7, P1517, DOI 10.2174/1381612013397267; Colley BS, 2010, EXP NEUROL, V224, P241, DOI 10.1016/j.expneurol.2010.03.026; Correia SC, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00138; Correia SC, 2010, J ALZHEIMERS DIS, V20, pS475, DOI 10.3233/JAD-2010-100669; Costa T, 2010, J NEUROSCI RES, V88, P1329, DOI 10.1002/jnr.22300; Dash PK, 2009, NEUROSCI LETT, V460, P103, DOI 10.1016/j.neulet.2009.04.028; Davis DP, 2003, CURR OPIN ANESTHESIO, V16, P447, DOI 10.1097/00001503-200310000-00002; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Ferrand-Drake M, 2003, J NEUROCHEM, V85, P1431, DOI 10.1046/j.1471-4159.2003.01794.x; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Friberg H, 1998, J NEUROSCI, V18, P5151, DOI 10.1523/JNEUROSCI.18-14-05151.1998; Friess SH, 2011, NEUROSURGERY, V69, P1139, DOI 10.1227/NEU.0b013e3182284aa1; Fu ES, 2005, CURR OPIN ANESTHESIO, V18, P181, DOI 10.1097/01.aco.0000162838.56344.88; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Genc S, 2004, RESTOR NEUROL NEUROS, V22, P105; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Goodman JC, 1996, J NEUROTRAUM, V13, P549, DOI 10.1089/neu.1996.13.549; Greco T, 2011, FREE RADICAL BIO MED, V51, P2164, DOI 10.1016/j.freeradbiomed.2011.09.017; Greco T, 2010, J ALZHEIMERS DIS, V20, pS427, DOI 10.3233/JAD-2010-100519; Green D, 1998, TRENDS CELL BIOL, V8, P267, DOI 10.1016/S0962-8924(98)01273-2; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Hansson MJ, 2011, J NEUROTRAUM, V28, P143, DOI 10.1089/neu.2010.1613; Hansson MJ, 2004, J NEUROCHEM, V89, P715, DOI 10.1111/j.1471-4159.2004.02400.x; Hatton J, 2008, J NEUROSURG, V109, P699, DOI 10.3171/JNS/2008/109/10/0699; Holloway R, 2007, ACTA NEUROCHIR, V149, P919, DOI 10.1007/s00701-007-1241-y; Hu SL, 2010, NEUROL RES, V32, P173, DOI 10.1179/174313209X414524; INAO S, 1988, J NEUROSURG, V69, P736, DOI 10.3171/jns.1988.69.5.0736; JANOFF A, 1964, Int Anesthesiol Clin, V2, P251, DOI 10.1097/00004311-196402000-00008; Jung JE, 2009, J NEUROSCI, V29, P7003, DOI 10.1523/JNEUROSCI.1110-09.2009; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Kottenberg E, 2012, ACTA ANAESTH SCAND, V56, P30, DOI 10.1111/j.1399-6576.2011.02585.x; Kristal BS, 2004, J BIOENERG BIOMEMBR, V36, P309, DOI 10.1023/B:JOBB.0000041759.35731.70; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; Lee JS, 2004, J NEUROTRAUM, V21, P549, DOI 10.1089/089771504774129883; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Levasseur JE, 2006, NEUROSURGERY, V59, P1122, DOI 10.1227/01.NEU.0000245581.00908.AF; Li PA, 2000, EXP NEUROL, V165, P153, DOI 10.1006/exnr.2000.7459; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Loaiza A, 2003, J NEUROSCI, V23, P7337; Longhi L, 2011, J CEREBR BLOOD F MET, V31, P1919, DOI 10.1038/jcbfm.2011.42; Lulic D, 2011, NEUROSURGERY, V68, P1172, DOI 10.1227/NEU.0b013e31820c6cdc; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Maas AI, 2007, LANCET NEUROL, V6, P20, DOI 10.1016/S1474-4422(06)70668-8; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; Matsumoto S, 1999, J CEREBR BLOOD F MET, V19, P736, DOI 10.1097/00004647-199907000-00002; Mattiasson G, 2003, J NEUROCHEM, V87, P532, DOI 10.1046/j.1471-4159.2003.02026.x; Mazzeo AT, 2008, ACTA NEUROCHIR, V150, P1019, DOI 10.1007/s00701-008-0021-7; Mazzeo AT, 2006, J NEUROTRAUM, V23, P962, DOI 10.1089/neu.2006.23.962; Mazzeo AT, 2009, J NEUROTRAUM, V26, P2195, DOI 10.1089/neu.2009.1012; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; Mirzayan MJ, 2008, NEUROL RES, V30, P476, DOI 10.1179/174313208X276916; Moore EM, 2011, ANAESTH INTENS CARE, V39, P356, DOI 10.1177/0310057X1103900306; Nakai A, 2004, PEDIATR NEUROL, V30, P247, DOI 10.1016/j.pediatrneurol.2003.09.006; Nelson DW, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-21; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Panickar KS, 2002, NEUROCHEM RES, V27, P161, DOI 10.1023/A:1014875210852; Papadopoulos V, 2006, NEUROSCIENCE, V138, P749, DOI 10.1016/j.neuroscience.2005.05.063; Papadopoulos V, 2009, EXP NEUROL, V219, P53, DOI 10.1016/j.expneurol.2009.04.016; Parker MA, 2002, J NEUROSCI RES, V69, P39, DOI 10.1002/jnr.10235; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pellerin L, 1997, GLIA, V21, P74, DOI 10.1002/(SICI)1098-1136(199709)21:1<74::AID-GLIA8>3.0.CO;2-1; Pellerin L, 2012, J CEREBR BLOOD F MET, V32, P1152, DOI 10.1038/jcbfm.2011.149; Perez-Pinzon MA, 2004, J BIOENERG BIOMEMBR, V36, P323, DOI 10.1023/B:JOBB.0000041762.47544.ff; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; Porras OH, 2004, J NEUROSCI, V24, P9669, DOI 10.1523/JNEUROSCI.1882-04.2004; Povlishock JT, 1996, ACT NEUR S, V66, P81; Ravati A, 2000, BRAIN RES, V866, P23, DOI 10.1016/S0006-8993(00)02210-1; REHNCRONA S, 1981, J CEREBR BLOOD F MET, V1, P297, DOI 10.1038/jcbfm.1981.34; Rice AC, 2002, BRAIN RES, V928, P156, DOI 10.1016/S0006-8993(01)03299-1; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Saugstad JA, 2010, J CEREBR BLOOD F MET, V30, P1564, DOI 10.1038/jcbfm.2010.101; Scafidi S, 2010, DEV NEUROSCI-BASEL, V32, P480, DOI 10.1159/000323178; Schurr A, 1997, BRAIN RES, V774, P221, DOI 10.1016/S0006-8993(97)81708-8; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; SHIGA Y, 1992, BRAIN RES, V595, P145, DOI 10.1016/0006-8993(92)91465-Q; SIEGEL JH, 1990, ARCH SURG-CHICAGO, V125, P498; SIESJO BK, 1981, J CEREBR BLOOD F MET, V1, P155, DOI 10.1038/jcbfm.1981.18; Signoretti S, 2004, J NEUROTRAUM, V21, P1154, DOI 10.1089/neu.2004.21.1154; Signoretti S, 2008, J NEUROSURG, V108, P42, DOI 10.3171/JNS/2008/108/01/0042; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Soane L, 2007, J NEUROSCI RES, V85, P3407, DOI 10.1002/jnr.21498; Soustiel JF, 2007, NEUROL RES, V29, P654, DOI 10.1179/016164107X240017; Starkov AA, 2004, CELL CALCIUM, V36, P257, DOI 10.1016/j.ceca.2004.02.012; Stavrovskaya IG, 2005, FREE RADICAL BIO MED, V38, P687, DOI 10.1016/j.freeradbiomed.2004.11.032; Stoica B, 2009, NEUROTHERAPEUTICS, V6, P14, DOI 10.1016/j.nurt.2008.10.029; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; SZABO I, 1991, J BIOL CHEM, V266, P3376; Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7; Turkyilmaz C, 2002, BRAIN RES, V955, P133, DOI 10.1016/S0006-8993(02)03395-4; Uchino H, 1995, ACTA PHYSIOL SCAND, V155, P469, DOI 10.1111/j.1748-1716.1995.tb09999.x; Uchino H, 1998, BRAIN RES, V812, P216, DOI 10.1016/S0006-8993(98)00902-0; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; Veenman L, 2007, CURR PHARM DESIGN, V13, P2385; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Vink R, 2002, EXPERT OPIN INV DRUG, V11, P1375, DOI 10.1517/13543784.11.10.1375; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Waldmeier PC, 2003, CURR MED CHEM, V10, P1485, DOI 10.2174/0929867033457160; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xiong Y, 2009, NEUROL RES, V31, P496, DOI 10.1179/174313208X353703; Yokobori S, 2011, J TRAUMA, V71, P1235, DOI 10.1097/TA.0b013e3182140dd7; YUAN XQ, 1993, J NEUROTRAUM, V10, P307, DOI 10.1089/neu.1993.10.307; Zauner A, 1997, NEUROL RES, V19, P265, DOI 10.1080/01616412.1997.11740812; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011; Zhang John H, 2005, Pathophysiology, V12, P63, DOI 10.1016/j.pathophys.2005.01.003; Zhao JB, 2011, CYTOKINE, V56, P343, DOI 10.1016/j.cyto.2011.07.018; Zhao QJ, 2011, J CRIT CARE, V26, P311, DOI 10.1016/j.jcrc.2010.08.014; Zhao XR, 2007, STROKE, V38, P3280, DOI 10.1161/STROKEAHA.107.486506; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	136	23	25	1	11	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets		2014	13	4					606	619		10.2174/187152731304140702112805			14	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	AN8EO	WOS:000340836200008	24168363				2022-02-06	
J	Zhang, W; Qian, CY; Li, SQ				Zhang, Wei; Qian, Chuan yun; Li, Shu qing			Protective Effect of SGK1 in Rat Hippocampal Neurons Subjected to Ischemia Reperfusion	CELLULAR PHYSIOLOGY AND BIOCHEMISTRY			English	Article						Neurons; Hippocampus; Ischemia reperfusion; SGK1; Apoptosis; Necrosis	CEREBRAL ISCHEMIA/REPERFUSION INJURY; TRAUMATIC BRAIN-INJURY; NERVE GROWTH-FACTOR; KINASE GENE FAMILY; PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; POSTCONDITIONING PROTECTS; TRANSCRIPTION FACTOR; SIGNALING PATHWAY; CELL-DEATH	Background/Aims: To investigate the protective effect of SGK1 (serum- and glucocorticoidinducible protein kinase 1) in rat hippocampal neurons in vitro and in vivo following ischemia reperfusion (I/R). Methods: Isolated rat hippocampal neurons were subjected to 2 h of oxygen and glucose deprivation (OGD) then returned to normoxic conditions for 10, 30 or 60 min. Cell apoptosis and protein expression of SGK1 were analyzed. To examine SGK1 function, we overexpressed SGK1 in rat hippocampal neurons. Finally we examined the involvement of PI3K/Akt/GSK3 beta signaling by treating the cells (untransfected or transfected with expression vector encoding SGK1) with the PI3K inhibitor LY294002. Findings were confirmed in vivo in a rat model of middle cerebral artery occlusion. Resuits:I/R caused a time-dependent increase in apoptosis, both in vitro and in vivo. SGK1 protein levels decreased significantly under the same conditions. Overexpression of SGK1 reduced apoptosis following OGD or I/R compared to cells transfected with empty vector and subjected to the same treatment, or sham-operated animals. Addition of LY294002 revealed that the action of SGK1 in suppressing apoptosis was mediated by the PI3K/Akt/GSK3 beta pathway. Conclusion: SGK1 plays a protective role in ischemia reperfusion in rat hippocampal neurons, exerting its effects via the PI3K/Akt/GSK313 pathway. Copyright (C) 2014 S Karger AG, Basel	[Zhang, Wei; Qian, Chuan yun] Kunming Med Univ, Affiliated Hosp 1, Dept Emergency Med, Kunming 650500, Yunnan, Peoples R China; [Li, Shu qing] Kunming Med Univ, Teaching & Res Sect Pathophysiol, Kunming 650500, Yunnan, Peoples R China		Li, SQ (corresponding author), Kunming Med Univ, Teaching & Res Sect Pathophysiol, 1168 West Chunrong Rd,Yuhua Ave, Kunming 650500, Yunnan, Peoples R China.	shuqinq28@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30971171]; National Key Technology RD ProgramNational Key Technology R&D Program [2014BAIO11300]; Education Department of Yunnan province [2013Y281]; Dr. Innovation of Kunming Medical University [2012D12]	This study was supported by grants from the National Natural Science Foundation of China (NO. 30971171), National Key Technology R&D Program (2014BAIO11300), the Education Department of Yunnan province (NO. 2013Y281), and the Dr. Innovation of Kunming Medical University (NO. 2012D12).	Andres-Mateos E, 2013, EMBO MOL MED, V5, P80, DOI 10.1002/emmm.201201443; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Chen J, 1998, J NEUROSCI, V18, P4914; Cheng J, 2007, J CEREBR BLOOD F MET, V27, P1553, DOI 10.1038/sj.jcbfm.9600457; Cheng JA, 2011, J CEREBR BLOOD F MET, V31, P339, DOI 10.1038/jcbfm.2010.98; Choi DW, 1996, CURR OPIN NEUROBIOL, V6, P667, DOI 10.1016/S0959-4388(96)80101-2; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Eves EM, 1998, MOL CELL BIOL, V18, P2143, DOI 10.1128/MCB.18.4.2143; Firestone GL, 2003, CELL PHYSIOL BIOCHEM, V13, P1, DOI 10.1159/000070244; Hokari M, 2010, NEUROPATHOLOGY, V30, P401, DOI 10.1111/j.1440-1789.2009.01086.x; Hu Q, 2011, BRAIN RES, V1367, P347, DOI 10.1016/j.brainres.2010.10.002; Hu SX, 2009, NEUROBIOL DIS, V33, P193, DOI 10.1016/j.nbd.2008.10.007; IMAIZUMI K, 1994, MOL BRAIN RES, V26, P189, DOI 10.1016/0169-328X(94)90090-6; Itoh T, 2010, NEUROCHEM RES, V35, P348, DOI 10.1007/s11064-009-0061-2; Jacobs Keith M, 2012, Int J Cell Biol, V2012, P930710, DOI 10.1155/2012/930710; Johnston SC, 2003, NEUROLOGY, V60, P1429, DOI 10.1212/01.WNL.0000063309.41867.0F; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Kotliarova S, 2008, CANCER RES, V68, P6643, DOI 10.1158/0008-5472.CAN-08-0850; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macas J, 2006, J NEUROSCI, V26, P13114, DOI 10.1523/JNEUROSCI.4667-06.2006; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Nishida Y, 2004, MOL BRAIN RES, V123, P121, DOI 10.1016/j.molbrainres.2004.01.008; NITATORI T, 1995, J NEUROSCI, V15, P1001; Peng B, 2012, BRAIN RES, V1445, P92, DOI 10.1016/j.brainres.2012.01.033; PETITO CK, 1987, NEUROLOGY, V37, P1281, DOI 10.1212/WNL.37.8.1281; Pignataro G, 2008, J CEREBR BLOOD F MET, V28, P232, DOI 10.1038/sj.jcbfm.9600559; Salma J, 2012, J NEUROSCI, V32, P2790, DOI 10.1523/JNEUROSCI.3609-11.2012; Sheng H, 2012, MOL CELL ENDOCRINOL, V362, P157, DOI 10.1016/j.mce.2012.06.003; Sonni S, 2013, CLEV CLIN J MED, V80, P566, DOI 10.3949/ccjm.80a.12141; Sun BZ, 2011, BIOCHEM BIOPH RES CO, V409, P808, DOI 10.1016/j.bbrc.2011.05.095; Uchida M, 2009, J CEREBR BLOOD F MET, V29, P1454, DOI 10.1038/jcbfm.2009.60; Waldegger S, 1997, P NATL ACAD SCI USA, V94, P4440, DOI 10.1073/pnas.94.9.4440; Watcharasit P, 2002, P NATL ACAD SCI USA, V99, P7951, DOI 10.1073/pnas.122062299; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; Wu XM, 2013, INT J CLIN EXP PATHO, V6, P1282; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Yuan YJ, 2011, BRAIN RES, V1367, P85, DOI 10.1016/j.brainres.2010.10.017	40	23	27	2	8	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-8987	1421-9778		CELL PHYSIOL BIOCHEM	Cell. Physiol. Biochem.		2014	34	2					299	312		10.1159/000363000			14	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	AR7MT	WOS:000343764600007	25034177	gold			2022-02-06	
J	Kramer, AH; Zygun, DA; Doig, CJ; Zuege, DJ				Kramer, Andreas H.; Zygun, David A.; Doig, Christopher J.; Zuege, Danny J.			Incidence of neurologic death among patients with brain injury: a cohort study in a Canadian health region	CANADIAN MEDICAL ASSOCIATION JOURNAL			English	Article							HOSPITAL CARDIAC-ARREST; POTENTIAL ORGAN DONORS; NEUROCRITICAL CARE; HEAD-INJURIES; UNITED-STATES; CASE-FATALITY; MORTALITY; DONATION; STROKE; DIAGNOSIS	Background: Hospital mortality has decreased over time for critically ill patients with various forms of brain injury. We hypothesized that the proportion of patients who progress to neurologic death may have also decreased. Methods: We performed a prospective cohort study involving consecutive adult patients with traumatic brain injury, subarachnoid hemorrhage, intracerebral hemorrhage or anoxic brain injury admitted to regional intensive care units in southern Alberta over a 10.5-year period. We used multivariable logistic regression to adjust for patient age and score on the Glasgow Coma Scale at admission, and to assess whether the proportion of patients who progress to neurologic death has changed over time. Results: The cohort consisted of 2788 patients. The proportion of patients who progressed to neurologic death was 8.1% at the start of the study period, and the adjusted odds of progressing to neurologic death decreased over the study period (odds ratio [OR] per yr 0.92, 95% confidence interval [CI] 0.87-0.98, p = 0.006). This change was most pronounced among patients with traumatic brain injury (OR per yr 0.87, 95% CI 0.78-0.96, p = 0.005); there was no change among patients with anoxic injury (OR per yr 0.96, 95% CI 0.85-1.09, p = 0.6). A review of the medical records suggests that missed cases of neurologic death were rare ( 0.5% of deaths). Interpretation: The proportion of patients with brain injury who progress to neurologic death has decreased over time, especially among those with head trauma. This finding may reflect positive developments in the prevention and care of brain injury. However, organ donation after neurologic death represents the major source of organs for transplantation. Thus, these findings may help explain the relatively stagnant rates of deceased organ donation in some regions of Canada, which in turn has important implications for the care of patients with end-stage organ failure.	[Kramer, Andreas H.; Zygun, David A.; Doig, Christopher J.; Zuege, Danny J.] Univ Calgary, Foothills Med Ctr, Dept Crit Care Med, Calgary, AB, Canada; [Kramer, Andreas H.; Zygun, David A.] Univ Calgary, Foothills Med Ctr, Dept Clin Neurosci, Calgary, AB, Canada; [Doig, Christopher J.] Univ Calgary, Foothills Med Ctr, Dept Community Hlth Sci, Calgary, AB, Canada; [Zuege, Danny J.] Univ Calgary, Foothills Med Ctr, Dept Med, Calgary, AB, Canada		Kramer, AH (corresponding author), Univ Calgary, Foothills Med Ctr, Dept Crit Care Med, Calgary, AB, Canada.	andreas.kramer@albertahealthservices.ca	Doig, Christopher/AAC-7949-2020; Zuege, Danny J./L-5368-2017	Doig, Christopher/0000-0002-8576-9139; Zuege, Danny J./0000-0003-2033-5847			Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; [Anonymous], 2010, ALB TRAFF COLL STAT; Barnieh L, 2006, CAN J ANAESTH, V53, P727, DOI 10.1007/BF03021633; Beaulieu MA, 1999, CAN J NEUROL SCI, V26, P64; Canadian Institute for Health Information, 2013, E STAT REP TRANSPL W; Canadian Institute for Health Information, 2006, HEAD INJ CAN DEC CHA; Canadian Institute for Health Information, CAN ORG REPL REG ANN; Champagne P, 2012, CAN J CARDIOL, V28, pS161, DOI 10.1016/j.cjca.2012.07.186; Cloutier R, 2006, CAN J ANAESTH, V53, P716, DOI 10.1007/BF03021631; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; de Keizer NF, 2000, INTENS CARE MED, V26, P577, DOI 10.1007/s001340051207; Dennis J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2674; Downie J, 2009, CAN J ANAESTH, V56, P851, DOI 10.1007/s12630-009-9130-x; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Haider AH, 2012, J TRAUMA ACUTE CARE, V73, P1340, DOI 10.1097/TA.0b013e318270bbca; Hernadez-Alejandro R, 2011, CAN J ANESTH, V58, P599, DOI 10.1007/s12630-011-9511-9; JENNETT B, 1975, LANCET, V1, P480; Jochmans I, 2012, TRANSPL INT, V25, P857, DOI 10.1111/j.1432-2277.2012.01510.x; Karkhaneh M, 2011, ACCIDENT ANAL PREV, V43, P788, DOI 10.1016/j.aap.2010.10.026; Kitamura T, 2012, CIRCULATION, V126, P2834, DOI 10.1161/CIRCULATIONAHA.112.109496; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kramer AH, 2013, CAN J ANESTH, V60, P966, DOI 10.1007/s12630-013-0001-0; Kramer AH, 2011, NEUROCRIT CARE, V14, P329, DOI 10.1007/s12028-011-9530-y; Kumar R, 2012, ANAESTH INTENS CARE, V40, P517, DOI 10.1177/0310057X1204000319; Lindsay MP, 2009, TRACKING HEART DIS S; Lovelock CE, 2010, NEUROLOGY, V74, P1494, DOI 10.1212/WNL.0b013e3181dd42b3; Mayo NE, 2007, NEUROLOGY, V68, P1122, DOI 10.1212/01.wnl.0000258664.12423.4c; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Rea TD, 2003, CIRCULATION, V108, P1196, DOI 10.1161/01.CIR.0000087403.24467.A4; Russell K, 2010, CAN MED ASSOC J, V182, P333, DOI 10.1503/cmaj.091080; Saidi RF, 2012, WORLD J SURG, V36, P2909, DOI 10.1007/s00268-012-1748-0; Shahpori R, 2009, ST HEAL T, V143, P81, DOI 10.3233/978-1-58603-979-0-81; Shemie SD, 2006, CAN MED ASSOC J, V175, pS1, DOI 10.1503/cmaj.060895; Shemie SD, 2006, CAN MED ASSOC J, V174, pS1, DOI 10.1503/cmaj.045142; Stewart TC, 2003, J TRAUMA, V54, P266, DOI 10.1097/01.TA.0000038699.47295.2D; Summers DM, 2010, TRANSPLANTATION, V90, P1506, DOI 10.1097/TP.0b013e3182007b33; Tenn-Lyn NA, 2006, CAN J ANAESTH, V53, P732, DOI 10.1007/BF03021634; Transport Canada, 2010, CAN MOT VEH TRAFF CO; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Wijdicks EFM, 2001, NEW ENGL J MED, V344, P1215, DOI 10.1056/NEJM200104193441606; Wijdicks EFM, 2004, CRIT CARE MED, V32, P2332, DOI 10.1097/01.CCM.0000145949.34618.E1	42	23	23	1	2	CMA-CANADIAN MEDICAL ASSOC	OTTAWA	1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 5W8, CANADA	0820-3946	1488-2329		CAN MED ASSOC J	Can. Med. Assoc. J.	DEC 10	2013	185	18					E838	E845		10.1503/cmaj.130271			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264TC	WOS:000327902600015	24167208	gold, Green Published			2022-02-06	
J	Dinsmore, J				Dinsmore, Judith			Traumatic brain injury: an evidence-based review of management	BJA EDUCATION			English	Article							HEAD-INJURY; RESUSCITATION; GUIDELINES		[Dinsmore, Judith] St George Hosp, Neuroanaesthesia, Blackshaw Rd, London SW17 0RE, England		Dinsmore, J (corresponding author), St George Hosp, Neuroanaesthesia, Blackshaw Rd, London SW17 0RE, England.	judith.dinsmore@nhs.net					Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bhalla T, 2012, PEDIATR ANESTH, V22, P627, DOI 10.1111/j.1460-9592.2012.03842.x; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Keeling D, 2011, BRIT J HAEMATOL, V154, P311, DOI 10.1111/j.1365-2141.2011.08753.x; Kramer AH, 2012, CRIT CARE, V16, DOI 10.1186/cc11812; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Myburgh J, 2007, NEW ENGL J MED, V357, P874; National Institute for Health and Clinical Excellence (NICE), 2007, NICE CLIN GUID; The Association of Anaesthetists of Great Britain and Ireland, 2006, REC SAF TRANSF PAT B; Tisdall MM, 2007, BRIT J ANAESTH, V99, P61, DOI 10.1093/bja/aem143; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901	19	23	25	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2058-5349	2058-5357		BJA EDUC	BJA Educ.	DEC	2013	13	6					189	195		10.1093/bjaceaccp/mkt010			7	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	VC4SK	WOS:000433776100001		Green Published, Bronze			2022-02-06	
J	Cuomo, O; Rispoli, V; Leo, A; Politi, GB; Vinciguerra, A; di Renzo, G; Cataldi, M				Cuomo, Ornella; Rispoli, Vincenzo; Leo, Antonio; Politi, Giovanni Bosco; Vinciguerra, Antonio; di Renzo, Gianfranco; Cataldi, Mauro			The Antiepileptic Drug Levetiracetam Suppresses Non-Convulsive Seizure Activity and Reduces Ischemic Brain Damage in Rats Subjected to Permanent Middle Cerebral Artery Occlusion	PLOS ONE			English	Article							LONG-TERM TREATMENT; SPREADING DEPRESSION; CALCIUM-CHANNELS; UCB L059; RELEASE; MODEL; EPILEPSY; DEPOLARIZATION; ETHOSUXIMIDE; INHIBITION	The antiepileptic drug Levetiracetam (Lev) has neuroprotective properties in experimental stroke, cerebral hemorrhage and neurotrauma. In these conditions, non-convulsive seizures (NCSs) propagate from the core of the focal lesion into perilesional tissue, enlarging the damaged area and promoting epileptogenesis. Here, we explore whether Lev neuroprotective effect is accompanied by changes in NCS generation or propagation. In particular, we performed continuous EEG recordings before and after the permanent occlusion of the middle cerebral artery (pMCAO) in rats that received Lev (100 mg/kg) or its vehicle immediately before surgery. Both in Lev-treated and in control rats, EEG activity was suppressed after pMCAO. In control but not in Lev-treated rats, EEG activity reappeared approximately 30-45 min after pMCAO. It initially consisted in single spikes and, then, evolved into spike-and-wave and polyspike-and-wave discharges. In Lev-treated rats, only rare spike events were observed and the EEG power was significantly smaller than in controls. Approximately 24 hours after pMCAO, EEG activity increased in Lev-treated rats because of the appearance of polyspike events whose power was, however, significantly smaller than in controls. In rats sacrificed 24 hours after pMCAO, the ischemic lesion was approximately 50% smaller in Lev-treated than in control rats. A similar neuroprotection was observed in rats sacrificed 72 hours after pMCAO. In conclusion, in rats subjected to pMCAO, a single Lev injection suppresses NCS occurrence for at least 24 hours. This electrophysiological effect could explain the long lasting reduction of ischemic brain damage caused by this drug.	[Cuomo, Ornella; Vinciguerra, Antonio; di Renzo, Gianfranco; Cataldi, Mauro] Univ Naples Federico II, Dept Neurosci Reprod & Odontostomatol Sci, Div Pharmacol, Naples, Italy; [Rispoli, Vincenzo; Leo, Antonio; Politi, Giovanni Bosco] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy		Cataldi, M (corresponding author), Univ Naples Federico II, Dept Neurosci Reprod & Odontostomatol Sci, Div Pharmacol, Naples, Italy.	cataldi@unina.it	Di Renzo, Gian C./P-3819-2017; Vinciguerra, Antonio/AAA-8094-2019; Leo, Antonio/AAC-4052-2020; Cataldi, Mauro/AAB-3642-2019	Di Renzo, Gian C./0000-0003-4467-240X; Vinciguerra, Antonio/0000-0003-0746-4935; Leo, Antonio/0000-0002-0061-1608; Cataldi, Mauro/0000-0001-7787-3406; CUOMO, ORNELLA/0000-0002-6459-2530	UCB PharmaUCB Pharma SA; Ricerca FinalizzataMinistry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF) [RF-FSL-352059]; Ministero dell'Istruzione, dell'Universita e della Ricerca, Programma Operativo Nazionale [PON_01602, 20089BARSR_002]; European CommunityEuropean Commission; European Social FundEuropean Social Fund (ESF); Regione CalabriaRegione Calabria	The present study was partially supported by a research grant by UCB Pharma. The funding company did not have any role in designing, performing or analyzing the data but approved both the initial protocol and the final manuscript. This economical support does not alter our adherence to all the PLOS ONE policies on sharing data and materials. Additional support was received from the following grants: Ricerca Finalizzata 2009 [Grant RF-FSL-352059], and Ministero dell'Istruzione, dell'Universita e della Ricerca, Programma Operativo Nazionale [Grants PON_01602 and 20089BARSR_002]. A. L. is recipient of a Ph.D. fellowship grant from the European Community, the European Social Fund and the Regione Calabria.	Angehagen M, 2003, NEUROREPORT, V14, P471, DOI 10.1097/01.wnr.0000059774.23521.b7; Belcastro V, 2011, BRAIN DEV-JPN, V33, P289, DOI 10.1016/j.braindev.2010.06.008; Burn J, 1997, BRIT MED J, V315, P1582, DOI 10.1136/bmj.315.7122.1582; Camilo O, 2004, STROKE, V35, P1769, DOI 10.1161/01.STR.0000130989.17100.96; Canals S, 2008, J CEREBR BLOOD F MET, V28, P1835, DOI 10.1038/jcbfm.2008.71; Cataldi M, 2005, J PHARMACOL EXP THER, V313, P720, DOI 10.1124/jpet.104.079327; Cataldi M, 2013, CURR NEUROPHARMACOL, V11, P276, DOI 10.2174/1570159X11311030004; Chang WP, 2009, J NEUROSCI, V29, P883, DOI 10.1523/JNEUROSCI.4521-08.2009; Clark WM, 1997, NEUROL RES, V19, P641; Costa C, 2006, STROKE, V37, P1319, DOI 10.1161/01.STR.0000217303.22856.38; Crepeau AZ, 2010, EXPERT REV NEUROTHER, V10, P159, DOI [10.1586/ern.10.5, 10.1586/ERN.10.3]; Cuomo O, 2008, J NEUROSCI, V28, P2053, DOI 10.1523/JNEUROSCI.4912-07.2008; Cuomo O, 2007, STROKE, V38, P3272, DOI 10.1161/STROKEAHA.107.488486; Custer KL, 2006, J NEUROSCI, V26, P1303, DOI 10.1523/JNEUROSCI.2699-05.2006; Doheny HC, 1999, EPILEPSY RES, V34, P161, DOI 10.1016/S0920-1211(98)00104-1; Dreier JP, 2012, BRAIN, V135, P259, DOI 10.1093/brain/awr303; Eikermann-Haerter K, 2012, CIRCULATION, V125, P335, DOI 10.1161/CIRCULATIONAHA.111.045096; Eyal S, 2004, EPILEPSIA, V45, P737, DOI 10.1111/j.0013-9580.2004.00104.x; Fleidervish IA, 2001, J NEUROSCI, V21, P4600, DOI 10.1523/JNEUROSCI.21-13-04600.2001; Fukuyama K, 2012, NEUROSCI LETT, V518, P69, DOI 10.1016/j.neulet.2012.03.056; GILL R, 1992, J CEREBR BLOOD F MET, V12, P371, DOI 10.1038/jcbfm.1992.54; Hanon E, 2001, SEIZURE-EUR J EPILEP, V10, P287, DOI 10.1053/seiz.2000.0511; Hartings JA, 2003, EXP NEUROL, V179, P139, DOI 10.1016/S0014-4886(02)00013-4; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Kilicdag H, 2013, EARLY HUM DEV, V89, P355, DOI 10.1016/j.earlhumdev.2012.12.002; LEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409; Leker RR, 2003, BRAIN RES REV, V42, P187, DOI 10.1016/S0165-0173(03)00170-X; Loscher W, 1998, J PHARMACOL EXP THER, V284, P474; Lu XCM, 2001, NEUROPATH APPL NEURO, V27, P481, DOI 10.1046/j.1365-2990.2001.00357.x; Lukyanetz EA, 2002, EPILEPSIA, V43, P9, DOI 10.1046/j.1528-1157.2002.24501.x; Lynch BA, 2003, P NATL ACAD SCI USA, V26, P9861; Margineanu DG, 2009, SEIZURE-EUR J EPILEP, V18, P453, DOI 10.1016/j.seizure.2009.01.002; Marini H, 2004, LIFE SCI, V74, P1253, DOI 10.1016/j.lfs.2003.08.006; Meehan AL, 2012, EPILEPSIA, V53, P469, DOI 10.1111/j.1528-1167.2011.03392.x; Meehan AL, 2011, J NEUROPHYSIOL, V106, P1227, DOI 10.1152/jn.00279.2011; Muller M, 1998, BRAIN RES, V812, P1, DOI 10.1016/S0006-8993(98)00812-9; Nagarkatti N, 2008, NEUROSCI LETT, V436, P289, DOI 10.1016/j.neulet.2008.02.076; Nakamura H, 2010, BRAIN, V133, P1994, DOI 10.1093/brain/awq117; Pignataro G, 2012, NEUROBIOL DIS, V45, P616, DOI 10.1016/j.nbd.2011.10.007; Rekling JC, 2003, NEUROSCI LETT, V335, P167, DOI 10.1016/S0304-3940(02)01193-X; Rigo JM, 2002, BRIT J PHARMACOL, V136, P659, DOI 10.1038/sj.bjp.0704766; Russo E, 2011, EPILEPSIA, V52, P1341, DOI 10.1111/j.1528-1167.2011.03112.x; Russo E, 2010, EPILEPSIA, V51, P1560, DOI 10.1111/j.1528-1167.2009.02400.x; Stratton SC, 2003, EPILEPSY RES, V53, P95, DOI 10.1016/S0920-1211(02)00254-1; Vinogradova LV, 2008, EPILEPSIA, V49, P1160, DOI 10.1111/j.1528-1167.2008.01594.x; Wang HC, 2006, NEUROCRIT CARE, V5, P71, DOI 10.1385/NCC:5:1:71; Williams AJ, 2004, J PHARMACOL EXP THER, V311, P220, DOI 10.1124/jpet.104.069146; Williams AJ, 2008, NEUROSCI LETT, V430, P7, DOI 10.1016/j.neulet.2007.09.052; Williams AJ, 2006, J PHARMACOL EXP THER, V318, P947, DOI 10.1124/jpet.106.105999; Yao J, 2010, J NEUROSCI, V30, P5569, DOI 10.1523/JNEUROSCI.4781-09.2010	50	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80852	10.1371/journal.pone.0080852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	WOS:000327254700208	24236205	gold, Green Submitted, Green Published			2022-02-06	
J	Kolmodin, L; Sekhon, MS; Henderson, WR; Turgeon, AF; Griesdale, DEG				Kolmodin, Leif; Sekhon, Mypinder S.; Henderson, William R.; Turgeon, Alexis F.; Griesdale, Donald E. G.			Hypernatremia in patients with severe traumatic brain injury: a systematic review	ANNALS OF INTENSIVE CARE			English	Article						Traumatic brain injury; Hypernatremia; Hyperosmolar therapy; Hypertonic saline	INTENSIVE-CARE-UNIT; HYPERTONIC SALINE SOLUTIONS; ACQUIRED HYPONATREMIA; MORTALITY; EPIDEMIOLOGY; MANNITOL; THERAPY; SODIUM; ILL	Background: Hypernatremia is common following traumatic brain injury (TBI) and occurs from a variety of mechanisms, including hyperosmotic fluids, limitation of free water, or diabetes insipidus. The purpose of this systematic review was to assess the relationship between hypernatremia and mortality in patients with TBI. Methods: We searched the following databases up to November 2012: MEDLINE, EMBASE, and CENTRAL. Using a combination of MeSH and text terms, we developed search filters for the concepts of hypernatremia and TBI and included studies that met the following criteria: (1) compared hypernatremia to normonatremia, (2) adult patients with TBI, (3) presented adjusted outcomes for mortality or complications. Results: Bibliographic and conference search yielded 1,152 citations and 11 abstracts, respectively. Sixty-five articles were selected for full-text review with 5 being included in our study. All were retrospective cohort studies totaling 5,594 (range 100-4,296) patients. There was marked between-study heterogeneity. The incidence of hypernatremia ranged between 16% and 40%. Use of hyperosmolar therapy was presented in three studies (range 14-85% of patients). Hypernatremia was associated with increased mortality across all four studies that presented this outcome. Only one study considered diabetes insipidus (DI) in their analysis where hypernatremia was associated with increased mortality in patients who did not receive DDAVP. Conclusions: Although hypernatremia was associated with increased mortality in the included studies, there was marked between-study heterogeneity. DI was a potential confounder in several studies. Considering these limitations, the clinical significance of hypernatremia in TBI is difficult to establish at this stage.	[Kolmodin, Leif; Sekhon, Mypinder S.; Henderson, William R.; Griesdale, Donald E. G.] Univ British Columbia, Dept Med, Div Crit Care Med, Vancouver, BC, Canada; [Griesdale, Donald E. G.] Univ British Columbia, Dept Anesthesia Pharmacol & Therapeut, Vancouver, BC, Canada; [Turgeon, Alexis F.] Univ Laval, Dept Anesthesiol, Div Crit Care, Quebec City, PQ, Canada; [Griesdale, Donald E. G.] Vancouver Coastal Hlth Res Inst, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada; [Sekhon, Mypinder S.; Henderson, William R.; Griesdale, Donald E. G.] Vancouver Gen Hosp, Vancouver, BC V5Z 1M9, Canada		Griesdale, DEG (corresponding author), Univ British Columbia, Dept Med, Div Crit Care Med, Vancouver, BC, Canada.	donald.griesdale@vch.ca	Griesdale, Donald/AAT-7762-2021	Griesdale, Donald/0000-0001-5985-8624	Vancouver Coastal Health Research Institute; Vancouver Hospital Department of Anesthesia; Fonds de recherche du Quebec-Sante (FRQ-S)	Dr. Griesdale is supported through a Clinician Scientist Award from the Vancouver Coastal Health Research Institute and through the Vancouver Hospital Department of Anesthesia. Dr. Turgeon is supported in part by a research career award from the Fonds de recherche du Quebec-Sante (FRQ-S).	Adrogue HJ, 2000, NEW ENGL J MED, V342, P1493, DOI 10.1056/NEJM200005183422006; Aiyagari V, 2006, J CRIT CARE, V21, P163, DOI 10.1016/j.jcrc.2005.10.002; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; Griesdale DEG, 2010, CAN J NEUROL SCI, V37, P43, DOI 10.1017/S031716710000963X; Hadjizacharia P, 2008, J AM COLL SURGEONS, V207, P477, DOI 10.1016/j.jamcollsurg.2008.04.017; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Himmelseher S, 2007, CURR OPIN ANESTHESIO, V20, P414, DOI 10.1097/ACO.0b013e3282eff9ea; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; Lescot T, 2006, CRIT CARE MED, V34, P3029, DOI 10.1097/01.CCM.0000243797.42346.64; Li M, 2012, HYPERNATREMIA SEVERI; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700; Lindner G, 2007, AM J KIDNEY DIS, V50, P952, DOI 10.1053/j.ajkd.2007.08.016; Maggiore U, 2009, CRIT CARE, V13, DOI 10.1186/cc7953; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Platt RW, 2009, AM J EPIDEMIOL, V170, P687, DOI 10.1093/aje/kwp175; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Salas M, 1999, AM J EPIDEMIOL, V149, P981; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shehata M, 2010, CRIT CARE, V14, P355; Stelfox HT, 2010, CAN J ANAESTH, V57, P650, DOI 10.1007/s12630-010-9309-1; Stelfox HT, 2008, CRIT CARE, V12, DOI 10.1186/cc7162; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Wells GA, 2009, NEWCASTLE OTTAWA SCA; Zygun DA, 2009, CRIT CARE, V13, DOI 10.1186/cc8014	36	23	25	0	2	SPRINGEROPEN	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2110-5820			ANN INTENSIVE CARE	Ann. Intensive Care	NOV 6	2013	3								35	10.1186/2110-5820-3-35			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT7ZY	WOS:000345154600001	24196399	Green Published, gold			2022-02-06	
J	Chen, XY; Li, K; Light, AR; Fu, KY				Chen, Xin-Yi; Li, Kai; Light, Alan R.; Fu, Kai-Yuan			Simvastatin Attenuates Formalin-Induced Nociceptive Behaviors by Inhibiting Microglial RhoA and p38 MAPK Activation	JOURNAL OF PAIN			English	Article						Formalin pain model; microglia; p38 mitogen-activated protein kinase; RhoA; statins	TRAUMATIC BRAIN-INJURY; COA REDUCTASE INHIBITORS; PERIPHERAL-NERVE INJURY; LONG-TERM HYPERALGESIA; SPINAL-CORD; NEUROPATHIC PAIN; PROTEIN-KINASE; STATINS; RAT; ATORVASTATIN	Several recent studies have revealed that statins exert anti-inflammatory effects in addition to their lipid-lowering property in vivo and in vitro. Recently, statins were shown to alleviate pain associated trauma in a neuropathic pain model. The aim of the present study was to investigate the underlying mechanisms of analgesia caused by the lipophilic statin simvastatin in an animal model of formalin-induced pain in the rat. Intrathecal pretreatment with simvastatin significantly attenuated the second phase of the acute nociceptive response to formalin injection, and daily administration of simvastatin for 7 days inhibited the long-term mechanical hyperalgesia caused by formalin injection. Spinal microglial activation (detected by lba-1 and CD11 b immunohistochemistry and Western blot), and phosphorylated-p38 mitogen-activated protein kinase (detected by immunohistochemistry and Western blot) were significantly inhibited by simvastatin treatment at day 7 after formalin injection. In addition, peripheral formalin injection induced a significant increase in microglial RhoA activation (detected by membrane RhoA translocation ratio using Western blot) in the spinal cord. The spinal RhoA activation in microglia was reversed by simvastatin treatment. These findings suggest that simvastatin attenuates formalin-induced nociceptive behaviors, at least in part, by inhibiting microglial RhoA and p38 mitogen-activated protein kinase activation. Perspective: Our novel findings indicated that simvastatin attenuated formalin-induced nociceptive responses by inhibiting micro glial RhoA and p38 mitogen-activated protein kinase activation. Inactivation of RhoA-p38 signaling pathway may be a pharmacologic target for treating microglia-directed central nervous system inflammation and chronic pain conditions. (C) 2013 by the American Pain Society	[Chen, Xin-Yi; Li, Kai; Fu, Kai-Yuan] Peking Univ, Sch & Hosp Stomatol, Ctr TMD & Orofacial Pain, Beijing 100081, Peoples R China; [Li, Kai] Peking Univ, Sch & Hosp Stomatol, Dept Gen Dent 2, Beijing 100081, Peoples R China; [Light, Alan R.] Univ Utah, Dept Anesthesiol, Salt Lake City, UT USA		Fu, KY (corresponding author), Peking Univ, Sch & Hosp Stomatol, Ctr TMD & Orofacial Pain, Zhong Guan Cun South Ave 22, Beijing 100081, Peoples R China.	kqkyfu@bjmu.edu.cn		Fu, Kai-Yuan/0000-0001-7049-9888; Li, Kai/0000-0003-4140-3802	NSFCNational Natural Science Foundation of China (NSFC) [30973337, 81271172]; Beijing Natural Science FoundationBeijing Natural Science Foundation [7122201]	The research was supported by NSFC grant no. 30973337 and no. 81271172 (K.-Y.F.), and Beijing Natural Science Foundation 7122201 (K.-Y.F.).	Balduini W, 2003, STROKE, V34, P2007, DOI 10.1161/01.STR.0000080677.24419.88; Bi XN, 2004, J BIOL CHEM, V279, P48238, DOI 10.1074/jbc.M405442200; Blanco-Colio LM, 2003, KIDNEY INT, V63, P12, DOI 10.1046/j.1523-1755.2003.00744.x; Carlin CM, 2007, AM J RESP CELL MOL, V37, P447, DOI 10.1165/rcmb.2007-0012OC; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Chu LW, 2012, INT J IMMUNOPATH PH, V25, P219, DOI 10.1177/039463201202500124; Clarke R, 2007, SIGHT SOUND, V17, P52; Cordle A, 2005, J BIOL CHEM, V280, P34202, DOI 10.1074/jbc.M505268200; Cordle A, 2005, J NEUROSCI, V25, P299, DOI 10.1523/JNEUROSCI.2544-04.2005; Coyle DE, 1998, GLIA, V23, P75; Fu KY, 2001, J PAIN, V2, P2, DOI 10.1054/jpai.2001.9804; Fu KY, 2000, NEUROSCIENCE, V101, P1127, DOI 10.1016/S0306-4522(00)00376-6; Garcia GG, 2011, PHARMACOL BIOCHEM BE, V100, P125, DOI 10.1016/j.pbb.2011.08.007; Ghittoni R, 2005, FASEB J, V19, P605, DOI 10.1096/fj.04-2702fje; Ginsberg HN, 1998, AM J CARDIOL, V81, p32B, DOI 10.1016/S0002-9149(98)00035-6; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Greenwood J, 2006, NAT REV IMMUNOL, V6, P358, DOI 10.1038/nri1839; Hains BC, 2006, J NEUROSCI, V26, P4308, DOI 10.1523/JNEUROSCI.0003-06.2006; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Jin SX, 2003, J NEUROSCI, V23, P4017; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Lennernas H, 1997, CLIN PHARMACOKINET, V32, P403, DOI 10.2165/00003088-199732050-00005; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Li K, 2010, J PAIN, V11, P1056, DOI 10.1016/j.jpain.2010.01.268; Liao JK, 2002, J CLIN INVEST, V110, P285, DOI 10.1172/JCI200216421; Lindberg C, 2005, J NEUROSCI RES, V82, P10, DOI 10.1002/jnr.20615; MELLER ST, 1994, NEUROPHARMACOLOGY, V33, P1471, DOI 10.1016/0028-3908(94)90051-5; Ohsawa M, 2008, PAIN, V134, P285, DOI 10.1016/j.pain.2007.04.031; Ohsawa M, 2012, J PHARMACOL SCI, V119, P102, DOI 10.1254/jphs.12007SC; Ohsawa M, 2011, PAIN, V152, P114, DOI 10.1016/j.pain.2010.10.005; Ramer LM, 2004, J NEUROSCI, V24, P10796, DOI 10.1523/JNEUROSCI.3337-04.2004; Ren K, 1999, PHYSIOL BEHAV, V67, P711, DOI 10.1016/S0031-9384(99)00136-5; Ruperez M, 2007, HYPERTENSION, V50, P377, DOI 10.1161/HYPERTENSIONAHA.107.091264; Sanchez-Aguilar M, 2013, J NEUROSURG, V118, P669, DOI 10.3171/2012.12.JNS121084; Senokuchi T, 2005, J BIOL CHEM, V280, P6627, DOI 10.1074/jbc.M412531200; Shi XQ, 2011, PAIN, V152, P1033, DOI 10.1016/j.pain.2011.01.006; Song JX, 2011, J CARDIOVASC PHARM, V57, P213, DOI 10.1097/FJC.0b013e31820376ac; Storkson RV, 1996, J NEUROSCI METH, V65, P167, DOI 10.1016/0165-0270(95)00164-6; Stuve O, 2003, CURR OPIN NEUROL, V16, P393, DOI 10.1097/01.wco.0000073942.19076.d1; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tatsumi S, 2005, NEUROSCIENCE, V131, P491, DOI 10.1016/j.neuroscience.2004.10.022; Tristano AG, 2006, INT IMMUNOPHARMACOL, V6, P1833, DOI 10.1016/j.intimp.2006.08.006; Tsuda M, 2004, GLIA, V45, P89, DOI 10.1002/glia.10308; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; Weitz-Schmidt G, 2002, TRENDS PHARMACOL SCI, V23, P482, DOI 10.1016/S0165-6147(02)02077-1; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058	48	23	27	3	14	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1526-5900			J PAIN	J. Pain	NOV	2013	14	11					1310	1319		10.1016/j.jpain.2013.05.011			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	252YD	WOS:000327047900005	23900131				2022-02-06	
J	de Guise, E; LeBlanc, J; Champoux, MC; Couturier, C; Alturki, AY; Lamoureux, J; Desjardins, M; Marcoux, J; Maleki, M; Feyz, M				de Guise, Elaine; LeBlanc, Joanne; Champoux, Marie-Claude; Couturier, Celine; Alturki, Abdulrahman Yaqub; Lamoureux, Julie; Desjardins, Monique; Marcoux, Judith; Maleki, Mohammed; Feyz, Mitra			The mini-mental state examination and the montreal cognitive assessment after traumatic brain injury: An early predictive study	BRAIN INJURY			English	Article						Montreal cognitive assessment; mini-mental state examination; level 1 trauma centre; outcome; traumatic brain injury	SEVERE HEAD-INJURY; ELDERLY-PATIENTS; ACUTE-CARE; PARKINSONS-DISEASE; SUBACUTE STROKE; MORTALITY; REHABILITATION; IMPAIRMENT; SCALE; COMA	Primary objective: To compare results on the Montreal Cognitive Assessment (MoCA) to those on the Mini-Mental State Examination (MMSE) in patients with traumatic brain injury (TBI) and to predict the outcome at discharge from the acute care setting. Research design: A retrospective study. Methods and procedures: The MoCA and the MMSE were administered to 214 patients with TBI during their acute care hospitalization in a Level I trauma centre. Outcome was measured with the Disability Rating Scale (DRS). Main outcomes and results: A linear regression determined that the MoCA, the MMSE, TBI severity, education level and presence of diffuse injuries predicted 57% of the total variability of the DRS scores. The model without the MMSE had a R-2 of 53.7% and the model without the MoCA had a R-2 of 55.0%. The models without the MMSE or the MoCA had a R-2 of 24.9%. Conclusions: These results indicated that the MoCA and the MMSE function as similar predictors of the DRS at discharge.	[de Guise, Elaine; Alturki, Abdulrahman Yaqub; Marcoux, Judith; Maleki, Mohammed] McGill Univ, Ctr Hlth, Montreal Gen Hosp, Neurol & Neurosurg Dept, Montreal, PQ H3G 1A4, Canada; [de Guise, Elaine] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [LeBlanc, Joanne; Champoux, Marie-Claude; Couturier, Celine; Feyz, Mitra] McGill Univ, Ctr Hlth, Montreal Gen Hosp, Traumat Brain Injury Program, Montreal, PQ H3G 1A4, Canada; [Alturki, Abdulrahman Yaqub] Natl Neurosci Inst, Riyadh, Saudi Arabia; [Lamoureux, Julie] Univ Montreal, Social & Prevent Med Dept, Montreal, PQ, Canada; [Desjardins, Monique] McGill Univ, Ctr Hlth, Montreal Gen Hosp, Dept Psychiat, Montreal, PQ H3G 1A4, Canada		de Guise, E (corresponding author), McGill Univ, Ctr Hlth, Montreal Gen Hosp Site,Room D13-124,1650 Cedar Av, Montreal, PQ H3G 1A4, Canada.	elainedeguise@hotmail.ca			Research Institute of the McGill University Health Center	We thank the Research Institute of the McGill University Health Center for their support.	Cameron J, 2012, HEART LUNG CIRC, V21, P806, DOI 10.1016/j.hlc.2012.07.050; De Guise E, 2005, BRAIN INJURY, V19, P1087, DOI 10.1080/02699050500149882; de Guise E, 2006, J HEAD TRAUMA REHAB, V21, P527, DOI 10.1097/00001199-200611000-00007; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; Dong YH, 2012, INT PSYCHOGERIATR, V24, P1749, DOI 10.1017/S1041610212001068; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Godefroy O, 2011, STROKE, V42, P1712, DOI 10.1161/STROKEAHA.110.606277; HAAS JF, 1987, J NEUROL NEUROSUR PS, V50, P52, DOI 10.1136/jnnp.50.1.52; Heruti RJ, 2002, ARCH PHYS MED REHAB, V83, P742, DOI 10.1053/apmr.2002.32739; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; Jaillard A, 2009, STROKE, V40, P2473, DOI 10.1161/STROKEAHA.108.541144; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Marmarou A, 2003, ACT NEUR S, V86, P7; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nazem S, 2009, J AM GERIATR SOC, V57, P304, DOI 10.1111/j.1532-5415.2008.02096.x; Olson R, 2011, SUPPORT CARE CANCER, V19, P1849, DOI 10.1007/s00520-010-1028-1; Pendlebury ST, 2010, STROKE, V41, P1290, DOI 10.1161/STROKEAHA.110.579888; Popovic IM, 2007, J NEUROL SCI, V257, P185, DOI 10.1016/j.jns.2007.01.029; Rabadi MH, 2008, ARCH PHYS MED REHAB, V89, P441, DOI 10.1016/j.apmr.2007.11.014; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Ritchie PD, 2000, J CLIN NEUROSCI, V7, P301, DOI 10.1054/jocn.1999.0198; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; Toglia J, 2011, ARCH PHYS MED REHAB, V92, P792, DOI 10.1016/j.apmr.2010.12.034; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Zadikoff C, 2008, MOVEMENT DISORD, V23, P297, DOI 10.1002/mds.21837; Zwecker M, 2002, ARCH PHYS MED REHAB, V83, P342, DOI 10.1053/apmr.2002.29641	33	23	24	0	20	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2013	27	12					1428	1434		10.3109/02699052.2013.835867			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	235UF	WOS:000325745500014	24102622				2022-02-06	
J	Ding, ZY; Zhang, JM; Xu, JY; Sheng, GJ; Huang, GR				Ding, Zhongyang; Zhang, Jiaming; Xu, Jinyu; Sheng, Guangjie; Huang, Guorong			Propofol Administration Modulates AQP-4 Expression and Brain Edema After Traumatic Brain Injury	CELL BIOCHEMISTRY AND BIOPHYSICS			English	Article						Propofol; Brain edema; AQP-4; IL-1 beta; TNF-alpha	SEVERE HEAD-INJURY; OXIDATIVE STRESS; AQUAPORIN-4; WATER; RATS; MICE; RECEPTOR; NEUROPROTECTION; ENCEPHALOPATHY; INFLAMMATION	The increased intracranial pressure caused by brain edema following traumatic brain injury (TBI) always leads to poor patient prognosis. Aquaporin-4 (AQP-4) plays an important role in edema formation and resolution, which may provide a novel therapeutic target for edema treatment. In this present study, we found that propofol treatment, within a short time, after TBI significantly reduced brain edema in a controlled cortical injury rat model and suppressed in vivo expression of AQP-4. The ameliorating effect of propofol was associated with attenuated expression of interleukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha). In addition, the regulatory effect of propofol on AQP-4 expression was investigated in cultured astrocytes. Results showed that propofol could block the stimulatory effect of IL-1 beta and TNF-alpha on AQP-4 expression in cultured astrocytes. We also found that both NF kappa B and p38/MAPK pathways were involved in IL-1 beta and TNF-alpha-induced AQP-4 expression and that propofol functions as a dual inhibitor of NF kappa B and p38/MAPK pathways. In conclusion, treatment with propofol, within a short time, after TBI attenuates cerebral edema and reduces the expression of AQP-4. Propofol modulates acute AQP-4 expression by attenuating IL-1 beta and TNF-alpha expression and inhibiting IL-1 beta and TNF-alpha induced AQP-4 expression.	[Ding, Zhongyang; Zhang, Jiaming; Xu, Jinyu; Sheng, Guangjie; Huang, Guorong] Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Emergency Ctr, Wuxi 214023, Peoples R China		Ding, ZY (corresponding author), Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Emergency Ctr, Wuxi 214023, Peoples R China.	drzyding@gmail.com					Agre P, 2004, NEUROSCIENCE, V129, P849, DOI 10.1016/j.neuroscience.2004.10.001; Alexander JJ, 2008, NEUROCHEM INT, V52, P447, DOI 10.1016/j.neuint.2007.08.006; Bemeur C, 2010, NEUROCHEM INT, V56, P213, DOI 10.1016/j.neuint.2009.11.010; Chen MJ, 2008, CURR NEUROPHARMACOL, V6, P102, DOI 10.2174/157015908784533879; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Di Giorgio AM, 2008, RESTOR NEUROL NEUROS, V26, P501; Feng Chun-sheng, 2004, Zhonghua Yi Xue Za Zhi, V84, P2110; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hewett SJ, 2006, J PHARMACOL EXP THER, V319, P1219, DOI 10.1124/jpet.106.109876; Iijima T, 2006, BRAIN RES, V1099, P25, DOI 10.1016/j.brainres.2006.04.117; Ito H, 1999, ACTA ANAESTH SCAND, V43, P153, DOI 10.1034/j.1399-6576.1999.430206.x; Ito H, 2006, J NEUROCHEM, V99, P107, DOI 10.1111/j.1471-4159.2006.04036.x; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; KIMELBERG HK, 1992, J NEUROTRAUM, V9, pS71; KOCHS E, 1992, ANESTHESIOLOGY, V76, P245, DOI 10.1097/00000542-199202000-00014; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Lazovic J, 2005, STROKE, V36, P2226, DOI 10.1161/01.STR.0000182255.08162.6a; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Nielsen S, 1997, J NEUROSCI, V17, P171; [潘彩飞 PAN Cai-fei], 2010, [中国病理生理杂志, Chinese Journal of Pathophysiology], V26, P96; Rajeevan MS, 2001, METHODS, V25, P443, DOI 10.1006/meth.2001.1266; Sanchez-Conde P, 2008, ANESTH ANALG, V106, P371, DOI 10.1213/ane.0b013e318160580b; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Tait MJ, 2008, TRENDS NEUROSCI, V31, P37, DOI 10.1016/j.tins.2007.11.003; Tang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027890; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Vizuete ML, 1999, NEUROBIOL DIS, V6, P245, DOI 10.1006/nbdi.1999.0246; Yang BX, 2008, J BIOL CHEM, V283, P15280, DOI 10.1074/jbc.M801425200; Zhang XJ, 2006, NEUROL INDIA, V54, P402; ZHU S, 2009, ANESTHESIA ANALGESIA, V109, P1436	33	23	33	0	14	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1085-9195	1559-0283		CELL BIOCHEM BIOPHYS	Cell Biochem. Biophys.	NOV	2013	67	2			SI		615	622		10.1007/s12013-013-9549-0			8	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Cell Biology	242YP	WOS:000326282900039	23494261				2022-02-06	
J	Van Cleve, W; Kernic, MA; Ellenbogen, RG; Wang, J; Zatzick, DF; Bell, MJ; Wainwright, MS; Groner, JI; Mink, RB; Giza, CC; Boyle, LN; Mitchell, PH; Rivara, FP; Vavilala, MS				Van Cleve, William; Kernic, Mary A.; Ellenbogen, Richard G.; Wang, Jin; Zatzick, Douglas F.; Bell, Michael J.; Wainwright, Mark S.; Groner, Jonathan I.; Mink, Richard B.; Giza, Christopher C.; Boyle, Linda Ng; Mitchell, Pamela H.; Rivara, Frederick P.; Vavilala, Monica S.		PEGASUS Pediat Guideline Adherence	National Variability in Intracranial Pressure Monitoring and Craniotomy for Children With Moderate to Severe Traumatic Brain Injury	NEUROSURGERY			English	Article						Decompressive craniectomy; Intracranial pressure monitoring	GLASGOW COMA SCALE; UNITED-STATES; OUTCOMES; PROGRAM; VOLUME; SCORE; CARE	BACKGROUND: Traumatic brain injury (TBI) is a significant cause of mortality and disability in children. Intracranial pressure monitoring (ICPM) and craniotomy/craniectomy (CRANI) may affect outcomes. Sources of variability in the use of these interventions remain incompletely understood. OBJECTIVE: To analyze sources of variability in the use of ICPM and CRANI. METHODS: Retrospective cross-sectional study of patients with moderate/severe pediatric TBI with the use of data submitted to the American College of Surgeons National Trauma Databank. RESULTS: We analyzed data from 7140 children at 156 US hospitals during 7 continuous years. Of the children, 27.4% had ICPM, whereas 11.7% had a CRANI. Infants had lower rates of ICPM and CRANI than older children. A lower rate of ICPM was observed among children hospitalized at combined pediatric/adult trauma centers than among children treated at adult-only trauma centers (relative risk = 0.80; 95% confidence interval 0.66-0.97). For ICPM and CRANI, 18.5% and 11.6%, respectively, of residual model variance was explained by between-hospital variation in care delivery, but almost no correlation was observed between within-hospital tendency toward performing these procedures. CONCLUSION: Infants received less ICPM than older children, and children hospitalized at pediatric trauma centers received less ICPM than children at adult-only trauma centers. In addition, significant between-hospital variability existed in the delivery of ICPM and CRANI to children with moderate-severe TBI.	[Van Cleve, William; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98104 USA; [Kernic, Mary A.; Rivara, Frederick P.] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA; [Ellenbogen, Richard G.] Univ Washington, Dept Neurol Surg, Seattle, WA 98104 USA; [Ellenbogen, Richard G.] Univ Washington, Dept Global Hlth Med, Seattle, WA 98104 USA; [Wang, Jin] Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Zatzick, Douglas F.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98104 USA; [Bell, Michael J.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Wainwright, Mark S.] Northwestern Univ, Dept Pediat, Chicago, IL 60611 USA; [Groner, Jonathan I.] Ohio State Univ, Coll Med, Dept Surg, Columbus, OH 43210 USA; [Mink, Richard B.] Los Angeles BioMed Res Inst, Harbor UCLA Med Ctr, Los Angeles, CA USA; [Mink, Richard B.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Giza, Christopher C.] Univ Calif Los Angeles, Div Neurosurg, Los Angeles, CA USA; [Giza, Christopher C.] Univ Calif Los Angeles, Div Pediat Neurol, Los Angeles, CA USA; [Boyle, Linda Ng] Univ Washington, Coll Engn, Seattle, WA 98104 USA; [Mitchell, Pamela H.] Univ Washington, Sch Nursing, Seattle, WA 98104 USA		Vavilala, MS (corresponding author), Univ Washington, 325 Ninth Ave,Box 359724, Seattle, WA 98104 USA.	vavilala@u.washington.edu		Groner, Jonathan/0000-0002-0998-593X	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01NS072308 to 03]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS072308] Funding Source: NIH RePORTER	The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article. This study was funded by the National Institutes of Health (NIH) 1R01NS072308 to 03.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS19; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Bates D., LME4 LINEAR MIXED EF; Bennett TD, 2012, ARCH PEDIAT ADOL MED, V166, P641, DOI 10.1001/archpediatrics.2012.322; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cho DY, 1995, PEDIATR NEUROSURG, V23, P192, DOI 10.1159/000120958; Clark DE, 2010, ICDPIC STATA MODULE; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dean NP, 2007, J NEUROSURG, V107, P387, DOI 10.3171/PED-07/11/387; Demetriades D, 2005, ANN SURG, V242, P512, DOI 10.1097/01.sla.0000184169.73614.09; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Durbin D R, 2001, Inj Prev, V7, P96, DOI 10.1136/ip.7.2.96; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Hill A, 2007, DATA ANAL USING REGR; Honaker J, 2011, J STAT SOFTW, V45, P1; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Lumley T, 2006, UW BIOSTATISTICS WOR; MacKenzie EJ, 2003, JAMA-J AM MED ASSOC, V289, P1515, DOI 10.1001/jama.289.12.1515; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; R Core Team, 2012, R LANG ENV STAT COMP; WELCH WP, 1993, NEW ENGL J MED, V328, P621, DOI 10.1056/NEJM199303043280906; WENNBERG J, 1982, SCI AM, V246, P120, DOI 10.1038/scientificamerican0482-120	25	23	23	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	NOV	2013	73	5					746	752		10.1227/NEU.0000000000000097			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	300MH	WOS:000330467500011	23863766	Green Accepted, Bronze			2022-02-06	
J	Moro, N; Ghavim, S; Harris, NG; Hovda, DA; Sutton, RL				Moro, Nobuhiro; Ghavim, Sima; Harris, Neil G.; Hovda, David A.; Sutton, Richard L.			Glucose administration after traumatic brain injury improves cerebral metabolism and reduces secondary neuronal injury	BRAIN RESEARCH			English	Article						C-14-2DG; Controlled cortical impact; Fluoro-Jade B; Hyperglycemia; Rat	CORTICAL IMPACT INJURY; PENTOSE-PHOSPHATE PATHWAY; INTENSIVE INSULIN THERAPY; FLUID PERCUSSION INJURY; TIGHT GLYCEMIC CONTROL; CLOSED-HEAD TRAUMA; 5-PERCENT DEXTROSE; BLOOD-FLOW; 0.9-PERCENT SALINE; ENERGY-METABOLISM	Clinical studies have indicated an association between acute hyperglycemia and poor outcomes in patients with traumatic brain injury (TBI), although optimal blood glucose levels needed to maximize outcomes for these patients remain under investigation. Previous results from experimental animal models suggest that post-TBI hyperglycemia may be harmful, neutral, or beneficial. The current studies determined the effects of single or multiple episodes of acute hyperglycemia on cerebral glucose metabolism and neuronal injury in a rodent model of unilateral controlled cortical impact (CCI) injury. In Experiment 1, a single episode of hyperglycemia (50% glucose at 2 g/kg, i.p.) initiated immediately after CCI was found to significantly attenuate a TBI-induced depression of glucose metabolism in cerebral cortex (4 of 6 regions) and subcortical regions (2 of 7) as well as to significantly reduce the number of dead/dying neurons in cortex and hippocampus at 24 h post-CCI. Experiment 2 examined effects of more prolonged and intermittent hyperglycemia induced by glucose administrations (2 g/kg, i.p.) at 0, 1,3 and 6 h post-CCI. The latter study also found significantly improved cerebral metabolism (in 3 of 6 cortical and 3 of 7 subcortical regions) and significant neuroprotection in cortex and hippocampus 1 day after CCI and glucose administration. These results indicate that acute episodes of post-TBI hyperglycemia can be beneficial and are consistent with other recent studies showing benefits of providing exogenous energy substrates during periods of increased cerebral metabolic demand. (C) 2013 Elsevier B.V. All rights reserved.	[Moro, Nobuhiro; Ghavim, Sima; Harris, Neil G.; Hovda, David A.; Sutton, Richard L.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [Moro, Nobuhiro; Ghavim, Sima; Harris, Neil G.; Hovda, David A.; Sutton, Richard L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Box 957039, Los Angeles, CA 90095 USA; [Hovda, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA		Sutton, RL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Box 957039, Los Angeles, CA 90095 USA.	moro.nobuhiro@nihon-u.ac.jp; sghavim@mednet.ucla.edu; ngharris@mednet.ucla.edu; dhovda@mednet.ucla.edu; rsutton@mednet.ucla.edu		Harris, Neil/0000-0002-1965-6750	UCLA Brain Injury Research Center; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [PO1NS058489]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS058489] Funding Source: NIH RePORTER	This work was supported by the UCLA Brain Injury Research Center and award PO1NS058489 from the National Institute of Neurological Disorders and Stroke (NINDS). The content is the sole responsibility of the authors and does not necessarily represent official views of the NINDS or the National Institutes of Health.	Alessandri B, 2000, ACTA NEUROCHIR SUPPL, V76, P425; Alessandri B, 2012, J NEUROTRAUM, V29, P2181, DOI 10.1089/neu.2011.2067; Alves OL, 2005, J NEUROTRAUM, V22, P733, DOI 10.1089/neu.2005.22.733; Aoyama N, 2008, BRAIN RES, V1230, P310, DOI 10.1016/j.brainres.2008.07.006; Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; Bartnik BL, 2007, J NEUROTRAUM, V24, P1079, DOI 10.1089/neu.2006.0210; Bartnik-Olson BL, 2010, J NEUROTRAUM, V27, P2191, DOI 10.1089/neu.2010.1508; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Chen T, 2000, J NEUROTRAUM, V17, P135, DOI 10.1089/neu.2000.17.135; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; Cherian L, 1997, CRIT CARE MED, V25, P1378, DOI 10.1097/00003246-199708000-00027; Cherian L, 1998, J NEUROTRAUM, V15, P307, DOI 10.1089/neu.1998.15.307; Cherian L, 1998, J NEUROTRAUM, V15, P1059, DOI 10.1089/neu.1998.15.1059; Choi BY, 2012, BRAIN RES, V1481, P49, DOI 10.1016/j.brainres.2012.08.032; Cornford EM, 1996, J NEUROTRAUM, V13, P523, DOI 10.1089/neu.1996.13.523; Deng-Bryant Y, 2011, J NEUROTRAUM, V28, P1813, DOI 10.1089/neu.2011.1822; Diaz-Parejo P, 2003, INTENS CARE MED, V29, P544, DOI 10.1007/s00134-003-1669-3; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; DUCKROW RB, 1987, J NEUROCHEM, V48, P989, DOI 10.1111/j.1471-4159.1987.tb05614.x; Duckrow RB, 1995, BRAIN RES, V703, P145, DOI 10.1016/0006-8993(95)01077-7; Duelli R, 2000, BRAIN RES, V858, P338, DOI 10.1016/S0006-8993(00)01942-9; Dusick JR, 2007, J CEREBR BLOOD F MET, V27, P1593, DOI 10.1038/sj.jcbfm.9600458; Fanne Rami Abu, 2011, J Neurosurg, V114, P85, DOI 10.3171/2010.4.JNS10263; FELDMAN Z, 1995, J NEUROSURG, V83, P1060, DOI 10.3171/jns.1995.83.6.1060; FOX PT, 1988, SCIENCE, V241, P462, DOI 10.1126/science.3260686; Fukushima M, 2009, J NEUROTRAUM, V26, P1095, DOI 10.1089/neu.2008.0771; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; Griesdale DEG, 2009, NEUROCRIT CARE, V11, P311, DOI 10.1007/s12028-009-9249-1; Griesemer D, 2007, J NEUROTRAUM, V24, P1823, DOI 10.1089/neu.2006.0237; Gurevich B, 1997, ANESTH ANALG, V84, P554, DOI 10.1097/00000539-199703000-00016; Hamlin GP, 2001, J NEUROTRAUM, V18, P1011, DOI 10.1089/08977150152693700; Hill J, 2010, J NEUROTRAUM, V27, P1439, DOI 10.1089/neu.2010.1328; Holloway R, 2007, ACTA NEUROCHIR, V149, P919, DOI 10.1007/s00701-007-1241-y; Hopwood SE, 2005, J CEREBR BLOOD F MET, V25, P391, DOI 10.1038/sj.jcbfm.9600050; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Hyder F, 2006, J CEREBR BLOOD F MET, V26, P865, DOI 10.1038/sj.jcbfm.9600263; Ip EY, 2003, J CEREBR BLOOD F MET, V23, P900, DOI 10.1097/01.WCB.0000076702.71231.F2; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Kinoshita K, 2002, J NEUROTRAUM, V19, P681, DOI 10.1089/08977150260139075; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Kokiko-Cochran ON, 2008, NEUROSCI LETT, V436, P27, DOI 10.1016/j.neulet.2008.02.046; Krishnappa IK, 1999, J NEUROTRAUM, V16, P213, DOI 10.1089/neu.1999.16.213; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Lee SM, 1999, ANN NY ACAD SCI, V893, P337, DOI 10.1111/j.1749-6632.1999.tb07849.x; Lin AL, 2010, P NATL ACAD SCI USA, V107, P8446, DOI 10.1073/pnas.0909711107; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; Marion Donald W, 2009, F1000 Med Rep, V1, DOI 10.3410/M1-42; Moro N, 2010, EXP NEUROL, V225, P391, DOI 10.1016/j.expneurol.2010.07.013; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Parkin MC, 2005, J CEREBR BLOOD F MET, V25, P402, DOI 10.1038/sj.jcbfm.9600051; Payne RS, 2003, BRAIN RES, V971, P9, DOI 10.1016/S0006-8993(03)02276-5; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Perner A, 2003, INTENS CARE MED, V29, P642, DOI 10.1007/s00134-002-1628-4; Prins ML, 2006, DEV NEUROSCI-BASEL, V28, P447, DOI 10.1159/000094170; Prins ML, 2009, J NEUROTRAUM, V26, P1083, DOI 10.1089/neu.2008-0769; Rice AC, 2002, BRAIN RES, V928, P156, DOI 10.1016/S0006-8993(01)03299-1; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; SCHUIER F, 1990, J CEREBR BLOOD F MET, V10, P765, DOI 10.1038/jcbfm.1990.134; SHAPIRA Y, 1995, J NEUROSURG ANESTH, V7, P17, DOI 10.1097/00008506-199501000-00004; SHAPIRA Y, 1992, ANESTHESIOLOGY, V77, P79, DOI 10.1097/00000542-199207000-00012; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Stover JF, 2002, INTENS CARE MED, V28, P1491, DOI 10.1007/s00134-002-1431-2; Suh SW, 2008, ANN NEUROL, V64, P654, DOI 10.1002/ana.21511; SUTTON RL, 1994, ACTA NEUROCHIR, P446; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Takahashi S, 2012, ASN NEURO, V4, P71, DOI 10.1042/AN20120002; Talmor D, 1998, ANESTH ANALG, V86, P1225, DOI 10.1097/00000539-199806000-00017; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa P, 2012, CRIT CARE MED, V40, P1923, DOI 10.1097/CCM.0b013e31824e0fcc; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Vink R, 1997, J CEREBR BLOOD F MET, V17, P50, DOI 10.1097/00004647-199701000-00007; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Yang M, 2009, INT J NURS STUD, V46, P753, DOI 10.1016/j.ijnurstu.2009.01.004; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021	86	23	26	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	OCT 16	2013	1535						124	136		10.1016/j.brainres.2013.08.044			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	236WY	WOS:000325831400012	23994447	Green Accepted			2022-02-06	
J	Sansonetti, D; Hoffmann, T				Sansonetti, Danielle; Hoffmann, Tammy			Cognitive assessment across the continuum of care: The importance of occupational performance-based assessment for individuals post-stroke and traumatic brain injury	AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL			English	Article						assessment outcomes; brain injury; cognition	STROKE REHABILITATION; TASK-ANALYSIS; IMPAIRMENTS; MANAGEMENT; THERAPISTS; DEMENTIA; PERCEIVE; RECALL; SYSTEM; PLAN	Background/aimWhen working with individuals following stroke or traumatic brain injury, an important role of the occupational therapist is to assess the impact of cognitive impairment on their ability to engage in occupations and resume important life roles. The aim of this study was to survey therapists' reasons for selection of and challenges with using various cognitive assessment approaches, across the continuum of care, when working with individuals following stroke and traumatic brain injury. MethodsA cross-sectional survey, completed via post or online, with responses from 209 Australian occupational therapists was conducted. Participants included clinicians working in acute, inpatient rehabilitation and community settings. ResultsOccupational performance-based assessments were ranked as the most important assessment method, with 69% of participants reporting using these assessments for more than 75% of their clients with cognitive impairment. Participants identified the lack of quantitative data provided by these assessments as a frequent challenge. The identification of cognitive deficits was the highest ranked reason for using cognitive screens and batteries. Challenges identified with using cognitive screens and batteries included difficulty linking assessment results to occupational performance, and difficulty using results to generate intervention strategies. The majority of participants reported using a combined approach to assessment, and used screens and batteries to support findings of occupational performance-based assessments. ConclusionsTargeted efforts to further incorporate standardised occupational performance-based methods into clinical practice, research, and ongoing professional development is required to enhance occupational therapy services when working with individuals with cognitive impairment.	[Sansonetti, Danielle] St Vincents Hosp, Occupat Therapy Dept, Melbourne, Vic 3101, Australia; [Sansonetti, Danielle] Eastern Hlth, Melbourne, Vic, Australia; [Hoffmann, Tammy] Bond Univ, Ctr Res Evidence Based Practice, Fac Hlth Sci & Med, Gold Coast, Qld, Australia; [Hoffmann, Tammy] Univ Queensland, Div Occupat Therapy, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia		Sansonetti, D (corresponding author), St Vincents Hosp, Occupat Therapy Dept, St Georges Hosp Campus,283 Cotham Rd, Melbourne, Vic 3101, Australia.	Danielle.Sansonetti@easternhealth.org.au	Hoffmann, Tammy/E-8029-2010	Hoffmann, Tammy/0000-0001-5210-8548			*AIHW, 2006, WE MAN STROK AUSTR; AIHW (Australian Institute of Health & Welfare), 2007, HOSP SEP DUE TRAUM B; Alotaibi NM, 2009, OCCUP THER HEALTH CA, V23, P302, DOI 10.3109/07380570903222583; Arthanat S, 2004, DISABIL REHABIL, V26, P235, DOI 10.1080/09638280310001644889; Aubin G, 2009, AUST OCCUP THER J, V56, P189, DOI 10.1111/j.1440-1630.2007.00725.x; BAUM C, 1993, AM J OCCUP THER, V47, P431, DOI 10.5014/ajot.47.5.431; Baum CM, 2010, NEUROPSYCHOLOGY EVER, P62; Douglas A, 2008, PHYS OCCUP THER GERI, V26, P13, DOI 10.1080/02703180801963758; Douglas Alison, 2007, Can J Occup Ther, V74, P370; Fry K, 2002, AUSTR OCCUPATIONAL T, V49, P182, DOI 10.1046/j.1440-1630.2002.00337.x; Gauggel S, 2000, J HEAD TRAUMA REHAB, V15, P710, DOI 10.1097/00001199-200002000-00009; Giles GM, 1998, COGNITION AND OCCUPATION IN REHABILITATION, P125; Groves D., 2010, OCCUPATIONAL THERAPY, V12, P20; Hartman-Maeir A, 2009, OCCUP THER HEALTH CA, V23, P1, DOI 10.1080/07380570802455516; Hartman-Maeir A, 2009, AM J OCCUP THER, V63, P592, DOI 10.5014/ajot.63.5.592; Koh CL, 2009, AUST OCCUP THER J, V56, P324, DOI 10.1111/j.1440-1630.2008.00764.x; Korner-Bitensky N, 2011, AUST OCCUP THER J, V58, P241, DOI 10.1111/j.1440-1630.2011.00943.x; Lee S S, 2001, Can J Occup Ther, V68, P41; Lewis MW, 2011, NEUROPSYCHOL REHABIL, V21, P145, DOI 10.1080/09602011.2010.543867; National Stroke Foundation, 2009, NAT STROK AUD AC SER; Nott MT, 2008, AUST OCCUP THER J, V55, P188, DOI 10.1111/j.1440-1630.2007.00685.x; NYGARD L, 1994, AM J OCCUP THER, V48, P689, DOI 10.5014/ajot.48.8.689; Ozdemir F, 2001, AM J PHYS MED REHAB, V80, P410, DOI 10.1097/00002060-200106000-00003; POOLE J, 1991, AM J OCCUP THER, V45, P1067; Salter K, 2005, DISABIL REHABIL, V27, P191, DOI 10.1080/09638280400008537; Sohlberg M., 2001, COGNITIVE REHABILITA; Toglia JP., 2009, WILLIARD SPACKMANS O, V11th ed., P739; Vining-Radomski M., 2008, OCCUPATIONAL THERAPY, P260; WHEATLEY CJ, 1994, AM J OCCUP THER, V48, P163, DOI 10.5014/ajot.48.2.163; Wilson BA, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P37, DOI 10.1017/CBO9780511581083.005; Woodford HJ, 2007, QJM-INT J MED, V100, P469, DOI 10.1093/qjmed/hcm051; World Health Organization, 2007, INT CLASS FUNCT DIS; Zwecker M, 2002, ARCH PHYS MED REHAB, V83, P342, DOI 10.1053/apmr.2002.29641	33	23	24	0	27	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0045-0766			AUST OCCUP THER J	Aust. Occup. Ther. J.	OCT	2013	60	5					334	342		10.1111/1440-1630.12069			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	228AM	WOS:000325157200005	24089985				2022-02-06	
J	Cripps, MW; Kutcher, ME; Daley, A; McCreery, RC; Greenberg, MD; Cachola, LM; Redick, BJ; Nelson, MF; Cohen, MJ				Cripps, Michael W.; Kutcher, Matthew E.; Daley, Aaron; McCreery, Ryan C.; Greenberg, Molly D.; Cachola, Leslie M.; Redick, Brittney J.; Nelson, Mary F.; Cohen, Mitchell Jay			Cause and timing of death in massively transfused trauma patients	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	Military Health Systems Research Symposium (MHSRS)	AUG 13-16, 2012	Fort Lauderdale, FL			Massive transfusion; cause of death; epidemiology of trauma	BLOOD-CELL RATIOS; EARLY COAGULOPATHY; EPIDEMIOLOGY; PLASMA; INJURY; IMPACT; HEMORRHAGE; MORTALITY; PLATELET	BACKGROUND: The purpose of this study was to characterize the cause of death in severely injured trauma patients to define potential responses to resuscitation. METHODS: Prospective analysis of 190 critically injured patients who underwent massive transfusion protocol (MTP) activation or received massive transfusion (910 U of packed red blood cells [RBC] per 24 hours). Cause of death was adjudicated into one of four categories as follows: (1) exsanguination, (2) early physiologic collapse, (3) late physiologic collapse, and (4) nonsurvivable injury. RESULTS: A total 190 patients underwent massive transfusion or MTP with 76 deaths (40% mortality), of whom 72 deaths were adjudicated to one of four categories: 33.3% died of exsanguination, 16.6% died of early physiologic collapse, 11.1% died of late physiologic collapse, while 38.8% died of nonsurvivable injuries. Patients who died of exsanguination were younger and had the highest RBC/fresh frozen plasma ratio (2.97 [2.24]), although the early physiologic collapse group survived long enough to use the most blood products (p < 0.001). The late physiologic collapse group had significantly fewer penetrating injuries, was older, and had significantly more crystalloid use but received a lower RBC/fresh frozen plasma ratio (1.50 [0.42]). Those who were determined to have a nonsurvivable injury had a lower presenting Glasgow Coma Scale (GCS) score, fewer penetrating injuries, and higher initial blood pressure reflecting a preponderance of nonsurvivable traumatic brain injury. The average survival time for patients with potentially survivable injuries was 2.4 hours versus 18.4 hours for nonsurvivable injuries (p < 0.001). CONCLUSION: Severely injured patients requiring MTP have a high mortality rate. However, no studies to date have addressed the cause of death after MTP. Characterization of cause of death will allow targeting of surgical and resuscitative conduct to allow extension of the physiologic reserve time, therefore rendering previously nonsurvivable injury potentially survivable. (J Trauma Acute Care Surg. 2013; 75: S255YS262. Copyright (C) 2013 by Lippincott Williams & Wilkins)	[Cripps, Michael W.] Univ Texas SW Med Ctr Dallas, Dept Surg, Div Burn Trauma Crit Care, Dallas, TX 75390 USA; [Kutcher, Matthew E.; McCreery, Ryan C.; Greenberg, Molly D.; Cachola, Leslie M.; Redick, Brittney J.; Nelson, Mary F.; Cohen, Mitchell Jay] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Surg, San Francisco, CA USA		Cripps, MW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Surg, Div Burn Trauma Crit Care, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	michael.cripps@utsouthwestern.edu		Cripps, Michael/0000-0002-1263-1876; Kutcher, Matthew/0000-0003-4566-5359	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K08GM085689] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K08 GM085689] Funding Source: Medline		BAKER CC, 1980, AM J SURG, V140, P144, DOI 10.1016/0002-9610(80)90431-6; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Cothren CC, 2007, WORLD J SURG, V31, P1507, DOI 10.1007/s00268-007-9087-2; Demetriades D, 2004, J AM COLL SURGEONS, V198, P20, DOI 10.1016/j.jamcollsurg.2003.09.003; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; Flaherty S, 2003, J TRAUMA, V54, P70; Ho AMH, 2012, BRIT J SURG, V99, P132, DOI 10.1002/bjs.7732; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Holcomb JB, 2007, ANN SURG, V245, P986, DOI 10.1097/01.sla.0000259433.03754.98; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kelly JF, 2008, J TRAUMA, V64, pS21, DOI 10.1097/TA.0b013e318160b9fb; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; Pang JM, 2008, INJURY, V39, P102, DOI 10.1016/j.injury.2007.05.022; Perkins JG, 2011, TRANSFUSION, V51, P242, DOI 10.1111/j.1537-2995.2010.02818.x; Potenza BM, 2004, J TRAUMA, V56, P68, DOI 10.1097/01.TA.0000101490.32972.9F; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Spinella PC, 2008, J TRAUMA, V64, pS69, DOI 10.1097/TA.0b013e318160ba2f; Stewart RM, 2003, J TRAUMA, V54, P66, DOI 10.1097/00005373-200301000-00009; Stinger HK, 2008, J TRAUMA, V64, pS79, DOI 10.1097/TA.0b013e318160a57b; Teixeira PGR, 2009, J TRAUMA, V66, P693, DOI 10.1097/TA.0b013e31817e5c77; Tien HC, 2007, J TRAUMA, V62, P142, DOI 10.1097/01.ta.0000251558.38388.47; Zehtabchi S, 2009, ACAD EMERG MED, V16, P371, DOI 10.1111/j.1553-2712.2009.00386.x	26	23	24	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2013	75			2			S255	S262		10.1097/TA.0b013e31829a24b4			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	300JV	WOS:000330461100028	23883917	Green Accepted			2022-02-06	
J	Eskandari, R; Filtz, MR; Davis, GE; Hoesch, RE				Eskandari, Ramin; Filtz, Michael R.; Davis, Gary E.; Hoesch, Robert E.			Effective treatment of refractory intracranial hypertension after traumatic brain injury with repeated boluses of 14.6% hypertonic saline Clinical article	JOURNAL OF NEUROSURGERY			English	Article						hypertonic saline solution; traumatic brain injury; intracranial pressure; refractory; intracranial hypertension; neurocritical care	SEVERE HEAD-INJURY; TRANSTENTORIAL HERNIATION; SODIUM-CHLORIDE; UNITED-STATES; MANNITOL; PRESSURE; CHILDREN; RESUSCITATION; THERAPY; MANAGEMENT	Object. Normal intracranial pressure (ICP) and cerebral perfusion pressure (CPP) have been identified as favorable prognostic factors in the outcome of patients with traumatic brain injuries (TBIs). Osmotic diuretics and hypertonic saline (HTS) are commonly used to treat elevated ICP in patients with TBI; however, sustained effects of repeated high-concentration HTS boluses for severely refractory ICP elevation have not been studied. The authors' goal in this study was to determine whether repeated 14.6% HTS boluses were efficacious in treating severely refractory intracranial hypertension in patients with TBI. Methods. In a prospective cohort study in a neurocritical care unit, adult TBI patients with sustained ICP > 30 mm Hg for more than 30 minutes after exhaustive medical and/or surgical therapy received repeated 15-minute boluses of 14.6% HTS over 12 hours through central venous access. Results. Response to treatment was evaluated in 11 patients. Within 5 minutes of bolus administration, mean ICP decreased from 40 to 33 mm Hg (30% reduction, p < 0.05). Intracranial pressure lowering effects were sustained for 12 hours (41% reduction, p < 0.05) with multiple boluses (mean number of boluses 7 +/- 5.5). The mean CPP increased 22% and 32% from baseline at 15 and 30 minutes, respectively (p < 0.05). The mean serum sodium level (S-Na) at baseline was 155 +/- 7.1 mEq/L, and after multiple boluses of 14.6% HTS, S-Na at 12 hours was 154 +/- 7.1 mEq/L. The mean heart rate, systolic blood pressure, blood urea nitrogen, and creatinine demonstrated no significant change throughout the study. Conclusions. The subset of TBI patients with intracranial hypertension that is completely refractory to all other medical therapies can be treated effectively and safely with repeated boluses of 14.6% HTS rather than a one-time dose.	[Eskandari, Ramin] Univ Utah, Dept Neurosurg, Salt Lake City, UT 84132 USA; [Hoesch, Robert E.] Univ Utah, Dept Neurol, Div Neurocrit Care, Salt Lake City, UT 84132 USA; [Filtz, Michael R.; Davis, Gary E.] Univ Utah Hosp, Dept Pharm Serv, Salt Lake City, UT USA		Hoesch, RE (corresponding author), Univ Utah, Dept Neurol, Div Neurocrit Care, 175 N Med Dr East, Salt Lake City, UT 84132 USA.	robert.hoesch@hsc.utah.edu					Balbino M, 2010, J TRAUMA, V68, P859, DOI 10.1097/TA.0b013e3181af69d3; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Beaumont A, 1999, CRIT REV NEUROSURG, V9, P207, DOI 10.1007/s003290050135; Bell Scott E, 2006, Curr Treat Options Neurol, V8, P167, DOI 10.1007/s11940-006-0007-9; Bhardwaj Anish, 2004, Curr Opin Crit Care, V10, P126, DOI 10.1097/00075198-200404000-00009; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Bratton SL, 2008, J NEUROTRAUM, V25, P276; Castillo LB, 2009, CRIT CARE RESUSC, V11, P151; Cohen H, 1924, BRIT MED J, V1924, P420, DOI 10.1136/bmj.1.3297.420; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; da Silva JC, 2010, NEUROL RES, V32, P139, DOI 10.1179/174313209X405119; Farahvar A, 2011, J NEUROSURG, V115, P191, DOI 10.3171/2011.4.JNS101116a; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Hartl R, 2008, CRIT CARE MED, V36, P1005, DOI 10.1097/CCM.0B013E318166FCF8; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; Himmelseher S, 2007, CURR OPIN ANESTHESIO, V20, P414, DOI 10.1097/ACO.0b013e3282eff9ea; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Kerwin AJ, 2009, J TRAUMA, V67, P277, DOI 10.1097/TA.0b013e3181acc726; Keyrouz SG, 2008, NEUROCRIT CARE, V9, P204, DOI 10.1007/s12028-008-9118-3; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Knapp JM, 2005, AACN ADV CRIT CARE, V16, P199, DOI 10.1097/00044067-200504000-00011; Koenig MA, 2008, NEUROLOGY, V70, P1023, DOI 10.1212/01.wnl.0000304042.05557.60; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Luostarinen T, 2011, NEUROCRIT CARE, V14, P238, DOI 10.1007/s12028-010-9475-6; Mirski MA, 2000, J NEUROSURG ANESTH, V12, P334, DOI 10.1097/00008506-200010000-00006; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; Munar F, 2000, J NEUROTRAUM, V17, P41, DOI 10.1089/neu.2000.17.41; Oddo M, 2009, J NEUROL NEUROSUR PS, V80, P916, DOI 10.1136/jnnp.2008.156596; Paredes-Andrade E, 2012, NEUROCRIT CARE, V17, P204, DOI 10.1007/s12028-011-9574-z; Qureshi AI, 1999, NEUROSURGERY, V44, P1055, DOI 10.1097/00006123-199905000-00064; Qureshi AI, 2002, J NEUROSURG ANESTH, V14, P22, DOI 10.1097/00008506-200201000-00005; Rockswold GL, 2009, NEUROSURGERY, V65, P1035, DOI 10.1227/01.NEU.0000359533.16214.04; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Saltarini M, 2002, Eur J Emerg Med, V9, P262, DOI 10.1097/00063110-200209000-00011; Schatzmann C, 1998, ACT NEUR S, V71, P31; Shackford SR, 1998, J TRAUMA, V44, P50, DOI 10.1097/00005373-199801000-00004; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Soustiel JF, 2006, BRAIN RES, V1101, P136, DOI 10.1016/j.brainres.2006.05.045; Strandvik GF, 2009, ANAESTHESIA, V64, P990, DOI 10.1111/j.1365-2044.2009.05986.x; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; Sutherland WD, 1911, BIOCHEM J, V5, P1; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; Wakai A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub2; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56; WORTHLEY LIG, 1988, J NEUROSURG, V68, P478, DOI 10.3171/jns.1988.68.3.0478; Yilmaz N, 2007, BRAIN RES, V1164, P132, DOI 10.1016/j.brainres.2007.06.017	50	23	23	3	8	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	AUG	2013	119	2					338	346		10.3171/2013.4.JNS121541			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	187CL	WOS:000322094400013	23706055				2022-02-06	
J	Raj, R; Siironen, J; Kivisaari, R; Hernesniemi, J; Tanskanen, P; Handolin, L; Skrifvars, MB				Raj, Rahul; Siironen, Jari; Kivisaari, Riku; Hernesniemi, Juha; Tanskanen, Paivi; Handolin, Lauri; Skrifvars, Markus B.			External Validation of the International Mission for Prognosis and Analysis of Clinical Trials Model and the Role of Markers of Coagulation	NEUROSURGERY			English	Article						Coagulation; Prognosis; Prognostic model; Traumatic brain injury; Validation	TRAUMATIC BRAIN-INJURY; ANTICOAGULATION; IMPACT; COAGULOPATHY; MODERATE; MORTALITY; INCREASE; DESIGN; SCORE	BACKGROUND: Markers of coagulation have shown to have important value in predicting traumatic brain injury outcome. OBJECTIVE: To externally validate and investigate the role of markers of coagulation for outcome prediction by using the International Mission for Prognosis and Analysis of Clinical Trials (IMPACT) model while adjusting for overall injury severity. METHODS: A retrospective chart analysis of traumatic brain injury patients admitted to Helsinki University Central Hospital between 2009 and 2010 was performed. Outcome was estimated by using the criteria of the IMPACT model. Admission international normalized ratio (INR) and platelet count were used as markers of coagulation. Overall injury severity was categorized with the injury severity score (ISS). Variables were added to the calculated IMPACT risk, generating new models. Model performance was assessed by analyzing and comparing the area under the curve (AUC) of the models. RESULTS: For 342 included patients, 6-month mortality was 32% and unfavorable neurological outcome was 36%. Patients with a poor outcome had lower platelets and higher INR and ISS than those with good outcome (P < .001). The IMPACT model had an AUC of 0.85 for predicting mortality and 0.81 for neurological outcome. Addition of INR but not ISS or platelets to the IMPACT predicted risk improved the predictive validity for mortality (Delta AUC 0.02, P = .034) but not neurological outcome (Delta AUC 0.00, P = .401). In multivariate analysis, INR remained significant for mortality but not for neurological outcome when adjusting for IMPACT risk and ISS (P = .012). CONCLUSION: The IMPACT model showed excellent performance, and INR was an independent predictor for mortality, independent of overall injury severity.	[Raj, Rahul; Siironen, Jari; Kivisaari, Riku; Hernesniemi, Juha] Univ Helsinki, Cent Hosp, Dept Neurosurg, FIN-00029 Helsinki, Finland; [Raj, Rahul; Tanskanen, Paivi; Skrifvars, Markus B.] Univ Helsinki, Cent Hosp, Dept Anaesthesiol & Intens Care Med, FIN-00029 Helsinki, Finland; [Handolin, Lauri] Univ Helsinki, Cent Hosp, Dept Orthoped & Traumatol, FIN-00029 Helsinki, Finland		Raj, R (corresponding author), Univ Helsinki, Cent Hosp, Dept Neurosurg, C-O Markus Skrifvars,Topeliuksenkatu 5,PL 266, FIN-00029 Helsinki, Finland.	rahul.raj@helsinki.fi	Raj, Rahul/K-7693-2012	Raj, Rahul/0000-0003-4243-9591	Division Of Mathematical SciencesNational Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS) [1106891] Funding Source: National Science Foundation		Ahmed N, 2009, SOUTH MED J, V102, P476, DOI 10.1097/SMJ.0b013e31819f97a3; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Franschman G, 2012, J NEUROTRAUM, V29, P128, DOI 10.1089/neu.2011.2044; Genet GF, 2013, J NEUROTRAUM, V30, P301, DOI 10.1089/neu.2012.2612; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; Ott MM, 2010, J TRAUMA, V68, P560, DOI 10.1097/TA.0b013e3181ad6600; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	26	23	23	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	AUG	2013	73	2					305	311		10.1227/01.neu.0000430326.40763.ec			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	299GD	WOS:000330383100045	23867260				2022-02-06	
J	Yi, X; Jin, GH; Zhang, XH; Mao, WF; Li, HM; Qin, JB; Shi, JH; Dai, K; Zhang, F				Yi, Xin; Jin, Guohua; Zhang, Xinhua; Mao, Weifeng; Li, Haoming; Qin, Jianbing; Shi, Jinhong; Dai, Kui; Zhang, Fan			Cortical Endogenic Neural Regeneration of Adult Rat after Traumatic Brain Injury	PLOS ONE			English	Article							STEM-CELLS; SUBVENTRICULAR ZONE; COGNITIVE FUNCTION; GENERATED NEURONS; CEREBRAL-CORTEX; RADIAL GLIA; NEUROGENESIS; NEOCORTEX; PROGENITOR; MIGRATION	Focal and diffuse neuronal loss happened after traumatic brain injury (TBI). With little in the way of effective repair, recent interest has focused on endogenic neural progenitor cells (NPCs) as a potential method for regeneration. Whether endogenic neural regeneration happened in the cortex of adult rat after TBI remains to be determined. In this study, rats were divided into a sham group and a TBI group, and the rat model of medium TBI was induced by controlled cortical impact. Rats were injected with BrdU at 1 to 7 days post-injury (dpi) to allow identification of differentiated cells and sacrificed at 1, 3, 7, 14 and 28 dpi for immunofluorescence. Results showed nestin(+)/sox-2(+) NPCs and GFAP(+)/sox-2(+) radial glial (RG)-like cells emerged in peri-injured cortex at 1, 3, 7, 14 dpi and peaked at 3 dpi. The number of GFAP(+)/sox-2(+) cells was less than that of nestin(+)/sox-2(+) cells. Nestin(+)/sox-2(+) cells from posterior periventricle (pPV) immigrated into peri-injured cortex through corpus callosum (CC) were found. DCX+/BrdU(+) newborn immature neurons in peri-injured cortex were found only at 3, 7, 14 dpi. A few MAP-2(+)/BrdU(+) newborn neurons in peri-injured cortex were found only at 7 and 14 dpi. NeuN(+)/BrdU(+) mature neurons were not found in peri-injured cortex at 1, 3, 7, 14 and 28 dpi. While GFAP(+)/BrdU(+) astrocytes emerged in peri-injured cortex at 1, 3, 7, 14, 28 dpi and peaked at 7 dpi then kept in a stable state. In the corresponding time point, the percentage of GFAP(+)/BrdU(+) astrocytes in BrdU(+) cells was more than that of NPCs or newborn neurons. No CNP+/BrdU(+) oligodendrocytes were found in peri-injured cortex. These findings suggest that NPCs from pPV and reactive RG-like cells emerge in peri-injured cortex of adult rats after TBI. It can differentiate into immature neurons and astrocytes, but the former fail to grow up to mature neurons.	[Yi, Xin] Soochow Univ, Coll Med, Dept Anat & Cytoneurobiol, Suzhou, Peoples R China; [Yi, Xin; Jin, Guohua; Zhang, Xinhua; Mao, Weifeng; Li, Haoming; Qin, Jianbing; Shi, Jinhong] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Dept Anat & Neurobiol, Nantong, Peoples R China; [Dai, Kui; Zhang, Fan] Nantong Univ, Xinglin Coll, Nantong, Peoples R China		Jin, GH (corresponding author), Nantong Univ, Jiangsu Key Lab Neuroregenerat, Dept Anat & Neurobiol, Nantong, Peoples R China.	jguohua@ntu.edu.cn		Zhang, Xin-hua/0000-0002-5702-6733	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31271138]; Jiangsu Natural Science FoundationNatural Science Foundation of Jiangsu Province [BK2012659]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 31271138), the Jiangsu Natural Science Foundation (Grant No. BK2012659), and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AI, 2012, J NEUROTRAUM, V29, P828, DOI 10.1089/neu.2011.1923; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Boockvar JA, 2005, NEUROSURGERY, V56, P163, DOI 10.1227/01.NEU.0000145866.25433.FF; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Ghashghaei HT, 2007, GENE DEV, V21, P3258, DOI 10.1101/gad.1580407; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Itoh T, 2005, NEUROREPORT, V16, P1687, DOI 10.1097/01.wnr.0000183330.44112.ab; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kornack DR, 2001, SCIENCE, V294, P2127, DOI 10.1126/science.1065467; Leavitt BR, 1999, EXP NEUROL, V157, P43, DOI 10.1006/exnr.1999.6982; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Li HM, 2011, IN VITRO CELL DEV-AN, V47, P431, DOI 10.1007/s11626-011-9422-7; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Otero L, 2012, HISTOL HISTOPATHOL, V27, P303, DOI 10.14670/HH-27.303; Oya S, 2009, NEUROSCIENCE, V158, P683, DOI 10.1016/j.neuroscience.2008.10.043; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Quinones-Hinojosa A, 2006, J COMP NEUROL, V494, P415, DOI 10.1002/cne.20798; Rakic P, 2004, NATURE, V427, P685, DOI 10.1038/427685a; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Richardson RM, 2006, ACTA NEUROCHIR, V148, P773, DOI 10.1007/s00701-006-0778-5; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Xuan WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053454; Zhao CS, 2008, EPILEPSIA, V49, P3, DOI 10.1111/j.1528-1167.2008.01632.x	38	23	25	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70306	10.1371/journal.pone.0070306			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	WOS:000323369700168	23922973	Green Published, Green Submitted, gold			2022-02-06	
J	Bose, P; Hou, JM; Nelson, R; Nissim, N; Parmer, R; Keener, J; Wacnik, PW; Thompson, FJ				Bose, Prodip; Hou, Jiamei; Nelson, Rachel; Nissim, Nicole; Parmer, Ron; Keener, Jonathon; Wacnik, Paul W.; Thompson, Floyd J.			Effects of Acute Intrathecal Baclofen in an Animal Model of TBI-Induced Spasticity, Cognitive, and Balance Disabilities	JOURNAL OF NEUROTRAUMA			English	Article						ankle torque; EMG, GABA(b); ITB; TBI spasticity	TRAUMATIC BRAIN-INJURY; MOTONEURONS IN-VIVO; PERSISTENT INWARD CURRENT; DEPENDENT ANKLE TORQUE; DIFFUSE AXONAL INJURY; SPINAL-CORD; LOCUS-CERULEUS; VESTIBULAR COMPENSATION; OVERGROUND LOCOMOTION; SYSTEMATIC VARIATIONS	Spasticity is a major health problem for patients with traumatic brain injury (TBI). In addition to spasticity, TBI patients exhibit enduring cognitive, balance, and other motor impairments. Although the use of antispastic medications, particularly ITB, can decrease the severity of TBI-induced spasticity, current guidelines preclude the use of ITB during the first year after TBI. Therefore, the present study was performed to quantitate disability in an animal model of closed-head TBI (cTBI; Mararou's model) after ITB treatment. After cTBI, significant deficits in spasticity and gait, cognitive, balance, and anxiety-like behaviors were detected. ITB (Lioresal (R)) or saline was administered using Alzet pumps (0.8 mu g/hour for 4 weeks). Spasticity measures using velocity-dependent ankle torque and ankle extensor muscle electromyography recordings, footprints (gait), balance performance tests, serial learning, and anxiety-like behaviors were performed at multiple post-treatment and -withdrawal of ITB time points. Our data indicated that 1 month of ITB treatment initiated at post-TBI week 1 blocked the early onset of spasticity and significantly attenuated late-onset spasticity and anxiety-like behavior with no significant adverse effects on cognitive and balance performance. This improved spasticity outcome was accompanied by marked up-regulation of gamma-aminobutyric acid (GABA)/GABA(b), norepinephrine, and brain-derived neurotrophic factor expression in spinal cord tissue. Early intervention with ITB treatment was safe, feasible, and effective in this cTBI animal model. Collectively, these data provide a strong molecular footprint of enhanced expression of reflex regulation by presynaptic inhibition. The possibility that acute ITB treatment may decrease maladaptive segmental and descending plasticity is discussed. The data provided by the present animal model initiates a pre-clinical platform for safety, feasibility, and efficacy of early ITB intervention after TBI.	[Bose, Prodip; Nelson, Rachel; Nissim, Nicole; Parmer, Ron; Thompson, Floyd J.] North Florida South Georgia VA Hlth Syst, Brain Rehabil Res Ctr 151, Gainesville, FL USA; [Bose, Prodip; Hou, Jiamei; Keener, Jonathon; Thompson, Floyd J.] Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA; [Bose, Prodip] Univ Florida, Dept Neurol, Gainesville, FL USA; [Thompson, Floyd J.] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Wacnik, Paul W.] Medtronic Inc, Neuromodulat Targeted Drug Delivery, Minneapolis, MN USA		Bose, P (corresponding author), Malcom Randal VA Med Ctr, Brain Rehabil Res Ctr 151, 1601 Southwest Archer Rd, Gainesville, FL 32608 USA.	prodip.bose@va.gov			Medtronic Inc.Medtronic; Department of Veteran AffairsUS Department of Veterans Affairs [B6570R, B78071, B7345S]; Veterans AffairsUS Department of Veterans Affairs [I01RX000502] Funding Source: NIH RePORTER	This work was supported by Medtronic Inc. and the Department of Veteran Affairs (Rehabilitation R&D Merit Review B6570R; R&D Merit B78071; R&D RCS B7345S).	Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Arolfo MP, 1998, HIPPOCAMPUS, V8, P109, DOI 10.1002/(SICI)1098-1063(1998)8:2<109::AID-HIPO2>3.3.CO;2-9; Balaban CD, 2000, NEUROSCIENCE, V99, P669, DOI 10.1016/S0306-4522(00)00232-3; Beaumont A, 2000, NEUROL RES, V22, P665; Bennett DJ, 1996, J PHYSIOL-LONDON, V495, P835, DOI 10.1113/jphysiol.1996.sp021636; Bennett DJ, 1998, J NEUROPHYSIOL, V80, P2023, DOI 10.1152/jn.1998.80.4.2023; BETTS RP, 1978, J NEUROL NEUROSUR PS, V41, P791, DOI 10.1136/jnnp.41.9.791; Bose P, 2002, J NEUROTRAUM, V19, P1231, DOI 10.1089/08977150260338029; Bose P.K., 2002, J NEUROTRAUM, V19, P1229; Bose PK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00258; BOWERY NG, 1980, NATURE, V283, P92, DOI 10.1038/283092a0; BOYESON MG, 1990, PHARMACOL BIOCHEM BE, V35, P497, DOI 10.1016/0091-3057(90)90279-Q; Campbell M, 2005, BRAIN INJURY, V19, P1095, DOI 10.1080/02699050500188898; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; CLARKE KA, 1992, BEHAV RES METH INSTR, V24, P407, DOI 10.3758/BF03203570; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; DENNIS T, 1985, N-S ARCH PHARMACOL, V331, P225, DOI 10.1007/BF00634242; Drake RG, 2003, ANN PHARMACOTHER, V37, P1177, DOI 10.1345/aph.1C465; DUNNMEYNELL A, 1994, BRAIN RES, V660, P88, DOI 10.1016/0006-8993(94)90842-7; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; FOSTER GA, 1989, BRAIN RES BULL, V22, P131, DOI 10.1016/0361-9230(89)90137-8; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Francisco GE, 2005, BRAIN INJURY, V19, P359, DOI 10.1080/02699050400003999; FUKUDA H, 1977, EUR J PHARMACOL, V44, P17; Garcia C, 2003, NEUROSCIENCE, V119, P721, DOI 10.1016/S0306-4522(03)00192-1; Gladden MH, 2000, J PHYSIOL-LONDON, V527, P213, DOI 10.1111/j.1469-7793.2000.00213.x; Gottshall K, 2011, NEUROREHABILITATION, V29, P167, DOI 10.3233/NRE-2011-0691; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Heskin-Sweezie R, 2010, NEUROSCIENCE, V169, P302, DOI 10.1016/j.neuroscience.2010.04.008; HOUNSGAARD J, 1984, EXP BRAIN RES, V55, P391; JANKOWSKA E, 1993, J PHYSIOL-LONDON, V461, P705, DOI 10.1113/jphysiol.1993.sp019537; JIMENEZ I, 1991, EXP BRAIN RES, V85, P103; KERNELL D, 1979, BRAIN RES, V160, P159, DOI 10.1016/0006-8993(79)90612-7; Khoshbouei H, 2002, PHARMACOL BIOCHEM BE, V71, P407, DOI 10.1016/S0091-3057(01)00683-9; KROIN JS, 1993, J NEUROSURG, V79, P544, DOI 10.3171/jns.1993.79.4.0544; Lee RH, 2003, J NEUROPHYSIOL, V89, P27, DOI 10.1152/jn.00137.2002; Lee RH, 1998, J NEUROPHYSIOL, V80, P572, DOI 10.1152/jn.1998.80.2.572; Lee RH, 1998, J NEUROPHYSIOL, V80, P583, DOI 10.1152/jn.1998.80.2.583; Lee RH, 1999, J NEUROPHYSIOL, V81, P2164, DOI 10.1152/jn.1999.81.5.2164; Lee RH, 2000, J NEUROSCI, V20, P6734, DOI 10.1523/JNEUROSCI.20-17-06734.2000; Li Y, 2004, J NEUROPHYSIOL, V92, P2694, DOI 10.1152/jn.00164.2004; Loy DN, 2002, EXP NEUROL, V177, P575, DOI 10.1006/exnr.2002.7959; Luft AR, 2002, EXP BRAIN RES, V142, P562, DOI 10.1007/s00221-001-0952-1; Luft AR, 2001, EXP BRAIN RES, V140, P112, DOI 10.1007/s002210100805; Magnuson DSK, 1999, EXP NEUROL, V156, P191, DOI 10.1006/exnr.1999.7016; Magnusson AK, 1998, BRAIN RES, V795, P307, DOI 10.1016/S0006-8993(98)00329-1; Magnusson AK, 2000, EXP BRAIN RES, V134, P32, DOI 10.1007/s002210000438; MALCANGIO M, 1993, NEUROSCI LETT, V158, P189, DOI 10.1016/0304-3940(93)90261-I; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Matsuyama K, 2004, PROG BRAIN RES, V143, P239, DOI 10.1016/S0079-6123(03)43024-0; McGuire L, 2011, EPIDEMIOLOGY TRAUMAT; McNamara RK, 1996, PHARMACOL BIOCHEM BE, V53, P303, DOI 10.1016/0091-3057(95)02025-X; Meythaler JM, 1999, ARCH PHYS MED REHAB, V80, P13, DOI 10.1016/S0003-9993(99)90301-5; Meythaler JM, 2003, ARCH PHYS MED REHAB, V84, P638, DOI 10.1016/S0003-9993(03)00105-9; Meythaler JM, 1997, J NEUROSURG, V87, P415, DOI 10.3171/jns.1997.87.3.0415; Meythaler JM, 2001, STROKE, V32, P2099, DOI 10.1161/hs0901.095682; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; NG HK, 1994, CLIN NEUROL NEUROSUR, V96, P24, DOI 10.1016/0303-8467(94)90025-6; POMPEIANO O, 1990, NEUROSCIENCE, V35, P227, DOI 10.1016/0306-4522(90)90078-I; POMPEIANO O, 1989, PROG BRAIN RES, V80, P329; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; PRICE GW, 1984, NATURE, V307, P71, DOI 10.1038/307071a0; QUEVEDO J, 1992, EXP BRAIN RES, V91, P29; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; REIER PJ, 1992, J NEUROTRAUM, V9, pS223; Rifici C, 1994, Funct Neurol, V9, P29; SALTUARI L, 1989, LANCET, V2, P503; SAWYNOK J, 1987, PHARMACOL BIOCHEM BE, V26, P463, DOI 10.1016/0091-3057(87)90148-1; SAWYNOK J, 1986, BRAIN RES, V386, P341, DOI 10.1016/0006-8993(86)90171-X; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; SCHUERGER RJ, 1993, EXP BRAIN RES, V92, P351; SCHWINDT P, 1980, J NEUROPHYSIOL, V43, P1296, DOI 10.1152/jn.1980.43.5.1296; SCHWINDT PC, 1980, J NEUROPHYSIOL, V43, P1700, DOI 10.1152/jn.1980.43.6.1700; Singer BJ, 2004, ARCH PHYS MED REHAB, V85, P1465, DOI 10.1016/j.apmr.2003.08.103; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Theiss RD, 2005, NEUROSCIENCE, V134, P803, DOI 10.1016/j.neuroscience.2005.04.041; Thompson F.J., 2002, J NEUROTRAUM, V19, P233; THOMPSON FJ, 1992, J NEUROPHYSIOL, V68, P1473, DOI 10.1152/jn.1992.68.5.1473; Thompson FJ, 1996, NEUROREPORT, V7, P2273; THOMPSON FJ, 1993, ADV NEUROL, V59, P175; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wang DC, 2002, J NEUROTRAUM, V19, P875, DOI 10.1089/08977150260190465; WINOCUR G, 1990, CAN J PSYCHOL, V44, P435, DOI 10.1037/h0084270; YARKONY GM, 1987, CLIN ORTHOP RELAT R, P93; Zarrindast MR, 2001, EUR J PHARMACOL, V411, P283, DOI 10.1016/S0014-2999(00)00906-7	88	23	23	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2013	30	13					1177	1191		10.1089/neu.2012.2740			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	174WB	WOS:000321186400009	23268729				2022-02-06	
J	Du, Q; Yang, DB; Shen, YF; Yu, WH; Zhang, ZY; Zhu, Q; Che, ZH; Liu, QJ; Wang, H; Dong, XQ				Du, Quan; Yang, Ding-Bo; Shen, Yong-Feng; Yu, Wen-Hua; Zhang, Zu-Yong; Zhu, Qiang; Che, Zhi-Hao; Liu, Qun-Jie; Wang, Hao; Dong, Xiao-Qiao			Plasma leptin level predicts hematoma growth and early neurological deterioration after acute intracerebral hemorrhage	PEPTIDES			English	Article						Leptin; Intracerebral hemorrhage; Hematoma growth; Early neurological deterioration; Biomarker	TRAUMATIC BRAIN-INJURY; CLINICAL-OUTCOMES; STROKE; INFLAMMATION	Higher plasma leptin levels have been associated with poor clinical outcomes after intracerebral hemorrhage. Nevertheless, their links with hematoma growth and early neurological deterioration are unknown. Therefore, we aimed to investigate the relationship between plasma leptin levels, hematoma growth, and early neurological deterioration in patients with acute intracerebral hemorrhage. We prospectively studied 102 consecutive patients with acute spontaneous basal ganglia hemorrhage presenting within 6 h from symptoms onset. Significant hematoma growth was defined as hematoma enlargement >33% at 24 h. Early neurological deterioration was defined as an increase of >= 4 points in National Institute of Health Stroke Scale score at 24 h from symptoms onset. We measured plasma leptin levels on admission using an enzyme-linked immunosorbent assay in a blinded fashion. In multivariate logistic regression analysis, plasma leptin level emerged as the independent predictor of hematoma growth (odds ratio, 1.182; 95% confidence interval, 1.061-2.598; P = 0.008) and early neurological deterioration (odds ratio, 1.193; 95% confidence interval, 1.075-2.873; P = 0.004). Using receiver operating characteristic curves, we calculated areas under the curve for hematoma growth (area under curve, 0.844; 95% confidence interval, 0.759-0.908) and early neurological deterioration (area under curve, 0.857; 95% confidence interval, 0.774-0.918). The predictive performance of leptin was similar to, but did not obviously improve that of hematoma volume. Thus, leptin may help in the prediction of hematoma growth and early neurological deterioration after intracerebral hemorrhage. (c) 2013 Elsevier Inc. All rights reserved.	[Du, Quan; Yang, Ding-Bo; Shen, Yong-Feng; Yu, Wen-Hua; Zhang, Zu-Yong; Zhu, Qiang; Che, Zhi-Hao; Liu, Qun-Jie; Wang, Hao; Dong, Xiao-Qiao] Nanjing Med Univ, Peoples Hosp Hangzhou 1, Dept Neurosurg, Hangzhou 310006, Zhejiang, Peoples R China		Dong, XQ (corresponding author), Nanjing Med Univ, Peoples Hosp Hangzhou 1, Dept Neurosurg, 261 Huansha Rd, Hangzhou 310006, Zhejiang, Peoples R China.	dxqhyy@163.com			Hangzhou Medical Research Fund Scheme A Class Project [2011A014]	This study was supported by a grant from Hangzhou Medical Research Fund Scheme A Class Project (No. 2011A014).	Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Brown R, 2008, NEUROSCI LETT, V432, P73, DOI 10.1016/j.neulet.2007.12.008; Carbone F, 2012, BIOCHIMIE, V94, P2082, DOI 10.1016/j.biochi.2012.05.018; Carlton ED, 2012, HORM BEHAV, V62, P272, DOI 10.1016/j.yhbeh.2012.04.010; Davis SM, 2006, NEUROLOGY, V66, P1175, DOI 10.1212/01.wnl.0000208408.98482.99; Delcourt C, 2012, NEUROLOGY, V79, P314, DOI 10.1212/WNL.0b013e318260cbba; DENNIS MS, 1993, STROKE, V24, P796, DOI 10.1161/01.STR.24.6.796; Dong XQ, 2010, WORLD NEUROSURG, V74, P286, DOI 10.1016/j.wneu.2010.02.019; Kim CK, 2013, J CEREBR BLOOD F MET, V33, P944, DOI 10.1038/jcbfm.2013.35; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; La Cava Antonio, 2012, Inflammation & Allergy Drug Targets, V11, P298; Lin C, 2012, PEPTIDES, V35, P166, DOI 10.1016/j.peptides.2012.03.024; Otero M, 2006, RHEUMATOLOGY, V45, P944, DOI 10.1093/rheumatology/kel157; Paz G, 2012, ARQ BRAS ENDOCRINOL, V56, P597, DOI 10.1590/S0004-27302012000900001; Rajendran K, 2012, THROMB J, V10, DOI 10.1186/1477-9560-10-13; Soderberg S, 2003, CEREBROVASC DIS, V15, P63, DOI 10.1159/000067128; Soderberg S, 1999, STROKE, V30, P328, DOI 10.1161/01.STR.30.2.328; Valerio A, 2009, STROKE, V40, P610, DOI 10.1161/STROKEAHA.108.528588; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Wang JA, 2010, PROG NEUROBIOL, V92, P463, DOI 10.1016/j.pneurobio.2010.08.001; Wei YZ, 2008, J PHARM PHARMACOL, V60, P1667, DOI 10.1211/jpp/60.12.0013; Zhang X, 2013, PEPTIDES, V43, P133, DOI 10.1016/j.peptides.2013.03.010; Zhao QJ, 2012, CLIN EXP HYPERTENS, V34, P161, DOI 10.3109/10641963.2011.561902	23	23	25	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	JUL	2013	45						35	39		10.1016/j.peptides.2013.04.017			5	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	170KW	WOS:000320850300006	23659863				2022-02-06	
J	Hayakawa, M; Gando, S; Ieko, M; Honma, Y; Homma, T; Yanagida, Y; Kubota, N; Uegaki, S; Sawamura, A; Asakura, H				Hayakawa, Mineji; Gando, Satoshi; Ieko, Masahiro; Honma, Yoshinori; Homma, Taeko; Yanagida, Yuichiro; Kubota, Nobuhiko; Uegaki, Shinji; Sawamura, Atsushi; Asakura, Hidesaku			MASSIVE AMOUNTS OF TISSUE FACTOR INDUCE FIBRINOGENOLYSIS WITHOUT TISSUE HYPOPERFUSION IN RATS	SHOCK			English	Article						Fibrin fibrinogen degradation products; fibrinolysin; fibrinolysis; multiple trauma; thromboplastin	TRAUMATIC BRAIN-INJURY; ACUTE COAGULOPATHY; MOLECULAR-MECHANISMS; HEAD-INJURY; PROTEIN-C; COAGULATION; MODELS; FIBRINOLYSIS; PATHOPHYSIOLOGY; DISORDERS	Trauma-induced tissue factor (TF) release into the systemic circulation is considered to play an important role in the development of disseminated intravascular coagulation (DIC) immediately after severe trauma. However, the relationship between TF and hyperfibrinolysis, especially fibrinogenolysis, has been unclear. A total of 18 rats were divided into three groups: (a) the control group was infused with normal saline; (b) the low-dose group was infused with 4 U/kg TF; and (c) the high-dose group was infused with 16 U/kg TF. Arterial blood was drawn immediately and 2 and 4 h after the start of TF infusion. At each sampling point, arterial blood gases, platelet counts, and coagulation variables were measured. The fibrinogen degradation products were evaluated by a Western blot analysis. Hypotension, hypoxemia, and lactic acidosis were not observed in any of the three groups. In proportion to the doses of TF, the platelet counts, coagulation, and fibrinolysis variables deteriorated in line with DIC. The alpha 2-plasmin inhibitor levels significantly decreased in the high-dose group compared with the other groups. The amounts of fibrinogen degradation products increased in proportion to the doses of TF. The plasmin-alpha 2-plasmin inhibitor complex level in the high-dose group increased more than that of the other groups. In conclusion, TF can induce DIC associated with fibrinolysis and fibrinogenolysis without tissue hypoperfusion. The decrease in the alpha 2-plasmin inhibitor level and the significant increase in the plasmin level may be the two main factors underlying the pathogenesis of hyperfibrin(ogen)olysis after TF administration.	[Hayakawa, Mineji; Gando, Satoshi; Honma, Yoshinori; Homma, Taeko; Yanagida, Yuichiro; Kubota, Nobuhiko; Uegaki, Shinji; Sawamura, Atsushi] Hokkaido Univ, Grad Sch Med, Dept Anesthesiol & Crit Care Med, Div Acute & Crit Care Med, Sapporo, Hokkaido, Japan; [Ieko, Masahiro] Hlth Sci Univ Hokkaido, Sch Dent, Dept Internal Med, Sapporo, Hokkaido, Japan; [Asakura, Hidesaku] Kanazawa Univ, Sch Med, Dept Internal Med 3, Kanazawa, Ishikawa 920, Japan		Hayakawa, M (corresponding author), Hokkaido Univ Hosp, Emergency & Crit Care Ctr, Kita Ku, N14W5, Sapporo, Hokkaido 0608648, Japan.	mineji@dream.com	Hayakawa, Mineji/G-2263-2012; Gando, Satoshi/T-7407-2019	Gando, Satoshi/0000-0002-3525-0750	Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [23792068]; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [25462818] Funding Source: KAKEN	Financial support was received from Grant-in-Aid for Young Scientists (B) (no. 23792068) from the Japan Society for the Promotion of Science.	Asakura H, 2003, BLOOD COAGUL FIBRIN, V14, P221, DOI 10.1097/01.mbc.0000061290.28953.57; Asakura H, 2002, CRIT CARE MED, V30, P161, DOI 10.1097/00003246-200201000-00023; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Chandler WL, 2010, AM J CLIN PATHOL, V134, P90, DOI 10.1309/AJCP3WPOYSKK6BFE; Cohen MJ, 2012, ANN SURG, V255, P379, DOI 10.1097/SLA.0b013e318235d9e6; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Dunbar NM, 2009, TRANSFUSION, V49, P2652, DOI 10.1111/j.1537-2995.2009.02335.x; Frith D, 2012, THROMB RES, V129, P551, DOI 10.1016/j.thromres.2011.11.053; Gando S, 1999, J TRAUMA, V46, P1070, DOI 10.1097/00005373-199906000-00018; GANDO S, 1992, CRIT CARE MED, V20, P594, DOI 10.1097/00003246-199205000-00009; Gando S, 2011, ANN SURG, V254, P10, DOI 10.1097/SLA.0b013e31821221b1; Gando S, 2009, J TRAUMA, V67, P381, DOI 10.1097/TA.0b013e3181a84f63; Hardy JF, 2005, VOX SANG, V89, P123, DOI 10.1111/j.1423-0410.2005.00678.x; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Kashuk JL, 2010, ANN SURG, V252, P434, DOI 10.1097/SLA.0b013e3181f09191; KOOISTRA T, 1994, INT J HEMATOL, V59, P233; Kushimoto S, 2003, J NEUROTRAUM, V20, P357, DOI 10.1089/089771503765172318; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Medved L, 2003, THROMB HAEMOSTASIS, V89, P409; Parr MJ, 2008, J TRAUMA, V65, P766, DOI 10.1097/TA.0b013e31818606d2; Rijken DC, 2009, J THROMB HAEMOST, V7, P4, DOI 10.1111/j.1538-7836.2008.03220.x; RISBERG B, 1986, CRIT CARE MED, V14, P917, DOI 10.1097/00003246-198611000-00001; Sawamura A, 2009, THROMB RES, V124, P608, DOI 10.1016/j.thromres.2009.06.034; Tsurupa G, 2001, BIOCHEMISTRY-US, V40, P801, DOI 10.1021/bi001789t; Wada H, 2010, THROMB RES, V125, P6, DOI 10.1016/j.thromres.2009.08.017; WEITZ JI, 1991, J CLIN INVEST, V87, P1082, DOI 10.1172/JCI115069	28	23	23	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1073-2322			SHOCK	Shock	JUN	2013	39	6					514	519		10.1097/SHK.0b013e318293980d			6	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	147WL	WOS:000319200700008	23542400	Green Submitted			2022-02-06	
J	Macdonald, RL; Jaja, B; Cusimano, MD; Etminan, N; Hanggi, D; Hasan, D; Ilodigwe, D; Lantigua, H; Le Roux, P; Lo, B; Louffat-Olivares, A; Mayer, S; Molyneux, A; Quinn, A; Schweizer, TA; Schenk, T; Spears, J; Todd, M; Torner, J; Vergouwen, MDI; Wong, GKC; Singh, J				Macdonald, R. Loch; Jaja, Blessing; Cusimano, Michael D.; Etminan, Nima; Hanggi, Daniel; Hasan, David; Ilodigwe, Don; Lantigua, Hector; Le Roux, Peter; Lo, Benjamin; Louffat-Olivares, Ada; Mayer, Stephan; Molyneux, Andrew; Quinn, Audrey; Schweizer, Tom A.; Schenk, Thomas; Spears, Julian; Todd, Michael; Torner, James; Vergouwen, Mervyn D. I.; Wong, George K. C.; Singh, Jeff		SAHIT Collaboration	SAHIT Investigators-on the Outcome of Some Subarachnoid Hemorrhage Clinical Trials	TRANSLATIONAL STROKE RESEARCH			English	Article						Clinical trial; Outcome; Subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; ACUTE STROKE TRIALS; COMMUNICATING ARTERY ANEURYSM; CEREBRAL INFARCTION; MAGNESIUM-SULFATE; COOPERATIVE ANEURYSM; STATISTICAL-ANALYSIS; RANDOMIZED-TRIAL; GRADE PATIENTS; DOUBLE-BLIND	Outcome of patients with aneurysmal subarachnoid hemorrhage (SAH) has improved over the last decades. Yet, case fatality remains nearly 40 % and survivors often have permanent neurological, cognitive and/or behavioural sequelae. Other than nimodipine drug or clinical trials have not consistently improved outcome. We formed a collaboration of SAH investigators to create a resource for prognostic analysis and for studies aimed at optimizing the design and analysis of phase 3 trials in aneurysmal SAH. We identified investigators with data from randomized, clinical trials of patients with aneurysmal SAH or prospectively collected single- or multicentre databases of aneurysmal SAH patients. Data are being collected and proposals to use the data and to design future phase 3 clinical trials are being discussed. This paper reviews some issues discussed at the first meeting of the SAH international trialists (SAHIT) repository meeting. Investigators contributed or have agreed to contribute data from several phase 3 trials including the tirilazad trials, intraoperative hypothermia for aneurysmal SAH trial, nicardipine clinical trials, international subarachnoid aneurysm trial, intravenous magnesium sulphate for aneurysmal SAH, magnesium for aneurysmal SAH and from prospectively-collected data from four institutions. The number of patients should reach 15,000. Some industry investigators refused to provide data and others reported that their institutional research ethics boards would not permit even deidentified or anonymized data to be included. Others reported conflict of interest that prevented them from submitting data. The problems with merging data were related to lack of common definitions and coding of variables, differences in outcome scales used, and times of assessment. Some questions for investigation that arose are discussed. SAHIT demonstrates the possibility of SAH investigators to contribute data for collaborative research. The problems are similar to those already documented in other similar collaborative efforts such as in head injury research. We encourage clinical trial and registry investigators to contact us and participate in SAHIT. Key issues moving forward will be to use common definitions (common data elements), outcomes analysis, and to prioritize research questions, among others.	[Macdonald, R. Loch; Jaja, Blessing; Cusimano, Michael D.; Ilodigwe, Don; Lo, Benjamin; Louffat-Olivares, Ada; Schweizer, Tom A.; Spears, Julian] Univ Toronto, St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Etminan, Nima; Hanggi, Daniel] Univ Dusseldorf, Fac Med, Dept Neurosurg, D-40225 Dusseldorf, Germany; [Hasan, David; Todd, Michael; Torner, James] Univ Iowa, Iowa City, IA USA; [Lantigua, Hector; Mayer, Stephan] Columbia Univ, New York, NY USA; [Le Roux, Peter] Univ Penn, Philadelphia, PA 19104 USA; [Molyneux, Andrew] Univ Oxford, Oxford, England; [Quinn, Audrey] Gen Infirm, Leeds LS1 3EX, W Yorkshire, England; [Schenk, Thomas] Kings Coll London, London WC2R 2LS, England; [Vergouwen, Mervyn D. I.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Wong, George K. C.] Chinese Univ Hong Kong, Ma Liu Shui, Hong Kong, Peoples R China; [Macdonald, R. Loch] Univ Toronto, St Michaels Hosp, Div Neurosurg,Labatt Family Ctr Excellence Brain, Keenan Res Ctr,Li Ka Shing Knowledge Inst,Dept Su, Toronto, ON M5B 1W8, Canada; [Singh, Jeff] Univ Toronto, Univ Hlth Network, Toronto, ON M5B 1W8, Canada		Macdonald, RL (corresponding author), Univ Toronto, St Michaels Hosp, Div Neurosurg,Labatt Family Ctr Excellence Brain, Keenan Res Ctr,Li Ka Shing Knowledge Inst,Dept Su, 30 Bond St, Toronto, ON M5B 1W8, Canada.	MacdonaldLo@smh.ca	Cusimano, Michael/X-4059-2019; Wong, George Kwok Chu/L-4344-2016; Wong, George KC/A-6378-2011	Wong, George KC/0000-0002-6078-2548; Cusimano, Michael/0000-0002-9989-0650; Singh, Jeffrey/0000-0003-3499-574X; hasan, david/0000-0002-8335-5442	Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR); Physicians Services Incorporated Foundation; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Brain Aneurysm Foundation; Integra; Heart and Stroke Foundation of CanadaHeart & Stroke Foundation of Canada; Canadian Stroke Network; Medical Research Council UKUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Cerecyte Coil Trial; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Ontario Ministry of Research and InnovationMinistry of Research and Innovation, Ontario; Netherlands Thrombosis Foundation; Netherlands Heart FoundationNetherlands Heart Foundation; Hong Kong Food and Health Bureau; Hong Kong University Grant Committee	Funded by a grant from the Canadian Institutes for Health Research.; Michael D. Cusimano receives grant support from the Canadian Institutes for Health Research. Nima Etminan receives grant support from Physicians Services Incorporated Foundation. David Hasan receives grant funding from National Institutes of Health and Brain Aneurysm Foundation. Peter Le Roux receives research funding from the National Institutes of Health and Integra and is a consultant for Codman, Integra and Edge Therapeutics. R. Loch Macdonald receives grant funding from the Canadian Institutes for Health Research, Heart and Stroke Foundation of Canada, Canadian Stroke Network, Brain Aneurysm Foundation and Physicians Services Incorporated Foundation. He is a consultant for Actelion Pharmaceuticals, Ltd. and Chief Scientific Officer of Edge Therapeutics, Inc. Stephan Mayer is a consultant for Actelion Pharmaceuticals, Ltd. Andrew Molyneux is a consultant for Micrus Endovascular and receives grant support from the Medical Research Council UK and Cerecyte Coil Trial. Tom A. Schweizer receives grant support from the Heart and Stroke Foundation of Canada, the Canadian Institutes of Health Research and the Ontario Ministry of Research and Innovation. Michael Todd receives grant support from the National Institutes of Health. James Torner receives grant support from the National Institutes of Health. Mervyn D. I. Vergouwen receives grant support from the Netherlands Thrombosis Foundation and Netherlands Heart Foundation. George K. C. Wong receives grant support from the Hong Kong Food and Health Bureau and the Hong Kong University Grant Committee.	Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Ali M, 2007, STROKE, V38, P1905, DOI 10.1161/STROKEAHA.106.473579; Ali M, 2012, INT J STROKE, V7, P133, DOI 10.1111/j.1747-4949.2011.00735.x; [Anonymous], 2012, MMWR-MORBID MORTAL W, V61, P379; Bath PMW, 2007, STROKE, V38, P1911, DOI 10.1161/STROKEAHA.106.474080; Bath PMW, 2012, STROKE, V43, P1171, DOI 10.1161/STROKEAHA.111.641456; Bellebaum C, 2004, J CLIN EXP NEUROPSYC, V26, P1081, DOI 10.1080/13803390490515342; Bendel P, 2009, NEURORADIOLOGY, V51, P711, DOI 10.1007/s00234-009-0552-5; Broderick JP, 2011, JAMA-J AM MED ASSOC, V306, P2026, DOI 10.1001/jama.2011.1622; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Cook DJ, 2012, CURR NEUROVASC RES, V9, P139; Dachs RJ, 2008, PLOS MED, V5, P705, DOI 10.1371/journal.pmed.0050113; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Deans KJ, 2007, CRIT CARE MED, V35, P1509, DOI 10.1097/01.CCM.0000266584.40715.A6; Di Vergouwen M, 2007, J CEREBR BLOOD F MET, V27, P1293, DOI 10.1038/sj.jcbfm.9600431; DISNEY L, 1989, CAN J NEUROL SCI, V16, P299, DOI 10.1017/S0317167100029127; Dreier JP, 2002, NEUROSURGERY, V51, P1457, DOI 10.1097/00006123-200212000-00017; Duncan PW, 2000, STROKE, V31, P1429, DOI 10.1161/01.STR.31.6.1429; Etminan N, 2011, J CEREBR BLOOD F MET, V31, P1443, DOI 10.1038/jcbfm.2011.7; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Fergusen S, 2007, NEUROSURGERY, V60, P658, DOI 10.1227/01.NEU.0000255396.23280.31; Fisher M, 2005, STROKE, V36, P1808, DOI 10.1161/01.STR.0000173403.60553.27; Fontanella M, 2003, ACTA NEUROCHIR, V145, P867, DOI 10.1007/s00701-003-0111-5; Frontera JA, 2009, STROKE, V40, P1963, DOI 10.1161/STROKEAHA.108.544700; Hadjivassiliou M, 2001, NEUROLOGY, V56, P1672, DOI 10.1212/WNL.56.12.1672; HALEY EC, 1993, J NEUROSURG, V78, P537, DOI 10.3171/jns.1993.78.4.0537; HALEY EC, 1994, J NEUROSURG, V80, P788, DOI 10.3171/jns.1994.80.5.0788; Hall CE, 2012, NEUROCRIT CARE, V16, P6, DOI 10.1007/s12028-011-9608-6; Hillis AE, 2000, J NEUROL NEUROSUR PS, V69, P608, DOI 10.1136/jnnp.69.5.608; Ilodigwe D, 2012, J NEUROSURG; Jaja BNR, 2013, NEUROCRIT CARE, V18, P143, DOI 10.1007/s12028-012-9792-z; Jang YG, 2009, NEUROCRIT CARE, V10, P141, DOI 10.1007/s12028-008-9147-y; JENNETT B, 1975, LANCET, V1, P480; KASUYA H, 2011, ACTA NEUROCHIR SUPPL, V2, P165, DOI DOI 10.1007/978-3-7091-0356-2_30; Khatri P, 2008, INT J STROKE, V3, P130, DOI 10.1111/j.1747-4949.2008.00151.x; King JT, 2006, NEUROSURGERY, V59, P803, DOI 10.1227/01.NEU.0000232666.67779.41; Kreiter KT, 2002, STROKE, V33, P200, DOI 10.1161/hs0102.101080; Kreiter KT, 2009, STROKE, V40, P2362, DOI 10.1161/STROKEAHA.109.547331; Lees KR, 2012, STROKE, V43, P1163, DOI 10.1161/STROKEAHA.111.641423; LeRoux PD, 1996, J NEUROSURG, V85, P39, DOI 10.3171/jns.1996.85.1.0039; Lovelock CE, 2010, NEUROLOGY, V74, P1494, DOI 10.1212/WNL.0b013e3181dd42b3; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Macdonald RL, 2008, STROKE, V39, P3015, DOI 10.1161/STROKEAHA.108.519942; Macdonald RL, 2012, STROKE, V43, P1463, DOI 10.1161/STROKEAHA.111.648980; Macdonald RL, 2011, LANCET NEUROL, V10, P618, DOI 10.1016/S1474-4422(11)70108-9; Macdonald RL, 2010, NEUROCRIT CARE, V13, P416, DOI 10.1007/s12028-010-9433-3; Manning L, 2005, EUR J NEUROL, V12, P466, DOI 10.1111/j.1468-1331.2005.01012.x; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Mavaddat N, 1999, J NEUROSURG, V91, P402, DOI 10.3171/jns.1999.91.3.0402; Mees SM, 2012, LANCET; MEES SMD, 2007, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000277.PUB3; Meinert C.L, 1986, CLIN TRIALS DESIGN C; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Muroi C, 2008, SURG NEUROL, V69, P33, DOI 10.1016/j.surneu.2007.07.015; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; OHMAN J, 1991, J NEUROSURG, V74, P14, DOI 10.3171/jns.1991.74.1.0014; Otawara Y, 2009, SURG NEUROL, V72, P592, DOI 10.1016/j.surneu.2009.06.016; PICKARD JD, 1989, BRIT MED J, V298, P636, DOI 10.1136/bmj.298.6674.636; Pluta RM, 2009, NEUROL RES, V31, P151, DOI 10.1179/174313209X393564; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Sahs AL, 1969, INTRACRANIAL ANEURYS; Saver JL, 2007, STROKE, V38, P3055, DOI 10.1161/STROKEAHA.107.488536; Scales DC, 2005, J CRIT CARE, V20, P6, DOI 10.1016/j.jcrc.2005.02.002; Schellinger PD, 2012, INT J STROKE, V7, P227, DOI 10.1111/j.1747-4949.2012.00773.x; Sehba FA, 2006, NEUROL RES, V28, P381, DOI 10.1179/016164106X114991; Taylor TN, 1996, STROKE, V27, P1459, DOI 10.1161/01.STR.27.9.1459; Tobin MJ, 2008, CHEST, V133, P1071, DOI 10.1378/chest.08-0077; van den Bergh WM, 2003, ACTA NEUROCHIR, V145, P195, DOI 10.1007/s00701-002-1064-9; van der Schaaf IC, 2002, STROKE, V33, P2043, DOI 10.1161/01.STR.0000024110.82735.5A; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Vergouwen MDI, 2012, STROKE, V43, P2671, DOI 10.1161/STROKEAHA.112.666693; Vergouwen MDI, 2011, J CEREBR BLOOD F MET, V31, P1545, DOI 10.1038/jcbfm.2011.56; Veyna RS, 2002, J NEUROSURG, V96, P510, DOI 10.3171/jns.2002.96.3.0510; Vincent JL, 2010, CRIT CARE MED, V38, pS534, DOI 10.1097/CCM.0b013e3181f208ac; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wong GKC, 2010, STROKE, V41, P921, DOI 10.1161/STROKEAHA.109.571125; Zhang S., 2010, COCHRANE DB SYST REV, V2	79	23	25	0	13	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1868-4483	1868-601X		TRANSL STROKE RES	Transl. Stroke Res.	JUN	2013	4	3					286	296		10.1007/s12975-012-0242-1			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	136XU	WOS:000318397800002	24323299				2022-02-06	
J	Zhang, YL; Chopp, M; Meng, YL; Zhang, ZG; Doppler, E; Mahmood, A; Xiong, Y				Zhang, Yanlu; Chopp, Michael; Meng, Yuling; Zhang, Zheng Gang; Doppler, Edith; Mahmood, Asim; Xiong, Ye			Improvement in functional recovery with administration of Cerebrolysin after experimental closed head injury	JOURNAL OF NEUROSURGERY			English	Article						Cerebrolysin; closed head injury; neuroprotection; rat; sensorimotor; spatial learning	TRAUMATIC BRAIN-INJURY; ENDOTHELIAL GROWTH-FACTOR; MARROW STROMAL CELLS; ALZHEIMERS-DISEASE; MATRIX METALLOPROTEINASES; NEUROTROPHIC TREATMENT; CEREBROSPINAL-FLUID; ADULT NEUROGENESIS; THERAPEUTIC WINDOW; GENE-EXPRESSION	Object. Cerebrolysin is a unique peptide preparation that mimics the action of neurotrophic factors. This study was designed to investigate the effects of acute treatment of experimental closed head injury (CHI) in rats with Cerebrolysin on neurological function. Methods. Adult male Wistar rats (n = 60) were subjected to impact acceleration induced CHI. Closed head injured rats received intraperitoneal injection of saline (n = 30) or Cerebrolysin (2.5 ml/kg, n = 30) starting 1 hour postinjury and administered once daily until they were killed (2 or 14 days after CHI). To evaluate functional outcome, the modified neurological severity score (mNSS), foot fault, adhesive removal, and Morris water maze (MWM) tests were performed. Animals were killed on Day 14 (n = 20) after injury, and their brains were removed and processed for measurement of neuronal cells, axonal damage, apoptosis, and neuroblasts. The remaining rats (n = 40) were killed 2 days postinjury to evaluate cerebral microvascular patency by fluorescein isothiocyanate (FITC) dextran perfusion (n = 16) and to measure the expression of vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) by using real-time reverse transcriptase-polymerase chain reaction (RT-PCR, n = 8) and by immunohistochemical analysis (n = 16). Results. At 14 days post-CHI, the Cerebrolysin treatment group exhibited significant improvements in functional outcomes (the adhesive removal, mNSS, foot-fault, and MWM tests), and significantly more neurons and neuroblasts were present in the dentate gyms (DG) (p < 0.05) compared with the saline-treated group (p < 0.05). At 2 days post-CM, the Cerebrolysin group exhibited a significantly higher percentage of phosphorylated neurofilament H (pNF-H)-positive staining area in the striatum (p < 0.05), a significant increase in the percentage of FITC-dextran perfused vessels in the brain cortex (p < 0.05), a significant increase in the number of VEGF-positive cells (p < 0.05), and a significant reduction in the MMP-9 staining area (p < 0.05) compared with the saline-treated group. There was no significant difference in mRNA levels of MMP-9 and VEGF in the hippocampus and cortex 48 hours postinjury between Cerebrolysin-and saline-treated rats that sustained CHI. Conclusions. Acute Cerebrolysin treatment improves functional recovery in rats after CHI. Cerebrolysin is neuroprotective for CHI (increased neurons in the dentate gyms and the CA3 regions of the hippocampus and increased neuroblasts in the dentate gyms) and may preserve axonal integrity in the striatum (significantly increased percentage of pNF-H-positive tissue in the striatum). Reduction of MMP-9 and elevation of VEGF likely contribute to enhancement of vascular patency and integrity as well as neuronal survival induced by Cerebrolysin. These promising results suggest that Cerebrolysin may be a useful treatment in improving the recovery of patients with CHI.	[Zhang, Yanlu; Meng, Yuling; Mahmood, Asim; Xiong, Ye] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Chopp, Michael; Zhang, Zheng Gang] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA; [Doppler, Edith] EVER Neuro Pharma GmbH, Clin Res & Pharmacol, Unterach, Austria		Xiong, Y (corresponding author), Henry Ford Hlth Syst, Dept Neurosurg, E&R Bldg,Room 3096,2799 West Grand Blvd, Detroit, MI 48202 USA.	yxiong1@hfhs.org		Xiong, Ye/0000-0001-9770-6031	EVER Neuro Pharma GmbH	EVER Neuro Pharma GmbH provided financial support for this study. Edith Doppler is an employee of Clinical Research and Pharmacology, EVER Neuro Pharma GmbH, Unterach, Austria.	Alvarez XA, 2011, EUR J NEUROL, V18, P59, DOI 10.1111/j.1468-1331.2010.03092.x; Alvarez XA, 2011, DRUG TODAY, V47, P487, DOI 10.1358/dot.2011.47.7.1656496; Alvarez XA, 2000, J NEURAL TRANSM-SUPP, P281; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Bitto A, 2012, CRIT CARE MED, V40, P945, DOI 10.1097/CCM.0b013e318236efde; Bornstein N, 2012, DRUG TODAY, V48, P43, DOI 10.1358/dot.2012.48(Suppl.A).1739723; Cernak I, 2002, J CLIN NEUROSCI, V9, P565, DOI 10.1054/jocn.2002.1132; Chen HH, 2007, NEUROBIOL AGING, V28, P1148, DOI 10.1016/j.neurobiolaging.2006.05.036; Chen JL, 2000, NEUROPHARMACOLOGY, V39, P711, DOI 10.1016/S0028-3908(00)00006-X; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Choi SH, 2006, J NEUROSCI METH, V156, P182, DOI 10.1016/j.jneumeth.2006.03.002; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Cui Q, 2006, MOL NEUROBIOL, V33, P155, DOI 10.1385/MN:33:2:155; Davis A E, 2000, Crit Care Nurs Q, V23, P1; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Ding JY, 2009, BRAIN RES, V1268, P125, DOI 10.1016/j.brainres.2009.02.060; Eder P, 2001, HISTOCHEM J, V33, P605, DOI 10.1023/A:1016394031947; Emery DL, 2005, J NEUROTRAUM, V22, P978, DOI 10.1089/neu.2005.22.978; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Goldie BJ, 2012, MOL NEUROBIOL, V45, P99, DOI 10.1007/s12035-011-8222-0; Grant P, 2000, J NEUROCYTOL, V29, P843, DOI 10.1023/A:1010999509251; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Gschanes A, 1997, J NEURAL TRANSM, V104, P1319, DOI 10.1007/BF01294733; Gutmann B, 2002, NEUROTOX RES, V4, P59, DOI 10.1080/10298420290007637; Hanson LR, 2009, AM J NEUROPROTEC NEU, V1, P60, DOI DOI 10.1166/AJNN.2009.1010; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Hayashi T, 2009, BRAIN RES, V1280, P172, DOI 10.1016/j.brainres.2009.05.040; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Imer M, 2009, NEUROL RES, V31, P977, DOI 10.1179/174313209X385617; Kawamata T, 1999, EXP NEUROL, V158, P89, DOI 10.1006/exnr.1999.7101; Liu XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023461; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Logan Ann, 1994, Progress in Growth Factor Research, V5, P379, DOI 10.1016/0955-2235(94)00008-9; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Lu DY, 2003, J HEAD TRAUMA REHAB, V18, P357, DOI 10.1097/00001199-200307000-00006; Mahmood A, 2007, NEUROSURGERY, V60, P546, DOI 10.1227/01.NEU.0000255346.25959.99; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Masliah E, 2012, DRUG TODAY, V48, P3, DOI 10.1358/dot.2012.48(Suppl.A).1739716; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nag S, 2009, ACTA NEUROPATHOL, V118, P197, DOI 10.1007/s00401-009-0541-0; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Oomen CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0003675; Pardridge WM, 2002, ADV EXP MED BIOL, V513, P397; Park CO, 2001, YONSEI MED J, V42, P518, DOI 10.3349/ymj.2001.42.5.518; Paxinos G, 1986, RAT BRAIN STEREOTAXI; Plosker GL, 2009, DRUG AGING, V26, P893, DOI 10.2165/11203320-000000000-00000; Pravdenkova SV, 1996, BRAIN RES, V729, P151, DOI 10.1016/S0006-8993(96)00222-3; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Rockenstein E, 2007, ACTA NEUROPATHOL, V113, P265, DOI 10.1007/s00401-006-0166-5; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Schauer E, 2006, J NEURAL TRANSM, V113, P855, DOI 10.1007/s00702-005-0384-3; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Sharma HS, 2007, ANN NY ACAD SCI, V1122, P95, DOI 10.1196/annals.1403.007; Sharma HS, 2010, ANN NY ACAD SCI, V1199, P125, DOI 10.1111/j.1749-6632.2009.05329.x; Tatebayashi Y, 2003, ACTA NEUROPATHOL, V105, P225, DOI 10.1007/s00401-002-0636-3; Thau-Zuchman O, 2012, NEUROSCIENCE, V202, P334, DOI 10.1016/j.neuroscience.2011.11.071; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Ubhi K, 2009, ACTA NEUROPATHOL, V117, P699, DOI 10.1007/s00401-009-0505-4; Valable S, 2005, J CEREBR BLOOD F MET, V25, P1491, DOI 10.1038/sj.jcbfm.9600148; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Wada K, 2003, STROKE, V34, P2722, DOI 10.1161/01.STR.0000094421.61917.71; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiong Y, 2011, TRANSL STROKE RES, V2, P619, DOI 10.1007/s12975-011-0120-2; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yasuhara T, 2004, REV NEUROSCIENCE, V15, P293; Zhang CL, 2010, J NEUROSCI RES, V88, P3275, DOI 10.1002/jnr.22495; Zhang L, 2003, CIRCULATION, V107, P2837, DOI 10.1161/01.CIR.0000068374.57764.EB; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	71	23	27	0	9	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	JUN	2013	118	6					1343	1355		10.3171/2013.3.JNS122061			13	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	150BY	WOS:000319366400035	23581594				2022-02-06	
J	Brown, RT; Kiely, DK; Bharel, M; Mitchell, SL				Brown, Rebecca T.; Kiely, Dan K.; Bharel, Monica; Mitchell, Susan L.			Factors Associated with Geriatric Syndromes in Older Homeless Adults	JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED			English	Article						Homeless people; aged; middle aged; geriatric syndromes	MINI-MENTAL-STATE; TRAUMATIC BRAIN-INJURY; SERVICES TASK-FORCE; RISK-FACTORS; SAN-FRANCISCO; HEALTH-STATUS; PRIMARY-CARE; ALCOHOL-USE; POPULATION; FALLS	Although older homeless adults have high rates of geriatric syndromes, risk factors for these syndromes are not known. We used multivariable regression models to estimate the association of subject characteristics with the total number of geriatric syndromes in 250 homeless adults aged 50 years and older. Geriatric syndromes included falls, cognitive impairment, frailty, major depression, sensory impairment, and urinary incontinence. A higher total number of geriatric syndromes was associated with having less than a high school education, medical comorbidities (diabetes and arthritis), alcohol and drug use problems, and difficulty performing one or more activities of daily living. Clinicians who care for older homeless patients with these characteristics should consider screening them for geriatric syndromes. Moreover, this study identifies potentially modifiable risk factors associated with the total number of geriatric syndromes in older homeless adults. This knowledge may provide targets for clinical interventions to improve the health of older homeless patients.	[Brown, Rebecca T.] Univ Calif San Francisco, Div Geriatr, San Francisco, CA 94143 USA; [Brown, Rebecca T.] San Francisco VA Med Ctr, San Francisco, CA 94122 USA; [Kiely, Dan K.; Mitchell, Susan L.] Hebrew SeniorLife Inst Aging Res, Boston, MA USA; [Bharel, Monica] Boston Healthcare Homeless Program, Boston, MA USA; [Bharel, Monica] Boston Med Ctr, Dept Med, Boston, MA USA; [Bharel, Monica] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Mitchell, Susan L.] Beth Israel Deaconess Med Ctr, Div Gerontol, Boston, MA 02215 USA		Brown, RT (corresponding author), San Francisco VA Med Ctr, 4150 Clement St,181G, San Francisco, CA 94122 USA.	rebecca.brown@ucsf.edu		Brown, Rebecca/0000-0001-7483-4137	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K24 AG033640, T32 AG023480, T32 AG000212] Funding Source: Medline; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K24AG033640, T32AG023480, T32AG000212] Funding Source: NIH RePORTER		Avery K, 2004, NEUROUROL URODYNAM, V23, P322, DOI 10.1002/nau.20041; Blazer DG, 2011, AM J GERIAT PSYCHIAT, V19, P685, DOI 10.1097/JGP.0b013e3182006a96; Bleijenberg N, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-16; Brown RT, 2012, J GEN INTERN MED, V27, P16, DOI 10.1007/s11606-011-1848-9; Burra TA, 2009, CAN J PSYCHIAT, V54, P123, DOI 10.1177/070674370905400210; Burt M.R., 1999, HOMELESSNESS PROGRAM; Calonge N, 2009, ANN INTERN MED, V151, P37, DOI 10.7326/0003-4819-151-1-200907070-00007; Cawthon PM, 2006, J AM GERIATR SOC, V54, P1649, DOI 10.1111/j.1532-5415.2006.00912.x; CHERPITEL CJ, 1995, ACCIDENT ANAL PREV, V27, P651, DOI 10.1016/0001-4575(95)00011-N; Cigolle CT, 2007, ANN INTERN MED, V147, P156, DOI 10.7326/0003-4819-147-3-200708070-00004; Cigolle CT, 2011, J GEN INTERN MED, V26, P272, DOI 10.1007/s11606-010-1510-y; COHEN CI, 1988, J AM GERIATR SOC, V36, P492, DOI 10.1111/j.1532-5415.1988.tb04018.x; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Culhane D. P., 2010, AGE STRUCTURE CONT H; CUMMINGS SR, 1988, J AM GERIATR SOC, V36, P613, DOI 10.1111/j.1532-5415.1988.tb06155.x; Dietz TL, 2009, J APPL GERONTOL, V28, P235, DOI 10.1177/0733464808326006; ESCOBAR JI, 1986, J NERV MENT DIS, V174, P607, DOI 10.1097/00005053-198610000-00005; Fazel S, 2008, PLOS MED, V5, P1670, DOI 10.1371/journal.pmed.0050225; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRATIGLIONI L, 1993, ANN NEUROL, V33, P258, DOI 10.1002/ana.410330306; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Garibaldi B, 2005, J GEN INTERN MED, V20, P726, DOI 10.1111/j.1525-1497.2005.0142.x; GELBERG L, 1990, J AM GERIATR SOC, V38, P1220, DOI 10.1111/j.1532-5415.1990.tb01503.x; Hahn JA, 2006, J GEN INTERN MED, V21, P775, DOI 10.1111/j.1525-1497.2006.00493.x; Heaton R. K., 2004, REVISED COMPREHENSIV; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Inouye SK, 2007, J AM GERIATR SOC, V55, P780, DOI 10.1111/j.1532-5415.2007.01156.x; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Kannus P, 2005, AM J PUBLIC HEALTH, V95, P422, DOI 10.2105/AJPH.2004.047779; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; Kessler RC, 2004, BIOL PSYCHIAT, V56, P730, DOI 10.1016/j.biopsych.2004.06.034; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kushel MB, 2001, JAMA-J AM MED ASSOC, V285, P200, DOI 10.1001/jama.285.2.200; MALMIVAARA A, 1993, AM J EPIDEMIOL, V138, P384, DOI 10.1093/oxfordjournals.aje.a116871; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Michael YL, 2010, ANN INTERN MED, V153, P815, DOI 10.7326/0003-4819-153-12-201012210-00008; MOR V, 1994, AM J PUBLIC HEALTH, V84, P1274, DOI 10.2105/AJPH.84.8.1274; Mukamal KJ, 2004, J AM GERIATR SOC, V52, P1174, DOI 10.1111/j.1532-5415.2004.52318.x; Pitz S, 2005, OPHTHALMOLOGICA, V219, P345, DOI 10.1159/000088376; Quirk M, 2009, HOMELESSNESS CITY BO; Razani J, 2007, ARCH CLIN NEUROPSYCH, V22, P333, DOI 10.1016/j.acn.2007.01.008; Reitan R, 1985, HALSTEAD REITAN NEUR; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722; Rockwood K, 2011, CAN MED ASSOC J, V183, pE487, DOI 10.1503/cmaj.101271; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; SAUNDERS PA, 1991, BRIT J PSYCHIAT, V159, P213, DOI 10.1192/bjp.159.2.213; Schiller Jeannine S, 2007, Adv Data, P1; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Sullivan G, 2001, PSYCHIATR SERV, V52, P1097, DOI 10.1176/appi.ps.52.8.1097; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; Tschanz JT, 2004, NEUROLOGY, V62, P1156, DOI 10.1212/01.WNL.0000118210.12660.C2; United States Interagency Council on Homelessness, 2010, OP DOORS FED STRAT P; White MC, 1997, J COMMUN HEALTH, V22, P271, DOI 10.1023/A:1025152403545	54	23	23	0	11	JOHNS HOPKINS UNIV PRESS	BALTIMORE	JOURNALS PUBLISHING DIVISION, 2715 NORTH CHARLES ST, BALTIMORE, MD 21218-4363 USA	1049-2089			J HEALTH CARE POOR U	J. Health Care Poor Underserved	MAY	2013	24	2					456	468		10.1353/hpu.2013.0077			13	Health Policy & Services; Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	153VU	WOS:000319631400005	23728022	Green Accepted			2022-02-06	
J	Marmarelis, VZ; Shin, DC; Orme, ME; Zhang, R				Marmarelis, V. Z.; Shin, D. C.; Orme, M. E.; Zhang, R.			Closed-Loop Dynamic Modeling of Cerebral Hemodynamics	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Cerebral autoregulation; Nonlinear modeling; Modeling cerebral hemodynamics; Closed-loop modeling; Cerebral flow autoregulation; Cerebral vasomotor reactivity	AUTONOMIC NEURAL-CONTROL; BLOOD-FLOW; AUTOREGULATION; PRESSURE; METHODOLOGY; SYSTEMS	The dynamics of cerebral hemodynamics have been studied extensively because of their fundamental physiological and clinical importance. In particular, the dynamic processes of cerebral flow autoregulation (CFA) and CO2 vasomotor reactivity have attracted broad attention because of their involvement in a host of pathologies and clinical conditions (e.g., hypertension, syncope, stroke, traumatic brain injury, vascular dementia, Alzheimer's disease, mild cognitive impairment etc.). This raises the prospect of useful diagnostic methods being developed on the basis of quantitative models of cerebral hemodynamics, if cerebral vascular dysfunction can be quantified reliably from data collected within practical clinical constraints. This paper presents a modeling method that utilizes beat-to-beat measurements of mean arterial blood pressure, cerebral blood flow velocity and end-tidal CO2 (collected non-invasively under resting conditions) to quantify the dynamics of CFA and cerebral vasomotor reactivity (CVMR). The unique and novel aspect of this dynamic model is that it is nonlinear and operates in a closed-loop configuration.	[Marmarelis, V. Z.; Shin, D. C.] Univ So Calif, Los Angeles, CA 90089 USA; [Orme, M. E.] Sonovation, Los Angeles, CA USA; [Zhang, R.] Univ Texas Dallas, SW Med Ctr, Dallas, TX USA		Marmarelis, VZ (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.	vzm@usc.edu			Biomedical Simulations Resource at the University of Southern California under NIH/NIBIB [P41-EB001978]; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG033106-01]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB001978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG033106] Funding Source: NIH RePORTER	This work was supported in part by the Biomedical Simulations Resource at the University of Southern California under NIH/NIBIB grant P41-EB001978 and NIA R01AG033106-01 grant to the UT-Southwestern Medical Center.	AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Bellapart J., ULTRASOUND MED BIOL, DOI [10.1016/j.ultrasmedbio.2009, DOI 10.1016/J.ULTRASMEDBI0.2009]; BUSSE R, 1985, BASIC RES CARDIOL, V80, P475, DOI 10.1007/BF01907912; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Giller CA, 2003, MED ENG PHYS, V25, P633, DOI 10.1016/S1350-4533(03)00028-6; Hu K, 2008, CARDIOVASC ENG, V8, P60, DOI 10.1007/s10558-007-9045-5; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Marmarelis V. Z., 2004, NONLINEAR DYNAMIC MO; Marmarelis Vz, 2012, Open Biomed Eng J, V6, P42, DOI 10.2174/1874230001206010042; Marmarelis VZ, 1997, ANN BIOMED ENG, V25, P239, DOI 10.1007/BF02648038; MARMARELIS VZ, 1993, ANN BIOMED ENG, V21, P573, DOI 10.1007/BF02368639; Mitsis GD, 2004, IEEE T BIO-MED ENG, V51, P1932, DOI 10.1109/TBME.2004.834272; Mitsis GD, 2002, ANN BIOMED ENG, V30, P555, DOI 10.1114/1.1477448; Mitsis GD, 2006, J APPL PHYSIOL, V101, P354, DOI 10.1152/japplphysiol.00548.2005; Mitsis GD, 2009, IEEE ENG MED BIOL, V28, P54, DOI 10.1109/MEMB.2009.934908; Panerai RB, 2000, IEEE T BIO-MED ENG, V47, P419, DOI 10.1109/10.827312; Panerai RB, 1999, AM J PHYSIOL-HEART C, V277, pH1089, DOI 10.1152/ajpheart.1999.277.3.H1089; Panerai RB, 2008, CARDIOVASC ENG, V8, P42, DOI 10.1007/s10558-007-9044-6; van Beek AHEA, 2008, J CEREBR BLOOD F MET, V28, P1071, DOI 10.1038/jcbfm.2008.13; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233; Zhang R, 2002, CIRCULATION, V106, P1814, DOI 10.1161/01.CIR.0000031798.07790.FE; Zhang R, 2007, HYPERTENSION, V49, P1149, DOI 10.1161/HYPERTENSIONAHA.106.084939; Zhang R, 2009, J PHYSIOL-LONDON, V587, P2567, DOI 10.1113/jphysiol.2008.168302	23	23	23	2	27	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	MAY	2013	41	5					1029	1048		10.1007/s10439-012-0736-8			20	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	124LJ	WOS:000317465000014	23292615	Green Accepted			2022-02-06	
J	Rashid, B; Destrade, M; Gilchrist, MD				Rashid, Badar; Destrade, Michel; Gilchrist, Michael D.			Influence of preservation temperature on the measured mechanical properties of brain tissue	JOURNAL OF BIOMECHANICS			English	Article						Traumatic brain injury (TBI); Post-mortem; Shear; Ogden model; Temperature	DEFORMATION; BEHAVIOR	The large variability in experimentally measured mechanical properties of brain tissue is due to many factors including heterogeneity, anisotropy, age dependence and post-mortem time. Moreover, differences in test protocols also influence these measured properties. This paper shows that the temperature at which porcine brain tissue is stored or preserved prior to testing has a significant effect on the mechanical properties of brain tissue, even when tests are conducted at the same temperatures. Three groups of brain tissue were stored separately for at least 1 h at three different preservation temperatures, i.e., ice cold, room temperature (22 degrees C) and body temperature (37 degrees C), prior to them all being tested at room temperature (similar to 22 degrees C). Significant differences in the corresponding initial elastic shear modulus mu (Pa) (at various amounts of shear, 0 <= K <= 1.0) were observed. The initial elastic moduli were 1043 +/- 271 Pa, 714 +/- 210 Pa and 497 +/- 156 Pa (mean +/- SD) at preservation temperatures of ice cold, 22 degrees C and 37 degrees C, respectively. Based on this investigation, it is strongly recommended that brain tissue samples must be preserved at an ice-cold temperature prior to testing in order to minimize the difference between the measured in vitro test results and the in vivo properties. A by-product of the study is that simple shear tests allow for large, almost perfectly homogeneous deformation of brain matter. (C) 2013 Elsevier Ltd. All rights reserved.	[Rashid, Badar; Destrade, Michel; Gilchrist, Michael D.] Natl Univ Ireland Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland; [Destrade, Michel] Natl Univ Ireland Galway, Sch Math Stat & Appl Math, Galway, Ireland		Gilchrist, MD (corresponding author), Natl Univ Ireland Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland.	Badar.Rashid@ucdconnect.ie; michel.destrade@nuigalway.ie; michael.gilchrist@ucd.ie	Destrade, Michel/O-5825-2019; Gilchrist, Michael D/B-6100-2017	Destrade, Michel/0000-0002-6266-1221; Gilchrist, Michael D/0000-0003-1765-429X	Irish Research Council for Science, Engineering and Technology (IRCSET), IrelandIrish Research Council for Science, Engineering and Technology	This work was supported for the first author by a Postgraduate Research Scholarship awarded in 2009 by the Irish Research Council for Science, Engineering and Technology (IRCSET), Ireland. The authors are most grateful to the reviewers for constructive comments on an earlier version of the paper.	BRANDS DWA, 2000, P 44 STAPP CAR CRASH, P249; Darvish KK, 2001, MED ENG PHYS, V23, P633, DOI 10.1016/S1350-4533(01)00101-1; Garo A, 2007, BIORHEOLOGY, V44, P51; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; McElhaney JH, 1973, PERSPECTIVES BIOMEDI, P215, DOI DOI 10.1007/978-1-349-01604-4_34; METZ H, 1970, J BIOMECH, V3, P453, DOI 10.1016/0021-9290(70)90017-5; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Miller K, 2000, J BIOMECH, V33, P1369, DOI 10.1016/S0021-9290(00)00120-2; Nicolle Stephane, 2004, Stapp Car Crash J, V48, P239; Ogden R.W., 1997, NONLINEAR ELASTIC DE; Pervin F, 2011, NEUROIMAGE, V54, pS98, DOI 10.1016/j.neuroimage.2010.03.077; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Peters GWM, 1997, BIORHEOLOGY, V34, P127, DOI 10.1016/S0006-355X(97)00009-7; Rashid B., 2012, THESIS U COLL DUBLIN; Rashid B., J MECH BEHAV BIOMED, DOI DOI 10.1016/JJMBBM.2012.07.015; Rashid B, 2012, J MECH BEHAV BIOMED, V14, P113, DOI 10.1016/j.jmbbm.2012.04.005; Rashid B, 2012, COMP MATER SCI, V64, P295, DOI 10.1016/j.commatsci.2012.05.030; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Shen F, 2006, J BIOMECH ENG-T ASME, V128, P797, DOI 10.1115/1.2264393; Tamura A, 2007, J BIOMECH SCI ENG, V2, P115, DOI [10.1299/jbse.2.115, DOI 10.1299/JBSE.2.115]; Tamura A, 2008, J BIOMECH SCI ENG, V3, P263, DOI DOI 10.1299/JBSE.3.263; Zhang JY, 2011, J BIOMECH, V44, P391, DOI 10.1016/j.jbiomech.2010.10.024	23	23	23	2	22	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	APR 26	2013	46	7					1276	1281		10.1016/j.jbiomech.2013.02.014			6	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	139LI	WOS:000318583800009	23523381	Green Submitted			2022-02-06	
J	Adamson, C; Yuan, WH; Babcock, L; Leach, JL; Seal, ML; Holland, SK; Wade, SL				Adamson, Chris; Yuan, Weihong; Babcock, Lynn; Leach, James L.; Seal, Marc L.; Holland, Scott K.; Wade, Shari L.			Diffusion tensor imaging detects white matter abnormalities and associated cognitive deficits in chronic adolescent TBI	BRAIN INJURY			English	Article						Traumatic brain injury; adolescents; executive functioning; diffusion tensor imaging; diffuse axonal injury	TRAUMATIC BRAIN-INJURY; BEHAVIOR RATING INVENTORY; EXECUTIVE FUNCTION; AXONAL INJURY; STRUCTURAL EVENTS; CHILDREN; RECOVERY; DAMAGE; PREDICTORS; PLASTICITY	Primary objective: This study examined long-term alterations in white matter microstructure following TBI in adolescence using diffusion tensor imaging (DTI). It was hypothesized that white matter integrity would be compromised in adolescents with TBI and would correlate with measures of executive functioning and cognitive abilities. Research design: This study employed whole-brain, voxel-wise, statistical comparison of DTI indices in youth of 12-17 years old (mean = 15.06) with TBI vs an age-and gender-matched cohort (mean age = 15.37). Methods and procedures: This study scanned 17 adolescents with complicated-mild-to-severe TBI, 1-3 years after injury, and 13 healthy adolescents. Tract-Based Spatial Statistics (TBSS) was employed for DTI analysis. Main outcomes and results: Overall diffusivity elevations were found in the TBI group with increases in axial diffusivity in the right hemisphere. White matter integrity was associated with word reading, planning and processing times in the TBI group, but not healthy controls. Conclusions: The detected abnormalities in axial diffusivity may reflect neuronal regeneration and cerebral reorganization after injury. These findings provide tentative evidence of persistent white matter alteration following TBI in adolescence. Associations of DTI indices with cognitive performance following TBI provide tentative support for links between white matter integrity and performance post-TBI.	[Adamson, Chris; Seal, Marc L.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Yuan, Weihong; Holland, Scott K.] Cincinnati Childrens Hosp Med Ctr, Pediat Neuroimaging Res Consortium, Cincinnati, OH USA; [Yuan, Weihong; Babcock, Lynn; Leach, James L.; Holland, Scott K.; Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Babcock, Lynn; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Emergency Div, Cincinnati, OH USA; [Leach, James L.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Seal, Marc L.] Univ Melbourne, Dept Paediat, Melbourne, Vic 3010, Australia		Wade, SL (corresponding author), Cincinnati Childrens Hosp, ML, 3333 Burnet Ave, Cincinnati, OH 45243 USA.	shari.wade@cchmc.org	Seal, Marc L/J-9290-2019	Seal, Marc L/0000-0002-8396-140X; Babcock, Lynn/0000-0002-2658-6893; Holland, Scott/0000-0003-3719-0875	NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000077] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH073764] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH073764] Funding Source: NIH RePORTER		Access Economics , 2009, EC COST SPIN CORD IN; Anderson V, 1998, BRAIN INJURY, V12, P937, DOI 10.1080/026990598121990; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Andersson JL, 2007, FMRIB TECH REP TRO7J FMRIB TECHNICAL REPO; Andersson JLR, 2007, NONLINEAR OPTIMISATI; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Delis DC., 2001, DELIS KAPLAN EXECUTI; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Guy SC, 2004, BRIEF SR BEHAV RATIN; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jeurissen B, 2010, ESTIMATING NUMBER FI; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Keyvani K, 2002, J NEUROPATH EXP NEUR, V61, P831, DOI 10.1093/jnen/61.10.831; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kurowski B, 2009, J PEDIATR REHAB MED, V2, P273, DOI 10.3233/PRM-2009-0093; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Langlois JA, 2006, TBI US EMERGENCY DEP; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Li J, 2011, EUR J NEUROSCI, V33, P933, DOI 10.1111/j.1460-9568.2010.07573.x; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; McCauley SR, 2011, J NEUROTRAUM, V28, P503, DOI 10.1089/neu.2010.1555; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nudo RJ, 2001, MUSCLE NERVE, V24, P1000, DOI 10.1002/mus.1104; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Schallert T, 2000, J CEREBR BLOOD F MET, V20, P1513, DOI 10.1097/00004647-200011000-00001; Schmithorst VJ, 2008, HUM BRAIN MAPP, V29, P696, DOI 10.1002/hbm.20431; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Singh M, 2010, MAGN RESON IMAGING, V28, P22, DOI 10.1016/j.mri.2009.05.049; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Tlustos SJ, 2011, J INT NEUROPSYCH SOC, V17, P181, DOI 10.1017/S1355617710001414; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wechsler D, 2004, WECHSLER INTELLIGENC, Vfourth; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020	52	23	24	0	22	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2013	27	4					454	463		10.3109/02699052.2012.750756			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	117LG	WOS:000316954300010	23472581	Green Accepted			2022-02-06	
J	Babcock, L; Byczkowski, T; Wade, SL; Ho, M; Bazarian, JJ				Babcock, Lynn; Byczkowski, Terri; Wade, Shari L.; Ho, Mona; Bazarian, Jeffrey J.			Inability of S100B to Predict Postconcussion Syndrome in Children Who Present to the Emergency Department With Mild Traumatic Brain Injury A Brief Report	PEDIATRIC EMERGENCY CARE			English	Article						mild traumatic brain injury; postconcussion syndrome; S100B; biomarker	MINOR HEAD-INJURY; NEURON-SPECIFIC ENOLASE; CONCUSSION SYMPTOMS QUESTIONNAIRE; SERUM-LEVELS; COMPUTED-TOMOGRAPHY; S-100B PROTEIN; MULTICENTER; RELIABILITY; BIOMARKERS; MANAGEMENT	Objective: This study aimed to explore the ability of the serum marker S100B to predict the development and severity of postconcussion syndrome (PCS) at 3 months in children after mild traumatic brain injury (mTBI). Methods: This is a retrospective analysis of a prospective observational study conducted in a pediatric emergency department (ED). Children were eligible for the study if they were between the ages 5 and 18 years, presented within 6 hours of injury, met the case definition of mTBI from American Congress of Rehabilitation Medicine, had a Glasgow Coma Scale score of greater than 13, consented to have blood drawn for S100B levels, and completed the 3-month telephone follow-up. At the follow-up, the Rivermead Postconcussion Questionnaire was conducted to determine the development and severity of PCS. Results: A total of 76 children were included in this cohort. The children had a mean (SD) age of 14.0 (3.1) years, 60.5% were male, and 89.5% had a Glasgow Coma Scale of 15. Twenty-eight (36.8%) developed PCS. For the children who developed PCS, the mean (SD) S100B level was 0.092 (0.376) mu g/L. For children who did not develop PCS (n = 48), the mean (SD) S100B level was 0.022 (0.031) mu g/L. The analyses did not support an association between initial S100B levels measured in the ED and development of PCS or severity of PCS symptoms. Conclusions: In this small sample, S100B, measured immediately after injury in the ED, did not seem to predict those children with mTBI who will go on to develop PCS.	[Babcock, Lynn; Bazarian, Jeffrey J.] Univ Rochester, Med Ctr, Dept Emergency Med, Rochester, NY 14642 USA; [Babcock, Lynn; Byczkowski, Terri; Ho, Mona] Cincinnati Childrens Hosp Med Ctr, Div Pediat Emergency Med, Cincinnati, OH 45229 USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA		Babcock, L (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pediat Emergency Med, 3333 Burnet Ave,ML 2008, Cincinnati, OH 45229 USA.	lynn.babcock@cchmc.org		Babcock, Lynn/0000-0002-2658-6893	National Institutes of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NIH/NINDS K23 NS41952-02]; New York State Department of Health [NYS DOH C806001]; University of Cincinnati Center for Clinical and Translational Science and Training; Division of Emergency Medicine at Cincinnati Children's Hospital Medical Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K24HD064754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS041952] Funding Source: NIH RePORTER	This study was in part funded by Dr Jeffrey Bazarian's Career Development K23 Award from the National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS K23 NS41952-02). S100B analysis was funded through a grant from the New York State Department of Health (NYS DOH C806001). This analysis was funded in part by Dr Babcock's KL2 Mentored Career Development Program in Clinical and Translational Research from the University of Cincinnati Center for Clinical and Translational Science and Training, as well as the Division of Emergency Medicine at Cincinnati Children's Hospital Medical Center.	Adami C, 2001, GLIA, V33, P131, DOI 10.1002/1098-1136(200102)33:2<131::AID-GLIA1012>3.0.CO;2-D; Akhtar Javed I, 2003, Pediatr Crit Care Med, V4, P322; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Babcock L, 2012, BRAIN INJURY, V26, P1372, DOI 10.3109/02699052.2012.694565; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bazarian JJ, 2001, K23NS4195202 NIHNIND; Beers SR, 2007, J NEUROTRAUM, V24, P97, DOI 10.1089/neu.2006.0055; Begaz T, 2006, J NEUROTRAUM, V23, P1201, DOI 10.1089/neu.2006.23.1201; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Berger RP, 2002, J NEUROTRAUM, V19, P1405, DOI 10.1089/089771502320914633; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Bergman DA, 1999, PEDIATRICS, V104, P1407; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Castellani C, 2009, ACTA PAEDIATR, V98, P1607, DOI 10.1111/j.1651-2227.2009.01423.x; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; Filippidis AS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10185; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Morochovic R, 2009, EUR J NEUROL, V16, P1112, DOI 10.1111/j.1468-1331.2009.02653.x; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; Piazza O, 2007, PEDIATR NEUROSURG, V43, P258, DOI 10.1159/000103304; Poli-de-Figueiredo Luiz F, 2006, Clinics, V61, P41, DOI 10.1590/S1807-59322006000100008; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Spinella PC, 2003, CRIT CARE MED, V31, P939, DOI 10.1097/01.CCM.0000053644.16336.52; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; Townend W, 2006, INJURY, V37, P1098, DOI 10.1016/j.injury.2006.07.014; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Wiesmann M, 1999, BIOL PSYCHIAT, V45, P1508, DOI 10.1016/S0006-3223(98)00217-0	41	23	24	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	APR	2013	29	4					458	461		10.1097/PEC.0b013e31828a202d			4	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	119NC	WOS:000317103300009	23528506	Green Accepted			2022-02-06	
J	Cheng, ZG; Zhang, GD; Shi, PQ; Du, BS				Cheng, Zhen-Guo; Zhang, Guo-Dong; Shi, Peng-Qiang; Du, Bao-Shun			Expression and antioxidation of Nrf2/ARE pathway in traumatic brain injury	ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE			English	Article						Traumatic brain injury; Nrf2/ARE pathway; Gene expression; Anti-oxidative stress	TRANSCRIPTION FACTOR NRF2; OXIDATIVE STRESS; NADPH OXIDASE; INHIBITION; MODULATION; PROTECTS; DAMAGE	Objective: To explore the expression of Nrf2/ARE pathway in hindbrain tissue after the traumatic brain injury (TBI) and its anti oxidative stress effect in the secondary nerve injury. Methods: The mice with Nrf2 gene knockout were used for the establishment of brain injury model. The experimental animals were divided into four groups: (Nrf2'/') sham- operation group, (Nrf2(-/-)) brain injury group, (Nrf2(-/-)) sham-operation group and (Nrf2'/') brain injury group. The specimen 24 h after cerebral trauma was selected. Then RT-PCR method was adopted to detect the expression of Nrf2 mRNA in brain; Western blotting method was adopted to detect the levels of Nrf2, HO-1 and NQO1 proteins in brain; ELISA method was adopted to detect the oxidative stress indicators: protein carbonyls, 4- hydroxy-2-nonenal (4-HNE) and 8-hydroxy-2'-deoxyguanosine (8-OHdG). Results: The Nrf2 mRNA and protein of Nrf2(-)/(-) mice were not expressed, and the difference of the relative amount of Nrf2 mRNA between Nrf2(+)/(+) TBI group and Nrf2(+)/(+) sham-operation group was not statistically significant (P>0.05); the level of Nrf2 protein in Nrf2(+)/(+) TBI group increased significantly compared with the Nrf2(+)/(+) sham-operation group (P<0.01); in the sham operation groups, the levels of HO-1 and NQO1 proteins of Nrf2(-)/(-) mice decreased obviously compared with the Nrf2(+)/(-) mice (P<0.01); after brain injury, the levels of HO-1 and NQO1 proteins of Nrf2(-)/(-) mice increased obviously compared with the corresponding sham operation group (P<0.01); the levels of HO-1 and NQO1 proteins of Nrf2(-)/(-) mice in TBI group had no obvious change compared with the corresponding sham-operation group (P>0.05); there was only a little amount of expression of protein carbonyls, 4-HNE and 8-OHdC proteins in brain tissues in the Nrf2(+)/(+) and Nrf2(-)/(-) sham-operation groups, and the difference was not statistically significant (P>0.05); after brain injury, the three oxidative stress indicators were significantly up regulated in the Nrf2(+)/(+) and Nrf2(-)/(-) groups, and the up regulation of the latter group was more significant (P<0.01). Conclusions: After TBI the Nrf2/ARE pathway is activated and the activity of Nrf2 transcription regulation increases. However, the regulation dose not occur in the gene transcription level and only could increase the Nrf2 protein level, while the mRNA expression level has no obvious change. The nerve cell protective effect of Nrf2/ARE pathway in TBI achieves through inhibiting the oxidative stress injuries.	[Cheng, Zhen-Guo; Zhang, Guo-Dong; Shi, Peng-Qiang; Du, Bao-Shun] Xinxiang Cent Hosp, Dept Neurosurg 2, Xinxiang 453000, Henan Province, Peoples R China		Cheng, ZG (corresponding author), Xinxiang Cent Hosp, Dept Neurosurg 2, Xinxiang 453000, Henan Province, Peoples R China.	czg1971@sina.com					Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Calabrese V, 2006, ANTIOXID REDOX SIGN, V8, P444, DOI 10.1089/ars.2006.8.444; Choi BY, 2012, BRAIN RES, V1481, P49, DOI 10.1016/j.brainres.2012.08.032; Darwish RS, 2007, J TRAUMA, V63, P439, DOI 10.1097/TA.0b013e318069178a; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Doverhag C, 2008, NEUROBIOL DIS, V31, P133, DOI 10.1016/j.nbd.2008.04.003; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE45, DOI 10.1097/HTR.0b013e31827340ba; Hatic H, 2012, J NEUROTRAUM, V29, P1188, DOI 10.1089/neu.2011.1806; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Luoma JI, 2011, STEROIDS, V76, P845, DOI 10.1016/j.steroids.2011.02.013; Mazur W, 2010, APMIS, V118, P703, DOI 10.1111/j.1600-0463.2010.02646.x; Ni HM, 2012, TOXICOL SCI, V127, P438, DOI 10.1093/toxsci/kfs133; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Otomo E, 2003, CEREBROVASC DIS, V15, P222, DOI 10.1159/000069318; Pan H, 2011, NEUROCHEM RES, V36, P2434, DOI 10.1007/s11064-011-0571-6; Siegel D, 2004, MOL PHARMACOL, V65, P1238, DOI 10.1124/mol.65.5.1238; Siow RCM, 2007, REDOX REP, V12, P11, DOI 10.1179/135100007X162167; Stelmasiak Z, 2000, Med Sci Monit, V6, P426; Tang ZS, 2010, J EXP MED, V207, P867, DOI 10.1084/jem.20091704; Vomhof-DeKrey EE, 2012, J NUTR BIOCHEM, V23, P1201, DOI 10.1016/j.jnutbio.2012.03.005; Zhao XR, 2007, STROKE, V38, P3280, DOI 10.1161/STROKEAHA.107.486506	22	23	26	2	18	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1995-7645	2352-4146		ASIAN PAC J TROP MED	Asian Pac. J. Trop. Med.	APR	2013	6	4					305	310		10.1016/S1995-7645(13)60061-9			6	Public, Environmental & Occupational Health; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Tropical Medicine	136AS	WOS:000318332400009	23608333	gold			2022-02-06	
J	Haneef, Z; Levin, HS; Frost, JD; Mizrahi, EM				Haneef, Zulfi; Levin, Harvey S.; Frost, James D., Jr.; Mizrahi, Eli M.			Electroencephalography and Quantitative Electroencephalography in Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						EEG; mild traumatic brain injury; postconcussive syndrome; quantitative EEG; TBI	MINOR HEAD-INJURY; POSTCONCUSSIONAL-SYNDROME; AMERICAN ACADEMY; BIOPHYSICAL LINKAGE; SPECTRAL-ANALYSIS; EEG; NEUROLOGY; ABNORMALITIES; FOLLOW; STATE	Mild traumatic brain injury (mTBI) causes brain injury resulting in electrophysiologic abnormalities visible in electroencephalography (EEG) recordings. Quantitative EEG (qEEG) makes use of quantitative techniques to analyze EEG characteristics such as frequency, amplitude, coherence, power, phase, and symmetry over time independently or in combination. QEEG has been evaluated for its use in making a diagnosis of mTBI and assessing prognosis, including the likelihood of progressing to the postconcussive syndrome (PCS) phase. We review the EEG and qEEG changes of mTBI described in the literature. An attempt is made to separate the findings seen during the acute, subacute, and chronic phases after mTBI. Brief mention is also made of the neurobiological correlates of qEEG using neuroimaging techniques or in histopathology. Although the literature indicates the promise of qEEG in making a diagnosis and indicating prognosis of mTBI, further study is needed to corroborate and refine these methods.	[Haneef, Zulfi; Frost, James D., Jr.; Mizrahi, Eli M.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Haneef, Zulfi] Michael E Debakey VA Med Ctr, Dept Neurol, Houston, TX USA; [Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA		Haneef, Z (corresponding author), Baylor Coll Med, Dept Neurol, 1 Baylor Plaza,MS NB302, Houston, TX 77030 USA.	haneef@bcm.edu			Department of DefenseUnited States Department of Defense [W81XWH-08-2-0149, PT74693P22]; Mission Connect Translational MTBI Translational Research Consortium: Neurophysiology Core; Mission Connect Translational MTBI Translational Research Consortium: Neuropsychology Core	This research is supported by the Department of Defense (Contract # W81XWH-08-2-0149; Grant # PT74693P22); The Mission Connect Translational MTBI Translational Research Consortium: Neurophysiology Core (Eli M. Mizrahi, PI) and Neuropsychology Core (Harvey S. Levin, PI).	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Arciniegas DB, 2011, INT J PSYCHOPHYSIOL, V82, P41, DOI 10.1016/j.ijpsycho.2011.03.004; Chen Xi-Ping, 2006, Neurosci Bull, V22, P165; Dow RS, 1944, AM J PSYCHIAT, V101, P174, DOI 10.1176/ajp.101.2.174; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Fenton GW, 1996, CLIN ELECTROENCEPHAL, V27, P174; Gaetz M, 2001, J HEAD TRAUMA REHAB, V16, P386, DOI 10.1097/00001199-200108000-00008; Geets W, 1985, Rev Electroencephalogr Neurophysiol Clin, V14, P333; GEETS W, 1985, ACTA NEUROL BELG, V85, P277; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Hayes R L, 1988, Brain Inj, V2, P31, DOI 10.3109/02699058809150930; Hoffman DA, 1999, J NEUROPSYCH CLIN N, V11, P401, DOI 10.1176/jnp.11.3.401; Johnstone J, 1991, J Insur Med, V23, P228; Kane NM, 1998, ELECTROEN CLIN NEURO, V106, P244, DOI 10.1016/S0013-4694(97)00141-7; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; KOUFEN H, 1978, FORTSCHR NEUROL PSYC, V46, P165; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; MCCLELLAND RJ, 1994, J ROY SOC MED, V87, P508; MEYER JS, 1955, ELECTROEN CLIN NEURO, V7, P529, DOI 10.1016/0013-4694(55)90078-X; Moeller JJ, 2011, ARCH NEUROL-CHICAGO, V68, P1595, DOI 10.1001/archneurol.2011.1080; Nuwer M, 1997, NEUROLOGY, V49, P277, DOI 10.1212/WNL.49.1.277; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Parsons LC, 1997, J NEUROTRAUM, V14, P549, DOI 10.1089/neu.1997.14.549; SCHERZER E, 1966, PSYCHIAT NEUROL, V152, P207; TEBANO MT, 1988, ELECTROEN CLIN NEURO, V70, P185, DOI 10.1016/0013-4694(88)90118-6; Thatcher RW, 1998, NEUROIMAGE, V7, P352, DOI 10.1006/nimg.1998.0330; Thatcher RW, 1998, NEUROIMAGE, V8, P307, DOI 10.1006/nimg.1998.0365; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Thatcher RW, 1999, CLIN ELECTROENCEPHAL, V30, P94, DOI 10.1177/155005949903000304; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; VONBIERBRAUER A, 1992, EEG-EMG-Z ELEK ELEKT, V23, P151; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; WATSON MR, 1995, BRIT J PSYCHIAT, V167, P514, DOI 10.1192/bjp.167.4.514	34	23	25	0	18	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2013	30	8			SI		653	656		10.1089/neu.2012.2585			4	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	133PO	WOS:000318151500007	23249295	Green Published			2022-02-06	
J	Li, XG; vot Holst, H; Kleiven, S				Li, Xiaogai; von Holst, Hans; Kleiven, Svein			Decompressive craniectomy causes a significant strain increase in axonal fiber tracts	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Axonal fiber tracts; Decompressive craniectomy; Diffusion-weighted image; Lagrangian finite strain tensor	TRAUMATIC BRAIN-INJURY; DYNAMIC STRETCH INJURY; SERIES	Decompressive craniectomy (DC) allows for the expansion of a swollen brain outside the skull and has the potential to reduce intracranial pressure. However, the stretching of axons may contribute to an unfavorable outcome in patients treated with DC. In this study, we present a method for quantifying and visualizing axonal fiber deformation during both the pre-craniectomy and post-craniectomy periods to provide more insight into the mechanical effects of this treatment on axonal fibers. The deformation of the brain tissue in the form of a Lagrangian finite strain tensor for the entire brain was obtained by a non-linear image registration method based on the CT scanning data sets of the patient. Axonal fiber tracts were extracted from diffusion-weighted images. Based on the calculated brain tissue strain tensor and the observed axonal fiber tracts, the deformation of axonal fiber tracts in the form of a first principal strain, axonal strain and axonal shear strain were quantified. The greatest axonal fiber displacement was predominantly located in the treated region of the craniectomy, accompanied by a large axonal deformation close to the skull edge of the craniectomy. The distortion (stretching or shearing) of axonal fibers in the treated area of the craniectomy may influence the axonal fibers in such a way that neurochemical events are disrupted. A quantitative model may clarify some of the potential problems with this treatment. (C) 2012 Elsevier Ltd. All rights reserved.	[Li, Xiaogai; von Holst, Hans; Kleiven, Svein] Royal Inst Technol KTH, Sch Technol & Hlth, Div Neuron Engn, SE-14152 Stockholm, Sweden; [von Holst, Hans] Karolinska Inst, Neurosurg Sect, Div Clin Neurosci, Stockholm, Sweden		Li, XG (corresponding author), Royal Inst Technol KTH, Sch Technol & Hlth, Div Neuron Engn, Alfred Nobels Alle 10, SE-14152 Stockholm, Sweden.	xiaogai@kth.se		Li, Xiaogai/0000-0001-8522-4705	Swedish Research CouncilSwedish Research CouncilEuropean Commission [621-2008-3400]; Swedish Governmental Agency for Innovation systems (VINNOVA)Vinnova; Chinese Council Scholarship (CSC)	This study was supported by Swedish Research Council D.nr. 621-2008-3400, the Swedish Governmental Agency for Innovation systems (VINNOVA), and the Chinese Council Scholarship (CSC) for the first author. We thank Professor Tieqiang Li (Karolinska Institute, Stockholm, Sweden) for providing the diffusion-weighted images and the MRI in this study.	Alexander DC, 2001, IEEE T MED IMAGING, V20, P1131, DOI 10.1109/42.963816; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Chatelin S, 2011, J MECH BEHAV BIOMED, V4, P1905, DOI 10.1016/j.jmbbm.2011.06.007; Chung RS, 2005, J NEUROTRAUM, V22, P1081, DOI 10.1089/neu.2005.22.1081; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Fowler SS, 2001, OTOLARYNG HEAD NECK, V124, P641, DOI 10.1067/mhn.2001.115908; Hill DLG, 2002, LECT NOTES COMPUT SC, V2488, P532; Holzapfel GA., 2000, NONLINEAR SOLID MECH; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Joseph R, 1996, NEUROPSYCHIATRY NEUR, Vsecond; Li X, 2012, FINITE ELEMENT NEURO; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Pieper S, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 and 2, P632; Servadei F, 2011, NEW ENGL J MED, V364, P1558, DOI 10.1056/NEJMe1102998; Smith DH, 1999, J NEUROSCI, V19, P4263; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Timmons SD, 2011, NEW ENGL J MED, V365, P373, DOI 10.1056/NEJMc1106421; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Vashu R, 2011, ACTA NEUROCHIR, V153, P2065, DOI 10.1007/s00701-011-1101-7; Vercauteren T, 2009, NEUROIMAGE, V45, pS61, DOI 10.1016/j.neuroimage.2008.10.040; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; Winter CD, 2005, J CLIN NEUROSCI, V12, P619, DOI 10.1016/j.jocn.2005.02.002; Wirtz C R, 1997, Neurosurg Focus, V2, pE3; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	26	23	23	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	APR	2013	20	4					509	513		10.1016/j.jocn.2012.04.019			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	126PF	WOS:000317632500004	23403173				2022-02-06	
J	Mioni, G; Mattalia, G; Stablum, F				Mioni, G.; Mattalia, G.; Stablum, F.			Time perception in severe traumatic brain injury patients: A study comparing different methodologies	BRAIN AND COGNITION			English	Article						Traumatic brain injury; Time perception; Time reproduction; Time production; Time discrimination	FRONTAL-LOBE LESIONS; CLOSED HEAD-INJURY; WORKING-MEMORY; TEMPORAL PERCEPTION; DIVIDED ATTENTION; PROCESSING SPEED; PRACTICAL SCALE; DURATION; INTERVALS; TASK	In this study, we investigated time perception in patients with traumatic brain injury (TBI). Fifteen TBI patients and 15 matched healthy controls participated in the study. Participants were tested with durations above and below 1 s on three different temporal tasks that involved time reproduction, production, and discrimination tasks. Data variables analyzed included amount of errors, relative errors, and coefficient of variation. Both groups completed a neuropsychological battery that included measures of attention, working memory, and executive functions. Results revealed significant differences between groups on the time reproduction and discrimination tasks, whereas groups showed similar performance on the time production task. Correlation analyses showed involvement of attention, working memory and executive functions on the time reproduction and time discrimination tasks, but there was no involvement on the time production task. These findings suggest that TBI does not impact specific temporal function. Rather, impairments in attention, working memory and executive function abilities may explain lower temporal performance in people with TBI. (C) 2013 Elsevier Inc. All rights reserved.	[Mioni, G.; Mattalia, G.; Stablum, F.] Univ Padua, Dipartimento Psicol Gen, I-35131 Padua, Italy		Mioni, G (corresponding author), Univ Padua, Dipartimento Psicol Gen, Via Venezia 8, I-35131 Padua, Italy.	giovanna.mioni@unipd.it		mioni, Giovanna/0000-0002-1212-4591; Stablum, Franca/0000-0003-0123-5090			Anderson CV, 1995, J CLIN EXP NEUROPSYC, V17, P900, DOI 10.1080/01688639508402438; Anderson JW, 2011, NEUROPSYCHOLOGY, V25, P36, DOI 10.1037/a0020333; Azouvi P, 1996, J CLIN EXP NEUROPSYC, V18, P317, DOI 10.1080/01688639608408990; Baudouin A, 2006, ACTA PSYCHOL, V121, P285, DOI 10.1016/j.actpsy.2005.07.004; Block R.A., 1990, COGNITIVE MODELS PSY, P1; Block RA, 1996, TIME AND MIND, P171; Block RA, 1998, PSYCHOL AGING, V13, P584, DOI 10.1037/0882-7974.13.4.584; Block RA, 2006, TIMING THE FUTURE: THE CASE FOR A TIME-BASED PROSPECTIVE MEMORY, P25, DOI 10.1142/9789812707123_0002; Boelen DHE, 2009, NEUROPSYCHOL REHABIL, V19, P625, DOI 10.1080/09602010802613853; BROUWER WH, 1989, CORTEX, V25, P219, DOI 10.1016/S0010-9452(89)80038-3; Brown SW, 1997, PERCEPT PSYCHOPHYS, V59, P1118, DOI 10.3758/BF03205526; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Casini L, 1999, NEUROPSYCHOLOGY, V13, P10, DOI 10.1037/0894-4105.13.1.10; CLAUSEN J, 1950, J EXP PSYCHOL, V40, P756, DOI 10.1037/h0056354; Craik FIM, 1999, PERCEPT PSYCHOPHYS, V61, P549, DOI 10.3758/BF03211972; Eisler H, 2008, PSYCHOLOGY OF TIME, P75, DOI 10.1016/B978-0-08046-977-5.00003-X; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; FRAISSE P, 1984, ANNU REV PSYCHOL, V35, P1, DOI 10.1146/annurev.ps.35.020184.000245; Gibbon J., 1984, TIMING TIME PERCEPTI, P52; Grondin S, 2004, CAN J EXP PSYCHOL, V58, P1, DOI 10.1037/h0087436; Grondin S, 1999, J EXP PSYCHOL HUMAN, V25, P993, DOI 10.1037/0096-1523.25.4.993; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Harrington DL, 1998, J NEUROSCI, V18, P1085; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; Laiacona M, 2000, NEUROL SCI, V21, P279, DOI 10.1007/s100720070065; Lejeune H, 2009, EUR J COGN PSYCHOL, V21, P941, DOI 10.1080/09541440802453006; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lewis PA, 2003, NEUROPSYCHOLOGIA, V41, P1583, DOI 10.1016/S0028-3932(03)00118-0; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Meck WH, 2005, BRAIN COGNITION, V58, P1, DOI 10.1016/j.bandc.2004.09.004; Meck WH, 1996, COGNITIVE BRAIN RES, V3, P227, DOI 10.1016/0926-6410(96)00009-2; MEYERS CA, 1992, NEUROPSY NEUROPSY BE, V5, P28; Nichelli P, 1995, ANN NY ACAD SCI, V769, P183, DOI 10.1111/j.1749-6632.1995.tb38139.x; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P477; Penney TB, 2008, PSYCHOLOGY OF TIME, P261, DOI 10.1016/B978-0-08046-977-5.00008-9; Perbal S, 2003, NEUROPSYCHOLOGIA, V41, P1599, DOI 10.1016/S0028-3932(03)00110-6; Perbal S, 2002, AGING NEUROPSYCHOL C, V9, P201, DOI 10.1076/anec.9.3.201.9609; Poppel E, 1997, TRENDS COGN SCI, V1, P56, DOI 10.1016/S1364-6613(97)01008-5; Poppel E, 2004, ACTA NEUROBIOL EXP, V64, P295; Rammsayer TH, 2001, EUR J COGN PSYCHOL, V13, P549, DOI 10.1080/09541440042000322; Rubia K, 2004, ACTA NEUROBIOL EXP, V64, P329; Rubia K, 2006, TIMING THE FUTURE: THE CASE FOR A TIME-BASED PROSPECTIVE MEMORY, P213, DOI 10.1142/9789812707123_0009; Schmitter-Edgecombe M, 2008, J CLIN EXP NEUROPSYC, V30, P212, DOI 10.1080/13803390701363803; TEASDALE G, 1974, LANCET, V2, P81; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; Wechsler D, 1981, WECHSLER ADULT INTEL; ZAKAY D, 1993, PERCEPTION, V22, P91, DOI 10.1068/p220091; Zakay D., 1996, ADV PSYCHOL, V115, P143, DOI [10.1016/S0166-4115(96), DOI 10.1016/S0166-4115(96)80057-4, 10.1016/S0166-4115(96)80057-4]; Zakay D., 1990, COGNITIVE MODELS PSY, P59; Zimmermann P, 2002, APPLIED NEUROPSYCHOLOGY OF ATTENTION: THEORY DIAGNOSIS AND REHABILITATION, P110	50	23	24	0	16	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626	1090-2147		BRAIN COGNITION	Brain Cogn.	APR	2013	81	3					305	312		10.1016/j.bandc.2012.12.005			8	Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	112LF	WOS:000316593000001	23395855				2022-02-06	
J	Shi, HY; Hwang, SL; Lee, KT; Lin, CL				Shi, Hon-Yi; Hwang, Shiuh-Lin; Lee, King-Teh; Lin, Chih-Lung			Temporal trends and volume-outcome associations after traumatic brain injury: a 12-year study in Taiwan	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; temporal trend; hospital volume; surgeon volume; outcome analysis	MANAGEMENT	Object. The purpose of this study was to evaluate temporal trends in traumatic brain injury (TBI); the impact of hospital volume and surgeon volume on length of stay (LOS), hospitalization cost, and in-hospital mortality rate; and to explore predictors of these outcomes in a nationwide population in Taiwan. Methods. This population-based patient cohort study retrospectively analyzed 16,956 patients who had received surgical treatment for TBI between 1998 and 2009. Bootstrap estimation was used to derive 95% confidence intervals for differences in effect sizes. Hierarchical linear regression models were used to predict outcomes. Results. Patients treated in very-high-volume hospitals were more responsive than those treated in low-volume hospitals in terms of LOS (-0.11; 95% CI -0.20 to -0.03) and hospitalization cost (-0.28; 95% CI -0.49 to -0.06). Patients treated by high-volume surgeons were also more responsive than those treated by low-volume surgeons in terms of LOS (-0.19; 95% CI -0.37 to -0.01) and hospitalization cost (-0.43; 95% CI -0.81 to -0.05). The mean LOS was 24.3 days and the average LOS for very-high-volume hospitals and surgeons was 61% and 64% shorter, respectively, than that for low-volume hospitals and surgeons. The mean hospitalization cost was US $7,292.10, and the average hospitalization cost for very-high-volume hospitals and surgeons was 19% and 22% lower, respectively, than that for low-volume hospitals and surgeons. Advanced age, male sex, high Charlson Comorbidity Index score, treatment in a low-volume hospital, and treatment by a low-volume surgeon were significantly associated with adverse outcomes (p < 0.001). Conclusions. The data suggest that annual surgical volume is the key factor in surgical outcomes in patients with TBI. The results improve the understanding of medical resource allocation for this surgical procedure, and can help to formulate public health policies for optimizing hospital resource utilization for related diseases. (http://thejns.org/doi/abs/10.3171/2012.12.JNS12693)	[Shi, Hon-Yi; Lee, King-Teh] Kaohsiung Med Univ, Dept Hlth Care Adm & Med Informat, Kaohsiung, Taiwan; [Hwang, Shiuh-Lin; Lin, Chih-Lung] Kaohsiung Med Univ Hosp, Dept Neurosurg, Kaohsiung 80708, Taiwan; [Hwang, Shiuh-Lin; Lin, Chih-Lung] Kaohsiung Med Univ, Fac Med, Coll Med, Kaohsiung, Taiwan; [Lee, King-Teh] Kaohsiung Med Univ Hosp, Dept Surg, Div Hepatobiliary Surg, Kaohsiung, Taiwan		Lin, CL (corresponding author), Kaohsiung Med Univ Hosp, Dept Neurosurg, 100 Shih Chun 1st Rd, Kaohsiung 80708, Taiwan.	hshi@kmu.edu.tw			National Science Council, TaiwanMinistry of Science and Technology, Taiwan [NSC99-2314-B-037-069-MY3]	This study was supported by funding from the National Science Council, Taiwan (Grant No. NSC99-2314-B-037-069-MY3). The authors report no conflict of interest concerning the materials and methods used in this study or the findings specified in this paper.	Bagshaw SM, 2007, CURR OPIN CRIT CARE, V13, P541, DOI 10.1097/MCC.0b013e3282e2a978; Cadotte DW, 2011, J NEUROSURG, V114, P1502, DOI 10.3171/2010.12.JNS10808; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Funk LM, 2011, ANN SURG, V253, P912, DOI 10.1097/SLA.0b013e318213862f; Huang SJ, 2010, BRAIN INJURY, V24, P1606, DOI 10.3109/02699052.2010.523056; Livingston EH, 2010, JAMA-J AM MED ASSOC, V304, P95, DOI 10.1001/jama.2010.905; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Ogilvy CS, 2011, J NEUROSURG, V114, P120, DOI 10.3171/2010.3.JNS091384; Ogiso S, 2011, SURG ENDOSC, V25, P1907, DOI 10.1007/s00464-010-1485-0; Panageas KS, 2003, ANN INTERN MED, V139, P658, DOI 10.7326/0003-4819-139-8-200310210-00009; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Peek-Asa C, 2011, ACCIDENT ANAL PREV, V43, P595, DOI 10.1016/j.aap.2010.07.019; Reaven Nancy L, 2009, J Intensive Care Med, V24, P131, DOI 10.1177/0885066608330211; Rosenthal G, 2011, J NEUROSURG, V114, P62, DOI 10.3171/2010.6.JNS091360; Saunders-Pullman R, 2011, GENDER MED, V8, P209, DOI 10.1016/j.genm.2011.05.002; Shamim MS, 2011, J NEUROSURG, V115, P1007, DOI 10.3171/2011.7.JNS101829; Singla A, 2010, SURG ENDOSC, V24, P662, DOI 10.1007/s00464-009-0665-2; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Walkey AJ, 2011, CRIT CARE MED, V39, P1322, DOI 10.1097/CCM.0b013e3182120829; Warner MA, 2010, J NEUROSURG, V113, P539, DOI 10.3171/2009.12.JNS091337; Zheng C, 2011, SURG ENDOSC, V25, P249, DOI 10.1007/s00464-010-1167-y	22	23	23	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	APR	2013	118	4					732	738		10.3171/2012.12.JNS12693			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	114BT	WOS:000316715700008	23350773				2022-02-06	
J	Williams, MW; Rapport, LJ; Hanks, RA; Millis, SR; Greene, HA				Williams, Michael W.; Rapport, Lisa J.; Hanks, Robin A.; Millis, Scott R.; Greene, Hillary A.			Incremental Validity of Neuropsychological Evaluations to Computed Tomography in Predicting Long-Term Outcomes after Traumatic Brain Injury	CLINICAL NEUROPSYCHOLOGIST			English	Article						Traumatic brain injury; Neuropsychological testing; Cognitive functioning; Computed tomography; Disability; Outcomes; Rehabilitation	SEVERE HEAD-INJURY; PRACTICAL SCALE; UNITED-STATES; FOLLOW-UP; REHABILITATION; PRODUCTIVITY; 1-YEAR; TESTS; CLASSIFICATION; SATISFACTION	This study evaluated the incremental utility of neuropsychological tests to computed tomography (CT) in predicting long-term outcomes of adults with moderate to severe traumatic brain injury (TBI). Participants were 288 adults with mild complicated, moderate, and severe TBI. Longitudinal data were evaluated during inpatient status in an urban rehabilitation hospital with a TBI Model System, as well as 1 and 2 years post injury. Predictors including demographic characteristics, injury severity, CT characteristics, and neuropsychological evaluations were regressed to outcomes of disability, life satisfaction, and employment at 1 and 2 years post injury. Prediction of life satisfaction was not improved with the use of CT characteristics or neuropsychological tests, but prediction of return to work was improved by these variables at 2 years post injury. Neuropsychological evaluations uniquely contributed to outcome predictions of functional disability, even after considering demographic and injury severity characteristics, including information from CT. In contrast, CT characteristics were not predictive of long-term functional disability at 1 or 2 years post TBI. Taken together, the findings indicate that neuropsychological tests add unique predictive information for long-term functional outcomes after TBI.	[Williams, Michael W.; Rapport, Lisa J.; Greene, Hillary A.] Wayne State Univ, Dept Psychol, Detroit, MI 48202 USA; [Hanks, Robin A.; Millis, Scott R.] Wayne State Univ, Sch Med, Detroit, MI USA		Rapport, LJ (corresponding author), Wayne State Univ, Dept Psychol, 5057 Woodward Ave,7th Floor, Detroit, MI 48202 USA.	rapport@wayne.edu		Parker, Hillary/0000-0002-8610-5975; Rapport, Lisa/0000-0001-8014-9523	Wayne State University Graduate School; National Institute of General Medicine - Initiative for Maximizing Student Development [GM058905-11]; National Institute on Disability & Rehabilitation Research Traumatic Brain Injury Model Systems Project [H133A080044]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM058905] Funding Source: NIH RePORTER	This project was supported by Wayne State University Graduate School, National Institute of General Medicine - Initiative for Maximizing Student Development (GM058905-11), and the National Institute on Disability & Rehabilitation Research Traumatic Brain Injury Model Systems Project (H133A080044). We would like to acknowledge Robert Kotasek for his work managing the dataset.	Atchison TB, 2004, CLIN NEUROPSYCHOL, V18, P249, DOI 10.1080/13854040490501475; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Benton A., 1994, CONTRIBUTIONS NEUROP; Bercaw EL, 2011, CLIN NEUROPSYCHOL, V25, P72, DOI 10.1080/13854046.2010.532813; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; Chesnut RM, 2000, J NEUROTRAUM, V17, P555; Corral L, 2009, BRAIN INJURY, V23, P403, DOI 10.1080/02699050902788477; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; Delis DC., 2001, DELIS KAPLAN EXECUTI; Delis DC, 1987, CALIFORNIA VERBAL LE; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Englander J, 2003, ARCH PHYS MED REHAB, V84, P214, DOI 10.1053/apmr.2003.50094; Faul M, 2010, TRAUMATIC BRAIN INJU; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Finkelstein E., 2006, INCIDENCE EC BURDEN; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Hamsher K., 1989, MULTILINGUAL APHASIA; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hoofien D, 2001, BRAIN INJURY, V15, P189; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; JENNETT B, 1976, LANCET, V1, P1031; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1992, J NEUROTRAUMA, V9, P287; Marshall LF, 1991, J NEUROSURG S, V75, P14; Matthews CG., 1964, INSTRUCTION MANUAL A; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Miller LJ, 2003, REHABIL PSYCHOL, V48, P237, DOI 10.1037/0090-5550.48.4.237; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Petroni G, 2010, J TRAUMA, V68, P564, DOI 10.1097/TA.0b013e3181ce1eed; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reitan R, 1985, HALSTEAD REITAN NEUR; Robertson IH, 2008, ARCH PHYS MED REHAB, V89, pS1, DOI 10.1016/j.apmr.2008.10.001; Ryu WHA, 2010, INT J REHABIL RES, V33, P84, DOI 10.1097/MRR.0b013e32832e6b4b; Schatz P, 2001, NEUROREHABILITATION, V16, P281; Schmidt M., 1996, REY AUDITORY VERBAL; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Smith A., 1982, SYMBOL DIGIT MODALIT; SmithKnapp K, 1996, BRAIN INJURY, V10, P651, DOI 10.1080/026990596124070; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tasaki O, 2009, J TRAUMA, V66, P304, DOI 10.1097/TA.0b013e31815d9d3f; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Uniform Data System for Medical Rehabilitation (UDSMR), 1997, GUID UN DAT SET MED; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; Zhu GW, 2009, J INT MED RES, V37, P983, DOI 10.1177/147323000903700402	52	23	23	0	13	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	APR 1	2013	27	3					356	375		10.1080/13854046.2013.765507			20	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	129JK	WOS:000317835100002	23391004				2022-02-06	
J	Purushothuman, S; Marotte, L; Stowe, S; Johnstone, DM; Stone, J				Purushothuman, Sivaraman; Marotte, Lauren; Stowe, Sally; Johnstone, Daniel M.; Stone, Jonathan			The Response of Cerebral Cortex to Haemorrhagic Damage: Experimental Evidence from a Penetrating Injury Model	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; AMYLOID PRECURSOR PROTEIN; BETA-OLIGOMER FORMATION; ALZHEIMERS-DISEASE; SENILE PLAQUES; HEAD-INJURY; RISK-FACTORS; MOUSE MODEL; CELL-DEATH; HYPOTHESIS	Understanding the response of the brain to haemorrhagic damage is important in haemorrhagic stroke and increasingly in the understanding the cerebral degeneration and dementia that follow head trauma and head-impact sports. In addition, there is growing evidence that haemorrhage from small cerebral vessels is important in the pathogenesis of age-related dementia (Alzheimer's disease). In a penetration injury model of rat cerebral cortex, we have examined the neuropathology induced by a needlestick injury, with emphasis on features prominent in the ageing and dementing human brain, particularly plaque-like depositions and the expression of related proteins. Needlestick lesions were made in neo- and hippocampal cortex in Sprague Dawley rats aged 3-5 months. Brains were examined after 1-30 d survival, for haemorrhage, for the expression of hyperphosphorylated tau, Ab, amyloid precursor protein (APP), for gliosis and for neuronal death. Temporal cortex from humans diagnosed with Alzheimer's disease was examined with the same techniques. Needlestick injury induced long-lasting changes-haem deposition, cell death, plaque-like deposits and glial invasion-along the needle track. Around the track, the lesion induced more transient changes, particularly upregulation of A beta, APP and hyperphosporylated tau in neurons and astrocytes. Reactions were similar in hippocampus and neocortex, except that neuronal death was more widespread in the hippocampus. In summary, experimental haemorrhagic injury to rat cerebral cortex induced both permanent and transient changes. The more permanent changes reproduced features of human senile plaques, including the formation of extracellular deposits in which haem and Ab-related proteins co-localised, neuronal loss and gliosis. The transient changes, observed in tissue around the direct lesion, included the upregulation of A beta, APP and hyperphosphorylated tau, not associated with cell death. The findings support the possibility that haemorrhagic damage to the brain can lead to plaque-like pathology.	[Purushothuman, Sivaraman; Stowe, Sally; Johnstone, Daniel M.; Stone, Jonathan] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Purushothuman, Sivaraman; Stowe, Sally; Johnstone, Daniel M.; Stone, Jonathan] Univ Sydney, Discipline Physiol, Sydney, NSW 2006, Australia; [Marotte, Lauren; Stowe, Sally] Australian Natl Univ, Res Sch Biol, Div Biomed Sci & Biochem, Canberra, ACT, Australia		Stone, J (corresponding author), Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia.	jonstone@eye.usyd.edu.au	Johnstone, Daniel/E-9929-2013	Johnstone, Daniel/0000-0003-2876-3299; Purushothuman, Sivaraman/0000-0002-0880-5060	Sir Zelman Cowen Universities Fund; Bluesand Foundation; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R28AA012725] Funding Source: NIH RePORTER	This work was supported by the Sir Zelman Cowen Universities Fund, and by the Bluesand Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball M, 1997, NEUROBIOL AGING, V18, pS1, DOI 10.1016/s0197-4580(97)00057-2; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Braak H, 1998, J NEURAL TRANSM-SUPP, P127; Braak H, 2004, NEUROBIOL AGING, V25, P713, DOI 10.1016/j.neurobiolaging.2003.12.015; Castellani RJ, 2011, J PATHOL, V224, P147, DOI 10.1002/path.2885; Chuang JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033120; Cordonnier C, 2006, NEUROLOGY, V66, P1356, DOI 10.1212/01.wnl.0000210535.20297.ae; Cullen KM, 2006, NEUROBIOL AGING, V27, P1786, DOI 10.1016/j.neurobiolaging.2005.10.016; Cullen KM, 2005, J CEREBR BLOOD F MET, V25, P1656, DOI 10.1038/sj.jcbfm.9600155; de la Torre JC, 2010, NEURODEGENER DIS, V7, P116, DOI 10.1159/000285520; de la Torre JC, 2004, NEUROL RES, V26, P517, DOI 10.1179/016164104225016254; de la Torre JC, 2000, ANN NY ACAD SCI, V924, P136; de la Torre JC, 2000, BRAIN RES REV, V34, P119, DOI 10.1016/S0165-0173(00)00043-6; Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010; delaTorre JC, 1997, ANN NY ACAD SCI, V826, P75; Deshpande A, 2009, J NEUROSCI, V29, P4004, DOI 10.1523/JNEUROSCI.5980-08.2009; DOWSON JH, 1992, NEUROBIOL AGING, V13, P493, DOI 10.1016/0197-4580(92)90077-B; DOWSON JH, 1981, HISTOPATHOLOGY, V5, P305, DOI 10.1111/j.1365-2559.1981.tb01789.x; FAKTOROVICH EG, 1992, J NEUROSCI, V12, P3554; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; HARDY JA, 1986, NEUROBIOL AGING, V7, P489, DOI 10.1016/0197-4580(86)90086-2; Hossmann KA, 2009, TXB STROKE MED, P1; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jolkkonen J, 2007, NEUROSCI LETT, V428, P99, DOI 10.1016/j.neulet.2007.09.043; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; Kumar-Singh S, 2005, AM J PATHOL, V167, P527, DOI 10.1016/S0002-9440(10)62995-1; Kumar-Singh S, 2002, AM J PATHOL, V161, P507, DOI 10.1016/S0002-9440(10)64207-1; Larrue V, 2001, STROKE, V32, P438, DOI 10.1161/01.STR.32.2.438; LASSMANN H, 1995, ACTA NEUROPATHOL, V89, P35, DOI 10.1007/BF00294257; Lee JS, 2011, NEUROSCI LETT, V489, P84, DOI 10.1016/j.neulet.2010.11.071; MacKenzie JM, 1996, J CLIN PATHOL, V49, P360, DOI 10.1136/jcp.49.5.360; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Maslim J, 1997, INVEST OPHTH VIS SCI, V38, P1667; MAXWELL WL, 1988, J PATHOL, V155, P327, DOI 10.1002/path.1711550408; Meadowcroft MD, 2009, J MAGN RESON IMAGING, V29, P997, DOI 10.1002/jmri.21731; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Mikula S, 2007, NEUROIMAGE, V35, P9, DOI 10.1016/j.neuroimage.2006.11.053; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Miyakawa T, 2000, ANN NY ACAD SCI, V903, P46, DOI 10.1111/j.1749-6632.2000.tb06349.x; Morrison JH, 2002, PROG BRAIN RES, V136, P467; Nakamura T, 2004, J NEUROSURG, V100, P672, DOI 10.3171/jns.2004.100.4.0672; OTSUKA N, 1991, BRAIN RES, V568, P335, DOI 10.1016/0006-8993(91)91422-W; Park A, 2010, TIME MAGAZINE, P30; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V400; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Poels MMF, 2010, STROKE, V41, pS103, DOI 10.1161/STROKEAHA.110.595181; PUCHTLER H, 1962, J HISTOCHEM CYTOCHEM, V10, P355, DOI 10.1177/10.3.355; Quintana C, 2007, J ALZHEIMERS DIS, V12, P157; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Saing T, 2012, J NEUROTRAUM, V29, P1054, DOI 10.1089/neu.2011.1957; Salminen A, 2008, J CELL MOL MED, V12, P2255, DOI 10.1111/j.1582-4934.2008.00496.x; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Smith MA, 2002, FREE RADICAL BIO MED, V33, P1194, DOI 10.1016/S0891-5849(02)01021-3; Stone J, 2008, MED HYPOTHESES, V71, P347, DOI 10.1016/j.mehy.2008.04.007; Szczygielski J, 2005, J NEURAL TRANSM, V112, P1547, DOI 10.1007/s00702-005-0326-0; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Thal DR, 2002, CLIN NEUROPATHOL, V21, P35; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; van Groen T, 2005, STROKE, V36, P1551, DOI 10.1161/01.STR.0000169933.88903.cf; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; WEN R, 1995, J NEUROSCI, V15, P7377; Wu CW, 2004, NEUROBIOL DIS, V17, P367, DOI 10.1016/j.nbd.2004.08.014; Yates PA, 2011, NEUROLOGY, V77, P48, DOI 10.1212/WNL.0b013e318221ad36	74	23	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59740	10.1371/journal.pone.0059740			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	WOS:000316546400060	23555765	gold, Green Published			2022-02-06	
J	Pretz, CR; Kozlowski, AJ; Dams-O'Connor, K; Kreider, S; Cuthbert, JP; Corrigan, JD; Heinemann, AW; Whiteneck, G				Pretz, Christopher R.; Kozlowski, Allan J.; Dams-O'Connor, Kristen; Kreider, Scott; Cuthbert, Jeffery P.; Corrigan, John D.; Heinemann, Allen W.; Whiteneck, Gale			Descriptive Modeling of Longitudinal Outcome Measures in Traumatic Brain Injury: A National Institute on Disability and Rehabilitation Research Traumatic Brain Injury Model Systems Study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Longitudinal studies; Regression analysis; Rehabilitation; Rehabilitation outcome; Traumatic brain injury	FUNCTIONAL INDEPENDENCE MEASURE; INPATIENT REHABILITATION; FIM INSTRUMENT; SCALE	Establishing accurate mathematical models of outcome measures is essential in understanding change throughout the rehabilitation process. The goal of this study is to identify the best-fitting descriptive models for a set of commonly adopted outcome measures found within the Traumatic Brain Injury Model Systems National Database where the modeling is based on data submission through 2011 and the complete range of recorded time points since injury for each individual, where time points range from admission to rehabilitation to 20 years postinjury. The statistical methodology and the application of the methodology contained herein may be used to assist researchers and clinicians in (1) modeling the outcome measures considered, (2) modeling various portions of these outcomes by stratification and/or truncating time periods, (3) modeling longitudinal outcome measures not considered, and (4) establishing models as a necessary precursor in conducting individual growth curve analysis. Archives of Physical Medicine and Rehabilitation 2013;94:579-88 (C) 2013 by the American Congress of Rehabilitation Medicine	[Pretz, Christopher R.; Kreider, Scott; Cuthbert, Jeffery P.; Whiteneck, Gale] Craig Hosp, Englewood, CO 80132 USA; [Pretz, Christopher R.; Kreider, Scott; Cuthbert, Jeffery P.; Whiteneck, Gale] Traumat Brain Injury Natl Stat & Data Ctr, Englewood, CO 80132 USA; [Kozlowski, Allan J.; Heinemann, Allen W.] Rehabil Inst Chicago, Ctr Rehabil Outcomes Res, Chicago, IL 60611 USA; [Kozlowski, Allan J.] Northwestern Univ, Feinberg Med Sch, Ctr Healthcare Studies, Chicago, IL 60611 USA; [Heinemann, Allen W.] Northwestern Univ, Feinberg Med Sch, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Dams-O'Connor, Kristen] Mt Sinai Sch Med, New York, NY USA; [Corrigan, John D.] Ohio State Univ, Wexner Med Ctr, Dept Phys Med & Rehabil, Columbus, OH 43210 USA		Pretz, CR (corresponding author), Craig Hosp, 3425 South Clarkson St, Englewood, CO 80132 USA.	cpretz@craighospital.org	Heinemann, Allen W./AAI-2790-2021; Heinemann, Allen W/K-6283-2012	Heinemann, Allen W./0000-0003-2782-7326; Heinemann, Allen W/0000-0003-2782-7326	Traumatic Brain Injury Model Systems National Data and Statistical Center; National Institute on Disability and Rehabilitation Research (NIDRR) [H133A110006]; NIDRR through the Rehabilitation Research and Training Center on Improving Measurement of Medical Rehabilitation Outcomes [H133B090024]; Traumatic Brain Injury Model System Centers grants from the NIDRR [H133A070029]; Mount Sinai Medical Center [H133A070033]	Supported by the Traumatic Brain Injury Model Systems National Data and Statistical Center, the National Institute on Disability and Rehabilitation Research (NIDRR) (grant no. H133A110006); the NIDRR through the Rehabilitation Research and Training Center on Improving Measurement of Medical Rehabilitation Outcomes (grant no. H133B090024); and Traumatic Brain Injury Model System Centers grants from the NIDRR to Ohio State University (grant no. H133A070029) and Mount Sinai Medical Center (grant no. H133A070033).	Boake C, 2000, SUPERVISION RATING S; Bryk, 2001, HIERARCHICAL LINEAR; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; DeLucia C, 2006, J PEDIATR PSYCHOL, V31, P1002, DOI 10.1093/jpepsy/jsj074; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Fitzmaurice G.M., 2004, APPL LONGITUDINAL AN, Ved; Granger CV, 2007, AM J PHYS MED REHAB, V86, P883, DOI 10.1097/PHM.0b013e318152058a; Houlden H, 2006, CLIN REHABIL, V20, P153, DOI 10.1191/0269215506cr917oa; Jackson DL, 2010, REHABIL PSYCHOL, V55, P272, DOI 10.1037/a0020462; Kozlowski AJ, 2013, ARCH PHYS MED REHAB, V94, P589, DOI 10.1016/j.apmr.2012.08.199; Kwok OM, 2008, REHABIL PSYCHOL, V53, P370, DOI 10.1037/a0012765; Pavot W., 1993, PSYCHOL ASSESSMENT, V52, P164, DOI DOI 10.1037/1040-3590.5.2.164; Scheuringer M, 2011, EUR J PHYS REHAB MED, V47, P25; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Singer J, 2003, APPL LONGITUDINAL DA APPL LONGITUDINAL DA, DOI [10.1093/acprof:oso/ 9780195152968.003.0001, DOI 10.1093/ACPROF:OSO/9780195152968.003.0001]; The SAS Institute, MIXED PROC; Traumatic Brain Injury Model Systems, TRAUM BRAIN INJ MOD; Warschausky S, 2001, ARCH PHYS MED REHAB, V82, P329, DOI 10.1053/apmr.2001.21510; Williams G, 2006, ARCH PHYS MED REHAB, V87, P437, DOI 10.1016/j.apmr.2005.10.028; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	21	23	23	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2013	94	3					579	588		10.1016/j.apmr.2012.08.197			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	106PZ	WOS:000316158500025	22902888				2022-02-06	
J	Wang, H; Anderson, LG; Lascola, CD; James, ML; Venkatraman, TN; Bennett, ER; Acheson, SK; Vitek, MP; Laskowitz, DT				Wang, Haichen; Anderson, Lauren G.; Lascola, Christopher D.; James, Michael L.; Venkatraman, Talaignair N.; Bennett, Ellen R.; Acheson, Shawn K.; Vitek, Michael P.; Laskowitz, Daniel T.			ApolipoproteinE mimetic peptides improve outcome after focal ischemia	EXPERIMENTAL NEUROLOGY			English	Article						Apolipoprotein E; Ischemic stroke; Reperfusion; Brain edema; Microglia; Inflammation	GLOBAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; D-ASPARTATE RECEPTOR; GLIAL CELL-CULTURES; CLOSED-HEAD INJURY; INTRACEREBRAL HEMORRHAGE; APOE GENOTYPE; MURINE MODEL; E-DEFICIENT; E PROTECTS	Growing clinical evidence implicates isoform-specific effects of apolipoprotein E (apoE) in reducing neuroinflammation and mediating adaptive responses following ischemic and traumatic brain injury. However, the intact apoE holoprotein does not cross the blood-brain barrier and thus has limited therapeutic potential. We have created a small peptide, COG1410 (acetyl-AS-Aib-LRKL-Aib-KRLL-amide), derived from the apoE receptor-binding region. COG1410 retains the anti-inflammatory and neuroprotective biological properties of the intact holoprotein and penetrates the blood-brain barrier. In the current study, we utilized a murine model of transient focal cerebral ischemia and reperfusion to demonstrate that intravenous (IV) administration of COG1410 reduces infarct volume and radiographic progression of infarct, and improves functional outcome as assessed by rotarod when delivered up to 4 h after ischemia onset. (c) 2012 Elsevier Inc. All rights reserved.	[Wang, Haichen; Anderson, Lauren G.; James, Michael L.; Bennett, Ellen R.; Vitek, Michael P.; Laskowitz, Daniel T.] Duke Univ, Sch Med, Dept Med Neurol, Durham, NC 27710 USA; [Lascola, Christopher D.; Venkatraman, Talaignair N.] Duke Univ, Sch Med, Dept Radiol, Durham, NC 27710 USA; [Lascola, Christopher D.; Vitek, Michael P.; Laskowitz, Daniel T.] Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA; [James, Michael L.; Laskowitz, Daniel T.] Duke Univ, Sch Med, Dept Anesthesiol, Durham, NC 27710 USA; [Acheson, Shawn K.] Duke Univ, Sch Med, Dept Psychiatiy, Durham, NC 27710 USA; [Acheson, Shawn K.] Durham VA Med Ctr, Neurobiol Res Lab, Durham, NC 27705 USA; [Vitek, Michael P.] Cognosci Inc, Res Triangle Pk, NC 27709 USA		Laskowitz, DT (corresponding author), Duke Univ, Sch Med, Dept Med Neurol, Box 2900, Durham, NC 27710 USA.	danl@neuro.duke.edu	James, Michael L./AAJ-5592-2020; Acheson, Shawn/A-3299-2016; Lascola, Christopher D/B-9126-2017	James, Michael L./0000-0002-8715-5210; Lascola, Christopher D/0000-0002-8031-782X; Vitek, Michael/0000-0001-8140-8048	Veterans AffairsUS Department of Veterans Affairs [IK2BX001267] Funding Source: NIH RePORTER; BLRD VA [IK2 BX001267] Funding Source: Medline		Aono M, 2003, NEUROSCIENCE, V116, P437, DOI 10.1016/S0306-4522(02)00709-1; Aono M, 2002, NEUROBIOL DIS, V11, P214, DOI 10.1006/nbdi.2002.0541; Bart RD, 1998, NEUROREPORT, V9, P2615, DOI 10.1097/00001756-199808030-00035; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Christensen DJ, 2011, J IMMUNOL, V186, P2535, DOI 10.4049/jimmunol.1002847; Colton CA, 2004, J NEUROIMMUNOL, V147, P62, DOI 10.1016/j.jneuroim.2003.10.015; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Gao J, 2006, NEUROCRIT CARE, V4, P25, DOI 10.1385/NCC:4:1:025; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hoane MR, 2007, J NEUROTRAUM, V24, P1108, DOI 10.1089/neu.2006.0254; Hoane MR, 2009, J NEUROTRAUM, V26, P121, DOI 10.1089/neu.2008.0565; Hoe HS, 2006, J BIOL CHEM, V281, P3425, DOI 10.1074/jbc.M509380200; Hoe HS, 2005, J NEUROCHEM, V93, P145, DOI 10.1111/j.1471-4159.2004.03007.x; Horsburgh K, 2000, J CEREBR BLOOD F MET, V20, P458, DOI 10.1097/00004647-200003000-00003; James ML, 2009, STROKE, V40, P632, DOI 10.1161/STROKEAHA.108.530402; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Laskowitz DT, 2006, ACTA NEUROL SCAND, V114, P15, DOI 10.1111/j.1600-0404.2006.00680.x; Laskowitz DT, 2007, J NEUROTRAUM, V24, P1093, DOI 10.1089/neu.2006.0192; Laskowitz DT, 2012, NEUROCRIT CARE, V16, P316, DOI 10.1007/s12028-011-9641-5; Laskowitz DT, 2010, J NEUROTRAUM, V27, P1983, DOI 10.1089/neu.2010.1396; Laskowitz DT, 1997, J CEREBR BLOOD F MET, V17, P753; Laskowitz DT, 2001, EXP NEUROL, V167, P74, DOI 10.1006/exnr.2001.7541; Laskowitz DT, 1998, J CEREBR BLOOD F MET, V18, P465, DOI 10.1097/00004647-199805000-00001; Lee Y, 2004, NEUROCHEM INT, V44, P107, DOI 10.1016/S0197-0186(03)00112-8; LINTON MF, 1991, J CLIN INVEST, V88, P270, DOI 10.1172/JCI115288; Lynch JR, 2003, J BIOL CHEM, V278, P48529, DOI 10.1074/jbc.M306923200; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; MARSHALL GR, 1990, P NATL ACAD SCI USA, V87, P487, DOI 10.1073/pnas.87.1.487; McAdoo JD, 2005, NEUROSCI LETT, V381, P305, DOI 10.1016/j.neulet.2005.02.036; Mesis Rachel G, 2006, Neurosurg Focus, V21, pE4; Pocivavsek A, 2009, J NEUROIMMUNOL, V214, P25, DOI 10.1016/j.jneuroim.2009.06.010; Ratnaparkhi GS, 2000, PROTEIN ENG, V13, P697, DOI 10.1093/protein/13.10.697; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sheng HX, 1999, STROKE, V30, P1118, DOI 10.1161/01.STR.30.5.1118; Sheng ZY, 2008, NEUROPHARMACOLOGY, V55, P204, DOI 10.1016/j.neuropharm.2008.05.016; Tlaskowitz D, 2007, PHARMACOGENOMICS, V8, P959, DOI 10.2217/14E22416.8.8.959; Tsuchiya D, 2003, BRAIN RES, V970, P131, DOI 10.1016/S0006-8993(03)02300-X; Tukhovskaya EA, 2009, J NEUROSCI RES, V87, P677, DOI 10.1002/jnr.21874; Wang H, 2007, NEUROSCIENCE, V144, P1324, DOI 10.1016/j.neuroscience.2006.11.017; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; Zhang XJ, 2006, NEUROL INDIA, V54, P402	42	23	27	0	16	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAR	2013	241						67	74		10.1016/j.expneurol.2012.11.027			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	095DV	WOS:000315315800009	23219883				2022-02-06	
J	Paintlia, MK; Paintlia, AS; Singh, AK; Singh, I				Paintlia, Manjeet K.; Paintlia, Ajaib S.; Singh, Avtar K.; Singh, Inderjit			S-Nitrosoglutathione Induces Ciliary Neurotrophic Factor Expression in Astrocytes, Which Has Implications to Protect the Central Nervous System under Pathological Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRILLARY ACIDIC PROTEIN; ACTIVATED-RECEPTOR-GAMMA; TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE ACTIVATION; IN-VITRO; SIGNALING PATHWAY; GLIAL-CELLS; CYCLOOXYGENASE-2 EXPRESSION; OLIGODENDROCYTE PROGENITORS; DEMYELINATING DISEASES	Accumulating evidence suggests that reactive astrogliosis has beneficial and detrimental outcomes in various CNS disorders, but the mechanism behind this dichotomy is unclear. Recent advances in this direction suggested that NO signaling is critical to regulate the outcomes of reactive astrogliosis in vivo. Using biochemical and genetic approaches, we here investigated the effect of S-nitrosoglutathione (GSNO; a physiological NO donor) in astrocytes in vitro settings. GSNO enhanced the expressions of glial fibrillary acidic protein and neurotrophic factors including ciliary neurotrophic factor (CNTF) in astrocytes in a dose-dependent manner. The enhanced CNTF expression in GSNO-treated astrocytes was ascribed to NO-mediated sGC/cGMP/PKG signaling. It was associated with p38 MAPK-dependent increased peroxisome proliferator-activated receptor-gamma transactivation. In addition, the chromatin accessibility of peroxisome proliferator-activated receptor-gamma accompanied with ATF2 and CREB (cAMP-response element-binding protein) was enhanced across the CNTF gene promoter in GSNO treated astrocytes. Interestingly, secreted CNTF was responsible for increased expression of glial fibrillary acidic protein in GSNO-treated astrocytes in an autocrine manner via a JAK2- and STAT3-dependent mechanism. In addition, CNTF secreted by GSNO-treated astrocytes enhanced the differentiation of immature oligodendrocytes in vitro. These effects of GSNO were consistent with an endogenously produced NO in astrocytes stimulated with proinflammatory cytokines in vitro. We conclude that NO signaling induces CNTF expression in astrocytes that favors the beneficial outcomes of reactive astrogliosis in vivo. Our data suggest that the endogenously produced NO or its exogenous source has potential to modulate the outcomes of reactive astrogliosis to protect CNS under pathological conditions.	[Paintlia, Manjeet K.; Paintlia, Ajaib S.; Singh, Inderjit] Med Univ S Carolina, Dept Pediat, Darby Childrens Res Inst, Charleston, SC 29425 USA; [Singh, Avtar K.] Ralph H Johnson Vet Affairs Med Ctr, Dept Pathol & Lab Med, Charleston, SC 29425 USA		Singh, I (corresponding author), Med Univ S Carolina, Dept Pediat, 173 Ashley Ave, Charleston, SC 29425 USA.	singhi@musc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-22576, NS-37766, VA-1BX001072, VA-BX001999, C06 RR018823, C06 RR015455]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [C06RR015455, C06RR018823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS037766, R01NS022576, R01NS072511, R37NS022576] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX001072] Funding Source: NIH RePORTER	This work was supported, in whole or in part, by National Institutes of Health Grants NS-22576, NS-37766, VA-1BX001072, VA-BX001999, C06 RR018823, and C06 RR015455.	Abramov AY, 2005, PHILOS T R SOC B, V360, P2309, DOI 10.1098/rstb.2005.1766; Albrecht PJ, 2003, NEUROBIOL DIS, V13, P89, DOI 10.1016/S0969-9961(03)00019-6; ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; Bayir H, 2007, J NEUROCHEM, V101, P168, DOI 10.1111/j.1471-4159.2006.04353.x; Bishop A, 2005, TOXICOLOGY, V208, P193, DOI 10.1016/j.tox.2004.11.034; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; Browning DD, 1999, J BIOL CHEM, V274, P537, DOI 10.1074/jbc.274.1.537; Browning DD, 2000, J BIOL CHEM, V275, P2811, DOI 10.1074/jbc.275.4.2811; BRUHWYLER J, 1993, NEUROSCI BIOBEHAV R, V17, P373, DOI 10.1016/S0149-7634(05)80114-9; Chien WL, 2008, EUR J PHARMACOL, V590, P233, DOI 10.1016/j.ejphar.2008.06.040; Chou PCT, 2011, J MAGN RESON IMAGING, V33, P1301, DOI 10.1002/jmri.22574; Ciani E, 2002, J NEUROCHEM, V82, P1282, DOI 10.1046/j.1471-4159.2002.01080.x; Crowe DL, 2000, ANTICANCER RES, V20, P2945; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Doronzo G, 2011, ATHEROSCLEROSIS, V216, P44, DOI 10.1016/j.atherosclerosis.2011.01.019; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; Escartin C, 2007, J NEUROSCI, V27, P7094, DOI 10.1523/JNEUROSCI.0174-07.2007; GHIRNIKAR RS, 1994, J NEUROSCI RES, V38, P376, DOI 10.1002/jnr.490380403; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Haider L, 2011, BRAIN, V134, P1914, DOI 10.1093/brain/awr128; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Hebert MA, 2000, ANN NY ACAD SCI, V914, P238, DOI 10.1111/j.1749-6632.2000.tb05200.x; Herx LM, 2001, J NEUROPATH EXP NEUR, V60, P961, DOI 10.1093/jnen/60.10.961; Hess DT, 2012, J BIOL CHEM, V287, P4411, DOI 10.1074/jbc.R111.285742; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; HUGHES SM, 1988, NATURE, V335, P70, DOI 10.1038/335070a0; Janabi N, 2002, J IMMUNOL, V168, P4747, DOI 10.4049/jimmunol.168.9.4747; Kacem K, 1998, GLIA, V23, P1; Kahn MA, 1997, J NEUROCHEM, V68, P1413; Khan M, 2005, J CEREBR BLOOD F MET, V25, P177, DOI 10.1038/sj.jcbfm.9600012; Khan M, 2006, NITRIC OXIDE-BIOL CH, V15, P114, DOI 10.1016/j.niox.2006.01.008; Khan M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-78; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Li ZM, 2004, J NEUROSCI RES, V78, P824, DOI 10.1002/jnr.20346; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Liu B, 2001, ARCH OPHTHALMOL-CHIC, V119, P240; LOUIS JC, 1993, SCIENCE, V259, P689, DOI 10.1126/science.8430320; Luna-Medina R, 2005, J BIOL CHEM, V280, P21453, DOI 10.1074/jbc.M414390200; MAGRINAT G, 1992, BLOOD, V80, P1880; Makwana M, 2007, J NEUROSCI, V27, P11201, DOI 10.1523/JNEUROSCI.2255-07.2007; Mander PK, 2006, J IMMUNOL, V176, P1046, DOI 10.4049/jimmunol.176.2.1046; MAYER M, 1994, DEVELOPMENT, V120, P143; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Murphy S, 2000, GLIA, V29, P1, DOI 10.1002/(SICI)1098-1136(20000101)29:1<1::AID-GLIA1>3.0.CO;2-N; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Na YJ, 2007, J NEUROCHEM, V103, P637, DOI 10.1111/j.1471-4159.2007.04769.x; Nath N, 2010, J NEUROIMMUNE PHARM, V5, P240, DOI 10.1007/s11481-009-9187-x; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Niedbala W, 2011, P NATL ACAD SCI USA, V108, P9220, DOI 10.1073/pnas.1100667108; Paintlia AS, 2006, J IMMUNOL, V176, P4385, DOI 10.4049/jimmunol.176.7.4385; Paintlia AS, 2010, GLIA, V58, P1669, DOI 10.1002/glia.21039; Paintlia AS, 2008, MOL PHARMACOL, V73, P1381, DOI 10.1124/mol.107.044230; Paintlia AS, 2005, FASEB J, V19, P1407, DOI 10.1096/fj.05-3861com; Prasad R, 2007, GLIA, V55, P65, DOI 10.1002/glia.20436; Ptasinska A, 2007, FASEB J, V21, P950, DOI 10.1096/fj.06-6822com; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Que LG, 2005, SCIENCE, V308, P1618, DOI 10.1126/science.1108228; Rostworowski M, 1997, J NEUROSCI, V17, P3664; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Sharma HS, 2000, ACTA NEUROCHIR SUPPL, V76, P81; Singh I, 1998, J BIOL CHEM, V273, P20354, DOI 10.1074/jbc.273.32.20354; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sriram K, 2004, J BIOL CHEM, V279, P19936, DOI 10.1074/jbc.M309304200; Vega-Avelaira D, 2007, BRAIN BEHAV IMMUN, V21, P617, DOI 10.1016/j.bbi.2006.10.007; Wilkins A, 2005, J NEUROCHEM, V92, P1487, DOI 10.1111/j.1471-4159.2004.02981.x; YU ACH, 1993, J NEUROSCI RES, V34, P295, DOI 10.1002/jnr.490340306	69	23	23	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3831	3843		10.1074/jbc.M112.405654			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	WOS:000314845000015	23264628	Green Published, hybrid			2022-02-06	
J	Morgan, AT; Masterton, R; Pigdon, L; Connelly, A; Liegeois, FJ				Morgan, Angela T.; Masterton, Richard; Pigdon, Lauren; Connelly, Alan; Liegeois, Frederique J.			Functional magnetic resonance imaging of chronic dysarthric speech after childhood brain injury: reliance on a left-hemisphere compensatory network	BRAIN			English	Article						brain injury; traumatic brain injury; plasticity; speech; dysarthria; functional MRI	DIFFERENTIAL-DIAGNOSIS; MOTOR-PERFORMANCE; LANGUAGE; FMRI; CHILDREN; REORGANIZATION; CLASSIFICATION; ARTICULATION; CEREBELLUM; PLASTICITY	Severe and persistent speech disorder, dysarthria, may be present for life after brain injury in childhood, yet the neural correlates of this chronic disorder remain elusive. Although abundant literature is available on language reorganization after lesions in childhood, little is known about the capacity of motor speech networks to reorganize after injury. Here, we examine the structural and functional neural correlates associated with chronic dysarthria after childhood-onset traumatic brain injury. Forty-nine participants aged 12 years 3 months to 24 years 11 months were recruited to the study: (i) a group with chronic dysarthria (n = 17); matched for age and sex with two control groups of (ii) healthy control subjects (n = 17); and (iii) individuals without dysarthria after traumatic brain injury (n = 15). A high-resolution 3D T-1-weighted whole-brain data set was acquired for voxel-based morphometry analyses of group differences in grey matter. Functional magnetic resonance imaging was used to localize activation associated with speaking single words (baseline: listening to words). Group differences on voxel-based morphometry revealed widespread grey matter reductions in the dysarthric group compared with healthy control subjects, including in numerous speech motor regions bilaterally, such as the cerebellum, the basal ganglia and primary motor cortex representation of the articulators. Relative to the non-dysarthric traumatic brain injury group, individuals with dysarthria showed reduced grey matter bilaterally in the ventral sensorimotor cortex, but this reduction was concomitant with increased functional activation only in the left-hemisphere cluster during speech. Finally, increased recruitment of Broca's area (Brodmann area 45, pars triangularis) but not its right homologue, correlated with better speech outcome, suggesting that this 'higher-level' area may be more critically involved with production when associated motor speech regions are damaged. We suggest that the bilateral morphological abnormalities within cortical speech networks in childhood prevented reorganization of speech function from the left-to right-hemisphere. Rather, functional reorganization involved over-recruitment of left-hemisphere motor regions, a reorganization method that was only partly relatively effective, given the presence of persisting yet mild speech deficits. The bilateral structural abnormalities found to limit functional reorganization here, may also be critical to poor speech prognosis for populations with congenital, degenerative or acquired neurological disorders throughout the lifespan.	[Morgan, Angela T.; Pigdon, Lauren] Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Morgan, Angela T.] Univ Melbourne, Dept Paediat, Melbourne, Vic 3010, Australia; [Morgan, Angela T.] Royal Childrens Hosp, Melbourne, Vic 3052, Australia; [Masterton, Richard; Connelly, Alan] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3084, Australia; [Liegeois, Frederique J.] UCL, Inst Child Hlth, London WC1N 1EH, England		Morgan, AT (corresponding author), Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	angela.morgan@mcri.edu.au	Connelly, Alan/A-9065-2013; Liegeois, Frederique/A-6351-2009; Morgan, Angela/J-5235-2017	Connelly, Alan/0000-0001-7159-8079; Morgan, Angela/0000-0003-1147-7405; Liegeois, Frederique/0000-0002-8640-6217	Transport Accident Commission: Victorian Neurotrauma Initiative [D131]; National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [607315, 1023043]	This study was supported by grant D131 from the Transport Accident Commission: Victorian Neurotrauma Initiative, awarded to A.T.M., F.J.L, A.C., and J-D.T.; and grants 607315 and 1023043 from the National Health and Medical Research Council awarded to A.T.M.	Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Anderson V, 2010, NEUROPSYCHOLOGIA, V48, P2041, DOI 10.1016/j.neuropsychologia.2010.03.025; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Brown J.R., 1975, MOTOR SPEECH DISORDE; Bunton K, 2007, J SPEECH LANG HEAR R, V50, P1481, DOI 10.1044/1092-4388(2007/102); Cahill LM, 2005, BRAIN INJURY, V19, P41, DOI 10.1080/02699050410001719961; Cahill LM, 2002, BRAIN INJURY, V16, P415, DOI 10.1080/02699050110119871; Duffy, 2005, MOTOR SPEECH DISORDE; Duffy JR, 2001, APHASIOLOGY, V15, P275, DOI 10.1080/02687040042000269; Eickhoff SB, 2009, PHILOS T R SOC A, V367, P2399, DOI 10.1098/rsta.2008.0287; Erickson-Levendoski E, 2011, J VOICE, V25, pE215, DOI 10.1016/j.jvoice.2011.02.009; Fair DA, 2010, BRAIN LANG, V114, P135, DOI 10.1016/j.bandl.2009.09.001; Gaillard WD, 2007, NEUROLOGY, V69, P1761, DOI 10.1212/01.wnl.0000289650.48830.1a; Gauthier LV, 2008, STROKE, V39, P1520, DOI 10.1161/STROKEAHA.107.502229; Golfinopoulos E, 2010, NEUROIMAGE, V52, P862, DOI 10.1016/j.neuroimage.2009.10.023; Guzzetta A, 2008, NEUROPEDIATRICS, V39, P157, DOI 10.1055/s-0028-1085465; Hayden D., 1999, VERBAL MOTOR PRODUCT; Heuninckx S, 2008, J NEUROSCI, V28, P91, DOI 10.1523/JNEUROSCI.3300-07.2008; Holland R, 2011, CURR BIOL, V21, P1403, DOI 10.1016/j.cub.2011.07.021; Karunanayaka PR, 2007, NEUROREHABILITATION, V22, P355; Kent RD, 2001, J SPEECH LANG HEAR R, V44, P535, DOI 10.1044/1092-4388(2001/042); Lidzba K, 2011, BRAIN LANG, V119, P6, DOI 10.1016/j.bandl.2011.02.003; Lidzba K, 2009, BRAIN, V132, DOI 10.1093/brain/awp197; Liegeois F, 2003, NAT NEUROSCI, V6, P1230, DOI 10.1038/nn1138; Liegeois F, 2011, EUR J PAEDIATR NEURO, V15, P283, DOI 10.1016/j.ejpn.2011.04.006; Liegeois F, 2004, BRAIN, V127, P1229, DOI 10.1093/brain/awh159; Liegeois F, NEUROLOGY IN PRESS; Liegeois F, 2010, BRAIN LANG, V114, P126, DOI 10.1016/j.bandl.2009.12.004; Liegeois FJ, 2012, NEUROSCI BIOBEHAV R, V36, P439, DOI 10.1016/j.neubiorev.2011.07.011; Loibl M, 2011, BEHAV BRAIN RES, V223, P280, DOI 10.1016/j.bbr.2011.04.040; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Morgan AT, 2007, BRAIN INJURY, V21, P1183, DOI 10.1080/02699050701649573; Morgan AT, 2011, BRAIN LANG, V117, P69, DOI 10.1016/j.bandl.2011.01.002; Morgan AT, 2010, FOLIA PHONIATR LOGO, V62, P120, DOI 10.1159/000287210; Morgan AT, 2010, CHILD CARE HLTH DEV, V36, P44, DOI 10.1111/j.1365-2214.2009.00961.x; Morgan AT, 2011, J EVAL CLIN PRACT, V17, P275, DOI 10.1111/j.1365-2753.2010.01436.x; Morgan AT, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006279.pub2; Murdoch B E, 1999, Pediatr Rehabil, V3, P5; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Pennington L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006937.pub2; Price CJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00237; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Riecker A, 2005, NEUROLOGY, V64, P700, DOI 10.1212/01.WNL.0000152156.90779.89; Riecker A, 2002, NEUROCASE, V8, P417, DOI 10.1076/neur.8.5.417.16181; Saur D, 2012, ARCH PHYS MED REHAB, V93, pS15, DOI 10.1016/j.apmr.2011.03.036; Sidtis JJ, 2010, BRAIN LANG, V114, P43, DOI 10.1016/j.bandl.2010.03.007; Simmons KC, 1997, J COMMUN DISORD, V30, P117, DOI 10.1016/S0021-9924(96)00058-5; Takai O, 2010, BRAIN LANG, V113, P39, DOI 10.1016/j.bandl.2010.01.008; Tillema JM, 2008, BRAIN LANG, V105, P99, DOI 10.1016/j.bandl.2007.07.127; Turkeltaub PE, 2011, NEUROLOGY, V76, P1726, DOI 10.1212/WNL.0b013e31821a44c1; Urban PP, 2006, BRAIN, V129, P767, DOI 10.1093/brain/awh708; Ventura MI, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-58; Wechsler D., 2011, WECHSLER ABBREVIATED; Wenke RJ, 2008, BRAIN INJURY, V22, P339, DOI 10.1080/02699050801960987; Wilcox K., 1999, CHILDRENS SPEECH INT; Witt RE, 2011, OTOLARYNG HEAD NECK, V144, P108, DOI 10.1177/0194599810390893; WORKINGER M S, 1992, Brain Injury, V6, P183, DOI 10.3109/02699059209029657	57	23	25	0	27	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	FEB	2013	136		2				646	657		10.1093/brain/aws355			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	090QX	WOS:000314995200030	23378215	Bronze			2022-02-06	
J	Nielsen, TH; Bindslev, TT; Pedersen, SM; Toft, P; Olsen, NV; Nordstrom, CH				Nielsen, T. H.; Bindslev, T. T.; Pedersen, S. M.; Toft, P.; Olsen, N. V.; Nordstrom, C. H.			Cerebral energy metabolism during induced mitochondrial dysfunction	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article							TRAUMATIC BRAIN-INJURY; GLYCOLYTIC METABOLITES; AMINO-ACIDS; INTRACEREBRAL MICRODIALYSIS; VOLATILE ANESTHETICS; COMPLETE ISCHEMIA; MECHANISMS; RAT; RESTITUTION; COMMON	Background In patients with traumatic brain injury as well as stroke, impaired cerebral oxidative energy metabolism may be an important factor contributing to the ultimate degree of tissue damage. We hypothesize that mitochondrial dysfunction can be diagnosed bedside by comparing the simultaneous changes in brain tissue oxygen tension (PbtO2) and cerebral cytoplasmatic redox state. The study describes cerebral energy metabolism during mitochondrial dysfunction induced by sevoflurane in piglets. Methods Ten piglets were included, seven in the experimental group (anesthetized with sevoflurane) and three in the control group (anesthetized with midazolam). PbtO2 and cerebral levels of glucose, lactate, and pyruvate were monitored bilaterally. The biochemical variables were obtained by intracerebral microdialysis. Results All global variables were within normal range and did not differ significantly between the groups except for blood lactate that was slightly higher in the experimental group. Mitochondrial dysfunction was observed in the group of animals initially anesthetized with sevoflurane. Cerebral glucose was significantly lower in the experimental group than in the control group whereas lactate and lactate/pyruvate ratio were significantly higher. Pyruvate and tissue oxygen tension remained within normal range in both groups. Changes of intracerebral variables indicating mitochondrial dysfunction were present already from the very start of the monitoring period. Conclusion Intracerebral microdialysis revealed mitochondrial dysfunction by marked increases in cerebral lactate and lactate/pyruvate ratio simultaneously with normal levels of pyruvate and a normal PbtO2. This metabolic pattern is distinctively different from cerebral ischemia, which is characterized by simultaneous decreases in PbtO2 and intracerebral pyruvate.	Odense Univ Hosp, Dept Anaesthesiol, DK-5000 Odense C, Denmark; [Nielsen, T. H.] Odense Univ Hosp, Dept Neurosurg, DK-5000 Odense C, Denmark		Nielsen, TH (corresponding author), Odense Univ Hosp, Dept Neurosurg, Sdr Blvd 29, DK-5000 Odense C, Denmark.	troels.nielsen@ouh.regionsyddanmark.dk	Nielsen, Troels Halfeld/G-3456-2015	Nielsen, Troels Halfeld/0000-0002-3943-8128; Toft, Palle/0000-0002-3188-449X	Odense University Hospital; A.P. Moller Foundation	The project was supported by grants from Odense University Hospital and the A.P. Moller Foundation.	Amer-Wahlin I, 2010, J MATERN-FETAL NEO M, V23, P158, DOI 10.3109/14767050903067360; Bains R, 2006, ACTA ANAESTH SCAND, V50, P572, DOI 10.1111/j.1399-6576.2006.00988.x; Bains R, 2009, ACTA ANAESTH SCAND, V53, P1354, DOI 10.1111/j.1399-6576.2009.02047.x; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Chen HI, 2011, NEUROSURGERY, V69, P53, DOI 10.1227/NEU.0b013e3182191451; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; COHEN PJ, 1973, ANESTHESIOLOGY, V39, P153, DOI 10.1097/00000542-197308000-00007; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; FOLBERGR.J, 1974, BRAIN RES, V80, P265, DOI 10.1016/0006-8993(74)90690-8; Gardenfors A, 2002, ACTA NEUROCHIR, V144, P601, DOI 10.1007/s00701-002-0954-1; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Horn T, 2010, NEUROCHEM INT, V57, P940, DOI 10.1016/j.neuint.2010.09.014; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Kopterides P, 2011, INTENS CARE MED, V37, P1756, DOI 10.1007/s00134-011-2336-8; Levy B, 2005, LANCET, V365, P871, DOI 10.1016/S0140-6736(05)71045-X; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Nielsen TH, 2011, NEUROCRIT CARE, V15, P585, DOI 10.1007/s12028-011-9563-2; Niizuma K, 2009, J NEUROCHEM, V109, P133, DOI 10.1111/j.1471-4159.2009.05897.x; NORBERG K, 1975, BRAIN RES, V86, P31, DOI 10.1016/0006-8993(75)90635-6; NORDSTROM CH, 1978, J NEUROCHEM, V30, P479, DOI 10.1111/j.1471-4159.1978.tb06553.x; NORDSTROM CH, 1978, STROKE, V9, P335, DOI 10.1161/01.STR.9.4.335; NORDSTROM CH, 1978, STROKE, V9, P327, DOI 10.1161/01.STR.9.4.327; NORDSTROM CH, 1978, ACTA PHYSIOL SCAND, V104, P271, DOI 10.1111/j.1748-1716.1978.tb06279.x; Nowak G, 2002, BRIT J SURG, V89, P1169, DOI 10.1046/j.1365-2168.2002.02187.x; Powers WJ, 2010, STROKE, V41, pS107, DOI 10.1161/STROKEAHA.110.595058; REHNCRONA S, 1979, STROKE, V10, P437, DOI 10.1161/01.STR.10.4.437; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Siesjo BK, 1999, ACTA NEUROCHIR SUPPL, V73, P7; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23	36	23	25	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-5172	1399-6576		ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	FEB	2013	57	2					229	235		10.1111/j.1399-6576.2012.02783.x			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	066WY	WOS:000313253800014	23017022				2022-02-06	
J	Girgis, H; Palmier, B; Croci, N; Soustrat, M; Plotkine, M; Marchand-Leroux, C				Girgis, Haymen; Palmier, Bruno; Croci, Nicole; Soustrat, Mathieu; Plotkine, Michel; Marchand-Leroux, Catherine			Effects of selective and non-selective cyclooxygenase inhibition against neurological deficit and brain oedema following closed head injury in mice	BRAIN RESEARCH			English	Article						Traumatic brain injury; Animal model; Cyclooxygenase; Behaviour; Brain oedema	FOCAL CEREBRAL-ISCHEMIA; INTRACEREBRAL HEMORRHAGE; INFLAMMATORY RESPONSE; BARRIER DISRUPTION; CELL-DEATH; RATS; NIMESULIDE; RECOVERY; ALPHA; MODEL	The implication of cyclooxygenase (COX) type 2 in post-traumatic consequences is so far controversial. In experimental models of traumatic brain injury (TBI), genetic disruption or pharmacological inhibition of COX-2 has been shown to be neuroprotective, deleterious or without effect. Therefore, the aim of our study was to investigate the effect of COX-2 inhibition against neurological deficit and brain oedema after TBI that was induced by mechanical percussion in male Swiss mice. Despite the increased level and activity of COX-2, its inhibition either with nimesulide (12 mg/kg) or meloxicam (2 mg/kg) modified neither the neurological score nor the brain water content that were evaluated at 6 and 24h after injury. Interestingly, the non-selective COX inhibition with indomethacin (5 mg/kg) significantly promoted neurological recovery at 6 and 24 h after trauma, without improving brain oedema. In conclusion, the present study yields considerable evidence that COX-2 may not solely constitute an interesting target for the treatment of TBI consequences. Our data point to a potentially deleterious role of COX-1 in the development of neurological impairment in brain-injured mice. However, the neuroprotective mechanism of indomethacin remains to be clarified. (C) 2012 Elsevier B.V. All rights reserved.	[Girgis, Haymen; Palmier, Bruno; Croci, Nicole; Soustrat, Mathieu; Plotkine, Michel; Marchand-Leroux, Catherine] Univ Paris 05, Lab Pharmacol Circulat Cerebrale, EA 4475, Fac Sci Pharmaceut & Biol, Paris, France		Marchand-Leroux, C (corresponding author), Univ Paris 05, Lab Pharmacol Circulat Cerebrale, EA 4475, Fac Sci Pharmaceut & Biol, Paris, France.	catherine.marchand@parisdescartes.fr	MARCHAND-LEROUX, Catherine/L-7453-2017	MARCHAND-LEROUX, Catherine/0000-0003-0113-5348	Academie Nationale de Medecine; Union des Blesses de la Face et de la Tete -Les Gueules Cassees-	This work was financially supported by "Academie Nationale de Medecine" and the "Union des Blesses de la Face et de la Tete -Les Gueules Cassees-".	Ahmad M, 2008, J NEUROSCI RES, V86, P3605, DOI 10.1002/jnr.21809; Aid S, 2010, J CEREBR BLOOD F MET, V30, P370, DOI 10.1038/jcbfm.2009.223; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; BOULU RG, 1981, EUR NEUROL, V20, P230, DOI 10.1159/000115240; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Candelario-Jalil E, 2004, BRAIN RES, V1007, P98, DOI 10.1016/j.brainres.2004.01.078; Candelario-Jalil E, 2002, EUR J PHARMACOL, V453, P189, DOI 10.1016/S0014-2999(02)02422-6; Candelario-Jalil E., 2007, J NEUROINFLAMM, V10, P4; Candelario-Jalil E, 2007, J PHARMACOL EXP THER, V323, P488, DOI 10.1124/jpet.107.127035; Candelario-Jalil E, 2007, J NEUROCHEM, V100, P1108, DOI 10.1111/j.1471-4159.2006.04280.x; Candelario-Jalil E, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-3; Candelario-Jalil E, 2009, AGING-US, V1, P350, DOI 10.18632/aging.100039; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Cernak I, 2001, CLIN EXP PHARMACOL P, V28, P922, DOI 10.1046/j.1440-1681.2001.03549.x; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; Chen XR, 2007, J NEUROTRAUM, V24, P1119, DOI 10.1089/neu.2006.0216; Choi SH, 2008, FASEB J, V22, P1491, DOI 10.1096/fj.07-9411com; Choi SH, 2009, AGING-US, V1, P234, DOI 10.18632/aging.100021; Chu K, 2004, J CEREBR BLOOD F MET, V24, P926, DOI 10.1097/01.WCB.0000130866.25040.7D; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gong C, 2001, BRAIN RES, V901, P38, DOI 10.1016/S0006-8993(01)02186-2; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Hakan T, 2010, NEUROL RES, V32, P629, DOI 10.1179/016164109X12464612122731; Hara K, 1998, NEUROSCI LETT, V256, P53, DOI 10.1016/S0304-3940(98)00755-1; Hellal F, 2004, NEUROSCI LETT, V357, P21, DOI 10.1016/j.neulet.2003.12.036; Hickey RW, 2007, PEDIATR RES, V62, P271, DOI 10.1203/PDR.0b013e3180db2902; Hinz B, 2002, J PHARMACOL EXP THER, V300, P367, DOI 10.1124/jpet.300.2.367; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Hurley SD, 2002, J NEUROTRAUM, V19, P1, DOI 10.1089/089771502753460196; Kelso ML, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-108; KIM HJ, 1989, J NEUROSURG, V71, P565, DOI 10.3171/jns.1989.71.4.0565; Koyfman L, 2000, J NEUROSURG ANESTH, V12, P44, DOI 10.1097/00008506-200001000-00009; Kunz T, 2006, RESTOR NEUROL NEUROS, V24, P55; Ladecola C, 2001, P NATL ACAD SCI USA, V98, P1294, DOI 10.1073/pnas.98.3.1294; Lehmann JM, 1997, J BIOL CHEM, V272, P3406, DOI 10.1074/jbc.272.6.3406; Louin G, 2006, NEUROPHARMACOLOGY, V50, P182, DOI 10.1016/j.neuropharm.2005.08.020; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Reilly P, 2007, PROG BRAIN RES, V161, P3, DOI 10.1016/S0079-6123(06)61001-7; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Siopi E, 2011, J NEUROTRAUM, V28, P2135, DOI 10.1089/neu.2010.1738; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; Thau-Zuchman O, 2012, J NEUROTRAUM, V29, P375, DOI 10.1089/neu.2010.1673; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	49	23	23	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 23	2013	1491						78	87		10.1016/j.brainres.2012.10.049			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	081KR	WOS:000314321600009	23122881				2022-02-06	
J	Deknuydt, F; Roquilly, A; Cinotti, R; Altare, F; Asehnoune, K				Deknuydt, Florence; Roquilly, Antoine; Cinotti, Raphael; Altare, Frederic; Asehnoune, Karim			An In Vitro Model of Mycobacterial Granuloma to Investigate the Immune Response in Brain-Injured Patients	CRITICAL CARE MEDICINE			English	Article						brain injury; cellular immunity; granulomas; immunosuppression; natural killer cells; nosocomial pneumonia; gamma delta t cells	VENTILATOR-ASSOCIATED PNEUMONIA; MULTINUCLEATED GIANT-CELLS; SYSTEMIC INFLAMMATORY RESPONSE; T-CELLS; INTERFERON-GAMMA; DENDRITIC CELLS; ORGAN FAILURE; TRAUMA; INNATE; INFECTIONS	Objective: We investigated the overall immune response to pathogens in brain-injured patients, and assessed its relationship to nosocomial pneumonia. Design: Observational study. Setting: Two surgical ICUs of a single institution. Patients: Severe brain-injured patients (n = 32) requiring mechanical ventilation and sex- and age-matched healthy donors (n = 25). Interventions: None. Measurements and Main Results: We evaluated, ex vivo, the ability of peripheral blood mononuclear cells from brain injury patients to develop an effective granulomatous response to mycobacteria. Thirty-two consecutive patients (25 traumatic brain injured and seven subarachnoid hemorrhage) were included. Median Glasgow Coma Scale was 7 (5-8). Thirteen (41%) patients developed nosocomial pneumonia. Peripheral blood mononuclear cells from brain-injured patients with nosocomial pneumonia generated significantly fewer mature granulomas compared with brain-injured patients without nosocomial pneumonia and with healthy donors. The percentage of multinucleated giant cells was lower in brain-injured patients without nosocomial pneumonia (1% [range: 0%-7%]) and in brain-injured patients with nosocomial pneumonia (4% [range: 2%-5%]) compared with healthy donors (20% [range: 15%-28%]). The blood levels of gamma delta T cells were significantly increased in brain-injured patients without nosocomial pneumonia (66% [range: 34%-69%]) compared with healthy donors (23% [range: 8%-61%]) and was not altered in brain-injured patients with nosocomial pneumonia (31% [range: 12%-44%]). The percentage of gamma delta T cells in granulomas was significantly decreased in brain injury patients with nosocomial pneumonia (5% [range: 4%-43%]) compared with healthy donors (43% [range: 19%-54%]) and was not significantly altered in brain-injured patients without nosocomial pneumonia (26% [range: 10%-41%]). The blood levels of natural killer cells were not altered in brain-injured patients. The percentage of natural killer cells in granulomas was significantly decreased in brain-injured patients with nosocomial pneumonia (3% [range: 1%-9%]) compared with brain-injured patients without nosocomial pneumonia (16% [range: 6%-29%]) and with healthy donors (17% [range: 10%-29%]). Conclusions: Brain-injured patients experienced a maturation defect of the ex vivo granulomatous response involving monocytes as well as natural killer cells and gamma delta T cells. (Crit Care Med 2013; 41:245-254)	[Deknuydt, Florence; Altare, Frederic] Univ Nantes, Inst Rech Therapeut, INSERM, U892, Nantes, France; [Roquilly, Antoine; Asehnoune, Karim] CHU Nantes, Serv Anesthesie Reanimat Chirurg, Hotel Dieu, F-44035 Nantes 01, France; [Roquilly, Antoine; Asehnoune, Karim] Univ Nantes, Fac Med, Lab UPRES EA Therapeut Clin & Expt Infect 3826, Nantes, France; [Cinotti, Raphael] CHU Nantes, Serv Anesthesie Reanimat Chirurg, HGRL, F-44035 Nantes 01, France		Deknuydt, F (corresponding author), Univ Nantes, Inst Rech Therapeut, INSERM, U892, Nantes, France.	karim.asehnoune@chu-nantes.fr	Roquilly, Antoine/P-9826-2017; altare, frederic/K-8664-2015	altare, frederic/0000-0002-5077-4616			Agbaht K, 2007, INTENS CARE MED, V33, P1387, DOI 10.1007/s00134-007-0729-5; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Bonneville M, 2006, CURR OPIN IMMUNOL, V18, P539, DOI 10.1016/j.coi.2006.07.002; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cheadle WG, 2005, AM J SURG, V190, P173, DOI 10.1016/j.amjsurg.2005.05.006; Cheron A, 2010, CRIT CARE, V14, DOI 10.1186/cc9331; Czaja AS, 2009, J TRAUMA, V67, P805, DOI 10.1097/TA.0b013e318185e1fb; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Hamada S, 2008, IMMUNOLOGY, V125, P170, DOI 10.1111/j.1365-2567.2008.02841.x; Heffernan DS, 2012, CRIT CARE, V16, DOI 10.1186/cc11157; Kalyan S, 2004, J INFECT DIS, V189, P1892, DOI 10.1086/383478; Kistowska M, 2008, EUR J IMMUNOL, V38, P2200, DOI 10.1002/eji.200838366; Lay G, 2007, J PATHOL, V211, P76, DOI 10.1002/path.2092; Lepelletier D, 2010, J NEUROSURG ANESTH, V22, P32, DOI 10.1097/ANA.0b013e3181bdf52f; Matsushima A, 2004, SHOCK, V22, P11, DOI 10.1097/01.shk.0000129203.84330.b3; McNally AK, 2011, ADV EXP MED BIOL, V713, P97, DOI 10.1007/978-94-007-0763-4_7; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Meisel C, 2011, NEW ENGL J MED, V365, P2134, DOI 10.1056/NEJMcibr1112454; Moretta A, 2002, NAT REV IMMUNOL, V2, P957, DOI 10.1038/nri956; MOST J, 1990, EUR J IMMUNOL, V20, P1661, DOI 10.1002/eji.1830200807; Mrakovcic-Sutic I, 2010, SCAND J IMMUNOL, V72, P57, DOI 10.1111/j.1365-3083.2010.02407.x; Munz C, 2005, J EXP MED, V202, P203, DOI 10.1084/jem.20050810; NEWTON DW, 1992, NAT IMMUN, V11, P335; Osborn TM, 2004, CRIT CARE MED, V32, P2234, DOI 10.1097/01.CCM.0000145586.23276.0F; Pelosi P, 2011, CRIT CARE MED, V39, P1482, DOI 10.1097/CCM.0b013e31821209a8; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Puissegur MP, 2004, CELL MICROBIOL, V6, P423, DOI 10.1111/j.1462-5822.2004.00371.x; Rincon-Ferrari MD, 2004, J TRAUMA, V57, P1234, DOI 10.1097/01.TA.0000119200.70853.23; Roquilly A, 2011, JAMA-J AM MED ASSOC, V305, P1201, DOI 10.1001/jama.2011.360; Roquilly A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013228; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097/01.CCM.0000181731.53912.D9; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Sarrafzadeh A, 2011, STROKE, V42, P53, DOI 10.1161/STROKEAHA.110.594705; Seguin P, 2006, CRIT CARE MED, V34, P1514, DOI 10.1097/01.CCM.0000214516.73076.82; Souza-Fonseca-Guimaraes F, 2012, MOL MED, V18, P270, DOI 10.2119/molmed.2011.00201; Spruijt NE, 2010, CRIT CARE, V14, DOI 10.1186/cc9218; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; TAKASHIMA T, 1993, J IMMUNOL, V150, P3002; Trouillet JL, 1998, AM J RESP CRIT CARE, V157, P531, DOI 10.1164/ajrccm.157.2.9705064; Tsuji S, 2000, INFECT IMMUN, V68, P6883, DOI 10.1128/IAI.68.12.6883-6890.2000; Venet F, 2008, J LEUKOCYTE BIOL, V83, P523, DOI 10.1189/jlb.0607371; Wesselkamper SC, 2008, J IMMUNOL, V181, P5481, DOI 10.4049/jimmunol.181.8.5481; Woiciechowsky C, 1999, J MOL MED-JMM, V77, P769, DOI 10.1007/s001099900051; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354	51	23	23	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JAN	2013	41	1					245	254		10.1097/CCM.0b013e3182676052			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	065LR	WOS:000313150300027	23128384				2022-02-06	
J	Heringhaus, A; Blom, MD; Wigert, H				Heringhaus, Alina; Blom, Michaela Dellenmark; Wigert, Helena			Becoming a parent to a child with birth asphyxia-From a traumatic delivery to living with the experience at home	INTERNATIONAL JOURNAL OF QUALITATIVE STUDIES ON HEALTH AND WELL-BEING			English	Article						Hypothermia treatment; neonatal care; nursing; infant; traumatic delivery; qualitative content analysis	INTENSIVE-CARE-UNIT; HYPOXIC-ISCHEMIC ENCEPHALOPATHY; PERINATAL ASPHYXIA; POSTTRAUMATIC STRESS; INDUCED HYPOTHERMIA; PREMATURE-INFANTS; MOTHERS; FATHERS; NEWBORN; NURSES	The aim of this study is to describe the experiences of becoming a parent to a child with birth asphyxia treated with hypothermia in the neonatal intensive care unit (NICU). In line with the medical advances, the survival of critically ill infants with increased risk of morbidity is increasing. Children who survive birth asphyxia are at a higher risk of functional impairments, cerebral palsy (CP), or impaired vision and hearing. Since 2006, hypothermia treatment following birth asphyxia is used in many of the Swedish neonatal units to reduce the risk of brain injury. To date, research on the experience of parenthood of the child with birth asphyxia is sparse. To improve today's neonatal care delivery, health-care providers need to better understand the experiences of becoming a parent to a child with birth asphyxia. A total of 26 parents of 16 children with birth asphyxia treated with hypothermia in a Swedish NICU were interviewed. The transcribed interview texts were analysed according to a qualitative latent content analysis. We found that the experience of becoming a parent to a child with birth asphyxia treated with hypothermia at the NICU was a strenuous journey of overriding an emotional rollercoaster, that is, from being thrown into a chaotic situation which started with a traumatic delivery to later processing the difficult situation of believing the child might not survive or was to be seriously affected by the asphyxia. The prolonged parent-infant separation due to the hypothermia treatment and parents' fear of touching the infant because of the high-tech equipment seemed to hamper the parent-infant bonding. The adaption of the everyday life at home seemed to be facilitated by the follow-up information of the doctor after discharge. The results of this study underline the importance of family-centered support during and also after the NICU discharge.	[Heringhaus, Alina; Blom, Michaela Dellenmark; Wigert, Helena] Sahlgrens Univ Hosp, Queen Silvia Childrens Hosp, SE-41685 Gothenburg, Sweden; [Wigert, Helena] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden		Heringhaus, A (corresponding author), Sahlgrens Univ Hosp, Queen Silvia Childrens Hosp, Div Neonataol, Gothenburg SU Ostra Smorslottsgatan 1, SE-41685 Gothenburg, Sweden.	alina.heringhaus@live.se		Dellenmark-Blom, Michaela/0000-0002-1467-9427			[Anonymous], EARLY HUM DEV, DOI DOI 10.1016/J.EARLHUMDEV.2010.09.006; Arockiasamy V, 2008, PEDIATRICS, V121, pE215, DOI 10.1542/peds.2007-1005; Azzopardi D, 2010, EARLY HUM DEV, V86, P345, DOI 10.1016/j.earlhumdev.2010.05.008; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Battin MR, 2001, PEDIATRICS, V107, P480, DOI 10.1542/peds.107.3.480; Beck CT, 2004, NURS RES, V53, P28, DOI 10.1097/00006199-200401000-00005; Black BP, 2009, RES NURS HEALTH, V32, P38, DOI 10.1002/nur.20298; Blackmon LR, 2006, PEDIATRICS, V117, P942, DOI 10.1542/peds.2005-2950; Bowlby J., 1982, ATTACHMENT LOSS ATTA; Brummelte S, 2011, EARLY HUM DEV, V87, P273, DOI 10.1016/j.earlhumdev.2011.01.030; Callery Peter, 2002, Evid Based Nurs, V5, P91, DOI 10.1136/ebn.5.3.91; Cleveland LM, 2008, JOGNN-J OBST GYN NEO, V37, P666, DOI 10.1111/j.1552-6909.2008.00288.x; Conz CA, 2009, REV ESC ENFERM USP, V43, P846; Cullberg J., 2006, KRIS UTVECKLING; Dahlberg K., 2008, REFLECTIVE LIFEWORLD, V2; Edwards AD, 2006, ARCH DIS CHILD-FETAL, V91, pF127, DOI 10.1136/adc.2005.071787; Ehrenstein V, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-14; Eiser C, 2005, J CHILD PSYCHOL PSYC, V46, P1169, DOI 10.1111/j.1469-7610.2005.00415.x; Fenwick J, 2001, J PERINAT NEONAT NUR, V15, P49, DOI 10.1097/00005237-200109000-00005; Forcada-Guex M, 2011, EARLY HUM DEV, V87, P21, DOI 10.1016/j.earlhumdev.2010.09.006; Garel M, 2007, CHILD CARE HLTH DEV, V33, P137, DOI 10.1111/j.1365-2214.2006.00663.x; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Groenendaal F, 2009, EARLY HUM DEV, V85, P73, DOI 10.1016/j.earlhumdev.2008.11.006; Hall EOC, 2005, SCAND J CARING SCI, V19, P179, DOI 10.1111/j.1471-6712.2005.00352.x; HARRISON H, 1993, PEDIATRICS, V92, P643; Heermann Judith A, 2005, Pediatr Nurs, V31, P176; Iversen AS, 2013, INT J QUAL STUD HEAL, V8, DOI 10.3402/qhw.v8i0.20007; Jackson K, 2003, J ADV NURS, V43, P120, DOI 10.1046/j.1365-2648.2003.02686.x; Jamsa K, 1998, Technol Health Care, V6, P225; Jolley Jeremy, 2009, J Pediatr Nurs, V24, P164, DOI 10.1016/j.pedn.2008.03.010; Kowalski WJ, 2006, J PERINATOL, V26, P44, DOI 10.1038/sj.jp.7211409; Lagercrantz H., 2008, NEONATOLOGI; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lefkowitz DS, 2010, J CLIN PSYCHOL MED S, V17, P230, DOI 10.1007/s10880-010-9202-7; Lindberg B, 2008, SCAND J CARING SCI, V22, P79, DOI 10.1111/j.1471-6712.2007.00563.x; Lindseth A, 2004, SCAND J CARING SCI, V18, P145, DOI 10.1111/j.1471-6712.2004.00258.x; Long M, 2007, JOGNN-J OBST GYN NEO, V36, P293, DOI 10.1111/J.1552-6909.2007.00150.x; Merlau-Ponty Maurice, 1995, PHENOMENOLOGY PERCEP; Mok E, 2006, J CLIN NURS, V15, P726, DOI 10.1111/j.1365-2702.2006.01359.x; Nassef SK, 2013, JOGNN-J OBST GYN NEO, V42, P38, DOI 10.1111/j.1552-6909.2012.01429.x; Palmer L, 2010, INT J QUAL STUD HEAL, V5, P1, DOI 10.3402/qhw.v5i3.5397; Perlman JM, 2006, PEDIATRICS, V117, pS28, DOI 10.1542/peds.2005-0620E; Pinelli J, 2008, J NEONATAL NURSING, V14, P156, DOI DOI 10.1016/J.JNN.2008.03.015; Polit DF., 2012, NURSING RES GENERATI, V9th ed.; Roka A, 2010, EARLY HUM DEV, V86, P361, DOI 10.1016/j.earlhumdev.2010.05.013; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Shankaran S, 2007, CLIN OBSTET GYNECOL, V50, P624, DOI 10.1097/GRF.0b013e31811eba5e; Swedish Paediatric Society, 2005, HYP TREATM ASPH NEWB; Treyvaud K, 2011, EARLY HUM DEV, V87, P427, DOI 10.1016/j.earlhumdev.2011.03.008; Wigert H, 2006, SCAND J CARING SCI, V20, P35, DOI 10.1111/j.1471-6712.2006.00377.x; Wigert H., 2007, INT J QUALITATIVE ST, V2, P45, DOI 10.1080/17482620600979195; Wigert H, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-3; Yager JY, 2004, BRAIN RES, V1011, P48, DOI 10.1016/j.brainres.2004.02.070; Ziegert K., 2011, INT J QUALITATIVE ST, V6, P1	54	23	28	1	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1748-2623	1748-2631		INT J QUAL STUD HEAL	Int. J. Qual. Stud. Health Well-Being		2013	8								20539	10.3402/qhw.v8i0.20539			13	Public, Environmental & Occupational Health; Nursing; Social Sciences, Biomedical	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Nursing; Biomedical Social Sciences	138BQ	WOS:000318483700001	23639330	Green Published, gold			2022-02-06	
J	Indyk, JA; Candido-Vitto, C; Wolf, IM; Venkataraman, S; Munoz, R; Saladino, RA; Witchel, SF; DeFranco, DB				Indyk, Justin A.; Candido-Vitto, Cristina; Wolf, Irene M.; Venkataraman, Shekhar; Munoz, Ricardo; Saladino, Richard A.; Witchel, Selma F.; DeFranco, Donald B.			Reduced Glucocorticoid Receptor Protein Expression in Children with Critical Illness	HORMONE RESEARCH IN PAEDIATRICS			English	Article						Glucocorticoid receptor; Pediatrics; Cortisol; Sepsis; Adrenal insufficiency	SEPTIC SHOCK; SEVERE SEPSIS; ADRENAL AXIS; CORTISOL; THERAPY; IDENTIFICATION; INSUFFICIENCY; MEDICINE	Background/Aims: The diagnostic criteria for critical illness-related corticoid insufficiency (CIRCI) are not well established, particularly for children. In addition to alterations in adrenal function, cellular resistance to glucocorticoid action could contribute to CIRCI due to alterations in the functioning of the intracellular receptor protein for corticosteroids, the glucocorticoid receptor (GR). Methods: We have therefore undertaken a pilot, prospective study to assess whether cellular GR activity can be measured in peripheral blood mononuclear cells (PBMCs) from critically ill children. Results: Total and cytoplasmic, but not nuclear GR levels were significantly lower in PBMCs from critically ill children (i.e. sepsis/septic shock and traumatic brain injury) compared to healthy controls. While total cortisol concentrations did not differ between test groups, salivary and serum-free cortisol concentrations were significantly greater in both groups of children with critical illness. Cortisol-binding globulin levels were significantly lower in patients with sepsis/septic shock. Conclusions: The lower total and cytoplasmic receptor levels in critically ill children suggest that the GR-mediated response to exogenous glucocorticoid therapy may be limited. However, the nuclear transport of GR in critically ill patients suggests that residual receptors in these patients retain functionality and may be accessible to therapeutic treatments that maximize their activity. Copyright (c) 2013 S. Karger AG, Basel	[Indyk, Justin A.; Candido-Vitto, Cristina; Witchel, Selma F.] Univ Pittsburgh, Sch Med, Div Pediat Endocrinol, Pittsburgh, PA USA; [Saladino, Richard A.] Univ Pittsburgh, Sch Med, Emergency Med Dept Pediat, Pittsburgh, PA USA; [Venkataraman, Shekhar; Munoz, Ricardo] Univ Pittsburgh, Sch Med, UPMC, Childrens Hosp Pittsburgh,Dept Crit Care Med, Pittsburgh, PA 15224 USA; [Wolf, Irene M.; DeFranco, Donald B.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA		Witchel, SF (corresponding author), Univ Pittsburgh, Sch Med, UPMC, Childrens Hosp Pittsburgh,Dept Crit Care Med, Pittsburgh, PA 15224 USA.	selma.witchel@chp.edu	Indyk, Justin A/C-8965-2013	Indyk, Justin/0000-0002-5576-8872			Annane D, 2009, JAMA-J AM MED ASSOC, V301, P2362, DOI 10.1001/jama.2009.815; Arafah BM, 2006, J CLIN ENDOCR METAB, V91, P3725, DOI 10.1210/jc.2006-0674; Biddie SC, 2012, RHEUMATOLOGY, V51, P403, DOI 10.1093/rheumatology/ker215; Cardona ML, 1950, ACTA PEDIAT ESP, V8, P421; Chrousos GP, 2007, STRESS, V10, P213, DOI 10.1080/10253890701292119; Cohen J, 2009, CRIT CARE RESUSC, V11, P287; Cooper Mark Stuart, 2007, J Intensive Care Med, V22, P348, DOI 10.1177/0885066607307832; De Bosscher K, 2009, MOL ENDOCRINOL, V23, P281, DOI 10.1210/me.2008-0283; DeFranco DB, 2002, MOL ENDOCRINOL, V16, P1449, DOI 10.1210/me.16.7.1449; den Brinker M, 2008, INTENS CARE MED, V34, P163, DOI 10.1007/s00134-007-0836-3; Flaster H, 2007, MOL ENDOCRINOL, V21, P1267, DOI 10.1210/me.2007-0065; Heitzer MD, 2007, REV ENDOCR METAB DIS, V8, P321, DOI 10.1007/s11154-007-9059-8; Henley DE, 2011, NEUROSCIENCE, V180, P1, DOI 10.1016/j.neuroscience.2011.02.053; Ho JT, 2006, J CLIN ENDOCR METAB, V91, P105, DOI 10.1210/jc.2005-0265; Jewell CM, 2007, J CLIN ENDOCR METAB, V92, P3268, DOI 10.1210/jc.2007-0642; Kleindienst A, 2009, J NEUROTRAUM, V26, P1435, DOI 10.1089/neu.2008.0601; Manary MJ, 2006, METABOLISM, V55, P550, DOI 10.1016/j.metabol.2005.11.009; Marik PE, 2008, CRIT CARE MED, V36, P1937, DOI 10.1097/CCM.0b013e31817603ba; Marketon JIW, 2010, TOXINS, V2, P1357, DOI 10.3390/toxins2061357; Menon K, 2007, PEDIATR CRIT CARE ME, V8, P276, DOI 10.1097/01.PCC.0000262796.38637.15; Mesotten D, 2008, NAT CLIN PRACT ENDOC, V4, P496, DOI 10.1038/ncpendmet0921; MOLIJN GJ, 1995, CLIN ENDOCRINOL, V43, P197, DOI 10.1111/j.1365-2265.1995.tb01915.x; Nicolaides NC, 2010, STEROIDS, V75, P1, DOI 10.1016/j.steroids.2009.09.002; Oakley RH, 2011, J BIOL CHEM, V286, P3177, DOI 10.1074/jbc.R110.179325; Samarasinghe RA, 2011, P NATL ACAD SCI USA, V108, P16657, DOI 10.1073/pnas.1102821108; SCHLECHTE JA, 1982, J STEROID BIOCHEM, V16, P69, DOI 10.1016/0022-4731(82)90145-5; SHER ER, 1994, J CLIN INVEST, V93, P33, DOI 10.1172/JCI116963; Siebig S, 2010, ANAESTH INTENS CARE, V38, P133, DOI 10.1177/0310057X1003800122; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; van den Akker ELT, 2009, INTENS CARE MED, V35, P1247, DOI 10.1007/s00134-009-1468-6; Venkataraman S, 2007, REV ENDOCR METAB DIS, V8, P365, DOI 10.1007/s11154-007-9058-9; Venkatesh B, 2011, BEST PRACT RES CL EN, V25, P719, DOI 10.1016/j.beem.2011.04.007; Wolf IM, 2008, J CELL BIOCHEM, V104, P1580, DOI 10.1002/jcb.21755; Wong HR, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-34; Yehuda R, 2002, BIOL PSYCHIAT, V52, P393, DOI 10.1016/S0006-3223(02)01357-4; Zimmerman JJ, 2007, PEDIATR CRIT CARE ME, V8, P530, DOI 10.1097/01.PCC.0000288710.11834.E6; Zimmerman JJ, 2011, PEDIATR CRIT CARE ME, V12, P525, DOI 10.1097/PCC.0b013e3181fe4474; Zimmerman JJ, 2011, PEDIATR CRIT CARE ME, V12, P2, DOI 10.1097/PCC.0b013e3181d903f6; Zimmerman JJ, 2010, INTENS CARE MED, V36, P1914, DOI 10.1007/s00134-010-2007-1	39	23	27	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1663-2818			HORM RES PAEDIAT	Horm. Res. Paediatr.		2013	79	3					169	178		10.1159/000348290			10	Endocrinology & Metabolism; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Pediatrics	138AS	WOS:000318481200007	23548248				2022-02-06	
J	Ponsford, J; Tweedly, L; Taffe, J				Ponsford, Jennie; Tweedly, Laura; Taffe, John			The relationship between alcohol and cognitive functioning following traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Alcohol use; Cognition; Memory; Executive function; Processing speed	SUBSTANCE-ABUSE; CONSUMPTION; DISORDERS; MODERATE; PERFORMANCE; PATTERNS; DRINKING; ATROPHY; MISUSE; DAMAGE	The present study aimed to examine the association between frequency and quantity of alcohol consumption and cognitive functioning following traumatic brain injury (TBI). Sixty moderately to severely injured individuals had completed the Alcohol Use Disorders Identification Test (AUDIT) to measure preinjury alcohol use soon after injury and were recruited and assessed with AUDIT and Time Line Follow-Back (TLFB), as a measure of frequency and quantity of alcohol consumption at 6-9 months post injury. Fifty participants completed both AUDIT and TLFB at a follow-up assessment at 12-15 months post injury. Measures of processing speed/attention, memory, and executive function were also administered. Regression analyses were used to examine the relationships between alcohol use and cognition at the two occasions of measurement. Harmful or hazardous alcohol use pre injury was associated with poorer memory performance on the California Verbal Learning Test (CVLT-II) and slower processing speed on Symbol Digit Modalities Test on average across postinjury measurement occasions, but not with executive functioning, measured by the Modified Six Elements Test (MSET) at 6-9 months post injury. On the other hand, executive functioning on MSET 6-9 months post injury was significantly poorer in participants who were consuming any alcohol at all in the month prior to follow-up assessment. The current study provides evidence showing that pre- and postinjury alcohol use is negatively associated with different aspects of cognitive functioning following TBI. In addition to providing some support for the provision of advice to abstain from alcohol after injury, these findings suggest that interventions to reduce postinjury alcohol use may be useful.	[Ponsford, Jennie; Tweedly, Laura; Taffe, John] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia; [Ponsford, Jennie] Epworth Med Fdn, Monash Epworth Rehabil Ctr, Melbourne, Vic, Australia; [Ponsford, Jennie] Natl Trauma Res Inst, Melbourne, Vic, Australia		Ponsford, J (corresponding author), Monash Univ, Sch Psychol & Psychiat, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu					Baguley IJ, 1997, ARCH PHYS MED REHAB, V78, P1248, DOI 10.1016/S0003-9993(97)90339-7; Barker LH, 1999, J INT NEUROPSYCH SOC, V5, P593, DOI 10.1017/S1355617799577023; Bigler ED, 1996, BRAIN INJURY, V10, P197, DOI 10.1080/026990596124511; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Bombardier CH, 1997, REHABIL PSYCHOL, V42, P259; Burgess P, 1996, BEHAV ASSESSMENT DYS; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P29; Delis D.C., 2000, CVLT 2 CALIFORNIA VE; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; Estruch R, 1997, J NEUROL SCI, V146, P145, DOI 10.1016/S0022-510X(96)00298-5; Green A, 2010, ALCOHOL CLIN EXP RES, V34, P443, DOI 10.1111/j.1530-0277.2009.01108.x; Harding AJ, 1996, NEUROSCIENCE, V72, P699, DOI 10.1016/0306-4522(95)00577-3; Harper C, 2005, ALCOHOL CLIN EXP RES, V29, P1106, DOI 10.1097/01.ALC.0000171490.09017.A9; Harper C, 2005, CURR OPIN PHARMACOL, V5, P73, DOI 10.1016/j.coph.2004.06.011; HARPER C, 1985, J NEUROL NEUROSUR PS, V48, P211, DOI 10.1136/jnnp.48.3.211; HARPER CG, 1988, BRIT J ADDICT, V83, P613; HAYAKAWA K, 1992, ACTA RADIOL, V33, P201; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Kleykamp BA, 2010, EXP CLIN PSYCHOPHARM, V18, P1, DOI 10.1037/a0018407; Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; Kreutzer JS, 1996, J HEAD TRAUMA REHAB, V11, P58, DOI 10.1097/00001199-199610000-00006; Kril JJ, 1997, NEUROSCIENCE, V79, P983, DOI 10.1016/S0306-4522(97)00083-3; Lange RT, 2007, NEUROPSYCHOLOGY, V21, P590, DOI 10.1037/0894-4105.21.5.590; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Marmarou A., 1990, J HEAD TRAUMA REHAB, V5, P21, DOI [10.1097/00001199-199009000-00006, DOI 10.1097/00001199-199009000-00006]; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; Oscar-Berman M, 2007, NEUROPSYCHOL REV, V17, P239, DOI 10.1007/s11065-007-9038-6; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; PFEFFERBAUM A, 1988, ALCOHOL CLIN EXP RES, V12, P81, DOI 10.1111/j.1530-0277.1988.tb00137.x; PFEFFERBAUM A, 1995, ALCOHOL CLIN EXP RES, V19, P1177, DOI 10.1111/j.1530-0277.1995.tb01598.x; PHILLIPS SC, 1987, BRAIN, V110, P301, DOI 10.1093/brain/110.2.301; Ponsford J., 2012, TRAUMATIC BRAIN INJU, V2nd Edition; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Ponsford JL, 1991, NEUROPSYCHOL REHABIL, V1, P241, DOI DOI 10.1080/09602019108402257; Rochat L, 2009, J NEUROPSYCHOL, V3, P213, DOI 10.1348/174866408X397656; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Searles JS, 2000, PSYCHOL ADDICT BEHAV, V14, P277, DOI 10.1037/0893-164X.14.3.277; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Smith, 1973, SYMBOL DIGIT MODALIT; SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41, DOI 10.1007/978-1-4612-0357-5_3; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; Sparadeo F. R., 1990, J HEAD TRAUMA REHAB, V5, P1, DOI DOI 10.1097/00001199-199009000-00004; Strauss E., 2006, COMPEDIUM NEUROPSYCH; Sullivan EV, 2009, ALCOHOL ALCOHOLISM, V44, P155, DOI 10.1093/alcalc/agn103; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Turner AP, 2006, REHABIL PSYCHOL, V51, P78, DOI 10.1037/0090-5550.51.1.78; Verbaten MN, 2009, HUM PSYCHOPHARM CLIN, V24, P199, DOI 10.1002/hup.1022; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Wilde EA, 2004, J NEUROTRAUM, V21, P137, DOI 10.1089/089771504322778604; Wood RL, 2008, BRAIN INJURY, V22, P905, DOI 10.1080/02699050802491271	54	23	24	0	16	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JAN 1	2013	35	1					103	112		10.1080/13803395.2012.752437			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	189YL	WOS:000322304100011	23339581				2022-02-06	
J	Wu, XM; Mao, H; Liu, J; Xu, J; Cao, JH; Gu, XX; Cui, G				Wu, Xinmin; Mao, Hui; Liu, Jiao; Xu, Jian; Cao, Jianhua; Gu, Xingxing; Cui, Gang			Dynamic change of SGK expression and its role in neuron apoptosis after traumatic brain injury	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY			English	Article						SGK; GSK3 beta/beta-catenin signaling pathway; traumatic brain injury (TBI); neuron apoptosis	GLYCOGEN-SYNTHASE KINASE-3-BETA; CELL-SURVIVAL RESPONSE; PKB/SGK-RESISTANT GSK3; PROTEIN-KINASE; SIGNALING PATHWAYS; BETA-CATENIN; RAT-BRAIN; ACTIVATION; PHOSPHORYLATION; SERUM	Aims: Activation of specific signaling pathways in response to mechanical trauma causes delayed neuronal apoptosis; GSK-3 beta/beta-catenin signaling plays a critical role in the apoptosis of neurons in CNS diseases, SGK was discovered as a regulator of GSK-3 beta/beta-catenin pathway, The goal of this study was to determine if the mechanism of cell death or survival mediated by the SGK/GSK-3 beta/beta-catenin pathway is involved in a rat model of TBI. Main methods: Here, an acute traumatic brain injury model was applied to investigate the expression change and possible roles of SGK, Expression of SGK, and total-GSK-3 beta, phospho-GSK3 beta on ser-9, beta-catenin, and caspase-3 were examined by immunohistochemistry and Western blot analysis. Double immunofluorescent staining was used to observe the SGK localizations. Si-RNA was performed to identify whether SGK regulates neuron apoptosis via GSK3 beta/beta-catenin pathway, ultimately inhibit caspase-3 activation. Key findings: Temporally, SGK expression showed an increase pattern after TBI and reached a peak at day 3. Spatially, SGK was widely expressed in the neuron, rarely in astrocytes and oligodendrocytes; in addition, the expression patterns of active caspase-3 and phospho-GSK3 beta were parallel with that of SGK, at the same time, the expression of beta-catenin shows similarity with SGK. In vitro, to further investigate the function of SGK, a neuronal cell line PC12 was employed to establish an apoptosis model. We analyzed the association of SGK with apoptosis on PC12 cells by western blot, immunofluorescent labeling and siRNA. Significance: the results implied that SGK plays an important role in neuron apoptosis via the regulation of GSK3 beta/beta-catenin signaling pathway; ultimately inhibit caspase-3 activation. Taken together, we inferred traumatic brain injury induced an upregulation of SGK in the central nervous system, which show a protective role in neuron apoptosis.	[Wu, Xinmin] Nantong Univ, Affiliated Hosp, Dept Neurol, Nantong 226001, Jiangsu, Peoples R China; [Mao, Hui] Nantong Univ, Affiliated Hosp, Dept Neurosurg, Nantong 226001, Jiangsu, Peoples R China; [Liu, Jiao] Nantong Univ, Dept Publ Hlth, Nantong 226001, Jiangsu, Peoples R China; [Xu, Jian; Cao, Jianhua] Nantong Univ, Affiliated Mental Hlth Ctr, Nantong 226001, Jiangsu, Peoples R China; [Gu, Xingxing] Nantong Univ, Key Lab Neurosci, Nantong 226001, Peoples R China; [Cui, Gang] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou 215006, Peoples R China		Gu, XX (corresponding author), Nantong Univ, Key Lab Neurosci, Nantong 226001, Peoples R China.	cuigang@suda.edu.cn			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81070992]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the Natural Science Foundation of China (81070992); and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; BelAiba RS, 2006, CIRC RES, V98, P828, DOI 10.1161/01.RES.0000210539.54861.27; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Bhat RV, 2000, P NATL ACAD SCI USA, V97, P11074, DOI 10.1073/pnas.190297597; Bhavsar SK, 2012, BIOCHEM BIOPH RES CO, V425, P6, DOI 10.1016/j.bbrc.2012.07.030; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Carmichael J, 2002, J BIOL CHEM, V277, P33791, DOI 10.1074/jbc.m204861200; Chen J, 2013, J MOL HISTOL, V44, P1, DOI 10.1007/s10735-012-9444-9; Cho JH, 2004, J BIOL CHEM, V279, P54716, DOI 10.1074/jbc.M403364200; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Endo H, 2006, STROKE, V37, P2140, DOI 10.1161/01.STR.0000229888.55078.72; Foller M, 2011, J AM SOC NEPHROL, V22, P873, DOI 10.1681/ASN.2010070757; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Hartigan JA, 1999, J BIOL CHEM, V274, P21395, DOI 10.1074/jbc.274.30.21395; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hetman M, 2000, J NEUROSCI, V20, P2567; Hilton GD, 2008, J CEREBR BLOOD F MET, V28, P1845, DOI 10.1038/jcbfm.2008.75; Hu SX, 2009, NEUROBIOL DIS, V33, P193, DOI 10.1016/j.nbd.2008.10.007; IMAIZUMI K, 1994, MOL BRAIN RES, V26, P189, DOI 10.1016/0169-328X(94)90090-6; Jin Y, 2012, ACTA PHARMACOL SIN, V33, P861, DOI 10.1038/aps.2012.59; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kaytor MD, 2002, CURR OPIN NEUROBIOL, V12, P275, DOI 10.1016/S0959-4388(02)00320-3; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Lang F, 2010, J PHYSIOL-LONDON, V588, P3349, DOI 10.1113/jphysiol.2010.190926; Leong MLL, 2003, J BIOL CHEM, V278, P5871, DOI 10.1074/jbc.M211649200; Liu YH, 2010, J NEUROTRAUM, V27, P361, DOI 10.1089/neu.2008.0581; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; LOGAN A, 1992, J NEUROSCI, V12, P3828; Maggirwar SB, 1999, J NEUROCHEM, V73, P578, DOI 10.1046/j.1471-4159.1999.0730578.x; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Reilly P, 2007, PROG BRAIN RES, V161, P3, DOI 10.1016/S0079-6123(06)61001-7; RINK A, 1995, AM J PATHOL, V147, P1575; Sakoda H, 2003, J BIOL CHEM, V278, P25802, DOI 10.1074/jbc.M301127200; Schoenebeck B, 2005, MOL CELL NEUROSCI, V30, P249, DOI 10.1016/j.mcn.2005.07.017; Siraskar B, 2011, PFLUG ARCH EUR J PHY, V462, P811, DOI 10.1007/s00424-011-1006-6; Tong N, 2001, EUR J NEUROSCI, V13, P1913, DOI 10.1046/j.0953-816x.2001.01572.x; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Yuan J, 2005, CELL DEATH DIFFER, V12, P1097, DOI 10.1038/sj.cdd.4401652; Zhao SF, 2012, NEUROL RES, V34, P400, DOI 10.1179/1743132812Y.0000000025; Zhu D, 2009, NEUROL RES, V31, P200, DOI 10.1179/174313209X393915	42	23	23	1	6	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1936-2625			INT J CLIN EXP PATHO	Int. J. Clin. Exp. Pathol.		2013	6	7					1282	1293					12	Oncology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Pathology	216VQ	WOS:000324314000007	23826409				2022-02-06	
J	Sellmann, T; Miersch, D; Kienbaum, P; Flohe, S; Schneppendahl, J; Lefering, R				Sellmann, Timur; Miersch, Daniel; Kienbaum, Peter; Flohe, Sascha; Schneppendahl, Johannes; Lefering, Rolf		DGU Trauma Registry	The Impact of Arterial Hypertension on Polytrauma and Traumatic Brain Injury	DEUTSCHES ARZTEBLATT INTERNATIONAL			English	Article							SUBDURAL HEMATOMAS; MANAGEMENT; COAGULOPATHY; INTUBATION; PREVENTION; DIAGNOSIS; MORTALITY	Background: Pre-hospital hypotension in trauma patients is associated with high mortality. Especially for patients with severe traumatic brain injury (TBI), arterial normotension or even hypertension (AHT) is considered an important mechanism for sustaining adequate cerebral perfusion pressure. The effect of pre-hospital arterial hypertension (pAHT) on in-hospital mortality after trauma has not been studied to date. Methods: We retrospectively analyzed data in the trauma registry of the German Society for Trauma Surgery (DGU) on all trauma patients in Germany from 1993 to 2008 who were 16 to 80 years old at the time of the trauma and had an injury severity score (ISS) of 9 or above (total, 42 500 patient data sets). For the analysis, we divided the patients into two groups: those with and those without TBI. We further divided the TBI patients into five subgroups depending on the course of their systolic blood pressure up to the moment of their arrival at the hospital. We also analyzed the patients' demographic data, patterns of injury, and accident mechanisms. Results: Trauma patients with TBI and pAHT (142 of 561 patients) had a significantly higher mortality than normotensive TBI patients (25.3% vs. 13.5%, p<0.001). Arterial hypertension that either rises or falls before the patient reaches the hospital is associated with higher in-hospital mortality. A logistical regression analysis of 5384 patients revealed that patients with pAHT (n = 561) had an odds ratio of 1.9 (95% confidence interval, 1.4 to 1.6) for death in the hospital compared to normotensive patients (n = 6020). Conclusion: Systolic blood pressure values above 160 mm Hg before arrival in the hospital worsen the outcome of trauma patients with TBI. Cite this as: Sellmann T, Miersch D, Kienbaum P, Flohe S, Schneppendahl J, Lefering R, and the DGU trauma registry: The impact of arterial hypertension on polytrauma and traumatic brain injury. Dtsch Arztebl Int 2012; 109(49): 849-56. DOI: 10.3238/arztebl.2012.0849	[Sellmann, Timur] Ev Krankenhaus Bethesda Duisburg gGmbH, Dept Anaesthesiol & Intens Care Med, Bethesda, MD USA; [Miersch, Daniel] Neuwerk Hosp Maria von den Aposteln, Div Orthoped, Monchengladbach, Germany; [Schneppendahl, Johannes] Univ Pittsburgh, Med Ctr, Dept Orthopaed Surg, Pittsburgh, PA 15260 USA; [Lefering, Rolf] Univ Witten Herdecke, Inst Res Operat Med IFOM Cologne, Fac Hlth, Dept Med, Witten, Germany; [Kienbaum, Peter] Univ Dusseldorf, Dusseldorf Univ Hosp, Dept Anaesthesiol, Dusseldorf, Germany; [Flohe, Sascha] Univ Dusseldorf, Dusseldorf Univ Hosp, Dept Trauma & Hand Surg, Dusseldorf, Germany		Miersch, D (corresponding author), Krankenhaus Neuwerk Maria von den Aposteln, Abt Orthopad, Dunner Str 214-216, D-41066 Monchengladbach, Germany.	d.miersch@kh-neuwerk.de	Kienbaum, Peter/ABG-7729-2020	Kienbaum, Peter/0000-0002-0655-9177; Flohe, Sascha/0000-0002-8033-1242	AUC GmbH	Professor Kienbaum is a consultant for Baxter, Air Liquide, and Molnlycke. Rolf Lefering has received reimbursement of conference fees and travel costs from AUC GmbH.	Araujo João Luiz Vitorino, 2012, Rev. Col. Bras. Cir., V39, P268; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bullock MR, 2006, NEUROSURGERY S, V58, P16; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COOPER K D, 1983, Neuroepidemiology, V2, P70, DOI 10.1159/000110512; Cushing H, 1901, B J HOPKINS HOSP, V126, P289; Davis DP, 2008, RESUSCITATION, V76, P333, DOI 10.1016/j.resuscitation.2007.08.004; Dewall Jeremy, 2010, JEMS, V35, P54, DOI 10.1016/S0197-2510(10)70095-4; Fields AM, 2009, J TRAUMA, V67, P867, DOI 10.1097/TA.0b013e3181b021c5; Franschman G, 2010, RESUSCITATION, V81, P261, DOI 10.1016/j.resuscitation.2009.11.004; Freeman WD, 2012, NEUROL CLIN, V30, P211, DOI 10.1016/j.ncl.2011.09.002; Gaetani P, 2012, J NEUROSURG SCI, V56, P231; Gennarelli TA., 2008, ABBREVIATED INJURY S; Glaeske G, 2008, GEK ARZNEIMITTEL REP; Grandhi R, 2012, NEUROSURGERY, V71, pE559, DOI 10.1227/01.neu.0000417738.39794.95; Lier H, 2009, ANAESTHESIST, V58, P1010, DOI 10.1007/s00101-009-1595-z; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; Maegele M, 2011, DTSCH ARZTEBL INT, V108, P827, DOI [10.3238/arztebl.2011.0827, 10.3238/arztebl.2011.0836a]; Mann V, 2010, ANAESTHESIST, V59, P739, DOI 10.1007/s00101-010-1771-1; Mayer SA, 2002, J INTENSIVE CARE MED, V17, P55, DOI 10.1046/j.1525-1489.2002.17201.x; Minardi J, 2009, MT SINAI J MED, V76, P138, DOI 10.1002/msj.20105; Moore MM, 2012, J TRAUMA ACUTE CARE, V73, P126, DOI 10.1097/TA.0b013e31824b01af; Mori T, 2006, ACTA NEUROCHIR SUPPL, V96, P40; Muhm M, 2011, ANAESTHESIST, V60, P534, DOI 10.1007/s00101-010-1846-z; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Rixen D, 2012, UNFALLCHIRURG, V115, P22, DOI 10.1007/s00113-011-2104-9; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Rowell SE, 2011, J TRAUMA, V71, pS384, DOI 10.1097/TA.0b013e3182287c8d; Ruchholtz S, 2008, DTSCH ARZTEBL INT, V105, P225, DOI 10.3238/arztebl.2008.0225; Senft C, 2009, NEUROL RES, V31, P1012, DOI 10.1179/174313209X409034; Stahel PF, 2005, ORTHOPADE, V34, P852, DOI 10.1007/s00132-005-0844-3; Stahel PF, 2008, INTENS CARE MED, V34, P402, DOI 10.1007/s00134-007-0889-3; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; TEASDALE G, 1974, LANCET, V2, P81; WHITE RJ, 1992, NEW ENGL J MED, V327, P1507; Zollner C, 2008, ANAESTHESIST, V57, P729, DOI 10.1007/s00101-008-1408-9	36	23	23	0	2	DEUTSCHER AERZTE-VERLAG GMBH	COLOGNE	DIESELSTRABE 2, POSTFACH 400265, D-50859 COLOGNE, GERMANY	1866-0452			DTSCH ARZTEBL INT	Dtsch. Arztebl. Int.	DEC 7	2012	109	49					849	856		10.3238/arztebl.2012.0849			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057QP	WOS:000312578400002	23267410	Green Published			2022-02-06	
J	Prodam, F; Caputo, M; Belcastro, S; Garbaccio, V; Zavattaro, M; Sama, MT; Bellone, S; Pagano, L; Bona, G; Aimaretti, G				Prodam, F.; Caputo, M.; Belcastro, S.; Garbaccio, V.; Zavattaro, M.; Sama, M. T.; Bellone, S.; Pagano, L.; Bona, G.; Aimaretti, G.			Quality of life, mood disturbances and psychological parameters in adult patients with GH deficiency	PANMINERVA MEDICA			English	Article						Hypopituitarism; Quality of life; Mental disorders	TRAUMATIC BRAIN-INJURY; GROWTH-HORMONE DEFICIENCY; PHOTON EMISSION CT; HEALTHY OLDER MEN; COGNITIVE FUNCTION; PITUITARY DISEASE; FACTOR-I; PLASMA-LEVELS; MILD; CHILDHOOD	An increased prevalence of depression, emotional lability, decreased energy levels, and poor quality of life have been reported in adults with GH deficiency (GHD). The impairment of psychological parameters depends on the aetiology of GHD and the presence of other pituitary hormone deficiencies because of hormonal effects on neural cell metabolism. Cognitive dysfunctions appear to be specifically related to GHD itself, whereas the lower emotional well-being and reduced motor performance are attributed to other pituitary hormone deficiencies. Traumatic Brain Injury causes very often hypopituitarism and GHD as well as other many psychological symptoms: cognitive impairment, sleeping disorders, and depression. Many neurobehavioral symptoms of post-concussion syndrome (PCS) are the same suffered by adult GHD and hypopituitaric patients but there are no data about the occurrence of hypopituitarism in PCS. In some studies treatment with rhGH is reported to have a beneficial effect and GHD could contribute itself to the global impairment of psychological dysfunctions. The link between psychosocial impairments and GHD is not fully understood. The effects of long-term rhGH therapy on cognitive functions are largely unknown. Thus, long-term placebo-controlled double-blind studies are required to investigate whether psychological dysfunctions are reversible on GH substitution.	[Prodam, F.; Caputo, M.; Belcastro, S.; Garbaccio, V.; Zavattaro, M.; Sama, M. T.; Pagano, L.; Aimaretti, G.] Amedeo Avogadro Univ, Dept Translat Med, Novara, Italy; [Prodam, F.; Bellone, S.; Bona, G.] Amedeo Avogadro Univ, Dept Hlth Sci, Div Pediat, Novara, Italy		Aimaretti, G (corresponding author), Univ Piemonte Orientale, Dept Translat Med, Via Solaroli 17, I-28100 Novara, Italy.	gianluca.aimaretti@med.unipmn.it	Prodam, Flavia/B-8844-2013; Bellone, Simonetta/K-2196-2016	Prodam, Flavia/0000-0001-9660-5335; 			Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Aimaretti G, 2007, NAT CLIN PRACT ENDOC, V3, P318, DOI 10.1038/ncpendmet0460; Aleman A, 1999, J CLIN ENDOCR METAB, V84, P471, DOI 10.1210/jc.84.2.471; Aleman A, 2000, NEUROPSYCHOBIOLOGY, V41, P73, DOI 10.1159/000026636; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Arwert LI, 2006, NEUROENDOCRINOLOGY, V83, P12, DOI 10.1159/000093337; Arwert LI, 2005, NEUROENDOCRINOLOGY, V82, P32, DOI 10.1159/000090123; Arwert LI, 2005, HORM BEHAV, V47, P343, DOI 10.1016/j.yhbeh.2004.11.015; Attanasio AF, 2005, J CLIN ENDOCR METAB, V90, P4525, DOI 10.1210/jc.2005-0439; Baum HBA, 1998, J CLIN ENDOCR METAB, V83, P3184, DOI 10.1210/jc.83.9.3184; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; Bulow B, 2002, CLIN ENDOCRINOL, V56, P183, DOI 10.1046/j.0300-0664.2001.01461.x; Bushnik T, 2007, BRAIN INJURY, V21, P559, DOI 10.1080/02699050701426915; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cook D M, 2000, Adv Intern Med, V45, P297; Copinschi G, 2010, J CLIN ENDOCR METAB, V95, P2195, DOI 10.1210/jc.2009-2080; Corneli Ginevra, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P301, DOI 10.1097/MED.0b013e3281e7e6e6; CUNEO RC, 1992, CLIN ENDOCRINOL, V37, P387, DOI 10.1111/j.1365-2265.1992.tb02347.x; Dam PS, 2010, NEUROBIOL AGING, P17; DEAN HJ, 1985, AM J DIS CHILD, V139, P1105, DOI 10.1001/archpedi.1985.02140130043027; DEBOER H, 1995, ENDOCR REV, V16, P63, DOI 10.1210/er.16.1.63; DONOVAN BT, 1978, PSYCHOL MED, V8, P305, DOI 10.1017/S0033291700014355; Fink G, 1996, CELL MOL NEUROBIOL, V16, P325, DOI 10.1007/BF02088099; Giusti M, 1998, EUR J CLIN INVEST, V28, P13; GONZALEZCLEMENTE JM, 1994, MED CLIN-BARCELONA, V102, P220; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Harvey S, 2003, J MOL NEUROSCI, V20, P1, DOI 10.1385/JMN:20:1:1; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Hoffman AR, 2005, GROWTH HORM IGF RES, V15, pS48, DOI 10.1016/j.ghir.2005.06.010; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; Johannsson G, 1996, CLIN ENDOCRINOL, V45, P305, DOI 10.1046/j.1365-2265.1996.00820.x; JOHANSSON JO, 1995, NEUROENDOCRINOLOGY, V61, P57, DOI 10.1159/000126813; KAWAI K, 1994, ENDOCR J, V41, P275, DOI 10.1507/endocrj.41.275; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Klose M, 2007, J CLIN ENDOCR METAB, V92, P3861, DOI 10.1210/jc.2007-0901; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; LAI ZN, 1991, BRAIN RES, V546, P222, DOI 10.1016/0006-8993(91)91485-J; Lasaite Lina, 2004, Medicina (Kaunas), V40, P740; Lawrance D, 2001, EUR J ENDOCRINOL, V56, P439; Lijffijt M, 2003, NEUROSCI LETT, V353, P123, DOI 10.1016/j.neulet.2003.09.028; Maric NP, 2010, J ENDOCRINOL INVEST, V33, P770, DOI [10.3275/7045, 10.1007/BF03350340]; McKenna SP, 1999, QUAL LIFE RES, V8, P373, DOI 10.1023/A:1008987922774; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Pavlovic D, 2010, EUR J NEUROL, V17, P696, DOI 10.1111/j.1468-1331.2009.02910.x; Peace KA, 1997, CLIN ENDOCRINOL, V46, P445, DOI 10.1046/j.1365-2265.1997.1600971.x; Popovic V, 2006, PITUITARY, V8, P239; Quik EH, 2010, NEUROSCI BIOBEHAV R, V34, P1137, DOI 10.1016/j.neubiorev.2010.01.001; Rollero A, 1998, NEUROPSYCHOBIOLOGY, V38, P73, DOI 10.1159/000026520; ROSEN T, 1994, CLIN ENDOCRINOL, V40, P111, DOI 10.1111/j.1365-2265.1994.tb02452.x; Ross JL, 2005, HORM RES, V64, P89, DOI 10.1159/000089323; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; STABLER B, 1992, CLIN ENDOCRINOL, V36, P467, DOI 10.1111/j.1365-2265.1992.tb02247.x; Stalnacke BM, 2007, J REHABIL MED, V39, P405, DOI 10.2340/16501977-0057; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Urban RJ, 2006, GROWTH HORM IGF RES, V16, pS25, DOI 10.1016/j.ghir.2006.03.017; van Dam PS, 2000, GROWTH HORM IGF RES, V10, P69, DOI 10.1016/S1096-6374(00)80013-1; van der Veen E, 1996, PSYCHONEUROENDOCRINO, V23, P45; van Nieuwpoort IC, 2008, EUR J ENDOCRINOL, V159, pS53, DOI 10.1530/EJE-08-0279; Wallymahmed ME, 1999, CLIN ENDOCRINOL, V51, P333; WOLKOWITZ OM, 1985, NEUROPSYCHOBIOLOGY, V14, P133, DOI 10.1159/000118219; Zenker S, 2002, EUR J ENDOCRINOL, V147, P165, DOI 10.1530/eje.0.1470165; Zitzmann M, 2001, EUR J ENDOCRINOL, V144, P183, DOI 10.1530/eje.0.1440183	69	23	24	0	11	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0031-0808	1827-1898		PANMINERVA MED	Panminerva Medica	DEC	2012	54	4					323	331					9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	058BF	WOS:000312608400009	23123585				2022-02-06	
J	Russo, AC				Russo, Arthur C.			Symptom Validity Test Performance and Consistency of Self-Reported Memory Functioning of Operation Enduring Freedom/Operation Iraqi Freedom Veterans with Positive Veteran Health Administration Comprehensive Traumatic Brain Injury Evaluations	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						TBI; symptom validity testing; WMT; veterans	NEUROPSYCHOLOGICAL PERFORMANCE; COMPLAINTS; ACADEMY; BIAS	Operation Enduring Freedom and Operation Iraqi Freedom combat veterans given definite diagnoses of mild Traumatic Brain Injury (TBI) during the Veteran Health Administration (VHA) Comprehensive TBI evaluation and reporting no post-deployment head injury were examined to assess (a) consistency of self-reported memory impairment and (b) symptom validity test (SVT) performance via a two-part study. Study 1 found that while 49 of 50 veterans reported moderate to very severe memory impairment during the VHA Comprehensive TBI evaluation, only 7 had reported any memory problem at the time of their Department of Defense (DOD) post-deployment health assessment. Study 2 found that of 38 veterans referred for neuropsychological evaluations following a positive VHA Comprehensive TBI evaluation, 68.4 failed the Word Memory Test, a forced choice memory recognition symptom validity task. Together, these studies raise questions concerning the use of veteran symptom self-report for TBI assessments and argue for the inclusion of SVTs and the expanded use of contemporaneous DOD records to improve the diagnostic accuracy of the VHA Comprehensive TBI evaluation.	[Russo, Arthur C.] Vet Adm New York Harbor Healthcare Syst, Dept Psychol, Brooklyn, NY USA		Russo, AC (corresponding author), Vet Adm New York Harbor Healthcare Syst, Psychol Dept 116B, 800 Poly Pl, Brooklyn, NY 11209 USA.	arthur.russo@va.gov					Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Axelrod BN, 2000, CLIN NEUROPSYCHOL, V14, P344, DOI 10.1076/1385-4046(200008)14:3;1-P;FT344; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; Boone K.B., 2007, ASSESSMENT FEIGNED C; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Branca B, 1996, HEADACHE, V36, P300, DOI 10.1046/j.1526-4610.1996.3605300.x; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Defense and Veterans Brain Injury Center, 2012, DOD WORLDW NUMB TBI; Department of Defense, 2002, MCM000602 DEP DEF JO; Department of Defense, 2003, ENH POSTP HLTH ASS U; Department of Defense, 2006, 649003 DEP DEF; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Fox DD, 2011, CLIN NEUROPSYCHOL, V25, P488, DOI 10.1080/13854046.2011.554443; Frueh BC, 2005, BRIT J PSYCHIAT, V186, P467, DOI 10.1192/bjp.186.6.467; Gass CS, 1997, J CLIN EXP NEUROPSYC, V19, P290, DOI 10.1080/01688639708403858; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2005, GREENS WORD MEMORY T, Vrev. ed.; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hepp U, 2006, BRIT J PSYCHIAT, V188, P278, DOI 10.1192/bjp.bp.104.008102; Hoge C., 2010, ONCE WARRIOR ALWAYS; Hoge CW, 2008, NEW ENGL J MED, V358, P2179; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Iverson G., 1999, J COGNITIVE REHABILI, P2; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; McCrea M., 2008, MILD TRAUMATIC BRAIN; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Roca V, 2001, AM J PSYCHIAT, V158, P1738, DOI 10.1176/appi.ajp.158.10.1738-a; Roemer L, 1997, AM J PSYCHIAT, V154, P1628, DOI 10.1176/ajp.154.11.1628; Rohling ML, 2000, ARCH CLIN NEUROPSYCH, V15, P843, DOI 10.1016/S0887-6177(00)80349-2; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Southwick SM, 1997, AM J PSYCHIAT, V154, P173; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Veterans Health Administration, 2010, TRAUM BRAIN INJ; Veterans Health Administration, 2010, SCREEN EV POSS TRAUM; West LK, 2011, J NEUROPSYCHOL, V5, P114, DOI 10.1348/174866410X521434; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020	48	23	23	0	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2012	27	8					840	848		10.1093/arclin/acs090			9	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	044RO	WOS:000311641000003	23059350	hybrid			2022-02-06	
J	Glushakova, OY; Jeromin, A; Martinez, J; Johnson, D; Denslow, N; Streeter, J; Hayes, RL; Mondello, S				Glushakova, Olena Y.; Jeromin, Andreas; Martinez, Juan; Johnson, Danny; Denslow, Nancy; Streeter, Jackson; Hayes, Ronald L.; Mondello, Stefania			Cerebrospinal Fluid Protein Biomarker Panel for Assessment of Neurotoxicity Induced by Kainic Acid in Rats	TOXICOLOGICAL SCIENCES			English	Article						biomarkers; neurotoxicity; kainic acid; CSF; GFAP; UCH-L1; SBDP150; SBDP145; SBDP120	ALPHA-II-SPECTRIN; TRAUMATIC BRAIN-INJURY; HIPPOCAMPAL CELL-PROLIFERATION; C-TERMINAL HYDROLASE-L1; BREAKDOWN PRODUCTS; NERVOUS-SYSTEM; FLUORO-JADE; NEUROLOGICAL COMPLICATIONS; ADJUVANT CHEMOTHERAPY; MOLECULAR-MECHANISMS	Glutamate excitotoxicity plays a key role in the etiology of a variety of neurological, psychiatric, and neurodegenerative disorders. The goal of this study was to investigate spatiotemporal distribution in the brain and cerebrospinal fluid (CSF) concentrations of ubiquitin C-terminal hydrolase-1 (UCH-L1), glial fibrillary acidic protein (GFAP), II-spectrin breakdown products (SBDP150, SBDP145, and SBDP120), and their relationship to neuropathology in an animal model of kainic acid (KA) excitotoxicity. Triple fluorescent labeling and Fluoro-Jade C staining revealed a reactive gliosis in brain and specific localization of degenerating neurons in hippocampus and entorhinal cortex of KA-treated rats. Immunohistochemistry showed upregulation of GFAP expression in hippocampus and cortex beginning 24h post KA injection and peaking at 48h. At these time points concurrent with extensive neurodegeneration all SBDPs were observed throughout the brain. At 24h post KA injection, a loss of structural integrity was observed in cellular distribution of UCH-L1 that correlated with an increase in immunopositive material in the extracellular matrix. CSF levels of UCH-L1, GFAP, and SBDPs were significantly increased in KA-treated animals compared with controls. The temporal increase in CSF biomarkers correlated with brain tissue distribution and neurodegeneration. This study provided evidence supporting the use of CSF levels of glial and neuronal protein biomarkers to assess neurotoxic damage in preclinical animal models that could prove potentially translational to the clinic. The molecular nature of these biomarkers can provide critical information on the underlying mechanisms of neurotoxicity that might facilitate the development of novel drugs and allow physicians to monitor drug safety.	[Glushakova, Olena Y.; Jeromin, Andreas; Martinez, Juan; Johnson, Danny; Streeter, Jackson; Hayes, Ronald L.; Mondello, Stefania] Banyan Biomarkers Inc, Alachua, FL 32615 USA; [Denslow, Nancy] Univ Florida, Ctr Environm & Human Toxicol, Dept Physiol Sci, Gainesville, FL 32611 USA		Mondello, S (corresponding author), Banyan Biomarkers Inc, 13400 Progress Blvd, Alachua, FL 32615 USA.	smondello@banyanbio.com	Glushakova, Olena/AAY-1130-2021; Mondello, Stefania/A-1813-2012	Glushakova, Olena/0000-0002-2109-3651; Mondello, Stefania/0000-0002-8587-3614	Department of Defense (DoD)United States Department of Defense [W81XWH-06-1-0517, W81XWH-10-C-0251]	Department of Defense (DoD; W81XWH-06-1-0517 and W81XWH-10-C-0251).	Araujo IM, 2008, J NEUROCHEM, V105, P666, DOI 10.1111/j.1471-4159.2007.05181.x; Arnaoutakis GJ, 2011, J THORAC CARDIOV SUR, V142, P902, DOI 10.1016/j.jtcvs.2011.06.027; Bajda M, 2011, CURR MED CHEM, V18, P4949, DOI 10.2174/092986711797535245; Barry JD, 2011, NEUROL CLIN, V29, P539, DOI 10.1016/j.ncl.2011.05.006; Benskey M, 2012, NEUROTOXICOLOGY, V33, P321, DOI 10.1016/j.neuro.2012.02.001; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Bi X, 1997, NEUROSCIENCE, V81, P1123, DOI 10.1016/S0306-4522(97)00218-2; Bi XN, 1996, BRAIN RES, V726, P98, DOI 10.1016/0006-8993(95)01360-1; Blyth BJ, 2011, J NEUROTRAUM, V28, P2453, DOI 10.1089/neu.2010.1653; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; Cai Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037599; Cardali S, 2006, J Neurosurg Sci, V50, P25; Cox CD, 2008, J NEUROTRAUM, V25, P1355, DOI 10.1089/neu.2008.0671; Crespo-Biel N, 2010, BIPOLAR DISORD, V12, P425, DOI 10.1111/j.1399-5618.2010.00825.x; Dietrich Joerg, 2006, J Biol, V5, P22, DOI 10.1186/jbiol50; Dietrich J, 2010, ADV EXP MED BIOL, V678, P77; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Doshi Shachee, 2009, Front Biosci (Schol Ed), V1, P466, DOI 10.2741/s38; Doyle KM, 2011, J CELL MOL MED, V15, P2025, DOI 10.1111/j.1582-4934.2011.01374.x; Ehrenreich H, 2011, MOL MED, V17, P1306, DOI 10.2119/molmed.2011.00259; ELLIOTT EM, 1993, J NEUROCHEM, V61, P57, DOI 10.1111/j.1471-4159.1993.tb03537.x; Farkas O, 2005, ACTA NEUROCHIR, V147, P855, DOI 10.1007/s00701-005-0559-6; Fujikawa DG, 2005, EPILEPSY BEHAV, V7, pS3, DOI 10.1016/j.yebeh.2005.08.003; Gilliams-Francis KL, 2003, EXP NEUROL, V184, P359, DOI 10.1016/j.expneurol.2003.07.003; Grant KS, 2010, NEUROTOXICOL TERATOL, V32, P132, DOI 10.1016/j.ntt.2009.09.005; Grill MF, 2011, BRIT J CLIN PHARMACO, V72, P381, DOI 10.1111/j.1365-2125.2011.03991.x; Haddad PM, 2008, HUM PSYCHOPHARM CLIN, V23, P15, DOI 10.1002/hup.918; Hopkins KJ, 2000, BRAIN RES, V864, P69, DOI 10.1016/S0006-8993(00)02137-5; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Jansen CE, 2011, SUPPORT CARE CANCER, V19, P1647, DOI 10.1007/s00520-010-0997-4; Kim K, 2011, J CELL PHYSIOL, V226, P2484, DOI 10.1002/jcp.22609; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Kondratyev A, 2004, MOL BRAIN RES, V121, P86, DOI 10.1016/j.molbrainres.2003.11.005; Lewis SB, 2007, J NEUROSURG, V107, P792, DOI 10.3171/JNS-07/10/0792; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Menon KN, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000042; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Nath R, 1998, J NEUROCHEM, V71, P186; Newton HB, 2012, HAND CLINIC, V105, P903, DOI 10.1016/B978-0-444-53502-3.00031-8; O'Callaghan James P, 2005, Expert Opin Drug Saf, V4, P433, DOI 10.1517/14740338.4.3.433; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Pike BR, 2004, J CEREBR BLOOD F MET, V24, P98, DOI 10.1097/01.WCB.0000098520.11962.37; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Pivovarova NB, 2010, FEBS J, V277, P3622, DOI 10.1111/j.1742-4658.2010.07754.x; Plunkett LM, 2007, LANCET, V369, P821, DOI 10.1016/S0140-6736(07)60396-1; Rajdev S, 2000, TOXICOL PATHOL, V28, P105, DOI 10.1177/019262330002800113; Rao DB, 2011, TOXICOL PATHOL, V39, P463, DOI 10.1177/0192623311401044; Ringger NC, 2004, J NEUROTRAUM, V21, P1443, DOI 10.1089/neu.2004.21.1443; Rodriguez Manuel J, 2009, Curr Drug Abuse Rev, V2, P99; Salloway S, 2008, ALZHEIMERS DEMENT, V4, P65, DOI 10.1016/j.jalz.2007.10.001; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Seigers R, 2008, BEHAV BRAIN RES, V186, P168, DOI 10.1016/j.bbr.2007.08.004; Seigers R, 2009, BEHAV BRAIN RES, V201, P279, DOI 10.1016/j.bbr.2009.02.025; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; Siman R, 2008, BRAIN RES, V1213, P1, DOI 10.1016/j.brainres.2008.03.034; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Stewart A, 2008, PSYCHO-ONCOLOGY, V17, P122, DOI 10.1002/pon.1210; Sun L, 2011, J RHEUMATOL, V38, P454, DOI 10.3899/jrheum.100550; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Tsai GC, 1998, ANNU REV MED, V49, P173; Vanderklish PW, 2000, INT J EXP PATHOL, V81, P323, DOI 10.1111/j.1365-2613.2000.00169.x; Wang Y, 2010, APOPTOSIS, V15, P1382, DOI 10.1007/s10495-010-0481-0; Warren MW, 2007, ACTA NEUROPATHOL, V114, P277, DOI 10.1007/s00401-007-0259-9; Wefel JS, 2012, CURR NEUROL NEUROSCI, V12, P267, DOI 10.1007/s11910-012-0264-9; Wefel JS, 2004, CANCER-AM CANCER SOC, V100, P2292, DOI 10.1002/cncr.20272; Weiss ES, 2009, ANN THORAC SURG, V88, P543, DOI 10.1016/j.athoracsur.2009.04.016; Yan XX, 2012, CURR GERIATR REP, V1, P85, DOI 10.1007/s13670-012-0009-2; Zheng XY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/457079	76	23	23	0	12	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1096-6080	1096-0929		TOXICOL SCI	Toxicol. Sci.	NOV	2012	130	1					158	167		10.1093/toxsci/kfs224			10	Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Toxicology	025CV	WOS:000310163200014	22790971	Bronze			2022-02-06	
J	Rashid, B; Destrade, M; Gilchrist, MD				Rashid, Badar; Destrade, Michel; Gilchrist, Michael D.			Inhomogeneous deformation of brain tissue during tension tests	COMPUTATIONAL MATERIALS SCIENCE			English	Article; Proceedings Paper	21st International Workshop on Computational Mechanics of Materials (IWCMM)	AUG 22-24, 2011	Univ Limerick, Limerick, IRELAND		Univ Limerick	Traumatic Brain Injury (TBI); Impact; Compression; Shear; Ogden; Hyperelastic; Elastic	MODEL; BEHAVIOR; STRETCH; COMPRESSION; STRAIN	Mechanical characterization of brain tissue has been investigated extensively by various research groups over the past 50 years. These properties are particularly important for modeling Traumatic Brain Injury (TBI). In this research, we present the design and calibration of a High Rate Tension Device (HRTD) capable of performing tests up to a maximum strain rate of 90/s. We use experimental and numerical methods to investigate the effects of inhomogeneous deformation of porcine brain tissue during tension at different specimen thicknesses (4.0-14.0 mm), by performing tension tests at a strain rate of 30/s. One-term Ogden material parameters (mu = 4395.0 Pa, alpha = -2.8) were derived by performing an inverse finite element analysis to model all experimental data. A similar procedure was adopted to determine Young's modulus (E = 11200 Pa) of the linear elastic regime. Based on this analysis, brain specimens of aspect ratio (diameter/thickness) S <= 1.0 are required to minimise the effects of inhomogeneous deformation during tension tests. (C) 2012 Elsevier B.V. All rights reserved.	[Rashid, Badar; Destrade, Michel; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland; [Destrade, Michel] Natl Univ Ireland Galway, Sch Math Stat & Appl Math, Galway, Ireland		Gilchrist, MD (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland.	Badar.Rashid@ucdconnect.ie; michel.destrade@nuigalway.ie; michael.gilchrist@ucd.ie	Destrade, Michel/O-5825-2019; Gilchrist, Michael D/B-6100-2017	Destrade, Michel/0000-0002-6266-1221; Gilchrist, Michael D/0000-0003-1765-429X			Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; Cheng S, 2007, J BIOMECH, V40, P117, DOI 10.1016/j.jbiomech.2005.11.004; Coats B, 2006, J BIOMECH, V39, P2521, DOI 10.1016/j.jbiomech.2005.07.020; Garo A, 2007, BIORHEOLOGY, V44, P51; Gilchrist MD, 2004, STRAIN, V40, P180, DOI 10.1111/j.1475-1305.2004.00168.x; Lin DC, 2009, BIOMECH MODEL MECHAN, V8, P345, DOI 10.1007/s10237-008-0139-9; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison B, 2000, J BIOMECH ENG-T ASME, V122, P224, DOI 10.1115/1.429650; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Nicolle S, 2005, BIORHEOLOGY, V42, P209; Ogden R.W., 1997, NONLINEAR ELASTIC DE; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Pfister BJ, 2003, ANN BIOMED ENG, V31, P589, DOI 10.1114/1.1566445; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Rashid B., J SPORTS EN IN PRESS, V226; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Raul JS, 2006, INT J LEGAL MED, V120, P212, DOI 10.1007/s00414-005-0018-1; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Tamura A, 2007, J BIOMECH SCI ENG, V2, P115, DOI [10.1299/jbse.2.115, DOI 10.1299/JBSE.2.115]; Tamura A, 2008, J BIOMECH SCI ENG, V3, P263, DOI DOI 10.1299/JBSE.3.263; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9	24	23	24	3	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0927-0256	1879-0801		COMP MATER SCI	Comput. Mater. Sci.	NOV	2012	64						295	300		10.1016/j.commatsci.2012.05.030			6	Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Materials Science	000OO	WOS:000308396200062		Green Submitted			2022-02-06	
J	Leonardi, AD; Keane, NJ; Bir, CA; Ryan, AG; Xu, LS; VandeVord, PJ				Leonardi, Alessandra Dal Cengio; Keane, Nickolas J.; Bir, Cynthia A.; Ryan, Anne G.; Xu, Liaosa; VandeVord, Pamela J.			Head orientation affects the intracranial pressure response resulting from shock wave loading in the rat	JOURNAL OF BIOMECHANICS			English	Article						Blast; Traumatic brain injury; Skull flexure; Orientation; Intracranial pressure	TRAUMATIC BRAIN-INJURY; BLAST INJURY; EXPOSURE; NEUROSCIENCE; MECHANISM	Since an increasing number of returning military personnel are presenting with neurological manifestations of traumatic brain injury (TB!), there has been a great focus on the effects resulting from blast exposure. It is paramount to resolve the physical mechanism by which the critical stress is being inflicted on brain tissue from blast wave encounters with the head. This study quantitatively measured the effect of head orientation on intracranial pressure (ICP) of rats exposed to a shock wave. Furthermore, the study examined how skull maturity affects ICP response of animals exposed to shock waves at various orientations. Results showed a significant increase in ICP values in larger rats at any orientation. Furthermore, when side-ICP values were compared to the other orientations, the peak pressures were significantly lower suggesting a relation between ICP and orientation of the head due to geometry of the skull and location of sutures. This finding accentuates the importance of skull dynamics in explaining possible injury mechanisms during blast. Also, the rate of pressure change was measured and indicated that the rate was significantly higher when the top of the head was facing the shock front. The results confirm that the biomechanical response of the superior rat skull is distinctive compared to other areas of the skull, suggesting a skull flexure mechanism. These results not only present insights into the mechanism of brain injury, but also provide information which can be used for designing more effective protective head gear. (C) 2012 Elsevier Ltd. All rights reserved.	[Leonardi, Alessandra Dal Cengio; Keane, Nickolas J.; Bir, Cynthia A.; VandeVord, Pamela J.] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48201 USA; [Leonardi, Alessandra Dal Cengio; VandeVord, Pamela J.] John D Dingell VA Med Ctr, Res & Dev Serv, Detroit, MI 48201 USA; [Ryan, Anne G.; Xu, Liaosa] Virginia Tech, Dept Stat, Blacksburg, VA 24061 USA		VandeVord, PJ (corresponding author), Virginia Tech Univ, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA.	adc.leonardi@gmail.com; nickolasjkeane@gmail.com; cbir@wayne.edu; agryan@vt.edu; liaosax@vt.edu; pvord@vt.edu		Bir, Cynthia/0000-0002-0777-0951	Department of DefenseUnited States Department of Defense [W81XWH-08-2-0207]	We would like to thank the WSU Bioengineering Center Staff for assisting with this project, and especially Dr. Wu, Mr. Mathie, and Mr. Ritzel. This project was partially funded by the Department of Defense (Award No. W81XWH-08-2-0207).	Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Born CT, 2005, SCAND J SURG, V94, P279, DOI 10.1177/145749690509400406; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; CLEMEDSON C, 1961, ACTA PHYSIOL SCAND, V51, P47, DOI 10.1111/j.1748-1716.1961.tb02112.x; CLEMEDSON CJ, 1956, ACTA PHYSL SCAND, V37, P204, DOI DOI 10.1111/J.1748-1716.1956.TB01356.X); Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hoffman SW, 2009, CLIN NEUROPSYCHOL, V23, P1400, DOI 10.1080/13854040903369433; JASLOW CR, 1990, J BIOMECH, V23, P313, DOI 10.1016/0021-9290(90)90059-C; Leonardi A.D., 2011, THESIS WAYNE STATE U; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Romba J.J., 1961, 1761 US ARM ORDN HUM; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; YOUNG MW, 1945, WAR MED, V8, P73	19	23	23	0	10	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290			J BIOMECH	J. Biomech.	OCT 11	2012	45	15					2595	2602		10.1016/j.jbiomech.2012.08.024			8	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	024KE	WOS:000310107300016	22947434				2022-02-06	
J	Storti, SF; Formaggio, E; Franchini, E; Bongiovanni, LG; Cerini, R; Fiaschi, A; Michel, CM; Manganotti, P				Storti, Silvia F.; Formaggio, Emanuela; Franchini, Enrica; Bongiovanni, Luigi G.; Cerini, Roberto; Fiaschi, Antonio; Michel, Christoph M.; Manganotti, Paolo			A multimodal imaging approach to the evaluation of post-traumatic epilepsy	MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE			English	Article						Post-traumatic epilepsy; EEG-fMRI; Source localization	INDEPENDENT COMPONENT ANALYSIS; INTERICTAL EPILEPTIFORM DISCHARGES; EEG-FMRI COREGISTRATION; FUNCTIONAL MRI; WAVE DISCHARGES; FOCAL EPILEPSY; SPIKE; ACTIVATION; NETWORKS; BRAIN	Electroencephalography-functional magnetic resonance imaging (EEG-fMRI) coregistration and high-density EEG (hdEEG) can be combined to map noninvasively abnormal brain activation elicited by epileptic processes. By combining noninvasive imaging techniques in a multimodal approach, we sought to investigate pathophysiological mechanisms underlying epileptic activity in seven patients with severe traumatic brain injury. Standard EEG and fMRI data were acquired during a single scanning session. The EEG-fMRI data were analyzed using the general linear model and independent component analysis. Source localization of interictal epileptiform discharges (IEDs) was performed using 256-channel hdEEG. Blood oxygenation level dependent (BOLD) localizations were then compared to EEG source reconstruction. On hdEEG, focal source localization was detected in all seven patients; in six out of seven it was concordant with the expected epileptic activity as defined by EEG data and clinical evaluation; and in four out of seven in whom IEDs were recorded, BOLD signal changes were observed. These activities were partially concordant with the source localization. Multimodal integration of EEG-fMRI and hdEEG combining two different methods to localize the same epileptic foci appears to be a promising tool to noninvasively map abnormal brain activation in patients with post-traumatic brain injury.	[Storti, Silvia F.; Franchini, Enrica; Bongiovanni, Luigi G.; Fiaschi, Antonio; Manganotti, Paolo] Univ Verona, Sect Clin Neurol, Dept Neurol Neuropsychol Morphol & Movement Sci, Policlin GB Rossi, I-37134 Verona, Italy; [Formaggio, Emanuela; Fiaschi, Antonio; Manganotti, Paolo] IRCCS San Camillo, Dept Neurophysiol, Venice, Italy; [Cerini, Roberto] Univ Verona, Dept Pathol & Diagnost, I-37134 Verona, Italy; [Michel, Christoph M.] Univ Geneva, Univ Med Sch, Funct Brain Mapping Lab, Dept Fundamental Neurosci, Geneva, Switzerland		Storti, SF (corresponding author), Univ Verona, Sect Clin Neurol, Dept Neurol Neuropsychol Morphol & Movement Sci, Policlin GB Rossi, Ple LA Scuro 10, I-37134 Verona, Italy.	silviafrancesca.storti@univr.it	Formaggio, Emanuela/K-1555-2016; Storti, Silvia Francesca/K-3142-2016; Formaggio, Emanuela/N-2278-2019; Storti, Silvia Francesca/AAB-8311-2022	Formaggio, Emanuela/0000-0002-3417-0388; Storti, Silvia Francesca/0000-0002-8605-803X; Formaggio, Emanuela/0000-0002-3417-0388; Storti, Silvia Francesca/0000-0002-8605-803X; Michel, Christoph/0000-0003-3426-5739	Center for Biomedical Imaging (CIBM) of the University of Geneva; Swiss Federal Institute of Technology, Lausanne (EPFL); Center for Biomedical Imaging (CIBM) of the University of Lausanne; University Hospital of Geneva, Switzerland; University Hospital of Lausanne, Switzerland; Cariverona, Verona, ItalyFondazione Cariverona	The development of CARTOOL is supported by the Center for Biomedical Imaging (CIBM) of the Universities of Geneva and Lausanne, the Swiss Federal Institute of Technology, Lausanne (EPFL), and the University Hospitals of Geneva and Lausanne, Switzerland. This study was supported by Cariverona, Verona, Italy.	Aghakhani Y, 2004, BRAIN, V127, P1127, DOI 10.1093/brain/awh136; Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; Archer JS, 2003, NEUROIMAGE, V20, P1915, DOI 10.1016/S1053-8119(03)00294-5; Baudewig J, 2001, CLIN NEUROPHYSIOL, V112, P1196, DOI 10.1016/S1388-2457(01)00562-4; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Benar CG, 2002, NEUROIMAGE, V17, P1182, DOI 10.1006/nimg.2002.1164; Borelli P, 2010, SEIZURE-EUR J EPILEP, V19, P605, DOI 10.1016/j.seizure.2010.09.001; Brodbeck V, 2011, BRAIN, V134, P2887, DOI 10.1093/brain/awr243; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Cordes D, 2002, MAGN RESON IMAGING, V20, P305, DOI 10.1016/S0730-725X(02)00503-9; Cosottini M, 2010, MAGN RESON IMAGING, V28, P388, DOI 10.1016/j.mri.2009.11.011; Del Felice A, 2009, EPILEPSY RES, V85, P321, DOI 10.1016/j.eplepsyres.2009.03.025; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Formaggio E, 2011, NEUROIMAGE, V54, P2719, DOI 10.1016/j.neuroimage.2010.11.038; Formaggio E, 2008, BRAIN TOPOGR, V21, P100, DOI 10.1007/s10548-008-0058-1; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Goldman RI, 2000, CLIN NEUROPHYSIOL, V111, P1974, DOI 10.1016/S1388-2457(00)00456-9; Gotman J, 2005, P NATL ACAD SCI USA, V102, P15236, DOI 10.1073/pnas.0504935102; Gotman J, 2006, J MAGN RESON IMAGING, V23, P906, DOI 10.1002/jmri.20577; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Groening K, 2009, NEUROIMAGE, V46, P827, DOI 10.1016/j.neuroimage.2009.02.026; Guggisberg AG, 2011, NEUROIMAGE, V57, P1348, DOI 10.1016/j.neuroimage.2011.05.076; IVES JR, 1993, ELECTROEN CLIN NEURO, V87, P417, DOI 10.1016/0013-4694(93)90156-P; Jacobs J, 2007, EPILEPSIA, V48, P2068, DOI 10.1111/j.1528-1167.2007.01192.x; Kobayashi E, 2006, BRAIN, V129, P366, DOI 10.1093/brain/awh710; Lantz G, 2003, J CLIN NEUROPHYSIOL, V20, P311, DOI 10.1097/00004691-200309000-00003; Laufs H, 2007, HUM BRAIN MAPP, V28, P1023, DOI 10.1002/hbm.20323; Lemieux L, 2001, NEUROIMAGE, V14, P1097, DOI 10.1006/nimg.2001.0896; Lemieux L, 2001, NEUROIMAGE, V14, P780, DOI 10.1006/nimg.2001.0853; Li QF, 2009, EPILEPSY RES, V87, P160, DOI 10.1016/j.eplepsyres.2009.08.018; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Luo C, 2010, EPILEPSY RES, V91, P133, DOI 10.1016/j.eplepsyres.2010.07.003; Manganotti P, 2008, MAGN RESON IMAGING, V26, P1089, DOI 10.1016/j.mri.2008.02.023; Mazzini L, 2003, EPILEPSIA, V44, P569, DOI 10.1046/j.1528-1157.2003.34902.x; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; Menon V, 2005, INT REV NEUROBIOL, V66, P291, DOI 10.1016/S0074-7742(05)66010-2; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Moeller F, 2011, HUM BRAIN MAPP, V32, P209, DOI 10.1002/hbm.21010; Niedermeyer E, 2004, ELECTROENCEPHALOGRAP; Ogawa S, 2000, P NATL ACAD SCI USA, V97, P11026, DOI 10.1073/pnas.97.20.11026; Ossenblok P, 1999, IEEE ENG MED BIOL, V18, P67, DOI 10.1109/51.765191; Pesaresi I, 2011, MAGN RESON MATER PHY, V24, P285, DOI 10.1007/s10334-011-0263-x; Ritter P, 2006, NEUROSCI BIOBEHAV R, V30, P823, DOI 10.1016/j.neubiorev.2006.06.008; Rodionov R, 2007, NEUROIMAGE, V38, P488, DOI 10.1016/j.neuroimage.2007.08.003; Rosenkranz K, 2010, MAGN RESON MATER PHY, V23, P309, DOI 10.1007/s10334-009-0196-9; Salek-Haddadi A, 2006, BRAIN RES, V1088, P148, DOI 10.1016/j.brainres.2006.02.098; Siniatchkin M, 2010, BRAIN, V133, P2798, DOI 10.1093/brain/awq183; Spinelli L, 2000, BRAIN TOPOGR, V13, P115, DOI 10.1023/A:1026607118642; Storti SF, 2010, BRAIN TOPOGR, V23, P46, DOI 10.1007/s10548-009-0117-2; Thirion B, 2006, NEUROIMAGE, V29, P321, DOI 10.1016/j.neuroimage.2005.06.054; Thom M, 2011, BRAIN, V134, P2969, DOI 10.1093/brain/awr209; Vaudano AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006475; Volman V, 2011, J NEUROPHYSIOL, V106, P1933, DOI 10.1152/jn.00458.2011; Vulliemoz S, 2010, NEUROIMAGE, V49, P3219, DOI 10.1016/j.neuroimage.2009.11.055; Vulliemoz S, 2009, NEUROIMAGE, V46, P834, DOI 10.1016/j.neuroimage.2009.01.070; Vulliemoz S, 2010, EPILEPSIA, V51, P491, DOI 10.1111/j.1528-1167.2009.02342.x	57	23	24	0	13	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0968-5243			MAGN RESON MATER PHY	Magn. Reson. Mat. Phys. Biol. Med.	OCT	2012	25	5					345	360		10.1007/s10334-012-0316-9			16	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	012JH	WOS:000309231900003	22592963	hybrid, Green Published			2022-02-06	
J	Lian, H; Shim, DJ; Gaddam, SSK; Rodriguez-Rivera, J; Bitner, BR; Pautler, RG; Robertson, CS; Zheng, H				Lian, Hong; Shim, David J.; Gaddam, Samson S. K.; Rodriguez-Rivera, Jennifer; Bitner, Brittany R.; Pautler, Robia G.; Robertson, Claudia S.; Zheng, Hui			I kappa B alpha deficiency in brain leads to elevated basal neuroinflammation and attenuated response following traumatic brain injury: implications for functional recovery	MOLECULAR NEURODEGENERATION			English	Article						NF kappa B; I kappa B alpha; Conditional knockout mice; TBI; Neuroinflammation; Cerebral blood flow; MRI	UBIQUITIN-PROTEASOME PATHWAY; CENTRAL-NERVOUS-SYSTEM; TRANSCRIPTION FACTOR; CELL-DEATH; INFLAMMATORY RESPONSE; SYNAPTIC PLASTICITY; CEREBRAL-ISCHEMIA; MEMORY FORMATION; C-REL; ACTIVATION	Background: The transcription factor NF kappa B is an important mediator of cell survival and inflammation in the immune system. In the central nervous system (CNS), NF kappa B signaling has been implicated in regulating neuronal survival following acute pathologic damage such as traumatic brain injury (TBI) and stroke. NF kappa B is normally bound by the principal inhibitory protein, I kappa B alpha, and sequestered in the cytoplasm. Activation of NF kappa B requires the degradation of I kappa B alpha, thereby freeing NF kappa B to translocate to the nucleus and activate the target genes. Mice deficient in I kappa B alpha display deregulated and sustained NF kappa B activation and early postnatal lethality, highlighting a critical role of I kappa B alpha in NF kappa B regulation. Results: We investigated the role of I kappa B alpha in regulating NF kappa B activity in the brain and the effects of the NF kappa B/I kappa B alpha pathway in mediating neuroinflammation under both physiological and brain injury conditions. We report that astrocytes, but not neurons, exhibit prominent NF kappa B activity, and that basal NF kappa B activity in astrocytes is elevated in the absence of I kappa B alpha. By generating mice with brain-specific deletion of I kappa B alpha, we show that I kappa B alpha deficiency does not compromise normal brain development. However, basal neuroinflammation detected by GFAP and Iba1 immunoreactivity is elevated. This leads to impaired inflammatory responses following TBI and worsened brain damage including higher blood brain barrier permeability, increased injury volumes and enlarged ventricle volumes. Conclusions: We conclude that, in the CNS, astrocyte is the primary cell type subject to NF kappa B regulation. We further demonstrate that I kappa B alpha plays an important role in regulating NF kappa B activity in the brain and a robust NF kappa B/I kappa B alpha-mediated neuroinflammatory response immediately following TBI is beneficial.	[Lian, Hong; Shim, David J.; Rodriguez-Rivera, Jennifer; Zheng, Hui] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Lian, Hong; Zheng, Hui] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Shim, David J.; Zheng, Hui] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Shim, David J.; Zheng, Hui] Baylor Coll Med, Med Sci Training Program, Houston, TX 77030 USA; [Gaddam, Samson S. K.; Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Bitner, Brittany R.; Pautler, Robia G.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Bitner, Brittany R.; Pautler, Robia G.; Zheng, Hui] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA		Zheng, H (corresponding author), Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA.	huiz@bcm.edu			 [P01 NS38660];  [R01 AG020670];  [AG032051];  [NS076117];  [R01 AG 029977];  [F30 NS061428]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS076117, P01NS038660, F30NS061428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG032051, R01AG029977, R01AG020670] Funding Source: NIH RePORTER	We are grateful to N. Aithmitti and X. Chen for expert technical support and members of the Zheng laboratory for constructive discussions and help with the manuscript. This work was supported by P01 NS38660 (to CSR), R01 AG020670, AG032051 and NS076117 (to HZ), R01 AG 029977 (to RGP), and F30 NS061428 (to DS).	Ahn HJ, 2008, LEARN MEMORY, V15, P539, DOI 10.1101/lm.866408; ALKALAY I, 1995, P NATL ACAD SCI USA, V92, P10599, DOI 10.1073/pnas.92.23.10599; Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Blondeau N, 2001, J NEUROSCI, V21, P4668, DOI 10.1523/JNEUROSCI.21-13-04668.2001; Browne KD, 2006, EXP NEUROL, V201, P301, DOI 10.1016/j.expneurol.2006.04.008; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; CHIAO PJ, 1994, P NATL ACAD SCI USA, V91, P28, DOI 10.1073/pnas.91.1.28; De Keyser J, 2008, J NEUROL SCI, V267, P3, DOI 10.1016/j.jns.2007.08.044; Foehr ED, 2000, J NEUROSCI, V20, P7556; Fridmacher V, 2003, J NEUROSCI, V23, P9403; Guo GW, 2006, ANTIOXID REDOX SIGN, V8, P911, DOI 10.1089/ars.2006.8.911; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Herkenham M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-141; Hinson SR, 2010, NEUROSCIENCE, V168, P1009, DOI 10.1016/j.neuroscience.2009.08.032; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kaltschmidt B, 2000, EXP BRAIN RES, V130, P100, DOI 10.1007/s002210050011; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; KALTSCHMIDT C, 1993, MECH DEVELOP, V43, P135, DOI 10.1016/0925-4773(93)90031-R; KALTSCHMIDT C, 1994, MOL CELL BIOL, V14, P3981, DOI 10.1128/MCB.14.6.3981; KALTSCHMIDT C, 1995, P NATL ACAD SCI USA, V92, P9618, DOI 10.1073/pnas.92.21.9618; Kassed CA, 2002, EXP NEUROL, V176, P277, DOI 10.1006/exnr.2002.7967; Klement JF, 1996, MOL CELL BIOL, V16, P2341; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee M, 2011, GLIA, V59, P152, DOI 10.1002/glia.21087; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Levenson JM, 2004, J NEUROSCI, V24, P3933, DOI 10.1523/JNEUROSCI.5646-03.2004; Li HM, 2010, P NATL ACAD SCI USA, V107, P17362, DOI 10.1073/pnas.1012568107; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Longhi L, 2001, J CEREBR BLOOD F MET, V21, P1241, DOI 10.1097/00004647-200111000-00001; Mao XRR, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-16; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nomoto Y, 2001, NEUROSURGERY, V48, P158, DOI 10.1097/00006123-200101000-00027; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Penkowa M, 2003, EXP NEUROL, V181, P130, DOI 10.1016/S0014-4886(02)00051-1; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Rocha SM, 2012, NEUROBIOL DIS, V47, P407, DOI 10.1016/j.nbd.2012.04.014; Rojo AI, 2004, J NEUROSCI, V24, P7324, DOI 10.1523/JNEUROSCI.2111-04.2004; Rupec RA, 2005, IMMUNITY, V22, P479, DOI 10.1016/j.immuni.2005.02.009; Sanz O, 2002, J NEUROSCI RES, V67, P772, DOI 10.1002/jnr.10140; Schneider A, 1999, NAT MED, V5, P554, DOI 10.1038/8432; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Stamatovic SM, 2006, ACTA NEUROCHIR SUPPL, V96, P444; Swartz KR, 2001, BRAIN RES, V896, P86, DOI 10.1016/S0006-8993(01)02013-3; Tam WF, 2001, J BIOL CHEM, V276, P7701, DOI 10.1074/jbc.C000916200; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Zhang W, 2005, J CEREBR BLOOD F MET, V25, P30, DOI 10.1038/sj.jcbfm.9600004; Ziebell JM, 2011, BRAIN RES, V1414, P94, DOI 10.1016/j.brainres.2011.07.056; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	56	23	23	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1750-1326			MOL NEURODEGENER	Mol. Neurodegener.	SEP 19	2012	7								47	10.1186/1750-1326-7-47			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	021ER	WOS:000309868600001	22992283	Green Published, gold			2022-02-06	
J	Xu, H; Zhang, SL; Tan, GW; Zhu, HW; Huang, CQ; Zhang, FF; Wang, ZX				Xu, H.; Zhang, S. L.; Tan, G. W.; Zhu, H. W.; Huang, C. Q.; Zhang, F. F.; Wang, Z. X.			REACTIVE GLIOSIS AND NEUROINFLAMMATION IN RATS WITH COMMUNICATING HYDROCEPHALUS	NEUROSCIENCE			English	Article						hydrocephalus; pathogenesis; gliosis; neuroinflammation	TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; CONGENITAL HYDROCEPHALUS; ASTROCYTES; MICROGLIA; EXPRESSION; INFLAMMATION; DAMAGE; MICE; ACTIVATION	Reactive gliosis has been implicated in injury and recovery patterns associated with hydrocephalus. The roles that these mechanisms play in the pathophysiology of hydrocephalus are still not clear in terms of cytopathology and gene expression. In this paper, we investigated the relationship between reactive gliosis and neuroinflammation of hydrocephalic rats of different severity at both cellular and molecular levels. Therefore 35 adult SD (standard deviation) rats were randomly divided into the normal group (n = 5), the sham operation group (n = 5) and the model group (n = 25). Hydrocephalic rat models were induced by intraventricular injections of 3% kaolin, and the ventricular dilatation was examined by MRI (magnetic resonance imaging) at 2-week postoperation. Then the model group was subdivided into the mild group (n = 5), the moderate group (n = 7) and the severe group (n = 9) according to the degree of ventricular dilatation. While IL-18 (interlukin 18), GFAP (glial fibrillary acidic protein), and Iba-1 (ionized calcium bindingadaptor molecule-1) were detected by ELISA (enzyme-linked immunosorbent assay), RT-PCR, immunohistochemistry, Western blot and correlation analysis were conducted at the same time. According to the result comparison between the normal group and the sham operation group, the ventricle of model group was obviously enlarged (P < 0.01). The expression of GFAP and Iba-1 was increased (P < 0.05) in brain tissue of the model group and IL-18 was also increased in CSF (cerebrosinal fluid) sample of model group. It was revealed by correlation analysis that the increase was positively correlated with the severity of ventricular dilatation. Conclusion: These results indicate that gliosis and inflammation continue to rise dramatically in experimental hydrocephalus and can be regarded as the main factors of hydrocephalus. Regulating the level of gliosis and alleviating inflammation may provide new therapeutic methods of hydrocephalus. (C) 2012 IBRO. Published by Elsevier Ltd. All rights reserved.	[Xu, H.; Zhang, S. L.; Tan, G. W.; Zhu, H. W.; Huang, C. Q.; Zhang, F. F.; Wang, Z. X.] Xiamen Univ, Affiliate Hosp 1, Dept Neurosurg, Xiamen 361003, Fujian Province, Peoples R China		Wang, ZX (corresponding author), Xiamen Univ, Affiliate Hosp 1, Dept Neurosurg, Xiamen 361003, Fujian Province, Peoples R China.	wangzx@xmbrain.com					Aoyama Y, 2006, J NEUROSURG, V104, P332, DOI 10.3171/ped.2006.104.5.332; Arevalo MA, 2012, J NEUROENDOCRINOL, V24, P183, DOI 10.1111/j.1365-2826.2011.02156.x; BANATI RB, 1993, GLIA, V7, P111, DOI 10.1002/glia.440070117; Bruce-Keller AJ, 1999, J NEUROSCI RES, V58, P191, DOI 10.1002/(SICI)1097-4547(19991001)58:1<191::AID-JNR17>3.0.CO;2-E; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; Bulat M, 2011, BRAIN RES REV, V65, P99, DOI 10.1016/j.brainresrev.2010.08.002; Bush TGNP, 1999, ACTA NEUROPATHOL, V23, P297; Ciccarelli R, 2000, GLIA, V29, P202, DOI 10.1002/(SICI)1098-1136(20000201)29:3<202::AID-GLIA2>3.0.CO;2-C; Conde JR, 2006, J NEUROPATH EXP NEUR, V65, P199, DOI 10.1097/01.jnen.0000202887.22082.63; Cristina A, 2007, MOL PHARMACOL, V72, P1228, DOI 10.1124/mol.107.037127; Del Bigio MR, 2010, DEV DISABIL RES REV, V16, P16, DOI 10.1002/ddrr.94; Del Bigio MR, 2001, NEUROSURG CLIN N AM, V12, P639, DOI 10.1016/S1042-3680(18)30022-6; Deren KE, 2010, EXP NEUROL, V226, P110, DOI 10.1016/j.expneurol.2010.08.010; Drogemuller K, 2008, J IMMUNOL, V181, P2683, DOI 10.4049/jimmunol.181.4.2683; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Escartin C, 2008, MOL NEUROBIOL, V38, P231, DOI 10.1007/s12035-008-8043-y; Evans WA, 1942, ARCH NEURO PSYCHIATR, V47, P931, DOI 10.1001/archneurpsyc.1942.02290060069004; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fetler L, 2005, SCIENCE, V309, P392, DOI 10.1126/science.1114852; Fukui O, 2006, BRAIN RES, V1121, P35, DOI 10.1016/j.brainres.2006.08.121; Girard S, 2009, PEDIATR NEUROL, V40, P168, DOI 10.1016/j.pediatrneurol.2008.09.016; Heales SJR, 2004, NEUROCHEM RES, V29, P513, DOI 10.1023/B:NERE.0000014822.69384.0f; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Hoshi A, 2011, EXP NEUROL, V227, P89, DOI 10.1016/j.expneurol.2010.09.016; Huang TT, 2009, NEUROTHERAPEUTICS, V6, P500, DOI 10.1016/j.nurt.2009.04.008; John GR, 2003, NEUROSCIENTIST, V9, P10, DOI 10.1177/1073858402239587; Khan OH, 2006, EXP NEUROL, V200, P311, DOI 10.1016/j.expneurol.2006.02.113; Kikuchi K, 2009, BIOCHEM BIOPH RES CO, V385, P132, DOI 10.1016/j.bbrc.2009.04.041; Klarica M, 2009, NEUROSCIENCE, V158, P1397, DOI 10.1016/j.neuroscience.2008.11.041; Liao CW, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-84; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Lopes LD, 2009, EXP NEUROL, V219, P187, DOI 10.1016/j.expneurol.2009.05.015; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Lynch MA, 2009, MOL NEUROBIOL, V40, P139, DOI 10.1007/s12035-009-8077-9; Mangano FT, 1998, NEUROL RES, V20, P697; Mao XY, 2006, EUR J NEUROSCI, V23, P2929, DOI 10.1111/j.1460-9568.2006.04829.x; Markiewicz I, 2006, ACTA NEUROBIOL EXP, V66, P343; McAllister James P 2nd, 2010, Cerebrospinal Fluid Res, V7, P7, DOI 10.1186/1743-8454-7-7; Michael VS, 2010, ACTA NEUROPATHOL, V119, P7; Miller Janet M, 2007, Cerebrospinal Fluid Res, V4, P5, DOI 10.1186/1743-8454-4-5; Miller JM, 2006, BRAIN RES, V1075, P36, DOI 10.1016/j.brainres.2005.12.094; Min KJ, 2006, J NEUROSCI, V26, P1880, DOI 10.1523/JNEUROSCI.3696-05.2006; Miyoshi K, 2008, J NEUROSCI, V28, P12775, DOI 10.1523/JNEUROSCI.3512-08.2008; Nagra G, 2008, AM J PHYSIOL-REG I, V294, pR1752, DOI 10.1152/ajpregu.00748.2007; Oreskovic D, 2011, PROG NEUROBIOL, V94, P238, DOI 10.1016/j.pneurobio.2011.05.005; Oreskovic D, 2010, BRAIN RES REV, V64, P241, DOI 10.1016/j.brainresrev.2010.04.006; Paul L, 2011, NEUROSURGERY, V68, P462, DOI 10.1227/NEU.0b013e3182011860; Ricci G, 2009, J BIOL PHYS, V35, P317, DOI 10.1007/s10867-009-9157-9; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Schipke CG, 2001, FASEB J, V15, P255, DOI 10.1096/fj.01-0514fje; Schmitz T, 2007, PEDIATR RES, V61, P722, DOI 10.1203/pdr.0b013e31805341f1; Siopi E, 2011, J NEUROTRAUM, V28, P2135, DOI 10.1089/neu.2010.1738; Sival Deborah A, 2008, Cerebrospinal Fluid Res, V5, P21, DOI 10.1186/1743-8454-5-21; Slobodian Ili, 2007, Cerebrospinal Fluid Res, V4, P9, DOI 10.1186/1743-8454-4-9; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; Verderio C, 2001, J IMMUNOL, V166, P6383, DOI 10.4049/jimmunol.166.10.6383; Voskuhl RR, 2009, J NEUROSCI, V29, P11511, DOI 10.1523/JNEUROSCI.1514-09.2009; Wu JM, 2009, NEUROL RES, V31, P183, DOI 10.1179/174313209X385680; Xue MZ, 2010, AM J PATHOL, V176, P1193, DOI 10.2353/ajpath.2010.090361; YAMADA H, 1992, J NEUROSURG, V76, P856, DOI 10.3171/jns.1992.76.5.0856; Yuan WH, 2010, FLUIDS BARRIERS CNS, V7, DOI 10.1186/1743-8454-7-19	65	23	25	0	16	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	AUG 30	2012	218						317	325		10.1016/j.neuroscience.2012.05.004			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	058CY	WOS:000312612900030	22583796				2022-02-06	
J	Lefebvre, H; Levert, MJ				Lefebvre, Helene; Levert, Marie-Josee			The close relatives of people who have had a traumatic brain injury and their special needs	BRAIN INJURY			English	Article						Caregivers needs; services; continuum of care; brain injury; developing reflexive analysis for partnership; qualitative research	INDIVIDUALS; EXPERIENCES; FAMILIES; CARERS	Primary objective: This study aims to paint a picture of the needs of people close to individuals with a TBI and the services offered to answer these needs, from the point of view of the individuals with a TBI and health professionals. Research design: This study has a qualitative design and a reflexive group was used to collect data. The demarche reflexive d'analyse en partenariat, DRAP (developing reflexive analysis for partnership) was used as a data collection method. The sample comprised Montreal family members (n = 4), Outaouais family members (n = 8), Abitibi family members (n = 7); Montreal care providers (n = 9), Outaouais care providers (n = 11) and Abitibi care providers (n = 9). Main outcomes and results: The results show that people close to individuals with a TBI need information on the health problem, specifically with regard to the diagnostic, the prognostic, and the factors that influence it, as well as the steps towards rehabilitation, and care and services. The results show that close ones need specific, quality services and continuity of services. Conclusion: In conclusion, the pertinence of this study lies in the desire of close ones and health professionals to ease the adaptation process imposed by a TBI, and to promote the well-being of informal caregivers.	[Lefebvre, Helene; Levert, Marie-Josee] Univ Montreal, Fac Nursing, Montreal, PQ H3C 3J7, Canada; [Lefebvre, Helene; Levert, Marie-Josee] Montreal Ctr Interdisciplinary Res Rehabil CRIR, Montreal, PQ, Canada; [Lefebvre, Helene; Levert, Marie-Josee] Hop Sacre Coeur, Res Ctr, Montreal, PQ H4J 1C5, Canada; [Lefebvre, Helene; Levert, Marie-Josee] Grp Interreseaux Rech Adaptat Famille & Son Envir, Montreal, PQ, Canada		Lefebvre, H (corresponding author), Univ Montreal, Fac Nursing, Box 6128,Downtown Stn, Montreal, PQ H3C 3J7, Canada.	helene.lefebvre@umontreal.ca			Consortium en traumatologie du Quebec (FRSQ)	This study was supported by the Consortium en traumatologie du Quebec (FRSQ).	Agence Nationale d'Accreditation: Et d'Evaluation en Sante, 2005, SORT MOND RET DOM PE; Baribeau C., 1996, REV SCI ED, V22, P577; Bond A Elaine, 2003, Crit Care Nurse, V23, P63; Boudreault P., 2006, ANIMATION GROUPES DE; Carriere M, 2005, ANAL COUT EFFICACITE; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; Duchesne S., 2005, ENTRETIEN COLLECTIF; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Fallowfield LJ, 2002, PALLIATIVE MED, V16, P297, DOI 10.1191/0269216302pm575oa; Gervais M, 1999, ETUDE EXPLORATOIRE B; Guba EG., 1989, 4 GENERATION EVALUAT; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Krueger KA, 1994, FOCUS GROUP PRACTICA; Lawlor MC, 1998, AM J OCCUP THER, V52, P259, DOI 10.5014/ajot.52.4.259; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Lefebvre H, 2004, PARTICIPATION SOCIAL; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Man DWK, 2002, BRAIN INJURY, V16, P1025, DOI 10.1080/0269905021000010087; Mayer R, 2000, DROPPED REF, P159; McLennan M, 1996, PATIENT EDUC COUNS, V27, P191, DOI 10.1016/0738-3991(95)00799-7; Ministere de la Sante: des Services Sociaux, 1999, PAR ORG; MUCHIELLI A, 1996, DICT METHODES QUALIT; Nolte ML, 1999, DISSERTATION ABSTR I, V60, P4900; O'Connell Bev, 2004, Int J Nurs Pract, V10, P121, DOI 10.1111/j.1440-172X.2004.00469.x; Paterson BL, 2001, METASTUDY QUALITATIV; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; PIRES A, 1997, RECHERCHE QUALITATIV, P173; Poupart J, 1997, ENJEUX EPISTEMOLOGIQ; Sinnakaruppan I, 2001, BRAIN INJURY, V15, P653; Strauss A., 1990, BASICS QUALITATIVE R; TOCHON Francois V., 1996, REV SCI ED, V22, P467, DOI DOI 10.7202/031889AR; Wiles R, 1998, J ADV NURS, V28, P794, DOI 10.1046/j.1365-2648.1998.00709.x	32	23	23	0	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2012	26	9					1084	1097		10.3109/02699052.2012.666364			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	971GI	WOS:000306191400005	22624724				2022-02-06	
J	Belanger, HG; Vanderploeg, RD; Soble, JR; Richardson, M; Groer, S				Belanger, Heather G.; Vanderploeg, Rodney D.; Soble, Jason R.; Richardson, Matthew; Groer, Shirley			Validity of the Veterans Health Administration's Traumatic Brain Injury Screen	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain concussion; Brain injuries; Diagnosis; Mass screening; Rehabilitation; Veterans Affairs (US)	CARE	Belanger HG, Vanderploeg RD, Sob le JR, Richardson M, Groer S. Validity of the Veterans Health Administration's traumatic brain injury screen. Arch Phys Med Rehabil 2012;93:1234-9. Objective: To compare the results of Veterans Affairs' (VA's) initial traumatic brain injury (TBI) Clinical Reminder Screen with the more extensive second-level Comprehensive TBI Evaluation in a national sample. Design: Criterion-standard. Setting: Veterans Health Administration system of polytrauma care. Participants: The data were from VA's centralized database Patient Care Services on the TBI Clinical Reminder Screen and Comprehensive TBI Evaluation results of veterans (N=48,175). Interventions: None. Main Outcome Measures: Sensitivity, specificity, positive predictive value, and negative predictive value of the TBI Clinical Reminder Screen were calculated by using the Comprehensive TBI Evaluation findings as the comparative standard for TBI confirmation. Results: The TBI Clinical Reminder Screen has generally good sensitivity (.87-.90) but poor specificity (.13-.18). In addition, the TBI Clinical Reminder Screen, when compared with the Comprehensive TBI Evaluation by a clinician, has generally poor negative predictive power (.31-.49) in this sample. However, negative predictive power is good with an estimated Veterans Health Administration system-wide TBI prevalence rate of 15% (.89). Positive predictive power was acceptable (.77) in this sample. The screen performs comparably across patient demographic and symptom severity characteristics, as well as across level of polytrauma care. Systematic evaluations by clinicians primarily reveal mental health perceived causes of ongoing symptoms. Conclusions: In summary, VA's Clinical Reminder Screen, when evaluated against the follow-up Comprehensive TBI Evaluation, has good sensitivity but poor specificity.	[Belanger, Heather G.] James A Haley Vet Hosp, Psychol Serv 116B, Dept Mental Hlth & Behav Sci, Tampa, FL 33612 USA; [Belanger, Heather G.; Vanderploeg, Rodney D.; Richardson, Matthew; Groer, Shirley] James A Haley Vet Hosp, HSR&D RR&D Ctr Excellence Maximizing Rehabil Outc, Tampa, FL 33612 USA; [Belanger, Heather G.; Vanderploeg, Rodney D.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Vanderploeg, Rodney D.] Univ S Florida, Dept Psychiat, Tampa, FL USA; [Belanger, Heather G.; Vanderploeg, Rodney D.] Def & Vet Brain Injury Ctr, Tampa, FL USA		Belanger, HG (corresponding author), James A Haley Vet Hosp, Psychol Serv 116B, Dept Mental Hlth & Behav Sci, Tampa, FL 33612 USA.	Heather.Belanger@va.gov			Department of Veterans Affairs, Veterans Health Administration, through SDR HSR&D, Screening Instruments and ProcessesUS Department of Veterans Affairs [08-411-TBI]; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs; James A. Haley Veterans' HospitalUS Department of Veterans Affairs	Supported by the Department of Veterans Affairs, Veterans Health Administration, through SDR HSR&D (no. 08-411-TBI) Screening Instruments and Processes, and the Defense and Veterans Brain Injury Center. Further support was provided by the James A. Haley Veterans' Hospital. The views expressed herein are those of the authors and do not necessarily reflect the views or the official policy of the Department of Army. Department of Defense, Department of Veterans Affairs, or US Government.	Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Fleiss J.L., 1981, STAT METHODS RATES P; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Grimes DA, 2002, LANCET, V359, P881, DOI 10.1016/S0140-6736(02)07948-5; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Terrio HP, 2011, REHABIL PSYCHOL, V56, P26, DOI 10.1037/a0022685; Van Dyke SA, 2010, MIL MED, V175, P947, DOI 10.7205/MILMED-D-10-00337	13	23	23	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUL	2012	93	7					1234	1239		10.1016/j.apmr.2012.03.003			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	971MU	WOS:000306208800018	22426242				2022-02-06	
J	Grinsell, MM; Butz, K; Gurka, MJ; Gurka, KK; Norwood, V				Grinsell, Matthew M.; Butz, Kirsten; Gurka, Matthew J.; Gurka, Kelly K.; Norwood, Victoria			Sport-Related Kidney Injury Among High School Athletes	PEDIATRICS			English	Article						kidney; sports; wounds and injuries	AMERICAN FOOTBALL; BRAIN-INJURY; PARTICIPATION; PATTERNS; CHILDREN	BACKGROUND AND OBJECTIVE: The American Academy of Pediatrics recommends a "qualified yes" for participation by athletes with single kidneys in contact/collision sports. Despite this recommendation, most physicians continue to discourage participation in contact/collision sports for patients with single kidneys. A major concern is the lack of prospective data quantifying the incidence of sport-related kidney injury. The objective was to quantify the incidence of sport-related kidney injury among high school varsity athletes and compare it with sport-related injuries of other organ systems. METHODS: Data from the National Athletic Trainers' Association High School Injury Surveillance Study, an observational cohort study collected during the 1995-1997 academic years, were used. Incidence rates for sport-specific injuries to select organs were computed and compared. RESULTS: Over 4.4 million athlete-exposures, defined as 1 athlete participating in 1 game or practice, and 23 666 injuries were reported. Eighteen kidney injuries, none of which were catastrophic or required surgery, were reported compared with 3450 knee, 2069 head/neck/spine, 1219 mild traumatic brain, 148 eye, and 17 testicle injuries. Student athletes incurring kidney injuries were most often playing football (12 injuries) or girls' soccer (2 injuries). Sport-specific rates of kidney injury were significantly lower than sport-specific rates of mild traumatic brain, head/neck/spine, and knee injuries for all sports as well as rates of baseball-and basketball-specific eye injuries (P < .01). CONCLUSIONS: Kidney injuries occur significantly less often than other injuries during sport. These data do not support limiting sport participation by athletes with single kidneys. Pediatrics 2012;130:e40-e45	[Grinsell, Matthew M.] Univ Utah, Sch Med, Dept Pediat, Div Nephrol & Hypertens, Salt Lake City, UT 84132 USA; [Butz, Kirsten] Univ Virginia, Dept Psychiat & Neurobehav Sci, Charlottesville, VA USA; [Gurka, Matthew J.; Norwood, Victoria] Univ Virginia, Dept Pediat, Charlottesville, VA USA; [Gurka, Matthew J.; Gurka, Kelly K.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Gurka, Matthew J.; Gurka, Kelly K.] W Virginia Univ, Dept Community Med, Morgantown, WV 26506 USA; [Gurka, Kelly K.] W Virginia Univ, Injury Control Res Ctr, Morgantown, WV 26506 USA		Grinsell, MM (corresponding author), Univ Utah, Sch Med, Dept Pediat, Div Nephrol & Hypertens, 30 North 1900 East,Room 2A100, Salt Lake City, UT 84132 USA.	matt.grinsell@hsc.utah.edu	Gurka, Kelly K./M-2004-2014	Gurka, Kelly K./0000-0003-2779-3234	NATA Research and Education Foundation; National Athletic Trainers' Association	Research support was provided by a grant from the NATA Research and Education Foundation.; We extend our sincere thanks to John Powell, PhD, as well as to the National Athletic Trainers' Association for their support of this project.	Anderson C R, 1995, Arch Fam Med, V4, P885, DOI 10.1001/archfami.4.10.885; Bailey R, 2006, J SCHOOL HEALTH, V76, P397, DOI 10.1111/j.1746-1561.2006.00132.x; Bonett DG, 2006, STAT MED, V25, P3039, DOI 10.1002/sim.2440; Brophy RH, 2008, AM J SPORT MED, V36, P85, DOI 10.1177/0363546507308940; Cantu RC, 2003, NEUROSURGERY, V53, P358, DOI 10.1227/01.NEU.0000073422.01886.88; Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4; DORSEN PJ, 1986, PHYSICIAN SPORTSMED, V14, P130, DOI 10.1080/00913847.1986.11709129; Eisenmann JC, 2005, AM HEART J, V149, P46, DOI 10.1016/j.ahj.2004.07.016; Grinsell MM, 2006, PEDIATRICS, V118, P1019, DOI 10.1542/peds.2006-0663; Johnson B, 2005, J UROLOGY, V174, P686, DOI 10.1097/01.ju.0000164719.91332.42; Krasnow S, 1990, SPORTS ILLUSTRA 0507, P1; Pate RR, 2000, ARCH PEDIAT ADOL MED, V154, P904, DOI 10.1001/archpedi.154.9.904; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Powell JW, 1999, J ATHL TRAINING, V34, P277; Powell JW, 2000, AM J SPORT MED, V28, P385, DOI 10.1177/03635465000280031801; Psooy Karen, 2006, Can J Urol, V13, P3120; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; RISSER WL, 1994, PEDIATRICS, V94, P757; Robson W L, 1995, Adv Pediatr, V42, P575; Salem Hosni Khairy, 2007, J Pediatr Urol, V3, P223, DOI 10.1016/j.jpurol.2006.07.006; Sharp DS, 2002, J UROLOGY, V168, P1811, DOI 10.1016/S0022-5347(05)64420-5; Spruijt-Metz D, 2011, J RES ADOLESCENCE, V21, P129, DOI 10.1111/j.1532-7795.2010.00719.x; Stokes ME, 2000, CATEGORICAL DATA ANA; Wan J, 2003, J UROLOGY, V170, P1525, DOI 10.1097/01.ju.0000084430.96658.05; Washington RL, 2001, PEDIATRICS, V107, P1205; WICHMANN S, 1992, PHYSICIAN SPORTSMED, V20, P176, DOI 10.1080/00913847.1992.11947420	26	23	24	0	6	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	JUL	2012	130	1					E40	E45		10.1542/peds.2011-2082			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	967KH	WOS:000305905900006	22711726				2022-02-06	
J	Lei, BL; Mace, B; Bellows, ST; Sullivan, PM; Vitek, MP; Laskowitz, DT; James, ML				Lei, Beilei; Mace, Brian; Bellows, Steven T.; Sullivan, Patrick M.; Vitek, Michael P.; Laskowitz, Daniel T.; James, Michael L.			Interaction Between Sex and Apolipoprotein E Genetic Background in a Murine Model of Intracerebral Hemorrhage	TRANSLATIONAL STROKE RESEARCH			English	Article						Apolipoprotein E; Sex differences; Murine; Intracerebral hemorrhage; Female	TRAUMATIC BRAIN-INJURY; MELBOURNE STROKE INCIDENCE; CLOSED-HEAD INJURY; APOE GENOTYPE; ISCHEMIC-STROKE; CASE-FATALITY; GENDER; MORTALITY; PEPTIDE; INFLAMMATION	Emerging evidence suggests sex and apolipoprotein E (APOE) genotype separately modify outcomes after intracerebral hemorrhage (ICH). We test the hypothesis that an interaction exists between sex and APOE polymorphism in modifying outcomes after ICH and is altered by administration of exogenous apoE-mimetic peptide. To define the effects of sex and APOE polymorphism in ICH, we created collagenase-induced ICH in male and female APOETR mice (targeted replacement mice homozygous for APOE3 or APOE4 alleles; n=12/group) and assessed performance on Rotarod (RR) and Morris water maze (MWM). To evaluate hematoma formation, we used hematoxylin and eosin staining at 24 h after injury (n=8/group). Using separate cohorts (n=12/group), apoE-mimetic peptide (COG1410 at 2 mg/kg) was administered after ICH, and mice were assessed by RR and MWM. Female mice outperformed male mice via RR and MWM by over 190% improvement through 7 days (RR) and 32 days (MWM) of testing after ICH (p<0.01). Female APOE3TR mice demonstrated improved function compared with all other groups (p<0.05) without any difference in hematoma volume at 24 h after injury in any group. Administration of a therapeutic apoE-mimetic peptide improved RR latencies through 7 days after ICH in male and female APOE4TR mice and MWM latencies over days 28-32 after ICH in male APOE4TR mice (p<0.05). Sex and APOE polymorphism influence functional outcomes in our murine model of ICH. Moreover, administration of exogenous apoE-mimetic peptide after injury differentially modifies the interaction between sex and APOE polymorphism.	[Bellows, Steven T.; Laskowitz, Daniel T.; James, Michael L.] Duke Univ, Dept Med Neurol, Durham, NC USA; [Lei, Beilei; Laskowitz, Daniel T.; James, Michael L.] Duke Univ, Multidisciplinary Neuroprotect Labs, Durham, NC USA; [Lei, Beilei; Laskowitz, Daniel T.; James, Michael L.] Duke Univ, Dept Anesthesiol, Durham, NC USA; [Mace, Brian; Sullivan, Patrick M.] Duke Univ, Dept Geriatr Med, Durham, NC USA; [Mace, Brian; Sullivan, Patrick M.] Durham Vet Affairs, Geriatr Res Educ & Clin Ctr, Durham, NC USA; [Laskowitz, Daniel T.] Duke Univ, Dept Neurobiol, Durham, NC USA; [Vitek, Michael P.] Cognosci Inc, Durham, NC USA		James, ML (corresponding author), Duke Univ, Dept Med Neurol, Durham, NC USA.	michael.james@duke.edu	James, Michael L./AAJ-5592-2020	James, Michael L./0000-0002-8715-5210; Vitek, Michael/0000-0001-8140-8048; Mace, Brian/0000-0002-5478-6227	American Heart Association Scientist Development GrantAmerican Heart Association; Foundation for Anesthesia Education and Research Mentored Research Training Grant	This project was funded by grants from the American Heart Association Scientist Development Grant and Foundation for Anesthesia Education and Research Mentored Research Training Grant (MLJ). Dr. Laskowitz has previously served as a consultant for Cognosci, Inc. Dr. Vitek is Chief Executive Officer of Cognosci, Inc. COG1410 was provided by Cognosci, Inc.	ALBERTS MJ, 1995, LANCET, V346, P575, DOI 10.1016/S0140-6736(95)91411-0; Appelros P, 2009, STROKE, V40, P1082, DOI 10.1161/STROKEAHA.108.540781; ATTELLA MJ, 1987, BEHAV NEURAL BIOL, V48, P352, DOI 10.1016/S0163-1047(87)90918-6; Brait VH, 2010, J CEREBR BLOOD F MET, V30, P1306, DOI 10.1038/jcbfm.2010.14; Broderick JP, 1999, STROKE, V30, P905, DOI 10.1161/01.STR.30.4.905; Cadilhac DA, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-49; Caligioni CS., 2009, CURR PROTOC NEUROSCI; Christensen DJ, 2011, J IMMUNOL, V186, P2535, DOI 10.4049/jimmunol.1002847; Colton CA, 2005, NEUROBIOL AGING, V26, P363, DOI 10.1016/j.neurobiolaging.2004.08.001; De Silva TM, 2009, STROKE, V40, P1091, DOI 10.1161/STROKEAHA.108.531707; Diringer MN, 1998, STROKE, V29, P1352, DOI 10.1161/01.STR.29.7.1352; Gao J, 2006, NEUROCRIT CARE, V4, P25, DOI 10.1385/NCC:4:1:025; Gromadzka G, 2007, ACTA NEUROL SCAND, V116, P392, DOI 10.1111/j.1600-0404.2007.00880.x; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Holscher C, 1999, BEHAV BRAIN RES, V100, P225, DOI 10.1016/S0166-4328(98)00134-X; James ML, 2009, J STROKE CEREBROVASC, V18, P144, DOI 10.1016/j.jstrokecerebrovasdis.2008.09.012; James ML, 2009, STROKE, V40, P632, DOI 10.1161/STROKEAHA.108.530402; James ML, 2008, NEUROCRIT CARE, V9, P139, DOI 10.1007/s12028-007-9030-2; Khan FA, 2005, NEUROEPIDEMIOLOGY, V24, P26, DOI 10.1159/000081046; Kimura Y, 1998, INTERNAL MED, V37, P736, DOI 10.2169/internalmedicine.37.736; Labovitz DL, 2005, NEUROLOGY, V65, P518, DOI 10.1212/01.wnl.0000172915.71933.00; Laskowitz DT, 2006, ACTA NEUROL SCAND, V114, P15, DOI 10.1111/j.1600-0404.2006.00680.x; Laskowitz DT, 2007, J NEUROTRAUM, V24, P1093, DOI 10.1089/neu.2006.0192; Laskowitz DT, 2012, NEUROCRIT CARE, V16, P316, DOI 10.1007/s12028-011-9641-5; Laskowitz DT, 2010, J NEUROTRAUM, V27, P1983, DOI 10.1089/neu.2010.1396; Laskowitz DT, 2001, EXP NEUROL, V167, P74, DOI 10.1006/exnr.2001.7541; Liu MY, 2008, J NEUROSCI METH, V171, P214, DOI 10.1016/j.jneumeth.2008.03.002; Liu MY, 2009, RESTOR NEUROL NEUROS, V27, P163, DOI 10.3233/RNN-2009-0467; Liu MY, 2007, J CEREBR BLOOD F MET, V27, P135, DOI 10.1038/sj.jcbfm.9600331; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; McCarron MO, 2003, ACTA NEUROL SCAND, V107, P106, DOI 10.1034/j.1600-0404.2003.01365.x; McCarron MO, 1999, NEUROLOGY, V53, P2176, DOI 10.1212/WNL.53.9.2176; Misra UK, 2001, J LEUKOCYTE BIOL, V70, P677; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nakamura T, 2004, J CEREBR BLOOD F MET, V24, P487, DOI 10.1097/00004647-200405000-00002; Ost M, 2008, ACTA ANAESTH SCAND, V52, P1364, DOI 10.1111/j.1399-6576.2008.01675.x; Qureshi AI, 1999, CRIT CARE MED, V27, P480, DOI 10.1097/00003246-199903000-00021; ROOF RL, 1993, BEHAV BRAIN RES, V57, P47, DOI 10.1016/0166-4328(93)90060-4; ROSENBERG GA, 1990, ACT NEUR S, V51, P280; Sacco RL, 1998, AM J EPIDEMIOL, V147, P259, DOI 10.1093/oxfordjournals.aje.a009445; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Thrift AG, 2009, NEUROEPIDEMIOLOGY, V32, P11, DOI 10.1159/000170086; Tlaskowitz D, 2007, PHARMACOGENOMICS, V8, P959, DOI 10.2217/14E22416.8.8.959; Tzourio C, 2008, NEUROLOGY, V70, P1322, DOI 10.1212/01.wnl.0000308819.43401.87; Vaartjes I, 2009, CEREBROVASC DIS, V28, P564, DOI 10.1159/000247600; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Vemmos KN, 1999, STROKE, V30, P363, DOI 10.1161/01.STR.30.2.363; Wang H, 2007, NEUROSCIENCE, V144, P1324, DOI 10.1016/j.neuroscience.2006.11.017; Woo D, 2005, STROKE, V36, P1874, DOI 10.1161/01.STR.0000177891.15082.b9; Zhang LF, 2003, STROKE, V34, P2091, DOI 10.1161/01.STR.0000087149.42294.8C; Zia E, 2009, STROKE, V40, P3567, DOI 10.1161/STROKEAHA.109.556324	51	23	24	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1868-4483	1868-601X		TRANSL STROKE RES	Transl. Stroke Res.	JUL	2012	3			1	SI		S94	S101		10.1007/s12975-012-0176-7			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	961AT	WOS:000305436500012	23935764	Green Accepted			2022-02-06	
J	Lee, CY; Jaw, T; Tseng, HC; Chen, IC; Liou, HH				Lee, Chun-Yao; Jaw, Thomas; Tseng, Huan-Chin; Chen, I-Chun; Liou, Horng-Huei			Lovastatin Modulates Glycogen Synthase Kinase-3 beta Pathway and Inhibits Mossy Fiber Sprouting after Pilocarpine-Induced Status Epilepticus	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; GRANULE CELL DISPERSION; TRAUMATIC BRAIN-INJURY; HIPPOCAMPAL SEIZURES; RAT HIPPOCAMPUS; DENTATE GYRUS; STATINS; MODEL; PHOSPHORYLATION; NEUROGENESIS	This study was undertaken to assay the effect of lovastatin on the glycogen synthase kinase-3 beta (GSK-3 beta) and collapsin responsive mediator protein-2 (CRMP-2) signaling pathway and mossy fiber sprouting (MFS) in epileptic rats. MFS in the dentate gyrus (DG) is an important feature of temporal lobe epilepsy (TLE) and is highly related to the severity and the frequency of spontaneous recurrent seizures. However, the molecular mechanism of MFS is mostly unknown. GSK-3 beta and CRMP-2 are the genes responsible for axonal growth and neuronal polarity in the hippocampus, therefore this pathway is a potential target to investigate MFS. Pilocarpine-induced status epilepticus animal model was taken as our researching material. Western blot, histological and electrophysiological techniques were used as the studying tools. The results showed that the expression level of GSK-3 beta and CRMP-2 were elevated after seizure induction, and the administration of lovastatin reversed this effect and significantly reduced the extent of MFS in both DG and CA3 region in the hippocampus. The alteration of expression level of GSK-3 beta and CRMP-2 after seizure induction proposes that GSK-3 beta and CRMP-2 are crucial for MFS and epiletogenesis. The fact that lovastatin reversed the expression level of GSK-3 beta and CRMP-2 indicated that GSK-3 beta and CRMP-2 are possible to be a novel mechanism of lovatstain to suppress MFS and revealed a new therapeutic target and researching direction for studying the mechanism of MFS and epileptogenesis.	[Liou, Horng-Huei] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Lee, Chun-Yao; Jaw, Thomas; Tseng, Huan-Chin; Chen, I-Chun; Liou, Horng-Huei] Natl Taiwan Univ, Coll Med, Dept Pharmacol, Taipei 10764, Taiwan		Lee, CY (corresponding author), Coll France, Ctr Interdisciplinaire Rech Biol, UMR CNRS 7241, INSERM U1050, F-75231 Paris, France.	hhl@ntu.edu.tw		Liou, Horng-Huei/0000-0001-6537-5346	National Science Council Taipei, TaiwanMinistry of Science and Technology, Taiwan [NSC 96-2323-B-002-014]	This work was supported by the National Science Council (NSC 96-2323-B-002-014) Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo JC, 2005, CURR OPIN CELL BIOL, V17, P112, DOI 10.1016/j.ceb.2005.01.004; Bagetta G, 2002, BIOCHEM BIOPH RES CO, V291, P255, DOI 10.1006/bbrc.2002.6424; Buckmaster PS, 2009, J NEUROSCI, V29, P8259, DOI 10.1523/JNEUROSCI.4179-08.2009; Calabresi P, 2003, ANN NEUROL, V53, P693, DOI 10.1002/ana.10603; Chang BS, 2003, NEW ENGL J MED, V349, P1257, DOI 10.1056/NEJMra022308; Cilio MR, 2003, EPILEPSIA, V44, P518, DOI 10.1046/j.1528-1157.2003.48802.x; De Simoni MG, 2000, EUR J NEUROSCI, V12, P2623, DOI 10.1046/j.1460-9568.2000.00140.x; Dudek FE, 2011, NEUROSCI LETT, V497, P240, DOI 10.1016/j.neulet.2011.03.071; Fahrner A, 2007, EXP NEUROL, V203, P320, DOI 10.1016/j.expneurol.2006.08.023; George SJ, 2002, AM J CARDIOL, V90, P1237, DOI 10.1016/S0002-9149(02)02841-2; Gobbo OL, 2004, NEUROSCIENCE, V125, P317, DOI 10.1016/j.neuroscience.2004.01.045; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Graber KD, 2004, ANN NEUROL, V55, P860, DOI 10.1002/ana.20124; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Han Y, 2005, BIOCHEM BIOPH RES CO, V327, P431, DOI 10.1016/j.bbrc.2004.12.028; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Kuo LW, 2008, NEUROIMAGE, V41, P789, DOI 10.1016/j.neuroimage.2008.03.013; Lee CY, 2009, BRIT J PHARMACOL, V158, P1753, DOI 10.1111/j.1476-5381.2009.00463.x; Lee JK, 2008, NEUROSCI LETT, V440, P260, DOI 10.1016/j.neulet.2008.05.112; Leite JP, 2002, EPILEPSY RES, V50, P93, DOI 10.1016/S0920-1211(02)00072-4; Longo BM, 1999, EPILEPSY RES, V36, P233, DOI 10.1016/S0920-1211(99)00054-6; Lynch M, 2000, J NEUROPHYSIOL, V83, P693, DOI 10.1152/jn.2000.83.2.693; McKenney JM, 2003, ANN PHARMACOTHER, V37, P1063, DOI 10.1345/aph.1C499; Nadler JV, 2003, NEUROCHEM RES, V28, P1649, DOI 10.1023/A:1026004904199; Planavila A, 2008, BBA-MOL CELL BIOL L, V1781, P26, DOI 10.1016/j.bbalip.2007.10.009; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Scharfman HE, 2000, J NEUROSCI, V20, P6144, DOI 10.1523/JNEUROSCI.20-16-06144.2000; Sironi L, 2003, ARTERIOSCL THROM VAS, V23, P322, DOI 10.1161/01.ATV.0000044458.23905.3B; Sutula T, 1996, J NEUROSCI, V16, P7398; Sutula Thomas, 2002, Epilepsy Curr, V2, P86, DOI 10.1046/j.1535-7597.2002.00032.x; Suzuki F, 2005, EPILEPSIA, V46, P193, DOI 10.1111/j.0013-9580.2005.35504.x; Takei Y, 2001, BRAIN DEV-JPN, V23, P406, DOI 10.1016/S0387-7604(01)00253-4; Takemiya T, 2003, PROSTAG OTH LIPID M, V71, P205, DOI 10.1016/S1098-8823(03)00040-6; Vaughan CJ, 2001, CNS DRUGS, V15, P589, DOI 10.2165/00023210-200115080-00002; Williams PA, 2002, J NEUROPHYSIOL, V88, P2075, DOI 10.1152/jn.2002.88.4.2075; Wu HT, 2008, J NEUROSURG, V109, P691, DOI 10.3171/JNS/2008/109/10/0691; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Xie CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024966; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zacco A, 2003, J NEUROSCI, V23, P11104	40	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e38789	10.1371/journal.pone.0038789			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	WOS:000305808700011	22761705	Green Published, gold			2022-02-06	
J	Chao, PK; Lu, KT; Jhu, JY; Wo, YYP; Huang, TC; Ro, LS; Yang, YL				Chao, Po-Kuan; Lu, Kwok-Tung; Jhu, Ji-Yi; Wo, Yu-Yuan Peter; Huang, Tai-Chun; Ro, Long-Sun; Yang, Yi-Ling			Indomethacin protects rats from neuronal damage induced by traumatic brain injury and suppresses hippocampal IL-1 beta release through the inhibition of Nogo-A expression	JOURNAL OF NEUROINFLAMMATION			English	Article						Nogo-A; Traumatic brain injury; Inflammation; IL-1 beta	CLOSED-HEAD INJURY; INTERLEUKIN-1 RECEPTOR ANTAGONIST; MONOCLONAL-ANTIBODY IN-1; SPINAL-CORD-INJURY; ADULT-RAT; INTRACRANIAL-PRESSURE; AXONAL REGENERATION; NERVOUS-SYSTEM; INFLAMMATION; MICE	Background: Nogo-A is a member of the reticulon family of membrane-associated proteins and plays an important role in axonal remodeling. The present study aimed to investigate alterations in Nogo-A expression following traumatic brain injury (TBI)-induced inflammation and neuronal damage. Methods: A weight-drop device was used to deliver a standard traumatic impact to rats. Western blot, RT-PCR and ELISA were used to analyze the expression of Nogo-A and IL-1 beta. Nogo-A antisense, and an irrelevant control oligonucleotide was intracerebroventricularly infused. We also performed H & E staining and luxol fast blue staining to evaluate the neuronal damage and demyelination resulting from TBI and various treatments. Results: Based on RT-PCR and western blot analyses, the expression of Nogo-A was found to be significantly upregulated in the hippocampus beginning eight hours after TBI. In addition, TBI caused an apparent elevation in IL-1 beta levels and severe neuronal damage and demyelination in the tested animals. All of the TBI-associated molecular and cellular consequences could be effectively reversed by treating the animals with the anti-inflammatory drug indomethacin. More importantly, the TBI-associated stimulation in the levels of both Nogo-A and IL-1 beta could be effectively inhibited by a specific Nogo-A antisense oligonucleotide. Conclusions: Our findings suggest that the suppression of Nogo-A expression appears to be an early response conferred by indomethacin, which then leads to decreases in the levels of IL-1 beta and TBI-induced neuron damage.	[Jhu, Ji-Yi; Wo, Yu-Yuan Peter; Yang, Yi-Ling] Natl Chia Yi Univ, Inst Biochem Sci & Technol, Chiayi, Taiwan; [Chao, Po-Kuan; Lu, Kwok-Tung; Huang, Tai-Chun] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Ro, Long-Sun] Chang Gung Mem Hosp, Dept Neurol, Taipei 10591, Taiwan; [Ro, Long-Sun] Chang Gung Univ, Taipei 10591, Taiwan		Yang, YL (corresponding author), Natl Chia Yi Univ, Inst Biochem Sci & Technol, 300 Univ Rd, Chiayi, Taiwan.	ylyang@mail.ncyu.edu.tw			National Science Council, TaiwanMinistry of Science and Technology, Taiwan [NSC 97-2320-B-415-006-MY3, 97-2320-B-003-001-MY3, 100-2320-B-003-004]; National Taiwan Normal University	This work was supported by grants NSC 97-2320-B-415-006-MY3 (Y-LY) and 97-2320-B-003-001-MY3 (K-TL), 100-2320-B-003-004 (K-TL) from the National Science Council, Taiwan. The publication fee was supported by National Taiwan Normal University.	Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Butterworth RF, 2011, NEUROCHEM INT, V59, P830, DOI 10.1016/j.neuint.2011.07.014; Candelario-Jalil E, 2007, J PHARMACOL EXP THER, V323, P488, DOI 10.1124/jpet.107.127035; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Cheatwood JL, 2008, STROKE, V39, P2091, DOI 10.1161/STROKEAHA.107.507426; Chen H, 2005, J CEREBR BLOOD F MET, V25, P54, DOI 10.1038/sj.jcbfm.9600006; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Correale J, 2004, J NEUROL, V251, P1304, DOI 10.1007/s00415-004-0649-z; Czigner A, 2007, ACTA NEUROCHIR, V149, P281, DOI 10.1007/s00701-006-1095-8; David S, 2008, TRENDS NEUROSCI, V31, P221, DOI 10.1016/j.tins.2008.02.002; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Fry EJ, 2007, NEURON, V53, P649, DOI 10.1016/j.neuron.2007.02.009; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Hanell A, 2010, J NEUROTRAUM, V27, P1297, DOI 10.1089/neu.2009.1255; Huber AB, 2002, J NEUROSCI, V22, P3553; Hunt D, 2003, MOL CELL NEUROSCI, V24, P1083, DOI 10.1016/j.mcn.2003.09.002; Koprivica V, 2005, SCIENCE, V310, P106, DOI 10.1126/science.1115462; Kraus JF, 1996, OCCUP MED, V11, P201; Kunz T, 2002, J NEUROTRAUM, V19, P1051, DOI 10.1089/089771502760341965; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Lu KT, 2008, CRIT CARE MED, V36, P917, DOI 10.1097/CCM.0B013E31816590C4; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; Mackrell PJ, 2001, SURGERY, V130, P826, DOI 10.1067/msy.2001.116669; Marklund N, 2009, NEUROSCIENCE, V163, P540, DOI 10.1016/j.neuroscience.2009.06.042; Marklund N, 2007, J NEUROSURG, V107, P844, DOI 10.3171/JNS-07/10/0844; Markus TM, 2005, ANN NEUROL, V58, P950, DOI 10.1002/ana.20676; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; MAX W, 1990, INQUIRY-J HEALTH CAR, V27, P332; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Papadopoulos CM, 2006, CEREB CORTEX, V16, P529, DOI 10.1093/cercor/bhi132; Rothwell NJ, 1999, J PHYSIOL-LONDON, V514, P3, DOI 10.1111/j.1469-7793.1999.003af.x; Seymour AB, 2005, J CEREBR BLOOD F MET, V25, P1366, DOI 10.1038/sj.jcbfm.9600134; Slavik RS, 1999, NEUROL RES, V21, P491; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Tian DS, 2009, J NEUROCHEM, V109, P1658, DOI 10.1111/j.1471-4159.2009.06077.x; Tofteng F, 2004, J CEREBR BLOOD F MET, V24, P798, DOI 10.1097/01.WCB.0000125648.03213.1D; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Venkatesh K, 2005, J NEUROSCI, V25, P808, DOI 10.1523/JNEUROSCI.4464-04.2005; Wang H, 2006, BRAIN RES, V1114, P212, DOI 10.1016/j.brainres.2006.07.056; Yan ZP, 2004, CELL IMMUNOL, V232, P116, DOI 10.1016/j.cellimm.2005.03.001; Yuan RD, 2007, INT J OPHTHALMOL, V7, P354; Z'Graggen WJ, 2000, J NEUROSCI, V20, P6561, DOI 10.1523/JNEUROSCI.20-17-06561.2000; Zagrebelsky M, 2010, J NEUROSCI, V30, P13220, DOI 10.1523/JNEUROSCI.1044-10.2010	49	23	24	0	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	JUN 7	2012	9								121	10.1186/1742-2094-9-121			9	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	986SM	WOS:000307364900001	22676811	Green Published, gold			2022-02-06	
J	Eriksson, EA; Barletta, JF; Figueroa, BE; Bonnell, BW; Vanderkolk, WE; McAllen, KJ; Ott, MM				Eriksson, Evert A.; Barletta, Jeffrey F.; Figueroa, Bryan E.; Bonnell, Bruce W.; Vanderkolk, Wayne E.; McAllen, Karen J.; Ott, Mickey M.			Cerebral perfusion pressure and intracranial pressure are not surrogates for brain tissue oxygenation in traumatic brain injury	CLINICAL NEUROPHYSIOLOGY			English	Article						Trauma; pBtO(2); Traumatic brain injury; Brain tissue oxygenation; Intracranial pressure; Intracranial monitor; Cerebral perfusion pressure	SEVERE HEAD-INJURY; BLOOD-FLOW; AUTOREGULATION; REACTIVITY; TENSION; HYPOXIA; VOLUME; PO2	Objective: Utilization of brain tissue oxygenation (pBtO(2)) is an important but controversial variable in the treatment of traumatic brain injury (TBI). We evaluated the correlation between pBtO(2)/CPP and pBtO(2)/ICP and determined the parameter most closely related to survival. Methods: Consecutive, adult patients with severe TBI and pBtO(2) monitors were retrospectively identified. Time-indexed measurements of pBtO(2), CPP and ICP were collected and correlation coefficients were determined. Patients were then stratified according to survival and pBtO(2), CPP and ICP values were compared between groups. Results: There were 4169 time-indexed data points (i.e., pBtO(2) with respective CPP and ICP values) in 15 patients. The cohort consisted of a mean age of 37 +/- 17 years, ISS of 27 +/- 7 and GCS of 4.5 +/- 1.5. Survival was 53% (8/15). In a normal regression models, neither the ICP (p = 0.58) nor the CPP (p = 0.71) predict pBtO(2) significantly. There was a significant difference in pBtO(2) in survivors (31.5 +/- 3.1 vs. 25.2 +/- 4.8, p = 0.010) but not in CPP or ICP. Survivors had a lower proportion of time with pBtO(2) < 25 mmHg [20% (3.4-44.6) vs. 40% (16.2-89), p = 0.049]. In contrast, survivors had a greater proportion of time with CPP < 70 and no difference in the proportion of time with and ICP > 20. Conclusions: CPP and ICP should not be used as surrogates for pBtO(2) since cerebral oxygenation varies independently of cerebral hemodynamics and pressures. Brain tissue oxygen monitoring in patients with TBI provides unique information regarding cerebral oxygenation the utility of which remains to be fully described. Significance: CPP and ICP are not surrogates for pBtO(2). Brain tissue oxygenation monitoring provides unique information for the treatment of traumatically injured patients. (C) 2011 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Eriksson, Evert A.] Med Univ S Carolina, Dept Trauma Crit Care, GRMERC MSU Surg Crit Care, Charleston, SC 29425 USA; [Barletta, Jeffrey F.] Midwestern Univ, Coll Pharm Glendale, Dept Pharm Practice, Downers Grove, IL USA; [Ott, Mickey M.] Vanderbilt Univ, Dept Trauma, GRMERC MSU Surg Crit Care, Nashville, TN USA		Eriksson, EA (corresponding author), Med Univ S Carolina, Dept Trauma Crit Care, GRMERC MSU Surg Crit Care, 96 Jonathan Lucas St,Suite 420, Charleston, SC 29425 USA.	evsurgery@gmail.com	Barletta, Jeffrey F./B-2644-2013	Barletta, Jeffrey/0000-0002-9054-8218; Eriksson, Evert/0000-0002-4099-325X			Artru F, 1998, NEUROL RES, V20, pS48; Bardt TF, 1998, ACT NEUR S, V71, P153; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; Czosnyka M, 2003, ACT NEUR S, V86, P581; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Dings J, 1997, NEUROL RES, V19, P241, DOI 10.1080/01616412.1997.11740806; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hoelper BM, 2005, ACTA NEUROCHIR, V147, P767, DOI 10.1007/s00701-005-0512-8; Jaeger M, 2005, ACTA NEUROCHIR, V147, P51, DOI 10.1007/s00701-004-0408-z; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; Lang EW, 2003, CRIT CARE MED, V31, P267, DOI 10.1097/00003246-200301000-00042; LeRoux PD, 1997, J NEUROSURG, V87, P1, DOI 10.3171/jns.1997.87.1.0001; Sarrafzadeh A S, 2000, Neurosurg Focus, V9, pe2; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; Stiefel MF, 2006, J NEUROSURG, V105, P281, DOI 10.3171/ped.2006.105.4.281; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; van Santbrink H, 2003, ACTA NEUROCHIR, V145, P429, DOI 10.1007/s00701-003-0032-3; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007	28	23	24	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	JUN	2012	123	6					1255	1260		10.1016/j.clinph.2011.08.035			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	947QV	WOS:000304445500024	22104471				2022-02-06	
J	Fujii, D; Fujii, DC				Fujii, Daryl; Fujii, Daniel C.			Psychotic Disorder Due to Traumatic Brain Injury: Analysis of Case Studies in the Literature	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							SCHIZOPHRENIA-LIKE PSYCHOSIS; NEGATIVE SYMPTOMS; HEAD-INJURY; PSYCHIATRIC-DISORDERS; VISUAL HALLUCINATIONS; MENTAL-ILLNESS; RISK; METAANALYSIS; PATIENT; PREVALENCE	The present study utilized methodology from a previous descriptive study that analyzed case studies of psychotic disorder due to traumatic brain injury (PD-TBI) reported in psychiatry and neurology journals. The purpose was to replicate findings from the PD-TBI literature and to elucidate a pattern of characteristics that would differentiate PD-TBI from schizophrenia. The findings supported both objectives. PD-TBI data were highly consistent with previous studies: PD-TBI differed from schizophrenia in showing more focal frontal and temporal abnormalities on neurological studies and a lower rate of negative symptoms. The authors discuss implications of these findings for conceptualizing psychosis as a neurobiological syndrome. (The Journal of Neuropsychiatry and Clinical Neurosciences 2012; 24:278-289)			Fujii, D (corresponding author), Pacific Isl Hlth Care Syst Vet Affairs, Community Living Ctr, Honolulu, HI USA.	dfujii07@gmail.com					AbdelMalik P, 2003, ARCH GEN PSYCHIAT, V60, P231, DOI 10.1001/archpsyc.60.3.231; ACHTE K, 1991, PSYCHOPATHOLOGY, V24, P309, DOI 10.1159/000284731; ACHTE KA, 1969, ACTA PSYCHIAT SCAND, V45, P1, DOI 10.1111/j.1600-0447.1969.tb06197.x; Aleman A, 2003, ARCH GEN PSYCHIAT, V60, P565, DOI 10.1001/archpsyc.60.6.565; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; American Psychiatric Association, DIAGN STAT MAN MENT, V4a; Bennouna M, 2005, J CLIN PSYCHOPHARM, V25, P505, DOI 10.1097/01.jcp.0000177851.31157.66; Bloom KK, 1998, AM J PHYS MED REHAB, V77, P157, DOI 10.1097/00002060-199803000-00017; Bobes J, 2010, J CLIN PSYCHIAT, V71, P280, DOI 10.4088/JCP.08m04250yel; Boutros NN, 2008, SCHIZOPHR RES, V99, P225, DOI 10.1016/j.schres.2007.11.020; BREIER A, 1991, ARCH GEN PSYCHIAT, V48, P239; Burke JG, 1999, J PSYCHIATR NEUROSCI, V24, P456; Butler PV, 2000, AUST NZ J PSYCHIAT, V34, P684, DOI 10.1080/j.1440-1614.2000.00758.x; Campbell BA, 2011, J PEDIAT HEMATOL ONC, V33, pE125, DOI 10.1097/MPH.0b013e3182036e06; Catalano G, 2009, J PSYCHIATR PRACT, V15, P484, DOI 10.1097/01.pra.0000364292.93704.65; CAZZULLO CL, 1989, PSYCHIAT RES, V29, P257, DOI 10.1016/0165-1781(89)90055-3; Chen YH, 2010, PSYCHOL MED, V22, P1; Coronado VG, 2006, JAMA-J AM MED ASSOC, V295, P1764; David AS, 2005, J NEUROL NEUROSUR PS, V76, pI53, DOI 10.1136/jnnp.2004.060475; Davidson LL, 2003, PSYCHIAT RES-NEUROIM, V122, P69, DOI 10.1016/S0925-4927(02)00118-X; Davison K, 1969, CURRENT PROBLEMS NEU, P113; Duggal HS, 2004, J NEUROPSYCH CLIN N, V16, P543, DOI 10.1176/appi.neuropsych.16.4.543; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Feinberg TE, 1999, CORTEX, V35, P373, DOI 10.1016/S0010-9452(08)70806-2; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; FORNAZZARI L, 1992, J NEUROPSYCH CLIN N, V4, P42; Francisco GE, 1996, AM J PHYS MED REHAB, V75, P63, DOI 10.1097/00002060-199601000-00016; Fujii D, 2004, J NEUROPSYCH CLIN N, V16, P306, DOI 10.1176/appi.neuropsych.16.3.306; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; Fujii D, SPECTRUM PSYCHOTIC D, P535; Fujii D, SPECTRUM PSYCHOTIC D, P3; Fujii Daryl, 2002, Cogn Neuropsychiatry, V7, P41, DOI 10.1080/135468000143000131; Fujii DE, 2004, CAN J PSYCHIAT, V49, P713, DOI 10.1177/070674370404901101; Fujii DE, 2004, SCHIZOPHR RES, V69, P67, DOI 10.1016/S0920-9964(03)00122-1; Fujii DE, 2003, SCHIZOPHR RES, V59, P219, DOI 10.1016/S0920-9964(01)00328-0; Fujii DE, 2001, J NEUROPSYCH CLIN N, V13, P61, DOI 10.1176/appi.neuropsych.13.1.61; Fujii DF, 2004, PROGR SCHIZOPHRENIA, P77; GEREZ M, 1995, BIOL PSYCHIAT, V38, P34, DOI 10.1016/0006-3223(94)00205-H; Greene MB, 2010, J CLIN PSYCHIAT, V71, P506, DOI 10.4088/JCP.09l05685yel; Guenedi Amr A, 2009, J Med Case Rep, V3, P9325, DOI 10.1186/1752-1947-3-9325; Guerreiro DF, 2009, BRAIN INJURY, V23, P1; GUREJE O, 1994, AM J PSYCHIAT, V151, P368; Harrison G, 2006, SCHIZOPHR RES, V88, P119, DOI 10.1016/j.schres.2006.07.001; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Henderson AS, 1998, INT J GERIATR PSYCH, V13, P484, DOI 10.1002/(SICI)1099-1166(199807)13:7<484::AID-GPS808>3.0.CO;2-7; Hien LT, 2005, J AM GERIATR SOC, V53, P1290, DOI 10.1111/j.1532-5415.2005.53403.x; Hwu HG, 2002, SCHIZOPHR RES, V56, P105, DOI 10.1016/S0920-9964(01)00251-1; Jardri R, 2011, AM J PSYCHIAT, V168, P73, DOI 10.1176/appi.ajp.2010.09101522; Jaskiw GE, 2002, SCHIZOPHR RES, V58, P205, DOI 10.1016/S0920-9964(02)00152-4; KENDLER KS, 1994, AM J PSYCHIAT, V151, P27; Kim E, 2002, J NEUROPSYCH CLIN N, V14, P202, DOI 10.1176/appi.neuropsych.14.2.202; Knobel A, 2008, EUR ARCH PSY CLIN N, V258, P76, DOI 10.1007/s00406-008-5008-0; Koponen H, 2003, INT CLIN PSYCHOPHARM, V18, P355, DOI 10.1097/00004850-200311000-00007; Koponen S, 2006, PSYCHIAT RES-NEUROIM, V146, P263, DOI 10.1016/j.pscychresns.2005.05.015; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Leboyer M, 2008, SCHIZOPHR RES, V102, P21, DOI 10.1016/j.schres.2008.04.003; LEWIS SW, 1990, BRIT J PSYCHIAT, V157, P16, DOI 10.1192/S0007125000291824; Makinen J, 2008, NORD J PSYCHIAT, V62, P334, DOI 10.1080/08039480801959307; Malaspina D, 2001, AM J PSYCHIAT, V158, P440, DOI 10.1176/appi.ajp.158.3.440; Mattioli F, 1999, CORTEX, V35, P413, DOI 10.1016/S0010-9452(08)70809-8; McCarley RW, 1999, BIOL PSYCHIAT, V45, P1099, DOI 10.1016/S0006-3223(99)00018-9; MICHALS ML, 1993, J CLIN PSYCHOPHARM, V13, P198; Miller J, 2009, PSYCHOSOMATICS, V50, P426, DOI 10.1176/appi.psy.50.4.426; NASRALLAH HA, 1983, J CLIN PSYCHIAT, V44, P407; Nielsen AS, 2002, SCHIZOPHR RES, V55, P93, DOI 10.1016/S0920-9964(01)00205-5; OWENS DGC, 1980, J NEUROL NEUROSUR PS, V43, P1065, DOI 10.1136/jnnp.43.12.1065; Pearlson GD, 1999, BIOL PSYCHIAT, V46, P627, DOI 10.1016/S0006-3223(99)00071-2; Ritchie E C, 1989, J Neuropsychiatry Clin Neurosci, V1, P449; ROUSSEAUX M, 1994, J NEUROL NEUROSUR PS, V57, P1268, DOI 10.1136/jnnp.57.10.1268; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; Schreiber S, 1998, INT CLIN PSYCHOPHARM, V13, P273, DOI 10.1097/00004850-199811000-00006; Sheehan W, 2006, ACTA PSYCHIAT SCAND, V114, P140, DOI 10.1111/j.1600-0447.2006.00869.x; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Steen RG, 2006, BRIT J PSYCHIAT, V188, P510, DOI 10.1192/bjp.188.6.510; Stephane M, 2004, BRAIN LANG, V89, P503, DOI 10.1016/j.bandl.2004.01.001; Stewart B, 2005, J NEUROPSYCH CLIN N, V17, P243, DOI 10.1176/appi.neuropsych.17.2.243; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tiwari Arun K, 2010, Dialogues Clin Neurosci, V12, P289; Tremeau F, 2011, PROG NEURO-PSYCHOPH, V35, P280, DOI 10.1016/j.pnpbp.2010.09.011; Viana BD, 2010, PROG NEURO-PSYCHOPH, V34, P233, DOI 10.1016/j.pnpbp.2009.08.026; VIOLON A, 1987, ACTA NEUROCHIR, V85, P96, DOI 10.1007/BF01456104; VITA A, 1991, AM J PSYCHIAT, V148, P1577; VITA A, 1988, SCHIZOPHR RES, V1, P329, DOI 10.1016/0920-9964(88)90046-1; Webb J, 2010, CNS SPECTRUMS, V15, P539, DOI 10.1017/S109285290000050X; White C, 2009, PSYCHOL MED, V39, P1447, DOI 10.1017/S003329170800514X; WILCOX JA, 1987, PSYCHIAT RES, V21, P303, DOI 10.1016/0165-1781(87)90013-8; Yung AR, 1996, SCHIZOPHRENIA BULL, V22, P353, DOI 10.1093/schbul/22.2.353; Zaidi SHH, 2008, BRAIN INJURY, V22, P99, DOI 10.1080/02699050701822493	89	23	26	1	11	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SUM	2012	24	3					278	289		10.1176/appi.neuropsych.11070176			12	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	057VS	WOS:000312592800038	23037642				2022-02-06	
J	Wu, N; Zou, XT; Tian, Y; Fitek, J; Maffeo, M; Niezrecki, C; Chen, J; Wang, XW				Wu, Nan; Zou, Xiaotian; Tian, Ye; Fitek, John; Maffeo, Michael; Niezrecki, Christopher; Chen, Julie; Wang, Xingwei			An ultra-fast fiber optic pressure sensor for blast event measurements	MEASUREMENT SCIENCE AND TECHNOLOGY			English	Article						pressure sensor; fiber optic; traumatic brain injury; shock tube	TRAUMATIC BRAIN-INJURY; SHOCK; WAVE; DIAPHRAGM	Soldiers who are exposed to explosions are at risk of suffering traumatic brain injury (TBI). Since the causal relationship between a blast and TBI is poorly understood, it is critical to have sensors that can accurately quantify the blast dynamics and resulting wave propagation through a helmet and skull that are imparted onto and inside the brain. To help quantify the cause of TBI, it is important to record transient pressure data during a blast event. However, very few sensors feature the capabilities of tracking the dynamic pressure transients due to the rapid change of the pressure during blast events, while not interfering with the physical material layers or wave propagation. In order to measure the pressure transients efficiently, a pressure sensor should have a high resonant frequency and a high spatial resolution. This paper describes an ultra-fast fiber optic pressure sensor based on the Fabry-Perot principle for the application of measuring the rapid pressure changes in a blast event. A shock tube experiment performed in US Army Natick Soldier Research, Development and Engineering Center has demonstrated that the resonant frequency of the sensor is 4.12 MHz, which is relatively close to the designed theoretical value of 4.113 MHz. Moreover, the experiment illustrated that the sensor has a rise time of 120 ns, which demonstrates that the sensor is capable of observing the dynamics of the pressure transient during a blast event.	[Wu, Nan; Tian, Ye; Wang, Xingwei] Univ Massachusetts Lowell, Dept Elect & Comp Engn, Lowell, MA 01854 USA; [Zou, Xiaotian] Univ Massachusetts Lowell, Dept Biomed Engn & Biotechnol, Lowell, MA 01854 USA; [Fitek, John; Maffeo, Michael] USA, Natick Soldier Res Dev & Engn Ctr, Natick, MA 01760 USA; [Niezrecki, Christopher; Chen, Julie] Univ Massachusetts Lowell, Dept Mech Engn, Lowell, MA 01854 USA		Wu, N (corresponding author), Univ Massachusetts Lowell, Dept Elect & Comp Engn, 1 Univ Ave, Lowell, MA 01854 USA.	xingwei_wang@uml.edu	Zou, Xiaotian/J-8657-2013; Tian, Ye/A-1090-2014	Tian, Ye/0000-0002-0785-1145	Army Research LaboratoryUnited States Department of DefenseUS Army Research Laboratory (ARL) [W911NF-07-2-0081]	The authors are grateful for the collaboration with Natick Soldier Research, Development and Engineering Center for sharing the shock tube and the reference pressure sensors. The authors also appreciate the Army Research Laboratory for sponsoring this work (Nanomanufacturing of Multifunctional Sensors Award Number W911NF-07-2-0081).	Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Irwin RJ, 1999, J TRAUMA, V47, P105, DOI 10.1097/00005373-199907000-00023; MacPherson WN, 2000, MEAS SCI TECHNOL, V11, P95, DOI 10.1088/0957-0233/11/2/302; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Parkes W, 2007, J MICROMECH MICROENG, V17, P1334, DOI 10.1088/0960-1317/17/7/016; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Wang A, 2001, J LIGHTWAVE TECHNOL, V19, P1495, DOI 10.1109/50.956136; Wang WH, 2010, OPT EXPRESS, V18, P9006, DOI 10.1364/OE.18.009006; Wang WH, 2009, OPT EXPRESS, V17, P16613, DOI 10.1364/OE.17.016613; Wang XW, 2006, OPT LETT, V31, P885, DOI 10.1364/OL.31.000885; Watson S, 2006, MEAS SCI TECHNOL, V17, P1337, DOI 10.1088/0957-0233/17/6/008; Wightman JM, 2001, ANN EMERG MED, V37, P664, DOI 10.1067/mem.2001.114906; Wu N, 2010, PROC SPIE, V7574, DOI 10.1117/12.842034; Xu JC, 2005, OPT LETT, V30, P3269, DOI 10.1364/OL.30.003269; Xu JC, 2005, IEEE PHOTONIC TECH L, V17, P870, DOI 10.1109/LPT.2005.844013; Zhu YZ, 2005, IEEE PHOTONIC TECH L, V17, P447, DOI 10.1109/LPT.2004.839002	19	23	23	6	31	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0957-0233	1361-6501		MEAS SCI TECHNOL	Meas. Sci. Technol.	MAY	2012	23	5							055102	10.1088/0957-0233/23/5/055102			7	Engineering, Multidisciplinary; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Instruments & Instrumentation	929CR	WOS:000303039300016					2022-02-06	
J	Hadjibashi, AA; Berry, C; Ley, EJ; Bukur, M; Mirocha, J; Stolpner, D; Salim, A				Hadjibashi, Anoushiravan Amini; Berry, Cherisse; Ley, Eric J.; Bukur, Marko; Mirocha, James; Stolpner, Dennis; Salim, Ali			Alcohol is Associated with a Lower Pneumonia Rate After Traumatic Brain Injury	JOURNAL OF SURGICAL RESEARCH			English	Article; Proceedings Paper	Annual Meeting of the Association-of-Academic-Surgery (AAS)/6th Annual Academic-Surgical Congress	FEB 01-03, 2011	Huntington Beach, CA	Assoc Acad Surg (AAS), Acad Surg		traumatic brain injury; alcohol; ethanol; pneumonia; infection; outcome	SEVERE HEAD-INJURY; SERUM ETHANOL LEVELS; MODERATE; INTOXICATION; MORTALITY; DEFICITS; LEVEL	Background. Recent evidence supports the beneficial effect of alcohol on patients with traumatic brain injury (TBI). Pneumonia is a known complication following TBI; thus, the purpose of this study was to evaluate the effects of alcohol on pneumonia rates following moderate to severe TBI. Methods. From 2005 to 2009, the Los Angeles County Trauma Database was queried for all patients >= 14 y of age with isolated moderate to severe TBI and admission serum alcohol levels. The incidence of pneumonia was compared between TBI patients with and without a positive blood alcohol concentration (BAC) level. The study population was then stratified into four BAC levels: None (0 mg/dL), low (0-100 mg/dL), moderate (100-230 mg/dL), and high (>= 230 mg/dL). Pneumonia rates were compared across these levels. Results. A total of 3547 patients with isolated, moderate to severe TBI were evaluated. Nearly 66% tested positive for alcohol. The pneumonia rate was significantly lower in the TBI patients who tested positive for alcohol (2.5%) compared with those who tested negative (4.0%, P = 0.017). The pneumonia rate also decreased across increasing BAC levels (linear trend P = 0.03). After logistic regression analysis, a positive ethanol (ETOH) level was associated with a reduced incidence of pneumonia (AOR = 0.62; 95% CI: 0.41-0.93; P = 0.020). Conclusion. A positive serum alcohol level was associated with a significantly lower pneumonia rate in isolated, moderate to severe TBI patients. This may explain the observed mortality reduction in TBI patients who test positive for alcohol. Additional research is warranted to investigate the potential therapeutic implications of this association. (C) 2012 Elsevier Inc. All rights reserved.	[Hadjibashi, Anoushiravan Amini; Berry, Cherisse; Ley, Eric J.; Bukur, Marko; Mirocha, James; Stolpner, Dennis; Salim, Ali] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA		Salim, A (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, 8700 Beverly Blvd,Suite 8215N, Los Angeles, CA 90048 USA.	ali.salim@cshs.org	Berry, Cherisse/AAO-5701-2020	Bukur, Marko/0000-0002-1850-7147			Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Albrecht RF, 1998, MAYO CLIN PROC, V73, P629; Berrouane Y, 1998, J HOSP INFECT, V40, P275, DOI 10.1016/S0195-6701(98)90303-6; Berry C, 2010, AM SURGEON, V76, P1067; Boddie DE, 2003, BRIT J NEUROSURG, V17, P405, DOI 10.1080/02688690310001611198; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Cazzadori A, 1997, RESP MED, V91, P193, DOI 10.1016/S0954-6111(97)90038-X; CHANDLER LJ, 1993, ALCOHOL CLIN EXP RES, V17, P54, DOI 10.1111/j.1530-0277.1993.tb00726.x; Dziedzic T, 2004, CRIT CARE, V8, P266, DOI 10.1186/cc2828; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; HSIEH AHH, 1992, AM REV RESPIR DIS, V146, P290, DOI 10.1164/ajrccm/146.2.290; Leone M, 2002, CRIT CARE MED, V30, P1741, DOI 10.1097/00003246-200208000-00011; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; QUATTROCCHI K B, 1991, Neurological Research, V13, P13; QUATTROCCHI K B, 1990, Journal of Neurotrauma, V7, P77, DOI 10.1089/neu.1990.7.77; QUATTROCCHI KB, 1992, J NEUROTRAUM, V9, P1, DOI 10.1089/neu.1992.9.1; RELLO J, 1992, EUR RESPIR J, V5, P1249; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Sall JM, 1996, EXP NEUROL, V139, P257, DOI 10.1006/exnr.1996.0099; Taylor AN, 2002, J NEUROTRAUM, V19, P1597, DOI 10.1089/089771502762300256; Woiciechowsky C, 1999, CRIT CARE, V3, pR107, DOI 10.1186/cc375; WOOLF PD, 1990, ALCOHOL CLIN EXP RES, V14, P205, DOI 10.1111/j.1530-0277.1990.tb00473.x	28	23	24	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	APR	2012	173	2					212	215		10.1016/j.jss.2011.05.029			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	906IQ	WOS:000301339100010	21737096				2022-02-06	
J	Larson, BE; Stockwell, DW; Boas, S; Andrews, T; Wellman, GC; Lockette, W; Freeman, K				Larson, Brett E.; Stockwell, David W.; Boas, Stefan; Andrews, Trevor; Wellman, George C.; Lockette, Warren; Freeman, Kalev			Cardiac Reactive Oxygen Species After Traumatic Brain Injury	JOURNAL OF SURGICAL RESEARCH			English	Article						traumatic brain injury; reactive oxygen species; adrenergic receptor antagonist	HEART-RATE-VARIABILITY; SUBARACHNOID HEMORRHAGE; BETA-ADRENOCEPTORS; PROPRANOLOL; BLOCKADE; STRESS; CATECHOLAMINES; ABNORMALITIES; HYPERTENSION; ATENOLOL	Background. Cardiovascular complications after traumatic brain injury (TBI) contribute to morbidity and mortality and may provide a target for therapy. We examined blood pressure and left ventricle contractility after TBI, and tested the hypothesis that beta-adrenergic blockade would decrease oxidative stress after TBI. Material and Methods. Rodents received fluid-percussioninjury or sham surgery, confirmed with magnetic resonance imaging (MRI) and histopathology. We followed recovery with sensorimotor coordination testing and blood pressure measurements. We assessed left ventricular ejection fraction using ECG-gated cardiac MRI and measured myocardial reactive oxygen species (ROS) with dihydroethidium. We randomized additional TBI and sham animals to postoperative treatment with propranolol or control, for measurement of ROS. Results. Blood pressure and cardiac contractility were elevated 48 h after TBI. Myocardial tissue sections showed increased ROS. Treatment with propranolol diminished ROS levels following TBI. Conclusions. TBI is associated with increased cardiac contractility and myocardial ROS; decreased myocardial ROS after beta-blockade suggests that sympathetic stimulation is a mechanism of oxidative stress. (C) 2012 Elsevier Inc. All rights reserved.	[Larson, Brett E.; Stockwell, David W.; Boas, Stefan; Wellman, George C.; Freeman, Kalev] Univ Vermont, Dept Surg, Burlington, VT 05405 USA; [Andrews, Trevor] Univ Vermont, Dept Radiol, Burlington, VT 05405 USA; [Wellman, George C.] Univ Vermont, Dept Pharmacol, Burlington, VT 05405 USA; [Lockette, Warren] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Andrews, Trevor] Philips Healthcare, Cleveland, OH USA		Freeman, K (corresponding author), Univ Vermont, Dept Surg, Burlington, VT 05405 USA.	Kalev.Freeman@uvm.edu		Andrews, Trevor/0000-0003-0331-1798	National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K08GM098795]; US Department of EnergyUnited States Department of Energy (DOE) [SC 0001753]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P01HL095488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K08GM098795] Funding Source: NIH RePORTER	The project described was supported by grant number K08GM098795 from the National Institute of General Medical Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. The MRI was supported in part by US Department of Energy SC 0001753. The authors acknowledge MRI technician: Jay Gonyea; ECG gating/ LVEF analysis: Tim Christian, M. D.; Surgery technician: Sheila Russell; Students: Angus Beal, Chary Loadholt, Peter Andriakos, Tabitha Trahan.	Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Bybee KA, 2008, CIRCULATION, V118, P397, DOI 10.1161/CIRCULATIONAHA.106.677625; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; CONNOR RCR, 1969, AM HEART J, V78, P145, DOI 10.1016/0002-8703(69)90001-5; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; CRUICKSHANK JM, 1987, LANCET, V2, P585, DOI 10.1016/s0140-6736(87)92984-9; CRUICKSHANK JM, 1974, BRIT HEART J, V36, P395; Cushing H., 1901, B J HOPKINS HOSP, V12, P3; DeRoss AL, 2002, J TRAUMA, V52, P708, DOI 10.1097/00005373-200204000-00017; Faul M, 2010, TRAUMATIC BRAIN INJU; Freeman N., 1939, AM J PHYSIOL, V128, P10; Grimson K., 1937, ANN SURG, V106, P25; Horinouchi T, 2007, LIFE SCI, V81, P399, DOI 10.1016/j.lfs.2007.06.003; HORTNAGL H, 1980, INTENS CARE MED, V6, P169, DOI 10.1007/BF01757299; Jacobs DG, 2003, J TRAUMA, V54, P391, DOI 10.1097/01.TA.0000042015.54022.BE; Kakinuma Y, 1998, NAT MED, V4, P1078, DOI 10.1038/2070; KASTE M, 1981, J NEUROSURG, V55, P511, DOI 10.3171/jns.1981.55.4.0511; Kojda G, 1999, CARDIOVASC RES, V43, P562, DOI 10.1016/S0008-6363(99)00169-8; KONO T, 1994, J AM COLL CARDIOL, V24, P636, DOI 10.1016/0735-1097(94)90008-6; Kurtz TW, 2005, HYPERTENSION, V45, P299, DOI 10.1161/01.HYP.0000150857.39919.cb; Ley EJ, 2010, J SURG RES, V163, P142, DOI 10.1016/j.jss.2010.04.046; Maramattom BV, 2006, MAYO CLIN PROC, V81, P192, DOI 10.4065/81.2.192; Marano G, 2002, J HYPERTENS, V20, P763, DOI 10.1097/00004872-200204000-00036; Martin M, 2005, J TRAUMA, V59, P1086, DOI 10.1097/01.ta.0000190249.19668.37; Morris JA, 2006, J TRAUMA, V60, P1165, DOI 10.1097/01.ta.0000220384.04978.3b; Murakami K, 2011, TRANSL STROKE RES, V2, P72, DOI 10.1007/s12975-010-0052-2; NEILDWYER G, 1978, BRIT MED J, V2, P990, DOI 10.1136/bmj.2.6143.990; Norris PR, 2006, ANN SURG, V243, P804, DOI 10.1097/01.sla.0000219642.92637.fd; Petronilho F, 2010, J SURG RES, V164, P316, DOI 10.1016/j.jss.2009.04.031; Reichenbach DB, 1970, HUM PATHOL, V1, P26; ROBERTSON CS, 1984, NEUROSURGERY, V15, P307, DOI 10.1227/00006123-198409000-00003; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; Rozas G, 1997, BRAIN RES PROTOC, V2, P75, DOI 10.1016/S1385-299X(97)00034-2; SINGAL PK, 1983, ADV EXP MED BIOL, V161, P391; TAKITA M, 1995, PHARMACOL BIOCHEM BE, V50, P225, DOI 10.1016/0091-3057(94)00301-X; Troncoso Brindeiro CM, 2007, AM J PHYSIOL, V293, pH2971; Walker A., 1944, J NEUROSURG, V1, P14; Wisbach G, 2007, J TRAUMA, V63, P26, DOI 10.1097/TA.0b013e31806864e2	39	23	26	1	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804			J SURG RES	J. Surg. Res.	APR	2012	173	2					E73	E81		10.1016/j.jss.2011.09.056			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	906IQ	WOS:000301339100004	22172132	Green Accepted			2022-02-06	
J	Weng, YL; Sun, SJ				Weng, Yinlun; Sun, Shijie			Therapeutic Hypothermia After Cardiac Arrest in Adults: Mechanism of Neuroprotection, Phases of Hypothermia, and Methods of Cooling	CRITICAL CARE CLINICS			English	Article						Cardiac arrest; Cardiopulmonary resuscitation; Hypothermia; Neurologic function	TRAUMATIC BRAIN-INJURY; COLD INTRAVENOUS FLUID; MICROVESSEL ENDOTHELIAL-CELLS; PROMISING TREATMENT MODALITY; AMERICAN-HEART-ASSOCIATION; 4-DEGREES-C NORMAL SALINE; GLOBAL CEREBRAL-ISCHEMIA; INDUCED AXONAL INJURY; ADVANCED LIFE-SUPPORT; MILD HYPOTHERMIA	Mild therapeutic hypothermia (32 degrees C-34 degrees C) has been shown to improve survival and neurologic outcomes after sudden cardiac arrest in clinical studies. Its use is recommended by the American Heart Association for unconscious adult patients with spontaneous circulation after out-of-hospital ventricular fibrillation. It decreases cerebral metabolism and protects the brain after ischemia by reduction of brain metabolism, attenuation of neuroexcitotoxic cascade, abolition of reactive oxygen species, and inhibition of apoptosis. This article addresses the mechanism of neuroprotection, phases of hypothermia, and noninvasive and invasive cooling methods.	[Weng, Yinlun; Sun, Shijie] Weil Inst Crit Care Med, Rancho Mirage, CA 92270 USA; [Sun, Shijie] Univ So Calif, Keck Sch Med, Los Angeles, CA 90089 USA		Sun, SJ (corresponding author), Weil Inst Crit Care Med, 35100 Bob Hope Dr, Rancho Mirage, CA 92270 USA.	shijiesun@aol.com			American Heart AssociationAmerican Heart Association [11IRG 487001]	The authors have received financial support through an American Heart Association grant (11IRG 487001). The authors have no relationship with any commercial company that has a direct financial interest in the subject matter or materials discussed in their article or with a company making a competing product.	Adachi M, 2001, PEDIATR RES, V50, P590, DOI 10.1203/00006450-200111000-00010; Agnew DM, 2003, PEDIATR RES, V54, P253, DOI 10.1203/01.PDR.0000072783.22373.FF; AKRIOTIS V, 1985, J LEUKOCYTE BIOL, V37, P51, DOI 10.1002/jlb.37.1.51; Al-Senani FM, 2004, RESUSCITATION, V62, P143, DOI 10.1016/j.resuscitation.2004.02.016; Alam HB, 2006, J TRAUMA, V60, P134, DOI 10.1097/01.ta.0000198469.95292.ec; Alzaga AG, 2006, RESUSCITATION, V70, P369, DOI 10.1016/j.resuscitation.2006.01.017; [Anonymous], 2004, ANN INTERN MED, V140, P182; AOKI M, 1993, ANN THORAC SURG, V55, P1093, DOI 10.1016/0003-4975(93)90014-9; Asensio VC, 1999, TRENDS NEUROSCI, V22, P504, DOI 10.1016/S0166-2236(99)01453-8; Bernard S, 2003, RESUSCITATION, V56, P9, DOI 10.1016/S0300-9572(02)00276-9; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bissonnette B, 2000, ANESTHESIOLOGY, V93, P611, DOI 10.1097/00000542-200009000-00008; Boddicker KA, 2005, CIRCULATION, V111, P3195, DOI 10.1161/CIRCULATIONAHA.104.492108; BROMONT C, 1989, STROKE, V20, P918, DOI 10.1161/01.STR.20.7.918; Bruel C, 2008, CRIT CARE, V12, DOI 10.1186/cc6809; Busch M, 2006, ACTA ANAESTH SCAND, V50, P1277, DOI 10.1111/j.1399-6576.2006.01147.x; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; Callaway CW, 2008, CRIT CARE MED, V36, P2607, DOI 10.1097/CCM.0b013e318184443b; Chi OZ, 2001, ANESTHESIOLOGY, V95, P933, DOI 10.1097/00000542-200110000-00023; Cobb LA, 2002, JAMA-J AM MED ASSOC, V288, P3008, DOI 10.1001/jama.288.23.3008; Colbourne F, 1997, MOL NEUROBIOL, V14, P171, DOI 10.1007/BF02740655; COLBOURNE F, 1994, BRAIN RES, V654, P265, DOI 10.1016/0006-8993(94)90488-X; COLBOURNE F, 1995, J NEUROSCI, V15, P7250; DANZL DF, 1994, NEW ENGL J MED, V331, P1756, DOI 10.1056/NEJM199412293312607; DEMPSEY RJ, 1987, NEUROSURGERY, V21, P177, DOI 10.1227/00006123-198708000-00007; DIETRICH WD, 1993, J CEREBR BLOOD F MET, V13, P541, DOI 10.1038/jcbfm.1993.71; Ehrlich MP, 2002, ANN THORAC SURG, V73, P191, DOI 10.1016/S0003-4975(01)03273-8; Erecinska M, 2003, J CEREBR BLOOD F MET, V23, P513, DOI 10.1097/01.WCB.0000066287.21705.21; Field JM, 2010, CIRCULATION, V122, pS640, DOI 10.1161/CIRCULATIONAHA.110.970889; Fischer S, 1999, AM J PHYSIOL-CELL PH, V276, pC812; Fischer S, 1999, MOL BRAIN RES, V74, P135, DOI 10.1016/S0169-328X(99)00272-7; Gal R, 2009, BRATISL MED J, V110, P222; Galea S, 2007, AM J EPIDEMIOL, V166, P534, DOI 10.1093/aje/kwm102; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1250; Gunn AJ, 2000, CURR OPIN PEDIATR, V12, P111, DOI 10.1097/00008480-200004000-00004; Gunn AJ, 1998, EARLY HUM DEV, V53, P19, DOI 10.1016/S0378-3782(98)00033-4; Gupta AK, 2002, BRIT J ANAESTH, V88, P188, DOI 10.1093/bja/88.2.188; HAGERDAL M, 1975, J NEUROCHEM, V24, P311, DOI 10.1111/j.1471-4159.1975.tb11881.x; Hammer MD, 2003, NEUROLOGIST, V9, P280, DOI 10.1097/01.nrl.0000094628.29312.2b; Haugk M, 2007, RESUSCITATION, V75, P76, DOI 10.1016/j.resuscitation.2007.03.001; Hickey RW, 2000, CRIT CARE MED, V28, P3511, DOI 10.1097/00003246-200010000-00027; Hildebrand F, 2005, CYTOKINE, V31, P382, DOI 10.1016/j.cyto.2005.06.008; Holzer M, 2005, CRIT CARE MED, V33, P1346, DOI 10.1097/01.CCM.0000166356.45902.A2; Holzer M, 2002, NEW ENGL J MED, V346, P549; Holzer M, 2006, STROKE, V37, P1792, DOI 10.1161/01.STR.0000227265.52763.16; Hong SB, 2002, ANESTH ANALG, V94, P157, DOI 10.1097/00000539-200201000-00030; HOSSMANN KA, 1988, CRIT CARE MED, V16, P964, DOI 10.1097/00003246-198810000-00007; Howes D, 2010, RESUSCITATION, V81, P388, DOI 10.1016/j.resuscitation.2009.12.025; Huang ZG, 1999, CAN J NEUROL SCI, V26, P298, DOI 10.1017/S0317167100000421; ILLIEVICH UM, 1994, ANESTH ANALG, V78, P905; Janata A, 2009, PROG CARDIOVASC DIS, V52, P168, DOI 10.1016/j.pcad.2009.07.001; Kamarainen A, 2008, RESUSCITATION, V79, P205, DOI 10.1016/j.resuscitation.2008.07.003; Katz LM, 2004, BRAIN RES, V1017, P85, DOI 10.1016/j.brainres.2004.05.020; Katz LM, 2004, CRIT CARE MED, V32, P806, DOI 10.1097/01.CCM.0000114998.00860.FD; Kawahara F, 2003, ACTA ANAESTH SCAND, V47, P419, DOI 10.1034/j.1399-6576.2003.00063.x; Kim F, 2005, CIRCULATION, V112, P715, DOI 10.1161/CIRCULATIONAHA.105.544528; Kim F, 2007, CIRCULATION, V115, P3064, DOI 10.1161/CIRCULATIONAHA.106.655480; Kliegel A, 2005, RESUSCITATION, V64, P347, DOI 10.1016/j.resuscitation.2004.09.002; Kliegel A, 2007, RESUSCITATION, V73, P46, DOI 10.1016/j.resuscitation.2006.08.023; KOMARA JS, 1986, ANN EMERG MED, V15, P384, DOI 10.1016/S0196-0644(86)80171-8; LANIER WL, 1995, J NEUROSURG ANESTH, V7, P216, DOI 10.1097/00008506-199507000-00021; LAPTOOK AR, 1995, STROKE, V26, P1240, DOI 10.1161/01.STR.26.7.1240; LAPTOOK AR, 1995, PEDIATR RES, V38, P919, DOI 10.1203/00006450-199512000-00015; LeDucq N, 1998, BIOCHEM J, V336, P501, DOI 10.1042/bj3360501; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Markarian GZ, 1996, NEUROSURGERY, V38, P542; Markgraf CG, 2001, J NEUROSURG, V95, P979, DOI 10.3171/jns.2001.95.6.0979; Maxwell WL, 2005, J NEUROTRAUM, V22, P873, DOI 10.1089/neu.2005.22.873; Merrill JE, 1996, TRENDS NEUROSCI, V19, P331, DOI 10.1016/0166-2236(96)10047-3; MILDE LN, 1992, J NEUROSURG ANESTH, V4, P211, DOI 10.1097/00008506-199207000-00012; NAKASHIMA K, 1995, ANESTHESIOLOGY, V82, P1199, DOI 10.1097/00000542-199505000-00015; Nolan JP, 2003, RESUSCITATION, V57, P231, DOI 10.1016/S0300-9572(03)00184-9; Nordmark J, 2005, RESUSCITATION, V66, P357, DOI 10.1016/j.resuscitation.2005.04.002; Novack TA, 1996, J CLIN EXP NEUROPSYC, V18, P685, DOI 10.1080/01688639608408292; Nozari A, 2006, CIRCULATION, V113, P2690, DOI 10.1161/CIRCULATIONAHA.106.613349; Oddo M, 2008, CRIT CARE MED, V36, P2296, DOI 10.1097/CCM.0b013e3181802599; PALMER C, 1989, ANESTHESIOLOGY, V71, P730, DOI 10.1097/00000542-198911000-00017; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Polderman KH, 2005, CRIT CARE MED, V33, P2744, DOI 10.1097/01.CCM.0000190427.88735.19; Polderman KH, 2004, INTENS CARE MED, V30, P556, DOI 10.1007/s00134-003-2152-x; Polderman KH, 2001, J NEUROSURG, V94, P697, DOI 10.3171/jns.2001.94.5.0697; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; Povlishock JT, 2009, J NEUROTRAUM, V26, P333, DOI 10.1089/neu.2008.0604; Povlishock JT, 1999, ACT NEUR S, V73, P15; Proulx CI, 2006, EUR J APPL PHYSIOL, V96, P434, DOI 10.1007/s00421-005-0063-y; Quinones-Hinojosa A, 2003, NEUROSURGERY, V52, P1178, DOI 10.1227/01.NEU.0000057836.64972.A0; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Raghupathi R, 1998, P W PHARMACOL SOC, V41, P241; Riter HG, 2009, RESUSCITATION, V80, P561, DOI 10.1016/j.resuscitation.2009.01.016; Sakoh M, 2003, AM J PHYSIOL-HEART C, V285, pH17, DOI 10.1152/ajpheart.01112.2002; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Schratter A, 2007, AM J EMERG MED, V25, P420, DOI 10.1016/j.ajem.2007.02.044; Shintani Y., 2010, STROKE RES TREAT, V2011, P809; SIESJO BK, 1989, ANN NY ACAD SCI, V568, P234; Silfvast T, 2003, RESUSCITATION, V57, P109, DOI 10.1016/S0300-9572(02)00438-0; Small DL, 1999, PROG CARDIOVASC DIS, V42, P185, DOI 10.1016/S0033-0620(99)70002-2; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; Staffey KS, 2008, RESUSCITATION, V78, P77, DOI 10.1016/j.resuscitation.2008.02.008; Sterz F, 1996, J NEUROSURG ANESTH, V8, P88, DOI 10.1097/00008506-199601000-00028; STERZ F, 1991, CRIT CARE MED, V19, P379, DOI 10.1097/00003246-199103000-00017; Sterz Fritz, 2006, Acute Card Care, V8, P25, DOI 10.1080/14628840600621371; Straus SMJM, 2004, J CLIN EPIDEMIOL, V57, P98, DOI 10.1016/S0895-4356(03)00210-5; Suehiro E, 2001, J NEUROSURG, V94, P493, DOI 10.3171/jns.2001.94.3.0493; Sun SJ, 2010, CRIT CARE MED, V38, P2282, DOI 10.1097/CCM.0b013e3181f9f9e3; Tsai MS, 2008, J AM COLL CARDIOL, V51, P1988, DOI 10.1016/j.jacc.2007.12.057; Uray T, 2008, RESUSCITATION, V77, P331, DOI 10.1016/j.resuscitation.2008.01.005; Wang GJ, 2002, NEUROSCIENCE, V114, P1081, DOI 10.1016/S0306-4522(02)00350-0; Weng Y, 2011, CRIT CARE MED; Williams GD, 1997, PEDIATR RES, V42, P700, DOI 10.1203/00006450-199711000-00024; Wolff B, 2009, INT J CARDIOL, V133, P223, DOI 10.1016/j.ijcard.2007.12.039; Xu LJ, 2002, J CEREBR BLOOD F MET, V22, P21, DOI 10.1097/00004647-200201000-00003	115	23	25	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-0704	1557-8232		CRIT CARE CLIN	Crit. Care Clin.	APR	2012	28	2					231	+		10.1016/j.ccc.2011.10.012			15	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	926IC	WOS:000302823500008	22433485				2022-02-06	
J	Albright, G; Goldman, R; Shockley, KM; McDevitt, F; Akabas, S				Albright, Glenn; Goldman, Ron; Shockley, Kristen M.; McDevitt, Fiona; Akabas, Sam			Using an Avatar-Based Simulation to Train Families to Motivate Veterans with Post-Deployment Stress to Seek Help at the VA	GAMES FOR HEALTH JOURNAL			English	Article							SUICIDE-PREVENTION; IMPACT; EFFICACY; DISORDER	Objective: This study examines the effectiveness of "Family of Heroes,'' an online avatar-based post-deployment stress and resiliency training simulation, in increasing families' engagement in motivating their veterans who exhibit signs of post-deployment stress, including post-traumatic stress disorder (PTSD), traumatic brain injury (TBI), depression, and suicide ideation, to seek help at the Veterans Administration (VA). Materials and Methods: Participants were randomly assigned to an experimental group (n = 50) that completed the online training and pre- and post-intervention and 1-month follow-up surveys or a control group (n = 44) who only completed a pre-test and a 1-month follow-up survey. Results: The experimental group exhibited significantly greater changes in its preparedness and likelihood to recognize signs of post-deployment stress and in approaching their veteran to discuss their concern and motivate them to seek help at the VA. This group also reported significant change in actual behavior in terms of discussing their concern with their veteran (79 percent approached to discuss vs. 56 percent for the control group). Finally, seven (22 percent) of the veterans who were approached by the experimental group started to receive mental health treatment (five at the VA). All seven were previously diagnosed with PTSD and/or depression but never before started treatment at the VA. Conclusion: Results strongly suggest that "Family of Heroes'' is an effective tool to engage families in taking an active role in motivating their veterans who exhibit signs of post-deployment stress to seek help at the VA. Results also suggest that the training can increase the actual number of veterans experiencing post-deployment stress who begin to receive treatment at the VA.	[Albright, Glenn; Shockley, Kristen M.] CUNY Bernard M Baruch Coll, Dept Psychol, New York, NY 10010 USA; [Albright, Glenn; Goldman, Ron; McDevitt, Fiona; Akabas, Sam] Kognito Interact, New York, NY 10001 USA		Albright, G (corresponding author), Kognito Interact, 130 West 25th St,Suite 1001, New York, NY 10001 USA.	info@kognito.com			Kognito Interactive	The authors wish to thank the many families of veterans who participated in this study. The study was funded by Kognito Interactive and conducted in June-July 2011.	BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bolton EE, 2002, MIL PSYCHOL, V14, P241, DOI 10.1207/S15327876MP1403_4; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Cross W, 2007, SUICIDE LIFE-THREAT, V37, P659, DOI 10.1521/suli.2007.37.6.659; Dekel R, 2010, AGGRESS VIOLENT BEH, V15, P303, DOI 10.1016/j.avb.2010.03.001; Department of Defense Task Force on Mental Health, 2007, ACH VIS REP DEP DEF; Department of Veteran's Affairs, 2010, VA SUIC PREV PROGR F; Department of Veterans Affairs, 2011, FACT SHEET VA SERV P; EDEN D, 1993, J APPL PSYCHOL, V78, P352, DOI 10.1037/0021-9010.78.3.352; Eden D, 2010, J MANAGE, V36, P687, DOI 10.1177/0149206308321553; Galovski T, 2004, AGGRESS VIOLENT BEH, V9, P477, DOI 10.1016/S1359-1789(03)00045-4; Glenn D Michael, 2002, Violence Vict, V17, P473, DOI 10.1891/vivi.17.4.473.33685; Keller DP, 2009, PROF PSYCHOL-RES PR, V40, P126, DOI 10.1037/a0014889; King DW, 2006, J APPL SOC PSYCHOL, V36, P2980, DOI 10.1111/j.0021-9029.2006.00138.x; KIRKPATRICK DL, 1979, TRAIN DEV J, V33, P78; Lester P, 2011, MIL MED, V176, P19, DOI 10.7205/MILMED-D-10-00122; Peterson H, 2001, FAMILIES EASE VA PRO; Ray SL, 2009, INT J NURS STUD, V46, P838, DOI 10.1016/j.ijnurstu.2009.01.002; Riggs DS, 2000, EFFECTIVE TREATMENTS FOR PTSD, P280; Selvin S., 1991, STAT ANAL EPIDEMIOLO; Tanielian T., 2008, INVISIBLE WOUNDS WAR; U.S. Census Bureau, 2000, AM FACT FIND VET; Wyman PA, 2008, J CONSULT CLIN PSYCH, V76, P104, DOI 10.1037/0022-006X.76.1.104	23	23	23	1	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2161-783X	2161-7856		GAMES HEALTH J	Games Health J.	FEB	2012	1	1					21	28		10.1089/g4h.2011.0003			8	Health Policy & Services; Public, Environmental & Occupational Health; Rehabilitation	Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Rehabilitation	V40YN	WOS:000209514000006	26196429				2022-02-06	
J	Kerman, M; Kanter, M; Coskun, KK; Erboga, M; Gurel, A				Kerman, Memduh; Kanter, Mehmet; Coskun, Kerim Kenan; Erboga, Mustafa; Gurel, Ahmet			Neuroprotective effects of Caffeic acid phenethyl ester on experimental traumatic brain injury in rats	JOURNAL OF MOLECULAR HISTOLOGY			English	Article						Traumatic brain injury; CAPE; Oxidative stress; Apoptosis; Rats	CLOSED-HEAD TRAUMA; LIPID-PEROXIDATION; REPERFUSION INJURY; N-ACETYLCYSTEINE; MECHANISMS; CASPASE-3; ISCHEMIA; DYSFUNCTION; STRESS; IMPACT	The aim of this study was to evaluate the therapeutic efficacy of caffeic acid phenethyl ester (CAPE) with an experimental traumatic brain injury (TBI) model in rats. Twenty-four adult male Sprague-Dawley rats were randomly divided into three groups of 8 rats each: control, TBI, and TBI + CAPE treatment. In TBI and TBI + CAPE treatment groups, a cranial impact was delivered to the skull from a height of 7 cm at a point just in front of the coronal suture and over the right hemisphere. Rats were sacrificed at 4 h after the onset of injury. Brain tissues were removed for biochemical and histopathological investigation. To date, no biochemical and histopathological changes of neurodegeneration in the frontal cortex after TBI in rats by CAPE treatment have been reported. The TBI significantly increased tissue malondialdehyde (MDA) levels, and significantly decreased tissue superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities, but not tissue catalase (CAT) activity, when compared with controls. The administration of a single dose of CAPE (10 mu mol/kg) 15 min after the trauma has shown protective effect via decreasing significantly the elevated MDA levels and also significantly increasing the reduced antioxidant enzyme (SOD and GPx) activities, except CAT activity. In the TBI group, severe degenerative changes, shrunken cytoplasma and extensively dark picnotic nuclei in neurons, as well as vacuolization indicating tissue edema formation. The morphology of neurons in the CAPE treatment group was well protected. The number of neurons in the trauma alone group was significantly less than that of both the control and TBI +CAPE treatment groups. The caspase 3 immunopositivity was increased in degenerating neurons of the traumatic brain tissue. Treatment of CAPE markedly reduced the immunoreactivity of degenerating neurons. TBI caused severe degenerative changes, shrunken cytoplasma, severely dilated cisternae of endoplasmic reticulum, markedly swollen mitochondria with degenerated cristae and nuclear membrane breakdown with chromatin disorganization in neurons of the frontal cortex. In conclusion, the CAPE treatment might be beneficial in preventing trauma-induced oxidative brain tissue damage, thus showing potential for clinical implications. We believe that further preclinical research into the utility of CAPE may indicate its usefulness as a potential treatment on neurodegeneration after TBI in rats.	[Kerman, Memduh; Coskun, Kerim Kenan] Private Sema Hosp, Dept Neurosurg, Istanbul, Turkey; [Kanter, Mehmet; Erboga, Mustafa] Trakya Univ, Dept Histol & Embryol, Fac Med, TR-22030 Edirne, Turkey; [Gurel, Ahmet] Private Sema Hosp, Dept Biochem, Istanbul, Turkey		Kerman, M (corresponding author), Private Sema Hosp, Dept Neurosurg, Istanbul, Turkey.	memduhkerman@yahoo.com.tr; mkanter65@yahoo.com					AEBI H, 1984, METHOD ENZYMOL, V105, P121; BAETHMANN A, 1989, J NEUROSURG, V70, P578, DOI 10.3171/jns.1989.70.4.0578; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Cernak I, 2002, J CLIN NEUROSCI, V9, P565, DOI 10.1054/jocn.2002.1132; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Cristofori L, 2001, J INVEST MED, V49, P450, DOI 10.2310/6650.2001.33790; Erhardt L, 1996, EUR HEART J, V17, P1781; Fadillioglu E, 2004, J APPL TOXICOL, V24, P47, DOI 10.1002/jat.945; Fadillioglu E, 2010, PROG NEURO-PSYCHOPH, V34, P1440, DOI 10.1016/j.pnpbp.2010.07.034; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Hepsen IF, 1997, J CATARACT REFR SURG, V23, P1572, DOI 10.1016/S0886-3350(97)80031-4; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Ilhan A, 1999, EUR J CARDIO-THORAC, V16, P458, DOI 10.1016/S1010-7940(99)00246-8; Irmak MK, 2001, UROL RES, V29, P190, DOI 10.1007/s002400100185; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Khan M, 2007, J NEUROCHEM, V102, P365, DOI 10.1111/j.1471-4159.2007.04526.x; Koltuksuz U, 1999, J PEDIATR SURG, V34, P1458, DOI 10.1016/S0022-3468(99)90103-3; Kus L, 2004, ACTA HISTOCHEM, V106, P289, DOI 10.1016/j.acthis.2004.05.002; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P344, DOI 10.1097/00004647-200104000-00003; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu J, 2003, NEUROPHARMACOLOGY, V44, P253, DOI 10.1016/S0028-3908(02)00380-5; Marshall L F, 2000, Clin Neurosurg, V46, P105; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; McCall J.M., 1987, ACTA ANAESTH BELG, V38, P279; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Montpied P, 2003, MOL BRAIN RES, V115, P111, DOI 10.1016/S0169-328X(03)00178-5; Nagaoka T, 2002, BIOORGAN MED CHEM, V10, P3351, DOI 10.1016/S0968-0896(02)00138-4; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Ogeturk M, 2005, J ETHNOPHARMACOL, V97, P273, DOI 10.1016/j.jep.2004.11.019; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ozen S, 2004, J APPL TOXICOL, V24, P27, DOI 10.1002/jat.941; Ozisik PA, 2007, SURG NEUROL, V68, P547, DOI 10.1016/j.surneu.2007.01.030; Ozsuer H, 2005, NEUROSURG REV, V28, P143, DOI 10.1007/s10143-004-0374-1; Ozyurt H, 2001, CELL BIOCHEM FUNCT, V19, P259, DOI 10.1002/cbf.923; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; RINK A, 1995, AM J PATHOL, V147, P1575; Russo A, 2002, FITOTERAPIA, V73, pS21, DOI 10.1016/S0367-326X(02)00187-9; SCATTON B, 1991, CEREBROVASC DIS, V1, P121, DOI 10.1159/000108829; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; SUN Y, 1988, CLIN CHEM, V34, P497; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Thomale UW, 2006, INTENS CARE MED, V32, P149, DOI 10.1007/s00134-005-2845-4; Ustun ME, 2001, INTENS CARE MED, V27, P264, DOI 10.1007/s001340000780; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; Yakovlev AG, 1997, J NEUROSCI, V17, P7415	56	23	25	0	14	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1567-2379	1567-2387		J MOL HISTOL	J. Mol. Histol.	FEB	2012	43	1					49	57		10.1007/s10735-011-9376-9			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	880AL	WOS:000299376400006	22124729				2022-02-06	
J	Wecht, JM; Rosado-Rivera, D; Jegede, A; Cirnigliaro, CM; Jensen, MA; Kirshblum, S; Bauman, WA				Wecht, Jill M.; Rosado-Rivera, Dwindally; Jegede, Adejoke; Cirnigliaro, Christopher M.; Jensen, Marley A.; Kirshblum, Steve; Bauman, William A.			Systemic and cerebral hemodynamics during cognitive testing	CLINICAL AUTONOMIC RESEARCH			English	Article						Paraplegia; Tetraplegia; Blood pressures; Transcranial Doppler ultrasound; Cerebral blood flow; Mental stimulation	SPINAL-CORD-INJURY; BLOOD-FLOW-VELOCITY; WHITE-MATTER HYPERINTENSITIES; CLOSED HEAD-INJURY; TRANSCRANIAL DOPPLER; ORTHOSTATIC HYPOTENSION; ARTERIAL STIFFNESS; MENTAL STRESS; PERFORMANCE; PRESSURE	Objective Cognitive deficits are reported in 10-60% of individuals with SCI, the primary etiology of these deficits is believed to be concomitant traumatic brain injury (TBI). We recently documented diminished memory and marginally deficient attention and processing speed in individuals with SCI discordant for hypotension but matched for TBI. Methods Twenty-nine individuals participated: 16 non-SCI controls, 6 paraplegic (T2-T10) and 7 tetraplegic (C4-C8). The Stroop test was used to measure cognitive function and transcranial Doppler ultrasound was used to measure cerebral blood flow (CBF) while resting (5 min) and continuously during cognitive testing. Mean arterial pressure (MAP) was calculated from three brachial blood pressures and cerebral vascular resistance index was calculated as: CVRi = MAP/CBF. Results The paraplegia group (54 +/- 6) was marginally older than the non-SCI (42 +/- 15; p = 0.06) and tetraplegic (42 +/- 11; p = 0.09) groups. Compared to non-SCI group, normalized t-score on the Stroop Color (SC) task was significantly lower in the paraplegic group (p < 0.05). In the tetraplegic group, MAP was significantly lower (p < 0.05) than the non-SCI and paraplegic groups, and related to SC t-score (r(2) = 0.873; p < 0.01). In the paraplegic group, CBF was reduced (p < 0.05) and CVRi increased (p < 0.05) compared to the non-SCI group, and CVRi was increased compared to the tetraplegic group (p < 0.05). A significant inverse relationship was noted between change in CVRi and SC t-score in the non-SCI group. Conclusion Asymptomatic hypotension relates to cognitive performance in persons with tetraplegia; therefore, BP normalization should be considered. The inappropriate cerebral vascular response to cognitive testing and poor test performance should be investigated in persons with paraplegia.	[Wecht, Jill M.; Rosado-Rivera, Dwindally; Jegede, Adejoke; Cirnigliaro, Christopher M.; Jensen, Marley A.; Bauman, William A.] James J Peters VA Med Ctr, Ctr Excellence Med Consequences Spinal Cord Injur, Bronx, NY 10468 USA; [Wecht, Jill M.; Bauman, William A.] James J Peters VAMC, Med Serv, Bronx, NY USA; [Wecht, Jill M.; Bauman, William A.] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Wecht, Jill M.; Bauman, William A.] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY USA; [Cirnigliaro, Christopher M.; Jensen, Marley A.; Kirshblum, Steve] Kessler Inst Rehabil, W Orange, NJ USA		Wecht, JM (corresponding author), James J Peters VA Med Ctr, Ctr Excellence Med Consequences Spinal Cord Injur, Rm 7A-13,130 W Kingsbridge Rd, Bronx, NY 10468 USA.	jm.wecht@va.gov			Veterans Affairs Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [A6161W, B3203R, B4162C]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NHS	This research was supported by the Veterans Affairs Rehabilitation Research and Development Service (grant no. A6161W, B3203R and B4162C).; We certify that no party having a direct interest in the results of the research supporting this article has or will confer a benefit on us or on any organization with which we are associated AND, if applicable, we certify that all financial and material support for this research (e. g., NIH or NHS grants) and work are clearly identified in the title page of the manuscript.	AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Barbosa DF, 2010, ARQ BRAS CARDIOL, V94, P507, DOI 10.1590/S0066-782X2010005000006; BAUMAN WA, 1994, METABOLISM, V43, P749, DOI 10.1016/0026-0495(94)90126-0; Bauman WA, 1999, ASSIST TECHNOL, V11, P88, DOI 10.1080/10400435.1999.10131993; BAUMAN WA, 1993, ARCH PHYS MED REHAB, V74, P740, DOI 10.1016/0003-9993(93)90036-A; BAUMAN WA, 1994, ARCH PHYS MED REHAB, V75, P946; Bernardi L, 2000, J AM COLL CARDIOL, V35, P1462, DOI 10.1016/S0735-1097(00)00595-7; BISHOP CCR, 1986, STROKE, V17, P913, DOI 10.1161/01.STR.17.5.913; BROWN TE, 1993, J APPL PHYSIOL, V75, P2310, DOI 10.1152/jappl.1993.75.5.2310; Carral JMC, 2007, GERONTOLOGY, V53, P340, DOI 10.1159/000104098; Chodzko-Zajko W J, 1994, Exerc Sport Sci Rev, V22, P195; Claydon VE, 2006, SPINAL CORD, V44, P341, DOI 10.1038/sj.sc.3101855; Claydon VE, 2006, J NEUROTRAUM, V23, P1713, DOI 10.1089/neu.2006.23.1713; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; DAVIDOFF G, 1988, ARCH PHYS MED REHAB, V69, P869; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P489; Davidoff G, 1990, Arch Clin Neuropsychol, V5, P77, DOI 10.1016/0887-6177(90)90009-E; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; DAVIDOFF GN, 1990, ARCH PHYS MED REHAB, V71, P326; de Leeuw FE, 2000, STROKE, V31, P425, DOI 10.1161/01.STR.31.2.425; DEARWATER SR, 1986, MED SCI SPORT EXER, V18, P541; Dowler R N, 1995, Appl Neuropsychol, V2, P124, DOI 10.1207/s15324826an0203&4_4; Dowler RN, 1997, J INT NEUROPSYCH SOC, V3, P464, DOI 10.1017/S1355617797004645; DROSTE DW, 1989, NEUROPSYCHOLOGIA, V27, P1221, DOI 10.1016/0028-3932(89)90034-1; DROSTE DW, 1989, STROKE, V20, P1005, DOI 10.1161/01.STR.20.8.1005; Duschek S, 2005, BEHAV MED, V30, P149, DOI 10.3200/BMED.30.4.149-160; Duschek S, 2004, PSYCHOPHYSIOLOGY, V41, P905, DOI 10.1111/j.1469-8986.2004.00249.x; Duschek S, 2003, CLIN AUTON RES, V13, P427, DOI 10.1007/s10286-003-0124-4; Duschek S, 2007, CLIN AUTON RES, V17, P69, DOI 10.1007/s10286-006-0379-7; Duschek S, 2007, PSYCHOPHYSIOLOGY, V44, P145, DOI 10.1111/j.1469-8986.2006.00472.x; Duschek S, 2009, BIOL PSYCHOL, V81, P110, DOI 10.1016/j.biopsycho.2009.03.003; Duschek S, 2008, HYPERTENS RES, V31, P1873, DOI 10.1291/hypres.31.1873; Garde E, 2000, LANCET, V356, P628, DOI 10.1016/S0140-6736(00)02604-0; Handrakis JP, 2009, CLIN AUTON RES, V19, P39, DOI 10.1007/s10286-008-0496-6; HARDERS AG, 1989, INT J NEUROSCI, V47, P91, DOI 10.3109/00207458908987421; HILL RD, 1993, J GERONTOL, V48, pP12, DOI 10.1093/geronj/48.1.P12; Hoshikawa Y, 1997, AM J PHYSIOL-HEART C, V272, pH1113, DOI 10.1152/ajpheart.1997.272.3.H1113; Jegede AB, 2010, CLIN AUTON RES, V20, P3, DOI 10.1007/s10286-009-0036-z; Karlsson AK, 1998, BRAIN, V121, P1711, DOI 10.1093/brain/121.9.1711; Kearney-Schwartz A, 2009, STROKE, V40, P1229, DOI 10.1161/STROKEAHA.108.532853; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Krassioukov A, 2006, PROG BRAIN RES, V152, P223, DOI 10.1016/S0079-6123(05)52014-4; Kuo HK, 2007, GERONTOLOGY, V53, P102, DOI 10.1159/000096792; LARSEN FS, 1994, STROKE, V25, P1985, DOI 10.1161/01.STR.25.10.1985; Moody M, 2005, AM J PHYSIOL-REG I, V288, pR1581, DOI 10.1152/ajpregu.00837.2004; Morris MC, 2002, NEUROEPIDEMIOLOGY, V21, P123, DOI 10.1159/000054809; Myers J, 2007, AM J PHYS MED REHAB, V86, P142, DOI 10.1097/PHM.0b013e31802f0247; Raji MA, 2004, ETHNIC DIS, V14, P26; RICHARDS JS, 1988, AM J PHYS MED REHAB, V67, P211, DOI 10.1097/00002060-198810000-00005; Rose KM, 2010, NEUROEPIDEMIOLOGY, V34, P1, DOI 10.1159/000255459; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; Sorond FA, 2008, CORTEX, V44, P179, DOI 10.1016/j.cortex.2006.01.003; SPIRDUSO WW, 1980, J GERONTOL, V35, P850, DOI 10.1093/geronj/35.6.850; Stefani A, 2009, J NEUROL SCI, V283, P109, DOI 10.1016/j.jns.2009.02.343; Triantafyllidi H, 2009, AM J HYPERTENS, V22, P525, DOI 10.1038/ajh.2009.35; van Gijn J, 2000, LANCET, V356, P612, DOI 10.1016/S0140-6736(00)02599-X; Vingerhoets G, 1999, STROKE, V30, P2152, DOI 10.1161/01.STR.30.10.2152; Wecht JM, 2006, CLIN AUTON RES, V16, P378, DOI 10.1007/s10286-006-0367-y; Wecht JM, 2005, J SPINAL CORD MED, V28, P103, DOI 10.1080/10790268.2005.11753806; Wecht JM, 2004, J SPINAL CORD MED, V27, P255, DOI 10.1080/10790268.2004.11753757; Wecht JM, 2003, AM J PHYSIOL-HEART C, V284, pH2393, DOI 10.1152/ajpheart.01115.2002; WILMOT CB, 1985, ARCH PHYS MED REHAB, V66, P227, DOI 10.1016/0003-9993(85)90148-0; Winker R, 2010, WIEN KLIN WOCHENSCHR, V122, P704, DOI 10.1007/s00508-010-1485-z; Yaffe K, 2009, NEUROLOGY, V72, P2029, DOI 10.1212/WNL.0b013e3181a92c36; Zhang R, 2009, J PHYSIOL-LONDON, V587, P2567, DOI 10.1113/jphysiol.2008.168302; Zlomanczuk P, 2006, J PHYSIOL PHARMACOL, V57, P417	66	23	23	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0959-9851	1619-1560		CLIN AUTON RES	Clin. Auton. Res.	FEB	2012	22	1					25	33		10.1007/s10286-011-0139-1			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899XE	WOS:000300849200004	21792728				2022-02-06	
J	Chen, ZY; Leung, LY; Mountney, A; Liao, ZL; Yang, WH; Lu, XCM; Dave, J; Deng-Bryant, Y; Wei, G; Schmid, K; Shear, DA; Tortella, FC				Chen, Zhiyong; Leung, Lai Yee; Mountney, Andrea; Liao, Zhilin; Yang, Weihong; Lu, Xi-Chun May; Dave, Jitendra; Deng-Bryant, Ying; Wei, Guo; Schmid, Kara; Shear, Deborah A.; Tortella, Frank C.			A Novel Animal Model of Closed-Head Concussive-Induced Mild Traumatic Brain Injury: Development, Implementation, and Characterization	JOURNAL OF NEUROTRAUMA			English	Article						biomarker; brain injury; closed-head injury; concussion; mild traumatic projectile concussive impact; motor function; rat helmet	PROFESSIONAL FOOTBALL; COGNITIVE DEFICITS; BIOMECHANICS; IMPACT	Closed-head concussive injury is one of the most common causes of traumatic brain injury (TBI). While single concussions result in short-term neurologic dysfunction, multiple concussions can result in cumulative damage and increased risk for neurodegenerative disease. Despite the prevalence of concussion, knowledge about what occurs in the brain following this injury is limited, in part due to the limited number of appropriate animal research models. To study clinically relevant concussion we recently developed a simple, non-invasive rodent model of closed-head projectile concussive impact (PCI) TBI. For this purpose, anesthetized rats were placed on a platform positioned above a torque-sealed microcentrifuge tube packed with fixed amounts of dry ice. Upon heating, rapid sublimation of the dry ice produced a build-up of compressed CO2 that triggered an eruptive force causing the cap to launch as an intact projectile, resulting in a targeted PCI head injury. A stainless steel helmet was implemented to protect the head from bruising, yet allowing the brain to sustain a mild PCI event. Depending on the injury location and the application of the helmet, PCI-induced injuries ranged from severe (i.e., head injury with subdural hematomas, intracranial hemorrhage, and brain tissue damage), to mild (no head injury, intracranial hemorrhage, or gross morphological pathology). Although no gross pathology was evident in mild PCI-induced injury, the following protein changes and behavioral abnormalities were detected between 1 and 24h after PCI injury: (1) upregulation of glial fibrillary acidic protein (GFAP) in hippocampal regions; (2) upregulation of ubiquitin carboxyl-terminal hydrolase L1 (UCHL-1) in cortical tissue; and (3) significant sensorimotor abnormalities. Overall, these results indicated that this PCI model was capable of replicating salient pathologies of a clinical concussion, and could generate reproducible and quantifiable outcome measures.	[Tortella, Frank C.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, Silver Spring, MD 20910 USA		Tortella, FC (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	Frank.Tortella@AMEDD.ARMY.MIL	Leung, Lai Yee/H-8204-2013; Dave, Jitendra R/A-8940-2011; Shear, Deborah/B-3607-2011		U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC)	This work was supported by core funding provided by the U.S. Army Medical Research and Materiel Command, Combat Casualty Care Research Program.	Armed Forces Health Surveillance Center, 2011, DOD WORLDW NUMB TRAU; Binder S, 2003, REPORT C MILD TRAUMA; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; BROWN IR, 1990, J NEUROSCI RES, V27, P247, DOI 10.1002/jnr.490270302; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Lee M, 2006, INT J IMPACT ENG, V33, P364, DOI 10.1016/j.ijimpeng.2006.09.075; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; Mondello S., 2011, CRITICAL CA IN PRESS; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Papa L., 2011, NAT NEUR S; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Tellier A, 2009, BRAIN INJURY, V23, P879, DOI 10.1080/02699050903200555; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9	21	23	23	0	13	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JAN 20	2012	29	2					268	280		10.1089/neu.2011.2057			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	885SO	WOS:000299801300007	21988140				2022-02-06	
J	Navarro, JC; Pillai, S; Cherian, L; Garcia, R; Grill, RJ; Robertson, CS				Navarro, Jovany Cruz; Pillai, Shibu; Cherian, Leela; Garcia, Robert; Grill, Raymond J.; Robertson, Claudia S.			Histopathological and Behavioral Effects of Immediate and Delayed Hemorrhagic Shock after Mild Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						cerebral ischemia; hypotension; mild traumatic brain injury; shock	CORTICAL IMPACT INJURY; RANDOMIZED CONTROLLED-TRIAL; CEREBRAL-BLOOD-FLOW; HEAD TRAUMA; FLUID RESUSCITATION; SECONDARY INSULT; PROGNOSTIC VALUE; HYPOTENSION; PRESSURE; MODEL	The purpose of this study was to investigate the increased susceptibility of the brain, after a controlled mild cortical impact injury, to a secondary ischemic insult. The effects of the duration and the timing of the secondary insult after the initial cortical injury were studied. Rats anesthetized with isoflurane underwent a 3 m/sec, 2.5-mm deformation cortical impact injury followed by hypotension to 40 mm Hg induced by withdrawing blood from a femoral vein. The duration of hypotension was varied from 40 to 60 mm. The timing of 60 min of hypotension was varied from immediately post-injury to 7 days after the injury. Outcome was assessed by behavioral tasks and histological examination at 2 weeks post-injury. A separate group of animals underwent measurement of the acute physiology including mean blood pressure (MAP), intracranial pressure (ICP), and cerebral blood flow (CBF) using a laser Doppler technique. Increasing durations of hypotension resulted in marked expansion of the contusion, from 6.5 +/- 1.8 mm(3) with sham hypotension to 27.1 +/- 3.9 mm(3) with 60 min of hypotension. This worsening of the contusion was found only when then hypotension occurred immediately after injury or at 1 h after injury. CA3 neuron loss followed a similar pattern, but the injury group differences were not significant. Motor tasks, including beam balance and beam walking, were significantly worse following 50 and 60 min of hypotension. Performance on the Morris water maze task was also significantly related to the injury group. Studies of the acute cerebral hemodynamics demonstrated that CBF was significantly more impaired during hypotension in the animals that underwent the mild TBI compared to those that underwent sham TBI. The perfusion deficit was worst at the impact site, but also significant in the pericontusional brain. With 50 and 60 min of hypotension, CBF did not recover following resuscitation at the impact site, and recovered only transiently in the pericontusional brain. These results demonstrate that mild TBI, like more severe levels of TBI, can impair the brain's ability to maintain CBF during a period of hypotension, and result in a worse outcome.	[Navarro, Jovany Cruz; Pillai, Shibu; Cherian, Leela; Garcia, Robert; Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Grill, Raymond J.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX USA		Robertson, CS (corresponding author), Baylor Coll Med, Dept Neurosurg, 1 Baylor Plaza, Houston, TX 77030 USA.	claudiar@bcm.edu			United States ArmyUnited States Department of Defense [W81XWH-08-2-0132, W81XWH-08-20-150]	This work was funded by United States Army Award numbers W81XWH-08-2-0132 (C.S.R.) and W81XWH-08-20150 (R.J.G.).	Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Ahn ES, 2008, J NEUROSURG, V108, P124, DOI 10.3171/JNS/2008/108/01/0124; Audenaert Kurt, 2003, Med Sci Monit, V9, pMT112; Baker AJ, 2008, J TRAUMA, V64, P348, DOI 10.1097/01.ta.0000245973.71929.db; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Carrillo P, 1998, J TRAUMA, V45, P239, DOI 10.1097/00005373-199808000-00007; Cherian L, 1996, J NEUROTRAUM, V13, P371, DOI 10.1089/neu.1996.13.371; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276, DOI 10.1152/ajpheart.1992.263.4.H1276; Exo JL, 2009, J NEUROTRAUM, V26, P2403, DOI 10.1089/neu.2009.0980; Feldman Z, 1997, J TRAUMA, V43, P667, DOI 10.1097/00005373-199710000-00017; Fritz HG, 2005, J NEUROTRAUM, V22, P807, DOI 10.1089/neu.2005.22.807; Geeraerts T, 2008, INTENS CARE MED, V34, P551, DOI 10.1007/s00134-007-0863-0; Giri BK, 2000, STROKE, V31, P961, DOI 10.1161/01.STR.31.4.961; Golding EM, 1998, J NEUROTRAUM, V15, P973, DOI 10.1089/neu.1998.15.973; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Henninger N, 2005, EXP NEUROL, V195, P447, DOI 10.1016/j.expneurol.2005.06.013; Hlatky R, 2002, J NEUROSURG, V97, P1054, DOI 10.3171/jns.2002.97.5.1054; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kroppenstedt SN, 1999, J NEUROSURG, V90, P520, DOI 10.3171/jns.1999.90.3.0520; Lorberboym M, 2002, AM J EMERG MED, V20, P310, DOI 10.1053/ajem.2002.34201; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Mathew BP, 1999, J NEUROTRAUM, V16, P1177, DOI 10.1089/neu.1999.16.1177; Matsushita Y, 2001, J CEREBR BLOOD F MET, V21, P847, DOI 10.1097/00004647-200107000-00010; Meier J, 2004, SHOCK, V22, P240, DOI 10.1097/01.shk.0000131192.02909.4c; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MOREHEAD M, 1994, J NEUROTRAUM, V11, P657, DOI 10.1089/neu.1994.11.657; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nariai T, 2001, J NEUROTRAUM, V18, P1323, DOI 10.1089/08977150152725623; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Paul M, 2010, TRAUMATIC BRAIN INJU; Schmidt RH, 2000, J NEUROTRAUM, V17, P1129, DOI 10.1089/neu.2000.17.1129; Schutz C, 2006, CRIT CARE MED, V34, P492, DOI 10.1097/01.CCM.0000198326.32049.7F; Sell SL, 2008, ANESTHESIOLOGY, V108, P873, DOI 10.1097/ALN.0b013e31816c8a15; Statler KD, 2000, CRIT CARE MED, V28, pA53	45	23	25	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 20	2012	29	2					322	334		10.1089/neu.2011.1979			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	885SO	WOS:000299801300011	22077317				2022-02-06	
J	Sarntinoranont, M; Lee, SJ; Hong, Y; King, MA; Subhash, G; Kwon, J; Moore, DF				Sarntinoranont, Malisa; Lee, Sung J.; Hong, Yu; King, Michael A.; Subhash, Ghatu; Kwon, Jiwoon; Moore, David F.			High-Strain-Rate Brain Injury Model Using Submerged Acute Rat Brain Tissue Slices	JOURNAL OF NEUROTRAUMA			English	Article						acute brain slice model; digital image correlation; high-strain-rate loading; hippocampal injury	FLUORO-JADE-C; MECHANICAL STRETCH; NEURONS; CARE	Blast-induced traumatic brain injury (bTBI) has received increasing attention in recent years due to ongoing military operations in Iraq and Afghanistan. Sudden impacts or explosive blasts generate stress and pressure waves that propagate at high velocities and affect sensitive neurological tissues. The immediate soft tissue response to these stress waves is difficult to assess using current in vivo imaging technologies. However, these stress waves and resultant stretching and shearing of tissue within the nano- to microsecond time scale of blast and impact are likely to cause initial injury. To visualize the effects of stress wave loading, we have developed a new ex vivo model in which living tissue slices from rat brain, attached to a ballistic gelatin substrate, were subjected to high-strain-rate loads using a polymer split Hopkinson pressure bar (PSHPB) with real-time highspeed imaging. In this study, average peak fluid pressure within the test chamber reached a value of 1584 +/- 63.3 psi. Cavitation due to a trailing underpressure wave was also observed. Time-resolved images of tissue deformation were collected and large maximum eigenstrains (0.03-0.42), minimum eigenstrains (-0.33 to -0.03), maximum shear strains (0.09-0.45), and strain rates (8.4x10(3)/sec) were estimated using digital image correlation (DIC). Injury at 4 and 6 h was quantified using Fluoro-Jade C. Neuronal injury due to PSHPB testing was found to be significantly greater than injury associated with the tissue slice paradigm alone. While large pressures and strains were encountered for these tests, this system provides a controllable test environment to study injury to submerged brain slices over a range of strain rate, pressure, and strain loads.	[Sarntinoranont, Malisa; Lee, Sung J.; Hong, Yu; Subhash, Ghatu; Kwon, Jiwoon] Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL 32611 USA; [King, Michael A.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32611 USA; [King, Michael A.] Malcolm Randall VA Med Ctr, Gainesville, FL USA; [Moore, David F.] Tulane Univ, Sch Med, Dept Neurol, New Orleans, LA 70112 USA		Subhash, G (corresponding author), Univ Florida, Dept Mech & Aerosp Engn, 129 NEB,POB 116250, Gainesville, FL 32611 USA.	subhash@ufl.edu	Subhash, Ghatu/J-4851-2017	Subhash, Ghatu/0000-0002-5996-0909	Army Research Office [W911NF-10-1-0276]	The authors would like to thank Dr. Stephen Blackband for kindly allowing us to use his laboratory facilities for animal surgery, and Dr. Jeremy Flint for providing guidance for brain slice experiments. The authors would like to thank Drs. Stan Svetlov and Bruce LaMattina for helpful discussions on bTBI. This research was funded in part by the Army Research Office (award number W911NF-10-1-0276).	Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bian GL, 2007, BRAIN RES, V1150, P55, DOI 10.1016/j.brainres.2007.02.078; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Jaffee MS, 2009, J REHABIL RES DEV, V46, P655, DOI 10.1682/JRRD.2008.09.0114; Kwon J, 2010, J BIOMECH, V43, P420, DOI 10.1016/j.jbiomech.2009.10.008; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lauret C, 2009, MED ENG PHYS, V31, P392, DOI 10.1016/j.medengphy.2008.05.004; Lee SJ, 2011, J BIOMED MATER RES B, V97B, P84, DOI 10.1002/jbm.b.31789; Liu QL, 2006, MECH MATER, V38, P1105, DOI 10.1016/j.mechmat.2006.01.001; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Miller DL, 2007, PROG BIOPHYS MOL BIO, V93, P314, DOI 10.1016/j.pbiomolbio.2006.07.027; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Morrison B, 2000, J BIOMECH ENG-T ASME, V122, P224, DOI 10.1115/1.429650; Nishimura N, 2006, NAT METHODS, V3, P99, DOI 10.1038/NMETH844; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Pan B, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/6/062001; RUAN JS, 1991, J BIOMECH ENG-T ASME, V113, P276, DOI 10.1115/1.2894885; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Smith DH, 1999, J NEUROSCI, V19, P4263; Subhash G, 2006, INT J IMPACT ENG, V32, P1113, DOI 10.1016/j.ijimpeng.2004.11.006; Subhash G., 2000, ASM HDB MECH TESTING, V8, P519; Subhash G., 2000, MECH TEST EVAL, P497, DOI [10.31399/asm.hb.v08, DOI 10.31399/ASM.HB.V08]; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Vogel A, 2005, APPL PHYS B-LASERS O, V81, P1015, DOI 10.1007/s00340-005-2036-6; Yanik MF, 2004, NATURE, V432, P822, DOI 10.1038/432822a; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	32	23	23	2	32	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 20	2012	29	2					418	429		10.1089/neu.2011.1772			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	885SO	WOS:000299801300021	21970544				2022-02-06	
J	Crane, AT; Fink, KD; Smith, JS				Crane, Andrew T.; Fink, Kyle D.; Smith, Jeffrey S.			The effects of acute voluntary wheel running on recovery of function following medial frontal cortical contusions in rats	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Traumatic brain injury; physiotherapy; executive function	TRAUMATIC BRAIN-INJURY; INHIBITORY CONTROL; EXERCISE; PLASTICITY; MOTOR; ENRICHMENT; LESIONS; CORTEX	Purpose: Traumatic brain injury (TBI) produces significant deficits in executive function, sensory-motor function, and on spatial learning tasks. We wish to study if recovery from TBI can be benefited by voluntary exercise. Methods: A variation of the stop-signal reaction time (SSRT) task was employed to measure rats ability to obtain maximum reinforcers in a complex behavioral task. A 2x2 (lesion x treatment) experimental design was constructed with 31 weight restricted male Long-Evans rats which received either bilateral cortical contusions to the medial frontal cortex or sham preparations following the acquisition of the SSRT task (matched based on pre-surgical performance). Following surgery, rats were randomly assigned to either an environment with free access to running wheels or traditional single housing without running wheels. Results: Rats receiving a bilateral TBI performed significantly worse than sham operated rats on a complex task. Contrary to our original hypothesis, acute exercise following injury exacerbated the deficits in the complex task that did not return to levels of the injured rats without access to running wheels until post-TBI day 13. Conclusion: We found a significant interaction between severe bilateral TBI and the introduction of voluntary exercise immediately post-injury. In this paradigm, voluntary wheel running exacerbated the TBI-induced deficit, rather than reducing it.	[Smith, Jeffrey S.] Saginaw Valley State Univ, Malcolm & Lois Field Endowed Chair Hlth Sci, Dept Hlth Sci, Crystal M Lange Coll Hlth & Human Serv, University Ctr, MI 48710 USA; [Crane, Andrew T.; Fink, Kyle D.] Cent Michigan Univ, Neurosci Grad Program, Mt Pleasant, MI USA		Smith, JS (corresponding author), Saginaw Valley State Univ, Malcolm & Lois Field Endowed Chair Hlth Sci, Dept Hlth Sci, Crystal M Lange Coll Hlth & Human Serv, 7400 Bay Rd, University Ctr, MI 48710 USA.	jsmith12@svsu.edu		Crane, Andrew/0000-0003-3452-2766; Smith, Jeffrey/0000-0001-5499-4475	Support of Mentors and their Students (SOMAS) program; M.J. Murdock Charitable Trust; National Science Foundation (NSF)National Science Foundation (NSF) [0633459]	This work was supported by funding from the Support of Mentors and their Students (SOMAS) program, the M.J. Murdock Charitable Trust, and the National Science Foundation (NSF award #0633459 to JSS, 2008). The authors would like to thank the students of the 2008 Principle and Procedures in Neuroscience class. ATC and KDF both provided the same amount of effort on this manuscript and therefore both deserve to share co-first authorship.	Anderson BJ, 2000, PHYSIOL BEHAV, V70, P425, DOI 10.1016/S0031-9384(00)00282-1; Anderson BJ, 2002, LEARN MEMORY, V9, P1, DOI 10.1101/lm.43402; Chytrova G, 2008, EUR J NEUROSCI, V27, P1, DOI 10.1111/j.1460-9568.2007.05982.x; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; Eagle DM, 2003, BEHAV BRAIN RES, V146, P131, DOI 10.1016/j.bbr.2003.09.022; Eagle DM, 2003, BEHAV NEUROSCI, V117, P1302, DOI 10.1037/0735-7044.117.6.1302; ETNIER JL, 1995, SPORTS MED, V19, P81, DOI 10.2165/00007256-199519020-00001; Faul M, 2010, TRAUMATIC BRAIN INJU; Floyd CL, 2007, PROG BRAIN RES, V161, P61, DOI 10.1016/S0079-6123(06)61005-4; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hicks RR, 1998, RESTOR NEUROL NEUROS, V12, P41; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; Kleim JA, 2003, NEUROCHEM RES, V28, P1757, DOI 10.1023/A:1026025408742; KOLB B, 1983, CAN J PSYCHOL, V37, P211, DOI 10.1037/h0080724; Marin R, 2003, PHYSIOL BEHAV, V80, P167, DOI 10.1016/j.physbeh.2003.06.001; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; Ploughman M, 2007, BRAIN RES, V1150, P207, DOI 10.1016/j.brainres.2007.02.065; Smith JS, 2000, NEURAL PLAST, V7, P73, DOI 10.1155/NP.2000.73; Stein DG, 2003, J HEAD TRAUMA REHAB, V18, P317, DOI 10.1097/00001199-200307000-00004; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Vaynman S, 2004, J NEUROSCI RES, V76, P356, DOI 10.1002/jnr.20077; Vaynman S, 2003, NEUROSCIENCE, V122, P647, DOI 10.1016/j.neuroscience.2003.08.001; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001	27	23	24	0	10	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2012	30	4					325	333		10.3233/RNN-2012-120232			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	973OA	WOS:000306368300006	22596352				2022-02-06	
J	Green, L; Godfrey, C; Soo, C; Anderson, V; Catroppa, C				Green, Laura; Godfrey, Celia; Soo, Chery; Anderson, Vicki; Catroppa, Cathy			Agreement between parent-adolescent ratings on psychosocial outcome and quality-of-life following childhood traumatic brain injury	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Childhood TBI; agreement; insight; proxy; PedsQL; SPRS-C	SHORT-TERM; SELF-REPORT; CHILDREN; HEALTH; AWARENESS; BEHAVIOR; RECOVERY; QUESTIONNAIRE; RELIABILITY; RELATIVES	Objective: This study investigated parent-adolescent agreement in long-term psychosocial and quality-of-life (QoL) outcomes. The sample comprised adolescents aged 15-18 years, who sustained childhood traumatic brain injury (TBI) between birth and 5 years of age. Methods: Thirty-three participants (17 adolescents with TBI and 16 TBI parent-proxies) were involved in the study which compared parent and adolescent ratings on the Sydney Psychosocial Reintegration Scale-Child form (SPRS-C) and the Pediatric Quality-of-Life Inventory (PedsQL). The questionnaires were administered through phone interviews. Results: As hypothesized, parent-adolescent agreement was acceptable for psychosocial outcome (intra-class coefficient [ICC] of 0.844, p < 0.001), whereas discrepancies were found for ratings of QoL (ICC of 0.506, p = 0.092). Conclusion: The finding that parents and adolescents agree on psychosocial outcome is promising for those instances when the patient is unable to report; however, discrepancies regarding QoL suggest caution needs to be taken when interpreting parent-rated QoL data.	[Godfrey, Celia; Soo, Chery; Anderson, Vicki; Catroppa, Cathy] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Green, Laura; Catroppa, Cathy] Univ Melbourne, Melbourne, Vic 3010, Australia; [Catroppa, Cathy] Royal Childrens Hosp, Melbourne, Vic, Australia		Catroppa, C (corresponding author), Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	cathy.catroppa@mcri.edu	Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436	Murdoch Children's Research Institute; Royal Children's Hospital, Melbourne; Victorian Government's Operational Infrastructure Support Program; Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia	This research was supported by the Murdoch Children's Research Institute, the Royal Children's Hospital, Melbourne and the Victorian Government's Operational Infrastructure Support Program. Funding was also provided from the Australian National Health and Medical Research Council.	Alonso EM, 2010, J PEDIATR-US, V156, P270, DOI 10.1016/j.jpeds.2009.08.048; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V, 2007, BRAIN INJURY, V21, P1399, DOI 10.1080/02699050701785070; Anderson V, 2010, NEUROPSYCHOLOGIA, V48, P2041, DOI 10.1016/j.neuropsychologia.2010.03.025; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; Berg-Nielsen TS, 2003, CHILD CARE HLTH DEV, V29, P207, DOI 10.1046/j.1365-2214.2003.00332.x; Brown M, 2000, BRAIN INJURY, V14, P5, DOI 10.1080/026990500120899; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Chevignard M, 2010, CHILD CARE HLTH DEV, V36, P31, DOI 10.1111/j.1365-2214.2009.00949.x; Cicchetti DV, 2001, J CLIN EXP NEUROPSYC, V23, P695, DOI 10.1076/jcen.23.5.695.1249; Coghill D, 2009, J CHILD PSYCHOL PSYC, V50, P544, DOI 10.1111/j.1469-7610.2009.02008.x; Crooks Carol Y, 2007, Phys Med Rehabil Clin N Am, V18, P681, DOI 10.1016/j.pmr.2007.06.005; Daniel A., 1983, POWER PRIVILEGE PRES; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Eiser C, 2001, QUAL LIFE RES, V10, P347, DOI 10.1023/A:1012253723272; Gan C, 2002, BRAIN INJURY, V16, P311, DOI 10.1080/02699050110104426; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Hart T, 2010, J HEAD TRAUMA REHAB, V25, P339, DOI 10.1097/HTR.0b013e3181c7e60b; Hartung CM, 2005, J PSYCHOPATHOL BEHAV, V27, P159, DOI 10.1007/s10862-005-0632-8; Hellawell DJ, 2000, DISABIL REHABIL, V22, P446, DOI 10.1080/09638280050045910; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; Kramer TL, 2004, J CHILD PSYCHOL PSYC, V45, P248, DOI 10.1111/j.1469-7610.2004.00217.x; Kuipers P, 2004, BRAIN INJURY, V18, P161, DOI 10.1080/0269905031000149524; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; Loeber R., 1989, DEV PSYCHOPATHOL, V1, P317, DOI DOI 10.1017/S095457940000050X; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; Prigatano GP, 1996, CLIN NEUROPSYCHOL, V10, P191, DOI 10.1080/13854049608406680; Salter K, 2008, BRAIN INJURY, V22, P820, DOI 10.1080/02699050802425428; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Snow AL, 2005, HEALTH SERV RES, V40, P1676, DOI 10.1111/j.1475-6773.2005.00447.x; Soo C, ADAPTING SYDNE UNPUB; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TEASDALE G, 1974, LANCET, V2, P81; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-1; Varni JW, 2007, HEALTH QUAL LIFE OUT, P5; Waters E, 2003, CHILD CARE HLTH DEV, V29, P501, DOI 10.1046/j.1365-2214.2003.00370.x; Wehmeier PM, 2008, CHILD ADOL PSYCH CL, V2, P1; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	51	23	23	0	17	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.		2012	15	2					105	113		10.3109/17518423.2011.638331			9	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Rehabilitation	923SB	WOS:000302638100004	22432599				2022-02-06	
J	Grujicic, M; d'Entremont, B; Pandurangan, B; Grujicic, A; LaBerge, M; Runt, J; Tarter, J; Dillon, G				Grujicic, M.; d'Entremont, B.; Pandurangan, B.; Grujicic, A.; LaBerge, M.; Runt, J.; Tarter, J.; Dillon, G.			A study of the blast-induced brain white-matter damage and the associated diffuse axonal injury	MULTIDISCIPLINE MODELING IN MATERIALS AND STRUCTURES			English	Article						Traumatic brain injury; Brain white matter; Diffuse axonal injury; Brain; Stress	MECHANICAL-PROPERTIES; IN-VIVO; TISSUE; BEHAVIOR; SHEAR; AFGHANISTAN; STEM	Purpose - Blast-induced traumatic brain injury (TBI) is a signature injury of the current military conflicts. Among the different types of TBI, diffuse axonal injury (DAI) plays an important role since it can lead to devastating effects in the inflicted military personnel. To better understand the potential causes associated with DAI, this paper aims to investigate a transient non-linear dynamics finite element simulation of the response of the brain white matter to shock loading. Design/methodology/approach - Brain white matter is considered to be a heterogeneous material consisting of fiber-like axons and a structure-less extracellular matrix (ECM). The brain white matter microstructure in the investigated corpus callosum region of the brain is idealized using a regular hexagonal arrangement of aligned equal-size axons. Deviatoric stress response of the axon and the ECM is modeled using a linear isotropic viscoelastic formulation while the hydrostatic stress response is modeled using a shock-type equation of state. To account for the stochastic character of the brain white matter microstructure and shock loading, a parametric study is carried out involving a factorial variation of the key microstructural and waveform parameters. Findings - The results obtained show that the extent of axon undulations and the strength of axon/ECM bonding profoundly affect the spatial distribution and magnitude of the axonal axial normal and shear stresses (the stresses which can cause diffuse axonal injury). Originality/value - The present approach enables a more accurate determination of the mechanical behavior of brain white matter when subjected to a shock.	[Grujicic, M.; d'Entremont, B.; Pandurangan, B.] Clemson Univ, Dept Mech Engn, Clemson, SC 29631 USA; [Grujicic, A.; LaBerge, M.] Clemson Univ, Dept Bioengn, Clemson, SC 29631 USA; [Runt, J.] Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA; [Tarter, J.; Dillon, G.] Penn State Univ, Appl Res Labs, University Pk, PA 16802 USA		Grujicic, M (corresponding author), Clemson Univ, Dept Mech Engn, Clemson, SC 29631 USA.	gmica@clemson.edu					ABAQUS, 2010, US DOC; Abolfathi N, 2009, COMPUT METHOD BIOMEC, V12, P249, DOI [10.1080/10255840802430587, 10.1080/10255840903097871]; Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; Arbogast KB, 1999, J BIOMECH, V32, P865, DOI 10.1016/S0021-9290(99)00042-1; Arbogast KB, 1997, J BIOMECH, V30, P757, DOI 10.1016/S0021-9290(97)00023-7; Bain AC, 2003, J BIOMECH ENG-T ASME, V125, P798, DOI 10.1115/1.1632627; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bilston LE, 1997, BIORHEOLOGY, V34, P377, DOI 10.1016/S0006-355X(98)00022-5; Bilston LE, 2001, BIORHEOLOGY, V38, P335; Brands Dave W A, 2002, Stapp Car Crash J, V46, P103; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Christou GA, 2010, THESIS; Donnelly BR, 1997, J BIOMECH ENG-T ASME, V119, P423, DOI 10.1115/1.2798289; Findley W.N., 1976, CREEP RELAXATION NON; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; Goel R, 2011, THESIS; Grujicic M, 2011, J MATER ENG PERFORM, V20, P877, DOI 10.1007/s11665-010-9724-z; Grujicic M, 2010, MATER DESIGN, V31, P4050, DOI 10.1016/j.matdes.2010.05.002; Grujicic M., 2011, J MAT DESIG IN PRESS; HASHIN Z, 1965, J APPL MECH, V32, P219, DOI 10.1115/1.3625735; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hrapko M, 2006, BIORHEOLOGY, V43, P623; Hyde D.W., 1988, USERS GUIDE MICROCOM; Meaney DF, 2003, BIOMECH MODEL MECHAN, V1, P279, DOI 10.1007/s10237-002-0020-1; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Miller K, 2000, J BIOMECH, V33, P1369, DOI 10.1016/S0021-9290(00)00120-2; Miller K, 2001, J BIOMECH, V34, P651, DOI 10.1016/S0021-9290(00)00236-0; Nicolle S, 2005, BIORHEOLOGY, V42, P209; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; STEPHEN G, 1995, AXON STRUCTURE FUNCT; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Wallsten S. J., 2005, 0519 SOC SCI RES NET; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006	39	23	23	0	0	EMERALD GROUP PUBLISHING LTD	BINGLEY	HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND	1573-6105	1573-6113		MULTIDISCIP MODEL MA	Multidiscip. Model. Mater. Struct.		2012	8	2					213	245		10.1108/15736101211251220			33	Materials Science, Multidisciplinary; Mechanics	Emerging Sources Citation Index (ESCI)	Materials Science; Mechanics	V1U7W	WOS:000217253900005					2022-02-06	
J	Arango-Lasprilla, JC; Ketchum, JM; Lewis, AN; Krch, D; Gary, KW; Dodd, BA				Arango-Lasprilla, Juan Carlos; Ketchum, Jessica M.; Lewis, Allen N.; Krch, Denise; Gary, Kelli W.; Dodd, Brett Anthony, Jr.			Racial and Ethnic Disparities in Employment Outcomes for Persons With Traumatic Brain Injury: A Longitudinal Investigation 1-5 Years After Injury	PM&R			English	Article							COMMUNITY INTEGRATION; ACUTE PREDICTORS; HEAD TRAUMA; RETURN; WORK; DISABILITY; REHABILITATION; POPULATION; PREVALENCE; LIFE	Objective: To determine whether differences exist in employment rates between whites, blacks, and Hispanics with traumatic brain injury (TBI) at 1, 2, or 5 years after injury; to determine whether changes occur in postinjury employment rates over time for whites, blacks, and Hispanics; and to determine whether changes in postinjury employment rates over time are different for whites, blacks, and Hispanics. Setting: Sixteen TBI Model System centers. Patients or Other Participants: Persons (3,940) with moderate-to-severe TBI who self-reported as white, black, or Hispanic. Main Outcome Measurements: Employment status dichotomized as competitively employed versus not competitively employed. Results: The odds of competitive employment were significantly greater for whites versus blacks at 1, 2, and 5 years after injury and were greater for whites versus Hispanics at 1 and 2 years after injury; whites and Hispanics did not differ significantly at 5 years after injury; and blacks and Hispanics were not significantly different at 1, 2, or 5 years after injury. The odds of employment increased significantly from 1-2, 2-5, and 1-5 years after injury for whites and Hispanics, whereas the odds of employment increased from 2-5 and 1-5 years after injury for blacks, with no significant difference between 1 and 2 years after injury for blacks. No evidence was found that the changes in employment rates over time were significantly different among the race and/or ethnicity groups. Conclusion: Future researchers should seek to identify causative factors for employment disparities, and rehabilitation professionals should work to mitigate inequalities in employment among racial and ethnic groups with TBI. PM R 2011;3:1083-1091	[Arango-Lasprilla, Juan Carlos] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Sch Med, Richmond, VA 23219 USA; [Ketchum, Jessica M.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23219 USA; [Ketchum, Jessica M.] Virginia Commonwealth Univ, Ctr Rehabil Sci & Engn, Richmond, VA 23219 USA; [Lewis, Allen N.] Virginia Commonwealth Univ, Dept Rehabil Counseling, Richmond, VA 23219 USA; [Krch, Denise] Kessler Fdn, Res Ctr, W Orange, NJ USA; [Gary, Kelli W.] Virginia Commonwealth Univ, Dept Occupat Therapy, Richmond, VA 23219 USA; [Dodd, Brett Anthony, Jr.] Regents Univ, Sch Psychol & Counseling, Virginia Beach, VA USA		Arango-Lasprilla, JC (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Sch Med, Richmond, VA 23219 USA.	jcarangolasp@vcu.edu	Ketchum, Jessica/AAE-8200-2020	Ketchum, Jessica/0000-0002-5566-3691	National Institute of Disability and Rehabilitation Research [H133A070036]; United States Department of EducationUS Department of Education [H133A080060]; Department of Education, NIDRR [H133P090009]	This work was supported by the National Institute of Disability and Rehabilitation Research (grant H133A070036) and the United States Department of Education (grant H133A080060).; The contents of this article were developed partially under a grant from the Department of Education, NIDRR grant number H133P090009. However, those contents do not necessarily represent the policy of the Department of Education, and you should not assume endorsement by the Federal Government.	Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Arango-Lasprilla JC, 2008, ARCH PHYS MED REHAB, V89, P988, DOI 10.1016/j.apmr.2008.02.012; Arango-Lasprilla JC, 2009, PM&R, V1, P41, DOI 10.1016/j.pmrj.2008.07.001; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; COOPER K D, 1983, Neuroepidemiology, V2, P70, DOI 10.1159/000110512; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Cardoso EDS, 2007, J HEAD TRAUMA REHAB, V22, P85, DOI 10.1097/01.HTR.0000265096.44683.6b; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Fleming J, 1999, BRAIN INJURY, V13, P417; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; FRANKOWSKI RF, 1985, CENTRAL NERVOUS SYST; Gamboa AM, 2006, NEUROREHABILITATION, V21, P327; Gary KW, 2010, J VOCAT REHABIL, V33, P65, DOI 10.3233/JVR-2010-0516; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; Izaute M, 2008, BRAIN INJURY, V22, P758, DOI 10.1080/02699050802366002; Johansson U, 2003, BRAIN INJURY, V17, P991, DOI 10.1080/0269905031000110508; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lemeshow S, 2000, APPL LOGISTIC REGRES; Lewis A, 2009, DISABIL REHABIL, V31, P1136, DOI 10.1080/09638280902773737; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; *STAT U NEW YORK B, 1997, GUID UN DAT SET MED; Tsaousides T, 2008, REHABIL PSYCHOL, V53, P456, DOI 10.1037/a0012579; U.S. Census Bureau, AM COMM SURV 5 YEAR; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	39	23	23	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	DEC	2011	3	12					1083	1091		10.1016/j.pmrj.2011.05.023			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	966YG	WOS:000305872700002	21872550				2022-02-06	
J	Auxemery, Y; Fidelle, G				Auxemery, Y.; Fidelle, G.			Psychosis and trauma. Theorical links between post-traumatic and psychotic symptoms	ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE			French	Article						Post-traumatic stress disorder; Psychosis; Schizophrenia; Trauma	SEVERE MENTAL-ILLNESS; STRESS-DISORDER; BRAIN-INJURY; SCHIZOPHRENIA; VETERANS; FEATURES; SEVERITY; HISTORY; ABUSE; PTSD	Introduction. - The co-occurrence between post-traumatic symptoms and psychotic symptoms is well described in the immediate suites of a trauma but can also be chronic. This symptomatic co-occurrence, rarely studied in the literature, is often approached under the sole angle of a primary post-traumatic stress disorder (PTSD) or of a primary psychosis, without federative will to unify the psychotic and post-traumatic symptoms within the same nosological framework. Individuals with schizophrenia or schizoaffective disorder report higher rates of trauma and assault than the general population. Literature findings. - High rates of PTSD have been noted in severe mental illness cohorts. Psychotic phenomena may be a relatively common manifestation in patients with chronic PTSD. Aim. The purpose of this paper is to expose the various theorical psychopathological aspects between the symptoms of psychosis and PTSD. In populations of veterans, positive and negative symptoms of psychosis in PTSD are described as delusional thoughts and hallucinations often combat-specific. Clinical findings. - When a PTSD becomes established at a subject to the personality of neurotic structure, the intensity of the PTSD's symptoms lead to a psychotic expression which constitutes a factor of seriousness. Besides, PTSD often induces a risk of substance use disorder supplying psychotic symptoms. Cannabis increases the hallucinations, cocaine strengthens an underlying paranoid tone, and alcohol implies withdrawal hallucinosis. Moreover, such consumption could be a risk factor for the future development of chronic psychosis. From another point of view, by basing themselves on the plasma dopamine beta-hydroxylase activity, some authors made the analogy between psychotic major depression and PTSD with psychotic features (also characterized as a distinct psychotic subtype of PTSD). However, other studies found no correlation between PTSD with psychotic features and family predisposition for schizophrenia or schizoaffective disorder. Discussion. - The determination of the structure of personality seems fundamental in the understanding of the symptoms. A personality of psychotic structure increases the risk of traumatization and PTSD. At the same time, the fragility of this structure causes an increased sensitivity to the trauma, which takes on a particular echo. Moreover, a trauma can test a Latent psychotic structure to reveal its existence. The experience of psychosis may be traumatic in itself for patients with, notably, seclusion and sedation during hospitalization. Lastly, the symptoms of this post-traumatic psychosis will be differentiated from neurological confusion caused by a traumatic brain injury. Clinicians often fail to screen routinely for trauma and PTSD symptoms in patients with severe mental illness because few systematic guidelines exist for the identification and treatment of this comorbidity. Conclusion. - The links between psychotic and psycho-traumatic symptoms are complex and multidirectional; this co-occurrence is a factor of seriousness. The clinician, while paying attention to these symptoms, has to distinguish the structure of the personality of the subject to articulate the psychotherapy and the pharmacological treatment. Further investigational studies may determine whether antipsychotics will enhance treatment response in PTSD patients with psychotic features. (C) L'Encephale, Paris, 2010.	[Auxemery, Y.] Hop Instruct Armees Legouest, Serv Psychiat & Psychol Clin, F-57077 Metz 3, France; [Fidelle, G.] Hop Instruct Armees Percy, F-92141 Clamart, France		Auxemery, Y (corresponding author), Hop Instruct Armees Legouest, Serv Psychiat & Psychol Clin, 27 Ave Plantieres,BP 90001, F-57077 Metz 3, France.	yann.auxemery@hotmail.fr					Ahmed I, 1998, Semin Clin Neuropsychiatry, V3, P23; American Psychiatric Association, 1980, DIAGN STAT MAN MENT; Auxemery Y., 2010, REV FRANCOPHONE STRE, V10, P169; Bennouna M, 2007, ENCEPHALE, V33, P616; Bessoles P, 2006, ENCEPHALE, V32, P729; Braakman MH, 2009, ACTA PSYCHIAT SCAND, V119, P15, DOI 10.1111/j.1600-0447.2008.01252.x; Brady KT, 2000, J CLIN PSYCHIAT, V61, P22; BRENDE JO, 1985, VIETNAM VETERANS ROA; Calhoun PS, 2007, SCHIZOPHR RES, V91, P210, DOI 10.1016/j.schres.2006.12.011; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Crocq L., 1992, PSYCHOL MED, V24, P427; Crocq L., 1999, TRAUMATISMES PSYCHIQ; De Mol J, 1982, Encephale, V8, P17; Goodman LA, 1997, SCHIZOPHRENIA BULL, V23, P685, DOI 10.1093/schbul/23.4.685; GREENFIELD SF, 1994, BRIT J PSYCHIAT, V164, P831, DOI 10.1192/bjp.164.6.831; Hamner MB, 1998, PSYCHIAT RES, V77, P175, DOI 10.1016/S0165-1781(98)00002-X; Hamner MB, 1999, BIOL PSYCHIAT, V45, P846, DOI 10.1016/S0006-3223(98)00301-1; Hamner MB, 2000, J NERV MENT DIS, V188, P217, DOI 10.1097/00005053-200004000-00004; Kozaric-Kovacic D, 2005, J CLIN PSYCHIAT, V66, P922, DOI 10.4088/JCP.v66n0716; LAVIE M, 2007, REV FRANCOPHONE STRE, V7, P11; Mueser KT, 1998, J CONSULT CLIN PSYCH, V66, P493, DOI 10.1037/0022-006X.66.3.493; Mueser KT, 2002, SCHIZOPHR RES, V53, P123, DOI 10.1016/S0920-9964(01)00173-6; Resnick SG, 2003, J ABNORM PSYCHOL, V112, P415, DOI 10.1037/0021-843X.112.3.415; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; Sareen J, 2005, J TRAUMA STRESS, V18, P313, DOI 10.1002/jts.20040; Sautter FJ, 2003, BIOL PSYCHIAT, V54, P1382, DOI 10.1016/S0006-3223(03)00571-7; Sautter FJ, 2002, AM J PSYCHIAT, V159, P1775, DOI 10.1176/appi.ajp.159.10.1775; Senninger JL, 1987, REV FR DOMMAGE CORP, V13, P131; Shaw K, 1997, J NERV MENT DIS, V185, P434, DOI 10.1097/00005053-199707000-00003; Shaw K, 2002, J TRAUMA STRESS, V15, P39, DOI 10.1023/A:1014331211311; Stewart SH, 1996, PSYCHOL BULL, V120, P83, DOI 10.1037/0033-2909.120.1.83; Strauss JL, 2006, SCHIZOPHR RES, V84, P165, DOI 10.1016/j.schres.2006.02.010; Thomas G, 2009, NEUROCHIRURGIE, V55, P36, DOI 10.1016/j.neuchi.2008.09.002; Vergnes C, 2007, REV FRANCOPHONE STRE, V7, P27; Zhang Qingchen, 2003, Curr Psychiatry Rep, V5, P197, DOI 10.1007/s11920-003-0042-0; Zimmerman M, 1999, J CLIN PSYCHIAT, V60, P311, DOI 10.4088/JCP.v60n0508	36	23	24	1	40	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0013-7006			ENCEPHALE	Enceph.-Rev. Psychiatr. Clin. Biol. Ther.	DEC	2011	37	6					433	438		10.1016/j.encep.2010.12.001			6	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	869CF	WOS:000298572600006	22137215				2022-02-06	
J	Taha, AA; Badr, L; Westlake, C; Dee, V; Mudit, M; Tiras, KL				Taha, Asma A.; Badr, Lina; Westlake, Cheryl; Dee, Vivien; Mudit, Mathur; Tiras, Kathyrne L.			Effect of Early Nutritional Support on Intensive Care Unit Length of Stay and Neurological Status at Discharge in Children With Severe Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE NURSING			English	Article							HEAD-INJURY; OUTCOMES	Pediatric severe traumatic brain injury treatment guidelines for nutrition indicate that "there are insufficient data to support a treatment guideline for this topic" (P. D. Adelson et al., 2003). Based on adult studies, the guideline provided an option for practitioners to start nutritional support within 72 hours of admission and full replacement by day 7. This retrospective, descriptive correlation study examined the timing of nutritional supplement initiation and the timing of achieving full caloric intake in relation to length of stay (LOS) in the intensive care unit (ICU) and patient disposition status at discharge from hospital in children 8-18 years old. Median time to initiation of nutrition was 1.5 days (0.02-11.9 days), and full caloric goals were achieved in 3.4 days (0.5-19.6 days). Median ICU LOS was 2.1 days (0.01-97.9 days). Overall, 48% of patients were discharged home; 28% experienced mild, moderate, or severe disability; and 24% either died or survived in a vegetative state. Early initiation and achieving full caloric intake were both positively correlated with shorter LOS in the ICU (p < .01, Spearman's rho correlational matrix) and better disposition status at discharge from the hospital (p < .05, Kruskal-Wallis test).	[Taha, Asma A.; Tiras, Kathyrne L.] Calif State Univ San Bernardino, San Bernardino, CA 92407 USA; [Taha, Asma A.; Tiras, Kathyrne L.] Loma Linda Univ, Med Ctr, Loma Linda, CA USA; [Badr, Lina] Azusa Pacific Univ, MSN Program, Azusa, CA USA; [Badr, Lina] Azusa Pacific Univ, PNP Program, Azusa, CA USA; [Westlake, Cheryl] Azusa Pacific Univ, Int Program, Azusa, CA USA; [Westlake, Cheryl] Azusa Pacific Univ, Community Program, Azusa, CA USA; [Westlake, Cheryl] Azusa Pacific Univ, Nursing PhD Program, Azusa, CA USA; [Dee, Vivien] Azusa Pacific Univ, PhD Program, Azusa, CA USA; [Mudit, Mathur] Loma Linda Univ, Div Pediat Crit Care Med, Loma Linda, CA 92350 USA		Taha, AA (corresponding author), Calif State Univ San Bernardino, San Bernardino, CA 92407 USA.	ataha@llu.edu			Azusa Pacific University	This work was funded by a Doctoral Dissertation Grant-Nursing PhD Program, Azusa Pacific University.	Adelson P. D., 2003, PEDIAT CRITICAL C S3, V4, P68; Amorde-Spalding K., 2008, PEDIAT MANUAL CLIN D; Bratton SL, 2007, J NEUROTRAUM, V24, P77; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Fiser DH, 2000, CRIT CARE MED, V28, P1173, DOI 10.1097/00003246-200004000-00043; Gurgueira GL, 2005, JPEN-PARENTER ENTER, V29, P176, DOI 10.1177/0148607105029003176; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Hulst JM, 2006, CURR OPIN CLIN NUTR, V9, P297, DOI 10.1097/01.mco.0000222115.91783.71; Ista Erwin, 2005, Crit Care Nurs Clin North Am, V17, P385, DOI 10.1016/j.ccell.2005.07.011; Joffe A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005144.pub2; Klodell CT, 2000, AM J SURG, V179, P168, DOI 10.1016/S0002-9610(00)00297-X; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lopez-Herce J, 2005, PEDIATR EMERG CARE, V21, P807; MOORE R, 1989, J TRAUMA, V29, P1633, DOI 10.1097/00005373-198912000-00007; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Paden M., 2002, INJURY LEADING CAUSE; Perel P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001530.pub2; PHILLIPS R, 1987, J NEUROSURG, V67, P846, DOI 10.3171/jns.1987.67.6.0846; Rhoney DH, 2002, NEUROL RES, V24, P613, DOI 10.1179/016164102101200456; Rogers EJ, 2003, NUTRITION, V19, P865, DOI 10.1016/S0899-9007(03)00170-9; Spalding HK, 2000, CRIT CARE MED, V28, P2041, DOI 10.1097/00003246-200006000-00060; Spinella PC, 2003, CRIT CARE MED, V31, P939, DOI 10.1097/01.CCM.0000053644.16336.52; Taylor SJ, 1999, CRIT CARE MED, V27, P2525, DOI 10.1097/00003246-199911000-00033; Thurman DJ, 2001, HEAD TRAUMA, P327; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011	26	23	23	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	DEC	2011	43	6					291	297		10.1097/JNN.0b013e318234e9b2			7	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	850PL	WOS:000297207700003	22089405				2022-02-06	
J	Sacco, K; Cauda, F; D'Agata, F; Duca, S; Zettin, M; Virgilio, R; Nascimbeni, A; Belforte, G; Eula, G; Gastaldi, L; Appendino, S; Geminiani, G				Sacco, Katiuscia; Cauda, Franco; D'Agata, Federico; Duca, Sergio; Zettin, Marina; Virgilio, Roberta; Nascimbeni, Alberto; Belforte, Guido; Eula, Gabriella; Gastaldi, Laura; Appendino, Silvia; Geminiani, Giuliano			A combined robotic and cognitive training for locomotor rehabilitation: evidences of cerebral functional reorganization in two chronic traumatic brain injured patients	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						motor training; cognitive training; motor imagery; locomotor rehabilitation; brain injury; robotic gait orthosis; functional magnetic resonance imaging; brain plasticity	DRIVEN GAIT ORTHOSIS; MOTOR IMAGERY; MENTAL PRACTICE; ANKLE DORSIFLEXION; STROKE PATIENTS; THERAPY; FMRI; CONNECTIVITY; ACTIVATION; PLASTICITY	It has been demonstrated that automated locomotor training can improve walking capabilities spinal cord-injured subjects but its effectiveness on brain damaged patients has not been well established. A possible explanation of the discordant results on the efficacy of robotic training in patients with cerebral lesions could be that these patients. besides stimulation of physiological motor patterns through passive leg movements, also need to train the cognitive aspects of motor control. Indeed another way to stimulated cerebral motor areas in paretic patients is to use the cognitive function of motor imagery. A promising possibility is thus to combine sensorimotor training with the use of motor imagery. The aim of this paper is to assess changes in brain activations after a combined sensorimotor and cognitive training for gait rehabilitation. The protocol consisted of the integrated use of a robotic gait orthosis prototype with locomotor imagery tasks. Assessment was conducted on two patients with chronic traumatic brain injury and major gait impairments, using functional magnetic resonance imaging. Physiatric functional scales were used to assess clinical outcomes. Results showed greater activation post-training in the sensorimotor and supplementary motor cortices, as well as enhanced functional connectivity within the motor network improvements in balance and, to a lesser extent, in gait outcomes were also found.	[Sacco, Katiuscia; Cauda, Franco; D'Agata, Federico; Geminiani, Giuliano] Univ Turin, Dept Psychol, Turin, Italy; [Sacco, Katiuscia; Cauda, Franco; D'Agata, Federico; Duca, Sergio; Geminiani, Giuliano] Koelliker Hosp, Dept Neuroradiol, Turin, Italy; [Sacco, Katiuscia; Geminiani, Giuliano] Neurosci Inst Turin, Turin, Italy; [Zettin, Marina; Virgilio, Roberta] Ctr Puzzle, Turin, Italy; [Nascimbeni, Alberto] Santa Croce Hosp, Physiatr Unit, Turin, Italy; [Belforte, Guido; Eula, Gabriella; Gastaldi, Laura; Appendino, Silvia] Politecn Torino, Dept Mech, Turin, Italy		Sacco, K (corresponding author), Univ Turin, Dept Psychol, Via Po 14, Turin, Italy.	katiuscia.sacco@unito.it	Cauda, Franco/G-5021-2010; Sacco, Katiuscia/J-2133-2012; D'Agata, Federico/ABG-8839-2021	Cauda, Franco/0000-0003-1526-8475; Sacco, Katiuscia/0000-0002-9660-5236; D'Agata, Federico/0000-0001-9432-0248	Piedmont RegionRegione Piemonte [4/2006]	This research was supported by the Piedmont Region, under the 2008 Human and Social Sciences grant, pursuant to Region Law no. 4/2006 (Regione Piemonte, bando Scienze Umane e Sociali 2008, L.R. n. 4/2006). The authors would like to thank the patients who participated in the study and their families.	Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Belforte G, 2001, MECHATRONICS, V11, P301, DOI 10.1016/S0957-4158(00)00017-9; Belforte G, 1997, SIMULATIONS IN BIOMEDICINE IV, P199; Berthoz A., 2000, BRAINS SENSE MOVEMEN; BOHANNON R W, 1989, Physiotherapy Canada, V41, P198; Colombo G, 2000, J REHABIL RES DEV, V37, P693; Colombo G, 2001, SPINAL CORD, V39, P252, DOI 10.1038/sj.sc.3101154; de Bode S, 2005, J CHILD NEUROL, V20, P64, DOI 10.1177/08830738050200011101; de Bode S, 2007, NEUROREHAB NEURAL RE, V21, P497, DOI 10.1177/1545968307299523; DECETY J, 1990, EUR ARCH PSY CLIN N, V240, P39, DOI 10.1007/BF02190091; Dickstein R, 2004, PHYS THER, V84, P1167, DOI 10.1093/ptj/84.12.1167; Dobkin BH, 2004, NEUROIMAGE, V23, P370, DOI 10.1016/j.neuroimage.2004.06.008; DRISKELL JE, 1994, J APPL PSYCHOL, V79, P481, DOI 10.1037/0021-9010.79.4.481; Dunsky A, 2006, INT J REHABIL RES, V29, P351, DOI 10.1097/MRR.0b013e328010f559; Enzinger C, 2008, STROKE, V39, P1507, DOI 10.1161/STROKEAHA.107.501999; Forrester LW, 2008, J REHABIL RES DEV, V45, P205, DOI 10.1682/JRRD.2007.02.0034; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Hidler J, 2009, NEUROREHAB NEURAL RE, V23, P5, DOI 10.1177/1545968308326632; HOLDEN MK, 1986, PHYS THER, V66, P1530, DOI 10.1093/ptj/66.10.1530; Hornby TG, 2008, STROKE, V39, P1786, DOI 10.1161/STROKEAHA.107.504779; Husemann B, 2007, STROKE, V38, P349, DOI 10.1161/01.STR.0000254607.48765.cb; Jackson PL, 2004, NEUROREHAB NEURAL RE, V18, P106, DOI 10.1177/0888439004265249; Jackson PL, 2001, ARCH PHYS MED REHAB, V82, P1133, DOI 10.1053/apmr.2001.24286; Jezernik S, 2003, SPINAL CORD, V41, P657, DOI 10.1038/sj.sc.3101518; KARNI A, 1995, NATURE, V377, P155; Kelly C, 2006, ARCH PHYS MED REHAB, V87, pS20, DOI 10.1016/j.apmr.2006.08.333; LAWRENCE DG, 1968, BRAIN, V91, P1, DOI 10.1093/brain/91.1.1; Li X, 2008, PROCEEDINGS OF THE 11TH JOINT CONFERENCE ON INFORMATION SCIENCES; MAHONEY F I, 1965, Md State Med J, V14, P61; Malouin F, 2004, NEUROREHAB NEURAL RE, V18, P66, DOI 10.1177/0888439004266304; Malouin F, 2010, PHYS THER, V90, P240, DOI 10.2522/ptj.20090029; Mayr A, 2007, NEUROREHAB NEURAL RE, V21, P307, DOI 10.1177/1545968307300697; Mehrholz J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006185.pub2; Milton J, 2008, METHODS, V45, P336, DOI 10.1016/j.ymeth.2008.05.002; Nelles G, 2004, RESTOR NEUROL NEUROS, V22, P239; PASCUALLEONE A, 1994, SCIENCE, V263, P1287, DOI 10.1126/science.8122113; Phillips JP, 2007, DEV MED CHILD NEUROL, V49, P39, DOI 10.1017/S0012162207000102; Rossini P M, 2007, Eura Medicophys, V43, P241; Sacco K, 2006, NEUROIMAGE, V32, P1441, DOI 10.1016/j.neuroimage.2006.05.018; Sacco K, 2009, BRAIN RES, V1297, P124, DOI 10.1016/j.brainres.2009.08.049; Sahyoun C, 2004, NEUROIMAGE, V21, P568, DOI 10.1016/j.neuroimage.2003.09.065; Schwartz I, 2009, PM&R, V1, P516, DOI 10.1016/j.pmrj.2009.03.009; SIRIGU A, 1995, NEUROREPORT, V6, P997, DOI 10.1097/00001756-199505090-00012; Talairach J., 1988, COPLANAR STEREOTAXIC; Waldner A, 2009, FUNCT NEUROL, V24, P173; Westlake KP, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-18; Winchester P, 2005, NEUROREHAB NEURAL RE, V19, P313, DOI 10.1177/1545968305281515; Wirz M, 2005, ARCH PHYS MED REHAB, V86, P672, DOI 10.1016/j.apmr.2004.08.004; Yen CL, 2008, NEUROREHAB NEURAL RE, V22, P22, DOI 10.1177/1545968307301875	49	23	23	1	20	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	NOV 23	2011	5									10.3389/fnhum.2011.00146			9	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	882GS	WOS:000299552400001	22275890	Green Published, gold			2022-02-06	
J	Risbud, RM; Lee, C; Porter, BE				Risbud, Rashmi M.; Lee, Carolyn; Porter, Brenda E.			Neurotrophin-3 mRNA a putative target of miR21 following status epilepticus	BRAIN RESEARCH			English	Article						Epilepsy; Hippocampus; Pilocarpine; MicroRNA; Neurotrophin-3; miR21	TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN-INJURY; RAT HIPPOCAMPUS; DENTATE GYRUS; MICRORNA MATURATION; GENE-REGULATION; EXPRESSION; NT-3; BDNF; EPILEPTOGENESIS	Status epilepticus induces a cascade of protein expression changes contributing to the subsequent development of epilepsy. By identifying the cascade of molecular changes that contribute to the development of epilepsy we hope to be able to design therapeutics for preventing epilepsy. MicroRNAs influence gene expression by altering mRNA stability and/or translation and have been implicated in the pathology of multiple diseases. MiR21 and its co-transcript miR21*, microRNAs produced from either the 5' or 3' ends of the same precursor RNA strand, are increased in the hippocampus following status epilepticus. We have identified a miR21 binding site, in the 3' UTR of neurotrophin-3 that inhibits translation. Neurotrophin-3 mRNA levels decrease in the hippocampus following SE concurrent with the increase in miR21. MiR21 levels in cultured hippocampal neurons inversely correlate with neurotrophin-3 mRNA levels. Treatment of hippocampal neuronal cultures with excess K(+)Cl(-), a depolarizing agent mimicking the episode of status epilepticus, also results in an increase in miR21 and a decrease in neurotrophin-3 mRNA. MiR21 is a candidate for regulating neurotrophin-3 signaling in the hippocampus following status epilepticus. (C) 2011 Elsevier BM. All rights reserved.	[Risbud, Rashmi M.; Lee, Carolyn; Porter, Brenda E.] Childrens Hosp Philadelphia, Dept Pediat, Div Neurol, Philadelphia, PA 19104 USA; [Porter, Brenda E.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA		Porter, BE (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Div Neurol, 502C Abramson Res Bldg,3516 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	porterb@email.chop.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS056222] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS056222] Funding Source: NIH RePORTER		Altman Naomi, 2005, Appl Bioinformatics, V4, P33, DOI 10.2165/00822942-200504010-00004; BENGZON J, 1993, NEUROSCIENCE, V53, P433, DOI 10.1016/0306-4522(93)90207-V; Binder DK, 2007, PROG BRAIN RES, V163, P371, DOI 10.1016/S0079-6123(07)63022-2; Buller B, 2010, FEBS J, V277, P4299, DOI 10.1111/j.1742-4658.2010.07818.x; CHENG B, 1994, BRAIN RES, V640, P56, DOI 10.1016/0006-8993(94)91857-0; Cummings DD, 1996, J NEUROSCI, V16, P5312; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Davis BN, 2010, MOL CELL, V39, P373, DOI 10.1016/j.molcel.2010.07.011; Elmer E, 1997, EXP NEUROL, V145, P93, DOI 10.1006/exnr.1997.6478; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; He XP, 2004, NEURON, V43, P31, DOI 10.1016/j.neuron.2004.06.019; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Hu K, 2011, NEUROSCI LETT, V488, P252, DOI 10.1016/j.neulet.2010.11.040; Kim SY, 1998, EPILEPSY RES, V29, P211; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lin EJD, 2003, EUR J NEUROSCI, V18, P2087, DOI 10.1046/j.1460-9568.2003.02926.x; Lowenstein DH, 1996, J NEUROSCI, V16, P1759; Lu TX, 2009, J IMMUNOL, V182, P4994, DOI 10.4049/jimmunol.0803560; Mudo G, 1996, EPILEPSIA, V37, P198, DOI 10.1111/j.1528-1157.1996.tb00012.x; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Noe F, 2008, BRAIN, V131, P1506, DOI 10.1093/brain/awn079; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Raol YH, 2006, J NEUROSCI, V26, P11342, DOI 10.1523/JNEUROSCI.3329-06.2006; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; SCHMIDTKASTNER R, 1995, EXP NEUROL, V136, P199, DOI 10.1006/exnr.1995.1096; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tsai CA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng052; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Xu B, 2002, NEUROSCIENCE, V115, P1295, DOI 10.1016/S0306-4522(02)00384-6; Yang JT, 2005, EXP NEUROL, V192, P437, DOI 10.1016/j.expneurol.2004.12.023; Ziu MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014724	33	23	29	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	NOV 18	2011	1424						53	59		10.1016/j.brainres.2011.09.039			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	854IG	WOS:000297487600006	22019057	Green Accepted			2022-02-06	
J	Bernhard, M; Matthes, G; Kanz, KG; Waydhas, C; Fischbacher, M; Fischer, M; Bottiger, BW				Bernhard, M.; Matthes, G.; Kanz, K. G.; Waydhas, C.; Fischbacher, M.; Fischer, M.; Boettiger, B. W.			Emergency anesthesia, airway management and ventilation in major trauma. Background and key messages of the interdisciplinary S3 guidelines for major trauma patients	ANAESTHESIST			German	Article						Multiple trauma; Airway management; Endotracheal intubation; Capnography; Emergency anesthesia	RAPID-SEQUENCE INTUBATION; ADVANCED LIFE-SUPPORT; HOSPITAL ENDOTRACHEAL INTUBATION; CRITICALLY-ILL PATIENTS; IN-LINE STABILIZATION; TIDAL CARBON-DIOXIDE; ACUTE LUNG INJURY; TRACHEAL INTUBATION; BRAIN-INJURY; PREHOSPITAL AIRWAY	Patients with multiple trauma presenting with apnea or a gasping breathing pattern (respiratory rate < 6/min) require prehospital endotracheal intubation (ETI) and ventilation. Additional indications are hypoxia (SpO2 < 90% despite oxygen insufflation and after exclusion of tension pneumothorax), severe traumatic brain injury [Glasgow Coma Scale (GCS) < 9], trauma-associated hemodynamic instability [systolic blood pressure (SBP) < 90 mmHg] and severe chest trauma with respiratory insufficiency (respiratory rate > 29/min). The induction of anesthesia after preoxygenation is conducted as rapid sequence induction (analgesic, hypnotic drug, neuromuscular blocking agent). With the availability of ketamine as a viable alternative, the use of etomidate is not encouraged due to its side effects on adrenal function. An electrocardiogram (ECG), blood pressure measurement and pulse oximetry are needed to monitor the emergency anesthesia and the secured airway. Capnography is absolutely mandatory to confirm correct placement of the endotracheal tube and to monitor tube dislocations as well as ventilation and oxygenation in the prehospital and hospital setting. Because airway management is often complicated in trauma patients, alternative devices and a fiber-optic endoscope need to be available within the hospital. Use of these alternative measures for airway management and ventilation should be considered at the latest after a maximum of three unsuccessful intubation attempts. Emergency medical service (EMS) physicians should to be trained in emergency anesthesia, ETI and alternative methods of airway management on a regular basis. Within hospitals ETI, emergency anesthesia and ventilation are to be conducted by trained and experienced anesthesiologists. When a difficult airway or induction of anesthesia is expected, endotracheal intubation should be supervised or conducted by an anesthesiologist. Normoventilation should be the goal of mechanical ventilation. After arrival in the resuscitation room the ventilation will be controlled and guided with the help of arterial blood gas analyses. After temporary removal of a cervical collar, the cervical spine needs to be immobilized by means of manual in-line stabilization when securing the airway.	[Boettiger, B. W.] Univ Klinikum Koln AoR, Klin Anasthesiol & Operat Intens Med, D-50937 Cologne, Germany; [Bernhard, M.] Univ Klinikum Leipzig, Zent Notaufnahme Notaufnahmestn, Leipzig, Germany; [Matthes, G.] Univ Greifswald, Greifswald, Germany; [Matthes, G.] Unfallkrankenhaus Berlin, Klin Unfallchirurg & Orthopadie, Berlin, Germany; [Kanz, K. G.] Klinikum Univ, Chirurg Klin & Poliklin, Munich, Germany; [Waydhas, C.; Fischbacher, M.] Univ Klinikum Essen, Klin Unfallchirurg, Essen, Germany; [Fischer, M.] Kliniken Landkreises Goppingen gGmbH, Klin Anasthesiol Operat Intens Med Notfallmed & S, Klin Eichert, Goppingen, Germany		Bottiger, BW (corresponding author), Univ Klinikum Koln AoR, Klin Anasthesiol & Operat Intens Med, Kerpener Str 62, D-50937 Cologne, Germany.	bernd.boettiger@uk-koeln.de					Adnet F, 1998, ANN EMERG MED, V32, P454, DOI 10.1016/S0196-0644(98)70175-1; Albrecht E, 2006, EUR J TRAUMA, V32, P516, DOI DOI 10.1007/S00068-006-6001-Z; AMATO MBP, 1995, AM J RESP CRIT CARE, V152, P1835, DOI 10.1164/ajrccm.152.6.8520744; American College of Surgeons Committee on Trauma, 2008, ATLS STUD COURS MAN; [Anonymous], 2004, DIN TASCH, pS385; Arbabi S, 2004, J TRAUMA, V56, P1029, DOI 10.1097/01.TA.0000123036.20919.4B; Aufmkolk M, 2003, UNFALLCHIRURG, V106, P746, DOI 10.1007/s00113-003-0640-7; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Becke K, 2007, ANASTH INTENSIVMED, V9, P624; Berlac P, 2008, ACTA ANAESTH SCAND, V52, P897, DOI 10.1111/j.1399-6576.2008.01673.x; Berlot G, 2009, EUR J EMERG MED, V16, P312, DOI 10.1097/MEJ.0b013e32832d3aa1; Bernhard M, 2011, EUR J ANAESTH, V28, P75, DOI 10.1097/EJA.0b013e328342325a; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; Bonhomme V, 2009, CURR OPIN ANESTHESIO, V22, P579, DOI 10.1097/ACO.0b013e32832e7adb; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P87; Braun U, 2004, ANASTH INTENSIVMED, V45, P302; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Caplan RA, 2003, ANESTHESIOLOGY, V98, P1269; Caulfield EV, 2009, J TRAUMA, V66, P1577, DOI 10.1097/TA.0b013e3181a3931d; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 1997, J TRAUMA, V42, pS4, DOI 10.1097/00005373-199705001-00002; Cobas MA, 2009, ANESTH ANALG, V109, P489, DOI 10.1213/ane.0b013e3181aa3063; Cogbill TH, 2008, J TRAUMA, V65, P994, DOI 10.1097/TA.0b013e318184ce12; Combes X, 2006, ACAD EMERG MED, V13, P828, DOI 10.1197/j.aem.2006.02.016; Cotton BA, 2008, ARCH SURG-CHICAGO, V143, P62, DOI 10.1001/archsurg.143.1.62; Cudnik MT, 2007, PREHOSP EMERG CARE, V11, P224, DOI 10.1080/10903120701205208; Davis DP, 2010, J TRAUMA, V69, P294, DOI 10.1097/TA.0b013e3181dc6c7f; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Deakin CD, 2010, RESUSCITATION, V81, P1305, DOI 10.1016/j.resuscitation.2010.08.017; Deakin CD, 2010, RESUSCITATION, V81, P539, DOI 10.1016/j.resuscitation.2010.02.001; Deutsche Gesellschaft fur Anasthesiologie und Intensivmedizin und Berufsverbande Deutscher Anasthesisten, 2007, ANASTH INTENSIVMED, V39, P470; Dewar D, 2009, INJURY, V40, P912, DOI 10.1016/j.injury.2009.05.024; DIN 75079 2002-08, 2004, DIN TASCH, V3, pS; DiRusso SM, 2005, J TRAUMA, V59, P84, DOI 10.1097/01.TA.0000171462.28379.F3; Dunham CM, 2003, J TRAUMA, V55, P162, DOI 10.1097/01.ta.0000083335.93868.2c; Dupanovic M, 2010, CURR OPIN ANESTHESIO, V23, P276, DOI 10.1097/ACO.0b013e3283360b4f; Eckstein M, 2000, J TRAUMA, V48, P643, DOI 10.1097/00005373-200004000-00010; Eich C, 2009, RESUSCITATION, V80, P888, DOI 10.1016/j.resuscitation.2009.05.008; El-Orbany M, 2010, ANESTH ANALG, V110, P1318, DOI 10.1213/ANE.0b013e3181d5ae47; EN 1789: 1999, 2004, DIN TASCH, V3, pS; Fakhry SM, 2006, J TRAUMA, V60, P997, DOI 10.1097/01.ta.0000217285.94057.5e; Franschman G, 2009, RESUSCITATION, V80, P1147, DOI 10.1016/j.resuscitation.2009.06.029; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Genzwurker H, 2007, ANAESTHESIST, V56, P665, DOI 10.1007/s00101-007-1194-9; Genzwurker HV, 2008, EUROANAESTHESIA; Gries A, 2008, ANAESTHESIST, V57, P562, DOI 10.1007/s00101-008-1373-3; Grmec S, 2004, EMERG MED J, V21, P518, DOI 10.1136/emj.2002.001974; Hager DN, 2005, AM J RESP CRIT CARE, V172, P1241, DOI 10.1164/rccm.200501-048CP; Heidegger T, 2005, BEST PRACT RES-CLIN, V19, P661, DOI 10.1016/j.bpa.2005.07.001; Helm M, 2006, BRIT J ANAESTH, V96, P67, DOI 10.1093/bja/aei275; Helm M, 2002, BRIT J ANAESTH, V88, P345, DOI 10.1093/bja/88.3.345; Henderson JJ, 2004, ANAESTHESIA, V59, P675, DOI 10.1111/j.1365-2044.2004.03831.x; Hildreth AN, 2008, J TRAUMA, V65, P573, DOI 10.1097/TA.0b013e31818255e8; Jabre P, 2009, LANCET, V374, P293, DOI 10.1016/S0140-6736(09)60949-1; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Katz SH, 2001, ANN EMERG MED, V37, P32, DOI 10.1067/mem.2001.112098; Keel, 2006, EUR J TRAUMA, V32, P387; Keul W, 2004, ANAESTHESIST, V53, P978, DOI 10.1007/s00101-004-0734-9; Klemen P, 2006, ACTA ANAESTH SCAND, V50, P1250, DOI 10.1111/J.1399-6576.2006.01039.X; Konrad C, 1998, ANESTH ANALG, V86, P635; Lackner CK, 2002, NOTFALL RETTUNGSMED, V5, P430; Lavery GG, 2008, CRIT CARE MED, V36, P2163, DOI 10.1097/CCM.0b013e31817d7ae1; Lecky F, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001429.pub2; Lee SW, 2009, J TRAUMA, V67, P526, DOI 10.1097/TA.0b013e3181866432; Liberman M, 2007, CURR OPIN CRIT CARE, V13, P691, DOI 10.1097/MCC.0b013e3282f1e77e; Manoach S, 2007, ANN EMERG MED, V50, P236, DOI 10.1016/j.annemergmed.2007.01.009; Morris C, 2009, ANAESTHESIA, V64, P532, DOI 10.1111/j.1365-2044.2008.05835.x; Mort TC, 2005, CRIT CARE MED, V33, P2672, DOI 10.1097/01.CCM.0000187131.67594.9E; Mort TC, 2004, ANESTH ANALG, V99, P607, DOI 10.1213/01.ANE.0000122825.04923.15; Mort TC, 2005, J CLIN ANESTH, V17, P255, DOI 10.1016/j.jclinane.2005.02.004; Mort TC, 2009, CRIT CARE MED, V37, P68, DOI 10.1097/CCM.0b013e318192845e; Muakkassa FF, 2010, J TRAUMA, V68, P1305, DOI 10.1097/TA.0b013e3181dcd137; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; Mutzbauer TS, 2008, NOTFALL RETTUNGSMED, V11, P310, DOI 10.1007/s10049-008-1038-4; NAEMT, 2009, PRAKL TRAUM; Newton A, 2008, J TRAUMA, V64, P487, DOI 10.1097/TA.0b013e31802e7476; Paal P, 2010, RESUSCITATION, V81, P148, DOI 10.1016/j.resuscitation.2009.10.023; Pelucio M, 1997, ACAD EMERG MED, V4, P563, DOI 10.1111/j.1553-2712.1997.tb03579.x; Ricard-Hibon A, 2002, EUR J ANAESTH, V19, P361, DOI 10.1017/S0265021502000583; RIVARA FP, 1989, JAMA-J AM MED ASSOC, V261, P566, DOI 10.1001/jama.261.4.566; Ruchholtz S, 2008, DTSCH ARZTEBL INT, V105, P225, DOI 10.3238/arztebl.2008.0225; Ruchholtz S, 2002, J TRAUMA, V52, P879, DOI 10.1097/00005373-200205000-00010; Santoni BG, 2009, ANESTHESIOLOGY, V110, P24, DOI 10.1097/ALN.0b013e318190b556; Schlechtriemen T, 2004, NOTFALL RETTUNGSMED, V7, P231; Schmidt UH, 2008, ANESTHESIOLOGY, V109, P973, DOI 10.1097/ALN.0b013e31818ddb90; Shah CV, 2008, CRIT CARE MED, V36, P2309, DOI 10.1097/CCM.0b013e318180dc74; Silvestri S, 2005, ANN EMERG MED, V45, P497, DOI 10.1016/j.annemergmed.2004.09.014; Sing RF, 1998, AM J EMERG MED, V16, P598, DOI 10.1016/S0735-6757(98)90227-3; Sise MJ, 2009, J TRAUMA, V66, P32, DOI 10.1097/TA.0b013e318191bb0c; Sloane C, 2000, J EMERG MED, V19, P259, DOI 10.1016/S0736-4679(00)00235-3; Stahel PF, 2008, INTENS CARE MED, V34, P402, DOI 10.1007/s00134-007-0889-3; Steinmann D, 2009, ANAESTHESIST, V58, P695, DOI 10.1007/s00101-009-1548-6; Stephens CT, 2009, ANESTH ANALG, V109, P866, DOI 10.1213/ane.0b013e3181ad87b0; Stiell IG, 2008, CAN MED ASSOC J, V178, P1141, DOI 10.1503/cmaj.071154; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Thierbach A, 2004, ANAESTHESIST, V53, P543, DOI 10.1007/s00101-004-0679-z; Timmermann A, 2007, ANAESTHESIST, V56, P328, DOI 10.1007/s00101-007-1153-5; Timmermann A, 2009, ANAESTHESIST, V58, P663, DOI 10.1007/s00101-009-1570-8; Timmermann A, 2010, ANASTH INTENSIVMED S, V51, P7; Timmermann A, 2007, ANESTH ANALG, V104, P619, DOI 10.1213/01.ane.0000253523.80050.e9; Timmermann A, 2006, RESUSCITATION, V70, P179, DOI 10.1016/j.resuscitation.2006.01.010; Tracy S, 2006, J TRAUMA, V61, P1162, DOI 10.1097/01.ta.0000243887.90697.06; TRUPKA A, 1995, UNFALLCHIRURG, V98, P111; von Elm E, 2009, BRIT J ANAESTH, V103, P371, DOI 10.1093/bja/aep202; Wang H E, 2001, Prehosp Emerg Care, V5, P134, DOI 10.1080/10903120190939995; Wang HE, 2006, ACAD EMERG MED, V13, P372, DOI 10.1197/j.aem.2005.11.001; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Wang HE, 2006, ANN EMERG MED, V47, P532, DOI 10.1016/j.annemergmed.2006.01.016; Wang HE, 2009, RESUSCITATION, V80, P50, DOI 10.1016/j.resuscitation.2008.08.016; Warner KJ, 2008, J TRAUMA, V64, P341, DOI 10.1097/TA.0b013e318160dfb3; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032; Warner KJ, 2009, J TRAUMA, V67, P45, DOI 10.1097/TA.0b013e3181a92a70; Warner KJ, 2009, J TRAUMA, V66, P26, DOI 10.1097/TA.0b013e3181957a25; Wayne M A, 1999, Prehosp Emerg Care, V3, P107, DOI 10.1080/10903129908958916; Wolfl CG, 2009, UNFALLCHIRURG, V112, P846, DOI 10.1007/s00113-009-1685-z	116	23	24	1	10	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0003-2417	1432-055X		ANAESTHESIST	Anaesthesist	NOV	2011	60	11					1027	+		10.1007/s00101-011-1957-1			11	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	852NM	WOS:000297364700007	22089890				2022-02-06	
J	Yang, CC; Shih, NC; Chang, WC; Huang, SK; Chien, CW				Yang, Chih-Chieh; Shih, Nai-Ching; Chang, Wen-Chiung; Huang, San-Kuei; Chien, Ching-Wen			Long-term medical utilization following ventilator-associated pneumonia in acute stroke and traumatic brain injury patients: a case-control study	BMC HEALTH SERVICES RESEARCH			English	Article						ventilator-associated pneumonia; medical utilization; longitudinal study; ICU; traumatic brain injury; acute hemorrhagic stroke; acute ischemic stroke	INTENSIVE-CARE-UNIT; LARGE US DATABASE; NOSOCOMIAL PNEUMONIA; MORTALITY-RATE; IMPACT; EPIDEMIOLOGY; OUTCOMES; SYSTEM; COST	Background: The economic burden of ventilator-associated pneumonia (VAP) during the index hospitalization has been confirmed in previous studies. However, the long-term economic impact is still unclear. The aim of this study is to examine the effect of VAP on medical utilization in the long term. Methods: This is a retrospective case-control study. Study subjects were patients experiencing their first traumatic brain injury, acute hemorrhagic stroke, or acute ischemic stroke during 2004. All subjects underwent endotracheal intubation in the emergency room (ER) on the day of admission or the day before admission, were transferred to the intensive care unit (ICU) and were mechanically ventilated for 48 hours or more. A total of 943 patients who developed VAP were included as the case group, and each was matched with two control patients without VAP by age (+/- 2 years), gender, diagnosis, date of admission (+/- 1 month) and hospital size, resulting in a total of 2,802 patients in the study. Using robust regression and Poisson regression models we examined the effect of VAP on medical utilization including hospitalization expenses, outpatient expenses, total medical expenses, number of ER visits, number of readmissions, number of hospitalization days and number of ICU days, during the index hospitalization and during the following 2-year period. Results: Patients in the VAP group had higher hospitalization expenses, longer length of stay in hospital and in ICU, and a greater number of readmissions than the control group patients. Conclusions: VAP has a significant impact on medical expenses and utilization, both during the index hospitalization during which VAP developed and in the longer term.	[Chien, Ching-Wen] Natl Yang Ming Univ, Insti Hosp & Hlth Care Adm, Taipei 112, Taiwan; [Yang, Chih-Chieh; Shih, Nai-Ching] Lotung Poh Al Hosp, Dept Emergency Med & Traumatol, Lotung 265, Yilan, Taiwan; [Chang, Wen-Chiung] Natl Taiwan Univ, Inst Hlth Policy & Management, Taipei 10764, Taiwan; [Huang, San-Kuei] Dept Hlth, Bur Natl Hlth Insurance, Taipei, Taiwan		Chien, CW (corresponding author), Natl Yang Ming Univ, Insti Hosp & Hlth Care Adm, 155,Sec 2,Linong St, Taipei 112, Taiwan.	ihhca@yahoo.com.tw					Arabi Y, 2008, INT J INFECT DIS, V12, P505, DOI 10.1016/j.ijid.2008.02.010; Bercault N, 2001, CRIT CARE MED, V29, P2303, DOI 10.1097/00003246-200112000-00012; Cocanour Christine S, 2005, Surg Infect (Larchmt), V6, P65, DOI 10.1089/sur.2005.6.65; Dietrich ES, 2002, INFECTION, V30, P61, DOI 10.1007/s15010-002-1083-8; Eachempati SR, 2010, SURG INFECT, V11, P13, DOI 10.1089/sur.2008.025; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Erbay Riza Hakan, 2004, BMC Pulm Med, V4, P3, DOI 10.1186/1471-2466-4-3; Gikas A, 2010, INFECTION, V38, P165, DOI 10.1007/s15010-010-0007-2; Hortal J, 2009, CRIT CARE, V13, DOI 10.1186/cc7896; Hugonnet S, 2004, INFECT CONT HOSP EP, V25, P1090, DOI 10.1086/502349; Kollef MH, 2005, CHEST, V128, P3854, DOI 10.1378/chest.128.6.3854; Muscedere JG, 2008, J CRIT CARE, V23, P5, DOI 10.1016/j.jcrc.2007.11.012; *NAT HLTH RES I, 2007, CLIN PRACT GUID PNEU; Nseir S, 2005, CHEST, V128, P1650, DOI 10.1378/chest.128.3.1650; Rello J, 2002, CHEST, V122, P2115, DOI 10.1378/chest.122.6.2115; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097/01.CCM.0000181731.53912.D9; Sheng WH, 2005, J FORMOS MED ASSOC, V104, P318; Suka M, 2007, INFECT CONT HOSP EP, V28, P307, DOI 10.1086/511997; Walkey AJ, 2009, INFECT CONT HOSP EP, V30, P319, DOI 10.1086/596103; Warren DK, 2003, CRIT CARE MED, V31, P1312, DOI 10.1097/01.CCM.0000063087.93157.06; Weigelt JA, 2010, AM J INFECT CONTROL, V38, P112, DOI 10.1016/j.ajic.2009.06.010; Zhan CL, 2006, HEALTH AFFAIR, V25, P1386, DOI 10.1377/hlthaff.25.5.1386	22	23	27	2	10	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1472-6963			BMC HEALTH SERV RES	BMC Health Serv. Res.	OCT 31	2011	11								289	10.1186/1472-6963-11-289			7	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	848LF	WOS:000297052400002	22040214	Green Published, gold			2022-02-06	
J	Doig, E; Fleming, J; Kuipers, P; Cornwell, P; Khan, A				Doig, Emmah; Fleming, Jennifer; Kuipers, Pim; Cornwell, Petrea; Khan, Asad			Goal-directed outpatient rehabilitation following TBI: A pilot study of programme effectiveness and comparison of outcomes in home and day hospital settings	BRAIN INJURY			English	Article						Brain injury; occupational therapy; goals	TRAUMATIC BRAIN-INJURY; OCCUPATIONAL PERFORMANCE-MEASURE; SELF-IDENTIFIED GOALS; THERAPY; ADULTS; ACHIEVEMENT; PATIENT; UTILITY; PEOPLE	Primary objective: To determine (i) the effectiveness of a goal-directed, environment-focused occupational therapy intervention and (ii) to compare rehabilitation gains across a day hospital (outpatient) setting and home setting. Research design: Repeated measures cross-over design with pre-post test measures and a baseline control period, random allocation to a treatment setting sequence and an independent outcome assessor who was blinded to treatment sequence. Methods and procedures: Descriptive and non-parametric comparative analyses employed. Fourteen participants with severe traumatic brain injury completed a 12 week outpatient occupational therapy programme. The programme was directed by the participant's chosen goals, which were established using a client-centred, structured, goal-planning process. Outcome measures included Goal attainment scaling, the Canadian Occupational Performance Measure, the Sydney Psychosocial Reintegration Scale, the Mayo-Portland Adaptability Index, the Craig Hospital Inventory of Environmental Factors and self-rated satisfaction with therapy. Main outcomes and results: The therapy programme resulted in significant improvements in goal attainment, occupational performance, psychosocial reintegration and ability and adjustment levels, compared with baseline. Differences in gains made in home vs day hospital settings were not statistically significant, with the exception of higher levels of patient satisfaction with therapy at home. Conclusions: To assist further with decision-making about where to conduct therapy, further research is needed to compare the outcomes and determine the cost effectiveness of therapy at home and in day hospital settings.	[Doig, Emmah; Fleming, Jennifer; Cornwell, Petrea; Khan, Asad] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia; [Kuipers, Pim] Griffith Univ, Ctr Functioning Disabil & Hlth Res, Princess Alexandra Hosp, Meadowbrook, Qld 4131, Australia; [Kuipers, Pim] Griffith Univ, Griffith Abil Res Programme, Meadowbrook, Qld 4131, Australia; Griffith Univ, Griffith Hlth Inst, Metro No Hlth Serv Dist N, Queensland Hlth, Mt Gravatt, Qld 4122, Australia		Doig, E (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia.	emmah.doig@optusnet.com.au	Khan, Asaduzzaman/F-8739-2010; Khan, Asad/R-8484-2016; Khan, Asad/N-7481-2019; Cornwell, Petrea/AAE-5547-2019; Doig, Emmah/AAG-6674-2021	Khan, Asaduzzaman/0000-0003-4188-2065; Khan, Asad/0000-0003-4188-2065; Khan, Asad/0000-0003-4188-2065; Doig, Emmah/0000-0002-7020-053X; Kuipers, Pim/0000-0003-0340-2286	Princess Alexandra Hospital Foundation; Queensland Health Community Rehabilitation Research Scheme; University of QueenslandUniversity of Queensland	We thank the Princess Alexandra Hospital Foundation and the Queensland Health Community Rehabilitation Research Scheme for providing grants to undertake this research. The principal researcher was in receipt of a University of Queensland Postgraduate Research Scholarship whilst conducting this research.	*AM OCC THER ASS, 1997, AM J OCCUPATIONAL TH, V51, P564; [Anonymous], 1994, Am J Occup Ther, V48, P1047; Bodiam C., 1999, BRIT J OCCUP THER, V62, P123, DOI [10.1177/030802269906200310, DOI 10.1177/030802269906200310]; Cooper B., 1996, CAN J OCCUP THER, V63, P9, DOI [10.1177/000841749606300103, DOI 10.1177/000841749606300103]; Craig Hospital Research Department, 2001, CRAIG HOSP INV ENV F; Dawson DR, 2009, CAN J OCCUP THER, V76, P115, DOI 10.1177/000841740907600209; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Doig E, 2011, DISABIL REHABIL, V33, P1203, DOI 10.3109/09638288.2010.525286; Doig E, 2010, AM J OCCUP THER, V64, P904, DOI 10.5014/ajot.2010.08156; Doig E, 2010, DISABIL REHABIL, V32, P2061, DOI 10.3109/09638281003797356; Doig E, 2009, AM J OCCUP THER, V63, P559, DOI 10.5014/ajot.63.5.559; GAUGGEL S, 2004, HDB MOTIVATIONAL COU; Jenkinson N, 2007, BRAIN INJURY, V21, P1283, DOI 10.1080/02699050701739531; JOYCE BM, 1994, AM J PHYS MED REHAB, V73, P10, DOI 10.1097/00002060-199473010-00003; KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KUIPERS P, 1999, J COGNITIVE REHABILI, V17, P6; Landa-Gonzalez BELKIS, 2001, Occup Ther Int, V8, P49, DOI 10.1002/oti.131; Lannin Natasha, 2003, Occup Ther Health Care, V17, P43, DOI 10.1080/J003v17n01_04; Law M., 1994, CANADIAN OCCUPATIONA, V2; Leach E, 2010, DISABIL REHABIL, V32, P159, DOI 10.3109/09638280903036605; Leathem J, 1996, BRAIN INJURY, V10, P27; Malec J. F., 2003, MANUAL MAYO PORTLAND; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; MALEC JF, 1991, ARCH PHYS MED REHAB, V72, P138; McPherson KM, 2009, CLIN REHABIL, V23, P296, DOI 10.1177/0269215509102980; OCONNOR P, 2002, HOSPITALISATION DUE; OTTENBACHER KJ, 1990, AM J OCCUP THER, V44, P519, DOI 10.5014/ajot.44.6.519; Phipps S, 2007, AM J OCCUP THER, V61, P328, DOI 10.5014/ajot.61.3.328; Pollock N, 1998, CANADIAN OCCUPATIONA; Ponsford J, 2006, NEUROPSYCHOL REHABIL, V16, P315, DOI 10.1080/09602010500176534; Rockwood K, 1997, J CLIN EPIDEMIOL, V50, P581, DOI 10.1016/S0895-4356(97)00014-0; Schneidert M, 2003, DISABIL REHABIL, V25, P588, DOI 10.1080/0963828031000137090; Siegert R, 2004, DISABIL REHABIL, V26, P1, DOI 10.1080/09638280410001644932; SPSS Inc, 2007, STAT PACK SOC SCI; TATE RL, 1999, J HEAD TRAUMA REHAB, V14, P453; Trombly CA, 1998, AM J OCCUP THER, V52, P810, DOI 10.5014/ajot.52.10.810; Trombly CA, 2002, AM J OCCUP THER, V56, P489, DOI 10.5014/ajot.56.5.489; Turner-Stokes L, 2005, COCHRANE DB SYST REV, V3, DOI DOI 10.1016/S0079-6123(09)17707-5; Von Koch L, 1998, DISABIL REHABIL, V20, P367, DOI 10.3109/09638289809166095; Wade DT, 2009, CLIN REHABIL, V23, P291, DOI 10.1177/0269215509103551; Watkins MP., 2015, FDN CLIN RES APPL PR, V3rd; WEBB PM, 1994, REHABIL PSYCHOL, V39, P179, DOI 10.1037/h0080321; Willer B, 1999, ARCH PHYS MED REHAB, V80, P399, DOI 10.1016/S0003-9993(99)90276-9; WILSON BA, 2003, BRAIN IMPAIR, V4, P25, DOI DOI 10.1375/BRIM.4.1.25.27030; Wressle E, 2002, J REHABIL MED, V34, P5, DOI 10.1080/165019702317242640	46	23	25	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2011	25	11					1114	1125		10.3109/02699052.2011.607788			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	829WC	WOS:000295614900010	21902462				2022-02-06	
J	Ji, SB; Ford, JC; Greenwald, RM; Beckwith, JG; Paulsen, KD; Flashman, LA; McAllister, TW				Ji, Songbai; Ford, James C.; Greenwald, Richard M.; Beckwith, Jonathan G.; Paulsen, Keith D.; Flashman, Laura A.; McAllister, Thomas W.			Automated subject-specific, hexahedral mesh generation via image registration	FINITE ELEMENTS IN ANALYSIS AND DESIGN			English	Article						Subject-specific; Automatic mesh generation; Hexahedral; Mesh quality; Finite element analysis; Traumatic brain injury; Biomechanics; Mutual information	TRAUMATIC BRAIN-INJURY; FINITE-ELEMENT; ALGORITHM	Generating subject-specific, all-hexahedral meshes for finite element analysis continues to be of significant interest in biomechanical research communities. To date, most automated methods "morph" an existing atlas mesh to match with a subject anatomy, which usually result in degradation in mesh quality because of mesh distortion. We present an automated meshing technique that produces satisfactory mesh quality and accuracy without mesh repair. An atlas mesh is first developed using a script. A subject-specific mesh is generated with the same script after transforming the geometry into the atlas space following rigid image registration, and is transformed back into the subject space. By meshing the brain in 11 subjects, we demonstrate that the technique's performance is satisfactory in terms of both mesh quality (99.5% of elements had a scaled Jacobian >0.6 while <0.01% were between 0 and 0.2) and accuracy (average distance between mesh boundary and geometrical surface was 0.07 mm while <1% greater than 0.5 mm). The combined computational cost for image registration and meshing was <4 min. Our results suggest that the technique is effective for generating subject-specific, all-hexahedral meshes and that it may be useful for meshing a variety of anatomical structures across different biomechanical research fields. Published by Elsevier B.V.	[Ji, Songbai; Greenwald, Richard M.; Paulsen, Keith D.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03766 USA; [Ford, James C.; Flashman, Laura A.; McAllister, Thomas W.] Dartmouth Med Sch, Dept Psychiat, Lebanon, NH USA; [Greenwald, Richard M.; Beckwith, Jonathan G.] Simbex, Lebanon, NH USA; [Paulsen, Keith D.] Norris Cotton Canc Ctr, Lebanon, NH USA		Ji, SB (corresponding author), Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03766 USA.	Songbai.Ji@Dartmouth.EDU	Ford, James/AAF-7039-2020		Institute for Computational Science at Dartmouth College, NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HD048638, R01NS055020]; CDCCentre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R01CE001254]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055020] Funding Source: NIH RePORTER	This research was supported in part by William H. Neukom 1964 Institute for Computational Science at Dartmouth College, NIH Grants R01HD048638, R01NS055020, and CDC grant R01CE001254.	Anderson AE, 2005, J BIOMECH ENG-T ASME, V127, P364, DOI 10.1115/1.1894148; Benzley SE, 1995, P 4 INT MESH ROUNDT; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bucki M, 2010, MED IMAGE ANAL, V14, P303, DOI 10.1016/j.media.2010.02.003; Castellano-Smith AD, 2001, LECT NOTES COMPUTER, P1091, DOI DOI 10.1007/3-540-45468-3_130; Cattaneo PM, 2009, ORTHOD CRANIOFAC RES, V12, P120, DOI 10.1111/j.1601-6343.2009.01445.x; Cebral JR, 2001, INT J NUMER METH ENG, V51, P985, DOI 10.1002/nme.205; Couteau B, 2000, J BIOMECH, V33, P1005, DOI 10.1016/S0021-9290(00)00055-5; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fuentes D, 2009, ANN BIOMED ENG, V37, P763, DOI 10.1007/s10439-008-9631-8; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Grosland NM, 2009, COMPUT METHOD BIOMEC, V12, P35, DOI [10.1080/10255840802136143, 10.1080/10255840903065134]; *HIBB KARLSS SOR, 2008, ABAQUS AN US MAN VER; Horgan T.J., 2005, FINITE ELEMENT MODEL; Ji SB, 2009, MED IMAGE ANAL, V13, P659, DOI 10.1016/j.media.2009.05.007; Knupp PM, 2001, SIAM J SCI COMPUT, V23, P193, DOI 10.1137/S1064827500371499; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Neal ML, 2010, BRIEF BIOINFORM, V11, P111, DOI 10.1093/bib/bbp049; O'Reilly MA, 2008, SPINE, V33, P1876, DOI 10.1097/BRS.0b013e31817d9ce5; Portnoy S, 2008, J BIOMECH, V41, P1897, DOI 10.1016/j.jbiomech.2008.03.035; Schonning A, 2009, COMPUT AIDED DESIGN, V41, P566, DOI 10.1016/j.cad.2007.10.007; Shepherd JF, 2010, FINITE ELEM ANAL DES, V46, P17, DOI 10.1016/j.finel.2009.06.024; Sigal IA, 2008, J BIOMECH, V41, P1381, DOI 10.1016/j.jbiomech.2008.02.019; Sigal IA, 2010, J BIOMECH, V43, P254, DOI 10.1016/j.jbiomech.2009.08.036; Southern J, 2008, PROG BIOPHYS MOL BIO, V96, P60, DOI 10.1016/j.pbiomolbio.2007.07.019; Taylor CA, 2009, ANNU REV BIOMED ENG, V11, P109, DOI 10.1146/annurev.bioeng.10.061807.160521; Wenk JF, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.4000165; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; *XYZ SCI APPL INC, TRUEGRID US MAN VERS	30	23	23	1	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-874X			FINITE ELEM ANAL DES	Finite Elem. Anal. Des.	OCT	2011	47	10					1178	1185		10.1016/j.finel.2011.05.007			8	Mathematics, Applied; Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Mathematics; Mechanics	782TS	WOS:000292035200006	21731153	Green Accepted			2022-02-06	
J	Wu, X; Sha, HY; Sun, YR; Gao, L; Liu, H; Yuan, Q; Zhang, T; Zhu, JH; Zhou, LF; Hu, J				Wu, Xing; Sha, Hongying; Sun, Yirui; Gao, Liang; Liu, Hua; Yuan, Qiang; Zhang, Tao; Zhu, Jianhong; Zhou, Liangfu; Hu, Jin			N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Isolated Traumatic Brain Injury: A Prospective Cohort Study	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						NT-proBNP; Traumatic brain injury; Hyponatremia; Intracranial pressure	PLASMA-CONCENTRATIONS; ISCHEMIC-STROKE; HYPONATREMIA	Background: The role of brain natriuretic peptide (BNP) after traumatic brain injury (TBI) remains unclear, and its relationship with hyponatremia is still controversial. The aim of this study is to investigate the secretion pattern of N-terminal (NT)-proBNP in patients with TBI and to assess the relationship between NT-proBNP, sodium balance, and intracranial pressure (ICP). Methods: We measured serum NT-proBNP levels of 84 patients with isolated TBI on a daily basis from day 1 to day 14 after injury. Results: In average, the peak of BNP level was measured at 703.9 pg/mL +/- 179.1 pg/mL on day 3 after injury, which was correlated to the severity of TBI. Among patients with severe TBI, plasma NT-proBNP concentrations in patients with hyponatremia were statistically higher than those without hyponatremia (p < 0.05). In the hyponatremic group, the plasma NT-proBNP increased to a peak of 1001.16 pg/mL +/- 131.52 pg/mL within 48 hours after injury and maintained at a high level for 3 days. In the normonatremic group, the plasma NT-proBNP reached a peak of 826.43 pg/mL +/- 337.43 pg/mL on day 5 and quickly decreased thereafter. In addition, we found plasma NT-proBNP concentrations in patients with ICP > 15 mm Hg were significantly higher than those in patients with ICP <= 15 mm Hg (p < 0.01). Conclusions: This study provides evidence that BNP plasma concentrations increase rapidly after TBI. Plasma BNP concentrations are correlated with hyponatremia in severe TBI patients but not in mild and moderate TBI patients. Furthermore, patients with elevated ICP have a higher serum BNP level in first 4 days after injury.	[Wu, Xing; Sha, Hongying; Sun, Yirui; Gao, Liang; Zhu, Jianhong; Zhou, Liangfu; Hu, Jin] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China; [Zhang, Tao] Fudan Univ, Huashan Hosp, Dept Lab Med, Shanghai 200433, Peoples R China; [Liu, Hua; Yuan, Qiang] Jiao Tong Univ, Dept Neurosurg, Hosp 6, Shanghai 200030, Peoples R China		Hu, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Wulumuqizhong Rd 12, Shanghai 200433, Peoples R China.	xggbtt@gmail.com			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [30600640, 30870805, 90919002, 30770824, 81000518]; National Basic Research ProgramNational Basic Research Program of China [2007CB947902, 2009CB941100, 2010CB945500]; Science and Technology Commission of Shanghai MunicipalityScience & Technology Commission of Shanghai Municipality (STCSM) [10JC1402300]; Shanghai Nature Science Foundation [08411952000]; Young Backbone Foundation of Fudan University; Open Foundation of State Key Laboratory of Medical Neurobiology	Supported by National Natural Science Foundation of China (NSFC Grants 30600640, 30870805, 90919002, 30770824, and 81000518), National Basic Research Program (2007CB947902, 2009CB941100, and 2010CB945500), The Science and Technology Commission of Shanghai Municipality Project (10JC1402300), Shanghai Nature Science Foundation (08411952000), Young Backbone Foundation of Fudan University, and Open Foundation of State Key Laboratory of Medical Neurobiology.	Al-Najjar Y, 2009, EUR J HEART FAIL, V11, P1155, DOI 10.1093/eurjhf/hfp147; Berendes E, 1997, LANCET, V349, P245, DOI 10.1016/S0140-6736(96)08093-2; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chang TP, 2010, J TRAUMA, V68, P1401, DOI 10.1097/TA.0b013e3181bb9a87; Di Angelantonlo E, 2007, J NEUROL SCI, V260, P139, DOI 10.1016/j.jns.2007.04.018; Kirchhoff C, 2006, J NEUROTRAUM, V23, P943, DOI 10.1089/neu.2006.23.943; Kirchhoff C, 2008, CRIT CARE, V12, DOI 10.1186/cc7013; Kortbeek JB, 2008, J TRAUMA, V64, P1638, DOI 10.1097/TA.0b013e3181744b03; Lu DC, 2008, SURG NEUROL, V69, P226, DOI 10.1016/j.surneu.2007.02.051; McGirt MJ, 2004, NEUROSURGERY, V54, P1369, DOI 10.1227/01.NEU.0000125016.37332.50; Montaner J, 2008, STROKE, V39, P2280, DOI 10.1161/STROKEAHA.107.505354; Moro N, 2007, SURG NEUROL, V68, P387, DOI 10.1016/j.surneu.2006.11.052; MUKOYAMA M, 1991, J CLIN INVEST, V87, P1402, DOI 10.1172/JCI115146; Nakagawa K, 2005, CEREBROVASC DIS, V19, P157, DOI 10.1159/000083249; Powner DJ, 2007, NEUROCRIT CARE, V7, P119, DOI 10.1007/s12028-007-0079-8; Rubattu S, 2008, AM J HYPERTENS, V21, P733, DOI 10.1038/ajh.2008.174; SAITO Y, 1989, BIOCHEM BIOPH RES CO, V158, P360, DOI 10.1016/S0006-291X(89)80056-7; Sherlock M, 2009, POSTGRAD MED J, V85, P171, DOI 10.1136/pgmj.2008.072819; SUDOH T, 1988, BIOCHEM BIOPH RES CO, V155, P726, DOI 10.1016/S0006-291X(88)80555-2; Sviri GE, 2006, ACTA NEUROCHIR, V148, P529, DOI 10.1007/s00701-005-0666-4; TAKAHASHI T, 1992, CIRC RES, V71, P9, DOI 10.1161/01.RES.71.1.9; Tomida M, 1998, STROKE, V29, P1584, DOI 10.1161/01.STR.29.8.1584	22	23	24	3	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	OCT	2011	71	4					820	825		10.1097/TA.0b013e3182277b69			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	833ZT	WOS:000295925700014	21808206				2022-02-06	
J	Dowds, MM; Lee, PH; Sheer, JB; O'Neil-Pirozzi, TM; Xenopoulos-Oddsson, A; Goldstein, R; Zainea, KL; Glenn, MB				Dowds, Murdo M.; Lee, Patricia H.; Sheer, Jeffrey B.; O'Neil-Pirozzi, Therese M.; Xenopoulos-Oddsson, Annette; Goldstein, Richard; Zainea, Kathryn L.; Glenn, Mel B.			Electronic Reminding Technology Following Traumatic Brain Injury: Effects on Timely Task Completion	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognitive disability; cognitive impairment; functional independence; handheld computers; memory disorders; prospective memory; rehabilitation; traumatic brain injury	MEMORY AID; HEAD-INJURY; REHABILITATION; DEVICES; ADULTS; PDAS	Objective: To determine whether automated reminders from 2 contemporary personal digital assistant (PDA) devices produce higher rates of timely task completion in people with traumatic brain injury (TBI). Setting: Outpatient and community rehabilitation settings. Participants: Thirty-six adults aged 18 to 66 years with TBI and self-determined complaints of memory impairment. Measures: Timely completion rates for assigned memory tasks under 4 randomly assigned memory aid conditions. Results: Significantly, higher completion rates were found when using either PDA device when compared with a combined baseline and paper memory aid condition (for Palm OS device, Incidence Rate Ratio [IRR] = 2.14, P < .0005, CI [confidence interval] = 1.77-2.59; for Microsoft Pocket PCOS device, IRR = 1.47, P < .001, CI = 1.18-1.82). A significant difference in completion rates was also found between the 2 PDA devices (IRR = 1.46, P < .0005, CI = 1.26-1.70), with the Palm version producing the better scores. Conclusions: Substantially higher rates of task completion (more than double in some cases) when using either PDA device suggest that rehabilitation clinicians can make productive use of PDA-based memory aids in their TBI patient populations. The strength of the effects of PDA device usage argues for further investigation of the impact of device usage on quality-of-life and costs of care, and of personal and caregiver factors predictive of successful and sustained device usage.	[Lee, Patricia H.] Univ Massachusetts, Dept Psychol, Boston, MA 02125 USA; [Sheer, Jeffrey B.] Harvard Univ, Sch Med, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA 02115 USA; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Speech Language Pathol & Audiol Dept, Boston, MA 02115 USA; [Xenopoulos-Oddsson, Annette; Goldstein, Richard; Glenn, Mel B.] Harvard Univ, Sch Med, Dept PM&R, Spaulding Rehabil Hosp, Boston, MA 02115 USA; [Zainea, Kathryn L.] Spaulding Rehabil Hosp, Assist Technol Ctr, Boston, MA USA		Dowds, MM (corresponding author), 5 Whittier Pl,Suite 101, Boston, MA 02114 USA.	murdomdowdsphd@verizon.net			National Institute on Disability and Rehabilitation Research, US Department of EducationUS Department of Education [H113A0101607A]	This study was funded by grant# H113A0101607A from the National Institute on Disability and Rehabilitation Research, US Department of Education. The authors wish to thank Roberta DePompei, PhD, for her leadership of the Assistive Technology Collaborative, and for her support for this component of the project.	BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Carey AC, 2005, MENT RETARD, V43, P322; Constantinidou F., 2004, TRAUMATIC BRAIN INJU, P337; DePompei R, 2004, LEARNING COGNITIVE C; DePompei R, 2008, NEUROREHABILITATION, V23, P487; DOWDS MM, 1999, ELECT MEMORY AIDS OU; DOWDS MM, 2005, REH PSYCH 2005 7 ANN; Ellis J, 2000, APPL COGNITIVE PSYCH, V14, pS1, DOI 10.1002/acp.767; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; Gentry T, 2008, BRAIN INJURY, V22, P19, DOI 10.1080/02699050701810688; Gillette Y, 2008, PSYCHOL SCHOOLS, V45, P665, DOI 10.1002/pits.20316; Hart T, 2004, J HEAD TRAUMA REHAB, V19, P351, DOI 10.1097/00001199-200409000-00001; Hart T, 2003, BRAIN INJURY, V17, P401, DOI 10.1080/0269905021000038438; Hart T, 2002, J HEAD TRAUMA REHAB, V17, P556, DOI 10.1097/00001199-200212000-00007; Hersh N A, 1994, NeuroRehabilitation, V4, P187, DOI 10.3233/NRE-1994-4309; Hilbe J. M., 2007, NEGATIVE BINOMIAL RE; Inglis EA, 2004, NEUROPSYCHOL REHABIL, V14, P77, DOI 10.1080/09602010343000129; KENNEDY M, 2008, ASHA LEADER, V11, P34; Kim HJ, 1999, BRAIN INJURY, V13, P147, DOI 10.1080/026990599121818; Kim HJ, 2000, BRAIN INJURY, V14, P187, DOI 10.1080/026990500120844; Manchester D, 2004, BRAIN INJURY, V18, P1067, DOI 10.1080/02699050410001672387; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; MCKINLAY W, 1999, REHABILITATION ADULT, P74; Bryen DN, 2007, INTELLECT DEV DISAB, V45, P1, DOI 10.1352/1934-9556(2007)45[1:CPUBAW]2.0.CO;2; O'Neil-Pirozzi TM, 2004, BRAIN INJURY, V18, P179, DOI 10.1080/0269905031000149560; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ONEILPIROZZI TM, J HEAD TRAU IN PRESS; PARENTE R, 1991, COGNITIVE REHABILITA, P147; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rothman KJ, 1998, MODERN EPIDEMIOLOGY; RYAN T V, 1992, Brain Injury, V6, P175, DOI 10.3109/02699059209029656; Sohlberg M., 2001, COGNITIVE REHABILITA; Sohlberg M. M., 2005, REHABILITATION TRAUM, P47; Sohlberg MM, 2007, J MED SPEECH-LANG PA, V15, pXV; THONEOTTO AIT, 2003, INT J PSYCHOL, V38, P1, DOI DOI 10.1080/00207590344000169; van den Broek MD, 2000, BRAIN INJURY, V14, P455; Wade TK, 2001, BRAIN INJURY, V15, P305, DOI 10.1080/026990501750111256; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME; Wilson BA, 1999, REHABIL PSYCHOL, V44, P284, DOI 10.1037/0090-5550.44.3.284; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wright P, 2001, BRAIN INJURY, V15, P787, DOI 10.1080/02699050110045161; [No title captured]	44	23	23	1	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2011	26	5					339	347		10.1097/HTR.0b013e3181f2bf1d			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	814VO	WOS:000294485500002	21464734				2022-02-06	
J	Zhang, Y; Liao, YH; Wang, DS; He, Y; Cao, DY; Zhang, FQ; Dou, KF				Zhang, Yi; Liao, Yonghui; Wang, Desheng; He, Yong; Cao, Dayong; Zhang, Fuqin; Dou, Kefeng			Altered Expression Levels of miRNAs in Serum as Sensitive Biomarkers for Early Diagnosis of Traumatic Injury	JOURNAL OF CELLULAR BIOCHEMISTRY			English	Article						miRNA; BIOMARKER; SERUM; TRAUMATIC INJURY; PARTIAL HEPATECTOMY	CIRCULATING MICRORNAS; SURGICAL TRAUMA; LIVER; MECHANISM; CANCER	MicroRNAs (miRNAs) are small non-coding RNAs of approximately 22 nucleotides in length which regulate gene expression negatively and play important roles in many pathological processes. It has been demonstrated that circulating miRNAs hold promise to serve as practicable molecular markers for diverse physiological and pathological conditions. In this investigation, we chose partial hepatectomy (PH) as traumatic injury model. There were significantly differential expression of miRNAs in rat serum post-traumatic injury (21 miRNAs were more than twofold up-regulated). Especially, the expression of miR-9 showed the highest up-regulated (>70-fold), and it possessed the characteristics of biomarker that was more sensitive than aspartate aminotransferase and alanine aminotransferase and C-reactive protein for traumatic liver injury. There was also a prominent increase in the expression levels of miR-9 in different brain areas after traumatic injury. Our data suggest that serum miR-9 may serve as promising biomarker for traumatic injury with high sensitivity. Furthermore, these findings may help to elucidate the complex network which mediates stress response to traumatic injury.J.Cell.Biochem. 112:2435-2442, 2011. (C) 2011Wiley-Liss, Inc.	[Zhang, Yi; Liao, Yonghui; Wang, Desheng; He, Yong; Cao, Dayong; Zhang, Fuqin; Dou, Kefeng] Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian 710032, Peoples R China		Dou, KF (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, 15 Changlexi Rd, Xian 710032, Peoples R China.	gdwkgwx@fmmu.edu.cn	Xia, Xianfeng/F-9169-2011		Key Program of National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81030010]	Grant sponsor: Key Program of National Natural Science Foundation of China; Grant number: 81030010.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; BOTHA AJ, 1995, SURGERY, V118, P358, DOI 10.1016/S0039-6060(05)80345-9; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Coolen M, 2009, CURR OPIN NEUROBIOL, V19, P461, DOI 10.1016/j.conb.2009.09.006; Desborough JP, 2000, BRIT J ANAESTH, V85, P109, DOI 10.1093/bja/85.1.109; Evans DC, 2007, CAN J SURG, V50, P364; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Higgins GM, 1931, ARCH PATHOL, V12, P186; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Leucht C, 2008, NAT NEUROSCI, V11, P641, DOI 10.1038/nn.2115; Li JN, 2009, AM J PATHOL, V175, P947, DOI 10.2353/ajpath.2009.090043; Liu NK, 2009, EXP NEUROL, V219, P424, DOI 10.1016/j.expneurol.2009.06.015; MacKenzie EJ, 2000, EPIDEMIOL REV, V22, P112, DOI 10.1093/oxfordjournals.epirev.a018006; MARUSZYNSKI M, 1995, SURG ENDOSC-ULTRAS, V9, P882; Menges T, 2008, CRIT CARE MED, V36, P1456, DOI 10.1097/CCM.0B013E318170ABB6; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Borque AM, 2007, AN MED INTERN, V24, P38; Neumaier M, 2006, ACTA ORTHOP, V77, P788, DOI 10.1080/17453670610013006; O'Hara SP, 2009, GASTROENTEROLOGY, V136, P17, DOI 10.1053/j.gastro.2008.11.028; Pasquale MD, 1996, CRIT CARE MED, V24, P1238, DOI 10.1097/00003246-199607000-00029; Pespeni M, 2005, J SURG RES, V126, P41, DOI 10.1016/j.jss.2005.01.012; Rinaldi A, 2010, BEHAV BRAIN RES, V208, P265, DOI 10.1016/j.bbr.2009.11.012; Rosell R, 2009, CLIN LUNG CANCER, V10, P8, DOI 10.3816/CLC.2009.n.001; Tsitsiou E, 2009, CURR OPIN PHARMACOL, V9, P514, DOI 10.1016/j.coph.2009.05.003; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wang JF, 2010, BIOCHEM BIOPH RES CO, V394, P184, DOI 10.1016/j.bbrc.2010.02.145; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Yu CH, 2009, DIGEST DIS SCI, V54, P2362, DOI 10.1007/s10620-008-0629-8	36	23	25	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0730-2312	1097-4644		J CELL BIOCHEM	J. Cell. Biochem.	SEP	2011	112	9					2435	2442		10.1002/jcb.23168			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	818QN	WOS:000294769500026	21538484				2022-02-06	
J	Russell, KL; Kutchko, KM; Fowler, SC; Berman, NEJ; Levant, B				Russell, Kristin L.; Kutchko, Katrina M.; Fowler, Stephen C.; Berman, Nancy E. J.; Levant, Beth			Sensorimotor behavioral tests for use in a juvenile rat model of traumatic brain injury: Assessment of sex differences	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Traumatic brain injury; Juvenile; Forelimb; Hind limb; Actometer; Beam walk; Controlled cortical impact; Sensorimotor	CONTROLLED CORTICAL IMPACT; SPINAL-CORD-INJURY; IMMATURE RAT; POSTNATAL-DEVELOPMENT; COGNITIVE FUNCTION; MOTOR DEFICITS; ANIMAL-MODELS; MOUSE MODEL; ADULT-RATS; MECHANISMS	Modeling juvenile traumatic brain injury (TBI) in rodents presents several unique challenges compared to adult TBI, one of which is selecting appropriate sensorimotor behavioral tasks that enable the assessment of the extent of injury and recovery over time in developing animals. To address this challenge, we performed a comparison of common sensorimotor tests in Long-Evans rats of various sizes and developmental stages (postnatal days 16-45,35-190 g). Tests were compared and selected for their developmental appropriateness, scalability for growth, pre-training requirements, and throughput capability. Sex differences in response to TBI were also assessed. Grid walk, automated gait analysis, rotarod, beam walk, spontaneous forelimb elevation test, and measurement of motor activity using the force-plate actometer were evaluated. Grid walk, gait analysis. and rotarod failed to meet one or more of the evaluation criteria. Beam walk, spontaneous forelimb elevation test, and measurement of motor activity using the force-plate actometer satisfied all criteria and were capable of detecting motor abnormalities in rats subjected to controlled cortical impact on postnatal day 17. No sex differences were detected in the acute effects of TBI or functional recovery during the 28 days after injury using these tests. This demonstrates the utility of these tests for the evaluation of sensorimotor function in studies using rat models of pediatric TBI, and suggests that pre-pubertal males and females respond similarly to TBI with respect to sensorimotor outcomes. (C) 2011 Elsevier B.V. All rights reserved.	[Russell, Kristin L.; Kutchko, Katrina M.; Levant, Beth] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Fowler, Stephen C.] Univ Kansas, Dept Pharmacol & Toxicol, Lawrence, KS 66045 USA; [Berman, Nancy E. J.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA		Levant, B (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol, Mail Stop 1018,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	krussel@kumc.edu; katrina.kutchko@coloradocollege.edu; scfowler@ku.edu; nberman@kumc.edu; blevant@kumc.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD059939, HD02528, RR016475, ES007079]; University of Kansas Medical Center; ASPET SURF program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD002528] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD059939] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [T32ES007079] Funding Source: NIH RePORTER	Supported by NIH HD059939 (B.L.), HD02528 (B.L., N.E.J.B., S.C.F.), RR016475 (B.L.), ES007079 (K.L.R.), the University of Kansas Medical Center Biomedical Research Training Program (K.L.R.), and the ASPET SURF program (K.M.K.).	Adelson PD, 1998, ACT NEUR S, V71, P104; Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Adelson PD, 2000, J NEUROTRAUM, V17, P273, DOI 10.1089/neu.2000.17.273; Adelson PD, 1999, EXP TOXICOL PATHOL, V51, P130; ALTMAN J, 1975, ANIM BEHAV, V23, P896, DOI 10.1016/0003-3472(75)90114-1; Appelberg KS, 2009, J NEUROTRAUM, V26, P497, DOI 10.1089/neu.2008.0664; Arnold AP, 2009, HORM BEHAV, V55, P570, DOI 10.1016/j.yhbeh.2009.03.011; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bilgen M, 2005, NEUROREHAB NEURAL RE, V19, P219, DOI 10.1177/1545968305278635; Bolton SJ, 1998, EXP NEUROL, V154, P231, DOI 10.1006/exnr.1998.6927; Bretzner F, 2008, EUR J NEUROSCI, V28, P1795, DOI 10.1111/j.1460-9568.2008.06462.x; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Davis AS, 2010, APPL NEUROPSYCHOL, V17, P104, DOI 10.1080/09084281003708951; Ek CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012021; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Faul M, 2010, TRAUMATIC BRAIN INJU; Fineman I, 2000, J NEUROTRAUM, V17, P739, DOI 10.1089/neu.2000.17.739; FINGER FW, 1969, J COMP PHYSIOL PSYCH, V68, P461, DOI 10.1037/h0027490; Fowler SC, 2001, J NEUROSCI METH, V107, P107, DOI 10.1016/S0165-0270(01)00359-4; Fowler SC, 2009, BEHAV BRAIN RES, V202, P130, DOI 10.1016/j.bbr.2009.03.022; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Ginstfeldt T, 2010, BRAIN INJURY, V24, P1123, DOI 10.3109/02699052.2010.506853; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Grossman KJ, 2011, BEHAV BRAIN RES, V217, P202, DOI 10.1016/j.bbr.2010.09.029; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hickey RW, 2007, PEDIATR RES, V62, P271, DOI 10.1203/PDR.0b013e3180db2902; Horton AM, 2010, APPL NEUROPSYCHOL, V17, P99, DOI 10.1080/09084281003708944; Huh JW, 2008, EXP NEUROL, V213, P84, DOI 10.1016/j.expneurol.2008.05.009; KALONIA H, 2010, PROG NEUROPSYCHOPHAR; KUNKELBAGDEN E, 1992, EXP NEUROL, V116, P40, DOI 10.1016/0014-4886(92)90174-O; Lajiness-O'Neill R, 2010, APPL NEUROPSYCHOL, V17, P83, DOI 10.1080/09084281003708837; Levant B, 2010, PHYSIOL BEHAV, V101, P176, DOI 10.1016/j.physbeh.2010.04.038; Li XL, 2004, EXP NEUROL, V187, P94, DOI 10.1016/j.expneurol.2004.01.004; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Lynn DA, 2009, DEV PSYCHOBIOL, V51, P513, DOI 10.1002/dev.20386; Mank JE, 2009, AM NAT, V173, P141, DOI 10.1086/595754; Narayana PA, 2004, J NEUROSCI RES, V78, P749, DOI 10.1002/jnr.20275; National Institute of Neurological Disorders and Stroke, 2002, TRAUM BRAIN INJ HOP; Noggle CA, 2010, APPL NEUROPSYCHOL, V17, P110, DOI 10.1080/09084281003708977; Ochalski PG, 2010, J NEUROTRAUM, V27, P647, DOI 10.1089/neu.2009.1142; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Pajoohesh-Ganji A, 2010, NEUROSCI RES, V67, P117, DOI 10.1016/j.neures.2010.02.009; Paxinos G, 1986, RAT BRAIN STEREOTAXI; Pitzer C, 2010, J NEUROCHEM, V113, P930, DOI 10.1111/j.1471-4159.2010.06659.x; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Raghupathi R, 2007, J NEUROTRAUM, V24, P1596, DOI 10.1089/neu.2007.3790; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Scafidi S, 2010, DEV NEUROSCI-BASEL, V32, P480, DOI 10.1159/000323178; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Sgado P, 2011, NEUROTOX RES, V20, P170, DOI 10.1007/s12640-010-9232-9; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; SHERWOOD NM, 1970, STEREOTAXIC ATLAS DE; Siegel C, 2010, J NEUROSCI RES, V88, P2765, DOI 10.1002/jnr.22406; SPEAR LP, 1983, DEV PSYCHOBIOL, V16, P83, DOI 10.1002/dev.420160203; Springer JE, 2010, J NEUROTRAUM, V27, P139, DOI 10.1089/neu.2009.0952; Sullivan JR, 2010, APPL NEUROPSYCHOL, V17, P93, DOI 10.1080/09084281003708852; Vandeputte C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-92; Wagner AK, 2007, J NEUROTRAUM, V24, P1308, DOI 10.1089/neu.2007.0274; Walker PA, 2009, J TRAUMA, V67, pS120, DOI 10.1097/TA.0b013e3181ad323a; WESTERGA J, 1990, DEV BRAIN RES, V57, P163, DOI 10.1016/0165-3806(90)90042-W; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009; Zhu CL, 2006, J NEUROCHEM, V96, P1016, DOI 10.1111/j.1471-4159.2005.03639.x	68	23	23	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270			J NEUROSCI METH	J. Neurosci. Methods	AUG 15	2011	199	2					214	222		10.1016/j.jneumeth.2011.05.008			9	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	799VN	WOS:000293314300006	21600923	Green Accepted, Green Published			2022-02-06	
J	Fuller, G; Bouamra, O; Woodford, M; Jenks, T; Patel, H; Coats, TJ; Oakley, P; Mendelow, AD; Pigott, T; Hutchinson, PJ; Lecky, F				Fuller, Gordon; Bouamra, Omar; Woodford, Maralyn; Jenks, Tom; Patel, Hirin; Coats, Timothy J.; Oakley, Peter; Mendelow, A. David; Pigott, Tim; Hutchinson, Peter J.; Lecky, Fiona			The Effect of Specialist Neurosciences Care on Outcome in Adult Severe Head Injury: A Cohort Study	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						critical care; neurosurgery; craniocerebral trauma; cohort studies; patient transfer	TRAUMATIC BRAIN-INJURY; MANAGEMENT; UNIT; EPIDEMIOLOGY; MORTALITY; ADMISSION; SURVIVAL; MODERATE; PATIENT; IMPACT	Background: Head injury is the leading cause of death in trauma. UK national guidelines have recommended that all patients with severe head injury (SHI) should be treated in neuroscience centers. The aim of this study was to investigate the effect of specialist neuroscience care on mortality after SHI. Methods: We conducted a cohort study using prospectively recorded data from the largest European trauma registry, for adult patients presenting with blunt trauma between 2003 and 2009. Mortality and unadjusted odds of death were compared for patients with SHI treated in neuroscience units (NSU) versus nonspecialist centers. To control for confounding, odds of death associated with non-NSU care were calculated using propensity score-adjusted multivariate logistic regression (explanatory covariates: age, Glasgow Coma Score, Injury Severity Score, treatment center). Sensitivity analyses were performed to study possible bias arising from selective enrollment, from loss to follow-up, and from hidden confounders. Results: 5411 patients were identified with SHI between 2003 and 2009, with 1485 (27.4%) receiving treatment entirely in non-NSU centers. SHI management in a non-NSU was associated with a 11% increase in crude mortality (P < 0.001) and 1.72-fold (95% confidence interval: 1.52-1.96) increase in odds of death. The case mix adjusted odds of death for patients treated in a non-NSU unit with SHI was 1.85 (95% confidence interval: 1.57-2.19). These results were not significantly changed in sensitivity analyses examining selective enrollment or loss to follow-up, and were robust to potential bias from unmeasured confounders. Conclusions: Our data support current national guidelines and suggest that increasing transfer rates to NSUs represents an important strategy in improving outcomes in patients with SHI.	[Fuller, Gordon; Bouamra, Omar; Woodford, Maralyn; Jenks, Tom; Lecky, Fiona] Univ Manchester, Trauma Audit & Res Network, Hlth Sci Res Grp, Manchester Acad Hlth Sci Ctr, Salford, Lancs, England; [Patel, Hirin] Salford Royal Hosp, Dept Neurosurg, Salford, Lancs, England; [Coats, Timothy J.] Univ Leicester, Emergency Med Acad Grp, Dept Cardiovasc Sci, Accid & Emergency Dept,Leicester Royal Infirm, Leicester, Leics, England; [Oakley, Peter] N Staffordshire NHS Trust Stoke On Trent, N Staffordshire Hosp, Stoke On Trent, Staffs, England; [Mendelow, A. David] Newcastle Gen Hosp, Dept Neurosurg, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; [Pigott, Tim] Walton Ctr NHS Fdn Trust, Dept Neurosurg, Liverpool, Merseyside, England; [Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge CB2 1TN, England		Fuller, G (corresponding author), Univ Manchester, Trauma Audit & Res Network, Hlth Sci Res Grp, Salford Royal Hosp,Manchester Acad Hlth Sci Ctr, Clin Sci Bldg,Eccles Old Rd, Loughborough LE12 5PE, Leics, England.	gordonwfuller@doctors.net.uk	Mendelow, Alexander/AAW-2878-2021; Coats, Timothy/AAW-1254-2021	Coats, Timothy/0000-0003-2736-2784; Fuller, Gordon Ward/0000-0001-8532-3500; bouamra, omar/0000-0002-3155-4634	Academy of Medical Sciences/Health Foundation; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0601025] Funding Source: UKRI	The authors declare that they have no conflicts of interest in relation to publication of this paper. PJH is supported by an Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship.	*AAAM COMM INJ SCA, 2008, ABBR INJ SCAL 2008 R; Bouamra O, 2006, J TRAUMA, V61, P701, DOI 10.1097/01.ta.0000197175.91116.10; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; CAIRNS HWB, 1947, NOTES NEUROSURGICAL; Crimmins DW, 2000, J NEUROL NEUROSUR PS, V68, P8, DOI 10.1136/jnnp.68.1.8; Department of Health, HOSP EP STAT; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Greenland S, 2005, J R STAT SOC A STAT, V168, P267, DOI 10.1111/j.1467-985X.2004.00349.x; Groenwold RHH, 2010, INT J EPIDEMIOL, V39, P107, DOI 10.1093/ije/dyp332; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hukkelhoven CWPM, 2005, INTENS CARE MED, V31, P799, DOI 10.1007/s00134-005-2628-y; Hutchinson P J, 2004, Curr Opin Crit Care, V10, P101, DOI 10.1097/00075198-200404000-00004; JENNETT B, 1975, LANCET, V1, P480; Klein Y, 2010, J TRAUMA, V69, P544, DOI 10.1097/TA.0b013e3181c99936; LEACH P, 2009, J TRAUMA MANAG OUTCO, V3, P3; LESKO M, 2008, COMMUNICATION; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Mendelow AD, 2008, LANCET, V372, P685, DOI 10.1016/S0140-6736(08)61280-5; Mirski MA, 2001, J NEUROSURG ANESTH, V13, P83, DOI 10.1097/00008506-200104000-00004; Murphy LS, 1999, BRIT J NEUROSURG, V13, P564, DOI 10.1080/02688699943060; Nakamura N, 2006, NEUROL MED-CHIR, V46, P567, DOI 10.2176/nmc.46.567; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; *NAT I CLIN EXC, 2007, CLIN GUID NAT I CLIN, V56; *NEUR CAR STAK GRO, NEUR CAR CAP DEM REP; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Petsas A, 2010, J NEUROSURG ANESTH, V22, P354, DOI 10.1097/ANA.0b013e3181f0da95; Royston P, 2005, STATA J, V5, P279, DOI 10.1177/1536867X0500500212; Rubin D.B., 1987, MULTIPLE IMPUTATION; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Schafer JL, 1997, ANAL INCOMPLETE MULT; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Stocchetti N, 1999, INTENS CARE MED, V25, P371, DOI 10.1007/s001340050860; Stranjalis G, 2008, J TRAUMA, V65, P789, DOI 10.1097/TA.0b013e3181469e26; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Teig M, 2010, J NEUROSURG ANESTH, V22, P357, DOI 10.1097/ANA.0b013e3181f0dada; Trojano M, 2009, Int MS J, V16, P90; Varelas PN, 2006, J NEUROSURG, V104, P713, DOI 10.3171/jns.2006.104.5.713; Westaby S, 2007, BRIT MED J, V335, P759, DOI 10.1136/bmj.39318.644549.AE	46	23	24	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2011	23	3					198	205		10.1097/ANA.0b013e3182161816			8	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	774YY	WOS:000291423900007	21546855	Green Accepted			2022-02-06	
J	Chou, PCT; Shunmugavel, A; El Sayed, H; Desouki, MM; Nguyen, SA; Khan, M; Singh, I; Bilgen, M				Chou, Peter Cheng-te; Shunmugavel, Anandakumar; El Sayed, Hanaa; Desouki, Mohamed Mokhtar; Nguyen, Shaun A.; Khan, Mushfiquddin; Singh, Inderjit; Bilgen, Mehmet			Preclinical Use of Longitudinal MRI for Screening the Efficacy of S-Nitrosoglutathione in Treating Spinal Cord Injury	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						spinal cord injury; preclinical screening; drug treatment efficacy; translational research	TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE; INFLAMMATORY RESPONSE; EXPERIMENTAL STROKE; RAT MODEL; NITROSYLATION; PROTECTS; NITROSATION; DISEASE	Purpose: To evaluate the therapeutic efficacy of S-nitrosoglutathione (GSNO) in spinal cord injury (SCI) using in vivo MRI in combination with neuorobehavioral testing and postmortem tissue analysis. Materials and Methods: Sixteen female rats were mildly injured at the vertebral T10 level and randomized into control (n = 8) and GSNO-treatment (n = 8) groups. GSNO was delivered at 0.05 mg/kg dose in saline by means of tail vein at 1 hr postinjury and then given orally on the following days. On postinjury days 1, 3, 7, and 28, the rats were tested behaviorally, then scanned using sagittal T2-weighted MRI for the quantification of lesion, edema, and hemorrhagic regions at the injury site. Excised cords were analyzed using histology and immunohistochemistry. Results: Treatment with GSNO was feasible in rats with SCI. On the average, the GSNO group at each scan day 1, 3, 7, and 28 exhibited better functional recovery as indicated by the behavioral performance of 52%, 33%, 19%, and 18%, and had smaller lesions of -4%, -16%, -20%, and -17% compared with the controls, respectively. Edema trend was parallel to the lesion volumes in both groups. Ex vivo data demonstrated that GSNO plays a role in neuronal tissue preservation and sparing. Conclusion: The data collectively provided the preliminary evidence that the injured rats responded favorably to GSNO treatment. Longitudinal MRI provides critical quantitative information regarding the changes in lesion properties, which helps evaluating the efficacy of an exogenous intervention in SCI.	[Bilgen, Mehmet] Univ Malaya, Fac Med, Kuala Lumpur 50603, Malaysia; [Chou, Peter Cheng-te; El Sayed, Hanaa] Med Univ S Carolina, Preclin Imaging Translat Res Lab, Charleston, SC 29425 USA; [Bilgen, Mehmet] Univ Malaya, Univ Malaya Res Imaging Ctr, Kuala Lumpur 50603, Malaysia		Bilgen, M (corresponding author), Univ Malaya, Fac Med, Kuala Lumpur 50603, Malaysia.	mehmet.bilgen@yahoo.com			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS052610, NS054019]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS054019, R21NS052610] Funding Source: NIH RePORTER	Contract grant sponsor: NIH; Contract grant number: NS052610, NS054019.	BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beckmann N, 2001, ANAT RECORD, V265, P85, DOI 10.1002/ar.1059; Bilgen M, 2005, NEUROREHAB NEURAL RE, V19, P219, DOI 10.1177/1545968305278635; Bilgen M, 2007, MAGN RESON IMAGING, V25, P657, DOI 10.1016/j.mri.2006.10.009; Campbell SJ, 2008, NEUROPHARMACOLOGY, V55, P780, DOI 10.1016/j.neuropharm.2008.06.074; Chiueh Chuang C., 2002, Pediatric Research, V51, P414, DOI 10.1203/00006450-200204000-00002; CHOU P, 2009, P 17 ANN SCI M EXH I; CHOU PC, 2008, NEUROANATOMY, V7, P83; Ditor DS, 2008, J NEUROSURG-SPINE, V9, P301, DOI 10.3171/SPI/2008/9/9/301; Ek CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012021; Fortenberry JD, 2001, INFLAMM RES, V50, P89; Foster MW, 2003, TRENDS MOL MED, V9, P160, DOI 10.1016/S1471-4914(03)00028-5; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Kaposzta Z, 2002, CIRCULATION, V105, P1480, DOI 10.1161/01.CIR.0000012347.47001.97; Khan M, 2005, J CEREBR BLOOD F MET, V25, P177, DOI 10.1038/sj.jcbfm.9600012; Khan M, 2006, NITRIC OXIDE-BIOL CH, V15, P114, DOI 10.1016/j.niox.2006.01.008; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Lammertse D, 2007, J SPINAL CORD MED, V30, P205, DOI 10.1080/10790268.2007.11753928; Martinez-Ruiz A, 2004, CARDIOVASC RES, V62, P43, DOI 10.1016/j.cardiores.2004.01.013; Massa SM, 2010, J CLIN INVEST, V120, P1774, DOI 10.1172/JCI41356; Mihai G, 2008, J NEUROTRAUM, V25, P1, DOI 10.1089/neu.2007.0338; Mohr S, 1997, BIOCHEM BIOPH RES CO, V238, P387, DOI 10.1006/bbrc.1997.7304; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Nout YS, 2009, CRIT CARE MED, V37, P2160, DOI 10.1097/CCM.0b013e3181a05d41; Patel CB, 2009, J NEUROTRAUM, V26, P1005, DOI 10.1089/neu.2008.0860; Prasad R, 2007, GLIA, V55, P65, DOI 10.1002/glia.20436; Rauhala P, 1998, FASEB J, V12, P165, DOI 10.1096/fasebj.12.2.165; Savidge TC, 2007, GASTROENTEROLOGY, V132, P1344, DOI 10.1053/j.gastro.2007.01.051; Schrammel A, 2003, FREE RADICAL BIO MED, V34, P1078, DOI 10.1016/S0891-5849(03)00038-8; Schwartz M, 2006, J NEUROTRAUM, V23, P360, DOI 10.1089/neu.2006.23.360; Shen J, 2009, ACAD RADIOL, V16, P1142, DOI 10.1016/j.acra.2009.03.016; Shunmugavel A, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-17; Tatar Ilkan, 2009, BMC Med Imaging, V9, P10, DOI 10.1186/1471-2342-9-10; Wong DF, 2009, NEUROPSYCHOPHARMACOL, V34, P187, DOI 10.1038/npp.2008.166	34	23	23	0	6	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1053-1807			J MAGN RESON IMAGING	J. Magn. Reson. Imaging	JUN	2011	33	6					1301	1311		10.1002/jmri.22574			11	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	772WD	WOS:000291267700004	21590998				2022-02-06	
J	Gomez-Pinilla, F; Gomez, AG				Gomez-Pinilla, Fernando; Gomez, Alexis G.			The Influence of Dietary Factors in Central Nervous System Plasticity and Injury Recovery	PM&R			English	Article							TRAUMATIC BRAIN-INJURY; SATURATED-FAT DIET; SYNAPTIC PLASTICITY; NEUROTROPHIC FACTOR; SPINAL-CORD; DOCOSAHEXAENOIC ACID; COGNITIVE FUNCTION; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; EXERCISE	Although feeding is an essential component of life, it is only recently that the actions of foods on brain plasticity and function have been scrutinized. There is evidence that select dietary factors are important modifiers of brain plasticity and can have an impact on central nervous system health and disease. Results of new research indicate that dietary factors exert their effects by affecting molecular events related to the management of energy metabolism and synaptic plasticity. Recent study results show that select dietary factors have mechanisms similar to those of exercise, and that, in some cases, dietary factors can complement the action of exercise. Abundant research findings in animal models of central nervous system injury support the idea that nutrients can be taken in through whole foods and dietary supplements to reduce the consequences of neural damage. Therefore, exercise and dietary management appear as a noninvasive and effective strategy to help counteract neurologic and cognitive disorders. PM R 2011;3:S111-S116	[Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Brain Injury Res Ctr, Dept Neurosurg, Los Angeles, CA 90095 USA; [Gomez-Pinilla, Fernando; Gomez, Alexis G.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA		Gomez-Pinilla, F (corresponding author), Univ Calif Los Angeles, Brain Injury Res Ctr, Dept Neurosurg, 621 Charles E Young Dr, Los Angeles, CA 90095 USA.	fgomezpi@ucla.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS50465-06, NS068473, NS56413]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS050465, RC1NS068473, R01NS056413] Funding Source: NIH RePORTER	Research support: This work was supported by National Institutes of Health Awards NS50465-06, NS068473, and NS56413.	ASSUNCAO M, 2009, NEUROBIOL AGING 0501; Bruce-Keller AJ, 1999, ANN NEUROL, V45, P8, DOI 10.1002/1531-8249(199901)45:1<8::AID-ART4>3.0.CO;2-V; Chandra V, 2001, NEUROLOGY, V57, P985, DOI 10.1212/WNL.57.6.985; Cota D, 2006, BRAIN RES REV, V51, P85, DOI 10.1016/j.brainresrev.2005.10.004; Daffner KR, 2010, J ALZHEIMERS DIS, V19, P1101, DOI 10.3233/JAD-2010-1306; Gomez-Pinilla F, 2001, EUR J NEUROSCI, V13, P1078, DOI 10.1046/j.0953-816x.2001.01484.x; Gomez-Pinilla F, 2008, SURG NEUROL, V70, P333, DOI 10.1016/j.surneu.2008.05.023; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Gomez-Pinilla F, 2008, EUR J NEUROSCI, V28, P2278, DOI 10.1111/j.1460-9568.2008.06524.x; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Huang WL, 2007, BRAIN, V130, P3004, DOI 10.1093/brain/awm223; Jacka FN, 2010, AM J PSYCHIAT, V167, P305, DOI 10.1176/appi.ajp.2009.09060881; Jiang J, 2007, EUR J PHARMACOL, V561, P54, DOI 10.1016/j.ejphar.2006.12.028; Jones CR, 1997, NEUROCHEM RES, V22, P663, DOI 10.1023/A:1027341707837; Kalantari H, 2010, BIOFACTORS, V36, P401, DOI 10.1002/biof.100; Kaur T, 2008, BRAIN COGNITION, V67, P25, DOI 10.1016/j.bandc.2007.10.003; Kiziltepe U, 2004, J VASC SURG, V40, P138, DOI 10.1016/j.jvs.2004.03.032; Kuriyama S, 2006, AM J CLIN NUTR, V83, P355; Lin MS, 2011, J SURG RES, V166, P280, DOI 10.1016/j.jss.2009.07.001; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Molteni R, 2004, P NATL ACAD SCI USA, V101, P8473, DOI 10.1073/pnas.0401443101; Molteni R, 2004, NEUROSCIENCE, V123, P429, DOI 10.1016/j.neuroscience.2003.09.020; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Nagappan G, 2005, TRENDS NEUROSCI, V28, P464, DOI 10.1016/j.tins.2005.07.003; Ng TP, 2006, AM J EPIDEMIOL, V164, P898, DOI 10.1093/aje/kwj267; Pasinetti Giulio Maria, 2007, V35, P159; Plunet WT, 2008, EXP NEUROL, V213, P28, DOI 10.1016/j.expneurol.2008.04.011; POWELL KE, 1994, MED SCI SPORT EXER, V26, P851; Raji CA, 2010, HUM BRAIN MAPP, V31, P353, DOI 10.1002/hbm.20870; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Sharma S, 2010, EXP NEUROL, V226, P191, DOI 10.1016/j.expneurol.2010.08.027; Shukitt-Hale B, 2009, NUTR NEUROSCI, V12, P135, DOI 10.1179/147683009X423292; Spencer JPE, 2009, GENES NUTR, V4, P243, DOI 10.1007/s12263-009-0136-3; Unno K, 2007, BIOGERONTOLOGY, V8, P89, DOI 10.1007/s10522-006-9036-8; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Vaynman S, 2005, NEUROREHAB NEURAL RE, V19, P283, DOI 10.1177/1545968305280753; Vaynman S, 2006, J NEUROSCI RES, V84, P699, DOI 10.1002/jnr.20979; Wu A, 2008, NEUROSCIENCE, V155, P751, DOI 10.1016/j.neuroscience.2008.05.061; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Wu AG, 2004, EUR J NEUROSCI, V19, P1699, DOI 10.1111/j.1460-9568.2004.03246.x; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; Ye K, 2010, J RADIAT RES, V51, P473, DOI 10.1269/jrr.10009; Ying Z, 2005, EXP NEUROL, V193, P411, DOI 10.1016/j.expneurol.2005.01.015; Zhang S, 2010, NEUROL RES, V32, P963, DOI 10.1179/016164110X12700393823570; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	50	23	23	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	JUN	2011	3	6		S			S111	S116		10.1016/j.pmrj.2011.03.001			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	961BB	WOS:000305437800018	21703566	Green Accepted			2022-02-06	
J	Wong, GKC; Yeung, JHH; Graham, CA; Zhu, XL; Rainer, TH; Poon, WS				Wong, George K. C.; Yeung, Janice H. H.; Graham, Colin A.; Zhu, Xian-lun; Rainer, Timothy H.; Poon, Wai S.			Neurological outcome in patients with traumatic brain injury and its relationship with computed tomography patterns of traumatic subarachnoid hemorrhage Clinical article	JOURNAL OF NEUROSURGERY			English	Article						mortality rate; multiple trauma; neurosurgery; neurological outcome; subarachnoid hemorrhage; traumatic brain injury	MODERATE HEAD-INJURY; ADMISSION; CLASSIFICATION; MULTICENTER; PROGRESSION; PREDICTION; VALIDATION; DIAGNOSIS; IMPACT; SCORE	Object. Traumatic subarachnoid hemorrhage (SAH) is a poor prognostic factor for traumatic brain injury. The authors aimed to further investigate neurological outcome among head injury patients by examining the prognostic values of CT patterns of traumatic SAH, in particular, the thickness and distribution. Methods. The study was conducted using a database in a regional trauma center in Hong Kong. Data had been prospectively collected in consecutive trauma patients between January 2006 and December 2008. Patients included in the study had significant head injury (as defined by a head Abbreviated Injury Scale [AIS] score of 2 or more) with traumatic SAH according to admission CT. Results. Over the 36-month period, 661 patients with significant head injury were admitted to the Prince of Wales Hospital in Hong Kong. Two hundred fourteen patients (32%) had traumatic SAH on admission CT. The mortality rate was significantly greater and a 6-month unfavorable outcome was significantly more frequent in patients with traumatic SAH. Multivariate analysis showed that the maximum thickness (mm) of traumatic SAH was independently associated with neurological outcome (OR 0.8.95% CI 0.7-0.9) and death (OR 1.3, 95% CI 1.2-1.5) but not with the extent or location of hemorrhage. Conclusions: Maximum thickness of traumatic SAH was a strong independent prognostic factor for death and clinical outcome. Anatomical distribution per se did not affect clinical outcome. (DOI: 10.3171/2011.1.JNS101102)	[Wong, George K. C.] Chinese Univ Hong Kong, Prince Wales Hosp, Div Neurosurg, Dept Surg, Shatin, Hong Kong, Peoples R China; [Yeung, Janice H. H.; Graham, Colin A.; Rainer, Timothy H.] Chinese Univ Hong Kong, Prince Wales Hosp, Accident & Emergency Med Acad Unit, Shatin, Hong Kong, Peoples R China		Wong, GKC (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Div Neurosurg, Dept Surg, Shatin, Hong Kong, Peoples R China.	georgewong@surgery.cuhk.edu.hk	Wong, George Kwok Chu/L-4344-2016; Wong, George KC/A-6378-2011; Poon, Wai Sang/F-1558-2011; Rainer, Timothy H/I-2591-2013; Graham, Colin A/B-4535-2013	Wong, George KC/0000-0002-6078-2548; Rainer, Timothy H/0000-0003-3355-3237; Graham, Colin A/0000-0002-4381-7470			*ASS ADV AUT MED, 1985, ABBR INJ SCAL 1985 V; Azian AA, 2001, ACTA NEUROCHIR, V143, P711, DOI 10.1007/s007010170051; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Cheng CH, 2008, ANN SURG, V247, P335, DOI 10.1097/SLA.0b013e31815ccc2e; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Choi JH, 2008, J TRAUMA, V65, P1028, DOI 10.1097/TA.0b013e31815eba9b; Claassen J, 2001, STROKE, V32, P2012, DOI 10.1161/hs0901.095677; Compagnone C, 2009, NEUROSURGERY, V64, P690, DOI 10.1227/01.NEU.0000340796.18738.F7; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Fainardi E, 2004, ACTA NEUROCHIR, V146, P257, DOI 10.1007/s00701-003-0207-y; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Greene KA, 1996, J TRAUMA, V41, P964, DOI 10.1097/00005373-199612000-00004; Hanlon RE, 2005, BRAIN INJURY, V19, P257, DOI 10.1080/02699050400004955; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; JENNETT B, 1975, LANCET, V1, P480; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; Miki T, 1998, J CLIN NEUROSCI, V5, P49, DOI 10.1016/S0967-5868(98)90202-8; Morris GF, 1997, CLIN NEUROL NEURO S1, V99, pS16; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Patel HC, 1999, HOSP MED, V60, P497, DOI 10.12968/hosp.1999.60.7.1155; Servadei F, 2002, ACT NEUR S, V81, P81; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tasaki O, 2009, J TRAUMA, V66, P304, DOI 10.1097/TA.0b013e31815d9d3f; TEASDALE G, 1974, LANCET, V2, P81; Vergouwen MDI, 2006, LANCET NEUROL, V5, P1029, DOI 10.1016/S1474-4422(06)70582-8; Wang HC, 2006, NEUROCRIT CARE, V5, P71, DOI 10.1385/NCC:5:1:71; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; Wong GK, 2009, BRIT J NEUROSURG, V23, P601, DOI 10.3109/02688690902948184; Zacharia TT, 2010, EMERG RADIOL, V17, P97, DOI 10.1007/s10140-009-0842-6	34	23	23	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUN	2011	114	6					1510	1515		10.3171/2011.1.JNS101102			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	770YB	WOS:000291123300005	21332291				2022-02-06	
J	Himanen, L; Portin, R; Hamalainen, P; Hurme, S; Hiekkanen, H; Tenovuo, O				Himanen, Leena; Portin, Raija; Hamalainen, Paivi; Hurme, Saija; Hiekkanen, Heli; Tenovuo, Olli			Risk factors for reduced survival after traumatic brain injury: A 30-year follow-up study	BRAIN INJURY			English	Article						Brain injuries; follow-up studies; survival; cognition	HEAD-INJURY; PSYCHIATRIC-DISORDERS; POPULATION; MORTALITY; RETURN; DEATH; SEVERITY; OUTCOMES; SUICIDE; COHORT	Primary objective: To evaluate risk factors for reduced survival in subjects with traumatic brain injury (TBI). Participants and methods: A retrospective follow-up of three decades included 192 subjects with TBI. Cognitive testing was carried out on average 2 years after the injury (at mean age of 39.0 years), during the years 1966-1972. Cox's regression and logistic regression analyses were used and the survival of the subjects was compared with the general population using the standardized mortality ratio (SMR). Results: Reduced survival was significantly associated with age at injury (p < 0.001) and vocational outcome (p = 0.003). Vocational outcome in turn was associated with age (p = 0.010), TBI severity (p < 0.001), cognitive impairment (p = 0.010), later TBIs (p = 0.007) and alcohol abuse (p = 0.015). Mortality in the younger patient group (age at death <40 years) was higher than in the general population (SMR 4.50, 95% CI = 2.02-10.01). Conclusions: A reduced working ability, influenced by age-, injury- and lifestyle-related factors, is associated with long-term survival after TBI. The mortality among younger patients is high, a finding which should be considered when planning the care after TBI.	[Himanen, Leena; Portin, Raija; Hiekkanen, Heli; Tenovuo, Olli] Turku Univ Hosp, Dept Neurol, FIN-20521 Turku, Finland; [Hamalainen, Paivi] Masku Rehabil Ctr, Masku, Finland; [Hurme, Saija] Univ Turku, Dept Biostat, SF-20500 Turku, Finland		Himanen, L (corresponding author), Turku Univ Hosp, Dept Neurol 720, PL 52, FIN-20521 Turku, Finland.	ls.himanen@pp1.inet.fi		Himanen, Leena/0000-0001-7261-8027	Jenny and Antti Wihuri foundation	Supported by a grant from the Jenny and Antti Wihuri foundation.	Baguley I, 2000, BRAIN INJURY, V14, P505; Benton AL, 1963, REVISED VISUAL RETEN; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; CONROY C, 1988, NEUROEPIDEMIOLOGY, V7, P13, DOI 10.1159/000110131; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Dischinger PC, 2001, J TRAUMA, V51, P877, DOI 10.1097/00005373-200111000-00009; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; KUJALA P, 1994, BRAIN, V117, P1115, DOI 10.1093/brain/117.5.1115; LEWIN W, 1979, BRIT MED J, V2, P1533, DOI 10.1136/bmj.2.6204.1533; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; Pentland B, 2005, J NEUROL NEUROSUR PS, V76, P395, DOI 10.1136/jnnp.2004.037861; Pickelsimer EE, 2006, J HEAD TRAUMA REHAB, V21, P491, DOI 10.1097/00001199-200611000-00004; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; Sundstrom T, 2007, J NEUROTRAUM, V24, P147, DOI 10.1089/neu.2006.0099; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; WALKER AE, 1971, ARCH NEUROL-CHICAGO, V24, P95, DOI 10.1001/archneur.1971.00480320023001; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Wechsler D., 1955, MANUAL WECHSLER ADUL; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223	33	23	23	0	8	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAY	2011	25	5					443	452		10.3109/02699052.2011.556580			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	745KQ	WOS:000289164700002	21401369				2022-02-06	
J	Savage, WJ; Barron-Casella, E; Fu, ZM; Dulloor, P; Williams, L; Crain, BJ; White, DA; Jennings, JM; Van Eyk, JE; Debaun, MR; Everett, A; Casella, JF				Savage, William J.; Barron-Casella, Emily; Fu, Zongming; Dulloor, Pratima; Williams, Lisa; Crain, Barbara J.; White, Desiree A.; Jennings, Jacky M.; Van Eyk, Jennifer E.; Debaun, Michael R.; Everett, Allen; Casella, James F.			Plasma glial fibrillary acidic protein levels in children with sickle cell disease	AMERICAN JOURNAL OF HEMATOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; NEURON-SPECIFIC ENOLASE; TRANSFUSION SIT TRIAL; ACUTE ISCHEMIC-STROKE; CEREBROSPINAL-FLUID; EARLY-DIAGNOSIS; SERUM; MARKERS; RELEASE; ANEMIA	To determine if glial fibrillary acidic protein (GFAP) is associated with brain injury in children with sickle cell disease (SCD), we measured plasma GFAP among cross-sectional groups of unselected children with SCD, subsets of children with SCD and normal brain MRI or MRI evidence of cerebral infarct, healthy pediatric controls, and adults with brain injury. Children with SCD had higher plasma GFAP than healthy pediatric controls (mean concentrations 0.14 +/- 0.37 vs. 0.07 +/- 0.08 ng/mL; P = 0.003); also, 16.0% (16/100) of children with SCD and cerebral infarct had GFAP elevations above the 95th percentile of healthy pediatric controls (P = 0.04). Although not statistically significant, children with SCD and cerebral infarct had more elevated GFAP levels than with SCD and no infarct (16/100, 16.0% vs. 14/168, 8.3%; P = 0.07). Children with SCD and acute brain ischemia had a higher proportion of elevated GFAP than SCD children with normal MRI (3/6, 50% vs. 8.3%; P = 0.01). GFAP was associated with elevated systolic blood pressure in the preceding year and correlated positively with white blood cell count and negatively with age and performance IQ. Plasma GFAP is elevated among children with SCD and may be associated with subclinical brain injury.	[Savage, William J.; Casella, James F.] JHUSOM, Div Transfus Med, Baltimore, MD 21117 USA; [Savage, William J.; Barron-Casella, Emily; Fu, Zongming; Williams, Lisa; Casella, James F.] JHUSOM, Div Pediat Hematol, Baltimore, MD USA; [Dulloor, Pratima; Everett, Allen] JHUSOM, Div Pediat Cardiol, Baltimore, MD USA; [Crain, Barbara J.] JHUSOM, Div Neuropathol, Baltimore, MD USA; [White, Desiree A.] Washington Univ, Dept Psychol, Sch Med, St Louis, MO 63130 USA; [Jennings, Jacky M.] JHUSOM, Div Gen Pediat & Adolescent Med, Baltimore, MD USA; [Van Eyk, Jennifer E.] JHUSOM, Div Cardiol, Baltimore, MD USA; [Debaun, Michael R.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63130 USA; [Debaun, Michael R.] Washington Univ, Sch Med, Dept Biostat, St Louis, MO 63130 USA; [Debaun, Michael R.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63130 USA		Savage, WJ (corresponding author), Carnegie 667,600 N Wolfe St, Baltimore, MD 21287 USA.	wsavage1@jhmi.edu		jennings, jacky/0000-0002-3789-5122	SIT Trial investigators [1U54HL090515, R01 HL091759, 5K12HL087169]; NHLBI Proteomic InitiativeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [N01-HV-28,120, 1U54RR023561, 5U01NS042804, 5K01DA022298, 5T15HL086386]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000052] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K12HL087169, T15HL086386, R01HL091759, U54HL090515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS042804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [K01DA022298] Funding Source: NIH RePORTER	Grant sponsor: SIT Trial investigators; Grant numbers: 1U54HL090515, R01 HL091759, 5K12HL087169. Grant sponsor: NHLBI Proteomic Initiative; Grant numbers: N01-HV-28,120, 1U54RR023561, 5U01NS042804, 5K01DA022298, 5T15HL086386	Allard L, 2005, CLIN CHEM, V51, P2043, DOI 10.1373/clinchem.2005.053942; Armstrong FD, 1996, PEDIATRICS, V97, P864; BEMBEA MM, 2010, PEDIAT CRIT CARE MED; Casella JF, 2010, PEDIATR HEMAT ONCOL, V27, P69, DOI 10.3109/08880010903360367; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; Hesse C, 2001, NEUROSCI LETT, V297, P187, DOI 10.1016/S0304-3940(00)01697-9; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Jauch EC, 2006, STROKE, V37, P2508, DOI 10.1161/01.STR.0000242290.01174.9e; Kinney TR, 1999, PEDIATRICS, V103, P640, DOI 10.1542/peds.103.3.640; LEWIS SA, 1984, P NATL ACAD SCI-BIOL, V81, P2743, DOI 10.1073/pnas.81.9.2743; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Ohene-Frempong K, 1998, BLOOD, V91, P288; PERSSON L, 1987, STROKE, V18, P911, DOI 10.1161/01.STR.18.5.911; Rashid P, 2003, STROKE, V34, P2741, DOI 10.1161/01.STR.0000092488.40085.15; Rivers CS, 2006, STROKE, V37, P1418, DOI 10.1161/01.STR.0000221294.90068.c4; SARNAIK S, 2009, ELEVATED SYSTOLIC BL; Schwamm LH, 1998, STROKE, V29, P2268, DOI 10.1161/01.STR.29.11.2268; Vendt BA, 2009, J DIGIT IMAGING, V22, P326, DOI 10.1007/s10278-008-9114-3; Vichinsky EP, 2010, JAMA-J AM MED ASSOC, V303, P1823, DOI 10.1001/jama.2010.562; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wang W, 2001, J PEDIATR-US, V139, P391, DOI 10.1067/mpd.2001.116935; Wunderlich MT, 2006, EUR J NEUROL, V13, P1118, DOI 10.1111/j.1468-1331.2006.01435.x; Zimmermann-Ivol CG, 2004, MOL CELL PROTEOMICS, V3, P66, DOI 10.1074/mcp.M300066-MCP200	23	23	23	0	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0361-8609			AM J HEMATOL	Am. J. Hematol.	MAY	2011	86	5					427	429		10.1002/ajh.21995			3	Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Hematology	766CB	WOS:000290756300010	21523806	Green Accepted, Bronze			2022-02-06	
J	Yeung, JHH; Mikocka-Walus, AA; Cameron, PA; Poon, WS; Ho, HF; Chang, A; Graham, CA; Rainer, TH				Yeung, Janice H. H.; Mikocka-Walus, Antonina A.; Cameron, Peter A.; Poon, Wai S.; Ho, Hiu F.; Chang, Annice; Graham, Colin A.; Rainer, Timothy H.			Protection From Traumatic Brain Injury in Hormonally Active Women vs Men of a Similar Age A Retrospective International Study	ARCHIVES OF SURGERY			English	Article							GENDER-DIFFERENCES; MALE-RATS; HEAD-INJURY; HONG-KONG; PROGESTERONE; EDEMA; CNS; MULTICENTER; VALIDATION; AUSTRALIA	Background: It has been suggested that women with traumatic brain injury have more favorable outcomes than do men because of higher levels of circulating estrogen and progesterone that may reduce brain edema. Objectives: To determine whether there is any association between sex and mortality in TBI patients and whether there is any association between sex and brain edema. Design: Retrospective cohort study using data from 2001 to 2007 collected from a trauma registry in Hong Kong and the Victorian State Trauma Registry. Setting: Two regional trauma centers in Hong Kong and 2 adult major trauma centers and 1 pediatric trauma center in Victoria, Australia. Main Outcome Measures: Mortality and brain edema. Patients: Trauma patients with an Abbreviated Injury Scale score (head) of at least 3 who were aged 12 to 45 years were included. Patients with minor head injury and undisplaced closed skull fracture were excluded. Results: Both the Hong Kong and Victorian data showed no significant difference in sex-related mortality. Increased mortality was associated with decreased systolic blood pressure and Glasgow Coma Scale score and with increased New Injury Severity Score or Injury Severity Score. In Hong Kong, brain edema was associated with female sex (P=.02), and the odds of brain edema in females were greater than for males. However, this association was not found in Victorian patients. Conclusion: This study found no significant association between sex and mortality in either Victoria or Hong Kong and does not support the concept that females have better outcomes after traumatic brain injury.	[Yeung, Janice H. H.; Graham, Colin A.; Rainer, Timothy H.] Chinese Univ Hong Kong, Accid & Emergency Med Acad Unit, Hong Kong, Hong Kong, Peoples R China; [Poon, Wai S.] Chinese Univ Hong Kong, Div Neurosurg, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Ho, Hiu F.; Chang, Annice] Queen Elizabeth Hosp, Dept Accid & Emergency, Hong Kong, Hong Kong, Peoples R China; [Mikocka-Walus, Antonina A.; Cameron, Peter A.] Monash Univ, Dept Epidemiol & Prevent Med, Clayton, Vic 3800, Australia; [Cameron, Peter A.] Monash Univ, Alfred Hosp, Emergency & Trauma Ctr, Melbourne, Vic 3181, Australia		Rainer, TH (corresponding author), Chinese Univ Hong Kong, Accid & Emergency Med Acad Unit, Trauma & Emergency Ctr, Prince Wales Hosp, Room 02C44,2-F Main Clin Block & Trauma Ctr, Shatin, Hong Kong, Peoples R China.	thrainer@cuhk.edu.hk	Graham, Colin A/B-4535-2013; Poon, Wai Sang/F-1558-2011; Mikocka-Walus, Antonina/B-4160-2010; Mikocka-Walus, Antonina/R-2363-2017; Rainer, Timothy H/I-2591-2013	Graham, Colin A/0000-0002-4381-7470; Mikocka-Walus, Antonina/0000-0003-4864-3956; Rainer, Timothy H/0000-0003-3355-3237; Cameron, Peter/0000-0002-1443-557X			Cameron PA, 2004, ANZ J SURG, V74, P424, DOI 10.1111/j.1445-1433.2004.03029.x; Cheng CH, 2008, ANN SURG, V247, P335, DOI 10.1097/SLA.0b013e31815ccc2e; Coimbra R, 2003, J TRAUMA, V54, P689, DOI 10.1097/01.TA.0000058314.31655.5F; Coughlan T, 2009, INT J NEUROSCI, V119, P1718, DOI 10.1080/00207450903116430; Deitch EA, 2007, ANN SURG, V246, P447, DOI 10.1097/SLA.0b013e318148566; Demetriades D, 2006, J TRAUMA, V61, P868, DOI 10.1097/01.ta.0000219135.33398.f3; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Farin A, 2003, J NEUROSURG, V98, P32, DOI 10.3171/jns.2003.98.1.0032; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Gannon CJ, 2002, J AM COLL SURGEONS, V195, P11, DOI 10.1016/S1072-7515(02)01187-0; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Hu ZY, 2009, CURR MED CHEM, V16, P1418, DOI 10.2174/092986709787846523; Kasturi BS, 2009, RESTOR NEUROL NEUROS, V27, P265, DOI [10.3233/RNN-2009-0475, 10.3233/RNN-2009-0476]; Kirkness Catherine J, 2004, Biol Res Nurs, V5, P299, DOI 10.1177/1099800404263050; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Ponsford JL, 2008, INJURY, V39, P67, DOI 10.1016/j.injury.2007.08.028; Rappold JF, 2002, J TRAUMA, V53, P436, DOI 10.1097/00005373-200209000-00007; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Shafi S, 2007, J TRAUMA, V63, P1138, DOI 10.1097/TA.0b013e3181568cd4; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Stein DG, 2010, AM J ROENTGENOL, V194, P20, DOI 10.2214/AJR.09.3407; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Vagnerova K, 2008, ANESTH ANALG, V107, P201, DOI 10.1213/ane.0b013e31817326a5; Wang JP, 2009, BRAIN RES BULL, V79, P426, DOI 10.1016/j.brainresbull.2009.05.018; Wohltmann CD, 2001, AM J SURG, V181, P297, DOI 10.1016/S0002-9610(01)00582-7; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901; Yeung JHH, 2008, INJURY, V39, P1034, DOI 10.1016/j.injury.2008.03.017	36	23	23	1	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0004-0010			ARCH SURG-CHICAGO	Arch. Surg.	APR	2011	146	4					436	442		10.1001/archsurg.2011.46			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	751VX	WOS:000289646900014	21502452	Bronze			2022-02-06	
J	Colantonio, A; Gerber, G; Bayley, M; Deber, R; Yin, JL; Kim, H				Colantonio, Angela; Gerber, Gary; Bayley, Mark; Deber, Raisa; Yin, Junlang; Kim, Hwan			DIFFERENTIAL PROFILES FOR PATIENTS WITH TRAUMATIC AND NON-TRAUMATIC BRAIN INJURY	JOURNAL OF REHABILITATION MEDICINE			English	Article						brain injuries; rehabilitation; treatment outcome	FUNCTIONAL INDEPENDENCE MEASURE; SPINAL-CORD-INJURY; REHABILITATION; RELIABILITY	Objective: To profile the demographic, clinical and environmental characteristics of persons with acquired brain injury receiving inpatient rehabilitation services in Canada. Design: This study utilizes data from the Canadian Institute for Health Information's National Rehabilitation Reporting System, between April 2001 and March 2006. The data were collected from publicly insured institutions providing inpatient rehabilitation across Canada. The main outcome measures examined were demographic and clinical characteristics. Participants: Adults with brain injury by traumatic (n=2675) vs non-traumatic causes (n=2759). Results: Approximately half of acquired brain injury patients receiving inpatient rehabilitation had non-traumatic causes of brain injury. Traumatic brain injury patients were more likely to be younger, male, from rural areas, and to make greater gains in rehabilitation. Differences were found in the types and numbers of comorbidities. However, patients from these 2 groups had similar lengths of rehabilitation stay. Conclusion: These findings support a differential profile of patients by brain injury aetiology. This has relevance for staff training, resource allocation and future research.	[Colantonio, Angela; Bayley, Mark; Yin, Junlang; Kim, Hwan] Univ Toronto, Toronto Rehabil Inst, Toronto, ON M5G 1V7, Canada; [Gerber, Gary] Univ Toronto, W Pk Healthcare Ctr, Toronto, ON M5G 1V7, Canada; [Deber, Raisa] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON M5G 1V7, Canada		Colantonio, A (corresponding author), Univ Toronto, Toronto Rehabil Inst, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca		Bayley, Mark/0000-0001-7860-9463; Colantonio, Angela/0000-0003-2094-4765; Deber, Raisa/0000-0003-0598-3926	Ontario Ministry of Health and Long Term CareMinistry of Health and Long-Term Care, Ontario; Toronto Rehabilitation Institute Foundation; Ontario Neurotrauma Foundation	We acknowledge support from a grant from the Ontario Ministry of Health and Long Term Care to the Toronto Rehabilitation Institute and the Toronto Rehabilitation Institute Foundation. We acknowledge support from a grant from the Ontario Neurotrauma Foundation. We thank the Canadian Institute for Health Information for providing access to National Rehabilitation Reporting System data and for use of the FIM (R) instrument. The FIM (R) instrument, data-set and impairment codes referenced herein arc the property of Uniform Data System for Medical Rehabilitation, a division of UB Foundation Activities, Inc.	*CAN I HLTH INF, 2005, INP REH CAN 2003 200; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P418, DOI 10.1016/j.apmr.2007.01.010; Cullen NK, 2008, BRAIN INJURY, V22, P1013, DOI 10.1080/02699050802530581; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; McKinley WO, 2001, AM J PHYS MED REHAB, V80, P693, DOI 10.1097/00002060-200109000-00010; McKinley WO, 2000, AM J PHYS MED REHAB, V79, P138, DOI 10.1097/00002060-200003000-00005; Mechanda K, 2007, POSTAL CODES MAP GEO; Ottenbacher KJ, 2004, JAMA-J AM MED ASSOC, V292, P1687, DOI 10.1001/jama.292.14.1687; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700	13	23	23	0	7	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977			J REHABIL MED	J. Rehabil. Med.	MAR	2011	43	4					311	315		10.2340/16501977-0783			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	743ID	WOS:000289011000006	21347507	Green Submitted, gold, Green Published			2022-02-06	
J	Hoffmeister, PG; Donat, CK; Schuhmann, MU; Voigt, C; Walter, B; Nieber, K; Meixensberger, J; Bauer, R; Brust, P				Hoffmeister, Peter-Georg; Donat, Cornelius K.; Schuhmann, Martin U.; Voigt, Cornelia; Walter, Bernd; Nieber, Karen; Meixensberger, Juergen; Bauer, Reinhard; Brust, Peter			Traumatic Brain Injury Elicits Similar Alterations in alpha 7 Nicotinic Receptor Density in Two Different Experimental Models	NEUROMOLECULAR MEDICINE			English	Article						Traumatic brain injury; alpha 7 nAChR; Autoradiography; Cholinergic system; alpha-Bungarotoxin	VESICULAR ACETYLCHOLINE TRANSPORTER; FLUID PERCUSSION INJURY; SEVERE HEAD-INJURY; RAT-BRAIN; IN-VIVO; BUNGAROTOXIN RECEPTORS; CALCIUM PERMEABILITY; CHOLINERGIC MARKERS; IMMATURE BRAIN; GABA RECEPTORS	Traumatic brain injury (TBI) is a major cause of death and disability worldwide, especially in children and young adults. Previous studies have shown alterations in the central cholinergic neurotransmission after TBI. We therefore determined alpha 7 nicotinic acetylcholine receptor (nAChR) densities in newborn piglets and adult rats after experimental TBI. Thirteen newborn piglets (post-TBI survival time: 6 h) underwent fluid percussion (FP) injury (n = 7) or sham operation (n = 6). Furthermore, adult rats randomized into three groups of post-TBI survival times (2, 24, 72 h) received controlled cortical impact injury (CCI, n = 8) or sham operation (n = 8). Brains were frozen, sagittally cut and incubated with the alpha 7-specific radioligand [I-125]alpha-bungarotoxin for autoradiography. In injured newborn piglets, decreased alpha 7 receptor densities were observed in the hippocampus (-38%), the hippocampus CA1 (-40%), thalamus (-30%) and colliculus superior (-30%). In adult rats, CCI decreased the receptor densities (between -16 and -47%) in almost any brain region within 2 and 24 h. In conclusion, widespread and significantly lowered alpha 7 nAChR densities were demonstrated in both TBI models. Our results suggest that a nearly similar TBI-induced decrease in the alpha 7 density in the brain of immature and adult animals is found, even with the differences in species, age and experimental procedures. The alterations make the alpha 7 nAChR a suitable target for drug development and neuroimaging after TBI.	[Hoffmeister, Peter-Georg; Donat, Cornelius K.; Brust, Peter] Res Ctr Dresden Rossendorf, Inst Radiopharm, D-04318 Leipzig, Germany; [Schuhmann, Martin U.; Voigt, Cornelia; Meixensberger, Juergen] Univ Leipzig, Dept Neurosurg, Leipzig, Germany; [Walter, Bernd] Zent Klin Bad Berka, Dept Neurosurg, Bad Berka, Germany; [Walter, Bernd; Bauer, Reinhard] Univ Jena, Inst Mol Cell Biol, Jena, Germany; [Nieber, Karen] Univ Leipzig, Inst Pharm, Leipzig, Germany		Donat, CK (corresponding author), Res Ctr Dresden Rossendorf, Inst Radiopharm, Permoserstr 15, D-04318 Leipzig, Germany.	c.donat@fzd.de		, Peter/0000-0001-5555-7058			Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Alexander SPH, 2006, BRIT J PHARMACOL, V147, pS1; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Bittigau P, 2004, EXP TOXICOL PATHOL, V56, P83, DOI 10.1016/j.etp.2004.04.006; BROIDE RS, 1995, NEUROSCIENCE, V67, P83, DOI 10.1016/0306-4522(94)00623-D; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; Burnashev N, 1998, CELL CALCIUM, V24, P325, DOI 10.1016/S0143-4160(98)90056-2; Carnevale D., 2007, CNS & Neurological Disorders-Drug Targets, V6, P388; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Ciallella JR, 1998, EXP NEUROL, V152, P11, DOI 10.1006/exnr.1998.6831; CLARKE PBS, 1985, J NEUROSCI, V5, P1307; Conejero-Goldberg C, 2008, NEUROSCI BIOBEHAV R, V32, P693, DOI 10.1016/j.neubiorev.2007.10.007; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; DEANGELIS MM, 1994, BRAIN RES, V653, P39, DOI 10.1016/0006-8993(94)90369-7; DIXON CE, 1994, NEUROSCI LETT, V180, P127, DOI 10.1016/0304-3940(94)90503-7; DOBBING J, 1982, BRIT MED J, V284, P1725, DOI 10.1136/bmj.284.6331.1725; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Donat CK, 2010, NEUROPATH APPL NEURO, V36, P225, DOI 10.1111/j.1365-2990.2009.01050.x; Donat CK, 2010, INT J DEV NEUROSCI, V28, P31, DOI 10.1016/j.ijdevneu.2009.10.001; Donat CK, 2008, BRAIN RES, V1246, P167, DOI 10.1016/j.brainres.2008.09.059; Donat CK, 2007, BRAIN INJURY, V21, P1031, DOI 10.1080/02699050701630359; Drisdel RC, 2000, J NEUROSCI, V20, P133, DOI 10.1523/JNEUROSCI.20-01-00133.2000; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; Dwyer JB, 2009, PHARMACOL THERAPEUT, V122, P125, DOI 10.1016/j.pharmthera.2009.02.003; Dwyer Jennifer B., 2008, Birth Defects Research, V84, P30, DOI 10.1002/bdrc.20118; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Forster E, 2006, NAT REV NEUROSCI, V7, P259, DOI 10.1038/nrn1882; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; IMPERATO A, 1993, EUR J PHARMACOL, V238, P135, DOI 10.1016/0014-2999(93)90518-M; Jankowitz BT, 2006, DEV NEUROSCI-BASEL, V28, P264, DOI 10.1159/000094153; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kelso ML, 2006, BRAIN RES, V1083, P204, DOI 10.1016/j.brainres.2006.01.127; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Lauder JM, 1999, ENVIRON HEALTH PERSP, V107, P65, DOI 10.2307/3434473; Levin ED, 2002, J NEUROBIOL, V53, P633, DOI 10.1002/neu.10151; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; LYETH BG, 1994, BRAIN RES, V640, P240, DOI 10.1016/0006-8993(94)91879-1; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; McCann CM, 2006, P NATL ACAD SCI USA, V103, P5149, DOI 10.1073/pnas.0600847103; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MILLER MM, 1982, BRAIN RES, V247, P355, DOI 10.1016/0006-8993(82)91261-6; Missios S, 2009, J NEUROTRAUM, V26, P1943, DOI [10.1089/neu.2009.0956, 10.1089/neu.2009-0956]; Moor E, 1998, EUR J PHARMACOL, V359, P119, DOI 10.1016/S0014-2999(98)00642-6; Mortazavi S, 1999, ANESTHESIOLOGY, V90, P1070, DOI 10.1097/00000542-199904000-00021; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; OrrUrtreger A, 1997, J NEUROSCI, V17, P9165; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Radcliffe KA, 1998, J NEUROSCI, V18, P7075; Rangwala F, 1997, J NEUROSCI, V17, P8201; Rasmusson DD, 2000, BEHAV BRAIN RES, V115, P205, DOI 10.1016/S0166-4328(00)00259-X; ROMIJN HJ, 1991, EARLY HUM DEV, V26, P61, DOI 10.1016/0378-3782(91)90044-4; Rosas-Ballina M, 2009, J INTERN MED, V265, P663, DOI 10.1111/j.1365-2796.2009.02098.x; SAIJA A, 1988, BRAIN RES, V452, P303, DOI 10.1016/0006-8993(88)90034-0; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Scremin OU, 2006, BRAIN RES, V1124, P155, DOI 10.1016/j.brainres.2006.09.062; Shao LF, 1999, J NEUROTRAUM, V16, P555, DOI 10.1089/neu.1999.16.555; Shein NA, 2008, BRAIN RES, V1244, P132, DOI 10.1016/j.brainres.2008.09.032; Shytle RD, 2004, J NEUROCHEM, V89, P337, DOI 10.1046/j.1471-4159.2004.02347.x; Slotkin TA, 2004, TOXICOL APPL PHARM, V198, P132, DOI 10.1016/j.taap.2003.06.001; Sparks JA, 1999, PSYCHOPHARMACOLOGY, V141, P145, DOI 10.1007/s002130050818; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Suzuki T, 2006, J NEUROSCI RES, V83, P1461, DOI 10.1002/jnr.20850; Tellez S, 1997, J NEUROCHEM, V68, P778; Terry AV, 2005, NEUROSCIENCE, V136, P519, DOI 10.1016/j.neuroscience.2005.08.006; Tribollet E, 2004, NEUROSCIENCE, V124, P405, DOI 10.1016/j.neuroscience.2003.09.028; Vargo JM, 1999, J TRAUMA, V47, P265, DOI 10.1097/00005373-199908000-00008; Verbois SL, 2000, J NEUROTRAUM, V17, P1001, DOI 10.1089/neu.2000.17.1001; Verbois SL, 2002, J NEUROTRAUM, V19, P1569, DOI 10.1089/089771502762300238; Walter B, 2004, J NEUROTRAUM, V21, P1076, DOI 10.1089/0897715041651024; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang Yan, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P591; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274; WISDEN W, 1992, J NEUROSCI, V12, P1040	80	23	25	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1535-1084	1559-1174		NEUROMOL MED	Neuromol. Med.	MAR	2011	13	1					44	53		10.1007/s12017-010-8136-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	726VB	WOS:000287753400013	20857232				2022-02-06	
J	Mena, OJ; Paul, I; Reichard, RR				Mena, Othon J.; Paul, Ian; Reichard, R. Ross			Ocular Findings in Raised Intracranial Pressure A Case of Terson Syndrome in a 7-Month-Old Infant	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						Terson syndrome; intracranial pressure; subarachnoid hemorrhage; aneurysm	HEMORRHAGE	We present the case of a 7-month-old female infant who was found crying and limp. She was transported to a hospital where a possible subarachnoid hemorrhage was diagnosed radiologically. Before further studies could be pursued, her condition worsened and she died. The autopsy demonstrated diffuse subarachnoid hemorrhage of the brain and along the spinal cord. The brain, spinal cord, and eyes were retained and examined postfixation. An aneurysm of the middle cerebral artery was identified. Examination of the eyes demonstrated bilateral optic nerve sheath hemorrhage and extensive retinal hemorrhages extending to the ora serrata. A rapid increase in intracranial pressure secondary to subarachnoid hemorrhage following rupture of an aneurysm can result in sequelae similar to those found in inflicted traumatic brain injury. In this case, the rise in intracranial pressure resulted in marked hemorrhage within the optic nerve sheaths as well as intra-and preretinal hemorrhages. Patients with subarachnoid hemorrhage, or other causes of rapidly increased intracranial pressure, may develop ocular hemorrhage (Terson syndrome). This case illustrates the importance of ruling out natural disease before attributing the autopsy findings to trauma, as well as the importance of postmortem fixation of pediatric brains and eyes prior to examination.	[Mena, Othon J.; Paul, Ian; Reichard, R. Ross] New Mexico Off Med Investigator, Albuquerque, NM USA		Mena, OJ (corresponding author), Cty San Diego Med Examiners Off, 5570 Overland Ave, San Diego, CA 92123 USA.	othon.mena@sdcounty.ca.gov					GIANGIACOMO J, 2005, CHILD MALTREATMENT, P83; JAY V, 1998, FORENSIC PATHOLOGY, V40; KAUR B, 1990, ARCH DIS CHILD, V65, P1369, DOI 10.1136/adc.65.12.1369; Medele RJ, 1998, J NEUROSURG, V88, P851, DOI 10.3171/jns.1998.88.5.0851; MULLER PJ, 1974, J NEUROSURG, V41, P160, DOI 10.3171/jns.1974.41.2.0160; OU R, 2008, TERSON SYNDROME	6	23	23	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0195-7910			AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	MAR	2011	32	1					55	57		10.1097/PAF.0b013e3181edee5b			3	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	718ML	WOS:000287126800012	20661124				2022-02-06	
J	Nation, AD; Nelson, NG; Yard, EE; Comstock, RD; McKenzie, LB				Nation, Adam D.; Nelson, Nicolas G.; Yard, Ellen E.; Comstock, R. Dawn; McKenzie, Lara B.			Football-Related Injuries Among 6-to 17-Year-Olds Treated in US Emergency Departments, 1990-2007	CLINICAL PEDIATRICS			English	Article						football; children; adolescents; injury; emergency department	YOUTH FOOTBALL; HIGH-SCHOOL; RISK-FACTORS; PLAYERS; COLLEGIATE; EPIDEMIOLOGY; CONCUSSION	Football is one of the most popular youth sports in the United States despite the high rate of injuries. Previously published studies have investigated football-related injuries that occurred in organized play but have excluded those that occurred during unorganized play. Through use of the National Electronic Injury Surveillance System database, cases of football-related injuries were identified for analysis. Sample weights were used to calculate national estimates. An estimated 5 252 721 children and adolescents 6 to 17 years old were treated in US emergency departments for football-related injuries. The annual number of cases increased by 26.5% over the 18-year study period. The 12- to 17-year-old age group accounted for 77.8% of all injuries and had nearly twice the odds of sustaining a concussion. The findings suggest the need for increased prevention efforts to lower the risk of football-related injury in children and adolescents.	[McKenzie, Lara B.] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH 43205 USA; [Comstock, R. Dawn; McKenzie, Lara B.] Ohio State Univ, Columbus, OH 43210 USA		McKenzie, LB (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	lara.mckenzie@nationwidechildrens.org	McKenzie, Lara/C-5122-2012	McKenzie, Lara/0000-0003-2889-0001			Adickes MS, 2004, SPORTS MED, V34, P201, DOI 10.2165/00007256-200434030-00005; Adirim TA, 2003, SPORTS MED, V33, P75, DOI 10.2165/00007256-200333010-00006; Bergeron MF, 2005, MED SCI SPORT EXER, V37, P1421, DOI 10.1249/01.mss.0000174891.46893.82; BRAUNWART B, 1889, JOURNEY CAMP ORIGINS; Bulut M, 2006, EMERG MED J, V23, P540, DOI 10.1136/emj.2005.029439; Dick R, 2007, J ATHL TRAINING, V42, P221; Dompier TP, 2007, J ATHL TRAINING, V42, P395; GOLDBERG B, 1988, PEDIATRICS, V81, P255; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Langburt W, 2001, J CHILD NEUROL, V16, P83, DOI 10.1177/088307380101600203; MAGGIO FP, 2007, NOTRE DAME GAME CHAN; Malina RM, 2006, CLIN J SPORT MED, V16, P214, DOI 10.1097/00042752-200605000-00005; *NAT FOOTB LEAG, NAT FOOTB LEAG HIST; Pincivero DM, 1997, SPORTS MED, V23, P247, DOI 10.2165/00007256-199723040-00004; *POP WARN LITTL SC, 2008, POP WARN LITTL SCHOL; Powell JW, 1999, J ATHL TRAINING, V34, P277; Schroeder T., 2001, NEISS SAMPLE DESIGN; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; SMITH RA, 1981, J SPORTS HIST, V8, P15; Stocker B D, 1997, J Ky Med Assoc, V95, P458; Stuart MJ, 2002, MAYO CLIN PROC, V77, P317, DOI 10.4065/77.4.317; TEITZ CC, 1987, J BONE JOINT SURG AM, V69A, P2, DOI 10.2106/00004623-198769010-00002; Turbeville SD, 2003, AM J SPORT MED, V31, P276, DOI 10.1177/03635465030310022001; Turbeville SD, 2003, AM J SPORT MED, V31, P974, DOI 10.1177/03635465030310063801; Tyler TF, 2006, AM J SPORT MED, V34, P471, DOI 10.1177/0363546505280429; U. S. Consumer Product Safety Commission, 2000, NAT EL INJ SURV SYST; *US BUR CENS, 1990, INT EST US POP AG SE; *US BUR CENS, NAT POP EST 2000S; *US CONS PROD SAF, 2009, NEISS COD MAN; Zemper Eric D., 1994, Journal of Athletic Training, V29, P44; 2007, 2007 SUPERSTUDY SPOR	31	23	23	0	14	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	MAR	2011	50	3					200	207		10.1177/0009922810388511			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	718TG	WOS:000287148500006	21127078				2022-02-06	
J	Brown, CVR; Hejl, K; Mandaville, AD; Chaney, PE; Stevenson, G; Smith, C				Brown, Carlos V. R.; Hejl, Kelli; Mandaville, Amy D.; Chaney, Paul E.; Stevenson, Guy; Smith, Charlotte			Swallowing dysfunction after mechanical ventilation in trauma patients	JOURNAL OF CRITICAL CARE			English	Article						Mechanical ventilation; Dysphagia; Swallowing; Aspiration		Background: Swallowing dysfunction can occur after mechanical ventilation, leading to complications such as aspiration and pneumonia. After mechanical ventilation, authors have recommended evaluating patients with contrast studies or endoscopy to identify patients at risk for swallowing dysfunction and aspiration. The purpose of the study was to determine if a bedside swallowing evaluation (BSE) can identify patients with swallowing dysfunction after mechanical ventilation. Methods: This is a 1-year (2008) prospective study of all adult trauma patients admitted to the intensive care unit requiring mechanical ventilation. Upon separation from mechanical, all patients received a BSE. The BSE used mental status, facial symmetry, swallow reflex, and oral ice chips and water to identify swallowing dysfunction. Patients who passed the BSE were advanced to oral intake per physician orders, whereas patients who failed the BSE were allowed nothing by mouth. Results: A total of 345 patients were included; 54 died before separation from mechanical ventilation and were excluded. The remaining 291 patients underwent BSE after separation from mechanical ventilation, with 143 (49%) passing and 148 (51%) failing. Patients who failed the BSE required mechanical ventilation longer than those who passed (14 +/- 13 vs 5 +/- 20 days, P = .001). In addition, only 23% of patients extubated within 72 hours failed the BSE, whereas 78% of those intubated more than 72 hours failed the BSE (P < .001). All patients who passed the BSE were discharged from the hospital without a clinical aspiration event. Independent risk factors for failure of BSE included tracheostomy, older age, prolonged mechanical ventilation, delirium tremens, traumatic brain injury, and spine fracture. Three (2%) patients who failed the BSE had a clinical aspiration event despite taking nothing by mouth. Conclusions: A simple BSE can be used to identify patients at risk for swallowing dysfunction after mechanical ventilation. More importantly, BSE can safely clear patients without swallowing dysfunction, avoiding costly and time-consuming contrast studies or endoscopic evaluation. (C) 2011 Elsevier Inc. All rights reserved.	[Brown, Carlos V. R.] Univ Med Ctr Brackenridge, Trauma Serv, Austin, TX 78701 USA		Brown, CVR (corresponding author), Univ Med Ctr Brackenridge, Trauma Serv, Austin, TX 78701 USA.	cvrbrown@seton.org					Morgan AS, 1999, J HEAD TRAUMA REHAB, V14, P454, DOI 10.1097/00001199-199910000-00006	1	23	23	0	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441			J CRIT CARE	J. Crit. Care	FEB	2011	26	1							108.e9	10.1016/j.jcrc.2010.05.036			4	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	722WL	WOS:000287465900027	20869841				2022-02-06	
J	Wang, L; Yuan, JS; Zhang, HX; Ding, H; Tang, XG; Wei, YZ				Wang Lei; Yuan Ji-shan; Zhang Hong-xi; Ding Hua; Tang Xing-guo; Wei Yong-zhong			Effect of leptin on bone metabolism in rat model of traumatic brain injury and femoral fracture	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Leptin; Brain injuries; Fractures; bone		Objective: To observe serum and callus leptin expression within the setting of fracture and traumatic brain injury (TBI). Methods: A total of 64 male SD rats were randomized equally into 4 groups: nonoperated group, TBI group, fracture group, and fracture+TBI group. Rats were sacrificed at 2, 4, 8 and 12 weeks after fracture+TBI. Serum leptin was detected using radioimmunoassay, and callus formation was measured radiologically. Callus leptin was analyzed by immunohistochemistry. Results: Serum leptin levels in the fracture group, TBI group and combined fracture+TBI group were all significantly increased compared with control group at the 2 week time-point (P<0.05). Serum leptin in the combined fracture+TBI group was significantly higher than that in the fracture and TBI groups at 4 and 8 weeks after injury (P<0.05). The percentage of leptin-positive cells in the fracture+TBI callus and callus volume were significantly higher than those in the fracture-only group (P<0.01). Conclusions: We demonstrated elevated leptin expression within healing bone especially in the first 8 weeks in a rat model of fracture and TBI. A close association exists between leptin levels and the degree of callus formation in fractures.	[Wang Lei; Yuan Ji-shan; Zhang Hong-xi; Ding Hua; Tang Xing-guo] Jiangsu Univ, Dept Orthoped, Affiliated Peoples Hosp, Zhenjiang 212001, Jiangsu, Peoples R China; [Wei Yong-zhong] Nanjing Med Univ, Dept Orthoped, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China		Yuan, JS (corresponding author), Jiangsu Univ, Dept Orthoped, Affiliated Peoples Hosp, Zhenjiang 212001, Jiangsu, Peoples R China.	wanglei0505779@126.com			Medical Science and Technology Development of Jiangsu Health Bureau, China [H200512]	This work was supported by funds from the Medical Science and Technology Development of Jiangsu Health Bureau (H200512), China.	Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Barr VA, 1999, J BIOL CHEM, V274, P21416, DOI 10.1074/jbc.274.30.21416; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; Bonnet N, 2007, BONE, V40, P1209, DOI 10.1016/j.bone.2007.01.006; Faggioni R, 2000, AM J PATHOL, V156, P1781, DOI 10.1016/S0002-9440(10)65049-3; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; Gordeladze JO, 2002, J CELL BIOCHEM, V85, P825, DOI 10.1002/jcb.10156; Janik JE, 1997, J CLIN ENDOCR METAB, V82, P3084, DOI 10.1210/jc.82.9.3084; Jeevanandam M, 1998, JPEN-PARENTER ENTER, V22, P340, DOI 10.1177/0148607198022006340; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; Kim JS, 1996, STROKE, V27, P1553, DOI 10.1161/01.STR.27.9.1553; Kolaczynski JW, 1996, DIABETES, V45, P699, DOI 10.2337/diabetes.45.5.699; Li JL, 2000, J BONE MINER RES, V15, P2042, DOI 10.1359/jbmr.2000.15.10.2042; Li S, 2001, Hua Xi Yi Ke Da Xue Xue Bao, V32, P240; Lin Ji, 2006, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V18, P19; Mantzoros CS, 1997, J CLIN ENDOCR METAB, V82, P3408, DOI 10.1210/jc.82.10.3408; Mantzoros CS, 1996, DIABETES, V45, P909, DOI 10.2337/diabetes.45.7.909; Miell JP, 1996, HORM METAB RES, V28, P704, DOI 10.1055/s-2007-979882; PASINETTI GM, 1993, NEUROSCIENCE, V54, P893, DOI 10.1016/0306-4522(93)90583-2; Patel L, 2002, J PEDIATR ENDOCR MET, V15, P963; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521, DOI 10.1302/0301-620X.69B4.3611150; Rayner DV, 2001, J MOL MED, V79, P8, DOI 10.1007/s001090100198; Reseland JE, 2001, J BONE MINER RES, V16, P1426, DOI 10.1359/jbmr.2001.16.8.1426; Rigaux P, 2005, JOINT BONE SPINE, V72, P146, DOI 10.1016/j.jbspin.2004.05.012; Schell H, 2006, BONE, V38, P547, DOI 10.1016/j.bone.2005.09.018; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; SPENCER RF, 1987, J BONE JOINT SURG BR, V69, P525, DOI 10.1302/0301-620X.69B4.3611151; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Tartaglia LA, 1997, J BIOL CHEM, V272, P6093, DOI 10.1074/jbc.272.10.6093; Thomas T, 1999, ENDOCRINOLOGY, V140, P1630, DOI 10.1210/en.140.4.1630; Thomas T, 2002, J BONE MINER RES, V17, P1563, DOI 10.1359/jbmr.2002.17.9.1563; Trentz OA, 2005, CRIT CARE MED, V33, P399, DOI 10.1097/01.CCM.0000152221.87477.21; Wang YH, 2005, ARCH PHYS MED REHAB, V86, P1964, DOI 10.1016/j.apmr.2005.04.017; Wilcockson DC, J CEREB BLOOD FLOW M, V22, P318; Yamashita T, 1998, BIOCHEM BIOPH RES CO, V246, P752, DOI 10.1006/bbrc.1998.8689; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	36	23	27	0	1	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	FEB	2011	14	1					7	13		10.3760/cma.j.issn.1008-1275.2011.01.002			7	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	VF1DB	WOS:000441948000002	21276361				2022-02-06	
J	Landi, A; Marotta, N; Mancarella, C; Marruzzo, D; Salvati, M; Delfini, R				Landi, Alessandro; Marotta, Nicola; Mancarella, Cristina; Marruzzo, Daniele; Salvati, Maurizio; Delfini, Roberto			Basal ganglia stroke due to mild head trauma in pediatric age - clinical and therapeutic management: a case report and 10 year literature review	ITALIAN JOURNAL OF PEDIATRICS			English	Article							ISCHEMIC-STROKE; BRAIN-INJURY; CHILDHOOD; MIGRAINE; CHILDREN	Ischemia of the basal ganglia as an immediate consequence of minor head injury in children is rare (< 2% of all ischemic stroke in childhood) and is due to vasospasm of the lenticulostriate arteries. The clinical history of these lesions is particularly favourable because they are usually small, and also because the facial-brachial-crural hemiparesis typical of this pathology usually regresses after a period ranging from several weeks to several months, despite the persistence of an ischemic area on MRI. This is due to the well known neuronal plasticity of the CNS, in particular, of the primary motor cortex. The most effective therapeutic approach appears to be the conservative one, although the best treatment regimen is still not well defined. Young patients should be closely monitored and treated conservatively with osmotic diuretics to reduce perilesional edema. At the same time, however, it is very important to exclude, by means of instrumental and laboratory studies, conditions that could favour the onset of ischemia, including emboligen heart disease, thrombophilia and acute traumatic arterial dissections. Generally speaking, the prognosis in these cases is good. The authors describe their experience treating a 10-month old baby girl, with a left lenticular nucleus ischemia and report a literature review.	[Landi, Alessandro; Marotta, Nicola; Mancarella, Cristina; Marruzzo, Daniele; Delfini, Roberto] Univ Rome Sapienza Rome, Dept Neurosurg Sci, Rome, Italy; [Salvati, Maurizio] Univ Rome Sapienza Rome, Dept Neurosurg, INM Neuromed, Pozzilli IS, Rome, Italy		Landi, A (corresponding author), Univ Rome Sapienza Rome, Dept Neurosurg Sci, Rome, Italy.	link55@libero.it	Salvati, Maurizio/AAC-5215-2022	Landi, Alessandro/0000-0003-4303-6110			Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Bernard TJ, 2008, ANN NEUROL, V63, P679, DOI 10.1002/ana.21406; BODENSTEINER JB, 1992, AM J DIS CHILD, V146, P100, DOI 10.1001/archpedi.1992.02160130102029; Buompadre MC, 2009, J CHILD NEUROL, V24, P685, DOI 10.1177/0883073808330163; DHARKER SR, 1993, NEUROSURGERY, V33, P863; Fullerton HJ, 2001, NEUROLOGY, V57, P1155, DOI 10.1212/WNL.57.7.1155; HAAS DC, 1975, ARCH NEUROL-CHICAGO, V32, P727, DOI 10.1001/archneur.1975.00490530049003; Kieslich M, 2002, J NEUROL NEUROSUR PS, V73, P13, DOI 10.1136/jnnp.73.1.13; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; Kors EE, 2001, ANN NEUROL, V49, P753, DOI 10.1002/ana.1031; MAKI I, 1980, CHILDS BRAIN, V7, P113; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; Nabika S, 2007, PEDIATR NEUROSURG, V43, P312, DOI 10.1159/000103313; Rana KS, 2006, INDIAN PEDIATR, V43, P994; Ruff R.M., 1993, J HEAD TRAUMA REHAB, V8, P86; Shaffer L, 2003, ARCH DIS CHILD, V88, P267, DOI 10.1136/adc.88.3.267; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; UMANSKY F, 1985, J NEUROSURG, V62, P261, DOI 10.3171/jns.1985.62.2.0261	18	23	25	0	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1720-8424			ITAL J PEDIATR	Ital. J. Pediatr.	JAN 6	2011	37								2	10.1186/1824-7288-37-2			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	798VV	WOS:000293241200002	21210991	gold, Green Published			2022-02-06	
J	Beller, JA; Gurkoff, GG; Berman, RF; Lyeth, BG				Beller, Justin A.; Gurkoff, Gene G.; Berman, Robert F.; Lyeth, Bruce G.			Pharmacological enhancement of glutamate transport reduces excitotoxicity in vitro	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Pharmacology; neurodegeneration; ceftriaxone; group II mGluR	TRAUMATIC BRAIN-INJURY; DEPENDENT TRANSCRIPTIONAL REGULATION; PROTEIN-KINASE-C; GROUP-II; SURFACE EXPRESSION; NEUROTRANSMITTER TRANSPORTERS; RECEPTOR ACTIVATION; NEURONAL INJURY; MOUSE MODEL; GLAST	Purpose: Glutamate transporters are responsible for removing glutamate from the extracellular space and have the potential to protect neurons from excitotoxicity. In the present study, the effects of ceftriaxone and (2R, 4R)-APDC (APDC) on the protein expression of GLAST and GLT-1, the rate of glutamate uptake, and neuroprotection were evaluated in a cell culture model of glutamate excitotoxicity. Methods: Mixed neuron/astrocyte cultures were prepared from 1 day old rat pups. Protein levels of GLAST and GLT-1 glutamate transporters were quantified using In-Cell Western techniques after acute or 5-day treatment with either ceftriaxone or APDC. Glutamate uptake was measured using Michaelis-Menten kinetics to evaluate the effects of 5-day treatment with ceftriaxone or APDC. Neuronal cell death in response to a 10-minute 1 mM glutamate challenge was measured following 5-day treatment with either ceftriaxone or APDC. Results: Five-day treatment with 100 mu M ceftriaxone significantly increased both GLAST and GLT-1 protein levels 31.3% and 47.5% above control, respectively, increased the V(max) 29.3%, increased the K(m) of glutamate uptake 117.9%, and reduced neuronal death 22.0% after a 1 mM glutamate challenge. Five-day treatment with 1 mM APDC significantly increased GLAST protein levels 27.6%, increased the V(max) 92.4%, increased the K(m) of glutamate transport 118.9%, and decreased neuronal death 36.8% after a 1 mM glutamate challenge. Conclusions: Chronic treatment with ceftriaxone or APDC provided neuroprotection from glutamate excitotoxicity while increasing GLAST and GLT-1 protein levels and increasing glutamate uptake. These compounds may have therapeutic potential in chronic excitotoxic neurodegenerative diseases.	[Beller, Justin A.; Gurkoff, Gene G.; Berman, Robert F.; Lyeth, Bruce G.] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95618 USA; [Gurkoff, Gene G.] Univ Calif Davis, NSF Ctr Biophoton Sci & Technol, Sacramento, CA 95817 USA; [Beller, Justin A.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA		Lyeth, BG (corresponding author), Univ Calif Davis, Dept Neurol Surg, 1 Shields Ave, Davis, CA 95618 USA.	bglyeth@ucdavis.edu		Lyeth, Bruce/0000-0003-4811-1474	National Institutes of Health NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 29995, NS 45136]; National Institute of Environmental Health SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [5 T32 ES07059]; Center for Biophotonics Science and Technology [PHY 0120999]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [T32ES007059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045136, R01NS029995] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health NINDS NS 29995, NS 45136 and the National Institute of Environmental Health Sciences 5 T32 ES07059. This work was also supported by the Center for Biophotonics Science and Technology, a designated NSF Science and Technology Center, managed by the University of California, Davis, under Cooperative Agreement number PHY 0120999. We would like to thank Robert Hunt, Emily Doisy, and Kimberly Katleba for their expert technical assistance on this project.	Agrawal N, 2005, P NATL ACAD SCI USA, V102, P3777, DOI 10.1073/pnas.0500055102; Allen JW, 1999, J PHARMACOL EXP THER, V290, P112; Benarroch EE, 2010, NEUROLOGY, V74, P259, DOI 10.1212/WNL.0b013e3181cc89e3; Bergles DE, 1998, J NEUROSCI, V18, P7709; Bristol LA, 1996, ANN NEUROL, V39, P676, DOI 10.1002/ana.410390519; CASADO M, 1993, J BIOL CHEM, V268, P27313; Conradt M, 1997, J NEUROCHEM, V68, P1244, DOI 10.1046/j.1471-4159.1997.68031244.x; Gegelashvili G, 1996, NEUROREPORT, V8, P261, DOI 10.1097/00001756-199612200-00052; Gegelashvili G, 2001, Prog Brain Res, V132, P267; Gegelashvili G, 2000, NEUROCHEM INT, V37, P163, DOI 10.1016/S0197-0186(00)00019-X; Harrison PJ, 2008, J PSYCHOPHARMACOL, V22, P308, DOI 10.1177/0269881108089818; Kalandadze A, 2002, J BIOL CHEM, V277, P45741, DOI 10.1074/jbc.M203771200; KANAI Y, 1993, FASEB J, V7, P1450, DOI 10.1096/fasebj.7.15.7903261; Kelso ML, 2011, NEUROSCI LETT, V488, P60, DOI 10.1016/j.neulet.2010.11.003; Kohara A, 2008, BRAIN RES, V1191, P168, DOI 10.1016/j.brainres.2007.11.035; Lee SG, 2008, J BIOL CHEM, V283, P13116, DOI 10.1074/jbc.M707697200; Lewerenz J, 2009, J NEUROCHEM, V111, P332, DOI 10.1111/j.1471-4159.2009.06347.x; Lipski J, 2007, NEUROSCIENCE, V146, P617, DOI 10.1016/j.neuroscience.2007.02.003; Lopez-Bayghen E, 2004, J NEUROCHEM, V91, P200, DOI 10.1111/j.1471-4159.2004.02706.x; Lyeth BG, 2001, EXP NEUROL, V169, P191, DOI 10.1006/exnr.2001.7643; Mafra RA, 2003, BRAZ J MED BIOL RES, V36, P951, DOI 10.1590/S0100-879X2003000700018; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Melzer N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003149; Mendez JA, 2004, J NEUROCHEM, V88, P835, DOI 10.1046/j.1471-4159.2003.02206.x; Nickell J, 2007, NEUROBIOL AGING, V28, P1737, DOI 10.1016/j.neurobiolaging.2006.07.015; Ramirez-Sotelo G, 2007, NEUROCHEM RES, V32, P73, DOI 10.1007/s11064-006-9227-3; Ramos KM, 2010, NEUROSCIENCE, V169, P1888, DOI 10.1016/j.neuroscience.2010.06.014; Robinson MB, 2002, J NEUROCHEM, V80, P1, DOI 10.1046/j.0022-3042.2001.00698.x; Rosas S, 2007, J NEUROCHEM, V101, P1134, DOI 10.1111/j.1471-4159.2007.04517.x; Rothstein JD, 1996, NEUROLOGY, V47, pS19, DOI 10.1212/WNL.47.4_Suppl_2.19S; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Shahlaie K, 2010, J NEUROTRAUM, V27, P175, DOI 10.1089/neu.2009.1003; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; Torres-Salazar D, 2007, MOL PHARMACOL, V72, P1100, DOI 10.1124/mol.107.041020; Verma R, 2010, EUR J PHARMACOL, V638, P65, DOI 10.1016/j.ejphar.2010.04.021; Vernon AC, 2008, NEUROREPORT, V19, P475, DOI 10.1097/WNR.0b013e3282f602df; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Xu NJ, 2003, J NEUROSCI, V23, P4775; Yang DN, 2004, NEUROSCI LETT, V357, P159, DOI 10.1016/j.neulet.2003.11.074; Zelenaia O, 2000, MOL PHARMACOL, V57, P667, DOI 10.1124/mol.57.4.667; Zeng LH, 2010, NEUROBIOL DIS, V37, P764, DOI 10.1016/j.nbd.2009.12.020; Zhong C, 2006, J NEUROCHEM, V97, P1015, DOI 10.1111/j.1471-4159.2006.03786.x; Zwienenberg M, 2001, NEUROSURGERY, V48, P1119, DOI 10.1097/00006123-200105000-00031	44	23	23	1	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028			RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2011	29	5					331	346		10.3233/RNN-2011-603			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	814VW	WOS:000294486300005	21846950				2022-02-06	
J	Chang, WH; Park, YH; Ohn, SH; Park, CH; Lee, PKW; Kim, YH				Chang, Won Hyuk; Park, Yun H.; Ohn, Suk Hoon; Park, Chang-hyun; Lee, Peter K. W.; Kim, Yun-Hee			Neural correlates of donepezil-induced cognitive improvement in patients with right hemisphere stroke: A pilot study	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Donepezil; Stroke; Cognitive impairment; functional MRI	TRAUMATIC BRAIN-INJURY; VASCULAR DEMENTIA; POSTSTROKE APHASIA; ALZHEIMERS-DISEASE; OPEN-LABEL; INTELLIGENCE; REHABILITATION; 24-WEEK; SYSTEM; TRIAL	Donepezil has been proven effective in the treatment of Alzheimer's disease and vascular dementia. However, its effects on the cognitive neural network have not been fully investigated. The purpose of this study was to evaluate the effect of donepezil on reorganisation of the cognitive neural network in patients with post-stroke cognitive impairment using functional MRI (fMRI). Fourteen patients with stroke in the right hemisphere were enrolled. Participants were randomly assigned to the experimental or the control group. Donepezil (5 mg) or placebo was administered daily for four weeks. Cognitive function assessment was performed before and immediately after treatment, and repeated one month after cessation of treatment. fMRI was performed before and after treatment. Ten out of 14 patients (six in the experimental group, four in the control group) successfully completed all experimental processes. The experimental group showed significant improvements in the Mini-Mental Status Examination during the post-treatment evaluation and one-month follow-up compared to the pre-treatment evaluation (p < .05). No improvement was observed in the control group. In the experimental group fMRI showed increased activation in both prefrontal areas, both inferior frontal lobes, and in the left inferior parietal lobe. Increased recruitment of the parieto-frontal networks in the selected patients was considered to be a neural correlate of cognitive improvement induced by donepezil.	[Kim, Yun-Hee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Phys Med & Rehabil,Div Neurorehabil Stroke &, Seoul 135710, South Korea; [Ohn, Suk Hoon] Hallym Univ, Hallym Sacred Heart Hosp, Sch Med, Dept Phys Med & Rehabil, Kyounggido, South Korea		Kim, YH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Phys Med & Rehabil,Div Neurorehabil Stroke &, 50 Irwon Dong, Seoul 135710, South Korea.	yunkim@skku.edu	Park, Chang-hyun/I-2217-2016; Kim, Yun Hee/F-4600-2014		KOSEFKorea Science and Engineering Foundation; Korean GovernmentKorean Government [M10644000022-06N4400-02210]; Clinical Medical Research Center; Samsung Medical CenterSamsung; IN-SUNG Foundation for Medical Research	This study was supported by a KOSEF grant funded by the Korean Government (no. M10644000022-06N4400-02210), Clinical Medical Research Center, Samsung Medical Center, and IN-SUNG Foundation for Medical Research.	Ballard C, 2003, INT PSYCHOGERIATR, V15, P123, DOI 10.1017/S1041610203009074; Berthier ML, 2005, DRUG AGING, V22, P163, DOI 10.2165/00002512-200522020-00006; Berthier ML, 2003, NEUROLOGY, V60, P1218, DOI 10.1212/01.WNL.0000055871.82308.41; Black S, 2003, STROKE, V34, P2323, DOI 10.1161/01.STR.0000091396.95360.E1; BOIVIN MJ, 1992, CORTEX, V28, P231, DOI 10.1016/S0010-9452(13)80051-2; Court J. A., 2002, VASCULAR COGNITIVE I; Cummings JL, 2000, AM J GERIAT PSYCHIAT, V8, P134, DOI 10.1176/appi.ajgp.8.2.134; Esposito G, 1999, BRAIN, V122, P963, DOI 10.1093/brain/122.5.963; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GOTTFRIES CG, 1994, DEMENTIA, V5, P163, DOI 10.1159/000106715; Gray JR, 2004, NAT REV NEUROSCI, V5, P471, DOI 10.1038/nrn1405; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Kim Y.H., 2001, J KOREAN ACAD REHABI, V25, P209; Lee KH, 2006, NEUROIMAGE, V29, P578, DOI 10.1016/j.neuroimage.2005.07.036; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; Mesulam M, 2003, NEUROLOGY, V60, P1183, DOI 10.1212/01.WNL.0000055927.22611.EB; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; Rogers SL, 1998, NEUROLOGY, V50, P136, DOI 10.1212/WNL.50.1.136; Roman GC, 2006, NEUROBIOL AGING, V27, P1769, DOI 10.1016/j.neurobiolaging.2005.10.004; Somerville J, 2000, J CLIN EXP NEUROPSYC, V22, P613, DOI 10.1076/1380-3395(200010)22:5;1-9;FT613; STARKSTEIN SE, 1993, STROKE, V24, P1625, DOI 10.1161/01.STR.24.11.1625; Swartz Richard H, 2003, J Stroke Cerebrovasc Dis, V12, P29, DOI 10.1053/jscd.2003.5; Taverni JP, 1998, BRAIN INJURY, V12, P77; Vinters HV, 2000, J NEUROPATH EXP NEUR, V59, P931, DOI 10.1093/jnen/59.11.931; Wilkinson D, 2003, NEUROLOGY, V61, P479, DOI 10.1212/01.WNL.0000078943.50032.FC	25	23	26	1	9	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2011	21	4					502	514		10.1080/09602011.2011.582708			13	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	885OO	WOS:000299788700004	21714757				2022-02-06	
J	d'Hemecourt, P				d'Hemecourt, Pierre			Subacute Symptoms of Sports-Related Concussion: Outpatient Management and Return to Play	CLINICS IN SPORTS MEDICINE			English	Article						Concussion; Symptom score; Neuropsychological testing; Balance testing; Return to play criteria	TRAUMATIC BRAIN-INJURY; NATIONAL-FOOTBALL-LEAGUE; HEAD-INJURY; CLINICAL MANAGEMENT; COLLEGIATE; RECOVERY; IMPACT; EPIDEMIOLOGY; CHILDREN; ENCEPHALOPATHY	Most concussion symptoms resolve within the first week after injury. Athletes with persistent symptoms may manifest subtle behavioral and cognitive changes. The astute clinician uses various information to determine when these symptoms have cleared before allowing the athlete to return to athletic competition.	Childrens Hosp, Div Sports Med, Boston, MA 02115 USA		d'Hemecourt, P (corresponding author), Childrens Hosp, Div Sports Med, 300 Longwood Ave, Boston, MA 02115 USA.	pierre.dhemecourt@childrens.harvard.edu					Barth JT, 1989, MILD HEAD INJURY, P257; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Cantu R, 2009, CLIN SPORTS MED, V7, P37; Cantu RC, 2007, NEUROSURGERY, V61, P223, DOI 10.1227/01.NEU.0000255514.73967.90; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; DICKER BG, 1992, J HEAD TRAUMA REHAB, V7, P83; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Gioia G, 2004, BRIT J SPORT MED, V38, P657; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; HERRING SA, 2005, MED SCI SPORTS EXERC, V37, P2012; IMOGEN L, 2009, J INT NEUROPSYCH SOC, V16, P17; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LeBlanc CMA, 2000, PEDIATRICS, V106, P1524, DOI 10.1542/peds.106.6.1524; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lenaerts Marc E, 2004, Curr Treat Options Neurol, V6, P507, DOI 10.1007/s11940-004-0008-5; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; SIOBOUNOV S, 2007, NEUROSURGERY, V61, P338; Tenovuo O, 2006, CURR OPIN NEUROL, V19, P528, DOI 10.1097/WCO.0b013e328010944f	43	23	23	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919			CLIN SPORT MED	Clin. Sports Med.	JAN	2011	30	1					63	+		10.1016/j.csm.2010.08.008			11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	691XR	WOS:000285114800007	21074082				2022-02-06	
J	Isik, HS; Gokyar, A; Yildiz, O; Bostanci, U; Ozdemir, C				Isik, Hasan Serdar; Gokyar, Ahmet; Yildiz, Omer; Bostanci, Ugur; Ozdemir, Cengiz			Pediatric head injuries, retrospective analysis of 851 patients: an epidemiological study	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			Turkish	Article						Childhood; epidemiology; head injury	TRAUMATIC BRAIN-INJURY; CHILDREN YOUNGER; CHILDHOOD; FALLS; CITY; HOSPITALIZATIONS; MORTALITY	BACKGROUND The aim of this study was to contribute to the epidemiological database of our country about pediatric head injuries. METHODS We retrospectively analyzed 851 patients younger than 14 years old with head injury, treated in the Neurosurgery Department of Samsun Mehmet Aydin Education and Research Hospital between January 2003 and June 2008. RESULTS Five hundred and fifty (65%) patients were male and 301 (35%) were female. Falls (70%) were the most common cause of head injury. According to Glasgow Coma Score (GCS), 74% of patients had mild (13-15), 22% moderate (9-12) and 4% severe (3-8) head injury. Eighty-seven (10.5%) patients were operated. The commonest operations were performed for depressed fractures and epidural hematomas. The mortality rate was 3.8% (33). Common causes of mortality were traffic accidents and falls from heights. CONCLUSION Other reported studies and this study show that the majority of pediatric head injuries occur as a result of preventable causes. It is important to have local epidemiological studies and data about head injuries in order to prevent these traumas before their occurrence.	[Isik, Hasan Serdar] Ordu Univ, Fac Med, Dept Neurosurg, Ordu, Turkey; [Gokyar, Ahmet] Med Pk Hosp, Dept Neurosurg, Samsun, Turkey; [Yildiz, Omer; Bostanci, Ugur; Ozdemir, Cengiz] Mehmet Aydm Training & Res Hosp, Dept Neurosurg, Samsun, Turkey		Isik, HS (corresponding author), 1068 Sok,Zirvekent Sitesi C Blok,D 4, Ordu, Turkey.	serdarisik1@hotmail.com	Gokyar, Ahmet/N-9877-2018	Gokyar, Ahmet/0000-0003-1942-587X			Al B, 2009, ULUS TRAVMA ACIL CER, V15, P141; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Brudvik C, 2000, INJURY, V31, P761, DOI 10.1016/S0020-1383(00)00093-0; Diamond IR, 2009, J TRAUMA, V66, P1189, DOI 10.1097/TA.0b013e31819adbb3; Durkin MS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.6.e74; Gill JR, 2009, ARCH PATHOL LAB MED, V133, P619, DOI 10.1043/1543-2165-133.4.619; Guzel A, 2007, ULUS TRAVMA ACIL CER, V13, P211; Gurses Dolunay, 2002, Ulus Travma Derg, V8, P156; Guzel Ahmet, 2006, Ulus Travma Acil Cerrahi Derg, V12, P299; Guzel A, 2009, ULUS TRAVMA ACIL CER, V15, P277; HALL JR, 1989, J TRAUMA, V29, P1273, DOI 10.1097/00005373-198909000-00015; Klin B, 2009, INJURY, V40, P1011, DOI 10.1016/j.injury.2009.01.135; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Love PF, 2009, J TRAUMA, V67, pS12, DOI 10.1097/TA.0b013e3181ac7f22; Marsh E, 2000, Int J Trauma Nurs, V6, P117, DOI 10.1067/mtn.2000.110620; National Center for Injury Prevention and Control Centers for Disease Control and Prevention, WEB BAS INJ STAT QUE; Okten A, 1996, ULUSAL TRAVMA DERGIS, V2, P94; Sahin S, 2002, ULUDAG TIP FAK DERG, V28, P45; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Shah S, 2007, INJURY PREV, V13, P316, DOI 10.1136/ip.2007.016048; Simsek Osman, 2005, Ulus Travma Acil Cerrahi Derg, V11, P310; Tabish A, 2006, INJURY, V37, P410, DOI 10.1016/j.injury.2006.01.039; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; Melo JRT, 2009, CHILD NERV SYST, V25, P1077, DOI 10.1007/s00381-009-0924-5; Van Loon Frederik P. L., 1995, Morbidity and Mortality Weekly Report, V44, P1; Verma S, 2009, INDIAN PEDIATR, V46, P168; Yanagawa Y, 2009, PEDIATR EMERG CARE, V25, P572, DOI 10.1097/PEC.0b013e3181b4f60e; Yeung JHH, 2009, INJURY, V40, P555, DOI 10.1016/j.injury.2008.08.015	28	23	23	0	7	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.		2011	17	2					166	172		10.5505/tjtes.2011.22800			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	742TX	WOS:000288968900013	21644096	Bronze			2022-02-06	
B	Iverson, GL; Lange, RT		Schoenberg, MR; Scott, JG		Iverson, Grant L.; Lange, Rael T.			Post-Concussion Syndrome	LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; CONTROLLED HISTORICAL COHORT; COMPLAINT BASE RATES; POSTCONCUSSION-SYNDROME; STEREOTYPE THREAT; NEUROPSYCHOLOGICAL ASSESSMENT; COGNITIVE PERFORMANCE; BEHAVIORAL SEQUELAE; DIAGNOSIS THREAT	The post-concussion syndrome (a.k.a., post-concussive disorder and post concussional disorder) has been controversial for decades. Without question, an acute post-concussion syndrome can be caused by the neurobiology of a mild traumatic brain injury (MTBI). Without question, a post-concussion syndrome can be worsened by psychological distress, social psychological factors (e.g., the nocebo effect, iatrogenesis, and misattributions), personality characteristics, and co-occurring conditions (e.g., chronic pain and insomnia). If due to the neurobiological effects of an injury to the brain, a post-concussion syndrome should be present in the first week post injury. Evaluating someone long after an injury, obtaining a cross-section of symptoms, and then attributing those symptoms to the remote injury can easily result in misdiagnosis. The widely-cited estimate of 10-20% of patients suffering a long-term post-concussion syndrome is both confusing and incorrect. It is confusing because there is often an assumption that if a person reports symptoms long after an MTBI, that the symptoms are causally-related to the biological effects of the injury (by logical inference, the symptoms are related to damage to the structure or function of the brain). However, it is well established that these symptoms could be caused, maintained, or worsened by a large number of factors that are unrelated to traumatically-induced cellular damage. It is incorrect because the constellation of symptoms comprising the post-concussion syndrome likely occurs in far fewer than 10-20% of patients with remote MTBIs. The estimates of 10-20% have typically been based on selected, non-representative samples of the entire population of people who sustain an MTBI, and some of the literature has been misinterpreted as showing evidence of a syndrome when it in fact illustrates isolated, non-specific symptom reporting. It is emphasized in this chapter that the post-concussion syndrome is a non-specific cluster of symptoms that can be mimicked by a number of pre-existing or comorbid conditions. The biologically-based, traumatically-induced syndrome, theoretically, can also occur in tandem with these conditions.	[Iverson, Grant L.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Iverson, Grant L.] British Columbia Mental Hlth & Addict Serv, Vancouver, BC, Canada; [Iverson, Grant L.; Lange, Rael T.] British Columbia Mental Hlth & Addict Serv, Coquitlam, BC, Canada		Iverson, GL (corresponding author), Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.	giverson@interchange.ubc.ca; rlange@dvbic.org					Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Aronson J, 1999, J EXP SOC PSYCHOL, V35, P29, DOI 10.1006/jesp.1998.1371; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; BIJUR PE, 1990, PEDIATRICS, V86, P337; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; BOONE KB, 1995, J CLIN PSYCHOL, V51, P457, DOI 10.1002/1097-4679(199505)51:3<457::AID-JCLP2270510322>3.0.CO;2-7; BROWN SJ, 1994, J NEUROPSYCH CLIN N, V6, P15; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cook J B, 1972, Scand J Rehabil Med, V4, P27; Croizet JC, 1998, PERS SOC PSYCHOL B, V24, P588, DOI 10.1177/0146167298246003; Davis CH, 2002, AM J PHYS MED REHAB, V81, P609, DOI 10.1097/00002060-200208000-00009; Doss R.C., 1999, J FORENSIC NEUROPSYC, V1, P5, DOI [https://doi.org/10.1300/J151v01n04_02, DOI 10.1300/J151V01N04_02, 10.1300/J151v01n04_02]; DUNN JT, 1995, J CLIN PSYCHOL, V51, P577, DOI 10.1002/1097-4679(199507)51:4<577::AID-JCLP2270510418>3.0.CO;2-E; Evered L, 2003, ASSESSMENT, V10, P420, DOI 10.1177/1073191103259539; FARMER MY, 1987, PEDIATR NEUROSCI, V13, P304, DOI 10.1159/000120348; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; Gasquoine P G, 2000, Appl Neuropsychol, V7, P83, DOI 10.1207/S15324826AN0702_3; GERBER DJ, 1995, J HEAD TRAUMA REHAB, V10, P28, DOI 10.1097/00001199-199508000-00004; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Greve KW, 2003, ARCH CLIN NEUROPSYCH, V18, P245, DOI 10.1016/S0887-6177(02)00137-3; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hahn RA, 1997, PREV MED, V26, P607, DOI 10.1006/pmed.1996.0124; Hawley CA, 2002, BRAIN INJURY, V16, P969, DOI 10.1080/02699050210147239; Heilbronner RL, 1993, TRIAL DIPLOMACY J, V16, P161; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Hilsabeck RC, 1998, J CLIN EXP NEUROPSYC, V20, P328, DOI 10.1076/jcen.20.3.328.813; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Iverson GL, 1996, J CLIN EXP NEUROPSYC, V18, P38, DOI 10.1080/01688639608408260; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Larrabee, 1997, Semin Clin Neuropsychiatry, V2, P196; Larrabee GJ, 2003, ARCH CLIN NEUROPSYCH, V18, P673, DOI 10.1016/S0887-6177(02)00157-9; Lees-Haley PR, 2001, ARCH CLIN NEUROPSYCH, V16, P689, DOI 10.1016/S0887-6177(00)00092-5; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; LeesHaley PR, 1996, PSYCHOL REP, V79, P811, DOI 10.2466/pr0.1996.79.3.811; LeesHaley PR, 1997, BRAIN INJURY, V11, P791; Levy B, 1996, J PERS SOC PSYCHOL, V71, P1092, DOI 10.1037/0022-3514.71.6.1092; Leyens JP, 2000, PERS SOC PSYCHOL B, V26, P1189, DOI 10.1177/0146167200262002; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Machulda MM, 1998, ARCH CLIN NEUROPSYCH, V13, P415, DOI 10.1016/S0887-6177(97)00031-0; MATEER CA, 2000, NEUROPSYCHOLOGICAL M; McCauley SR, 2005, J NERV MENT DIS, V193, P540, DOI 10.1097/01.nmd.0000172592.05801.71; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; Mickeviciene D, 2002, EUR J NEUROL, V9, P581, DOI 10.1046/j.1468-1331.2002.00497.x; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; Millis SR, 1998, J CLIN EXP NEUROPSYC, V20, P167, DOI 10.1076/jcen.20.2.167.1171; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Nacajauskaite O, 2006, BRAIN DEV-JPN, V28, P507, DOI 10.1016/j.braindev.2006.02.010; Necajauskaite Olga, 2005, Medicina (Kaunas), V41, P457; Nolin P, 2006, BRAIN INJURY, V20, P1147, DOI 10.1080/02699050601049247; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; RADANOV BP, 1992, SPINE, V17, P127, DOI 10.1097/00007632-199202000-00001; Reynolds S, 2003, J HEAD TRAUMA REHAB, V18, P139, DOI 10.1097/00001199-200303000-00005; Rohling Martin L, 2002, CNS Spectr, V7, P387; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Satz P, 1999, J CLIN EXP NEUROPSYC, V21, P620, DOI 10.1076/jcen.21.5.620.870; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; Steele CM, 1997, AM PSYCHOL, V52, P613, DOI 10.1037/0003-066X.52.6.613; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Sullivan Michael J L, 2002, Pain Res Manag, V7, P120; Sumanti M, 2006, CLIN NEUROPSYCHOL, V20, P754, DOI 10.1080/13854040500428467; SWEET JJ, 1999, FORENSIC NEUROPSYCHO; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Temple RO, 2003, CLIN NEUROPSYCHOL, V17, P402, DOI 10.1076/clin.17.3.402.18080; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Walsh M, 1999, SEX ROLES, V41, P219, DOI 10.1023/A:1018854212358; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3; World Health Organization, 2004, ICD 10 INT STAT CLAS; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593	100	23	23	0	11	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-0-387-70703-7				2011							745	763		10.1007/978-0-387-76978-3_24	10.1007/978-0-387-76978-3		19	Clinical Neurology; Neurosciences; Psychology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Psychology	BTF43	WOS:000286799800024					2022-02-06	
J	MacGregor, AJ; Dougherty, AL; Morrison, RH; Quinn, KH; Galarneau, MR				MacGregor, Andrew J.; Dougherty, Amber L.; Morrison, Rosemary H.; Quinn, Kimberly H.; Galarneau, Michael R.			Repeated concussion among US military personnel during Operation Iraqi Freedom	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						blast; combat; concussion; concussive injury; deployment; head injury; head trauma; military; multiple; severity; traumatic brain injury	TRAUMATIC BRAIN-INJURY; PROFESSIONAL FOOTBALL; RECURRENT CONCUSSION; AFGHANISTAN; PLAYERS	Concussions are a predominant injury of the conflicts in Iraq and Afghanistan. The aims of this study were to describe repeated concussive events among U.S. military personnel injured in Operation Iraqi Freedom and examine subsequent healthcare utilization. We reviewed clinical records from the Expeditionary Medical Encounter Database to identify servicemembers with repeat concussions. We abstracted demographic and injury-specific variables, calculated time between events, and identified healthcare utilization from electronic medical databases. Overall, 113 personnel experienced more than one concussion between 2004 and 2008. A majority of these incidents were blast related. The median time between events was 40 days, with 20% experiencing a second event within 2 weeks of the first and 87% within 3 months. Time between events was not associated with severity of the second event. Greater severity of the second concussive event was associated with higher postinjury utilization of mental health and neurology services. This study is one of the first to describe repeated concussions in a combat setting. We found that repeated concussions occur within a short interval among deployed personnel, although the effects of the first event are unclear. Further research is needed to define the effect of repeated concussions on the health of combat veterans.	[MacGregor, Andrew J.; Dougherty, Amber L.; Morrison, Rosemary H.; Quinn, Kimberly H.; Galarneau, Michael R.] USN, Hlth Res Ctr, Dept Med Modeling Simulat & Mission Support, San Diego, CA 92106 USA		Dougherty, AL (corresponding author), USN, Hlth Res Ctr, 140 Sylvester Rd, San Diego, CA 92106 USA.	amber.dougherty@med.navy.mil		MacGregor, Andrew/0000-0003-1020-7390	Department of DefenseUnited States Department of Defense [PT090804, 61024]	This material was based on work supported by the Congressionally Directed Medical Research Programs, Department of Defense (proposal PT090804 under work unit 61024).	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barth JT, 1989, MILD HEAD INJURY; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Commission on Professional Hospital Activities, 1977, INT CLASS DIS; Galarneau MR, 2006, MIL MED, V171, P691, DOI 10.7205/MILMED.171.8.691; Gennarelli TA, 2005, ABBREVIATED INJURY S; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; GRONWALL D, 1975, LANCET, V2, P995; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Martin EM, 2008, AM J NURS, V108, P40, DOI 10.1097/01.NAJ.0000315260.92070.3f; McAllister T., 2005, TXB TRAUMATIC BRAIN, P279; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D; RAND, 2008, INVISIBLE WOUNDS WAR; SALCIDO R, 1992, Brain Injury, V6, P293, DOI 10.3109/02699059209029671; Slobounov S, 2009, CLIN NEUROPHYSIOL, V120, P862, DOI 10.1016/j.clinph.2009.03.009; Teasdale TW, 2003, J NEUROL NEUROSUR PS, V74, P933, DOI 10.1136/jnnp.74.7.933; Thornton AE, 2008, J CLIN EXP NEUROPSYC, V30, P398, DOI 10.1080/13803390701443662; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Zeitzer MB, 2008, AAOHN J, V56, P347, DOI 10.3928/08910162-20080801-03	28	23	23	0	3	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2011	48	10					1269	1277		10.1682/JRRD.2011.01.0013			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	V28XL	WOS:000208713400013	22234670	Bronze			2022-02-06	
J	Szmydynger-Chodobska, J; Zink, BJ; Chodobski, A				Szmydynger-Chodobska, Joanna; Zink, Brian J.; Chodobski, Adam			Multiple sites of vasopressin synthesis in the injured brain	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						activated microglia; arginine vasopressin; cerebrovascular endothelium; macrophages; traumatic brain injury	RAT CHOROID-PLEXUS; ARGININE-VASOPRESSIN; EXPRESSION; RECEPTORS; KINETICS	Previous studies have indicated that the primary targets for vasopressin actions on the injured brain are the cerebrovascular endothelium and astrocytes, and that vasopressin amplifies the posttraumatic production of proinflammatory mediators. Here, the controlled cortical impact model of traumatic brain injury in rats was used to identify the sources of vasopressin in the injured brain. Injury increased vasopressin synthesis in the hypothalamus and cerebral cortex adjacent to the posttraumatic lesion. In the cortex, vasopressin was predominantly produced by activated microglia/macrophages, and, to a lesser extent, by the cerebrovascular endothelium. These data further support the pathophysiological role of vasopressin in brain injury. Journal of Cerebral Blood Flow & Metabolism (2011) 31, 47-51; doi:10.1038/jcbfm.2010.188; published online 20 October 2010	[Szmydynger-Chodobska, Joanna] Brown Univ, Dept Emergency Med, Alpert Med Sch, Coro Ctr W, Providence, RI 02903 USA		Szmydynger-Chodobska, J (corresponding author), Brown Univ, Dept Emergency Med, Alpert Med Sch, Coro Ctr W, Room 112,1 Hoppin St, Providence, RI 02903 USA.	Joanna_Szmydynger-Chodobska@brown.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS49479]; Department of Emergency Medicine at the Alpert Medical School of Brown University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049479] Funding Source: NIH RePORTER	This work was supported by grant NS49479 from the NIH (to AC) and by funds from the Department of Emergency Medicine at the Alpert Medical School of Brown University.	Barreca T, 2001, CEREBROVASC DIS, V11, P113, DOI 10.1159/000047622; BUIJS RM, 1978, CELL TISSUE RES, V186, P423, DOI 10.1007/BF00224932; Chodobski A, 1997, MOL BRAIN RES, V48, P67, DOI 10.1016/S0169-328X(97)00079-X; Liu XZ, 2000, HEALTH POLICY PLANN, V15, P157, DOI 10.1093/heapol/15.2.157; LOESCH A, 1993, BRAIN RES, V611, P333, DOI 10.1016/0006-8993(93)90522-O; SOFRONIEW MV, 1983, PROG BRAIN RES, V60, P101; SORENSEN PS, 1985, J NEUROL NEUROSUR PS, V48, P50, DOI 10.1136/jnnp.48.1.50; Szmydynger-Chodobska J, 2004, J NEUROTRAUM, V21, P1090, DOI 10.1089/0897715041651033; Szmydynger-Chodobska J, 2006, NEUROENDOCRINOLOGY, V84, P339, DOI 10.1159/000097989; Szmydynger-Chodobska J, 2010, J NEUROTRAUM, V27, P1449, DOI 10.1089/neu.2010.1331; Vakili A, 2005, J CEREBR BLOOD F MET, V25, P1012, DOI 10.1038/sj.jcbfm.9600097; Xu Miao, 2007, Chin J Traumatol, V10, P90; Yoshida M, 2006, ENDOCRINOLOGY, V147, P2850, DOI 10.1210/en.2005-1222; ZLOKOVIC BV, 1990, BIOCHIM BIOPHYS ACTA, V1025, P191, DOI 10.1016/0005-2736(90)90097-8; ZLOKOVIC BV, 1991, AM J PHYSIOL, V260, pF216, DOI 10.1152/ajprenal.1991.260.2.F216	15	23	23	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JAN	2011	31	1					47	51		10.1038/jcbfm.2010.188			5	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	702BX	WOS:000285870700007	20959854	Green Published, Bronze			2022-02-06	
J	Whiteside, D; Wald, D; Busse, M				Whiteside, Douglas; Wald, Danielle; Busse, Michelle			Classification Accuracy of Multiple Visual Spatial Measures in the Detection of Suspect Effort	CLINICAL NEUROPSYCHOLOGIST			English	Article						Symptom validity testing; Effort; Neuropsychological evaluation; Visual spatial	MALINGERED NEUROCOGNITIVE DYSFUNCTION; TRAUMATIC BRAIN-INJURY; RECOGNITION; PERFORMANCE; INDICATORS; VALIDATION; TESTS	A wide variety of cognitive measures, particularly memory measures, have been studied for their ability to detect suspect effort, or biased responding on neuropsychological assessment instruments. However, visual spatial measures have received less attention. The purpose of this study was to evaluate the classification accuracy of several commonly used visual spatial measures, including the Judgment of Line Orientation Test, the Benton Facial Recognition Test, the Hooper Visual Organization Test, and the Rey Complex Figure Test-Copy and Recognition trials. Participants included 491 consecutive referrals who participated in a comprehensive neuropsychological assessment and met study criteria. Participants were divided into two groups identified as either unbiased responding (UR, N = 415) or biased responding (BR, N = 30) based on their performance on two measures of effort. The remaining participants (N = 46) had discrepant performance on the symptom validity measures and were excluded from further analysis. The groups differed significantly on all measures. Additionally, receiver operating characteristic (ROC) analysis indicated all of the measures had acceptable classification accuracy, but a measure combining scores from all of the measures had excellent classification accuracy. Results indicated that various cut-off scores on the measures could be used depending on the context of the evaluation. Suggested cut-off scores for the measures had sensitivity levels of approximately 32-46%, when specificity was at least 87%. When combined, the measures suggested cut-off scores had sensitivity increase to 57% while maintaining the same level of specificity (87%). The results were discussed in the context of research advocating the use of multiple measures of effort.	[Whiteside, Douglas] Argosy Univ Seattle, Amer Sch Profess Psychol, Seattle, WA 98105 USA		Whiteside, D (corresponding author), Argosy Univ Seattle, Amer Sch Profess Psychol, 2601 A Elliott Ave, Seattle, WA 98105 USA.	dwhiteside@argosy.edu	Whiteside, Douglas/AAK-6396-2020	Whiteside, Douglas/0000-0002-8454-4413			Benton A., 1994, CONTRIBUTIONS NEUROP; BERNARD LC, 1993, J CLIN PSYCHOL, V49, P45, DOI 10.1002/1097-4679(199301)49:1<45::AID-JCLP2270490107>3.0.CO;2-7; Boone K. B., 2002, DOT COUNTING TEST MA; Boone KB, 2000, ARCH CLIN NEUROPSYCH, V15, P227, DOI 10.1016/S0887-6177(99)00014-1; BOONE KB, 2007, ASSESSMENT MALINGERE, P27; CONDER R, 1992, COMPUTERIZED ASSESSM; Curtis KL, 2006, ASSESSMENT, V13, P46, DOI 10.1177/1073191105285210; Delis D.C., 2000, CALIFORNIA VERBAL LE; Demakis GJ, 2004, APPL NEUROPSYCHOL, V11, P222; Green P., 1996, WORD MEMORY TEST USE; Greiffenstein M. F., 1994, PSYCHOL ASSESSMENT, V18, P573; GREIFFENSTEIN MF, 2007, ASSESSMENT MALINGERE, P100; Hooper H., 1958, HOOPER VISUAL ORG TE; Iverson G L, 2001, Appl Neuropsychol, V8, P167, DOI 10.1207/S15324826AN0803_6; Larrabee G. J., 2007, ASSESSMENT MALINGERE, P80; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Lemeshow S, 2000, APPL LOGISTIC REGRES; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; Meyers J., 1995, REY COMPLEX FIGURE R; Meyers J E, 1999, Appl Neuropsychol, V6, P208, DOI 10.1207/s15324826an0604_3; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; Meyers JE, 1998, APPL NEUROPSYCHOL, V5, P120, DOI 10.1207/s15324826an0503_2; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; *PSYCH CORP, 2001, WECHL TEST AD READ; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Sherman DS, 2002, CLIN NEUROPSYCHOL, V16, P242, DOI 10.1076/clin.16.3.242.13860; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Suhr J. A., 2007, ASSESSMENT MALINGERE, P80; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tranel D, 2009, J CLIN EXP NEUROPSYC, V31, P219, DOI 10.1080/13803390802317542; Van Allen MW, 1968, CORTEX, V93, P38, DOI [10.1016/S0010-9452(68)80018-8, DOI 10.1016/S0010-9452(68)80018, 10.1016/S0010-9452(68)80018]	34	23	23	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2011	25	2					287	301	PII 931806742	10.1080/13854046.2010.538436			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	722DX	WOS:000287412500006	21331981				2022-02-06	
S	Yang, KH; Mao, HJ; Wagner, C; Zhu, F; Chou, CC; King, AI		Bilston, LE		Yang, King H.; Mao, Haojie; Wagner, Christina; Zhu, Feng; Chou, Clifford C.; King, Albert I.			Modeling of the Brain for Injury Prevention	NEURAL TISSUE BIOMECHANICS	Studies in Mechanobiology Tissue Engineering and Biomaterials		English	Article; Book Chapter							FINITE-ELEMENT-ANALYSIS; CORTICAL CONTUSION INJURY; FILLED SPHERICAL-SHELL; HUMAN HEAD; DYNAMIC-RESPONSE; ELASTIC MODEL; IMPACT; SIMULATION; PREDICTION; CONSEQUENCES	From an ethical point of view, it is extremely difficult to propose a well-controlled human subject study aimed at understanding brain injury mechanisms and establishing the associated tolerance values. For this reason, many numerical models of the human and animal head or brain have been developed over the past several decades in an attempt to obtain in-depth insights into brain injury biomechanics, minimizing the need for human subject research. This chapter highlights and contrasts the essence of human and animal head numerical models developed for studying blunt impact and blast-induced brain injuries. Even with the vast amount of literature produced by these investigations and studies, the precise mechanisms of brain injury have not yet been fully established to date. Through this review, it is clear that a lot of information can be garnered by numerical brain modeling but few efforts have been devoted so far to using these numerical models to provide guidelines in the discovery of brain injury mechanisms. Based on the brain models reported in the current literature, there are some inherent deficiencies. However, with further revisions and improvements to the currently available models, as opposed to developing new models from scratch, these issues can be overcome, and the slate of the art can be advanced. More research effort into brain injury mechanisms, especially under in vivo conditions, is needed for computational model improvements so that the injury mechanisms can be thoroughly understood and effective countermeasures for protecting human from traumatic brain injury can be developed.	[Yang, King H.; Mao, Haojie; Wagner, Christina; Zhu, Feng; Chou, Clifford C.; King, Albert I.] Wayne State Univ, Detroit, MI 48202 USA		Yang, KH (corresponding author), Wayne State Univ, Detroit, MI 48202 USA.	aa0007@wayne.edu	Mao, Haojie/Q-7514-2018	Mao, Haojie/0000-0002-7563-9234; Chou, Clifford/0000-0002-9127-1660			ABEL JM, 1978, 22 STAPP CAR CRASH C; ALBSHARAT A, 1999, 43 STAPP CAR CRASH C; ALEM NM, 1974, P 18 STAPP CAR CRASH; Allsop D, 1988, P 32 STAPP CAR CRASH; ANDERSON RW, 2000, STUDY BIOMECHANICS A; Bandak F, 1994, 38 STAPP CAR CRASH C; BANDAK FA, 1995, J NEUROTRAUM, V12, P679, DOI 10.1089/neu.1995.12.679; BANDAK FA, 1995, J NEUROTRAUM, V12, P635, DOI 10.1089/neu.1995.12.635; Bilston LE, 2001, BIORHEOLOGY, V38, P335; Brands D W, 2000, Stapp Car Crash J, V44, P249; BRANDS DWA, 2002, P 46 STAPP CAR CRASH, P103; Chafi MS, 2008, PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS AND EXPOSITION 2007, VOL 2, P211; CHAFI MS, 2009, ANN BIOMED ENG E PUB; Chakrabarty SP, 2009, MATH BIOSCI, V219, P129, DOI 10.1016/j.mbs.2009.03.005; CHAN HS, 1974, J BIOMECH, V7, P43, DOI 10.1016/0021-9290(74)90069-4; CHAN HS, 1974, P 18 STAPP CAR CRASH; Chen M, 2009, J NEUROSCI METH, V179, P111, DOI 10.1016/j.jneumeth.2009.01.010; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; CHU CS, 1994, J BIOMECH, V27, P187, DOI 10.1016/0021-9290(94)90208-9; CLAESSENS M, 1997, P 41 ANN STAPP CAR C; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Coats B, 2007, STAPP CAR CRASH JO, V51, P1; Couper Z, 2008, BIOMECH MODEL MECHAN, V7, P105, DOI 10.1007/s10237-007-0079-9; Desantis Klinich Kathleen, 2002, Stapp Car Crash J, V46, P165; DIMASI F, 1991, AUTO TRAFFIC SAFETY, V1; DiMasi F.P., 1995, P 39 STAPP CAR CRASH; Domont A., 1992, P 36 STAPP CAR CRASH, DOI [10.4271/922527, DOI 10.4271/922527]; ENGIN AE, 1970, J BIOMECH, V3, P11, DOI 10.1016/0021-9290(70)90047-3; EPPINGER R, 1994, P NHTSA 14 INT TECHN; FAN WRS, 1971, P 15 STAPP CAR CRASH; Finkel MF, 2006, J NEUROL SCI, V249, P63, DOI 10.1016/j.jns.2006.06.005; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fitch MT, 1999, J NEUROSCI, V19, P8182; FRANKLYN M, 2005, STAPP CAR CRASH J, V50; Franklyn Melanie, 2007, Critical Reviews in Biomedical Engineering, V35, P197; Fredriksson R, 2007, STAPP CAR CRASH JO, V51, P155; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Gao CP, 2008, ACTA NEUROCHIR SUPPL, V102, P279, DOI 10.1007/978-3-211-85578-2_52; Gao CP, 2005, P ANN INT IEEE EMBS, P4337; Goldsmith W., 1966, P HEAD INJURY C, P350; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hagemann A, 2002, MED IMAGE ANAL, V6, P375, DOI 10.1016/S1361-8415(02)00059-2; HARDY CH, 1971, 8 DIV ENG BROWN U; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; HODGSON VR, 1968, P 12 STAPP CAR CRASH; HODGSON VR, 1967, P 11 STAPP CAR CRASH; Holmberg P, 2009, CURR NEUROVASC RES, V6, P1; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hosey R. R., 1982, FINITE ELEMENTS BIOM, P379; Hu JW, 2007, J NEUROSURG, V106, P164, DOI 10.3171/jns.2007.106.1.164; Huang HM, 2000, MED BIOL ENG COMPUT, V38, P253, DOI 10.1007/BF02347044; JIN X, 2010, J BIOMECH; Jin Xin, 2006, Stapp Car Crash J, V50, P637; Jin X, 2007, STAPP CAR CRASH JO, V51, P115; Johnson EAC, 2005, J BIOMECH, V38, P39, DOI 10.1016/j.jbiomech.2004.03.018; KANG HS, 1997, 41 STAPP CAR CRASH C; KHALIL TB, 1977, J BIOMECH, V10, P119, DOI 10.1016/0021-9290(77)90075-6; KHALIL TB, 1974, INT J MECH SCI, V16, P609, DOI 10.1016/0020-7403(74)90061-7; KHALIL TB, 1982, P 26 STAPP CAR CRASH; Kimpara Hideyuki, 2006, Stapp Car Crash J, V50, P509; KING AI, 1976, J BIOMECH, V9, P301, DOI 10.1016/0021-9290(76)90052-X; KING AI, 1999, P 1999 BIOENG C ASME, P269; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; KRABBEL G, 1995, J NEUROTRAUM, V12, P735, DOI 10.1089/neu.1995.12.735; KUIJPERS AHWM, 1995, J NEUROTRAUM, V12, P715, DOI 10.1089/neu.1995.12.715; Kumaresan S, 1996, MED BIOL ENG COMPUT, V34, P27, DOI 10.1007/BF02637019; Kurosawa Y, 2008, IEEE ENG MED BIO, P4090, DOI 10.1109/IEMBS.2008.4650108; KURTZ SM, 1998, P 8 INJ PREV BIO S W; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lee M-C, 1987, 31 STAPP CAR CRASH C; Levchakov A, 2006, J NEUROTRAUM, V23, P1570, DOI 10.1089/neu.2006.23.1570; Li JR, 2007, BIOMED SCI INSTRUM, V43, P24; Lighthall J.W., 1989, P 12 INT TECHN C EXP, P627; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Mao HJ, 2010, BIOMECH MODEL MECHAN, V9, P763, DOI 10.1007/s10237-010-0212-z; Mao HJ, 2010, J NEUROTRAUM, V27, P877, DOI 10.1089/neu.2008.0616; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; MARTINEZ JL, 1968, P 12 STAPP CAR CRASH; MERCHANT HC, 1974, J BIOMECH, V7, P295, DOI 10.1016/0021-9290(74)90022-0; Meyer R., 2002, EXPLOSIVES, V5th; MILLER RT, 1998, 42 STAPP CAR CRASH C; MILLER RT, 1999, 43 STAPP CAR CRASH C; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Moss W.C., 2009, J ACOUST SOC AM, V125, P2650; NAHUM A, 1980, P 24 STAPP CAR CRASH; NAHUM AM, 1981, 25 STAPP CAR CRASH C; Nahum AM, 1977, P 21 STAPP CAR CRASH; NAHUM AM, 1979, P 23 STAPP CAR CRASH; Newman J, 2000, 44 STAPP CAR CRASH C; Nyquist G. W., 1986, P 30 STAPP CAR CRASH; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V400; Pena A, 2005, ACT NEUR S, V95, P333; PINTAR FA, 1995, P 39 STAPP CAR CRASH; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; PRANGE MT, 1999, STAPP CAR CRASH C S; PRANGE MT, 2000, P 44 STAPP CAR CRASH; Raul JS, 2008, INT J LEGAL MED, V122, P359, DOI 10.1007/s00414-008-0248-0; Raul JS, 2006, INT J LEGAL MED, V120, P212, DOI 10.1007/s00414-005-0018-1; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; Roth S, 2008, COMPUT METH PROG BIO, V90, P262, DOI 10.1016/j.cmpb.2008.01.007; Roth S, 2007, INT J LEGAL MED, V121, P223, DOI 10.1007/s00414-006-0129-3; Roth S, 2009, COMPUT METH PROG BIO, V93, P32, DOI 10.1016/j.cmpb.2008.08.001; Rousseau Philippe, 2010, Stapp Car Crash J, V54, P37; Ruan J, 2001, Stapp Car Crash J, V45, P395; RUAN JS, 1995, J NEUROTRAUM, V12, P725, DOI 10.1089/neu.1995.12.725; Ruan JS, 2006, J BIOMECH, V39, P383, DOI 10.1016/j.jbiomech.2005.03.004; RUAN JS, 1994, J BIOMECH ENG-T ASME, V116, P44, DOI 10.1115/1.2895703; RUAN JS, 1991, J BIOMECH ENG-T ASME, V113, P276, DOI 10.1115/1.2894885; RUAN JS, 1993, STAPP C P SAE; RUAN JS, 1994, P 38 STAPP CAR CRASH; Saberi H, 2007, COMPUT AIDED SURG, V12, P131, DOI 10.1080/10929080701294828; SACZALSKI KJ, 1978, AVIAT SPACE ENVIR MD, V49, P114; Sarron JC, 2000, J TRAUMA, V49, P923, DOI 10.1097/00005373-200011000-00021; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Shafieian M, 2009, J BIOMECH, V42, P2136, DOI 10.1016/j.jbiomech.2009.05.041; SHREIBER DI, 1997, 41 STAPP CAR CRASH C; SHUGAR TA, 1975, P 19 STAPP CAR CRASH; SLATTENSCHEK A, 1971, P 15 STAPP CAR CRASH; Sotudehchafi M, 2007, PROCEEDING OF THE ASME SUMMER BIOENGINEERING CONFERENCE - 2007, P349; Soza Grzegorz, 2003, Comput Aided Surg, V8, P241, DOI 10.3109/10929080309146059; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts EG, 2008, STAPP CAR C, V52, P1; Takizawa Hideo, 1994, Neurologia Medico-Chirurgica, V34, P65, DOI 10.2176/nmc.34.65; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; THIBAULT KT, 1997, P WINT ANN M ASME; THUNNISSEN J, 1995, P 39 STAPP CAR CRASH; THURMAN DL, 2000, TRAUMATIC BRAIN INJU; Turquier F, 1996, 40 STAPP CAR CRASH C; UENO K, 1995, J NEUROTRAUM, V12, P695, DOI 10.1089/neu.1995.12.695; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Ward C., 1980, 24 STAPP CAR CRASH C; WARD C, 1975, 19 STAPP CAR CRASH C; WARD C, 1982, P 26 STAPP CAR CRASH; WARD CC, 1978, AVIAT SPACE ENVIR MD, V49, P136; WILLINGER CM, 1992, NEW CONCEPT CONTRECO, P283; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; WILLINGER R, 1995, HEAD BIOMECHANICS FI, P245; Wittek A, 2008, COMPUT METHOD BIOMEC, V11, P135, DOI [10.1080/10255840701688095, 10.1080/10255840802296665]; WITTEK A, 2005, BRAIN SHIFT COMPUT 2, V8, P583; Xu Wei, 2008, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V25, P556; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; Zhang Jiangyue, 2006, Annu Proc Assoc Adv Automot Med, V50, P1; Zhang Jiangyue, 2009, Biomed Sci Instrum, V45, P119; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang Liying, 2002, Stapp Car Crash J, V46, P145; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; ZHOU C, 1994, 38 STAPP CAR CRASH C; Zhou C, 1995, P 39 STAPP CAR CRASH; Zhu Feng, 2010, Stapp Car Crash J, V54, P211; Zhu Q, 2006, DEV NEUROSCI-BASEL, V28, P388, DOI 10.1159/000094165; Zong Z, 2006, J BIOMECH, V39, P284, DOI 10.1016/j.jbiomech.2004.11.015; ZOROYA G, 2005, KEY IRAQ WOUND BRAIN	167	23	23	0	11	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES	1868-2006		978-3-642-13889-8	STUD MECHANOBIOL TIS	Stud. Mechanobiol. Tissue Eng. Biomater.		2011	3						69	120		10.1007/8415_2010_62	10.1007/978-3-642-13890-4		52	Biotechnology & Applied Microbiology; Engineering, Biomedical; Neurosciences	Book Citation Index – Science (BKCI-S)	Biotechnology & Applied Microbiology; Engineering; Neurosciences & Neurology	BWN19	WOS:000294272200005					2022-02-06	
J	Araujo, IM; Carreira, BP; Carvalho, CM; Carvalho, AP				Araujo, Ines M.; Carreira, Bruno P.; Carvalho, Caetana M.; Carvalho, Arselio P.			Calpains and Delayed Calcium Deregulation in Excitotoxicity	NEUROCHEMICAL RESEARCH			English	Article						Neuronal death; Excitotoxicity; Neurodegeneration; Sodium-calcium exchanger; Glutamate; Calpain	ACUTE GLUTAMATE EXCITOTOXICITY; BRAIN-INJURY; HIPPOCAMPAL-NEURONS; NA+/CA2+ EXCHANGE; CA1 NEURONS; MITOCHONDRIAL DEPOLARIZATION; REPERFUSION INJURY; STATUS EPILEPTICUS; IN-VITRO; INHIBITOR	Overactivation of glutamate receptors results in neurodegeneration in a variety of brain pathologies, including ischemia, epilepsy, traumatic brain injury and slow-progressing neurodegenerative disorders. In all these pathologies, it is well accepted that the calcium-dependent cysteine proteases calpains are key players in the mechanisms of neuronal cell death. Many research groups have been actively pursuing to establish a link between the deregulation of intracellular Ca2+ homeostasis associated with excitotoxicity and calpain activity. It is well established that these two events are connected and interact synergistically to promote neurodegeneration, but whether calpain activity depends on or contributes to Ca2+ deregulation is still under debate.	[Araujo, Ines M.; Carreira, Bruno P.; Carvalho, Caetana M.; Carvalho, Arselio P.] Univ Coimbra, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal		Araujo, IM (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal.	inaraujo@cnc.cj.uc.pt	Araujo, Ines M/F-4703-2012	Araujo, Ines M/0000-0002-2438-0111; Carreira, Bruno P./0000-0002-7874-6545	Foundation for Science and Technology (FCT), PortugalPortuguese Foundation for Science and Technology [PTDC/SAU-NEU/102612/2008, PTDC/SAU-NMC/112183/2009]; FCTPortuguese Foundation for Science and TechnologyEuropean Commission [SFRH/BD/23754/2005]	This work was funded by Foundation for Science and Technology (FCT), Portugal, Grants PTDC/SAU-NEU/102612/2008 and PTDC/SAU-NMC/112183/2009. Bruno P. Carreira is funded by a fellowship provided by FCT (SFRH/BD/23754/2005).	Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Abramov AY, 2010, BBA-GEN SUBJECTS, V1800, P297, DOI 10.1016/j.bbagen.2009.08.002; Araujo IM, 2007, CELL DEATH DIFFER, V14, P1635, DOI 10.1038/sj.cdd.4402171; Araujo IM, 2008, J NEUROCHEM, V105, P666, DOI 10.1111/j.1471-4159.2007.05181.x; Araujo IM, 2005, CNS NEUROL DISORD-DR, V4, P319, DOI 10.2174/1568007054546126; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Bevers MB, 2008, J CEREBR BLOOD F MET, V28, P655, DOI 10.1038/sj.jcbfm.9600595; Bevers MB, 2010, EXP NEUROL, V224, P170, DOI 10.1016/j.expneurol.2010.03.007; Brustovetsky T, 2010, J NEUROSCI RES, V88, P1317, DOI 10.1002/jnr.22295; Budd SL, 1996, J NEUROCHEM, V67, P2282; Czeiter E, 2009, MOLECULES, V14, P5115, DOI 10.3390/molecules14125115; Dietz RM, 2007, HIPPOCAMPUS, V17, P1049, DOI 10.1002/hipo.20336; FRANDSEN A, 1993, J NEUROCHEM, V60, P1202, DOI 10.1111/j.1471-4159.1993.tb03278.x; Gerencser AA, 2009, J NEUROCHEM, V110, P990, DOI 10.1111/j.1471-4159.2009.06194.x; Higuchi M, 2005, J BIOL CHEM, V280, P15229, DOI 10.1074/jbc.M500939200; Kawamura M, 2005, BRAIN RES, V1037, P59, DOI 10.1016/j.brainres.2004.12.050; Khodorov B, 2004, PROG BIOPHYS MOL BIO, V86, P279, DOI 10.1016/j.pbiomolbio.2003.10.002; KIEDROWSKI L, 1994, NEURON, V12, P295, DOI 10.1016/0896-6273(94)90272-0; Kiedrowski L, 2007, J NEUROCHEM, V100, P915, DOI 10.1111/j.1471-4159.2006.04308.x; Kupina NC, 2001, J NEUROTRAUM, V18, P1229, DOI 10.1089/089771501317095269; Li PA, 1998, NEUROSCI LETT, V247, P17, DOI 10.1016/S0304-3940(98)00266-3; Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]; Markgraf CG, 1998, STROKE, V29, P152, DOI 10.1161/01.STR.29.1.152; Matsuda T, 2001, J PHARMACOL EXP THER, V298, P249; Molinaro P, 2008, J NEUROSCI, V28, P1179, DOI 10.1523/JNEUROSCI.4671-07.2008; Nicholls DG, 1998, BIOFACTORS, V8, P287, DOI 10.1002/biof.5520080317; Nicholls DG, 1998, BBA-BIOENERGETICS, V1366, P97, DOI 10.1016/S0005-2728(98)00123-6; Nicholls DG, 1999, BIOCHEM SOC SYMP, V66, P55, DOI 10.1042/bss0660055; NICHOLLS DG, 1986, BRIT MED BULL, V42, P353, DOI 10.1093/oxfordjournals.bmb.a072152; Pilitsis JG, 2001, BRAIN RES, V916, P192, DOI 10.1016/S0006-8993(01)02896-7; RAMI A, 1993, BRAIN RES, V609, P67, DOI 10.1016/0006-8993(93)90856-I; Saatman KE, 2000, J CEREBR BLOOD F MET, V20, P66, DOI 10.1097/00004647-200001000-00010; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; Sattler R, 1996, BRAIN RES, V719, P239, DOI 10.1016/0006-8993(96)00125-4; Schroder UH, 1999, NEUROPHARMACOLOGY, V38, P319, DOI 10.1016/S0028-3908(98)00198-1; Storozhevykh TP, 2010, NEUROCHEM RES, V35, P323, DOI 10.1007/s11064-009-0058-x; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; Vergun O, 1999, J PHYSIOL-LONDON, V519, P451, DOI 10.1111/j.1469-7793.1999.0451m.x; Wang SH, 2008, BRAIN RES BULL, V76, P90, DOI 10.1016/j.brainresbull.2007.12.006; Zhao XR, 2008, J NEUROTRAUM, V25, P1195, DOI 10.1089/neu.2008.0635	41	23	24	0	8	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190			NEUROCHEM RES	Neurochem. Res.	DEC	2010	35	12			SI		1966	1969		10.1007/s11064-010-0323-z			4	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	695IX	WOS:000285364900013	21110090				2022-02-06	
J	Bastian, JD; Buchler, L; Meyer, DC; Siebenrock, KA; Keel, MJB				Bastian, Johannes Dominik; Buechler, Lorenz; Meyer, Dominik Christoph; Siebenrock, Klaus Arno; Keel, Marius Johann Baptist			Surgical Hip Dislocation for Osteochondral Transplantation as a Salvage Procedure for a Femoral Head Impaction Fracture	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						anterior hip dislocation; surgical hip dislocation; osteochondral autograft; impaction fracture	ARTICULAR-CARTILAGE DEFECTS; AUTOLOGOUS TRANSPLANTATION; TRAUMATIC DISLOCATION; ANTERIOR DISLOCATION; JOINT; OSSIFICATION; IMPINGEMENT; REPLACEMENT; ALLOGRAFTS; OSTEOTOMY	Obturator anterior hip dislocation is very rare. Poor results are described in patients with additional large transchondral fractures and treatment of these injuries remains challenging. Appropriate treatment recommendations are missing in the literature. This case report introduces surgical hip dislocation for osteochondral autograft transplantation with graft harvest from the nonweightbearing area of the head-neck junction as a salvage procedure in a large femoral head defect. We report the treatment and outcome of a 48-year-old man who sustained an anterior dislocation of the left hip after a motorcycle accident. After initial closed reduction in the emergency room, imaging analysis revealed a large osteochondral defect of the femoral head within the weightbearing area (10 x 20 mm, depth: 5 mm). The hip was exposed with a surgical hip dislocation using a trochanteric osteotomy. An osteochondral autograft was harvested from a nonweightbearing area of the femoral head and transferred into the defect. The patient was prospectively examined clinically and radiologically. Two years postoperatively, the patient was free of pain and complaints. The function of the injured hip was comparable to that of the contralateral, healthy hip and showed satisfying radiologic results. Surgical hip dislocation with a trochanteric flip osteotomy is a simple, one-step technique that allows full inspection of the hip to treat osteochondral femoral defects by osteochondral transplantation. The presented technique, used as a salvage procedure in a large femoral head defect, yielded good clinical and satisfying radiologic outcomes at the midterm.	[Bastian, Johannes Dominik; Buechler, Lorenz; Siebenrock, Klaus Arno; Keel, Marius Johann Baptist] Univ Bern, Dept Orthoped Surg, Inselspital, CH-3010 Bern, Switzerland; [Meyer, Dominik Christoph] Univ Zurich, Dept Orthoped, Zurich, Switzerland		Bastian, JD (corresponding author), Univ Bern, Dept Orthoped Surg, Inselspital, Freiburgstr 3, CH-3010 Bern, Switzerland.	johannesbastian@gmx.de		Buchler, Lorenz/0000-0002-6779-6432; Siebenrock, Klaus Arno/0000-0003-3627-4313			Al-Shaikh RA, 2002, FOOT ANKLE INT, V23, P381, DOI 10.1177/107110070202300502; Ansah P, 2007, J BONE JOINT SURG AM, V89A, P2188, DOI 10.2106/JBJS.F.00299; Bastian JD, 2009, OSTEOARTHR CARTILAGE, V17, P539, DOI 10.1016/j.joca.2008.08.005; Bastian JD, 2009, CLIN ORTHOP RELAT R, V467, P732, DOI 10.1007/s11999-008-0649-x; Beck M, 2009, CLIN ORTHOP RELAT R, V467, P769, DOI 10.1007/s11999-008-0653-1; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629, DOI 10.2106/00004623-197355080-00006; Bugbee WD, 1999, CLIN SPORT MED, V18, P67, DOI 10.1016/S0278-5919(05)70130-7; Croft SJ, 2006, EMERG MED J, V23, DOI 10.1136/emj.2005.031013; DELEE JC, 1980, J BONE JOINT SURG AM, V62, P960, DOI 10.2106/00004623-198062060-00012; DREINHOFER KE, 1994, J BONE JOINT SURG BR, V76B, P6, DOI 10.1302/0301-620X.76B1.8300683; DUSSAULT RG, 1980, RADIOLOGY, V135, P627, DOI 10.1148/radiology.135.3.7384446; Egli RJ, 2003, BONE, V33, P352, DOI 10.1016/S8756-3282(03)00192-3; EPSTEIN HC, 1973, CLIN ORTHOP RELAT R, P116; ERB RE, 1995, AM J ROENTGENOL, V165, P1215, DOI 10.2214/ajr.165.5.7572506; Ertel, 2005, EUR J TRAUMA, V31, P138, DOI DOI 10.1007/S00068-005-1403-7; Espinosa N, 2006, J BONE JOINT SURG AM, V88A, P925, DOI 10.2106/JBJS.E.00290; Espinosa Norman, 2007, J Bone Joint Surg Am, V89 Suppl 2 Pt.1, P36, DOI 10.2106/JBJS.F.01123; Ferguson SJ, 2003, J BIOMECH, V36, P171, DOI 10.1016/S0021-9290(02)00365-2; FRIEDLAENDER GE, 1992, ORTHOPEDICS, V15, P1171; Ganz R, 2001, J BONE JOINT SURG BR, V83B, P1119, DOI 10.1302/0301-620X.83B8.11964; Gautier E, 2000, J BONE JOINT SURG BR, V82B, P679, DOI 10.1302/0301-620X.82B5.10426; Gudas R, 2006, KNEE SURG SPORT TR A, V14, P834, DOI 10.1007/s00167-006-0067-0; Guo JJ, 2010, INT ORTHOP, V34, P319, DOI 10.1007/s00264-009-0849-3; HADDAD RJ, 1990, J BONE JOINT SURG BR, V72, P2, DOI 10.1302/0301-620X.72B1.2298788; Hangody L, 2008, INJURY, V39, pS32, DOI 10.1016/j.injury.2008.01.041; HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012; Hart R, 2003, ARTHROSCOPY, V19, DOI 10.1016/j.arthro.2003.10.025; Henle P, 2007, INJURY, V38, P478, DOI 10.1016/j.injury.2007.01.023; HOROWITZ MC, 1991, J BONE JOINT SURG AM, V73A, P1157, DOI 10.2106/00004623-199173080-00004; Horowitz MC, 1996, CLIN ORTHOP RELAT R, P25; Krueger A, 2007, ARTHROSCOPY, V23, P1285, DOI 10.1016/j.arthro.2007.07.002; Labler L, 2009, J TRAUMA, V66, P749, DOI 10.1097/TA.0b013e318171971a; Mardones RA, 2005, J BONE JOINT SURG AM, V87A, P273, DOI 10.2106/JBJS.D.01793; MEYERS MH, 1985, CLIN ORTHOP RELAT R, P111; Ohlendorf C, 1996, J ORTHOPAED RES, V14, P413, DOI 10.1002/jor.1100140311; Philippon MJ, 2009, ARTHROSCOPY, V25, P169, DOI 10.1016/j.arthro.2008.09.013; Rittmeister M, 2005, ORTHOPADE, V34, P320, DOI 10.1007/s00132-005-0776-y; Sahin V, 2003, J TRAUMA, V54, P520, DOI 10.1097/01.TA.0000020394.32496.52; Scheibel M, 2004, J BONE JOINT SURG BR, V86B, P991, DOI 10.1302/0301-620X.86B7.14941; Siebenrock KA, 2002, J ORTHOP TRAUMA, V16, P543, DOI 10.1097/00005131-200209000-00002; Siebenrock KA, 1998, J ORTHOP TRAUMA, V12, P387, DOI 10.1097/00005131-199808000-00004; Sirlin CB, 2001, RADIOLOGY, V219, P35, DOI 10.1148/radiology.219.1.r01ap0435; Sotereanos Nicholas G, 2008, Orthopedics, V31, P177, DOI 10.3928/01477447-20080201-33; Stevenson S, 1996, CLIN ORTHOP RELAT R, P86; TEHRANZADEH J, 1990, AM J ROENTGENOL, V155, P1049, DOI 10.2214/ajr.155.5.2120934; THOMPSON VP, 1951, J BONE JOINT SURG AM, V33-A, P746, DOI 10.2106/00004623-195133030-00023; Tonnis D, 1999, J BONE JOINT SURG AM, V81A, P1747; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Zahiri CA, 1998, J ARTHROPLASTY, V13, P890, DOI 10.1016/S0883-5403(98)90195-4	50	23	26	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0890-5339	1531-2291		J ORTHOP TRAUMA	J. Orthop. Trauma	DEC	2010	24	12					E113	E118		10.1097/BOT.0b013e3181dfbb52			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	679HF	WOS:000284151800001	21076245				2022-02-06	
J	Van Dyke, SA; Axelrod, BN; Schutte, C				Van Dyke, Sarah A.; Axelrod, Bradley N.; Schutte, Christian			Test-Retest Reliability of the Traumatic Brain Injury Screening Instrument	MILITARY MEDICINE			English	Article							DEPLOYMENT; IRAQ; AFGHANISTAN	The Traumatic Brain Injury Screening Instrument (TBISI) was implemented in Veterans Affairs medical facilities in an attempt to identify Operation Enduring Freedom and Operation Iraqi Freedom (OEF/OIF) veterans with possible mild TBI. Despite its widespread implementation, the reliability and validity of the screening tool has not yet been established. The current study reports preliminary findings on the test-retest reliability of the TBISI in 44 OEF/OIF veterans referred for neuropsychological evaluation following a positive TBI screen. Results suggest overall poor test-retest reliability of the TBI screening tool with regard to type of event, injuries sustained, and resulting sequelae. These findings underscore the importance of further investigation of its psychometric properties to promote accurate identification and referral of veterans with possible TBI.	[Van Dyke, Sarah A.; Axelrod, Bradley N.; Schutte, Christian] John D Dingell Vet Affairs Med Ctr, Detroit, MI 48201 USA		Van Dyke, SA (corresponding author), John D Dingell Vet Affairs Med Ctr, 4646 John R St, Detroit, MI 48201 USA.				Department of Veterans Affairs Predoctoral-Associated Health Rehabilitation Research Fellowship Program	This work was supported by the Department of Veterans Affairs Predoctoral-Associated Health Rehabilitation Research Fellowship Program.	COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Fleiss J.L., 1981, STAT METHODS RATES P; Hill JJ, 2009, AM J PHYS MED REHAB, V88, P605, DOI 10.1097/PHM.0b013e3181ae0f83; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; McCrea M., 2008, MILD TRAUMATIC BRAIN; Schwab KA, 2006, NEUROLOGY, V66, pA235; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; *US GOV ACC OFF, 2008, GAO08276	9	23	23	0	4	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075			MIL MED	Milit. Med.	DEC	2010	175	12					947	949		10.7205/MILMED-D-10-00337			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	691KO	WOS:000285078900005	21265299	Bronze			2022-02-06	
J	Lane-Brown, A; Tate, R				Lane-Brown, Amanda; Tate, Robyn			Evaluation of an Intervention for Apathy After Traumatic Brain Injury: A Multiple-Baseline, Single-Case Experimental Design	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						acquired brain injury; apathy; diminished motivation; drive; goals; intervention; rehabilitation; single-case experimental design; traumatic brain injury; treatment	STRESS SCALES DASS; SELF-AWARENESS; PSYCHOMETRIC PROPERTIES; RELIABILITY; DEFICITS; FATIGUE; SYSTEMS; ADULTS	Background: Apathy is diminished initiation, sustained activity, and concern about goal-directed behaviors. It occurs in between 46% and 71% of adults with traumatic brain injury and has widespread effects. Despite this, evidence for treatment of apathy is sparse, with no evidence for treatments aimed at sustaining activity toward goal-directed behavior. Method: A multiple-baseline, single-case experimental design evaluated a novel treatment for apathy in a 32-year-old man with traumatic brain injury. This treatment incorporated motivational interviewing and external compensation to increase sustained activity toward cumulative goals. Results: A specific treatment effect was demonstrated. Reliable Change Indices indicated a significant decrease in apathy that was maintained at 1-month follow-up. Conclusion: Treatment had a strong and specific effect on treated goal-directed activity and decreased apathy. The success of treatment was dependent on initiation as well as sustaining goal-directed activity.	Univ Sydney, Rehabil Studies Unit, Sydney, NSW 2006, Australia; Royal Rehabil Ctr, Sydney, NSW, Australia		Lane-Brown, A (corresponding author), Univ Sydney, Rehabil Studies Unit, POB 6, Ryde, NSW 1680, Australia.	amandal@med.usyd.edu.au			Rehabilitation Studies Unit; Northern Medical Research Foundation; Northern Clinical School, University of SydneyUniversity of Sydney; Australian GovernmentAustralian GovernmentCGIAR	This study was supported by the University of Sydney and funding has been provided by the Rehabilitation Studies Unit, the Northern Medical Research Foundation and the Northern Clinical School, University of Sydney, and the Australian Government through an Australian Postgraduate Award. The authors thank Michael Perdices for advice on statistical analysis.	Beeson PM, 2006, NEUROPSYCHOL REV, V16, P161, DOI 10.1007/s11065-006-9013-7; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Bombardier CH, 1999, REHABIL PSYCHOL, V44, P52, DOI 10.1037/0090-5550.44.1.52; Borgaro SR, 2004, BRAIN INJURY, V18, P685, DOI 10.1080/02699050310001646080; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Box G. E. P., 1970, TIME SERIES ANAL FOR; Brodie DA, 2005, J ADV NURS, V50, P518, DOI 10.1111/j.1365-2648.2005.03422.x; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Burgess P, 1996, BEHAV ASSESSMENT DYS; BURKE W H, 1991, Brain Injury, V5, P241, DOI 10.3109/02699059109008095; Crawford JR, 1997, CLIN NEUROPSYCHOL, V11, P192, DOI 10.1080/13854049708407050; Crawford JR, 2003, BRIT J CLIN PSYCHOL, V42, P111, DOI 10.1348/014466503321903544; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; DiIorio C, 2008, AIDS CARE, V20, P273, DOI 10.1080/09540120701593489; Drummond AER, 1994, BR J OCCUP THER, V57, P414, DOI DOI 10.1177/030802269405701102; Dunn C, 2001, ADDICTION, V96, P1725, DOI 10.1046/j.1360-0443.2001.961217253.x; Evans JJ, 1998, J INT NEUROPSYCH SOC, V4, P399, DOI 10.1017/S1355617798003993; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Fleming JM, 1996, BRAIN INJURY, V10, P1; Gauggel S., 2004, HDB MOTIVATIONAL COU, P439; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; Gray J.M, 1994, CLIN REHABIL, V8, P188, DOI [10.1177/026921559400800302, DOI 10.1177/026921559400800302, DOI 10.1080/09602010902949207]; Hersh N A, 1994, NeuroRehabilitation, V4, P187, DOI 10.3233/NRE-1994-4309; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; JACOBSON NS, 1984, BEHAV THER, V15, P336, DOI 10.1016/S0005-7894(84)80002-7; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Lane-Brown AT, 2009, NEUROPSYCHOL REHABIL, V19, P481, DOI 10.1080/09602010902949207; Lane-Brown AT, 2009, BRAIN INJURY, V23, P999, DOI 10.3109/02699050903379347; Lane-Brown A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006341.pub2; Locke EA, 1996, APPL PREV PSYCHOL, V5, P117, DOI 10.1016/S0962-1849(96)80005-9; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; Malec JF, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199706000-00002; MALEC JF, 2003, MANUAL MAYO PORLAND; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; Marin RS, 1997, PSYCHIAT ANN, V27, P30, DOI 10.3928/0048-5713-19970101-08; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; Marin RS, 2005, J HEAD TRAUMA REHAB, V20, pCP1; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Miller W.R., 1995, MOTIVATIONAL ENHANCE; Norton LE, 2001, AM J GERIAT PSYCHIAT, V9, P41; PERDICES M, 2005, BRAIN IMPAIRMENT, V0006, P00219; Perdices M, 2009, NEUROPSYCHOL REHABIL, V19, P904, DOI 10.1080/09602010903040691; REY A, 1964, LEXAMEN CLIN PSYCHOL; Rollnick S., 1995, BEHAV COGN PSYCHOTH, V23, P322, DOI [10.1017/S135246580001643X, 10.1017/S135246580001643X., DOI 10.1017/S135246580001643X]; Rubak S, 2005, BRIT J GEN PRACT, V55, P305; Simmond M, 2003, BRAIN INJURY, V17, P325, DOI 10.1080/0269905021000013219; SMITH RB, 1994, BRAIN INJURY, V8, P357, DOI 10.3109/02699059409150986; Sohlberg McK. M., 1988, COGNITIVE REHABILITA, V6, P36; Thurstone L. L, 1962, PRIMARY MENTAL ABILI; TRYON WW, 1982, J APPL BEHAV ANAL, V15, P423, DOI 10.1901/jaba.1982.15-423; van Reekum R, 2005, J NEUROPSYCH CLIN N, V17, P7, DOI 10.1176/appi.neuropsych.17.1.7; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; *WHO, 1975, WHO SCI GROUP GUID E	58	23	23	0	22	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2010	25	6					459	469		10.1097/HTR.0b013e3181d98e1d			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	679HA	WOS:000284151300008	20414129				2022-02-06	
J	Gosselin, N; Saluja, RS; Chen, JK; Bottari, C; Johnston, K; Ptito, A				Gosselin, Nadia; Saluja, Rajeet Singh; Chen, Jen-Kai; Bottari, Carolina; Johnston, Karen; Ptito, Alain			Brain Functions After Sports-Related Concussion: Insights From Event-Related Potentials and Functional MRI	PHYSICIAN AND SPORTSMEDICINE			English	Article						concussion; sports; athletes; event-related potentials; functional magnetic resonance imaging; mild traumatic brain injury	PROFESSIONAL FOOTBALL PLAYERS; MENS ICE HOCKEY; MAGNETIC-RESONANCE; HEAD-INJURY; HIGH-SCHOOL; WORKING-MEMORY; INTERNATIONAL-CONFERENCE; POSTCONCUSSION SYNDROME; COGNITIVE IMPAIRMENT; RECURRENT CONCUSSION	The high incidence of concussions in contact sports and their impact on brain functions are a major cause for concern. To improve our understanding of brain functioning aft er sports-related concussion, advanced functional assessment techniques, namely event-related potentials (ERPs) and functional magnetic resonance imaging (fMRI), have been recently used in research studies. Contrary to neuropsychological tests that measure verbal and/or motor responses, ERPs and fMRI assess the neural activities associated with cognitive/behavioral demands, and thus provide access to better comprehension of brain functioning. In fact, ERPs have excellent temporal resolution, and fMRI identifies the involved structures during a task. This article describes ERP and fMRI techniques and reviews the results obtained with these tools in sports-related concussion. Although these techniques are not yet readily available, they off er a unique clinical approach, particularly for complex cases (ie, athletes with multiple concussions, chronic symptoms) and objective measures that provide valuable information to guide management and return-to-play decision making.	[Ptito, Alain] McGill Univ, Ctr Hlth, Dept Psychol, Montreal, PQ H3A 1A1, Canada; [Gosselin, Nadia; Saluja, Rajeet Singh; Chen, Jen-Kai; Bottari, Carolina; Ptito, Alain] McGill Univ, Montreal Neurol Inst, Cognit Neurosci Unit, Montreal, PQ, Canada; [Gosselin, Nadia; Saluja, Rajeet Singh; Chen, Jen-Kai; Bottari, Carolina; Ptito, Alain] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 1A1, Canada; [Bottari, Carolina] McGill Univ, Sch Rehabil, Montreal, PQ H3A 1A1, Canada; [Johnston, Karen] Toronto Rehabil Inst, Sport Concuss Clin, Toronto, ON, Canada; [Johnston, Karen] Univ Toronto, Dept Neurosurg, Toronto, ON, Canada		Ptito, A (corresponding author), McGill Univ, Ctr Hlth, Dept Psychol, 1025 Pine Ave W, Montreal, PQ H3A 1A1, Canada.	alain.ptito@mcgill.ca					Agel J, 2007, J ATHL TRAINING, V42, P241; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Bargallo N, 2008, EUR J RADIOL, V67, P401, DOI 10.1016/j.ejrad.2008.02.043; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Benke T, 2006, EPILEPSIA, V47, P1308, DOI 10.1111/j.1528-1167.2006.00549.x; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Boutin D, 2008, NEUROCASE, V14, P239, DOI 10.1080/13554790802247543; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CHEN J, 2009, BR J SPORTS MED S1, V43, P104; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Dickerson BC, 2007, NEUROTHERAPEUTICS, V4, P360, DOI 10.1016/j.nurt.2007.05.007; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Echemendia RJ, 2003, APPL NEUROPSYCHOL, V10, P48, DOI 10.1207/S15324826AN1001_7; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Emery CA, 2006, CLIN J SPORT MED, V16, P20, DOI 10.1097/01.jsm.0000184638.72075.b7; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gessel LM, 2007, J ATHL TRAINING, V42, P495; GOSSELIN N, 2010, BRAIN INJURY, V24, P221; GOSSELIN N, 2010, J COGNITIVE NEUROS S, P168; Gosselin N, 2006, CLIN NEUROPHYSIOL, V117, P2228, DOI 10.1016/j.clinph.2006.07.130; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hoge RD, 2001, J CHEM NEUROANAT, V22, P43, DOI 10.1016/S0891-0618(01)00114-4; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Johnston Karen M, 2004, Curr Sports Med Rep, V3, P316; Jolicoeur P, 2006, PSYCHOL RES-PSYCH FO, V70, P414, DOI 10.1007/s00426-005-0008-4; Jotwani V, 2010, CURR SPORT MED REP, V9, P21, DOI 10.1249/JSR.0b013e3181ccb55e; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; KRAMER AF, 1988, BIOL PSYCHOL, V26, P231, DOI 10.1016/0301-0511(88)90022-1; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; Larsen S, 2007, INT J MED ROBOT COMP, V3, P262, DOI 10.1002/rcs.149; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; MacQueen GM, 2009, J PSYCHIATR NEUROSCI, V34, P343; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; MCCARTHY G, 1981, SCIENCE, V211, P77, DOI 10.1126/science.7444452; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; POLICH J, 1986, ELECTROEN CLIN NEURO, V63, P251, DOI 10.1016/0013-4694(86)90093-3; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; SQIRES KC, 1977, ELECTROEN CLIN NEURO, V42, P1; STULEMEIJER M, J NEUROTRAUMA; TEASDALE G, 1974, LANCET, V2, P81; THERIAULT M, J CLIN EXP NEUROPSYC; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; WICKENS C, 1983, SCIENCE, V221, P1080, DOI 10.1126/science.6879207; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	71	23	23	0	29	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	OCT	2010	38	3					27	37		10.3810/psm.2010.10.1805			11	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	764LI	WOS:000290630600012	20959693				2022-02-06	
J	Musacchio, MJ; Smith, AP; McNeal, CA; Munoz, L; Rothenberg, DM; von Roenn, KA; Byrne, RW				Musacchio, Michael J., Jr.; Smith, Adam P.; McNeal, Christopher A.; Munoz, Lorenzo; Rothenberg, David M.; von Roenn, Kelvin A.; Byrne, Richard W.			Neuro-Critical Care Skills Training Using a Human Patient Simulator	NEUROCRITICAL CARE			English	Article						Neurocritical care; Human patient simulator; Neurosurgical training	PERFORMANCE; VALIDITY	Neurosurgical trainees regularly encounter critical care situations. Traditionally, education was accomplished through lecture and experience. Increasingly, human patient simulators (HPS) are employed, allowing trainees to sharpen skills in a safe and realistic environment. We describe our experience using HPS in neurosurgical training. We developed a critical care training program for residents and medical students using HPS. We used a hi-fidelity, lifelike Human Patient Simulator (TM) (HPS (TM)) produced by Medical Education Technologies, Inc.(TM) to simulate realistic scenarios for trainee education. Topics included spinal shock, closed head injury, and cerebral vasospasm. A three-way evaluation model was employed to test validity, including pre- and post-exercise testing, survey feedback, and videotaped replay. The simulation exercises were conducted by a neuro-critical care attending, a senior neurosurgical resident, and a HPS technician. We currently have 29 participants. On a 20-point critical care multiple-choice exam for these participants, average improvement has been 4.5 points or 25%. In subgroup analysis, average improvement was 4.75 points (24%) amongst neurosurgery residents, 3.07 points (18%) amongst neurology residents, 7 points (38%) amongst general surgery residents, and 7 points (38%) amongst senior medical students. Post-exercise evaluations were overwhelmingly positive. Neurosurgical critical care education is important for safe and effective care for patients. Clinical experience and didactic lectures help trainees obtain a solid knowledge base, but do not provide the benefit for learning in a fail-safe environment. Through the use of HPS, we have enhanced the critical care education of our trainees.	[Musacchio, Michael J., Jr.; Smith, Adam P.; Munoz, Lorenzo; von Roenn, Kelvin A.; Byrne, Richard W.] Rush Univ, Med Ctr, Dept Neurosurg, Chicago, IL 60612 USA; [McNeal, Christopher A.] Rush Univ, Simulat Lab, Chicago, IL 60612 USA; [Rothenberg, David M.] Rush Univ, Med Ctr, Dept Anesthesiol, Chicago, IL 60612 USA		Smith, AP (corresponding author), Rush Univ, Med Ctr, Dept Neurosurg, 1725 W Harrison Ave,Suite 1115, Chicago, IL 60612 USA.	adam_smith@rush.edu	Byrne, Richard/Q-9644-2019				Boulet JR, 2003, ANESTHESIOLOGY, V99, P1270, DOI 10.1097/00000542-200312000-00007; CHOPRA V, 1994, BRIT J ANAESTH, V73, P293, DOI 10.1093/bja/73.3.293; Croley WC, 2007, CRIT CARE MED, V35, pS117, DOI 10.1097/01.CCM.0000252917.25301.18; Devitt JH, 1998, ANESTH ANALG, V86, P1160, DOI 10.1097/00000539-199806000-00004; Devitt JH, 2001, ANESTHESIOLOGY, V95, P36, DOI 10.1097/00000542-200107000-00011; Grenvik Ake, 2004, Curr Opin Crit Care, V10, P233, DOI 10.1097/01.ccx.0000132654.52131.32; Hammond Jeffrey, 2004, Curr Opin Crit Care, V10, P325, DOI 10.1097/01.ccx.0000140950.47361.c9; Lighthall GK, 2003, CRIT CARE MED, V31, P2437, DOI 10.1097/01.CCM.0000089645.94121.42; Maran NJ, 2003, MED EDUC, V37, P22, DOI 10.1046/j.1365-2923.37.s1.9.x; Schwid HA, 2002, ANESTHESIOLOGY, V97, P1434, DOI 10.1097/00000542-200212000-00015; Steadman RH, 2006, CRIT CARE MED, V34, P151, DOI 10.1097/01.CCM.0000190619.42013.94; Tsai TC, 2003, MED EDUC, V37, P72, DOI 10.1046/j.1365-2923.37.s1.3.x; Weller JM, 2003, BRIT J ANAESTH, V90, P43, DOI 10.1093/bja/aeg002	13	23	24	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2010	13	2					169	175		10.1007/s12028-010-9405-7			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	653LS	WOS:000282093500002	20625852				2022-02-06	
J	Banos, JH; Novack, TA; Brunner, R; Renfroe, S; Lin, HY; Meythaler, J				Banos, James H.; Novack, Thomas A.; Brunner, Robert; Renfroe, Sharon; Lin, Hui-Yi; Meythaler, Jay			Impact of Early Administration of Sertraline on Cognitive and Behavioral Recovery in the First Year After Moderate to Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						behavior; cognition; sertraline hydrochloride; traumatic brain injury	DEPRESSION FOLLOWING MILD; SEROTONIN; AGONIST	Objective: To assess the efficacy of sertraline administered in the first 3 months after moderate to severe traumatic brain injury (TBI) in improving cognitive and behavioral outcomes. Design: Double-blind, randomized controlled trial. Setting: Academic medical center. Participants: Ninety-nine individuals randomized to placebo (n = 50) or sertraline 50 mg (n = 49) conditions. There were no group differences in age, gender, education, or severity of injury. Interventions: Participants were enrolled an average of 21 days after injury (none > 8 weeks), followed by oral administration of placebo or sertraline 50 mg for 3 months. Main Outcome Measures: Wechsler Memory Scale-Third Edition Logical Memory, Trail Making Test, Wechsler Adult Intelligence Scale-Third Edition Working Memory Index, Symbol-DigitModalities Test, Wisconsin Card Sorting Test (64-item), Neurobehavioral Functioning Inventory administered 3, 6, and 12 months after the onset of injury. Results: Early administration of sertraline did not result in improved cognitive functioning during the year after injury compared with placebo administration. Those receiving placebo performed marginally better than the treatment group on a measure of executive function, but this appeared to be inauthentic. The treatment group followed expected recovery patterns based on existing literature. The placebo group performed better than expected on some measures, primarily due to differential dropout. Conclusions: Sertraline does not appear to prevent development of cognitive and behavioral problems following TBI, although this does not negate evidence for the treatment (as opposed to prophylactic) role of sertraline to address emotional and neurobehavioral problems in individuals with TBI.	[Banos, James H.; Novack, Thomas A.; Brunner, Robert; Renfroe, Sharon] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL 35249 USA; [Lin, Hui-Yi] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat, Tampa, FL 33612 USA; [Meythaler, Jay] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI USA		Banos, JH (corresponding author), Univ Alabama Birmingham, Dept Phys Med & Rehabil, SRC 530,619 19th St S, Birmingham, AL 35249 USA.	banos@uab.edu		Lin, Hui-Yi/0000-0002-3307-5549	National Institute on Disability and Rehabilitation Research [H133A980010]	This project was supported by the National Institute on Disability and Rehabilitation Research grant H133A980010, Traumatic Brain Injury Model System Project.	Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Heaton R., 2000, WISCONSIN CARD SORTI; HOLM S, 1979, SCAND J STAT, V6, P65; Horsfield SA, 2002, INT J PSYCHIAT MED, V32, P337, DOI 10.2190/KQ48-XT0L-2H14-5UMV; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Karakucuk EI, 1997, NEUROPEPTIDES, V31, P259, DOI 10.1016/S0143-4179(97)90057-3; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; KREUTZER J, 1999, NEUROBEHAVIORAL FUNC; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Meythaler JM, 2001, BRAIN INJURY, V15, P321, DOI 10.1080/026990501750111274; Novack TA, 2000, BRAIN INJURY, V14, P987; Novack TA, 2009, J NEUROTRAUM, V26, P1921, DOI 10.1089/neu.2009.0895; Ohman J, 2001, J NEUROTRAUM, V18, P1313, DOI 10.1089/08977150152725614; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Smith A., 1982, SYMBOL DIGIT MODALIT; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wheaton P, 2009, J CLIN PSYCHOPHARM, V29, P468, DOI 10.1097/JCP.0b013e3181b66f04; WHITAKERAZMITIA PM, 1990, ANN NY ACAD SCI, V600, P315, DOI 10.1111/j.1749-6632.1990.tb16892.x; Zauner A, 1996, TRAUMATIC BRAIN INJU, P97	24	23	23	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2010	25	5					357	361		10.1097/HTR.0b013e3181d6c715			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	649JR	WOS:000281765400008	20220529				2022-02-06	
J	Feng, JF; Zhang, KM; Jiang, JY; Gao, GY; Fu, XA; Liang, YM				Feng, Jun-feng; Zhang, Kui-ming; Jiang, Ji-yao; Gao, Guo-yi; Fu, Xi'an; Liang, Yu-min			Effect of Therapeutic Mild Hypothermia on the Genomics of the Hippocampus After Moderate Traumatic Brain Injury in Rats	NEUROSURGERY			English	Article						Genomics; Hippocampus; Mild hypothermia; Real-time quantitative RT-PCR; Traumatic brain injury	DIFFERENTIAL GENE-EXPRESSION; TISSUE-TYPE TRANSGLUTAMINASE; COPY NUMBER VARIATION; RIM-BINDING PROTEINS; IMMEDIATE-EARLY GENE; NERVE GROWTH-FACTOR; NEUROTROPHIC FACTOR; CEREBRAL-CORTEX; ALTERED EXPRESSION; CELL-ADHESION	BACKGROUND: Traumatic brain injury (TBI), a major cause of morbidity and mortality, is a serious public health concern. OBJECTIVE: To evaluate the effect of mild hypothermia on gene expression in the hippocampus and to try to elucidate molecular mechanisms of hypothermic neuroprotection after TBI. METHODS: Rats were subjected to mild hypothermia (group 1: n = 3, 33 degrees C, 3H) or normothermia (group 2: n = 3; 37 degrees C, 3H) after TBI. Six genome arrays were applied to detect the gene expression profiles of ipsilateral hippocampus. Functional clustering and gene ontology analysis were then carried out. Another 20 rats were randomly assigned to 4 groups (n = 5 per group): group 3, sham-normothermia; group 4, sham-hypothermia; group 5, TBI-normothermia; and group 6, TBI-hypothermia. Real-time fluorescent quantitative reverse-transcription polymerase chain reaction was used to detect specific selected genes. RESULTS: We found that 133 transcripts in the hypothermia group were statistically different from those in the normothermia group, including 57 transcripts that were upregulated and 76 that were downregulated after TBI (P < .01). Most of these genes were involved in various pathophysiological processes, and some were critical to cell survival. Analysis showed that 9 gene ontology categories were significantly affected by hypothermia, including the most affected categories: synapse organization and biogenesis (upregulated) and regulation of inflammatory response (downregulated). The mRNA expression of Ank3, Cmbp, Nrxn3, Tgm2, and Fcgr3 was regulated by hypothermia, TBI, or a combination of TBI and hypothermia compared with the sham-normothermia group. Their mRNA expression was significantly regulated by hypothermia in TBI groups. CONCLUSION: Posttraumatic mild hypothermia has a significant effect on the gene expression profiles of the hippocampus, especially those genes belonging to the 9 gene ontology categories. Differential expression of those genes may be involved in the most fundamental molecular mechanisms of cerebral protection by mild hypothermia after TBI.	[Feng, Jun-feng; Jiang, Ji-yao; Gao, Guo-yi; Liang, Yu-min] Shanghai Jiao Tong Univ, Sch Med, Dept Neurosurg, Renji Hosp, Shanghai 200127, Peoples R China; [Zhang, Kui-ming] Tongji Univ, Dept Neurosurg, Shanghai E Hosp, Shanghai 200092, Peoples R China; [Fu, Xi'an] Nanjin Med Univ, Suzhou Hosp, Dept Neurosurg, Suzhou, Peoples R China		Jiang, JY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Neurosurg, Renji Hosp, Shanghai 200127, Peoples R China.	jiangjyb@163.com			Chinese National Human Genome Center, Shanghai; National Key Basic Research ProjectNational Basic Research Program of China [2005CB522604]; National Science and Nature Grants [30571908, 30901543]; Science and Technology Committee of ShanghaiShanghai Science & Technology Committee [07JC14038]; Program for Shanghai Outstanding Medical Academic Leader; MOE, PRC	We thank Dr Bruce G. Lyeth, Department of Neurological Surgery, University of California Davis, for his editorial support and critical review of the article. We also thank Dr Xiong Hui Li Qi of the Chinese National Human Genome Center, Shanghai for their support in molecular experiments.; This work was supported by the National Key Basic Research Project (grant 2005CB522604), National Science and Nature Grants (grant 30571908, 30901543), Science and Technology Committee of Shanghai (grant 07JC14038), Program for Shanghai Outstanding Medical Academic Leader, and the Excellent Young Teachers Program of MOE, PRC. The authors have no personal financial or institutional interest in any of the drugs, materials, or devices described in this article.	Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Andringa G, 2004, FASEB J, V18, P932, DOI 10.1096/fj.03-0829fje; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Breunis WB, 2008, BLOOD, V111, P1029, DOI 10.1182/blood-2007-03-079913; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Cohen R, 2003, J BIOL CHEM, V278, P9258, DOI 10.1074/jbc.M210270200; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Fairchild KD, 2004, AM J PHYSIOL-CELL PH, V287, pC422, DOI 10.1152/ajpcell.00507.2003; Fairchild KD, 2000, J INTERF CYTOK RES, V20, P1049, DOI 10.1089/107999000750053708; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Gebicke-Haerter PJ, 2005, J NEUROSCI RES, V81, P327, DOI 10.1002/jnr.20479; Gomez-Pinilla F, 2008, EUR J NEUROSCI, V28, P2278, DOI 10.1111/j.1460-9568.2008.06524.x; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; Henry RA, 2007, EUR J NEUROSCI, V25, P3513, DOI 10.1111/j.1460-9568.2007.05625.x; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Hu De-zhi, 2005, Chin J Traumatol, V8, P23; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI [10.1089/neu.2008.0743, 10.1089/neu.2008-0743]; HUGHES P, 1993, NEUROSCIENCE, V57, P319, DOI 10.1016/0306-4522(93)90065-N; Ishikawa Y, 2006, ACTA NEUROCHIR SUPPL, V96, P163; Jia F, 2009, J NEUROTRAUM, V26, P243, DOI 10.1089/neu.2008.0670; Jiang JY, 2009, J NEUROTRAUM, V26, P399, DOI 10.1089/neu.2008.0525; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Jin KL, 2001, ANN NEUROL, V50, P93, DOI 10.1002/ana.1073; Jones RA, 1997, J CELL SCI, V110, P2461; KAPFHAMER D, 1995, GENOMICS, V27, P189, DOI 10.1006/geno.1995.1023; Kattenstroth G, 2004, P NATL ACAD SCI USA, V101, P2607, DOI 10.1073/pnas.0308626100; Kizhatil K, 2004, J BIOL CHEM, V279, P16706, DOI 10.1074/jbc.M314296200; Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200; Ko JW, 2006, J NEUROSCI, V26, P963, DOI 10.1523/JNEUROSCI.4475-05.2006; Kobori N, 2002, MOL BRAIN RES, V104, P148, DOI 10.1016/S0169-328X(02)00331-5; Lee JM, 2004, J BIOL CHEM, V279, P53725, DOI 10.1074/jbc.M407627200; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; Long Y, 2003, J NEUROSCI RES, V71, P710, DOI 10.1002/jnr.10524; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Matsuo R, 2001, BIOCHEM BIOPH RES CO, V289, P479, DOI 10.1006/bbrc.2001.5975; Mishra S, 2006, J BIOL CHEM, V281, P5532, DOI 10.1074/jbc.M506864200; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Norlund MA, 1999, BRAIN RES, V851, P154, DOI 10.1016/S0006-8993(99)02179-4; Ooshio T, 2004, J BIOL CHEM, V279, P31365, DOI 10.1074/jbc.M401957200; Peng XJ, 1999, FEBS LETT, V446, P35, DOI 10.1016/S0014-5793(99)00018-6; PETERS LL, 1995, J CELL BIOL, V130, P313, DOI 10.1083/jcb.130.2.313; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Rall JM, 2003, NEUROPATH APPL NEURO, V29, P118, DOI 10.1046/j.1365-2990.2003.00439.x; Rao VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/jnr.10486; Rowen L, 2002, GENOMICS, V79, P587, DOI 10.1006/geno.2002.6734; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; Sugita S, 1999, NEURON, V22, P489, DOI 10.1016/S0896-6273(00)80704-7; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Thevananther S, 1998, J BIOL CHEM, V273, P23952, DOI 10.1074/jbc.273.37.23952; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tolentino PJ, 2004, J NEUROCHEM, V89, P1301, DOI 10.1111/j.1471-4159.2004.02436.x; Tolentino PJ, 2002, J NEUROCHEM, V80, P579, DOI 10.1046/j.0022-3042.2001.00726.x; Truettner J, 1999, J NEUROTRAUM, V16, P471, DOI 10.1089/neu.1999.16.471; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; VEDELER CA, 1992, J NEUROSCI RES, V31, P654, DOI 10.1002/jnr.490310409; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C; von Gertten C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-69; Wagner KR, 2006, ACTA NEUROCHIR SUPPL, V96, P177; Wang Y, 2002, P NATL ACAD SCI USA, V99, P14464, DOI 10.1073/pnas.182532999; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Yoshiya K, 2003, J NEUROTRAUM, V20, P1147, DOI 10.1089/089771503770802844; Zhu D, 2007, BIOCHEM BIOPH RES CO, V361, P922, DOI 10.1016/j.bbrc.2007.07.083	71	23	26	1	14	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	SEP	2010	67	3					730	742		10.1227/01.NEU.0000378023.81727.6E			13	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	641TS	WOS:000281153200022	20651628				2022-02-06	
J	Timmons, SD				Timmons, Shelly D.			Current trends in neurotrauma care	CRITICAL CARE MEDICINE			English	Article						neurotrauma; neurocritical care; traumatic brain injury; hypertonic saline; decompressive craniotomy; hypothermia; beta-blockers	TRAUMATIC BRAIN-INJURY; HYPERTONIC SALINE RESUSCITATION; SEVERE HEAD-INJURY; LACTATED RINGERS SOLUTION; TISSUE OXYGEN-TENSION; EARLY DECOMPRESSIVE CRANIECTOMY; MILD HYPOTHERMIA THERAPY; REFRACTORY INTRACRANIAL HYPERTENSION; 7.5-PERCENT SODIUM-CHLORIDE; CEREBRAL PERFUSION-PRESSURE	Severe traumatic brain injury remains a significant cause of mortality and morbidity worldwide. The use of therapeutic interventions such as hypertonic saline administration and decompressive craniectomy have solid foundations and can improve outcomes, although questions remain about patient selection, optimal timing, and comparisons to other treatments. Hypothermia, while having promise, has not definitively been shown to benefit patients with traumatic brain injury, although clinical trials are underway. The use of beta-blockers in traumatic brain injury has been proposed as a neuroprotective measure, but data are lacking to support widespread clinical use. Brain tissue oxygenation monitoring is gaining widespread acceptance as a safe tool to provide additional information both to guide therapeutic interventions and to further elucidate mechanisms of secondary brain injury. Evidence is also mounting that guided therapy using brain tissue oxygenation in addition to intracranial pressure and cerebral perfusion pressure monitoring leads to better outcomes after traumatic brain injury. (Crit Care Med 2010; 38[Suppl.]: S431-S444)	Univ Tennessee, Hlth Sci Ctr, Div Neurotrauma, Semmes Murphey Neurol & Spine Inst, Memphis, TN 38163 USA		Timmons, SD (corresponding author), Univ Tennessee, Hlth Sci Ctr, Div Neurotrauma, Semmes Murphey Neurol & Spine Inst, Memphis, TN 38163 USA.						Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; AARABI B, 2009, FOCUS, V26, pE8; Aarabi B, 2009, NEUROSURGERY, V64, P927, DOI 10.1227/01.NEU.0000341907.30831.D2; Adamo MA, 2009, J NEUROSURG-PEDIATR, V3, P334, DOI 10.3171/2008.12.PEDS08310; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS12; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Aibiki M, 2000, CRIT CARE MED, V28, P3902, DOI 10.1097/00003246-200012000-00029; Alam HB, 2000, J SURG RES, V94, P145, DOI 10.1006/jsre.2000.6011; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Alderson P, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001048.pub2, DOI 10.1002/14651858.CD001048.PUB2]; Alessandri B, 2004, J NEUROSCI METH, V139, P161, DOI 10.1016/j.jneumeth.2004.04.021; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Artru F, 1998, NEUROL RES, V20, pS48; Bardt TF, 1998, ACT NEUR S, V71, P153; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Bayir H, 2009, CRIT CARE MED, V37, P689, DOI 10.1097/CCM.0b013e318194abf2; BERGER S, 1995, NEUROSURGERY, V37, P98, DOI 10.1227/00006123-199507000-00015; Berger S, 2002, J TRAUMA, V53, P558, DOI 10.1097/00005373-200209000-00027; BERTONE JJ, 1990, AM J VET RES, V51, P999; BERTONE JJ, 1992, AM J VET RES, V53, P1844; Bond M R, 1979, Acta Neurochir Suppl (Wien), V28, P126; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS21; Brain Trauma Foundation American Association of Neurological Surgeons Congress of Neurological Surgeons AANS/CNS Joint Section on Neurotrauma and Critical Care, 2008, J NEUROTRAUM, V25, P276; Brasel KJ, 2008, J AM COLL SURGEONS, V206, P220, DOI 10.1016/j.jamcollsurg.2007.07.020; BRITT RH, 1978, NEUROSURGERY, V2, P195, DOI 10.1227/00006123-197805000-00001; Bulger EM, 2008, ARCH SURG-CHICAGO, V143, P139, DOI 10.1001/archsurg.2007.41; Bulger EM, 2007, ANN SURG, V245, P635, DOI 10.1097/01.sla.0000251367.44890.ae; Bullock MR, 2006, NEUROSURGERY S, V58, pSi; Cairns Chris J S, 2002, Curr Opin Crit Care, V8, P106, DOI 10.1097/00075198-200204000-00003; Chen HI, 2008, NEUROSURGERY, V63, P880, DOI 10.1227/01.NEU.0000327882.10629.06; Childs C, 2006, NEUROCRIT CARE, V5, P10, DOI 10.1385/NCC:5:1:10; Christian E, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E9; Ciesla DJ, 2000, J TRAUMA, V48, P388, DOI 10.1097/00005373-200003000-00004; CLARK K, 1968, J NEUROSURG, V29, P367, DOI 10.3171/jns.1968.29.4.0367; Clausen T, 2004, BRAIN RES, V1019, P113, DOI 10.1016/j.brainres.2004.05.099; CLIBBARO S, 2007, SURG NEUROL, V68, P632; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1992, J NEUROTRAUM, V9, pS487; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Clifton GL, 2009, J NEUROTRAUM, V26, P393, DOI 10.1089/neu.2008.0556; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Coplin WM, 2001, NEUROL RES, V23, P277, DOI 10.1179/016164101101198433; Cormio M, 1999, J NEUROTRAUM, V16, P927, DOI 10.1089/neu.1999.16.927; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Cudd TA, 1998, SHOCK, V10, P32, DOI 10.1097/00024382-199807000-00006; Danish SF, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS945; De Luca GP, 2000, ACTA NEUROCHIR SUPPL, V76, P401; Deb S, 1999, J TRAUMA, V46, P582, DOI 10.1097/00005373-199904000-00005; DEFIGUEIREDO LFP, 1995, CARDIOVASC SURG, V3, P679; Dine CJ, 2009, EMERG MED CLIN N AM, V27, P137, DOI 10.1016/j.emc.2008.07.003; Dings J, 1998, NEUROL RES, V20, pS71; Dings J, 1997, NEUROL RES, V19, P241, DOI 10.1080/01616412.1997.11740806; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; Einhaus S L, 1996, J Tenn Med Assoc, V89, P81; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Elliott MB, 2009, BRAIN RES, V1305, P183, DOI 10.1016/j.brainres.2009.09.104; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; FANCONY G, 2008, CRIT CARE MED, V36, P295; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; Figaji AA, 2008, NEUROSURGERY, V63, P83, DOI 10.1227/01.NEU.0000335074.39728.00; Figaji AA, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E4; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; GAAB MR, 1990, ACT NEUR S, V51, P326; Gal R, 2002, CLIN NEUROL NEUROSUR, V104, P318, DOI 10.1016/S0303-8467(02)00023-9; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Gopinath SP, 1999, CRIT CARE MED, V27, P2337, DOI 10.1097/00003246-199911000-00003; GOWER DJ, 1988, NEUROSURGERY, V23, P417, DOI 10.1227/00006123-198810000-00002; GRAND PO, 2000, SCHWEIZ MED WOCHENSC, V30, P1538; Grant FC, 1939, ANN SURG, V110, P488, DOI 10.1097/00000658-193910000-00002; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Gupta AK, 1999, ANESTH ANALG, V88, P549, DOI 10.1097/00000539-199903000-00016; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Harris OA, 2009, J NEUROSURG, V110, P1256, DOI 10.3171/2009.1.JNS081320; Hartl R, 1997, ACT NEUR S, V70, P40; Hejazi N, 2002, EUR J PEDIATR, V161, P99, DOI 10.1007/s00431-001-0864-x; Hemphill JC, 2005, AM J NEURORADIOL, V26, P1095; Hemphill JC, 2001, NEUROSURGERY, V48, P377, DOI 10.1097/00006123-200102000-00028; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Henker RA, 1998, NEUROSURGERY, V42, P1071, DOI 10.1097/00006123-199805000-00071; Hlatky R, 2008, J NEUROSURG, V108, P53, DOI 10.3171/JNS/2008/108/01/0053; Ho CL, 2008, J NEUROSURG, V108, P943, DOI 10.3171/JNS/2008/108/5/0943; Hoelper BM, 2005, ACTA NEUROCHIR, V147, P767, DOI 10.1007/s00701-005-0512-8; Holcroft J W, 1989, Prog Clin Biol Res, V299, P331; HOLCROFT JW, 1987, ANN SURG, V206, P279, DOI 10.1097/00000658-198709000-00006; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; HUANG PP, 1995, ANN SURG, V221, P543, DOI 10.1097/00000658-199505000-00012; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; Hutchinson Peter, 1800, Neurosurg Focus, V22, pE14; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Imberti R, 2005, J NEUROSURG, V102, P455, DOI 10.3171/jns.2005.102.3.0455; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Jaeger M, 2005, ACTA NEUROCHIR, V147, P51, DOI 10.1007/s00701-004-0408-z; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; KERR FWL, 1968, MAYO CLIN PROC, V43, P852; Kerwin AJ, 2009, J TRAUMA, V67, P277, DOI 10.1097/TA.0b013e3181acc726; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Kunze E, 1998, ACT NEUR S, V71, P16; Leal-Noval SR, 2006, INTENS CARE MED, V32, P1733, DOI 10.1007/s00134-006-0376-2; Lescot T, 2006, CRIT CARE MED, V34, P3029, DOI 10.1097/01.CCM.0000243797.42346.64; Ley EJ, 2009, J TRAUMA, V66, P154, DOI 10.1097/TA.0b013e31819388be; Liu WG, 2006, J INT MED RES, V34, P58, DOI 10.1177/147323000603400107; MANINGAS PA, 1989, AM J SURG, V157, P528, DOI 10.1016/0002-9610(89)90654-5; Marion DW, 2006, NEUROSURGERY, V58, P655; Marion DW, 2004, CRIT CARE MED, V32, pS43, DOI 10.1097/01.CCM.0000110731.69637.16; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARMAROU A, 1992, J NEUROTRAUM, V9, pS327; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; Mayzler O, 2006, J NEUROSURG ANESTH, V18, P24, DOI 10.1097/01.ana.0000188358.41284.cb; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Meier U, 2000, ACTA NEUROCHIR SUPPL, V76, P475; MELLERGARD P, 1990, NEUROSURGERY, V27, P654, DOI 10.1227/00006123-199010000-00029; MELLERGARD P, 1992, NEUROSURGERY, V31, P671; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Messina AR, 2003, ELECTR POW SYST RES, V64, P17, DOI 10.1016/S0378-7796(02)00151-7; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Naredi S, 1998, INTENS CARE MED, V24, P446, DOI 10.1007/s001340050594; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Narotam PK, 2008, J NEUROSURG, V109, P1065, DOI 10.3171/JNS.2008.109.12.1065; Natale JE, 2000, CRIT CARE MED, V28, P2608, DOI 10.1097/00003246-200007000-00071; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; Oddo M, 2009, J NEUROL NEUROSUR PS, V80, P916, DOI 10.1136/jnnp.2008.156596; OGATA H, 1993, CIRC SHOCK, V41, P113; Pascual JL, 2003, J TRAUMA, V54, pS133, DOI 10.1097/01.TA.0000064526.33647.63; Pascual JL, 2003, J TRAUMA, V54, P121, DOI 10.1097/00005373-200301000-00015; Pascual JL, 2002, ANN SURG, V236, P634, DOI 10.1097/00000658-200211000-00014; PASCUAL JMS, 1992, CRIT CARE MED, V20, P200, DOI 10.1097/00003246-199202000-00009; Pascual JL, 2008, AM SURGEON, V74, P253; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Patel NY, 2000, J TRAUMA, V48, P367, DOI 10.1097/00005373-200003000-00001; Piepgras A, 1998, NEUROSURGERY, V42, P311, DOI 10.1097/00006123-199802000-00058; Pinto FCG, 2006, J TRAUMA, V60, P758, DOI 10.1097/01.ta.0000214581.89316.73; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Polderman KH, 2004, INTENS CARE MED, V30, P1860, DOI 10.1007/s00134-004-2383-5; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; PROUGH DS, 1985, CRIT CARE MED, V13, P407, DOI 10.1097/00003246-198505000-00008; Qiu Wu-si, 2005, Chin J Traumatol, V8, P27; Qiu Wu-si, 2006, Chin J Traumatol, V9, P238; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; Qiu WS, 2006, J CLIN NEUROSCI, V13, P995, DOI 10.1016/j.jocn.2006.02.027; Quigley A, 2009, BRAIN RES, V1304, P138, DOI 10.1016/j.brainres.2009.09.062; Qureshi AI, 1999, J TRAUMA, V47, P659, DOI 10.1097/00005373-199910000-00009; RAMIRES JAF, 1992, CIRC SHOCK, V37, P220; Leal-Noval SR, 2008, CRIT CARE MED, V36, P1290, DOI 10.1097/CCM.0b013e3181692dfc; RANSOHOFF J, 1971, J NEUROSURG, V34, P70, DOI 10.3171/jns.1971.34.1.0070; RANSOHOFF J, 1971, J NEUROL NEUROSUR PS, V34, P106, DOI 10.1136/jnnp.34.1.106-a; Reithmeier T, 2005, CHILD NERV SYST, V21, P249, DOI 10.1007/s00381-004-1044-x; RESNICK DK, 1994, NEUROSURGERY, V34, P252, DOI 10.1227/00006123-199402000-00007; Rhee P, 2000, CRIT CARE MED, V28, P74, DOI 10.1097/00003246-200001000-00012; Rhee P, 1998, J TRAUMA, V44, P313, DOI 10.1097/00005373-199802000-00014; Riordan WP, 2007, J TRAUMA, V63, P503, DOI 10.1097/TA.0b013e3181271c34; Rockswold GL, 2009, NEUROSURGERY, V65, P1035, DOI 10.1227/01.NEU.0000359533.16214.04; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; Rozet I, 2007, ANESTHESIOLOGY, V107, P697, DOI 10.1097/01.anes.0000286980.92759.94; Rubiano AM, 2009, ULUS TRAVMA ACIL CER, V15, P28; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Sahuquillo J, 2009, INTENS CARE MED, V35, P890, DOI 10.1007/s00134-008-1357-4; Sakowitz OW, 2007, J TRAUMA, V62, P292, DOI 10.1097/01.ta.0000203560.03937.2d; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; SCHMALL LM, 1990, EQUINE VET J, V22, P273, DOI 10.1111/j.2042-3306.1990.tb04266.x; SCHMALL LM, 1990, EQUINE VET J, V22, P278, DOI 10.1111/j.2042-3306.1990.tb04267.x; SCHMOKER JD, 1991, J TRAUMA, V31, P1607, DOI 10.1097/00005373-199112000-00007; Schneider GH, 2002, ACT NEUR S, V81, P77; Sell SL, 2008, ANESTHESIOLOGY, V108, P873, DOI 10.1097/ALN.0b013e31816c8a15; Shackford SR, 1998, J TRAUMA, V44, P50, DOI 10.1097/00005373-199801000-00004; Shackford SR, 1997, J TRAUMA, V42, pS48, DOI 10.1097/00005373-199705001-00009; Sheikh AA, 1996, CRIT CARE MED, V24, P1226, DOI 10.1097/00003246-199607000-00027; SHIGEMORI M, 1980, ACTA NEUROCHIR, V54, P61, DOI 10.1007/BF01401944; Shiozaki T, 1999, J NEUROSURG, V91, P185, DOI 10.3171/jns.1999.91.2.0185; Shiozaki T, 1998, J NEUROSURG, V89, P206, DOI 10.3171/jns.1998.89.2.0206; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Smrcka M, 2005, ACT NEUR S, V95, P273; Soukiasian HJ, 2002, AM SURGEON, V68, P1066; Soustiel JF, 2006, BRAIN RES, V1101, P136, DOI 10.1016/j.brainres.2006.05.045; SPIERS JP, 1993, CIRC SHOCK, V40, P29; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; Stiefel MF, 2006, J NEUROSURG, V105, P281, DOI 10.3171/ped.2006.105.4.281; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Stone JG, 1997, NEUROSURGERY, V41, P20, DOI 10.1097/00006123-199707000-00007; Subrato D, 2000, J TRAUMA, V49, P47, DOI 10.1097/00005373-200007000-00007; Sydenham E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub3; Tateishi A, 1998, NEUROSURGERY, V42, P1065, DOI 10.1097/00006123-199805000-00066; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Taylor Edward E, 2008, Proc (Bayl Univ Med Cent), V21, P120; Taylor G, 1996, J PEDIATR SURG, V31, P65, DOI 10.1016/S0022-3468(96)90321-8; TEASDALE G, 1974, LANCET, V2, P81; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Thompson HJ, 2003, J NEUROL NEUROSUR PS, V74, P614, DOI 10.1136/jnnp.74.5.614; Thorat JD, 2008, J CLIN NEUROSCI, V15, P143, DOI 10.1016/j.jocn.2006.08.014; TIMMONS SD, NEUROLOGICAL SURG CO; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Tokutomi T, 2009, J TRAUMA, V66, P166, DOI 10.1097/TA.0b013e318157dbec; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Tortorici MA, 2007, CRIT CARE MED, V35, P2196, DOI 10.1097/01.CCM.0000281517.97507.6E; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; Valadka AB, 2002, ACT NEUR S, V81, P299; Valadka AB, 2000, J TRAUMA, V49, P1, DOI 10.1097/00005373-200007000-00001; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Varon J, 2008, CHEST, V133, P1267, DOI 10.1378/chest.07-2190; VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065; VASSAR MJ, 1993, J TRAUMA, V34, P622, DOI 10.1097/00005373-199305000-00003; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; VENES JL, 1975, J NEUROSURG, V42, P429, DOI 10.3171/jns.1975.42.4.0429; Wade CE, 1997, SURGERY, V122, P609, DOI 10.1016/S0039-6060(97)90135-5; WALSH JC, 1991, J SURG RES, V50, P284, DOI 10.1016/0022-4804(91)90192-O; Wang H, 2004, J NEUROSURG, V100, P272, DOI 10.3171/jns.2004.100.2.0272; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; Whitfield PC, 2001, NEUROSURGERY, V49, P225, DOI 10.1097/00006123-200107000-00042; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4; WISNER DH, 1990, J TRAUMA, V30, P75, DOI 10.1097/00005373-199001000-00011; Woertgen C, 2004, ACTA NEUROCHIR, V146, P691, DOI 10.1007/s00701-004-0280-x; WORTHLEY LIG, 1988, J NEUROSURG, V68, P478, DOI 10.3171/jns.1988.68.3.0478; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P616, DOI 10.2176/nmc.33.616; YAMAURA A, 1979, Neurologia Medico-Chirurgica, V19, P717, DOI 10.2176/nmc.19.717; Yan Y, 2001, Chin J Traumatol, V4, P8; Yan Y, 2010, J CLIN NEUROSCI, V17, P196, DOI 10.1016/j.jocn.2009.05.022; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Yilmaz N, 2007, BRAIN RES, V1164, P132, DOI 10.1016/j.brainres.2007.06.017; YOUNES RN, 1992, SURGERY, V111, P380; Zhi DS, 2003, SURG NEUROL, V59, P381, DOI 10.1016/S0090-3019(03)00148-4; ZHU V, 2003, CHIN J TRAUMATOL, V6, P152; ZORNOW MH, 1989, J TRAUMA, V29, P484, DOI 10.1097/00005373-198904000-00011; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	252	23	23	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	SEP	2010	38	9		S			S431	S444		10.1097/CCM.0b013e3181ec57ab			14	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	647FB	WOS:000281602100004	20724876				2022-02-06	
J	Bellander, BM; Lidman, O; Ohlsson, M; Meijer, B; Piehl, F; Svensson, M				Bellander, Bo-Michael; Lidman, Olle; Ohlsson, Marcus; Meijer, Britt; Piehl, Fredrik; Svensson, Mikael			Genetic regulation of microglia activation, complement expression, and neurodegeneration in a rat model of traumatic brain injury	EXPERIMENTAL BRAIN RESEARCH			English	Article						Traumatic brain injury; Inflammation; Complement; Neurodegeneration; Strain dependent; T cells; Polymorphonuclear cells	COLONY-STIMULATING FACTORS; TUMOR-NECROSIS-FACTOR; CLOSED-HEAD INJURY; SPINAL-CORD INJURY; MONOCLONAL-ANTIBODY; NERVOUS-SYSTEM; INFLAMMATORY RESPONSE; MOUSE STRAINS; AMINO-ACIDS; CELL-DEATH	Secondary brain damage following traumatic brain injury in part depends on neuroinflammation, a process where genetic factors may play an important role. We examined the response to a standardized cortical contusion in two different inbred rat strains, Dark Agouti (DA) and Piebald Virol Glaxo (PVG). Both are well characterized in models of autoimmune neuroinflammation, where DA is susceptible and PVG resistant. We found that infiltration of polymorphonuclear granulocytes (PMN) at 3-day postinjury was more pronounced in PVG. DA was more infiltrated by T cells at 3-day postinjury, showed an enhanced glial activation at 7-day postinjury and higher expression of C3 complement at 7-day postinjury. Neurodegeneration, assessed by Fluoro-Jade, was also more pronounced in the DA strain at 30-day postinjury. These results demonstrate differences in the response to cortical contusion injury attributable to genetic influences and suggest a link between injury-induced inflammation and neurodegeneration. Genetic factors that regulate inflammation elicited by brain trauma may be important for the development of secondary brain damage.	[Bellander, Bo-Michael; Ohlsson, Marcus; Meijer, Britt; Svensson, Mikael] Karolinska Univ, Neurosurg Sect, Dept Clin Neurosci, Hosp Solna, S-17176 Stockholm, Sweden; [Lidman, Olle; Piehl, Fredrik] Karolinska Univ, Sect Clin CNS Res, Dept Clin Neurosci, Hosp Solna, S-17176 Stockholm, Sweden		Bellander, BM (corresponding author), Karolinska Univ, Neurosurg Sect, Dept Clin Neurosci, Hosp Solna, R3-02, S-17176 Stockholm, Sweden.	bo-michael.bellander@karolinska.se	Ohlsson, Marcus R/H-1395-2011; Piehl, Fredrik/E-3451-2013; Svensson, Mikael/F-8662-2012	Svensson, Mikael/0000-0003-1179-7003	European UnionEuropean Commission; NeuroproMiSe [LSHM-CT-2005-018637]; EURATools [LSHG-CT-2005-019015]; Wadsworth Foundation; Torsten and Ragnar Soderberg's Foundation; Bjorklund's Foundation; Nils and Bibbi Jenssen's Foundation; Montel Williams Foundation, Magn	This work is supported by 6th Framework Program of the European Union; NeuroproMiSe, LSHM-CT-2005-018637 and the EURATools, LSHG-CT-2005-019015; as well as by grants from the Wadsworth Foundation, Torsten and Ragnar Soderberg's Foundation, Bjorklund's Foundation, Nils and Bibbi Jenssen's Foundation, Montel Williams Foundation, Magn.	BARCLAY AN, 1981, IMMUNOLOGY, V42, P593; Bellander BM, 1996, J NEUROSURG, V85, P468, DOI 10.3171/jns.1996.85.3.0468; Bellander BM, 2004, J NEUROTRAUM, V21, P605, DOI 10.1089/089771504774129937; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X; BROWN EJ, 1991, CURR OPIN IMMUNOL, V3, P76, DOI 10.1016/0952-7915(91)90081-B; BRUCK W, 1991, J NEUROL SCI, V103, P182, DOI 10.1016/0022-510X(91)90162-Z; CAMPBELL AK, 1981, BIOCHEM J, V194, P551, DOI 10.1042/bj1940551; DALLMAN MJ, 1984, EUR J IMMUNOL, V14, P260, DOI 10.1002/eji.1830140311; DAMOISEAUX JGMC, 1994, IMMUNOLOGY, V83, P140; DEBRUIJN MHL, 1985, P NATL ACAD SCI USA, V82, P708; ESSER AF, 1991, IMMUNOL TODAY, V12, P316, DOI 10.1016/0167-5699(91)90006-F; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fox GB, 1999, J NEUROTRAUM, V16, P377, DOI 10.1089/neu.1999.16.377; FRANK MM, 1991, IMMUNOL TODAY, V12, P322, DOI 10.1016/0167-5699(91)90009-I; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; GIULIAN D, 1993, J NEUROSCI, V13, P29; GIULIAN D, 1988, J NEUROSCI, V8, P4707; HARLAN JM, 1985, BLOOD, V65, P513; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Inman D, 2002, J COMP NEUROL, V451, P225, DOI 10.1002/cne.10340; KATAYAMA Y, 1995, BRAIN PATHOL, V5, P427, DOI 10.1111/j.1750-3639.1995.tb00621.x; KINOSHITA T, 1991, IMMUNOL TODAY, V12, P291, DOI 10.1016/0167-5699(91)90001-A; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Leinhase I, 2006, EXP NEUROL, V199, P454, DOI 10.1016/j.expneurol.2006.01.033; Lidman O, 2003, J NEUROSCI, V23, P9817; Lidman O, 2002, NEUROREPORT, V13, P1589, DOI 10.1097/00001756-200209160-00003; Lorentzen JC, 1997, J NEUROIMMUNOL, V80, P31, DOI 10.1016/S0165-5728(97)00131-8; LUCCHESI BR, 1986, ANNU REV PHARMACOL, V26, P201, DOI 10.1146/annurev.pa.26.040186.001221; Lundberg C, 2001, J COMP NEUROL, V431, P75; MCGEER PL, 1989, CAN J NEUROL SCI, V16, P516, DOI 10.1017/S0317167100029863; MCGEER PL, 1993, GLIA, V7, P84, DOI 10.1002/glia.440070114; Morgan BP, 1999, CRIT REV IMMUNOL, V19, P173; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Ohlsson M, 2003, J NEUROTRAUM, V20, P895, DOI 10.1089/089771503322385827; OKUSAWA S, 1987, J IMMUNOL, V139, P2635; OKUSAWA S, 1988, J EXP MED, V168, P443, DOI 10.1084/jem.168.1.443; OLNEY JW, 1971, EXP BRAIN RES, V14, P61; PIANI D, 1991, NEUROSCI LETT, V133, P159, DOI 10.1016/0304-3940(91)90559-C; Piehl F, 1999, J NEUROIMMUNOL, V101, P87, DOI 10.1016/S0165-5728(99)00136-8; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Rancan M, 2003, J CEREBR BLOOD F MET, V23, P1070, DOI 10.1097/01.WCB.0000084250.20114.2C; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; REYNOLDS CW, 1981, J IMMUNOL, V127, P2204; ROBINSON AP, 1986, IMMUNOLOGY, V57, P239; ROSEN H, 1990, J LEUKOCYTE BIOL, V48, P465, DOI 10.1002/jlb.48.5.465; Royle SJ, 1999, BRAIN RES, V816, P337, DOI 10.1016/S0006-8993(98)01122-6; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; SCHINDLER R, 1990, BLOOD, V76, P1631; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schwartz M, 2003, J CEREBR BLOOD F MET, V23, P385, DOI 10.1097/01.WCB.0000061881.75234.5E; Soares HD, 1995, J NEUROSCI, V15, P8223; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; Steward O, 1999, EXP NEUROL, V157, P19, DOI 10.1006/exnr.1999.7040; STOLL G, 1991, ANN NEUROL, V30, P147, DOI 10.1002/ana.410300205; Sunnemark D, 2003, BRAIN PATHOL, V13, P617; SUZUMURA A, 1990, J NEUROIMMUNOL, V30, P111, DOI 10.1016/0165-5728(90)90094-4; SVENSSON M, 1995, MOL CHEM NEUROPATHOL, V24, P53, DOI 10.1007/BF03160112; SVENSSON M, 1992, J NEUROIMMUNOL, V40, P99, DOI 10.1016/0165-5728(92)90217-9; Swanberg M, 2005, NAT GENET, V37, P486, DOI 10.1038/ng1544; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; THERY C, 1991, EUR J NEUROSCI, V3, P1155, DOI 10.1111/j.1460-9568.1991.tb00050.x; VACA K, 1992, EXP NEUROL, V118, P62, DOI 10.1016/0014-4886(92)90023-J; VANGURI P, 1988, J BIOL CHEM, V263, P7228; Weissert R, 1998, J CLIN INVEST, V102, P1265, DOI 10.1172/JCI3022; WEKERLE H, 1987, J EXP BIOL, V132, P43; WETSEL RA, 1995, CURR OPIN IMMUNOL, V7, P48, DOI 10.1016/0952-7915(95)80028-X; WILLIAMS AF, 1977, CELL, V12, P663, DOI 10.1016/0092-8674(77)90266-5; Witgen BM, 2006, J NEUROTRAUM, V23, P1320, DOI 10.1089/neu.2006.23.1320; YAO J, 1990, J NEUROSCI RES, V27, P36, DOI 10.1002/jnr.490270106	76	23	23	0	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	AUG	2010	205	1					103	114		10.1007/s00221-010-2342-z			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	629YR	WOS:000280238000010	20602094				2022-02-06	
J	Mefire, AC; Pagbe, JJ; Fokou, M; Nguimbous, JF; Guifo, ML; Bahebeck, J				Mefire, Alain Chichom; Pagbe, Jean Jacques; Fokou, Marcus; Nguimbous, Jean Francois; Guifo, Marc Leroy; Bahebeck, Jean			Analysis of epidemiology, lesions, treatment and outcome of 354 consecutive cases of blunt and penetrating trauma to the chest in an African setting	SOUTH AFRICAN JOURNAL OF SURGERY			English	Article							THORACIC TRAUMA; INJURY	Background. The proportion of death and disability related to trauma is increasing in Third-World countries. Thoracic trauma is significantly involved, but few data are available on this issue in African countries with specific local conditions. Methods. The aim of the study is to analyse the diagnosis and management procedures in thoracic trauma in a typical African country. The records of 354 patients admitted to an emergency unit for chest trauma over a 13-year period were retrospectively analysed. Results. The sample included patients with 231 cases of blunt and 123 of penetrating trauma to the chest; their mean age was 41.86 years, and the male:female ratio was 4.2:1. The majority (N=226) of the injuries were sustained in road traffic accidents, and the most common lesions were rib fractures (50.3%) and haemothorax (38.7%). The diagnosis was based on physical examination and standard chest radiographs in most cases. At least one associated lesion was found in 260 (73.45%) patients. The mean injury severity score (ISS) for our patients was 16.39. Most patients were managed conservatively (N=303); thoracotomy was performed mostly on penetrating trauma patients. Morbidity occurred in 49 patients, mainly affecting those treated with thoracic drainage, and 27 patients (7.6%) died. Factors related to mortality were ISS score and association with neurotrauma. Conclusions. Chest trauma can be managed in our Cameroonian environment, with morbidity and mortality comparable with that of Western countries. Diagnosis must still rely on physical examination, chest radiographs and thoracic echography, which are affordable tools.	[Mefire, Alain Chichom] Univ Buea, Fac Hlth Sci, Yaounde, Cameroon; [Mefire, Alain Chichom] Reg Hosp Limbe, Yaounde, Cameroon; [Pagbe, Jean Jacques; Fokou, Marcus; Nguimbous, Jean Francois] Gen Reference Hosp, Yaounde, Cameroon; [Guifo, Marc Leroy; Bahebeck, Jean] Cent Hosp, Yaounde, Cameroon		Mefire, AC (corresponding author), Univ Buea, Fac Hlth Sci, Yaounde, Cameroon.						Adegboye V O, 2002, Afr J Med Med Sci, V31, P149; Adegboye V O, 2001, Afr J Med Med Sci, V30, P327; Bokhari F, 2002, J TRAUMA, V53, P1135, DOI 10.1097/00005373-200212000-00017; Demetriades D, 2002, Scand J Surg, V91, P41; Esme H, 2007, THORAC CARDIOV SURG, V55, P190, DOI 10.1055/s-2006-955883; Farooq Umar, 2006, J Coll Physicians Surg Pak, V16, P101; Karmy-Jones R, 2001, ARCH SURG-CHICAGO, V136, P513, DOI 10.1001/archsurg.136.5.513; Khan B, 2007, INT J ALGEBR COMPUT, V17, P1, DOI 10.1142/S0218196707003330; Kulshrestha P, 2004, J TRAUMA, V57, P576, DOI 10.1097/01.TA.0000091107.00699.C7; Liman ST, 2003, EUR J CARDIO-THORAC, V23, P374, DOI 10.1016/S1010-7940(02)00813-8; McEwan K, 2007, EMERG MED J, V24, P581, DOI 10.1136/emj.2007.051334; Mirvis SE, 2005, SEMIN ULTRASOUND CT, V26, P305, DOI 10.1053/j.sult.2005.08.001; Nordberg E, 2000, E AFR MED J, V77, pS1; Patel VI, 2004, J NATL MED ASSOC, V96, P1553; Rashid MA, 2000, EUR J SURG, V166, P22; Schmidt U, 1998, J TRAUMA, V44, P98, DOI 10.1097/00005373-199801000-00010; Segers P, 2001, ACTA CHIR BELG, V101, P277; Soffer D, 2004, J TRAUMA, V56, P953, DOI 10.1097/01.TA.0000127806.39852.4E	18	23	24	0	2	SA MEDICAL ASSOC	PRETORIA	BLOCK F CASTLE WALK CORPORATE PARK, NOSSOB STREET, ERASMUSKLOOF EXT3, PRETORIA, 0002, SOUTH AFRICA	0038-2361	2078-5151		S AFR J SURG	South Afr. J. Surg.	AUG	2010	48	3					90	93					4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	644GD	WOS:000281360900005	21924001				2022-02-06	
J	Weishaupt, N; Silasi, G; Colbourne, F; Fouad, K				Weishaupt, Nina; Silasi, Gergely; Colbourne, Frederick; Fouad, Karim			Secondary Damage in the Spinal Cord after Motor Cortex Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						spinal cord injury; stroke; traumatic brain injury; wallerian degeneration	CENTRAL-NERVOUS-SYSTEM; WALLERIAN DEGENERATION; RHESUS-MONKEY; FLUORO-JADE; BRAIN; ACTIVATION; RESPONSES; RECOVERY; INNATE; CNS	When neurons within the motor cortex are fatally injured, their axons, many of which project into the spinal cord, undergo wallerian degeneration. Pathological processes occurring downstream of the cortical damage have not been extensively studied. We created a focal forelimb motor cortex injury in rats and found that axons from cell bodies located in the hindlimb motor cortex (spared by the cortical injury) become secondarily damaged in the spinal cord. To assess axonal degeneration in the spinal cord, we quantified silver staining in the corticospinal tract (CST) at 1 week and 4 weeks after the injury. We found a significant increase in silver deposition at the thoracic spinal cord level at 4 weeks compared to 1 week post-injury. At both time points, no degenerating neurons could be found in the hindlimb motor cortex. In a separate experiment, we showed that direct injury of neurons within the hindlimb motor cortex caused marked silver deposition in the thoracic CST at 1 week post-injury, and declined thereafter. Therefore, delayed axonal degeneration in the thoracic spinal cord after a focal forelimb motor cortex injury is indicative of secondary damage at the spinal cord level. Furthermore, immunolabeling of spinal cord sections showed that a local inflammatory response dominated by partially activated Iba-1-positive microglia is mounted in the CST, a viable mechanism to cause the observed secondary degeneration of fibers. In conclusion, we demonstrate that following motor cortex injury, wallerian degeneration of axons in the spinal cord leads to secondary damage, which is likely mediated by inflammatory processes.	[Fouad, Karim] Univ Alberta, Fac Rehabil Med, Edmonton, AB T6G 2G4, Canada; [Weishaupt, Nina; Silasi, Gergely; Colbourne, Frederick; Fouad, Karim] Univ Alberta, Ctr Neurosci, Edmonton, AB T6G 2G4, Canada; [Colbourne, Frederick] Univ Alberta, Dept Psychol, Edmonton, AB T6G 2G4, Canada		Fouad, K (corresponding author), Univ Alberta, Fac Rehabil Med, 3-87 Corbett Hall, Edmonton, AB T6G 2G4, Canada.	karim.fouad@ualberta.ca	Colbourne, Frederick/ABB-7774-2020	Colbourne, Frederick/0000-0002-9567-2082; Silasi, Gergely/0000-0003-1036-1304; Fouad, Karim/0000-0003-3654-7852	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP 77530, MOP 97781]; Alberta Heritage Foundation for Medical ResearchAlberta Heritage Foundation for Medical ResearchGeneral Electric [sti 200600442, sti 200600018]	This work was supported by the Canadian Institutes of Health Research (MOP 77530 to K. F. and MOP 97781 to F. C.), and the Alberta Heritage Foundation for Medical Research (sti 200600442 to K. F. and sti 200600018 to F. C.). F. C. and K. F. are Alberta Heritage Foundation for Medical Research Senior Scholars.	Basiri M, 2010, BRAIN RES BULL, V81, P43, DOI 10.1016/j.brainresbull.2009.11.002; Bethea JR, 2002, CURR OPIN NEUROL, V15, P355, DOI 10.1097/00019052-200206000-00021; Bolton DAE, 2006, BEHAV BRAIN RES, V168, P272, DOI 10.1016/j.bbr.2005.11.017; Choo AM, 2008, EXP NEUROL, V212, P490, DOI 10.1016/j.expneurol.2008.04.038; Crutcher KA, 2006, J NEUROIMMUNE PHARM, V1, P195, DOI 10.1007/s11481-006-9021-7; Czeiter E, 2008, J NEUROTRAUM, V25, P205, DOI 10.1089/neu.2007.0331; Dirnagl U, 2004, E SCHERING RES FDN W, V47, P87; Fu D, 2004, NEUROSCIENCE, V125, P819, DOI 10.1016/j.neuroscience.2004.02.012; Hagg T, 2006, J NEUROTRAUM, V23, P264, DOI 10.1089/neu.2006.23.263; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; IIZUKA H, 1989, STROKE, V20, P1396, DOI 10.1161/01.STR.20.10.1396; Ishida Y, 2002, SPINE, V27, P1652, DOI 10.1097/00007632-200208010-00011; Kanazawa H, 2002, J BIOL CHEM, V277, P20026, DOI 10.1074/jbc.M109218200; Kolb B, 1997, NEUROSCIENCE, V76, P1139, DOI 10.1016/S0306-4522(96)00448-4; KOSHINAGA M, 1995, J NEUROTRAUM, V12, P209, DOI 10.1089/neu.1995.12.209; Moisse K, 2006, BBA-MOL BASIS DIS, V1762, P1083, DOI 10.1016/j.bbadis.2006.03.001; Moisse K, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-29; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Nagamoto-Combs K, 2010, J NEUROTRAUM, V27, P565, DOI 10.1089/neu.2009.0966; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Prewitt CMF, 1997, EXP NEUROL, V148, P433, DOI 10.1006/exnr.1997.6694; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Schwartz M, 2003, J CEREBR BLOOD F MET, V23, P385, DOI 10.1097/01.WCB.0000061881.75234.5E; Schwartz M, 1999, TRENDS NEUROSCI, V22, P295, DOI 10.1016/S0166-2236(99)01405-8; Shi FJ, 2009, J NEUROTRAUM, V26, P2083, DOI 10.1089/neu.2008-0706; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Wang L, 2009, NEUROPATHOLOGY, V29, P230, DOI 10.1111/j.1440-1789.2008.00969.x; Whishaw IQ, 2000, NEUROPHARMACOLOGY, V39, P788, DOI 10.1016/S0028-3908(99)00259-2; Windle V, 2006, EXP NEUROL, V201, P324, DOI 10.1016/j.expneurol.2006.04.012; Xue MZ, 2000, STROKE, V31, P1721, DOI 10.1161/01.STR.31.7.1721; Ye XM, 2001, BRAIN RES PROTOC, V8, P104, DOI 10.1016/S1385-299X(01)00086-1; Zhao HG, 2008, BRAIN RES, V1246, P158, DOI 10.1016/j.brainres.2008.08.096; Zilles K., 1985, CORTEX RAT STEREOTAX	36	23	23	1	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2010	27	8					1387	1397		10.1089/neu.2010.1346			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	639OU	WOS:000280984900004	20515316				2022-02-06	
J	Ferguson, S; Mouzon, B; Kayihan, G; Wood, M; Poon, F; Doore, S; Mathura, V; Humphrey, J; O'Steen, B; Hayes, R; Roses, A; Mullan, M; Crawford, F				Ferguson, S.; Mouzon, B.; Kayihan, G.; Wood, M.; Poon, F.; Doore, S.; Mathura, V.; Humphrey, J.; O'Steen, B.; Hayes, R.; Roses, A.; Mullan, M.; Crawford, F.			APOLIPOPROTEIN E GENOTYPE AND OXIDATIVE STRESS RESPONSE TO TRAUMATIC BRAIN INJURY	NEUROSCIENCE			English	Article						APOE; traumatic brain injury; microarray; oxidative stress; transgenic	CLOSED-HEAD INJURY; ONSET ALZHEIMERS-DISEASE; NITRIC-OXIDE PRODUCTION; NF-KAPPA-B; TRANSGENIC MICE; APOE GENOTYPE; DEFICIENT MICE; PROTEIN; ALLELE; ACTIVATION	Traumatic Brain Injury (TBI) is known to result in oxidative stress, and as variation at the Apolipoprotein E (APOE) gene has been shown to influence outcome following TBI, but through as yet unclear mechanisms, we used transgenic APOE mouse models to examine the relationship between APOE genotype and oxidative stress following TBI. We administered a controlled cortical impact (CCI) injury or sham injury to transgenic mice expressing either human APOE3 or APOE4 on a murine APOE-deficient background. RNA was prepared from the ipsilateral hippocampi and cortices retrieved at 24 h and 1 month post-TBI. Microarray analysis was performed on unpooled samples from three mice per group to determine the genomic response to TBI and to specifically investigate the response of genes involved in oxidative stress mechanisms. Our data demonstrated TBI-induced expression of many more anti-oxidant related genes in the APOE3 mice, suggesting a potential anti-oxidative role for ApoE3 compared to ApoE4. However, in an additional cohort of mice we isolated the ipsilateral hippocampi, cortices, and cerebella at 1 month after TBI or sham injury for immunohistochemical analysis of markers of oxidative stress: the formation and presence of carbonyls (indication of general oxidative modification), 3-nitrotyrosine (3NT; specific to protein modification), or 4-hydroxyl-2-nonenal (HNE; specific to lipid peroxidation). Although we observed significant increases in all three markers of oxidative stress in response to injury, and genotype was a significant factor for carbonyl and 3NT, we found no significant interaction between genotype and injury. This may be due to the overwhelming effect of injury compared to genotype in our ANOVA, but nonetheless suggests that an influence on oxidative stress response is not the primary mechanism behind the APOE-genotype dependent effects on outcome following TBI. (C) 2010 IBRO. Published by Elsevier Ltd. All rights reserved.	[Ferguson, S.; Mouzon, B.; Kayihan, G.; Wood, M.; Poon, F.; Doore, S.; Mathura, V.; Humphrey, J.; Mullan, M.; Crawford, F.] Roskamp Inst, Sarasota, FL 34243 USA; [O'Steen, B.] Univ Florida, McKnight Brain Inst, Ctr Traumat Brain Injury Studies, Gainesville, FL USA; [Hayes, R.] Banyan Biomarkers, Alachua, FL 32615 USA; [Roses, A.] Duke Univ, R David Thomas Execut Training Ctr, Durham, NC USA		Ferguson, S (corresponding author), Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA.	sferguson@rfdn.org		Doore, Sarah/0000-0002-7672-2355; Mullan, Michael/0000-0002-1473-7527	VA Merit awardUS Department of Veterans Affairs; Roskamp Foundation; DoDUnited States Department of Defense [W81XWH-07-1-0700]	This work was supported by a VA Merit award to FC, by the Roskamp Foundation and in part by DoD contract W81XWH-07-1-0700 (FC).	Alberghini A, 2005, J BIOL CHEM, V280, P30120, DOI 10.1074/jbc.M500971200; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Beni SM, 2004, FASEB J, V18, P149, DOI 10.1096/fj.03-0323fje; BERGER R, 1995, SOMAT CELL MOLEC GEN, V21, P121, DOI 10.1007/BF02255787; Brigelius-Flohe R, 2006, BIOL CHEM, V387, P1329, DOI 10.1515/BC.2006.166; Colton CA, 2004, J NEUROIMMUNOL, V147, P62, DOI 10.1016/j.jneuroim.2003.10.015; Crawford F, 2009, NEUROSCIENCE, V159, P1349, DOI 10.1016/j.neuroscience.2009.01.033; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Crawford FC, 2007, BRAIN RES, V1185, P45, DOI 10.1016/j.brainres.2007.09.042; de Haan JB, 1998, J BIOL CHEM, V273, P22528, DOI 10.1074/jbc.273.35.22528; Edenberg HJ, 2008, HUM MOL GENET, V17, P963, DOI 10.1093/hmg/ddm368; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Haddad JJ, 2002, J NEUROIMMUNOL, V133, P1, DOI 10.1016/S0165-5728(02)00357-0; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; Hirota K, 2000, BIOCHEM BIOPH RES CO, V274, P177, DOI 10.1006/bbrc.2000.3106; Huebbe P, 2007, MOL NUTR FOOD RES, V51, P1510, DOI 10.1002/mnfr.200700194; Jaffrey SR, 1998, NEURON, V20, P115, DOI 10.1016/S0896-6273(00)80439-0; Jakobsson PJ, 1997, J BIOL CHEM, V272, P22934, DOI 10.1074/jbc.272.36.22934; Jofre-Monseny L, 2008, MOL NUTR FOOD RES, V52, P131, DOI 10.1002/mnfr.200700322; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Juurlink B H, 1998, J Spinal Cord Med, V21, P309; Kharrazi H, 2008, CLIN BIOCHEM, V41, P932, DOI 10.1016/j.clinbiochem.2008.05.001; Kurooka H, 1997, GENOMICS, V39, P331, DOI 10.1006/geno.1996.4493; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lauderback CM, 2001, BIOCHEMISTRY-US, V40, P2548, DOI 10.1021/bi002312k; Lomnitski L, 1997, PHARMACOL BIOCHEM BE, V56, P669, DOI 10.1016/S0091-3057(96)00412-1; Lomnitski L, 2000, EXP TOXICOL PATHOL, V52, P177; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Marcourakis T, 2008, CELL BIOCHEM FUNCT, V26, P852, DOI 10.1002/cbf.1516; Matsubara K, 2002, NEUROTOXICOL TERATOL, V24, P593, DOI 10.1016/S0892-0362(02)00212-X; Mauri M, 2006, FUNCT NEUROL, V21, P223; Mazur-Kolecka B, 2003, BRAIN RES, V983, P48, DOI 10.1016/S0006-8993(03)03026-9; Milojevic J, 2007, J AM CHEM SOC, V129, P4282, DOI 10.1021/ja067367+; Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55; Mori T, 2003, J NEUROPATH EXP NEUR, V62, P280, DOI 10.1093/jnen/62.3.280; OKAMURA N, 1990, J CLIN INVEST, V85, P1583, DOI 10.1172/JCI114608; OKUIZUMI K, 1994, NAT GENET, V7, P10, DOI 10.1038/ng0594-10b; Ozturk E, 2008, PROG NEURO-PSYCHOPH, V32, P81, DOI 10.1016/j.pnpbp.2007.07.016; Pedersen WA, 2000, J NEUROCHEM, V74, P1426, DOI 10.1046/j.1471-4159.2000.0741426.x; Pombo CM, 1997, J BIOL CHEM, V272, P29372, DOI 10.1074/jbc.272.46.29372; Pombo CM, 1996, EMBO J, V15, P4537, DOI 10.1002/j.1460-2075.1996.tb00831.x; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Ramassamy C, 2000, NEUROBIOL DIS, V7, P23, DOI 10.1006/nbdi.1999.0273; Ramassamy C, 2001, MOL BRAIN RES, V86, P76, DOI 10.1016/S0169-328X(00)00268-0; Sabo T, 2000, NEUROSCIENCE, V101, P879, DOI 10.1016/S0306-4522(00)00438-3; SAUNDERS AM, 1993, LANCET, V342, P710, DOI 10.1016/0140-6736(93)91709-U; Sharapova TA, 2009, CONTEMP PROBL ECOL+, V2, P72, DOI 10.1134/S1995425509010123; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765; Sroussi HY, 2009, FEMS IMMUNOL MED MIC, V55, P55, DOI 10.1111/j.1574-695X.2008.00498.x; TEESDALE GM, 1997, LANCET, V350, P1069; VANDUIJN CM, 1994, NAT GENET, V7, P74, DOI 10.1038/ng0594-74; Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; White F, 2001, NEUROBIOL DIS, V8, P611, DOI 10.1006/nbdi.2001.0401; Xiong Ye, 2004, J Stroke Cerebrovasc Dis, V13, P129, DOI 10.1016/j.jstrokecerebrovasdis.2004.05.001; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Xu PT, 1996, NEUROBIOL DIS, V3, P229, DOI 10.1006/nbdi.1996.0023; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	59	23	24	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience	JUL 14	2010	168	3					811	819		10.1016/j.neuroscience.2010.01.031			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	608UM	WOS:000278611500022	20105454				2022-02-06	
J	Barker, LA; Andrade, J; Morton, N; Romanowski, CAJ; Bowles, DP				Barker, L. A.; Andrade, J.; Morton, N.; Romanowski, C. A. J.; Bowles, D. P.			Investigating the 'latent' deficit hypothesis: Age at time of head injury, implicit and executive functions and behavioral insight	NEUROPSYCHOLOGIA			English	Article						Developmental; Trajectory; Cognition; Awareness	TRAUMATIC BRAIN-INJURY; UNDERSTANDING AWARENESS DEFICITS; SELF-AWARENESS; DEVELOPMENTAL DIFFERENCES; ADOLESCENT BRAIN; CHILDHOOD; PERFORMANCE; MATURATION; COGNITION; VALIDITY	This study investigated the 'latent deficit' hypothesis in two groups of head-injured patients with predominantly frontal lesions, those injured prior to steep morphological and corresponding functional maturational periods for frontal networks (<= age 25), and those injured >28 years. The latent deficit hypothesis proposes that early injuries produce enduring cognitive deficits manifest later in the lifespan with graver consequences for behavior than adult injuries, particularly after frontal pathology (Eslinger, Grattan, Damasio & Damasio, 1992). Implicit and executive deficits both contribute to behavioral insight after frontal head injury (Barker, Andrade, Romanowski, Morton, & Wasti, 2006). On the basis of morphological and behavioral data, we hypothesized that early injury would confer greater vulnerability to impairment on tasks associated with frontal regions than later injury. Patients completed experimental tasks of implicit cognition, executive function measures and the DEX measure of behavioral insight (Behavioral Assessment of the Dysexecutive Syndrome: Wilson, Alderman, Burgess, Emslie, & Evans, 1996). The Early Injury group were more impaired on implicit cognition tasks compared to controls that Late Injury patients. There were no marked group differences on most executive function measures. Executive ability only contributed to behavioral awareness in the Early Injury Group. Findings showed that age at injury moderates the relationship between executive and implicit cognition and behavioral insight and that early injuries result in long-standing deficits to functions associated with frontal regions partially supporting the latent deficit hypothesis. (C) 2010 Elsevier Ltd. All rights reserved.	[Barker, L. A.; Bowles, D. P.] Sheffield Hallam Univ, Dept Psychol, Brain Behav & Cognit Grp, Sheffield S10 2BP, S Yorkshire, England; [Andrade, J.] Univ Plymouth, Sch Psychol, Plymouth PL4 8AA, Devon, England; [Morton, N.] Tickhill Rd Hosp, Rotherham Doncaster S Humber Mental Hlth NHS Fdn, Neurorehabil Serv, Doncaster DN4 8QL, England; [Romanowski, C. A. J.] Royal Hallamshire Hosp, Dept Acad Radiol, Sheffield S10 2JF, S Yorkshire, England		Barker, LA (corresponding author), Sheffield Hallam Univ, Dept Psychol, Brain Behav & Cognit Grp, Sheffield S10 2BP, S Yorkshire, England.	l.barker@shu.ac.uk	Andrade, Jackie/H-1215-2013	Andrade, Jackie/0000-0002-6626-7192	PPP Foundation [577/365]	This research was funded by the PPP Foundation (grant no. 577/365). The authors wish to thank participants who took part in the study and Dr Howard Jackson of the Transitional Rehabilitation Unit, St. Helens. This study was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.	Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Andrade J, 2001, BRIT J ANAESTH, V86, P189, DOI 10.1093/bja/86.2.189; Andres P, 2002, NEUROPSYCHOLOGIA, V40, P835, DOI 10.1016/S0028-3932(01)00182-8; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Barker LA, 2006, NEUROPSYCHOLOGIA, V44, P1413, DOI 10.1016/j.neuropsychologia.2005.12.005; Barker LA, 2006, J EXP PSYCHOL LEARN, V32, P636, DOI 10.1037/0278-7393.32.3.636; Barker LA, 2004, NEUROCASE, V10, P233, DOI 10.1080/13554790490495096; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Beldarrain MG, 2002, EXP BRAIN RES, V142, P529, DOI 10.1007/s00221-001-0935-2; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P606, DOI 10.1017/S1355617705050721; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; BO J, 2009, EXPT BRAIN RES, V190, P317; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess P.W., 1997, HAYLING BRIXTON TEST; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Chan RCK, 2008, J NEUROL NEUROSUR PS, V79, P86, DOI 10.1136/jnnp.2007.117184; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Craik FIM, 1999, PSYCHOL SCI, V10, P26, DOI 10.1111/1467-9280.00102; D'Argembeau A, 2005, NEUROIMAGE, V25, P616, DOI 10.1016/j.neuroimage.2004.11.048; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; DAMASIO H, 1990, LESION ANAL NEUROPSY; DEMIR OE, 2009, DEVELOPMENTAL SCI, P1; Eslinger PJ, 2004, BRAIN COGNITION, V55, P84, DOI 10.1016/s0278-2626(03)00281-1; Eslinger PJ, 2000, DEV NEUROPSYCHOL, V18, P297, DOI 10.1207/S1532694203Eslinger; ESLINGER PJ, 1997, DEV PREFRONTAL CORTE; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; Frith CD, 2008, NEURON, V60, P503, DOI 10.1016/j.neuron.2008.10.032; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Hamsher K., 1989, MULTILINGUAL APHASIA; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Hayes BK, 1996, J EXP CHILD PSYCHOL, V63, P22, DOI 10.1006/jecp.1996.0041; Heaton R.K., 1981, WISCONSIN CARD SORTI; Hebb DO, 1949, ORG BEHAV NEUROPSYCH; Honda M, 1998, BRAIN, V121, P2159, DOI 10.1093/brain/121.11.2159; Huizinga M, 2006, NEUROPSYCHOLOGIA, V44, P2017, DOI 10.1016/j.neuropsychologia.2006.01.010; Jaccard J., 2003, SAGE U PAPERS SERIES; Jimenez L, 2001, Q J EXP PSYCHOL-A, V54, P345, DOI 10.1080/02724980042000200; Johnston MV, 2009, DEV DISABIL RES REV, V15, P94, DOI 10.1002/ddrr.64; Kennard MA, 1940, ARCH NEURO PSYCHIATR, V44, P377, DOI 10.1001/archneurpsyc.1940.02280080137008; Kolb B., 1995, BRAIN PLASTICITY BEH; Kolb B., 1990, FUNDAMENTALS HUMAN N; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; LEVIN HS, 1991, DEV NEUROPSYCHOL, V7, P377, DOI 10.1080/87565649109540499; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lieberman MD, 2000, PSYCHOL BULL, V126, P109, DOI 10.1037/0033-2909.126.1.109; Lin CCH, 2000, J CLIN EXP NEUROPSYC, V22, P69, DOI 10.1076/1380-3395(200002)22:1;1-8;FT069; Meulemans T, 1998, J EXP CHILD PSYCHOL, V69, P199, DOI 10.1006/jecp.1998.2442; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; MORRIS RG, 2004, COGNITIVE NEUROPSYCH; MORTON N, 2010, BRAIN INJURY, V24, P38; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Ownsworth T, 2006, NEUROPSYCHOL REHABIL, V16, P415, DOI 10.1080/09602010500505641; Ownsworth TL, 2000, CLIN NEUROPSYCHOL, V14, P76, DOI 10.1076/1385-4046(200002)14:1;1-8;FT076; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Ponsford J, 2004, COGNITIVE BEHAV REHA; Riddle WR, 2008, J MAGN RESON IMAGING, V28, P320, DOI 10.1002/jmri.21450; Romine CB, 2005, APPL NEUROPSYCHOL, V12, P190, DOI 10.1207/s15324826an1204_2; Rosen HJ, 2010, NEUROIMAGE, V49, P3358, DOI 10.1016/j.neuroimage.2009.11.041; SCHACTER DL, 1990, J CLIN EXP NEUROPSYC, V12, P155, DOI 10.1080/01688639008400962; Schmitz TW, 2006, NEUROPSYCHOLOGIA, V44, P762, DOI 10.1016/j.neuropsychologia.2005.07.012; Seger CA, 1997, CONSCIOUS COGN, V6, P108, DOI 10.1006/ccog.1996.0285; Seidler RD, 2005, EXP BRAIN RES, V165, P114, DOI 10.1007/s00221-005-2284-z; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sosin DM, 1996, PEDIATRICS, V98, P868; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Steinberg L, 2007, CURR DIR PSYCHOL SCI, V16, P55, DOI 10.1111/j.1467-8721.2007.00475.x; STUSS D, 2007, T ROYAL SOC LONDON B, V362, P901; Sullivan JR, 2009, APPL NEUROPSYCHOL, V16, P62, DOI 10.1080/09084280802644243; Thomas KM, 2004, J COGNITIVE NEUROSCI, V16, P1339, DOI 10.1162/0898929042304688; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Tranel D, 2000, DEV NEUROPSYCHOL, V18, P273, DOI 10.1207/S1532694201Tranel; Vaidya CJ, 2007, NEUROPSYCHOLOGY, V21, P497, DOI 10.1037/0894-4105.21.4.497; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WILLIAMS D, 1992, BRAIN COGNITION, V20, P196, DOI 10.1016/0278-2626(92)90069-X; Wise K, 2005, BRAIN INJURY, V19, P765, DOI 10.1080/0269905050019977; Wong PS, 1997, CONSCIOUS COGN, V6, P519, DOI 10.1006/ccog.1997.0322; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	93	23	23	1	16	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	JUL	2010	48	9					2550	2563		10.1016/j.neuropsychologia.2010.05.001			14	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	634ID	WOS:000280573300015	20470806	Green Submitted, Green Accepted			2022-02-06	
J	Dudek, FE; Bertram, EH				Dudek, F. Edward; Bertram, Edward H.			COUNTERPOINT TO "WHAT IS AN EPILEPTIC SEIZURE?" BY D'AMBROSIO AND MILLER	EPILEPSY CURRENTS			English	Article							COMPLEX PARTIAL SEIZURES; TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC EPILEPSY; LONG; RATS; EEG	D'Ambrosio and Miller argue that brief (i.e., one to a few seconds), rhythmic electrographic events accompanied by behavioral arrest, which they have observed in rats after lateral fluid percussion (i.e., in an animal model of traumatic brain injury), should be considered seizures in this model of posttraumatic epilepsy (1). A counter argument is that these events are not characteristic of the seizures seen clinically in posttraumatic epilepsy or in other forms of acquired epilepsy. Furthermore, several types of brief, rhythmic activity can be recorded in the electroencephalogram (EEG) of animals and humans without epilepsy. One cannot exclude the possibility that such events represent normal electrical activity, which may (or even may not) occur more often after brain injury. Thus, caution is required. In this counterpoint to "What Is an Epileptic Seizure?" by D'Ambrosio and Miller, the assertion is made that experimental studies on animal models of acquired epilepsy that claim electrographic events to be seizures, when the possibility exists that they may not be seizures characteristic of human acquired epilepsy, could be counterproductive, since research resources could be focused on animal models that may not actually demonstrate acquired epilepsy.	[Dudek, F. Edward] Univ Utah, Sch Med, Dept Physiol, Salt Lake City, UT 84108 USA; [Bertram, Edward H.] Univ Virginia, Hlth Sci Ctr, Dept Neurol, Charlottesville, VA 22908 USA		Dudek, FE (corresponding author), Univ Utah, Sch Med, Dept Physiol, 420 Chipeta Way,Suite 1700, Salt Lake City, UT 84108 USA.	ed.dudek@hsc.utah.edu					Afra P, 2008, EPILEPSIA, V49, P677, DOI 10.1111/j.1528-1167.2007.01420.x; Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Benbadis SR, 2008, EUR NEUROL, V59, P267, DOI 10.1159/000115641; Bye AME, 2000, J PAEDIATR CHILD H, V36, P244, DOI 10.1046/j.1440-1754.2000.00496.x; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; D'Ambrosio R, 2010, EPILEPSY CURR, V10, P61, DOI 10.1111/j.1535-7511.2010.01358.x; D'Ambrosio R, 2009, BRAIN, V132, P2805, DOI 10.1093/brain/awp217; DEVINSKY O, 1988, NEUROLOGY, V38, P1347, DOI 10.1212/WNL.38.9.1347; Dube C, 2006, BRAIN, V129, P911, DOI 10.1093/brain/awl018; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Jenssen S, 2006, EPILEPSIA, V47, P1499, DOI 10.1111/j.1528-1167.2006.00622.x; Kelly Kevin M, 2004, Epilepsy Curr, V4, P160, DOI 10.1111/j.1535-7597.2004.44015.x; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; RAKHADE S, 2008, SOC NEUR ABSTR; Santoshkumar B, 2009, CLIN NEUROPHYSIOL, V120, P856, DOI 10.1016/j.clinph.2009.03.005; Shaw FZ, 2004, J NEUROPHYSIOL, V91, P63, DOI 10.1152/jn.00487.2003; Statler KD, 2009, EPILEPSY RES, V86, P221, DOI 10.1016/j.eplepsyres.2009.05.006; THEODORE WH, 1994, NEUROLOGY, V44, P1403, DOI 10.1212/WNL.44.8.1403; THEODORE WH, 1983, NEUROLOGY, V33, P1115; WILLIAMSON PD, 1985, ANN NEUROL, V18, P497, DOI 10.1002/ana.410180413; [No title captured]	24	23	24	0	1	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1535-7597			EPILEPSY CURR	Epilepsy Curr.	JUL-AUG	2010	10	4					91	94		10.1111/j.1535-7511.2010.01368.x			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	652PY	WOS:000282022800007	20697504	Green Published			2022-02-06	
J	Darwish, RS; Amiridze, NS				Darwish, Ribal S.; Amiridze, Nana S.			Detectable Levels of Cytochrome c and Activated Caspase-9 in Cerebrospinal Fluid after Human Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Activated caspase-9; Cytochrome c; Traumatic brain injury	SEVERE HEAD-INJURY; UP-REGULATION; APOPTOSIS; INVOLVEMENT; CHILDREN; INFANTS; RELEASE; DEATH	The intrinsic pathway of apoptosis has been proposed as one mechanism of cell death after traumatic brain injury (TBI). This study tested the hypothesis that cytochrome c and activated caspase-9 are released into the cerebrospinal fluid (CSF) after severe TBI and that their presence correlates with mitochondrial injury and severity of neurologic outcome. Nine adult patients with severe TBI (GCS a parts per thousand currency sign 8) underwent placement of intraventricular catheters for monitoring and management of intracranial pressure. CSF was sampled at catheter insertion (2-26 h after injury) and at intervals of 24, 48, and 72 h thereafter. Control samples were obtained from patients undergoing spinal anesthesia (ASA1). CSF levels of cytochrome c and activated caspase-9 were measured using ELISA. Cytochrome c was detected in 18 (51.4%) samples, in the range of 0.08-5 ng/ml; mean value for cytochrome c was 0.44 ng/ml (SD +/- A 0.632). Activated caspase-9 was detected in 10 samples (28.6%); mean value was 0.28 ng/ml (SD +/- A 0.39). R (s) between cytochrome c and Glasgow outcome score (GOS) was -0.25 (P = 0.14), and between GOS and activated caspase-9 was -0.35 (P = 0.04). R calculated based on linear regression of activated caspase-9 and cytochrome c concentrations was 0.18. Control CSF samples had no detectable levels of either marker (detection level for cytochrome c was 0.08 ng/ml and 0.20 for activated caspase-9). We concluded that activated caspase-9 and cytochrome c are present in the CSF of patients with severe TBI. Activated caspase-9 shows weak correlation with poor neurologic outcome.	[Darwish, Ribal S.] Univ Maryland, Med Ctr, Dept Anesthesiol, Crit Care Med Div, Baltimore, MD 21201 USA; [Amiridze, Nana S.] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA		Darwish, RS (corresponding author), Univ Maryland, Med Ctr, Dept Anesthesiol, Crit Care Med Div, 22 S Greene St, Baltimore, MD 21201 USA.	Rdarwish@anes.umm.edu; Namiridze@umm.edu		Darwish, Ribal/0000-0003-0727-0401			Bayir H, 2003, J CEREBR BLOOD F MET, V23, P51, DOI 10.1097/01.WCB.0000040399.30600.E3; Chiaretti A, 2008, J NEUROTRAUM, V25, P225, DOI 10.1089/neu.2007.0405; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; DARWISH R, 2004, ANN M AM ASS NEUR SU; Darwish RS, 2007, J TRAUMA, V63, P439, DOI 10.1097/TA.0b013e318069178a; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Ertel W, 1997, J NEUROIMMUNOL, V80, P93, DOI 10.1016/S0165-5728(97)00139-2; Harter L, 2001, J NEUROIMMUNOL, V121, P76, DOI 10.1016/S0165-5728(01)00409-X; Kirchhoff C, 2008, EUR J MED RES, V13, P464; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lenzlinger PM, 2002, J NEUROIMMUNOL, V122, P167, DOI 10.1016/S0165-5728(01)00466-0; Li YZ, 1999, MOL MED, V5, P232, DOI 10.1007/BF03402120; Qiu JH, 2002, J NEUROSCI, V22, P3504; Satchell MA, 2005, J CEREBR BLOOD F MET, V25, P919, DOI 10.1038/sj.jcbfm.9600088; Uzan M, 2006, ACTA NEUROCHIR, V148, P1157, DOI 10.1007/s00701-006-0887-1; Wright KM, 2007, CELL DEATH DIFFER, V14, P625, DOI 10.1038/sj.cdd.4402024; Yakovlev AG, 1997, J NEUROSCI, V17, P7415	18	23	25	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933			NEUROCRIT CARE	Neurocrit. Care	JUN	2010	12	3					337	341		10.1007/s12028-009-9328-3			5	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	590RJ	WOS:000277244700004	20087688				2022-02-06	
J	Gervasi, O; Magni, R; Zampolini, M				Gervasi, Osvaldo; Magni, Riccardo; Zampolini, Mauro			Nu!RehaVR: virtual reality in neuro tele-rehabilitation of patients with traumatic brain injury and stroke	VIRTUAL REALITY			English	Article						Nu!RehaVR; Virtual reality; Tele-rehabilitation; Neurological disease; Nu!Reha desk; Traumatic brain Injury; Stroke patients; X3D; Ajax3D	UPPER EXTREMITY; TELEREHABILITATION; NEEDS; INTERNET; GLOVE	The availability of virtual environments on the Web is fostering new applications of virtual reality in several fields, including some therapeutical applications. We present an application of virtual reality applied to the tele-rehabilitation of patients with traumatic brain injury and stroke. Our system, based on X3D and Ajax3D technologies, enhances the possibility of making tele-rehabilitation exercises aimed at the recovery of the neurological disease. The system, called Nu!RehaVR, has been designed to integrate the activity carried out on a tele-rehabilitation system, Nu!Reha (Nu!Reha is a trademark of Pragma Engineering srl. See http://www.nureha.eu) desk, with the activities performed in the virtual worlds, through some rehabilitation exercises in contexts incompatible with the patients' impairments (not able to move or forced in static positions because of therapies, etc.). The architecture of Nu!RehaVR and the environments associated to two exercises, "Utilising an elevator to reach a given floor" and "Crossing a road using a traffic light", are illustrated. These exercises can be considered as prototypes of a series of tele-rehabilitation exercises which help to stimulate the patients performing actions in relatively dangerous scenarios. The system is designed to allow the remote monitoring and assessment of the patient's activities by the medical staff at the hospital using the communication facilities of the tele-rehabilitation system.	[Gervasi, Osvaldo] Univ Perugia, Dept Math & Comp Sci, I-06123 Perugia, Italy; [Magni, Riccardo] Pragma Engn Srl, I-06100 Perugia, Italy; [Zampolini, Mauro] Foligno Hosp, Reg Umbria ASL3, Dept Rehabil, I-06034 Foligno, PG, Italy		Gervasi, O (corresponding author), Univ Perugia, Dept Math & Comp Sci, Via Vanvitelli 1, I-06123 Perugia, Italy.	osvaldo@unipg.it; riccardo.magni@pragmaeng.it; m.zampolini@als3.umbria.it	Gervasi, Osvaldo/B-9234-2013; Gervasi, Osvaldo/AAH-2792-2019	Gervasi, Osvaldo/0000-0003-4327-520X; Gervasi, Osvaldo/0000-0003-4327-520X	EUEuropean Commission	EU projects IST H-CAD and eTen Hellodoc are acknowledged for having promoted the concept of tele-rehabilitation applied to neuro-rehabilitation practice and for the support provided. The Working Group "ELAMS" of the COST D37 Action is acknowledged for the useful knowledge and technology contribution provided to the present research.	Burdea G, 2000, IEEE T REHABIL ENG, V8, P430, DOI 10.1109/86.867886; Carey JR, 2007, NEUROREHAB NEURAL RE, V21, P216, DOI 10.1177/1545968306292381; Hauber RP, 2002, J HEAD TRAUMA REHAB, V17, P535, DOI 10.1097/00001199-200212000-00005; Heuser A, 2007, IEEE T NEUR SYS REH, V15, P43, DOI 10.1109/TNSRE.2007.891393; Hill AJ, 2006, AM J SPEECH-LANG PAT, V15, P45, DOI 10.1044/1058-0360(2006/006); Holden MK, 2007, IEEE T NEUR SYS REH, V15, P36, DOI 10.1109/TNSRE.2007.891388; Holden MK, 2005, CYBERPSYCHOL BEHAV, V8, P187, DOI 10.1089/cpb.2005.8.187; HUMBLER NR, 2004, TELEMED J E-HEALTH, V10, P129; HUYGENS B, 2008, J TELEMED TELECARE, V14, P249, DOI DOI 10.1258/JET.2008.080104; IRON L, 2004, MED INFORM INTERNET, V29, P119; IRON L, 2001, STUD HLTH TECHNOL IN, V81, P386; Jack D, 2001, IEEE T NEUR SYS REH, V9, P308, DOI 10.1109/7333.948460; Nakanishi J, 2004, NEURAL NETWORKS, V17, P1453, DOI 10.1016/j.neunet.2004.05.003; Page SJ, 2007, ARCH PHYS MED REHAB, V88, P922, DOI 10.1016/j.apmr.2007.03.038; Placidi G, 2007, COMPUT BIOL MED, V37, P1100, DOI 10.1016/j.compbiomed.2006.09.011; PRINTABLE DH, 2004, J REHABIL RES DEV, V41, P481; Reinkensmeyer DJ, 2002, IEEE T NEUR SYS REH, V10, P102, DOI 10.1109/TNSRE.2002.1031978; Ricker JH, 2002, J HEAD TRAUMA REHAB, V17, P242, DOI 10.1097/00001199-200206000-00005; Riva G, 2005, CYBERPSYCHOL BEHAV, V8, P220, DOI 10.1089/cpb.2005.8.220; Riva G, 2007, LECT NOTES COMPUT SC, V4563, P699; Rizzo AA, 2004, TELEMED J E-HEALTH, V10, P184, DOI 10.1089/1530562041641336; Robinson SS, 2003, TELEMED J E-HEALTH, V9, P57, DOI 10.1089/153056203763317657; Russell TG, 2002, J TELEMED TELECARE, V8, P50, DOI 10.1258/13576330260440853; Sanford JA, 2004, ASSIST TECHNOL, V16, P43, DOI 10.1080/10400435.2004.10132073; Sanford JA, 2006, J AM GERIATR SOC, V54, P1641, DOI 10.1111/j.1532-5415.2006.00913.x; Torsney K, 2003, NEUROREHABILITATION, V18, P183; Wilson BA, 1996, J HEAD TRAUMA REHAB, V11, P54, DOI 10.1097/00001199-199604000-00006; ZAMPOLINI M, 2007, IEEE VIRTUAL RE 0927, P83; Zampolini M, 2008, LECT NOTES COMPUT SC, V5073, P78	29	23	23	1	23	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	1359-4338			VIRTUAL REAL-LONDON	Virtual Real.	JUN	2010	14	2					131	141		10.1007/s10055-009-0149-7			11	Computer Science, Interdisciplinary Applications; Computer Science, Software Engineering; Imaging Science & Photographic Technology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Computer Science; Imaging Science & Photographic Technology	838HV	WOS:000296279600004					2022-02-06	
J	Kaye, AJ; Gallagher, R; Callahan, JM; Nance, ML				Kaye, Adam J.; Gallagher, Rachel; Callahan, James M.; Nance, Michael L.			Mild Traumatic Brain Injury in the Pediatric Population: The Role of the Pediatrician in Routine Follow-Up	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Mild traumatic brain injury; Pediatrics; Head trauma; Follow-up care; Primary care	SPORT-RELATED CONCUSSION; CLOSED-HEAD INJURY; CHILDREN; PREDICTION; MANAGEMENT; SYMPTOMS	Background: Traumatic brain injury is common in children. Fortunately, most patients suffer mild traumatic brain injury ( MTBI). Appropriate guidelines for follow-up care are not well established. We sought to determine practice experience and preferences of general pediatricians related to follow-up care of MTBI. Methods: Members of the American Academy of Pediatrics Council of Community Pediatrics and general pediatricians in the Pennsylvania Chapter of the American Academy of Pediatrics participated in a web-based survey regarding practice setting, level of comfort caring for patients with MTBI, and referral patterns for such patients. Results: A total of 298 pediatricians responded. An urban or suburban practice setting was reported by 83.3% with a wide distribution in practice experience ( 0 - 10 years 40.5%, 11 - 20 years 24.5%, >21 years 35%). Most respondents ( 54.5%) had cared for at least 2 to 5 patients with MTBI in the past 6 months but only 8% had seen >10 patients. Fifty-nine percent had not participated in continuing medical education activities related to MTBI and 62.2% did not use neurocognitive tests. The majority ( 89%) thought that they were the appropriate provider for follow-up; this declined to 61.2% for patients with loss of consciousness and only 5.4% if patients had persistent symptoms. Neurologists ( 75%) were the consultant of choice for referral. Increased practice experience was associated with an increased comfort in determining return to play status. Conclusion: In this survey, pediatricians thought that they were the most appropriate clinicians to follow-up patients with MTBI. However, most accepted this responsibility without the benefit of specific continuing medical education or using neurocognitive tests. Ensuring the availability of appropriate resources for pediatricians to care for these patients is important.	[Nance, Michael L.] Childrens Hosp Philadelphia, Dept Surg, Philadelphia, PA 19104 USA; [Kaye, Adam J.] Hosp Univ Penn, Dept Surg, Philadelphia, PA 19104 USA; [Gallagher, Rachel] Childrens Hosp, Dept Med, Div Emergency Med, Boston, MA 02115 USA; [Callahan, James M.] Univ Penn, Sch Med, Dept Pediat, Div Emergency Med, Philadelphia, PA 19104 USA		Nance, ML (corresponding author), Childrens Hosp Philadelphia, Dept Surg, 34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	nance@email.chop.edu					Bergman DA, 1999, PEDIATRICS, V104, P1407; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; *CAN PED SOC, 2006, PEDIAT CHILD HLTH, V11, P420; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cohen JS, 2009, CURR OPIN PEDIATR, V21, P288, DOI 10.1097/MOP.0b013e32832b1195; Demorest RA, 2005, PEDIATRICS, V115, P28, DOI 10.1542/peds.2004-0266; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Haydel MJ, 2003, ANN EMERG MED, V42, P507, DOI 10.1067/S0196-0644(03)00512-2; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; McCrory Paul, 2005, Clin J Sport Med, V15, P48; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Nance ML, 2009, ANN SURG, V249, P859, DOI 10.1097/SLA.0b013e3181a41ae5; *NAT CTR INJ PREV, 2003, FACTS PHYS MILD TRAU; Purcell L, 2008, CLIN PEDIATR, V47, P106, DOI 10.1177/0009922807306053; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Thiessen ML, 2006, PEDIATR CLIN N AM, V53, P1, DOI 10.1016/j.pcl.2005.09.004; Thompson Matthew D, 2003, Semin Pediatr Neurol, V10, P130, DOI 10.1016/S1071-9091(03)00021-4; ACUTE CONCUSSION EVA	21	23	23	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUN	2010	68	6					1396	1400		10.1097/TA.0b013e3181cf7d1b			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	610ES	WOS:000278714600024	20539184				2022-02-06	
J	Zeng, T; Gao, L				Zeng Tao; Gao Liang			Management of patients with severe traumatic brain injury guided by intraventricular intracranial pressure monitoring: a report of 136 cases	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Brain injuries; Intracranial pressure; Ventriculostomy		Objective: To evaluate the effect of the treatment modality guided by intraventricular intracranial pressure (ICP) monitoring on patients with severe traumatic brain injury (TBI). Methods: The clinical data of a group of 136 severely brain-injured patients admitted to Shanghai Neurosurgical Emergency Center from December 2004 to February 2006 were studied. Results: The intraventricular ICP monitor was placed in all the 136 patients via Kocher's pathway, Paine's pathway or intraoperative opened ventricle. In this series, the probe was placed during the procedure of craniotomy in 98 patients; for other 38 patients, the probe was placed initially to measure or to monitor ICP. A stepwise protocol targeting at ICP control (<= 20 mm Hg) and optimal cerebral perfusion pressure (CPP) maintenance (60-90 mm Hg) was deployed. Among them, 76 patients survived with good recovery, 14 with moderate disability, 24 with severe disability, 10 with vegetative state, and 12 died. Complications associated with intraventricular ICP monitoring included hemorrhage and infection. Hemorrhage occurred in 1 patient and infection in 5 patients. There were no unacceptable complications related to ICP monitoring. Conclusions: Ventricular access for ICP monitoring can be safely and accurately achieved. ICP monitoring via ventriculostomy may facilitate an early and accurate intervention for severely brain-injured patients. The intraventricular ICP monitoring is a low-risk procedure and can yield great benefits for management of patients with severe TBI.	[Zeng Tao] Fujian Med Univ, Union Hosp, Neurosurg Dept, Fuzhou 350001, Fujian, Peoples R China; [Gao Liang] Fudan Univ, Huashan Hosp, Neurosurg Dept, Shanghai 200040, Peoples R China		Gao, L (corresponding author), Fudan Univ, Huashan Hosp, Neurosurg Dept, Shanghai 200040, Peoples R China.	lianggaoh@yahoo.com.cn					Abadal-Centellas JM, 2007, J TRAUMA, V62, P282, DOI 10.1097/01.ta.0000199422.01949.78; Arbour Richard, 2004, Crit Care Nurse, V24, P19; Bekar A, 1998, NEUROSURG REV, V21, P254, DOI 10.1007/BF01105781; Bullock R., 1996, EUR J EMERG MED, V3, P109, DOI 10.1097/00063110-199606000-00010; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; Maas Andrew I.R., 2000, Curr Opin Crit Care, V6, P281, DOI 10.1097/00075198-200008000-00008; Rebuck JA, 2000, J NEUROL NEUROSUR PS, V69, P381, DOI 10.1136/jnnp.69.3.381; ROBERTSON C, 2004, YOUMANS NEUROLOGICAL, V4, P5103; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Vitaz TW, 2001, J TRAUMA, V51, P369, DOI 10.1097/00005373-200108000-00025	13	23	28	0	1	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	JUN	2010	13	3					146	151		10.3760/cma.j.issn.1008-1275.2010.03.003			6	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	VF0ZE	WOS:000441901200004	20515591				2022-02-06	
J	Swanson, EW; Mascitelli, J; Stiefel, M; MacMurtrie, E; Levine, J; Kofke, WA; Yang, W; Le Roux, PD				Swanson, Edward W.; Mascitelli, Justin; Stiefel, Michael; MacMurtrie, Eileen; Levine, Joshua; Kofke, W. Andrew; Yang, Wei; Le Roux, Peter D.			Patient Transport and Brain Oxygen in Comatose Patients	NEUROSURGERY			English	Article						Brain oxygen; Computed tomography; Intracranial pressure; Subarachnoid hemorrhage; Transport; Traumatic brain injury	SERIAL COMPUTED-TOMOGRAPHY; CRITICALLY-ILL PATIENTS; INTRAHOSPITAL TRANSPORT; RESPIRATORY-FUNCTION; INJURY; COMPLICATIONS; MANAGEMENT; CARE; DETERIORATION; HEMORRHAGE	OBJECTIVE: Transport of critically ill intensive care unit patients may be hazardous. We examined whether brain oxygen (brain tissue oxygen partial pressure [PbtO(2)]) is influenced by transport to and from a follow-up head computed tomography (transport head computed tomography [tHCT]) scan. METHODS: Forty-five patients (24 men, 21 women; Glasgow Coma Scale score <= 8; mean age, 47.3 +/- 19.0 years) who had a traumatic brain injury (n = 26) or subarachnoid hemorrhage (n = 19) were retrospectively identified from a prospective observational cohort of PbtO(2) monitoring in a neurosurgical intensive care unit at a university-based level I trauma center. PbtO(2), intracranial pressure, and cerebral perfusion pressure were monitored continuously and compared during the 3 hours before and after 100 tHCT scans. RESULTS: The mean PbtO(2) before and after the tHCT scans for all 100 scans was 37.9 +/- 19.8 mm Hg and 33.9 +/- 17.2 mm Hg, respectively (P = .0001). A decrease in PbtO2 (>5%) occurred after 54 tHCTs (54%) and in 36 patients (80%). In instances in which a decrease occurred, the average decrease in mean, minimum, and maximum PbtO(2) was 23.6%, 29%, and 18.1%, respectively. This decrease was greater when PbtO(2) was compromised (<25 mm Hg) before tHCT. An episode of brain hypoxia (<15 mm Hg) was identified in the 3 hours before tHCT in 9 and after tHCT in 19 instances. On average, an episode of brain hypoxia was 46.6 +/- 16.0 (standard error) minutes longer after tHCT than before tHCT (P = .008). Multivariate analysis suggests that changes in lung function (PaO2/fraction of inspired oxygen [FiO(2)] ratio) may account for the reduced PbtO(2) after tHCT (parameter estimate 0.45, 95% confidence interval: 0.024-0.871; P = .04). CONCLUSION: These data suggest that transport to and from the intensive care unit may adversely affect PbtO(2). This deleterious effect is greater when PbtO(2) is already compromised and may be associated with lung function.	[Swanson, Edward W.; Mascitelli, Justin; Stiefel, Michael; MacMurtrie, Eileen; Levine, Joshua; Kofke, W. Andrew; Le Roux, Peter D.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19107 USA; [Levine, Joshua; Kofke, W. Andrew] Univ Penn, Dept Neurol, Philadelphia, PA 19107 USA; [Levine, Joshua; Kofke, W. Andrew] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19107 USA; [Yang, Wei] Univ Penn, Dept Biostat & Epidemiol, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19107 USA		Le Roux, PD (corresponding author), Univ Penn, Dept Neurosurg, 330 S 9th St, Philadelphia, PA 19107 USA.	lerouxp@uphs.upenn.edu	Yang, Wei/A-9223-2009	Yang, Wei/0000-0001-8984-4389; Swanson, Edward/0000-0001-5689-4419	Integra Foundation; Neurologica	This work is supported by research grants from the Integra Foundation ( P. D. L.) and Neurologica ( P. D. L.). The authors have no personal financial or institutional interest in any of the drugs, materials, or devices described in this article.	ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; Bercault N, 2005, CRIT CARE MED, V33, P2471, DOI 10.1097/01.CCM.0000185644.54646.65; BRAMAN SS, 1987, ANN INTERN MED, V107, P469, DOI 10.7326/0003-4819-107-4-469; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chao A, 2001, J TRAUMA, V51, P870, DOI 10.1097/00005373-200111000-00008; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Doring B L, 1999, J Neurosci Nurs, V31, P80; Evans A, 1995, Am J Crit Care, V4, P106; Gracias VH, 2004, J TRAUMA, V56, P469, DOI 10.1097/01.TA.0000114274.95423.C0; Gunnarsson T, 2000, J NEUROSURG, V93, P432, DOI 10.3171/jns.2000.93.3.0432; KOBAYASHI S, 1983, SURG NEUROL, V20, P25, DOI 10.1016/0090-3019(83)90101-5; Lahner D, 2007, WIEN KLIN WOCHENSCHR, V119, P412, DOI 10.1007/s00508-007-0813-4; LEDWITH M, J NEUROSCI IN PRESS; LeRoux PD, 1996, J NEUROSURG, V85, P39, DOI 10.3171/jns.1996.85.1.0039; LINK J, 1990, CRIT CARE MED, V18, P1427, DOI 10.1097/00003246-199012000-00024; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; Lovell MA, 2001, ANAESTH INTENS CARE, V29, P400, DOI 10.1177/0310057X0102900412; Marx G, 1998, INTENS CARE MED, V24, P1157, DOI 10.1007/s001340050739; McKhann GM, 2004, MANAGEMENT CEREBRAL, P431; Nortje J, 2006, BRIT J ANAESTH, V97, P95, DOI 10.1093/bja/ael137; Papson JPN, 2007, ACAD EMERG MED, V14, P574, DOI 10.1197/j.aem.2007.02.034; PEACE K, 2009, AM ASS NEUR SURG ANN; Rello J, 1996, AM J RESP CRIT CARE, V154, P111, DOI 10.1164/ajrccm.154.1.8680665; ROBERSON FC, 1979, SURG NEUROL, V12, P161; ROBERTSON C, 2004, YOUMANS NEUROLOGICAL, P5103; Rose JC, 2006, CURR OPIN CRIT CARE, V12, P97, DOI 10.1097/01.ccx.0000216574.26686.e9; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Singhal AB, 2005, STROKE, V36, P797, DOI 10.1161/01.STR.0000158914.66827.2e; SMITH I, 1990, CRIT CARE MED, V18, P278, DOI 10.1097/00003246-199003000-00006; Smith JS, 2007, J TRAUMA, V63, P75, DOI 10.1097/01.ta.0000245991.42871.87; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; SZEM JW, 1995, CRIT CARE MED, V23, P1660, DOI 10.1097/00003246-199510000-00009; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; Warren J, 2004, CRIT CARE MED, V32, P256, DOI 10.1097/01.CCM.0000104917.39204.0A; WAYDHAS C, 1995, INTENS CARE MED, V21, P784, DOI 10.1007/BF01700959; WEG JG, 1989, CHEST, V96, P631, DOI 10.1378/chest.96.3.631; Winn HR., 2004, MANAGEMENT CEREBRAL, P303; Zanetta G, 2002, INTENS CARE MED, V28, P443, DOI 10.1007/s00134-002-1242-5	43	23	23	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	MAY	2010	66	5					925	931		10.1227/01.NEU.0000368543.59446.A4			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	587DY	WOS:000276970800019	20404697				2022-02-06	
J	Weeks, SR; McAuliffe, CL; DuRussel, D; Pasquina, PF				Weeks, Sharon R.; McAuliffe, Caitlin L.; DuRussel, David; Pasquina, Paul F.			Physiological and Psychological Fatigue in Extreme Conditions: The Military Example	PM&R			English	Article							PROLONGED PHYSICAL STRESS; SLEEP; RESPONSES; HORMONES; ENERGY; EXERCISE; BRAIN	The extreme conditions causing fatigue in military service members in combat and combat training deserve special consideration. The collective effects of severe exertion, limited caloric intake, and sleep deprivation, combined with the inherent stressors of combat, lead to both physiological and psychological fatigue that may significantly impair performance. Studies of combat training have revealed a myriad of endocrine, cognitive, and neurological changes that occur as a result of exposure to extreme conditions. Further contributory effects of multiple military deployments, post-traumatic stress disorder, and traumatic brain injury may also influence both the susceptibility to and expression of fatigue states. Further research is needed to explore these effects to enhance military readiness and performance as well as prevent injuries. PM R 2010;2:438-441	[Weeks, Sharon R.; McAuliffe, Caitlin L.; DuRussel, David; Pasquina, Paul F.] Walter Reed Army Med Ctr, Dept Orthopaed & Rehabil, Washington, DC 20307 USA		Pasquina, PF (corresponding author), Walter Reed Army Med Ctr, Dept Orthopaed & Rehabil, 6900 Georgia Ave NW, Washington, DC 20307 USA.	paul.pasquina@us.army.mil		Weeks, Sharon/0000-0002-9952-9136	Military Amputee Research Program; Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; Center for Neuroscience and Regenerative Medicine (CNRM) at the Uniformed Services University of the Health Sciences	Funded by the Military Amputee Research Program; Funded by the Center for Neuroscience and Regenerative Medicine; The views expressed in this article are those of the authors and do not reflect the official policy of the Department of the Army, Department of Defense, or the United States Government. The authors would also like to acknowledge the support of the Center for Neuroscience and Regenerative Medicine (CNRM) at the Uniformed Services University of the Health Sciences	Armentrout JJ, 2006, AVIAT SPACE ENVIR MD, V77, P963; BAHR R, 1991, ACTA PHYSIOL SCAND, V141, P555, DOI 10.1111/j.1748-1716.1991.tb09117.x; Belasco A., 2007, COST IRAQ AFGHANISTA; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Belmont A, 2009, NEUROREHAB NEURAL RE, V23, P939, DOI 10.1177/1545968309340327; BELYAVIN A, 1987, ELECTROEN CLIN NEURO, V66, P137, DOI 10.1016/0013-4694(87)90183-0; Bruner E. F., 2006, MILITARY FORCES WHAT; CA Morgan, 2000, ASSESSMENT HUMANS EX, P612; Caldwell J A, 2001, Air Med J, V20, P25; Caldwell JA, 2002, INT J AVIAT PSYCHOL, V12, P19, DOI 10.1207/S15327108IJAP1201_3; Friedl KE, 2000, J APPL PHYSIOL, V88, P1820, DOI 10.1152/jappl.2000.88.5.1820; Gomez-Merino D, 2003, MIL MED, V168, P1034, DOI 10.1093/milmed/168.12.1034; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hosek J., 2006, DEPLOYMENTS AFFECT S; LeDuc PA, 2005, AVIAT SPACE ENVIR MD, V76, pC86; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Morgan CA, 2000, BIOL PSYCHIAT, V47, P891, DOI 10.1016/S0006-3223(99)00307-8; Nindl BC, 2003, J APPL PHYSIOL, V95, P1083, DOI 10.1152/japplphysiol.01148.2002; OGILVIE RD, 1992, SLEEP, AROUSAL, AND PERFORMANCE, P73; OPSTAD PK, 1992, J CLIN ENDOCR METAB, V74, P1176, DOI 10.1210/jc.74.5.1176; OPSTAD PK, 1994, EUR J ENDOCRINOL, V131, P56, DOI 10.1530/eje.0.1310056; OPSTAD PK, 1991, ACTA ENDOCRINOL-COP, V125, P14, DOI 10.1530/acta.0.1250014; Peterson AL, 2008, MIL MED, V173, P230, DOI 10.7205/MILMED.173.3.230; Rabinowitz YG, 2009, MIL MED, V174, P358, DOI 10.7205/MILMED-D-01-5008; Ray W. J., 1990, PRINCIPLES PSYCHOPHY, P385; Reger MA, 2009, J CLIN PSYCHIAT, V70, P1266, DOI 10.4088/JCP.08m04361; Roy-Byrne P, 2004, PSYCHOL MED, V34, P363, DOI 10.1017/S0033291703008894; van Zuiden M, 2009, BRAIN BEHAV IMMUN, V23, P1132, DOI 10.1016/j.bbi.2009.07.004	29	23	24	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	MAY	2010	2	5					438	441		10.1016/j.pmrj.2010.03.023			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	V23SB	WOS:000208361400015	20656625				2022-02-06	
J	McNett, MM; Gianakis, A				McNett, Molly M.; Gianakis, Anastasia			Nursing Interventions for Critically Ill Traumatic Brain Injury Patients	JOURNAL OF NEUROSCIENCE NURSING			English	Article								Neuroscience intensive care unit (ICU) nurses deliver a number of interventions when caring for critically ill traumatic brain injury (TBI) patients. Yet, there is little research evidence documenting specific nursing interventions performed. As part of a larger study investigating ICU nurse judgments about secondary brain injury, ICU nurses were asked to identify interventions routinely performed when caring for TBI patients. Quantitative and qualitative analyses indicate that all nurses routinely monitored hemodynamic parameters such as oxygen saturation, blood pressure, and temperature. Nurses were responsible for monitoring intracranial pressure and cerebral perfusion pressure approximately 50% of the time. Qualitative analyses revealed that additional nursing interventions could be categorized as neurophysiological interventions, psychosocial interventions, injury prevention interventions, and interventions to maintain a therapeutic milieu. Findings from this study provide evidence of the multifaceted role of the neuroscience ICU nurse caring for TBI patients and can be used in future research investigating the impact of nursing interventions on patient outcomes.	[McNett, Molly M.; Gianakis, Anastasia] Metrohlth Med Ctr, Neurosurg Spine & Surg Intens Care Unit, Cleveland, OH USA		McNett, MM (corresponding author), Metrohlth Med Ctr, Neurosurg Spine & Surg Intens Care Unit, Cleveland, OH USA.	mmcnett@metrohealth.org					Albano C, 2005, CRIT CARE NURS Q, V28, P135, DOI 10.1097/00002727-200504000-00006; Bader Mary Kay, 2003, Crit Care Nurse, V23, P29; Chamberlain D J, 1998, Aust Crit Care, V11, P123, DOI 10.1016/S1036-7314(98)70499-0; Cook NF, 2004, J CLIN NURS, V13, P835, DOI 10.1111/j.1365-2702.2004.01001.x; FONTEYN ME, 1994, NURSING INFORMATICS: AN INTERNATIONAL OVERVIEW FOR NURSING IN A TECHNOLOGICAL ERA, P481; Ladanyi Suzy, 2008, Aust Crit Care, V21, P141, DOI 10.1016/j.aucc.2008.02.003; Langlois JA, 2006, TRAUMATIC BRAIN INJU; LITTLEJOHNS L, 2009, MONITORING TECHNOLOG; MCNETT M, 2009, AM J CRITICAL CARE; McNett M, 2009, DIMENS CRIT CARE NUR, V28, P182, DOI 10.1097/DCC.0b013e3181a473d7; Olson DM, 2005, AACN ADV CRIT CARE, V16, P441, DOI 10.1097/00044067-200510000-00003; Presciutti Mary, 2006, J Neurosci Nurs, V38, P296; The Brain Trauma Foundation, GUID MAN SEV TRAUM B; Thompson Hilaire J, 2007, J Neurosci Nurs, V39, P196; Villanueva N E, 1999, J Neurosci Nurs, V31, P216; Wong F W, 2000, Crit Care Nurse, V20, P18; [No title captured]	17	23	24	1	7	AMER ASSOC NEUROSCIENCE NURSES	GLENVIEW	4700 W LAKE AVENUE, GLENVIEW, IL 60025 USA	0888-0395			J NEUROSCI NURS	J. Neurosci. Nurs.	APR	2010	42	2					71	77		10.1097/JNN.0b013e3181ce5b8a			7	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	576CU	WOS:000276122400003	20422792				2022-02-06	
J	Larson, EB; Heinemann, AW				Larson, Eric B.; Heinemann, Allen W.			Rasch Analysis of the Executive Interview (The EXIT-25) and Introduction of an Abridged Version (The Quick EXIT)	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Cognition; Frontal lobe; Mental processes; Neuropsychological tests; Psychometrics; Rehabilitation; Stroke	BEDSIDE ASSESSMENT; COGNITIVE IMPAIRMENT; FREEDOM HOUSE; DEMENTIA; SCHIZOPHRENIA; ASSOCIATION; DYSFUNCTION; PREDICTORS; RETIREES; LEVEL	Larson EB, Heinemann AW. Rasch analysis of the Executive Interview (The EXIT-25) and introduction of an abridged version (The Quick Exit). Arch Phys Med Rehabil 2010;91:389-94. Objectives: To evaluate the psychometric properties of the Executive Interview (EXIT-25) and to propose modifications that will improve those properties. Design: Rasch analysis of existing datasets contributed by 3 prior projects, all of which examined criterion-related validity of the EXIT-25. Setting: A large, urban, academic free-standing rehabilitation facility. Participants: The sample of 147 was comprised of 109 adults diagnosed with stroke evaluated during inpatient rehabilitation and 38 adults with traumatic brain injury evaluated during inpatient (n=11) or outpatient rehabilitation (n=27). Interventions: Not applicable. Main Outcome Measures: The EXIT-25, Repeatable Battery for the Assessment of Neuropsychological Status, and Trails A and B. Results: Eleven of the 25 items correlated weakly with the total measure and misfit the rating scale model. Deleting these 11 items improved the internal consistency of the remaining 14 items and enhanced the measure's criterion-related validity. Conclusions: The EXIT-25 can be reduced from 25 to 14 items without reducing internal consistency. Convergent validity of the abbreviated measure is supported by moderate-size correlations with standard measures of cognitive deficits.	[Larson, Eric B.; Heinemann, Allen W.] Northwestern Univ, Feinberg Sch Med, Rehabil Inst Chicago, Chicago, IL 60611 USA		Larson, EB (corresponding author), Northwestern Univ, Feinberg Sch Med, Rehabil Inst Chicago, 345 E Super St, Chicago, IL 60611 USA.	elarson@ric.org	Heinemann, Allen W/K-6283-2012; Heinemann, Allen W./AAI-2790-2021; Larson, Eric/AAD-9567-2021	Heinemann, Allen W/0000-0003-2782-7326; Heinemann, Allen W./0000-0003-2782-7326; 	U.S. Department of EducationUS Department of Education; National Institute on Disability and Rehabilitation Research [H133B30024]; Midwest Regional Traumatic Brain Injury Model System [HI33N060014]	Supported in part by the U.S. Department of Education, National Institute on Disability and Rehabilitation Research, (grant no. H133B30024) through the Rehabilitation Research and Training Center on Enhancing Quality of Life of Stroke Survivors, and the Midwest Regional Traumatic Brain Injury Model System: Innovative Approaches to Improve Cognition. Function, and Community Living (grant no. HI33N060014).	Berghuis JP, 1999, J ACQ IMMUN DEF SYND, V21, P134; Gildengers AG, 2004, AM J PSYCHIAT, V161, P736, DOI 10.1176/appi.ajp.161.4.736; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Holzer JC, 1997, J AM ACAD PSYCHIATRY, V25, P531; Kelly C, 2000, BRIT J PSYCHIAT, V177, P348, DOI 10.1192/bjp.177.4.348; Larson EB, 2008, PERCEPT MOTOR SKILL, V106, P725, DOI 10.2466/PMS.106.3.725-736; Linacre John M, 2002, J Appl Meas, V3, P85; Mann LS, 1999, PSYCHOL REP, V84, P319, DOI 10.2466/PR0.84.1.319-322; Marin RS, 2003, J GERIATR PSYCH NEUR, V16, P112, DOI 10.1177/0891988703016002009; O'Shaughnessy Joyce A, 2005, Clin Breast Cancer, V5, P439, DOI 10.3816/CBC.2005.n.002; O'Shaughnessy Joyce A, 2002, Clin Breast Cancer, V3 Suppl 3, pS116, DOI 10.3816/CBC.2002.s.022; Quinn J, 2001, SCHIZOPHR RES, V49, P79, DOI 10.1016/S0920-9964(99)00220-0; Randolph C., 1998, REPEATABLE BATTERY A; Rasch G., 1960, PROBABILISTIC MODELS; Royall DR, 2000, J GERONTOL A-BIOL, V55, pM541, DOI 10.1093/gerona/55.9.M541; Royall DR, 1998, J AM GERIATR SOC, V46, P1519, DOI 10.1111/j.1532-5415.1998.tb01536.x; Royall DR, 2004, J AM GERIATR SOC, V52, P346, DOI 10.1111/j.1532-5415.2004.52104.x; Royall DR, 2005, J AM GERIATR SOC, V53, P11, DOI 10.1111/j.1532-5415.2005.53004.x; Royall DR, 2005, J GERONTOL A-BIOL, V60, P1059, DOI 10.1093/gerona/60.8.1059; ROYALL DR, 1993, AM J PSYCHIAT, V150, P1813; ROYALL DR, 1992, J AM GERIATR SOC, V40, P1221, DOI 10.1111/j.1532-5415.1992.tb03646.x; ROYALL DR, 1993, NEUROPSY NEUROPSY BE, V6, P235; Royall DR, 1999, J GERONTOL B-PSYCHOL, V54, pP328, DOI 10.1093/geronb/54B.5.P328; ROYALL DR, 1994, EXP AGING RES, V20, P95, DOI 10.1080/03610739408253956; Schillerstrom JE, 2003, PSYCHOSOMATICS, V44, P290, DOI 10.1176/appi.psy.44.4.290; Stewart JT, 1999, AM J GERIAT PSYCHIAT, V7, P259, DOI 10.1097/00019442-199908000-00011; Stokholm J, 2005, J AM GERIATR SOC, V53, P1577, DOI 10.1111/j.1532-5415.2005.53470.x; Sweet JJ, 2006, CLIN NEUROPSYCHOL, V20, P325, DOI 10.1080/13854040600760488; *WAR DEP, 1944, ARM IND TEST BATT; Wright B, 1982, RATING SCALE ANAL RA	30	23	23	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2010	91	3					389	394		10.1016/j.apmr.2009.11.015			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	592YM	WOS:000277417900010	20298829				2022-02-06	
J	Peltier, J; Verclytte, S; Delmaire, C; Deramond, H; Pruvo, JP; Le Gars, D; Godefroy, O				Peltier, Johann; Verclytte, Sebastien; Delmaire, Christine; Deramond, Herve; Pruvo, Jean-Pierre; Le Gars, Daniel; Godefroy, Olivier			Microsurgical anatomy of the ventral callosal radiations: new destination, correlations with diffusion tensor imaging fiber-tracking, and clinical relevance	JOURNAL OF NEUROSURGERY			English	Article						corpus callosum; white matter; fiber dissection technique; anatomy; MR imaging	HUMAN CORPUS-CALLOSUM; CLOSED-HEAD-INJURY; NEUROPSYCHOLOGICAL EVALUATION; SIGNAL INTENSITY; SCHIZOPHRENIA; 3RD-VENTRICLE; ABNORMALITIES; CONNECTIONS; CALLOSOTOMY; ANTERIOR	Object. In the current literature, there is a lack of a detailed map of the origin, course, and connections of the ventral callosal radiations of the human brain. Methods. The authors used an older dissection technique based on a freezing process as well as diffusion tensor imaging to investigate this area of the human brain. Results. The authors demonstrated interconnections between areas 11, 12, and 25 for the callosal radiations of the trunk and rostrum of the corpus callosum; between areas 9, 10, and 32 for the genu; and between areas 6, 8, and 9 for the ventral third of the body. The authors identified new ventral callosal connections crossing the rostrum between both temporal poles and coursing within the temporal stem, and they named these connections the "callosal radiations of Peltier." They found that the breadth of the callosal radiations slightly increases along their course from the rostrum to the first third of the body of the corpus callosum. Conclusions. The fiber dissection and diffusion tensor imaging techniques are complementary not only in their application to the study of the commissural system in the human brain, but also in their practical use for diagnosis and surgical planning. Further investigations, neurocognitive tests, and other contributions will permit elucidation of the functional relevance of the newly identified callosal radiations in patients with disease involving the ventral corpus callosum. (DOI: 10.3171/2009.6.JNS081712)	[Peltier, Johann; Le Gars, Daniel] Univ Picardy Jules Verne, Lab Anat & Organogenesis, Amiens, France; [Verclytte, Sebastien; Delmaire, Christine; Pruvo, Jean-Pierre; Godefroy, Olivier] Lille Univ Hosp, Dept Neuroradiol, Lille, France; [Peltier, Johann] Univ Picardy Jules Verne, CNRS, UMR 8160, Lab Funct Neurosci & Pathol, Amiens, France; [Deramond, Herve] Amiens Univ Hosp, Dept Neuroradiol, F-80054 Amiens 1, France		Peltier, J (corresponding author), Amiens Univ Hosp, Dept Neurosurg, Victor Pauchet Pl, F-80054 Amiens 1, France.	peltier.johann@chu-amiens.fr	Godefroy, Olivier/D-6117-2012	Godefroy, Olivier/0000-0001-6789-6620			ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Arguin M, 2000, NEUROPSYCHOLOGIA, V38, P283, DOI 10.1016/S0028-3932(99)00077-9; BENTIN S, 1984, NEUROPSYCHOLOGIA, V22, P601, DOI 10.1016/0028-3932(84)90024-1; Boussaoud D, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-67; Brambilla P, 2004, J NEUROL NEUROSUR PS, V75, P221; Carr DB, 1998, SYNAPSE, V29, P193; CASTROCALDAS A, 1989, NEUROSURGERY, V25, P442, DOI 10.1227/00006123-198909000-00020; CLARK CR, 1989, BRAIN, V112, P165, DOI 10.1093/brain/112.1.165; DAVID AS, 1994, BEHAV BRAIN RES, V64, P203, DOI 10.1016/0166-4328(94)90132-5; Debierre C. M., 1907, CERVEAU MOELLE EPINI; DELACOSTE MC, 1985, J NEUROPATH EXP NEUR, V44, P578, DOI 10.1097/00005072-198511000-00004; DERIBET RM, 1957, ANATOMIE SCHEMATIQUE; DIMOND SJ, 1977, BRAIN, V100, P543, DOI 10.1093/brain/100.3.543; Duffau H, 2004, J NEUROSURG, V100, P431, DOI 10.3171/jns.2004.100.3.0431; EGAAS B, 1995, ARCH NEUROL-CHICAGO, V52, P794, DOI 10.1001/archneur.1995.00540320070014; Foong J, 2000, J NEUROL NEUROSUR PS, V68, P242, DOI 10.1136/jnnp.68.2.242; Friedman MA, 2003, NEUROSURGERY, V52, P791, DOI 10.1227/01.NEU.0000053367.94965.6B; Giedd JN, 1999, PROG NEURO-PSYCHOPH, V23, P571; HABIB M, 1994, REV NEUROPSYCHOL, V4, P69; Hutter B O, 1997, J Neurosurg Sci, V41, P123; JEEVES MA, 1979, J NEUROL NEUROSUR PS, V42, P134, DOI 10.1136/jnnp.42.2.134; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; KAWAGUCHI Y, 1992, EXP BRAIN RES, V88, P33, DOI 10.1007/BF02259126; Keshavan MS, 2002, J NEUROL NEUROSUR PS, V72, P757, DOI 10.1136/jnnp.72.6.757; Klingler J, 1935, SCHWEIZ ARCH NEUROL, V36, P247; Lassonde M, 1997, J Neurosurg Sci, V41, P67; LEVIN HS, 1990, J NEUROSURG, V73, P77, DOI 10.3171/jns.1990.73.1.0077; Mac Master FP, 1999, PROG NEURO-PSYCHOPH, V23, P601; Mazza M, 2004, BRAIN COGNITION, V55, P525, DOI 10.1016/j.bandc.2004.03.005; Paturet G., 1964, TRAITE ANATOMIE HUMA, VIV; PETERSON BS, 1994, PSYCHIAT RES, V55, P86; PUJOL J, 1993, ANN NEUROL, V34, P71, DOI 10.1002/ana.410340113; RAINE A, 1990, ARCH GEN PSYCHIAT, V47, P1060; Rhoton AL, 2007, NEUROSURGERY, V61, P1, DOI 10.1227/01.NEU.0000280027.92382.2B; Rumsey JM, 1996, BIOL PSYCHIAT, V39, P769, DOI 10.1016/0006-3223(95)00225-1; SAPPEY PC, 1877, TRAITE ANATOMIE DESC, V3; Suwanwela NC, 2002, J NEUROL NEUROSUR PS, V72, P533; Velut S, 1998, NEUROCHIRURGIE, V44, P17; Winkler PA, 1997, NEUROSURGERY, V40, P973, DOI 10.1097/00006123-199705000-00020; Winkler PA, 1999, NEUROSURGERY, V45, P309, DOI 10.1097/00006123-199908000-00023; Wong TT, 2006, CHILD NERV SYST, V22, P999, DOI 10.1007/s00381-006-0133-4; Yang Y, 2008, SURG NEUROL, V70, P252, DOI 10.1016/j.surneu.2007.06.076; [No title captured]	43	23	23	1	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	MAR	2010	112	3					512	519		10.3171/2009.6.JNS081712			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	562IQ	WOS:000275043900007	19612974				2022-02-06	
J	Sahin, S; Erturer, E; Ozturk, I; Toker, S; Seckin, F; Akman, S				Sahin, Suner; Erturer, Erden; Ozturk, Irfan; Toker, Serdar; Seckin, Faik; Akman, Senol			Radiographic and functional results of osteosynthesis using the proximal femoral nail antirotation (PFNA) in the treatment of unstable intertrochanteric femoral fractures	ACTA ORTHOPAEDICA ET TRAUMATOLOGICA TURCICA			English	Article						Bone nails; femoral neck fractures/surgery; fracture fixation, intramedullary/instrumentation/methods; hip fractures/surgery	PERTROCHANTERIC HIP-FRACTURES; TROCHANTERIC FRACTURES; SCREW-PLATE; FIXATION; FEMUR; FAILURE; GAMMA; ELEMENT	Objectives: We evaluated the radiographic and functional results of the proximal femoral nail antirotation (PFNA) system in patients with unstable intertrochanteric femoral fractures. Methods: The study included 45 patients (25 women, 20 men; mean age 72 years; range 27 to 97 years) who underwent osteosynthesis using the PFNA for unstable intertrochanteric femoral fractures. The fractures were in the right hip in 25 patients, and in the left hip in 20 patients. The fractures were classified according to the AO system. One patient had an open fracture due to firearm injury (Gustilo-Anderson 3A). The patients underwent surgery within a mean of eight days (range 2 to 21 days) from injury. The mean hospital stay was 13.5 days (range 4 to 25 days). Closed reduction was achieved in all the patients. The results were assessed clinically and radiographically. The neck-shaft angle of the femur (collodiaphysial angle) and the tip-apex distance were measured. The position of the helical screw within the femoral head was determined using the method of Cleveland and Bosworth. Clinical evaluation was made using the Harris hip score. Perioperative and postoperative complications were recorded. The mean follow-up period was 17.3 months (range 6 to 23 months). Results: The mean operation time was 37.8 min (range 22 to.118 min) and the mean blood loss was 225 ml (range 150 to 450 ml). During surgery, femoral shaft fracture occurred in three patients, and greater trochanter fracture occurred in nine patients. Union was obtained in all the patients. Reduction was poor in four patients (8.9%), acceptable in seven patients (15.6%), and good in 34 patients (75.6%). The mean collodiaphysial angle was 136.7 degrees (range 125 degrees to 148 degrees). The tip-apex distance was <25 mm in 36 patients (80%), and >= 25 mm in nine patients (20%). The position of the helical screw in the femoral head was appropriate in 38 patients (84.4%). Postoperative complications included secondary varus (n=2, 4.4%), calcification at the tip of the greater trochanter (n=7, 15.5%), sensitivity over the fascia lata (n=7), medial thigh pain (n=11, 24.4%), and screw cut-out (n=1, 2.2%). Nine patients developed femoral shortness (mean 9.4 mm; range 8 to 113 mm). Screws showed lateral displacement in five patients (11.1%), which was less than 5 mm in four patients. Secondary surgery was required in four patients (8.9%). The mean Harris hip score was 77.8. Harris hip scores were very good in 11 patients (24.4%), good in 19 patients (42.2%), moderate in nine patients (20%), and poor in six patients (13.3%). Conclusion: Due to advantages of high union rate, early postoperative mobilization, and short operation time, PFNA osteosynthesis is the method of choice for surgical treatment of unstable intertrochanteric femoral fractures.	[Toker, Serdar] Dumlupinar Univ, Fac Med, Dept Orthoped & Traumatol, TR-43270 Kutahya, Turkey; [Sahin, Suner; Erturer, Erden; Ozturk, Irfan; Seckin, Faik; Akman, Senol] Sisli Etfal Training & Res Hosp, Dept Orthoped & Traumatol, Istanbul, Turkey		Toker, S (corresponding author), Dumlupinar Univ, Fac Med, Dept Orthoped & Traumatol, Tavsanli Yolu 10 Km, TR-43270 Kutahya, Turkey.	tokerserdar@hotmail.com	erturer, erden/AAO-2634-2020; Toker, Serdar/L-7990-2013	erturer, erden/0000-0003-4489-5937; 			Al-yassari G, 2002, INJURY, V33, P395, DOI 10.1016/S0020-1383(02)00008-6; Banan H, 2002, INJURY, V33, P401, DOI 10.1016/S0020-1383(02)00054-2; BAUMGAERTNER MR, 1995, J BONE JOINT SURG AM, V77A, P1058, DOI 10.2106/00004623-199507000-00012; Boldin C, 2003, ACTA ORTHOP SCAND, V74, P53, DOI 10.1080/00016470310013662; Brunner A, 2008, J ORTHOP TRAUMA, V22, P731, DOI 10.1097/BOT.0b013e3181893b1b; CLEVELAND M, 1947, J BONE JOINT SURG, V29, P1049; Dodds SD, 2004, CURR OPIN ORTHOP, V15, P12; Domingo LJ, 2001, INT ORTHOP, V25, P298; DOPPELT SH, 1980, ORTHOP CLIN N AM, V11, P507; Ekstrom W, 2007, J ORTHOP TRAUMA, V21, P18, DOI 10.1097/BOT.0b013e31802b41cf; Fogagnolo F, 2004, ARCH ORTHOP TRAUM SU, V124, P31, DOI 10.1007/s00402-003-0586-9; Gotfried Y, 2000, J ORTHOP TRAUMA, V14, P490, DOI 10.1097/00005131-200009000-00005; Gotfried Y, 2004, CLIN ORTHOP RELAT R, P82, DOI 10.1097/01.blo.0000132264.14046.c2; Haidukewych GT, 2001, J BONE JOINT SURG AM, V83A, P643, DOI 10.2106/00004623-200105000-00001; HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012; Hay D, 2003, J BONE JOINT SURG BR, V85B, P1037, DOI 10.1302/0301-620X.85B7.14372; HORNBY R, 1989, J BONE JOINT SURG BR, V71, P619, DOI 10.1302/0301-620X.71B4.2670950; JACOBS RR, 1980, CLIN ORTHOP RELAT R, P62; KAUFER H, 1980, CLIN ORTHOP RELAT R, P53; Kesmezacar Hayrettin, 2005, Acta Orthop Traumatol Turc, V39, P287; Lenich A, 2006, ARCH ORTHOP TRAUM SU, V126, P706, DOI 10.1007/s00402-006-0117-6; Menezes DFA, 2005, CLIN ORTHOP RELAT R, P221, DOI 10.1097/01.blo.0000176448.00020.fa; Mereddy P, 2009, INJURY, V40, P428, DOI 10.1016/j.injury.2008.10.014; Parker MJ, 1996, INT ORTHOP, V20, P163, DOI 10.1007/s002640050055; Pervez H, 2004, INJURY, V35, P994, DOI 10.1016/j.injury.2003.10.028; RHA JD, 1993, INT ORTHOP, V17, P320; Sadowski C, 2002, J BONE JOINT SURG AM, V84A, P372, DOI 10.2106/00004623-200203000-00007; Schipper IB, 2004, J BONE JOINT SURG BR, V86B, P86, DOI 10.1302/0301-620X.86B1.14455; Schipper IB, 2002, CLIN ORTHOP RELAT R, P277, DOI 10.1097/01.blo.0000026575.55792.eb; Seral B, 2004, INJURY, V35, P130, DOI 10.1016/S0020-1383(03)00076-7; Siegmeth AW, 2005, J BONE JOINT SURG BR, V87B, P1123, DOI 10.1302/0301-620X.87B8; Simmermacher RKJ, 2008, INJURY, V39, P932, DOI 10.1016/j.injury.2008.02.005; SIMPSON AHRW, 1989, INJURY, V20, P227, DOI 10.1016/0020-1383(89)90120-4; Sommers MB, 2004, J ORTHOP TRAUMA, V18, P361, DOI 10.1097/00005131-200407000-00006; STEINBERG GG, 1988, ORTHOPEDICS, V11, P265; Takigami I, 2008, BULL HOSP JT DIS, V66, P276; Tyllianakis Minos, 2004, Acta Orthop Belg, V70, P444; WOLFGANG GL, 1982, CLIN ORTHOP RELAT R, P148	38	23	43	0	14	TURKISH ASSOC ORTHOPAEDICS TRAUMATOLOGY	ISTANBUL	TIP FAKULTESI ORTOPEDI VE TRAVMATOLOJI KLINIGI, ISTANBUL, TOPKAPI 34390, TURKEY	1017-995X			ACTA ORTHOP TRAUMATO	Acta Orthop. Traumatol. Turc.	MAR-APR	2010	44	2					127	134		10.3944/AOTT.2010.2237			8	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	641OL	WOS:000281137600008	20676015	gold, Green Submitted			2022-02-06	
J	Sbordone, RJ; Ruff, RM				Sbordone, Robert J.; Ruff, Ronald M.			Re-examination of the Controversial Coexistence of Traumatic Brain Injury and Posttraumatic Stress Disorder: Misdiagnosis and Self-Report Measures	PSYCHOLOGICAL INJURY & LAW			English	Article						Posttraumatic stress disorder; Traumatic brain injury	NEUROPSYCHOLOGICAL FINDINGS; HIPPOCAMPAL VOLUME; COMBAT VETERANS; HEAD-INJURY; MEMORY; AMNESIA; COMPLAINTS; SYMPTOMS; PTSD; DISABILITY	The coexistence of traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD) remains a controversial issue in the literature. To address this controversy, we focused primarily on the civilian-related literature of TBI and PTSD. Some investigators have argued that individuals who had been rendered unconscious or suffered amnesia due to a TBI are unable to develop PTSD because they would be unable to consciously experience the symptoms of fear, helplessness, and horror associated with the development of PTSD. Other investigators have reported that individuals who sustain TBI, regardless of its severity, can develop PTSD even in the context of prolonged unconsciousness. A careful review of the methodologies employed in these studies reveals that investigators who relied on clinical interviews of TBI patients to diagnose PTSD found little or no evidence of PTSD. In contrast, investigators who relied on PTSD questionnaires to diagnose PTSD found considerable evidence of PTSD. Further analysis revealed that many of the TBI patients who were initially diagnosed with PTSD according to self-report questionnaires did not meet the diagnostic criteria for PTSD upon completion of a clinical interview. In particular, patients with severe TBI were often misdiagnosed with PTSD. A number of investigators found that many of the severe TBI patients failed to follow the questionnaire instructions and erroneously endorsed PTSD symptoms because of their cognitive difficulties. Because PTSD questionnaires are not designed to discriminate between PTSD and TBI symptoms or determine whether a patient's responses are accurate or exaggerated, studies that rely on self-report questionnaires to evaluate PTSD in TBI patients are at risk of misdiagnosing PTSD. Further research should evaluate the degree to which misdiagnosis of PTSD occurs in individuals who have sustained mild TBI.	[Sbordone, Robert J.] 24422 Ave Carlota,Suite 270, Laguna Hills, CA 92653 USA; [Ruff, Ronald M.] San Francisco Clin Neurosci, San Francisco, CA 94109 USA		Sbordone, RJ (corresponding author), 24422 Ave Carlota,Suite 270, Laguna Hills, CA 92653 USA.	bobneurpsy@aol.com; ronruff@mindspring.com					Adams RD, 1997, PRINCIPLES NEUROLOGY, V6th; *AM PSYCH ASS, 1994, DIAGN STAT MENT DIS; American Psychiatric Association, 1980, DIAGN STAT MAN MENT; Barrett DH, 1996, AM J PSYCHIAT, V153, P1492; Bartzokis G, 2001, ARCH GEN PSYCHIAT, V58, P461, DOI 10.1001/archpsyc.58.5.461; Benson D.F., 1986, FRONTAL LOBES; Berthier M L, 1998, Depress Anxiety, V8, P43, DOI 10.1002/(SICI)1520-6394(1998)8:1<43::AID-DA9>3.0.CO;2-6; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Bohnen N., 1992, J NERV MENT DIS, V180, P183; Bremner JD, 2007, NEUROIMAG CLIN N AM, V17, P523, DOI 10.1016/j.nic.2007.07.003; Bremner J. Douglas, 2006, CNS & Neurological Disorders-Drug Targets, V5, P503; Bremner J Douglas, 2002, Curr Psychiatry Rep, V4, P254, DOI 10.1007/s11920-996-0044-9; BREMNER JD, 1993, AM J PSYCHIAT, V150, P235; Brenner LA, 2009, MIL MED, V174, P347, DOI 10.7205/MILMED-D-01-5808; Briere J., 2001, DETAILED ASSESSMENT; Brunson KL, 2001, MOL PSYCHIATR, V6, P647, DOI 10.1038/sj.mp.4000942; Bryant RA, 2000, PSYCHOL ASSESSMENT, V12, P61, DOI 10.1037/1040-3590.12.1.61; Bryant RA, 2003, BIOL PSYCHIAT, V53, P789, DOI 10.1016/S0006-3223(02)01895-4; Bryant RA, 1998, PSYCHOL ASSESSMENT, V10, P215, DOI 10.1037/1040-3590.10.3.215; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Bryant RA, 1997, CLIN PSYCHOL REV, V17, P757, DOI 10.1016/S0272-7358(97)00052-4; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Bryant RA., 2000, ACUTE STRESS DISORDE; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Bryant RA, 2007, J CONSULT CLIN PSYCH, V75, P812, DOI 10.1037/0022-006X.75.5.812; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Conners C. K., 1992, CONNERS CONTINUOUS P; Crowell TA, 2002, CLIN NEUROPSYCHOL, V16, P310, DOI 10.1076/clin.16.3.310.13851; Das R. H., 2008, NEW ENGL J MED, V359, P2178; EVERLY GS, 1989, PERCEPT MOTOR SKILL, V68, P807, DOI 10.2466/pms.1989.68.3.807; First M.B., 1994, STRUCTURED CLIN INTE; Flesher MR, 2001, BRAIN INJURY, V15, P879, DOI 10.1080/02699050110065682; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1002/jts.2490060405; FORRESTER G, 1994, BRAIN INJURY, V8, P175, DOI 10.3109/02699059409150969; FOX RP, 1972, COMPR PSYCHIAT, V13, P435, DOI 10.1016/0010-440X(72)90085-5; Francati V, 2007, DEPRESS ANXIETY, V24, P202, DOI 10.1002/da.20208; Fuster, 2015, PREFRONTAL CORTEX; Geuze E, 2008, J PSYCHIATR RES, V42, P659, DOI 10.1016/j.jpsychires.2007.06.007; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; GOLDSMITH W, 1969, ARCH GEN PSYCHIAT, V20, P78; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Harvey AG, 2003, J INT NEUROPSYCH SOC, V9, P663, DOI 10.1017/S1355617703940069; Hickling EJ, 1998, BRAIN INJURY, V12, P265, DOI 10.1080/026990598122566; Hochstrasser B, 1996, EUR ARCH PSY CLIN N, V246, P261, DOI 10.1007/BF02190278; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Horowitz M. J., 1976, STRESS RESPONSE SYND; Jatzko A, 2006, J AFFECT DISORDERS, V94, P121, DOI 10.1016/j.jad.2006.03.010; Jennett B, 1981, MANAGEMENT HEAD INJU; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KEANE TM, 1987, J CLIN PSYCHOL, V43, P32, DOI 10.1002/1097-4679(198701)43:1<32::AID-JCLP2270430106>3.0.CO;2-X; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kibby M Y, 1997, Appl Neuropsychol, V4, P34, DOI 10.1207/s15324826an0401_4; King NS, 1997, J NEUROL NEUROSUR PS, V62, P82, DOI 10.1136/jnnp.62.1.82; Koenen KC, 2001, BRAIN COGNITION, V45, P64, DOI 10.1006/brcg.2000.1256; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; KOLB B, 2003, FUNDAMENTALS HUMAN N; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; LEESHALEY PR, 1994, J CLIN PSYCHOL, V50, P252, DOI 10.1002/1097-4679(199403)50:2<252::AID-JCLP2270500217>3.0.CO;2-T; Leskin LP, 2007, NEUROPSYCHOLOGY, V21, P275, DOI 10.1037/0894-4105.21.3.275; Malec JF, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P15; Malhi GS, 1998, BRIT J PSYCHIAT, V173, P537, DOI 10.1192/bjp.173.6.537a; Max JE, 1998, J NERV MENT DIS, V186, P589, DOI 10.1097/00005053-199810000-00001; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; McMillan TM, 1996, BRAIN INJURY, V10, P749, DOI 10.1080/026990596124016; McMillan TM, 2003, NEUROPSYCHOL REHABIL, V13, P149, DOI 10.1080/09602010244000453; McMillan TM, 2001, BRAIN INJURY, V15, P39, DOI 10.1080/02699050118030; Middelboe T., 1992, European Psychiatry, V7, P183; Neylan TC, 2004, J TRAUMA STRESS, V17, P41, DOI 10.1023/B:JOTS.0000014675.75686.ee; Oscar-Berman M, 1998, MEMORY NEURODEGENERA, P3; Rey A., 1964, EXAMEN CLIN PSYCHOL; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Sanchez MM, 2001, DEV PSYCHOPATHOL, V13, P419, DOI 10.1017/S0954579401003029; Sapolsky RM, 1996, SCIENCE, V273, P749, DOI 10.1126/science.273.5276.749; Saul R. E., 1993, PHYS MED REHABILITAT, P581; Sbordone R. J., 2007, NEUROPSYCHOLOGY PSYC; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Sbordone RJ, 1996, NEUROREHABILITATION, V7, P15, DOI 10.3233/NRE-1996-7103; Schmidt M., 1996, REY AUDITORY VERBAL; Stern RA, 1996, J NEUROPSYCH CLIN N, V8, P181; Sumpter RE, 2006, BRAIN INJURY, V20, P93, DOI 10.1080/02699050500394090; Sumpter RE, 2005, BRIT J PSYCHIAT, V186, P423, DOI 10.1192/bjp.186.5.423; TEASDALE G, 1974, LANCET, V2, P81; Tischler L, 2006, ANN NY ACAD SCI, V1071, P405, DOI 10.1196/annals.1364.031; UDDO M, 1993, J PSYCHOPATHOL BEHAV, V15, P43, DOI 10.1007/BF00964322; Wakefield JC, 2002, ARCH GEN PSYCHIAT, V59, P129, DOI 10.1001/archpsyc.59.2.129; Warden DL, 1997, J NEUROPSYCH CLIN N, V9, P18; Wearden AJ, 1996, J PSYCHOSOM RES, V41, P197, DOI 10.1016/0022-3999(96)00131-6; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wolfe J., 1994, NEUROPSYCHOLOGICAL E, P285; Woon FL, 2008, HIPPOCAMPUS, V18, P729, DOI 10.1002/hipo.20437; Xydakis MS, 2008, NEW ENGL J MED, V358, P2177, DOI 10.1056/NEJMc086083; YEHUDA R, 1995, AM J PSYCHIAT, V152, P137; Yehuda R, 2007, J PSYCHIATR RES, V41, P435, DOI 10.1016/j.jpsychires.2005.12.002	100	23	24	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	MAR	2010	3	1			SI		63	76		10.1007/s12207-010-9066-z			14	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	VB3XZ	WOS:000415448300006	20927197	Green Published, hybrid			2022-02-06	
J	Spulber, S; Schultzberg, M				Spulber, Stefan; Schultzberg, Marianne			Connection between inflammatory processes and transmittor function-Modulatory effects of interleukin-1	PROGRESS IN NEUROBIOLOGY			English	Article; Proceedings Paper	Conference on Chemical Neuroanatomy held in honor of Nils Ake Hikkarp	DEC, 2008	Stockholm, SWEDEN			Ageing; Alzheimer's disease; Cytokine; Development; Inflammation; Neurodegeneration; Neurogenesis; IL-1 receptor antagonist	MESENCEPHALIC PROGENITOR CELLS; LONG-TERM POTENTIATION; CLOSED-HEAD INJURY; RAT ADRENAL-GLAND; RECEPTOR ANTAGONIST; ALZHEIMERS-DISEASE; KAINIC ACID; MESSENGER-RNA; IMMUNE-SYSTEM; AGED MICE	Cells in the nervous system can respond to different kinds of stress, e.g. injury, with production and release of inflammatory molecules, including cytokines. One of the most important proinflammatory cytokines is interleukin-1, affecting most organs of the body. The high constitutive expression of interleukin-1 in the adrenal gland provides a source for local and systemic actions, in addition to activated monocytes. In the brain, the constitutive expression is low, but activated microglia produce and release interleukin-1 during pathological conditions such as neurodegenerative disorders (e.g. stroke, traumatic brain injury, Alzheimer's disease, Parkinson's disease). Interleukin-1 has an important role in mediating 'sickness symptoms' such as fever, in response to infections. Its role in neurodegeneration is not fully elucidated, but there is evidence for involvement in both amyloidosis and tau pathology, major neuropathological hallmarks of Alzheimer's disease. The interleukin-1 family at present consists of 11 members, one of which is the endogenous receptor antagonist. Overexpression of this antagonist in the CNS in a transgenic mouse strain, Tg hsIL-1ra, has allowed studies on morphological and functional effects of blocking interleukin-1 receptor-mediated activity in the brain. Marked alterations of brain morphology such as reduced hippocampal and cortical volume correlate with behavioural deficits. Decreased anxiety and impaired long-term memory are among the consequences. Intact interleukin-1 signalling is important for the brain's ability to adapt to acute and chronic neuroinflammation. Increased amplitude and prolongation of proinflammatory cytokine production underly the behavioural alterations characteristic for ageing. Moreover, deregulated expression of interleukin-1 is associated with ageing-related chronic neurodegenerative disorders. (C) 2009 Elsevier Ltd. All rights reserved.	[Spulber, Stefan; Schultzberg, Marianne] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Neurodegenerat, SE-14186 Stockholm, Sweden		Schultzberg, M (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Neurodegenerat, Floor 5, SE-14186 Stockholm, Sweden.	Marianne.Schultzberg@ki.se	Schultzberg, Marianne/E-7076-2014; Spulber, Stefan/J-2989-2012	Schultzberg, Marianne/0000-0002-8314-0927; Spulber, Stefan/0000-0001-8122-6738			AKANEYA Y, 1995, EXP NEUROL, V136, P44, DOI 10.1006/exnr.1995.1082; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; ANDERSSON C, 1992, NEUROSCIENCE, V47, P481, DOI 10.1016/0306-4522(92)90262-Z; Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; ATKINS E, 1955, J EXP MED, V101, P519, DOI 10.1084/jem.101.5.519; BELLINGER FP, 1993, BRAIN RES, V628, P227, DOI 10.1016/0006-8993(93)90959-Q; Bellucci A, 2004, AM J PATHOL, V165, P1643, DOI 10.1016/S0002-9440(10)63421-9; BESEDOVSKY H, 1986, SCIENCE, V233, P652, DOI 10.1126/science.3014662; Besedovsky HO, 1996, ENDOCR REV, V17, P64, DOI 10.1210/er.17.1.64; BETZ AL, 1995, J CEREBR BLOOD F MET, V15, P547, DOI 10.1038/jcbfm.1995.68; BRENNEMAN DE, 1992, J NEUROCHEM, V58, P454, DOI 10.1111/j.1471-4159.1992.tb09743.x; Butterfield DA, 2005, EXP GERONTOL, V40, P774, DOI 10.1016/j.exger.2005.05.007; BUXBAUM JD, 1992, P NATL ACAD SCI USA, V89, P10075, DOI 10.1073/pnas.89.21.10075; CACABELOS R, 1991, METHOD FIND EXP CLIN, V13, P455; Carvey PM, 2001, EXP NEUROL, V171, P98, DOI 10.1006/exnr.2001.7735; Coogan AN, 1999, NEUROSCIENCE, V93, P57, DOI 10.1016/S0306-4522(99)00100-1; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; de la Mano A, 2007, CYTOKINE, V37, P128, DOI 10.1016/j.cyto.2007.03.004; DEL BR, 1995, NEUROSCI LETT, V188, P70; Deniz-Naranjo MC, 2008, EUR J NEUROL, V15, P1080, DOI 10.1111/j.1468-1331.2008.02252.x; Dilger RN, 2008, J LEUKOCYTE BIOL, V84, P932, DOI 10.1189/jlb.0208108; DINARELLO CA, 1994, FASEB J, V8, P1314, DOI 10.1096/fasebj.8.15.8001745; DINARELLO CA, 1984, REV INFECT DIS, V6, P51, DOI 10.1016/S1359-6101(97)00023-3; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; DOLPHIN A, 1979, MOL PHARMACOL, V15, P1; Dong HX, 2003, J NEUROSCI, V23, P1742; Dunn AJ, 2006, CLIN NEUROSCI RES, V6, P52, DOI 10.1016/j.cnr.2006.04.002; DUNN AJ, 1988, LIFE SCI, V43, P429, DOI 10.1016/0024-3205(88)90522-X; Dziegielewska KM, 2000, CELL TISSUE RES, V299, P335; Engstrom L, 2008, ENDOCRINOLOGY, V149, P1436, DOI 10.1210/en.2007-1456; Eriksson C, 1999, NEUROSCIENCE, V93, P915, DOI 10.1016/S0306-4522(99)00178-5; Eriksson C, 1998, MOL BRAIN RES, V58, P195, DOI 10.1016/S0169-328X(98)00125-9; Eriksson C, 2000, J NEUROSCI RES, V60, P266, DOI 10.1002/(SICI)1097-4547(20000415)60:2<266::AID-JNR16>3.0.CO;2-P; FORLONI G, 1992, MOL BRAIN RES, V16, P128, DOI 10.1016/0169-328X(92)90202-M; GARCIA JH, 1995, AM J PATHOL, V147, P1477; Garlind A, 1999, BRAIN RES, V826, P112, DOI 10.1016/S0006-8993(99)01092-6; GIULIAN D, 1988, J NEUROSCI, V8, P709; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Hattiangady B, 2008, NEUROBIOL AGING, V29, P129, DOI 10.1016/j.neurobiolaging.2006.09.015; Johansson S, 2002, J COMP NEUROL, V443, P237, DOI 10.1002/cne.10119; KABIERSCH A, 1988, Brain Behavior and Immunity, V2, P267, DOI 10.1016/0889-1591(88)90028-1; Kinoshita D, 2009, PHYSIOL BEHAV, V96, P328, DOI 10.1016/j.physbeh.2008.10.018; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Li YK, 2003, J NEUROSCI, V23, P1605; Lindberg C, 2005, J MOL NEUROSCI, V27, P1, DOI 10.1385/JMN:27:1:001; Ling ZD, 1998, EXP NEUROL, V149, P411, DOI 10.1006/exnr.1998.6715; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; LUNDBERG JM, 1986, REGUL PEPTIDES, V13, P169, DOI 10.1016/0167-0115(86)90224-7; Lundkvist J, 1999, AM J PHYSIOL-REG I, V276, pR644, DOI 10.1152/ajpregu.1999.276.3.R644; McColl BW, 2008, J NEUROSCI, V28, P9451, DOI 10.1523/JNEUROSCI.2674-08.2008; MRAK RE, 1995, HUM PATHOL, V26, P816, DOI 10.1016/0046-8177(95)90001-2; NOBEL CSI, 1995, NEUROIMMUNOMODULAT, V2, P61, DOI 10.1159/000096873; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Oprica M, 2007, J CELL MOL MED, V11, P810, DOI 10.1111/j.1582-4934.2007.00074.x; Oprica M, 2005, BRAIN BEHAV IMMUN, V19, P223, DOI 10.1016/j.bbi.2004.07.006; Parish CL, 2002, J NEUROSCI, V22, P8034; Priebe K, 2005, DEV PSYCHOBIOL, V47, P398, DOI 10.1002/dev.20098; Relton JK, 1996, EXP NEUROL, V138, P206, DOI 10.1006/exnr.1996.0059; Riaz SS, 2004, DEV BRAIN RES, V153, P39, DOI 10.1016/j.devbrainres.2004.07.006; Rooker S, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/90123; Rosmaninho-Salgado J, 2007, PEPTIDES, V28, P310, DOI 10.1016/j.peptides.2006.11.015; Schneider H, 1998, P NATL ACAD SCI USA, V95, P7778, DOI 10.1073/pnas.95.13.7778; SCHULTZBERG M, 1989, NEUROSCIENCE, V30, P805, DOI 10.1016/0306-4522(89)90171-1; SCHULTZBERG M, 1995, J INTERF CYTOK RES, V15, P721, DOI 10.1089/jir.1995.15.721; SCHULTZBERG M, 1978, NEUROSCIENCE, V3, P1169, DOI 10.1016/0306-4522(78)90137-9; Shaftel SS, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-7; Sheng JG, 2000, EXP NEUROL, V163, P388, DOI 10.1006/exnr.2000.7393; Sparkman NL, 2008, NEUROIMMUNOMODULAT, V15, P323, DOI 10.1159/000156474; SPULBER S, 2008, THESIS KAROLINSKA I; Spulber S, 2008, EUR J NEUROSCI, V27, P549, DOI 10.1111/j.1460-9568.2008.06050.x; Spulber S, 2009, J NEUROIMMUNOL, V208, P46, DOI 10.1016/j.jneuroim.2009.01.010; Storch A, 2001, EXP NEUROL, V170, P317, DOI 10.1006/exnr.2001.7706; Stroemer RP, 1997, J CEREBR BLOOD F MET, V17, P597; Tanji K, 2003, NEUROREPORT, V14, P413, DOI 10.1097/01.wnr.0000059783.23521.7c; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Thornton P, 2006, J NEUROCHEM, V98, P258, DOI 10.1111/j.1471-4159.2006.03872.x; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Vawter MP, 1996, EXP NEUROL, V142, P179, DOI 10.1006/exnr.1996.0189; Yang GY, 1998, J CEREBR BLOOD F MET, V18, P840, DOI 10.1097/00004647-199808000-00004; Ye SM, 2001, NEUROIMMUNOMODULAT, V9, P183, DOI 10.1159/000049025; Ye SM, 1999, J NEUROIMMUNOL, V93, P139, DOI 10.1016/S0165-5728(98)00217-3; Yirmiya R, 2002, NEUROBIOL LEARN MEM, V78, P379, DOI 10.1006/nlme.2002.4072; Zaharia MD, 1996, PSYCHOPHARMACOLOGY, V128, P227, DOI 10.1007/s002130050130	85	23	29	1	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0301-0082	1873-5118		PROG NEUROBIOL	Prog. Neurobiol.	FEB 9	2010	90	2			SI		256	262		10.1016/j.pneurobio.2009.10.015			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	578KZ	WOS:000276293700014	19853010				2022-02-06	
J	Katz-Leurer, M; Rotem, H; Keren, O; Meyer, S				Katz-Leurer, Michal; Rotem, Hemda; Keren, Ofer; Meyer, Shirley			Heart rate and heart rate variability at rest and during exercise in boys who suffered a severe traumatic brain injury and typically-developed controls	BRAIN INJURY			English	Article						Autonomic nervous system diseases; traumatic brain injury; heart rate; parasympathetic nervous system; sympathetic nervous system; rehabilitation	AEROBIC CAPACITY; HRV	Objectives: To measure heart rate (HR) and heart rate variability (HRV) at rest and during exercise in children with post-severe traumatic brain injury as compared to age-matched typically-developed controls. Design: Comparative study. Setting: Out-patient rehabilitation department. Participants: Twelve boys post-severe traumatic brain injury (TBI) (aged 7-13 years) and 18 typically-developed (TD) boys matched for age. Interventions: HR and HRV were determined at rest and at a steady functional walking rate on the treadmill. Main outcome measures: HR and HRV parameters include: time domain parameters: standard deviation of the R-R interval, square root of the mean squared differences of successive R-R differences at rest and during steady-state exercise. Results: Children post-TBI demonstrated higher mean HR values at rest (TBI 91.8 +/- 7.0 beats per minute vs 72.0 +/- 7.1 beats per minute in controls, p < 0.05) and during exercise (TBI 123.4 +/- 15.5 beats per minute vs 113.0 +/- 9.1 beats per minute in controls, p < 0.05). At rest, the time domain measures of HRV were significantly lower in the TBI group (p < 0.05). Time domain mean values decreased significantly during exercise only among the TD children. Conclusions: The findings of this study suggest that among children post-severe TBI, the cardiac autonomic mechanism is less efficient at rest and less adaptive to exercise and activity as compared to TD children.	[Katz-Leurer, Michal] Tel Aviv Univ, Sackler Fac Med, Sch Hlth Profess, Phys Therapy Dept, IL-69978 Tel Aviv, Israel; [Katz-Leurer, Michal; Rotem, Hemda; Keren, Ofer; Meyer, Shirley] Alyn Childrens Orthoped Hosp, Jerusalem, Israel; [Katz-Leurer, Michal; Rotem, Hemda; Keren, Ofer; Meyer, Shirley] Rehabil Ctr, Jerusalem, Israel		Katz-Leurer, M (corresponding author), Tel Aviv Univ, Sackler Fac Med, Sch Hlth Profess, Phys Therapy Dept, IL-69978 Tel Aviv, Israel.	michalkz@post.tau.ac.il					Biswas AK, 2000, CRIT CARE MED, V28, P3907, DOI 10.1097/00003246-200012000-00030; Camm AJ, 1996, CIRCULATION, V93, P1043; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Goldstein B, 1996, CRIT CARE MED, V24, P234, DOI 10.1097/00003246-199602000-00009; GROSWASSER Z, 1987, SURG NEUROL, V27, P331, DOI 10.1016/0090-3019(87)90007-3; Iellamo F, 1999, CIRCULATION, V100, P27, DOI 10.1161/01.CIR.100.1.27; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; Katz-Leurer M, 2005, NEUROREHABILITATION, V20, P91; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; King ML, 1997, BRAIN INJURY, V11, P445; KORPELAINEN JT, 1994, STROKE, V25, P787, DOI 10.1161/01.STR.25.4.787; Korpelainen JT, 1999, CLIN AUTON RES, V9, P325, DOI 10.1007/BF02318379; Korpelainen JT, 1996, ACTA NEUROL SCAND, V94, P337, DOI 10.1111/j.1600-0404.1996.tb07076.x; LAROVERE MT, 1992, CHEST, V101, pS299, DOI 10.1378/chest.101.5.299S; Mossberg KA, 2008, PHYS THER, V88, P77, DOI 10.2522/ptj.20070022; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; Palmer-McLean K, 2003, ACSMS EXERCISE MANAG, P238; ROBINSON BF, 1966, CIRC RES, V19, P400, DOI 10.1161/01.RES.19.2.400; Su CF, 2005, CLIN NEUROPHYSIOL, V116, P1273, DOI 10.1016/j.clinph.2005.01.010; TEASDALE G, 1974, LANCET, V2, P81; Vitale AE, 1997, BRAIN INJURY, V11, P67, DOI 10.1080/026990597123827; YAMOUR BJ, 1980, AM HEART J, V99, P294, DOI 10.1016/0002-8703(80)90343-9	24	23	23	1	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	2					110	114		10.3109/02699050903508234			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	597BF	WOS:000277729500006	20085448				2022-02-06	
J	Kavanagh, L; Rowe, D; Hersch, J; Barnett, KJ; Reznik, R				Kavanagh, Leila; Rowe, Donald; Hersch, Jolyn; Barnett, Kylie J.; Reznik, Robert			Neurocognitive deficits and psychiatric disorders in a NSW prison population	INTERNATIONAL JOURNAL OF LAW AND PSYCHIATRY			English	Article						Forensic mental health; Prison population; IntegNeuro; Neurocognitive; Co-morbid psychiatric disorders	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; TRAUMATIC BRAIN-INJURY; HYPERACTIVITY DISORDER; ADULT PSYCHOPATHY; INMATES; IMPULSIVITY; PERFORMANCE; PREVALENCE; BEHAVIOR; BATTERY	Approximately 75% of inmates in New South Wales (NSW) have mental health issues (Butler & Alnutt, 2003). Scarce resources force the management of acute psychiatric symptoms only, meaning that co-morbid conditions such as neurocognitive deficits are less likely to be assessed. The objective of this study was to investigate the utility of a computerized battery in the assessment of inmates within the criminal justice system. Thirty male inmates were assessed. Data were compared to matched controls. The custodial sample was characterized by an increase in the prevalence of previous trauma; high levels of depression. anxiety and stress and neurocognitive deficits, including sustained attention, impulsivity and executive dysfunction. Crown Copyright (C) 2009 Published by Elsevier Ltd. All rights reserved.	[Kavanagh, Leila; Reznik, Robert] Justice Hlth, Sydney, NSW 2036, Australia; [Rowe, Donald; Barnett, Kylie J.] Brain Resource, Sydney, NSW 2007, Australia; [Hersch, Jolyn] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia		Kavanagh, L (corresponding author), Justice Hlth, POB 150, Matraville, NSW 2036, Australia.	leila.kavanagh@justicehealth.nsw.gov.au		Hersch, Jolyn/0000-0001-5225-6639			American Psychological Association, 1987, GUID COMP BAS TESTS; Birmingham L, 1999, BRIT J PSYCHIAT, V174, P378, DOI 10.1192/bjp.174.5.378; Butler T., 1997, PRELIMINARY FINDINGS; Butler T., 2003, MENTAL ILLNESS NEW S; CHILES JA, 1990, HOSP COMMUNITY PSYCH, V41, P1132; Cima M, 2008, BIOL PSYCHOL, V78, P75, DOI 10.1016/j.biopsycho.2007.12.011; Clark C, 2002, J CHILD PSYCHOL PSYC, V43, P785, DOI 10.1111/1469-7610.00084; Clark CR, 2006, ARCH CLIN NEUROPSYCH, V21, P449, DOI 10.1016/j.acn.2006.06.005; Eyestone L L, 1994, Bull Am Acad Psychiatry Law, V22, P181; Frazier TW, 2004, NEUROPSYCHOLOGY, V18, P543, DOI 10.1037/0894-4105.18.3.543; GATT JM, 2009, MOL PSYCHIATR, V143, P1; Gordon E., 2003, AUSTRALAS PSYCHIATRY, V11, P156, DOI [DOI 10.1046/J.1039-8562.2003.00533.X, 10.1046/j.1039-8562.2003.00533.x]; Gudjonsson GH, 2008, PSYCHOL MED, V38, P1037, DOI 10.1017/S0033291708002882; Hervey AS, 2004, NEUROPSYCHOLOGY, V18, P485, DOI 10.1037/0894-4105.18.3.485; HICKIE IB, 2001, MED J AUSTRALIA, V175, pS2; Jacob CP, 2007, EUR ARCH PSY CLIN N, V257, P309, DOI 10.1007/s00406-007-0722-6; Johansson P, 2005, J PERS DISORD, V19, P94, DOI 10.1521/pedi.19.1.94.62183; Lang S, 2002, ACTA PSYCHIAT SCAND, V106, P93, DOI 10.1034/j.1600-0447.106.s412.20.x; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Montero M.G., 2001, ALCOHOL USE DISORDER; Murphy K, 1996, COMPR PSYCHIAT, V37, P393, DOI 10.1016/S0010-440X(96)90022-X; Paul RH, 2005, INT J NEUROSCI, V115, P1549, DOI 10.1080/00207450590957890; Paul RH, 2007, INT J NEUROSCI, V117, P549, DOI 10.1080/00207450600773665; Rasmussen K, 2001, J AM ACAD PSYCHIATRY, V29, P186; Rose EJ, 2006, J AFFECT DISORDERS, V90, P149, DOI 10.1016/j.jad.2005.11.003; Rosler M, 2004, EUR ARCH PSY CLIN N, V254, P365, DOI 10.1007/S00406-004-0516-Z; Schofield PW, 2006, BRAIN INJURY, V20, P1409, DOI 10.1080/02699050601130443; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Stalenheim EG, 1996, ACTA PSYCHIAT SCAND, V94, P217, DOI 10.1111/j.1600-0447.1996.tb09852.x; Taylor FB, 2000, J CHILD ADOL PSYCHOP, V10, P311, DOI 10.1089/cap.2000.10.311; Turner DC, 2004, BIOL PSYCHIAT, V55, P1031, DOI 10.1016/j.biopsych.2004.02.008; Vitacco MJ, 2001, J AM ACAD PSYCHIATRY, V29, P374; VITELLI R, 1995, INT J OFFENDER THER, V40, P263; Young S, 2009, PERS INDIV DIFFER, V46, P265, DOI 10.1016/j.paid.2008.10.003	34	23	23	0	16	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0160-2527			INT J LAW PSYCHIAT	Int. J. Law Psychiatr.	JAN-FEB	2010	33	1					20	26		10.1016/j.ijlp.2009.10.004			7	Law; Psychiatry	Social Science Citation Index (SSCI)	Government & Law; Psychiatry	549UC	WOS:000274078800004	19922999				2022-02-06	
J	Miller, MA; Conley, Y; Scanlon, JM; Ren, DX; Kamboh, MI; Niyonkuru, C; Wagner, AK				Miller, Megan A.; Conley, Yvette; Scanlon, Joelle M.; Ren, Dianxu; Kamboh, M. Ilyas; Niyonkuru, Christian; Wagner, Amy K.			APOE genetic associations with seizure development after severe traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; post-traumatic seizures; APOE; genetic susceptibility	TEMPORAL-LOBE EPILEPSY; LATE POSTTRAUMATIC SEIZURES; APOLIPOPROTEIN-E POLYMORPHISM; CONTROLLED CORTICAL IMPACT; AMYLOID-BETA PLAQUES; E EPSILON 4; HEAD-INJURY; ALZHEIMERS-DISEASE; SENILE PLAQUES; RISK-FACTORS	Primary objective: The purpose of the current study is to assess the role of the APOE genotype in post-traumatic seizure (PTS) development. Research design: A retrospective study of 322 adult Caucasians with a severe TBI and APOE genotype. Methods and procedures: Medical records were searched for PTS. Time to first seizure was categorized as early, late or delayed-onset PTS. Potential PTS associations by genotype, grouped genotype and allele were investigated. Main outcome and results: No statistically significant associations were found. However, two out of the four individuals (50%) with the E4/E4 genotype had late/delayed-onset PTS. Furthermore, none with a E2/E2 or E2/E4 genotype seized in the late periods. Conclusions: The results of this study may suggest 4/4 as a risk genotype for late/delayed onset PTS and a potential neuroprotective role of the E2 allele. However, this study did not definitively support a role for the APOE genotype in PTS susceptibility and indicates that larger populations are needed to fully evaluate the potential impact of APOE on PTS.	[Miller, Megan A.; Scanlon, Joelle M.; Niyonkuru, Christian; Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Conley, Yvette; Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Conley, Yvette; Ren, Dianxu] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15213 USA; [Conley, Yvette; Kamboh, M. Ilyas] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15213 USA		Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 5th Ave,Suite 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu		Kamboh, M. Ilyas/0000-0002-3453-1438	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIHR01HD048162, NIHP50NS030318, NIHR01NR008424]; DODUnited States Department of Defense [W81XWH-07-1-0701]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR008424] Funding Source: NIH RePORTER	The authors would like to acknowledge the NIH grant number NIHR01HD048162, NIHP50NS030318, and NIHR01NR008424 as well as DOD grant number W81XWH-07-1-0701.	Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Anderson GD, 2009, EPILEPSY BEHAV, V16, P501, DOI 10.1016/j.yebeh.2009.08.025; Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Blumcke I, 1997, NEUROREPORT, V8, P1235; Briellmann RS, 2000, NEUROLOGY, V55, P435, DOI 10.1212/WNL.55.3.435; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Bushnik T, 2004, J HEAD TRAUMA REHAB, V19, P296, DOI 10.1097/00001199-200407000-00004; Cavalleri GL, 2007, LANCET NEUROL, V6, P970, DOI 10.1016/S1474-4422(07)70247-8; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Chu AY, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-108; Clark RSB, 1996, J CEREBR BLOOD F MET, V16, P253, DOI 10.1097/00004647-199603000-00010; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; Englander J, 2009, J NEUROTRAUM, V26, P1471, DOI 10.1089/neu.2008.0729; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Gambardella A, 1999, EPILEPSIA, V40, P1804, DOI 10.1111/j.1528-1157.1999.tb01602.x; Gouras GK, 1997, ANN NEUROL, V41, P402, DOI 10.1002/ana.410410317; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; Hayes GM, 2009, J VET EMERG CRIT CAR, V19, P629, DOI 10.1111/j.1476-4431.2009.00478.x; HIXSON JE, 1990, J LIPID RES, V31, P545; Holtzman DM, 1999, J CLIN INVEST, V103, pR15, DOI 10.1172/JCI6179; Horsburgh K, 2000, NEUROBIOL AGING, V21, P245, DOI 10.1016/S0197-4580(00)00097-X; Hung CC, 2005, PHARMACOGENOMICS, V6, P411, DOI 10.1517/14622416.6.4.411; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JENNETT B, 1975, LANCET, V1, P480; Johnson VE, 2009, J NEUROTRAUM, V26, P1197, DOI [10.1089/neu.2008.0843, 10.1089/neu.2008-0843]; KAMBOH MI, 1995, NAT GENET, V11, P104, DOI 10.1038/ng0995-104d; Kay AD, 2003, J NEUROTRAUM, V20, P943, DOI 10.1089/089771503770195795; Lichtman SW, 2000, NEUROLOGY, V55, P1536, DOI 10.1212/WNL.55.10.1536; Lin CM, 2009, SURG NEUROL, V72, P50, DOI 10.1016/j.wneu.2009.09.004; MACKENZIE IRA, 1994, ACTA NEUROPATHOL, V87, P504; Martel CL, 1997, J NEUROCHEM, V69, P1995; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mohler L, 2008, J NEUROTRAUM, V25, P874; Nathoo N, 2003, J CLIN PATHOL-MOL PA, V56, P132, DOI 10.1136/mp.56.3.132; NICOLINI C, 1995, ELECTR BIOT ADV FOR, V1, P135; Rocchi A, 2009, CURR ALZHEIMER RES, V6, P224, DOI 10.2174/156720509788486644; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SMITH KR, 1994, ARCH NEUROL-CHICAGO, V51, P653, DOI 10.1001/archneur.1994.00540190029012; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Wagner AK, 2005, CRIT CARE MED, V33, P407, DOI 10.1097/01.CCM.0000153931.23488.DD; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; YOUNG B, 1987, J NEUROSURG, V67, P668, DOI 10.3171/jns.1987.67.5.0668; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	57	23	24	0	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2010	24	12					1468	1477		10.3109/02699052.2010.520299			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	667NR	WOS:000283200800009	20961174				2022-02-06	
J	Nott, MT; Chapparo, C; Heard, R; Baguley, IJ				Nott, Melissa T.; Chapparo, Christine; Heard, Robert; Baguley, Ian J.			Patterns of agitated behaviour during acute brain injury rehabilitation	BRAIN INJURY			English	Article						Agitation; cognition; rehabilitation; post-traumatic amnesia	POSTTRAUMATIC AMNESIA PTA; TRAUMATIC HEAD-INJURY; SCALE; RECOVERY; DURATION	Objective: To monitor daily shift-by-shift changes in agitated behaviour during adult brain injury rehabilitation. Design: A prospective, descriptive study. Methods: Eight participants were monitored daily for up to 28 days. The Agitated Behaviour Scale (ABS) evaluated behaviour during three nursing shifts (morning, afternoon, night). Severity of agitation, peak intensity and concomitant behaviours were calculated. Shift differences and patterns of behavioural changes were analysed. Results: Four hundred and seven recordings were taken with the ABS. All participants demonstrated multiple agitated behaviours (between 3-13 concomitant behaviours per person); the most common behaviours were representative of the ABS Disinhibition sub-scale. Weekly peak intensity ranged from 14-55 on the ABS. Mean ABS scores were highest during the afternoon shift and lowest at night. Improved cognition was associated with resolving agitated behaviour; while persistent agitated behaviour was associated with low levels of cognition. Minimal agitated behaviour was observed in participants who emerged from post-traumatic amnesia. Conclusions: Agitated behaviour during acute brain injury rehabilitation has a complex clinical presentation. High levels of agitation observed during the afternoon shift may be associated with low levels of structured activities available at that time, higher levels of environmental stimuli during visiting times and increased cognitive fatigue. Lower cognitive ability was related to consistently higher levels of agitated behaviour and vice-versa.	[Nott, Melissa T.; Baguley, Ian J.] Westmead Hosp, Brain Injury Rehabil Serv, Wentworthville, NSW 2145, Australia; [Chapparo, Christine; Heard, Robert] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia; [Baguley, Ian J.] Univ Sydney, Sydney Med Sch, Dept Rehabil Med, Sydney, NSW 2006, Australia		Nott, MT (corresponding author), Westmead Hosp, Brain Injury Rehabil Serv, POB 355, Wentworthville, NSW 2145, Australia.	melissan@biru.wsahs.nsw.gov.au	Nott, Melissa T/M-6778-2018; Baguley, Ian/AAM-5828-2021; Baguley, Ian J/K-6878-2013	Nott, Melissa T/0000-0001-7088-5826; Baguley, Ian J/0000-0001-5650-3705			Ahmed S, 2000, BRAIN INJURY, V14, P765; Beaulieu C, 2008, J HEAD TRAUMA REHAB, V23, P304, DOI 10.1097/01.HTR.0000336843.60961.b7; BERMANN DE, 1988, HEAD INJURY GUIDE FU, P45; BOGNER J, 1995, NEUROREHABILITATION, V5, P293, DOI 10.3233/NRE-1995-5403; Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91, DOI 10.1097/00001199-199902000-00012; Bogner JA, 2000, J HEAD TRAUMA REHAB, V15, P656, DOI 10.1097/00001199-200002000-00005; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; Burnett DM, 1999, NEUROREHABILITATION, V13, P165; COHENMANSFIELD J, 1989, J GERONTOL, V44, pM77, DOI 10.1093/geronj/44.3.M77; CORRIGAN J D, 1992, Brain Injury, V6, P155, DOI 10.3109/02699059209029653; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; CORRIGAN JD, 1988, ARCH PHYS MED REHAB, V69, P487; Ducharme JM, 1999, BRAIN INJURY, V13, P645, DOI 10.1080/026990599121232; Fluharty G, 2001, BRAIN INJURY, V15, P995, DOI 10.1080/02699050010025795; GEFFEN G, 1994, AUST OCCUP THER J, V41, P31, DOI DOI 10.1111/J.1440-1630.1994.TB01809.X; GEFFEN GM, 1991, NEUROREPORT, V2, P105, DOI 10.1097/00001756-199102000-00010; GILES GM, 1999, REHABILITATION SEVER, P97; GURKA JA, 2005, BRAIN INJURY S1, V19, P1; Hagen C, 1979, REHABILITATION HEAD, P87; HAGEN C, 2001, RELEARNING TIMES, V8, P1; Herbel K, 1990, Rehabil Nurs, V15, P66; Kadyan V, 2004, AM J PHYS MED REHAB, V83, P747, DOI 10.1097/01.PHM.0000140790.30468.F4; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Lequerica AH, 2007, J HEAD TRAUMA REHAB, V22, P177, DOI 10.1097/01.HTR.0000271118.96780.bc; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; MYSIW WJ, 1988, AM J PHYS MED REHAB, V67, P29, DOI 10.1097/00002060-198802000-00006; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; Plylar P A, 1989, J Neurosci Nurs, V21, P353; Pryor J, 2004, DISABIL REHABIL, V26, P974, DOI 10.1080/09638280410001702397; Radomski M.V., 2008, OCCUPATIONAL THERAPY; REYES RL, 1981, ARCH PHYS MED REHAB, V62, P20; Riedel D, 1997, Rehabil Nurs, V22, P36; Sandel ME, 1996, ARCH PHYS MED REHAB, V77, P617, DOI 10.1016/S0003-9993(96)90306-8; Shores E A, 1995, Appl Neuropsychol, V2, P167; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Tate RL, 2001, J HEAD TRAUMA REHAB, V16, P525, DOI 10.1097/00001199-200112000-00002; van der Naalt J, 2000, BRAIN INJURY, V14, P781; Weir N, 2006, BRAIN INJURY, V20, P927, DOI 10.1080/02699050600832684; WILSON J, 1999, REHABILITATION SEVER, P54	40	23	23	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	10					1214	1221		10.3109/02699052.2010.506858			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	667MJ	WOS:000283197100008	20715891				2022-02-06	
J	Preissig, CM; Rigby, MR				Preissig, Catherine M.; Rigby, Mark R.			A disparity between physician attitudes and practice regarding hyperglycemia in pediatric intensive care units in the United States: a survey on actual practice habits	CRITICAL CARE			English	Article							GLUCOSE CONTROL; INSULIN THERAPY; MORTALITY; VARIABILITY; MANAGEMENT; MORBIDITY; DEATH	Introduction: Hyperglycemia is common in critically ill patients and is associated with increased morbidity and mortality. Strict glycemic control improves outcomes in some adult populations and may have similar effects in children. While glycemic control has become standard care in adults, little is known regarding hyperglycemia management strategies used by pediatric critical care practitioners. We sought to assess both the beliefs and practice habits regarding glycemic control in pediatric intensive care units (ICUs) in the United States (US). Methods: We surveyed 30 US pediatric ICUs from January to May 2009. Surveys were conducted by phone between the investigators and participating centers and consisted of a 22-point questionnaire devised to assess physician perceptions and center-specific management strategies regarding glycemic control. Results: ICUs included a cross section of centers throughout the US. Fourteen out of 30 centers believe all critically ill hyperglycemic adults should be treated, while 3/30 believe all critically ill children should be treated. Twenty-nine of 30 believe some subsets of adults with hyperglycemia should be treated, while 20/30 believe some subsets of children should receive glycemic control. A total of 70%, 73%, 80%, 27%, and 40% of centers believe hyperglycemia adversely affects outcomes in cardiac, trauma, traumatic brain injury, general medical, and general surgical pediatric patients, respectively. However, only six centers use a standard, uniform approach to treat hyperglycemia at their institution. Sixty percent of centers believe hypoglycemia is more dangerous than hyperglycemia. Seventy percent listed fear of management-induced hypoglycemia as a barrier to glycemic control at their center. Conclusions: Considerable disparity exists between physician beliefs and actual practice habits regarding glycemic control among pediatric practitioners, with few centers reporting the use of any consistent standard approach to screening and management. Physicians wishing to practice glycemic control in their critically ill pediatric patients may want to consider adopting center-wide uniform approaches to improve safety and efficacy of treatment.	[Preissig, Catherine M.] Med Ctr Cent Georgia, Dept Pediat, Div Pediat Crit Care Med, Macon, GA 31201 USA; [Preissig, Catherine M.; Rigby, Mark R.] Emory Univ, Sch Med, Dept Pediat, Div Pediat Crit Care, Atlanta, GA 30322 USA		Preissig, CM (corresponding author), Med Ctr Cent Georgia, Dept Pediat, Div Pediat Crit Care Med, 777 Hemlock St, Macon, GA 31201 USA.	preissig.catherine@mccg.org	Gupta, Yashdeep/J-4450-2014	Gupta, Yashdeep/0000-0002-4345-717X			*ACE ADA TASK FORC, 2009, ENDOCR PRACT, V15, P1; [Anonymous], 2005, DIABETES CARE, V28, pS4; Branco Ricardo G, 2005, Pediatr Crit Care Med, V6, P470, DOI 10.1097/01.PCC.0000161284.96739.3A; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Clausen TD, 2005, DIABETES CARE, V28, P990; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; Faustino EV, 2005, J PEDIATR-US, V146, P30, DOI 10.1016/j.jpeds.2004.08.076; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Finney SJ, 2003, JAMA-J AM MED ASSOC, V290, P2041, DOI 10.1001/jama.290.15.2041; Griesdale DEG, 2009, CAN MED ASSOC J, V180, P821, DOI 10.1503/cmaj.090206; Hays SP, 2006, PEDIATRICS, V118, P1811, DOI 10.1542/peds.2006-0628; Hirshberg E, 2008, PEDIATR CRIT CARE ME, V9, P361, DOI 10.1097/PCC.0b013e318172d401; Hirshberg E, 2008, CHEST, V133, P1328, DOI 10.1378/chest.07-2702; *I HEALTHC IMPR, MAINT AD GLYC CONTR; Inzucchi SE, 2006, NEW ENGL J MED, V355, P1903, DOI 10.1056/NEJMcp060094; Klein GW, 2008, J PEDIATR-US, V153, P379, DOI 10.1016/j.jpeds.2008.04.012; Krinsley JS, 2004, MAYO CLIN PROC, V79, P992, DOI 10.4065/79.8.992; Nayak P, 2009, PEDIATR CRIT CARE ME, V10, P303, DOI 10.1097/PCC.0b013e318198b012; Odetola FO, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1920; Preissig CM, 2008, PEDIATR CRIT CARE ME, V9, P581, DOI 10.1097/PCC.0b013e31818d36cb; Preissig CM, 2009, J PEDIATR-US, V155, P734, DOI 10.1016/j.jpeds.2009.05.007; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Srinivasan Vijay, 2004, Pediatr Crit Care Med, V5, P329, DOI 10.1097/01.PCC.0000128607.68261.7C; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vlasselaers D, 2009, LANCET, V373, P547, DOI 10.1016/S0140-6736(09)60044-1; Wintergerst KA, 2006, PEDIATRICS, V118, P173, DOI 10.1542/peds.2005-1819; Yung M, 2008, PEDIATR CRIT CARE ME, V9, P147, DOI 10.1097/PCC.0b013e3181668c22; 2004, CRIT CARE MED, V32, P281	29	23	23	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care		2010	14	1							R11	10.1186/cc8865			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587KD	WOS:000276989800045	20128893	Green Published, gold			2022-02-06	
J	Shahlaie, K; Lyeth, BG; Gurkoff, GG; Muizelaar, JP; Berman, RF				Shahlaie, Kiarash; Lyeth, Bruce G.; Gurkoff, Gene G.; Muizelaar, J. Paul; Berman, Robert F.			Neuroprotective Effects of Selective N-Type VGCC Blockade on Stretch-Injury-Induced Calcium Dynamics in Cortical Neurons	JOURNAL OF NEUROTRAUMA			English	Article						in vitro; neuroprotection; N-type VGCC; SNX-185; traumatic brain injury	TRAUMATIC BRAIN-INJURY; INTRACELLULAR FREE CALCIUM; FOCAL CEREBRAL-ISCHEMIA; FLUID-PERCUSSION INJURY; CHANNEL ANTAGONIST; MITOCHONDRIAL DYSFUNCTION; DELAYED DEPOLARIZATION; CULTURED ASTROCYTES; CA-45 ACCUMULATION; SODIUM-CHANNELS	Acute elevation in intracellular calcium ([Ca2+](i)) following traumatic brain injury (TBI) can trigger cellular mechanisms leading to neuronal dysfunction and death. The mechanisms underlying these processes are not completely understood, but calcium influx through N-type voltage-gated calcium channels (VGCCs) appears to play a central role. The present study examined the time course of [Ca2+](i) flux, glutamate release, and loss of cell viability following injury using an in vitro neuronal-glial cortical cell-culture model of TBI. The effects of N-channel blockade with SNX-185 (e.g. omega-conotoxin TVIA) before or after injury were also examined. Neuronal injury produced a transient elevation in [Ca2+](i), increased glutamate release, and resulted in neuronal and glial death. SNX-185 administered before or immediately after cell injury reduced glutamate release and increased the survival of neurons and astrocytes, whereas delayed treatment did not improve cell survival but significantly facilitated the return of [Ca2+](i) to baseline levels. The new findings that N-type VGCCs are critically involved in injury-induced glutamate release and recovery of [Ca2+](i) argue for continued investigation of this treatment strategy for the clinical management of TBI. In particular, SNX-185 may represent an effective class of drugs that can significantly protect injured neurons from the secondary insults that commonly occur after TBI.	[Shahlaie, Kiarash; Lyeth, Bruce G.; Gurkoff, Gene G.; Muizelaar, J. Paul; Berman, Robert F.] Univ Calif Davis, Dept Neurol Surg, Sch Med, Sacramento, CA 95817 USA		Shahlaie, K (corresponding author), Univ Calif Davis, Dept Neurol Surg, Sch Med, 4860 Y St,Suite 3740, Sacramento, CA 95817 USA.	krshahlaie@gmail.com		Lyeth, Bruce/0000-0003-4811-1474	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 39090, NS 29995, NS 45136]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045136, R01NS029995, R01NS039090] Funding Source: NIH RePORTER	The authors thank Ryan Martin, Kim Katleba, and Dr. Candace Floyd for their invaluable assistance with these experiments, and William T. O'Connor for performing the analysis of the glutamate levels. This research was supported by NIH NS 39090 (RFB), NIH NS 29995 (BGL), and NS 45136 (BGL).	Ahmed SM, 2002, J NEUROTRAUM, V19, P1619, DOI 10.1089/089771502762300274; Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; Atkins CM, 2006, J CEREBR BLOOD F MET, V26, P1507, DOI 10.1038/sj.jcbfm.9600301; Berman RF, 2000, J NEUROSURG, V93, P821, DOI 10.3171/jns.2000.93.5.0821; Bowersox SS, 1997, BRAIN RES, V747, P343; Bowersox SS, 1996, J PHARMACOL EXP THER, V279, P1243; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; Colbourne F, 1999, STROKE, V30, P662, DOI 10.1161/01.STR.30.3.662; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Floyd CL, 2007, PROG BRAIN RES, V161, P61, DOI 10.1016/S0079-6123(06)61005-4; Floyd CL, 2001, GLIA, V33, P12, DOI 10.1002/1098-1136(20010101)33:1<12::AID-GLIA1002>3.0.CO;2-V; Folkerts MM, 2007, J NEUROTRAUM, V24, P638, DOI 10.1089/neu.2006.0188; Hellmich HL, 2007, BRAIN RES, V1127, P119, DOI 10.1016/j.brainres.2006.09.094; HOVDA DA, 1994, ACTA NEUROCHIR, P521; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Kovesdi E, 2007, PROG BRAIN RES, V161, P81, DOI 10.1016/S0079-6123(06)61006-6; LaPlaca MC, 1997, J NEUROTRAUM, V14, P355, DOI 10.1089/neu.1997.14.355; Lee LL, 2004, EXP NEUROL, V190, P70, DOI 10.1016/j.expneurol.2004.07.003; Meberg PJ, 2003, METHOD CELL BIOL, V71, P111, DOI 10.1016/S0091-679X(03)01007-0; Muellner A, 2003, J NEUROTRAUM, V20, P745, DOI 10.1089/089771503767869971; Newcomb R, 2000, PEPTIDES, V21, P491, DOI 10.1016/S0196-9781(00)00175-3; OORSCHOT DE, 1989, EXP BRAIN RES, V78, P132; Perez-Pinzon MA, 1997, J NEUROL SCI, V153, P25, DOI 10.1016/S0022-510X(97)00196-2; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; Samii A, 1999, J NEUROTRAUM, V16, P879, DOI 10.1089/neu.1999.16.879; SCHANNE FAX, 1979, SCIENCE, V206, P700, DOI 10.1126/science.386513; Schinder AF, 1996, J NEUROSCI, V16, P6125; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Smith DH, 1999, J NEUROSCI, V19, P4263; Staats PS, 2004, JAMA-J AM MED ASSOC, V291, P63, DOI 10.1001/jama.291.1.63; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Tavalin SJ, 1997, J NEUROPHYSIOL, V77, P632, DOI 10.1152/jn.1997.77.2.632; Tavalin SJ, 1995, J NEUROPHYSIOL, V74, P2767, DOI 10.1152/jn.1995.74.6.2767; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; VALENTINO K, 1993, P NATL ACAD SCI USA, V90, P7894, DOI 10.1073/pnas.90.16.7894; Verweij BH, 2000, J NEUROSURG, V93, P829, DOI 10.3171/jns.2000.93.5.0829; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; Wang YX, 1998, N-S ARCH PHARMACOL, V357, P159, DOI 10.1007/PL00005150; Weber JT, 2004, CURR NEUROVASC RES, V1, P151, DOI 10.2174/1567202043480134; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Wong J, 2005, NEUROCRIT CARE, V3, P177, DOI 10.1385/NCC:3:2:177; YOUNG W, 1992, J NEUROTRAUM, V9, pS9; YOUNG W, 1996, NEUROTRAUMA, P1421; Yudofsky S.C., 2005, TXB TRAUMATIC BRAIN, P27; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zhong C, 2006, J NEUROCHEM, V97, P1015, DOI 10.1111/j.1471-4159.2006.03786.x	51	23	25	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2010	27	1					175	187		10.1089/neu.2009.1003			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	548RF	WOS:000273983200015	19772476	Green Published			2022-02-06	
J	Weber, M; Edwards, MG				Weber, Mareen; Edwards, Martin Gareth			The effect of brain injury terminology on university athletes' expected outcome from injury, familiarity and actual symptom report	BRAIN INJURY			English	Article						Mild brain injury; concussion; head injury; outcome; sport; cognition	HEAD-INJURY; COGNITIVE PERFORMANCE; DIAGNOSIS THREAT; CONCUSSION; MISCONCEPTIONS; FOOTBALL; SPORTS; EXPECTATION; KNOWLEDGE; PLAYERS	Primary objective: To determine the influence of the terms concussion, mild traumatic brain injury and minor head injury on expected injury outcome, term-related familiarity and actual symptom reporting. Research design: A questionnaire varied the terms concussion, mild traumatic brain injury and minor head injury. Methods and procedures: Two hundred and twenty-four university students were allocated one questionnaire version. Participants rated injury outcome statements for their truthfulness, specified term familiarity and completed measures on post-concussion symptoms, anxiety, depression, pain and affectivity. Chi-square tests compared response frequencies of statement ratings and familiarity between questionnaire versions and a rank-based multivariate method compared psychological measures between questionnaire versions. Main outcomes and results: Terminology significantly influenced both expected injury outcome and familiarity. Outcome expectations were reliably more negative for the term mild traumatic brain injury than concussion or minor head injury. Mild traumatic brain injury was the least familiar term. However, terminology groups did not differ in actual symptom reporting. Conclusions: The data showed that the use of terminology affected athletes' injury outcome expectations and familiarity. The impact of the data and advice for the best term for future use are discussed. While it is not easy to make a clear recommendation, the data clearly indicate a strong need for education of brain injury at university level and possibly beyond.	[Weber, Mareen; Edwards, Martin Gareth] Univ Birmingham, Sch Sport & Exercise Sci, Birmingham B15 2TT, W Midlands, England		Weber, M (corresponding author), Univ Birmingham, Sch Sport & Exercise Sci, Birmingham B15 2TT, W Midlands, England.	mareen.weber@gmail.com	Edwards, Martin/A-9765-2009	Edwards, Martin/0000-0003-4532-2436			Anderson T, 2006, PRACTICAL NEUROLOGY, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Becker MH, 1974, BEHAV SCI PREVENTIVE, P25; Chapman RCG, 2010, BRAIN INJURY, V24, P797, DOI 10.3109/02699051003709607; Delaney JS, 2001, CLIN J SPORT MED, V11, P234, DOI 10.1097/00042752-200110000-00005; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; IVERSON GL, 2009, MTBI 2009 INT C MILD; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kelly JP, 2000, SEMIN NEUROL, V20, P165, DOI 10.1055/s-2000-9835; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; LaBotz M, 2005, CLIN J SPORT MED, V15, P73, DOI 10.1097/01.jsm.0000157649.99867.fc; Leventhal H., 2003, SELF REGULATION HLTH, DOI DOI 10.4324/9780203553220; Lovell M, 2009, CLIN SPORT MED, V28, P95, DOI 10.1016/j.csm.2008.08.008; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2001, BRIT J SPORT MED, V35, P288, DOI 10.1136/bjsm.35.5.288; MCDOWELL I, 2003, MEASURING HLTH GUIDE, P335; McGrane SA, 2000, BRAIN INJURY, V14, P975; Mulhern S, 2006, J PSYCHOSOM RES, V61, P439, DOI 10.1016/j.jpsychores.2006.03.004; R Core Team, 2017, R LANG ENV STAT COMP; SEFTON JM, 2003, THESIS CENTRAL CONNE, P63; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; McLeod TCV, 2008, CLIN J SPORT MED, V18, P235, DOI 10.1097/JSM.0b013e3181705756; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WILCOX RR, 2005, INTRO ROBUST ESTIMAT, P377; WILLER B, 1993, ARCH CLIN NEUROPSYCH, V8, P461, DOI 10.1016/0887-6177(93)90009-P; Wills SM, 2001, BRAIN INJURY, V15, P645, DOI 10.1080/02699050010010502; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	46	23	23	0	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	11					1364	1371		10.3109/02699052.2010.507110			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	667MY	WOS:000283198800012	20715897				2022-02-06	
J	Young, AE				Young, Amanda E.			Employment maintenance and the factors that impact it after vocational rehabilitation and return to work	DISABILITY AND REHABILITATION			English	Article						Return to work; rehabilitation; participation barriers and facilitators	LOW-BACK-PAIN; TRAUMATIC BRAIN-INJURY; MUSCULOSKELETAL DISORDERS; RECOVERY EXPECTATIONS; OCCUPATIONAL INJURY; SICKNESS ABSENCE; DISABILITY; HEALTH; RECURRENCE; EPISODES	Purpose. To determine post-return-to-work disability and functioning amongst occupationally injured workers and to test the extent to which demographic and other variables relate to employment maintenance. In addition, the project sought to document what workers believe determined their work continuation. Method. Semi-structured in-depth interviews were conducted to inquire about participant's (N=150) post-vocational rehabilitation return-to-work experiences. Results were interpreted using the health and health-related domains from the International Classification of Functioning, Disability and Health. Results. Although most participants were working at the time of interview, almost all were experiencing functional-or activity-based restrictions. Factors differentiating those employed from those not, were largely contextual and included relationships with supervisors, economic climate, and working conditions. Conclusions. The findings stress the importance of considering environmental strains when planning return to work and indicate ways to assist workers to achieve return-to-work success.	Ctr Disabiilty Res, Liberty Mutual Res Inst Safety, Hopkinton, MA 01748 USA		Young, AE (corresponding author), Ctr Disabiilty Res, Liberty Mutual Res Inst Safety, 71 Frankland Rd, Hopkinton, MA 01748 USA.	amandae.young@libertymutual.com	Young, Amanda/H-8851-2016	Young, Amanda/0000-0002-7288-3469			ABENHAIM L, 1988, BRIT J IND MED, V45, P829; American Association for Public Opinion Research, 2008, STAND DEF FIN DISP C; Baril R, 2003, SOC SCI MED, V57, P2101, DOI 10.1016/S0277-9536(03)00131-X; Burdorf A, 2006, OCCUP ENVIRON MED, V63, P522, DOI 10.1136/oem.2005.019745; Campbell Research and Consulting, 2000, NAT RET TO WORK MON; Cole DC, 2002, CAN MED ASSOC J, V166, P749; Concha-Barrientos M, 2005, AM J IND MED, V48, P470, DOI 10.1002/ajim.20226; Duggan CH, 2008, DISABIL REHABIL, V30, P978, DOI 10.1080/09638280701797549; Gross DP, 2005, J OCCUP ENVIRON MED, V47, P428, DOI 10.1097/01.jom.0000158706.96994.a5; Gross DP, 2004, SPINE, V29, P920, DOI 10.1097/00007632-200404150-00020; Kenny D, 1998, AUST J REHAB COUNSEL, V4, P97; Levack W, 2004, DISABIL REHABIL, V26, P290, DOI 10.1080/09638280310001647615; Lotters F, 2005, SCAND J WORK ENV HEA, V31, P367; Lotters F, 2005, SPINE, V30, P1086; Lysaght RM, 2008, WORK, V30, P255; MURPHY G, 2001, RETURN WORK FOLLOWIN; Nieuwenhuijsen K, 2004, OCCUP ENVIRON MED, V61, P817, DOI 10.1136/oem.2003.009688; *OFF MAN BUDG, 1987, STAND IND CLASS SIC; Office for National Statistics, 2000, STAND OCC CLASS 2000; ROSSIGNOL M, 1992, SPINE, V17, P1043, DOI 10.1097/00007632-199209000-00006; Schonherr MC, 2004, SPINAL CORD, V42, P177, DOI 10.1038/sj.sc.3101581; Schultz IZ, 2005, HANDBOOK OF COMPLEX OCCUPATIONAL DISABILITY CLAIMS: EARLY RISK IDENTIFICATIONS, INTERVENTION, AND PREVENTION, P523; Shaw WS, 2003, J OCCUP REHABIL, V13, P129, DOI 10.1023/A:1024997000505; Stamm T, 2007, CURR OPIN RHEUMATOL, V19, P184, DOI 10.1097/BOR.0b013e3280148e64; Subramanian A, 2006, J OCCUP REHABIL, V16, P123, DOI 10.1007/s10926-005-9012-1; Sundar V, 2008, DISABIL REHABIL, V30, P955, DOI 10.1080/09638280701800285; Tsaousides T, 2008, REHABIL PSYCHOL, V53, P456, DOI 10.1037/a0012579; U. S. Department of Labor Bureau of Labor Statistics, 1992, OCC INJ ILLN CLASS M; Vercillo A, 2008, JOB RETENTION SUCCES; Wasiak R, 2006, SPINE, V31, P219, DOI 10.1097/01.brs.0000194774.85971.df; Wasiak R, 2004, J OCCUP ENVIRON MED, V46, P68, DOI 10.1097/01.jom.0000105987.32375.3d; Wasiak R, 2007, J OCCUP REHABIL, V17, P766, DOI 10.1007/s10926-007-9101-4; Westmorland Muriel G, 2004, Work, V23, P31; World Health Organization, 2002, COMM LANG FUNCT DIS; Young AE, 2005, J OCCUP REHABIL, V15, P557, DOI 10.1007/s10926-005-8034-z; Young AE, 2002, J OCCUP REHABIL, V12, P175, DOI 10.1023/A:1016894628429; Young AE, 2009, DISABIL REHABIL, V31, P2013, DOI 10.3109/09638280902887412; 1997, BLS HDB METHODS	38	23	23	0	11	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0963-8288			DISABIL REHABIL	Disabil. Rehabil.		2010	32	20					1621	1632		10.3109/09638281003611029			12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	660RQ	WOS:000282661800001	20158373				2022-02-06	
J	Hayes, GM				Hayes, Galina M.			Severe seizures associated with traumatic brain injury managed by controlled hypothermia, pharmacologic coma, and mechanical ventilation in a dog	JOURNAL OF VETERINARY EMERGENCY AND CRITICAL CARE			English	Article						canine; cooling; head trauma	SEVERE HEAD-INJURY; THERAPEUTIC HYPOTHERMIA; INTRACRANIAL-PRESSURE; MODERATE HYPOTHERMIA; STATUS EPILEPTICUS; MODEL	Objective To describe the management and outcome of a dog presenting with intractable seizures associated with traumatic brain injury. Case Summary A spayed female Wheaten Terrier was presented to an emergency clinic with neurologic deficits (modified Glasgow coma scale of 10) shortly after a road traffic accident. Seizures were uncontrolled despite aggressive pharmacologic intervention. Controlled hypothermia to achieve a rectal temperature of 33-35 degrees C (91.4-95 degrees F) was initiated as a protective measure to reduce intracranial pressure and cerebral metabolic rate, and to assist with seizure control. Intubation and mechanical ventilation were required to protect the airway and manage hypercapnia associated with hypoventilation. The patient went on to make a full recovery, although behavioral changes were noted by the owners for an 8-week period following injury. New or Unique Information Provided To the author's knowledge, this is the first instance of therapeutic hypothermia reported in the veterinary literature. A short review of this treatment modality is provided.	[Hayes, Galina M.] Western Vet Specialist Ctr, Emergency Dept, Calgary, AB T3C 0J8, Canada		Hayes, GM (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Clin Studies, Guelph, ON N1G 2W1, Canada.	galina@uoguelph.ca					Abate MG, 2008, MINERVA ANESTESIOL, V74, P425; ALDERSON P, 2004, COCHRANE DB SYST REV, V18; BAGLEY RS, 1995, J AM VET MED ASSOC, V207, P588; BRATTON SL, 2007, J NEUROTRAUM, V24, P21; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Chesnut Randall M., 1997, Emergency Medicine Clinics of North America, V15, P581, DOI 10.1016/S0733-8627(05)70319-9; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; COHEN SM, 2005, TXB CRITICAL CARE, P377; Ganong WE, 2005, REV MED PHYSL, P597; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; LOTHMAN E, 1990, NEUROLOGY, V40, P13; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; Matsushita Y, 2001, CRIT CARE MED, V29, P2060, DOI 10.1097/00003246-200111000-00004; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Moore FA, 2004, LANCET, V363, P1988, DOI 10.1016/S0140-6736(04)16415-5; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Parviainen I, 2006, INTENS CARE MED, V32, P1075, DOI 10.1007/s00134-006-0154-1; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Platt SR, 2001, J VET INTERN MED, V15, P581, DOI 10.1892/0891-6640(2001)015&lt;0581:TPVOTM&gt;2.3.CO;2; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Polderman KH, 2004, INTENS CARE MED, V30, P556, DOI 10.1007/s00134-003-2152-x; POMERANZ S, 1993, J NEUROSURG, V79, P241, DOI 10.3171/jns.1993.79.2.0241; Ract C, 2007, INTENS CARE MED, V33, P645, DOI 10.1007/s00134-007-0558-6; Stocchetti N, 2007, INTENS CARE MED, V33, P1682, DOI 10.1007/s00134-007-0798-5; Sturges BK., 2009, SMALL ANIMAL CRITICA, P883; Syring RS, 2001, J AM VET MED ASSOC, V218, P1124, DOI 10.2460/javma.2001.218.1124	29	23	23	0	17	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1479-3261			J VET EMERG CRIT CAR	J. Vet. Emerg. Crit. Care	DEC	2009	19	6					629	634		10.1111/j.1476-4431.2009.00478.x			6	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	530KQ	WOS:000272590400013	20017770				2022-02-06	
J	Jin, W; Wang, HD; Hu, ZG; Yan, W; Chen, G; Yin, HX				Jin, Wei; Wang, Han-Dong; Hu, Zhi-gang; Yan, Wei; Chen, Gang; Yin, Hong-Xia			Transcription Factor Nrf2 Plays a Pivotal Role in Protection Against Traumatic Brain Injury-Induced Acute Intestinal Mucosal Injury in Mice	JOURNAL OF SURGICAL RESEARCH			English	Article						nuclear factor E2-related factor 2; traumatic brain injury; intestine; inflammation; oxidative stress	ABERRANT CRYPT FOCI; OXIDATIVE STRESS; ENHANCES SUSCEPTIBILITY; NRF2-DEFICIENT MICE; HEAD-INJURY; RATS; CHEMOPREVENTION; CARCINOGENESIS; ANTIOXIDANT; INDUCTION	Background. Traumatic brain injury (TBI) can induce an acute intestinal mucosal injury. Nuclear factor erythroid 2-related factor 2 (Nrf2) has a unique role in many physiological stress processes, but its contribution to intestinal mucosal injury after TBI remains to be determined. Materials and Methods. Wildtype Nrf2 (+/+) and Nrf2 (-/-) deficient mice were subjected to a moderately severe weight-drop impact head injury. Intestinal mucosal morphological changes, plasma endotoxin, intestinal permeability, apoptosis, inflammatory cytokines, and antioxidant/detoxifying enzymes were measured at 24 hours after TBI. Results. Nrf2 deficient mice were found to be more susceptible to TBI-induced acute intestinal mucosal injury, as characterized by the higher increase in gut structure damage, plasma endotoxin, intestinal permeability, and apoptosis after TBI. This exacerbation of intestinal mucosal injury in Nrf2 deficient mice was associated with increased intestinal mRNA and protein expression of inflammatory cytokines such as tumor necrosis factor-alpha, interleukin-1 beta and interleukin-6, and with decreased intestinal mRNA expression and activity levels of antioxidant and detoxifying enzymes including NAD(P)H: quinone oxidoreductase 1 (NQO1) and glutathione S-transferase alpha-1 (GST-alpha 1), compared with their wildtype Nrf2 ( +/+) counterparts after TBI. Conclusions. We show for the first time that mice lacking Nrf2 are more susceptible to TBI-induced acute intestinal mucosal injury. Our data suggests that Nrf2 plays an important role in protecting TBI-induced intestinal mucosal injury, possibly by regulating of inflammatory cytokines and inducing of antioxidant and detoxifying enzymes. (C) 2009 Elsevier Inc. All rights reserved.	[Jin, Wei; Wang, Han-Dong; Hu, Zhi-gang; Chen, Gang; Yin, Hong-Xia] Nanjing Univ, Dept Neurosurg, Sch Med, Jinling Hosp, Nanjing 210002, Jiangsu Prov, Peoples R China; [Yan, Wei] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China		Wang, HD (corresponding author), Nanjing Univ, Dept Neurosurg, Sch Med, Jinling Hosp, 305 E Zhongshan Rd, Nanjing 210002, Jiangsu Prov, Peoples R China.	hdwang_jw@yahoo.com.cn	Yin, Hong/AAC-5784-2020	Yan, Wei/0000-0002-1123-0835	Jinling Hospital of China	The authors acknowledge support for this work by grants from Jinling Hospital of China. They thank Dr. Bo Wu and Dr. Geng-bao Feng for technical assistance.	Begleiter A, 2003, CANCER EPIDEM BIOMAR, V12, P566; BENSON AM, 1980, P NATL ACAD SCI-BIOL, V77, P5216, DOI 10.1073/pnas.77.9.5216; Braun S, 2002, MOL CELL BIOL, V22, P5492, DOI 10.1128/MCB.22.15.5492-5505.2002; Chen G, 2008, J SURG RES, V147, P92, DOI 10.1016/j.jss.2007.05.029; Chen XL, 2004, CURR PHARM DESIGN, V10, P879, DOI 10.2174/1381612043452901; Chung FL, 2000, CARCINOGENESIS, V21, P2287, DOI 10.1093/carcin/21.12.2287; Doig CJ, 1998, AM J RESP CRIT CARE, V158, P444, DOI 10.1164/ajrccm.158.2.9710092; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hang CH, 2007, J SURG RES, V137, P53, DOI 10.1016/j.jss.2006.06.026; HECHT SS, 1995, J CELL BIOCHEM, P195; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jain AK, 2005, J BIOL CHEM, V280, P29158, DOI 10.1074/jbc.M502083200; Kelly VP, 2000, CANCER RES, V60, P957; Khor TO, 2006, CANCER RES, V66, P11580, DOI 10.1158/0008-5472.CAN-06-3562; Kupina NC, 2001, J NEUROTRAUM, V18, P1229, DOI 10.1089/089771501317095269; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; McMahon M, 2001, CANCER RES, V61, P3299; Osburn WO, 2007, INT J CANCER, V121, P1883, DOI 10.1002/ijc.22943; Osburn WO, 2006, ARCH BIOCHEM BIOPHYS, V454, P7, DOI 10.1016/j.abb.2006.08.005; Owuor ED, 2002, BIOCHEM PHARMACOL, V64, P765, DOI 10.1016/S0006-2952(02)01137-1; Pilitsis JG, 2001, NEUROL RES, V23, P227, DOI 10.1179/016164101101198389; Pool-Zobel B, 2005, MUTAT RES-FUND MOL M, V591, P74, DOI 10.1016/j.mrfmmm.2005.04.020; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; ROSS D, 1993, CANCER METAST REV, V12, P83, DOI 10.1007/BF00689803; Sasaki M, 2007, J CLIN BIOCHEM NUTR, V40, P1, DOI 10.3164/jcbn.40.1; Shapiro TA, 2001, CANCER EPIDEM BIOMAR, V10, P501; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; Soffler C, 2007, VET CLIN N AM-EQUINE, V23, P135, DOI 10.1016/j.cveq.2006.11.004; SUGIE S, 1994, CARCINOGENESIS, V15, P1555, DOI 10.1093/carcin/15.8.1555; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790	35	23	29	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	DEC	2009	157	2					251	260		10.1016/j.jss.2008.08.003			10	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	583CL	WOS:000276650200018	19394962				2022-02-06	
J	Lu, XCM; Si, YZ; Williams, AJ; Hartings, JA; Gryder, D; Tortella, FC				Lu, Xi-Chun M.; Si, Yuanzheng; Williams, Anthony J.; Hartings, Jed A.; Gryder, Divina; Tortella, Frank C.			NNZ-2566, a glypromate analog, attenuates brain ischemia-induced non-convulsive seizures in rats	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						brain ischemia; EEG; NNZ-2566; rats; seizures	GLYCINE-PROLINE-GLUTAMATE; N-TERMINAL TRIPEPTIDE; INTENSIVE-CARE UNIT; GROWTH-FACTOR-I; STATUS EPILEPTICUS; EPILEPSY; INJURY; INFLAMMATION; PATHOPHYSIOLOGY; ACTIVATION	Ischemic and traumatic brain injuries often induce non-convulsive seizures (NCSs), which likely contribute to the worsening of neurological outcomes. Here, we evaluated the effect of glycyl-L-methylprolyl-L-glutamic acid (NNZ-2566) to lessen the severity of NCSs caused by permanent middle cerebral artery occlusion (pMCAo). Continuous electroencephalographic recordings were performed in rats during pMCAo. Glycyl-L-methylprolyl-L-glutamic acid (3, 10, or 100 mg/kg bolus followed by an infusion of a fixed dose of 3 mg/kg per hour for 12 h) was delivered at 20 mins after pMCAo (before the first NCS event) or delayed until immediately after the first NCS event occurred. Control rats received pMCAo and saline treatment. The results revealed that 91% of the saline-treated animals had NCSs (23 episodes per rat and 1238 secs per rat) with an onset latency of 35 mins after injury. When NNZ-2566 was administered before the NCS events, it dose-dependently reduced the NCS incidence to 36%-80%, decreased NCS frequency to 5-16 episodes per rat, and shortened the total duration of NCS to 251-706 secs per rat. The two high doses significantly reduced the infarct volume by 28%-30%. Delayed treatment also attenuated NCS duration but had no effect on the infarct volume. Results indicate that NNZ-2566 possesses a unique therapeutic potential as a safe prophylactic agent that synergistically provides neuroprotection and reduces injury-induced seizures. Journal of Cerebral Blood Flow & Metabolism (2009) 29, 1924-1932; doi:10.1038/jcbfm.2009.109; published online 29 July 2009	[Lu, Xi-Chun M.; Si, Yuanzheng; Williams, Anthony J.; Hartings, Jed A.; Gryder, Divina; Tortella, Frank C.] Walter Reed Army Inst Res, Div Psychiat & Neurosci, Dept Appl Neurobiol, Silver Spring, MD 20910 USA		Lu, XCM (corresponding author), Walter Reed Army Inst Res, Div Psychiat & Neurosci, Dept Appl Neurobiol, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	may.lu@us.army.mil		Hartings, Jed/0000-0001-8583-3471	CRADA (Cooperative Research and Development Agreement) with Neuren Pharmaceuticals Ltd. [W81XWH-050074]	We would like to thank Ms Angela Fleming, Ms Xiaofang Yang, Mr Paul Guevarra, and Ms Ying Cao for their invaluable assistance in the technical aspects of this study, and Ms Christine Gallo for her review and comments on the paper. These studies were supported in part by a CRADA (Cooperative Research and Development Agreement) with Neuren Pharmaceuticals Ltd. (W81XWH-050074).	Amantea D, 2009, FEBS J, V276, P13, DOI 10.1111/j.1742-4658.2008.06766.x; Baker AM, 2005, NEUROPEPTIDES, V39, P81, DOI 10.1016/j.npep.2004.11.001; Batchelor DC, 2003, ANAL BIOCHEM, V323, P156, DOI 10.1016/j.ab.2003.08.032; Bickerdike MJ, 2009, J NEUROL SCI, V278, P85, DOI 10.1016/j.jns.2008.12.003; Choi J, 2008, YONSEI MED J, V49, P1, DOI 10.3349/ymj.2008.49.1.1; Fabene PF, 2008, NAT MED, V14, P1377, DOI 10.1038/nm.1878; JORDAN KG, 1995, NEUROL CLIN, V13, P579, DOI 10.1016/S0733-8619(18)30035-5; JORDAN KG, 1993, J CLIN NEUROPHYSIOL, V10, P445, DOI 10.1097/00004691-199310000-00006; Litt B, 1998, EPILEPSIA, V39, P1194, DOI 10.1111/j.1528-1157.1998.tb01311.x; Lu XCM, 2009, J NEUROTRAUM, V26, P141, DOI 10.1089/neu.2008.0629; Maganti R, 2008, EPILEPSY BEHAV, V12, P572, DOI 10.1016/j.yebeh.2007.12.002; Ravizza T, 2006, NEUROBIOL DIS, V24, P128, DOI 10.1016/j.nbd.2006.06.003; Ravizza T, 2006, NEUROSCIENCE, V137, P301, DOI 10.1016/j.neuroscience.2005.07.063; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rizzi M, 2003, NEUROBIOL DIS, V14, P494, DOI 10.1016/j.nbd.2003.08.001; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Svedin P, 2007, DEV NEUROSCI-BASEL, V29, P393, DOI 10.1159/000105480; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Vezzani A, 2008, BRAIN BEHAV IMMUN, V22, P797, DOI 10.1016/j.bbi.2008.03.009; Vezzani A, 2008, EPILEPSIA, V49, P24, DOI 10.1111/j.1528-1167.2008.01490.x; Viviani B, 2003, J NEUROSCI, V23, P8692; Waterhouse EJ, 1998, EPILEPSY RES, V29, P175, DOI 10.1016/S0920-1211(97)00071-5; Wei H, 2008, J NEUROTRAUM, V25, P917; Williams AJ, 2004, J PHARMACOL EXP THER, V311, P220, DOI 10.1124/jpet.104.069146; Williams AJ, 2008, NEUROSCI LETT, V430, P7, DOI 10.1016/j.neulet.2007.09.052; Williams AJ, 2006, J PHARMACOL EXP THER, V318, P947, DOI 10.1124/jpet.106.105999	28	23	23	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	DEC	2009	29	12					1924	1932		10.1038/jcbfm.2009.109			9	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	524ZJ	WOS:000272182600007	19638995	Bronze			2022-02-06	
J	Avraham, Y; Grigoriadis, NC; Magen, I; Poutahidis, T; Vorobiav, L; Zolotarev, O; Ilan, Y; Mechoulam, R; Berry, EM				Avraham, Y.; Grigoriadis, N. C.; Magen, I.; Poutahidis, T.; Vorobiav, L.; Zolotarev, O.; Ilan, Y.; Mechoulam, R.; Berry, E. M.			Capsaicin affects brain function in a model of hepatic encephalopathy associated with fulminant hepatic failure in mice	BRITISH JOURNAL OF PHARMACOLOGY			English	Article						hepatic encephalopathy; fulminant hepatic failure; capsaicin; cannabinoids; thioacetamide; TRPV1 receptors; astrogliosis; catecholamines; serotonin; cognition	CANNABINOID RECEPTOR AGONIST; CLOSED-HEAD INJURY; LIVER-DISEASE; CB2 RECEPTORS; MOUSE-BRAIN; ENDOCANNABINOIDS; ASTROGLIOSIS; SYSTEM; 2-AG; EXPRESSION	Background and purpose: Hepatic encephalopathy is a neuropsychiatric syndrome caused by liver failure. In view of the effects of cannabinoids in a thioacetamide-induced model of hepatic encephalopathy and liver disease and the beneficial effect of capsaicin (a TRPV1 agonist) in liver disease, we assumed that capsaicin may also affect hepatic encephalopathy. Experimental approach: Fulminant hepatic failure was induced in mice by thioacetamide and 24 h later, the animals were injected with one of the following compound(s): 2-arachidonoylglycerol (CB1, CB2 and TRPV1 receptor agonist); HU308 (CB2 receptor agonist), SR141716A (CB1 receptor antagonist); SR141716A+2-arachidonoylglycerol; SR144528 (CB2 receptor antagonist); capsaicin; and capsazepine (TRPV1 receptor agonist and antagonist respectively). Their neurological effects were evaluated on the basis of activity in the open field, cognitive function in an eight-arm maze and a neurological severity score. The mice were killed 3 or 14 days after thioacetamide administration. 2-arachidonoylglycerol and 5-hydroxytryptamine (5-HT) levels were determined by gas chromatography-mass spectrometry and high-performance liquid chromatography with electrochemical detection, respectively. Results: Capsaicin had a neuroprotective effect in this animal model as shown by the neurological score, activity and cognitive function. The effect of capsaicin was blocked by capsazepine. Thioacetamide induced astrogliosis in the hippocampus and the cerebellum and raised brain 5-hydroxytryptamine levels, which were decreased by capsaicin, SR141716A and HU-308. Thioacetamide lowered brain 2-arachidonoylglycerol levels, an effect reversed by capsaicin. Conclusions: Capsaicin improved both liver and brain dysfunction caused by thioacetamide, suggesting that both the endocannabinoid and the vanilloid systems play important roles in hepatic encephalopathy. Modulation of these systems may have therapeutic value.	[Avraham, Y.; Magen, I.; Vorobiav, L.; Zolotarev, O.; Berry, E. M.] Hadassah Hebrew Univ, Dept Metab & Human Nutr, Braun Sch Publ Hlth, Sch Med, IL-91120 Jerusalem, Israel; [Grigoriadis, N. C.] Aristotle Univ Thessaloniki, Dept Neurol, AHEPA Univ Hosp, GR-54006 Thessaloniki, Greece; [Poutahidis, T.] Aristotle Univ Thessaloniki, Dept Pathol, Sch Vet Med, GR-54006 Thessaloniki, Greece; [Ilan, Y.] Hadassah Univ Hosp, Liver Unit, IL-91120 Jerusalem, Israel; [Mechoulam, R.] Hebrew Univ Jerusalem, Dept Med Chem & Nat Prod, Fac Med, Jerusalem, Israel		Avraham, Y (corresponding author), Hadassah Hebrew Univ, Dept Metab & Human Nutr, Braun Sch Publ Hlth, Sch Med, IL-91120 Jerusalem, Israel.	yosefa@md.huji.ac.il		Magen, Iddo/0000-0002-3011-3175	Israel Science FoundationIsrael Science Foundation	We would like to thank the Israel Science Foundation for the support of the study.	Ahboucha S, 2007, METAB BRAIN DIS, V22, P291, DOI 10.1007/s11011-007-9065-2; Alexander SPH, 2008, BRIT J PHARMACOL, V153, pS1, DOI 10.1038/sj.bjp.0707746; Archer VE, 2002, MED HYPOTHESES, V59, P450, DOI 10.1016/S0306-9877(02)00152-4; Avraham Y, 2006, NEUROBIOL DIS, V21, P237, DOI 10.1016/j.nbd.2005.07.008; Avraham Y, 1996, BRAIN RES, V732, P133, DOI 10.1016/0006-8993(96)00514-8; Avraham Y, 2008, AM J GASTROENTEROL, V103, P3047, DOI 10.1111/j.1572-0241.2008.02155.x; Avraham Y, 2008, PROSTAG LEUKOTR ESS, V79, P35, DOI 10.1016/j.plefa.2008.07.003; BALASINGAM V, 1994, J NEUROSCI, V14, P846; Batkai S, 2001, NAT MED, V7, P827, DOI 10.1038/89953; Benito C, 2003, J NEUROSCI, V23, P11136; BLUNDELL JE, 1992, AM J CLIN NUTR, V55, P155, DOI 10.1093/ajcn/55.1.155s; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Dagon Y, 2007, FASEB J, V21, P2431, DOI 10.1096/fj.06-7705com; Di Marzo V, 1998, FEBS LETT, V436, P449, DOI 10.1016/S0014-5793(98)01175-2; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; Fernandez-Martinez A, 2004, J HEPATOL, V40, P963, DOI 10.1016/j.jhep.2004.02.019; Fioravanti B, 2008, J NEUROSCI, V28, P11593, DOI 10.1523/JNEUROSCI.3322-08.2008; FITZ GJ, 2002, SLEISENGER FORDTRANS, P1543; FRIDE E, 1993, EUR J PHARMACOL, V231, P313, DOI 10.1016/0014-2999(93)90468-W; Gabbay E, 2005, LIVER INT, V25, P921, DOI 10.1111/j.1478-3231.2005.01180.x; Golech SA, 2004, MOL BRAIN RES, V132, P87, DOI 10.1016/j.molbrainres.2004.08.025; Haider S, 2004, POL J PHARMACOL, V56, P73; Hanus L, 2003, BRAIN RES, V983, P144, DOI 10.1016/S0006-8993(03)03046-4; Herber DL, 2006, GLIA, V53, P382, DOI 10.1002/glia.20272; Izzo AA, 2008, GUT, V57, P1140, DOI 10.1136/gut.2008.148791; Julien B, 2005, GASTROENTEROLOGY, V128, P742, DOI 10.1053/j.gastro.2004.12.050; Kim CS, 2003, CELL SIGNAL, V15, P299, DOI 10.1016/S0898-6568(02)00086-4; Kunos G, 2006, NAT MED, V12, P607, DOI 10.1038/nm0606-608; Lee JS, 2004, ARCH PHARM RES, V27, P1147, DOI 10.1007/BF02975121; Lee WS, 2005, J PEDIATR GASTR NUTR, V40, P575, DOI 10.1097/01.MPG.0000158524.30294.E2; Li Y, 2003, GUT, V52, P293, DOI 10.1136/gut.52.2.293; Lotersztajn S, 2008, BRIT J PHARMACOL, V153, P286, DOI 10.1038/sj.bjp.0707511; Lu IJ, 2005, J APPL PHYSIOL, V98, P1646, DOI 10.1152/japplphysiol.01133.2004; Magen I, 2008, CURR PHARM DESIGN, V14, P2362, DOI 10.2174/138161208785740063; Mechoulam R, 2007, MOL NEUROBIOL, V36, P68, DOI 10.1007/s12035-007-8008-6; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Morgan MY, 2007, METAB BRAIN DIS, V22, P389, DOI 10.1007/s11011-007-9060-7; Panikashvili D, 2006, NEUROBIOL DIS, V22, P257, DOI 10.1016/j.nbd.2005.11.004; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; PICK CG, 1983, INT J NEUROSCI, V21, P63, DOI 10.3109/00207458308986121; Rohl C, 2007, BRAIN RES, V1129, P43, DOI 10.1016/j.brainres.2006.10.057; Shawcross D, 2005, LANCET, V365, P431, DOI 10.1016/S0140-6736(05)17832-5; Teixeira-Clerc F, 2008, PATHOL BIOL, V56, P36, DOI 10.1016/j.patbio.2007.01.001; Teixeira-Clerc F, 2006, NAT MED, V12, P671, DOI 10.1038/nm1421; Varga K, 1998, FASEB J, V12, P1035, DOI 10.1096/fasebj.12.11.1035; ZIMMERMANN C, 1989, HEPATOLOGY, V9, P594, DOI 10.1002/hep.1840090414	48	23	25	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	OCT	2009	158	3					896	906		10.1111/j.1476-5381.2009.00368.x			11	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	507CB	WOS:000270826600024	19764982	Bronze, Green Published			2022-02-06	
J	Wright, MJ; Woo, E; Schmitter-Edgecombe, M; Hinkin, CH; Miller, EN; Gooding, AL				Wright, Matthew J.; Woo, Ellen; Schmitter-Edgecombe, Maureen; Hinkin, Charles H.; Miller, Eric N.; Gooding, Amanda L.			The Item-Specific Deficit Approach to evaluating verbal memory dysfunction: Rationale, psychometrics, and application	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Memory; Psychometrics; Brain injury; Traumatic brain injury; Human immunodeficiency virus	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; HIV-ASSOCIATED DEMENTIA; TEMPORAL-LOBE EPILEPSY; CLOSED-HEAD INJURY; EPISODIC MEMORY; PARKINSONS-DISEASE; LEARNING TEST; LONG-TERM; RETRIEVAL DEFICITS	In the current study, we introduce the Item-Specific Deficit Approach (ISDA), a novel method for characterizing memory process deficits in list-learning data. To meet this objective, we applied the ISDA to California Verbal Learning Test (CVLT) data collected from a sample of 132 participants (53 healthy participants and 79 neurologically compromised participants). Overall, the ISDA indices measuring encoding, consolidation, and retrieval deficits demonstrated advantages over some traditional indices and indicated acceptable reliability and validity. Currently, the ISDA is intended for experimental use, although further research may support its utility for characterizing memory impairments in clinical assessments.	[Wright, Matthew J.; Woo, Ellen; Hinkin, Charles H.; Miller, Eric N.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA USA; [Woo, Ellen] Univ Calif Los Angeles, Alzheimers Dis Res Ctr, Los Angeles, CA USA; [Schmitter-Edgecombe, Maureen] Washington State Univ, Pullman, WA 99164 USA; [Hinkin, Charles H.; Gooding, Amanda L.] Vet Adm Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Miller, Eric N.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA		Wright, MJ (corresponding author), Harbor UCLA Med Ctr, 1000 W Carson St,D-2 Annex,5,Box 495, Torrance, CA 90509 USA.	mwright@labiomed.org		Miller, Eric/0000-0002-0650-714X	Marchionne Memorial Doctoral Fellowship (Washington State University); National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R03 HD35838, R01 NS47690, R01 MH585522, T32 MH019535]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD035838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH058552, T32MH019535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047690] Funding Source: NIH RePORTER	Special thanks go to Anna Curren and for her assistance. This work was supported by a Marchionne Memorial Doctoral Fellowship (Washington State University) as well as National Institutes of Health funding (R03 HD35838, R01 NS47690, R01 MH585522, and T32 MH019535). Profitable use of the item-specific deficit approach (ISDA) is under the protection of U.S. Patent No. 60/862,837.	AbouHamden A, 1997, J NEUROTRAUM, V14, P699, DOI 10.1089/neu.1997.14.699; Aggleton JP, 2006, TRENDS COGN SCI, V10, P455, DOI 10.1016/j.tics.2006.08.003; Alessio A, 2004, EPILEPSY BEHAV, V5, P22, DOI 10.1016/j.yebeh.2003.10.010; ANASTASI A, 1988, PSYCHOL TESTING, P109; Ariza M, 2006, BRAIN INJURY, V20, P1053, DOI 10.1080/02699050600909862; Beatty WW, 2003, ARCH CLIN NEUROPSYCH, V18, P509, DOI 10.1016/S0887-6177(02)00148-8; Bernard F, 2001, NEUROREPORT, V12, P1737, DOI 10.1097/00001756-200106130-00044; Bor D, 2004, EUR J NEUROSCI, V19, P3365, DOI 10.1111/j.1460-9568.2004.03438.x; Buckner RL, 1999, NAT NEUROSCI, V2, P311, DOI 10.1038/7221; Cappa SF, 2003, EUR J NEUROL, V10, P11, DOI 10.1046/j.1468-1331.2003.00537.x; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Cohen R, 2006, CLIN NEUROPSYCHOLOGY, P572; CRONBACH LJ, 1984, ESSENTIALS PSYCHOL T, P158; DELIS D, 1987, CALIFORNIA VERBAL LE; DELIS DC, 2000, CALIFORNIA VERBAL LE, V2; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Dolan RJ, 1999, HIPPOCAMPUS, V9, P25, DOI 10.1002/(SICI)1098-1063(1999)9:1<25::AID-HIPO3>3.3.CO;2-W; ELLIS HC, 1983, FUNDAMENTALS HUMAN M, P84; ERBER JT, 1985, EXP AGING RES, V11, P101, DOI 10.1080/03610738508259288; Evans JJ, 2000, NEUROPSYCHOL REHABIL, V10, P67, DOI 10.1080/096020100389309; Faglioni P, 2000, NEUROPSYCHOLOGY, V14, P456, DOI 10.1037//0894-4105.14.3.456; Fernandez G, 1998, J NEUROSCI, V18, P1841; Fuster JM, 2000, INT J PSYCHOPHYSIOL, V35, P155, DOI 10.1016/S0167-8760(99)00050-1; GEISELMAN RE, 1982, J EXP PSYCHOL GEN, V111, P109, DOI 10.1037/0096-3445.111.1.109; GIMRANOV RF, 2005, HUM PHYSIOL+, V31, P398; Greicius MD, 2003, HIPPOCAMPUS, V13, P164, DOI 10.1002/hipo.10064; Habib R, 2003, TRENDS COGN SCI, V7, P241, DOI 10.1016/S1364-6613(03)00110-4; Heaton R K, 1995, J Int Neuropsychol Soc, V1, P231; Howe M. L, 1988, COGNITIVE DEV ADULTH, P39, DOI 10.1007/978-1-4612-3852-2_2; Jefferies E, 2004, J MEM LANG, V51, P623, DOI 10.1016/j.jml.2004.07.005; Karlsgodt KH, 2005, NEUROIMAGE, V25, P1224, DOI 10.1016/j.neuroimage.2005.01.038; KEHOE J, 1995, PRACTICAL ASSESSMENT, V10; KLINE TJB, 2005, PSYCHOL TESTING PRAC, P167; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; Lezak MD, 2004, NEUROPSYCHOLOGICAL A, P414; Manly JJ, 2004, APPL NEUROPSYCHOL, V11, P37, DOI 10.1207/s15324826an1101_5; Manly JJ, 2002, J INT NEUROPSYCH SOC, V8, P341, DOI 10.1017/S1355617702813157; NIELSENBOHLMAN L, 1994, NEUROREPORT, V5, P1517, DOI 10.1097/00001756-199407000-00027; Nixon S.J., 1996, NEUROPSYCHOLOGY CLIN, P9, DOI [DOI 10.1037/10198-001, https://doi.org/10.1037/10198-001]; Norman MA, 2000, J CLIN EXP NEUROPSYC, V22, P80, DOI 10.1076/1380-3395(200002)22:1;1-8;FT080; Nyberg L, 2002, COGNITIVE BRAIN RES, V13, P281, DOI 10.1016/S0926-6410(02)00052-6; Nyberg L, 1996, PSYCHON B REV, V3, P135, DOI 10.3758/BF03212412; PEAVY G, 1994, J CLIN EXP NEUROPSYC, V16, P508, DOI 10.1080/01688639408402662; Pedhazur E., 1991, MEASUREMENT DESIGN A, P81; POSTMAN L, 1971, EXPT PSYCHOL; RIEFER DM, 1991, B PSYCHONOMIC SOC, V29, P415; Rund BR, 1999, ACTA PSYCHIAT SCAND, V100, P85, DOI 10.1111/j.1600-0447.1999.tb10829.x; Scott JC, 2006, NEUROPSYCHOLOGIA, V44, P1336, DOI 10.1016/j.neuropsychologia.2006.01.008; SPILICH GJ, 1982, EXPT AGING RES, V8, P45; SQUIRE LR, 1994, INT REV NEUROBIOL, V37, P243; Squire LR, 1998, HIPPOCAMPUS, V8, P205, DOI 10.1002/(SICI)1098-1063(1998)8:3<205::AID-HIPO3>3.0.CO;2-I; SQUIRE LR, 1980, NEUROPSYCHOLOGIA, V18, P368; Stip E, 2007, CLIN NEUROPHARMACOL, V30, P218, DOI 10.1097/WNF.0B013E318059BE76; Strange BA, 2002, J NEUROSCI, V22, P523, DOI 10.1523/JNEUROSCI.22-02-00523.2002; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.0.CO;2-G; TULVING E, 1973, PSYCHOL REV, V80, P352, DOI 10.1037/h0020071; Tulving E, 1997, CURR OPIN NEUROBIOL, V7, P209, DOI 10.1016/S0959-4388(97)80009-8; TULVING E, 1968, J EXP PSYCHOL, V77, P593, DOI 10.1037/h0026069; URBINA S, 2004, ESSENTIALS PSYCHOL T, P117; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Vingerhoets G, 2006, EPILEPSY BEHAV, V8, P422, DOI 10.1016/j.yebeh.2005.11.013; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 1997, WECHSLER MEMORY SCAL; White DA, 1997, J CLIN EXP NEUROPSYC, V19, P357, DOI 10.1080/01688639708403864; Whitehead A, 2004, INT J GERIATR PSYCH, V19, P624, DOI 10.1002/gps.1133; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; Wilde MC, 1995, J CLIN EXP NEUROPSYC, V17, P849, DOI 10.1080/01688639508402434; [No title captured], DOI DOI 10.1177/107319119500200205	68	23	23	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	OCT	2009	31	7					790	802		10.1080/13803390802508918			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	500AS	WOS:000270270000002	19142773	Green Accepted			2022-02-06	
J	Blum, J; Hansen, M; Rommens, PM				Blum, Jochen; Hansen, Matthias; Rommens, Pol Maria			Angle-Stable Intramedullary Nailing of Proximal Humerus Fractures with the PHN (Proximal Humeral Nail)	OPERATIVE ORTHOPADIE UND TRAUMATOLOGIE			German	Article						Proximal humerus fracture; Intramedullary nailing; Angular stability; Internal fixation	SHAFT FRACTURES; INTERNAL-FIXATION; DISPLACED FRACTURES; 4-PART FRACTURES; OPEN REDUCTION; STABILIZATION; ANTEGRADE; 3-PART; HEAD	Stable fixation of two- and three-part fractures of the proximal humerus through minimally invasive operative technique and rapid bone healing as well as restoration of original anatomy. Early functional training with the goal of restoration of former mobility and daily activities. Unstabile two- and three-part fractures of the proximal humerus (AO classification: 11-A2, 11-A3, 11-B1, 11-B2, 11-B3). Subcapital nonunion of the humerus. Pathologic fractures. Pediatric fractures of the proximal humerus. Fractures of the proximal humerus types 11-C2 und 11-C3 according to the AO classification. Active local infection, e.g., after former operation. Closed reduction. Anterior acromial incision, splitting of the deltoid muscle and the rotator cuff. Opening of the medullary canal with the awl. Nail introduction. Spiral blade introduction in cannulated technique through stab incision. Distal interlocking through aiming device, angle-stable blocking of nail and blade through end cap. Postoperative fixation in Gilchrist sling until 2nd postoperative day; then physiotherapy respecting fracture type and stability, local swelling, patient's age and compliance, and concomitant injuries. 151 proximal humeral fractures were treated with a proximal humeral nail (PHN). 108 patients could be followed up 1 year postoperatively. Significant complications were perforation of the articular surface through bolts or blades (n = 8), implant-related pain (n = 10), fragment dislocation (n = 2), nonunion (n = 2), humeral head necrosis (n = 3), and superficial infection (n = 1). 1 year after the operation, the Constant-Murley Score showed a median value of 75.3 in the injured shoulder and of 89.9 in the uninjured shoulder. The DASH (Disability of the Arm, Shoulder and Hand) Score was 5.9 preoperatively and 9.3 at 1 year postoperatively. The worst results regarding the Constant-Murley Score as well as the DASH Score were found in C-type fractures.	[Blum, Jochen; Hansen, Matthias] Johannes Gutenberg Univ Mainz, Klinikum Worms, Akad Lehrkrankenhaus, Klin Unfall Hand & Wiederherstellungschirurg, D-67550 Worms, Germany; [Rommens, Pol Maria] Univ Kliniken Mainz, Klin & Poliklin Unfallchirurg, Mainz, Germany		Blum, J (corresponding author), Johannes Gutenberg Univ Mainz, Klinikum Worms, Akad Lehrkrankenhaus, Chefarzt Klin Unfall Hand & Wiederherstellungschi, D-67550 Worms, Germany.	Jochen.blum@klinikum-worms.de	Hansen, Matthias/AAH-7248-2021				Blum J, 2002, UNFALLCHIRURG, V105, P9, DOI 10.1007/s113-002-8158-5; Blum J, 2001, J ORTHOP TRAUMA, V15, P342, DOI 10.1097/00005131-200106000-00007; Blum J, 1998, UNFALLCHIRURG, V101, P342, DOI 10.1007/s001130050279; BLUM J, 2000, SURG TECHNIQUES ORTH, P10; BLUM J, 2003, AKTUEL TRAUMATOL, V33, P7; BLUM J, 2006, OSTEO TRAUMA CARE, V14, P34; Blum J, 2007, EUR J TRAUMA EMERG S, V33, P149, DOI 10.1007/s00068-007-7035-3; CONSTANT CR, 1987, CLIN ORTHOP RELAT R, P160; ESSER RD, 1994, CLIN ORTHOP RELAT R, V299, P244; FLATOW EL, 1991, J BONE JOINT SURG AM, V73A, P1213, DOI 10.2106/00004623-199173080-00011; Germann G, 1999, Handchir Mikrochir Plast Chir, V31, P149, DOI 10.1055/s-1999-13902; Hessmann MH, 2005, J TRAUMA, V58, P1194, DOI 10.1097/01.TA.0000170400.68994.AB; Hessmann MH, 2001, CHIRURG, V72, P1235, DOI 10.1007/s001040170026; HESSMANN MH, 2003, EUR J TRAUMA, V29, P253; Hintermann B, 2000, J BONE JOINT SURG BR, V82B, P1107, DOI 10.1302/0301-620X.82B8.10330; HORAKI HS, 1975, CLIN ORTHOP RELAT R, V112, P250; JIHVANG K, 1996, CLIN ORTHOP RELAT R, V327, P225; KOCIALKOWSKI A, 1990, INJURY, V21, P209, DOI 10.1016/0020-1383(90)90003-D; Lill H, 2001, CHIRURG, V72, P1224, DOI 10.1007/s001040170025; LIND T, 1989, ARCH ORTHOP TRAUM SU, V108, P285, DOI 10.1007/BF00932316; Mittlmeier TWF, 2003, J BONE JOINT SURG AM, V85A, P136, DOI 10.2106/00004623-200300004-00019; Resch H, 1997, J BONE JOINT SURG BR, V79B, P295, DOI 10.1302/0301-620X.79B2.6958; RESCH H, 2001, INJURY S1, V32; ROMMENS PM, 1995, J BONE JOINT SURG BR, V77B, P84, DOI 10.1302/0301-620X.77B1.7822403; ROMMENS PM, 1998, CLIN ORTHOP RELAT R, V350, P26; ROMMENS PM, 1998, TECHNIQUES ORTHOPAED, V13, P51; ROSE SH, 1982, CLIN ORTHOP RELAT R, V168, P24	27	23	25	0	3	URBAN & VOGEL	MUNICH	NEUMARKTER STRASSE 43, D-81673 MUNICH, GERMANY	0934-6694	1439-0981		OPER ORTHOP TRAUMATO	Oper. Orthopade Traumatol.	SEP	2009	21	3					296	311		10.1007/s00064-009-1806-4			16	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	498ZJ	WOS:000270185400006	19779685				2022-02-06	
J	Radomski, MV; Davidson, L; Voydetich, D; Erickson, MW				Radomski, Mary Vining; Davidson, Leslie; Voydetich, Deborah; Erickson, Mary W.			Occupational Therapy for Service Members With Mild Traumatic Brain Injury	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						brain injuries; evidence-based practice; military personnel; occupational therapy; physical therapy; practice guidelines	POSTTRAUMATIC-STRESS-DISORDER; SELF-IDENTIFIED GOALS; HEAD-INJURY; COGNITIVE REHABILITATION; SYMPTOMS; ADULTS; ACHIEVEMENT; AFGHANISTAN; GUIDELINES; AWARENESS	More occupational therapists are needed to provide client-centered, evidence-based rehabilitation to the large numbers of service members who sustained mild traumatic brain injury (mTBI) while deployed in Afghanistan and Iraq. The Proponency for Rehabilitation and Reintegration tasked a team of occupational and physical therapists to assemble evidence-based best practices specific to mTBI. Despite the fact that evidence-based reviews, guidelines, and research regarding occupational therapy for mTBI are sparse, the team developed the Clinical Practice Guidance: Occupational Therapy and Physical Therapy for Mild Traumatic Brain Injury. Occupational therapy practice recommendations specific to client education, vision, cognition, resumption of roles, and emotional well-being are summarized for civilians and characterized as practice standards or practice options. By using evidence-informed and holistic services, occupational therapists have the potential to lead rehabilitation and reintegration efforts for service members with mTBI and advance changes in the profession itself.	[Davidson, Leslie] Shenandoah Univ, Winchester, VA USA; [Voydetich, Deborah] Dept Vet Affairs Med Ctr, Polytrauma Transit Rehabil Program, Minneapolis, MN USA; [Erickson, Mary W.] Off Surg Gen, Reintegrat Branch, Proponency Off Rehabil & Reintegrat, Falls Church, VA USA			mary.radomski@allina.com					Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; Baron K., 2006, USERS MANUAL OCCUPAT; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; BROWN M, 2006, INTRO PARTICIPATION; BRYAN VL, 2004, TRAUMATIC BRAIN INJU, P455; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Cappa SF, 2003, EUR J NEUROL, V10, P11, DOI 10.1046/j.1468-1331.2003.00537.x; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cohen A H, 1992, J Am Optom Assoc, V63, P530; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; *DEF VET BRAIN INJ, 2006, DVBIC WORK GROUP AC; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; DOUGHERTY PM, 1993, COGNITIVE REHABILITA; EDNA TH, 1987, ACTA NEUROCHIR, V86, P12, DOI 10.1007/BF01419498; Eriksson Gunilla, 2005, Scand J Occup Ther, V12, P40, DOI 10.1080/11038120510027630; Fleming JM, 1996, BRAIN INJURY, V10, P1; Forsyth K., 1999, BRIT J OCCUP THER, V62, P69, DOI [10.1177/030802269906200208, DOI 10.1177/030802269906200208]; Freed S, 1997, BRAIN INJURY, V11, P25, DOI 10.1080/026990597123782; Gerardi S. M., 2004, US ARMY MED DEP J, P20; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jackson George L, 2008, N C Med J, V69, P43; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kielhofner Gary, 1999, Work, V12, P71; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; Klonoff PS, 2006, BRAIN INJURY, V20, P601, DOI 10.1080/02699050600744301; Law M., 1994, CANADIAN OCCUPATIONA, V2; MALEC J, 2005, INTRO MAYO PORTLAND; MAPLES WC, 1995, NO STATE U COLL OPTO; Mateer CA, 2005, J HEAD TRAUMA REHAB, V20, P62, DOI 10.1097/00001199-200501000-00007; McColl MA, 2002, AM J OCCUP THER, V56, P350, DOI 10.5014/ajot.56.3.350; Michel J A, 2006, Eura Medicophys, V42, P59; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; MONTGOMERY GK, 1995, BRAIN INJURY, V9, P453, DOI 10.3109/02699059509008205; MORTERA M, 2004, DEV COGNITIVE SCREEN; MORTERA M, 2006, PHYS DISABILITIES SP, V29, P1; Myers CS, 1915, LANCET, V1, P316; New Zealand Guidelines Group, 2006, TRAUM BRAIN INJ DIAG; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; PADULA W, 2007, BRAIN INJURY MED, P511; PADULA WV, 1994, BRAIN INJURY, V8, P125, DOI 10.3109/02699059409150964; Peloso PM, 2004, J REHABIL MED, V36, P106, DOI 10.1080/16501960410023868; Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; PRIGATANO GP, 1991, AWARENESS DEFICITS B; RADOMSKI MV, 1995, AM J OCCUP THER, V49, P487, DOI 10.5014/ajot.49.6.487; RADOMSKI MV, 2008, OCCUPATIONAL THERAPY, P748; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; Roley S., 2008, AM OCCUPATIONAL THER, V62, P625, DOI [10.5014/ajot.62.6.625, DOI 10.5014/AJOT.62.6.625]; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Scheiman M., 2002, UNDERSTANDING MANAGI, V2nd; Schmitz TW, 2006, NEUROPSYCHOLOGIA, V44, P762, DOI 10.1016/j.neuropsychologia.2005.07.012; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Stein Franklin, 2001, Work, V17, P235; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Testa JA, 2006, J HEAD TRAUMA REHAB, V21, P236, DOI 10.1097/00001199-200605000-00004; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Toglia JP, 2005, COGNITION OCCUPATION, P29; Toglia JP., 1993, CONTEXTUAL MEMORY TE; Trombly CA, 1998, AM J OCCUP THER, V52, P810, DOI 10.5014/ajot.52.10.810; Trombly CA, 2002, AM J OCCUP THER, V56, P489, DOI 10.5014/ajot.56.5.489; *US DEP DEF, 2007, TRAUM BRAIN INJ DEF; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warren, 1998, BRAIN INJURY VISUAL; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; Zasler N., 2007, BRAIN INJURY MED PRI; Zoltan B., 2007, VISION PERCEPTION CO	76	23	23	0	17	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	SEP-OCT	2009	63	5			SI		646	655		10.5014/ajot.63.5.646			10	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	493SG	WOS:000269757700016	19785265				2022-02-06	
J	Turkoglu, OF; Eroglu, H; Okutan, O; Gurcan, O; Bodur, E; Sargon, MF; Oner, L; Beskonakli, E				Turkoglu, Omer Faruk; Eroglu, Hakan; Okutan, Ozerk; Gurcan, Oktay; Bodur, Ebru; Sargon, Mustafa F.; Oener, Levent; Beskonakli, Etem			Atorvastatin efficiency after traumatic brain injury in rats	SURGICAL NEUROLOGY			English	Article						Atorvastatin; Brain edema; Traumatic brain injury; Lipid peroxidation	DEXAMETHASONE SODIUM-PHOSPHATE; NERVOUS-SYSTEM; NITRIC-OXIDE; CEREBRAL-ISCHEMIA; CORTICAL-NEURONS; BLOOD-FLOW; STROKE; SUPEROXIDE; MECHANISMS; STATINS	Background: The neuroprotective effects of statins possibly depend on their pleiotropic effect such as antioxidative and anti-inflammatory properties. In this study, we have evaluated the efficiency of atorvastatin on brain edema, lipid peroxidation, and ultrastructural changes in TBI animal model. Methods: Modified Feeney method has been used for the trauma model in rats. Only craniectomy for group A and trauma after craniectomy for group B was the procedure for animals. For the trauma, rods weighing 24 g were dropped on a foot plate just over the dura. Atorvastatin (1 mg/kg, IP) was administered to the animals in group C after craniectomy and trauma; but on the other hand, animals in group D received only 0.5 mL PEG as the vehicle. Brains were harvested 24 hours after the trauma for the assays of wet-dry weight, lipid peroxidation level, and ultrastructural investigations. Lipid peroxidation levels, TEM, and UNGS were the investigated parameters. The statistical comparisons between the groups were investigated by 1-way ANOVA and post hoc analysis by Duncan and Dunnett T3 test within the groups at the significance level P = .05. Results: Trauma increased water contents of the brain tissues and lipid peroxidation levels in groups B and D. When compared with the results of group B (brain edema, 84.694% +/- 1.510%; lipid peroxidation, 74.932 +/- 2.491 nmol/g tissue), atorvastatin (1 mg/kg) significantly decreased brain edema (77.362% +/- 1.448%), lipid peroxidation level (58.335 +/- 3.980 nmol/g tissue), and UNGS scores in group C (P < 0.05). Conclusion: In this descriptive study, the remarkable improvements of atorvastatin on brain edema, lipid peroxidation, and ultrastructural investigations encouraged us for a further dose optimization study. (C) 2009 Elsevier Inc. All rights reserved.	[Turkoglu, Omer Faruk; Okutan, Ozerk; Beskonakli, Etem] Ankara Ataturk Res & Educ Hosp, Dept Neurol Surg, TR-06800 Ankara, Turkey; [Eroglu, Hakan; Oener, Levent] Hacettepe Univ, Fac Pharm, Dept Pharmaceut Technol, TR-06100 Ankara, Turkey; [Gurcan, Oktay] Ankara Numune Training & Res Hosp, Dept Neurol Surg, TR-06100 Ankara, Turkey; [Bodur, Ebru] Hacettepe Univ, Fac Med, Dept Biochem, TR-06100 Ankara, Turkey; [Sargon, Mustafa F.] Hacettepe Univ, Fac Med, Dept Anat, TR-06100 Ankara, Turkey		Turkoglu, OF (corresponding author), Ankara Ataturk Res & Educ Hosp, Dept Neurol Surg, TR-06800 Ankara, Turkey.	ofturkoglu@yahoo.com	BODUR, EBRU/I-8382-2013; gurcan, oktay/AAW-7810-2021; ONER, LEVENT/J-1032-2013; BODUR, EBRU/AAR-8545-2020; Sargon, Mustafa F./AAZ-5470-2021; EROGLU, HAKAN/J-1040-2013	BODUR, EBRU/0000-0001-5829-5487; ONER, LEVENT/0000-0002-6510-7680; BODUR, EBRU/0000-0001-5829-5487; Sargon, Mustafa F./0000-0001-6360-6008; Eroglu, Hakan/0000-0001-6361-0074			BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Blanco M, 2007, NEUROLOGY, V69, P904, DOI 10.1212/01.wnl.0000269789.09277.47; Bosel J, 2005, J NEUROCHEM, V92, P1386, DOI 10.1111/j.1471-4159.2004.02980.x; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; BULLOCK R, 1991, J NEUROSURG, V74, P794, DOI 10.3171/jns.1991.74.5.0794; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Burney S, 1999, MUTAT RES-FUND MOL M, V424, P37, DOI 10.1016/S0027-5107(99)00006-8; Buttmann M, 2007, J NEUROCHEM, V102, P1001, DOI 10.1111/j.1471-4159.2007.04563.x; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Cottrell JR, 2000, J NEUROPHYSIOL, V84, P1573, DOI 10.1152/jn.2000.84.3.1573; Eroglu H, 2001, J MICROENCAPSUL, V18, P603; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; HALLIWELL B, 1985, TRENDS NEUROSCI, V8, P22, DOI 10.1016/0166-2236(85)90010-4; Hayashi T, 2005, BRAIN RES, V1037, P52, DOI 10.1016/j.brainres.2004.12.051; Hong H, 2006, AM J PHYSIOL-HEART C, V291, pH2210, DOI 10.1152/ajpheart.01270.2005; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Kuipers HF, 2007, BIOMED PHARMACOTHER, V61, P400, DOI 10.1016/j.biopha.2007.06.005; Laufs U, 2000, STROKE, V31, P2442, DOI 10.1161/01.STR.31.10.2442; LEFFLER CW, 1990, AM J PHYSIOL, V259, pH1230, DOI 10.1152/ajpheart.1990.259.4.H1230; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lipton SA, 2007, CURR DRUG TARGETS, V8, P621, DOI 10.2174/138945007780618472; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; MAXWELL RE, 1971, J NEUROSURG, V34, P477, DOI 10.3171/jns.1971.34.4.0477; Murakami K, 1999, PROG NEUROBIOL, V57, P289, DOI 10.1016/S0301-0082(98)00047-1; Ozdemir D, 2005, PHYSIOL RES, V54, P631; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Riad A, 2007, EUR J PHARMACOL, V569, P204, DOI 10.1016/j.ejphar.2007.04.065; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Seyfried D, 2004, J NEUROSURG, V101, P104, DOI 10.3171/jns.2004.101.1.0104; Sparks D L, 2002, J Nutr Health Aging, V6, P324; Tsubokawa T, 2007, STROKE, V38, P1057, DOI 10.1161/01.STR.0000257978.70312.1d; Turkoglu OF, 2008, J CLIN NEUROSCI, V15, P60, DOI 10.1016/j.jocn.2007.03.005; Vaughan CJ, 1999, STROKE, V30, P1969, DOI 10.1161/01.STR.30.9.1969; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; WEI EP, 1986, AM J PHYSIOL, V251, pH693, DOI 10.1152/ajpheart.1986.251.4.H693; Willerson JT, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000129535.04194.38; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158; Zacco A, 2003, J NEUROSCI, V23, P11104	39	23	24	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.	AUG	2009	72	2					146	152		10.1016/j.surneu.2008.07.004			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	481CY	WOS:000268785900008	18786717				2022-02-06	
J	Leliefeld, PH; Gooskens, RHJM; Braun, KPJ; Ramos, LMP; Uiterwaal, CSPM; Regli, LPE; Tulleken, CAF; Kappelle, LJ; Hanlo, PW				Leliefeld, Paul H.; Gooskens, Rob H. J. M.; Braun, Kees P. J.; Ramos, Lino M. P.; Uiterwaal, Cuno S. P. M.; Regli, Luca P. E.; Tulleken, Cees A. F.; Kappelle, L. Jaap; Hanlo, Patrick W.			Longitudinal diffusion-weighted imaging in infants with hydrocephalus: decrease in tissue water diffusion after cerebrospinal fluid diversion Clinical article	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article; Proceedings Paper	36th Annual Meeting of the International-Society-for-Pediatric-Neurosurgery	OCT 12-16, 2008	Cape Town, SOUTH AFRICA	Int Soc Pediat Neurosurg		apparent diffusion coefficient; infant; hydrocephalus; magnetic resonance imaging; intracranial pressure; cerebrospinal fluid	CEREBRAL-BLOOD-FLOW; NORMAL-PRESSURE HYDROCEPHALUS; TRAUMATIC BRAIN-INJURY; WHITE-MATTER EDEMA; ROTTERDAM TELETRANSDUCER; INTRACRANIAL-PRESSURE; EPIDURAL PRESSURE; PRETERM INFANTS; MRI; SPECTROSCOPY	Object. Progressive hydrocephalus may lead to edema of the periventricular white matter and to damage of the brain parenchyma because of compression, stretching, and ischemia. The aim of the present study was to investigate whether cerebral edema can be quantified using diffusion-weighted imaging in infants with hydrocephalus and whether CSF diversion could decrease cerebral edema. Methods. Diffusion-weighted MR imaging was performed in 24 infants with progressive hydrocephalus before and after CSF diversion. Parametric images of the trace apparent diffusion coefficients (ADCs) were obtained. The ADCs of 5 different cortical and subcortical regions of interest were calculated pre- and postoperatively in each patient. The ADC values were compared with age-related normal values. Mean arterial blood pressure and anterior fontanel pressure were measured immediately after each MR imaging study. Results. After CSF diversion, the mean ADC decreased from a preoperative value of 1209 +/- 116 x 10(-6) mm(2)/second to a postoperative value of 928 +/- 64 x 10(-6) mm(2)/second (p < 0.005). Differences between pre- and postoperative ADC values were most prominent in the periventricular white matter, supporting the existence of preoperative periventricular edema. Compared with age-related normal values, the preoperative ADC values were higher and the postoperative ADC values were lower, although within normal range. The decrease in ADC after CSF drainage was more rapid than the more gradual physiological decrease that is related to age. The preoperative ICP was elevated in all patients. After CSF diversion the ICP decreased significantly to within the normal range. A linear correlation between ADC values and ICP was found (correlation coefficient 0.496, p < 0.001). In all patients the mean arterial blood pressure was within physiological limits both pre- and postoperatively. Conclusions. This study shows a rapid and more extensive decrease in ADC values after CSF diversion than is to be expected from physiological ADC decrease solely due to increasing patient age. The preoperative ADC increase can be explained by interstitial edema caused by transependymal CSF leakage or by vasogenic edema caused by capillary compression and stretching of the brain parenchyma. This study population of infants with (early recognized) hydrocephalus did not suffer from cytotoxic edema. These findings may help to detect patients at risk for cerebral damage by differentiating between progressive and compensated hydrocephalus. (DOI: 10.3171/2009.3.PEDS08337)	[Leliefeld, Paul H.; Regli, Luca P. E.; Tulleken, Cees A. F.; Hanlo, Patrick W.] Univ Med Ctr Utrecht, Dept Neurosurg, NL-3584 CX Utrecht, Netherlands; [Leliefeld, Paul H.; Gooskens, Rob H. J. M.; Braun, Kees P. J.; Regli, Luca P. E.; Tulleken, Cees A. F.; Kappelle, L. Jaap; Hanlo, Patrick W.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, NL-3584 CX Utrecht, Netherlands; [Gooskens, Rob H. J. M.; Braun, Kees P. J.] Univ Med Ctr Utrecht, Dept Child Neurol, NL-3584 CX Utrecht, Netherlands; [Ramos, Lino M. P.] Univ Med Ctr Utrecht, Dept Radiol, NL-3584 CX Utrecht, Netherlands; [Kappelle, L. Jaap] Univ Med Ctr Utrecht, Dept Neurol, NL-3584 CX Utrecht, Netherlands; [Uiterwaal, Cuno S. P. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3584 CX Utrecht, Netherlands		Leliefeld, PH (corresponding author), Univ Med Ctr Utrecht, Dept Neurosurg, G 03-124,Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	p.h.leliefeld@umcutrecht.nl					Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Anegawa S, 1991, HYDROCEPHALUS PATHOG, P248; Baldauf J, 2007, CHILD NERV SYST, V23, P623, DOI 10.1007/s00381-007-0335-4; Braun KPJ, 2003, J MAGN RESON IMAGING, V17, P291, DOI 10.1002/jmri.10270; Braun KPJ, 1998, MAGN RESON MED, V40, P832, DOI 10.1002/mrm.1910400608; Braun KPJ, 1997, BRAIN RES, V757, P295, DOI 10.1016/S0006-8993(97)00345-4; Counsell SJ, 2006, PEDIATRICS, V117, P376, DOI 10.1542/peds.2005-0820; Counsell SJ, 2003, PEDIATRICS, V112, P1, DOI 10.1542/peds.112.1.1; DEJONG DA, 1975, BIOTELEMETRY, V2, P257; DEJONG DA, 1983, MED PROG TECHNOL, V10, P89; DEJONG DA, 1982, BIOTELEM PAT MON, V9, P154; DELBIGIO MR, 1993, ACTA NEUROPATHOL, V85, P573, DOI 10.1007/BF00334666; Dombrowski SM, 2006, J CEREBR BLOOD F MET, V26, P1298, DOI 10.1038/sj.jcbfm.9600282; Dorenbeck U, 2005, ROFO-FORTSCHR RONTG, V177, P99, DOI 10.1055/s-2004-813728; EBISU T, 1993, JMRI-J MAGN RESON IM, V3, P863, DOI 10.1002/jmri.1880030612; Erdem G, 2007, MAGN RESON IMAGING, V25, P1417, DOI 10.1016/j.mri.2007.03.028; Forbes KPN, 2002, RADIOLOGY, V222, P405, DOI 10.1148/radiol.2222010179; Gass A, 2001, J NEUROL SCI, V186, pS15, DOI 10.1016/S0022-510X(01)00487-7; GIDEON P, 1994, ACTA RADIOL, V35, P514; Hanlo PW, 1996, CHILD NERV SYST, V12, P200, DOI 10.1007/BF00301251; Hanlo PW, 1997, DEV MED CHILD NEUROL, V39, P286; Hou DJ, 2007, J NEUROTRAUM, V24, P1558, DOI 10.1089/neu.2007.0339; Inaba H, 2008, ANN ONCOL, V19, P178, DOI 10.1093/annonc/mdm466; JORGENSEN PB, 1972, INTRACRANIAL PRESSUR, P41; KAISER AM, 1986, NEUROPEDIATRICS, V17, P100, DOI 10.1055/s-2008-1052509; Kantarci K, 2003, NEUROIMAG CLIN N AM, V13, P197, DOI 10.1016/S1052-5149(03)00025-X; Karahalios DG, 1996, NEUROLOGY, V46, P198, DOI 10.1212/WNL.46.1.198; Kim E, 2007, AM J NEURORADIOL, V28, P1652, DOI 10.3174/ajnr.A0655; KIRKPATRICK M, 1989, ARCH DIS CHILD, V64, P124, DOI 10.1136/adc.64.1.124; Kristensen B, 1996, J NEUROL NEUROSUR PS, V60, P282, DOI 10.1136/jnnp.60.3.282; Leliefeld PH, 2008, J NEUROSURG-PEDIATR, V2, P163, DOI 10.3171/PED/2008/2/9/163; Luthra G, 2007, AM J NEURORADIOL, V28, P1332, DOI 10.3174/ajnr.A0548; MAMO HL, 1987, STROKE, V18, P1074, DOI 10.1161/01.STR.18.6.1074; Massicotte EM, 2000, J NEUROSURG, V92, P442, DOI 10.3171/jns.2000.92.3.0442; McAllister JP, 1998, NEUROSURG CLIN N AM, V9, P73; MINNS RA, 1989, ARCH DIS CHILD, V64, P814, DOI 10.1136/adc.64.6.814; Moustafa RR, 2007, CRIT CARE, V11, DOI 10.1186/cc5973; NAKADA J, 1992, ACTA NEUROCHIR, V114, P43, DOI 10.1007/BF01401113; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; O'Brien TJ, 2007, J CLIN NEUROSCI, V14, P841, DOI 10.1016/j.jocn.2006.07.003; Oi S, 2006, CHILD NERV SYST, V22, P662, DOI 10.1007/s00381-005-0020-4; PETERS RJA, 1995, CHILD NERV SYST, V11, P207, DOI 10.1007/BF00277655; PLANDSOEN WCG, 1987, MED PROG TECHNOL, V13, P21; Pronin I N, 2000, Zh Vopr Neirokhir Im N N Burdenko, P14; SCHETTINI A, 1971, J NEUROSURG, V34, P38, DOI 10.3171/jns.1971.34.1.0038; Sotak CH, 2004, NEUROCHEM INT, V45, P569, DOI 10.1016/j.neuint.2003.11.010; SUNDBARG G, 1972, INTRACRANIAL PRESSUR, P46; Tanaka A, 1997, NEUROSURGERY, V40, P1161, DOI 10.1097/00006123-199706000-00009; van Everdingen KJ, 1998, STROKE, V29, P1783, DOI 10.1161/01.STR.29.9.1783; van Lindert EJ, 2006, CHILD NERV SYST, V22, P1529, DOI 10.1007/s00381-006-0189-1; VOLPE JJ, 1979, NEUROLOGY, V29, P632, DOI 10.1212/WNL.29.5.632; VOLPE JJ, 1995, NEUROLOGY NEWBORN, P457; Williams H, 2008, MED HYPOTHESES, V70, P743, DOI 10.1016/j.mehy.2007.08.013; Yikilmaz A, 2008, PEDIATR RADIOL, V38, P129, DOI 10.1007/s00247-007-0538-6; YORDY M, 1986, PEDIATR NEUROSCI, V12, P226, DOI 10.1159/000120256	55	23	23	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JUL	2009	4	1					56	63		10.3171/2009.3.PEDS08337			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Pediatrics; Surgery	462VB	WOS:000267384000017	19569912				2022-02-06	
J	Sorani, MD; Lee, M; Kim, H; Meeker, M; Manley, GT				Sorani, Marco D.; Lee, Michaela; Kim, Helen; Meeker, Michele; Manley, Geoffrey T.			Race\Ethnicity and Outcome After Traumatic Brain Injury at a Single, Diverse Center	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Race; Ethnicity; Traumatic brain injury; Mortality; Glasgow Outcome Scale	SEVERE HEAD-INJURY; ENDOTRACHEAL INTUBATION; FUNCTIONAL OUTCOMES; RACIAL DISPARITIES; REHABILITATION; FIELD; COMA; AGE; MANAGEMENT; MODERATE	Background: Many factors may predict mortality and disability after traumatic brain injury (TBI), including age and injury severity. However, the role of race\ethnicity has typically been studied tangentially or in homogeneous settings. We investigated whether race\ethnicity was associated with medical outcomes at a single, diverse center. Methods: We retrospectively identified patients with TBI older than 17 years with blunt injuries admitted to a Level I trauma center from 2001 to 2004. Glasgow Outcome Scale (GOS) was used to determine outcome at discharge. We performed multivariable logistic regression on two measures of outcome by dichotomizing Glasgow Outcome Scale scores. Results: We identified 357 patients with TBI from five categories: whites (46.2%), Asians (19.9%), Hispanics (17.9%), blacks (10.9%), and other\ unknown (5.0%). Without adjusting for other factors, Asians experienced higher mortality (odds ratio [OR] = 2.25, p = 0.01) compared with whites but not degree of disability. After adjusting for age and Injury Severity Score, a weaker trend remained for higher mortality in Asians (OR = 1.38, p = 0.35), and after excluding cases of assault, the finding was again significant (OR = 2.00, p = 0.04). We also confirmed the recently reported OR of higher mortality among blacks (OR = 1.30). Hispanics seemed to do slightly better at discharge. Conclusions: The question of whether and how race plays a role in TBI is controversial. At a single, diverse center, we found that mortality is associated with race, age, and Injury Severity Score. Future clinical studies will benefit from detailed genotypic and phenotypic data and should balance larger sample sizes with ethnic diversity.	[Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94110 USA; [Sorani, Marco D.] Univ Calif San Francisco, Program Biol & Med Informat, San Francisco, CA 94110 USA; [Kim, Helen] Univ Calif San Francisco, Dept Anesthesiol, San Francisco, CA 94110 USA; [Lee, Michaela; Meeker, Michele; Manley, Geoffrey T.] San Francisco Gen Hosp, San Francisco, CA 94110 USA		Manley, GT (corresponding author), Univ Calif San Francisco, Dept Neurosurg, 1001 Potrero Ave Room 101, San Francisco, CA 94110 USA.	manleyg@neurosurg.ucsf.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS049691, NS050173]; UCSF Brain and Spinal Injury Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS049691, R01NS050173] Funding Source: NIH RePORTER	Supported by NIH grants NS049691 (to M.S.) and NS050173 (to G.T.M.) and by the UCSF Brain and Spinal Injury Center.	[Anonymous], 1990, ABBR INJ SCAL 1990 R; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bazarian JJ, 2003, ACAD EMERG MED, V10, P1209, DOI 10.1197/S1069-6563(03)00491-3; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; Brown CVR, 2006, J TRAUMA, V61, P572, DOI 10.1097/01.ta.0000200842.19740.38; Burchard E., 2002, GENOME BIOL, V3, P1, DOI DOI 10.1186/GB-2002-3-7-COMMENT2007; Burchard EG, 2004, AM J RESP CRIT CARE, V169, P386, DOI 10.1164/rccm.200309-1293OC; Burnett DM, 2000, BRAIN INJURY, V14, P713; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Collins JK, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-15; COOPER PR, 2000, HEAD INJURY; Davis DP, 2006, J TRAUMA, V60, P985, DOI 10.1097/01.ta.0000205860.96209.1c; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Farin A, 2003, J NEUROSURG, V98, P32, DOI 10.3171/jns.2003.98.1.0032; Gargiullo P, 2002, JAMA-J AM MED ASSOC, V287, P1391; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Hemphill JC, 2004, STROKE, V35, P1130, DOI 10.1161/01.STR.0000125858.71051.ca; JENNETT B, 1975, LANCET, V1, P480; Johnstone B, 2003, BRAIN INJURY, V17, P95, DOI 10.1080/0269905021000010212; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Kim H, 2007, STROKE, V38, P2430, DOI 10.1161/STROKEAHA.107.485573; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Marwick C, 2000, JAMA-J AM MED ASSOC, V283, P989, DOI 10.1001/jama.283.8.989; Moles DR, 1999, BRIT J ORAL MAX SURG, V37, P301, DOI 10.1054/bjom.1998.0040; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Munro PT, 2002, BRIT MED J, V325, P1001, DOI 10.1136/bmj.325.7371.1001; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; Odebode TO, 2004, PEDIATR SURG INT, V20, P348, DOI 10.1007/s00383-004-1196-5; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Riechers RG, 2005, J NEUROTRAUM, V22, P1327, DOI 10.1089/neu.2005.22.1327; Sander AM, 2007, NEUROREHABILITATION, V22, P9; Selassie AW, 2004, AM J EMERG MED, V22, P465, DOI 10.1016/j.ajem.2004.07.024; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Shigemori M, 2002, NEUROL RES, V24, P41, DOI 10.1179/016164102101199521; SLEE VN, 1978, ANN INTERN MED, V88, P424, DOI 10.7326/0003-4819-88-3-424; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; SNIEZEK JE, 1989, JAMA-J AM MED ASSOC, V262, P2270, DOI 10.1001/jama.262.16.2270; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; *US BUR CENS, 2003, US CENS BUR GUID PRE; Wall SP, 2005, ACAD EMERG MED, V12, P862, DOI 10.1197/j.aem.2005.05.003; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774; Willis F, 2003, J NATL MED ASSOC, V95, P71; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592; 2001, RACIAL ETHNIC DIVERS; SFGH 2004 ANN REPORT; 2007, WHAT IS TRAUMATIC BR	55	23	23	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	2009	67	1					75	80		10.1097/TA.0b013e31818234e8			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	470CZ	WOS:000267953100013	19590312				2022-02-06	
J	Kelly, P; MacCormick, J; Strange, R				Kelly, Patrick; MacCormick, Judith; Strange, Rebecca			Non-accidental head injury in New Zealand: The outcome of referral to statutory authorities	CHILD ABUSE & NEGLECT			English	Article						Child abuse; Non-accidental head injury; Shaken baby syndrome; Child neglect; Substantiation; Risk factors; Recurrence; Legal system	SHAKEN-BABY-SYNDROME; TRAUMATIC BRAIN-INJURY; RISK-FACTORS; MALTREATMENT; CHILDREN; CHALLENGES; INFANTS; ABUSE	Objectives: To describe the outcome of referral to the statutory authorities for infants under 2 years with non-accidental head injury (NAHI), and to establish whether the authorities held sufficient information to develop a risk profile for these cases. Methods: Retrospective review of cases admitted to hospital in Auckland, New Zealand from 1988 to 1998. Records from the hospital admission, child protective services and Police were reviewed, up to 19 years from diagnosis. Results: Of 39 infants, 33 survived to leave hospital. Documentation of risk factors was erratic, and sometimes incongruent between agencies. Inter-agency case conferences took place in 17/39 (44%). The Department of Child, Youth and Family Services (CYF) used an informal family agreement to secure safety in 15/33 survivors (45%). Family Group Conferences occurred in 17/33 (52%). Nine of 33 were placed permanently outside the home (27%), two (6%) with unrelated caregivers. Charges were laid in 18/39 cases (46%). Fifteen cases came to trial, with 14 convictions (36%). Of the survivors, 44% were later renotified to CYF. There was no obvious relationship between type of intervention and re-notification. Conclusions: Ensuring the safety of an infant with NAHI, and identifying and taking appropriate action with regard to the offender, are complex tasks. In New Zealand, data collection is often incomplete and inter-agency practice and collaboration is variable. Although the rate of prosecution was relatively high by international standards, many children were later notified again for further concerns of abuse or neglect, Suggesting that our interventions have been only partially successful. Practice implications: This paper suggests that all infants admitted to hospital with non-accidental head injury should become part of a prospective inter-agency research study, using a standardised data collection instrument. This should include the systematic collection of all data known or suspected to be associated with risk of child abuse, and incorporate long-term prospective follow-up, regardless of child protective or legal outcomes. Without large numbers followed prospectively and according to sound methodology, it is difficult to prove which forms of intervention are better than others at reducing the risk of further abuse. (C) 2009 Elsevier Ltd. All rights reserved.	[Kelly, Patrick; MacCormick, Judith] Starship Childrens Hosp, Te Puaruruhau Child Abuse Assessment Unit, Auckland 1, New Zealand; [Strange, Rebecca] Auckland Dist Hlth Board & Child Youth & Family L, Auckland, New Zealand		Kelly, P (corresponding author), Starship Childrens Hosp, Te Puaruruhau Child Abuse Assessment Unit, Pk Rd,Private Bag 92024, Auckland 1, New Zealand.			Kelly, Patrick/0000-0002-8813-8877			ALEXANDER R, 1990, AM J DIS CHILD, V144, P58, DOI 10.1001/archpedi.1990.02150250068033; *AUCKL DISTR HLTH, 2007, LEG ISS REL CHILDR; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Barr RG, 2006, CHILD ABUSE NEGLECT, V30, P7, DOI 10.1016/j.chiabu.2005.06.009; Barr RG, 2008, AM J PREV MED, V34, pS106, DOI 10.1016/j.amepre.2008.01.021; BROWN MJA, 2000, CARE PROTECTION IS A; *CAB HLTH FAM SERV, 2007, REP CHILD AB NEGL; Caton A, 2000, SOCIAL WORK NOW, V17, P28; Chadwick DL, 1998, PEDIATRICS, V101, P321, DOI 10.1542/peds.101.2.321; CONNOLLY M, 2006, PRACTICE NOTE CHIEF; *DEP CHILD YOUTH F, 2001, LETS STOP CHILD AB T; *DEP SOC WELF, 1999, STAT REP YEAR END 19; Dias MS, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1896; DOOLAN M, 1991, PREVENTING JUVENILE; Dyer C, 2005, BRIT MED J, V331, P253, DOI 10.1136/bmj.331.7511.253-a; Ellaway BA, 2004, ARCH DIS CHILD, V89, P845, DOI 10.1136/adc.2003.035493; Ellison K, 2008, MICH HIST REV, V34, P162; Haviland J, 1997, ARCH DIS CHILD, V77, P504, DOI 10.1136/adc.77.6.504; Hindley N, 2006, ARCH DIS CHILD, V91, P744, DOI 10.1136/adc.2005.085639; Hobbs C, 2005, ARCH DIS CHILD, V90, P952, DOI 10.1136/adc.2003.037739; Hussey JM, 2005, CHILD ABUSE NEGLECT, V29, P479, DOI 10.1016/j.chiabu.2003.12.005; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; KELLY P, 2004, NZ MED J, V117, P1047; Kelly P, 2008, J PAEDIATR CHILD H, V44, P99, DOI 10.1111/j.1440-1754.2007.01234.x; King WJ, 2003, CAN MED ASSOC J, V168, P155; KIRO C, 2006, INT C FAM GROUP C; *LAW COMM, 2003, LAW COMM PUBL, V282; Mansell J., 2006, SOCIAL POLICY J NZ, P97; Minns RA, 2008, AM J PREV MED, V34, pS126, DOI 10.1016/j.amepre.2008.01.016; National Society for the Prevention of Cruelty to Children, 2002, WHICH YOU DID IT PRO; *NZ CHILDR YOUNG P, 1996, BREAK CYCL INT PROT; *OFF CHILDR COMM, 2006, SAF CHILDR HOSP; *OFF COMM CHILDR, 2003, REP INV DEATHS SJ AP; Office of the Commissioner for Children, 2000, FIN REP INV DEATH RI; OREILLY L, 1997, CASE REV VK WATSON; Overpeck MD, 1998, NEW ENGL J MED, V339, P1211, DOI 10.1056/NEJM199810223391706; Reijneveld SA, 2004, LANCET, V364, P1340, DOI 10.1016/S0140-6736(04)17191-2; RENOUF J, 1990, CHILDREN YOUNG PERSO; Ricci L, 2003, CHILD ABUSE NEGLECT, V27, P271, DOI 10.1016/S0145-2134(03)00006-1; ROBERTSON JP, 1996, 5 OFF COMM CHILDR; Runyan DK, 2008, AM J PREV MED, V34, pS112, DOI 10.1016/j.amepre.2008.01.011; Sibert JR, 2002, CHILD ABUSE NEGLECT, V26, P267, DOI 10.1016/S0145-2134(01)00324-6; Sidebotham P, 2006, CHILD ABUSE NEGLECT, V30, P497, DOI 10.1016/j.chiabu.2005.11.005; Smith JAS, 2005, J PAEDIATR CHILD H, V41, P513, DOI 10.1111/j.1440-1754.2005.00694.x; Stiffman MN, 2002, PEDIATRICS, V109, P615, DOI 10.1542/peds.109.4.615; Theodore AD, 2005, PEDIATRICS, V115, pE331, DOI 10.1542/peds.2004-1033; WATT E, 2003, HIST YOUTH JUSTICE 2; Wirtz SJ, 2008, AM J PREV MED, V34, pS134, DOI 10.1016/j.amepre.2007.11.004; Wu SS, 2004, CHILD ABUSE NEGLECT, V28, P1253, DOI 10.1016/j.chiabu.2004.07.005	52	23	25	1	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2134	1873-7757		CHILD ABUSE NEGLECT	Child Abuse Negl.	JUN	2009	33	6					393	401		10.1016/j.chiabu.2008.09.008			9	Family Studies; Psychology, Social; Social Work	Social Science Citation Index (SSCI)	Family Studies; Psychology; Social Work	459QN	WOS:000267118800012	19481802				2022-02-06	
J	Chung, RS; Leung, YK; Butler, CW; Chen, Y; Eaton, ED; Pankhurst, MW; West, AK; Guillemin, GJ				Chung, R. S.; Leung, Y. K.; Butler, C. W.; Chen, Y.; Eaton, E. D.; Pankhurst, M. W.; West, A. K.; Guillemin, G. J.			Metallothionein Treatment Attenuates Microglial Activation and Expression of Neurotoxic Quinolinic Acid Following Traumatic Brain Injury	NEUROTOXICITY RESEARCH			English	Article						Traumatic brain injury; Neuroinflammation; Neuron-glia interactions	KYNURENINE PATHWAY; DISEASE; CNS; METABOLISM; CELLS; BETA; PROTECT; FAMILY; ZINC	The kynurenine pathway has been implicated as a major component of the neuroinflammatory response to brain injury and neurodegeneration. We found that the neurotoxic kynurenine pathway intermediate quinolinic acid (QUIN) is rapidly expressed, within 24 h, by reactive microglia following traumatic injury to the rodent neocortex. Furthermore, administration of the astrocytic protein metallothionein attenuated this neuroinflammatory response by reducing microglial activation (by approximately 30%) and QUIN expression. The suppressive effect of MT was confirmed upon cultured cortical microglia, with 1 mu g/ml MT almost completely blocking interferon-gamma induced activation of microglia and QUIN expression. These results demonstrate the neuroimmunomodulatory properties of MT, which may have therapeutic applications for the treatment of traumatic brain injury.	[Chung, R. S.; Leung, Y. K.; Butler, C. W.; Eaton, E. D.; Pankhurst, M. W.; West, A. K.] Univ Tasmania, Menzies Res Inst, NeuroRepair Grp, Hobart, Tas 7001, Australia; [Chen, Y.; Guillemin, G. J.] Univ New S Wales, Ctr Immunol, Sydney, NSW 2052, Australia		Chung, RS (corresponding author), Univ Tasmania, Menzies Res Inst, NeuroRepair Grp, Private Bag 58, Hobart, Tas 7001, Australia.	rschung@utas.edu.au; g.guillemin@cfi.unsw.edu.au	West, Adrian/AAR-8857-2021; Pankhurst, Michael/F-2585-2017; Guillemin, Gilles J/C-3878-2015; Chung, Roger/ABF-8395-2020	Pankhurst, Michael/0000-0002-0976-5742; Guillemin, Gilles J/0000-0001-8105-4470; Chung, Roger/0000-0002-9286-947X	Australian Research CouncilAustralian Research Council [DP0556630, LP0774820, DP0984673]; National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [490025, 544913]	This work was supported by research grants from the Australian Research Council (DP0556630; LP0774820) and National Health and Medical Research Council (ID# 490025, 544913). RSC holds an Australian Research Council ARF Fellowship (DP0984673).	Ambjorn M, 2008, J NEUROCHEM, V104, P21, DOI 10.1111/j.1471-4159.2007.05036.x; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; Christofides J, 2006, J NEUROCHEM, V97, P1078, DOI 10.1111/j.1471-4159.2006.03807.x; Chung RS, 2008, J NEUROCHEM, V104, P14, DOI 10.1111/j.1171-4159.2007.05026.x; Chung RS, 2007, CELL MOL LIFE SCI, V64, P2716, DOI 10.1007/s00018-007-7267-8; Chung RS, 2008, J BIOL CHEM, V283, P15349, DOI 10.1074/jbc.M708446200; Chung RS, 2004, CELL MOL LIFE SCI, V61, P1238, DOI 10.1007/s00018-004-4026-y; Chung RS, 2003, J NEUROSCI, V23, P3336; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; ERICKSON JC, 1994, BRAIN RES, V649, P297, DOI 10.1016/0006-8993(94)91076-6; Floden AM, 2006, J NEUROSCI, V26, P4644, DOI 10.1523/JNEUROSCI.4822-05.2006; FOSTER AC, 1984, NEUROSCI LETT, V48, P273, DOI 10.1016/0304-3940(84)90050-8; Garcao P, 2006, J NEUROSCI RES, V84, P182, DOI 10.1002/jnr.20870; Giralt M, 2002, EXP NEUROL, V173, P114, DOI 10.1006/exnr.2001.7772; Guillemin GJ, 2007, J NEUROSCI, V27, P12884, DOI 10.1523/JNEUROSCI.4101-07.2007; Guillemin GJ, 2005, NEUROPATH APPL NEURO, V31, P395, DOI 10.1111/j.1365-2990.2005.00655.x; Guillemin GJ, 2001, J NEUROCHEM, V78, P842, DOI 10.1046/j.1471-4159.2001.00498.x; Guillemin GJ, 2003, ADV EXP MED BIOL, V527, P105; Hartai Z, 2005, ACTA NEUROL SCAND, V112, P93, DOI 10.1111/j.1600-0404.2005.00442.x; Heyes MP, 1996, ADV EXP MED BIOL, V398, P125; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; Jhamandas KH, 2000, NEUROTOX RES, V2, P139, DOI 10.1007/BF03033790; Kauppinen TM, 2008, J NEUROSCI, V28, P5827, DOI 10.1523/JNEUROSCI.1236-08.2008; Kukacka J, 2006, NEUROENDOCRINOL LETT, V27, P116; Laporte V, 2004, J LEUKOCYTE BIOL, V76, P451, DOI 10.1189/jlb.1203620; Mackay GM, 2006, EUR J NEUROL, V13, P30, DOI 10.1111/j.1468-1331.2006.01220.x; Penkowa M, 2002, J COMP NEUROL, V444, P174, DOI 10.1002/cne.10149; Penkowa M, 1999, J NEUROSCI, V19, P2535; Platten M, 2005, SCIENCE, V310, P850, DOI 10.1126/science.1117634; Ruddick Jon P., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000068; Smythe GA, 2002, ANAL BIOCHEM, V301, P21, DOI 10.1006/abio.2001.5490; West AK, 2004, REV NEUROSCIENCE, V15, P157; Yin XY, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-21; YOUN J, 1995, J TOXICOL ENV HEALTH, V45, P397, DOI 10.1080/15287399509532004; Youn J, 1999, TOXICOL SCI, V52, P199, DOI 10.1093/toxsci/52.2.199	35	23	23	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1029-8428			NEUROTOX RES	Neurotox. Res.	MAY	2009	15	4					381	389		10.1007/s12640-009-9044-y			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	428HG	WOS:000264838000009	19384571				2022-02-06	
J	Levine, J; Greenwald, BD				Levine, Jaime; Greenwald, Brian D.			Fatigue in Parkinson Disease, Stroke, and Traumatic Brain Injury	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Fatigue; Traumatic brain injury; Parkinson disease; Stroke; Cerebrovascular accident; Post-stroke syndrome	QUALITY-OF-LIFE; EXCESSIVE DAYTIME SLEEPINESS; DOUBLE-BLIND; POSTSTROKE FATIGUE; AMBULATORY ACTIVITY; PHYSICAL FATIGUE; MILD STROKE; LONG-TERM; FOLLOW-UP; PLACEBO	Fatigue is a disabling symptom common to many neurologic conditions, including Parkinson disease, post-stroke syndromes, and traumatic brain injury. Fatigue in the neurologic population is defined differently from that in the general population, and this has implications for assessment, research, and treatment. A considerable amount of research has been done in recent years aiming to describe, quantify, and ultimately treat this problem. There are relatively few proven treatments for fatigue in these populations, but the mainstays of therapy can be divided into pharmacologic and nonpharmacologic approaches.	[Levine, Jaime] St Vincents Med Ctr, Dept Phys Med & Rehabil, New York, NY 10011 USA; [Greenwald, Brian D.] Mt Sinai Med Ctr, Dept Rehabil Med, New York, NY 10029 USA		Levine, J (corresponding author), St Vincents Med Ctr, Dept Phys Med & Rehabil, 170 W 12th St,Link 103, New York, NY 10011 USA.	rehabdoc@mac.com					Alves G, 2004, NEUROLOGY, V63, P1908, DOI 10.1212/01.WNL.0000144277.06917.CC; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; BELZA BL, 1993, NURS RES, V42, P93; Borek LL, 2006, CNS SPECTRUMS, V11, P541, DOI 10.1017/S1092852900013560; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Buck D, 2004, CEREBROVASC DIS, V17, P143, DOI 10.1159/000075783; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Bushnik T, 2007, BRAIN INJURY, V21, P559, DOI 10.1080/02699050701426915; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Carlsson GE, 2004, DISABIL REHABIL, V26, P1373, DOI 10.1080/09638280400000211; Carlsson GE, 2003, CEREBROVASC DIS, V16, P383, DOI 10.1159/000072561; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Choi-Kwon S, 2007, CEREBROVASC DIS, V23, P103, DOI 10.1159/000097045; Culbertson WC, 2004, ASSESSMENT, V11, P27, DOI 10.1177/1073191103258590; de Groot MH, 2003, ARCH PHYS MED REHAB, V84, P1714, DOI 10.1053/S0003-9993(03)00346-0; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; FRIEDMAN J, 1993, NEUROLOGY, V43, P2016, DOI 10.1212/WNL.43.10.2016; Garber CE, 2003, NEUROLOGY, V60, P1119, DOI 10.1212/01.WNL.0000055868.06222.AB; Havlikova E, 2008, EUR J NEUROL, V15, P475, DOI 10.1111/j.1468-1331.2008.02103.x; Herlofson K, 2003, ACTA NEUROL SCAND, V107, P1, DOI 10.1034/j.1600-0404.2003.02033.x; Ingles JL, 1999, ARCH PHYS MED REHAB, V80, P173, DOI 10.1016/S0003-9993(99)90116-8; Jaracz K, 2007, NEUROL NEUROCHIR POL, V41, P36; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; Karlsen K, 1999, MOVEMENT DISORD, V14, P237, DOI 10.1002/1531-8257(199903)14:2<237::AID-MDS1006>3.3.CO;2-O; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Leone H, 2005, J CLIN PHARM THER, V30, P101, DOI 10.1111/j.1365-2710.2005.00628.x; Lou JS, 2003, MOVEMENT DISORD, V18, P1108, DOI 10.1002/mds.10505; Lou JS, 2001, MOVEMENT DISORD, V16, P190, DOI 10.1002/mds.1042; Lynch J, 2007, J PSYCHOSOM RES, V63, P539, DOI 10.1016/j.jpsychores.2007.08.004; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Mead G, 2007, STROKE, V38, P2090, DOI 10.1161/STROKEAHA.106.478941; Meindorfner C, 2005, MOVEMENT DISORD, V20, P832, DOI 10.1002/mds.20412; Mendonca DA, 2007, MOVEMENT DISORD, V22, P2070, DOI 10.1002/mds.21656; Michael K, 2007, TOP STROKE REHABIL, V14, P5, DOI 10.1310/tsr1402-5; Michael KM, 2006, REHABIL NURS, V31, P210, DOI 10.1002/j.2048-7940.2006.tb00137.x; Naess H, 2006, STROKE, V37, P1232, DOI 10.1161/01.STR.0000217652.42273.02; Nutt JG, 2007, ARCH NEUROL-CHICAGO, V64, P319, DOI 10.1001/archneur.64.3.319; Okun MS, 2006, ARCH NEUROL-CHICAGO, V63, P729, DOI 10.1001/archneur.63.5.729; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ondo WG, 2005, J NEUROL NEUROSUR PS, V76, P1636, DOI 10.1136/jnnp.2005.065870; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Oved D, 2006, MOVEMENT DISORD, V21, P1257, DOI 10.1002/mds.20929; Pucci E, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002818.pub2; Rahman S, 2008, MOVEMENT DISORD, V23, P1428, DOI 10.1002/mds.21667; Ripley DL, 2006, J HEAD TRAUMA REHAB, V21, P85, DOI 10.1097/00001199-200601000-00010; Rochester L, 2004, ARCH PHYS MED REHAB, V85, P1578, DOI 10.1016/j.apmr.2004.01.025; Rochester L, 2006, DISABIL REHABIL, V28, P1365, DOI 10.1080/09638280600638034; Schepers VP, 2006, ARCH PHYS MED REHAB, V87, P184, DOI 10.1016/j.apmr.2005.10.005; Shulman LM, 2001, MOVEMENT DISORD, V16, P507, DOI 10.1002/mds.1099; SZYMANSKI HV, 1992, INT J PSYCHIAT MED, V22, P357, DOI 10.2190/XARA-B1EF-J2HC-VAE0; Uc EY, 2006, NEUROLOGY, V67, P1774, DOI 10.1212/01.wnl.0000245086.32787.61; van de Port IGL, 2007, CEREBROVASC DIS, V23, P40, DOI 10.1159/000095757; van de Port IGL, 2006, STROKE, V37, P167, DOI 10.1161/01.STR.0000195180.69904.f2; VANHILTEN JJ, 1993, J NEURAL TRANSM-PARK, V5, P235; WELLS MR, 2003, FDN OSTEOPATHIC MED, P63; Zesiewicz TA, 2007, DISABIL REHABIL, V29, P1934, DOI 10.1080/09638280701257247; Zesiewicz Theresa A, 2006, Expert Rev Neurother, V6, P1811, DOI 10.1586/14737175.6.12.1811; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	63	23	23	0	18	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	MAY	2009	20	2					347	+		10.1016/j.pmr.2008.12.006			16	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	450KC	WOS:000266398400006	19389616				2022-02-06	
J	Broomhall, LGJ; Clark, CR; McFarlane, AC; O'Donnell, M; Bryant, R; Creamer, M; Silove, D				Broomhall, Luke G. J.; Clark, C. Richard; McFarlane, Alexander C.; O'Donnell, Meagan; Bryant, Richard; Creamer, Mark; Silove, Derek			Early Stage Assessment and Course of Acute Stress Disorder After Mild Traumatic Brain Injury	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article						Acute stress disorder; mild traumatic brain injury; posttraumatic stress disorder	POSTTRAUMATIC-STRESS; PSYCHOMETRIC PROPERTIES; PSYCHIATRIC MORBIDITY; HEAD-INJURY; CONSEQUENCES; ACCIDENTS; SCALE; PTSD	Although it has been established that acute stress disorder (ASD) and posttraumatic stress disorder occur after mild traumatic brain injury (MTBI) the qualitative differences in symptom presentation between injury survivors with and without a MTBI have not been explored in depth. This study aimed to compare the ASD and posttraumatic stress disorder symptom presentation of injury survivors with and without MTBI. One thousand one hundred sixteen participants between the ages of 17 to 65 years (mean age: 38.97 years, SD: 14.23) were assessed in the acute hospital after a traumatic injury. Four hundred seventy-five individuals met the criteria for MTBI. Results showed a trend toward higher levels of ASD in the MTBI group compared with the non-MTBI group. Those with a MTBI and ASD had longer hospital admissions and higher levels of distress associated with their symptoms. Although many of the ASD symptoms that the MTBI group scored significantly higher were also part of a postconcussive syndrome, higher levels of avoidance symptoms may suggest that this group is at risk for longer term poor psycho logical adjustment. Mild TBI patients may represent a injury group at risk for poor psychological adjustment after traumatic injury.	[Broomhall, Luke G. J.; Clark, C. Richard] Flinders Univ S Australia, Sch Psychol, Adelaide, SA 5001, Australia; [McFarlane, Alexander C.] Flinders Univ S Australia, Sch Psychiat, Adelaide, SA 5001, Australia; [O'Donnell, Meagan; Creamer, Mark] Univ Melbourne, Dept Psychiat, Melbourne, Vic 3010, Australia; [Bryant, Richard; Silove, Derek] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia		Broomhall, LGJ (corresponding author), Flinders Univ S Australia, Sch Psychol, GPO Box 2100, Adelaide, SA 5001, Australia.	luke.broomhall@flinders.edu.au	clark, christopher richard/B-3525-2012; Bryant, Richard/AAA-6479-2019	Bryant, Richard/0000-0002-9607-819X; O'Donnell, Meaghan/0000-0003-4349-0022	National Health and Medical Research Council ProgramNational Health and Medical Research Council of Australia [300304]; Victorian Trauma Foundation [V- 11]; National Health and Medical Research Council Australian Clinical ResearchNational Health and Medical Research Council of Australia [359284]	Supported by a National Health and Medical Research Council Program Grant (300304), a Victorian Trauma Foundation grant (V- 11), and a National Health and Medical Research Council Australian Clinical Research Fellowship (359284).	American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Blake DD, 1998, CLIN ADM PTSD SCALE; Bryant RA, 2005, PSYCHOL SCI, V16, P749, DOI 10.1111/j.1467-9280.2005.01608.x; Bryant RA, 1998, PSYCHOL ASSESSMENT, V10, P215, DOI 10.1037/1040-3590.10.3.215; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; Bryant Richard A, 2005, J Trauma Dissociation, V6, P5, DOI 10.1300/J229v06n02_02; Carty J, 2006, J AFFECT DISORDERS, V90, P257, DOI 10.1016/j.jad.2005.11.011; Creamer M, 2005, BEHAV RES THER, V43, P1383, DOI 10.1016/j.brat.2004.11.001; FAO EB, 1989, BEHAV THER, V20, P155; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; Harvey AG, 1998, J NERV MENT DIS, V186, P333, DOI 10.1097/00005053-199806000-00002; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; McMillan TM, 1997, CURR OPIN NEUROL, V10, P479, DOI 10.1097/00019052-199712000-00008; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P507, DOI 10.1176/appi.ajp.161.3.507; Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rees R, 2005, INTERRUPTED LIVES RE; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Schnyder U, 2001, AM J RESP CRIT CARE, V164, P653, DOI 10.1164/ajrccm.164.4.2008087; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029	27	23	25	3	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-3018			J NERV MENT DIS	J. Nerv. Ment. Dis.	MAR	2009	197	3					178	181		10.1097/NMD.0b013e318199fe7f			4	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	420BL	WOS:000264263300006	19282684				2022-02-06	
J	Relyea-Chew, A; Hollingworth, W; Chan, L; Comstock, BA; Overstreet, KA; Jarvik, JG				Relyea-Chew, Annemarie; Hollingworth, William; Chan, Leighton; Comstock, Bryan A.; Overstreet, Karen A.; Jarvik, Jeffrey G.			Personal Bankruptcy After Traumatic Brain or Spinal Cord Injury: The Role of Medical Debt	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Health care costs; Insurance, health; Rehabilitation; Spinal cord injuries	HEALTH PLAN; INSURANCE; DECISION; COVERAGE; RISK	Objective: To estimate the prevalence of medical debt among traumatic brain injury (TBI) and spinal cord injury (SCI) patients who discharged their debts through bankruptcy. Design: A cross-sectional comparison of bankruptcy filings of injured versus randomly selected bankruptcy petitioners. Setting: Patients hospitalized with SCI or TBI (1996-2002) and personal bankruptcy petitioners (2001-2004) in western Washington State. Participants: Subjects (N = 186) who filed for bankruptcy, comprised of 93 patients with previous SCI or TBI and 93 randomly selected bankruptcy petitioners. Interventions: Not applicable. Main Outcome Measures: Medical and nonmedical debt, assets, income, expenses, and employment recorded in the bankruptcy petition. Results: Five percent of randomly selected petitioners and 26% of petitioners with TBI or SCI had substantial medical debt (debt that accounted for more than 20% of all unsecured debts). SCI and TB I petitioners had fewer assets and were more likely to be receiving government income assistance at the time of bankruptcy than controls. SCI and TBI patients with a higher blood alcohol content at injury were more likely to have substantial medical debts (odds ratio=2.70; 95% confidence interval, 1.04-7.00). Conclusions: Medical debt plays an important role in some bankruptcies after TBI or SCI. We discuss policy options for reducing financial distress after serious injury.	[Hollingworth, William] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; [Relyea-Chew, Annemarie; Jarvik, Jeffrey G.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Comstock, Bryan A.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Jarvik, Jeffrey G.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Jarvik, Jeffrey G.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Comstock, Bryan A.; Jarvik, Jeffrey G.] Univ Washington, Ctr Cost & Outcomes Res, Seattle, WA 98195 USA; [Relyea-Chew, Annemarie] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Chan, Leighton] NIH, Ctr Clin, Dept Rehabil Med, Bethesda, MD 20892 USA; [Overstreet, Karen A.] Western Dist Washington, US Bankruptey Court, Seattle, WA USA		Hollingworth, W (corresponding author), Univ Bristol, Dept Social Med, Canynge Hall, Bristol BS8 2PR, Avon, England.	william.hollingworth@bristol.ac.uk	Jarvik, Jeffrey/AAL-4292-2021	Hollingworth, William/0000-0002-0840-6254	Royalty Research Fund of the University of WashingtonUniversity of Washington; intramural research program of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	Supported by the Royalty Research Fund of the University of Washington and the intramural research program of the National Institutes of Health.	[Anonymous], BANKR STAT; BAKER WA, 1976, INORG CHIM ACTA, V16, P5, DOI 10.1016/S0020-1693(00)91684-0; Carlson MJ, 2006, ANN FAM MED, V4, P391, DOI 10.1370/afm.573; Cook J, 1998, JAMA-J AM MED ASSOC, V279, P822; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Domowitz I, 1999, J FINANC, V54, P403, DOI 10.1111/0022-1082.00110; Dranove D, 2006, HEALTH AFFAIR, V25, pW74, DOI 10.1377/hlthaff.25.w74; Fay S, 2002, AM ECON REV, V92, P706, DOI 10.1257/00028280260136327; *FED RES STAT REL, CONS CRED; Gabel J, 2003, HEALTH AFFAIR, V22, P117, DOI 10.1377/hlthaff.22.5.117; GILMER T, 2005, HLTH AFF MILLW S JAN; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; HIMMELSTEIN DU, 2005, HLTH AFF MILLW S JAN; HOLAHAN J, 2002, HLTH AFF MILLWOOD S, pW187; Hollingworth W, 2007, MED CARE, V45, P702, DOI 10.1097/MLR.0b013e318041f765; *HOUS COMM FIN I I, 2004, 2014 HB HOUS COMM FI; Jensen S, 2005, AM BANKRUPT LAW J, V79, P485; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; Martin MJ, 2005, J TRAUMA, V59, P860, DOI 10.1097/01.ta.0000187964.47703.e9; McMordie W R, 1988, Brain Inj, V2, P357, DOI 10.3109/02699058809150908; Meade MA, 2004, ARCH PHYS MED REHAB, V85, P1782, DOI 10.1016/j.apmr.2004.05.001; Moore L, 2006, J TRAUMA, V60, P1238, DOI 10.1097/01.ta.0000195593.60245.80; *NAT AC PR I MED, 2004, COMM CONS UN INS AM; Rivara FP, 2000, J TRAUMA, V48, P115, DOI 10.1097/00005373-200001000-00019; Singleton Michael, 2004, Traffic Inj Prev, V5, P144, DOI 10.1080/713903941; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; Sullivan T. A., 2000, FRAGILE MIDDLE CLASS; Wharam JF, 2007, JAMA-J AM MED ASSOC, V297, P1093, DOI 10.1001/jama.297.10.1093; Woolhandler S, 2003, JAMA-J AM MED ASSOC, V290, P798; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5	31	23	23	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2009	90	3					413	419		10.1016/j.apmr.2008.07.031			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	421YW	WOS:000264395200007	19254605	Green Published, Green Accepted			2022-02-06	
J	Gonzalez, SL; Lopez-Costa, JJ; Labombarda, F; Deniselle, MCG; Guennoun, R; Schumacher, M; De Nicola, AF				Gonzalez, Susana L.; Jose Lopez-Costa, Juan; Labombarda, Florencia; Gonzalez Deniselle, Maria Claudia; Guennoun, Rachida; Schumacher, Michael; De Nicola, Alejandro F.			Progesterone Effects on Neuronal Ultrastructure and Expression of Microtubule-associated Protein 2 (MAP2) in Rats with Acute Spinal Cord Injury	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Chromatolysis; Electron microscopy; MAP2; Motoneuron; Neuroprotection; Progesterone; Spinal cord injury	TRAUMATIC BRAIN-INJURY; NEUROTROPHIC FACTOR EXPRESSION; AMYOTROPHIC-LATERAL-SCLEROSIS; MYELIN BASIC-PROTEIN; VENTRAL HORN NEURONS; NEUROACTIVE STEROIDS; SENSORY NEURONS; MOTOR-NEURONS; SCHWANN-CELLS; DEGENERATION	(1) Following acute spinal cord injury, progesterone modulates several molecules essential for motoneuron function, although the morphological substrates for these effects are unknown. (2) The present study analyzed morphological changes in motoneurons distal to the lesion site from rats with or without progesterone treatment. We employed electron microscopy to study changes in nucleus and cytoplasm and immunohistochemistry for the microtubule-associated protein 2 (MAP2) for changes in cytoskeleton. (3) After spinal cord injury, the nucleoplasm appeared more finely dispersed resulting in reduced electron opacity and the nucleus adopted an eccentric position. Changes of perikarya included dissolution of Nissl bodies and dissociation of polyribosomes (chromatolysis). After progesterone treatment for 3 days, the deafferented motoneurons now presented a clumped nucleoplasm, a better-preserved rough endoplasmic reticulum and absence of chromatolysis. Progesterone partially prevented development of nuclear eccentricity. Whereas 50% of injured motoneurons showed nuclear eccentricity, only 16% presented this phenotype after receiving progesterone. Additionally, injured rats showed reduced immunostaining for MAP2 in dendrites, pointing to cytoskeleton abnormalities, whereas progesterone treatment attenuated the injury-induced loss of MAP2. (4) Our data indicated that progesterone maintained in part neuronal ultrastructure, attenuated chromatolysis, and preclude the loss of MAP2, suggesting a protective effect during the early phases of spinal cord injury.	[Gonzalez, Susana L.; Labombarda, Florencia; Gonzalez Deniselle, Maria Claudia; De Nicola, Alejandro F.] Inst Biol & Med Expt, Lab Neuroendocrine Biochem, RA-1428 Buenos Aires, DF, Argentina; [Gonzalez, Susana L.; Labombarda, Florencia; Gonzalez Deniselle, Maria Claudia; De Nicola, Alejandro F.] Univ Buenos Aires, Dept Human Biochem, Fac Med, Buenos Aires, DF, Argentina; [Jose Lopez-Costa, Juan] Univ Buenos Aires, Inst Biol Celular & Neurociencias Prof Eduardo De, Fac Med, Buenos Aires, DF, Argentina; [Guennoun, Rachida; Schumacher, Michael] Univ Paris 11, F-94276 Le Kremlin Bicetre, France; [Guennoun, Rachida; Schumacher, Michael] INSERM, UMR 788, F-94276 Le Kremlin Bicetre, France		De Nicola, AF (corresponding author), Inst Biol & Med Expt, Lab Neuroendocrine Biochem, Obligado 2490, RA-1428 Buenos Aires, DF, Argentina.	denicola@dna.uba.ar	Guennoun, Rachida/F-2420-2011; Schumacher, Michael/G-3581-2013	Guennoun, Rachida/0000-0002-9219-7300; Schumacher, Michael/0000-0001-6117-5371	FONCYTFONCyT [25610]; National Research Council of ArgentinaConsejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [5542]; University of Buenos AiresUniversity of Buenos Aires [M022, M808]	The authors acknowledge the support of FONCYT (BID OC AR PICT 2004 # 25610), the National Research Council of Argentina (CONICET, PIP 5542), and the University of Buenos Aires (M022 and M808). We deeply thank Ms. Mariana Lopez Ravasio for electron microscopic techniques and Juan Pablo Corazza for help with photography.	Acheson A, 1996, PHILOS T ROY SOC B, V351, P417, DOI 10.1098/rstb.1996.0037; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Azcoitia I, 2003, NEUROBIOL AGING, V24, P853, DOI 10.1016/S0197-4580(02)00234-8; Bareyre FM, 2003, TRENDS NEUROSCI, V26, P555, DOI 10.1016/j.tins.2003.08.004; BARR ML, 1948, J COMP NEUROL, V89, P93, DOI 10.1002/cne.900890203; BERNHARDT R, 1984, J COMP NEUROL, V226, P203, DOI 10.1002/cne.902260205; Bjugn R, 1997, EXP NEUROL, V148, P179, DOI 10.1006/exnr.1997.6610; CACERES A, 1988, MOL BRAIN RES, V3, P233, DOI 10.1016/0169-328X(88)90046-0; CRAGG BG, 1970, BRAIN RES, V23, P1, DOI 10.1016/0006-8993(70)90345-8; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Davies AM, 1996, NEUROCHEM RES, V21, P749, DOI 10.1007/BF02532296; De Nicola AF, 2006, J MOL NEUROSCI, V28, P3, DOI 10.1385/JMN:28:1:3; Deniselle MCG, 2005, EXP NEUROL, V195, P518, DOI 10.1016/j.expneurol.2005.06.015; Deniselle MCG, 2002, J STEROID BIOCHEM, V83, P199, DOI 10.1016/S0960-0760(02)00262-5; Desarnaud F, 1998, J NEUROCHEM, V71, P1765; di Michele F, 2000, NEUROSCI LETT, V284, P65, DOI 10.1016/S0304-3940(00)00965-4; Di Stefano G, 2006, REJUV RES, V9, P94; EIDELBERG E, 1989, BRAIN RES BULL, V22, P39, DOI 10.1016/0361-9230(89)90125-1; Farah CA, 2005, J BIOL CHEM, V280, P9439, DOI 10.1074/jbc.M412304200; Fee DB, 2007, BRAIN RES, V1137, P146, DOI 10.1016/j.brainres.2006.12.024; Fontaine-Lenoir V, 2006, P NATL ACAD SCI USA, V103, P4711, DOI 10.1073/pnas.0600113103; Fukumitsu H, 1997, NEUROSCI LETT, V238, P107, DOI 10.1016/S0304-3940(97)00852-5; Garay L, 2007, J STEROID BIOCHEM, V107, P228, DOI 10.1016/j.jsbmb.2007.03.040; Ghoumari AM, 2003, J NEUROCHEM, V86, P848, DOI 10.1046/j.1471-4159.2003.01881.x; GOLD BG, 1991, J NEUROSCI, V11, P943; Deniselle MCG, 2007, EXP NEUROL, V203, P406, DOI 10.1016/j.expneurol.2006.08.019; Gonzalez SL, 2005, J STEROID BIOCHEM, V94, P143, DOI 10.1016/j.jsbmb.2005.01.016; Gonzalez SL, 2004, NEUROSCIENCE, V125, P605, DOI 10.1016/j.neuroscience.2004.02.024; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Hayashi T, 1998, STROKE, V29, P1007, DOI 10.1161/01.STR.29.5.1007; HAYES RL, 1995, J NEUROTRAUM, V12, P933, DOI 10.1089/neu.1995.12.933; Ibanez C, 2003, PROG NEUROBIOL, V71, P49, DOI 10.1016/j.pneurobio.2003.09.002; Jamieson SMF, 2007, NEUROTOXICOLOGY, V28, P1092, DOI 10.1016/j.neuro.2007.04.009; Kaur P, 2007, J NEUROSCI RES, V85, P2441, DOI 10.1002/jnr.21370; Kikuchi H, 1999, ACTA NEUROPATHOL, V97, P13, DOI 10.1007/s004010050950; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; Kupina NC, 2003, EXP NEUROL, V180, P55, DOI 10.1016/S0014-4886(02)00048-1; Labombarda F, 2006, ENDOCRINOLOGY, V147, P1847, DOI 10.1210/en.2005-0955; Labombarda F, 2006, J NEUROTRAUM, V23, P181, DOI 10.1089/neu.2006.23.181; Labombarda F, 2003, J NEUROCHEM, V87, P902, DOI 10.1046/j.1471-4159.2003.02055.x; Labombarda F, 2002, J NEUROTRAUM, V19, P343, DOI 10.1089/089771502753594918; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Magnaghi V, 2001, BRAIN RES REV, V37, P360, DOI 10.1016/S0165-0173(01)00140-0; MARSH HN, 1993, J NEUROSCI, V13, P4281; McIlwain DL, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-19; Melcangi RC, 2006, J MOL NEUROSCI, V28, P1, DOI 10.1385/JMN:28:1:1; MIRANDA RC, 1993, P NATL ACAD SCI USA, V90, P6439, DOI 10.1073/pnas.90.14.6439; NACIMIENTO W, 1995, ACTA NEUROPATHOL, V90, P552; Patte-Mensah C, 2004, J COMP NEUROL, V477, P286, DOI 10.1002/cne.20251; PRICE DL, 1972, J CELL BIOL, V53, P24, DOI 10.1083/jcb.53.1.24; Reyna-Neyra A, 2002, BRAIN RES BULL, V58, P607, DOI 10.1016/S0361-9230(02)00829-8; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Siegel S., 1989, NONPARAMETRIC STAT B, V2nd; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Springer JE, 1997, J NEUROCHEM, V69, P1592, DOI 10.1046/j.1471-4159.1997.69041592.x; Stein DG, 2005, ANN NY ACAD SCI, V1052, P152, DOI 10.1196/annals.1347.011; Thomas AJ, 1999, SPINE, V24, P2134, DOI 10.1097/00007632-199910150-00013; WAKAYAMA I, 1992, BRAIN RES, V586, P12, DOI 10.1016/0006-8993(92)91365-L; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Yu WR, 2000, ACTA NEUROPATHOL, V100, P546, DOI 10.1007/s004010000206; Zeman RJ, 2004, EXP NEUROL, V187, P460, DOI 10.1016/j.expneurol.2004.03.006; Zhang SX, 2000, J NEUROPATH EXP NEUR, V59, P287, DOI 10.1093/jnen/59.4.287	62	23	28	0	4	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	FEB	2009	29	1					27	39		10.1007/s10571-008-9291-0			13	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	403XA	WOS:000263114100004	18584320				2022-02-06	
J	Shahlaie, K; Boggan, JE; Latchaw, RE; Ji, C; Muizelaar, JP				Shahlaie, Kiarash; Boggan, James E.; Latchaw, Richard E.; Ji, Cheng; Muizelaar, J. Paul			Posttraumatic Vasospasm Detected by Continuous Brain Tissue Oxygen Monitoring: Treatment with Intraarterial Verapamil and Balloon Angioplasty	NEUROCRITICAL CARE			English	Article						Vasospasm; Traumatic brain injury; Brain tissue oxygen; PbtO2; Angioplasty; Verapamil	CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; TRAUMATIC SUBARACHNOID HEMORRHAGE; TRANSCRANIAL DOPPLER ULTRASOUND; INTRACRANIAL ARTERIAL SPASM; TIME-COURSE; HEMODYNAMIC DISTURBANCES; CT-SCAN; VELOCITY; NIMODIPINE	Posttraumatic vasospasm (PTV) is a relatively common event following traumatic brain injury (TBI) that has been strongly correlated with worse neurological outcome in many studies. However, vasospasm continues to be an under-recognized source of secondary injury following TBI, and currently published guidelines do not address screening or management strategies for PTV. Brain tissue oxygen (PbtO2) monitoring probes allow for continuous screening for cerebral hypoxia following TBI, but their use as a monitor for PTV has not been previously described. Case report and literature review. We present a case of PTV identified by persistent low PbtO2 despite aggressive medical therapy. Computed tomography and digital subtraction angiography confirmed severe cerebral arterial vasospasm involving both anterior and posterior circulations. The patient was successfully treated with serial intraarterial therapy including balloon angioplasty and verapamil infusion. Posttraumatic vasospasm should be included in the differential diagnosis of cerebral hypoxia (e.g., low PbtO2) following TBI. Management strategies for PTV may include early, aggressive intraarterial therapies including drug infusion and balloon angioplasty.	[Shahlaie, Kiarash; Boggan, James E.; Muizelaar, J. Paul] Univ Calif Davis, Med Ctr, Dept Neurol Surg, Sch Med, Sacramento, CA 95817 USA; [Latchaw, Richard E.; Ji, Cheng] Univ Calif Davis, Med Ctr, Dept Radiol, Sacramento, CA 95817 USA		Shahlaie, K (corresponding author), Univ Calif Davis, Med Ctr, Dept Neurol Surg, Sch Med, 4860 Y St,Suite 3740, Sacramento, CA 95817 USA.	krshahlaie@ucdavis.edu					Armin SS, 2006, NEUROL RES, V28, P445, DOI 10.1179/016164106X115053; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; ARSENI C, 1971, ACTA NEUROCHIR, V24, P25, DOI 10.1007/BF01403138; ARUTIUNOV AI, 1974, J NEUROSURG, V40, P459, DOI 10.3171/jns.1974.40.4.0459; BAILEY I, 1991, ACTA NEUROCHIR, V110, P97, DOI 10.1007/BF01400674; Bakshi A, 1998, NATL MED J INDIA, V11, P220; BRAAKMAN R, 1994, J NEUROSURG, V80, P797; *BRAIN TRAUM FDN, 2007, J NEUROTRAUMA S1, V24, pS65; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cairns CJS, 2003, ANAESTH INTENS CARE, V31, P87, DOI 10.1177/0310057X0303100117; CHAN KH, 1992, SURG NEUROL, V38, P433, DOI 10.1016/0090-3019(92)90111-Y; CHAN KH, 1992, NEUROSURGERY, V30, P697; CHAN KH, 1993, ACTA NEUROCHIR, P81; COLUMELLA F, 1963, ACTA RADIOL DIAGN, V1, P239, DOI 10.1177/028418516300100217; Compton J S, 1987, Br J Neurosurg, V1, P435, DOI 10.3109/02688698708999633; Devlin JW, 2000, NEUROSURGERY, V47, P1243, DOI 10.1097/00006123-200011000-00048; Doppenberg EMR, 1998, ACT NEUR S, V71, P166; Doppenberg EMR, 1998, SURG NEUROL, V49, P650, DOI 10.1016/S0090-3019(97)00355-8; Dorhout SM, 2008, STROKE, V39, P514, DOI 10.1161/STROKEAHA.107.496802; Echlin FA, 1942, ARCH NEURO PSYCHIATR, V47, P77, DOI 10.1001/archneurpsyc.1942.02290010087007; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; FRENIDENFELT H, 1963, ACTA RADIOL, V1, P278; GAETANI P, 1994, J NEUROL NEUROSUR PS, V57, P66, DOI 10.1136/jnnp.57.1.66; GOMEZ CR, 1991, SURG NEUROL, V35, P30, DOI 10.1016/0090-3019(91)90198-I; GROLIMUND P, 1988, LANCET, V1, P1173; Hadani M, 1997, J NEUROTRAUM, V14, P629, DOI 10.1089/neu.1997.14.629; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; HARDERS AG, 1987, J NEUROSURG, V66, P718, DOI 10.3171/jns.1987.66.5.0718; Hoelper BM, 2003, NEUROSURGERY, V52, P970, DOI 10.1227/01.NEU.0000053033.98317.A3; JAKOBSEN M, 1990, ACTA NEUROL SCAND, V82, P311; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; KISTLER JP, 1983, NEUROLOGY, V33, P424, DOI 10.1212/WNL.33.4.424; Kochanowicz J, 2006, NEURORADIOLOGY, V48, P31, DOI 10.1007/s00234-005-0009-4; KORDESTANI RK, 1995, NEUROSURG CLIN N AM, V6, P657; Kostron H, 1985, Neurochirurgia (Stuttg), V28 Suppl 1, P103; KOSTRON H, 1984, Neurological Research, V6, P29; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; Lee KH, 2006, NEUROCRIT CARE, V4, P68, DOI 10.1385/NCC:4:1:068; LEWIS WH, 1968, ANN MO BOT GARD, V55, P31, DOI 10.2307/2394818; LINDEGAARD KF, 1989, ACTA NEUROCHIR, V100, P12, DOI 10.1007/BF01405268; MACPHERS.P, 1973, J NEUROL NEUROSUR PS, V36, P1069, DOI 10.1136/jnnp.36.6.1069; MACPHERSON P, 1978, J NEUROL NEUROSUR PS, V41, P122, DOI 10.1136/jnnp.41.2.122; MARSHALL LF, 1978, J NEUROSURG, V48, P560, DOI 10.3171/jns.1978.48.4.0560; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; MARTIN NA, 1995, J NEUROTRAUM, V12, P897, DOI 10.1089/neu.1995.12.897; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; Meixensberger J, 2003, NEUROL RES, V25, P445, DOI 10.1179/016164103101201823; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; Muench E, 2007, CRIT CARE MED, V35, P1844, DOI 10.1097/01.CCM.0000275392.08410.DD; Muizelaar JP, 1999, J NEUROSURG, V91, P51, DOI 10.3171/jns.1999.91.1.0051; MUTTAQIN Z, 1991, NEUROSURG REV, V14, P321, DOI 10.1007/BF00383273; Newell D W, 1992, Clin Neurosurg, V39, P348; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Ojha BK, 2005, SURG NEUROL, V64, P174, DOI 10.1016/j.surneu.2004.11.030; PASQUALIN A, 1984, NEUROSURGERY, V15, P855, DOI 10.1227/00006123-198412000-00015; Radhakrishnan D, 1997, ANAESTHESIA, V52, P489, DOI 10.1111/j.1365-2044.1997.112-az0105.x; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Romner B, 1996, J NEUROSURG, V85, P90, DOI 10.3171/jns.1996.85.1.0090; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Rozsa L, 1989, Radiol Diagn (Berl), V30, P151; SANDER D, 1993, J NEUROL SCI, V119, P1, DOI 10.1016/0022-510X(93)90185-2; Sarrafzadeh AS, 2002, CRIT CARE MED, V30, P1062, DOI 10.1097/00003246-200205000-00018; SEIFERT V, 1995, J NEUROSURG, V82, P55, DOI 10.3171/jns.1995.82.1.0055; Soustiel JF, 2004, SURG NEUROL, V62, P201, DOI 10.1016/j.surneu.2003.10.037; Soustiel JF, 2002, ACTA NEUROCHIR, V144, P137, DOI 10.1007/s007010200016; Soustiel JF, 2002, STROKE, V33, P72, DOI 10.1161/hs0102.100484; STEIGER HJ, 1994, NEUROSURGERY, V34, P79; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; SUWANWELA C, 1972, J NEUROSURG, V36, P314, DOI 10.3171/jns.1972.36.3.0314; SYMON L, 1967, J NEUROL NEUROSUR PS, V30, P497, DOI 10.1136/jnnp.30.6.497; Taneda M, 1996, J NEUROSURG, V84, P762, DOI 10.3171/jns.1996.84.5.0762; TEASDALE G, 1990, ACT NEUR S, V51, P315; Vajkoczy P, 2003, J NEUROSURG, V98, P1227, DOI 10.3171/jns.2003.98.6.1227; Vajramani GV, 1999, BRIT J NEUROSURG, V13, P468, DOI 10.1080/02688699943277; Vath A, 2002, ACT NEUR S, V81, P307; WADWORTH AN, 1992, DRUG AGING, V2, P262, DOI 10.2165/00002512-199202040-00002; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015; WEIR B, 1978, J NEUROSURG, V48, P173, DOI 10.3171/jns.1978.48.2.0173; Wilensky Eileen Maloney, 2005, J Neurosci Nurs, V37, P278; Wilkins R H, 1990, Neurosurg Clin N Am, V1, P329; WILKINS RH, 1970, J NEUROSURG, V32, P626, DOI 10.3171/jns.1970.32.6.0626; Xiao Xingyi, 2002, Chin J Traumatol, V5, P380; Yamada K, 1998, NEUROSURGERY, V43, P153, DOI 10.1097/00006123-199807000-00101; Zubkov AY, 1999, J NEUROTRAUM, V16, P763, DOI 10.1089/neu.1999.16.763; Zubkov ZY, 2000, SURG NEUROL, V53, P126; ZURYNSKI YA, 1995, J NEUROL SCI, V134, P41, DOI 10.1016/0022-510X(95)00178-X; ZURYNSKI YA, 1995, J NEUROL SCI, V134, P33, DOI 10.1016/0022-510X(95)00172-9; ZWIENENBERGLEE M, 2006, NEUROSURGERY S3, V59, pS3, DOI DOI 10.1227/01.NEU.000023952.07760.59; ZWIENENBERGLEE M, 2003, NEUROSURGERY, V59, pS139	90	23	24	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2009	10	1					61	69		10.1007/s12028-008-9138-z			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	397GZ	WOS:000262652200009	18807219				2022-02-06	
J	Gallek, MJ; Conley, YP; Sherwood, PR; Horowitz, MB; Kassam, A; Alexander, SA				Gallek, Matthew J.; Conley, Yvette P.; Sherwood, Paula R.; Horowitz, Michael B.; Kassam, Amin; Alexander, Sheila A.			APOE Genotype and Functional Outcome Following Aneurysmal Subarachnoid Hemorrhage	BIOLOGICAL RESEARCH FOR NURSING			English	Article						apolipoprotein E; subarachnoid hemorrhage; cerebral vasospasm; Modified Rankin Score; Glasgow Outcome Score	APOLIPOPROTEIN-E POLYMORPHISM; TRANSGENIC MICE; HEAD-INJURY; ALLELE; CHOLESTEROL; STROKE; SCALE; ASSOCIATION; POPULATION; DISABILITY	Apolipoprotein E (apoE), the major apolipoprotein in the central nervous system, has been shown to influence neurologic disease progression and response to neurologic injury in a gene-specific manner. Presence of the APOE4 allele is associated with poorer response to traumatic brain injury and ischemic stroke, but the association between APOE genotype and outcome following aneurysmal subarachnoid hemorrhage (SAH) remains unclear. The purpose of this project was to investigate the association between APOE genotype and outcome after SAH. We also explored the association of APOE4 genotype and cerebral vasospasm (CV) presence in a subsample of our population with available angiographic data. A sample of 206 aneurysmal SAH participants had APOE genotyping performed, Glasgow outcome scores (GOS) and modified Rankin scores (MRS) collected at 3 and 6 months after aneurysm rupture. No significant association was found between the presence of the APOE4 genotype and functional outcomes controlling for age, race, size of hemorrhage (Fisher grade), and severity of injury (Hunt & Hess grade). However when controlling for CV and the covariates listed above, individuals with the APOE4 allele had worse functional outcomes at both time points. The presence of the APOE2 allele was not associated with functional outcomes even when considering presence of CV. There was no difference in mortality associated with APOE4 presence, APOE2 presence, or presence of CV. These findings suggest APOE4 allele is associated with poor outcome after aneurysmal SAH.	[Gallek, Matthew J.; Conley, Yvette P.; Sherwood, Paula R.; Alexander, Sheila A.] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA; [Horowitz, Michael B.; Kassam, Amin] Univ Pittsburgh, Dept Neurosurg, Pittsburgh, PA USA		Gallek, MJ (corresponding author), 1305 N Martin Ave,POB 210203, Tucson, AZ 85721 USA.	mgallek@nursing.arizona.edu			National Institutes of Health/National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01-NR004339]; Neuroscience Nursing Foundation; Merck Company Foundation/ANFMerck & Company; Sigma Theta Tau International Honor Society for Nurses-Eta chapter; Leslie Hoffman Endowed Acute Care Research Fund; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [T32NR009759, R01NR004339] Funding Source: NIH RePORTER	The parent study from which the participants were recruited is supported by the National Institutes of Health/National Institute of Nursing Research (R01-NR004339). This work was supported by the Neuroscience Nursing Foundation, the Merck Company Foundation/ANF grant, Sigma Theta Tau International Honor Society for Nurses-Eta chapter, and the Leslie Hoffman Endowed Acute Care Research Fund.	ALBERTS MJ, 1995, LANCET, V346, P575, DOI 10.1016/S0140-6736(95)91411-0; BEDERSON JB, 1995, STROKE, V26, P1086, DOI 10.1161/01.STR.26.6.1086; Blain JF, 2006, NEUROBIOL DIS, V21, P505, DOI 10.1016/j.nbd.2005.08.010; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DeMattos RB, 2001, J LIPID RES, V42, P976; Dunn LT, 2001, NEUROSURGERY, V48, P1006, DOI 10.1097/00006123-200105000-00007; Fisher C M, 1975, Clin Neurosurg, V22, P117; Fleisher A, 2005, ARCH NEUROL-CHICAGO, V62, P953, DOI 10.1001/archneur.62.6.953; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hayashi H, 2002, NEUROREPORT, V13, P383, DOI 10.1097/00001756-200203250-00004; Hayashi H, 2007, J NEUROSCI, V27, P1933, DOI 10.1523/JNEUROSCI.5471-06.2007; HIXSON JE, 1990, J LIPID RES, V31, P545; Isoniemi H, 2006, J NEUROTRAUM, V23, P1600, DOI 10.1089/neu.2006.23.1600; JENNETT B, 1976, MED J AUSTRALIA, V2, P475, DOI 10.5694/j.1326-5377.1976.tb130352.x; JENNETT B, 1975, LANCET, V1, P480; Ji ZS, 2002, J BIOL CHEM, V277, P21821, DOI 10.1074/jbc.M112109200; Jiang Y, 2006, NEUROSCI LETT, V408, P155, DOI 10.1016/j.neulet.2006.08.082; KAMBOH MI, 1995, ATHEROSCLEROSIS, V112, P145, DOI 10.1016/0021-9150(94)05409-C; KASSELL NF, 1985, STROKE, V16, P562, DOI 10.1161/01.STR.16.4.562; Lanterna LA, 2005, NEUROLOGY, V64, P1238, DOI 10.1212/01.WNL.0000156523.77347.B4; Laskowitz DT, 1998, J CEREBR BLOOD F MET, V18, P465, DOI 10.1097/00004647-199805000-00001; Leung CHS, 2002, STROKE, V33, P548, DOI 10.1161/hs0202.102326; Lynch JR, 2001, J NEUROIMMUNOL, V114, P107, DOI 10.1016/S0165-5728(00)00459-8; MAAS AIR, 1983, J NEUROSURG, V58, P321, DOI 10.3171/jns.1983.58.3.0321; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Morris PG, 2004, ACTA NEUROL SCAND, V109, P205, DOI 10.1034/j.1600-0404.2003.00206.x; Niskakangas T, 2001, STROKE, V32, P1181, DOI 10.1161/01.STR.32.5.1181; OKUIZUMI K, 1994, NAT GENET, V7, P10, DOI 10.1038/ng0594-10b; ROSES AD, 1994, J NEUROPATH EXP NEUR, V53, P429, DOI 10.1097/00005072-199409000-00002; ROSES AD, 1994, LANCET, V343, P1564, DOI 10.1016/S0140-6736(94)92960-2; Ruigrok YM, 2005, J NEUROL, V252, P417, DOI 10.1007/s00415-005-0661-y; Sabo T, 2000, NEUROSCIENCE, V101, P879, DOI 10.1016/S0306-4522(00)00438-3; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; Sturm JW, 2002, STROKE, V33, P762, DOI 10.1161/hs0302.103815; Sulter G, 1999, STROKE, V30, P1538, DOI 10.1161/01.STR.30.8.1538; Sun YL, 1998, J NEUROSCI, V18, P3261; Tang J, 2003, SURG NEUROL, V60, P391, DOI 10.1016/S0090-3019(03)00323-9; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Tolar M, 1999, J NEUROSCI, V19, P7100, DOI 10.1523/JNEUROSCI.19-16-07100.1999; VANDUIJN CM, 1994, NAT GENET, V7, P74, DOI 10.1038/ng0594-74; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; VOLDBY B, 1982, J NEUROSURG, V56, P186, DOI 10.3171/jns.1982.56.2.0186; Weisgraber Karl H., 1994, Current Opinion in Lipidology, V5, P110, DOI 10.1097/00041433-199404000-00007; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	46	23	27	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1099-8004	1552-4175		BIOL RES NURS	Biol. Res. Nurs.	JAN	2009	10	3					205	212		10.1177/1099800408323221			8	Nursing	Science Citation Index Expanded (SCI-EXPANDED)	Nursing	386UH	WOS:000261907600002	19017669	Green Accepted			2022-02-06	
J	Gerring, JP; Grados, MA; Slomine, B; Christensen, JR; Salorio, CF; Cole, WR; Vasa, RA				Gerring, Joan P.; Grados, Marco A.; Slomine, Beth; Christensen, James R.; Salorio, Cynthia F.; Cole, Wesley R.; Vasa, Roma A.			Disruptive behaviour disorders and disruptive symptoms after severe paediatric traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; oppositional defiant disorder; conduct disorder	CLOSED-HEAD-INJURY; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; POSTTRAUMATIC-STRESS-DISORDER; OPPOSITIONAL DEFIANT DISORDER; DISABILITY RATING-SCALE; OVERT AGGRESSION SCALE; PRELIMINARY EFFICACY; CONDUCT DISORDER; DEVELOPMENTAL PSYCHOPATHOLOGY; SUBSEQUENT DEVELOPMENT	Objective: To determine pre-injury prevalence and post-injury incidence of DSM-III-R oppositional defiant disorder (ODD) and conduct disorder (CD), increase in disruptive symptoms after severe paediatric traumatic brain injury (TBI) and risk factors associated with development of these disturbances. Methods: Ninety-four children were followed 1 one year after severe TBI. Assessments of pre-injury and 1-year psychiatric status were ascertained by parent report. The 1-year incidence of disruptive behaviour disorders/symptoms was the main outcome measure. Results: The pre-injury prevalence of ODD and CD in the TBI sample was 6% and 8%, respectively, the prevalence of pre-injury CD being significantly higher than in a reference population. The incidence of new-onset ODD and CD 1-year post-injury was 9% and 8%, respectively, the incidence of new-onset CD being significantly higher than in a reference population. ODD symptoms and total number of disruptive symptoms increased significantly over the first post-injury year. Significant risk factors for disruptive disorders/symptoms included higher pre-injury psychosocial adversity, delinquency ratings and affective lability. Conclusions: Pre-injury conduct disorder is a significant risk factor for post-injury disruptive behaviours. New-onset CD and disruptive symptoms are consequences of TBI at 1-year post-injury. Risk factors for these post-injury disturbances are similar to risk factors in non-TBI populations.	[Gerring, Joan P.; Grados, Marco A.; Slomine, Beth; Christensen, James R.; Salorio, Cynthia F.; Cole, Wesley R.; Vasa, Roma A.] Johns Hopkins Bayview Med Ctr, Baltimore, MD 21224 USA		Gerring, JP (corresponding author), Johns Hopkins Bayview Med Ctr, D2E,4940 Eastern Ave, Baltimore, MD 21224 USA.	jgerring@jhmi.edu		Grados, Marco/0000-0002-6189-6264	NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K20 MH-00997]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K20MH000997] Funding Source: NIH RePORTER	This work was supported by NIMH grant K20 MH-00997.	Achenbach T. M., 1993, EMPIRICALLY BASED TA; Alderman N, 1997, BRAIN INJURY, V11, P503, DOI 10.1080/713802182; American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; BLACKER D, 2000, AM PSYCHIAT ASS TASK, P1; Breslau N, 2006, ARCH GEN PSYCHIAT, V63, P1238, DOI 10.1001/archpsyc.63.11.1238; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Cole WR, 2008, BRAIN INJURY, V22, P932, DOI 10.1080/02699050802454808; DISCALA C, 1991, ARCH PHYS MED REHAB, V72, P662; EDELBROCK C, 1985, CHILD DEV, V56, P265, DOI 10.1111/j.1467-8624.1985.tb00104.x; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Gerring J, 2000, BRAIN INJURY, V14, P205; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Gerring JP, 2002, J AM ACAD CHILD PSY, V41, P157, DOI 10.1097/00004583-200202000-00009; Gerson AC, 1996, PSYCHIAT RES, V65, P189, DOI 10.1016/S0165-1781(96)02851-X; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Guttmann-Steinmetz S, 2006, J AM ACAD CHILD PSY, V45, P440, DOI 10.1097/01.chi.0000196422.42599.63; Herskovits EH, 1999, RADIOLOGY, V213, P389, DOI 10.1148/radiology.213.2.r99nv45389; Herskovits EH, 2003, NEUROIMAGE, V19, P1664, DOI 10.1016/S1053-8119(03)00231-3; Herskovits EH, 2002, RADIOLOGY, V224, P345, DOI 10.1148/radiol.2242011439; Hill J, 2002, J CHILD PSYCHOL PSYC, V43, P133, DOI 10.1111/1469-7610.00007; Hinshaw S P, 1994, Prog Exp Pers Psychopathol Res, P3; HINSHAW SP, 1993, DEV PSYCHOPATHOL, V5, P31, DOI 10.1017/S0954579400004247; Hinshaw SP, 2002, J ABNORM CHILD PSYCH, V30, P431, DOI 10.1023/A:1019808712868; Hollingshead A. B, 1975, 4 FACTOR INDEX UNPUB; Jensen PS, 1999, J AM ACAD CHILD PSY, V38, P1569, DOI 10.1097/00004583-199912000-00019; Lahey BB, 1996, J AM ACAD CHILD PSY, V35, P855, DOI 10.1097/00004583-199607000-00011; LANGLEY J, 1983, Journal of Pediatric Psychology, V8, P181, DOI 10.1093/jpepsy/8.2.181; LECKMAN JF, 1982, ARCH GEN PSYCHIAT, V39, P879; Loeber R, 2000, DEV PSYCHOPATHOL, V12, P737, DOI 10.1017/S0954579400004107; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 1997, BRAIN INJURY, V11, P699; Max JE, 1998, J NERV MENT DIS, V186, P325, DOI 10.1097/00005053-199806000-00001; Moffitt TE, 2008, J CHILD PSYCHOL PSYC, V49, P3, DOI 10.1111/j.1469-7610.2007.01823.x; OSBERG JS, 1990, AM J PHYS MED REHAB, V69, P67, DOI 10.1097/00002060-199004000-00004; Paris R., 1974, CLIN NEUROPSYCHOLOGY, P179; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reich W, 2000, J AM ACAD CHILD PSY, V39, P59, DOI 10.1097/00004583-200001000-00017; Rowe R, 2002, J CHILD PSYCHOL PSYC, V43, P365, DOI 10.1111/1469-7610.00027; Salorio CF, 2005, J INT NEUROPSYCH SOC, V11, P686, DOI 10.1017/S1355617705050885; Salorio CF, 2008, PEDIATR CRIT CARE ME, V9, P47, DOI 10.1097/01.PCC.0000298638.66240.0E; Shaffer D, 1996, J AM ACAD CHILD PSY, V35, P865, DOI 10.1097/00004583-199607000-00012; Slifer KJ, 2009, DEV DISABIL RES REV, V15, P144, DOI 10.1002/ddrr.60; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Speltz ML, 1999, J AM ACAD CHILD PSY, V38, P838, DOI 10.1097/00004583-199907000-00013; Stouthamer-Loeber M, 2002, J CONSULT CLIN PSYCH, V70, P111, DOI 10.1037//0022-006X.70.1.111; SZATMARI P, 1994, INT J METHOD PSYCH, V4, P231; Vasa RA, 2004, BIOL PSYCHIAT, V55, P208, DOI 10.1016/S0006-3223(03)00708-X; Vasa RA, 2002, J AM ACAD CHILD PSY, V41, P148, DOI 10.1097/00004583-200202000-00008; Wade SL, 2009, J HEAD TRAUMA REHAB, V24, P239, DOI 10.1097/HTR.0b013e3181ad6680; Wade SL, 2008, J HEAD TRAUMA REHAB, V23, P369, DOI 10.1097/01.HTR.0000341432.67251.48; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35	59	23	23	0	32	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2009	23	12					944	955		10.3109/02699050903285531			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	529YL	WOS:000272555200002	19831491				2022-02-06	
J	Ghosh, A; Wilde, EA; Hunter, JV; Bigler, ED; Chu, ZL; Li, XQ; Vasquez, AC; Menefee, D; Yallampalli, R; Levin, HS				Ghosh, Alokananda; Wilde, Elisabeth A.; Hunter, Jill V.; Bigler, Erin D.; Chu, Zili; Li, Xiaoqi; Vasquez, Ana C.; Menefee, Deleene; Yallampalli, Ragini; Levin, Harvey S.			The relation between Glasgow Coma Scale score and later cerebral atrophy in paediatric traumatic brain injury	BRAIN INJURY			English	Article						Paediatric; neuroimaging; Glasgow Coma Scale (GCS); traumatic brain injury; MR imaging; children	CLOSED-HEAD-INJURY; POSTTRAUMATIC AMNESIA; QUANTITATIVE-ANALYSIS; CHILDREN; PREDICTORS; SEVERITY; MODERATE; MRI; CONSCIOUSNESS; ADOLESCENTS	Primary objective: To examine initial Glasgow Coma Scale (GCS) score and its relationship with later cerebral atrophy in children with traumatic brain injury (TBI) using Quantitative Magnetic Resonance Imaging (QMRI) at 4 months post-injury. It was hypothesized that a lower GCS score would predict later generalized atrophy. As a guide in assessing paediatric TBI patients, the probability of developing chronic cerebral atrophy was determined based on the initial GCS score. Methods and procedures: The probability model used data from 45 paediatric patients (mean age = 13.6) with mild-to-severe TBI and 41 paediatric (mean age = 12.4) orthopaedically-injured children. Results: This study found a 24% increase in the odds of developing an abnormal ventricle-to-brain ratio (VBR) and a 27% increase in the odds of developing reduced white matter percentage on neuroimaging with each numerical drop in GCS score. Logistic regression models with cut-offs determined by normative QMRI data confirmed that a lower initial GCS score predicts later atrophy. Conclusion: GCS is a commonly used measure of injury severity. It has proven to be a prognostic indicator of cognitive recovery and functional outcome and is also predictive of later parenchymal change.	[Wilde, Elisabeth A.] Baylor Coll Med, Cognit Neurosci Lab, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Hunter, Jill V.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Ghosh, Alokananda] Presbyterian Med Ctr, Dallas, TX USA; [Ghosh, Alokananda; Hunter, Jill V.; Chu, Zili] Texas Childrens Hosp, EB Singleton Dept Diagnost Imaging, Houston, TX 77030 USA; [Bigler, Erin D.] Brigham Young Univ, Dept Neurosci, Provo, UT 84602 USA; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Yallampalli, Ragini] Univ Houston, Dept Psychol, Houston, TX USA		Wilde, EA (corresponding author), Baylor Coll Med, Cognit Neurosci Lab, Dept Phys Med & Rehabil, 1709 Dryden Rd,Ste 725, Houston, TX 77030 USA.	ewilde@bcm.tmc.edu	Menefee, Deleene/AAZ-3382-2021		National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS021889]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	This research was supported by grant NS021889 awarded to Harvey S. Levin, PhD, by the National Institutes of Health. We gratefully acknowledge the assistance of Summer Lane and Lori Cook for their assistance in patient recruitment and Stacey K. Martin for her assistance in manuscript preparation. We would also like to acknowledge the generous support of Mission Connect of the TIRR Foundation.	Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; BERRYHILL P, 1995, NEUROSURGERY, V37, P392, DOI 10.1227/00006123-199509000-00004; BERRYHILL P, 1995, NEUROSURGERY, V37, P399; BIGLER ED, 1995, ARCH CLIN NEUROPSYCH, V10, P159, DOI 10.1016/0887-6177(94)E0003-8; BIGLER ED, 2005, NEUROPSYCHIATRY TRAU, P79; Bigler ED, 2006, AM J PHYS MED REHAB, V85, P793, DOI 10.1097/01.phm.0000237873.26250.e1; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; CULLUM CM, 1986, J CLIN EXP NEUROPSYC, V8, P437, DOI 10.1080/01688638608401333; DIKMEN S, 1995, J HEAD TRAUMA REHAB, V10, P74, DOI 10.1097/00001199-199502000-00008; Diringer MN, 1997, ARCH NEUROL-CHICAGO, V54, P606, DOI 10.1001/archneur.1997.00550170078017; DISCALA C, 1992, AM J PHYS MED REHAB, V71, P145, DOI 10.1097/00002060-199206000-00004; FILLEY CM, 1987, ARCH NEUROL-CHICAGO, V44, P194, DOI 10.1001/archneur.1987.00520140058018; GALE SD, 1995, J NEUROTRAUM, V12, P151, DOI 10.1089/neu.1995.12.151; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; LEVI L, 1991, BRIT J NEUROSURG, V5, P617, DOI 10.3109/02688699109002885; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; LEVIN HS, 1997, NEUROSURGERY, V40, P440; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MCDONALD CM, 1994, ARCH PHYS MED REHAB, V75, P328, DOI 10.1016/0003-9993(94)90038-8; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; Serra-Grabulosa JM, 2005, J NEUROL NEUROSUR PS, V76, P129, DOI 10.1136/jnnp.2004.027631; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; TEASDALE G, 1974, LANCET, V2, P81; Thakker JC, 1997, CRIT CARE MED, V25, P1396, DOI 10.1097/00003246-199708000-00030; Verger K, 2001, BRAIN INJURY, V15, P211; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2006, BRAIN INJURY, V20, P695, DOI 10.1080/02699050600744079; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012	38	23	26	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	3					228	233	PII 908612472	10.1080/02699050802672789			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	406AJ	WOS:000263267100006	19205959				2022-02-06	
J	Hartman-Maeir, A; Katz, N; Baum, CM				Hartman-Maeir, Adina; Katz, Noomi; Baum, Carolyn			Cognitive Functional Evaluation (CFE) Process for Individuals with Suspected Cognitive Disabilities	OCCUPATIONAL THERAPY IN HEALTH CARE			English	Article						Occupational therapy; evaluation process; cognitive deficits	TRAUMATIC BRAIN-INJURY; EVERYDAY MEMORY; SELF-AWARENESS; INTERRATER RELIABILITY; DISCRIMINANT VALIDITY; SIMPLIFIED VERSION; OBSERVED TASKS; PERFORMANCE; DEMENTIA; DEFICITS	The purpose of this paper is to conceptualize the evaluation process for individuals with suspected cognitive disabilities. The Cognitive Functional Evaluation (CFE) process yields a comprehensive profile of the clients' cognitive strengths and weaknesses in occupational performance. The components of the CFE are outlined in six stages as a decision tree with examples of standardized instruments from which to choose the assessments for each client evaluated: (1) interview and background information; (2) cognitive screening and baseline status tests; (3) general measures of cognition and executive functions in occupation; (4) cognitive tests for specific domains; (5) measures of specific cognitive domains in occupations; and (6) environmental assessment. The first three stages are required to ascertain basic cognitive abilities underlying occupational performance. Tests for each stage can be chosen from the ones listed according to the client characteristics and the theory utilized, there is no need to use all of them. Once this data is available a further decision is made whether a more in-depth assessment is needed (stages (4) and (5)). The environmental component is evaluated in all instances with at least one of the assessments. The CFE process for individuals with suspected cognitive disabilities is recommended to be used by occupational therapists as a common ground for evaluation, documentation, and communicating information.	[Hartman-Maeir, Adina; Katz, Noomi] Hebrew Univ & Hadassah, Sch Occupat Therapy, Jerusalem, Israel; [Katz, Noomi] Ono Acad Coll, Inst Hlth & Med Profess, Kiryat Ono, Israel; [Baum, Carolyn] Washington Univ, Program Occupat Therapy, St Louis, MO 63130 USA		Hartman-Maeir, A (corresponding author), Sch Occupat Therapy, POB 24026, IL-91240 Jerusalem, Israel.	amaeir@mscc.huji.ac.il		Maeir, Adina/0000-0002-3356-5847			Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Allen C., 1992, OCCUPATIONAL THERAPY; Allen C. K., 2007, ALLEN COGNITIVE LEVE; Allen CK, 1998, COGNITION AND OCCUPATION IN REHABILITATION, P225; [Anonymous], 2006, J COGNITIVE NEUROSCI, V18, P1223; Asher I. E., 2007, OCCUPATIONAL THERAPY; Azouvi P, 2003, ARCH PHYS MED REHAB, V84, P51, DOI 10.1053/apmr.2003.50062; BARYOSEF C, 1999, PHYS OCCUPATIONAL TH, V17, P65, DOI DOI 10.1300/J148V17N01_06; BAUM C, 1993, AM J OCCUP THER, V47, P431, DOI 10.5014/ajot.47.5.431; Baum C. M., 2001, ACTIVITY CARD SORT A; BAUM CM, AM J OCCUPA IN PRESS; Baum CM, 1998, HOME OCCUPATIO UNPUB; Berg C, 2006, OTJR-OCCUP PART HEAL, V26, P143, DOI 10.1177/153944920602600404; BRASWELL D, 1993, PROFILE EXECUTIVE CO; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; BURNS T, 2006, COGNITIVE PERFORMANC; CERMAK SA, 1995, AM J OCCUP THER, V49, P500, DOI 10.5014/ajot.49.6.500; CHUI T, 2006, SAFETY ASSESSMENT FU; Cornish IM, 2000, BRIT J PSYCHOL, V91, P427, DOI 10.1348/000712600161916; Dawson D. R., 2005, M INT NEUR SOC ST LO; Diehl M, 2005, J APPL GERONTOL, V24, P211, DOI 10.1177/0733464804273772; Edwards, 2003, EXECUTIVE FUNCTION P; Elazar B., 1996, GERIATRIC VERSION LO; Emslie H., 2003, BEHAV ASSESSMENT DYS; EREZ A. B., 2003, PHYS OCCUPATIONAL TH, V22, P29; Fisher A.G., 2006, ASSESSMENT MOTOR PRO, V1; Fisher A.G., 2006, ASSESSMENT MOTOR PRO, V2; Fisher AG, 2005, SCH AMPS SCH VERSION; Fleming JM, 1996, BRAIN INJURY, V10, P1; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freedman M., 1994, CLOCK DRAWING NEUROP; Gioia GA IP, 2000, BEHAV RATING INVENTO; Gitlin LN, 2002, DISABIL REHABIL, V24, P59, DOI 10.1080/09638280110066325; Goverover Y, 2005, ARCH PHYS MED REHAB, V86, P2303, DOI 10.1016/j.apmr.2005.05.016; Goverover Y, 2004, OTJR-OCCUP PART HEAL, V24, P103, DOI 10.1177/153944920402400304; Goverover Y, 2004, AM J OCCUP THER, V58, P104, DOI 10.5014/ajot.58.1.104; Goverover Y, 2002, AM J OCCUP THER, V56, P509, DOI 10.5014/ajot.56.5.509; Harel H., 2007, ISR SOC PHYS REH MED; Hartman-Maeir A., 2005, ISR SOC OCC THER C H; Hartman-Maeir A., 2007, KETTLE TEST BRIEF CO; Hartman-Maeir A., AM J OCCUPA IN PRESS; HARTMANMAEIR A, 1995, AM J OCCUP THER, V49, P507, DOI 10.5014/ajot.49.6.507; Josman N, 2000, OCCUP THER J RES, V20, P241, DOI 10.1177/153944920002000402; Josman N., 2005, COGNITION OCCUPATION, P169; Josman Naomi, 2000, Physical and Occupational Therapy in Pediatrics, V19, P39, DOI 10.1300/J006v19n03_04; Katz N, 1999, ARCH PHYS MED REHAB, V80, P379, DOI 10.1016/S0003-9993(99)90273-3; Katz N, 1997, NEUROREHABILITATION, V9, P179, DOI 10.3233/NRE-1997-9302; KATZ N, 2005, COGNITION OCCUPATION, P3; Katz N., 2000, LOEWENSTEIN OCCUPATI; Katz N., 2007, OCCUPATIONAL THERAPY, V27, P1; Katz N., 2005, COGNITION OCCUPATION; Katz N., 2006, ROUTINE TASK I UNPUB; Katz N., 1996, ISRAEL J OCCUPATIONA, V5, pE185; Katz N, 2005, DYNAMIC OCCUPATIONAL; Katz N, 2007, AM J OCCUP THER, V61, P41, DOI 10.5014/ajot.61.1.41; KATZMAN R, 1983, AM J PSYCHIAT, V140, P734; Kielhofner G, 2002, MODEL HUMAN OCCUPATI; Knight C, 2002, NEUROPSYCHOL REHABIL, V12, P231, DOI 10.1080/09602010244000039; Kottorp A., 2005, ASSESSMENT AWARENESS; Levav M., 2006, WFOT C SYDN AUSTR; Levy L. L., 2005, COGNITION OCCUPATION, P347; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Mandich A.D., 2004, PEDIAT ACTIVITY CARD; Manly T., 2001, J CHILD PSYCHOL PSYC, V9, P181; Mueller J., 2007, COGNISTAT MANUAL; Olsson E, 2006, NEUROPSYCHOL REHABIL, V16, P257, DOI 10.1080/09602010500176328; Ownsworth TL, 2000, CLIN NEUROPSYCHOL, V14, P76, DOI 10.1076/1385-4046(200002)14:1;1-8;FT076; Pollock N, 1998, CANADIAN OCCUPATIONA; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; REVACH A, 2005, AOTA C LONG BEACH CA; Robertson I., 1994, TEST EVERYDAY ATTENT; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SMITH NR, 1986, AM J OCCUP THER, V40, P278, DOI 10.5014/ajot.40.4.278; Sohlberg M. M., 2001, COGNITIVE REHABILITA, P125; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; Tham K, 2001, AM J OCCUP THER, V55, P46, DOI 10.5014/ajot.55.1.46; Tham K., 1999, SCAND J OCCUP THER, V6, P184; Toglia J, 2000, NEUROREHABILITATION, V15, P57; TOGLIA JP, 1994, DYNAMIC ASSESSMENT C; Toglia JP, 2005, COGNITION OCCUPATION, P29; Toglia JP., 1993, CONTEXTUAL MEMORY TE; Wilson B., 2005, RIVERMEAD BEHAV MEMO; Wilson B., 1999, BEHAVIOURAL INATTENT BEHAV INATTENTION TE; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; Wise K, 2005, BRAIN INJURY, V19, P765, DOI 10.1080/0269905050019977	87	23	25	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0738-0577	1541-3098		OCCUP THER HEALTH CA	Occup. Ther. Health Care		2009	23	1					1	23		10.1080/07380570802455516			23	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V60YN	WOS:000210866000001	23930828				2022-02-06	
J	Llorente, AM; Voigt, RG; Williams, J; Frailey, JK; Satz, P; D'Elia, LF				Llorente, Antolin M.; Voigt, Robert G.; Williams, Jane; Frailey, J. Kennard; Satz, Paul; D'Elia, Louis F.			Children's Color Trails Test 1 2: Test-Retest Reliability and Factorial Validity	CLINICAL NEUROPSYCHOLOGIST			English	Article						ADHD; Attention; Children's Color Trails Test; Factorial validity; Test-retest reliability	PATTERNS	This investigation examined the test-retest reliability and the factorial validity of the Children's Color Trails Test 1 2 (CCTT) using two distinct and independent studies and their respective research samples. The reliability of the CCTT was evaluated in a study with 6-12-year-old children (n = 54) strictly selected and diagnosed with attention-deficit/hyperactivity disorder from an interventional protocol using test-retest coefficients at 8- and 16-week time intervals. Factorial validity was investigated using groups of children with traumatic brain injury (TBI) (n = 137), children with other types of trauma than brain or head injury (Other Injury) (n = 132), and healthy controls (n = 114) from a protocol assessing the neuropsychological sequelae of traumatic brain injury. The results revealed completion time test-retest reliability in the moderate range, which may be considered modest (rtt =.46-.68) in this sample of children with ADHD. Interference reliability coefficients were greater and in the moderate-high range (rtt =.75-.78). Factorial analytic results revealed a three-factor structure solution for all three groups (TBI, Other Injury, and controls). As a result of CCTT's factorial loadings, Factor 1 was labeled speed of perceptual tracking and susceptibility to interference, Factor 2 was labeled inattention and impulsivity, and Factor 3 was labeled simple inattention. Relative limitations and strengths associated with this investigation including practice effects associated with repeated CCTT administrations also were addressed within the context of the extant findings and existing trail-making test literature.	[Llorente, Antolin M.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21209 USA; [Voigt, Robert G.] Mayo Clin, Div Dev & Behav Pediat, Rochester, MN USA; [Williams, Jane] Wake Forest Univ, Bowman Gray Sch Med, Dept Pediat, Winston Salem, NC 27103 USA; [Frailey, J. Kennard] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Satz, Paul; D'Elia, Louis F.] Univ Calif Los Angeles, Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Satz, Paul; D'Elia, Louis F.] Univ Calif Los Angeles, Neuropsychiat Inst & Hosp, Los Angeles, CA 90024 USA		Llorente, AM (corresponding author), Univ Maryland, Sch Med, Dept Pediat, 1708 W Rogers Ave, Baltimore, MD 21209 USA.	allorente@mwph.org	Voigt, Robert/AAO-6336-2021		Martek Biosciences Corporation, Columbia, Maryland, USA	Portions of this research were supported in part by grants from Martek Biosciences Corporation, Columbia, Maryland, USA to Antolin M. Llorente and Robert G. Voigt.	Achenbach TM, 1991, MANUAL CHILD BEHAV C; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Anastasi A., 1988, PSYCHOL TESTING; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; Baron I. S., 2004, NEUROPSYCHOLOGICAL E; BASSA F M, 1984, South African Journal of Psychology, V14, P118; BUTLER M, 1991, PROF PSYCHOL-RES PR, V22, P510, DOI 10.1037/0735-7028.22.6.510; CARREON JL, 1989, PERCEPT MOTOR SKILL, V68, P627; Costello A., 2005, PAN PACIFIC MANAGEME, V10, P1, DOI DOI 10.7275/JYJ1-4868; D'Elia, 1994, COLOR TRAILS TEST PR; DYE OA, 1979, PERCEPT MOTOR SKILL, V48, P296, DOI 10.2466/pms.1979.48.1.296; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Goldstein G, 1989, CLIN NEUROPSYCHOL, V3, P265, DOI DOI 10.1080/13854048908404088; JACOBSON NS, 1984, BEHAV THER, V15, P336, DOI 10.1016/S0005-7894(84)80002-7; Leark R, 1996, TOVA TEST VARIABLES; Lee TMC, 2000, J CLIN EXP NEUROPSYC, V22, P772, DOI 10.1076/jcen.22.6.772.954; Llorente AM., 2003, CHILDRENS COLOR TRAI; MAJ M, 1993, ARCH CLIN NEUROPSYCH, V8, P123, DOI 10.1016/0887-6177(93)90030-5; MAJ M, 1994, ARCH GEN PSYCHIAT, V51, P51; Majovski L. V., 1997, HDB CLIN CHILD NEURO, P63; MATARAZZO JD, 1974, J NERV MENT DIS, V158, P37, DOI 10.1097/00005053-197401000-00006; Mok N, 2008, APPL NEUROPSYCHOL, V15, P123, DOI 10.1080/09084280802083962; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Reitan R., 1979, MANUAL ADM NEUROPSYC; REITAN RM, 1985, J CLIN PSYCHOL, V41, P643, DOI 10.1002/1097-4679(198509)41:5<643::AID-JCLP2270410510>3.0.CO;2-A; ROSIN J, 1989, South African Journal of Psychology, V19, P6; ROSIN J, 1989, South African Journal of Psychology, V19, P14; ROURKE BP, 1975, J ABNORM PSYCHOL, V84, P412; Sattler J. M., 1988, ASSESSMENT CHILDREN; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; TSOI MM, 1989, PROF PSYCHOL-RES PR, V20, P248, DOI 10.1037/0735-7028.20.4.248; Voigt RG, 2001, J PEDIATR-US, V139, P189, DOI 10.1067/mpd.2001.116050; WILLIAMS J, 1995, ARCH CLIN NEUROPSYCH, V10, P211, DOI 10.1016/0887-6177(94)00041-N; WINSBERG BG, 1982, PSYCHOPHARMACOLOGY, V76, P329, DOI 10.1007/BF00449120	34	23	23	1	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2009	23	4					645	660	PII 904602995	10.1080/13854040802427795			16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	442VQ	WOS:000265869100111	18942031				2022-02-06	
J	Minor, LB; Lasker, DM				Minor, Lloyd B.; Lasker, David M.			Tonic and phasic contributions to the pathways mediating compensation and adaptation of the vestibulo-ocular reflex	JOURNAL OF VESTIBULAR RESEARCH-EQUILIBRIUM & ORIENTATION			English	Article; Proceedings Paper	Symposium on Vestibular Compensation held at the 32nd Annual Midwinter Meeting of the Association-for-Research-in-Otolaryngology	FEB 14-19, 2009	Baltimore, MD	Assoc Res Otolaryngol		Regular afferent; irregular afferent; labyrinthectomy; vestibular; semicircular canals; mathematical model; high acceleration head movement; vestibular hypofunction; retinal slip error	HIGH-ACCELERATION ROTATIONS; SQUIRREL-MONKEY; HIGH-FREQUENCY; VESTIBULAR-NERVE; RESPONSES; HEAD; COMPONENTS; CHINCHILLA; AFFERENTS; DYNAMICS	Processes of vestibular compensation mediate recovery of many aspects of vestibular dysfunction following unilateral vestibular injury. The VOR in response to high-frequency, high-acceleration head movements, however, retains an enduring asymmetry. Head movements that are inhibitory with respect to semicircular canals on the intact side lead to a diminished VOR whereas head movements that are excitatory for semicircular canals on the intact side lead to a VOR that returns close to normal. We review our work directed toward understanding the processes of VOR compensation to high-frequency, high-acceleration head movements and the related topic of adaptation to changes in the visual requirements for a compensatory VOR. Our work has shown that the processes of both compensation and adaptation to these stimuli can be described by a mathematical model with inputs from tonic and phasic components. We have further shown that the dynamics of regular afferents have close resemblance to the tonic pathway whereas the dynamics of irregular afferents match those of the phasic pathway.	[Minor, Lloyd B.; Lasker, David M.] Johns Hopkins Univ, Dept Otolaryngol Head & Neck Surg, Sch Med, Baltimore, MD 21205 USA		Lasker, DM (corresponding author), Johns Hopkins Univ, Dept Otolaryngol Head & Neck Surg, Sch Med, Ross Bldg,Suite 710,720 Rutland Ave, Baltimore, MD 21205 USA.	dlasker@jhmi.edu			NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01 DC-02390, R01 DC002390-09, R01 DC002390-05, R01 DC002390-07, R01 DC002390, R01 DC002390-08, R01 DC002390-06] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC002390] Funding Source: NIH RePORTER		Aw ST, 1996, J NEUROPHYSIOL, V76, P4021, DOI 10.1152/jn.1996.76.6.4021; BAIRD RA, 1988, J NEUROPHYSIOL, V60, P182, DOI 10.1152/jn.1988.60.1.182; Baloh RW, 2003, NEW ENGL J MED, V348, P1027, DOI 10.1056/NEJMcp021154; Carey JP, 2007, OTOL NEUROTOL, V28, P356, DOI 10.1097/01.mao.0000253284.40995.d8; Carey JP, 2002, JARO-J ASSOC RES OTO, V3, P430, DOI 10.1007/s101620010053; Clendaniel RA, 2002, J NEUROPHYSIOL, V88, P3534, DOI 10.1152/jn.00404.2002; Clendaniel RA, 2001, J NEUROPHYSIOL, V86, P1594, DOI 10.1152/jn.2001.86.4.1594; Collewijn H, 2000, J NEUROPHYSIOL, V84, P376, DOI 10.1152/jn.2000.84.1.376; Cremer PD, 1998, BRAIN, V121, P699, DOI 10.1093/brain/121.4.699; CULLEN KE, 2010, J VESTIB RES UNPUB; Curthoys I S, 1995, J Vestib Res, V5, P67; HALMAGYI GM, 1988, ARCH NEUROL-CHICAGO, V45, P737, DOI 10.1001/archneur.1988.00520310043015; HALMAGYI GM, 1990, EXP BRAIN RES, V81, P479, DOI 10.1007/BF02423496; HONRUBIA V, 1984, AM J OTOLARYNG, V5, P15, DOI 10.1016/S0196-0709(84)80016-2; Hullar TE, 2005, J NEUROPHYSIOL, V93, P2777, DOI 10.1152/jn.01002.2004; Hullar TE, 1999, J NEUROPHYSIOL, V82, P2000, DOI 10.1152/jn.1999.82.4.2000; Huterer M, 2002, J NEUROPHYSIOL, V88, P13, DOI 10.1152/jn.2002.88.1.13; JENKINS HA, 1985, LARYNGOSCOPE, V95, P1224; Lasker DM, 1999, J NEUROPHYSIOL, V82, P1271, DOI 10.1152/jn.1999.82.3.1271; Lasker DM, 2002, ANN NY ACAD SCI, V956, P324, DOI 10.1111/j.1749-6632.2002.tb02831.x; Lasker DM, 2000, J NEUROPHYSIOL, V83, P2482, DOI 10.1152/jn.2000.83.5.2482; LISBERGER SG, 1986, J NEUROSCI, V6, P346; LISBERGER SG, 1984, SCIENCE, V225, P74, DOI 10.1126/science.6610214; Minor LB, 1999, NEUROLOGY, V53, P2158, DOI 10.1212/WNL.53.9.2158; Minor LB, 1999, J NEUROPHYSIOL, V82, P1254, DOI 10.1152/jn.1999.82.3.1254; PAIGE GD, 1989, ACTA OTO-LARYNGOL, V108, P1, DOI 10.3109/00016488909107385; Palla A, 2004, JARO-J ASSOC RES OTO, V5, P427, DOI 10.1007/s10162-004-4035-4; SMITH PF, 1988, BRAIN RES BRAIN RES, V14, P308; Straka H, 2009, ANN NY ACAD SCI, V1164, P37, DOI 10.1111/j.1749-6632.2008.03740.x; Ushio M., 2009, Society for Neuroscience Abstract Viewer and Itinerary Planner, V39; ZEE DS, BASIC APPL ASPECTS V, P125	31	23	23	0	7	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0957-4271	1878-6464		J VESTIBUL RES-EQUIL	J. Vestib. Res.-Equilib. Orientat.		2009	19	5-6					159	170		10.3233/VES-2009-0353			12	Neurosciences; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Otorhinolaryngology	603PJ	WOS:000278220200003	20495233	Green Accepted			2022-02-06	
J	Sacks, AL; Fenske, CL; Gordon, WA; Hibbard, MR; Perez, K; Brandau, S; Cantor, J; Ashman, T; Spielman, LA				Sacks, Amanda L.; Fenske, Cheree L.; Gordon, Wayne A.; Hibbard, Mary R.; Perez, Ken; Brandau, Susan; Cantor, Joshua; Ashman, Teresa; Spielman, Lisa A.			Co-Morbidity of Substance Abuse and Traumatic Brain Injury	JOURNAL OF DUAL DIAGNOSIS			English	Article						Co-morbidity; substance abuse; traumatic brain injury; screening; treatment	HEAD-INJURY; ALCOHOL-USE; INTOXICATION; IDENTIFICATION; INDIVIDUALS; VIOLENCE; CLIENTS; CRIME	While there has been considerable research on the patterns of pre- and post-substance use among individuals with traumatic brain injury (TBI), little is known about the incidence of co-morbidity between TBI and substance abuse (SA) in individuals whose primary disorder is SA. In the current study, the prevalence of co-occurring TBI in individuals seeking treatment for SA was examined. A total of 845 individuals seeking treatment for SA in New York State were screened via the Brain Injury Screening Questionnaire for the presence of a co-morbid TBI. Results indicate that more than 50% of the sample had results that were positive for a TBI. On average, individuals reported a mean of 6 +/- 8 blows to the head, with the number ranging from 0 to 57 and the average age of the first TBI being 14.5 years. Results indicate a high level of co-morbidity between TBI and SA and the need for routine screening for TBI in this population.	[Gordon, Wayne A.; Hibbard, Mary R.] Mt Sinai Med Ctr, Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA; [Perez, Ken; Brandau, Susan] New York State Off Alcohol & Subst Abuse Serv, Albany, NY USA; [Spielman, Lisa A.] Consultat Serv, Congers, NY USA		Gordon, WA (corresponding author), Mt Sinai Med Ctr, Mt Sinai Sch Med, Dept Rehabil Med, 1 Gustave L Levy Pl,Box 1240, New York, NY 10029 USA.	wayne.gordon@mssm.edu	Ashman, Teresa/B-1621-2013				Ashman TA, 2004, BRAIN INJURY, V18, P191, DOI 10.1080/0269905031000149506; Boles SM, 2003, AGGRESS VIOLENT BEH, V8, P155, DOI 10.1016/S1359-1789(01)00057-X; BRISMAR B, 1983, ACTA CHIR SCAND, V149, P11; *CDCP, 2004, REP C MILD TRAUM BRA; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; Corrigan JD, 2005, PSYCHOL ADDICT BEHAV, V19, P131, DOI 10.1037/0893-164X.19.2.131; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2008, BRAIN INJURY, V22, P223, DOI 10.1080/02699050801938967; Cunningham RM, 2002, ALCOHOL ALCOHOLISM, V37, P236, DOI 10.1093/alcalc/37.3.236; Drubach D A, 1993, Md Med J, V42, P989; Fals-Stewart W, 2003, EXP CLIN PSYCHOPHARM, V11, P34, DOI 10.1037/1064-1297.11.1.34; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; Hoaken PNS, 2003, ADDICT BEHAV, V28, P1533, DOI 10.1016/j.addbeh.2003.08.033; Karon SL, 2007, J HEAD TRAUMA REHAB, V22, P350, DOI 10.1097/01.HTR.0000300230.13490.11; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475; Kolakowsky-Hayner SA, 2001, BRAIN INJURY, V15, P53, DOI 10.1080/02699050150209138; Kreutzer JS, 1996, J HEAD TRAUMA REHAB, V11, P58, DOI 10.1097/00001199-199610000-00006; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; Lehmkul D, 1988, TIRR SYMPTOM CHECKLI; Picard M, 1991, HELPS BRIEF SCREENIN; Rutland-Brown W, 2008, J HEAD TRAUMA REHAB, V23, P84, DOI 10.1097/01.HTR.0000314527.78134.70; SPARADEO FR, 2001, BRAIN INJURY SOURCE, V5, P24; STRAUSS D, 2001, BRAIN INJURY SOURCE, V5, P8; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; *US DEP HHS, 2002, SUMM FIND 2000 NAT H; Vickery CD, 2008, ARCH PHYS MED REHAB, V89, P48, DOI 10.1016/j.apmr.2007.07.047; Walker R, 2007, J HEAD TRAUMA REHAB, V22, P360, DOI 10.1097/01.HTR.0000300231.90619.50	31	23	24	0	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1550-4263	1550-4271		J DUAL DIAGN	J. Dual Diagn.		2009	5	3-4					404	417		10.1080/15504260903182755			14	Psychology, Clinical; Substance Abuse; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Substance Abuse; Psychiatry	668XB	WOS:000283306900010					2022-02-06	
J	Tsushima, WT; Lum, M; Geling, O				Tsushima, William T.; Lum, Mark; Geling, Olga			Sex differences in the long-term neuropsychological outcome of mild traumatic brain injury	BRAIN INJURY			English	Article						Sex differences; neuropsychological outcome; brain injury	HEAD-INJURY; GENDER-DIFFERENCES; POSTCONCUSSION SYNDROME; NORMATIVE DATA	Primary objective: To investigate possible sex differences in neuropsychological functioning among patients following mild traumatic brain injury (TBI). Methods and procedures: Retrospective records analysis of the neuropsychological test results of 102 participants with head injury, including 62 males and 40 females. Main outcome and results: A multivariate analysis of variance indicated that females and males performed similarly on neuropsychological tests, on average, 2 years after minor head trauma. A sex-by-age interaction effect was found on the Category and Trail Making A Tests, with a pattern similar to those obtained in a previous research. Conclusions: Although past research has found that females develop more TBI-related neuropsychological deficits than males in the immediate post-injury period, the present study found that, overall, sex differences in the performance of patients with mild TBI on a variety of neuropsychological tests were insignificant. More investigation into the sex-by-age interaction effect appears warranted.	[Tsushima, William T.] Straub Clin & Hosp, Dept Psychiat & Psychol, Honolulu, HI 96813 USA; [Lum, Mark] Stanford Univ, Dept Biomech Engn, Palo Alto, CA 94304 USA; [Geling, Olga] Univ Hawaii Manoa, Dept Publ Hlth Sci, John A Burns Sch Med, Honolulu, HI 96822 USA		Tsushima, WT (corresponding author), Straub Clin & Hosp, Dept Psychiat & Psychol, 888 S King St, Honolulu, HI 96813 USA.	wtsushima@straub.net		Lum, Mark/0000-0002-6634-6413			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; BIGLER ED, 2001, TXB TRAUMATIC BRAIN, P79; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BORNSTEIN RA, 1985, J CLIN PSYCHOL, V41, P651, DOI 10.1002/1097-4679(198509)41:5<651::AID-JCLP2270410511>3.0.CO;2-C; Boyar J I, 1975, Hawaii Med J, V34, P94; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; COVASSIN T, 2007, J ATHL TRAINING, V38, P238; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; DIKMEN S, 2009, NEUROPSYCHOLOGICAL A, P597; DODRILL CB, 1979, J CLIN PSYCHOL, V35, P236, DOI 10.1002/1097-4679(197904)35:2<236::AID-JCLP2270350202>3.0.CO;2-9; Donders J, 2002, NEUROPSYCHOLOGY, V16, P491, DOI 10.1037//0894-4105.16.4.491; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Heaton RK, 1991, COMPREHENSIVE NORMS; Heaton RK, 1996, NEUROPSYCHOLOGICAL A, P141; Henry G K, 2000, Appl Neuropsychol, V7, P65, DOI 10.1207/S15324826AN0702_1; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; Kirkness Catherine J, 2004, Biol Res Nurs, V5, P299, DOI 10.1177/1099800404263050; KLAUBER MR, 1981, NEUROSURGERY, V9, P236, DOI 10.1227/00006123-198109000-00003; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Margulies S, 2000, J CLIN NEUROSCI, V7, P400, DOI 10.1054/jocn.1999.0681; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Niemeier JP, 2007, NEUROPSYCHOL REHABIL, V17, P293, DOI 10.1080/09602010600814729; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Reitan R.M., 1993, HALSTEADREITAN NEURO; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; TSUSHIMA WT, 1995, ADV MED PSYCHOTHERAP, V8, P137; Vagnerova K, 2008, ANESTH ANALG, V107, P201, DOI 10.1213/ane.0b013e31817326a5; Wong TM, 2000, CRIT ISS NE, P3; YEUDALL LT, 1987, J CLIN PSYCHOL, V43, P346, DOI 10.1002/1097-4679(198705)43:3<346::AID-JCLP2270430308>3.0.CO;2-Q	38	23	23	0	16	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	10					809	814	PII 914068901	10.1080/02699050903200530			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	485SP	WOS:000269144600004	19697169				2022-02-06	
J	Schneiders, AG; Sullivan, SJ; McCrory, PR; Gray, A; Maruthayanar, S; Singh, P; Ranhotigammage, P; Van der Salm, R				Schneiders, A. G.; Sullivan, S. J.; McCrory, P. R.; Gray, A.; Maruthayanar, S.; Singh, P.; Ranhotigammage, P.; Van der Salm, R.			The effect of exercise on motor performance tasks used in the neurological assessment of sports-related concussion	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							ERROR SCORING SYSTEM; POSTURAL STABILITY; RUGBY UNION; BALANCE; RELIABILITY; AGREEMENT; EXERTION; PLAYERS; ELICITS; FATIGUE	Sports-related concussion is assessed using both cognitive and motor performance tasks. There is limited understanding of how exercise affects these measures. The purpose of this study was to investigate the effect of moderate-intensity exercise on three selected measures of motor performance. A repeated measures design was used to compare baseline motor performance scores with post-exercise scores with an exercise intervention modelled on the physiological demands of a team sport. 30 physically active subjects performed timed motor performance tasks: Finger-to-Nose (FTN), Tandem Gait (TG) and Single Leg Stance (SLS). The tasks were administered twice pre-exercise and twice post-exercise. FTN, TG and SLS demonstrated high test-retest reliability (ICC values >0.8). 15 minutes of moderate-intensity exercise caused a significant improvement in FTN (T2 = 2.66 (SD 0.38), T3 = 2.49 (0.32); p<0.001) and TG (T2 = 13.08 (2.84), T3 = 12.23 (2.22); p = 0.001), but not in SLS (T2 = 5.94 (4.99), T3 = 5.91 (5.54); p = 0.507). Improvement in the performance of motor tasks after exercise has implications for the immediate assessment of sports-related concussion, given that measures of motor performance are utilised in concussion assessment instruments.	[Schneiders, A. G.] Univ Otago, Sch Physiotherapy, Ctr Physiotherapy Res, Dunedin 9054, New Zealand; [McCrory, P. R.] Univ Melbourne, Ctr Hlth Exercise & Sports Med, Melbourne, Vic, Australia; [Gray, A.] Univ Otago, Dept Prevent & Social Med, Dunedin 9054, New Zealand		Schneiders, AG (corresponding author), Univ Otago, Sch Physiotherapy, Ctr Physiotherapy Res, POB 56, Dunedin 9054, New Zealand.	tony.schneiders@otago.ac.nz	McCrory, Paul/Q-8688-2019; Gray, Andrew Robert/L-9161-2015; Schneiders, Anthony/F-4212-2015	Gray, Andrew Robert/0000-0003-4299-2194; McCrory, Paul/0000-0003-4850-0568; Schneiders, Anthony/0000-0002-1583-3879			[Anonymous], 1999, SAS STAT V8 SOFTW US; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Deutsch MU, 1998, J SPORT SCI, V16, P561, DOI 10.1080/026404198366524; Duthie G, 2003, SPORTS MED, V33, P973, DOI 10.2165/00007256-200333130-00003; DWYER GB, 2005, ACSMS HLTH RELATED P, P162; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; JOHNSTON K, 1998, CAN J NEUROL SCI, V25, pS98; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; Kingma H, 2006, CURR OPIN NEUROL, V19, P21, DOI 10.1097/01.wco.0000199021.48538.d9; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Nardone A, 1997, ELECTROMYOGR MOTOR C, V105, P309, DOI 10.1016/S0924-980X(97)00040-4; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Stolze H, 2002, J NEUROL NEUROSUR PS, V73, P310, DOI 10.1136/jnnp.73.3.310; Susco TM, 2004, J ATHL TRAINING, V39, P241; SWAINE BR, 1993, PHYS THER, V73, P71, DOI 10.1093/ptj/73.2.71; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Warren J, 2006, PHYS THER SPORT, V7, P185, DOI 10.1016/j.ptsp.2006.06.002; Wilkins JC, 2004, J ATHL TRAINING, V39, P156	20	23	23	0	13	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	DEC	2008	42	12					1011	1013		10.1136/bjsm.2007.041665			3	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	385SI	WOS:000261833500022	18308895				2022-02-06	
J	Jeon, IC; Kim, OL; Kim, MS; Kim, SH; Chang, CH; Bai, DS				Jeon, Ik-Chan; Kim, Oh-Lyong; Kim, Min-Su; Kim, Seong-Ho; Chang, Chul-Hoon; Bai, Dai-Seg			The Effect of Premorbid Demographic Factors on the Recovery of Neurocognitive Function in Traumatic Brain Injury Patients	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Traumatic brain injury; Premorbid demographic factors; Prognosis	SEVERE HEAD-INJURY; PERFORMANCE; PROGNOSIS; EDUCATION; FLUENCY; GENDER; IMPACT; AGE; MANAGEMENT; FAS	Objective : Premorbid demographic backgrounds of injured individuals are likely to reflect more accurately the status of patients with traumatic brian injury (TBI) than clinical factors. However, the concrete study about the relationship between the demographic factors and neurocognitive function in TBI patients has not been reported. The object of this study was to evaluate the effect of premorbid demographic factors on the recovery of neurocognitive function following TBI. Methods : From July 1998 to February 2007, 293 patients (males 228, female: 65) with a history of head injury, who had recovered from the acute phase, were selected from our hospital to include in this study. We analyzed the effect of premorbid demographic factors including age, sex, educational level and occupation on the recovery of neurocognitive function in each TBI subgroup as defined by Glasgow Coma Scale (GCS) score. Intelligence and memory are components of neurocognitive function, and the Korean Wechsler Intelligence Scale (K-WAIS) and the Korean memory assessment scale (K-MAS) were used in this study. The results were considered significant at p < 0.05. Results : The higher level of education was a good prognostic factor for intelligence regardless of GCS score and younger age group showed a better result for memory with an exception of severe TBI group. In the severe TBI group, the meaningful effect of demographic factors was not noted by the cause of influence of severe brain injury. Conclusion : The demographic factors used in this study may be helpful for predicting the precise prognosis and developing an appropriate rehabilitation program for TBI patients.	[Jeon, Ik-Chan; Kim, Oh-Lyong; Kim, Min-Su; Kim, Seong-Ho; Chang, Chul-Hoon] Yeungnam Univ, Dept Neurosurg, Coll Med, Taegu 705717, South Korea; [Bai, Dai-Seg] Yeungnam Univ, Dept Psychiat, Coll Med, Taegu 705717, South Korea		Kim, OL (corresponding author), Yeungnam Univ, Dept Neurosurg, Coll Med, 317-1 Daemyeong Dong, Taegu 705717, South Korea.	olkim@med.yu.ac.kr	Jeon, Ikchan/AAZ-6368-2020	Jeon, Ikchan/0000-0002-1293-2724	Yeungnam University	This research Was Supported by the Yeungnam University research grants in 2004.	Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Bittner RM, 2007, BRAIN INJURY, V21, P709, DOI 10.1080/02699050701468917; BOLLA KI, 1990, J CLIN PSYCHOL, V46, P623, DOI 10.1002/1097-4679(199009)46:5<623::AID-JCLP2270460513>3.0.CO;2-C; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JENNETT B, 1976, LANCET, V1, P1031; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Langeluddecke PM, 2003, CLIN NEUROPSYCHOL, V17, P273, DOI 10.1076/clin.17.2.273.16499; LECKLITER IN, 1989, J CLIN PSYCHOL, V45, P484, DOI 10.1002/1097-4679(198907)45:4<484::AID-JCLP2270450402>3.0.CO;2-L; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; OVERGAARD J, 1973, LANCET, V2, P631; Ruff RM, 1997, BRAIN LANG, V57, P394, DOI 10.1006/brln.1997.1755; Sherrill-Pattison S, 2000, CLIN NEUROPSYCHOL, V14, P496, DOI 10.1076/clin.14.4.496.7196; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P161; Wagner AK, 2004, J NEUROTRAUM, V21, P125, DOI 10.1089/089771504322778596	22	23	23	0	7	KOREAN NEUROSURGICAL SOC	SEOUL	#402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	NOV	2008	44	5					295	302		10.3340/jkns.2008.44.5.295			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	380ND	WOS:000261471500002	19119465	gold, Green Published			2022-02-06	
J	Mehta, S; Routt, MLC				Mehta, Samir; Routt, M. L. Chip, Jr.			Irreducible Fracture-Dislocations of the Femoral Head Without Posterior Wall Acetabular Fractures	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						femoral head fracture; irreducible hip fracture-dislocation; Smith-Petersen exposure	TERM-FOLLOW-UP; TRAUMATIC DISLOCATION; HIP DISLOCATIONS; INJURY	Objective: To define the unique clinical and radiographic features, operative treatment, and complications of irreducible femoral head fracture-dislocation without associated posterior wall fracture. Design: Retrospective clinical study from a prospectively gathered trauma database. Setting: Level I trauma center. Patients/Participants: During a 6-year period (from January 2000 until August 2006), 72 patients with fractures of the femoral head (OTA 31 C) were treated at a level I trauma center. Seven (9.7%) patients had irreducible femoral head fracture-dislocations without associated posterior wall acetabular fractures and underwent operative management. Intervention: Open reduction and internal fixation of the irreducible femoral head fracture-dislocation with miniature fragment screw fixation using a Smith-Petersen exposure. Main Outcome Measures: Clinical and radiographic markers of irreducibility, surgical findings, fixation methods, reduction accuracy, and injury- and treatment-related complications. Results: Standardized postoperative pelvic computed tomography scans revealed that all 7 femoral head fractures were accurately reduced. Two patients with delayed operative management developed femoral head aseptic necrosis and underwent hip arthroplasty. Conclusions: Irreducible femoral head fracture-dislocations without associated posterior wall fractures occur rarely., but are heralded by unique clinical and radiographic features. These patients warrant special consideration in terms of recognition and management. The physical examination findings and specific radiographic markers should alert the Surgeon to this injury pattern and its related complications. Closed reduction of this fracture-dislocation should not be attempted. Delayed operative management may be related to femoral head aseptic necrosis. Accurate reduction and stable fixation can successfully be performed through a Smith-Petersen surgical exposure using small or miniature fragment cortical screws alone.	[Mehta, Samir] Hosp Univ Penn, Dept Orthopaed Surg, Philadelphia, PA 19104 USA; [Routt, M. L. Chip, Jr.] Univ Washington, Harborview Med Ctr, Dept Orthopaed & Sport Med, Seattle, WA 98104 USA		Mehta, S (corresponding author), Hosp Univ Penn, Dept Orthopaed Surg, 2 Silverstein,3400 Spruce St, Philadelphia, PA 19104 USA.	samir.mehta@uphs.upenn.edu					BOSSE MJ, 1988, J BONE JOINT SURG AM, V70A, P1231, DOI 10.2106/00004623-198870080-00016; Brumback R J, 1987, Hip, P181; BUTLER JE, 1981, J BONE JOINT SURG AM, V63, P1292, DOI 10.2106/00004623-198163080-00011; CANALE ST, 1979, J BONE JOINT SURG AM, V61, P7, DOI 10.2106/00004623-197961010-00003; CHAKRABORTI S, 1975, INJURY, V7, P134, DOI 10.1016/0020-1383(75)90011-X; DELEE JC, 1980, J BONE JOINT SURG AM, V62, P960, DOI 10.2106/00004623-198062060-00012; EPSTEIN HC, 1974, J BONE JOINT SURG AM, VA 56, P1103, DOI 10.2106/00004623-197456060-00001; EPSTEIN HC, 1985, CLIN ORTHOP RELAT R, P9; HOUGAARD K, 1986, ARCH ORTHOP TRAUM SU, V106, P32, DOI 10.1007/BF00435649; Kaempffe F A, 1991, J Orthop Trauma, V5, P439, DOI 10.1097/00005131-199112000-00009; Kim Yoon Taek, 2003, J Orthop Sci, V8, P232, DOI 10.1007/s007760300039; LANGSTEVENSON A, 1987, INJURY, V18, P264, DOI 10.1016/0020-1383(87)90011-8; Marchetti ME, 1996, J ORTHOP TRAUMA, V10, P455, DOI 10.1097/00005131-199610000-00002; Matta JM, 1996, J BONE JOINT SURG AM, V78A, P1632, DOI 10.2106/00004623-199611000-00002; McKee MD, 1998, J ORTHOP TRAUMA, V12, P223, DOI 10.1097/00005131-199805000-00001; Mostafa MM, 2001, INT ORTHOP, V25, P51, DOI 10.1007/s002640000209; Sahin V, 2003, J TRAUMA, V54, P520, DOI 10.1097/01.TA.0000020394.32496.52; Stannard JP, 2000, CLIN ORTHOP RELAT R, P44; Swiontkowski M F, 1992, J Orthop Trauma, V6, P437, DOI 10.1097/00005131-199212000-00008; THOMPSON VP, 1951, J BONE JOINT SURG AM, V33-A, P746, DOI 10.2106/00004623-195133030-00023; TRUETA J, 1953, J BONE JOINT SURG BR, V35, P442, DOI 10.1302/0301-620X.35B3.442; YANG RS, 1991, CLIN ORTHOP RELAT R, P218; Yue JJ, 1996, J ORTHOP TRAUMA, V10, P447, DOI 10.1097/00005131-199610000-00001	23	23	23	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0890-5339	1531-2291		J ORTHOP TRAUMA	J. Orthop. Trauma	NOV-DEC	2008	22	10					686	692		10.1097/BOT.0b013e31818e2a86			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	371GO	WOS:000260820000003	18978543				2022-02-06	
J	Wu, AP; Davidson, T				Wu, Amy P.; Davidson, Terence			Posttraumatic anosmia secondary to central nervous system injury	AMERICAN JOURNAL OF RHINOLOGY			English	Article						Anosmia; closed head injury; MRI; nervous system diseases; olfaction disorders; olfactory bulb; olfactory tracts; trauma	OLFACTORY DYSFUNCTION	Background: The presumed pathogenesis of posttraumatic anosmia is stretching or shearing of the olfactory nerves in a coup-contracoup head contusion. Direct injury to the brain is an alternate mechanism of injury. In this study we report a case where direct injury to the brain is the probable mechanism of injury. Methods: A case report was performed. Results: A 55-year-old man presented with loss of smell beginning I month after a closed head injury with loss of consciousness. The MRI showed posttraumatic scarring in the region of the olfactory bulbs. Conclusion: This case suggests that central nervous system injury to the olfactory bulbs and tracts may be a mechanism of posttraumatic anosmia.	Univ Calif San Diego, Med Ctr, Div Otolaryngol Head & Neck Surg, San Diego, CA 92103 USA; Vet Adm San Diego Hlth Care Syst, San Diego, CA USA		Davidson, T (corresponding author), Univ Calif San Diego, Sch Med, 9500 Gilman Dr,Evergreen,MC 0617, La Jolla, CA 92093 USA.	tdavidson@ucsd.edu					Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; Kern RC, 2000, LARYNGOSCOPE, V110, P2106, DOI 10.1097/00005537-200012000-00025; Reiter ER, 2004, OTOLARYNG CLIN N AM, V37, P1167, DOI 10.1016/j.otc.2004.06.005; Wise JB, 2006, ANN OTO RHINOL LARYN, V115, P124, DOI 10.1177/000348940611500208; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171	5	23	23	0	5	OCEAN SIDE PUBLICATIONS INC	PROVIDENCE	95 PITMAN ST, PROVIDENCE, RI 02906 USA	1050-6586			AM J RHINOL	Am. J. Rhinol.	NOV-DEC	2008	22	6					606	607		10.2500/ajr.2008.22.3238			2	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	391AU	WOS:000262205600008	19178798				2022-02-06	
J	Niedzwecki, CM; Marwitz, JH; Ketchum, JM; Cifu, DX; Dillard, CM; Monasterio, EA				Niedzwecki, Christian M.; Marwitz, Jenniftr H.; Ketchum, Jessica M.; Cifu, David X.; Dillard, Charles M.; Monasterio, Eugenio A.			Traumatic brain injury: A comparison of inpatient functional outcomes between children and adults	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						age; functional independence measure; functional outcomes; pediatric rehabilitation; predictive model; traumatic brain injury	NONDISABLED JAPANESE CHILDREN; LENGTH-OF-STAY; INDEPENDENCE MEASURE; HEAD-INJURY; DEVELOPMENTAL-DISABILITIES; COMMUNITY INTEGRATION; YOUNG-CHILDREN; OLDER-ADULTS; SHORT-TERM; REHABILITATION	Objectives: To examine age-related differences in functional outcomes following traumatic brain injury. Participants and procedure: Seventy-six patients admitted to a pediatric acute rehabilitation hospital were compared with 2548 adult patients in the National Institute on Disability and Rehabilitation Research-funded traumatic brain injury model systems national database. Main outcome measures: Functional Independence Measure totals during inpatient rehabilitation. Results: Increasing age was significantly associated with improved outcome in children and with poorer outcome in adults. Conclusion: The relationship between age and functional outcome is different within different age groups (pediatric vs adult), and the effect of moderating variables differs by age group.	[Niedzwecki, Christian M.; Marwitz, Jenniftr H.; Cifu, David X.; Dillard, Charles M.; Monasterio, Eugenio A.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA; [Ketchum, Jessica M.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23298 USA; [Monasterio, Eugenio A.] Childrens Hosp Richmond, Richmond, VA USA		Niedzwecki, CM (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Box 980677, Richmond, VA 23298 USA.	cniedzwecki@mcvh-vcu.edu	Ketchum, Jessica/AAE-8200-2020	Cifu, David/0000-0003-1600-9387; Ketchum, Jessica/0000-0002-5566-3691			Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Azaula M, 2000, ARCH PHYS MED REHAB, V81, P307, DOI 10.1016/S0003-9993(00)90076-5; BRESLAU N, 1990, ARCH GEN PSYCHIAT, V47, P15; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Carter GM, 2002, ANAL INITIAL IMPLEME; Chen CC, 2005, AM J PHYS MED REHAB, V84, P671, DOI 10.1097/01.phm.0000176439.32318.36; Chen CC, 2004, AM J OCCUP THER, V58, P44, DOI 10.5014/ajot.58.1.44; CHOI SC, 1983, J NEUROSURG, V59, P294, DOI 10.3171/jns.1983.59.2.0294; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; DISCALA C, 1991, ARCH PHYS MED REHAB, V72, P662; DISCALA C, 1992, AM J PHYS MED REHAB, V71, P145, DOI 10.1097/00002060-199206000-00004; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Dumas HM, 2002, AM J PHYS MED REHAB, V81, P661, DOI 10.1097/00002060-200209000-00005; Englander J, 2003, ARCH PHYS MED REHAB, V84, P214, DOI 10.1053/apmr.2003.50094; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Finkelstein E., 2006, INCIDENCE EC BURDEN; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Garcia RA, 2002, AM J PHYS MED REHAB, V81, P458, DOI 10.1097/00002060-200206000-00011; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; GRANGER CV, 1993, ARCH PHYS MED REHAB, V74, P133; GRANGER CV, 1986, GUIDE USE UNIFORM DA; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC10; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC27; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P681, DOI 10.1016/0003-9993(93)90024-5; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lewis JK, 2000, J HEAD TRAUMA REHAB, V15, P930, DOI 10.1097/00001199-200006000-00006; Liu MG, 1998, AM J PHYS MED REHAB, V77, P36, DOI 10.1097/00002060-199801000-00006; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; MCDONALD CM, 1994, ARCH PHYS MED REHAB, V75, P328, DOI 10.1016/0003-9993(94)90038-8; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; Miller P, 2006, ANESTH ANALG, V103, P869, DOI 10.1213/01.ane.0000237327.12205.dc; Morrison Wynne E, 2004, Pediatr Crit Care Med, V5, P145, DOI 10.1097/01.PCC.0000112373.71645.2A; MSALL ME, 1994, CLIN PEDIATR, V33, P421, DOI 10.1177/000992289403300708; MSALL ME, 1994, CLIN PEDIATR, V33, P431, DOI 10.1177/000992289403300709; Ottenbacher KJ, 2004, JAMA-J AM MED ASSOC, V292, P1687, DOI 10.1001/jama.292.14.1687; Ottenbacher KJ, 1996, DEV MED CHILD NEUROL, V38, P907; Ottenbacher KJ, 1997, ARCH PHYS MED REHAB, V78, P1309, DOI 10.1016/S0003-9993(97)90302-6; Ottenbacher KJ, 1999, DEV MED CHILD NEUROL, V41, P186, DOI 10.1017/S0012162299000377; Ottenbacher KJ, 2000, ARCH PHYS MED REHAB, V81, P1317, DOI 10.1053/apmr.2000.9387; Paret G, 1998, J NEUROTRAUM, V15, P967, DOI 10.1089/neu.1998.15.967; RAPHAELY RC, 1980, PEDIATR CLIN N AM, V27, P715; Rice SA, 2005, ARCH PHYS MED REHAB, V86, P834, DOI 10.1016/j.apmr.2004.11.006; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Smith JS, 2007, J TRAUMA, V63, P75, DOI 10.1097/01.ta.0000245991.42871.87; Swaine BR, 2000, AM J PHYS MED REHAB, V79, P412, DOI 10.1097/00002060-200009000-00002; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tsuji T, 1999, AM J PHYS MED REHAB, V78, P208, DOI 10.1097/00002060-199905000-00003; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; Wechsler B, 2005, J TRAUMA, V58, P940, DOI 10.1097/01.TA.0000162630.78386.98; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Ziviani Jenny, 2001, Physical and Occupational Therapy in Pediatrics, V21, P91	64	23	23	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2008	23	4					209	219		10.1097/01.HTR.0000327253.61751.29			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	331KU	WOS:000258011900003	18650765				2022-02-06	
J	Zhang, J; Li, Y; Zheng, XG; Gao, Q; Liu, ZW; Qu, RJ; Bornernan, J; Elias, SB; Chopp, M				Zhang, Jing; Li, Yi; Zheng, Xuguang; Gao, Qi; Liu, Zhongwu; Qu, Runjiang; Bornernan, Jade; Elias, Stanton B.; Chopp, Michael			Bone marrow stromal cells protect oligodendrocytes from oxygen-glucose deprivation injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						bone marrow stromal cells; oligodendrocytes; oxygen-glucose deprivation	PHOSPHATIDYLINOSITOL 3-KINASE-AKT PATHWAY; GROWTH-FACTOR PRODUCTION; SIGNAL-REGULATED KINASE; TRAUMATIC BRAIN-INJURY; SPINAL-CORD INJURY; NEUROTROPHIC FACTOR; WHITE-MATTER; FUNCTIONAL RECOVERY; IN-VITRO; CEREBRAL-ISCHEMIA	Oligodendrocyte (OLG) damage leads to demyelination, which is frequently observed in ischemic cerebrovascular diseases. In this study, we investigated the effect of bone marrow stromal cells (BMSCs) on OLGs subjected to oxygen-glucose deprivation (OGD). N20.1 cells (mouse OLG cell line) were transferred into an anaerobic chamber for 3 hr in glucose-free and serum-free medium. After OGD incubation, OLG cultures were divided into the following groups: 1) OGD alone, 2) OLG cocultured with BMSCs, 3) treatment with the phosphoinostide 3-kinase (PI3k) inhibitor LY294002, 4) LY294002-treated OLGs with BMSC cocultured, and 5) anti-p75 anti body-treated OLGs. After an additional 3 hr of reoxygenation incubation, OLG viability and apoptosis were measured. The mRNA expression in the BMSCs and OLGs was analyzed using quantitative real-time PCR (RT-PCR). Serine/threonine-specific protein kinase (Akt), phosphorylated Akt (p-Akt), p75, and caspase 3 protein expressions in OLGs were measured by Western blot. Our results suggest that BMSCs produce growth factors, activate the Akt pathway, and increase the survival of OLGs. BMSCs also reduce p75 and caspase 3 expressions in the OGD-OLGs, which leads to decreased OLG apoptosis. BMSCs participate in OLG protection that may occur with promoting growth factors/PI3K/Akt and inhibiting the p75/caspase pathways. Our study provides insight into white matter damage and the therapeutic benefits of BMSC-based remyelinating therapy after stroke and demyelinating diseases. (c) 2008 Wiley-Liss, Inc.	[Zhang, Jing; Li, Yi; Zheng, Xuguang; Gao, Qi; Liu, Zhongwu; Qu, Runjiang; Elias, Stanton B.; Chopp, Michael] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA; [Bornernan, Jade] Cognate BioServ Inc, Baltimore, MD USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA		Chopp, M (corresponding author), Henry Ford Hlth Syst, Dept Neurol, Educ & Res Bldg 3056,2799 W Grand Blvd, Detroit, MI 48202 USA.	chopp@neuro.hfh.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01 NS042345, P01 NS042345-04, R01 NS045041, R01 NS45041, P01 NS42345] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045041, P01NS042345] Funding Source: NIH RePORTER		Anitha M, 2006, J CLIN INVEST, V116, P344, DOI 10.1172/JCI26295; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bhave SV, 1999, J NEUROSCI, V19, P3277, DOI 10.1523/jneurosci.19-09-03277.1999; Braydich-Stolle L, 2007, DEV BIOL, V304, P34, DOI 10.1016/j.ydbio.2006.12.013; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Coffer PJ, 1998, BIOCHEM J, V335, P1; Coulson EJ, 2000, CLIN EXP PHARMACOL P, V27, P537, DOI 10.1046/j.1440-1681.2000.03295.x; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; DIVE C, 1992, BIOCHIM BIOPHYS ACTA, V1133, P275, DOI 10.1016/0167-4889(92)90048-G; Dolcet X, 1999, J NEUROCHEM, V73, P521, DOI 10.1046/j.1471-4159.1999.0730521.x; Focke PJ, 2003, J NEUROBIOL, V55, P151, DOI 10.1002/neu.10204; Foulstone EJ, 1999, NEUROSCI LETT, V264, P125, DOI 10.1016/S0304-3940(99)00166-4; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Gao Q, 2005, NEUROSCIENCE, V136, P123, DOI 10.1016/j.neuroscience.2005.06.091; Gresle MM, 2006, BRAIN RES, V1110, P13, DOI 10.1016/j.brainres.2006.06.111; Hajduch E, 2001, FEBS LETT, V492, P199, DOI 10.1016/S0014-5793(01)02242-6; Hauck SM, 2006, MOL CELL BIOL, V26, P2746, DOI 10.1128/MCB.26.7.2746-2757.2006; Imai H, 2001, STROKE, V32, P2149, DOI 10.1161/hs0901.095725; Itakura M, 2005, J NEUROCHEM, V94, P502, DOI 10.1111/j.1471-4159.2005.03242.x; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Lee J, 2007, DEVELOPMENT, V134, P1853, DOI 10.1242/dev.003004; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Li Y, 2006, EXP NEUROL, V198, P313, DOI 10.1016/j.expneurol.2005.11.029; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Li YL, 2001, J MATER RES, V16, P67, DOI 10.1557/JMR.2001.0014; Lin DC, 2006, MOL CELL BIOL, V26, P8928, DOI 10.1128/MCB.00228-06; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyons SA, 1998, J CEREBR BLOOD F MET, V18, P521, DOI 10.1097/00004647-199805000-00007; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Matute C, 2007, J ANAT, V210, P693, DOI 10.1111/j.1469-7580.2007.00733.x; McCarran WJ, 2007, J NEUROSCI, V27, P4220, DOI 10.1523/JNEUROSCI.5542-06.2007; Mielke JG, 2006, NEUROSCIENCE, V143, P165, DOI 10.1016/j.neuroscience.2006.07.055; Mockridge JW, 2000, BIOCHEM BIOPH RES CO, V273, P322, DOI 10.1006/bbrc.2000.2934; Mograbi B, 2001, J BIOL CHEM, V276, P45307, DOI 10.1074/jbc.M101220200; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Paez PM, 2004, GLIA, V46, P207, DOI 10.1002/glia.20001; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Politi LE, 2001, J NEUROCHEM, V76, P1199, DOI 10.1046/j.1471-4159.2001.00128.x; Rajagopal R, 2004, J NEUROSCI, V24, P6650, DOI 10.1523/JNEUROSCI.0010-04.2004; RALIBEK UL, 2005, PFLUGERS ARCH, V450, P355; Shah A, 2005, CLIN CANCER RES, V11, P2930, DOI 10.1158/1078-0432.CCR-04-1385; Shibata M, 2000, J CLIN INVEST, V106, P643, DOI 10.1172/JCI10203; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Syroid DE, 2000, J NEUROSCI, V20, P5741, DOI 10.1523/JNEUROSCI.20-15-05741.2000; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Tsui CC, 2006, J AM SOC NEPHROL, V17, P1543, DOI 10.1681/ASN.2005080835; Ulrich E, 1998, ONCOGENE, V16, P825, DOI 10.1038/sj.onc.1201842; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; Veit C, 2004, CANCER RES, V64, P5291, DOI 10.1158/0008-5472.CAN-04-1112; VERITY AN, 1993, J NEUROCHEM, V60, P577, DOI 10.1111/j.1471-4159.1993.tb03188.x; Villegas SN, 2006, BRAIN RES BULL, V71, P116, DOI 10.1016/j.brainresbull.2006.08.014; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang HJ, 2007, ACTA PHARMACOL SIN, V28, P166, DOI 10.1111/j.1745-7254.2007.00494.x; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang L, 2005, J CEREBR BLOOD F MET, V25, P1150, DOI 10.1038/sj.jcbfm.9600112; Wang X, 2001, J BIOL CHEM, V276, P33812, DOI 10.1074/jbc.M010548200; Wilkins A, 2003, J NEUROSCI, V23, P4967, DOI 10.1523/jneurosci.23-12-04967.2003; Xie YM, 2000, J BIOL CHEM, V275, P29868, DOI 10.1074/jbc.M005071200; Yamaguchi A, 2001, J BIOL CHEM, V276, P5256, DOI 10.1074/jbc.M008552200; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Yoon SO, 1998, J NEUROSCI, V18, P3273; Yoshioka A, 2000, BRAIN RES, V854, P207, DOI 10.1016/S0006-8993(99)02359-8; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zhang J, 2005, EXP NEUROL, V195, P16, DOI 10.1016/j.expneurol.2005.03.018; Zhang J, 2004, BRAIN RES, V1030, P19, DOI 10.1016/j.brainres.2004.09.061; Zhang J, 2006, J NEUROSCI RES, V84, P587, DOI 10.1002/jnr.20962	79	23	24	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	MAY 15	2008	86	7					1501	1510		10.1002/jnr.21617			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	299BZ	WOS:000255732100007	18214988	Green Accepted			2022-02-06	
J	Moore, DF; Radovitzky, RA; Shupenko, L; Klinoff, A; Jaffee, MS; Rosen, JM				Moore, David F.; Radovitzky, Raul A.; Shupenko, Leslie; Klinoff, Andrew; Jaffee, Michael S.; Rosen, Joseph M.			Blast physics and central nervous system injury	FUTURE NEUROLOGY			English	Article								The effect of blast on biological tissue is well documented for particular organ systems such as the lung. This is not the case for the CNS, where the mechanism of CNS injury following a detonation and blast wave is unclear. The effect of blast on traumatic brain injury (TBI) has come into particular focus with the Global War on Terror and Operation Iraqi Freedom, and Operation Enduring Freedom where TBI has become known as the signature injury of these conflicts. The reason for the prominence of TBI in these particular conflicts as opposed to others is unclear, but may result from the increased survivability of blast due to improvements in body armor. In this review, we trace the historical context of blast injury and develop current concepts from this framework, in addition to highlighting many remaining unsolved questions.	[Moore, David F.; Shupenko, Leslie; Jaffee, Michael S.] Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Bldg 1,Room B207,6900 Georgia Ave NW, Washington, DC 20309 USA; [Radovitzky, Raul A.] MIT, Dept Aeronaut & Astronaut, Cambridge, MA 02139 USA; [Klinoff, Andrew] Raytheon Integrated Def Syst, Dept Adv Algorithms, Woburn, MA 01801 USA; [Rosen, Joseph M.] Dartmouth Hitchcock Med Ctr, Dept Plast Surg, Dept Plast Surg, Hanover, NH 03756 USA		Moore, DF (corresponding author), Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Bldg 1,Room B207,6900 Georgia Ave NW, Washington, DC 20309 USA.	david.f.moore@amedd.army.mil; rapa@mit.edu; leslie.shupenko@amedd.army.mil; andrew_a_klinoff@raytheon.com; michael.jaffee@amedd.army.mil	Radovitzky, Raul A/A-5353-2009	Radovitzky, Raul A/0000-0001-6339-2708			[Anonymous], 1813, Edinb Med Surg J, V9, P134; [Anonymous], 1998, BRAIN INJ; [Anonymous], NMR BIOMED; [Anonymous], J APPL MECH; [Anonymous], 1997, MAN CONC SPORTS; [Anonymous], 1982, ISR J MED SCI; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Aschkenasy-Steuer G, 2005, CRIT CARE, V9, P490, DOI 10.1186/cc3762; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; CLEMEDSON C. J., 1954, MILITARY SURGEON, V114, P424; CLEMEDSON CJ, 1956, PHYSIOL REV, V36, P336, DOI 10.1152/physrev.1956.36.3.336; Coats B, 2006, J BIOMECH, V39, P2521, DOI 10.1016/j.jbiomech.2005.07.020; Cooper GJ, 1996, J TRAUMA, V40, pS105, DOI 10.1097/00005373-199603001-00024; Courtney A, 2007, BRAIN INJURY, V21, P657, DOI 10.1080/02699050701481571; Cullis I G, 2001, J R Army Med Corps, V147, P16; DENNYBROWN D, 1945, PHYSIOL REV, V25, P296, DOI 10.1152/physrev.1945.25.2.296; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Dickson D, 1943, LANCET, V1, P385; Elsayed NM, 1997, TOXICOLOGY, V121, P1, DOI 10.1016/S0300-483X(97)03651-2; Eulion JF, 1942, NEW ENGL J MED, V226, P1; Finkel MF, 2006, J NEUROL SCI, V249, P63, DOI 10.1016/j.jns.2006.06.005; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Gorrie C, 2002, J NEUROTRAUM, V19, P1171, DOI 10.1089/08977150260337976; Guthrie J, 1842, INJURIES HEAD AFFECT; Guy R J, 2000, J R Nav Med Serv, V86, P27; Guy RJ, 2004, J ROY SOC MED, V97, P255, DOI 10.1258/jrsm.97.5.255-a; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Iverson G.L., 2006, BRAIN INJURY MED PRI, P333; Jars M, 1768, HIST ACAD ROY SCI ME, V229; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kambouchev N, 2006, J APPL PHYS, V100, DOI 10.1063/1.2349483; Kaur C., 1997, Annals Academy of Medicine Singapore, V26, P27; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Moore D, 2007, 2007 INT BRAIN MAPP; Mott FW, 1916, LANCET, V1, P331; Petras JM, 1997, TOXICOLOGY, V121, P41, DOI 10.1016/S0300-483X(97)03654-8; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; REILLY P, 2005, HEAD INJURY PATHOPHY; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Saraf H, 2007, J BIOMECH, V40, P1960, DOI 10.1016/j.jbiomech.2006.09.021; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Strehlow R, 1976, SCIENCE, V2, P27; Stuhmiller J, 2001, CONVENTIONAL WARFARE, P241; Stuhmiller JH, 1997, TOXICOLOGY, V121, P91, DOI 10.1016/S0300-483X(97)03658-5; SUNESON A, 1990, J TRAUMA, V30, P295, DOI 10.1097/00005373-199003000-00007; Suneson A, 2000, MIL MED, V165, P119, DOI 10.1093/milmed/165.2.119; Sylvia FR, 2001, MIL MED, V166, P918, DOI 10.1093/milmed/166.10.918; Tolifree R, 1834, BALTIMORE MED SURG J, VII, P57; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xydakis MS, 2007, NEW ENGL J MED, V357, P830, DOI 10.1056/NEJMc076071; Yilmaz S, 2007, AM J EMERG MED, V25, P97, DOI 10.1016/j.ajem.2006.04.014; Zenin V, 1963, VZRYVNOE DELO, V52, P1; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	63	23	26	0	0	FUTURE MEDICINE LTD	LONDON	UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3 1QB, ENGLAND	1479-6708	1748-6971		FUTUR NEUROL	Futur. Neurol.	MAY	2008	3	3					243	250		10.2217/14796708.3.3.243			8	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V5K2P	WOS:000219684200008					2022-02-06	
J	Morris, S; Ridley, S; Lecky, FE; Munro, V; Christensen, MC				Morris, S.; Ridley, S.; Lecky, F. E.; Munro, V.; Christensen, M. C.			Determinants of hospital costs associated with traumatic brain injury in England and Wales	ANAESTHESIA			English	Article; Proceedings Paper	Meeting of the European-Association-for-Trauma-and-Emergency-Surgery/European-Trauma-Society Congress	MAY, 2007	Graz, AUSTRIA	European Assoc Trauma & Emergency Surg, European Trauma Soc			HEAD-INJURY; CARE; PREDICTION; MODERATE; OUTCOMES; EUROPE	Using data from the Trauma Audit Research Network, we investigated the costs of acute care in patients >= 18 years of age hospitalised for traumatic brain injury between January 2000 and December 2005 in England and Wales. Traumatic brain injury patients were defined and stratified using the Abbreviated Injury Scale. A total of 6484 traumatic brain injury patients were identified; 22.3% had an Abbreviated Injury Scale score of three, 38.0% of four and 39.7% of five. Median age (IQR) was 42 years (28-59) and 76.7% were men. Primary cause of injury was motor vehicle collisions (42.4%) followed by falls (38.0%). In total 23.7% of the patients died before discharge. Hospitalisation costs averaged 15 pound 462 (SD 16 pound 844). Costs varied significantly by age, Glasgow Coma Score, Injury Severity Score, coexisting injuries of the thorax, spine and lower limb, hospital mortality, availability of neurosurgical services, and specialty of attendants seen in the Accident and Emergency department.	[Morris, S.] Brunel Univ, Hlth Econ Res Grp, Uxbridge UB8 3PH, Middx, England; [Ridley, S.] Glan Clwyd Gen Hosp, Rhyl LL18 5UJ, Denbigh, Wales; [Lecky, F. E.] Univ Manchester, Salford M6 8HD, Lancs, England; [Munro, V.] Novo Nordisk Ltd, Crawley RH11 9RT, W Sussex, England; [Christensen, M. C.] Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark		Morris, S (corresponding author), Brunel Univ, Hlth Econ Res Grp, Uxbridge UB8 3PH, Middx, England.	stephen.morris@brunel.ac.uk		Morris, Stephen/0000-0002-5828-3563			Berg J, 2005, EUR J NEUROL, V12, P85, DOI 10.1111/j.1468-1331.2005.01200.x; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; Bouamra O, 2006, J TRAUMA, V61, P701, DOI 10.1097/01.ta.0000197175.91116.10; Brell M, 2001, NEUROCIRUGIA, V12, P105; Department of Health, 2005, NHS REF COSTS 2004 A; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Firsching R, 2001, WORLD J SURG, V25, P1221; Hyam JA, 2006, CRIT CARE, V10, DOI 10.1186/cc5066; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; Lecky FE, 2002, EMERG MED J, V19, P520, DOI 10.1136/emj.19.6.520; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Morris S, 2007, ANAESTHESIA, V62, P43, DOI 10.1111/j.1365-2044.2006.04896.x; *NAT I HLTH CLIN E, 2004, TECHN APPR GUID, V83, P13; National Institute for Health and Clinical Excellence, 2003, HEAD INJ TRIAG ASS I; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; *ROYAL COLL SURG, 1999, REP WORK PART MAN PA; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; [No title captured]	18	23	23	0	10	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	0003-2409			ANAESTHESIA	Anaesthesia	MAY	2008	63	5					499	508		10.1111/j.1365-2044.2007.05432.x			10	Anesthesiology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	287PB	WOS:000254927900009	18412648	Bronze			2022-02-06	
J	Stylianos, S; Ford, HR				Stylianos, Steven; Ford, Henri R.			Outcomes in pediatric trauma care	SEMINARS IN PEDIATRIC SURGERY			English	Article						Pediatric trauma; Processes of care; Quality	EVIDENCE-BASED GUIDELINES; BLUNT SPLENIC INJURIES; NONOPERATIVE MANAGEMENT; PRACTICE PATTERNS; ISOLATED SPLEEN; CHILDREN; ADULT; SURGEONS; CENTERS; FRACTURES	Variation in clinical practice patterns has attracted the attention of specialty organizations, payers, government health agencies, and the public. Such variation raises concerns about efficacy and cost relative to the care provided. Consequently, the establishment of national benchmarks has become an increasing priority in trauma care as well as elsewhere in the health sector. Comparing treatment of pediatric injury by hospital type or physician expertise has often created more controversy than conformity. Three key components that help define quality of care include infrastructure, process, and outcome. This report will highlight outcomes studies in pediatric trauma care, often comparing outcomes by physician and hospital expertise. We will discuss pediatric trauma mortality and outcomes in abdominal, closed head, and orthopedic injuries with an emphasis on functional outcomes. Much of the data are derived from large regional and national databases, which are increasingly available and useful in the analysis of specific aspects of our health care delivery system. (C) 2008 Elsevier Inc. All rights reserved.	[Stylianos, Steven] Miami Childrens Hosp, Dept Pediat Surg, Miami, FL 33155 USA; [Ford, Henri R.] Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles, Dept Surg, Los Angeles, CA 90033 USA		Stylianos, S (corresponding author), Miami Childrens Hosp, Dept Pediat Surg, 3200 SW 60th Court,Suite 201, Miami, FL 33155 USA.	steven.stylianos@mch.com			Department of Health and Human Services, Maternal and Child Health Bureau [HO3MC0006]	Dr. Stylianos was supported in part by Grant #HO3MC0006 from the Department of Health and Human Services, Maternal and Child Health Bureau.	Birkmeyer JD, 1998, SURGERY, V124, P917, DOI 10.1067/msy.1998.90268; Bowman SM, 2005, JAMA-J AM MED ASSOC, V294, P2611, DOI 10.1001/jama.294.20.2611; DAMELIO LF, 1995, AM SURGEON, V61, P968; Davis DH, 2005, PEDIATRICS, V115, P89, DOI 10.1542/peds.2004-0508; Densmore JC, 2006, J PEDIATR SURG, V41, P92, DOI 10.1016/j.jpedsurg.2005.10.013; Farrell Louise Szypulski, 2004, Pediatr Crit Care Med, V5, P5, DOI 10.1097/01.PCC.0000102223.77194.D7; Figaji AA, 2006, SAMJ S AFR MED J, V96, P969; FORTUNE JB, 1992, J TRAUMA, V33, P130, DOI 10.1097/00005373-199207000-00024; Frumiento C, 2000, J PEDIATR SURG, V35, P985, DOI 10.1053/jpsu.2000.6948; Hall JR, 1996, J PEDIATR SURG, V31, P72, DOI 10.1016/S0022-3468(96)90322-X; Heyworth BE, 2004, J PEDIATR ORTHOPED, V24, P455, DOI 10.1097/01241398-200409000-00001; Holmes JH, 2005, J TRAUMA, V59, P1309, DOI 10.1097/01.ta.0000197366.38404.79; Jacobs IA, 2001, AM SURGEON, V67, P149; KELLER MS, 1995, J PEDIATR SURG, V30, P221, DOI 10.1016/0022-3468(95)90564-2; KNUDSON MM, 1992, J TRAUMA, V32, P729, DOI 10.1097/00005373-199206000-00009; Mooney DP, 2005, J TRAUMA, V58, P108, DOI 10.1097/01.TA.0000153746.76095.03; Mooney DP, 2004, J TRAUMA, V56, P328, DOI 10.1097/01.TA.0000053737.16542.FB; Mooney DP, 1998, J PEDIATR SURG, V33, P1076, DOI 10.1016/S0022-3468(98)90534-6; Myers JG, 2000, J TRAUMA, V48, P801, DOI 10.1097/00005373-200005000-00002; Osler TM, 2001, J TRAUMA, V50, P96, DOI 10.1097/00005373-200101000-00017; Potoka DA, 2001, J TRAUMA, V51, P824, DOI 10.1097/00005373-200111000-00002; Potoka DA, 2000, J TRAUMA, V49, P237, DOI 10.1097/00005373-200008000-00009; RHODES M, 1993, J TRAUMA, V35, P384, DOI 10.1097/00005373-199309000-00009; Segui-Gomez M, 2003, J PEDIATR SURG, V38, P1162, DOI 10.1016/S0022-3468(03)00262-8; SIMS CA, BLUNT SOLID IN PRESS; Smith JT, 1999, J PEDIATR ORTHOPED, V19, P553, DOI 10.1097/00004694-199907000-00027; Stylianos S, 2006, J AM COLL SURGEONS, V202, P247, DOI 10.1016/j.jamcollsurg.2005.10.012; Stylianos S, 2002, J PEDIATR SURG, V37, P453, DOI 10.1053/jpsu.2002.30860; Stylianos S, 2000, J PEDIATR SURG, V35, P164, DOI 10.1016/S0022-3468(00)90003-4; Todd SR, 2004, J TRAUMA, V57, P1065, DOI 10.1097/01.TA.0000103988.66443.0E; Vitale MG, 2005, J PEDIATR ORTHOPED, V25, P581, DOI 10.1097/01.bpo.0000175112.91122.41; Winthrop AL, 2005, J TRAUMA, V58, P468, DOI 10.1097/01.TA.0000153940.23471.B7	32	23	26	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1055-8586	1532-9453		SEMIN PEDIATR SURG	Semin. Pediatr. Surg.	MAY	2008	17	2					110	115		10.1053/j.sempedsurg.2008.02.006			6	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	408CU	WOS:000263412100006	18395660				2022-02-06	
J	Foley, LM; Hitchens, TK; Melick, JA; Bayir, H; Ho, C; Kochanek, PM				Foley, Lesley M.; Hitchens, T. Kevin; Melick, John A.; Bayir, Huelya; Ho, Chien; Kochanek, Patrick M.			Effect of inducible nitric oxide synthase on cerebral blood flow after experimental traumatic brain injury in mice	JOURNAL OF NEUROTRAUMA			English	Article						arterial spin labeling; head injury; iNOS; magnetic resonance imaging; perfusion	CONTROLLED CORTICAL IMPACT; SELECTIVE-INHIBITION; EXPRESSION; PERFUSION; DEFICIENT; NO; NEUROPROTECTION; NEUROGENESIS; ANGIOGENESIS; ATTENUATION	Inducible nitric oxide synthase (iNOS) has been suggested to play a complex role in the response to central nervous system insults such as traumatic brain injury (TBI) and cerebral ischemia. In the current study, we quantified maps of regional cerebral blood flow (CBF) using an arterial spin-labeling magnetic resonance imaging (MRI) technique, at 24 and 72 h after experimental TBI in iNOS knockout (KO) and wild-type (WT) mice. Our hypothesis was that iNOS would contribute to the level of CBF at 72 h after experimental TBI in mice. Comparing anatomical brain regions of interest (ROIs) at 24-h post controlled cortical impact (CCI), there were significant reductions in CBF in the hemisphere, cortex, and contusion-rich area of the cortex of injured animals versus naive, regardless of genotype. Regional assessment of CBF at 72 h after injury demonstrated that recovery of CBF was reduced in the ipsilateral hippocampus, thalamus, and amygdala/piriform cortex in iNOS KO versus WT mice by 26%, 15%, and 21%, respectively; this attenuated recovery was restricted to structures outside the contusion. These regions with reduced CBF in iNOS KO mice represented ROIs where CBF in the WT was either numerically or statistically greater than that seen in respective WT naive, suggesting a contribution of iNOS to delayed posttraumatic hyperemia. However, pixel analysis denoted that the contribution of iNOS to CBF at 72 h was not limited to hyperemia flows. In conclusion, iNOS plays a role in the recovery of CBF after CCI in mice. Questions remain if this effect represents a homeostatic component of CBF recovery, pathologic vasodilatation linked to inflammation, or NO-mediated facilitation of angiogenesis.	[Hitchens, T. Kevin; Ho, Chien] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Foley, Lesley M.; Hitchens, T. Kevin; Ho, Chien] Carnegie Mellon Univ, Pittsburgh NMR Ctr Biomed Res, Pittsburgh, PA 15213 USA; [Melick, John A.; Bayir, Huelya; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Crit Care Med, Pittsburgh, PA 15260 USA		Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Crit Care Med, 3434 5th Ave, Pittsburgh, PA 15260 USA.	kochanekpm@ccm.upmc.edu	Kochanek, Patrick M/D-2371-2015; Ho, Chien/O-6112-2016	Kochanek, Patrick M/0000-0002-2627-913X; Ho, Chien/0000-0002-4094-9232	NIBIB NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41 EB-001977] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 30318] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB001977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS030318, P50NS030318, P20NS030318] Funding Source: NIH RePORTER		ABRAMOFF MD, 2005, J BIOPHOTONICS INT, V11, P36; Bayir H, 2005, J CEREBR BLOOD F MET, V25, P673, DOI 10.1038/sj.jcbfm.9600068; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; Cullis ER, 2006, MICROVASC RES, V71, P76, DOI 10.1016/j.mvr.2006.01.004; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; Foley LM, 2005, MAGN RESON MED, V54, P798, DOI 10.1002/mrm.20621; Gahm C, 2000, NEUROSURGERY, V46, P169, DOI 10.1093/neurosurgery/46.1.169; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P166, DOI 10.1097/00004647-200302000-00004; Hendrich KS, 1999, MAGN RESON MED, V42, P673, DOI 10.1002/(SICI)1522-2594(199910)42:4<673::AID-MRM8>3.0.CO;2-B; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; IADECOLA C, 1995, AM J PHYSIOL-REG I, V268, pR286, DOI 10.1152/ajpregu.1995.268.1.R286; Iadecola C, 1997, J NEUROSCI, V17, P9157; Iadecola C, 1996, STROKE, V27, P1373, DOI 10.1161/01.STR.27.8.1373; Jafarian-Tehrani M, 2005, NITRIC OXIDE-BIOL CH, V12, P61, DOI 10.1016/j.niox.2004.12.001; Kapinya KJ, 2002, STROKE, V33, P1889, DOI 10.1161/01.STR.0000020092.41820.58; Kawano T, 2007, J CEREBR BLOOD F MET, V27, P1453, DOI 10.1038/sj.jcbfm.9600449; Louin G, 2006, NEUROPHARMACOLOGY, V50, P182, DOI 10.1016/j.neuropharm.2005.08.020; Okamoto H, 1998, STROKE, V29, P1209, DOI 10.1161/01.STR.29.6.1209; Pearse DD, 2003, J NEUROPATH EXP NEUR, V62, P1096, DOI 10.1093/jnen/62.11.1096; Petrov T, 2000, ACTA NEUROPATHOL, V100, P196, DOI 10.1007/s004019900167; Pierce ET., 1971, ATLAS MOUSE BRAIN SP; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Steiner J, 2004, NITRIC OXIDE-BIOL CH, V10, P162, DOI 10.1016/j.niox.2004.03.005; Stoffel M, 2000, ACTA NEUROCHIR SUPPL, V76, P357; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Whalen MJ, 1999, J NEUROTRAUM, V16, P299, DOI 10.1089/neu.1999.16.299; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Willmot M, 2005, FREE RADICAL BIO MED, V39, P412, DOI 10.1016/j.freeradbiomed.2005.03.028; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59; ZHANG WG, 1995, MAGNET RESON MED, V33, P370, DOI 10.1002/mrm.1910330310; ZHANG WG, 1993, MAGNET RESON MED, V29, P416, DOI 10.1002/mrm.1910290323; Zhao P, 2004, ANESTHESIOLOGY, V101, P695, DOI 10.1097/00000542-200409000-00018; Zhu DY, 2003, J NEUROSCI, V23, P223	38	23	25	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2008	25	4					299	310		10.1089/neu.2007.0471			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	282PL	WOS:000254579600003	18373480	Green Submitted			2022-02-06	
J	Vilela, MD				Vilela, Marcelo Duarte			Delayed paradoxical herniation after a decompressive craniectomy: case report	SURGICAL NEUROLOGY			English	Article						lumbar puncture; decompressive craniectomy; paradoxical herniation; blood patch; cranioplasty	TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; INTRACRANIAL HYPOTENSION; PUNCTURE; DRAINAGE; SURGERY	Background: Paradoxical herniation can occur as a complication of lumbar puncture in patients who had a decompressive craniectomy. The supposed mechanism is the development of a negative pressure gradient that allows the brain to shift toward the infratentorial space with subsequent herniation. Trendelenburg position plus early cranioplasty has been the suggested treatment to eliminate the gradient. Case Description: A 53-year-old woman had a decompressive hemicraniectomy for SAH-related swelling. A lumbar puncture was performed on postoperative day 5 to rule out infection. She remained neurologically stable until 6 weeks later, when she deteriorated because of a paradoxical herniation. Head positioning and cranioplasty were only temporarily helpful. She developed a second episode of decline a few days later due to an extraaxial CSF collection. A lumbar blood patch plus drainage of the collection successfully allowed full neurologic recovery. Conclusions: Cranioplasty and head positioning alone might not be sufficient to eliminate the negative pressure gradient. A blood patch should be part of the management of paradoxical herniation. (c) 2008 Elsevier Inc. All rights reserved.	Univ Washington, Harborview Med Ctr, Dept Neurol Surg, Seattle, WA 98104 USA		Vilela, MD (corresponding author), Univ Washington, Harborview Med Ctr, Dept Neurol Surg, 325 9Th Ave, Seattle, WA 98104 USA.	mdvilela@u.washington.edu					Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; ANDRIEU JM, 1995, IMMUNOL TODAY, V16, P5, DOI 10.1016/0167-5699(95)80062-X; Binder DK, 2002, NEUROSURGERY, V51, P830, DOI 10.1227/01.NEU.0000024286.95876.2F; Bloch J, 2003, J NEUROL NEUROSUR PS, V74, P992, DOI 10.1136/jnnp.74.7.992; Carter BS, 1997, NEUROSURGERY, V40, P1168, DOI 10.1097/00006123-199706000-00010; Ebel H, 1999, CHILD NERV SYST, V15, P84, DOI 10.1007/s003810050337; Harscher S, 2006, ACTA NEUROCHIR, V148, P31, DOI 10.1007/s00701-005-0617-0; Heuer GG, 2004, J NEUROSURG, V101, P408, DOI 10.3171/jns.2004.101.3.0408; Klimo P, 2004, J NEUROSURG, V100, P215, DOI 10.3171/jns.2004.100.2.0215; Komotar RJ, 2005, NEUROSURGERY, V57, P286, DOI 10.1227/01.NEU.0000166661.96546.33; Mori K, 2004, SURG NEUROL, V62, P420, DOI 10.1016/j.surneu.2003.12.017; OVELESE AA, 2005, NEUROSURGERY, V57, P594; Rutigliano D, 2006, J PEDIATR SURG, V41, P83, DOI 10.1016/j.jpedsurg.2005.10.010; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Samadani U, 2003, NEUROSURGERY, V52, P148, DOI 10.1097/00006123-200301000-00019; Schievink WI, 2006, JAMA-J AM MED ASSOC, V295, P2286, DOI 10.1001/jama.295.19.2286; Schwab S, 1998, NERVENARZT, V69, P896, DOI 10.1007/s001150050360; Smith ER, 2002, NEUROSURGERY, V51, P117, DOI 10.1097/00006123-200207000-00018; SNOW RB, 1991, NEUROSURGERY, V28, P880, DOI 10.1227/00006123-199106000-00016; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Vakharia SB, 1997, ANESTH ANALG, V84, P585, DOI 10.1097/00000539-199703000-00022; van Crevel H, 2002, J NEUROL, V249, P129, DOI 10.1007/PL00007855	22	23	27	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0090-3019			SURG NEUROL	Surg. Neurol.	MAR	2008	69	3					293	296		10.1016/j.surneu.2007.01.027			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	275SJ	WOS:000254091600016	17586009				2022-02-06	
J	Yen, TS; Liau, CC; Chen, YS; Chao, A				Yen, Ting-Shan; Liau, Chun-Chih; Chen, Yih-Sharng; Chao, Anne			Extracorporeal membrane oxygenation resuscitation for traumatic brain injury after decompressive craniotomy	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						traumatic brain injury; shock; resuscitation; extracorporeal membrane oxygenation; acute respiratory distress syndrome	RESPIRATORY-DISTRESS-SYNDROME	Acute cardiopulmonary failure in patients with increased intracranial pressure is a significant management challenge to physicians. We report on a 21-year-old patient with traumatic brain injury who developed intractable hypoxemia and hypotension after undergoing a decompressive craniotomy. Venoarterial extracorporeal membrane oxygenation was initiated to resuscitate the patient. Extracorporeal membrane oxygenation is considered contraindicated in patients with intracranial bleeding because systemic heparin is needed during the support of extracorporeal membrane oxygenation. We describe our successful experience in tackling this dilemma. (c) 2007 Elsevier B.V. All rights reserved.	[Yen, Ting-Shan; Chao, Anne] Natl Taiwan Univ Hosp, Dept Anesthesiol, Taipei 100, Taiwan; [Liau, Chun-Chih] Taipei Hosp, Dept Hlth Execut Yuan, Dept Neurosurg, Taipei 242, Taiwan; [Chen, Yih-Sharng] Natl Taiwan Univ Hosp, Dept Cardiovasc Surg, Taipei 100, Taiwan		Chao, A (corresponding author), Natl Taiwan Univ Hosp, Dept Anesthesiol, 7 Chung Shan S Rd, Taipei 100, Taiwan.	chaoanne@yahoo.com		Chen, Yih-Sharng/0000-0003-3846-8162; Chao, Anne/0000-0002-7170-3817			Bein T, 2005, J TRAUMA, V58, P1294, DOI 10.1097/01.TA.0000173275.06947.5C; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Etemadrezaie H, 2007, CLIN NEUROL NEUROSUR, V109, P166, DOI 10.1016/j.clineuro.2006.09.001; Reynolds HN, 1999, PERFUSION-UK, V14, P489, DOI 10.1177/026765919901400612; Senunas LE, 1997, CLIN ORTHOP RELAT R, P32	7	23	25	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	MAR	2008	110	3					295	297		10.1016/j.clineuro.2007.10.017			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	285PQ	WOS:000254789100018	18068892				2022-02-06	
J	Wang, VY; Manley, G				Wang, Vincent Y.; Manley, Geoffrey			Recognition of paroxysmal autonomic instability with dystonia (PAID) in a patient with traumatic brain injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							DIENCEPHALIC SEIZURES; DYSAUTONOMIA; HYPERTHERMIA		[Wang, Vincent Y.; Manley, Geoffrey] Univ Calif San Francisco, Brain & Spinal Injury Ctr, Dept Neurol Surg, San Francisco, CA 94143 USA		Manley, G (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, 1001 Potrero Ave, San Francisco, CA 94110 USA.	manleyg@neurosurg.ucsf.edu					Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; BULLARD DE, 1987, ANN NEUROL, V21, P609, DOI 10.1002/ana.410210617; Cuny E, 2001, BRAIN INJURY, V15, P917, DOI 10.1080/02699050110065277; MEYTHALER JM, 1994, ARCH PHYS MED REHAB, V75, P816; PRANZATELLI MR, 1991, J CHILD NEUROL, V6, P115, DOI 10.1177/088307389100600204; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X	9	23	24	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	FEB	2008	64	2					500	502		10.1097/TA.0b013e31804a5738			3	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	264KV	WOS:000253287100050	18301221				2022-02-06	
J	Cremer, OL				Cremer, O. L.			Does ICP monitoring make a difference in neurocritical care?	EUROPEAN JOURNAL OF ANAESTHESIOLOGY			English	Article; Proceedings Paper	Brain Annual Meeting	MAY 09-12, 2007	Brescia, ITALY			head injury; intracranial pressure monitoring; blood pressure; intracerebral; outcome	SEVERE HEAD-INJURY; TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE MONITORS; CEREBRAL PERFUSION-PRESSURE; INTENSIVE-CARE; HEMORRHAGIC COMPLICATIONS; NEUROSURGICAL CENTERS; PULMONARY-ARTERY; CLINICAL-TRIALS; MANAGEMENT	Raised intracranial pressure and low cerebral perfusion pressure are associated with ischaemia and poor outcome after brain injury. Therefore, many management protocols target these variables. However, there are no randomized controlled trials that have demonstrated the effectiveness of intracranial pressure-guided care in severely head-injured patients. Observational studies of such therapy have yielded inconsistent results, ranging from decreased mortality to no effect or increased morbidity or mortality. A recent cohort study supports the notion that the possible benefits of intracranial pressure monitoring after traumatic brain injury are small - if present - and would exceed a number needed for the treatment of 16. Furthermore, intracranial pressure monitoring and aggressive management of intracranial pressure and cerebral perfusion pressure have been associated with increased lengths of stay in the neurocritical care unit, conceivable costs and possibly an increased rate of complications. Against this background, there is sufficient clinical equipoise to warrant an adequately powered randomized controlled trial to compare intracranial pressure-guided care with supportive critical care without intracranial pressure monitoring in patients with severe traumatic brain injury. However, the realization of such a trial is likely to be problematic for a number of reasons, not least of which them firmly held biases of many clinicians.	Univ Utrecht Hosp, Dept Intens Care, NL-3508 GA Utrecht, Netherlands		Cremer, OL (corresponding author), Univ Utrecht Hosp, Dept Intens Care, POB 85500, NL-3508 GA Utrecht, Netherlands.	o.l.cremer@umcutrecht.nl	Cremer, Olaf L/G-3855-2016	Cremer, Olaf L/0000-0003-4264-1108			AUCOIN PJ, 1986, AM J MED, V80, P369, DOI 10.1016/0002-9343(86)90708-4; Bekar A, 1998, NEUROSURG REV, V21, P254, DOI 10.1007/BF01105781; Blaha M, 2005, J NEUROL NEUROSUR PS, V76, P147, DOI 10.1136/jnnp.2003.030817; Blaha M, 2003, PEDIATR NEUROSURG, V39, P27, DOI 10.1159/000070877; *BRAIN T FDN, 2000, MAN PROGN SEV TRAUM; *BRAIN TRAU FDN, GUID MAN SEV TRAUM I; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Cremer OL, 2001, LANCET, V357, P117, DOI 10.1016/S0140-6736(00)03547-9; Cremer OL, 2006, J TRAUMA, V61, P1484, DOI 10.1097/01.ta.0000195981.63776.ba; Crockard H A, 1976, Surg Neurol, V5, P151; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; FREEMAN R, 1990, NEW ENGL J MED, V322, P624, DOI 10.1056/NEJM199003013220910; Gelabert-Gonzalez M, 2006, ACTA NEUROCHIR, V148, P435, DOI 10.1007/s00701-005-0683-3; GELPKE GJ, 1983, J NEUROSURG, V59, P745, DOI 10.3171/jns.1983.59.5.0745; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; Kornecki A, 2002, CHILD NERV SYST, V18, P375, DOI 10.1007/s00381-002-0613-0; Lane PL, 2000, CAN J SURG, V43, P442; Lee TT, 1998, ACTA NEUROCHIR, V140, P41, DOI 10.1007/s007010050055; Maas AIR, 2004, ACT NEUR S, V89, P113; Maitinez-Manas RM, 2000, J NEUROL NEUROSUR PS, V69, P82, DOI 10.1136/jnnp.69.1.82; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; McKeating EG, 1998, BRIT J NEUROSURG, V12, P7; MILLER J D, 1987, Neurological Research, V9, P193; MINDERMANN T, 1992, ACTA NEUROCHIR, V116, P60, DOI 10.1007/BF01541255; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Murphy LS, 1999, BRIT J NEUROSURG, V13, P564, DOI 10.1080/02688699943060; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Natale Renato, 2003, J Obstet Gynaecol Can, V25, P1007; Odetola FO, 2006, PEDIATRICS, V117, P1893, DOI 10.1542/peds.2005-2179; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sahjpaul R, 2000, CAN J NEUROL SCI, V27, P143; Sahuquillo J, 1999, J NEUROSURG, V90, P16, DOI 10.3171/jns.1999.90.1.0016; Sandham JD, 2003, NEW ENGL J MED, V348, P5, DOI 10.1056/NEJMoa021108; Shigemori M, 2002, NEUROL RES, V24, P41, DOI 10.1179/016164102101199521; Steiner LA, 2003, J CEREBR BLOOD F MET, V23, P1371, DOI 10.1097/01.WCB.0000090861.67713.10; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P479, DOI DOI 10.1089/NEU.2000.17.479; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vincent JL, 2005, CRIT CARE MED, V33, P1392, DOI 10.1097/01.CCM.0000166890.93559.2D; Wheeler AP, 2006, NEW ENGL J MED, V354, P2213; Wilkins IA, 2001, ANAESTHESIA, V56, P350, DOI 10.1046/j.1365-2044.2001.01708.x	50	23	23	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0265-0215	1365-2346		EUR J ANAESTH	Eur. J. Anaesth.		2008	25			42			87	93		10.1017/S0265021507003237			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Anesthesiology	283AY	WOS:000254610100015	18289423				2022-02-06	
